data_1p7m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p7m _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' NE2' ' A' ' 175' ' ' HIS . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.658 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.594 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.696 HE22 ' CG1' ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.578 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' CZ2' ' CZ ' ' A' ' 16' ' ' TYR . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.696 ' CG1' HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 53.3 m-85 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.946 0.311 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 84' ' ' GLY . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 92' ' ' ILE . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' OG ' ' A' ' 118' ' ' SER . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 115' ' ' PHE . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.561 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.573 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.657 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.657 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.437 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.547 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.631 0.729 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.2 m -53.08 144.77 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 0.0 109.618 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.14 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.525 -0.734 . . . . 0.0 112.13 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.686 ' CZ2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -83.7 -1.03 53.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.58 -1.541 . . . . 0.0 109.478 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -84.93 -42.37 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 108.823 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.4 m -78.66 5.09 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.78 -108.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.632 -0.668 . . . . 0.0 109.775 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.35 143.61 93.69 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.806 . . . . 0.0 109.838 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 -28.29 58.25 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.083 1.855 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.32 -36.18 82.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.894 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -55.41 -42.11 73.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.039 . . . . 0.0 110.603 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.85 -40.82 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 110.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.682 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.19 -50.35 64.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.678 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -66.58 -39.78 88.6 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.696 -1.252 . . . . 0.0 110.164 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -69.34 -50.33 47.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 112.523 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -75.14 -5.98 47.19 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.941 -1.099 . . . . 0.0 110.567 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -94.9 -35.48 12.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.832 -1.168 . . . . 0.0 112.294 -177.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 22' ' ' GLY . 13.0 pt-20 -174.42 48.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.374 -1.454 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' CH2' ' CZ2' ' A' ' 6' ' ' TRP . 20.5 t-105 -70.87 66.76 0.37 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 60.72 52.81 50.15 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.617 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.2 t -108.59 -42.29 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.36 -1.082 . . . . 0.0 109.13 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.7 Cg_endo -95.94 150.55 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.558 2.839 . . . . 0.0 112.649 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -68.27 141.63 55.82 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -99.83 147.82 25.09 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.06 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 90.9 m-20 -80.88 167.91 19.35 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 m -59.87 -35.07 74.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -67.15 -39.96 86.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 0.0 112.461 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -59.04 -38.92 80.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 0.0 110.309 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 6.5 mp -58.62 -36.94 74.84 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.686 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -63.26 -48.12 79.52 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -69.82 -30.97 68.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.783 -1.198 . . . . 0.0 109.473 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.22 -48.56 56.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.791 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.43 -28.6 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 109.476 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.6 -51.32 29.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.956 -1.09 . . . . 0.0 109.418 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.85 -37.49 73.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 108.98 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 tp10 -61.65 -37.06 82.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.4 -35.33 90.84 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 42' ' ' ALA . 86.9 mt-30 -62.06 -31.48 71.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.459 -1.024 . . . . 0.0 110.995 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.594 HE22 ' CB ' ' A' ' 164' ' ' SER . 5.4 pt20 -61.26 6.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.837 -1.165 . . . . 0.0 110.53 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.59 123.3 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.3 -33.78 0.16 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 73.2 mt -94.44 155.99 16.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -1.213 . . . . 0.0 110.439 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.3 m -73.18 156.62 38.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -59.85 -32.42 70.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.42 -0.8 . . . . 0.0 109.725 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -35.82 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -57.6 -37.37 73.12 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 53' ' ' ARG . 85.1 t -66.69 -36.81 78.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.885 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.97 -47.64 84.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.911 -1.118 . . . . 0.0 109.806 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.49 -49.68 74.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.818 -1.176 . . . . 0.0 108.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.586 ' HZ1' ' CB ' ' A' ' 52' ' ' LYS . 8.9 mtmp? -65.72 -26.19 67.64 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.253 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 49' ' ' VAL . 38.1 ttm180 -55.12 -42.49 73.03 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.49 -40.85 76.78 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.093 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.769 ' N ' HD21 ' A' ' 55' ' ' ASN . 0.8 OUTLIER -64.34 -34.86 79.11 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HH ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -60.95 -39.25 88.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -59.66 -36.43 76.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.398 -0.814 . . . . 0.0 109.054 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.79 89.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.838 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.9 m -75.0 -44.95 45.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.64 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.22 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 N--CA 1.491 1.374 0 CA-C-O 121.245 0.435 . . . . 0.0 112.933 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.94 -36.33 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 0.0 110.236 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -47.07 83.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 111.271 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 m -67.66 -33.46 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.517 -1.364 . . . . 0.0 109.326 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.28 -20.58 65.59 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.01 -9.14 40.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.0 mmm -82.75 119.68 24.64 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.57 173.81 7.43 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.347 -0.846 . . . . 0.0 110.449 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.61 -29.85 39.71 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.52 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -60.96 -48.46 81.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.987 -1.07 . . . . 0.0 108.177 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.16 -41.52 98.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.7 -42.36 76.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.682 -0.636 . . . . 0.0 109.983 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -58.18 -39.18 78.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 108.661 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 35.0 ttm-85 -61.74 -40.29 94.58 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 0.0 109.294 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 mt -65.43 -33.25 75.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.608 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.18 -36.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 108.404 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -106.49 -2.93 21.44 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.829 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.593 ' C ' ' H ' ' A' ' 84' ' ' GLY . 46.4 t0 -78.38 106.71 10.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.15 -1.594 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 67.56 -19.81 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.575 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 71.5 36.03 62.79 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.4 pt -29.28 -94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 122.127 -0.631 . . . . 0.0 110.544 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 8.3 tt -170.58 -37.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.128 -0.982 . . . . 0.0 109.07 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 17.9 mmt180 -72.03 156.02 39.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.802 0.81 . . . . 0.0 110.595 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -111.01 178.87 4.21 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 10.3 ptp180 -56.7 -43.8 80.9 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 110.58 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -56.38 -57.95 16.75 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.342 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HZ1' ' CB ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -63.46 -43.25 97.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.071 -1.252 . . . . 0.0 110.161 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 92' ' ' ILE . 19.4 mm -57.64 -52.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -50.91 -32.64 21.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.843 -1.161 . . . . 0.0 108.881 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.02 96.45 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -0.925 . . . . 0.0 108.563 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.42 ' CD1' ' HH ' ' A' ' 56' ' ' TYR . 80.2 mt -65.66 -42.23 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.388 -0.82 . . . . 0.0 109.121 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.02 -44.24 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.73 92.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.67 -37.85 74.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -1.11 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.14 76.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 109.197 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -56.67 -38.19 71.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.92 -30.61 70.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.94 -44.0 90.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.0 -37.16 83.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.028 -1.045 . . . . 0.0 109.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.09 -38.63 88.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.0 108.704 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -70.13 -40.35 74.9 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.641 0.734 . . . . 0.0 109.321 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.03 -23.74 65.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -91.93 -6.18 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.26 26.29 74.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -118.07 108.26 42.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -52.79 145.64 38.92 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.985 1.79 . . . . 0.0 112.381 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.618 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -59.26 -46.88 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.209 1.004 . . . . 0.0 109.372 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.82 68.33 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 109.846 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.81 -47.92 82.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.97 -1.081 . . . . 0.0 111.806 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.618 ' CD2' ' O ' ' A' ' 112' ' ' PHE . 12.5 p90 -71.62 -43.62 65.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.804 -1.185 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.509 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 1.9 p -65.16 -54.45 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.358 -1.464 . . . . 0.0 110.129 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.419 ' H ' HG12 ' A' ' 116' ' ' VAL . 53.7 m95 -55.14 -23.45 21.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.05 -1.032 . . . . 0.0 108.25 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.72 -29.58 70.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 108.966 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -86.94 9.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.025 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.1 35.21 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 44.2 35.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.748 . . . . 0.0 110.373 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -146.97 147.52 29.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.62 142.05 62.86 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.462 2.108 . . . . 0.0 112.023 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -113.0 132.06 55.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 108.814 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.551 ' C ' HE21 ' A' ' 125' ' ' GLN . 34.6 ttp -89.55 127.35 35.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.93 -1.107 . . . . 0.0 109.415 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -96.55 130.12 43.79 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 109.29 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -91.92 27.31 2.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.194 -0.941 . . . . 0.0 110.754 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.449 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -64.61 142.56 58.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.728 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.6 p -109.02 -35.46 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.68 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.7 p -124.96 162.34 24.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.474 -0.766 . . . . 0.0 109.609 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.8 -36.28 71.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 109.177 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -79.27 0.14 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 108.992 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -103.01 8.4 38.92 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -93.58 126.0 51.64 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -70.91 139.74 36.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.489 1.459 . . . . 0.0 112.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -111.73 5.03 18.92 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -145.72 86.91 1.75 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.682 . . . . 0.0 109.304 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.17 162.77 18.63 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.94 -41.14 77.47 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.25 1.3 . . . . 0.0 111.8 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.95 74.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 108.585 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -64.32 -44.71 90.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.501 -0.749 . . . . 0.0 109.643 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.95 -37.61 86.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.21 -31.98 64.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.54 -48.16 73.4 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.369 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -57.41 -42.27 81.98 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.63 -1.293 . . . . 0.0 108.493 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -65.0 -42.28 94.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.494 -0.754 . . . . 0.0 109.887 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.589 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.4 -47.9 68.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.48 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 1.8 mm? -63.48 -40.23 96.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.21 -0.931 . . . . 0.0 109.157 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -60.28 -39.11 85.7 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.959 -1.088 . . . . 0.0 110.123 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -71.42 -35.74 71.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 111.304 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.589 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.64 -1.87 10.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.775 -1.203 . . . . 0.0 109.653 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.6 17.8 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -93.49 111.33 22.97 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.746 -1.182 . . . . 0.0 107.816 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -97.35 174.07 6.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 0.0 110.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CB ' ' HZ1' ' A' ' 91' ' ' LYS . 91.3 m-85 61.71 61.51 1.43 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.193 0.997 . . . . 0.0 109.092 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.0 m -137.13 41.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -37.44 160.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.586 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 28.0 m -57.78 -30.02 65.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.57 -0.959 . . . . 0.0 109.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.463 ' O ' ' OG ' ' A' ' 164' ' ' SER . 97.0 m -77.73 -34.91 52.4 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.01 -37.56 77.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.568 . . . . 0.0 110.072 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.586 ' SG ' ' O ' ' A' ' 159' ' ' THR . 32.0 p -67.27 -47.2 71.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.176 -0.952 . . . . 0.0 109.045 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.27 -42.21 84.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.069 . . . . 0.0 109.888 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.594 ' CB ' HE22 ' A' ' 41' ' ' GLN . 20.8 m -58.79 -42.46 89.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -38.3 81.4 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.203 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 19.2 mtm -63.46 -36.14 82.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 110.869 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' A' ' 164' ' ' SER . 35.3 mt-30 -57.57 -44.29 85.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.926 -1.109 . . . . 0.0 110.782 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.84 -17.85 27.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.995 -1.065 . . . . 0.0 110.334 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.37 -26.06 68.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.486 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.53 50.09 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.53 -37.3 85.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.633 -0.922 . . . . 0.0 110.248 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.8 138.27 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 109.555 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 84.1 m-20 -121.69 135.99 54.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.544 -0.722 . . . . 0.0 110.622 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER 156.06 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.715 -0.616 . . . . 0.0 110.914 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 12.6 m170 55.88 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.126 -0.984 . . . . 0.0 108.664 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 178' ' ' GLY . 21.5 m -136.57 40.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 176' ' ' VAL . 0.4 OUTLIER 34.8 27.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.749 0.785 . . . . 0.0 109.966 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -162.4 34.66 0.34 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 17.7 t . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.447 -1.031 . . . . 0.0 109.438 -179.726 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 3' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.07 159.31 22.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.546 -0.721 . . . . 0.0 109.988 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -44.57 97.99 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.273 -0.892 . . . . 0.0 111.214 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.607 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -83.5 -0.45 50.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.76 -1.435 . . . . 0.0 109.493 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.53 -48.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.1 m -77.79 -0.59 27.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -81.46 -49.0 11.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.495 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -147.82 158.1 42.97 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 108.945 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.48 -24.52 22.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.526 2.151 . . . . 0.0 113.002 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.28 -38.53 89.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.844 -1.16 . . . . 0.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.66 -36.56 84.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.06 -44.38 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 110.41 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.683 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.71 -50.98 46.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.423 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -62.15 -37.89 86.91 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.667 -1.27 . . . . 0.0 109.48 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -73.62 -44.27 57.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.619 -0.676 . . . . 0.0 111.633 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' C ' HD21 ' A' ' 19' ' ' ASN . 64.1 m-20 -72.37 -7.74 51.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.76 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.7 OUTLIER -91.33 -72.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.767 -1.208 . . . . 0.0 111.344 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.57 81.67 1.1 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.867 -1.146 . . . . 0.0 110.892 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.607 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 16.9 t-105 -80.34 71.16 7.13 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.69 55.42 22.78 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.3 t -107.01 -39.74 0.16 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.401 -1.058 . . . . 0.0 109.545 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 83.1 Cg_endo -97.88 153.24 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.497 2.798 . . . . 0.0 112.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -66.36 148.38 51.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 169' ' ' CYS . 82.8 p -95.2 159.29 15.08 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.977 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -96.2 167.94 10.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -61.98 -37.18 83.82 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.932 -1.105 . . . . 0.0 110.664 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -71.47 -39.83 70.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 112.596 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 15.3 mmmt -56.26 -37.04 69.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.653 -1.279 . . . . 0.0 109.108 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mt -57.33 -37.59 72.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.567 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.8 -47.03 85.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.575 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -69.9 -38.87 76.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.232 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 39.9 tpp -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.54 -0.725 . . . . 0.0 111.212 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -69.55 -27.58 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -70.03 -42.3 73.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.814 -1.179 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 5.4 mp -73.89 -39.05 64.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -63.43 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.86 -38.42 59.79 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.295 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 42' ' ' ALA . 12.0 tt0 -62.62 -24.73 67.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.963 -1.316 . . . . 0.0 110.194 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 6.5 mm100 -48.27 -6.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.802 -1.186 . . . . 0.0 110.522 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -67.02 112.75 4.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.833 -1.167 . . . . 0.0 109.825 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.13 -27.11 0.2 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.691 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.575 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.1 mm? -98.16 151.14 20.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.336 . . . . 0.0 110.649 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.5 m -75.79 162.85 27.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -62.6 -38.37 89.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 0.0 110.868 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.934 -1.104 . . . . 0.0 109.127 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -63.45 -40.11 96.26 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.728 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -33.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 109.635 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.17 -45.18 75.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -42.89 90.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.482 ' CE ' HE21 ' A' ' 40' ' ' GLN . 25.0 ttpp -62.86 -33.81 76.05 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.301 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -57.61 -40.33 78.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -73.33 -47.17 44.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.075 -1.016 . . . . 0.0 111.18 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.73 HD21 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -75.77 -37.56 59.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.689 -1.257 . . . . 0.0 110.427 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.73 ' N ' HD21 ' A' ' 55' ' ' ASN . 79.0 t80 -58.74 -46.36 87.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.906 -1.121 . . . . 0.0 109.1 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.76 -31.27 71.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 108.898 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.69 38.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.148 -0.97 . . . . 0.0 111.293 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.64 -44.31 43.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.974 -1.079 . . . . 0.0 111.34 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 56' ' ' TYR . 66.5 m-85 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.96 -1.087 . . . . 0.0 110.562 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 N-CA-C 114.844 1.055 . . . . 0.0 114.844 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.78 -29.86 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 109.033 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.05 -35.64 79.21 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.61 -36.3 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.21 64.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.32 -10.39 32.88 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 93.2 mtp -74.08 109.69 7.77 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.458 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.3 pt20 -97.38 -176.17 3.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.787 -0.571 . . . . 0.0 110.017 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -59.86 -32.49 70.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.327 -0.858 . . . . 0.0 110.884 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 88.5 tt0 -59.49 -47.01 87.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.368 -1.457 . . . . 0.0 109.042 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -35.77 74.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.088 -1.008 . . . . 0.0 108.816 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -43.92 83.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.436 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -56.95 -35.7 69.39 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HG3' HH11 ' A' ' 78' ' ' ARG . 22.8 ttm-85 -59.27 -37.57 77.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.0 -33.08 73.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.665 -0.647 . . . . 0.0 112.659 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.5 m -52.0 -17.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.7 -1.25 . . . . 0.0 110.334 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -124.0 13.79 9.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.179 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.8 m-20 -96.99 104.89 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.895 -1.128 . . . . 0.0 110.559 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.84 -15.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.886 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.03 37.82 49.08 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 30.7 pt -47.86 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.567 -0.961 . . . . 0.0 110.019 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.674 ' CG2' ' H ' ' A' ' 87' ' ' ARG . 11.1 tt -55.63 -105.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.674 ' H ' ' CG2' ' A' ' 86' ' ' ILE . 13.3 tpt180 -85.03 153.5 22.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.564 -1.335 . . . . 0.0 108.262 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -120.42 -33.79 3.78 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.535 -0.728 . . . . 0.0 111.211 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -125.73 -22.8 4.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 111.431 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.24 -91.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.635 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.95 -29.19 68.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.126 -1.22 . . . . 0.0 109.934 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ILE . 12.2 mm -56.9 -56.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.765 -1.209 . . . . 0.0 109.484 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 92' ' ' ILE . 92.9 mt-30 -50.91 -35.41 32.98 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.295 -1.503 . . . . 0.0 108.015 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.0 80.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.78 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' ILE . 96.1 mt -69.24 -33.14 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 110.847 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 96' ' ' ILE . 1.2 mp -58.79 -48.71 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.729 -1.232 . . . . 0.0 108.82 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.88 -35.04 90.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -55.38 -38.66 69.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.186 -1.185 . . . . 0.0 109.574 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.72 79.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.849 -1.157 . . . . 0.0 109.362 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -62.42 -37.56 86.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.029 -1.044 . . . . 0.0 109.866 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.4 72.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 108.905 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.721 ' CE1' ' CE1' ' A' ' 112' ' ' PHE . 63.7 t80 -61.46 -44.18 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.7 mm? -61.84 -33.96 75.1 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -64.24 -38.43 91.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.882 . . . . 0.0 111.459 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.704 ' SD ' ' CG ' ' A' ' 112' ' ' PHE . 8.2 ttm -64.49 -42.76 95.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.69 -1.256 . . . . 0.0 108.757 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.95 -37.99 84.29 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.267 0.556 . . . . 0.0 109.576 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.0 -24.55 67.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -88.18 -10.9 48.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.129 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.33 27.67 73.55 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.226 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 4.8 tt0 -116.88 103.47 52.19 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.103 -1.233 . . . . 0.0 110.343 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.77 138.59 41.29 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.833 1.689 . . . . 0.0 112.011 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.721 ' CE1' ' CE1' ' A' ' 102' ' ' TYR . 65.0 m-85 -58.8 -41.78 87.55 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.9 0.857 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.33 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 110.577 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.98 -48.3 79.44 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.109 -0.994 . . . . 0.0 112.346 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.7 p90 -70.79 -43.85 67.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.663 -1.273 . . . . 0.0 110.507 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.571 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.4 p -65.41 -55.39 20.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.848 -1.157 . . . . 0.0 110.868 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' A' ' 122' ' ' HIS . 48.6 m95 -55.35 -23.07 22.08 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.198 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -75.58 -33.56 60.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.094 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -65.88 -32.5 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.037 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.52 17.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 108.994 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 123' ' ' GLN . 45.3 t30 60.13 43.85 13.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.829 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.577 ' N ' ' O ' ' A' ' 117' ' ' TRP . 11.3 t-160 41.92 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -126.46 151.28 72.5 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.604 -0.685 . . . . 0.0 109.285 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.76 153.73 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.523 2.149 . . . . 0.0 112.184 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 137.58 47.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 95.8 mmm -95.14 118.86 32.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.81 122.65 32.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.258 -0.901 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -93.44 23.1 4.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.05 139.11 48.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 109.62 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 m -100.01 -21.88 15.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 108.63 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -140.88 163.82 31.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.248 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.58 -39.53 76.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.323 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.1 p -64.22 -29.65 70.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -80.36 5.64 14.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 108.954 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 4.5 tp -83.05 129.19 62.22 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.891 . . . . 0.0 108.905 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.73 137.0 31.71 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.132 1.888 . . . . 0.0 112.248 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.5 p -105.66 0.1 26.06 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.529 -0.732 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.1 t -147.18 92.34 2.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.39 -0.819 . . . . 0.0 108.995 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.63 ' H ' ' HG ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -105.03 158.26 32.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -54.17 -40.41 82.08 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.835 1.69 . . . . 0.0 111.186 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.91 -40.48 63.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 139' ' ' THR . 67.7 p -67.81 -38.02 82.75 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.176 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.12 -41.09 95.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -0.97 . . . . 0.0 108.669 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.29 64.35 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.26 -45.5 87.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.614 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 11.6 m -62.88 -40.47 97.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.147 -0.97 . . . . 0.0 109.595 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.658 ' CG ' ' HZ2' ' A' ' 151' ' ' LYS . 27.1 ttpp -60.3 -41.67 93.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.504 -0.747 . . . . 0.0 111.111 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -46.06 66.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.814 -1.178 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.23 -36.9 82.64 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.128 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -60.6 -41.55 94.97 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.063 -1.023 . . . . 0.0 110.016 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.658 ' HZ2' ' CG ' ' A' ' 147' ' ' LYS . 22.8 mttp -80.15 -16.63 54.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.742 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.475 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -84.44 2.72 39.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.71 19.09 49.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -98.87 113.47 25.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.214 -1.168 . . . . 0.0 109.123 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -89.13 175.1 7.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.388 0.613 . . . . 0.0 110.002 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 55.13 59.31 4.08 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.701 0.762 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.0 m -135.67 35.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.336 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.0 166.06 1.06 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.2 p -58.45 -30.7 67.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -1.104 . . . . 0.0 109.365 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.3 m -67.48 -39.63 85.27 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.02 -44.13 88.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.614 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 1.9 m -64.11 -41.02 97.41 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.452 -0.78 . . . . 0.0 109.846 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -44.19 89.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.241 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -61.78 -40.14 94.14 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -61.45 -38.5 87.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 82.1 mtp -65.58 -34.64 78.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 111.629 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 3.9 pt20 -63.68 -42.01 98.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.684 -1.26 . . . . 0.0 111.683 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.492 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -85.91 -24.65 26.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 111.697 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 0.9 OUTLIER -65.97 -22.38 66.47 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.762 -1.211 . . . . 0.0 110.431 -178.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.0 2.7 58.16 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.92 -32.01 73.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.77 -0.841 . . . . 0.0 110.041 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.94 148.32 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.062 -1.024 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 20.5 m120 -113.76 164.85 13.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 3.9 m-20 90.26 81.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.082 0.468 . . . . 0.0 110.257 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.467 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 53.3 m170 -52.68 -46.14 67.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.042 -1.036 . . . . 0.0 108.825 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 178' ' ' GLY . 4.8 m -158.1 29.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.458 -0.777 . . . . 0.0 110.202 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t 53.01 2.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 109.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -141.05 32.37 2.11 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.943 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 109.024 179.756 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.437 ' NH1' ' HG3' ' A' ' 3' ' ' ARG . 38.3 mtm-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.699 0.761 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.34 153.46 38.35 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.78 98.47 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.345 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.598 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.31 -3.21 58.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.61 -1.524 . . . . 0.0 109.448 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.2 t -80.86 -35.15 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -76.88 4.93 8.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 10' ' ' ASP . 1.3 mm-40 -90.64 -159.38 0.61 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -44.75 155.6 0.38 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.001 -1.062 . . . . 0.0 108.914 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.25 -16.65 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 0.0 112.228 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.2 mt -58.42 -39.68 80.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -67.92 -36.24 79.84 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.061 -1.024 . . . . 0.0 109.335 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.39 -44.85 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.781 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.11 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.737 -1.227 . . . . 0.0 109.554 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.438 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 3.1 t80 -66.62 -35.84 81.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 55.4 t-80 -61.58 -41.17 97.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 111.69 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 6.2 m-20 -96.6 -1.67 46.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.827 -1.17 . . . . 0.0 112.358 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -103.41 -30.05 10.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.529 -1.357 . . . . 0.0 112.324 -178.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 94.7 mt-10 -155.97 24.73 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.144 -1.597 . . . . 0.0 111.507 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.598 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.6 t90 -98.87 65.25 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.49 62.58 0.87 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.687 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.696 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -157.89 -35.61 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.152 -1.205 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.696 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 98.6 Cg_endo -98.41 149.97 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.363 2.042 . . . . 0.0 112.331 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.2 166.77 22.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 130.16 45.69 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.567 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.91 157.1 16.99 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 m -56.69 -34.68 67.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.901 -1.125 . . . . 0.0 109.187 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -67.53 -41.57 84.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -63.92 -38.96 93.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.987 -1.071 . . . . 0.0 110.152 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -61.04 -35.97 78.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 109.656 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.495 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 90.6 t80 -66.96 -50.25 62.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 110.95 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -66.84 -40.14 87.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.79 -1.194 . . . . 0.0 109.629 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.583 ' C ' ' SD ' ' A' ' 34' ' ' MET . 10.0 tmm? -62.75 -50.72 69.95 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.684 -0.635 . . . . 0.0 110.763 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.546 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.1 tp -62.32 -27.49 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 73.0 m -68.07 -45.35 74.07 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.552 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.39 -44.37 68.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.125 -0.985 . . . . 0.0 109.416 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -61.94 -32.79 73.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -37.3 76.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -87.07 -2.99 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -1.119 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.5 -0.92 44.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.088 -1.007 . . . . 0.0 109.86 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.99 112.99 7.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.205 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.81 -33.62 5.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 44' ' ' LEU . 5.6 mp -102.61 152.55 21.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.266 . . . . 0.0 110.325 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 m -64.56 156.73 28.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.419 -0.801 . . . . 0.0 108.97 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -60.71 -35.09 75.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.74 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -30.92 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.84 -1.163 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.7 m -58.12 -42.41 85.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.836 -1.165 . . . . 0.0 108.914 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -71.17 -31.93 45.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.535 -0.728 . . . . 0.0 109.379 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 tp -55.35 -49.25 72.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.085 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -58.35 -42.73 87.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -65.32 -31.05 71.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.211 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 37.7 ttm180 -54.38 -44.78 72.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -69.59 -38.95 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.597 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.16 -42.71 59.5 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 111.012 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.73 -49.99 75.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.912 -1.117 . . . . 0.0 110.495 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.466 ' HG3' HH11 ' A' ' 57' ' ' ARG . 3.1 ptm180 -59.69 -30.79 69.03 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.939 -1.1 . . . . 0.0 109.005 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.4 93.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.2 m -75.15 -43.83 50.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.979 -1.075 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.075 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo . . . . . 0 N--CA 1.49 1.305 0 CA-C-O 121.059 0.358 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.87 -44.09 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.953 -1.092 . . . . 0.0 109.871 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 68' ' ' VAL . 5.3 pttp -65.93 -33.21 75.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.109 -0.994 . . . . 0.0 109.044 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.45 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 84.4 t -60.25 -38.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 108.951 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.04 -19.24 65.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.19 -15.51 18.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 78.1 mtp -68.88 113.78 6.6 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.3 tt0 -96.16 174.12 7.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.328 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 95.7 mt-10 -52.17 -32.06 34.28 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.98 -45.45 82.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.2 -38.1 87.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.947 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.04 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.978 -1.077 . . . . 0.0 108.156 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 78' ' ' ARG . 24.3 ttm-85 -63.77 -48.01 78.66 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.513 ' C ' ' N ' ' A' ' 81' ' ' GLN . 66.2 mt -70.78 -34.47 71.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.761 -0.587 . . . . 0.0 110.99 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' LEU . 4.2 t -48.28 -17.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.513 ' N ' ' C ' ' A' ' 79' ' ' LEU . 5.7 mt-30 -110.8 -12.14 14.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 53.2 t0 -83.15 109.66 17.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 75.98 -17.35 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.145 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 78.79 36.89 27.66 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLY . 6.4 pt -47.19 175.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -1.197 . . . . 0.0 108.35 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.64 95.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.13 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 31.5 ptt180 -54.92 125.09 18.83 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.714 0.769 . . . . 0.0 109.305 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.7 m-70 166.96 78.36 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -48.73 -32.33 8.32 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.91 2.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -60.55 -39.96 89.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.327 . . . . 0.0 109.409 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.8 -40.3 82.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.177 -0.952 . . . . 0.0 109.09 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.563 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 6.9 mm100 -55.44 -36.35 66.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 108.893 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.69 85.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.05 -43.26 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.2 mm -59.59 -43.63 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.42 -36.09 90.29 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -60.06 -35.82 75.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -1.111 . . . . 0.0 109.834 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.23 83.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.045 . . . . 0.0 109.214 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -62.2 -36.09 80.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.364 -0.835 . . . . 0.0 109.318 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.74 81.89 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.242 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.98 -43.49 95.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.8 mt -60.97 -25.62 66.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.458 ' CD ' ' C ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -67.37 -41.58 84.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 110.057 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.451 ' N ' ' HG3' ' A' ' 104' ' ' GLN . 94.2 mmm -66.13 -40.28 90.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.125 -0.984 . . . . 0.0 108.688 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -70.69 -39.93 73.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.275 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.14 -23.85 64.23 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -93.89 -9.76 36.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.3 24.35 74.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -117.46 101.64 52.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.17 147.33 66.14 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.325 2.017 . . . . 0.0 112.523 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 35.9 m-85 -60.7 -39.35 88.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.523 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.35 -32.57 74.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.946 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.35 -46.7 82.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.669 -1.27 . . . . 0.0 112.204 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.8 p90 -73.02 -43.84 61.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.632 -1.292 . . . . 0.0 110.999 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.1 p -62.87 -54.0 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.629 -1.294 . . . . 0.0 110.37 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 122' ' ' HIS . 34.2 m95 -53.94 -27.04 28.51 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -76.26 -35.52 58.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.576 -0.702 . . . . 0.0 109.941 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -61.89 -31.09 71.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -97.99 17.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 63.41 33.56 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.685 -0.634 . . . . 0.0 110.401 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' TRP . 95.9 m-70 51.44 29.32 5.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.136 -0.978 . . . . 0.0 110.95 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -135.34 142.56 41.95 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.961 -1.087 . . . . 0.0 109.906 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.27 147.98 43.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.266 1.977 . . . . 0.0 111.671 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.417 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -120.0 126.48 50.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 90.2 mtp -102.74 116.0 31.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 108.753 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.521 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -89.72 144.43 25.98 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.43 28.35 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 111.78 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.485 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -67.64 134.87 51.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 0.0 108.504 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.9 p -97.17 -21.59 17.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 110.228 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.485 ' HG1' ' H ' ' A' ' 134' ' ' GLU . 3.3 p -129.3 162.15 28.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 109.711 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.91 -36.35 76.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.412 -0.805 . . . . 0.0 109.38 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 62.4 p -68.2 -29.7 68.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.96 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.485 ' H ' ' HG1' ' A' ' 131' ' ' THR . 76.3 mm-40 -83.41 6.42 20.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.86 143.2 35.01 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.06 145.6 31.42 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.525 2.15 . . . . 0.0 112.865 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.43 0.6 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.481 ' O ' ' OG ' ' A' ' 138' ' ' SER . 10.8 p -145.68 94.74 2.54 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.503 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -106.02 153.98 39.83 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.65 -37.61 91.16 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.752 1.635 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.89 58.12 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.642 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.503 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 60.6 m -63.15 -42.24 99.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.966 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -60.81 -39.62 89.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 109.231 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.54 77.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.41 -47.84 83.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 109.625 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.641 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 13.8 t -63.48 -43.71 96.51 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.196 -0.94 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.58 -44.26 94.57 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 152' ' ' ARG . . . -72.17 -44.35 63.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.137 -0.977 . . . . 0.0 109.367 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.419 ' CD2' HH21 ' A' ' 152' ' ' ARG . 75.3 mt -65.39 -39.1 91.82 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.287 -0.883 . . . . 0.0 109.738 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.47 -39.35 90.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.973 -1.079 . . . . 0.0 109.695 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.32 -30.61 71.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 110.071 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.419 HH21 ' CD2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -72.86 0.66 10.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.954 -1.092 . . . . 0.0 108.642 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.88 26.55 24.12 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.815 -1.184 . . . . 0.0 110.297 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -97.11 112.43 24.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 0.0 109.745 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -91.38 168.96 11.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.97 64.19 1.8 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 108.482 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 157' ' ' VAL . 7.1 p -153.52 41.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.95 -175.39 0.08 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 p -66.62 -26.7 67.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -1.048 . . . . 0.0 110.415 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -70.99 -34.05 71.01 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.5 -44.56 76.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.094 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 146' ' ' SER . 7.3 m -64.95 -36.02 83.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.522 -0.736 . . . . 0.0 109.655 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -69.69 -45.96 67.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 110.87 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.607 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 87.1 p -63.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.875 -1.141 . . . . 0.0 109.188 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -62.44 -49.28 76.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.576 -0.702 . . . . 0.0 110.365 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.05 -40.62 96.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.008 -1.057 . . . . 0.0 111.148 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.538 ' OE1' ' CD2' ' A' ' 163' ' ' TYR . 4.6 mp0 -74.76 -40.77 61.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.906 -1.121 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.86 60.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.051 -1.031 . . . . 0.0 112.536 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 36.1 m -65.65 -48.72 71.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.676 -1.265 . . . . 0.0 111.964 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.65 -2.38 1.46 Allowed Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.579 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.9 mt -59.97 -35.33 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.94 -1.33 . . . . 0.0 110.126 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.41 ' CG1' HE21 ' A' ' 167' ' ' GLN . 0.4 OUTLIER -140.54 140.32 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.719 -1.238 . . . . 0.0 110.075 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -110.37 124.04 50.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 13.7 p30 180.0 54.33 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.234 -0.916 . . . . 0.0 111.475 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.544 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 25.6 m170 -57.94 -46.34 85.22 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.48 -1.387 . . . . 0.0 108.788 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -175.23 18.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 37.2 t 62.32 -41.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.752 -0.593 . . . . 0.0 110.587 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -81.66 4.87 71.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.27 . . . . 0.0 109.643 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.441 0.639 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.35 146.74 47.11 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.551 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.3 -24.33 21.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' A' ' 6' ' ' TRP . 4.5 t90 -81.47 9.51 7.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -1.219 . . . . 0.0 109.731 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.4 -25.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 0.0 110.669 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -81.19 6.34 14.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.087 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -86.22 -59.7 2.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -111.4 156.29 41.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 110.311 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.28 -37.22 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.966 2.444 . . . . 0.0 113.198 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.23 -35.03 77.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.129 -0.982 . . . . 0.0 110.441 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CD1' ' OD1' ' A' ' 10' ' ' ASP . 6.4 m-85 -56.55 -36.25 69.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.971 -1.081 . . . . 0.0 109.791 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.401 ' H ' HD13 ' A' ' 14' ' ' ILE . 1.9 mp -52.35 -43.94 41.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.69 -48.77 65.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' HA ' HD21 ' A' ' 19' ' ' ASN . 16.4 t80 -62.34 -43.13 99.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.57 -43.04 91.0 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.448 -0.782 . . . . 0.0 111.549 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.29 -14.19 61.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 111.605 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 80.6 m-20 -73.77 -69.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.626 -1.296 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -175.83 59.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' TRP . 7.7 t90 -96.42 68.92 2.59 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.04 -3.8 6.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.705 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -105.51 -16.98 0.16 Allowed Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.6 -0.941 . . . . 0.0 111.861 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 91.7 Cg_endo -86.44 150.87 9.07 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 121.833 1.688 . . . . 0.0 113.088 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.04 170.86 10.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.618 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 1.8 p -91.18 120.36 32.05 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.772 -1.205 . . . . 0.0 111.043 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -105.74 154.14 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -61.58 -36.66 81.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.811 -1.181 . . . . 0.0 109.825 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -73.17 -50.81 20.53 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 110.97 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.655 ' HZ1' ' CE ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -63.94 -25.37 68.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.903 -1.123 . . . . 0.0 108.691 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.02 -44.29 91.7 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.5 t80 -68.94 -46.5 68.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 111.155 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.69 -35.29 77.01 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.509 -1.369 . . . . 0.0 109.761 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.655 ' CE ' ' HZ1' ' A' ' 30' ' ' LYS . 38.7 ttm -68.72 -43.79 75.25 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.927 -1.108 . . . . 0.0 110.991 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 165' ' ' PHE . 1.4 tp -63.19 -29.32 46.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.953 -1.092 . . . . 0.0 109.831 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 57.8 m -71.77 -49.21 40.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.043 -1.036 . . . . 0.0 110.413 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 mm? -66.23 -42.06 89.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.632 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 32.5 tp10 -66.39 -38.22 87.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.893 . . . . 0.0 109.746 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.55 -36.63 78.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.418 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 99.2 mm-40 -82.84 -7.77 59.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.221 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -89.48 4.17 50.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.075 . . . . 0.0 110.722 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 118.82 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 0.0 110.07 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.19 -1.01 89.41 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 46' ' ' TRP . 4.5 mm? -107.13 163.36 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.243 -1.151 . . . . 0.0 110.121 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 47' ' ' ILE . 60.6 m -80.98 22.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.669 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.7 OUTLIER 62.96 -39.85 0.17 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 109.758 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.563 ' H ' ' C ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -62.06 -35.47 68.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.921 -1.112 . . . . 0.0 108.225 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -59.24 -44.48 92.36 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.068 -1.02 . . . . 0.0 108.622 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.3 t -69.03 -35.83 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.11 -48.93 72.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.034 -1.041 . . . . 0.0 109.03 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -59.83 -42.62 93.97 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HZ2' ' HG3' ' A' ' 40' ' ' GLN . 1.6 ttmt -62.34 -32.33 73.09 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 40.9 ttm180 -53.66 -45.68 70.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.234 -0.916 . . . . 0.0 109.244 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.02 -44.26 85.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.816 -1.153 . . . . 0.0 108.614 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.683 HD22 ' CB ' ' A' ' 85' ' ' ILE . 27.5 t30 -63.27 -37.95 89.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 45.1 t80 -56.84 -42.92 80.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG3' HH11 ' A' ' 57' ' ' ARG . 15.8 mmm-85 -59.34 -35.59 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 108.906 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.48 96.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 110.399 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.656 ' SG ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -78.3 -45.87 21.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 111.434 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 87.4 m-85 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.9 -1.125 . . . . 0.0 109.629 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 114.041 0.746 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.1 t -76.41 -38.93 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.621 -1.299 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -63.83 -42.65 97.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.082 -1.011 . . . . 0.0 108.579 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.97 -37.89 81.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.258 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.64 63.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.8 -8.5 46.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.7 mtp -83.25 115.76 22.1 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.24 167.44 11.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.65 -31.89 39.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.021 -1.049 . . . . 0.0 110.132 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -55.09 -41.48 71.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 85.3 m-20 -62.45 -37.99 88.02 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.2 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.472 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.96 -40.79 96.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 110.136 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 5.0 ptp180 -75.54 -33.01 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 109.274 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.99 -33.23 75.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.907 . . . . 0.0 111.397 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 m -54.19 -17.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.67 -1.269 . . . . 0.0 108.843 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.41 -2.33 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 55.1 t0 -81.55 108.25 14.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.701 -1.249 . . . . 0.0 109.273 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.32 -11.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.612 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.39 34.41 57.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.683 ' CB ' HD22 ' A' ' 55' ' ' ASN . 20.6 pt -52.56 -177.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -1.006 . . . . 0.0 110.344 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 tt -56.98 89.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 32.2 ptt180 -51.91 134.25 31.67 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.628 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.636 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.0 m-70 164.31 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 89' ' ' ARG . 15.6 ptt-85 -42.87 -32.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.079 . . . . 0.0 110.184 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.86 -62.35 6.18 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.912 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.406 ' H ' ' HD2' ' A' ' 91' ' ' LYS . 3.2 mptt -63.79 -38.28 90.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.869 -1.371 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 2.1 pt20 -55.65 -33.08 63.74 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.82 -1.175 . . . . 0.0 108.305 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.405 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -63.04 -38.59 91.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 108.811 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.5 -47.35 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 109.224 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.6 mp -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.448 -0.783 . . . . 0.0 109.942 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.27 -39.8 90.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -58.93 -35.71 73.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.542 -0.975 . . . . 0.0 109.683 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.78 -46.19 83.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -56.4 -41.61 76.57 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.985 -1.072 . . . . 0.0 108.693 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.04 71.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.636 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 48.7 t80 -63.32 -43.02 98.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -65.25 -31.9 73.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.6 -40.04 94.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -0.854 . . . . 0.0 110.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.685 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 80.6 mtp -67.52 -37.7 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.63 -41.08 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.085 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.05 -22.15 66.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -12.19 30.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.81 27.19 73.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.34 100.46 52.93 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.247 -1.149 . . . . 0.0 109.877 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.2 149.63 84.14 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.381 2.054 . . . . 0.0 112.146 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 33.6 m-85 -63.06 -40.07 96.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 111.195 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.17 77.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.077 -1.014 . . . . 0.0 111.062 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -63.02 -47.02 84.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.184 -0.948 . . . . 0.0 112.606 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -72.14 -44.52 63.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.538 -1.351 . . . . 0.0 110.718 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.523 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 3.9 p -60.49 -52.09 65.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.603 -1.311 . . . . 0.0 109.446 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.618 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 20.7 m95 -55.66 -24.36 33.53 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.3 p -65.57 -42.72 91.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 109.98 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.58 -36.47 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.988 -1.07 . . . . 0.0 109.171 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 t -86.37 13.9 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.697 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 121' ' ' ASN . 2.2 m120 57.17 31.97 20.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 56.17 32.67 20.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 111.437 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.69 149.75 41.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 110.066 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.58 145.0 68.77 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.809 2.34 . . . . 0.0 112.874 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.555 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.58 132.42 55.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.467 -0.771 . . . . 0.0 109.8 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.555 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.0 mtt -101.46 123.44 45.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.917 -1.114 . . . . 0.0 108.952 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -92.96 -20.41 20.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.879 -1.138 . . . . 0.0 110.16 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 57.22 44.77 21.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.383 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.01 148.77 51.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.25 -28.3 8.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.629 ' HG1' ' H ' ' A' ' 134' ' ' GLU . 5.2 p -131.9 164.15 26.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.15 -42.22 85.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 108.857 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 95.9 p -72.43 -19.33 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.629 ' H ' ' HG1' ' A' ' 131' ' ' THR . 39.2 tp10 -71.9 -10.42 59.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 tp -74.11 127.13 88.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 120.997 -1.064 . . . . 0.0 108.191 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.61 135.34 17.87 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.979 1.786 . . . . 0.0 113.014 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.6 p -112.13 4.94 18.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.6 t -138.77 93.19 2.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.384 -0.822 . . . . 0.0 109.003 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.57 158.9 50.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.15 -39.06 92.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.901 1.734 . . . . 0.0 111.21 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.64 -44.29 67.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 108.698 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.1 p -62.72 -40.72 98.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -63.28 -37.99 89.4 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.185 -0.947 . . . . 0.0 108.787 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.45 84.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.494 -0.754 . . . . 0.0 109.991 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.93 -40.49 95.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.627 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 25.2 t -64.35 -51.53 62.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.9 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -67.99 -39.64 83.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.84 -1.162 . . . . 0.0 109.299 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.87 83.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.5 mt -68.02 -35.76 78.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.003 -1.061 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.71 84.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.976 -1.077 . . . . 0.0 109.68 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.09 -32.39 71.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.21 -0.932 . . . . 0.0 110.455 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -72.33 -1.0 13.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.969 -1.082 . . . . 0.0 108.826 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.08 26.93 42.5 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -98.45 112.59 24.56 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.758 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -89.8 170.97 9.96 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 59.39 65.84 1.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.921 0.867 . . . . 0.0 109.679 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.8 m -140.97 38.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.43 168.35 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.3 m -57.42 -31.67 66.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.583 -0.951 . . . . 0.0 109.134 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.4 p -71.36 -33.92 70.01 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.82 -45.43 91.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.057 0.932 . . . . 0.0 108.533 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 146' ' ' SER . 28.3 m -63.8 -45.18 90.82 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.446 0.641 . . . . 0.0 109.9 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -31.81 73.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.969 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.463 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 29.9 t -59.56 -49.25 78.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 10.6 m-85 -59.75 -47.6 85.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.471 -1.393 . . . . 0.0 109.131 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.8 mmm -52.55 -42.22 64.22 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.576 -1.249 . . . . 0.0 108.389 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -43.16 18.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.51 -0.743 . . . . 0.0 111.064 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.22 13.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -0.943 . . . . 0.0 113.088 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.541 ' SG ' ' CG2' ' A' ' 26' ' ' THR . 0.5 OUTLIER -54.16 -18.91 4.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.628 -1.295 . . . . 0.0 110.861 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.98 -0.47 59.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.67 -35.14 72.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.403 -1.057 . . . . 0.0 109.348 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 m -131.06 143.98 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.14 117.69 34.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 175' ' ' HIS . 12.9 p-10 -178.85 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 174' ' ' ASP . 35.8 m170 -49.1 -39.25 27.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' VAL . 6.2 p 175.62 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' VAL . 1.4 p 30.69 112.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.261 1.029 . . . . 0.0 112.206 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.51 48.47 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 120.696 -1.252 . . . . 0.0 110.569 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 120.715 -1.462 . . . . 0.0 108.676 179.433 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.487 HH12 ' CG1' ' A' ' 14' ' ' ILE . 80.5 mtm180 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.19 143.24 58.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.192 0.996 . . . . 0.0 110.226 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.22 -21.51 32.98 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -77.3 -4.28 44.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.953 -1.322 . . . . 0.0 108.864 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 9' ' ' GLN . 2.6 t -102.31 -31.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -70.54 6.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.393 -0.817 . . . . 0.0 110.035 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' VAL . 91.4 mt-30 -81.36 -105.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.953 -1.092 . . . . 0.0 110.511 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.47 159.97 63.07 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.935 . . . . 0.0 110.439 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.36 -35.58 17.99 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.188 2.592 . . . . 0.0 113.245 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.89 -31.8 71.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.075 -1.015 . . . . 0.0 110.608 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.42 -33.56 69.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 110.964 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.487 ' CG1' HH12 ' A' ' 3' ' ' ARG . 3.4 mp -58.53 -41.03 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.746 -1.221 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.614 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.01 -50.74 53.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.062 . . . . 0.0 109.452 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.429 ' HA ' HD21 ' A' ' 19' ' ' ASN . 28.9 t80 -63.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.363 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -66.58 -42.86 86.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 110.373 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -74.65 -10.28 59.38 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 20.7 m-80 -69.6 -76.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.885 -1.134 . . . . 0.0 108.426 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' O ' ' C ' ' A' ' 21' ' ' TRP . 94.6 mt-10 -151.92 -39.5 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.613 ' C ' ' O ' ' A' ' 20' ' ' GLU . 8.4 t90 -3.38 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.808 0.813 . . . . 0.0 111.241 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 142.41 -23.68 2.36 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.142 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.71 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 11.6 m -125.5 10.87 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.663 -0.904 . . . . 0.0 112.676 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 73.5 Cg_endo -75.72 143.79 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.346 1.364 . . . . 0.0 112.874 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -86.12 148.3 25.76 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.59 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 1.6 p -88.25 120.6 29.77 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.522 -1.271 . . . . 0.0 111.436 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -105.89 159.26 16.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 m -64.67 -38.08 89.78 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.466 -1.396 . . . . 0.0 110.469 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -75.13 -49.92 18.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 111.866 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -59.23 -40.49 86.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.949 -1.094 . . . . 0.0 109.398 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' N ' HD11 ' A' ' 31' ' ' LEU . 9.5 mp -62.69 -38.24 89.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.317 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 1.3 t80 -59.88 -39.46 85.39 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.472 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.12 -39.82 63.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.311 -0.868 . . . . 0.0 108.936 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.624 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 26.0 ttm -59.5 -49.61 77.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.835 . . . . 0.0 110.848 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.13 -35.26 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.673 -1.267 . . . . 0.0 108.817 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 72.2 m -67.23 -36.98 82.8 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.583 ' CD1' HH21 ' A' ' 57' ' ' ARG . 1.8 mp -73.21 -48.76 32.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -63.19 -37.55 87.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.826 . . . . 0.0 108.859 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.46 -35.88 92.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -74.48 -8.63 56.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.966 . . . . 0.0 109.382 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -74.21 -5.64 43.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.51 122.87 14.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.011 -1.055 . . . . 0.0 109.283 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.62 -25.99 0.28 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 42' ' ' ALA . 87.6 mt -105.48 144.61 32.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -1.144 . . . . 0.0 110.233 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -75.75 157.52 33.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -56.91 -34.51 68.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.498 -0.752 . . . . 0.0 110.296 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -35.35 67.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -62.69 -44.31 96.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.333 -0.855 . . . . 0.0 109.983 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.31 -24.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.219 -0.926 . . . . 0.0 109.168 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.54 -47.87 82.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.0 110.003 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -61.4 -49.68 75.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.913 -1.117 . . . . 0.0 109.033 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -77.21 -5.82 50.68 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.067 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.3 ttm180 -65.9 -55.74 15.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -66.2 -45.84 79.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.663 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.24 -45.87 79.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.956 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 56.7 t80 -63.44 -46.3 86.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.875 -1.14 . . . . 0.0 110.476 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.583 HH21 ' CD1' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -54.31 -34.42 60.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.856 -1.153 . . . . 0.0 109.676 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.29 79.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.087 -1.008 . . . . 0.0 110.469 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.79 -43.7 62.45 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 112.638 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 66.6 m-85 . . . . . 0 N--CA 1.501 2.091 0 O-C-N 120.739 -1.225 . . . . 0.0 112.079 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 CA-C-O 121.279 0.45 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.71 -46.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -65.4 -34.61 78.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.6 t -60.34 -37.55 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.818 . . . . 0.0 109.53 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.75 -15.28 63.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.53 -5.07 49.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 0.0 109.853 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.1 mmm -77.97 116.5 18.51 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -95.12 175.69 6.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.201 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.86 -33.57 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.716 -0.615 . . . . 0.0 110.542 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -57.83 -42.0 83.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 84.8 m-20 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.53 -40.09 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.461 -0.774 . . . . 0.0 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -66.04 -40.26 90.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 7.1 ptp180 -74.61 -38.71 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.717 -1.239 . . . . 0.0 109.225 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 10.4 mt -65.49 -32.35 73.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.73 . . . . 0.0 110.615 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG12 HH12 ' A' ' 87' ' ' ARG . 41.3 t -48.24 -38.36 8.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.14 2.02 45.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 19.7 t70 -87.43 110.6 20.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 81.67 -15.13 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.676 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.05 37.41 49.72 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pt -58.74 -166.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.197 -1.178 . . . . 0.0 110.107 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 15.7 tt -66.98 94.46 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 0.0 109.463 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.615 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 4.6 mtt-85 -51.78 117.86 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.915 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.681 ' CD2' ' HZ1' ' A' ' 91' ' ' LYS . 3.5 m-70 170.62 68.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -48.73 -34.16 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.26 -62.65 6.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.681 ' HZ1' ' CD2' ' A' ' 88' ' ' HIS . 33.7 mtmm -62.44 -40.68 97.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.085 -1.244 . . . . 0.0 110.322 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 92' ' ' ILE . 43.8 mm -61.18 -43.89 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.959 -1.088 . . . . 0.0 110.513 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.43 74.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.796 -1.19 . . . . 0.0 109.368 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.59 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.17 -31.14 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -58.56 -46.25 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.807 -1.183 . . . . 0.0 108.395 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.1 -33.19 86.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -56.16 -42.2 76.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.194 . . . . 0.0 109.826 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.28 -47.6 67.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.087 . . . . 0.0 108.894 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -56.77 -36.25 69.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.458 -0.776 . . . . 0.0 109.1 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.43 72.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.057 -1.027 . . . . 0.0 108.927 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.7 -42.66 97.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.0 mm? -61.44 -32.95 72.94 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -63.62 -36.69 84.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.587 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.3 tpp -64.23 -40.76 96.71 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.028 0.918 . . . . 0.0 108.899 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.6 -38.98 92.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.5 -24.31 66.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -90.97 -15.84 29.02 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.6 27.19 73.58 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.644 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.99 101.93 47.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.195 -1.179 . . . . 0.0 109.565 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.53 138.16 14.46 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.769 1.646 . . . . 0.0 112.383 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -51.88 -39.12 58.46 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.237 1.018 . . . . 0.0 109.198 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.12 65.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 109.957 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -66.63 -48.64 68.82 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 111.892 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.8 p90 -73.95 -38.29 64.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.54 -1.35 . . . . 0.0 111.274 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 115' ' ' PHE . 17.5 m -66.92 -52.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.318 -1.489 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.59 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.3 m95 -55.03 -27.13 42.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 t -76.14 -40.0 53.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.464 -0.773 . . . . 0.0 110.541 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.28 -24.88 65.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.284 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.0 m -100.84 19.11 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.418 -0.801 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.63 36.19 22.55 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.76 -0.588 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 52.68 37.3 23.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 111.218 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.08 149.85 25.94 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 109.315 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.83 150.78 62.27 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 112.2 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' C ' ' OE1' ' A' ' 125' ' ' GLN . 4.6 tm0? -102.43 132.0 48.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 98.2 mmm -94.23 117.81 30.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 109.233 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 174' ' ' ASP . 1.2 m -93.07 119.46 32.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.64 21.45 4.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.031 -1.043 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.48 142.22 56.68 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.484 -0.76 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 58.2 p -106.61 -25.01 11.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 108.865 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -130.12 164.27 24.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.549 -0.72 . . . . 0.0 109.092 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.4 mt -57.66 -35.0 69.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 108.773 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.2 t -61.06 -35.95 78.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.53 0.52 25.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.2 tp -79.84 125.9 81.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.26 132.36 13.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.764 1.643 . . . . 0.0 112.725 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 p -111.65 7.15 20.35 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -144.92 89.35 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.527 -0.733 . . . . 0.0 109.462 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.505 ' H ' ' HG ' ' A' ' 142' ' ' SER . 39.1 p -108.99 151.93 42.16 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.601 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.63 -34.69 74.57 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.667 1.578 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.95 -45.76 56.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.451 -0.781 . . . . 0.0 109.0 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.505 ' HG ' ' H ' ' A' ' 139' ' ' THR . 82.7 p -69.01 -36.69 78.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.28 -0.887 . . . . 0.0 109.096 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.49 -38.95 93.1 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.76 -27.24 63.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tp -69.03 -44.95 71.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.723 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 7.7 t -62.62 -47.09 85.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.913 . . . . 0.0 110.868 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -65.06 -37.83 88.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.775 -1.203 . . . . 0.0 109.879 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.36 -44.83 70.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.1 -1.0 . . . . 0.0 109.389 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 149' ' ' LEU . 1.2 mm? -63.24 -38.31 90.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -61.29 -41.08 96.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.144 -0.972 . . . . 0.0 110.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 153' ' ' GLY . 66.1 mttm -68.65 -36.58 78.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.97 -1.081 . . . . 0.0 111.762 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -71.11 7.05 1.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.78 -1.2 . . . . 0.0 110.143 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 82.98 22.68 57.2 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.34 112.57 24.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.218 -1.166 . . . . 0.0 108.015 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.44 174.95 6.6 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 59.68 48.65 9.12 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.564 0.697 . . . . 0.0 109.875 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.27 43.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.67 160.1 0.48 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -56.8 -30.91 64.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.64 -0.917 . . . . 0.0 109.881 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -75.6 -31.45 59.95 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -72.48 -35.99 53.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.2 m -69.28 -40.58 77.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.803 . . . . 0.0 109.38 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.51 -45.24 76.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.499 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 33.6 t -61.35 -39.34 90.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.563 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 47.9 t80 -58.54 -47.78 83.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.714 -0.616 . . . . 0.0 110.445 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 63.9 mtp -72.43 -39.56 67.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.055 -1.028 . . . . 0.0 109.536 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.647 HE21 ' N ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 110.211 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.647 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -78.34 -38.71 41.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 109.882 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.624 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 44.3 m -54.53 -16.95 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.343 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.55 -1.31 58.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.95 -30.91 71.23 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -1.078 . . . . 0.0 109.525 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.3 t -116.14 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 6.4 m-80 -125.01 162.41 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 15.3 t0 89.3 69.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.126 0.489 . . . . 0.0 110.563 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -51.59 -59.09 4.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.78 160.71 36.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.14 113.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.524 -1.36 . . . . 0.0 108.793 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.75 67.33 1.69 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.747 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 5.3 t . . . . . 0 N--CA 1.495 1.808 0 O-C-N 120.816 -1.403 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.626 HH11 ' CG ' ' A' ' 3' ' ' ARG . 2.2 mtt-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.693 0.759 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.4 m -57.94 154.75 11.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.618 0.723 . . . . 0.0 110.254 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.13 -44.79 96.11 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.487 -0.758 . . . . 0.0 112.478 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.646 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -80.49 1.22 30.23 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.474 -1.604 . . . . 0.0 109.828 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 9' ' ' GLN . 2.2 t -89.39 -47.7 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.829 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -77.77 6.28 7.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 0.8 OUTLIER -91.58 -58.93 2.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.787 -0.571 . . . . 0.0 110.492 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.88 160.0 67.15 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.66 -32.11 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.041 2.494 . . . . 0.0 112.728 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.31 -40.26 89.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.121 -0.987 . . . . 0.0 109.477 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 6' ' ' TRP . 29.5 m-85 -65.92 -38.52 88.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.977 -1.077 . . . . 0.0 109.702 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.3 mt -55.69 -40.56 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.394 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.5 -51.74 18.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.974 -1.079 . . . . 0.0 109.419 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.459 ' HA ' HD21 ' A' ' 19' ' ' ASN . 31.8 t80 -60.9 -41.54 96.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.776 . . . . 0.0 109.991 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.47 -45.5 92.75 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.639 -0.663 . . . . 0.0 110.493 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -74.06 -7.38 52.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.448 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.673 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 38.1 m-80 -81.01 -77.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 110.288 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' GLY . 92.7 mt-10 -154.71 71.69 0.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 110.343 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.503 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 31.4 t-105 -70.14 63.31 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 67.83 64.99 2.88 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.018 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.666 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 25.5 t -114.67 -36.2 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.425 -1.044 . . . . 0.0 109.742 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 41.6 Cg_endo -95.21 151.8 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.962 2.441 . . . . 0.0 112.989 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.34 143.24 56.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 p -99.01 155.51 17.39 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.95 . . . . 0.0 111.863 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -97.72 166.68 11.37 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' HG ' ' HB1' ' A' ' 113' ' ' ALA . 14.0 m -57.33 -37.09 71.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.091 -1.006 . . . . 0.0 110.398 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -65.46 -42.47 92.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 111.035 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -59.05 -34.87 72.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.175 -0.953 . . . . 0.0 109.035 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.54 -33.26 75.5 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.84 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 89.4 t80 -65.92 -50.33 64.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 0.0 110.181 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -68.81 -30.21 68.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.83 -1.169 . . . . 0.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.0 tpt -70.28 -50.23 41.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.64 -29.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 61.4 m -71.62 -48.18 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.043 . . . . 0.0 110.022 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.67 -39.01 84.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -62.89 -31.19 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 109.939 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.34 -41.6 55.2 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.123 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mm-40 -67.89 -29.82 69.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.694 -1.474 . . . . 0.0 110.974 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' GLN . 4.5 pt20 -41.3 -31.94 0.26 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 0.0 109.829 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.63 116.98 7.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.01 -1.056 . . . . 0.0 108.716 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.66 -36.74 3.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' GLN . 4.5 mm? -105.14 150.04 25.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.164 -1.198 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 t -76.62 150.28 36.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 1.1 t-105 -54.72 -35.59 63.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -41.04 90.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.067 -1.021 . . . . 0.0 108.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.0 m -57.84 -38.42 75.59 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.8 t -66.5 -37.25 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.21 -50.6 70.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.06 -1.025 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -57.49 -37.76 73.46 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -73.18 -24.25 60.53 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 42.2 ttm180 -55.12 -45.06 75.53 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.08 -40.71 91.07 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.798 ' N ' HD21 ' A' ' 55' ' ' ASN . 0.7 OUTLIER -69.08 -31.92 71.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.886 0.85 . . . . 0.0 108.984 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 52' ' ' LYS . 58.7 t80 -56.14 -50.89 69.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.31 -28.0 67.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.048 -1.033 . . . . 0.0 109.22 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.57 -36.47 82.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 110.262 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.642 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.96 -45.62 26.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.642 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 98.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.926 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.499 0 N-CA-C 113.168 0.411 . . . . 0.0 113.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.91 -46.52 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.716 -1.24 . . . . 0.0 109.975 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.78 -33.02 74.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.774 -1.204 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.91 -37.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' CB ' HH21 ' A' ' 100' ' ' ARG . . . -65.61 -17.2 64.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.2 -10.94 29.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.642 -0.662 . . . . 0.0 109.734 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.58 114.39 9.61 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.062 -1.024 . . . . 0.0 108.686 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 8.1 tt0 -95.89 172.77 7.81 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 94.3 mt-10 -51.79 -30.48 23.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.825 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -55.48 -44.33 76.38 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 119.909 -1.744 . . . . 0.0 108.44 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 70.6 m-20 -70.86 -35.26 72.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.478 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.455 HG11 HE21 ' A' ' 93' ' ' GLN . 1.0 OUTLIER -73.96 -34.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.258 -1.526 . . . . 0.0 109.3 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.72 -40.86 98.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -70.68 -34.42 71.98 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.443 -1.303 . . . . 0.0 108.967 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.456 ' C ' ' N ' ' A' ' 81' ' ' GLN . 72.9 mt -68.26 -34.94 77.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.38 -19.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 79' ' ' LEU . 12.8 mt-30 -106.52 -15.42 14.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.483 -0.76 . . . . 0.0 109.912 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' A' ' 84' ' ' GLY . 82.1 m-20 -78.9 109.86 13.57 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.703 -1.199 . . . . 0.0 109.948 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.0 -18.9 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.32 33.01 61.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLY . 9.7 pt -36.22 156.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.649 -0.912 . . . . 0.0 110.234 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.45 -35.04 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.301 -0.874 . . . . 0.0 110.39 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.5 147.29 53.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.935 -178.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 89' ' ' ARG . 97.7 m-70 -124.16 170.69 10.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.59 -0.694 . . . . 0.0 109.38 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 88' ' ' HIS . 35.3 ttp180 -40.14 -35.78 0.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.19 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.66 -64.02 2.34 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 7.5 mptt -60.39 -36.99 79.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -1.19 . . . . 0.0 110.107 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.87 -47.48 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.632 -1.292 . . . . 0.0 109.292 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.455 HE21 HG11 ' A' ' 76' ' ' VAL . 33.4 mm-40 -52.5 -34.82 51.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.06 -1.025 . . . . 0.0 108.71 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.67 89.02 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.507 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.83 -43.75 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 108.673 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.6 mp -60.41 -41.77 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 108.646 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -38.07 93.44 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.78 -37.97 71.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.446 -1.032 . . . . 0.0 109.482 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.02 83.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.027 -1.045 . . . . 0.0 109.406 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.499 HH21 ' CB ' ' A' ' 69' ' ' ALA . 5.1 tpp180 -55.0 -39.44 69.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.268 -0.895 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.93 69.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 59.2 t80 -64.24 -43.06 96.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.1 mm? -63.2 -28.95 70.4 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.69 -41.55 83.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.219 -0.926 . . . . 0.0 111.362 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.678 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.8 mtp -69.1 -37.29 78.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.749 -1.22 . . . . 0.0 109.293 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.65 -39.85 84.58 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -15.77 62.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -92.95 -11.98 31.96 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.39 21.44 79.59 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.68 101.24 53.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.192 -1.181 . . . . 0.0 109.374 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.35 146.1 95.86 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.157 1.905 . . . . 0.0 112.273 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.6 m-85 -59.66 -45.21 92.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB1' ' HG ' ' A' ' 28' ' ' SER . . . -64.98 -28.41 69.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 17.3 t70 -59.45 -52.46 65.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.964 -1.085 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -75.08 -39.87 60.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.496 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 18.5 t -59.0 -54.75 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 120.619 -1.301 . . . . 0.0 109.9 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 122' ' ' HIS . 56.1 m95 -62.02 -21.99 65.34 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 108.958 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 50.6 m -68.46 -37.47 80.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 109.254 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.515 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 18.3 m-85 -69.37 -31.26 69.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.403 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.54 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 39.3 t -87.99 15.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.836 -1.165 . . . . 0.0 109.711 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.585 ' OD1' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER 78.78 11.38 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.699 -0.626 . . . . 0.0 109.836 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 65.7 20.57 11.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 110.893 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 15.1 mt-30 -146.51 150.94 42.07 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.941 -1.099 . . . . 0.0 109.236 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -49.24 142.25 22.11 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.862 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -110.77 142.62 42.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.565 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 92.1 mmm -99.93 130.26 46.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.73 123.04 35.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.093 -1.005 . . . . 0.0 109.879 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -91.93 27.35 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.79 . . . . 0.0 110.284 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.97 35.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.5 p -93.51 -22.36 18.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.127 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 49.4 p -133.64 167.85 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.016 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 -33.56 73.41 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.6 t -73.92 -13.17 60.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 110.43 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -94.16 4.05 54.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mm -92.49 122.35 64.57 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.83 140.78 32.56 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.84 1.693 . . . . 0.0 112.516 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.9 p -101.62 3.35 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.8 p -144.99 87.5 1.83 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.442 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.76 155.17 36.64 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -54.51 -36.52 88.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.879 1.719 . . . . 0.0 110.741 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.74 -43.12 59.99 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.809 -0.756 . . . . 0.0 108.984 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' A' ' 143' ' ' ASP . 61.8 p -70.18 -38.13 75.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.139 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.577 ' N ' ' HG ' ' A' ' 142' ' ' SER . 19.7 t70 -62.28 -38.93 91.23 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.177 -0.952 . . . . 0.0 108.881 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.515 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -68.83 -34.55 75.68 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.298 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mp -57.5 -46.29 83.95 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 0.0 108.639 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.545 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 8.9 t -60.7 -50.29 74.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.105 -0.997 . . . . 0.0 108.954 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.415 ' HB3' ' HZ1' ' A' ' 147' ' ' LYS . 7.6 mtpp -61.29 -40.41 94.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 109.267 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.99 22.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.83 -33.13 74.6 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -61.32 -42.24 98.34 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.982 -1.074 . . . . 0.0 109.671 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -68.45 -28.4 67.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.945 . . . . 0.0 110.55 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -72.7 1.35 8.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.906 -1.121 . . . . 0.0 108.675 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 78.59 27.32 57.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.64 112.88 24.58 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.652 0.739 . . . . 0.0 109.848 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -88.1 176.77 7.14 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.13 62.72 1.56 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.011 -1.056 . . . . 0.0 108.23 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.03 41.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.42 154.79 4.07 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 m -52.54 -32.01 38.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.27 -1.135 . . . . 0.0 109.557 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -72.09 -29.93 64.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.25 -0.906 . . . . 0.0 108.725 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 161' ' ' ILE . 25.7 mm -64.67 -44.92 96.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.815 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 146' ' ' SER . 97.9 m -60.8 -39.02 87.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.47 -47.81 53.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 111.063 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.499 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 19.9 m -63.43 -36.77 84.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.044 -1.035 . . . . 0.0 108.696 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 5.3 t80 -60.15 -46.24 90.35 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.153 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 12.5 ptp -71.49 -34.08 69.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.511 -1.368 . . . . 0.0 110.626 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.503 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -61.48 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.818 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -87.14 -22.98 25.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.199 -0.938 . . . . 0.0 111.592 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 1.5 m -68.76 -19.31 64.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.964 -1.085 . . . . 0.0 111.102 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.49 0.83 57.93 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.37 -30.97 72.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.615 -0.932 . . . . 0.0 109.426 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.07 142.15 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 75.0 m-20 -111.71 164.11 13.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 5.5 t0 86.71 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.597 0.713 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.477 ' CD2' ' CD1' ' A' ' 21' ' ' TRP . 20.9 m170 -54.35 -48.26 71.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -152.07 38.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.484 -179.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.436 ' CG2' ' OD2' ' A' ' 174' ' ' ASP . 24.0 t 45.15 13.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.0 110.672 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -157.4 31.74 0.53 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.117 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.122 -1.222 . . . . 0.0 109.873 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.416 HH12 HD11 ' A' ' 14' ' ' ILE . 84.6 mtt180 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.39 0.614 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.37 152.93 40.69 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.274 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -53.03 -25.86 25.59 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.78 13.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.028 -1.278 . . . . 0.0 109.623 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 5' ' ' GLY . 75.9 t -138.74 -23.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 110.269 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -71.83 5.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 109.949 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -115.39 -75.45 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.341 -0.85 . . . . 0.0 110.57 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.02 139.46 90.46 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.986 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 -53.21 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.526 2.151 . . . . 0.0 113.194 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.91 -33.91 62.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.912 -1.118 . . . . 0.0 109.742 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -52.89 -40.18 63.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.416 HD11 HH12 ' A' ' 3' ' ' ARG . 83.1 mt -54.12 -39.84 43.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.447 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.636 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.18 -51.1 22.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.96 -1.087 . . . . 0.0 109.535 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 22.7 t80 -60.76 -41.08 94.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 0.0 109.72 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -58.66 -44.85 90.26 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.47 -0.769 . . . . 0.0 109.618 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.92 -30.36 68.81 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.645 -0.659 . . . . 0.0 110.836 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 55.9 m-80 -60.21 -53.56 56.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 111.126 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' GLY . 10.9 pt-20 176.05 72.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.2 -0.938 . . . . 0.0 110.334 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.401 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 44.9 t-105 -70.52 60.73 0.22 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 71.27 49.67 25.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -107.18 -42.63 0.13 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.322 -1.105 . . . . 0.0 110.563 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.9 Cg_endo -91.14 151.87 3.8 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.261 2.641 . . . . 0.0 113.183 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.39 144.21 54.82 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.55 ' OG1' ' SG ' ' A' ' 169' ' ' CYS . 6.1 p -99.16 148.79 23.73 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.102 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -96.41 166.43 11.7 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -56.01 -31.5 63.13 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.777 -1.202 . . . . 0.0 109.632 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -65.65 -43.0 90.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.565 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -63.72 -34.96 79.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.131 -0.981 . . . . 0.0 109.125 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 31' ' ' LEU . 1.4 mm? -56.22 -41.67 76.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.718 -0.614 . . . . 0.0 109.643 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -69.57 -43.17 73.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 77.1 mt-10 -69.35 -45.39 69.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.86 -1.15 . . . . 0.0 109.332 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.9 ttm -62.19 -51.05 69.38 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.493 -0.754 . . . . 0.0 111.146 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.27 -26.16 38.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.853 -1.154 . . . . 0.0 109.716 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.45 -54.02 19.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.941 -1.099 . . . . 0.0 109.737 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 33' ' ' GLU . 2.0 mm? -71.88 -38.51 69.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.145 . . . . 0.0 108.843 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.564 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 3.5 tp10 -62.13 -32.34 72.91 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.514 -0.741 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.68 -13.73 82.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.91 -8.38 43.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.311 . . . . 0.0 111.319 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 2.2 pt20 -80.38 1.83 27.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.573 -1.329 . . . . 0.0 110.176 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -62.87 117.58 6.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -29.31 1.66 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 42' ' ' ALA . 19.1 mt -98.46 146.12 26.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -1.114 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 m -67.81 152.66 45.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -60.21 -37.13 79.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.675 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -67.73 -35.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.088 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -59.57 -42.12 91.73 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.959 -1.088 . . . . 0.0 108.125 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 54.0 t -67.72 -35.06 71.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.36 -51.67 67.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.148 -0.97 . . . . 0.0 109.688 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -57.9 -43.13 85.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -66.92 -28.84 68.62 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.06 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.7 ttm180 -53.52 -43.79 68.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.822 -1.174 . . . . 0.0 109.097 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -73.25 -49.14 29.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.216 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 24.0 p30 -80.95 -42.62 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.757 -1.214 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.601 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 53.1 t80 -62.76 -44.64 95.67 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.809 -1.182 . . . . 0.0 109.937 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -31.82 71.92 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.37 -42.7 98.88 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.018 -1.052 . . . . 0.0 110.335 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 m -78.37 -43.26 28.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.0 113.087 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 93.3 m-85 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 120.734 -1.229 . . . . 0.0 112.398 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.486 1.077 0 CA-C-O 121.401 0.5 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.43 -43.65 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -67.45 -38.18 84.09 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.69 -39.25 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.83 -14.94 63.37 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 -9.64 53.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 82.3 mmm -77.77 112.28 14.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.6 pt20 -95.87 -177.07 3.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.341 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.03 -33.44 72.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 110.801 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.0 tt0 -58.58 -43.33 89.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.7 -1.25 . . . . 0.0 109.08 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -65.23 -38.89 91.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.696 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.75 -44.31 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.726 . . . . 0.0 110.576 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.473 ' CB ' HH21 ' A' ' 89' ' ' ARG . 5.7 pt-20 -63.18 -35.83 81.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.637 -1.289 . . . . 0.0 108.943 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -69.18 -44.03 73.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLN . 90.2 mt -69.56 -32.86 71.9 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' LEU . 34.5 m -47.83 -16.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.438 -1.414 . . . . 0.0 108.928 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LEU . 20.6 pt20 -124.55 -2.18 7.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.637 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 56.2 t0 -83.76 111.01 18.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.474 -1.391 . . . . 0.0 109.222 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 85.27 -5.46 0.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.899 -0.501 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.91 37.68 60.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -70.79 -162.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -1.147 . . . . 0.0 109.493 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 86' ' ' ILE . 98.6 mt -77.25 118.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.942 0.877 . . . . 0.0 109.133 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.6 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.3 mtp180 -80.68 125.64 30.28 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.81 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.473 HH21 ' CB ' ' A' ' 77' ' ' GLU . 41.8 ttm180 -44.79 -33.31 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 0.0 109.763 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.63 -59.79 6.82 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.975 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -60.65 -42.21 96.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.843 -1.386 . . . . 0.0 110.862 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 29.0 mm -62.63 -43.49 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.939 -1.101 . . . . 0.0 110.203 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.33 -31.63 65.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 109.258 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HA ' HE21 ' A' ' 93' ' ' GLN . . . -67.92 -39.29 83.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.518 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.413 HG23 HD11 ' A' ' 95' ' ' ILE . 91.4 mt -66.07 -35.73 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.811 . . . . 0.0 110.675 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.06 -39.88 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.466 -1.396 . . . . 0.0 107.25 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.39 -34.19 89.25 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.06 -40.3 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -1.222 . . . . 0.0 108.472 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.35 86.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.604 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -61.49 -36.98 82.0 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 152' ' ' ARG . . . -63.04 -30.75 71.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 108.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.03 -43.32 99.02 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -63.7 -34.52 78.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.97 -39.38 94.52 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.321 -0.862 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.6 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 29.8 tpp -63.91 -46.58 84.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.42 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.37 -38.6 80.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.03 -24.59 64.64 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -91.93 -12.01 34.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.63 26.8 73.65 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.427 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.6 ' O ' ' SD ' ' A' ' 105' ' ' MET . 2.0 mt-10 -120.33 101.93 46.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.219 -1.165 . . . . 0.0 109.868 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.79 142.49 25.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.805 1.67 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 43.9 m-85 -59.86 -38.88 83.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.321 -0.862 . . . . 0.0 110.905 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.23 68.14 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.962 -1.086 . . . . 0.0 110.433 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.487 ' O ' ' OG ' ' A' ' 118' ' ' SER . 81.1 m-20 -65.82 -47.45 74.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.063 . . . . 0.0 112.292 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.5 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.0 p90 -74.27 -37.66 63.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.52 -1.362 . . . . 0.0 111.154 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG11 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -63.41 -52.46 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.328 -1.482 . . . . 0.0 109.894 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.593 ' O ' ' N ' ' A' ' 122' ' ' HIS . 54.1 m95 -58.41 -25.07 61.71 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.115 . . . . 0.0 108.033 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 45.9 m -75.86 -38.0 58.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.481 -0.762 . . . . 0.0 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -62.88 -32.47 73.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 109.819 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.4 p -92.62 19.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.125 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 122' ' ' HIS . 6.4 m120 66.25 34.89 6.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.757 -0.59 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 117' ' ' TRP . 86.2 t60 38.31 33.94 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 0.0 109.907 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -130.89 153.18 81.63 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.91 140.52 35.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.183 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.584 HE21 ' C ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -109.26 123.89 50.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.073 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.584 ' C ' HE21 ' A' ' 125' ' ' GLN . 71.7 mtm -94.71 117.08 29.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.029 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.0 115.35 24.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.268 -0.895 . . . . 0.0 108.974 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.61 19.9 5.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 109.416 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 136.03 55.23 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -97.16 -12.22 23.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 0.0 108.969 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 p -140.02 163.62 32.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.499 -0.751 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.42 -34.29 76.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.136 -0.978 . . . . 0.0 109.134 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.9 p -72.92 -19.52 61.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.768 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -84.15 3.88 32.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.36 138.84 23.97 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.26 135.9 30.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.303 2.002 . . . . 0.0 112.601 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -111.45 1.95 17.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.039 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -147.32 90.06 1.84 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.6 OUTLIER -109.71 156.71 39.28 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 109.042 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.5 -37.48 90.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.021 1.814 . . . . 0.0 111.338 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.11 -41.92 66.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.899 . . . . 0.0 108.666 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -68.03 -42.28 80.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.82 . . . . 0.0 109.351 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.88 -42.31 90.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.65 74.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.0 tp -60.72 -46.07 91.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.363 -0.836 . . . . 0.0 108.861 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.44 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 5.7 t -58.41 -46.81 85.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 109.669 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.67 -44.63 96.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 109.946 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.682 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.25 -44.8 78.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.36 -36.34 83.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -60.61 -39.44 88.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.448 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' C ' ' H ' ' A' ' 153' ' ' GLY . 25.4 mmtm -64.98 -36.49 84.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.682 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.8 5.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.99 24.98 63.01 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.86 111.92 23.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.503 -0.998 . . . . 0.0 108.412 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -96.28 176.72 5.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 57.61 47.14 16.42 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.52 36.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.73 171.38 0.05 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.0 p -60.81 -28.13 68.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.148 . . . . 0.0 109.325 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -65.59 -38.31 89.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.94 -44.42 81.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 146' ' ' SER . 84.7 m -63.68 -42.64 98.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.611 -0.68 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.428 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.59 -40.95 80.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 110.035 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 38' ' ' GLU . 76.9 p -63.34 -40.21 96.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.916 . . . . 0.0 109.873 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 1.7 t80 -59.32 -43.85 92.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.099 -1.001 . . . . 0.0 109.388 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.0 mtp -62.26 -38.87 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -41.88 89.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.451 -0.78 . . . . 0.0 111.244 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.63 5.8 41.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.049 -1.032 . . . . 0.0 111.362 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.592 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 21.0 t -96.76 -13.01 22.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.737 -1.227 . . . . 0.0 110.31 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.55 -5.98 57.25 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.592 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -62.94 -33.58 75.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.951 -1.323 . . . . 0.0 109.613 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.02 138.68 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.6 m120 -113.27 164.02 14.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.434 -0.791 . . . . 0.0 110.132 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.6 OUTLIER 92.4 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.377 0.608 . . . . 0.0 110.332 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 16.2 m170 -53.45 -38.6 63.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 176' ' ' VAL . 2.9 p -162.18 55.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 176' ' ' VAL . 13.5 p 23.51 67.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.335 0.588 . . . . 0.0 111.156 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.47 35.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 31.0 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.119 -1.224 . . . . 0.0 109.487 179.503 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' NE2' ' A' ' 175' ' ' HIS . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.658 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.594 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.696 HE22 ' CG1' ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.578 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' CZ2' ' CZ ' ' A' ' 16' ' ' TYR . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.696 ' CG1' HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 53.3 m-85 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.946 0.311 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 84' ' ' GLY . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 92' ' ' ILE . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' OG ' ' A' ' 118' ' ' SER . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 115' ' ' PHE . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.561 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.573 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.657 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.657 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.437 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.547 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 131.38 28.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.819 . . . . 0.0 110.043 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.01 -27.97 52.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -2.96 58.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.379 -1.071 . . . . 0.0 108.987 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER -95.42 -23.29 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.586 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -63.7 6.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 109.439 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.574 ' H ' ' C ' ' A' ' 7' ' ' VAL . 85.0 mt-30 -91.63 -168.37 2.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.4 153.42 1.33 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.4 -0.813 . . . . 0.0 109.869 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.19 -20.72 32.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.63 -37.56 76.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 109.875 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CE2' ' OE1' ' A' ' 9' ' ' GLN . 2.6 m-85 -67.05 -35.33 79.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.72 -36.68 67.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.586 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.14 -49.9 58.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.882 -1.136 . . . . 0.0 108.899 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 21' ' ' TRP . 19.6 t80 -63.79 -41.29 97.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 108.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -70.85 -42.07 70.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.683 -0.636 . . . . 0.0 110.8 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.87 -10.45 58.52 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 110.517 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 83.7 m-20 -80.02 -76.13 0.23 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.788 -1.195 . . . . 0.0 109.364 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 21' ' ' TRP . 95.6 mt-10 -146.88 -65.41 0.28 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 21' ' ' TRP . 8.3 t90 26.35 63.12 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.377 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 120.5 57.55 0.24 Allowed Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.829 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.748 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 p -176.49 -21.16 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 113.487 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.748 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 72.8 Cg_endo -89.24 150.89 5.55 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.612 1.541 . . . . 0.0 113.258 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.02 156.21 39.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.06 132.12 36.22 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.595 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.93 147.15 29.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -60.85 -35.62 77.03 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -75.26 -50.62 15.55 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.508 -0.745 . . . . 0.0 111.072 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -34.96 77.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.963 -1.086 . . . . 0.0 109.291 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.615 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 65.8 mt -63.29 -36.5 83.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.149 -0.969 . . . . 0.0 109.199 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.29 -43.0 92.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.61 -38.02 80.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.984 -1.072 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.2 tpp -63.3 -50.65 69.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.679 -0.638 . . . . 0.0 111.006 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.94 -27.08 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.228 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.8 t -71.02 -53.92 13.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 108.861 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.07 -38.91 92.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 108.512 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.572 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -67.5 -39.24 85.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 108.891 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.57 94.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.11 -4.89 43.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 109.661 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -78.15 2.82 16.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.116 . . . . 0.0 109.977 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -65.22 132.09 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.043 . . . . 0.0 109.093 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.15 -29.77 0.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 42' ' ' ALA . 79.7 mt -98.14 139.89 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.608 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.7 m -69.18 154.39 42.13 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.247 -0.908 . . . . 0.0 108.661 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.55 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 1.2 t-105 -55.15 -39.56 69.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.0 . . . . 0.0 109.841 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -37.64 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -0.956 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -57.98 -41.76 83.65 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.954 -1.091 . . . . 0.0 108.531 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -67.05 -31.65 54.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.809 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -48.59 81.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.088 -1.008 . . . . 0.0 109.939 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 53.1 mttt -62.21 -46.37 89.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.784 -1.197 . . . . 0.0 108.1 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.31 -16.44 61.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttm180 -63.69 -46.51 85.19 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -65.9 -45.41 82.09 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.2 m-80 -67.88 -43.09 80.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.654 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 89.8 t80 -60.44 -47.22 87.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 0.0 110.24 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -58.04 -34.2 69.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.042 -1.036 . . . . 0.0 109.837 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.77 95.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.896 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.6 m -72.98 -43.96 61.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.039 . . . . 0.0 111.079 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.654 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 84.9 m-85 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.055 . . . . 0.0 110.906 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 N--CA 1.489 1.24 0 N-CA-C 115.287 1.226 . . . . 0.0 115.287 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -37.45 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.615 -1.303 . . . . 0.0 110.891 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -35.34 69.62 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.112 -0.993 . . . . 0.0 110.982 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 69' ' ' ALA . 3.7 m -73.94 -36.35 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.282 -1.511 . . . . 0.0 108.246 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -60.39 -20.54 59.96 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.91 -11.3 36.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.552 ' CE ' ' OD2' ' A' ' 75' ' ' ASP . 4.1 mmm -75.57 119.86 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.564 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 7.0 tt0 -95.57 168.49 10.66 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 109.901 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 98.1 mt-10 -49.75 -25.74 3.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.955 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 108.076 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -70.13 -37.8 75.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.918 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.606 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 49.5 t -61.8 -44.06 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.63 -0.669 . . . . 0.0 110.749 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.69 -32.81 74.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 108.14 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -67.95 -42.88 80.27 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.605 0.716 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.6 -33.58 72.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 111.722 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.463 ' CG2' ' NH1' ' A' ' 89' ' ' ARG . 55.2 t -48.24 -31.28 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.892 -1.13 . . . . 0.0 108.527 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -100.43 -4.48 28.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.18 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 84' ' ' GLY . 57.5 t0 -88.22 109.32 19.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.763 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.34 -16.34 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.472 -0.768 . . . . 0.0 109.656 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.48 35.33 47.59 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.0 pt -54.8 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -1.109 . . . . 0.0 110.207 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -53.53 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' ILE . 59.8 mtp180 -53.19 106.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.407 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.53 92.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 89' ' ' ARG . 5.4 mtt-85 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.545 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.31 -59.32 7.98 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.229 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -61.42 -43.43 98.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.923 -1.339 . . . . 0.0 110.914 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.58 -49.15 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.0 110.529 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.89 65.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.83 -1.169 . . . . 0.0 109.019 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.56 94.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.174 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.61 -40.81 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.2 mp -58.18 -45.16 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.09 94.13 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -51.38 -44.09 62.06 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.054 -1.262 . . . . 0.0 108.965 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 102' ' ' TYR . . . -64.54 -39.93 94.67 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.274 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.97 -37.74 61.46 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.29 70.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' ALA . 42.0 t80 -63.43 -43.43 97.49 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.56 -34.76 78.52 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.2 -37.26 84.64 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.329 -0.949 . . . . 0.0 109.546 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 99.1 mmm -70.71 -41.69 71.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 108.339 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -58.75 -24.35 61.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.03 -12.56 28.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.96 24.03 74.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -120.52 101.83 45.8 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.358 -1.084 . . . . 0.0 109.584 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.88 150.23 73.17 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.145 1.897 . . . . 0.0 112.377 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 73.0 m-85 -58.05 -40.68 81.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.351 -0.843 . . . . 0.0 110.489 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.6 72.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.779 . . . . 0.0 112.442 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.93 -53.92 22.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 0.0 111.873 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 1.9 p90 -68.27 -40.93 81.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.006 -1.059 . . . . 0.0 111.658 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 14.7 p -64.88 -48.93 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 110.377 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 122' ' ' HIS . 10.9 m95 -55.14 -27.5 45.88 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.3 t -71.8 -36.49 70.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.44 -0.787 . . . . 0.0 110.598 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -66.72 -28.78 68.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.25 19.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 20.0 m120 64.11 44.02 4.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.7 -0.625 . . . . 0.0 110.222 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 44.94 12.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 110.527 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mt-30 -131.16 149.92 75.07 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.208 -0.933 . . . . 0.0 109.267 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HB2' HD22 ' A' ' 173' ' ' ASN . 32.8 Cg_endo -67.22 162.16 39.76 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.298 1.999 . . . . 0.0 111.722 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.65 135.39 49.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 109.673 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.2 mtt -90.31 116.45 28.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 109.093 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -89.89 111.4 22.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.209 -0.932 . . . . 0.0 109.1 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -92.51 17.53 9.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 109.286 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.07 141.9 57.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 134' ' ' GLU . 42.6 p -98.82 -11.37 21.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.669 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -145.34 160.09 42.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.29 -42.71 96.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -65.24 -31.78 73.11 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.494 ' OE1' ' OG1' ' A' ' 130' ' ' THR . 63.6 tt0 -80.85 1.47 30.56 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.597 -0.689 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.83 143.74 27.0 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 108.732 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.15 136.54 12.93 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.202 1.935 . . . . 0.0 112.414 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.3 p -107.17 2.99 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.019 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t -147.24 90.66 1.9 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.416 -0.802 . . . . 0.0 108.988 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.499 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 39.6 p -100.32 152.06 37.72 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.45 -36.6 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.582 1.521 . . . . 0.0 111.269 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -39.65 63.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.561 ' HG ' ' CE ' ' A' ' 166' ' ' MET . 68.5 m -66.42 -46.73 75.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.6 -38.88 82.43 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.029 -1.044 . . . . 0.0 109.154 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.38 63.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.512 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 2.8 tm? -59.47 -46.33 89.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.683 ' HG ' ' N ' ' A' ' 147' ' ' LYS . 0.8 OUTLIER -63.05 -46.14 88.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.478 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.683 ' N ' ' HG ' ' A' ' 146' ' ' SER . 30.1 mtpt -59.18 -37.91 78.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.752 -0.593 . . . . 0.0 109.614 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.07 68.6 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.286 -0.883 . . . . 0.0 109.854 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.81 -36.4 78.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.6 -39.95 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.088 . . . . 0.0 108.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -65.73 -33.58 76.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 3.7 mmp_? -71.4 3.08 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 109.202 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.1 26.11 38.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.66 116.25 30.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.475 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -92.06 174.47 7.3 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.562 0.696 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 58.78 58.76 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.572 0.701 . . . . 0.0 109.772 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.2 OUTLIER -126.75 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.53 150.5 0.36 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.1 m -53.17 -29.47 31.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.315 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -74.24 -35.51 63.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -66.33 -36.74 78.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -69.48 -38.37 77.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.041 . . . . 0.0 109.394 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.497 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.66 -46.8 74.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.509 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 95.0 p -65.19 -33.34 75.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 108.824 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.578 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 49.4 t80 -59.25 -46.07 89.48 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.614 -0.679 . . . . 0.0 109.679 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.561 ' CE ' ' HG ' ' A' ' 142' ' ' SER . 22.0 mtm -63.33 -38.0 89.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.525 HE22 ' CG2' ' A' ' 172' ' ' VAL . 84.0 mm-40 -60.44 -42.67 96.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.962 -1.086 . . . . 0.0 109.811 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.411 -0.806 . . . . 0.0 109.983 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 66.9 m -58.36 -31.11 67.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.928 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.08 0.44 44.74 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.33 -28.72 69.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.969 . . . . 0.0 109.777 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.525 ' CG2' HE22 ' A' ' 167' ' ' GLN . 21.6 t -112.94 147.83 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.038 . . . . 0.0 110.544 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -125.57 164.34 20.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.2 m-20 76.58 70.39 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.665 -0.647 . . . . 0.0 110.457 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.424 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 22.0 m170 -47.24 -38.19 11.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 108.418 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 178' ' ' GLY . 3.5 p -166.04 18.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.403 ' CG2' ' C ' ' A' ' 176' ' ' VAL . 1.3 t 65.39 -44.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -83.48 29.6 3.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.444 -1.033 . . . . 0.0 109.721 -179.605 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.438 0.637 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.14 147.76 52.85 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.439 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.16 96.14 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 121.669 -0.644 . . . . 0.0 112.045 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -87.73 -0.68 57.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.486 -1.596 . . . . 0.0 110.124 -179.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.21 -44.56 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.141 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m -76.59 7.07 4.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 108.756 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 7.4 tt0 -91.99 -116.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.467 -0.771 . . . . 0.0 109.745 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.5 m-20 -79.41 154.79 76.72 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 108.962 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' O ' ' N ' ' A' ' 13' ' ' TYR . 19.4 Cg_endo -65.16 -160.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.438 2.092 . . . . 0.0 111.88 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt 61.96 -39.47 0.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.472 -0.768 . . . . 0.0 110.004 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.7 m-85 -63.4 -39.13 93.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.23 -43.73 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.624 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.49 -51.09 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.424 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.448 ' HA ' HD21 ' A' ' 19' ' ' ASN . 1.2 t80 -61.36 -41.52 97.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -70.53 -36.07 73.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.07 -5.04 58.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.081 -1.012 . . . . 0.0 111.008 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 85.5 m-20 -83.75 -77.01 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.692 -1.255 . . . . 0.0 110.492 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -153.18 55.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.687 ' CH2' ' CE2' ' A' ' 6' ' ' TRP . 6.7 t90 -103.07 73.65 1.25 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 152.4 -20.71 0.83 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.637 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.712 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 7.9 m -123.4 7.1 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.429 -1.042 . . . . 0.0 113.18 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 71.7 Cg_endo -76.51 149.75 31.1 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.592 1.528 . . . . 0.0 113.416 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -91.88 166.01 12.95 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.611 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 10.5 p -91.71 107.84 19.49 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.481 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 96.2 m-20 -84.69 168.58 15.12 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 m -76.99 -41.5 42.64 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.845 -1.16 . . . . 0.0 111.558 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' CD ' ' OH ' ' A' ' 102' ' ' TYR . 26.9 mmtp -76.19 -42.8 45.13 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 32.0 mmtm -58.46 -40.5 82.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.811 -1.18 . . . . 0.0 110.848 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.599 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.75 -40.26 79.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 109.712 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.09 -47.76 83.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.57 -40.06 73.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.915 -1.116 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.57 -52.51 63.11 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.0 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.52 -28.21 44.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.037 -1.039 . . . . 0.0 110.132 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.34 -46.85 66.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.014 -1.054 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 37' ' ' LEU . 4.6 mm? -69.29 -38.83 78.51 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 108.992 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -57.75 -36.29 71.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.414 -0.804 . . . . 0.0 109.253 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.7 -42.85 59.39 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' ALA . 62.6 tp60 -65.73 -32.56 74.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 0.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 40' ' ' GLN . 2.2 pp0? -41.89 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.005 -1.059 . . . . 0.0 109.688 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.98 -1.075 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.05 -35.62 2.55 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.309 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 4.0 mm? -95.7 144.39 26.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -1.214 . . . . 0.0 110.304 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.9 m -68.67 153.2 44.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 108.764 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.663 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -62.07 -37.0 83.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.003 -1.061 . . . . 0.0 109.81 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -38.52 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.53 -1.356 . . . . 0.0 109.033 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.1 m -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.01 -40.84 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.673 . . . . 0.0 109.401 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.85 -45.68 85.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.779 -1.201 . . . . 0.0 109.11 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -64.41 -37.15 86.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 108.401 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -59.66 -37.27 78.28 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.663 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 77.3 mtt180 -59.39 -39.78 84.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.012 -1.055 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.96 -45.23 78.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.216 -1.552 . . . . 0.0 110.732 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.68 HD21 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -81.69 -39.86 23.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.861 -1.149 . . . . 0.0 110.476 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' N ' HD21 ' A' ' 55' ' ' ASN . 54.2 t80 -60.88 -47.0 88.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.899 -1.125 . . . . 0.0 109.477 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HG3' HH11 ' A' ' 57' ' ' ARG . 21.3 mmm-85 -63.08 -33.87 76.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.117 -0.989 . . . . 0.0 108.829 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.38 70.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.8 m -75.04 -43.3 54.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.039 -1.038 . . . . 0.0 111.448 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.083 . . . . 0.0 111.044 -178.833 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.451 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 97.1 Cg_exo . . . . . 0 N--CA 1.487 1.103 0 N-CA-C 114.011 0.735 . . . . 0.0 114.011 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.39 -38.17 68.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.266 -1.521 . . . . 0.0 109.177 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -32.87 74.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.99 -1.069 . . . . 0.0 110.379 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.514 HG21 ' N ' ' A' ' 69' ' ' ALA . 20.5 m -63.83 -37.25 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.209 -1.557 . . . . 0.0 108.96 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' N ' HG21 ' A' ' 68' ' ' VAL . . . -58.6 -23.43 58.74 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.46 -9.04 36.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttm -77.8 121.34 23.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 20.6 pt20 -95.49 176.7 6.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.23 -35.63 77.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 41.1 tp10 -54.05 -45.72 71.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.936 -1.102 . . . . 0.0 108.198 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -64.37 -38.13 89.95 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.574 0.702 . . . . 0.0 109.141 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -38.64 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 110.183 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 3.7 pt-20 -72.93 -42.29 63.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.921 -1.112 . . . . 0.0 111.818 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -74.2 -38.18 63.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.691 -1.256 . . . . 0.0 110.417 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.514 ' CD1' ' C ' ' A' ' 79' ' ' LEU . 0.4 OUTLIER -67.11 -32.3 73.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.985 . . . . 0.0 109.829 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -49.71 -24.75 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -85.64 -6.66 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.132 -0.98 . . . . 0.0 108.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' GLY . 97.1 m-20 -77.97 108.13 11.01 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.509 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 69.63 -15.49 0.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.698 . . . . 0.0 109.839 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.4 34.67 57.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.652 ' O ' ' N ' ' A' ' 87' ' ' ARG . 21.9 pt -46.3 176.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.432 -1.04 . . . . 0.0 109.41 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.5 tt -52.29 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 85' ' ' ILE . 9.3 ptp180 -54.07 133.33 43.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.863 0.839 . . . . 0.0 110.342 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 4.0 m-70 175.15 65.94 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -46.05 -29.33 1.45 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 110.09 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.35 -61.06 5.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.01 -38.38 85.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.99 -44.43 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 110.043 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.422 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -57.69 -32.35 67.27 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.9 -1.125 . . . . 0.0 108.767 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.75 -37.7 82.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 0.0 109.437 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.1 -32.22 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.7 mm -59.12 -43.97 90.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 108.245 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.23 -29.86 76.34 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -58.62 -43.44 89.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.061 -1.258 . . . . 0.0 109.235 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.55 94.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.86 -1.15 . . . . 0.0 109.449 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.29 -35.53 69.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.898 -1.126 . . . . 0.0 108.939 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.32 -28.89 64.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.048 -1.033 . . . . 0.0 108.398 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' CD ' ' A' ' 29' ' ' LYS . 80.8 t80 -64.33 -43.22 95.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.05 -32.95 74.92 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.561 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 14.5 mm100 -59.4 -39.28 82.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.811 -1.155 . . . . 0.0 108.753 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.525 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 97.6 mmm -67.6 -40.27 84.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.996 -1.065 . . . . 0.0 109.049 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 75.9 mm-40 -72.06 -42.24 66.47 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.413 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -57.71 -25.17 59.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.561 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 17.0 m120 -92.62 -10.08 38.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 67.69 23.64 73.96 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -116.53 105.07 50.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.142 -1.211 . . . . 0.0 109.934 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -56.18 152.28 38.92 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.35 2.034 . . . . 0.0 113.01 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 25.5 m-85 -62.42 -38.94 91.63 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.774 0.797 . . . . 0.0 110.706 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.62 -35.48 79.7 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.535 -0.728 . . . . 0.0 111.724 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.46 -43.42 98.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.3 p90 -74.93 -43.99 51.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.321 -1.487 . . . . 0.0 111.01 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.475 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 14.9 m -58.43 -49.38 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 120.073 -1.642 . . . . 0.0 109.053 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.611 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.2 m95 -55.94 -27.41 52.27 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.12 -0.988 . . . . 0.0 108.629 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m -70.58 -41.49 72.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.238 -0.914 . . . . 0.0 111.103 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.457 ' CD1' ' CB ' ' A' ' 144' ' ' ALA . 30.9 m-85 -67.02 -30.31 70.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.767 -1.208 . . . . 0.0 110.377 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.85 15.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 109.597 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.408 HD21 ' HG3' ' A' ' 123' ' ' GLN . 5.2 t30 59.89 36.08 21.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.84 . . . . 0.0 110.371 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 47.38 29.9 1.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -0.992 . . . . 0.0 109.821 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.408 ' HG3' HD21 ' A' ' 121' ' ' ASN . 2.6 mm-40 -131.94 148.33 69.43 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.092 -1.005 . . . . 0.0 109.881 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.82 149.37 86.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.51 2.14 . . . . 0.0 111.959 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 126' ' ' MET . 4.2 tm0? -115.34 139.49 49.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.0 109.835 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.555 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.1 mpp? -100.54 118.3 36.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.142 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.413 HG21 ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -72.14 -35.47 69.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 109.21 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 54.4 41.09 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.126 -0.984 . . . . 0.0 109.837 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -102.53 145.58 29.39 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.47 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.4 p -106.96 -29.55 9.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.696 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -134.77 165.67 24.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.658 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.87 -31.99 67.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.494 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -72.79 -10.96 60.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 109.577 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -100.92 10.74 40.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.33 111.91 60.92 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.92 142.86 28.62 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.729 1.619 . . . . 0.0 111.779 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 48.6 p -110.99 7.57 21.63 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -135.14 95.48 3.31 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -116.58 154.42 49.16 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.92 -38.6 86.23 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.719 1.613 . . . . 0.0 111.488 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.27 -43.12 64.76 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.531 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 143' ' ' ASP . 85.8 p -62.73 -39.03 92.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 108.651 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.583 ' N ' ' HG ' ' A' ' 142' ' ' SER . 27.5 t70 -61.57 -37.55 84.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 119' ' ' PHE . . . -66.51 -39.04 88.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.721 -0.612 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.62 -40.07 92.18 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.998 -1.064 . . . . 0.0 109.517 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.584 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 14.5 m -59.85 -47.37 86.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.707 -1.246 . . . . 0.0 110.44 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -74.02 -38.03 64.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.867 -1.145 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.53 -43.19 70.08 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.558 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.03 -43.15 79.41 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.19 -0.944 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -64.33 -39.92 94.85 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.863 -1.148 . . . . 0.0 109.727 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -70.18 -26.37 63.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.673 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -76.23 1.85 14.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.056 -1.028 . . . . 0.0 108.38 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.06 26.94 29.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.77 116.03 31.56 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.768 -0.842 . . . . 0.0 108.811 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.12 171.12 9.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 56.47 61.22 2.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 0.0 108.938 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.89 40.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.45 173.72 0.04 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.5 m -59.17 -31.13 68.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.905 -0.762 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 50.4 p -72.36 -34.78 68.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 108.74 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.26 -44.34 97.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 108.813 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.584 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 87.7 m -62.71 -43.98 97.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.76 -44.93 76.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.897 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.522 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 15.9 m -59.62 -41.57 90.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 109.441 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 3.3 t80 -59.56 -47.29 86.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 109.767 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 76.1 mtp -63.42 -32.71 74.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.29 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -44.98 88.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 110.785 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 111.731 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -55.48 -23.61 26.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.95 -1.094 . . . . 0.0 110.441 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.91 -2.16 59.91 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.7 mt -62.79 -27.94 69.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.542 -0.975 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.85 133.07 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.117 -0.989 . . . . 0.0 109.46 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 19.3 m-80 -108.7 163.07 13.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.428 -0.795 . . . . 0.0 109.645 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 85.49 69.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.787 -0.57 . . . . 0.0 110.982 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.434 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 3.4 m170 -55.69 -48.99 74.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 0.0 108.945 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 177' ' ' VAL . 5.7 m -139.33 30.19 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 109.588 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 176' ' ' VAL . 37.5 t 52.58 105.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.74 45.0 6.57 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.33 . . . . 0.0 108.677 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.686 0.755 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.78 154.07 26.76 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.696 0.76 . . . . 0.0 109.508 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -52.85 -47.96 58.14 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.682 -0.636 . . . . 0.0 112.413 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -88.12 -0.52 57.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.433 -1.628 . . . . 0.0 110.496 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG21 ' CG ' ' A' ' 17' ' ' HIS . 7.6 t -77.0 -41.03 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.858 -1.152 . . . . 0.0 109.241 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -71.7 -4.66 28.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 68.9 tp60 -60.62 -42.97 97.93 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.881 -0.512 . . . . 0.0 110.38 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -161.76 159.35 22.52 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.672 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.29 -35.39 62.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.81 2.34 . . . . 0.0 112.483 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.5 mt -61.83 -39.59 92.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.31 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.547 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -64.48 -40.59 95.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.408 -0.807 . . . . 0.0 109.252 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.4 mt -56.77 -40.01 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.11 76.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.835 -1.166 . . . . 0.0 109.587 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 2.0 t80 -65.68 -40.14 92.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.778 . . . . 0.0 110.17 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 7' ' ' VAL . 47.4 t-80 -73.58 -35.53 65.44 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 110.791 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -80.51 -8.72 59.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.168 -0.957 . . . . 0.0 111.775 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 2.9 p30 -84.14 -58.0 2.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.52 -1.362 . . . . 0.0 110.849 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.2 mt-10 -148.69 -54.07 0.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.492 -1.38 . . . . 0.0 109.666 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.594 ' C ' ' O ' ' A' ' 20' ' ' GLU . 5.8 t90 2.24 66.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.592 0.711 . . . . 0.0 111.607 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 148.63 -21.35 1.32 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.286 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.6 m -119.31 3.09 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.623 0 O-C-N 121.62 -0.929 . . . . 0.0 112.814 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 84.7 Cg_endo -79.93 150.68 21.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.468 1.445 . . . . 0.0 112.837 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -97.98 168.41 10.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 36.8 p -91.8 118.0 30.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.708 -1.245 . . . . 0.0 110.29 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -108.06 144.47 35.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.9 m -59.99 -35.94 76.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.882 -1.136 . . . . 0.0 109.027 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.62 -50.2 22.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.689 -0.632 . . . . 0.0 110.316 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -27.31 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.84 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -66.86 -36.99 83.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.017 -1.052 . . . . 0.0 109.214 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.8 t80 -64.77 -48.43 74.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.62 -32.09 65.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.757 -1.214 . . . . 0.0 109.11 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -48.82 63.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.633 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.23 -27.8 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.423 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 97.9 m -69.19 -50.05 50.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.185 -0.947 . . . . 0.0 109.898 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.4 mt -67.95 -37.4 81.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.087 -1.008 . . . . 0.0 108.927 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -66.88 -39.15 87.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.623 -0.673 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.44 -35.86 92.31 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -72.23 -6.46 43.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -1.202 . . . . 0.0 109.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -77.04 -1.98 31.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -69.07 121.56 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 108.851 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.58 -31.83 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 42' ' ' ALA . 30.2 mt -101.48 144.09 30.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.117 . . . . 0.0 109.838 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -69.49 156.25 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -56.99 -36.5 70.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.173 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -35.49 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.5 m -59.24 -41.83 89.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.868 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -68.0 -32.56 56.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.132 -0.98 . . . . 0.0 109.492 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.94 -43.97 94.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.183 -0.948 . . . . 0.0 110.354 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.89 75.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 14.6 mtmm -78.89 -7.4 57.92 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.323 -0.861 . . . . 0.0 109.295 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.2 ttm180 -65.68 -46.86 77.49 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.7 -45.99 67.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.978 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -66.25 -43.16 87.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.537 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 68.9 t80 -59.79 -45.47 92.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.872 . . . . 0.0 110.94 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -61.76 -29.5 70.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.828 -1.17 . . . . 0.0 108.986 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -66.36 -36.21 82.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.95 -45.22 78.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.827 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 44.8 m-85 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.495 1.595 0 N-CA-C 113.455 0.521 . . . . 0.0 113.455 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -61.52 -45.93 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.917 -1.115 . . . . 0.0 110.156 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.14 -37.8 86.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.403 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.63 -36.91 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.216 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -65.1 -18.94 65.72 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.84 -7.88 57.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.3 mtp -82.99 113.15 20.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -95.88 177.59 5.72 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 98.3 mt-10 -55.29 -31.78 61.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.224 -0.922 . . . . 0.0 110.879 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 -45.08 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 108.237 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -64.27 -38.67 91.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.23 -42.7 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.423 -0.798 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.6 -44.22 89.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.519 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 2.4 ptp180 -75.78 -33.62 60.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.857 -1.152 . . . . 0.0 110.001 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -61.6 -32.83 72.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.299 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.6 t -49.3 -34.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 108.662 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.84 -1.02 30.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 55.6 t0 -80.7 108.82 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.447 -1.408 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 76.27 -12.21 1.05 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.438 -0.788 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 77.07 33.29 45.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt -57.47 -166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -1.213 . . . . 0.0 109.332 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.01 95.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.155 -0.965 . . . . 0.0 109.129 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.649 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -57.66 109.65 0.75 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.714 0.769 . . . . 0.0 109.34 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 1.8 m80 -178.14 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -50.32 -31.59 14.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.318 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.71 -62.52 6.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -64.52 -40.82 96.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.785 -1.42 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.17 -48.91 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.085 -1.01 . . . . 0.0 110.449 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.56 -29.22 66.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.661 -1.275 . . . . 0.0 108.953 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.438 ' N ' ' HG3' ' A' ' 93' ' ' GLN . . . -64.3 -37.59 88.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.45 -40.16 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.93 -43.01 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 108.76 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.93 -35.91 88.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.12 -37.03 76.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -1.118 . . . . 0.0 109.163 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.91 87.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.981 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 27.8 mmt180 -60.62 -38.16 83.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.093 -1.004 . . . . 0.0 109.446 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.84 71.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 108.593 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.53 -43.74 96.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.62 -32.66 74.21 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.22 -35.11 79.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.305 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.59 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.1 tpp -63.8 -43.6 95.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.492 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -37.02 78.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.24 -24.71 66.56 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.1 m120 -93.21 -15.05 26.35 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.91 27.17 73.71 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.442 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' A' ' 105' ' ' MET . 2.0 tt0 -121.52 102.21 42.55 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.136 -1.214 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.53 141.6 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.933 1.755 . . . . 0.0 112.641 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -56.08 -38.76 71.11 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.229 1.014 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.36 -27.76 66.53 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.708 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -68.09 -48.44 65.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.095 . . . . 0.0 111.969 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.2 p90 -70.8 -37.37 73.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.763 -1.211 . . . . 0.0 110.943 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.29 -49.05 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.382 -1.449 . . . . 0.0 109.956 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.635 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 26.4 m95 -56.56 -27.1 56.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.2 t -75.73 -36.69 59.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.253 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.2 -26.02 65.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.965 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.64 19.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.717 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 69.28 35.93 2.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.765 . . . . 0.0 110.557 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 117' ' ' TRP . 1.1 t-80 45.01 30.23 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.393 -0.817 . . . . 0.0 111.344 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.66 147.99 20.04 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.637 -1.29 . . . . 0.0 110.134 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.05 148.6 85.72 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.613 2.209 . . . . 0.0 111.93 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.59 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -122.06 128.37 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.59 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.2 mtt -103.35 120.73 41.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -87.73 -26.43 22.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.439 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 57.03 45.35 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 177' ' ' VAL . . . -66.77 149.4 50.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.3 p -102.9 -25.1 13.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.051 -1.031 . . . . 0.0 109.412 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 p -136.17 162.66 32.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.158 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.31 -37.04 79.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 108.945 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.2 m -62.75 -31.42 72.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.372 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -75.19 -0.66 20.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 110.081 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.6 tp -76.46 125.57 87.35 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.999 -1.063 . . . . 0.0 108.314 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 163' ' ' TYR . 55.9 Cg_endo -74.94 136.4 20.48 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.926 1.75 . . . . 0.0 112.454 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.5 p -114.37 6.53 16.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.0 t -152.16 88.28 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.432 -0.792 . . . . 0.0 109.448 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.518 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.7 OUTLIER -102.43 155.4 36.55 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.74 -38.96 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.727 1.618 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.52 -42.06 59.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 139' ' ' THR . 88.2 p -65.86 -39.03 90.35 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.525 -0.735 . . . . 0.0 109.443 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.31 -44.77 86.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.195 -0.941 . . . . 0.0 109.144 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.08 74.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -43.78 75.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.656 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.96 -39.29 83.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.168 -0.957 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.45 -43.79 88.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 110.389 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.98 74.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.43 -38.05 89.66 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.88 -40.24 94.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.971 -1.081 . . . . 0.0 110.242 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 153' ' ' GLY . 18.4 mttp -65.28 -38.56 90.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 111.641 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -71.27 9.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 0.0 110.085 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 76.04 26.14 65.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.97 112.61 24.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -93.1 176.62 6.34 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 57.58 54.9 6.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.451 -0.781 . . . . 0.0 109.2 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.16 38.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.57 164.36 0.52 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.9 m -53.98 -34.42 59.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.499 -1.001 . . . . 0.0 109.431 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 m -68.62 -37.25 79.58 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.1 -44.31 98.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.656 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.1 m -58.05 -51.56 69.17 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -71.66 -37.88 70.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 0.0 111.733 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.496 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 13.4 m -59.12 -40.73 86.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 111.131 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.574 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.4 OUTLIER -78.36 -35.47 47.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 110.569 -179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.4 mtp -57.92 -36.15 72.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.657 -1.277 . . . . 0.0 109.291 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.66 -42.42 98.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.34 -37.8 22.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.536 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -26.12 48.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.273 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.54 -2.39 57.38 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -37.36 73.74 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.243 -1.151 . . . . 0.0 108.753 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 0.9 OUTLIER -137.2 129.66 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 109.063 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.457 ' C ' ' CG ' ' A' ' 174' ' ' ASP . 37.9 t-20 -104.98 125.23 50.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.371 -0.831 . . . . 0.0 108.878 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -178.98 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.895 -1.128 . . . . 0.0 111.587 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 3.2 m170 -48.96 -52.12 26.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.97 -1.706 . . . . 0.0 107.13 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 p 178.03 150.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 129' ' ' ALA . 27.6 t -62.21 135.37 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.893 -1.129 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.76 38.85 12.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.552 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.125 -1.221 . . . . 0.0 109.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 4' ' ' CYS . 26.9 ttm180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 3' ' ' ARG . 4.3 m -42.35 149.3 0.17 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -0.865 . . . . 0.0 109.248 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.29 -33.58 61.59 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 121.153 -0.967 . . . . 0.0 112.75 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.569 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -85.56 2.1 46.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.298 -1.707 . . . . 0.0 111.759 -177.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.57 -45.24 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 109.971 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -65.25 -17.43 64.49 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -65.43 -40.68 93.6 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.873 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.18 163.21 24.3 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.933 . . . . 0.0 109.845 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 13' ' ' TYR . 35.7 Cg_endo -68.92 -161.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.943 2.429 . . . . 0.0 112.51 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mt 62.54 -54.86 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.774 -0.579 . . . . 0.0 109.555 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -57.15 -45.76 83.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.279 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 HH12 ' A' ' 3' ' ' ARG . 85.9 mt -54.68 -42.86 63.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.733 -0.605 . . . . 0.0 110.585 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.13 98.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.711 -1.243 . . . . 0.0 108.419 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.658 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.0 t80 -71.67 -31.47 66.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.623 0.725 . . . . 0.0 110.001 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -64.14 -44.68 91.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 112.382 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.69 -4.52 37.1 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.717 -1.239 . . . . 0.0 112.815 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.743 HD21 ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -96.01 -15.68 22.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.462 -1.399 . . . . 0.0 112.243 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.743 ' N ' HD21 ' A' ' 19' ' ' ASN . 14.0 pt-20 177.07 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.728 -1.232 . . . . 0.0 109.276 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.458 ' CH2' ' CZ2' ' A' ' 6' ' ' TRP . 4.8 t90 -131.88 83.52 2.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.186 0.993 . . . . 0.0 108.887 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.3 -20.31 11.33 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.701 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 28.9 m -110.71 -12.38 0.12 Allowed Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 112.957 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 75.5 Cg_endo -80.05 150.68 20.68 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.358 1.372 . . . . 0.0 114.122 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -96.18 159.75 14.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.639 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 1.7 p -86.72 111.48 20.74 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.566 -1.334 . . . . 0.0 110.886 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 70.1 m-20 -94.24 156.73 16.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -67.4 -39.71 85.59 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.565 -1.334 . . . . 0.0 110.282 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -75.19 -50.12 17.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 111.804 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -61.3 -30.1 70.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.589 -1.319 . . . . 0.0 109.19 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 4.7 mp -57.14 -39.56 75.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.092 -1.005 . . . . 0.0 108.45 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.572 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 63.2 t80 -63.25 -45.46 91.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.467 -0.771 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -67.45 -40.69 85.42 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.827 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.4 tpp -65.07 -52.55 54.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.451 -0.781 . . . . 0.0 110.223 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.75 -27.17 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 109.03 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 47.7 m -70.57 -52.4 21.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.3 mt -66.79 -39.23 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 108.764 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' OE2' ' CB ' ' A' ' 164' ' ' SER . 13.3 tp10 -64.19 -37.72 88.49 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.642 -0.661 . . . . 0.0 109.865 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.51 -33.14 70.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 25.6 mm-40 -81.71 -1.45 47.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.514 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -78.78 -2.25 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.015 . . . . 0.0 109.323 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.71 113.84 10.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 -34.63 3.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -95.62 145.43 25.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -1.095 . . . . 0.0 109.63 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -71.97 152.88 42.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 109.203 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.658 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 2.5 t-105 -59.64 -28.9 67.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 110.161 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -29.36 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.564 -1.335 . . . . 0.0 109.487 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 m -68.54 -44.04 75.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.112 -0.992 . . . . 0.0 108.829 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.69 -26.08 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -54.98 -43.94 74.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -37.04 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.12 -36.88 85.08 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -57.93 -46.53 84.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.803 -0.561 . . . . 0.0 111.769 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 55' ' ' ASN . 15.2 pt-20 -72.5 -44.32 62.4 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.787 -1.196 . . . . 0.0 110.727 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.711 HD21 ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -73.06 -32.17 64.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.746 -1.221 . . . . 0.0 109.396 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.711 ' N ' HD21 ' A' ' 55' ' ' ASN . 71.4 t80 -58.57 -46.5 86.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 109.525 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -65.05 -32.13 73.7 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.014 -1.075 . . . . 0.0 109.034 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.15 99.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.863 -1.148 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.4 m -77.49 -44.6 28.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 109.675 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.659 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 96.8 m-85 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.53 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.491 1.325 0 CA-C-O 120.95 0.312 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.63 -43.24 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.606 -1.309 . . . . 0.0 108.302 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.6 t -60.7 -38.72 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 108.825 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.37 -14.53 63.01 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.5 -12.37 29.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 90.8 mtp -76.74 110.31 11.23 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.549 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -96.8 -174.75 3.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.408 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -55.38 -30.59 60.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.813 -0.554 . . . . 0.0 110.791 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.0 pt-20 -60.6 -42.22 96.32 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.119 -1.613 . . . . 0.0 109.452 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' CG ' ' A' ' 74' ' ' GLU . 90.3 m-20 -66.92 -38.92 87.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -36.22 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.838 -1.164 . . . . 0.0 109.71 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -59.36 -36.31 75.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.712 -1.242 . . . . 0.0 107.794 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HG3' HH11 ' A' ' 78' ' ' ARG . 24.4 ttm-85 -70.32 -42.03 72.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.568 -0.708 . . . . 0.0 110.304 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLN . 94.3 mt -69.76 -34.66 74.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.423 -0.798 . . . . 0.0 112.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.9 m -50.1 -16.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.521 -1.362 . . . . 0.0 108.868 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' LEU . 23.0 pt20 -120.87 -4.43 9.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.203 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 56.2 t0 -81.5 109.58 16.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.691 -1.256 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 75.6 -17.02 0.54 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.456 -0.778 . . . . 0.0 109.3 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 80.47 32.36 34.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 87' ' ' ARG . 15.5 pt -54.48 -179.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.02 -1.282 . . . . 0.0 109.332 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 12.4 tt -60.82 89.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.587 ' O ' ' CD2' ' A' ' 88' ' ' HIS . 6.2 ptp180 -56.06 144.24 29.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 111.115 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 159.14 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 89' ' ' ARG . 1.1 mtt-85 -51.02 -38.07 49.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.424 -0.797 . . . . 0.0 108.941 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.13 -49.19 59.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.34 -45.08 94.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -1.133 . . . . 0.0 110.056 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.75 -44.12 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.069 -1.019 . . . . 0.0 109.726 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.616 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 44.5 mt-30 -54.64 -34.05 61.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.862 -1.149 . . . . 0.0 108.995 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.65 99.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.59 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.1 mm -61.93 -39.15 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 109.115 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.3 mm -59.67 -43.1 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 108.912 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.44 -32.86 85.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.52 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 m120 -61.2 -41.44 96.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.157 . . . . 0.0 109.842 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.91 98.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -62.49 -40.21 95.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.253 -0.904 . . . . 0.0 109.269 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 152' ' ' ARG . . . -63.4 -34.58 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.35 -43.12 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.0 -33.2 75.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -62.91 -37.44 86.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 109.583 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 24.0 ttm -62.86 -40.89 98.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.994 -1.066 . . . . 0.0 108.447 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.04 -35.27 79.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -64.88 -20.96 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -92.28 -17.63 24.49 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.76 73.61 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.35 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.583 ' O ' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -116.92 107.37 46.12 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.88 144.47 15.17 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.83 1.687 . . . . 0.0 112.637 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.59 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -61.65 -44.52 96.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.893 0.854 . . . . 0.0 109.917 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.29 -27.68 62.62 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.019 -1.051 . . . . 0.0 111.192 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -62.85 -49.01 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.835 -1.166 . . . . 0.0 111.118 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 4.2 p90 -72.04 -34.4 68.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.816 -1.178 . . . . 0.0 110.022 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.3 t -63.05 -54.86 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.749 -1.219 . . . . 0.0 109.87 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.639 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 57.5 m95 -59.32 -22.2 60.89 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.072 -1.017 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -66.68 -45.05 80.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 110.406 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -67.92 -29.14 68.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.094 -1.004 . . . . 0.0 109.918 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 t -87.26 18.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.525 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 123' ' ' GLN . 75.4 m-20 60.86 39.76 16.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.436 0.636 . . . . 0.0 110.007 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 42.05 25.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.404 -0.81 . . . . 0.0 110.536 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -145.66 148.28 36.02 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 120.933 -1.104 . . . . 0.0 109.511 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 19.1 Cg_endo -62.98 146.8 94.94 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.278 1.986 . . . . 0.0 111.434 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -103.59 137.63 41.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.6 mtt -93.02 120.01 32.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.26 120.37 29.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -91.0 16.63 9.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.03 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 136.49 49.31 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.7 p -99.07 -22.21 15.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.544 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 p -136.41 165.6 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -0.931 . . . . 0.0 109.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.1 mt -59.26 -34.39 72.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.046 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.3 m -69.79 -11.96 61.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -0.792 . . . . 0.0 109.697 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.09 6.44 47.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 mm -97.3 118.09 64.89 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.23 137.95 19.64 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.943 1.762 . . . . 0.0 112.227 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.2 p -95.71 4.21 53.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.6 t -137.8 95.3 3.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.4 p -109.27 150.83 41.58 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.35 -36.03 77.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.579 1.519 . . . . 0.0 111.432 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.15 -43.23 58.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.248 -0.908 . . . . 0.0 108.858 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 95.6 p -65.16 -39.9 93.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.9 -37.59 85.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.26 86.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 109.91 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.62 -46.42 87.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.017 -1.052 . . . . 0.0 109.054 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.6 t -62.1 -43.18 99.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 110.149 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -62.52 -45.43 93.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.45 -44.73 67.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.99 -36.67 80.39 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.245 -0.91 . . . . 0.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -60.45 -38.65 84.85 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.705 -1.247 . . . . 0.0 108.581 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.73 -19.94 54.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.545 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -78.97 0.9 25.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.119 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.42 26.64 32.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.52 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 1.3 m-85 -101.11 113.51 26.6 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.38 -1.071 . . . . 0.0 109.575 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -91.81 173.9 7.62 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 55.73 45.27 24.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.089 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.478 ' O ' ' CG1' ' A' ' 157' ' ' VAL . 9.3 p -132.09 49.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.42 177.1 6.07 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.578 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 54.9 m -58.6 -32.67 69.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.588 -0.948 . . . . 0.0 110.178 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.6 p -72.82 -28.25 62.44 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.917 -1.114 . . . . 0.0 109.061 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.2 mm -68.03 -45.31 83.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 110.152 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 159' ' ' THR . 3.1 p -65.89 -36.87 84.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.734 ' HH ' HE22 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -66.09 -45.97 79.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.454 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.4 m -61.98 -39.1 91.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.075 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -59.2 -41.09 87.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.082 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.2 mtp -62.51 -39.75 94.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 111.413 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.734 HE22 ' HH ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -74.29 -39.21 63.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.823 -1.173 . . . . 0.0 111.455 -178.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.423 ' N ' ' HG2' ' A' ' 167' ' ' GLN . . . -79.22 -40.2 31.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 110.889 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.677 ' HG ' ' H ' ' A' ' 171' ' ' LEU . 21.6 p -60.51 -28.77 68.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.99 2.57 42.27 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.677 ' H ' ' HG ' ' A' ' 169' ' ' CYS . 35.1 mt -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.74 143.32 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.209 -0.932 . . . . 0.0 109.583 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 34.7 m120 -111.41 163.54 13.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.437 -0.79 . . . . 0.0 110.205 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.1 OUTLIER 83.28 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.242 0.544 . . . . 0.0 109.947 179.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -50.95 -44.47 60.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 108.7 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.677 ' C ' ' H ' ' A' ' 178' ' ' GLY . 30.6 m -149.5 28.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.412 -0.805 . . . . 0.0 109.624 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.2 t 60.56 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.415 -0.803 . . . . 0.0 110.409 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -137.3 60.05 0.62 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.283 -1.128 . . . . 0.0 110.107 -179.432 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 3' ' ' ARG . 28.3 mtm-85 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.523 0.678 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.45 141.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.558 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.19 94.91 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.543 -0.723 . . . . 0.0 112.097 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -84.55 1.32 46.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.642 -1.504 . . . . 0.0 109.887 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.81 -50.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -67.99 -3.82 11.25 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.86 -39.31 94.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.404 0.621 . . . . 0.0 109.587 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -174.01 158.47 2.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.41 -0.807 . . . . 0.0 109.208 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' TYR . 12.0 Cg_endo -57.46 -161.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.478 2.119 . . . . 0.0 111.742 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -52.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 11' ' ' PRO . 14.1 m-85 -60.38 -31.66 70.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.131 -0.98 . . . . 0.0 108.893 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 mm -56.26 -40.33 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.98 -50.47 28.49 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.182 -0.949 . . . . 0.0 109.82 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 42.7 t80 -63.13 -40.78 98.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 110.579 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -60.28 -43.9 95.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.035 -1.041 . . . . 0.0 109.835 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -82.09 -14.48 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.419 -0.801 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.767 ' ND2' ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -79.28 -57.18 3.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.528 -1.357 . . . . 0.0 110.597 -178.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.767 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 2.2 pt-20 -175.45 78.82 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.596 -1.315 . . . . 0.0 110.03 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CZ3' ' NE1' ' A' ' 6' ' ' TRP . 7.7 t90 -100.77 68.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.01 -1.056 . . . . 0.0 108.523 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.55 9.75 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.662 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 96.9 t -111.01 -30.88 0.14 Allowed Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.649 -0.912 . . . . 0.0 111.927 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 67.7 Cg_endo -86.17 154.07 9.58 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.543 2.162 . . . . 0.0 113.539 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -65.93 170.5 5.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.594 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 4.8 p -92.13 124.6 36.34 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.811 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -102.48 149.13 24.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -65.07 -38.8 91.98 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.825 -1.172 . . . . 0.0 110.576 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HZ2' ' CB ' ' A' ' 29' ' ' LYS . 7.0 mtmp? -72.87 -50.71 22.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 111.61 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -63.34 -33.37 75.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.647 -1.283 . . . . 0.0 109.496 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.3 -39.13 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.267 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -59.29 -41.79 89.77 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.106 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CD ' ' NH2' ' A' ' 57' ' ' ARG . 40.5 mt-10 -71.68 -36.26 70.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.114 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.424 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -64.99 -47.15 78.56 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 111.377 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -65.98 -36.12 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.733 -1.23 . . . . 0.0 110.038 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m -70.17 -38.81 75.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.019 -1.05 . . . . 0.0 109.261 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 37' ' ' LEU . 3.1 mp -66.79 -44.59 80.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.489 -0.757 . . . . 0.0 109.817 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -67.83 -32.3 72.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.36 -33.58 32.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 42' ' ' ALA . 56.3 tp60 -75.44 -35.46 60.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.422 -1.046 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.613 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -44.15 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.314 -0.866 . . . . 0.0 110.741 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -60.68 112.78 2.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.677 -1.264 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.0 -36.83 2.13 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.602 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.8 mt -91.64 146.71 23.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.088 -1.242 . . . . 0.0 110.529 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.1 m -69.71 156.15 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -62.72 -37.8 87.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 110.297 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -63.52 -39.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 109.733 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -58.8 -38.31 78.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.899 -1.126 . . . . 0.0 108.198 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.3 t -64.34 -37.58 80.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.601 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 50' ' ' LEU . 7.1 tt -55.73 -47.15 77.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -61.91 -46.97 87.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.947 -1.096 . . . . 0.0 109.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.04 -11.81 59.85 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.942 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.674 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 38.4 ttm180 -63.19 -46.12 88.53 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.67 -41.62 68.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.009 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -70.04 -45.2 67.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.063 . . . . 0.0 111.054 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 49.8 t80 -60.86 -48.47 81.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.897 -1.127 . . . . 0.0 110.523 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.522 ' NH2' ' CD ' ' A' ' 33' ' ' GLU . 16.7 mmm180 -57.77 -31.95 67.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.06 65.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.832 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.1 m -73.16 -26.06 61.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 112.189 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 79.6 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 120.536 -1.353 . . . . 0.0 111.336 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.491 1.349 0 CA-C-O 120.994 0.331 . . . . 0.0 112.853 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.79 -37.35 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.887 -1.133 . . . . 0.0 108.856 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -35.73 66.38 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.6 t -59.52 -38.82 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.32 -16.44 63.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.97 -5.13 53.62 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.8 mmm -79.3 116.78 19.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 2.8 pt20 -95.67 177.33 5.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.5 mt-10 -59.41 -35.04 73.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.812 . . . . 0.0 110.304 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.6 tt0 -58.4 -46.44 86.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.807 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -64.93 -38.88 92.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.836 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.55 -43.54 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.45 -0.781 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.28 -39.18 92.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.508 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 78' ' ' ARG . 28.7 ttm-85 -60.81 -39.27 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 108.733 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' N ' ' A' ' 81' ' ' GLN . 80.2 mt -68.97 -33.24 73.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.652 -0.655 . . . . 0.0 110.874 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.11 -18.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 108.675 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.3 mt-30 -118.76 -11.47 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 84' ' ' GLY . 17.5 t70 -79.47 109.75 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 72.73 -19.01 0.32 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 64.2 35.47 92.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.538 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.5 pt -31.81 -105.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.208 -0.583 . . . . 0.0 111.823 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 6.4 tt -161.44 -48.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.685 -1.259 . . . . 0.0 110.218 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.584 ' NH1' ' CD2' ' A' ' 56' ' ' TYR . 9.2 mtt180 -63.33 149.04 46.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.001 -1.062 . . . . 0.0 109.409 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' ARG . 88.8 m-70 -108.04 167.74 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 109.765 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER -43.33 -40.74 3.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.136 -0.977 . . . . 0.0 109.992 -179.142 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.23 -59.26 7.56 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.303 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.55 -40.18 96.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -1.086 . . . . 0.0 110.193 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.66 -52.91 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 110.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.599 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 39.1 mt-30 -52.41 -33.81 45.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.906 -1.121 . . . . 0.0 110.099 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.57 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.874 -1.141 . . . . 0.0 109.226 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -72.09 -32.56 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 111.123 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.0 -42.61 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.542 -1.348 . . . . 0.0 108.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.93 72.69 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.66 -43.37 96.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -1.184 . . . . 0.0 109.945 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.92 73.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.048 -1.032 . . . . 0.0 108.787 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -61.54 -35.67 78.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.804 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.23 73.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 108.649 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -64.48 -43.17 95.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.14 -27.75 68.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -68.06 -38.18 82.15 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.697 0.76 . . . . 0.0 109.245 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.571 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 34.5 ttm -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.942 0.877 . . . . 0.0 108.95 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.0 -36.89 85.07 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.48 -25.69 66.23 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -91.12 -12.27 36.07 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.57 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.93 27.51 73.64 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.48 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -117.37 102.8 52.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.84 144.18 21.49 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.024 1.816 . . . . 0.0 112.813 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -55.46 -40.66 71.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.033 0.921 . . . . 0.0 108.989 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.23 -27.09 64.19 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 110.494 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.96 -53.6 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.905 -1.122 . . . . 0.0 111.202 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.5 p90 -70.73 -32.61 69.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.953 -1.092 . . . . 0.0 109.611 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -64.96 -54.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.16 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.594 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 54.3 m95 -57.36 -26.72 61.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 108.532 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 66.3 p -77.68 -31.53 52.57 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.322 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -68.78 -32.32 71.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.6 p -88.61 18.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.312 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 66.36 27.4 10.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.867 . . . . 0.0 109.534 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 51.19 33.11 8.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.454 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -137.09 150.0 68.02 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.22 145.67 39.31 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.488 2.126 . . . . 0.0 111.847 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.509 ' NE2' ' N ' ' A' ' 126' ' ' MET . 2.2 tm0? -108.15 129.2 55.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.509 ' N ' ' NE2' ' A' ' 125' ' ' GLN . 9.0 mtm -117.7 108.48 15.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.068 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -102.68 128.74 49.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.099 -1.0 . . . . 0.0 109.271 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.86 34.58 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.097 -1.002 . . . . 0.0 110.607 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 176' ' ' VAL . . . -58.32 145.82 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 108.762 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.1 p -91.84 -15.22 28.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.065 -1.022 . . . . 0.0 110.343 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -142.46 162.9 34.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 109.685 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.0 mt -59.61 -33.05 70.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -65.42 -29.09 69.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.329 -0.857 . . . . 0.0 110.886 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -85.49 -1.8 57.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.996 -1.065 . . . . 0.0 109.854 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.14 143.78 57.43 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 108.851 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.67 142.94 40.89 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.423 2.082 . . . . 0.0 112.848 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 t -125.55 4.89 7.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.9 p -157.41 87.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 163.56 16.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.509 -0.745 . . . . 0.0 109.054 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.18 -39.72 85.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.702 1.601 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.67 -43.18 66.48 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.109 -1.036 . . . . 0.0 108.549 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 p -63.51 -44.07 95.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.25 -37.55 85.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.078 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.4 95.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 109.798 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.11 -45.54 75.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -59.0 -40.23 84.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.748 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -62.68 -49.42 75.2 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 110.653 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.69 76.81 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.121 -0.987 . . . . 0.0 109.473 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.419 ' HG ' HH21 ' A' ' 152' ' ' ARG . 32.5 mt -66.91 -39.74 87.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -0.902 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -38.78 87.75 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.754 -1.216 . . . . 0.0 110.34 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -84.62 -14.68 47.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 111.948 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.488 ' O ' ' OE1' ' A' ' 104' ' ' GLN . 85.9 mtm180 -88.53 8.2 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.687 -1.258 . . . . 0.0 109.521 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.37 21.04 53.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -100.99 110.37 22.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 108.6 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -93.68 175.13 6.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 57.18 57.59 4.43 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.106 0.955 . . . . 0.0 109.124 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.4 m -128.91 42.27 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.24 162.7 0.4 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.7 m -53.65 -29.49 38.6 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -1.089 . . . . 0.0 108.921 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -73.52 -32.29 64.15 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 108.547 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.57 -45.74 98.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.48 -0.762 . . . . 0.0 109.073 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.64 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.525 -0.734 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.95 -45.94 72.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 0.0 109.692 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 97.0 p -68.81 -31.13 69.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 108.414 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.579 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 79.5 t80 -64.3 -48.0 77.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.864 -0.522 . . . . 0.0 110.277 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ptm -72.91 -32.35 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -58.18 -42.18 85.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.701 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.424 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -92.98 -32.97 14.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 111.136 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 76.3 m -54.62 -24.09 19.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.864 -1.147 . . . . 0.0 110.517 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.82 0.56 48.96 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.66 -34.0 76.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.34 -1.094 . . . . 0.0 110.165 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.1 147.52 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.093 0.949 . . . . 0.0 111.003 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.85 103.52 9.42 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 58.9 p30 -173.86 70.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.067 -1.021 . . . . 0.0 111.284 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 176' ' ' VAL . 30.8 m170 -57.95 -43.09 86.19 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.58 -1.325 . . . . 0.0 108.244 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 168.23 3.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.87 -35.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -83.8 11.92 54.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.043 . . . . 0.0 109.344 -179.661 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 56.1 mtp180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.806 0.812 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.29 146.85 2.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.9 80.47 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.429 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.56 ' CZ2' ' CH2' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.617 -1.519 . . . . 0.0 110.461 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.22 -41.9 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.907 -1.121 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.6 m -79.4 5.7 12.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 108.872 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.72 -60.48 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.763 . . . . 0.0 109.973 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.16 157.04 75.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.92 -30.32 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.584 2.189 . . . . 0.0 112.143 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.69 -37.34 86.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 -39.93 95.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.136 -0.978 . . . . 0.0 109.27 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.0 mt -54.68 -44.51 70.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.474 -0.766 . . . . 0.0 110.611 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.93 -47.93 73.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.728 -1.232 . . . . 0.0 109.224 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.7 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.7 t80 -62.12 -40.74 96.93 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.913 0.863 . . . . 0.0 108.805 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -71.48 -39.22 71.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -78.46 -5.9 53.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.189 -0.944 . . . . 0.0 111.863 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 87.1 m-20 -76.87 -75.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.527 -1.358 . . . . 0.0 110.001 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 21' ' ' TRP . 96.0 mt-10 -145.56 -40.96 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.139 -0.975 . . . . 0.0 108.724 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.592 ' C ' ' O ' ' A' ' 20' ' ' GLU . 6.4 t90 -4.68 74.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.106 0.955 . . . . 0.0 111.084 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 149.47 -25.32 1.22 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 19.6 m -120.06 4.01 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.575 -0.956 . . . . 0.0 112.766 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 69.8 Cg_endo -75.69 147.21 31.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.174 1.25 . . . . 0.0 112.987 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.68 166.37 13.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.631 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 7.6 p -99.32 108.84 21.47 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.338 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -89.32 167.17 13.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 m -73.13 -37.33 66.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.474 -1.391 . . . . 0.0 110.465 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -74.85 -41.53 59.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -59.66 -37.0 77.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.593 -1.317 . . . . 0.0 110.487 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.595 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -59.33 -38.15 79.58 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.981 -178.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.68 -45.85 90.87 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.452 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -71.22 -40.69 70.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.022 -1.049 . . . . 0.0 108.636 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.3 tpp -64.64 -48.44 74.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.641 -0.662 . . . . 0.0 110.62 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.21 -29.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.999 -1.063 . . . . 0.0 109.469 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.9 m -70.74 -48.83 52.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.022 -1.049 . . . . 0.0 109.042 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.66 -39.7 80.54 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.295 -0.878 . . . . 0.0 109.01 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.07 -37.82 86.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.421 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.54 -36.87 91.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.42 -24.18 67.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.469 -1.018 . . . . 0.0 110.061 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.8 pp0? -69.74 -3.29 14.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.711 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.43 112.71 1.67 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.725 -1.235 . . . . 0.0 109.084 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.8 -14.68 1.4 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.0 mm? -103.93 154.93 19.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.184 -1.186 . . . . 0.0 110.178 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -71.5 153.71 42.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 109.773 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.7 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -64.77 -41.99 95.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 110.434 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -31.25 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 109.728 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 m -58.11 -40.86 82.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.84 -28.04 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.097 -1.002 . . . . 0.0 109.43 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -53.44 53.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 109.827 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -61.34 -44.46 97.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.673 -1.267 . . . . 0.0 108.154 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -65.62 -26.71 67.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.3 ttm180 -53.96 -44.04 70.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.779 -1.201 . . . . 0.0 107.918 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.49 -37.05 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.397 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -78.35 -45.65 22.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.873 -1.142 . . . . 0.0 111.155 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.663 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 40.2 t80 -58.87 -46.43 87.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.159 . . . . 0.0 109.945 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 2.4 ppt_? -66.6 -29.47 69.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.11 -0.993 . . . . 0.0 109.37 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -69.08 -43.24 74.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.746 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.52 -45.46 68.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.858 -1.151 . . . . 0.0 110.648 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.462 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 20.5 m-85 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.985 -1.072 . . . . 0.0 109.997 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.024 0.343 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.79 -46.18 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.939 -1.1 . . . . 0.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.12 75.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.095 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.02 -38.22 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.545 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . . . -68.67 -14.91 63.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.08 -9.57 45.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.57 -0.707 . . . . 0.0 109.094 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.462 ' SD ' ' CD2' ' A' ' 60' ' ' PHE . 97.1 mtp -82.18 112.84 19.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.434 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -95.77 -176.49 3.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 109.98 -178.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.61 -33.12 67.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 110.617 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.0 -33.13 75.3 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 108.506 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 62.3 m-20 -68.22 -40.1 82.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.528 -0.733 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -66.69 -33.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.743 -1.223 . . . . 0.0 109.254 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.511 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.8 mt-10 -63.99 -36.56 84.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.072 -1.017 . . . . 0.0 108.648 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 78' ' ' ARG . 19.6 ttm-85 -61.77 -47.03 87.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 ' C ' ' N ' ' A' ' 81' ' ' GLN . 91.9 mt -69.88 -33.49 72.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 111.209 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.9 t -49.6 -18.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 108.689 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.5 mt-30 -113.31 -13.78 12.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.551 -0.718 . . . . 0.0 109.775 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 19.0 t70 -81.23 109.1 15.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.685 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 76.29 -17.17 0.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 72.04 36.47 60.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 7.6 pt -50.33 -172.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.446 -1.032 . . . . 0.0 110.337 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.527 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 18.9 tt -59.41 93.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 94.1 mtt180 -52.27 139.73 23.33 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.593 -0.692 . . . . 0.0 109.794 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 164.76 63.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 11.6 ptm180 -49.36 -38.45 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.337 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -64.59 -59.18 8.55 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.515 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.82 -41.47 95.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.879 -1.365 . . . . 0.0 109.849 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 92' ' ' ILE . 97.0 mt -58.88 -42.43 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 110.025 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.87 -32.92 68.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.754 -1.216 . . . . 0.0 108.548 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.22 83.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 108.934 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.3 mm -57.27 -41.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 108.84 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.65 -40.41 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.82 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.34 85.46 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.58 -37.55 76.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.424 -1.045 . . . . 0.0 109.088 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.89 95.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -56.72 -42.99 80.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 108.507 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.03 70.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.45 -0.781 . . . . 0.0 108.965 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.16 -42.92 99.73 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.52 -31.62 70.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.32 -40.43 90.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.128 -0.983 . . . . 0.0 110.322 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.683 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 71.3 mtp -71.73 -39.33 70.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.958 -1.089 . . . . 0.0 108.803 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.41 -41.81 88.75 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.819 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.83 -21.37 66.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -92.9 -11.05 34.43 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.59 26.57 74.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -118.42 101.5 50.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.243 -1.151 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 145.01 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.237 1.958 . . . . 0.0 112.414 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.683 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 31.7 m-85 -60.8 -43.42 98.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.27 -33.29 75.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 111.139 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.36 -48.52 80.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.033 -1.042 . . . . 0.0 112.133 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.3 p90 -70.16 -45.18 67.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.685 -1.259 . . . . 0.0 111.12 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.54 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.9 p -59.84 -50.09 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.468 -1.395 . . . . 0.0 109.581 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.631 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 17.0 m95 -54.99 -24.48 24.39 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.527 ' HG ' ' N ' ' A' ' 119' ' ' PHE . 5.3 p -70.61 -38.86 74.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.496 -0.753 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.527 ' N ' ' HG ' ' A' ' 118' ' ' SER . 32.6 m-85 -64.96 -32.17 73.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.718 -1.239 . . . . 0.0 109.476 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.0 m -96.92 17.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.366 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 121' ' ' ASN . 1.3 m120 57.74 40.93 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.544 -0.722 . . . . 0.0 110.059 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 121' ' ' ASN . 49.8 t-80 43.16 27.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.992 . . . . 0.0 109.805 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 2.6 mm-40 -126.9 149.72 69.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.43 147.99 87.56 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.532 2.154 . . . . 0.0 112.157 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.32 139.45 50.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.3 mtt -100.34 122.15 42.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.98 118.11 24.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 108.571 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.82 19.88 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.12 129.43 36.77 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.274 -0.892 . . . . 0.0 109.365 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.9 p -100.96 -21.32 15.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.7 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.42 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 10.8 p -131.64 162.78 29.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.2 mt -58.78 -37.32 76.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 108.823 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.7 m -76.32 -3.2 35.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 131' ' ' THR . 31.9 tp10 -101.69 12.53 36.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -100.48 106.96 45.93 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.71 137.7 82.46 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.83 1.686 . . . . 0.0 112.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 p -103.78 4.09 34.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.4 ' HG ' HG21 ' A' ' 159' ' ' THR . 3.8 m -142.29 85.74 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.401 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 14.2 p -102.35 151.49 38.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -52.73 -35.73 70.01 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.508 1.472 . . . . 0.0 111.284 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.49 -43.05 61.03 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 166' ' ' MET . 56.8 m -66.17 -43.57 86.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -66.17 -37.47 85.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.91 -31.2 66.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.42 -46.65 79.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.642 -0.661 . . . . 0.0 109.537 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.594 ' CA ' ' HG ' ' A' ' 162' ' ' CYS . 19.4 m -61.3 -40.88 95.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.077 -1.015 . . . . 0.0 109.518 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -61.22 -43.57 98.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 110.039 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.17 70.79 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.49 -37.92 83.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 109.223 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -61.57 -40.0 93.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.034 -1.041 . . . . 0.0 109.498 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.6 -15.34 57.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.907 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.424 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -83.0 4.16 27.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.156 -0.965 . . . . 0.0 108.835 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.53 24.78 49.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.57 112.89 25.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.983 . . . . 0.0 108.849 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -93.44 172.93 7.97 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.648 -0.657 . . . . 0.0 109.231 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 57.84 61.31 2.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.843 . . . . 0.0 109.055 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.85 39.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.51 162.91 0.07 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.4 HG21 ' HG ' ' A' ' 138' ' ' SER . 30.6 m -55.03 -31.39 61.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.457 -1.026 . . . . 0.0 109.005 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.6 p -72.34 -31.89 66.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.36 -45.02 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.594 ' HG ' ' CA ' ' A' ' 146' ' ' SER . 1.7 m -67.0 -41.81 86.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -0.764 . . . . 0.0 109.407 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.44 -46.84 68.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.589 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 18.3 m -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.853 -1.154 . . . . 0.0 109.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -59.29 -47.71 84.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 110.652 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 11.9 ptp -66.42 -29.19 69.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.132 . . . . 0.0 110.657 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -57.35 -40.0 77.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.872 -1.143 . . . . 0.0 110.746 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.14 -33.16 11.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 111.124 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -54.62 -27.64 40.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.975 -1.078 . . . . 0.0 109.69 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.55 54.36 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.069 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 169' ' ' CYS . 6.4 mt -63.3 -30.69 71.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.199 -1.177 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.9 m -125.77 137.88 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.834 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.4 m120 -104.32 164.3 11.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.745 . . . . 0.0 109.413 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 89.58 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.425 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 17.7 m170 -51.55 -44.74 62.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 108.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 28.2 m -157.91 37.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.73 . . . . 0.0 109.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 176' ' ' VAL . 16.0 t 37.84 93.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.24 -4.35 7.26 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 3' ' ' ARG . 8.7 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 108.482 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.717 0.77 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 145.87 55.03 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.83 49.84 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.408 -0.808 . . . . 0.0 111.833 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -84.37 2.97 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.536 -1.567 . . . . 0.0 109.77 -179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.84 -46.45 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 109.158 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -73.17 -2.02 19.94 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.895 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 62.8 tt0 -67.81 -41.7 82.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -154.63 159.92 31.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 109.984 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.8 -38.47 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.991 2.46 . . . . 0.0 112.463 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' CD1' ' HZ1' ' A' ' 51' ' ' LYS . 96.9 mt -61.72 -32.88 73.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.44 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -62.96 -41.84 99.65 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.296 -0.878 . . . . 0.0 110.207 -179.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.27 -38.29 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 110.523 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.654 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.48 -50.65 58.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 109.539 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 1.2 t80 -60.91 -37.21 81.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 110.01 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -59.1 -43.05 91.85 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.416 -0.803 . . . . 0.0 110.651 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -80.36 -16.06 55.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 110.712 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.654 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 34.8 m-80 -64.58 -53.94 39.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 177.57 57.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 108.829 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.449 ' CH2' ' CE2' ' A' ' 6' ' ' TRP . 4.2 t90 -97.66 63.93 1.76 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . 108.87 59.85 0.53 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.857 -1.164 . . . . 0.0 111.562 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -157.88 -36.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.486 . . . . 0.0 112.037 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 46.5 Cg_endo -96.15 152.05 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.702 2.268 . . . . 0.0 114.032 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 26' ' ' THR . 86.2 tt0 -68.9 160.15 31.26 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.425 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 2.3 p -95.06 152.48 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.492 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -103.65 151.46 22.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -62.79 -36.23 82.44 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.911 -1.118 . . . . 0.0 109.418 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -74.89 -50.33 17.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 110.811 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.75 -25.16 68.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.958 -1.089 . . . . 0.0 108.69 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.58 -39.47 76.85 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -69.32 -44.52 71.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.695 -0.628 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.54 -28.37 66.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.14 . . . . 0.0 110.21 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.5 ttm -71.47 -52.06 20.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.867 -1.146 . . . . 0.0 110.444 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.1 -29.02 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.749 -1.219 . . . . 0.0 109.709 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.01 -44.1 90.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.065 -1.022 . . . . 0.0 109.038 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -43.58 68.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 31.5 mm-40 -62.81 -33.52 75.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -0.806 . . . . 0.0 109.104 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.14 -36.32 88.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.77 -3.63 39.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -1.174 . . . . 0.0 109.992 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -79.26 -0.69 33.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.04 122.76 18.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.162 -0.961 . . . . 0.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.04 -32.85 0.92 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.9 mm? -98.47 150.03 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.286 . . . . 0.0 109.996 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.5 p -65.61 157.29 30.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.33 -31.08 70.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -40.8 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.413 -0.804 . . . . 0.0 109.877 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 m -57.37 -38.92 74.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.081 -1.012 . . . . 0.0 108.35 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -64.17 -36.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.23 -47.48 78.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -0.966 . . . . 0.0 109.046 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HZ1' ' CD1' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -62.5 -34.09 76.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' C ' HD21 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -84.52 -10.65 57.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.005 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 41.1 ttm180 -66.72 -51.16 59.17 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.54 -36.13 76.08 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.229 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.603 ' ND2' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.13 -34.88 68.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.015 -1.053 . . . . 0.0 109.929 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 82.9 t80 -60.7 -47.47 86.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 7.9 ptm180 -66.86 -28.23 68.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.919 -1.113 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -67.7 -37.98 83.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 111.267 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -77.41 -45.66 25.16 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.749 -1.219 . . . . 0.0 110.768 -178.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 110.334 -179.527 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.508 2.341 0 N-CA-C 116.982 1.878 . . . . 0.0 116.982 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.3 -30.13 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.917 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -39.82 66.97 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.331 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.34 -40.71 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.766 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.33 -16.28 59.89 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.02 -6.38 58.75 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 67.6 mmm -82.74 117.24 22.52 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -94.89 172.27 8.26 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.12 -0.988 . . . . 0.0 109.857 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -54.33 -31.47 54.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.486 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.31 -44.41 75.78 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.651 -1.28 . . . . 0.0 108.37 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.24 -37.81 86.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.93 -44.83 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 0.0 109.591 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.76 -38.06 89.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 108.628 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -60.93 -39.95 91.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 109.373 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.01 -33.24 75.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.16 -33.8 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -109.34 -4.04 16.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.557 -0.714 . . . . 0.0 110.949 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 84' ' ' GLY . 35.7 t0 -82.0 108.68 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.281 -1.512 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.91 -16.06 0.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.421 -0.799 . . . . 0.0 109.548 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.01 33.18 57.7 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 22.1 pt -54.73 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -1.114 . . . . 0.0 110.205 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 10.6 tt -57.71 86.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -54.21 138.64 38.01 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.698 0.761 . . . . 0.0 110.434 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 3.1 m-70 160.58 77.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.491 ' CD ' ' H ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.18 -35.27 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.533 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 -56.26 25.63 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -65.8 -41.43 91.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.295 . . . . 0.0 110.614 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.66 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 0.0 110.443 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -34.52 65.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.667 -1.271 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.13 -37.51 87.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.948 . . . . 0.0 109.153 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.62 -44.27 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 108.821 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.45 -41.12 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.59 90.86 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -40.53 87.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 0.0 109.264 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.23 -43.89 93.56 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.072 -1.017 . . . . 0.0 109.001 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.644 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -52.16 -42.07 63.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 108.793 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.417 ' HA ' HE21 ' A' ' 104' ' ' GLN . . . -65.44 -29.32 69.99 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.713 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 45.9 t80 -62.79 -44.86 95.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.9 mm? -62.82 -33.36 75.07 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' A' ' 101' ' ' ALA . 54.9 mt-30 -66.08 -36.94 84.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.392 -0.817 . . . . 0.0 110.444 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 82.9 mmm -71.56 -40.3 70.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.71 -39.33 70.23 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.19 -20.03 64.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -85.89 -8.98 57.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.77 26.34 73.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.04 101.79 49.62 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.497 -1.002 . . . . 0.0 109.678 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.25 143.7 41.83 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.342 2.028 . . . . 0.0 112.204 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.713 ' CZ ' ' CD1' ' A' ' 102' ' ' TYR . 58.5 m-85 -64.66 -45.33 87.21 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.039 0.924 . . . . 0.0 110.665 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.6 -26.91 68.9 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.473 -0.767 . . . . 0.0 110.947 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.5 ' O ' ' OG ' ' A' ' 118' ' ' SER . 60.4 t0 -66.24 -49.35 67.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.863 -1.148 . . . . 0.0 111.862 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.3 p90 -69.74 -44.51 70.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.864 -1.148 . . . . 0.0 111.355 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.559 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 3.3 p -61.0 -53.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.512 -1.367 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.43 ' H ' ' CG1' ' A' ' 116' ' ' VAL . 37.5 m95 -55.82 -23.09 28.32 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.496 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 13.3 m -69.26 -38.87 78.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.084 -1.01 . . . . 0.0 109.782 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.55 -33.9 77.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.0 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 m -91.82 18.58 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.055 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.61 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 59.2 m-80 58.62 43.96 18.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 0.0 109.496 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 28.9 p-80 41.51 24.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.491 -0.756 . . . . 0.0 110.058 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -135.46 153.76 78.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.086 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 147.46 95.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.653 2.235 . . . . 0.0 112.376 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -100.36 131.7 46.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.761 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.7 mtt -96.88 113.25 24.77 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -93.24 115.9 28.49 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -87.84 19.31 3.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 140.75 52.29 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.261 -0.899 . . . . 0.0 109.122 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.29 -28.65 10.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.3 p -128.18 162.37 27.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.52 -0.737 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.91 -36.87 70.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.054 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.2 m -61.84 -30.34 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.19 -6.5 57.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 109.816 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.52 131.8 76.7 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 138' ' ' SER . 74.3 Cg_endo -79.41 -21.58 8.78 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.844 1.696 . . . . 0.0 112.649 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 136' ' ' PRO . 0.2 OUTLIER 52.36 -1.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.767 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -148.37 83.15 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.065 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -95.62 159.08 33.34 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.9 -38.13 85.88 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.843 1.695 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.01 -45.02 52.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.465 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 18.1 m -62.95 -43.0 99.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.735 . . . . 0.0 109.061 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.83 -42.05 97.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 108.932 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.1 -29.0 66.99 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.81 83.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.648 -0.657 . . . . 0.0 109.484 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.606 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 3.8 m -66.19 -41.02 90.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 0.0 110.161 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -58.3 -38.66 77.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.845 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.13 6.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.93 -31.94 70.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 109.968 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -61.05 -45.12 96.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.789 -1.195 . . . . 0.0 109.581 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -84.48 -13.5 51.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.411 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -81.75 2.99 27.38 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.864 -1.148 . . . . 0.0 109.484 -178.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.1 21.18 33.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -109.66 111.13 22.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -1.073 . . . . 0.0 109.308 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -94.64 -178.31 4.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 55.32 40.48 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 108.93 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.03 48.37 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.61 162.2 0.5 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -58.18 -30.61 66.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.496 -1.002 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.5 m -72.32 -37.24 68.97 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.141 -0.974 . . . . 0.0 108.674 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.74 -39.88 87.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.606 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 1.4 m -62.2 -49.35 76.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.87 . . . . 0.0 109.828 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.716 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -65.16 -41.0 95.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 20.1 m -64.38 -43.02 95.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.11 -0.994 . . . . 0.0 109.56 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.9 88.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 98.8 mtp -60.89 -40.55 93.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 111.289 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.716 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 46.9 mt-30 -64.04 -44.74 91.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 111.222 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.26 63.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.019 . . . . 0.0 110.612 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -39.09 67.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 0.0 111.288 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.9 0.61 17.3 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -1.188 . . . . 0.0 109.887 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.32 150.34 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 21.4 m120 -128.57 163.56 24.74 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.386 0.612 . . . . 0.0 110.72 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.9 t0 89.52 74.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.471 0.653 . . . . 0.0 109.755 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.418 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 9.2 m170 -58.35 -44.6 88.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 177' ' ' VAL . 12.9 m -157.99 29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.905 . . . . 0.0 109.992 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 176' ' ' VAL . 85.8 t 55.24 113.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.888 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.14 33.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.354 -1.086 . . . . 0.0 109.45 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.346 0.593 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 133.67 51.15 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.918 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.78 -30.8 76.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.08 -1.51 26.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 108.334 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' ND1' ' A' ' 17' ' ' HIS . 1.1 t -102.29 -28.0 3.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.392 0.615 . . . . 0.0 109.395 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.1 m -70.66 5.2 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.9 . . . . 0.0 110.634 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -84.11 -149.18 0.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.789 -1.195 . . . . 0.0 109.275 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.67 158.6 11.42 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.575 ' C ' ' H ' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 -160.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.837 2.358 . . . . 0.0 111.468 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 -40.42 0.27 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.012 -1.055 . . . . 0.0 109.135 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' H ' ' C ' ' A' ' 11' ' ' PRO . 1.3 m-85 -64.48 -36.63 84.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.894 -1.129 . . . . 0.0 109.413 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 2.1 mp -56.78 -46.83 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.544 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.04 69.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.995 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.2 t80 -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.011 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.401 ' ND1' HG23 ' A' ' 7' ' ' VAL . 14.6 t-80 -76.08 -32.12 59.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.94 -10.33 59.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.956 -1.09 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 19.7 p30 -90.95 -70.41 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.602 -1.311 . . . . 0.0 112.464 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.676 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.2 mt-10 -126.5 -69.09 0.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.943 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.452 ' CD1' ' O ' ' A' ' 21' ' ' TRP . 30.1 t-105 51.72 44.83 28.96 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.68 41.45 19.67 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 120.491 -1.381 . . . . 0.0 110.969 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -106.98 -41.88 0.14 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.218 . . . . 0.0 109.993 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 95.4 Cg_endo -98.57 154.03 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.794 2.996 . . . . 0.0 112.821 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.36 144.2 55.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.418 ' HG1' ' HG ' ' A' ' 169' ' ' CYS . 67.4 p -105.46 155.44 19.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.773 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -92.16 167.1 12.28 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -59.95 -36.8 77.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 111.197 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.1 -41.55 90.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 112.264 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -62.34 -38.68 90.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.603 -1.311 . . . . 0.0 108.855 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -56.76 -39.1 73.41 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.231 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.404 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 81.9 t80 -60.73 -40.3 91.83 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -70.69 -43.38 69.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.905 -1.122 . . . . 0.0 108.778 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.479 ' SD ' ' CD1' ' A' ' 165' ' ' PHE . 58.2 ttm -63.82 -47.36 81.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 110.462 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -65.46 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 67.2 m -69.36 -51.11 40.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.99 -1.068 . . . . 0.0 109.652 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 2.2 mp -68.44 -42.0 79.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.196 -0.94 . . . . 0.0 108.965 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 9.1 tp10 -62.55 -35.74 80.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.619 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.29 -28.1 49.0 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -79.41 -12.87 59.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 109.807 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -74.79 11.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 111.303 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -68.62 112.94 5.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.367 -1.458 . . . . 0.0 109.238 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.27 -0.35 0.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.3 tp -106.66 145.2 32.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.193 -1.18 . . . . 0.0 109.857 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.7 m -64.39 157.06 27.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.837 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.612 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 2.8 t-105 -71.13 -43.81 66.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.489 -0.757 . . . . 0.0 110.708 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -27.22 35.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.959 -1.088 . . . . 0.0 109.097 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -63.86 -40.23 96.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -0.935 . . . . 0.0 109.895 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.2 m -69.82 -28.83 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.084 -1.01 . . . . 0.0 108.993 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.06 -47.31 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -56.64 -45.85 81.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' TYR . 21.3 ttpp -59.82 -32.59 70.8 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -55.35 -45.25 76.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.531 -0.731 . . . . 0.0 109.576 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -68.66 -46.11 69.98 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.02 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 14.0 m-80 -64.34 -34.65 78.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.776 . . . . 0.0 109.142 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.1 t80 -56.6 -42.29 78.49 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -63.37 -38.22 90.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.09 -41.25 86.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.667 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -75.15 -45.39 41.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.0 111.229 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 81.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 N-CA-C 114.75 1.019 . . . . 0.0 114.75 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.07 -44.83 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 111.121 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.49 -40.6 95.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.5 -41.77 93.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.801 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.68 60.73 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.18 -14.53 28.92 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.739 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.5 mtp -82.78 113.14 20.22 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.61 -177.64 3.99 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.766 -1.209 . . . . 0.0 110.958 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.42 -36.65 69.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 109.136 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.81 -49.04 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.581 -1.325 . . . . 0.0 108.128 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.34 -35.66 74.26 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.55 -37.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.28 -0.887 . . . . 0.0 108.748 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.02 -39.8 83.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -65.37 -33.48 76.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.361 0.6 . . . . 0.0 109.507 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.29 -34.47 74.75 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.266 -0.896 . . . . 0.0 110.447 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.1 t -56.03 -17.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -109.73 -17.26 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -1.0 . . . . 0.0 110.077 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.6 m-20 -80.04 109.78 14.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.75 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.98 -16.21 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.675 . . . . 0.0 109.246 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.7 42.73 86.87 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.8 pt -52.52 -166.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.836 -0.802 . . . . 0.0 109.846 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.07 98.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.511 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 11.2 ptp180 -52.68 116.82 2.5 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.675 0.75 . . . . 0.0 109.696 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 168.23 70.56 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.023 -1.048 . . . . 0.0 108.197 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -44.34 -42.44 6.79 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.694 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -47.97 -51.85 18.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -65.18 -45.38 85.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -1.128 . . . . 0.0 109.861 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 mm -60.75 -44.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.631 -0.668 . . . . 0.0 110.005 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -56.83 -38.31 72.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.823 -1.173 . . . . 0.0 110.167 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.97 82.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.41 -39.46 74.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 96' ' ' ILE . 25.5 mm -59.16 -46.22 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.591 0.71 . . . . 0.0 110.269 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.85 -28.78 73.94 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.55 -40.52 97.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -1.16 . . . . 0.0 110.009 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -49.83 61.23 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 108.95 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -55.81 -38.08 69.51 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' HE21 ' A' ' 104' ' ' GLN . . . -65.46 -29.54 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.083 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.01 -42.27 94.59 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.2 mm? -62.78 -33.52 75.35 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 101' ' ' ALA . 51.8 mt-30 -62.59 -36.54 83.05 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.533 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 39.1 tpp -61.01 -47.64 85.52 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.121 -0.987 . . . . 0.0 108.337 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.67 -35.73 70.96 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.3 t-20 -91.43 -18.12 24.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.51 27.57 73.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.3 mt-10 -114.26 108.58 50.04 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.72 -0.87 . . . . 0.0 109.57 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -51.73 139.75 48.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.965 1.777 . . . . 0.0 112.069 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.01 -37.84 67.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.756 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.27 64.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.636 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -62.96 -45.05 94.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.688 -1.257 . . . . 0.0 111.249 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -77.39 -40.51 43.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.91 -1.119 . . . . 0.0 111.601 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 115' ' ' PHE . 21.6 m -63.2 -48.84 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 119.547 -1.97 . . . . 0.0 108.662 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 122' ' ' HIS . 46.3 m95 -61.26 -23.67 65.83 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.8 t -70.22 -44.48 68.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.095 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.447 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 24.1 m-85 -61.19 -30.28 70.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 109.812 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.5 18.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 123' ' ' GLN . 82.0 m-20 56.99 42.31 26.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 110.176 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 37.67 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.67 -0.644 . . . . 0.0 109.361 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.3 mm100 -122.84 112.37 30.61 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.349 -0.844 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.27 150.45 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.882 1.722 . . . . 0.0 111.227 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 142.44 46.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.044 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.7 mtt -91.2 130.27 37.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.78 . . . . 0.0 109.638 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.441 HG23 ' N ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -93.44 -58.91 2.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 109.745 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.447 ' H ' ' HB2' ' A' ' 174' ' ' ASP . 71.7 mt-30 59.26 44.26 15.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.34 156.23 28.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.451 -0.781 . . . . 0.0 109.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -92.53 -12.79 30.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -168.55 -179.34 3.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -36.39 83.48 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 t -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.897 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -81.7 5.41 18.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.621 -1.299 . . . . 0.0 109.334 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.61 136.01 20.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.13 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.89 140.37 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.415 2.077 . . . . 0.0 112.883 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.7 -1.47 24.45 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 108.957 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -145.97 92.3 2.18 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.501 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.63 154.82 39.79 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.195 -0.941 . . . . 0.0 108.979 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -54.1 -34.65 79.03 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.715 1.61 . . . . 0.0 111.105 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -48.63 51.06 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.467 -0.771 . . . . 0.0 109.029 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -64.06 -42.06 97.14 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.644 0.735 . . . . 0.0 109.362 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.03 -39.11 77.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.581 -0.7 . . . . 0.0 109.47 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -65.64 -31.74 72.92 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.6 -46.74 88.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 26.3 t -60.47 -43.62 96.75 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.428 ' HG2' ' HZ1' ' A' ' 151' ' ' LYS . 28.8 ttpt -64.56 -47.3 79.28 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.518 -0.739 . . . . 0.0 110.17 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.63 77.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.404 ' HG ' ' NH2' ' A' ' 152' ' ' ARG . 35.1 mt -66.25 -36.77 83.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.8 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.34 -40.86 92.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.608 -1.308 . . . . 0.0 110.01 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.428 ' HZ1' ' HG2' ' A' ' 147' ' ' LYS . 44.3 mttp -68.82 -36.6 78.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.969 . . . . 0.0 111.47 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 74.2 mtm180 -72.26 3.7 4.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.64 20.15 52.03 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -96.93 110.34 22.88 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.29 . . . . 0.0 109.796 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -90.62 178.28 6.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.887 -0.508 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 58.33 47.69 13.59 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.238 1.018 . . . . 0.0 108.889 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.7 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.11 160.41 0.79 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.6 m -59.66 -33.18 71.22 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.512 -0.993 . . . . 0.0 109.188 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.0 m -71.86 -36.07 70.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.91 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.907 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 146' ' ' SER . 20.6 m -67.84 -39.97 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.245 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -44.01 97.35 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.605 -0.685 . . . . 0.0 110.077 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 59.2 p -61.54 -35.45 77.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CD1' ' SD ' ' A' ' 34' ' ' MET . 18.5 t80 -61.5 -41.43 97.28 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 110.063 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.563 ' CG ' HE21 ' A' ' 167' ' ' GLN . 2.4 ptm -67.48 -36.92 82.07 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.902 -1.124 . . . . 0.0 110.795 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.563 HE21 ' CG ' ' A' ' 166' ' ' MET . 85.5 mm-40 -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.842 -1.162 . . . . 0.0 110.893 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.0 -16.0 21.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.39 -0.819 . . . . 0.0 111.937 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 2.2 t -74.56 -46.11 41.04 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.381 -1.449 . . . . 0.0 110.407 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 -1.42 3.9 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.488 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.8 mp -61.51 -31.57 71.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.025 -1.279 . . . . 0.0 110.685 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.9 154.54 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.959 -1.088 . . . . 0.0 109.049 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 28.6 p30 -124.06 162.77 22.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.171 -0.956 . . . . 0.0 110.046 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 91.56 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -51.73 -39.62 58.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.026 . . . . 0.0 108.623 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.633 ' CG1' ' H ' ' A' ' 177' ' ' VAL . 2.8 p -145.15 -104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.622 -0.674 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.633 ' H ' ' CG1' ' A' ' 176' ' ' VAL . 1.1 t -138.4 -41.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 108.292 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.28 67.55 0.52 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.338 . . . . 0.0 110.17 179.899 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.47 ' HG3' HH11 ' A' ' 3' ' ' ARG . 30.4 mtm-85 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.813 0.816 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.47 131.17 42.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.612 0.72 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.83 -18.42 53.31 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -4.02 58.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -1.141 . . . . 0.0 109.984 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER -111.43 -10.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.205 -0.934 . . . . 0.0 109.8 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.5 m -70.78 5.99 1.69 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 108.799 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.0 mt-30 -63.1 -88.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.804 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 165.88 -38.06 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 0.0 111.556 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' ASP . 61.1 Cg_endo -91.12 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.775 2.317 . . . . 0.0 115.532 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' TYR . 26.0 mt -32.34 -32.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.941 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' PRO . 4.3 m-85 -44.98 -40.59 6.57 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.843 -1.16 . . . . 0.0 109.913 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.8 mt -61.76 -46.38 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.54 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.02 39.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.126 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 10.0 t80 -62.51 -41.85 99.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -63.05 -38.07 89.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.79 -1.72 58.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 112.217 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.695 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -100.95 -34.03 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.506 -1.371 . . . . 0.0 111.13 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.695 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 93.5 mt-10 -153.19 -73.98 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.577 -1.327 . . . . 0.0 110.554 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.477 ' CE3' ' CE2' ' A' ' 16' ' ' TYR . 8.4 t-105 39.76 45.83 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.098 0.951 . . . . 0.0 108.804 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' ALA . . . 74.45 49.2 12.0 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.487 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.657 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 t -108.69 -35.93 0.15 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.195 -1.18 . . . . 0.0 109.074 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.657 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.2 Cg_endo -92.13 154.69 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 123.367 2.711 . . . . 0.0 112.148 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HE2' ' C ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -64.39 151.95 42.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.91 27.2 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.506 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -102.83 158.62 16.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 m -56.33 -33.73 65.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.777 -1.202 . . . . 0.0 109.006 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' NZ ' ' OH ' ' A' ' 102' ' ' TYR . 14.2 mmtt -67.14 -39.0 86.49 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.747 -0.595 . . . . 0.0 110.933 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -62.27 -44.31 96.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.005 -1.06 . . . . 0.0 110.003 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -62.24 -37.97 87.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.0 -53.08 60.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.09 -1.006 . . . . 0.0 110.511 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.01 -40.71 78.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 108.872 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.659 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 3.3 ttm -62.87 -49.33 75.28 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 111.125 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 tp -62.21 -27.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.948 -1.095 . . . . 0.0 108.962 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.41 -54.26 11.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -0.973 . . . . 0.0 109.798 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.0 mm? -71.07 -39.87 71.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 0.0 109.017 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 9.7 tp10 -59.57 -32.01 69.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.13 80.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.669 HE21 ' CD1' ' A' ' 44' ' ' LEU . 55.2 tp60 -69.25 -30.7 68.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.095 -1.238 . . . . 0.0 109.952 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.583 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -51.03 -3.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 110.368 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -63.28 112.42 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.877 -1.14 . . . . 0.0 109.319 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.05 -13.5 0.49 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.669 ' CD1' HE21 ' A' ' 40' ' ' GLN . 9.7 mt -101.98 159.52 15.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.043 -1.269 . . . . 0.0 110.354 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.495 ' OG ' ' OG1' ' A' ' 48' ' ' THR . 1.2 p -85.29 147.18 26.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.463 -0.773 . . . . 0.0 108.916 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.583 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -60.95 -40.75 94.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.422 -0.798 . . . . 0.0 110.592 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -39.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.004 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.495 ' OG1' ' OG ' ' A' ' 45' ' ' SER . 84.8 m -61.55 -40.53 95.04 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -66.37 -35.57 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.49 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 7.5 tt -58.83 -52.33 66.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -58.49 -41.9 86.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.592 -1.317 . . . . 0.0 107.966 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -65.64 -25.73 67.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.81 -43.23 76.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 47.0 mp0 -68.36 -39.95 81.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 10.7 m-80 -69.85 -37.88 76.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 0.0 109.606 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -60.69 -48.79 80.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.798 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -25.79 68.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.164 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.09 82.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 110.7 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.15 -46.26 61.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.865 -1.147 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.002 179.826 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.494 1.515 0 N-CA-C 113.102 0.385 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.35 -46.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.777 -1.202 . . . . 0.0 109.753 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -32.68 73.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.385 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.42 -39.34 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.351 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.93 65.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.7 59.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.4 mtp -85.15 113.22 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.527 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -95.92 176.08 6.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.465 -0.772 . . . . 0.0 109.524 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.4 mt-10 -52.84 -31.04 37.0 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.143 -0.973 . . . . 0.0 109.44 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.79 -49.65 76.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.175 -0.953 . . . . 0.0 108.454 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.21 -38.39 88.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.8 -43.37 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.733 . . . . 0.0 110.193 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.13 -33.69 72.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.23 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 43.1 ttm180 -64.25 -46.26 84.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 110.104 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.438 ' C ' ' N ' ' A' ' 81' ' ' GLN . 47.1 mt -67.32 -33.4 75.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 110.756 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.08 -18.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' N ' ' C ' ' A' ' 79' ' ' LEU . 22.0 mt-30 -110.4 -17.82 13.38 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.659 -0.65 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 84' ' ' GLY . 54.1 m-20 -76.78 108.68 9.97 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.86 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 71.14 -18.71 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.54 -0.725 . . . . 0.0 109.817 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.66 34.69 84.29 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 84' ' ' GLY . 7.7 pt -42.82 160.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 tt -63.85 -29.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.31 -0.869 . . . . 0.0 110.909 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 44.9 mtt-85 -63.77 145.37 55.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 109.889 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' ARG . 34.5 m80 -122.72 162.07 22.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 109.444 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 89' ' ' ARG . 5.4 ptm180 -41.51 -40.81 1.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.56 -66.5 2.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.809 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.657 ' HZ3' HE22 ' A' ' 40' ' ' GLN . 28.1 mtmt -61.83 -38.08 86.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -1.148 . . . . 0.0 110.455 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.44 HD13 HG22 ' A' ' 92' ' ' ILE . 98.1 mt -58.64 -54.13 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.829 -1.169 . . . . 0.0 109.966 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.6 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 42.9 mt-30 -51.93 -32.44 32.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 109.443 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.94 95.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.075 -1.016 . . . . 0.0 109.851 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.4 -36.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.641 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mp -58.36 -46.86 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.723 -1.236 . . . . 0.0 108.723 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.89 -35.79 92.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 84.3 m-20 -58.77 -37.01 75.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.457 -1.025 . . . . 0.0 109.719 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.14 90.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.987 -1.071 . . . . 0.0 108.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -59.02 -36.48 75.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.59 76.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.477 ' OH ' ' NZ ' ' A' ' 29' ' ' LYS . 72.6 t80 -62.99 -42.54 99.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.42 -33.79 76.69 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -63.43 -36.34 83.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.249 -0.907 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 87.0 mmm -68.74 -42.91 76.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.914 -1.116 . . . . 0.0 110.164 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.34 -37.33 83.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.494 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -94.49 -10.45 32.25 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.04 74.26 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.42 100.43 51.46 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 149.39 75.18 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.335 2.023 . . . . 0.0 111.946 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.546 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 40.0 m-85 -60.7 -33.33 72.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.328 -0.857 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.19 -34.9 71.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.712 -1.243 . . . . 0.0 111.467 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.43 -49.55 77.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.664 -1.272 . . . . 0.0 111.523 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.2 p90 -71.23 -35.3 71.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.205 . . . . 0.0 109.381 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.3 t -64.22 -54.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.05 . . . . 0.0 109.63 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' HIS . 60.3 m95 -57.51 -21.2 36.33 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 108.555 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 16.1 p -72.24 -36.97 69.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.415 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 20.7 m-85 -69.78 -33.74 72.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.936 -1.103 . . . . 0.0 110.289 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.66 18.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.976 -1.078 . . . . 0.0 109.682 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 65.05 37.91 6.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 109.957 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 24.6 t-80 42.33 36.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 110.875 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.39 21.51 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 109.159 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.44 143.38 47.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.206 1.937 . . . . 0.0 111.577 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -108.05 145.92 33.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.924 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 126' ' ' MET . 14.8 ptt? -97.92 121.38 39.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.425 -0.797 . . . . 0.0 108.947 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 m -90.0 119.93 30.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 109.43 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -91.52 18.59 7.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.52 143.06 56.58 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.088 -1.007 . . . . 0.0 109.421 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -105.0 -26.87 11.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.3 p -130.13 163.87 25.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.94 -37.04 70.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m -82.91 4.64 24.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.832 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -98.0 5.05 49.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 127.02 34.99 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.109 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 139.75 36.26 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.901 1.734 . . . . 0.0 112.253 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 t -103.18 -2.49 27.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.822 . . . . 0.0 108.811 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.0 t -134.85 96.34 3.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.6 159.79 35.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -53.94 -40.74 79.68 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.317 1.344 . . . . 0.0 111.399 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.93 67.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 m -60.21 -42.63 95.52 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.56 -0.713 . . . . 0.0 109.467 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -64.76 -41.21 96.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.191 -0.943 . . . . 0.0 109.161 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.415 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -72.76 -29.49 63.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.404 -0.81 . . . . 0.0 108.859 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -47.74 66.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.393 -0.817 . . . . 0.0 109.148 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.521 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 12.1 t -63.82 -42.65 97.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.857 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.47 -42.18 95.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.288 -0.883 . . . . 0.0 110.374 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.33 79.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.721 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.54 -38.87 84.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 109.352 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.11 -38.6 86.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.926 -1.108 . . . . 0.0 108.709 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -81.8 -14.26 56.59 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.451 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -83.38 0.74 44.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.732 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.41 19.92 43.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -100.61 112.83 25.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.623 -0.928 . . . . 0.0 108.622 179.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -97.27 166.46 11.55 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.498 ' O ' ' OG ' ' A' ' 146' ' ' SER . 7.4 p -158.81 41.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.29 174.5 0.2 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.8 p -62.31 -24.28 67.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.14 . . . . 0.0 109.224 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.0 m -66.34 -38.63 88.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 161' ' ' ILE . 23.1 mm -70.04 -44.69 78.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.9 m -61.91 -33.95 75.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.159 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -72.02 -47.83 48.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.969 -1.082 . . . . 0.0 110.709 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 92.7 p -67.35 -32.25 73.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.028 -1.045 . . . . 0.0 109.263 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -65.53 -37.1 85.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.347 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.403 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 2.1 ttp -69.4 -42.72 74.72 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.155 -0.965 . . . . 0.0 110.849 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 2.2 pt20 -68.74 -41.48 78.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.657 -1.277 . . . . 0.0 111.404 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -77.6 -37.44 50.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.032 -1.042 . . . . 0.0 112.047 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CD2' ' A' ' 165' ' ' PHE . 78.8 m -63.7 -44.18 94.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.769 -1.207 . . . . 0.0 111.699 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.39 4.67 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.435 ' CD1' ' CE1' ' A' ' 165' ' ' PHE . 15.9 mt -60.73 -37.12 80.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -1.217 . . . . 0.0 109.581 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -128.25 146.09 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 109.269 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 67.2 m-20 -109.09 164.12 12.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.408 -0.807 . . . . 0.0 110.245 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 91.35 78.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.217 0.532 . . . . 0.0 110.81 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -53.37 -69.31 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.09 155.37 41.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.22 126.87 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.0 109.487 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.21 40.03 14.54 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.588 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.738 -1.448 . . . . 0.0 108.511 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.589 ' CB ' ' CZ ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.406 0.622 . . . . 0.0 109.599 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -45.78 127.87 8.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.778 0.799 . . . . 0.0 110.263 -179.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.67 57.04 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -53.92 -38.75 65.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' CG1' ' NH1' ' A' ' 3' ' ' ARG . 63.3 t -69.53 -36.38 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.64 -0.662 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -71.17 -3.41 19.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.035 . . . . 0.0 110.267 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.34 -38.73 91.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.227 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.77 160.43 30.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.047 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -34.67 14.68 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.91 2.406 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.43 -34.51 76.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.833 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.5 -40.24 78.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.603 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.407 ' H ' HD13 ' A' ' 14' ' ' ILE . 2.5 mp -52.68 -39.54 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.942 -1.099 . . . . 0.0 109.238 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.594 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.85 -48.63 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 109.223 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' HA ' HD21 ' A' ' 19' ' ' ASN . 28.9 t80 -61.49 -38.8 88.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 110.019 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.93 -43.9 94.49 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.451 -0.781 . . . . 0.0 111.707 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -77.51 -10.76 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 78.6 m-20 -78.31 -70.99 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.652 -1.28 . . . . 0.0 110.322 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -167.59 54.88 0.07 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.045 . . . . 0.0 109.362 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 21' ' ' TRP . 7.4 t90 -96.35 63.26 2.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.115 -0.991 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . 105.41 62.15 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.087 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.669 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -159.41 -36.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.227 -1.161 . . . . 0.0 110.742 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 68.4 Cg_endo -99.57 150.92 0.54 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 122.845 2.363 . . . . 0.0 113.204 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.05 147.8 44.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.0 p -109.5 150.96 27.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.662 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.41 164.17 13.12 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -58.98 -34.47 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.901 -1.124 . . . . 0.0 109.72 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -65.17 -40.41 94.27 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.387 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -59.52 -40.89 88.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 mt -60.71 -35.17 75.66 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.619 -0.676 . . . . 0.0 109.698 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.37 -52.65 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 110.595 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -68.75 -33.36 73.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.512 -1.367 . . . . 0.0 108.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.98 -39.52 83.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.671 . . . . 0.0 110.149 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 165' ' ' PHE . 1.2 tp -66.56 -28.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 109.519 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.9 m -68.81 -49.79 55.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.944 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -68.86 -45.07 71.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.022 -1.049 . . . . 0.0 109.458 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -63.99 -32.96 74.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.89 44.05 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -72.95 -36.41 67.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.538 -0.978 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.28 -19.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -66.34 112.57 4.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.903 -1.123 . . . . 0.0 109.071 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.72 -36.41 3.53 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 2.4 mm? -103.25 171.2 7.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.136 -1.214 . . . . 0.0 110.203 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.0 m -92.53 154.14 18.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.653 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.539 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -60.61 -41.6 95.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.682 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -44.47 91.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.954 -1.091 . . . . 0.0 108.895 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.7 m -58.11 -39.21 78.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.0 t -64.51 -32.34 57.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.73 -45.86 85.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.051 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.21 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 108.606 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -12.59 59.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.396 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -71.35 -46.49 60.38 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.26 -41.02 90.49 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.62 -34.33 72.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.588 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.566 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 79.6 t80 -58.45 -46.56 86.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.085 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -65.29 -28.4 69.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.32 86.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 110.545 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -77.42 -45.77 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.934 -1.104 . . . . 0.0 110.749 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 120.838 -1.164 . . . . 0.0 109.918 -179.783 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.491 1.379 0 CA-C-O 121.095 0.373 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.34 -41.69 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -62.44 -33.71 75.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.038 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.0 -38.41 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.41 -18.0 64.97 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.55 -5.36 59.29 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.3 mmm -80.91 115.32 20.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -95.44 173.48 7.5 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.455 -0.778 . . . . 0.0 110.39 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.54 -31.86 66.5 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.398 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.08 -31.48 72.0 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.766 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.47 -46.63 79.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 110.614 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.49 -37.56 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.681 -1.262 . . . . 0.0 109.413 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.537 ' CD ' HH21 ' A' ' 89' ' ' ARG . 81.2 mm-40 -55.9 -38.29 70.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.875 -1.14 . . . . 0.0 108.145 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -65.69 -41.67 92.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 82' ' ' ASP . 43.1 mt -69.99 -33.08 71.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.843 -0.535 . . . . 0.0 110.742 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' LEU . 24.5 t -47.97 -31.04 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.92 -6.33 32.5 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.619 ' C ' ' H ' ' A' ' 84' ' ' GLY . 64.6 t0 -81.53 106.55 13.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.592 -1.317 . . . . 0.0 109.622 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.06 -16.05 0.12 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.599 -0.688 . . . . 0.0 109.55 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.1 39.81 36.38 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 pt -47.27 151.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -1.038 . . . . 0.0 109.97 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.4 tt -63.89 -26.75 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.459 -0.775 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 87' ' ' ARG . 39.9 mtt-85 -66.64 148.34 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 89' ' ' ARG . 70.9 t60 -132.12 -179.04 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.491 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.631 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 37.7 ttm180 -52.98 -38.0 61.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.917 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.33 -59.62 7.63 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.955 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.57 -44.3 96.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -1.221 . . . . 0.0 111.084 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.24 -46.23 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.711 -1.243 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -51.41 -35.93 41.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.628 -1.295 . . . . 0.0 108.009 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.39 75.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.324 -0.86 . . . . 0.0 109.083 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.2 mt -71.99 -40.97 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 111.176 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.29 -43.03 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.587 -1.321 . . . . 0.0 108.989 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.17 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.415 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 3.5 m120 -60.32 -36.96 79.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -1.148 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.8 89.13 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 0.0 108.334 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -65.97 -34.34 77.89 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.95 -31.72 72.88 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -62.51 -42.48 99.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.5 -31.6 72.42 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.49 -39.87 94.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.186 -0.946 . . . . 0.0 110.364 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.698 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 5.8 ttm -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.795 -1.191 . . . . 0.0 108.94 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.24 -35.27 80.28 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -21.9 66.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -88.47 -13.02 41.36 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.2 27.28 73.79 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.197 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.595 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.1 mt-10 -126.02 100.52 30.23 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.291 . . . . 0.0 109.35 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.81 144.08 27.86 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.263 1.976 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.698 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 71.4 m-85 -60.68 -34.93 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.56 -33.01 66.49 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.293 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -63.19 -48.19 79.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.696 -1.252 . . . . 0.0 111.598 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.502 ' O ' ' OG ' ' A' ' 118' ' ' SER . 2.1 p90 -75.34 -32.93 61.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.808 -1.182 . . . . 0.0 109.886 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 t -59.69 -55.4 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 108.934 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' HIS . 71.9 m95 -62.01 -21.59 65.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 21.6 p -76.04 -34.21 59.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -0.974 . . . . 0.0 109.744 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.435 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 1.8 m-85 -64.7 -36.12 83.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.008 -1.057 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.76 18.02 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.192 -0.943 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 68.01 17.04 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.493 -0.755 . . . . 0.0 109.924 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' N ' ' O ' ' A' ' 117' ' ' TRP . 2.1 t60 61.18 29.2 18.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.116 -0.99 . . . . 0.0 110.122 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -133.3 150.03 74.1 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.213 -0.929 . . . . 0.0 109.866 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.34 145.16 53.0 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.559 2.172 . . . . 0.0 111.989 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.575 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -111.5 131.38 55.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.101 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.575 ' C ' HE22 ' A' ' 125' ' ' GLN . 64.4 mtt -104.85 117.09 33.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 129' ' ' ALA . 1.1 m -97.09 -47.7 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.037 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 59.43 47.13 11.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.543 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 177' ' ' VAL . . . -77.85 157.75 29.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.456 -0.777 . . . . 0.0 109.189 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 t -105.09 -26.18 12.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.61 ' HG1' ' HG ' ' A' ' 133' ' ' SER . 40.3 p -131.5 163.66 27.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -0.903 . . . . 0.0 109.678 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.92 -32.44 70.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.61 ' HG ' ' HG1' ' A' ' 131' ' ' THR . 87.8 p -63.62 -26.25 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.798 . . . . 0.0 110.27 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -87.69 -0.81 57.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.292 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -87.98 128.68 53.0 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.61 140.25 26.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.313 2.009 . . . . 0.0 112.999 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.2 p -118.7 5.91 11.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.3 p -159.05 85.82 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.561 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -98.24 162.16 22.96 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.868 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.32 -40.72 76.96 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.402 1.401 . . . . 0.0 111.071 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -42.87 70.11 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.561 ' OG ' ' N ' ' A' ' 139' ' ' THR . 59.7 p -64.17 -45.47 88.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.466 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -63.93 -40.46 96.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.658 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -70.05 -29.28 66.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.272 -0.892 . . . . 0.0 108.825 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.409 HD11 ' CE2' ' A' ' 115' ' ' PHE . 13.3 tp -64.72 -43.09 94.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.655 -0.653 . . . . 0.0 109.875 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.662 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.05 -43.25 83.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.44 ' CG ' ' NZ ' ' A' ' 151' ' ' LYS . 34.3 ttpt -57.19 -44.77 83.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.478 -0.764 . . . . 0.0 110.788 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.63 70.75 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.001 -1.062 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.76 -38.44 90.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.431 -0.793 . . . . 0.0 109.832 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -41.96 98.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.034 -1.041 . . . . 0.0 109.06 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.44 ' NZ ' ' CG ' ' A' ' 147' ' ' LYS . 60.9 mttp -77.42 -13.45 59.92 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.99 -1.069 . . . . 0.0 110.233 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -7.05 59.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.96 -1.088 . . . . 0.0 108.717 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.46 25.07 8.95 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -104.56 113.59 27.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -1.077 . . . . 0.0 109.145 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 43.2 mttt -90.98 -176.69 4.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.863 . . . . 0.0 110.433 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 6.4 p90 42.48 47.72 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.0 0.905 . . . . 0.0 109.285 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 157' ' ' VAL . 7.3 p -128.62 46.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.37 172.96 1.76 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.5 m -57.86 -33.79 69.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -1.021 . . . . 0.0 110.06 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.429 ' HG1' ' N ' ' A' ' 161' ' ' ILE . 48.2 p -68.6 -31.67 71.01 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.04 -1.037 . . . . 0.0 108.279 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.502 ' O ' ' CE2' ' A' ' 165' ' ' PHE . 31.5 mm -65.88 -44.75 92.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.045 0.926 . . . . 0.0 108.986 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.662 ' SG ' ' N ' ' A' ' 146' ' ' SER . 53.1 m -58.12 -47.82 82.09 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.609 0.718 . . . . 0.0 110.576 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -64.17 -31.36 72.52 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.466 -0.771 . . . . 0.0 110.88 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.414 ' HA ' HE21 ' A' ' 167' ' ' GLN . 98.5 p -61.33 -48.32 81.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.502 ' CE2' ' O ' ' A' ' 161' ' ' ILE . 21.4 m-85 -64.35 -39.28 93.58 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 109.899 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 87.7 mtp -53.33 -37.49 62.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.665 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.703 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 36.1 mt-30 -68.02 -39.46 83.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.652 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.73 -40.16 14.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 111.136 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.8 -28.12 46.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.945 . . . . 0.0 110.634 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.26 -2.75 47.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 171' ' ' LEU . 6.9 mp -60.82 -38.52 85.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.381 -1.07 . . . . 0.0 109.853 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 3.9 p -138.1 151.19 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 111.457 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.406 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 0.7 OUTLIER -114.87 98.09 6.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 53.1 p30 -132.6 21.13 4.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 176' ' ' VAL . 5.9 m170 -49.05 -45.69 43.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.486 -1.384 . . . . 0.0 108.912 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.543 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 3.0 p 145.43 155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' ALA . 69.6 t -57.6 -38.76 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.965 -1.084 . . . . 0.0 110.341 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.41 ' H ' HG21 ' A' ' 176' ' ' VAL . . . -80.16 29.4 2.48 Favored Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.077 -1.014 . . . . 0.0 111.073 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.599 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.8 t . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.869 -1.371 . . . . 0.0 109.34 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.678 0.752 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.25 152.99 38.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.803 0.811 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.27 -40.73 60.88 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.711 -0.618 . . . . 0.0 111.967 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -88.92 -3.74 58.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.487 -1.596 . . . . 0.0 110.055 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.89 -40.36 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.997 -1.064 . . . . 0.0 109.315 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -77.01 -0.95 26.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 108.811 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 42.8 tt0 -64.46 -41.85 96.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.485 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 173.35 166.13 0.28 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.95 -1.094 . . . . 0.0 109.753 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 13' ' ' TYR . 50.6 Cg_exo -48.18 -167.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.534 2.156 . . . . 0.0 113.075 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.0 mt 63.57 -47.21 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.864 -0.523 . . . . 0.0 109.789 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.8 m-85 -62.51 -39.98 95.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.994 -1.066 . . . . 0.0 109.395 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.91 -44.29 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 110.304 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.631 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.2 -50.23 64.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.767 -1.208 . . . . 0.0 109.361 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.4 t80 -62.03 -42.58 99.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.822 . . . . 0.0 109.769 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -69.76 -41.6 74.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.459 -0.775 . . . . 0.0 110.349 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -74.96 -6.69 50.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 110.55 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-80 -71.77 -76.92 0.1 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.023 -1.048 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' C ' ' A' ' 21' ' ' TRP . 84.5 mt-10 -151.13 -51.85 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.567 ' C ' ' O ' ' A' ' 20' ' ' GLU . 3.8 t90 24.62 72.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.85 48.92 0.44 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.019 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.753 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.5 m -163.9 -27.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.252 -1.146 . . . . 0.0 112.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.753 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 44.9 Cg_endo -87.14 151.16 8.16 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.661 1.574 . . . . 0.0 113.79 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.11 152.06 29.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.659 ' HG1' ' HE1' ' A' ' 117' ' ' TRP . 2.9 p -94.98 137.87 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.918 -1.114 . . . . 0.0 111.186 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -98.15 157.64 16.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.574 ' C ' ' HH ' ' A' ' 102' ' ' TYR . 16.3 m -55.25 -35.43 64.98 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.503 -1.373 . . . . 0.0 109.067 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -69.45 -36.55 76.71 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.816 -0.552 . . . . 0.0 111.672 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -63.81 -41.46 97.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.746 -1.221 . . . . 0.0 110.619 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 6.7 mp -57.09 -39.0 74.18 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.763 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 78.2 t80 -66.53 -52.58 44.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 110.597 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -67.34 -38.52 84.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 108.923 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 ttm -70.28 -47.9 59.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.505 -0.747 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.86 -31.85 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.868 -1.145 . . . . 0.0 109.441 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.8 m -69.65 -45.9 67.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.008 -1.057 . . . . 0.0 108.983 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.402 HD11 HH11 ' A' ' 53' ' ' ARG . 79.8 mt -67.33 -38.33 84.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.469 -0.77 . . . . 0.0 109.468 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -64.82 -35.55 81.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.952 . . . . 0.0 109.862 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.95 -35.27 53.3 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.027 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . 24.8 mt-30 -63.52 -33.65 76.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.275 . . . . 0.0 110.747 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -43.62 -22.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.779 -1.201 . . . . 0.0 110.265 -179.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -54.95 112.65 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.929 -1.107 . . . . 0.0 109.148 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.61 -25.84 1.69 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.7 mm? -102.56 164.97 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -99.47 148.3 24.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.574 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.78 -39.98 72.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.006 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.97 -1.081 . . . . 0.0 109.122 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.7 m -64.4 -40.03 95.0 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' ARG . 1.4 t -65.89 -35.79 75.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -55.89 -50.39 70.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.3 mttt -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.596 -1.315 . . . . 0.0 108.864 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mmpp? -63.26 -26.43 68.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' VAL . 17.3 ttm-85 -53.68 -45.87 70.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.4 -41.03 89.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.489 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 9.4 m-80 -69.11 -36.17 77.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.47 -48.6 80.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 110.66 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -69.24 -27.22 65.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.772 -1.205 . . . . 0.0 109.143 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -36.91 75.52 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 m -76.62 -45.9 28.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.948 -1.095 . . . . 0.0 110.193 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.847 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.494 1.533 0 N-CA-C 113.121 0.393 . . . . 0.0 113.121 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.77 -45.61 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.722 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -34.53 72.73 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -41.41 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.955 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -17.3 63.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.05 55.99 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 95.2 mtp -85.35 114.23 22.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.86 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -95.68 -177.83 4.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.2 -31.19 67.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 110.596 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.58 -49.26 75.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.751 -1.218 . . . . 0.0 108.988 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.92 -38.99 90.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -58.46 -41.95 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -0.76 . . . . 0.0 109.306 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' C ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -60.48 -33.33 72.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.96 . . . . 0.0 109.359 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -69.61 -46.93 65.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.988 . . . . 0.0 110.239 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.89 -32.44 69.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.76 -0.587 . . . . 0.0 112.182 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.7 t -49.47 -27.1 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.746 -1.221 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.42 -9.36 14.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 84' ' ' GLY . 43.3 m-20 -73.49 111.09 8.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.549 -1.344 . . . . 0.0 109.169 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.22 -15.75 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.763 . . . . 0.0 109.214 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 76.71 38.94 30.51 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.0 pt -52.03 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.374 -1.074 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.3 mt -65.03 98.07 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.967 -1.083 . . . . 0.0 108.889 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.648 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 3.0 mtt-85 -55.49 132.76 49.25 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.648 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.4 m-70 156.51 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.642 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.6 OUTLIER -54.47 -35.67 63.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.167 -0.958 . . . . 0.0 108.809 -179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.21 -54.43 37.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.93 -43.63 95.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -1.178 . . . . 0.0 109.599 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 92' ' ' ILE . 92.6 mt -58.23 -45.21 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.03 -1.044 . . . . 0.0 109.251 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.65 -33.71 68.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.921 -1.112 . . . . 0.0 109.339 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.3 82.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.045 -1.034 . . . . 0.0 108.459 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.61 -43.6 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.47 -0.769 . . . . 0.0 109.767 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.33 -46.4 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 108.583 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.33 95.41 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -59.07 -37.07 76.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -1.176 . . . . 0.0 109.411 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.0 86.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -0.983 . . . . 0.0 109.641 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -57.87 -38.27 75.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.176 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.27 79.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.574 ' HH ' ' C ' ' A' ' 28' ' ' SER . 41.7 t80 -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -64.16 -42.04 96.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.17 -0.957 . . . . 0.0 109.443 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.643 ' SD ' ' CE1' ' A' ' 112' ' ' PHE . 80.5 mtp -68.66 -39.5 80.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.15 -41.23 86.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.428 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.73 -19.54 65.83 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -92.52 -9.5 41.1 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.41 25.2 75.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -115.45 102.47 54.41 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.372 -1.075 . . . . 0.0 109.297 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.14 148.99 29.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.643 ' CE1' ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -68.73 -43.36 76.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.76 0.791 . . . . 0.0 110.352 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.36 -26.69 64.8 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.053 -1.029 . . . . 0.0 110.689 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -57.41 -49.15 77.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.742 -1.224 . . . . 0.0 110.923 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 8.6 p90 -76.0 -36.35 59.21 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 110.19 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.76 -55.13 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.706 -1.246 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HE1' ' HG1' ' A' ' 26' ' ' THR . 67.5 m95 -58.24 -21.71 49.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.181 -0.949 . . . . 0.0 108.654 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 25.1 p -73.57 -32.59 64.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.927 -1.108 . . . . 0.0 109.846 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -69.63 -30.54 68.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.832 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.09 19.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.098 -1.001 . . . . 0.0 109.405 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 122' ' ' HIS . 69.3 m-20 61.94 42.03 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.0 110.799 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER 41.89 29.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.6 178.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.0 147.67 35.65 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.857 -1.152 . . . . 0.0 109.853 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.62 139.34 88.5 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.302 2.001 . . . . 0.0 111.811 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.9 147.55 36.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.825 . . . . 0.0 109.65 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.6 mtt -95.11 125.97 40.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.188 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -40.92 83.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 108.841 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 62.48 44.94 6.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.635 -0.665 . . . . 0.0 110.401 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -106.74 139.22 41.52 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.5 p -101.05 -14.22 17.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.011 -1.056 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -151.05 169.38 21.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.071 . . . . 0.0 109.963 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.1 -34.72 73.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.43 -0.794 . . . . 0.0 109.338 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -73.89 -11.48 60.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -98.68 14.9 26.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.59 98.34 17.11 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.474 1.449 . . . . 0.0 112.227 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.5 p -97.38 1.86 49.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.393 -0.817 . . . . 0.0 109.446 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -138.79 91.16 2.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.269 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.2 156.16 37.34 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -52.29 -39.2 73.03 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.041 1.827 . . . . 0.0 111.628 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.41 -44.36 52.25 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.066 -1.021 . . . . 0.0 108.605 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -68.02 -37.48 81.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -66.22 -35.64 80.97 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 108.598 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.1 93.06 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.559 -0.713 . . . . 0.0 109.37 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.96 -46.78 87.21 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.097 -1.041 . . . . 0.0 108.517 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.593 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 23.6 m -56.44 -40.63 75.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.692 -1.255 . . . . 0.0 108.921 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -65.9 -50.65 63.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.426 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.37 88.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.33 -38.82 85.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.973 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -61.25 -40.19 93.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.877 -1.14 . . . . 0.0 109.195 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -65.87 -33.55 76.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 110.374 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.568 ' O ' ' NE2' ' A' ' 104' ' ' GLN . 2.5 mmp_? -72.24 2.94 5.14 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.04 -1.038 . . . . 0.0 108.876 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.16 52.46 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.72 115.44 27.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.723 -0.869 . . . . 0.0 108.781 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -89.34 167.41 13.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.624 -0.673 . . . . 0.0 110.397 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 57.62 59.87 3.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.619 -0.676 . . . . 0.0 109.956 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 22.6 m -131.56 33.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.539 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.08 164.19 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.4 p -58.91 -22.88 60.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -1.137 . . . . 0.0 108.889 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -75.76 -32.69 60.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.445 HD13 HG22 ' A' ' 161' ' ' ILE . 22.5 mm -67.69 -45.25 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.593 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.6 m -63.04 -40.21 97.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.399 0.618 . . . . 0.0 109.867 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -70.07 -41.92 73.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.556 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.3 m -60.66 -44.54 96.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -0.838 . . . . 0.0 108.97 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.573 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 3.0 t80 -62.92 -40.05 96.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.823 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.93 -40.23 88.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.569 -0.707 . . . . 0.0 112.765 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.4 pt20 -79.66 -46.34 17.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.193 -1.567 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.47 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -73.28 -28.63 62.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.955 -1.091 . . . . 0.0 111.364 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 30.4 p -67.1 -29.75 69.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 111.39 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 109.01 -1.8 31.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.515 ' H ' ' HG ' ' A' ' 169' ' ' CYS . 27.5 mt -61.01 -36.31 79.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.091 -1.241 . . . . 0.0 110.324 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.4 151.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.055 -1.028 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 81.8 m-20 -114.77 162.98 16.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.606 -0.684 . . . . 0.0 110.102 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 96.42 75.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.098 0.475 . . . . 0.0 110.008 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.457 ' NE2' ' O ' ' A' ' 21' ' ' TRP . 21.0 m170 -52.11 -41.05 62.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.116 -0.99 . . . . 0.0 108.71 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 176' ' ' VAL . 7.7 p -168.54 28.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 176' ' ' VAL . 42.0 t 56.19 118.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.0 109.906 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.56 9.52 62.87 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.236 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.279 . . . . 0.0 108.951 179.889 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.71 0.767 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -178.1 154.55 0.88 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.17 -45.3 95.54 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.548 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.686 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -88.8 -4.41 58.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.361 -1.67 . . . . 0.0 109.988 -178.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.14 -41.1 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.131 -0.98 . . . . 0.0 109.333 178.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.7 -9.59 58.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 108.875 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -69.63 -39.97 76.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -0.791 . . . . 0.0 111.257 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.26 157.59 30.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.508 -1.37 . . . . 0.0 111.239 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' TYR . 18.3 Cg_endo -63.5 179.96 0.81 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.251 2.634 . . . . 0.0 112.286 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.1 mt 66.24 -44.14 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -55.44 -35.69 65.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.15 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 1.9 mp -54.24 -43.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.07 . . . . 0.0 108.984 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.661 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -64.88 -49.27 71.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -58.36 -37.0 74.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.204 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -62.49 -45.33 93.49 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.141 -0.975 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -83.27 -2.59 56.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.661 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 25.6 m-80 -76.5 -75.17 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.838 -1.164 . . . . 0.0 109.159 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -168.98 69.11 0.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.143 -0.973 . . . . 0.0 109.76 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.4 t90 -79.83 60.71 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.978 -1.076 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.45 64.19 1.46 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.583 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.716 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -137.87 -33.73 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.2 -1.176 . . . . 0.0 111.041 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.716 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 64.8 Cg_endo -97.08 150.45 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.737 2.291 . . . . 0.0 113.395 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.9 147.64 51.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -101.71 151.45 22.02 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.543 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 5.9 t70 -94.35 157.01 16.23 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 m -50.29 -32.76 17.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -178.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -71.51 -39.31 70.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.681 -0.637 . . . . 0.0 111.63 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -62.66 -39.12 92.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.836 -1.165 . . . . 0.0 110.276 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 6.1 mp -56.45 -40.08 74.22 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.786 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 89.8 t80 -62.56 -46.66 87.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -71.53 -36.45 71.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.051 -1.031 . . . . 0.0 109.078 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.1 ttm -69.13 -47.9 63.83 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.047 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.15 -29.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.52 -1.362 . . . . 0.0 109.912 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 86.1 m -68.49 -52.75 28.84 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.493 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.6 mt -64.9 -40.19 94.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.585 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 66.1 mm-40 -63.43 -31.13 72.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.026 -1.046 . . . . 0.0 108.573 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 -37.08 85.07 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 42' ' ' ALA . 96.2 mt-30 -58.65 -35.05 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.826 -0.808 . . . . 0.0 111.459 -178.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.585 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 6.4 pt20 -70.96 9.59 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.631 -1.293 . . . . 0.0 110.177 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -54.96 112.92 1.15 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.937 -1.102 . . . . 0.0 108.589 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.15 -14.37 0.44 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 42' ' ' ALA . 31.2 tp -106.77 145.95 31.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.562 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.0 157.13 4.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.702 0.763 . . . . 0.0 111.198 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.82 -37.07 62.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.796 -0.565 . . . . 0.0 110.119 179.316 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -40.36 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.021 -1.049 . . . . 0.0 110.077 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.7 m -57.6 -38.5 75.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.09 -1.006 . . . . 0.0 108.34 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.5 t -65.06 -33.75 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.722 -0.611 . . . . 0.0 109.367 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.47 -48.66 78.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -63.02 -45.8 90.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.968 -1.083 . . . . 0.0 109.441 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -79.26 -8.99 59.47 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.266 -179.08 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.99 -54.45 13.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.756 -1.215 . . . . 0.0 108.492 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -39.96 94.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.498 -0.751 . . . . 0.0 109.733 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 85' ' ' ILE . 39.7 t30 -74.96 -46.49 35.15 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.15 -0.969 . . . . 0.0 110.893 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 59.4 t80 -63.41 -49.2 74.71 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.095 -1.003 . . . . 0.0 110.139 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HG3' HH11 ' A' ' 57' ' ' ARG . 3.6 ptm180 -58.12 -33.92 69.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.89 -1.131 . . . . 0.0 109.13 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.88 82.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 110.177 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.4 -43.67 63.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.819 -1.176 . . . . 0.0 110.505 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 84.1 m-85 . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 110.134 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 N-CA-C 115.584 1.34 . . . . 0.0 115.584 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.77 -34.97 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.909 -1.12 . . . . 0.0 108.853 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 -38.19 68.88 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.73 -36.4 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -17.59 64.72 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.25 -14.86 25.06 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.466 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 42.5 mmm -73.86 111.21 8.79 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.594 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 8.8 mt-30 -97.06 172.17 8.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.12 -29.25 29.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.46 -45.9 80.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.892 -1.13 . . . . 0.0 109.323 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.7 p30 -66.05 -36.36 83.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 108.577 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 80.7 t -62.19 -44.13 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 110.487 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.84 -39.64 78.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -66.23 -39.56 89.65 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.59 0.709 . . . . 0.0 109.349 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mt -64.56 -32.68 74.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.654 -0.654 . . . . 0.0 111.136 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.6 t -48.91 -35.2 6.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -113.61 4.24 16.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.87 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 43.4 t0 -90.58 111.21 22.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.546 -1.346 . . . . 0.0 110.625 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 76.6 -16.73 0.6 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.547 -0.721 . . . . 0.0 109.658 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.34 28.32 60.12 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.301 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 87' ' ' ARG . 23.2 pt -57.03 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.083 -1.246 . . . . 0.0 109.779 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.568 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 1.5 tt -58.63 76.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.174 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.26 117.39 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.3 OUTLIER -158.69 -34.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.44 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.541 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 65.45 -36.66 0.23 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.902 -0.498 . . . . 0.0 110.401 178.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 88' ' ' HIS . . . -73.51 -59.49 4.11 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.269 -1.443 . . . . 0.0 109.585 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.61 -33.55 72.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -1.069 . . . . 0.0 109.9 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.8 mt -64.98 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -32.38 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.89 -39.26 90.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 109.159 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.07 -35.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.189 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 96' ' ' ILE . 20.8 mm -62.26 -47.63 92.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 109.489 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.69 71.95 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 98' ' ' ASN . 1.6 m-80 -68.97 -35.54 76.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.128 -1.219 . . . . 0.0 110.536 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.05 90.69 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 108.854 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.59 -35.92 81.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.05 179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.33 70.5 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.68 -40.46 96.86 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.28 -34.08 77.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.78 -37.12 86.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 110.087 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CD1' ' A' ' 112' ' ' PHE . 8.6 ttm -65.92 -43.05 89.25 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.923 -1.11 . . . . 0.0 109.316 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -63.18 -36.75 84.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.613 -0.679 . . . . 0.0 109.352 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.77 -18.75 64.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.57 -16.36 25.78 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.91 27.06 73.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.545 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.5 mm-40 -114.58 101.57 54.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 110.065 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.97 141.67 45.89 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.16 1.907 . . . . 0.0 112.485 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CD1' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -55.5 -44.0 76.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.701 0.762 . . . . 0.0 111.246 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.42 -27.75 64.51 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 111.023 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -61.86 -47.71 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.014 -1.054 . . . . 0.0 111.368 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 4.5 p90 -76.56 -33.48 58.52 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.708 -1.245 . . . . 0.0 109.671 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.48 -55.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.826 -1.171 . . . . 0.0 110.45 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CH2' HD21 ' A' ' 171' ' ' LEU . 73.8 m95 -60.02 -22.89 63.2 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 109.268 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 83.1 p -70.74 -37.04 73.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.017 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.438 ' N ' ' HG ' ' A' ' 118' ' ' SER . 14.2 m-85 -65.67 -35.97 82.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.691 -1.256 . . . . 0.0 108.596 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.22 14.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.317 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 59.16 37.05 24.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 117' ' ' TRP . 4.9 m80 46.39 24.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.061 -1.024 . . . . 0.0 109.768 179.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 149.01 71.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.502 -0.749 . . . . 0.0 110.239 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.56 144.41 66.55 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.056 2.504 . . . . 0.0 111.841 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -111.52 137.2 49.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.866 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 87.9 mtp -92.3 131.09 37.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.728 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -78.62 -41.98 30.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 56.85 45.11 22.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.987 -1.071 . . . . 0.0 109.376 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.404 ' H ' HG21 ' A' ' 127' ' ' THR . . . -102.03 140.44 36.31 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.6 p -97.1 -24.0 15.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.101 -0.999 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -140.99 166.2 25.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 108.834 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.34 -35.07 76.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.55 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -64.74 -27.57 68.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.787 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.85 3.74 16.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 135' ' ' ILE . 2.3 tp -91.29 123.84 63.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.56 138.19 13.49 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.023 1.815 . . . . 0.0 112.409 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.5 p -108.27 14.37 24.97 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.2 p -153.92 84.61 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.64 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.588 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.6 OUTLIER -105.15 157.14 34.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.101 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.14 -40.65 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.466 1.444 . . . . 0.0 111.848 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -41.55 70.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.021 -1.05 . . . . 0.0 108.306 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.616 ' HG ' ' N ' ' A' ' 143' ' ' ASP . 97.4 p -64.53 -43.9 92.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.687 . . . . 0.0 109.373 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.616 ' N ' ' HG ' ' A' ' 142' ' ' SER . 95.5 m-20 -62.57 -36.5 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.143 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.77 -31.16 72.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.759 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.64 -47.46 59.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.944 -1.097 . . . . 0.0 109.575 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.606 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 1.7 m -57.8 -46.1 85.13 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.536 -1.353 . . . . 0.0 110.532 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -70.5 -39.3 74.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.814 -1.179 . . . . 0.0 109.653 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.14 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.543 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.46 -35.96 81.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.057 -1.027 . . . . 0.0 109.415 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.07 -42.42 98.47 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 109.582 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -67.79 -32.43 73.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.469 -0.769 . . . . 0.0 111.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -68.14 -8.31 37.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.749 -1.219 . . . . 0.0 109.103 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.09 31.36 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -95.99 117.62 31.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.586 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 23.1 mtmt -90.47 -175.28 4.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.506 0.67 . . . . 0.0 110.813 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 8.5 p90 47.45 48.6 16.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.525 0.678 . . . . 0.0 110.344 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.59 39.95 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.17 164.06 0.44 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -57.17 -33.57 67.58 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.32 -1.106 . . . . 0.0 109.862 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.3 p -71.29 -34.36 70.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 108.844 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 161' ' ' ILE . 16.2 mm -60.54 -44.15 95.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.606 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 63.2 m -65.45 -32.67 74.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.647 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -68.79 -44.77 72.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.005 -1.06 . . . . 0.0 109.564 179.728 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.3 p -63.92 -37.37 87.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 108.762 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 57.7 t80 -60.82 -41.43 95.73 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.826 0.822 . . . . 0.0 109.142 178.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 37.1 mmm -59.33 -40.31 85.94 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.838 -0.539 . . . . 0.0 111.457 -178.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.647 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.7 pt20 -80.21 -47.27 14.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.606 -1.309 . . . . 0.0 110.997 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.68 -17.84 64.16 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.805 -1.184 . . . . 0.0 110.634 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 66.4 m -83.32 -19.6 35.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.836 -1.165 . . . . 0.0 111.822 -178.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.51 1.25 64.23 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.404 HD21 ' CH2' ' A' ' 117' ' ' TRP . 94.2 mt -65.77 -35.24 80.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.704 -0.88 . . . . 0.0 109.357 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.14 135.93 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 108.915 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 58.8 m-20 -114.52 162.69 16.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.92 -179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.7 OUTLIER 92.05 79.11 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.224 0.535 . . . . 0.0 110.605 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -54.84 -70.6 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.158 -0.964 . . . . 0.0 108.629 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.62 148.28 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 108.831 179.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.16 130.92 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.617 -1.302 . . . . 0.0 109.121 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.29 40.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.041 -1.27 . . . . 0.0 109.13 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.72 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.46 -25.04 57.39 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' HA ' HE21 ' A' ' 9' ' ' GLN . 2.7 t90 -99.06 27.8 4.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -1.23 . . . . 0.0 109.986 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.54 -27.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.903 -1.123 . . . . 0.0 111.321 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.7 m -79.86 -2.75 44.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.701 -1.249 . . . . 0.0 109.16 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 6' ' ' TRP . 59.4 mt-30 -66.63 -37.74 85.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.341 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.36 158.77 8.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.669 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.6 Cg_endo -60.57 -163.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.809 2.339 . . . . 0.0 112.164 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp 61.0 -46.52 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.919 -0.488 . . . . 0.0 110.054 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.6 m-85 -59.39 -37.86 79.05 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 109.451 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 14' ' ' ILE . 3.0 mp -54.89 -44.75 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.638 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.4 85.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.907 -1.121 . . . . 0.0 108.995 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.552 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 23.5 t80 -65.52 -36.17 83.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -58.91 -44.29 91.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 112.214 -178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.79 -0.55 45.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.917 -1.115 . . . . 0.0 112.271 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.784 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -99.98 -30.66 11.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.536 -1.352 . . . . 0.0 112.068 -178.48 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.784 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 89.9 mt-10 -160.29 22.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.431 -1.418 . . . . 0.0 109.825 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.552 ' CE3' ' CE2' ' A' ' 16' ' ' TYR . 3.1 t90 -106.15 72.43 0.93 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 110.461 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.04 4.41 35.85 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.285 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.0 m -115.0 -21.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.0 112.431 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 85.8 Cg_endo -86.75 150.46 8.62 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.925 1.75 . . . . 0.0 114.293 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -88.08 159.31 18.29 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.541 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 2.6 p -84.08 122.53 28.93 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.776 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -106.12 167.25 9.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -74.52 -38.08 62.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.101 -1.624 . . . . 0.0 110.681 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -74.12 -50.46 19.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -0.901 . . . . 0.0 112.343 -177.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -57.82 -36.79 72.75 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.072 -1.018 . . . . 0.0 109.804 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 5.8 mp -66.76 -35.32 79.81 Favored 'General case' 0 C--N 1.286 -2.168 0 O-C-N 121.634 -0.666 . . . . 0.0 109.923 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.07 -48.11 83.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.538 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.62 -27.62 60.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.842 -1.161 . . . . 0.0 109.598 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.551 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 60.1 ttm -66.72 -50.93 61.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.664 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.44 -34.22 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 0.0 108.924 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 85.6 m -71.8 -51.95 20.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.927 . . . . 0.0 109.604 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.494 HD13 HH11 ' A' ' 53' ' ' ARG . 24.6 mt -67.16 -38.69 85.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 6.8 tp10 -62.75 -33.38 75.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.72 -36.4 93.24 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 4.8 mp0 -63.11 -26.58 68.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.047 -1.267 . . . . 0.0 110.691 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' OE1' ' OE2' ' A' ' 38' ' ' GLU . 1.9 pt20 -66.37 -2.94 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.853 -1.154 . . . . 0.0 110.856 -178.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -60.31 112.47 1.95 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.612 -1.305 . . . . 0.0 108.595 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.97 -7.93 2.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . 25.5 tp -109.95 144.8 37.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -1.205 . . . . 0.0 109.957 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.3 m -64.12 149.98 46.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.516 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.88 -38.48 61.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.698 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -35.81 63.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.98 -1.075 . . . . 0.0 108.309 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.1 m -61.06 -44.24 97.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -69.1 -25.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.0 tt -63.79 -51.65 63.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 54.7 mttt -60.33 -44.41 95.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.661 -1.275 . . . . 0.0 108.13 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -74.29 -10.46 59.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 53' ' ' ARG . 16.3 ttm-85 -64.63 -45.13 88.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 57.2 mp0 -70.69 -44.15 67.57 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.608 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 11.0 m-80 -69.92 -39.81 75.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.93 -1.106 . . . . 0.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.81 -48.19 82.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 111.097 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -65.7 -27.33 68.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 109.266 -179.729 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.31 -42.54 99.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.907 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -74.38 -45.57 46.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.923 -1.111 . . . . 0.0 109.983 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.021 -1.049 . . . . 0.0 110.258 179.623 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 N-CA-C 112.995 0.344 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.08 -41.07 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.949 -1.094 . . . . 0.0 109.164 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -33.94 76.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.73 -41.68 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.643 -0.661 . . . . 0.0 109.552 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.85 -14.23 62.79 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.65 -9.49 49.41 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.281 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.9 mtp -78.18 113.07 15.79 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -95.31 177.95 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.974 . . . . 0.0 109.964 -178.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -55.13 -28.68 54.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.783 . . . . 0.0 110.667 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -63.17 -41.24 99.2 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.106 -1.621 . . . . 0.0 109.134 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.53 -38.72 90.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.393 -0.817 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -31.27 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.667 -1.27 . . . . 0.0 109.204 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.03 -39.63 90.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.085 -1.009 . . . . 0.0 110.548 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' ' N ' ' A' ' 79' ' ' LEU . 7.6 ptp180 -74.33 -40.79 61.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.709 -1.244 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 15.9 mt -65.8 -33.21 75.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -48.57 -30.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.453 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -106.53 -0.33 24.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.443 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 84' ' ' GLY . 66.5 t0 -80.43 107.95 13.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.499 -1.376 . . . . 0.0 109.55 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.68 -14.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.668 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 68.42 35.9 82.88 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -28.0 -91.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.165 -0.609 . . . . 0.0 110.592 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -175.98 -44.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -0.967 . . . . 0.0 109.575 179.679 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -64.22 156.04 29.98 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.155 -0.966 . . . . 0.0 110.034 -178.65 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -106.68 169.52 8.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.589 0.709 . . . . 0.0 109.631 -179.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.14 -33.72 63.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.51 -59.18 5.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.406 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 11.6 tptm -60.63 -42.64 97.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.723 -1.457 . . . . 0.0 110.163 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -57.17 -47.38 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.992 -1.068 . . . . 0.0 109.766 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.07 -31.99 44.69 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.742 -1.224 . . . . 0.0 108.289 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.03 77.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.013 -1.054 . . . . 0.0 109.089 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.86 -45.54 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.187 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.39 -36.35 72.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.899 -1.126 . . . . 0.0 109.078 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.41 -36.39 83.81 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -60.51 -35.9 77.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.537 -0.978 . . . . 0.0 108.573 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.462 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -53.27 -41.19 65.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' ' CE2' ' A' ' 154' ' ' PHE . . . -65.28 -31.55 72.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.887 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.06 -44.36 97.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -61.41 -35.81 78.58 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.55 -34.0 77.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.331 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 36.0 ttm -63.78 -40.93 97.88 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -38.42 91.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.1 m120 -90.47 -14.73 32.2 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.48 27.87 73.54 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.965 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.4 tp10 -124.79 102.03 32.4 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.996 -1.296 . . . . 0.0 110.124 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.69 150.09 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.012 1.808 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -61.23 -45.08 96.04 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.127 0.965 . . . . 0.0 110.052 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.37 66.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.702 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -68.83 -45.18 71.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.438 -1.414 . . . . 0.0 112.214 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.0 p90 -70.99 -36.22 72.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.471 -1.393 . . . . 0.0 110.501 -178.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 ' CG1' ' CZ ' ' A' ' 115' ' ' PHE . 31.3 m -65.42 -52.44 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 119.961 -1.712 . . . . 0.0 109.542 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.541 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 50.9 m95 -56.63 -22.68 35.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 108.508 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.6 p -74.39 -35.7 63.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.978 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 9.7 m-85 -68.22 -29.43 68.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.195 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.67 18.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.513 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 122' ' ' HIS . 15.7 m120 58.95 39.43 23.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.3 t60 40.57 29.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -127.26 146.93 59.9 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.38 140.39 52.7 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.606 2.204 . . . . 0.0 112.186 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -107.23 127.97 54.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 108.783 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 mtt -101.72 122.73 44.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.67 116.41 28.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -93.38 21.86 5.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.988 . . . . 0.0 109.988 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.38 51.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.383 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 99.0 m -93.65 -31.21 14.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.4 p -133.52 162.89 30.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.02 -35.48 71.33 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.136 -0.978 . . . . 0.0 108.952 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 m -60.55 -25.38 66.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -88.89 -4.38 58.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 0.0 109.713 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.85 130.7 37.7 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 147.45 26.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.233 1.956 . . . . 0.0 112.513 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -103.44 9.53 37.68 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -144.93 98.82 3.24 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.234 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.425 ' N ' ' OG ' ' A' ' 142' ' ' SER . 10.0 p -109.14 155.01 41.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.59 -39.37 75.61 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.979 1.786 . . . . 0.0 111.441 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.38 62.31 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.386 -0.926 . . . . 0.0 108.786 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 139' ' ' THR . 94.7 p -65.31 -39.22 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.428 -0.795 . . . . 0.0 109.981 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.482 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -63.12 -34.31 77.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.537 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.67 -47.84 81.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.942 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.566 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 27.8 m -60.87 -44.96 96.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.845 -1.159 . . . . 0.0 109.543 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -67.81 -44.22 77.83 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.487 -0.758 . . . . 0.0 109.598 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.38 -41.8 80.03 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.498 -0.751 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.439 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 26.2 mt -68.01 -44.35 76.74 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -62.21 -42.44 99.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.66 -31.54 70.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 111.371 -178.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.439 ' NH2' ' CD2' ' A' ' 149' ' ' LEU . 86.5 mtm180 -80.25 4.25 18.25 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.963 -1.085 . . . . 0.0 110.159 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.41 20.74 34.14 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.946 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' ' CB ' ' A' ' 101' ' ' ALA . 36.4 m-85 -102.82 110.91 23.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.132 -1.216 . . . . 0.0 108.772 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -91.72 172.59 8.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.404 ' CE1' ' HE3' ' A' ' 91' ' ' LYS . 63.4 m-85 58.27 69.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.185 0.993 . . . . 0.0 108.842 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 158' ' ' GLY . 30.2 m -150.93 38.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -43.72 166.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -58.07 -28.96 65.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.558 -0.966 . . . . 0.0 109.217 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.7 p -73.31 -31.39 63.99 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.1 mm -69.76 -44.96 78.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.566 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 35.9 m -66.26 -34.84 78.91 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.537 0.684 . . . . 0.0 109.871 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -70.57 -45.29 65.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.911 . . . . 0.0 109.644 -179.613 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.509 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 93.3 p -67.81 -32.03 72.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.038 . . . . 0.0 108.422 178.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.581 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 42.9 t80 -58.67 -45.25 89.82 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.753 -0.592 . . . . 0.0 109.706 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 81.3 mtp -66.4 -38.71 88.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.538 ' CG ' ' HE1' ' A' ' 21' ' ' TRP . 1.2 tp-100 -64.26 -46.08 85.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.371 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.63 -37.75 49.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 58.3 m -56.77 -28.68 61.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 110.03 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.52 2.95 56.48 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.84 -33.85 76.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -1.089 . . . . 0.0 109.814 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.36 130.09 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 70.0 m-20 -108.55 163.82 12.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.434 -0.791 . . . . 0.0 109.939 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.7 m-20 86.13 74.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.228 0.537 . . . . 0.0 110.016 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.48 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 23.3 m80 -54.93 -61.4 2.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.815 . . . . 0.0 109.065 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.25 152.66 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.627 -0.671 . . . . 0.0 109.197 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.76 130.81 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.02 -1.05 . . . . 0.0 109.026 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.12 10.54 64.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.15 . . . . 0.0 109.329 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 126.47 27.44 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.878 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.89 -20.67 20.33 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -95.53 -4.31 45.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 110.21 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.88 -26.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -3.61 28.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 110.065 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 89.6 mm-40 -65.96 -48.45 71.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.987 -1.071 . . . . 0.0 110.67 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.89 153.8 23.21 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.848 -1.158 . . . . 0.0 109.837 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -54.77 -32.87 78.53 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.159 1.906 . . . . 0.0 113.421 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.3 mt -59.86 -35.16 74.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.774 -1.204 . . . . 0.0 110.328 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -62.21 -34.61 76.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.881 -1.137 . . . . 0.0 109.942 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.63 -42.74 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.917 -1.114 . . . . 0.0 108.935 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.84 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 61.7 t80 -65.42 -42.83 92.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.53 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -64.89 -36.25 83.76 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.2 -0.938 . . . . 0.0 110.684 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -74.6 -19.03 60.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 112.303 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 33.4 p30 -88.31 -55.18 3.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.47 -177.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.689 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 16.0 pt-20 -163.73 68.74 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.093 -1.63 . . . . 0.0 111.856 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.577 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 31.3 t-105 -77.6 64.35 2.89 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.24 44.66 27.89 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.3 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.666 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.4 t -107.01 -32.85 0.18 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.344 -1.092 . . . . 0.0 110.682 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.0 Cg_endo -87.57 154.76 7.7 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 123.116 2.544 . . . . 0.0 112.705 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.94 162.17 17.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.08 115.25 26.48 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.421 -176.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 93.8 m-20 -89.77 157.98 17.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 178.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 20.7 m -65.89 -45.86 80.46 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.051 -1.656 . . . . 0.0 111.325 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 32' ' ' PHE . 39.1 mmtm -63.6 -51.06 66.91 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.338 -0.851 . . . . 0.0 112.362 -177.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -56.9 -36.76 70.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 108.148 -179.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 31' ' ' LEU . 9.4 mp -65.8 -30.6 71.27 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.24 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 28' ' ' SER . 4.8 m-30 -58.92 -50.84 72.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.39 -1.324 . . . . 0.0 107.89 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -68.38 -44.63 74.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.283 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 36.4 tpp -50.84 -49.99 57.63 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.256 -0.902 . . . . 0.0 111.121 -178.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.87 -29.09 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.6 -1.313 . . . . 0.0 109.25 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -71.25 -47.93 54.14 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.8 -40.35 83.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.867 -1.146 . . . . 0.0 109.503 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -59.11 -36.51 75.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 108.983 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.46 -32.62 78.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.1 -1.4 44.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -1.1 . . . . 0.0 109.991 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -89.4 -7.51 55.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.005 -179.837 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.53 120.14 13.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.997 -1.064 . . . . 0.0 109.073 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.65 -37.84 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 44' ' ' LEU . 5.7 mp -98.98 148.79 23.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 109.883 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -66.67 153.71 42.46 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -58.13 -35.21 71.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.295 -179.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -29.12 46.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.9 m -61.27 -41.36 96.81 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.893 -1.13 . . . . 0.0 109.37 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -70.26 -30.24 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 109.181 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.73 -46.76 88.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.6 mtmt -63.29 -44.63 94.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.85 -1.156 . . . . 0.0 108.784 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -77.02 -9.62 58.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 108.723 179.345 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.5 ttm180 -67.12 -46.26 74.67 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.23 -42.88 92.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 17.1 m-80 -69.41 -41.73 76.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.822 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.9 t80 -61.39 -44.52 97.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.504 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -57.6 -38.48 74.98 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.414 -0.803 . . . . 0.0 109.948 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.9 -34.51 75.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.283 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.0 m -72.94 -43.75 61.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.234 -0.916 . . . . 0.0 111.161 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.664 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 CA--C 1.543 0.949 0 N-CA-C 115.689 1.38 . . . . 0.0 115.689 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 0.0 112.077 -176.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -33.83 64.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.751 -1.218 . . . . 0.0 108.921 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.78 -37.41 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 0.0 108.355 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.15 64.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.53 -6.22 50.12 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.059 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.44 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 89.8 mtp -75.62 114.16 13.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.597 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 6.3 tt0 -95.32 171.68 8.56 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.508 0.67 . . . . 0.0 110.128 -177.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 99.2 mt-10 -53.24 -28.52 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -56.56 -50.7 71.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.882 -1.136 . . . . 0.0 108.898 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.6 p30 -63.83 -37.02 85.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 108.786 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 76.3 t -56.47 -41.84 73.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 108.983 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -57.82 -40.8 80.85 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -62.32 -43.7 98.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' GLN . 53.2 mt -67.53 -33.69 75.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.03 -16.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 108.736 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -122.87 -9.76 8.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.271 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 84' ' ' GLY . 76.1 m-20 -74.07 109.18 7.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.279 -1.513 . . . . 0.0 109.966 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.4 -13.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.58 -0.7 . . . . 0.0 109.615 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.11 37.2 38.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.5 pt -53.0 -166.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mm -54.07 90.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 85' ' ' ILE . 24.4 ttp180 -62.02 112.75 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.013 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.3 m-70 169.46 81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' HIS . 25.6 ptt180 -42.64 -38.52 2.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.581 -0.7 . . . . 0.0 110.114 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.79 -54.5 36.89 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -62.54 -39.96 95.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.245 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -60.9 -39.81 83.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.836 -1.165 . . . . 0.0 108.798 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.591 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 93.3 mt-30 -55.39 -36.8 66.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.845 -1.159 . . . . 0.0 108.463 178.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.24 87.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 108.974 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.58 -44.24 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.805 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.1 mm -59.58 -42.06 86.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 108.486 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.07 91.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 12.9 m120 -57.05 -39.16 74.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.64 71.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.252 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -62.73 -38.64 91.31 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.88 70.31 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.33 -0.856 . . . . 0.0 108.723 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.597 ' OH ' ' CZ ' ' A' ' 32' ' ' PHE . 64.4 t80 -64.65 -42.88 95.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.91 -32.7 71.01 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.11 -32.12 71.8 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.176 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.9 mmm -65.66 -42.39 91.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 109' ' ' GLY . 96.9 mt-10 -71.88 -41.16 68.34 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.45 -26.74 43.94 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.88 -9.1 29.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 68.89 26.68 74.47 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -117.6 101.2 52.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.75 154.36 26.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.426 2.084 . . . . 0.0 112.541 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -62.18 -45.4 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.864 0.84 . . . . 0.0 109.324 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.67 -27.38 64.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 111.123 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -70.63 -52.74 19.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.711 -1.243 . . . . 0.0 111.607 -178.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 2.2 p90 -67.16 -39.89 86.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.936 -1.103 . . . . 0.0 111.041 -178.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 8.1 p -65.88 -48.94 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -179.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.503 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 12.8 m95 -56.45 -25.48 50.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -67.18 -45.46 76.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 110.552 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 32.0 m-85 -62.96 -32.25 73.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.002 -1.061 . . . . 0.0 110.17 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.68 18.41 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.714 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 123' ' ' GLN . 62.5 m-20 59.31 40.54 21.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.728 -0.608 . . . . 0.0 109.78 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 43.48 26.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.802 179.332 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 121' ' ' ASN . 1.9 pt20 -139.8 154.62 71.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.63 152.31 59.19 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.858 2.372 . . . . 0.0 112.951 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 126' ' ' MET . 10.7 tm0? -109.4 127.83 54.67 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.62 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 61.1 mtm -91.03 118.63 30.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 109.692 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 116.3 26.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.347 -0.845 . . . . 0.0 109.482 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -93.78 14.0 20.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 136.54 53.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -93.63 -22.63 18.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.504 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.5 p -133.68 163.01 30.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.2 mt -59.24 -39.62 83.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.1 t -60.61 -33.23 72.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -81.96 2.64 29.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.836 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.92 142.87 25.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.117 -0.989 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.91 143.63 37.07 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.365 2.043 . . . . 0.0 112.655 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -123.98 2.58 8.69 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.8 p -154.7 85.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.11 166.87 9.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.22 -41.45 65.63 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.624 1.549 . . . . 0.0 112.283 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -41.73 80.03 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.025 -1.047 . . . . 0.0 108.676 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.0 p -66.81 -45.24 78.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.56 -40.69 96.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -67.89 -30.76 70.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.7 tp -69.19 -42.0 76.39 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -0.752 . . . . 0.0 110.321 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.573 ' CA ' ' SG ' ' A' ' 162' ' ' CYS . 0.3 OUTLIER -63.72 -50.28 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.449 -179.1 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -65.77 -36.14 82.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.948 -1.095 . . . . 0.0 109.366 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.22 -50.47 39.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.762 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.65 -36.36 83.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 109.661 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -60.49 -38.5 84.49 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.959 -1.088 . . . . 0.0 108.767 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 153' ' ' GLY . 1.4 mmmp? -62.52 -33.71 75.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.326 -0.859 . . . . 0.0 110.09 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -70.55 3.86 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.02 -1.05 . . . . 0.0 108.844 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 82.1 26.79 47.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -94.42 115.58 27.8 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.531 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -93.41 169.03 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 56.21 55.11 7.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.068 -1.02 . . . . 0.0 108.54 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.444 ' O ' ' CG1' ' A' ' 157' ' ' VAL . 7.3 p -142.08 47.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.03 -178.5 3.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.1 m -61.1 -33.47 73.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.631 -0.923 . . . . 0.0 110.511 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.4 p -67.79 -35.38 78.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.898 -1.126 . . . . 0.0 108.05 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.58 -42.38 92.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.573 ' SG ' ' CA ' ' A' ' 146' ' ' SER . 77.1 m -63.89 -41.29 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.691 -0.631 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.3 -44.37 65.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.838 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.462 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 23.2 m -65.19 -38.98 92.22 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.571 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 87.1 t80 -60.21 -49.65 76.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.702 -0.624 . . . . 0.0 111.051 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 12.8 ptm -71.5 -38.62 71.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.868 -1.145 . . . . 0.0 109.746 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.577 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -62.55 -42.48 99.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 110.498 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.564 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -89.05 -27.56 20.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.968 -1.082 . . . . 0.0 111.018 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.571 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 24.3 m -60.87 -21.12 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.818 -1.176 . . . . 0.0 110.119 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.75 0.09 34.27 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.37 -34.09 76.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.099 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.16 138.1 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 91.0 m-20 -115.06 163.13 16.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.628 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.0 t70 86.07 77.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.465 0.65 . . . . 0.0 109.778 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 4.6 m170 -55.72 -53.13 60.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 0.0 109.084 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.8 m -147.43 38.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.2 t 61.27 111.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.472 0.653 . . . . 0.0 110.276 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 44.86 71.02 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . 0.635 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 7.6 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.285 . . . . 0.0 109.388 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.691 0.758 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.84 149.93 43.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.052 0.93 . . . . 0.0 110.817 -178.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.78 -41.64 94.07 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.635 -0.665 . . . . 0.0 111.458 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.697 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -85.74 -2.37 58.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.544 -1.563 . . . . 0.0 109.645 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.5 t -78.16 -37.85 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.983 -1.073 . . . . 0.0 108.502 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -80.88 0.68 34.13 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.644 -0.822 . . . . 0.0 108.795 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.36 -55.43 5.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 110.867 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.52 161.0 61.27 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.37 -35.82 13.04 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.083 2.522 . . . . 0.0 112.981 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.422 ' CD1' ' NZ ' ' A' ' 51' ' ' LYS . 55.8 mt -62.61 -34.02 76.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.868 -1.145 . . . . 0.0 109.737 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.7 OUTLIER -59.2 -36.91 76.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 1.5 mp -52.7 -46.21 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 110.394 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.7 64.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.957 -1.089 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.1 t80 -63.49 -39.96 95.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.41 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 48.5 t-80 -76.07 -40.53 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 111.507 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.91 -15.14 63.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 112.008 -177.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 6.9 p30 -71.14 -77.09 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.255 -1.528 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -149.1 -49.07 0.15 Allowed 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.756 -1.215 . . . . 0.0 110.256 -179.443 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.697 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.9 t-105 59.03 87.22 0.08 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.185 -178.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.66 73.06 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.79 176.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.668 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 77.2 t -110.33 -32.85 0.14 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-N 119.353 1.577 . . . . 0.0 110.542 177.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.1 Cg_endo -85.54 152.07 10.33 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.2 1.933 . . . . 0.0 112.729 -178.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' OE1' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -67.48 169.03 9.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.8 p -94.09 141.14 28.88 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.05 -178.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD1' ' OE1' ' A' ' 25' ' ' GLU . 92.0 m-20 -102.92 150.2 23.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -61.98 -35.99 80.14 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.666 -1.271 . . . . 0.0 110.052 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -74.95 -50.37 16.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD3' ' H ' ' A' ' 27' ' ' ASP . 7.4 ptmm? -62.54 -32.18 73.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.819 -1.175 . . . . 0.0 109.584 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 165' ' ' PHE . 45.8 mt -57.38 -37.5 72.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 108.539 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -65.73 -45.45 82.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.882 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.38 -40.19 95.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.895 -1.128 . . . . 0.0 109.3 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 35' ' ' ILE . 8.5 tmm? -62.12 -47.04 86.35 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 111.339 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.588 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.2 tp -62.48 -27.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 -178.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.8 m -70.24 -49.98 44.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 110.003 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 3.9 mm? -69.33 -42.23 75.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.068 -1.02 . . . . 0.0 109.566 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -66.51 -32.07 73.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.785 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.62 40.15 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -88.51 -0.64 57.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -1.218 . . . . 0.0 110.076 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.6 3.34 22.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 109.665 -179.567 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -75.42 117.17 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.36 -6.75 1.06 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.604 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 4.3 tp -103.51 169.18 8.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -1.116 . . . . 0.0 108.862 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.419 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 3.9 t -94.84 141.68 28.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 108.763 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 5.5 t-105 -55.58 -34.12 64.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -37.69 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.793 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 m -57.9 -45.36 86.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.903 -1.123 . . . . 0.0 108.616 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.85 -29.37 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 108.679 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.59 -41.33 76.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 108.673 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.611 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 12.2 mmtt -57.8 -41.49 82.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.9 -18.98 61.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -60.63 -42.48 97.0 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -69.32 -46.03 68.08 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.685 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.7 m-80 -64.12 -32.81 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 108.516 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 52' ' ' LYS . 75.3 t80 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -60.04 -38.31 82.39 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.452 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.09 82.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.854 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 85' ' ' ILE . 1.8 m -71.67 -45.08 63.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 110.258 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 29.2 m-85 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.291 -0.881 . . . . 0.0 109.765 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.494 1.503 0 CA-C-O 121.223 0.426 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.14 -44.23 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 110.219 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -36.99 85.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 109.946 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.42 -39.38 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.92 -16.23 63.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.93 58.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 mmm -78.01 113.21 15.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 7.4 tt0 -95.68 167.43 11.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 108.906 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 96.2 mt-10 -52.63 -30.31 30.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.243 -0.911 . . . . 0.0 110.855 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -57.39 -45.19 84.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.541 -1.35 . . . . 0.0 107.704 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -62.95 -39.76 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 HG22 HE21 ' A' ' 93' ' ' GLN . 75.5 t -59.6 -42.7 89.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.536 -0.728 . . . . 0.0 110.026 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.406 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 74.9 mm-40 -57.38 -37.11 72.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.069 -1.019 . . . . 0.0 108.396 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG3' HH11 ' A' ' 78' ' ' ARG . 16.2 ttm-85 -66.19 -36.98 84.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.504 -0.747 . . . . 0.0 109.521 179.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.26 -40.34 93.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.718 . . . . 0.0 112.445 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 77' ' ' GLU . 4.4 m -59.01 -16.83 10.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.478 -1.389 . . . . 0.0 108.024 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -104.67 -14.36 15.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.507 -0.746 . . . . 0.0 109.153 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 84' ' ' GLY . 63.0 m-20 -81.78 105.52 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.09 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.15 -15.57 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.545 -0.722 . . . . 0.0 109.984 179.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 66.19 35.96 91.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.5 pt -28.68 -101.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.156 -0.614 . . . . 0.0 111.541 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 85' ' ' ILE . 9.1 tt -168.77 -34.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.06 -179.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 87' ' ' ARG . 5.0 mtt-85 -59.22 149.2 29.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.623 -0.673 . . . . 0.0 109.419 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.404 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -106.36 160.19 15.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.244 -0.91 . . . . 0.0 109.327 179.902 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.77 -46.24 15.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 110.049 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -53.11 36.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 51.1 mttp -61.13 -40.7 94.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 92' ' ' ILE . 66.7 mt -58.76 -47.76 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.153 -0.967 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.444 HE21 HG22 ' A' ' 76' ' ' VAL . 46.9 mm-40 -52.97 -35.03 58.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.824 -1.173 . . . . 0.0 108.941 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.42 80.63 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.7 -47.38 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.56 -0.712 . . . . 0.0 109.422 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.9 mp -60.08 -38.97 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 108.952 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.6 -35.75 89.99 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -62.33 -37.81 87.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -1.067 . . . . 0.0 109.693 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.38 96.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.02 . . . . 0.0 109.804 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.87 -39.2 90.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.981 -1.074 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.06 68.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.603 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 75.8 t80 -63.41 -44.41 94.7 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.86 -31.71 72.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -64.81 -35.97 82.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.916 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 81.0 mmm -67.93 -40.0 83.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.732 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.99 -40.07 78.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.542 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.35 -23.8 66.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.441 ' OD1' ' CD ' ' A' ' 110' ' ' GLU . 10.4 t-20 -85.71 -7.15 58.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 26.23 74.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CD ' ' OD1' ' A' ' 108' ' ' ASN . 96.1 mt-10 -124.48 102.06 33.35 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -1.071 . . . . 0.0 109.729 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.478 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 18.4 Cg_exo -60.64 147.47 94.63 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.004 1.803 . . . . 0.0 112.066 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 102' ' ' TYR . 25.2 m-85 -57.5 -37.64 73.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.103 -0.998 . . . . 0.0 109.45 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.84 -29.86 70.83 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.526 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.56 -50.65 62.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 112.174 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.483 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 4.1 p90 -72.4 -38.1 68.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.754 -1.216 . . . . 0.0 111.308 -177.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.45 -49.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.117 -1.614 . . . . 0.0 109.354 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -60.32 -24.15 64.78 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 108.622 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -64.66 -42.33 95.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.0 109.912 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -68.11 -32.74 73.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.64 16.92 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.62 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 122' ' ' HIS . 16.6 m120 56.98 36.92 28.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.698 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 121' ' ' ASN . 78.0 m80 44.03 33.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -139.15 151.83 68.47 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.01 . . . . 0.0 109.867 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.03 144.48 34.11 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.789 2.326 . . . . 0.0 112.205 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.472 ' NE2' ' H ' ' A' ' 126' ' ' MET . 2.3 tm0? -112.26 141.99 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.337 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.472 ' H ' ' NE2' ' A' ' 125' ' ' GLN . 85.2 mmm -96.65 118.01 32.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -88.63 117.49 27.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.194 -0.941 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.52 20.77 3.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.225 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 127' ' ' THR . . . -66.93 135.21 53.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 109.536 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.1 p -100.67 -19.88 15.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.399 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.0 p -128.75 158.84 37.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.47 -0.769 . . . . 0.0 109.097 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.2 mt -57.82 -40.74 80.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -73.84 -19.14 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.827 . . . . 0.0 109.568 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -74.44 -9.29 58.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 108.509 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.6 132.53 46.47 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.39 135.34 22.22 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.931 1.754 . . . . 0.0 112.442 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.9 p -101.06 3.88 41.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 138' ' ' SER . 59.6 p -141.06 91.76 2.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 109.064 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.649 ' HG1' ' H ' ' A' ' 142' ' ' SER . 40.1 p -110.89 156.88 40.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.07 -39.49 70.17 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.147 1.231 . . . . 0.0 111.222 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.72 71.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.649 ' H ' ' HG1' ' A' ' 139' ' ' THR . 86.6 p -63.41 -42.06 98.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -0.789 . . . . 0.0 109.834 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.0 -39.78 94.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.883 . . . . 0.0 110.229 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.85 79.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.38 -46.24 77.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 110.725 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.636 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 15.0 m -61.06 -48.82 79.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.223 -0.923 . . . . 0.0 110.726 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -37.56 81.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.01 -1.056 . . . . 0.0 109.349 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.27 74.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.118 -0.988 . . . . 0.0 109.66 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.61 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 19.1 mt -67.86 -42.35 81.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.966 -1.084 . . . . 0.0 108.841 179.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -59.47 -37.44 78.22 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.274 -0.891 . . . . 0.0 110.594 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -74.34 -23.04 58.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.877 -1.139 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.61 ' NH2' ' CD2' ' A' ' 149' ' ' LEU . 81.6 mtm180 -83.67 6.05 22.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.31 21.14 39.13 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -99.69 112.23 24.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -1.208 . . . . 0.0 108.976 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -89.75 178.59 6.21 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 55.95 56.71 5.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 108.824 -179.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.3 40.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -50.04 157.87 1.74 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.8 m -52.73 -32.67 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.319 -1.106 . . . . 0.0 108.742 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 m -69.09 -36.01 77.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 161' ' ' ILE . 21.2 mm -62.06 -45.02 99.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.595 0.712 . . . . 0.0 109.394 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.636 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.2 m -64.32 -39.7 94.44 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.503 -0.748 . . . . 0.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -43.25 77.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.95 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.3 m -61.8 -36.54 81.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 109.589 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.591 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -61.13 -50.49 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.428 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.2 ptm -62.52 -37.62 86.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.044 -1.035 . . . . 0.0 110.268 -178.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -40.82 87.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 111.627 -178.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.39 15.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.957 -1.089 . . . . 0.0 112.752 -177.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -50.19 70.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.664 -1.272 . . . . 0.0 112.047 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.43 2.36 0.96 Allowed Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.2 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.93 -33.91 72.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.616 -1.52 . . . . 0.0 109.121 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.25 150.91 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.599 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 83.7 m-20 -117.89 164.09 15.58 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.599 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 18.9 t0 96.05 84.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.605 0.717 . . . . 0.0 110.017 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -55.74 -49.71 72.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.604 -0.685 . . . . 0.0 109.848 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 7.1 m -157.54 24.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.71 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.9 t 56.11 111.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.429 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.36 10.0 52.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 120.924 -1.339 . . . . 0.0 109.215 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.477 ' HG3' HH11 ' A' ' 3' ' ' ARG . 22.0 mtm-85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -69.95 156.57 38.91 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.793 0.806 . . . . 0.0 109.516 -179.556 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.13 95.73 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.146 -0.971 . . . . 0.0 112.844 -177.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.703 ' CZ2' ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -88.76 -3.82 58.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.323 -1.693 . . . . 0.0 111.608 -177.673 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 4' ' ' CYS . 2.7 m -87.25 -31.61 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.384 -1.448 . . . . 0.0 108.58 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -62.97 -18.07 62.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -59.85 -40.97 90.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.241 0.544 . . . . 0.0 109.98 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.35 160.37 51.91 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.02 -55.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.219 2.613 . . . . 0.0 113.44 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.98 -32.01 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.703 ' CE1' ' CZ2' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -56.78 -39.17 73.59 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.896 -1.128 . . . . 0.0 109.584 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.09 -41.27 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -49.62 73.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 109.847 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 27.9 t80 -61.5 -42.73 99.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.357 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' A' ' 17' ' ' HIS . 8.5 t-80 -66.66 -37.63 85.18 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.516 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.41 -13.19 61.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 12.0 p30 -86.89 -70.88 0.58 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 119.855 -1.778 . . . . 0.0 110.276 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.591 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.4 mt-10 -136.86 -72.61 0.44 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.017 -1.052 . . . . 0.0 110.038 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.59 ' CD1' ' O ' ' A' ' 21' ' ' TRP . 8.8 t90 47.39 49.72 15.42 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.926 -0.484 . . . . 0.0 110.721 -178.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.38 72.3 0.99 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.513 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.682 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -166.23 -30.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.01 -1.288 . . . . 0.0 112.837 179.37 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 28.6 Cg_endo -91.98 154.22 3.3 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 123.022 2.481 . . . . 0.0 112.615 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 26' ' ' THR . 85.8 tt0 -66.55 156.36 35.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.401 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 1.5 p -91.43 134.09 34.92 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.594 -177.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -99.85 158.14 16.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.656 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 1.3 m -57.69 -37.69 73.91 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.541 -1.349 . . . . 0.0 109.832 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -61.29 -46.14 91.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 111.165 -178.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -36.93 81.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.567 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.17 -39.32 75.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.564 -0.71 . . . . 0.0 110.501 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CE1' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -70.18 -54.09 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.456 -178.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -71.02 -30.41 66.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.902 -1.124 . . . . 0.0 109.774 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 27.8 ttm -67.16 -52.15 45.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.885 -1.134 . . . . 0.0 110.984 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.25 -31.06 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.519 -1.363 . . . . 0.0 111.117 -178.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 60.4 m -70.31 -37.21 74.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.476 -1.39 . . . . 0.0 109.802 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.0 mp -73.46 -40.27 64.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.189 -0.945 . . . . 0.0 110.247 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' CD ' ' HG ' ' A' ' 164' ' ' SER . 72.2 mm-40 -63.17 -36.83 84.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.0 108.685 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.44 -36.73 78.42 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -69.01 -28.51 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -1.123 . . . . 0.0 109.885 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' ' CB ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -74.38 -3.05 28.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.987 -1.071 . . . . 0.0 110.309 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.59 117.82 4.24 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.726 -1.233 . . . . 0.0 108.809 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.48 -36.72 2.02 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.6 mm? -90.92 150.58 21.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.077 -1.249 . . . . 0.0 109.984 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.5 m -63.98 154.56 33.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.785 . . . . 0.0 109.447 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.545 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -61.2 -40.92 95.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.656 179.604 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -59.22 -35.86 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -58.74 -39.26 80.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.146 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.85 -49.6 76.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 0.0 109.403 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.622 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -57.45 -43.37 83.91 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.425 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' NH2' ' CZ2' ' A' ' 46' ' ' TRP . 37.1 ttm180 -60.64 -42.02 96.1 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.623 -1.298 . . . . 0.0 107.8 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.09 -42.41 66.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.91 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 23.4 m-80 -75.12 -43.4 53.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.021 -1.05 . . . . 0.0 110.023 -179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.478 ' N ' ' O ' ' A' ' 52' ' ' LYS . 63.4 t80 -58.23 -49.1 78.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.743 -0.598 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -63.04 -33.86 76.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.969 -1.082 . . . . 0.0 109.142 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.66 76.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.143 -0.973 . . . . 0.0 109.586 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.643 ' SG ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -73.66 -44.86 55.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.604 -179.253 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 78.0 m-85 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 120.903 -1.123 . . . . 0.0 110.636 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 N--CA 1.496 1.667 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.73 -45.8 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.899 -1.126 . . . . 0.0 109.788 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.94 -33.37 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.038 -1.039 . . . . 0.0 109.479 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.13 -38.98 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.204 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.51 66.06 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.88 -6.39 59.34 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.9 mtp -88.42 111.6 21.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.33 -172.93 2.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -57.16 -25.55 59.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.061 -1.025 . . . . 0.0 110.504 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.02 -45.34 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.766 -1.208 . . . . 0.0 109.113 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -68.82 -36.75 78.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 109.155 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.11 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.027 . . . . 0.0 110.081 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -65.54 -43.7 89.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 11.1 ptp180 -75.16 -32.8 61.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.632 -1.292 . . . . 0.0 109.322 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' C ' ' N ' ' A' ' 81' ' ' GLN . 61.3 mt -70.61 -35.58 73.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 111.851 -179.187 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.8 m -50.39 -17.94 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.686 -1.259 . . . . 0.0 109.161 -179.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.424 ' N ' ' C ' ' A' ' 79' ' ' LEU . 16.1 pt20 -117.84 -8.17 10.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 46.3 m-20 -77.95 107.86 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.61 -1.307 . . . . 0.0 109.51 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 82.27 -13.24 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.835 -0.541 . . . . 0.0 109.896 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.45 37.9 30.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.2 pt -58.49 -168.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.002 -1.293 . . . . 0.0 109.498 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -65.86 93.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.313 -0.867 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 88' ' ' HIS . 32.5 ttt-85 -55.23 106.46 0.23 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 2.5 m-70 179.88 72.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 15.3 ptm180 -45.56 -42.51 11.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -51.23 -54.17 24.62 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.211 -178.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -64.09 -42.33 96.97 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.037 -1.272 . . . . 0.0 109.774 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.04 -44.26 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.405 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.2 mt-30 -56.97 -36.13 69.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.653 -1.279 . . . . 0.0 109.736 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.79 83.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 109.079 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.45 -39.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 108.926 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.88 -43.3 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.7 -35.43 81.44 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.49 -35.88 78.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.378 -1.072 . . . . 0.0 108.93 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.04 91.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.847 . . . . 0.0 108.843 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -61.13 -36.28 79.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.42 74.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.187 -0.946 . . . . 0.0 109.024 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -61.76 -44.23 97.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.99 -36.64 80.0 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -64.8 -36.81 85.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.945 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.459 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 94.4 mmm -64.68 -40.09 94.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.869 -1.144 . . . . 0.0 108.826 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 109' ' ' GLY . 80.7 mm-40 -67.64 -38.06 83.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -58.09 -25.67 61.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -93.46 -12.6 29.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.63 22.53 71.69 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -114.56 102.78 55.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 109.556 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.52 152.68 46.21 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.953 1.768 . . . . 0.0 112.274 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.09 -40.27 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.618 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.43 69.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 111.074 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.55 -53.03 39.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.082 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.533 ' O ' ' OG ' ' A' ' 118' ' ' SER . 3.3 p90 -72.1 -41.43 67.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.667 -1.27 . . . . 0.0 111.75 -177.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 117' ' ' TRP . 30.4 m -59.69 -50.35 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 119.945 -1.722 . . . . 0.0 109.794 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.419 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 15.0 m95 -57.26 -24.41 54.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.533 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 45.9 p -66.32 -42.13 88.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.063 -1.023 . . . . 0.0 110.404 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.17 -33.35 74.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.076 -1.015 . . . . 0.0 110.283 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.06 15.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 109.19 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.14 37.52 26.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.699 . . . . 0.0 110.554 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 48.71 29.45 2.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -0.952 . . . . 0.0 110.424 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.43 148.97 42.62 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.784 -1.197 . . . . 0.0 109.856 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.44 147.64 90.6 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.92 2.413 . . . . 0.0 112.905 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 126' ' ' MET . 11.5 tm0? -105.4 135.24 47.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.232 -0.917 . . . . 0.0 109.223 179.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.482 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 62.9 mtt -93.04 134.66 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.2 -54.72 3.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -0.989 . . . . 0.0 109.354 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 58.63 50.11 9.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.406 ' H ' HG23 ' A' ' 127' ' ' THR . . . -90.02 142.35 27.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.6 p -81.13 -24.6 37.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.003 -1.061 . . . . 0.0 108.916 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 p -143.51 164.67 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.13 -31.86 72.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.026 -1.046 . . . . 0.0 108.841 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -64.29 -28.73 69.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.2 -2.4 37.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.56 127.17 86.45 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.75 -1.219 . . . . 0.0 107.965 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.412 ' O ' ' CE2' ' A' ' 163' ' ' TYR . 56.9 Cg_endo -73.49 137.74 25.87 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.132 1.888 . . . . 0.0 113.292 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.3 p -110.29 6.54 22.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 m -147.97 90.89 1.87 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.204 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 139' ' ' THR . 1.0 OUTLIER -108.0 155.52 39.89 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -52.82 -33.89 62.91 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 120.946 1.097 . . . . 0.0 111.539 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.67 -46.21 55.0 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.24 -0.913 . . . . 0.0 109.176 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.9 p -63.47 -41.4 98.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.073 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.57 -43.92 97.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.57 67.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.483 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -47.21 84.39 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.627 -0.671 . . . . 0.0 110.338 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 35.9 t -65.59 -41.62 92.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 109.841 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -60.57 -38.71 85.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.13 -54.62 16.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.045 -1.035 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.09 -31.69 69.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -60.5 -43.26 97.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.503 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -72.12 -27.75 62.83 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 110.358 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.459 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.7 OUTLIER -73.9 5.35 4.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.006 . . . . 0.0 109.019 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.63 25.72 52.78 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.4 116.39 32.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.436 -1.037 . . . . 0.0 109.452 179.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -94.6 176.4 6.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 56.92 53.34 8.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 146' ' ' SER . 31.4 m -130.19 43.82 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.29 165.69 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.592 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 18.7 m -54.06 -33.82 58.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.614 -0.933 . . . . 0.0 109.214 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.6 m -72.72 -33.59 66.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.54 -44.63 99.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.642 -0.661 . . . . 0.0 110.047 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' A' ' 159' ' ' THR . 0.8 OUTLIER -65.46 -46.65 78.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.093 -1.004 . . . . 0.0 109.682 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -63.74 -38.8 92.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 109.581 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.544 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 79.4 p -63.37 -37.21 86.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -63.7 -40.72 97.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.772 . . . . 0.0 110.203 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.6 mtm -66.85 -39.24 87.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 111.014 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.401 HE22 ' CB ' ' A' ' 172' ' ' VAL . 73.5 mm-40 -64.72 -36.15 83.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.983 -1.073 . . . . 0.0 111.084 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.51 19.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 112.295 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -68.06 -48.95 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.796 -1.19 . . . . 0.0 111.717 -177.878 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.32 -11.06 2.76 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.923 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.5 mt -51.13 -30.78 17.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -1.198 . . . . 0.0 109.749 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.401 ' CB ' HE22 ' A' ' 167' ' ' GLN . 22.0 t -119.82 150.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -137.69 163.76 30.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.657 . . . . 0.0 109.853 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 90.17 75.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.147 0.498 . . . . 0.0 110.62 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -52.37 -53.3 46.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.6 m -151.37 -162.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.18 122.92 39.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.43 68.59 1.62 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.034 -1.274 . . . . 0.0 109.18 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.385 0.612 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.34 154.43 19.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.262 -0.899 . . . . 0.0 109.282 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -92.29 0.1 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.776 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.902 ' CZ3' H3A2 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.845 ' OH ' H3A1 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.729 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.658 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.594 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.696 HE22 ' CG1' ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.578 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.696 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.696 ' CG1' HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.673 ' C ' ' H ' ' A' ' 62' ' ' GLN . 53.3 m-85 -85.85 18.58 2.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ARG . 9.2 t-80 -56.97 17.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.353 -0.842 . . . . 0.0 111.112 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.673 ' H ' ' C ' ' A' ' 60' ' ' PHE . 20.1 pt20 -79.43 -17.98 53.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.951 -1.093 . . . . 0.0 110.651 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 42.3 p90 38.32 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.454 -0.779 . . . . 0.0 110.035 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' GLN . 71.2 m-20 -127.39 91.9 44.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.03 -30.23 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.244 1.963 . . . . 0.0 112.402 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' N ' HE22 ' A' ' 62' ' ' GLN . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OE1' ' A' ' 62' ' ' GLN . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 84' ' ' GLY . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 92' ' ' ILE . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' OG ' ' A' ' 118' ' ' SER . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 115' ' ' PHE . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.561 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.573 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.657 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.657 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.437 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.547 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.4 t -67.84 79.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 68.93 -48.3 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 179' ' ' CYS . 31.5 t -170.27 71.71 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 183' ' ' PRO . 1.9 t80 -71.66 122.53 87.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 45.5 Cg_endo -74.77 176.01 10.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.231 1.954 . . . . 0.0 112.112 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.72 2.96 34.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.69 -72.83 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -1.113 . . . . 0.0 108.725 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 187' ' ' PRO . 1.4 mptt -111.98 -25.19 0.13 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 110.943 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 186' ' ' LYS . 31.3 Cg_exo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.691 1.594 . . . . 0.0 112.089 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.902 H3A2 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.601 0.715 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 178' ' ' GLY . 53.7 tp10 -101.95 143.11 32.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -94.34 160.89 14.47 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 110.26 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.2 m -53.08 144.77 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 0.0 109.618 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.14 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.525 -0.734 . . . . 0.0 112.13 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.8 ' CZ3' H3A1 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -83.7 -1.03 53.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.58 -1.541 . . . . 0.0 109.478 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -84.93 -42.37 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 108.823 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.4 m -78.66 5.09 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.78 -108.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.632 -0.668 . . . . 0.0 109.775 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.35 143.61 93.69 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.806 . . . . 0.0 109.838 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 -28.29 58.25 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.083 1.855 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.32 -36.18 82.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.894 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -55.41 -42.11 73.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.039 . . . . 0.0 110.603 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.85 -40.82 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 110.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.682 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.19 -50.35 64.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.678 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -66.58 -39.78 88.6 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.696 -1.252 . . . . 0.0 110.164 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -69.34 -50.33 47.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 112.523 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -75.14 -5.98 47.19 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.941 -1.099 . . . . 0.0 110.567 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -94.9 -35.48 12.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.832 -1.168 . . . . 0.0 112.294 -177.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 22' ' ' GLY . 13.0 pt-20 -174.42 48.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.374 -1.454 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.726 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 20.5 t-105 -70.87 66.76 0.37 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 60.72 52.81 50.15 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.617 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.2 t -108.59 -42.29 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.36 -1.082 . . . . 0.0 109.13 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.7 Cg_endo -95.94 150.55 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.558 2.839 . . . . 0.0 112.649 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -68.27 141.63 55.82 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -99.83 147.82 25.09 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.06 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 90.9 m-20 -80.88 167.91 19.35 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 m -59.87 -35.07 74.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -67.15 -39.96 86.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 0.0 112.461 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -59.04 -38.92 80.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 0.0 110.309 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 6.5 mp -58.62 -36.94 74.84 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.686 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -63.26 -48.12 79.52 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -69.82 -30.97 68.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.783 -1.198 . . . . 0.0 109.473 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.22 -48.56 56.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.791 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.43 -28.6 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 109.476 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.6 -51.32 29.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.956 -1.09 . . . . 0.0 109.418 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.85 -37.49 73.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 108.98 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 tp10 -61.65 -37.06 82.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.4 -35.33 90.84 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 42' ' ' ALA . 86.9 mt-30 -62.06 -31.48 71.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.459 -1.024 . . . . 0.0 110.995 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.594 HE22 ' CB ' ' A' ' 164' ' ' SER . 5.4 pt20 -61.26 6.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.837 -1.165 . . . . 0.0 110.53 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.59 123.3 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.3 -33.78 0.16 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 73.2 mt -94.44 155.99 16.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -1.213 . . . . 0.0 110.439 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.3 m -73.18 156.62 38.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.644 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.8 OUTLIER -59.85 -32.42 70.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.42 -0.8 . . . . 0.0 109.725 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -35.82 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -57.6 -37.37 73.12 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 53' ' ' ARG . 85.1 t -66.69 -36.81 78.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.885 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.97 -47.64 84.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.911 -1.118 . . . . 0.0 109.806 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.49 -49.68 74.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.818 -1.176 . . . . 0.0 108.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.586 ' HZ1' ' CB ' ' A' ' 52' ' ' LYS . 8.9 mtmp? -65.72 -26.19 67.64 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.253 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 49' ' ' VAL . 38.1 ttm180 -55.12 -42.49 73.03 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.49 -40.85 76.78 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.093 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.769 ' N ' HD21 ' A' ' 55' ' ' ASN . 0.8 OUTLIER -64.34 -34.86 79.11 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HH ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -60.95 -39.25 88.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 61' ' ' HIS . 46.1 mtp180 -59.66 -36.43 76.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.398 -0.814 . . . . 0.0 109.054 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.79 89.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.838 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 64.9 m -75.0 -44.95 45.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.64 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' O ' ' N ' ' A' ' 62' ' ' GLN . 83.1 m-85 -111.7 -41.96 3.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 33.9 t-80 63.79 -56.18 0.21 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 60' ' ' PHE . 64.6 mt-30 -71.6 -31.84 67.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 61' ' ' HIS . 17.2 p90 38.73 27.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.472 -0.767 . . . . 0.0 110.174 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -82.99 138.34 42.94 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.374 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -49.97 -48.92 17.63 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.107 1.871 . . . . 0.0 112.933 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.94 -36.33 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 0.0 110.236 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -47.07 83.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 111.271 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 m -67.66 -33.46 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.517 -1.364 . . . . 0.0 109.326 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.28 -20.58 65.59 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.01 -9.14 40.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.0 mmm -82.75 119.68 24.64 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.57 173.81 7.43 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.347 -0.846 . . . . 0.0 110.449 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.61 -29.85 39.71 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.52 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -60.96 -48.46 81.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.987 -1.07 . . . . 0.0 108.177 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.16 -41.52 98.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.7 -42.36 76.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.682 -0.636 . . . . 0.0 109.983 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -58.18 -39.18 78.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 108.661 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 35.0 ttm-85 -61.74 -40.29 94.58 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 0.0 109.294 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 mt -65.43 -33.25 75.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.608 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.18 -36.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 108.404 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -106.49 -2.93 21.44 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.829 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.593 ' C ' ' H ' ' A' ' 84' ' ' GLY . 46.4 t0 -78.38 106.71 10.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.15 -1.594 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 67.56 -19.81 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.575 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 71.5 36.03 62.79 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.4 pt -29.28 -94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 122.127 -0.631 . . . . 0.0 110.544 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 8.3 tt -170.58 -37.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.128 -0.982 . . . . 0.0 109.07 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 17.9 mmt180 -72.03 156.02 39.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.802 0.81 . . . . 0.0 110.595 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -111.01 178.87 4.21 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 10.3 ptp180 -56.7 -43.8 80.9 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 110.58 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -56.38 -57.95 16.75 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.342 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HZ1' ' CB ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -63.46 -43.25 97.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.071 -1.252 . . . . 0.0 110.161 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 92' ' ' ILE . 19.4 mm -57.64 -52.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -50.91 -32.64 21.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.843 -1.161 . . . . 0.0 108.881 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.02 96.45 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -0.925 . . . . 0.0 108.563 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.42 ' CD1' ' HH ' ' A' ' 56' ' ' TYR . 80.2 mt -65.66 -42.23 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.388 -0.82 . . . . 0.0 109.121 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.02 -44.24 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.73 92.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.67 -37.85 74.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -1.11 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.14 76.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 109.197 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -56.67 -38.19 71.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.92 -30.61 70.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.94 -44.0 90.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.0 -37.16 83.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.028 -1.045 . . . . 0.0 109.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.09 -38.63 88.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.0 108.704 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -70.13 -40.35 74.9 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.641 0.734 . . . . 0.0 109.321 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.03 -23.74 65.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -91.93 -6.18 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.26 26.29 74.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -118.07 108.26 42.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -52.79 145.64 38.92 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.985 1.79 . . . . 0.0 112.381 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.618 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -59.26 -46.88 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.209 1.004 . . . . 0.0 109.372 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.82 68.33 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 109.846 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.81 -47.92 82.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.97 -1.081 . . . . 0.0 111.806 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.618 ' CD2' ' O ' ' A' ' 112' ' ' PHE . 12.5 p90 -71.62 -43.62 65.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.804 -1.185 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.509 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 1.9 p -65.16 -54.45 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.358 -1.464 . . . . 0.0 110.129 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.419 ' H ' HG12 ' A' ' 116' ' ' VAL . 53.7 m95 -55.14 -23.45 21.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.05 -1.032 . . . . 0.0 108.25 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.72 -29.58 70.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 108.966 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -86.94 9.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.025 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.1 35.21 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 44.2 35.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.748 . . . . 0.0 110.373 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -146.97 147.52 29.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.62 142.05 62.86 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.462 2.108 . . . . 0.0 112.023 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -113.0 132.06 55.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 108.814 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.551 ' C ' HE21 ' A' ' 125' ' ' GLN . 34.6 ttp -89.55 127.35 35.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.93 -1.107 . . . . 0.0 109.415 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -96.55 130.12 43.79 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 109.29 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -91.92 27.31 2.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.194 -0.941 . . . . 0.0 110.754 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.449 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -64.61 142.56 58.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.728 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.6 p -109.02 -35.46 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.68 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.7 p -124.96 162.34 24.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.474 -0.766 . . . . 0.0 109.609 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.8 -36.28 71.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 109.177 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -79.27 0.14 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 108.992 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -103.01 8.4 38.92 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 mm -93.58 126.0 51.64 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -70.91 139.74 36.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.489 1.459 . . . . 0.0 112.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -111.73 5.03 18.92 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -145.72 86.91 1.75 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.682 . . . . 0.0 109.304 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.17 162.77 18.63 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.94 -41.14 77.47 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.25 1.3 . . . . 0.0 111.8 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.95 74.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 108.585 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -64.32 -44.71 90.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.501 -0.749 . . . . 0.0 109.643 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.95 -37.61 86.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.21 -31.98 64.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.54 -48.16 73.4 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.369 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -57.41 -42.27 81.98 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.63 -1.293 . . . . 0.0 108.493 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -65.0 -42.28 94.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.494 -0.754 . . . . 0.0 109.887 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.589 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.4 -47.9 68.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.48 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 1.8 mm? -63.48 -40.23 96.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.21 -0.931 . . . . 0.0 109.157 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -60.28 -39.11 85.7 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.959 -1.088 . . . . 0.0 110.123 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -71.42 -35.74 71.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 111.304 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.589 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.64 -1.87 10.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.775 -1.203 . . . . 0.0 109.653 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.6 17.8 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -93.49 111.33 22.97 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.746 -1.182 . . . . 0.0 107.816 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -97.35 174.07 6.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 0.0 110.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CB ' ' HZ1' ' A' ' 91' ' ' LYS . 91.3 m-85 61.71 61.51 1.43 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.193 0.997 . . . . 0.0 109.092 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.0 m -137.13 41.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -37.44 160.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.586 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 28.0 m -57.78 -30.02 65.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.57 -0.959 . . . . 0.0 109.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.463 ' O ' ' OG ' ' A' ' 164' ' ' SER . 97.0 m -77.73 -34.91 52.4 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.01 -37.56 77.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.568 . . . . 0.0 110.072 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.586 ' SG ' ' O ' ' A' ' 159' ' ' THR . 32.0 p -67.27 -47.2 71.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.176 -0.952 . . . . 0.0 109.045 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.27 -42.21 84.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.069 . . . . 0.0 109.888 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.594 ' CB ' HE22 ' A' ' 41' ' ' GLN . 20.8 m -58.79 -42.46 89.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -38.3 81.4 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.203 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 19.2 mtm -63.46 -36.14 82.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 110.869 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' A' ' 164' ' ' SER . 35.3 mt-30 -57.57 -44.29 85.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.926 -1.109 . . . . 0.0 110.782 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.84 -17.85 27.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.995 -1.065 . . . . 0.0 110.334 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.37 -26.06 68.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.486 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.53 50.09 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.53 -37.3 85.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.633 -0.922 . . . . 0.0 110.248 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.8 138.27 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 109.555 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 84.1 m-20 -121.69 135.99 54.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.544 -0.722 . . . . 0.0 110.622 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER 156.06 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.715 -0.616 . . . . 0.0 110.914 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 12.6 m170 55.88 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.126 -0.984 . . . . 0.0 108.664 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 178' ' ' GLY . 21.5 m -136.57 40.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 176' ' ' VAL . 0.4 OUTLIER 34.8 27.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.749 0.785 . . . . 0.0 109.966 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -162.4 34.66 0.34 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.64 130.2 39.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.447 -1.031 . . . . 0.0 109.438 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 86.3 m -50.72 -39.39 51.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.0 m -70.5 -32.62 70.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.693 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 183' ' ' PRO . 69.0 t80 -77.97 135.75 62.75 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.484 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 37.3 Cg_endo -68.17 129.71 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.016 1.81 . . . . 0.0 111.902 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.91 6.54 9.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 183' ' ' PRO . 2.0 m-80 59.03 25.01 13.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.854 -0.792 . . . . 0.0 109.211 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 185' ' ' ASN . 3.1 mptp? 44.65 73.33 0.99 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.612 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo . . . . . 0 C--N 1.306 -1.676 0 C-N-CA 122.536 2.158 . . . . 0.0 112.198 -179.489 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.8 H3A1 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -94.96 155.29 16.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.192 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 3' ' ' ARG . 0.7 OUTLIER -57.26 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 109.505 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.07 159.31 22.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.546 -0.721 . . . . 0.0 109.988 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -44.57 97.99 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.273 -0.892 . . . . 0.0 111.214 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.829 ' CZ3' H3A1 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -83.5 -0.45 50.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.76 -1.435 . . . . 0.0 109.493 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.53 -48.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.1 m -77.79 -0.59 27.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -81.46 -49.0 11.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.495 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -147.82 158.1 42.97 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 108.945 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.48 -24.52 22.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.526 2.151 . . . . 0.0 113.002 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.28 -38.53 89.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.844 -1.16 . . . . 0.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.66 -36.56 84.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.06 -44.38 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 110.41 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.683 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.71 -50.98 46.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.423 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -62.15 -37.89 86.91 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.667 -1.27 . . . . 0.0 109.48 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -73.62 -44.27 57.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.619 -0.676 . . . . 0.0 111.633 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' C ' HD21 ' A' ' 19' ' ' ASN . 64.1 m-20 -72.37 -7.74 51.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.76 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.7 OUTLIER -91.33 -72.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.767 -1.208 . . . . 0.0 111.344 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.57 81.67 1.1 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.867 -1.146 . . . . 0.0 110.892 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.861 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 16.9 t-105 -80.34 71.16 7.13 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.69 55.42 22.78 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.3 t -107.01 -39.74 0.16 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.401 -1.058 . . . . 0.0 109.545 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 83.1 Cg_endo -97.88 153.24 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.497 2.798 . . . . 0.0 112.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -66.36 148.38 51.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 169' ' ' CYS . 82.8 p -95.2 159.29 15.08 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.977 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -96.2 167.94 10.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -61.98 -37.18 83.82 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.932 -1.105 . . . . 0.0 110.664 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -71.47 -39.83 70.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 112.596 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 15.3 mmmt -56.26 -37.04 69.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.653 -1.279 . . . . 0.0 109.108 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mt -57.33 -37.59 72.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.567 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.8 -47.03 85.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.575 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -69.9 -38.87 76.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.232 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 39.9 tpp -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.54 -0.725 . . . . 0.0 111.212 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -69.55 -27.58 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -70.03 -42.3 73.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.814 -1.179 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 5.4 mp -73.89 -39.05 64.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 72.1 mm-40 -63.43 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 110.202 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.86 -38.42 59.79 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.295 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 42' ' ' ALA . 12.0 tt0 -62.62 -24.73 67.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.963 -1.316 . . . . 0.0 110.194 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.623 ' NE2' ' H8 ' ' A' ' 189' ' ' ADK . 6.5 mm100 -48.27 -6.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.802 -1.186 . . . . 0.0 110.522 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -67.02 112.75 4.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.833 -1.167 . . . . 0.0 109.825 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.13 -27.11 0.2 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.691 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.1 mm? -98.16 151.14 20.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.336 . . . . 0.0 110.649 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.5 m -75.79 162.85 27.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.654 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.3 OUTLIER -62.6 -38.37 89.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 0.0 110.868 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.934 -1.104 . . . . 0.0 109.127 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -63.45 -40.11 96.26 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.728 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -33.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 109.635 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.17 -45.18 75.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -42.89 90.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.482 ' CE ' HE21 ' A' ' 40' ' ' GLN . 25.0 ttpp -62.86 -33.81 76.05 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.301 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -57.61 -40.33 78.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -73.33 -47.17 44.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.075 -1.016 . . . . 0.0 111.18 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.73 HD21 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -75.77 -37.56 59.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.689 -1.257 . . . . 0.0 110.427 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.73 ' N ' HD21 ' A' ' 55' ' ' ASN . 79.0 t80 -58.74 -46.36 87.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.906 -1.121 . . . . 0.0 109.1 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.621 ' O ' ' ND1' ' A' ' 61' ' ' HIS . 20.0 mmm180 -61.76 -31.27 71.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 108.898 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.69 38.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.148 -0.97 . . . . 0.0 111.293 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.64 -44.31 43.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.974 -1.079 . . . . 0.0 111.34 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 56' ' ' TYR . 66.5 m-85 -82.08 -2.99 53.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.96 -1.087 . . . . 0.0 110.562 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' ND1' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -53.9 -30.37 45.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.952 -1.093 . . . . 0.0 109.286 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.67 -35.39 77.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 108.901 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 39.3 m-85 -109.91 -88.76 0.49 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 1.2 m-20 87.62 -73.09 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.74 0 C-N-CA 124.961 1.304 . . . . 0.0 113.938 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 63' ' ' PHE . 24.4 Cg_endo -97.19 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 122.362 1.879 . . . . 0.0 114.844 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.78 -29.86 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 109.033 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.05 -35.64 79.21 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.61 -36.3 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.21 64.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.32 -10.39 32.88 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 93.2 mtp -74.08 109.69 7.77 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.458 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.3 pt20 -97.38 -176.17 3.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.787 -0.571 . . . . 0.0 110.017 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -59.86 -32.49 70.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.327 -0.858 . . . . 0.0 110.884 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 88.5 tt0 -59.49 -47.01 87.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.368 -1.457 . . . . 0.0 109.042 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -35.77 74.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.088 -1.008 . . . . 0.0 108.816 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -43.92 83.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.436 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -56.95 -35.7 69.39 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HG3' HH11 ' A' ' 78' ' ' ARG . 22.8 ttm-85 -59.27 -37.57 77.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.0 -33.08 73.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.665 -0.647 . . . . 0.0 112.659 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.5 m -52.0 -17.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.7 -1.25 . . . . 0.0 110.334 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -124.0 13.79 9.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.179 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.8 m-20 -96.99 104.89 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.895 -1.128 . . . . 0.0 110.559 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.84 -15.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.886 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.03 37.82 49.08 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 30.7 pt -47.86 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.567 -0.961 . . . . 0.0 110.019 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.674 ' CG2' ' H ' ' A' ' 87' ' ' ARG . 11.1 tt -55.63 -105.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.674 ' H ' ' CG2' ' A' ' 86' ' ' ILE . 13.3 tpt180 -85.03 153.5 22.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.564 -1.335 . . . . 0.0 108.262 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -120.42 -33.79 3.78 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.535 -0.728 . . . . 0.0 111.211 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -125.73 -22.8 4.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 111.431 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.24 -91.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.635 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.95 -29.19 68.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.126 -1.22 . . . . 0.0 109.934 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ILE . 12.2 mm -56.9 -56.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.765 -1.209 . . . . 0.0 109.484 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 92' ' ' ILE . 92.9 mt-30 -50.91 -35.41 32.98 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.295 -1.503 . . . . 0.0 108.015 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.0 80.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.78 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' ILE . 96.1 mt -69.24 -33.14 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 110.847 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 96' ' ' ILE . 1.2 mp -58.79 -48.71 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.729 -1.232 . . . . 0.0 108.82 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.88 -35.04 90.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -55.38 -38.66 69.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.186 -1.185 . . . . 0.0 109.574 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.72 79.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.849 -1.157 . . . . 0.0 109.362 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -62.42 -37.56 86.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.029 -1.044 . . . . 0.0 109.866 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.74 -31.4 72.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 108.905 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.721 ' CE1' ' CE1' ' A' ' 112' ' ' PHE . 63.7 t80 -61.46 -44.18 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.7 mm? -61.84 -33.96 75.1 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -64.24 -38.43 91.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.882 . . . . 0.0 111.459 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.704 ' SD ' ' CG ' ' A' ' 112' ' ' PHE . 8.2 ttm -64.49 -42.76 95.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.69 -1.256 . . . . 0.0 108.757 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.95 -37.99 84.29 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.267 0.556 . . . . 0.0 109.576 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.0 -24.55 67.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -88.18 -10.9 48.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.129 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.33 27.67 73.55 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.226 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 4.8 tt0 -116.88 103.47 52.19 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.103 -1.233 . . . . 0.0 110.343 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.77 138.59 41.29 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.833 1.689 . . . . 0.0 112.011 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.721 ' CE1' ' CE1' ' A' ' 102' ' ' TYR . 65.0 m-85 -58.8 -41.78 87.55 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.9 0.857 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.33 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 110.577 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.98 -48.3 79.44 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.109 -0.994 . . . . 0.0 112.346 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.7 p90 -70.79 -43.85 67.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.663 -1.273 . . . . 0.0 110.507 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.571 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.4 p -65.41 -55.39 20.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.848 -1.157 . . . . 0.0 110.868 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' A' ' 122' ' ' HIS . 48.6 m95 -55.35 -23.07 22.08 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.198 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -75.58 -33.56 60.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.094 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -65.88 -32.5 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.037 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.52 17.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 108.994 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 123' ' ' GLN . 45.3 t30 60.13 43.85 13.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.829 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.577 ' N ' ' O ' ' A' ' 117' ' ' TRP . 11.3 t-160 41.92 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -126.46 151.28 72.5 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.604 -0.685 . . . . 0.0 109.285 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.76 153.73 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.523 2.149 . . . . 0.0 112.184 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 137.58 47.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 95.8 mmm -95.14 118.86 32.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.81 122.65 32.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.258 -0.901 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -93.44 23.1 4.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.05 139.11 48.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 109.62 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 m -100.01 -21.88 15.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 108.63 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -140.88 163.82 31.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.248 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.58 -39.53 76.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.323 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.1 p -64.22 -29.65 70.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -80.36 5.64 14.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 108.954 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 4.5 tp -83.05 129.19 62.22 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.891 . . . . 0.0 108.905 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.73 137.0 31.71 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.132 1.888 . . . . 0.0 112.248 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.5 p -105.66 0.1 26.06 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.529 -0.732 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.1 t -147.18 92.34 2.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.39 -0.819 . . . . 0.0 108.995 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.63 ' H ' ' HG ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -105.03 158.26 32.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -54.17 -40.41 82.08 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.835 1.69 . . . . 0.0 111.186 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.91 -40.48 63.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 139' ' ' THR . 67.7 p -67.81 -38.02 82.75 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.176 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.12 -41.09 95.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -0.97 . . . . 0.0 108.669 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.29 64.35 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.26 -45.5 87.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.614 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 11.6 m -62.88 -40.47 97.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.147 -0.97 . . . . 0.0 109.595 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.658 ' CG ' ' HZ2' ' A' ' 151' ' ' LYS . 27.1 ttpp -60.3 -41.67 93.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.504 -0.747 . . . . 0.0 111.111 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -46.06 66.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.814 -1.178 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.23 -36.9 82.64 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.128 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -60.6 -41.55 94.97 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.063 -1.023 . . . . 0.0 110.016 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.658 ' HZ2' ' CG ' ' A' ' 147' ' ' LYS . 22.8 mttp -80.15 -16.63 54.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.742 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.475 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -84.44 2.72 39.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.71 19.09 49.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -98.87 113.47 25.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.214 -1.168 . . . . 0.0 109.123 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -89.13 175.1 7.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.388 0.613 . . . . 0.0 110.002 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 55.13 59.31 4.08 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.701 0.762 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.0 m -135.67 35.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.336 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.0 166.06 1.06 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.2 p -58.45 -30.7 67.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -1.104 . . . . 0.0 109.365 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.3 m -67.48 -39.63 85.27 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.02 -44.13 88.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.614 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 1.9 m -64.11 -41.02 97.41 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.452 -0.78 . . . . 0.0 109.846 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -44.19 89.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.241 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -61.78 -40.14 94.14 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -61.45 -38.5 87.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 82.1 mtp -65.58 -34.64 78.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 111.629 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 3.9 pt20 -63.68 -42.01 98.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.684 -1.26 . . . . 0.0 111.683 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.492 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -85.91 -24.65 26.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 111.697 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE2' ' A' ' 165' ' ' PHE . 0.9 OUTLIER -65.97 -22.38 66.47 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.762 -1.211 . . . . 0.0 110.431 -178.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.0 2.7 58.16 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.92 -32.01 73.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.77 -0.841 . . . . 0.0 110.041 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.94 148.32 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.062 -1.024 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 20.5 m120 -113.76 164.85 13.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 3.9 m-20 90.26 81.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.082 0.468 . . . . 0.0 110.257 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.467 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 53.3 m170 -52.68 -46.14 67.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.042 -1.036 . . . . 0.0 108.825 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 178' ' ' GLY . 4.8 m -158.1 29.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.458 -0.777 . . . . 0.0 110.202 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t 53.01 2.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 109.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -141.05 32.37 2.11 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.943 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 182' ' ' TYR . 50.6 t -90.61 112.08 23.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 109.024 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.537 ' C ' ' H ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -42.55 -39.33 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.03 24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.627 -0.67 . . . . 0.0 109.623 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 180' ' ' CYS . 55.4 t80 -105.46 103.14 41.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.748 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.55 135.65 70.31 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.895 1.73 . . . . 0.0 112.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.16 -14.17 0.56 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -84.78 8.76 16.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 108.972 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 150.44 96.75 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.942 . . . . 0.0 109.358 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 C--N 1.311 -1.409 0 C-N-CA 122.735 2.29 . . . . 0.0 112.367 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.861 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.419 0.628 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -94.31 170.3 9.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.329 -0.857 . . . . 0.0 108.866 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.437 ' NH1' ' HG3' ' A' ' 3' ' ' ARG . 38.3 mtm-85 -107.0 168.39 9.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.597 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.34 153.46 38.35 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.78 98.47 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.345 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.883 ' CZ3' H3A1 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -84.31 -3.21 58.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.61 -1.524 . . . . 0.0 109.448 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.2 t -80.86 -35.15 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -76.88 4.93 8.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 10' ' ' ASP . 1.3 mm-40 -90.64 -159.38 0.61 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -44.75 155.6 0.38 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.001 -1.062 . . . . 0.0 108.914 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.25 -16.65 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 0.0 112.228 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.2 mt -58.42 -39.68 80.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -67.92 -36.24 79.84 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.061 -1.024 . . . . 0.0 109.335 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.39 -44.85 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.781 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.11 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.737 -1.227 . . . . 0.0 109.554 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.438 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 3.1 t80 -66.62 -35.84 81.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 55.4 t-80 -61.58 -41.17 97.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 111.69 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 6.2 m-20 -96.6 -1.67 46.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.827 -1.17 . . . . 0.0 112.358 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -103.41 -30.05 10.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.529 -1.357 . . . . 0.0 112.324 -178.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 94.7 mt-10 -155.97 24.73 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.144 -1.597 . . . . 0.0 111.507 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.916 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.6 t90 -98.87 65.25 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.49 62.58 0.87 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.687 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.696 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -157.89 -35.61 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.152 -1.205 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.696 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 98.6 Cg_endo -98.41 149.97 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.363 2.042 . . . . 0.0 112.331 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.2 166.77 22.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 130.16 45.69 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.567 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.91 157.1 16.99 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 m -56.69 -34.68 67.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.901 -1.125 . . . . 0.0 109.187 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -67.53 -41.57 84.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -63.92 -38.96 93.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.987 -1.071 . . . . 0.0 110.152 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -61.04 -35.97 78.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 109.656 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.495 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 90.6 t80 -66.96 -50.25 62.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 110.95 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -66.84 -40.14 87.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.79 -1.194 . . . . 0.0 109.629 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.583 ' C ' ' SD ' ' A' ' 34' ' ' MET . 10.0 tmm? -62.75 -50.72 69.95 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.684 -0.635 . . . . 0.0 110.763 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.546 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.1 tp -62.32 -27.49 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 73.0 m -68.07 -45.35 74.07 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.552 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.39 -44.37 68.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.125 -0.985 . . . . 0.0 109.416 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -61.94 -32.79 73.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -37.3 76.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -87.07 -2.99 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -1.119 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.5 -0.92 44.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.088 -1.007 . . . . 0.0 109.86 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.99 112.99 7.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.205 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.81 -33.62 5.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 44' ' ' LEU . 5.6 mp -102.61 152.55 21.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.266 . . . . 0.0 110.325 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 m -64.56 156.73 28.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.419 -0.801 . . . . 0.0 108.97 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.667 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.2 OUTLIER -60.71 -35.09 75.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.74 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -30.92 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.84 -1.163 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.7 m -58.12 -42.41 85.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.836 -1.165 . . . . 0.0 108.914 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -71.17 -31.93 45.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.535 -0.728 . . . . 0.0 109.379 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 tp -55.35 -49.25 72.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.085 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -58.35 -42.73 87.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -65.32 -31.05 71.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.211 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 37.7 ttm180 -54.38 -44.78 72.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -69.59 -38.95 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.597 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.16 -42.71 59.5 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 111.012 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.73 -49.99 75.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.912 -1.117 . . . . 0.0 110.495 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 61' ' ' HIS . 3.1 ptm180 -59.69 -30.79 69.03 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.939 -1.1 . . . . 0.0 109.005 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.4 93.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.2 m -75.15 -43.83 50.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.979 -1.075 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 62' ' ' GLN . 76.6 m-85 -96.55 18.69 13.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.075 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' ARG . 5.1 t-80 -42.36 -24.5 0.05 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.513 -0.742 . . . . 0.0 111.367 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . 75.3 mm-40 -51.07 -29.59 13.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.74 -1.225 . . . . 0.0 109.08 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.67 50.51 10.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -0.931 . . . . 0.0 111.614 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.588 ' H ' ' CE ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -140.82 80.49 17.69 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.609 -1.307 . . . . 0.0 108.678 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -40.22 -22.78 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.272 1.981 . . . . 0.0 112.981 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' ASP . 74.0 t -65.87 -44.09 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.953 -1.092 . . . . 0.0 109.871 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' CE ' ' H ' ' A' ' 64' ' ' ASP . 5.3 pttp -65.93 -33.21 75.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.109 -0.994 . . . . 0.0 109.044 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 84.4 t -60.25 -38.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 108.951 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.04 -19.24 65.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.19 -15.51 18.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 78.1 mtp -68.88 113.78 6.6 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.3 tt0 -96.16 174.12 7.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.328 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 95.7 mt-10 -52.17 -32.06 34.28 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.98 -45.45 82.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.2 -38.1 87.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.947 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.04 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.978 -1.077 . . . . 0.0 108.156 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 78' ' ' ARG . 24.3 ttm-85 -63.77 -48.01 78.66 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.513 ' C ' ' N ' ' A' ' 81' ' ' GLN . 66.2 mt -70.78 -34.47 71.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.761 -0.587 . . . . 0.0 110.99 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' LEU . 4.2 t -48.28 -17.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.513 ' N ' ' C ' ' A' ' 79' ' ' LEU . 5.7 mt-30 -110.8 -12.14 14.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 53.2 t0 -83.15 109.66 17.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 75.98 -17.35 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.145 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 78.79 36.89 27.66 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLY . 6.4 pt -47.19 175.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -1.197 . . . . 0.0 108.35 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.64 95.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.13 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 31.5 ptt180 -54.92 125.09 18.83 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.714 0.769 . . . . 0.0 109.305 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.7 m-70 166.96 78.36 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -48.73 -32.33 8.32 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.91 2.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -60.55 -39.96 89.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.327 . . . . 0.0 109.409 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.8 -40.3 82.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.177 -0.952 . . . . 0.0 109.09 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.563 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 6.9 mm100 -55.44 -36.35 66.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 108.893 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.69 85.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.05 -43.26 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.2 mm -59.59 -43.63 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.42 -36.09 90.29 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -60.06 -35.82 75.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -1.111 . . . . 0.0 109.834 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.23 83.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.045 . . . . 0.0 109.214 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -62.2 -36.09 80.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.364 -0.835 . . . . 0.0 109.318 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.74 81.89 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.242 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.98 -43.49 95.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.8 mt -60.97 -25.62 66.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.458 ' CD ' ' C ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -67.37 -41.58 84.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 110.057 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.451 ' N ' ' HG3' ' A' ' 104' ' ' GLN . 94.2 mmm -66.13 -40.28 90.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.125 -0.984 . . . . 0.0 108.688 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -70.69 -39.93 73.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.275 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.14 -23.85 64.23 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -93.89 -9.76 36.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.3 24.35 74.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -117.46 101.64 52.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.17 147.33 66.14 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.325 2.017 . . . . 0.0 112.523 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 35.9 m-85 -60.7 -39.35 88.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.523 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.35 -32.57 74.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.946 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.35 -46.7 82.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.669 -1.27 . . . . 0.0 112.204 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.8 p90 -73.02 -43.84 61.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.632 -1.292 . . . . 0.0 110.999 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.1 p -62.87 -54.0 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.629 -1.294 . . . . 0.0 110.37 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 122' ' ' HIS . 34.2 m95 -53.94 -27.04 28.51 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -76.26 -35.52 58.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.576 -0.702 . . . . 0.0 109.941 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -61.89 -31.09 71.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -97.99 17.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 63.41 33.56 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.685 -0.634 . . . . 0.0 110.401 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' TRP . 95.9 m-70 51.44 29.32 5.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.136 -0.978 . . . . 0.0 110.95 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -135.34 142.56 41.95 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.961 -1.087 . . . . 0.0 109.906 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.27 147.98 43.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.266 1.977 . . . . 0.0 111.671 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.417 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -120.0 126.48 50.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 90.2 mtp -102.74 116.0 31.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 108.753 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.521 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -89.72 144.43 25.98 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.43 28.35 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 111.78 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.485 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -67.64 134.87 51.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 0.0 108.504 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.9 p -97.17 -21.59 17.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 110.228 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.485 ' HG1' ' H ' ' A' ' 134' ' ' GLU . 3.3 p -129.3 162.15 28.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 109.711 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.91 -36.35 76.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.412 -0.805 . . . . 0.0 109.38 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 62.4 p -68.2 -29.7 68.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.96 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.485 ' H ' ' HG1' ' A' ' 131' ' ' THR . 76.3 mm-40 -83.41 6.42 20.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.86 143.2 35.01 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.06 145.6 31.42 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.525 2.15 . . . . 0.0 112.865 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.43 0.6 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.481 ' O ' ' OG ' ' A' ' 138' ' ' SER . 10.8 p -145.68 94.74 2.54 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.503 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -106.02 153.98 39.83 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.65 -37.61 91.16 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.752 1.635 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.89 58.12 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.642 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.503 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 60.6 m -63.15 -42.24 99.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.966 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -60.81 -39.62 89.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 109.231 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.54 77.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.41 -47.84 83.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 109.625 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.641 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 13.8 t -63.48 -43.71 96.51 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.196 -0.94 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.58 -44.26 94.57 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 152' ' ' ARG . . . -72.17 -44.35 63.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.137 -0.977 . . . . 0.0 109.367 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.419 ' CD2' HH21 ' A' ' 152' ' ' ARG . 75.3 mt -65.39 -39.1 91.82 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.287 -0.883 . . . . 0.0 109.738 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.47 -39.35 90.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.973 -1.079 . . . . 0.0 109.695 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.32 -30.61 71.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 110.071 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.419 HH21 ' CD2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -72.86 0.66 10.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.954 -1.092 . . . . 0.0 108.642 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.88 26.55 24.12 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.815 -1.184 . . . . 0.0 110.297 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -97.11 112.43 24.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 0.0 109.745 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -91.38 168.96 11.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.97 64.19 1.8 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 108.482 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 157' ' ' VAL . 7.1 p -153.52 41.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.95 -175.39 0.08 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 p -66.62 -26.7 67.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -1.048 . . . . 0.0 110.415 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -70.99 -34.05 71.01 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.5 -44.56 76.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.094 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 146' ' ' SER . 7.3 m -64.95 -36.02 83.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.522 -0.736 . . . . 0.0 109.655 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -69.69 -45.96 67.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 110.87 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.607 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 87.1 p -63.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.875 -1.141 . . . . 0.0 109.188 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -62.44 -49.28 76.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.576 -0.702 . . . . 0.0 110.365 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.05 -40.62 96.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.008 -1.057 . . . . 0.0 111.148 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.538 ' OE1' ' CD2' ' A' ' 163' ' ' TYR . 4.6 mp0 -74.76 -40.77 61.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.906 -1.121 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.86 60.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.051 -1.031 . . . . 0.0 112.536 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 36.1 m -65.65 -48.72 71.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.676 -1.265 . . . . 0.0 111.964 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.65 -2.38 1.46 Allowed Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.579 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.9 mt -59.97 -35.33 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.94 -1.33 . . . . 0.0 110.126 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.41 ' CG1' HE21 ' A' ' 167' ' ' GLN . 0.4 OUTLIER -140.54 140.32 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.719 -1.238 . . . . 0.0 110.075 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -110.37 124.04 50.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 13.7 p30 180.0 54.33 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.234 -0.916 . . . . 0.0 111.475 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.544 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 25.6 m170 -57.94 -46.34 85.22 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.48 -1.387 . . . . 0.0 108.788 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -175.23 18.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 37.2 t 62.32 -41.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.752 -0.593 . . . . 0.0 110.587 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -81.66 4.87 71.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 49.2 t -69.75 135.18 49.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.27 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -54.16 -37.48 64.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 99.2 m -62.15 -19.71 63.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.345 -0.847 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -60.5 135.46 91.82 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.128 -0.983 . . . . 0.0 109.895 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.54 172.63 15.32 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.54 2.16 . . . . 0.0 112.22 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.97 0.93 54.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -88.3 -69.53 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -1.013 . . . . 0.0 109.065 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -118.38 80.3 16.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.722 2.281 . . . . 0.0 112.367 -179.604 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.916 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' C ' ' SG ' ' A' ' 180' ' ' CYS . 62.8 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -100.01 139.91 34.99 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -65.96 154.58 38.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.405 -0.809 . . . . 0.0 109.844 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.35 146.74 47.11 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.551 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.3 -24.33 21.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.798 ' CE2' H3A2 ' A' ' 189' ' ' ADK . 4.5 t90 -81.47 9.51 7.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -1.219 . . . . 0.0 109.731 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.4 -25.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 0.0 110.669 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -81.19 6.34 14.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.087 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -86.22 -59.7 2.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -111.4 156.29 41.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 110.311 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.28 -37.22 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.966 2.444 . . . . 0.0 113.198 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.23 -35.03 77.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.129 -0.982 . . . . 0.0 110.441 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.749 ' OH ' H3A3 ' A' ' 189' ' ' ADK . 6.4 m-85 -56.55 -36.25 69.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.971 -1.081 . . . . 0.0 109.791 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.401 ' H ' HD13 ' A' ' 14' ' ' ILE . 1.9 mp -52.35 -43.94 41.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.69 -48.77 65.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' HA ' HD21 ' A' ' 19' ' ' ASN . 16.4 t80 -62.34 -43.13 99.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.57 -43.04 91.0 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.448 -0.782 . . . . 0.0 111.549 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.29 -14.19 61.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 111.605 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 80.6 m-20 -73.77 -69.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.626 -1.296 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -175.83 59.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' TRP . 7.7 t90 -96.42 68.92 2.59 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.04 -3.8 6.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.705 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -105.51 -16.98 0.16 Allowed Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.6 -0.941 . . . . 0.0 111.861 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 91.7 Cg_endo -86.44 150.87 9.07 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 121.833 1.688 . . . . 0.0 113.088 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.04 170.86 10.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.618 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 1.8 p -91.18 120.36 32.05 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.772 -1.205 . . . . 0.0 111.043 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -105.74 154.14 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -61.58 -36.66 81.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.811 -1.181 . . . . 0.0 109.825 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -73.17 -50.81 20.53 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 110.97 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.655 ' HZ1' ' CE ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -63.94 -25.37 68.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.903 -1.123 . . . . 0.0 108.691 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.02 -44.29 91.7 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.5 t80 -68.94 -46.5 68.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 111.155 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.69 -35.29 77.01 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.509 -1.369 . . . . 0.0 109.761 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.655 ' CE ' ' HZ1' ' A' ' 30' ' ' LYS . 38.7 ttm -68.72 -43.79 75.25 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.927 -1.108 . . . . 0.0 110.991 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 165' ' ' PHE . 1.4 tp -63.19 -29.32 46.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.953 -1.092 . . . . 0.0 109.831 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 57.8 m -71.77 -49.21 40.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.043 -1.036 . . . . 0.0 110.413 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 mm? -66.23 -42.06 89.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.632 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 32.5 tp10 -66.39 -38.22 87.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.893 . . . . 0.0 109.746 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.55 -36.63 78.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.418 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 99.2 mm-40 -82.84 -7.77 59.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.221 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -89.48 4.17 50.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.075 . . . . 0.0 110.722 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 118.82 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 0.0 110.07 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.19 -1.01 89.41 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 46' ' ' TRP . 4.5 mm? -107.13 163.36 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.243 -1.151 . . . . 0.0 110.121 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 47' ' ' ILE . 60.6 m -80.98 22.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.669 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.7 OUTLIER 62.96 -39.85 0.17 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 109.758 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.563 ' H ' ' C ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -62.06 -35.47 68.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.921 -1.112 . . . . 0.0 108.225 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -59.24 -44.48 92.36 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.068 -1.02 . . . . 0.0 108.622 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.3 t -69.03 -35.83 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.11 -48.93 72.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.034 -1.041 . . . . 0.0 109.03 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -59.83 -42.62 93.97 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HZ2' ' HG3' ' A' ' 40' ' ' GLN . 1.6 ttmt -62.34 -32.33 73.09 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 40.9 ttm180 -53.66 -45.68 70.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.234 -0.916 . . . . 0.0 109.244 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.02 -44.26 85.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.816 -1.153 . . . . 0.0 108.614 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.683 HD22 ' CB ' ' A' ' 85' ' ' ILE . 27.5 t30 -63.27 -37.95 89.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 45.1 t80 -56.84 -42.92 80.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 61' ' ' HIS . 15.8 mmm-85 -59.34 -35.59 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 108.906 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.48 96.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 110.399 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.656 ' SG ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -78.3 -45.87 21.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 111.434 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 87.4 m-85 -95.39 -47.15 6.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.9 -1.125 . . . . 0.0 109.629 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.64 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 35.1 t-80 61.98 -51.17 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.851 -0.531 . . . . 0.0 110.106 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.602 ' N ' ' O ' ' A' ' 60' ' ' PHE . 2.6 pt20 -81.61 -35.4 30.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.41 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 43.2 p90 40.26 24.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.517 -0.74 . . . . 0.0 111.144 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.4 OUTLIER -78.61 153.02 78.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.506 -1.371 . . . . 0.0 108.612 179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.1 -41.77 26.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.607 2.205 . . . . 0.0 114.041 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.1 t -76.41 -38.93 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.621 -1.299 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -63.83 -42.65 97.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.082 -1.011 . . . . 0.0 108.579 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.97 -37.89 81.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.258 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.64 63.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.8 -8.5 46.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.7 mtp -83.25 115.76 22.1 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.24 167.44 11.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.65 -31.89 39.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.021 -1.049 . . . . 0.0 110.132 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -55.09 -41.48 71.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 85.3 m-20 -62.45 -37.99 88.02 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.2 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.472 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.96 -40.79 96.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 110.136 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 5.0 ptp180 -75.54 -33.01 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 109.274 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.99 -33.23 75.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.907 . . . . 0.0 111.397 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 m -54.19 -17.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.67 -1.269 . . . . 0.0 108.843 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.41 -2.33 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 55.1 t0 -81.55 108.25 14.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.701 -1.249 . . . . 0.0 109.273 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.32 -11.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.612 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.39 34.41 57.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.683 ' CB ' HD22 ' A' ' 55' ' ' ASN . 20.6 pt -52.56 -177.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -1.006 . . . . 0.0 110.344 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 tt -56.98 89.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 32.2 ptt180 -51.91 134.25 31.67 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.628 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.636 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.0 m-70 164.31 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 89' ' ' ARG . 15.6 ptt-85 -42.87 -32.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.079 . . . . 0.0 110.184 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.86 -62.35 6.18 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.912 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.406 ' H ' ' HD2' ' A' ' 91' ' ' LYS . 3.2 mptt -63.79 -38.28 90.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.869 -1.371 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 2.1 pt20 -55.65 -33.08 63.74 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.82 -1.175 . . . . 0.0 108.305 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.405 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -63.04 -38.59 91.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 108.811 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.5 -47.35 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 109.224 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.6 mp -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.448 -0.783 . . . . 0.0 109.942 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.27 -39.8 90.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -58.93 -35.71 73.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.542 -0.975 . . . . 0.0 109.683 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.78 -46.19 83.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -56.4 -41.61 76.57 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.985 -1.072 . . . . 0.0 108.693 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.04 71.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.636 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 48.7 t80 -63.32 -43.02 98.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -65.25 -31.9 73.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.6 -40.04 94.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -0.854 . . . . 0.0 110.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.685 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 80.6 mtp -67.52 -37.7 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.63 -41.08 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.085 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.05 -22.15 66.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -12.19 30.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.81 27.19 73.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.34 100.46 52.93 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.247 -1.149 . . . . 0.0 109.877 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.2 149.63 84.14 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.381 2.054 . . . . 0.0 112.146 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 33.6 m-85 -63.06 -40.07 96.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 111.195 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.17 77.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.077 -1.014 . . . . 0.0 111.062 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -63.02 -47.02 84.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.184 -0.948 . . . . 0.0 112.606 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -72.14 -44.52 63.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.538 -1.351 . . . . 0.0 110.718 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.523 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 3.9 p -60.49 -52.09 65.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.603 -1.311 . . . . 0.0 109.446 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.618 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 20.7 m95 -55.66 -24.36 33.53 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.3 p -65.57 -42.72 91.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 109.98 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.58 -36.47 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.988 -1.07 . . . . 0.0 109.171 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 t -86.37 13.9 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.697 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 121' ' ' ASN . 2.2 m120 57.17 31.97 20.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 56.17 32.67 20.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 111.437 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.69 149.75 41.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 110.066 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.58 145.0 68.77 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.809 2.34 . . . . 0.0 112.874 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.555 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.58 132.42 55.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.467 -0.771 . . . . 0.0 109.8 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.555 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.0 mtt -101.46 123.44 45.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.917 -1.114 . . . . 0.0 108.952 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -92.96 -20.41 20.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.879 -1.138 . . . . 0.0 110.16 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 57.22 44.77 21.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.383 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.01 148.77 51.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.25 -28.3 8.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.629 ' HG1' ' H ' ' A' ' 134' ' ' GLU . 5.2 p -131.9 164.15 26.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.15 -42.22 85.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 108.857 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 95.9 p -72.43 -19.33 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.629 ' H ' ' HG1' ' A' ' 131' ' ' THR . 39.2 tp10 -71.9 -10.42 59.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 tp -74.11 127.13 88.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 120.997 -1.064 . . . . 0.0 108.191 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.61 135.34 17.87 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.979 1.786 . . . . 0.0 113.014 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.6 p -112.13 4.94 18.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.6 t -138.77 93.19 2.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.384 -0.822 . . . . 0.0 109.003 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.57 158.9 50.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.15 -39.06 92.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.901 1.734 . . . . 0.0 111.21 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.64 -44.29 67.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 108.698 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.1 p -62.72 -40.72 98.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -63.28 -37.99 89.4 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.185 -0.947 . . . . 0.0 108.787 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.45 84.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.494 -0.754 . . . . 0.0 109.991 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.93 -40.49 95.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.627 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 25.2 t -64.35 -51.53 62.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.9 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -67.99 -39.64 83.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.84 -1.162 . . . . 0.0 109.299 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.87 83.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.5 mt -68.02 -35.76 78.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.003 -1.061 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.71 84.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.976 -1.077 . . . . 0.0 109.68 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.09 -32.39 71.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.21 -0.932 . . . . 0.0 110.455 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -72.33 -1.0 13.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.969 -1.082 . . . . 0.0 108.826 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.08 26.93 42.5 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -98.45 112.59 24.56 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.758 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -89.8 170.97 9.96 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 59.39 65.84 1.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.921 0.867 . . . . 0.0 109.679 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.8 m -140.97 38.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.43 168.35 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.3 m -57.42 -31.67 66.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.583 -0.951 . . . . 0.0 109.134 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.4 p -71.36 -33.92 70.01 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.82 -45.43 91.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.057 0.932 . . . . 0.0 108.533 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 146' ' ' SER . 28.3 m -63.8 -45.18 90.82 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.446 0.641 . . . . 0.0 109.9 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -31.81 73.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.969 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.463 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 29.9 t -59.56 -49.25 78.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 10.6 m-85 -59.75 -47.6 85.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.471 -1.393 . . . . 0.0 109.131 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.8 mmm -52.55 -42.22 64.22 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.576 -1.249 . . . . 0.0 108.389 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -43.16 18.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.51 -0.743 . . . . 0.0 111.064 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.22 13.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -0.943 . . . . 0.0 113.088 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.541 ' SG ' ' CG2' ' A' ' 26' ' ' THR . 0.5 OUTLIER -54.16 -18.91 4.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.628 -1.295 . . . . 0.0 110.861 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.98 -0.47 59.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.67 -35.14 72.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.403 -1.057 . . . . 0.0 109.348 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 m -131.06 143.98 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.14 117.69 34.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 175' ' ' HIS . 12.9 p-10 -178.85 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 174' ' ' ASP . 35.8 m170 -49.1 -39.25 27.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' VAL . 6.2 p 175.62 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' VAL . 1.4 p 30.69 112.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.261 1.029 . . . . 0.0 112.206 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.51 48.47 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 120.696 -1.252 . . . . 0.0 110.569 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 182' ' ' TYR . 1.2 t -66.44 149.83 49.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.715 -1.462 . . . . 0.0 108.676 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.504 ' SG ' ' C ' ' A' ' 1' ' ' MET . 76.4 m -46.25 -38.41 8.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 0.0 109.11 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.6 t -75.31 13.63 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 108.889 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.581 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.6 t80 -118.74 79.22 16.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.685 -0.634 . . . . 0.0 109.467 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.68 151.66 28.64 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.582 2.188 . . . . 0.0 112.176 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 153.1 -28.28 0.8 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 186' ' ' LYS . 53.4 t30 -100.45 -28.16 13.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -1.127 . . . . 0.0 109.292 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 185' ' ' ASN . 25.7 mmtm 42.16 65.47 4.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.54 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.304 -1.767 0 C-N-CA 122.72 2.28 . . . . 0.0 112.138 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.798 H3A2 ' CE2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 70.2 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -104.58 141.61 36.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.487 HH12 ' CG1' ' A' ' 14' ' ' ILE . 80.5 mtm180 -83.3 171.01 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.19 143.24 58.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.192 0.996 . . . . 0.0 110.226 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.22 -21.51 32.98 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.814 ' CZ2' H3A1 ' A' ' 189' ' ' ADK . 2.5 t90 -77.3 -4.28 44.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.953 -1.322 . . . . 0.0 108.864 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 9' ' ' GLN . 2.6 t -102.31 -31.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -70.54 6.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.393 -0.817 . . . . 0.0 110.035 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' VAL . 91.4 mt-30 -81.36 -105.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.953 -1.092 . . . . 0.0 110.511 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.47 159.97 63.07 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.935 . . . . 0.0 110.439 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.36 -35.58 17.99 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.188 2.592 . . . . 0.0 113.245 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.89 -31.8 71.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.075 -1.015 . . . . 0.0 110.608 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.781 ' OH ' H3A3 ' A' ' 189' ' ' ADK . 14.5 m-85 -58.42 -33.56 69.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 110.964 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.487 ' CG1' HH12 ' A' ' 3' ' ' ARG . 3.4 mp -58.53 -41.03 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.746 -1.221 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.614 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.01 -50.74 53.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.062 . . . . 0.0 109.452 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.429 ' HA ' HD21 ' A' ' 19' ' ' ASN . 28.9 t80 -63.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.363 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -66.58 -42.86 86.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 110.373 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -74.65 -10.28 59.38 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 20.7 m-80 -69.6 -76.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.885 -1.134 . . . . 0.0 108.426 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' O ' ' C ' ' A' ' 21' ' ' TRP . 94.6 mt-10 -151.92 -39.5 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.613 ' C ' ' O ' ' A' ' 20' ' ' GLU . 8.4 t90 -3.38 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.808 0.813 . . . . 0.0 111.241 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 142.41 -23.68 2.36 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.142 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.71 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 11.6 m -125.5 10.87 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.663 -0.904 . . . . 0.0 112.676 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 73.5 Cg_endo -75.72 143.79 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.346 1.364 . . . . 0.0 112.874 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -86.12 148.3 25.76 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.59 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 1.6 p -88.25 120.6 29.77 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.522 -1.271 . . . . 0.0 111.436 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -105.89 159.26 16.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 m -64.67 -38.08 89.78 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.466 -1.396 . . . . 0.0 110.469 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -75.13 -49.92 18.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 111.866 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -59.23 -40.49 86.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.949 -1.094 . . . . 0.0 109.398 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' N ' HD11 ' A' ' 31' ' ' LEU . 9.5 mp -62.69 -38.24 89.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.317 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 1.3 t80 -59.88 -39.46 85.39 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.472 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.12 -39.82 63.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.311 -0.868 . . . . 0.0 108.936 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.624 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 26.0 ttm -59.5 -49.61 77.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.835 . . . . 0.0 110.848 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.13 -35.26 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.673 -1.267 . . . . 0.0 108.817 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 72.2 m -67.23 -36.98 82.8 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.583 ' CD1' HH21 ' A' ' 57' ' ' ARG . 1.8 mp -73.21 -48.76 32.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 72.1 mm-40 -63.19 -37.55 87.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.826 . . . . 0.0 108.859 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.46 -35.88 92.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -74.48 -8.63 56.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.966 . . . . 0.0 109.382 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -74.21 -5.64 43.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.51 122.87 14.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.011 -1.055 . . . . 0.0 109.283 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.62 -25.99 0.28 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 42' ' ' ALA . 87.6 mt -105.48 144.61 32.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -1.144 . . . . 0.0 110.233 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -75.75 157.52 33.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.5 OUTLIER -56.91 -34.51 68.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.498 -0.752 . . . . 0.0 110.296 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -35.35 67.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -62.69 -44.31 96.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.333 -0.855 . . . . 0.0 109.983 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.31 -24.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.219 -0.926 . . . . 0.0 109.168 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.54 -47.87 82.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.0 110.003 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -61.4 -49.68 75.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.913 -1.117 . . . . 0.0 109.033 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -77.21 -5.82 50.68 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.067 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.3 ttm180 -65.9 -55.74 15.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -66.2 -45.84 79.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.663 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.24 -45.87 79.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.956 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 60' ' ' PHE . 56.7 t80 -63.44 -46.3 86.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.875 -1.14 . . . . 0.0 110.476 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.701 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -54.31 -34.42 60.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.856 -1.153 . . . . 0.0 109.676 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.29 79.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.087 -1.008 . . . . 0.0 110.469 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.79 -43.7 62.45 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 112.638 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 56' ' ' TYR . 66.6 m-85 -111.72 -46.22 3.27 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.739 -1.225 . . . . 0.0 112.079 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.701 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -91.25 61.23 4.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.235 -177.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.619 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 88.1 mt-30 -49.78 -35.68 23.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 156.65 -0.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.275 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.45 94.81 48.81 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.916 -1.115 . . . . 0.0 109.892 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -51.44 -26.9 22.77 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.319 2.013 . . . . 0.0 112.063 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.71 -46.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -65.4 -34.61 78.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.6 t -60.34 -37.55 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.818 . . . . 0.0 109.53 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.75 -15.28 63.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.53 -5.07 49.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 0.0 109.853 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.1 mmm -77.97 116.5 18.51 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -95.12 175.69 6.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.201 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.86 -33.57 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.716 -0.615 . . . . 0.0 110.542 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -57.83 -42.0 83.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 84.8 m-20 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.53 -40.09 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.461 -0.774 . . . . 0.0 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -66.04 -40.26 90.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 7.1 ptp180 -74.61 -38.71 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.717 -1.239 . . . . 0.0 109.225 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 60' ' ' PHE . 10.4 mt -65.49 -32.35 73.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.73 . . . . 0.0 110.615 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG12 HH12 ' A' ' 87' ' ' ARG . 41.3 t -48.24 -38.36 8.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.14 2.02 45.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 19.7 t70 -87.43 110.6 20.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 81.67 -15.13 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.676 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.05 37.41 49.72 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pt -58.74 -166.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.197 -1.178 . . . . 0.0 110.107 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 15.7 tt -66.98 94.46 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 0.0 109.463 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.615 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 4.6 mtt-85 -51.78 117.86 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.915 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.681 ' CD2' ' HZ1' ' A' ' 91' ' ' LYS . 3.5 m-70 170.62 68.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -48.73 -34.16 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.26 -62.65 6.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.681 ' HZ1' ' CD2' ' A' ' 88' ' ' HIS . 33.7 mtmm -62.44 -40.68 97.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.085 -1.244 . . . . 0.0 110.322 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 92' ' ' ILE . 43.8 mm -61.18 -43.89 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.959 -1.088 . . . . 0.0 110.513 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.43 74.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.796 -1.19 . . . . 0.0 109.368 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.59 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.17 -31.14 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -58.56 -46.25 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.807 -1.183 . . . . 0.0 108.395 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.1 -33.19 86.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -56.16 -42.2 76.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.194 . . . . 0.0 109.826 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.28 -47.6 67.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.087 . . . . 0.0 108.894 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -56.77 -36.25 69.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.458 -0.776 . . . . 0.0 109.1 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.43 72.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.057 -1.027 . . . . 0.0 108.927 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.7 -42.66 97.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.0 mm? -61.44 -32.95 72.94 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -63.62 -36.69 84.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.587 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.3 tpp -64.23 -40.76 96.71 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.028 0.918 . . . . 0.0 108.899 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.6 -38.98 92.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.5 -24.31 66.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -90.97 -15.84 29.02 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.6 27.19 73.58 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.644 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.99 101.93 47.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.195 -1.179 . . . . 0.0 109.565 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.53 138.16 14.46 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.769 1.646 . . . . 0.0 112.383 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -51.88 -39.12 58.46 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.237 1.018 . . . . 0.0 109.198 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.12 65.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 109.957 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -66.63 -48.64 68.82 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 111.892 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.8 p90 -73.95 -38.29 64.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.54 -1.35 . . . . 0.0 111.274 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 115' ' ' PHE . 17.5 m -66.92 -52.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.318 -1.489 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.59 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.3 m95 -55.03 -27.13 42.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 t -76.14 -40.0 53.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.464 -0.773 . . . . 0.0 110.541 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.28 -24.88 65.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.284 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.0 m -100.84 19.11 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.418 -0.801 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.63 36.19 22.55 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.76 -0.588 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 52.68 37.3 23.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 111.218 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.08 149.85 25.94 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 109.315 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.83 150.78 62.27 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 112.2 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' C ' ' OE1' ' A' ' 125' ' ' GLN . 4.6 tm0? -102.43 132.0 48.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 98.2 mmm -94.23 117.81 30.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 109.233 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 174' ' ' ASP . 1.2 m -93.07 119.46 32.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.64 21.45 4.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.031 -1.043 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.48 142.22 56.68 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.484 -0.76 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 58.2 p -106.61 -25.01 11.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 108.865 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -130.12 164.27 24.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.549 -0.72 . . . . 0.0 109.092 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.4 mt -57.66 -35.0 69.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 108.773 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.2 t -61.06 -35.95 78.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.53 0.52 25.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.2 tp -79.84 125.9 81.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.26 132.36 13.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.764 1.643 . . . . 0.0 112.725 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 p -111.65 7.15 20.35 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -144.92 89.35 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.527 -0.733 . . . . 0.0 109.462 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.505 ' H ' ' HG ' ' A' ' 142' ' ' SER . 39.1 p -108.99 151.93 42.16 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.601 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.63 -34.69 74.57 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.667 1.578 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.95 -45.76 56.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.451 -0.781 . . . . 0.0 109.0 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.505 ' HG ' ' H ' ' A' ' 139' ' ' THR . 82.7 p -69.01 -36.69 78.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.28 -0.887 . . . . 0.0 109.096 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.49 -38.95 93.1 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.76 -27.24 63.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tp -69.03 -44.95 71.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.723 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 7.7 t -62.62 -47.09 85.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.913 . . . . 0.0 110.868 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -65.06 -37.83 88.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.775 -1.203 . . . . 0.0 109.879 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.36 -44.83 70.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.1 -1.0 . . . . 0.0 109.389 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 149' ' ' LEU . 1.2 mm? -63.24 -38.31 90.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -61.29 -41.08 96.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.144 -0.972 . . . . 0.0 110.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 153' ' ' GLY . 66.1 mttm -68.65 -36.58 78.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.97 -1.081 . . . . 0.0 111.762 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -71.11 7.05 1.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.78 -1.2 . . . . 0.0 110.143 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 82.98 22.68 57.2 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.34 112.57 24.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.218 -1.166 . . . . 0.0 108.015 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.44 174.95 6.6 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 59.68 48.65 9.12 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.564 0.697 . . . . 0.0 109.875 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.27 43.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.67 160.1 0.48 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -56.8 -30.91 64.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.64 -0.917 . . . . 0.0 109.881 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -75.6 -31.45 59.95 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -72.48 -35.99 53.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.2 m -69.28 -40.58 77.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.803 . . . . 0.0 109.38 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.51 -45.24 76.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.632 ' OG ' ' N7 ' ' A' ' 189' ' ' ADK . 33.6 t -61.35 -39.34 90.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.563 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 47.9 t80 -58.54 -47.78 83.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.714 -0.616 . . . . 0.0 110.445 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 63.9 mtp -72.43 -39.56 67.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.055 -1.028 . . . . 0.0 109.536 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.647 HE21 ' N ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 110.211 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.647 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -78.34 -38.71 41.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 109.882 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.624 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 44.3 m -54.53 -16.95 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.343 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.55 -1.31 58.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.95 -30.91 71.23 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -1.078 . . . . 0.0 109.525 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.3 t -116.14 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 6.4 m-80 -125.01 162.41 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 15.3 t0 89.3 69.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.126 0.489 . . . . 0.0 110.563 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -51.59 -59.09 4.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.78 160.71 36.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.14 113.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.524 -1.36 . . . . 0.0 108.793 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.75 67.33 1.69 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.747 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 5.3 t -84.33 72.17 10.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.816 -1.403 . . . . 0.0 109.222 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.5 OUTLIER 31.55 33.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.68 -0.637 . . . . 0.0 111.488 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER 178.88 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.59 -1.319 . . . . 0.0 110.391 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.526 ' CE2' ' CG ' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -87.29 114.69 59.79 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.412 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 59.1 Cg_endo -76.88 136.9 17.15 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.108 1.872 . . . . 0.0 112.054 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -135.21 -7.19 2.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 186' ' ' LYS . 31.0 p-10 -98.31 -57.37 2.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.18 . . . . 0.0 109.991 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 16.5 mttt -99.41 153.29 37.86 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.938 . . . . 0.0 109.491 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.634 2.223 . . . . 0.0 111.985 179.818 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.814 H3A1 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HG ' ' A' ' 180' ' ' CYS . 41.6 mtm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 3' ' ' ARG . 1.1 tm-20 -88.92 140.75 29.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 108.955 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.626 HH11 ' CG ' ' A' ' 3' ' ' ARG . 2.2 mtt-85 -93.65 170.65 9.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.4 m -57.94 154.75 11.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.618 0.723 . . . . 0.0 110.254 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.13 -44.79 96.11 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.487 -0.758 . . . . 0.0 112.478 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.946 ' CZ3' H3A1 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -80.49 1.22 30.23 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.474 -1.604 . . . . 0.0 109.828 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 9' ' ' GLN . 2.2 t -89.39 -47.7 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.829 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -77.77 6.28 7.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 0.8 OUTLIER -91.58 -58.93 2.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.787 -0.571 . . . . 0.0 110.492 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.88 160.0 67.15 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.66 -32.11 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.041 2.494 . . . . 0.0 112.728 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.31 -40.26 89.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.121 -0.987 . . . . 0.0 109.477 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 6' ' ' TRP . 29.5 m-85 -65.92 -38.52 88.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.977 -1.077 . . . . 0.0 109.702 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.3 mt -55.69 -40.56 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.394 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.5 -51.74 18.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.974 -1.079 . . . . 0.0 109.419 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.459 ' HA ' HD21 ' A' ' 19' ' ' ASN . 31.8 t80 -60.9 -41.54 96.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.776 . . . . 0.0 109.991 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.47 -45.5 92.75 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.639 -0.663 . . . . 0.0 110.493 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -74.06 -7.38 52.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.448 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.673 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 38.1 m-80 -81.01 -77.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 110.288 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' GLY . 92.7 mt-10 -154.71 71.69 0.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 110.343 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.881 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 31.4 t-105 -70.14 63.31 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 67.83 64.99 2.88 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.018 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.666 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 25.5 t -114.67 -36.2 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.425 -1.044 . . . . 0.0 109.742 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 41.6 Cg_endo -95.21 151.8 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.962 2.441 . . . . 0.0 112.989 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.34 143.24 56.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 p -99.01 155.51 17.39 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.95 . . . . 0.0 111.863 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -97.72 166.68 11.37 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' HG ' ' HB1' ' A' ' 113' ' ' ALA . 14.0 m -57.33 -37.09 71.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.091 -1.006 . . . . 0.0 110.398 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -65.46 -42.47 92.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 111.035 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -59.05 -34.87 72.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.175 -0.953 . . . . 0.0 109.035 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.54 -33.26 75.5 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.84 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 89.4 t80 -65.92 -50.33 64.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 0.0 110.181 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -68.81 -30.21 68.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.83 -1.169 . . . . 0.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.0 tpt -70.28 -50.23 41.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.651 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.64 -29.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 61.4 m -71.62 -48.18 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.043 . . . . 0.0 110.022 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.67 -39.01 84.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.521 ' HE2' ' C8 ' ' A' ' 189' ' ' ADK . 69.2 mm-40 -62.89 -31.19 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 109.939 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.34 -41.6 55.2 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.123 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mm-40 -67.89 -29.82 69.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.694 -1.474 . . . . 0.0 110.974 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' GLN . 4.5 pt20 -41.3 -31.94 0.26 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 0.0 109.829 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.63 116.98 7.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.01 -1.056 . . . . 0.0 108.716 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.66 -36.74 3.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' GLN . 4.5 mm? -105.14 150.04 25.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.164 -1.198 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 t -76.62 150.28 36.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 1.1 t-105 -54.72 -35.59 63.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -41.04 90.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.067 -1.021 . . . . 0.0 108.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.0 m -57.84 -38.42 75.59 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.8 t -66.5 -37.25 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.21 -50.6 70.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.06 -1.025 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -57.49 -37.76 73.46 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -73.18 -24.25 60.53 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 42.2 ttm180 -55.12 -45.06 75.53 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.08 -40.71 91.07 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.798 ' N ' HD21 ' A' ' 55' ' ' ASN . 0.7 OUTLIER -69.08 -31.92 71.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.886 0.85 . . . . 0.0 108.984 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 52' ' ' LYS . 58.7 t80 -56.14 -50.89 69.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.2 ptm180 -67.31 -28.0 67.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.048 -1.033 . . . . 0.0 109.22 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.57 -36.47 82.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 110.262 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.642 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.96 -45.62 26.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.642 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 98.4 m-85 -91.43 -48.59 6.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.926 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER 59.94 -45.32 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.694 -0.628 . . . . 0.0 111.102 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.592 ' CD ' ' H ' ' A' ' 64' ' ' ASP . 2.0 pp0? -57.73 -32.86 67.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.322 -0.861 . . . . 0.0 111.259 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.15 26.66 2.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.722 -1.236 . . . . 0.0 109.658 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.592 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -118.64 96.03 49.55 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -31.65 17.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.26 1.974 . . . . 0.0 113.168 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.91 -46.52 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.716 -1.24 . . . . 0.0 109.975 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.78 -33.02 74.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.774 -1.204 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.91 -37.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' CB ' HH21 ' A' ' 100' ' ' ARG . . . -65.61 -17.2 64.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.2 -10.94 29.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.642 -0.662 . . . . 0.0 109.734 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.58 114.39 9.61 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.062 -1.024 . . . . 0.0 108.686 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 8.1 tt0 -95.89 172.77 7.81 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 94.3 mt-10 -51.79 -30.48 23.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.825 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -55.48 -44.33 76.38 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 119.909 -1.744 . . . . 0.0 108.44 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 70.6 m-20 -70.86 -35.26 72.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.478 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.455 HG11 HE21 ' A' ' 93' ' ' GLN . 1.0 OUTLIER -73.96 -34.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.258 -1.526 . . . . 0.0 109.3 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.72 -40.86 98.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -70.68 -34.42 71.98 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.443 -1.303 . . . . 0.0 108.967 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' C ' ' N ' ' A' ' 81' ' ' GLN . 72.9 mt -68.26 -34.94 77.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.38 -19.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 79' ' ' LEU . 12.8 mt-30 -106.52 -15.42 14.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.483 -0.76 . . . . 0.0 109.912 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' A' ' 84' ' ' GLY . 82.1 m-20 -78.9 109.86 13.57 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.703 -1.199 . . . . 0.0 109.948 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.0 -18.9 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.32 33.01 61.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLY . 9.7 pt -36.22 156.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.649 -0.912 . . . . 0.0 110.234 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.45 -35.04 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.301 -0.874 . . . . 0.0 110.39 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.5 147.29 53.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.935 -178.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 89' ' ' ARG . 97.7 m-70 -124.16 170.69 10.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.59 -0.694 . . . . 0.0 109.38 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 88' ' ' HIS . 35.3 ttp180 -40.14 -35.78 0.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.19 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.66 -64.02 2.34 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 7.5 mptt -60.39 -36.99 79.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -1.19 . . . . 0.0 110.107 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.87 -47.48 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.632 -1.292 . . . . 0.0 109.292 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.455 HE21 HG11 ' A' ' 76' ' ' VAL . 33.4 mm-40 -52.5 -34.82 51.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.06 -1.025 . . . . 0.0 108.71 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.67 89.02 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.507 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.83 -43.75 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 108.673 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.6 mp -60.41 -41.77 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 108.646 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -38.07 93.44 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.78 -37.97 71.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.446 -1.032 . . . . 0.0 109.482 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.02 83.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.027 -1.045 . . . . 0.0 109.406 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.499 HH21 ' CB ' ' A' ' 69' ' ' ALA . 5.1 tpp180 -55.0 -39.44 69.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.268 -0.895 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.93 69.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 59.2 t80 -64.24 -43.06 96.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.1 mm? -63.2 -28.95 70.4 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.69 -41.55 83.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.219 -0.926 . . . . 0.0 111.362 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.678 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.8 mtp -69.1 -37.29 78.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.749 -1.22 . . . . 0.0 109.293 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.65 -39.85 84.58 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -15.77 62.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -92.95 -11.98 31.96 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.39 21.44 79.59 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.68 101.24 53.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.192 -1.181 . . . . 0.0 109.374 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.35 146.1 95.86 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.157 1.905 . . . . 0.0 112.273 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.6 m-85 -59.66 -45.21 92.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB1' ' HG ' ' A' ' 28' ' ' SER . . . -64.98 -28.41 69.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 118' ' ' SER . 17.3 t70 -59.45 -52.46 65.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.964 -1.085 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -75.08 -39.87 60.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.496 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 18.5 t -59.0 -54.75 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 120.619 -1.301 . . . . 0.0 109.9 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 122' ' ' HIS . 56.1 m95 -62.02 -21.99 65.34 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 108.958 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 50.6 m -68.46 -37.47 80.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 109.254 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.515 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 18.3 m-85 -69.37 -31.26 69.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.403 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.54 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 39.3 t -87.99 15.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.836 -1.165 . . . . 0.0 109.711 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.585 ' OD1' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER 78.78 11.38 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.699 -0.626 . . . . 0.0 109.836 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 65.7 20.57 11.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 110.893 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 15.1 mt-30 -146.51 150.94 42.07 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.941 -1.099 . . . . 0.0 109.236 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -49.24 142.25 22.11 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.862 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -110.77 142.62 42.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.565 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 92.1 mmm -99.93 130.26 46.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.73 123.04 35.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.093 -1.005 . . . . 0.0 109.879 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -91.93 27.35 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.79 . . . . 0.0 110.284 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.97 35.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.5 p -93.51 -22.36 18.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.127 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 49.4 p -133.64 167.85 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.016 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 -33.56 73.41 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.6 t -73.92 -13.17 60.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 110.43 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -94.16 4.05 54.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mm -92.49 122.35 64.57 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.83 140.78 32.56 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.84 1.693 . . . . 0.0 112.516 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.9 p -101.62 3.35 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.8 p -144.99 87.5 1.83 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.442 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.76 155.17 36.64 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -54.51 -36.52 88.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.879 1.719 . . . . 0.0 110.741 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.74 -43.12 59.99 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.809 -0.756 . . . . 0.0 108.984 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' A' ' 143' ' ' ASP . 61.8 p -70.18 -38.13 75.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.139 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.577 ' N ' ' HG ' ' A' ' 142' ' ' SER . 19.7 t70 -62.28 -38.93 91.23 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.177 -0.952 . . . . 0.0 108.881 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.515 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -68.83 -34.55 75.68 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.298 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mp -57.5 -46.29 83.95 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 0.0 108.639 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.545 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 8.9 t -60.7 -50.29 74.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.105 -0.997 . . . . 0.0 108.954 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.415 ' HB3' ' HZ1' ' A' ' 147' ' ' LYS . 7.6 mtpp -61.29 -40.41 94.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 109.267 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.99 22.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.83 -33.13 74.6 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -61.32 -42.24 98.34 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.982 -1.074 . . . . 0.0 109.671 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -68.45 -28.4 67.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.945 . . . . 0.0 110.55 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -72.7 1.35 8.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.906 -1.121 . . . . 0.0 108.675 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 78.59 27.32 57.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.64 112.88 24.58 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.652 0.739 . . . . 0.0 109.848 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -88.1 176.77 7.14 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.13 62.72 1.56 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.011 -1.056 . . . . 0.0 108.23 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.03 41.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.42 154.79 4.07 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 m -52.54 -32.01 38.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.27 -1.135 . . . . 0.0 109.557 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -72.09 -29.93 64.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.25 -0.906 . . . . 0.0 108.725 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 161' ' ' ILE . 25.7 mm -64.67 -44.92 96.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.815 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 146' ' ' SER . 97.9 m -60.8 -39.02 87.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.47 -47.81 53.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 111.063 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.499 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 19.9 m -63.43 -36.77 84.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.044 -1.035 . . . . 0.0 108.696 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 5.3 t80 -60.15 -46.24 90.35 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.153 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 12.5 ptp -71.49 -34.08 69.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.511 -1.368 . . . . 0.0 110.626 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.503 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -61.48 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.818 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 167' ' ' GLN . . . -87.14 -22.98 25.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.199 -0.938 . . . . 0.0 111.592 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 1.5 m -68.76 -19.31 64.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.964 -1.085 . . . . 0.0 111.102 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.49 0.83 57.93 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.37 -30.97 72.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.615 -0.932 . . . . 0.0 109.426 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.07 142.15 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 75.0 m-20 -111.71 164.11 13.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 5.5 t0 86.71 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.597 0.713 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.477 ' CD2' ' CD1' ' A' ' 21' ' ' TRP . 20.9 m170 -54.35 -48.26 71.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -152.07 38.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.484 -179.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.436 ' CG2' ' OD2' ' A' ' 174' ' ' ASP . 24.0 t 45.15 13.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.0 110.672 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -157.4 31.74 0.53 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.117 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 7.1 t -93.77 146.25 24.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -1.222 . . . . 0.0 109.873 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.626 ' HG ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -67.84 -21.4 65.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.702 . . . . 0.0 110.762 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.5 t -97.59 -29.41 13.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.942 -1.099 . . . . 0.0 112.573 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.46 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -67.47 133.05 92.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.215 -1.553 . . . . 0.0 109.81 -178.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.82 126.98 11.82 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.433 2.089 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.96 -32.52 0.8 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -155.52 11.95 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -1.001 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.34 82.7 24.33 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.516 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 -179.598 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.946 H3A1 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.561 ' H2 ' ' CB ' ' A' ' 180' ' ' CYS . 70.5 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.69 154.38 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.416 HH12 HD11 ' A' ' 14' ' ' ILE . 84.6 mtt180 -75.04 159.31 31.88 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.37 152.93 40.69 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.274 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 7' ' ' VAL . . . -53.03 -25.86 25.59 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.772 ' CZ2' ' C3A' ' A' ' 189' ' ' ADK . 1.8 t90 -75.78 13.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.028 -1.278 . . . . 0.0 109.623 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 5' ' ' GLY . 75.9 t -138.74 -23.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 110.269 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -71.83 5.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 109.949 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -115.39 -75.45 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.341 -0.85 . . . . 0.0 110.57 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.02 139.46 90.46 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.986 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 -53.21 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.526 2.151 . . . . 0.0 113.194 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.91 -33.91 62.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.912 -1.118 . . . . 0.0 109.742 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.893 ' OH ' H3A1 ' A' ' 189' ' ' ADK . 3.3 m-85 -52.89 -40.18 63.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.416 HD11 HH12 ' A' ' 3' ' ' ARG . 83.1 mt -54.12 -39.84 43.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.447 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.636 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.18 -51.1 22.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.96 -1.087 . . . . 0.0 109.535 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 22.7 t80 -60.76 -41.08 94.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 0.0 109.72 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.608 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 39.3 t-80 -58.66 -44.85 90.26 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.47 -0.769 . . . . 0.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.92 -30.36 68.81 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.645 -0.659 . . . . 0.0 110.836 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 55.9 m-80 -60.21 -53.56 56.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 111.126 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' GLY . 10.9 pt-20 176.05 72.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.2 -0.938 . . . . 0.0 110.334 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.731 ' CZ3' ' HC2' ' A' ' 189' ' ' ADK . 44.9 t-105 -70.52 60.73 0.22 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 71.27 49.67 25.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -107.18 -42.63 0.13 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.322 -1.105 . . . . 0.0 110.563 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.9 Cg_endo -91.14 151.87 3.8 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.261 2.641 . . . . 0.0 113.183 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.39 144.21 54.82 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.55 ' OG1' ' SG ' ' A' ' 169' ' ' CYS . 6.1 p -99.16 148.79 23.73 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.102 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -96.41 166.43 11.7 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -56.01 -31.5 63.13 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.777 -1.202 . . . . 0.0 109.632 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -65.65 -43.0 90.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.565 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -63.72 -34.96 79.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.131 -0.981 . . . . 0.0 109.125 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 31' ' ' LEU . 1.4 mm? -56.22 -41.67 76.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.718 -0.614 . . . . 0.0 109.643 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -69.57 -43.17 73.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 77.1 mt-10 -69.35 -45.39 69.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.86 -1.15 . . . . 0.0 109.332 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.9 ttm -62.19 -51.05 69.38 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.493 -0.754 . . . . 0.0 111.146 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.27 -26.16 38.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.853 -1.154 . . . . 0.0 109.716 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.45 -54.02 19.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.941 -1.099 . . . . 0.0 109.737 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 33' ' ' GLU . 2.0 mm? -71.88 -38.51 69.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.145 . . . . 0.0 108.843 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.631 ' HE2' HN61 ' A' ' 189' ' ' ADK . 3.5 tp10 -62.13 -32.34 72.91 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.514 -0.741 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.68 -13.73 82.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.91 -8.38 43.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.311 . . . . 0.0 111.319 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.667 ' NE2' ' N7 ' ' A' ' 189' ' ' ADK . 2.2 pt20 -80.38 1.83 27.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.573 -1.329 . . . . 0.0 110.176 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -62.87 117.58 6.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -29.31 1.66 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 42' ' ' ALA . 19.1 mt -98.46 146.12 26.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -1.114 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 m -67.81 152.66 45.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.507 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.4 OUTLIER -60.21 -37.13 79.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.675 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -67.73 -35.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.088 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -59.57 -42.12 91.73 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.959 -1.088 . . . . 0.0 108.125 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 54.0 t -67.72 -35.06 71.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.36 -51.67 67.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.148 -0.97 . . . . 0.0 109.688 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -57.9 -43.13 85.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -66.92 -28.84 68.62 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.06 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.7 ttm180 -53.52 -43.79 68.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.822 -1.174 . . . . 0.0 109.097 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -73.25 -49.14 29.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.216 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 24.0 p30 -80.95 -42.62 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.757 -1.214 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.601 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 53.1 t80 -62.76 -44.64 95.67 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.809 -1.182 . . . . 0.0 109.937 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 HH21 ' CD2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -61.61 -31.82 71.92 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.37 -42.7 98.88 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.018 -1.052 . . . . 0.0 110.335 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 m -78.37 -43.26 28.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.0 113.087 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CD2' ' CZ ' ' A' ' 56' ' ' TYR . 93.3 m-85 -107.4 7.38 29.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.734 -1.229 . . . . 0.0 112.398 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 61' ' ' HIS . 65.2 t60 -151.82 60.18 0.86 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.551 -1.343 . . . . 0.0 108.562 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.679 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 89.6 mt-30 -57.41 -42.93 83.25 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.441 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.679 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 85.9 m-85 -163.8 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.217 -0.993 . . . . 0.0 112.288 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.03 146.24 31.58 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 111.136 -176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.43 -17.41 30.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.26 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.43 -43.65 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -67.45 -38.18 84.09 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.69 -39.25 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.83 -14.94 63.37 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 -9.64 53.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 82.3 mmm -77.77 112.28 14.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.6 pt20 -95.87 -177.07 3.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.341 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.03 -33.44 72.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 110.801 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.0 tt0 -58.58 -43.33 89.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.7 -1.25 . . . . 0.0 109.08 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -65.23 -38.89 91.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.696 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.75 -44.31 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.726 . . . . 0.0 110.576 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.473 ' CB ' HH21 ' A' ' 89' ' ' ARG . 5.7 pt-20 -63.18 -35.83 81.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.637 -1.289 . . . . 0.0 108.943 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -69.18 -44.03 73.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLN . 90.2 mt -69.56 -32.86 71.9 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 79' ' ' LEU . 34.5 m -47.83 -16.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.438 -1.414 . . . . 0.0 108.928 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LEU . 20.6 pt20 -124.55 -2.18 7.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.637 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 56.2 t0 -83.76 111.01 18.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.474 -1.391 . . . . 0.0 109.222 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 85.27 -5.46 0.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.899 -0.501 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.91 37.68 60.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -70.79 -162.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -1.147 . . . . 0.0 109.493 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 86' ' ' ILE . 98.6 mt -77.25 118.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.942 0.877 . . . . 0.0 109.133 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.6 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.3 mtp180 -80.68 125.64 30.28 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.81 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.473 HH21 ' CB ' ' A' ' 77' ' ' GLU . 41.8 ttm180 -44.79 -33.31 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 0.0 109.763 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.63 -59.79 6.82 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.975 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -60.65 -42.21 96.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.843 -1.386 . . . . 0.0 110.862 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 29.0 mm -62.63 -43.49 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.939 -1.101 . . . . 0.0 110.203 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.33 -31.63 65.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 109.258 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HA ' HE21 ' A' ' 93' ' ' GLN . . . -67.92 -39.29 83.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.518 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.413 HG23 HD11 ' A' ' 95' ' ' ILE . 91.4 mt -66.07 -35.73 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.811 . . . . 0.0 110.675 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.06 -39.88 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.466 -1.396 . . . . 0.0 107.25 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.39 -34.19 89.25 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.06 -40.3 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -1.222 . . . . 0.0 108.472 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.35 86.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.604 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -61.49 -36.98 82.0 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 152' ' ' ARG . . . -63.04 -30.75 71.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 108.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.03 -43.32 99.02 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -63.7 -34.52 78.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.97 -39.38 94.52 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.321 -0.862 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.6 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 29.8 tpp -63.91 -46.58 84.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.42 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.37 -38.6 80.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.03 -24.59 64.64 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -91.93 -12.01 34.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.63 26.8 73.65 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.427 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.6 ' O ' ' SD ' ' A' ' 105' ' ' MET . 2.0 mt-10 -120.33 101.93 46.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.219 -1.165 . . . . 0.0 109.868 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.79 142.49 25.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.805 1.67 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 43.9 m-85 -59.86 -38.88 83.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.321 -0.862 . . . . 0.0 110.905 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.23 68.14 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.962 -1.086 . . . . 0.0 110.433 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.487 ' O ' ' OG ' ' A' ' 118' ' ' SER . 81.1 m-20 -65.82 -47.45 74.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.063 . . . . 0.0 112.292 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.5 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.0 p90 -74.27 -37.66 63.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.52 -1.362 . . . . 0.0 111.154 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG11 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -63.41 -52.46 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.328 -1.482 . . . . 0.0 109.894 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.593 ' O ' ' N ' ' A' ' 122' ' ' HIS . 54.1 m95 -58.41 -25.07 61.71 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.115 . . . . 0.0 108.033 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 45.9 m -75.86 -38.0 58.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.481 -0.762 . . . . 0.0 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -62.88 -32.47 73.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 109.819 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.4 p -92.62 19.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.125 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 122' ' ' HIS . 6.4 m120 66.25 34.89 6.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.757 -0.59 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 117' ' ' TRP . 86.2 t60 38.31 33.94 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 0.0 109.907 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -130.89 153.18 81.63 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.91 140.52 35.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.183 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.584 HE21 ' C ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -109.26 123.89 50.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.073 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.584 ' C ' HE21 ' A' ' 125' ' ' GLN . 71.7 mtm -94.71 117.08 29.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.029 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.0 115.35 24.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.268 -0.895 . . . . 0.0 108.974 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.61 19.9 5.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 109.416 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 136.03 55.23 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -97.16 -12.22 23.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 0.0 108.969 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 p -140.02 163.62 32.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.499 -0.751 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.42 -34.29 76.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.136 -0.978 . . . . 0.0 109.134 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.9 p -72.92 -19.52 61.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.768 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -84.15 3.88 32.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.36 138.84 23.97 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.26 135.9 30.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.303 2.002 . . . . 0.0 112.601 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -111.45 1.95 17.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.039 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -147.32 90.06 1.84 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.6 OUTLIER -109.71 156.71 39.28 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 109.042 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.5 -37.48 90.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.021 1.814 . . . . 0.0 111.338 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.11 -41.92 66.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.899 . . . . 0.0 108.666 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -68.03 -42.28 80.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.82 . . . . 0.0 109.351 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.88 -42.31 90.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.65 74.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.0 tp -60.72 -46.07 91.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.363 -0.836 . . . . 0.0 108.861 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.44 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 5.7 t -58.41 -46.81 85.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 109.669 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.67 -44.63 96.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 109.946 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.682 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.25 -44.8 78.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.36 -36.34 83.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -60.61 -39.44 88.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.448 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' C ' ' H ' ' A' ' 153' ' ' GLY . 25.4 mmtm -64.98 -36.49 84.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.682 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.8 5.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.99 24.98 63.01 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.86 111.92 23.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.503 -0.998 . . . . 0.0 108.412 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -96.28 176.72 5.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 57.61 47.14 16.42 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.52 36.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.73 171.38 0.05 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.0 p -60.81 -28.13 68.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.148 . . . . 0.0 109.325 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -65.59 -38.31 89.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.94 -44.42 81.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 146' ' ' SER . 84.7 m -63.68 -42.64 98.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.611 -0.68 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.428 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.59 -40.95 80.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 110.035 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 38' ' ' GLU . 76.9 p -63.34 -40.21 96.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.916 . . . . 0.0 109.873 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 1.7 t80 -59.32 -43.85 92.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.099 -1.001 . . . . 0.0 109.388 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.0 mtp -62.26 -38.87 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -41.88 89.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.451 -0.78 . . . . 0.0 111.244 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.63 5.8 41.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.049 -1.032 . . . . 0.0 111.362 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.592 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 21.0 t -96.76 -13.01 22.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.737 -1.227 . . . . 0.0 110.31 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.55 -5.98 57.25 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.592 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -62.94 -33.58 75.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.951 -1.323 . . . . 0.0 109.613 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.02 138.68 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.6 m120 -113.27 164.02 14.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.434 -0.791 . . . . 0.0 110.132 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.6 OUTLIER 92.4 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.377 0.608 . . . . 0.0 110.332 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 16.2 m170 -53.45 -38.6 63.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 176' ' ' VAL . 2.9 p -162.18 55.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 176' ' ' VAL . 13.5 p 23.51 67.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.335 0.588 . . . . 0.0 111.156 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.47 35.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 31.0 t -105.05 148.37 26.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.119 -1.224 . . . . 0.0 109.487 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.561 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 49.0 t -56.0 -41.42 74.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.821 . . . . 0.0 109.687 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.608 ' SG ' ' CE1' ' A' ' 17' ' ' HIS . 0.8 OUTLIER -59.02 -38.64 79.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.444 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.514 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -102.48 106.83 51.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.87 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 185' ' ' ASN . 39.4 Cg_endo -74.57 141.22 27.72 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.003 1.802 . . . . 0.0 112.67 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 185' ' ' ASN . . . -75.79 11.22 11.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 184' ' ' GLY . 11.5 t-20 78.54 22.59 0.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.689 -0.889 . . . . 0.0 109.768 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -96.92 151.57 37.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo . . . . . 0 C--N 1.313 -1.297 0 C-N-CA 122.451 2.101 . . . . 0.0 112.258 179.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.893 H3A1 ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.385 0.612 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.34 154.43 19.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.262 -0.899 . . . . 0.0 109.282 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -92.29 0.1 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.776 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.902 ' CZ3' H3A2 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.845 ' OH ' H3A1 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.729 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.658 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.594 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.696 HE22 ' CG1' ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.578 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.696 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.696 ' CG1' HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.673 ' C ' ' H ' ' A' ' 62' ' ' GLN . 53.3 m-85 -85.85 18.58 2.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ARG . 9.2 t-80 -56.97 17.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.353 -0.842 . . . . 0.0 111.112 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.673 ' H ' ' C ' ' A' ' 60' ' ' PHE . 20.1 pt20 -79.43 -17.98 53.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.951 -1.093 . . . . 0.0 110.651 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 42.3 p90 38.32 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.454 -0.779 . . . . 0.0 110.035 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' GLN . 71.2 m-20 -127.39 91.9 44.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.03 -30.23 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.244 1.963 . . . . 0.0 112.402 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' N ' HE22 ' A' ' 62' ' ' GLN . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OE1' ' A' ' 62' ' ' GLN . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 84' ' ' GLY . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 92' ' ' ILE . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.497 ' O ' ' OG ' ' A' ' 118' ' ' SER . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 115' ' ' PHE . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.561 ' O ' ' CG2' ' A' ' 177' ' ' VAL . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.573 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.657 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.657 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.437 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.547 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.4 t -67.84 79.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 68.93 -48.3 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 179' ' ' CYS . 31.5 t -170.27 71.71 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 183' ' ' PRO . 1.9 t80 -71.66 122.53 87.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 45.5 Cg_endo -74.77 176.01 10.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.231 1.954 . . . . 0.0 112.112 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.72 2.96 34.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.69 -72.83 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -1.113 . . . . 0.0 108.725 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 187' ' ' PRO . 1.4 mptt -111.98 -25.19 0.13 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 110.943 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 186' ' ' LYS . 31.3 Cg_exo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.691 1.594 . . . . 0.0 112.089 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.902 H3A2 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.199 0.523 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -92.69 167.35 11.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.34 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -118.11 154.66 31.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 131.38 28.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.819 . . . . 0.0 110.043 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.01 -27.97 52.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.914 ' CZ2' H3A1 ' A' ' 189' ' ' ADK . 0.7 OUTLIER -85.35 -2.96 58.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.379 -1.071 . . . . 0.0 108.987 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER -95.42 -23.29 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.586 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -63.7 6.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 109.439 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.574 ' H ' ' C ' ' A' ' 7' ' ' VAL . 85.0 mt-30 -91.63 -168.37 2.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.4 153.42 1.33 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.4 -0.813 . . . . 0.0 109.869 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.19 -20.72 32.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.63 -37.56 76.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 109.875 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.994 ' OH ' H3A3 ' A' ' 189' ' ' ADK . 2.6 m-85 -67.05 -35.33 79.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.72 -36.68 67.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.586 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.14 -49.9 58.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.882 -1.136 . . . . 0.0 108.899 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 21' ' ' TRP . 19.6 t80 -63.79 -41.29 97.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 108.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -70.85 -42.07 70.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.683 -0.636 . . . . 0.0 110.8 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.87 -10.45 58.52 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 110.517 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 83.7 m-20 -80.02 -76.13 0.23 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.788 -1.195 . . . . 0.0 109.364 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 21' ' ' TRP . 95.6 mt-10 -146.88 -65.41 0.28 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 21' ' ' TRP . 8.3 t90 26.35 63.12 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.377 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 120.5 57.55 0.24 Allowed Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.829 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.748 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 p -176.49 -21.16 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 113.487 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.748 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 72.8 Cg_endo -89.24 150.89 5.55 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.612 1.541 . . . . 0.0 113.258 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.02 156.21 39.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.06 132.12 36.22 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.595 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.93 147.15 29.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -60.85 -35.62 77.03 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -75.26 -50.62 15.55 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.508 -0.745 . . . . 0.0 111.072 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -34.96 77.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.963 -1.086 . . . . 0.0 109.291 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.615 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 65.8 mt -63.29 -36.5 83.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.149 -0.969 . . . . 0.0 109.199 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.29 -43.0 92.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.61 -38.02 80.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.984 -1.072 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.2 tpp -63.3 -50.65 69.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.679 -0.638 . . . . 0.0 111.006 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.94 -27.08 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.228 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.8 t -71.02 -53.92 13.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 108.861 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.07 -38.91 92.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 108.512 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.572 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -67.5 -39.24 85.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 108.891 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.57 94.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.11 -4.89 43.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 109.661 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -78.15 2.82 16.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.116 . . . . 0.0 109.977 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -65.22 132.09 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.043 . . . . 0.0 109.093 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.15 -29.77 0.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 42' ' ' ALA . 79.7 mt -98.14 139.89 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.608 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.7 m -69.18 154.39 42.13 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.247 -0.908 . . . . 0.0 108.661 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.656 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 1.2 t-105 -55.15 -39.56 69.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.0 . . . . 0.0 109.841 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -37.64 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -0.956 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -57.98 -41.76 83.65 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.954 -1.091 . . . . 0.0 108.531 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -67.05 -31.65 54.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.809 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -48.59 81.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.088 -1.008 . . . . 0.0 109.939 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 53.1 mttt -62.21 -46.37 89.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.784 -1.197 . . . . 0.0 108.1 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.31 -16.44 61.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttm180 -63.69 -46.51 85.19 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -65.9 -45.41 82.09 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.2 m-80 -67.88 -43.09 80.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.654 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 89.8 t80 -60.44 -47.22 87.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 0.0 110.24 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.414 HH21 ' HE2' ' A' ' 61' ' ' HIS . 57.0 mtp180 -58.04 -34.2 69.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.042 -1.036 . . . . 0.0 109.837 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.77 95.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.896 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.6 m -72.98 -43.96 61.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.039 . . . . 0.0 111.079 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.654 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 84.9 m-85 -96.27 10.03 39.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.055 . . . . 0.0 110.906 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' HE2' HH21 ' A' ' 57' ' ' ARG . 0.0 OUTLIER -66.12 21.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.839 -1.163 . . . . 0.0 109.662 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 99.3 mm-40 -79.04 -34.78 43.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 91.2 m-85 -161.53 -104.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.0 m-20 154.23 -42.36 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 64' ' ' ASP . 50.9 Cg_endo -94.77 -108.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.657 2.238 . . . . 0.0 115.287 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -37.45 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.615 -1.303 . . . . 0.0 110.891 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -35.34 69.62 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.112 -0.993 . . . . 0.0 110.982 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 69' ' ' ALA . 3.7 m -73.94 -36.35 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.282 -1.511 . . . . 0.0 108.246 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' N ' HG23 ' A' ' 68' ' ' VAL . . . -60.39 -20.54 59.96 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.91 -11.3 36.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.552 ' CE ' ' OD2' ' A' ' 75' ' ' ASP . 4.1 mmm -75.57 119.86 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.564 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 7.0 tt0 -95.57 168.49 10.66 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 109.901 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 98.1 mt-10 -49.75 -25.74 3.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.955 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 108.076 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -70.13 -37.8 75.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.918 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.606 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 49.5 t -61.8 -44.06 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.63 -0.669 . . . . 0.0 110.749 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.69 -32.81 74.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 108.14 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -67.95 -42.88 80.27 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.605 0.716 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.6 -33.58 72.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 111.722 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.463 ' CG2' ' NH1' ' A' ' 89' ' ' ARG . 55.2 t -48.24 -31.28 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.892 -1.13 . . . . 0.0 108.527 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -100.43 -4.48 28.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.18 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 84' ' ' GLY . 57.5 t0 -88.22 109.32 19.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.763 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.34 -16.34 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.472 -0.768 . . . . 0.0 109.656 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.48 35.33 47.59 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.0 pt -54.8 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -1.109 . . . . 0.0 110.207 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -53.53 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' ILE . 59.8 mtp180 -53.19 106.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.407 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.53 92.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 89' ' ' ARG . 5.4 mtt-85 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.545 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.31 -59.32 7.98 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.229 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -61.42 -43.43 98.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.923 -1.339 . . . . 0.0 110.914 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.58 -49.15 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.0 110.529 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.89 65.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.83 -1.169 . . . . 0.0 109.019 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.56 94.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.174 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.61 -40.81 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.2 mp -58.18 -45.16 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.09 94.13 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -51.38 -44.09 62.06 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.054 -1.262 . . . . 0.0 108.965 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 102' ' ' TYR . . . -64.54 -39.93 94.67 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.274 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.97 -37.74 61.46 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.29 70.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' ALA . 42.0 t80 -63.43 -43.43 97.49 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.56 -34.76 78.52 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.2 -37.26 84.64 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.329 -0.949 . . . . 0.0 109.546 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 99.1 mmm -70.71 -41.69 71.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 108.339 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -58.75 -24.35 61.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.03 -12.56 28.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.96 24.03 74.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -120.52 101.83 45.8 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.358 -1.084 . . . . 0.0 109.584 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.88 150.23 73.17 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.145 1.897 . . . . 0.0 112.377 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 73.0 m-85 -58.05 -40.68 81.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.351 -0.843 . . . . 0.0 110.489 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.6 72.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.779 . . . . 0.0 112.442 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.93 -53.92 22.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 0.0 111.873 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 1.9 p90 -68.27 -40.93 81.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.006 -1.059 . . . . 0.0 111.658 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 14.7 p -64.88 -48.93 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 110.377 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 122' ' ' HIS . 10.9 m95 -55.14 -27.5 45.88 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.3 t -71.8 -36.49 70.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.44 -0.787 . . . . 0.0 110.598 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -66.72 -28.78 68.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.25 19.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 20.0 m120 64.11 44.02 4.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.7 -0.625 . . . . 0.0 110.222 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 44.94 12.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 110.527 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mt-30 -131.16 149.92 75.07 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.208 -0.933 . . . . 0.0 109.267 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HB2' HD22 ' A' ' 173' ' ' ASN . 32.8 Cg_endo -67.22 162.16 39.76 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.298 1.999 . . . . 0.0 111.722 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.65 135.39 49.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 109.673 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.2 mtt -90.31 116.45 28.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 109.093 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -89.89 111.4 22.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.209 -0.932 . . . . 0.0 109.1 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -92.51 17.53 9.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 109.286 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.07 141.9 57.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 134' ' ' GLU . 42.6 p -98.82 -11.37 21.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.669 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -145.34 160.09 42.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.29 -42.71 96.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -65.24 -31.78 73.11 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.494 ' OE1' ' OG1' ' A' ' 130' ' ' THR . 63.6 tt0 -80.85 1.47 30.56 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.597 -0.689 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.83 143.74 27.0 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 108.732 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.15 136.54 12.93 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.202 1.935 . . . . 0.0 112.414 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.3 p -107.17 2.99 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.019 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t -147.24 90.66 1.9 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.416 -0.802 . . . . 0.0 108.988 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.499 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 39.6 p -100.32 152.06 37.72 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.45 -36.6 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.582 1.521 . . . . 0.0 111.269 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -39.65 63.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.561 ' HG ' ' CE ' ' A' ' 166' ' ' MET . 68.5 m -66.42 -46.73 75.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.6 -38.88 82.43 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.029 -1.044 . . . . 0.0 109.154 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.38 63.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.512 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 2.8 tm? -59.47 -46.33 89.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.683 ' HG ' ' N ' ' A' ' 147' ' ' LYS . 0.8 OUTLIER -63.05 -46.14 88.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.478 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.683 ' N ' ' HG ' ' A' ' 146' ' ' SER . 30.1 mtpt -59.18 -37.91 78.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.752 -0.593 . . . . 0.0 109.614 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.07 68.6 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.286 -0.883 . . . . 0.0 109.854 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.81 -36.4 78.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.6 -39.95 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.088 . . . . 0.0 108.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -65.73 -33.58 76.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 3.7 mmp_? -71.4 3.08 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 109.202 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.1 26.11 38.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.66 116.25 30.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.475 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -92.06 174.47 7.3 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.562 0.696 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 58.78 58.76 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.572 0.701 . . . . 0.0 109.772 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.2 OUTLIER -126.75 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.53 150.5 0.36 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.1 m -53.17 -29.47 31.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.315 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -74.24 -35.51 63.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -66.33 -36.74 78.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -69.48 -38.37 77.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.041 . . . . 0.0 109.394 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.497 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.66 -46.8 74.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.509 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 95.0 p -65.19 -33.34 75.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 108.824 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.578 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 49.4 t80 -59.25 -46.07 89.48 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.614 -0.679 . . . . 0.0 109.679 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.561 ' CE ' ' HG ' ' A' ' 142' ' ' SER . 22.0 mtm -63.33 -38.0 89.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.525 HE22 ' CG2' ' A' ' 172' ' ' VAL . 84.0 mm-40 -60.44 -42.67 96.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.962 -1.086 . . . . 0.0 109.811 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.411 -0.806 . . . . 0.0 109.983 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 66.9 m -58.36 -31.11 67.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.928 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.08 0.44 44.74 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.33 -28.72 69.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.969 . . . . 0.0 109.777 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.525 ' CG2' HE22 ' A' ' 167' ' ' GLN . 21.6 t -112.94 147.83 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.038 . . . . 0.0 110.544 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -125.57 164.34 20.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.588 ' OD1' ' CZ ' ' A' ' 182' ' ' TYR . 2.2 m-20 76.58 70.39 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.665 -0.647 . . . . 0.0 110.457 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.424 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 22.0 m170 -47.24 -38.19 11.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 108.418 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 178' ' ' GLY . 3.5 p -166.04 18.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.403 ' CG2' ' C ' ' A' ' 176' ' ' VAL . 1.3 t 65.39 -44.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -83.48 29.6 3.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 182' ' ' TYR . 26.2 t -93.64 120.52 34.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.444 -1.033 . . . . 0.0 109.721 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.468 ' C ' ' H ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -46.17 -43.15 14.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.774 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -61.69 -3.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.588 ' CZ ' ' OD1' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -126.04 81.28 66.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.559 ' C ' ' H ' ' A' ' 185' ' ' ASN . 1.2 Cg_endo -77.74 -78.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.721 2.281 . . . . 0.0 111.885 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 54.73 4.45 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 183' ' ' PRO . 9.7 p30 -97.49 -13.11 21.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -1.137 . . . . 0.0 109.937 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -93.91 154.77 40.75 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.319 -0.863 . . . . 0.0 109.655 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 122.67 2.247 . . . . 0.0 112.108 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.994 H3A3 ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.02 142.92 33.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.204 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -83.7 168.11 16.58 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.256 -0.903 . . . . 0.0 109.702 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.14 147.76 52.85 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.439 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.16 96.14 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 121.669 -0.644 . . . . 0.0 112.045 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -87.73 -0.68 57.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.486 -1.596 . . . . 0.0 110.124 -179.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.21 -44.56 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.141 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m -76.59 7.07 4.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 108.756 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 7.4 tt0 -91.99 -116.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.467 -0.771 . . . . 0.0 109.745 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.5 m-20 -79.41 154.79 76.72 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 108.962 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' O ' ' N ' ' A' ' 13' ' ' TYR . 19.4 Cg_endo -65.16 -160.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.438 2.092 . . . . 0.0 111.88 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt 61.96 -39.47 0.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.472 -0.768 . . . . 0.0 110.004 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.7 m-85 -63.4 -39.13 93.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.23 -43.73 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.624 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.49 -51.09 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.424 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.448 ' HA ' HD21 ' A' ' 19' ' ' ASN . 1.2 t80 -61.36 -41.52 97.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 48.1 t-80 -70.53 -36.07 73.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.07 -5.04 58.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.081 -1.012 . . . . 0.0 111.008 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 85.5 m-20 -83.75 -77.01 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.692 -1.255 . . . . 0.0 110.492 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -153.18 55.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.956 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 6.7 t90 -103.07 73.65 1.25 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 152.4 -20.71 0.83 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.637 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.712 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 7.9 m -123.4 7.1 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.429 -1.042 . . . . 0.0 113.18 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 71.7 Cg_endo -76.51 149.75 31.1 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.592 1.528 . . . . 0.0 113.416 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -91.88 166.01 12.95 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.611 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 10.5 p -91.71 107.84 19.49 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.481 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 96.2 m-20 -84.69 168.58 15.12 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 m -76.99 -41.5 42.64 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.845 -1.16 . . . . 0.0 111.558 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' CD ' ' OH ' ' A' ' 102' ' ' TYR . 26.9 mmtp -76.19 -42.8 45.13 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 32.0 mmtm -58.46 -40.5 82.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.811 -1.18 . . . . 0.0 110.848 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.599 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.75 -40.26 79.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 109.712 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.09 -47.76 83.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.57 -40.06 73.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.915 -1.116 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.57 -52.51 63.11 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.0 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.52 -28.21 44.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.037 -1.039 . . . . 0.0 110.132 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.34 -46.85 66.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.014 -1.054 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 37' ' ' LEU . 4.6 mm? -69.29 -38.83 78.51 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 108.992 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.606 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 59.0 mm-40 -57.75 -36.29 71.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.414 -0.804 . . . . 0.0 109.253 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.7 -42.85 59.39 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' ALA . 62.6 tp60 -65.73 -32.56 74.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 0.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 40' ' ' GLN . 2.2 pp0? -41.89 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.005 -1.059 . . . . 0.0 109.688 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.98 -1.075 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.05 -35.62 2.55 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.309 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 4.0 mm? -95.7 144.39 26.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -1.214 . . . . 0.0 110.304 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.9 m -68.67 153.2 44.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 108.764 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CE3' ' C5 ' ' A' ' 189' ' ' ADK . 0.8 OUTLIER -62.07 -37.0 83.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.003 -1.061 . . . . 0.0 109.81 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -38.52 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.53 -1.356 . . . . 0.0 109.033 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.1 m -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.01 -40.84 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.673 . . . . 0.0 109.401 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.85 -45.68 85.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.779 -1.201 . . . . 0.0 109.11 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -64.41 -37.15 86.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 108.401 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -59.66 -37.27 78.28 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.663 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 77.3 mtt180 -59.39 -39.78 84.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.012 -1.055 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.96 -45.23 78.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.216 -1.552 . . . . 0.0 110.732 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.68 HD21 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -81.69 -39.86 23.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.861 -1.149 . . . . 0.0 110.476 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' N ' HD21 ' A' ' 55' ' ' ASN . 54.2 t80 -60.88 -47.0 88.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.899 -1.125 . . . . 0.0 109.477 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' ND1' ' A' ' 61' ' ' HIS . 21.3 mmm-85 -63.08 -33.87 76.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.117 -0.989 . . . . 0.0 108.829 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.38 70.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.8 m -75.04 -43.3 54.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.039 -1.038 . . . . 0.0 111.448 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -85.04 -1.99 57.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.083 . . . . 0.0 111.044 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.48 ' ND1' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -52.03 -51.8 55.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.99 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.5 -25.49 68.04 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -102.74 60.49 0.8 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.13 164.17 0.39 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.471 -0.768 . . . . 0.0 109.924 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.451 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 97.1 Cg_exo -31.55 -66.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 123.694 2.929 . . . . 0.0 114.011 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.39 -38.17 68.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.266 -1.521 . . . . 0.0 109.177 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -32.87 74.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.99 -1.069 . . . . 0.0 110.379 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.514 HG21 ' N ' ' A' ' 69' ' ' ALA . 20.5 m -63.83 -37.25 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.209 -1.557 . . . . 0.0 108.96 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' N ' HG21 ' A' ' 68' ' ' VAL . . . -58.6 -23.43 58.74 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.46 -9.04 36.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttm -77.8 121.34 23.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 20.6 pt20 -95.49 176.7 6.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.23 -35.63 77.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 41.1 tp10 -54.05 -45.72 71.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.936 -1.102 . . . . 0.0 108.198 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -64.37 -38.13 89.95 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.574 0.702 . . . . 0.0 109.141 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -38.64 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 110.183 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 3.7 pt-20 -72.93 -42.29 63.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.921 -1.112 . . . . 0.0 111.818 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -74.2 -38.18 63.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.691 -1.256 . . . . 0.0 110.417 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.514 ' CD1' ' C ' ' A' ' 79' ' ' LEU . 0.4 OUTLIER -67.11 -32.3 73.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.985 . . . . 0.0 109.829 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -49.71 -24.75 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -85.64 -6.66 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.132 -0.98 . . . . 0.0 108.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' GLY . 97.1 m-20 -77.97 108.13 11.01 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.509 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 69.63 -15.49 0.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.698 . . . . 0.0 109.839 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.4 34.67 57.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.652 ' O ' ' N ' ' A' ' 87' ' ' ARG . 21.9 pt -46.3 176.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.432 -1.04 . . . . 0.0 109.41 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.5 tt -52.29 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 85' ' ' ILE . 9.3 ptp180 -54.07 133.33 43.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.863 0.839 . . . . 0.0 110.342 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 4.0 m-70 175.15 65.94 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -46.05 -29.33 1.45 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 110.09 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.35 -61.06 5.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.01 -38.38 85.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.99 -44.43 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 110.043 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -57.69 -32.35 67.27 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.9 -1.125 . . . . 0.0 108.767 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.75 -37.7 82.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 0.0 109.437 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.1 -32.22 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.7 mm -59.12 -43.97 90.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 108.245 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.23 -29.86 76.34 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -58.62 -43.44 89.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.061 -1.258 . . . . 0.0 109.235 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.55 94.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.86 -1.15 . . . . 0.0 109.449 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.29 -35.53 69.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.898 -1.126 . . . . 0.0 108.939 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.32 -28.89 64.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.048 -1.033 . . . . 0.0 108.398 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' CD ' ' A' ' 29' ' ' LYS . 80.8 t80 -64.33 -43.22 95.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.05 -32.95 74.92 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.561 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 14.5 mm100 -59.4 -39.28 82.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.811 -1.155 . . . . 0.0 108.753 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.525 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 97.6 mmm -67.6 -40.27 84.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.996 -1.065 . . . . 0.0 109.049 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 75.9 mm-40 -72.06 -42.24 66.47 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.413 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -57.71 -25.17 59.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.561 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 17.0 m120 -92.62 -10.08 38.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 67.69 23.64 73.96 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -116.53 105.07 50.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.142 -1.211 . . . . 0.0 109.934 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -56.18 152.28 38.92 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.35 2.034 . . . . 0.0 113.01 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 25.5 m-85 -62.42 -38.94 91.63 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.774 0.797 . . . . 0.0 110.706 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.62 -35.48 79.7 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.535 -0.728 . . . . 0.0 111.724 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.46 -43.42 98.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.3 p90 -74.93 -43.99 51.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.321 -1.487 . . . . 0.0 111.01 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.475 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 14.9 m -58.43 -49.38 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 120.073 -1.642 . . . . 0.0 109.053 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.611 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.2 m95 -55.94 -27.41 52.27 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.12 -0.988 . . . . 0.0 108.629 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m -70.58 -41.49 72.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.238 -0.914 . . . . 0.0 111.103 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.457 ' CD1' ' CB ' ' A' ' 144' ' ' ALA . 30.9 m-85 -67.02 -30.31 70.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.767 -1.208 . . . . 0.0 110.377 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.85 15.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 109.597 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.408 HD21 ' HG3' ' A' ' 123' ' ' GLN . 5.2 t30 59.89 36.08 21.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.84 . . . . 0.0 110.371 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 47.38 29.9 1.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -0.992 . . . . 0.0 109.821 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.408 ' HG3' HD21 ' A' ' 121' ' ' ASN . 2.6 mm-40 -131.94 148.33 69.43 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.092 -1.005 . . . . 0.0 109.881 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.82 149.37 86.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.51 2.14 . . . . 0.0 111.959 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 126' ' ' MET . 4.2 tm0? -115.34 139.49 49.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.0 109.835 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.555 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.1 mpp? -100.54 118.3 36.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.142 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.413 HG21 ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -72.14 -35.47 69.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 109.21 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 54.4 41.09 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.126 -0.984 . . . . 0.0 109.837 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -102.53 145.58 29.39 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.47 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.4 p -106.96 -29.55 9.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.696 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -134.77 165.67 24.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.658 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.87 -31.99 67.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.494 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -72.79 -10.96 60.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 109.577 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -100.92 10.74 40.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.33 111.91 60.92 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.92 142.86 28.62 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.729 1.619 . . . . 0.0 111.779 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 48.6 p -110.99 7.57 21.63 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -135.14 95.48 3.31 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -116.58 154.42 49.16 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.92 -38.6 86.23 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.719 1.613 . . . . 0.0 111.488 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.27 -43.12 64.76 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.531 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 143' ' ' ASP . 85.8 p -62.73 -39.03 92.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 108.651 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.583 ' N ' ' HG ' ' A' ' 142' ' ' SER . 27.5 t70 -61.57 -37.55 84.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 119' ' ' PHE . . . -66.51 -39.04 88.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.721 -0.612 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.62 -40.07 92.18 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.998 -1.064 . . . . 0.0 109.517 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.584 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 14.5 m -59.85 -47.37 86.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.707 -1.246 . . . . 0.0 110.44 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -74.02 -38.03 64.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.867 -1.145 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.53 -43.19 70.08 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.558 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.03 -43.15 79.41 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.19 -0.944 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -64.33 -39.92 94.85 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.863 -1.148 . . . . 0.0 109.727 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -70.18 -26.37 63.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.673 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -76.23 1.85 14.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.056 -1.028 . . . . 0.0 108.38 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.06 26.94 29.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.77 116.03 31.56 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.768 -0.842 . . . . 0.0 108.811 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.12 171.12 9.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 56.47 61.22 2.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 0.0 108.938 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.89 40.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.45 173.72 0.04 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.5 m -59.17 -31.13 68.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.905 -0.762 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 50.4 p -72.36 -34.78 68.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 108.74 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.26 -44.34 97.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 108.813 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.584 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 87.7 m -62.71 -43.98 97.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.76 -44.93 76.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.897 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.522 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 15.9 m -59.62 -41.57 90.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 109.441 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 3.3 t80 -59.56 -47.29 86.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 109.767 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 76.1 mtp -63.42 -32.71 74.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.29 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -44.98 88.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 110.785 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 111.731 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -55.48 -23.61 26.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.95 -1.094 . . . . 0.0 110.441 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.91 -2.16 59.91 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.7 mt -62.79 -27.94 69.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.542 -0.975 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.85 133.07 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.117 -0.989 . . . . 0.0 109.46 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 19.3 m-80 -108.7 163.07 13.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.428 -0.795 . . . . 0.0 109.645 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 85.49 69.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.787 -0.57 . . . . 0.0 110.982 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.434 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 3.4 m170 -55.69 -48.99 74.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 0.0 108.945 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 177' ' ' VAL . 5.7 m -139.33 30.19 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 109.588 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 176' ' ' VAL . 37.5 t 52.58 105.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.524 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . 83.74 45.0 6.57 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 145.19 24.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.33 . . . . 0.0 108.677 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 94.3 m -51.53 -47.72 63.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.391 -0.818 . . . . 0.0 111.969 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 17' ' ' HIS . 72.5 m -77.71 11.83 1.94 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.775 -1.203 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.589 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -126.32 80.36 69.03 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.451 -0.781 . . . . 0.0 110.182 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 185' ' ' ASN . 47.9 Cg_endo -87.13 -73.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 123.241 2.628 . . . . 0.0 111.505 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.87 -49.29 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 183' ' ' PRO . 18.2 m120 -107.57 -75.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -1.07 . . . . 0.0 109.201 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -76.24 150.05 82.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 C-N-CA 122.569 2.179 . . . . 0.0 112.321 -179.793 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.956 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.25 146.33 28.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.861 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -63.32 161.28 14.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.435 -0.791 . . . . 0.0 110.406 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.78 154.07 26.76 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.696 0.76 . . . . 0.0 109.508 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -52.85 -47.96 58.14 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.682 -0.636 . . . . 0.0 112.413 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.881 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.12 -0.52 57.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.433 -1.628 . . . . 0.0 110.496 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG21 ' CG ' ' A' ' 17' ' ' HIS . 7.6 t -77.0 -41.03 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.858 -1.152 . . . . 0.0 109.241 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -71.7 -4.66 28.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 68.9 tp60 -60.62 -42.97 97.93 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.881 -0.512 . . . . 0.0 110.38 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -161.76 159.35 22.52 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.672 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.29 -35.39 62.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.81 2.34 . . . . 0.0 112.483 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.5 mt -61.83 -39.59 92.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.31 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.737 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.2 OUTLIER -64.48 -40.59 95.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.408 -0.807 . . . . 0.0 109.252 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.4 mt -56.77 -40.01 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.11 76.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.835 -1.166 . . . . 0.0 109.587 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 2.0 t80 -65.68 -40.14 92.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.778 . . . . 0.0 110.17 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 7' ' ' VAL . 47.4 t-80 -73.58 -35.53 65.44 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 110.791 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -80.51 -8.72 59.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.168 -0.957 . . . . 0.0 111.775 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 2.9 p30 -84.14 -58.0 2.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.52 -1.362 . . . . 0.0 110.849 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.2 mt-10 -148.69 -54.07 0.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.492 -1.38 . . . . 0.0 109.666 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.951 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 5.8 t90 2.24 66.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.592 0.711 . . . . 0.0 111.607 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 148.63 -21.35 1.32 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.286 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.6 m -119.31 3.09 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.623 0 O-C-N 121.62 -0.929 . . . . 0.0 112.814 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 84.7 Cg_endo -79.93 150.68 21.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.468 1.445 . . . . 0.0 112.837 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -97.98 168.41 10.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 36.8 p -91.8 118.0 30.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.708 -1.245 . . . . 0.0 110.29 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -108.06 144.47 35.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.9 m -59.99 -35.94 76.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.882 -1.136 . . . . 0.0 109.027 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.62 -50.2 22.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.689 -0.632 . . . . 0.0 110.316 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -27.31 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.84 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -66.86 -36.99 83.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.017 -1.052 . . . . 0.0 109.214 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.8 t80 -64.77 -48.43 74.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.62 -32.09 65.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.757 -1.214 . . . . 0.0 109.11 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -48.82 63.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.633 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.23 -27.8 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.423 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 97.9 m -69.19 -50.05 50.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.185 -0.947 . . . . 0.0 109.898 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.4 mt -67.95 -37.4 81.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.087 -1.008 . . . . 0.0 108.927 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.697 ' HE2' HN61 ' A' ' 189' ' ' ADK . 4.6 tp10 -66.88 -39.15 87.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.623 -0.673 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.44 -35.86 92.31 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -72.23 -6.46 43.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -1.202 . . . . 0.0 109.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -77.04 -1.98 31.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -69.07 121.56 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 108.851 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.58 -31.83 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 42' ' ' ALA . 30.2 mt -101.48 144.09 30.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.117 . . . . 0.0 109.838 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -69.49 156.25 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.663 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.5 OUTLIER -56.99 -36.5 70.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.173 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -35.49 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.5 m -59.24 -41.83 89.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.868 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -68.0 -32.56 56.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.132 -0.98 . . . . 0.0 109.492 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.94 -43.97 94.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.183 -0.948 . . . . 0.0 110.354 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.89 75.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 14.6 mtmm -78.89 -7.4 57.92 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.323 -0.861 . . . . 0.0 109.295 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.2 ttm180 -65.68 -46.86 77.49 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.7 -45.99 67.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.978 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -66.25 -43.16 87.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.537 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 68.9 t80 -59.79 -45.47 92.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.872 . . . . 0.0 110.94 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -61.76 -29.5 70.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.828 -1.17 . . . . 0.0 108.986 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -66.36 -36.21 82.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.95 -45.22 78.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.827 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 44.8 m-85 -83.26 -43.03 16.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.596 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 64.81 -47.84 0.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 109.928 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 26.0 mt-30 -74.88 -34.13 62.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' HIS . 23.1 p90 40.86 21.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.239 -0.913 . . . . 0.0 110.525 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' GLN . 8.7 m-20 -92.54 144.55 28.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 108.991 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.25 -51.0 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.514 2.143 . . . . 0.0 113.455 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -61.52 -45.93 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.917 -1.115 . . . . 0.0 110.156 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.14 -37.8 86.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.403 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 64' ' ' ASP . 56.1 t -63.63 -36.91 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -65.1 -18.94 65.72 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.84 -7.88 57.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.3 mtp -82.99 113.15 20.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -95.88 177.59 5.72 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 98.3 mt-10 -55.29 -31.78 61.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.224 -0.922 . . . . 0.0 110.879 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 -45.08 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 108.237 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -64.27 -38.67 91.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.23 -42.7 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.423 -0.798 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.6 -44.22 89.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.519 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 2.4 ptp180 -75.78 -33.62 60.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.857 -1.152 . . . . 0.0 110.001 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -61.6 -32.83 72.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.299 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.6 t -49.3 -34.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 108.662 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.84 -1.02 30.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 55.6 t0 -80.7 108.82 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.447 -1.408 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 76.27 -12.21 1.05 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.438 -0.788 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 77.07 33.29 45.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt -57.47 -166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -1.213 . . . . 0.0 109.332 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.01 95.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.155 -0.965 . . . . 0.0 109.129 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.649 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -57.66 109.65 0.75 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.714 0.769 . . . . 0.0 109.34 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 1.8 m80 -178.14 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -50.32 -31.59 14.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.318 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.71 -62.52 6.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -64.52 -40.82 96.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.785 -1.42 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.17 -48.91 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.085 -1.01 . . . . 0.0 110.449 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.56 -29.22 66.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.661 -1.275 . . . . 0.0 108.953 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' N ' ' HG3' ' A' ' 93' ' ' GLN . . . -64.3 -37.59 88.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.45 -40.16 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.93 -43.01 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 108.76 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.93 -35.91 88.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.12 -37.03 76.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -1.118 . . . . 0.0 109.163 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.91 87.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.981 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 27.8 mmt180 -60.62 -38.16 83.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.093 -1.004 . . . . 0.0 109.446 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.84 71.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 108.593 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.53 -43.74 96.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.62 -32.66 74.21 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.22 -35.11 79.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.305 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.59 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.1 tpp -63.8 -43.6 95.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.492 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -37.02 78.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.24 -24.71 66.56 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.1 m120 -93.21 -15.05 26.35 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.91 27.17 73.71 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.442 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' A' ' 105' ' ' MET . 2.0 tt0 -121.52 102.21 42.55 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.136 -1.214 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.53 141.6 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.933 1.755 . . . . 0.0 112.641 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -56.08 -38.76 71.11 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.229 1.014 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.36 -27.76 66.53 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.708 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -68.09 -48.44 65.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.095 . . . . 0.0 111.969 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.2 p90 -70.8 -37.37 73.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.763 -1.211 . . . . 0.0 110.943 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.29 -49.05 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.382 -1.449 . . . . 0.0 109.956 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.635 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 26.4 m95 -56.56 -27.1 56.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.2 t -75.73 -36.69 59.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.253 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.2 -26.02 65.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.965 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.64 19.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.717 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 69.28 35.93 2.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.765 . . . . 0.0 110.557 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 117' ' ' TRP . 1.1 t-80 45.01 30.23 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.393 -0.817 . . . . 0.0 111.344 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.66 147.99 20.04 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.637 -1.29 . . . . 0.0 110.134 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.05 148.6 85.72 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.613 2.209 . . . . 0.0 111.93 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.59 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -122.06 128.37 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.59 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.2 mtt -103.35 120.73 41.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -87.73 -26.43 22.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.439 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 57.03 45.35 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 177' ' ' VAL . . . -66.77 149.4 50.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.3 p -102.9 -25.1 13.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.051 -1.031 . . . . 0.0 109.412 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 p -136.17 162.66 32.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.158 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.31 -37.04 79.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 108.945 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.2 m -62.75 -31.42 72.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.372 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -75.19 -0.66 20.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 110.081 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.6 tp -76.46 125.57 87.35 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.999 -1.063 . . . . 0.0 108.314 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 163' ' ' TYR . 55.9 Cg_endo -74.94 136.4 20.48 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.926 1.75 . . . . 0.0 112.454 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.5 p -114.37 6.53 16.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.0 t -152.16 88.28 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.432 -0.792 . . . . 0.0 109.448 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.518 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.7 OUTLIER -102.43 155.4 36.55 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.74 -38.96 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.727 1.618 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.52 -42.06 59.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 139' ' ' THR . 88.2 p -65.86 -39.03 90.35 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.525 -0.735 . . . . 0.0 109.443 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.31 -44.77 86.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.195 -0.941 . . . . 0.0 109.144 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.08 74.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -43.78 75.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.656 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.96 -39.29 83.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.168 -0.957 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.45 -43.79 88.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 110.389 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.98 74.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.43 -38.05 89.66 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.88 -40.24 94.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.971 -1.081 . . . . 0.0 110.242 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 153' ' ' GLY . 18.4 mttp -65.28 -38.56 90.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 111.641 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -71.27 9.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 0.0 110.085 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 76.04 26.14 65.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.97 112.61 24.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -93.1 176.62 6.34 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 57.58 54.9 6.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.451 -0.781 . . . . 0.0 109.2 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.16 38.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.57 164.36 0.52 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.9 m -53.98 -34.42 59.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.499 -1.001 . . . . 0.0 109.431 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 m -68.62 -37.25 79.58 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.1 -44.31 98.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.656 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.1 m -58.05 -51.56 69.17 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -71.66 -37.88 70.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 0.0 111.733 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.496 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 13.4 m -59.12 -40.73 86.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 111.131 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.574 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.4 OUTLIER -78.36 -35.47 47.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 110.569 -179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.4 mtp -57.92 -36.15 72.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.657 -1.277 . . . . 0.0 109.291 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.66 -42.42 98.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.34 -37.8 22.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.536 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -26.12 48.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.273 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.54 -2.39 57.38 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -37.36 73.74 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.243 -1.151 . . . . 0.0 108.753 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 0.9 OUTLIER -137.2 129.66 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 109.063 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.457 ' C ' ' CG ' ' A' ' 174' ' ' ASP . 37.9 t-20 -104.98 125.23 50.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.371 -0.831 . . . . 0.0 108.878 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -178.98 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.895 -1.128 . . . . 0.0 111.587 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.501 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 3.2 m170 -48.96 -52.12 26.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.97 -1.706 . . . . 0.0 107.13 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 p 178.03 150.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 129' ' ' ALA . 27.6 t -62.21 135.37 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.893 -1.129 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 81.76 38.85 12.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.591 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -95.45 107.04 19.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -1.221 . . . . 0.0 109.971 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.576 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER 63.87 -55.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 179' ' ' CYS . 94.4 m -157.47 13.76 0.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.89 . . . . 0.0 110.384 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.408 ' HB3' ' H ' ' A' ' 178' ' ' GLY . 1.0 OUTLIER -65.14 119.3 57.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.8 -1.188 . . . . 0.0 108.937 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -75.45 150.3 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 112.498 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 149.59 -26.27 1.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -86.49 6.59 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 109.824 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -79.79 154.26 75.67 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.212 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.307 -1.633 0 C-N-CA 122.556 2.17 . . . . 0.0 112.203 179.902 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.951 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 1.9 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.592 ' H ' ' CG ' ' A' ' 1' ' ' MET . 82.8 tt0 -99.21 144.23 28.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 4' ' ' CYS . 26.9 ttm180 -68.99 170.26 10.16 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 3' ' ' ARG . 4.3 m -42.35 149.3 0.17 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -0.865 . . . . 0.0 109.248 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.29 -33.58 61.59 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 121.153 -0.967 . . . . 0.0 112.75 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.813 ' CZ3' H3A1 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -85.56 2.1 46.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.298 -1.707 . . . . 0.0 111.759 -177.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.57 -45.24 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 109.971 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -65.25 -17.43 64.49 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -65.43 -40.68 93.6 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.873 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.18 163.21 24.3 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.933 . . . . 0.0 109.845 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 13' ' ' TYR . 35.7 Cg_endo -68.92 -161.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.943 2.429 . . . . 0.0 112.51 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mt 62.54 -54.86 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.774 -0.579 . . . . 0.0 109.555 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.86 ' HH ' H3A3 ' A' ' 189' ' ' ADK . 0.3 OUTLIER -57.15 -45.76 83.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.279 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 HH12 ' A' ' 3' ' ' ARG . 85.9 mt -54.68 -42.86 63.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.733 -0.605 . . . . 0.0 110.585 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.13 98.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.711 -1.243 . . . . 0.0 108.419 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.658 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.0 t80 -71.67 -31.47 66.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.623 0.725 . . . . 0.0 110.001 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -64.14 -44.68 91.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 112.382 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.69 -4.52 37.1 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.717 -1.239 . . . . 0.0 112.815 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.743 HD21 ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -96.01 -15.68 22.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.462 -1.399 . . . . 0.0 112.243 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.743 ' N ' HD21 ' A' ' 19' ' ' ASN . 14.0 pt-20 177.07 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.728 -1.232 . . . . 0.0 109.276 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.935 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 4.8 t90 -131.88 83.52 2.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.186 0.993 . . . . 0.0 108.887 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.3 -20.31 11.33 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.701 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 28.9 m -110.71 -12.38 0.12 Allowed Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 112.957 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 75.5 Cg_endo -80.05 150.68 20.68 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.358 1.372 . . . . 0.0 114.122 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -96.18 159.75 14.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.639 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 1.7 p -86.72 111.48 20.74 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.566 -1.334 . . . . 0.0 110.886 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 70.1 m-20 -94.24 156.73 16.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -67.4 -39.71 85.59 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.565 -1.334 . . . . 0.0 110.282 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -75.19 -50.12 17.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 111.804 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -61.3 -30.1 70.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.589 -1.319 . . . . 0.0 109.19 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 4.7 mp -57.14 -39.56 75.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.092 -1.005 . . . . 0.0 108.45 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.572 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 63.2 t80 -63.25 -45.46 91.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.467 -0.771 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -67.45 -40.69 85.42 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.827 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.4 tpp -65.07 -52.55 54.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.451 -0.781 . . . . 0.0 110.223 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.75 -27.17 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 109.03 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 47.7 m -70.57 -52.4 21.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.3 mt -66.79 -39.23 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 108.764 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' OE2' ' CB ' ' A' ' 164' ' ' SER . 13.3 tp10 -64.19 -37.72 88.49 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.642 -0.661 . . . . 0.0 109.865 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.51 -33.14 70.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 25.6 mm-40 -81.71 -1.45 47.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.514 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -78.78 -2.25 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.015 . . . . 0.0 109.323 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.71 113.84 10.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 -34.63 3.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -95.62 145.43 25.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -1.095 . . . . 0.0 109.63 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -71.97 152.88 42.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 109.203 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.664 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 2.5 t-105 -59.64 -28.9 67.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 110.161 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -29.36 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.564 -1.335 . . . . 0.0 109.487 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 m -68.54 -44.04 75.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.112 -0.992 . . . . 0.0 108.829 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.69 -26.08 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -54.98 -43.94 74.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -37.04 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.12 -36.88 85.08 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -57.93 -46.53 84.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.803 -0.561 . . . . 0.0 111.769 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 55' ' ' ASN . 15.2 pt-20 -72.5 -44.32 62.4 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.787 -1.196 . . . . 0.0 110.727 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.711 HD21 ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -73.06 -32.17 64.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.746 -1.221 . . . . 0.0 109.396 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.711 ' N ' HD21 ' A' ' 55' ' ' ASN . 71.4 t80 -58.57 -46.5 86.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 109.525 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 61' ' ' HIS . 13.4 ptm180 -65.05 -32.13 73.7 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.014 -1.075 . . . . 0.0 109.034 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.15 99.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.863 -1.148 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.4 m -77.49 -44.6 28.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 109.675 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.659 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 96.8 m-85 -94.67 19.76 9.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.53 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 t60 -41.03 -15.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.562 -0.711 . . . . 0.0 110.519 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 60' ' ' PHE . 95.3 mt-30 -51.09 -31.33 18.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.848 -1.157 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 51.04 27.27 3.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.697 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -125.07 92.49 47.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.195 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.43 -34.68 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.527 2.151 . . . . 0.0 112.667 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.63 -43.24 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.606 -1.309 . . . . 0.0 108.302 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.6 t -60.7 -38.72 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 108.825 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.37 -14.53 63.01 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.5 -12.37 29.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 90.8 mtp -76.74 110.31 11.23 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.549 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -96.8 -174.75 3.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.408 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -55.38 -30.59 60.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.813 -0.554 . . . . 0.0 110.791 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.0 pt-20 -60.6 -42.22 96.32 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.119 -1.613 . . . . 0.0 109.452 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' CG ' ' A' ' 74' ' ' GLU . 90.3 m-20 -66.92 -38.92 87.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -36.22 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.838 -1.164 . . . . 0.0 109.71 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -59.36 -36.31 75.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.712 -1.242 . . . . 0.0 107.794 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HG3' HH11 ' A' ' 78' ' ' ARG . 24.4 ttm-85 -70.32 -42.03 72.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.568 -0.708 . . . . 0.0 110.304 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLN . 94.3 mt -69.76 -34.66 74.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.423 -0.798 . . . . 0.0 112.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.9 m -50.1 -16.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.521 -1.362 . . . . 0.0 108.868 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' LEU . 23.0 pt20 -120.87 -4.43 9.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.203 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 56.2 t0 -81.5 109.58 16.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.691 -1.256 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 75.6 -17.02 0.54 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.456 -0.778 . . . . 0.0 109.3 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 80.47 32.36 34.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 87' ' ' ARG . 15.5 pt -54.48 -179.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.02 -1.282 . . . . 0.0 109.332 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 12.4 tt -60.82 89.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.587 ' O ' ' CD2' ' A' ' 88' ' ' HIS . 6.2 ptp180 -56.06 144.24 29.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 111.115 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 159.14 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 89' ' ' ARG . 1.1 mtt-85 -51.02 -38.07 49.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.424 -0.797 . . . . 0.0 108.941 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.13 -49.19 59.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.34 -45.08 94.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -1.133 . . . . 0.0 110.056 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.75 -44.12 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.069 -1.019 . . . . 0.0 109.726 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.616 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 44.5 mt-30 -54.64 -34.05 61.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.862 -1.149 . . . . 0.0 108.995 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.65 99.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.59 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.1 mm -61.93 -39.15 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 109.115 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.3 mm -59.67 -43.1 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 108.912 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.44 -32.86 85.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.52 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 m120 -61.2 -41.44 96.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.157 . . . . 0.0 109.842 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.91 98.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -62.49 -40.21 95.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.253 -0.904 . . . . 0.0 109.269 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 152' ' ' ARG . . . -63.4 -34.58 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.35 -43.12 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.0 -33.2 75.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -62.91 -37.44 86.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 109.583 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 24.0 ttm -62.86 -40.89 98.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.994 -1.066 . . . . 0.0 108.447 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.04 -35.27 79.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -64.88 -20.96 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -92.28 -17.63 24.49 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.76 73.61 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.35 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.583 ' O ' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -116.92 107.37 46.12 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.88 144.47 15.17 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.83 1.687 . . . . 0.0 112.637 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.59 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -61.65 -44.52 96.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.893 0.854 . . . . 0.0 109.917 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.29 -27.68 62.62 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.019 -1.051 . . . . 0.0 111.192 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -62.85 -49.01 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.835 -1.166 . . . . 0.0 111.118 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 4.2 p90 -72.04 -34.4 68.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.816 -1.178 . . . . 0.0 110.022 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.3 t -63.05 -54.86 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.749 -1.219 . . . . 0.0 109.87 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.639 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 57.5 m95 -59.32 -22.2 60.89 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.072 -1.017 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -66.68 -45.05 80.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 110.406 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -67.92 -29.14 68.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.094 -1.004 . . . . 0.0 109.918 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 t -87.26 18.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.525 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 123' ' ' GLN . 75.4 m-20 60.86 39.76 16.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.436 0.636 . . . . 0.0 110.007 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 42.05 25.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.404 -0.81 . . . . 0.0 110.536 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -145.66 148.28 36.02 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 120.933 -1.104 . . . . 0.0 109.511 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 19.1 Cg_endo -62.98 146.8 94.94 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.278 1.986 . . . . 0.0 111.434 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -103.59 137.63 41.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.6 mtt -93.02 120.01 32.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.26 120.37 29.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -91.0 16.63 9.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.03 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 136.49 49.31 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.7 p -99.07 -22.21 15.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.544 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 p -136.41 165.6 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -0.931 . . . . 0.0 109.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.1 mt -59.26 -34.39 72.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.046 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.3 m -69.79 -11.96 61.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -0.792 . . . . 0.0 109.697 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.09 6.44 47.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 mm -97.3 118.09 64.89 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.23 137.95 19.64 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.943 1.762 . . . . 0.0 112.227 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.2 p -95.71 4.21 53.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.6 t -137.8 95.3 3.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.4 p -109.27 150.83 41.58 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.35 -36.03 77.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.579 1.519 . . . . 0.0 111.432 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.15 -43.23 58.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.248 -0.908 . . . . 0.0 108.858 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 95.6 p -65.16 -39.9 93.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.9 -37.59 85.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.26 86.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 109.91 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.62 -46.42 87.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.017 -1.052 . . . . 0.0 109.054 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.6 t -62.1 -43.18 99.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 110.149 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -62.52 -45.43 93.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.45 -44.73 67.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.99 -36.67 80.39 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.245 -0.91 . . . . 0.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -60.45 -38.65 84.85 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.705 -1.247 . . . . 0.0 108.581 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.73 -19.94 54.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.545 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -78.97 0.9 25.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.119 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.42 26.64 32.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.52 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 1.3 m-85 -101.11 113.51 26.6 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.38 -1.071 . . . . 0.0 109.575 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -91.81 173.9 7.62 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 55.73 45.27 24.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.089 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.478 ' O ' ' CG1' ' A' ' 157' ' ' VAL . 9.3 p -132.09 49.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.42 177.1 6.07 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.578 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 54.9 m -58.6 -32.67 69.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.588 -0.948 . . . . 0.0 110.178 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.6 p -72.82 -28.25 62.44 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.917 -1.114 . . . . 0.0 109.061 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.2 mm -68.03 -45.31 83.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 110.152 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 159' ' ' THR . 3.1 p -65.89 -36.87 84.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.734 ' HH ' HE22 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -66.09 -45.97 79.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.454 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.4 m -61.98 -39.1 91.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.075 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -59.2 -41.09 87.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.082 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 73.2 mtp -62.51 -39.75 94.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 111.413 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.734 HE22 ' HH ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -74.29 -39.21 63.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.823 -1.173 . . . . 0.0 111.455 -178.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.423 ' N ' ' HG2' ' A' ' 167' ' ' GLN . . . -79.22 -40.2 31.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 110.889 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.677 ' HG ' ' H ' ' A' ' 171' ' ' LEU . 21.6 p -60.51 -28.77 68.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.99 2.57 42.27 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.677 ' H ' ' HG ' ' A' ' 169' ' ' CYS . 35.1 mt -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.74 143.32 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.209 -0.932 . . . . 0.0 109.583 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 34.7 m120 -111.41 163.54 13.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.437 -0.79 . . . . 0.0 110.205 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.1 OUTLIER 83.28 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.242 0.544 . . . . 0.0 109.947 179.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -50.95 -44.47 60.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 108.7 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.677 ' C ' ' H ' ' A' ' 178' ' ' GLY . 30.6 m -149.5 28.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.412 -0.805 . . . . 0.0 109.624 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.2 t 60.56 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.415 -0.803 . . . . 0.0 110.409 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -137.3 60.05 0.62 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 181' ' ' CYS . 6.3 t -96.77 114.09 25.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -1.128 . . . . 0.0 110.107 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 64.03 -57.37 0.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 109.715 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.56 ' N ' ' O ' ' A' ' 179' ' ' CYS . 42.2 t -176.71 59.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.39 123.53 71.17 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 184' ' ' GLY . 60.0 Cg_endo -77.52 -83.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.998 1.799 . . . . 0.0 112.071 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.421 ' H ' ' HG2' ' A' ' 183' ' ' PRO . . . 88.71 -27.86 6.89 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.74 -3.82 59.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.731 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.24 156.24 40.3 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.133 -0.979 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--N 1.305 -1.73 0 C-N-CA 122.443 2.095 . . . . 0.0 111.941 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.935 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.3 151.56 22.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.171 -0.956 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 3' ' ' ARG . 28.3 mtm-85 -70.36 177.7 3.24 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.523 0.678 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.45 141.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.558 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.19 94.91 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.543 -0.723 . . . . 0.0 112.097 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.93 ' CZ3' H3A2 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -84.55 1.32 46.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.642 -1.504 . . . . 0.0 109.887 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.81 -50.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -67.99 -3.82 11.25 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.86 -39.31 94.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.404 0.621 . . . . 0.0 109.587 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -174.01 158.47 2.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.41 -0.807 . . . . 0.0 109.208 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' TYR . 12.0 Cg_endo -57.46 -161.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.478 2.119 . . . . 0.0 111.742 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -52.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 11' ' ' PRO . 14.1 m-85 -60.38 -31.66 70.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.131 -0.98 . . . . 0.0 108.893 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 mm -56.26 -40.33 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.98 -50.47 28.49 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.182 -0.949 . . . . 0.0 109.82 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 42.7 t80 -63.13 -40.78 98.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 110.579 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -60.28 -43.9 95.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.035 -1.041 . . . . 0.0 109.835 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -82.09 -14.48 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.419 -0.801 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.767 ' ND2' ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -79.28 -57.18 3.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.528 -1.357 . . . . 0.0 110.597 -178.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.767 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 2.2 pt-20 -175.45 78.82 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.596 -1.315 . . . . 0.0 110.03 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CZ3' ' NE1' ' A' ' 6' ' ' TRP . 7.7 t90 -100.77 68.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.01 -1.056 . . . . 0.0 108.523 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.55 9.75 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.662 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 96.9 t -111.01 -30.88 0.14 Allowed Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.649 -0.912 . . . . 0.0 111.927 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 67.7 Cg_endo -86.17 154.07 9.58 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.543 2.162 . . . . 0.0 113.539 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -65.93 170.5 5.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.594 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 4.8 p -92.13 124.6 36.34 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.811 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -102.48 149.13 24.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -65.07 -38.8 91.98 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.825 -1.172 . . . . 0.0 110.576 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HZ2' ' CB ' ' A' ' 29' ' ' LYS . 7.0 mtmp? -72.87 -50.71 22.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 111.61 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -63.34 -33.37 75.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.647 -1.283 . . . . 0.0 109.496 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.3 -39.13 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.267 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -59.29 -41.79 89.77 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.106 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CD ' ' NH2' ' A' ' 57' ' ' ARG . 40.5 mt-10 -71.68 -36.26 70.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.114 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.424 ' SD ' ' CB ' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -64.99 -47.15 78.56 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 111.377 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -65.98 -36.12 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.733 -1.23 . . . . 0.0 110.038 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m -70.17 -38.81 75.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.019 -1.05 . . . . 0.0 109.261 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 37' ' ' LEU . 3.1 mp -66.79 -44.59 80.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.489 -0.757 . . . . 0.0 109.817 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.609 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 66.4 mm-40 -67.83 -32.3 72.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.36 -33.58 32.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 42' ' ' ALA . 56.3 tp60 -75.44 -35.46 60.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.422 -1.046 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.613 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -44.15 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.314 -0.866 . . . . 0.0 110.741 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -60.68 112.78 2.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.677 -1.264 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.0 -36.83 2.13 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.602 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.8 mt -91.64 146.71 23.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.088 -1.242 . . . . 0.0 110.529 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.1 m -69.71 156.15 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.734 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -62.72 -37.8 87.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 110.297 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -63.52 -39.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 109.733 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -58.8 -38.31 78.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.899 -1.126 . . . . 0.0 108.198 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.3 t -64.34 -37.58 80.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.601 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 50' ' ' LEU . 7.1 tt -55.73 -47.15 77.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -61.91 -46.97 87.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.947 -1.096 . . . . 0.0 109.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.04 -11.81 59.85 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.942 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.674 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 38.4 ttm180 -63.19 -46.12 88.53 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.67 -41.62 68.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.009 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -70.04 -45.2 67.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.063 . . . . 0.0 111.054 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 49.8 t80 -60.86 -48.47 81.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.897 -1.127 . . . . 0.0 110.523 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.522 ' NH2' ' CD ' ' A' ' 33' ' ' GLU . 16.7 mmm180 -57.77 -31.95 67.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.06 65.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.832 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.1 m -73.16 -26.06 61.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 112.189 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 79.6 m-85 -113.11 -48.36 2.98 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.536 -1.353 . . . . 0.0 111.336 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' CG ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -176.81 112.36 0.09 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' HIS . 93.6 mt-30 -47.42 -35.67 8.75 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.133 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 1.3 p90 -177.93 39.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.191 -0.943 . . . . 0.0 111.404 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -131.88 81.08 63.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.615 -1.303 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.59 -14.35 1.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.78 2.32 . . . . 0.0 112.853 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.79 -37.35 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.887 -1.133 . . . . 0.0 108.856 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -35.73 66.38 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' ' CG ' ' A' ' 61' ' ' HIS . 64.6 t -59.52 -38.82 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.429 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.32 -16.44 63.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.97 -5.13 53.62 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.8 mmm -79.3 116.78 19.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 2.8 pt20 -95.67 177.33 5.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.5 mt-10 -59.41 -35.04 73.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.812 . . . . 0.0 110.304 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.6 tt0 -58.4 -46.44 86.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.807 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -64.93 -38.88 92.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.836 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.55 -43.54 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.45 -0.781 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.28 -39.18 92.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.508 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 78' ' ' ARG . 28.7 ttm-85 -60.81 -39.27 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 108.733 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' N ' ' A' ' 81' ' ' GLN . 80.2 mt -68.97 -33.24 73.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.652 -0.655 . . . . 0.0 110.874 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.11 -18.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 108.675 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.3 mt-30 -118.76 -11.47 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 84' ' ' GLY . 17.5 t70 -79.47 109.75 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 72.73 -19.01 0.32 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 64.2 35.47 92.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.538 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.5 pt -31.81 -105.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.208 -0.583 . . . . 0.0 111.823 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 6.4 tt -161.44 -48.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.685 -1.259 . . . . 0.0 110.218 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' NH1' ' CD2' ' A' ' 56' ' ' TYR . 9.2 mtt180 -63.33 149.04 46.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.001 -1.062 . . . . 0.0 109.409 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' ARG . 88.8 m-70 -108.04 167.74 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 109.765 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER -43.33 -40.74 3.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.136 -0.977 . . . . 0.0 109.992 -179.142 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.23 -59.26 7.56 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.303 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.55 -40.18 96.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -1.086 . . . . 0.0 110.193 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.66 -52.91 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 110.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.599 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 39.1 mt-30 -52.41 -33.81 45.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.906 -1.121 . . . . 0.0 110.099 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.57 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.874 -1.141 . . . . 0.0 109.226 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -72.09 -32.56 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 111.123 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.0 -42.61 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.542 -1.348 . . . . 0.0 108.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.93 72.69 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.66 -43.37 96.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -1.184 . . . . 0.0 109.945 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.92 73.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.048 -1.032 . . . . 0.0 108.787 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -61.54 -35.67 78.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.804 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.23 73.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 108.649 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -64.48 -43.17 95.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.14 -27.75 68.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -68.06 -38.18 82.15 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.697 0.76 . . . . 0.0 109.245 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.571 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 34.5 ttm -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.942 0.877 . . . . 0.0 108.95 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.0 -36.89 85.07 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.48 -25.69 66.23 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -91.12 -12.27 36.07 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.57 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.93 27.51 73.64 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.48 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -117.37 102.8 52.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.84 144.18 21.49 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.024 1.816 . . . . 0.0 112.813 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -55.46 -40.66 71.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.033 0.921 . . . . 0.0 108.989 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.23 -27.09 64.19 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 110.494 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.96 -53.6 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.905 -1.122 . . . . 0.0 111.202 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.5 p90 -70.73 -32.61 69.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.953 -1.092 . . . . 0.0 109.611 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -64.96 -54.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.16 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.594 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 54.3 m95 -57.36 -26.72 61.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 108.532 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 66.3 p -77.68 -31.53 52.57 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.322 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -68.78 -32.32 71.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.6 p -88.61 18.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.312 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 66.36 27.4 10.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.867 . . . . 0.0 109.534 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 51.19 33.11 8.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.454 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -137.09 150.0 68.02 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.22 145.67 39.31 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.488 2.126 . . . . 0.0 111.847 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.509 ' NE2' ' N ' ' A' ' 126' ' ' MET . 2.2 tm0? -108.15 129.2 55.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.509 ' N ' ' NE2' ' A' ' 125' ' ' GLN . 9.0 mtm -117.7 108.48 15.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.068 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -102.68 128.74 49.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.099 -1.0 . . . . 0.0 109.271 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.86 34.58 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.097 -1.002 . . . . 0.0 110.607 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 176' ' ' VAL . . . -58.32 145.82 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 108.762 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.1 p -91.84 -15.22 28.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.065 -1.022 . . . . 0.0 110.343 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -142.46 162.9 34.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 109.685 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.0 mt -59.61 -33.05 70.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -65.42 -29.09 69.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.329 -0.857 . . . . 0.0 110.886 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -85.49 -1.8 57.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.996 -1.065 . . . . 0.0 109.854 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.14 143.78 57.43 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 108.851 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.67 142.94 40.89 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.423 2.082 . . . . 0.0 112.848 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 t -125.55 4.89 7.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.9 p -157.41 87.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 163.56 16.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.509 -0.745 . . . . 0.0 109.054 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.18 -39.72 85.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.702 1.601 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.67 -43.18 66.48 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.109 -1.036 . . . . 0.0 108.549 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 p -63.51 -44.07 95.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.25 -37.55 85.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.078 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.4 95.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 109.798 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.11 -45.54 75.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -59.0 -40.23 84.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.748 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -62.68 -49.42 75.2 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 110.653 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.69 76.81 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.121 -0.987 . . . . 0.0 109.473 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.419 ' HG ' HH21 ' A' ' 152' ' ' ARG . 32.5 mt -66.91 -39.74 87.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -0.902 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -38.78 87.75 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.754 -1.216 . . . . 0.0 110.34 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -84.62 -14.68 47.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 111.948 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.488 ' O ' ' OE1' ' A' ' 104' ' ' GLN . 85.9 mtm180 -88.53 8.2 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.687 -1.258 . . . . 0.0 109.521 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.37 21.04 53.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -100.99 110.37 22.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 108.6 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -93.68 175.13 6.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 57.18 57.59 4.43 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.106 0.955 . . . . 0.0 109.124 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.4 m -128.91 42.27 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.24 162.7 0.4 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.7 m -53.65 -29.49 38.6 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -1.089 . . . . 0.0 108.921 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -73.52 -32.29 64.15 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 108.547 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.57 -45.74 98.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.48 -0.762 . . . . 0.0 109.073 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.64 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.525 -0.734 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.95 -45.94 72.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 0.0 109.692 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 97.0 p -68.81 -31.13 69.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 108.414 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.579 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 79.5 t80 -64.3 -48.0 77.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.864 -0.522 . . . . 0.0 110.277 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ptm -72.91 -32.35 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -58.18 -42.18 85.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.701 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' CB ' ' SD ' ' A' ' 34' ' ' MET . . . -92.98 -32.97 14.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 111.136 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 76.3 m -54.62 -24.09 19.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.864 -1.147 . . . . 0.0 110.517 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.82 0.56 48.96 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.66 -34.0 76.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.34 -1.094 . . . . 0.0 110.165 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.1 147.52 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.093 0.949 . . . . 0.0 111.003 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.85 103.52 9.42 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 174' ' ' ASP . 58.9 p30 -173.86 70.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.067 -1.021 . . . . 0.0 111.284 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 176' ' ' VAL . 30.8 m170 -57.95 -43.09 86.19 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.58 -1.325 . . . . 0.0 108.244 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 178' ' ' GLY . 0.5 OUTLIER 168.23 3.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.87 -35.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -83.8 11.92 54.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 12.8 t -85.75 121.53 28.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.043 . . . . 0.0 109.344 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.514 ' C ' ' H ' ' A' ' 182' ' ' TYR . 49.3 t -52.69 -34.59 52.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.629 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.84 17.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.635 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 180' ' ' CYS . 20.4 t80 -118.45 83.7 21.82 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.85 141.59 65.74 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.644 2.229 . . . . 0.0 111.919 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.68 -21.13 0.8 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -84.09 3.34 35.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.177 . . . . 0.0 109.397 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.91 162.41 44.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 0.0 109.764 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 112.262 179.647 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.93 H3A2 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -109.89 142.77 40.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.392 -0.817 . . . . 0.0 109.77 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 56.1 mtp180 -58.81 -46.36 87.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 108.887 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' N ' ' OE1' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -170.29 146.85 2.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.9 80.47 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.429 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.606 ' CE3' H3A2 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.617 -1.519 . . . . 0.0 110.461 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.22 -41.9 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.907 -1.121 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.519 ' HG ' ' CD ' ' A' ' 2' ' ' GLU . 67.6 m -79.4 5.7 12.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 108.872 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.72 -60.48 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.763 . . . . 0.0 109.973 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.16 157.04 75.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.92 -30.32 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.584 2.189 . . . . 0.0 112.143 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.69 -37.34 86.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.753 ' OH ' H3A1 ' A' ' 189' ' ' ADK . 1.6 m-85 -63.86 -39.93 95.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.136 -0.978 . . . . 0.0 109.27 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.0 mt -54.68 -44.51 70.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.474 -0.766 . . . . 0.0 110.611 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.93 -47.93 73.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.728 -1.232 . . . . 0.0 109.224 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.7 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.7 t80 -62.12 -40.74 96.93 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.913 0.863 . . . . 0.0 108.805 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -71.48 -39.22 71.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -78.46 -5.9 53.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.189 -0.944 . . . . 0.0 111.863 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 87.1 m-20 -76.87 -75.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.527 -1.358 . . . . 0.0 110.001 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 21' ' ' TRP . 96.0 mt-10 -145.56 -40.96 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.139 -0.975 . . . . 0.0 108.724 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.889 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 6.4 t90 -4.68 74.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.106 0.955 . . . . 0.0 111.084 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 149.47 -25.32 1.22 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 19.6 m -120.06 4.01 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.575 -0.956 . . . . 0.0 112.766 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 69.8 Cg_endo -75.69 147.21 31.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.174 1.25 . . . . 0.0 112.987 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.68 166.37 13.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.631 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 7.6 p -99.32 108.84 21.47 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.338 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -89.32 167.17 13.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 m -73.13 -37.33 66.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.474 -1.391 . . . . 0.0 110.465 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -74.85 -41.53 59.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -59.66 -37.0 77.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.593 -1.317 . . . . 0.0 110.487 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.595 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -59.33 -38.15 79.58 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.981 -178.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.68 -45.85 90.87 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.452 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -71.22 -40.69 70.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.022 -1.049 . . . . 0.0 108.636 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.3 tpp -64.64 -48.44 74.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.641 -0.662 . . . . 0.0 110.62 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.21 -29.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.999 -1.063 . . . . 0.0 109.469 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.9 m -70.74 -48.83 52.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.022 -1.049 . . . . 0.0 109.042 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.66 -39.7 80.54 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.295 -0.878 . . . . 0.0 109.01 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.07 -37.82 86.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.421 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.54 -36.87 91.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.42 -24.18 67.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.469 -1.018 . . . . 0.0 110.061 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.8 pp0? -69.74 -3.29 14.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.711 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.43 112.71 1.67 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.725 -1.235 . . . . 0.0 109.084 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.8 -14.68 1.4 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.0 mm? -103.93 154.93 19.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.184 -1.186 . . . . 0.0 110.178 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -71.5 153.71 42.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 109.773 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.7 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -64.77 -41.99 95.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 110.434 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -31.25 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 109.728 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 m -58.11 -40.86 82.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.84 -28.04 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.097 -1.002 . . . . 0.0 109.43 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -53.44 53.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 109.827 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -61.34 -44.46 97.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.673 -1.267 . . . . 0.0 108.154 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -65.62 -26.71 67.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.3 ttm180 -53.96 -44.04 70.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.779 -1.201 . . . . 0.0 107.918 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.49 -37.05 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.397 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -78.35 -45.65 22.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.873 -1.142 . . . . 0.0 111.155 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.663 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 40.2 t80 -58.87 -46.43 87.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.159 . . . . 0.0 109.945 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.673 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 2.4 ppt_? -66.6 -29.47 69.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.11 -0.993 . . . . 0.0 109.37 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -69.08 -43.24 74.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.746 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.52 -45.46 68.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.858 -1.151 . . . . 0.0 110.648 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' C ' ' H ' ' A' ' 62' ' ' GLN . 20.5 m-85 -79.23 -47.72 15.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.985 -1.072 . . . . 0.0 109.997 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' CE1' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 48.06 5.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.334 -0.854 . . . . 0.0 110.071 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.632 ' C ' ' H ' ' A' ' 64' ' ' ASP . 96.4 mm-40 -65.39 -38.76 90.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.947 -1.096 . . . . 0.0 109.974 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.28 3.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -128.13 99.29 25.18 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 108.911 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.73 -23.07 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.784 . . . . 0.0 112.439 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.79 -46.18 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.939 -1.1 . . . . 0.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.12 75.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.095 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.02 -38.22 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.545 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . . . -68.67 -14.91 63.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.08 -9.57 45.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.57 -0.707 . . . . 0.0 109.094 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.462 ' SD ' ' CD2' ' A' ' 60' ' ' PHE . 97.1 mtp -82.18 112.84 19.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.434 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -95.77 -176.49 3.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 109.98 -178.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.61 -33.12 67.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 110.617 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.0 -33.13 75.3 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 108.506 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 62.3 m-20 -68.22 -40.1 82.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.528 -0.733 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -66.69 -33.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.743 -1.223 . . . . 0.0 109.254 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.511 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.8 mt-10 -63.99 -36.56 84.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.072 -1.017 . . . . 0.0 108.648 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 78' ' ' ARG . 19.6 ttm-85 -61.77 -47.03 87.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 ' C ' ' N ' ' A' ' 81' ' ' GLN . 91.9 mt -69.88 -33.49 72.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 111.209 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.9 t -49.6 -18.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 108.689 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.5 mt-30 -113.31 -13.78 12.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.551 -0.718 . . . . 0.0 109.775 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 19.0 t70 -81.23 109.1 15.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.685 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 76.29 -17.17 0.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 72.04 36.47 60.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 7.6 pt -50.33 -172.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.446 -1.032 . . . . 0.0 110.337 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.527 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 18.9 tt -59.41 93.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 94.1 mtt180 -52.27 139.73 23.33 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.593 -0.692 . . . . 0.0 109.794 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 164.76 63.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 11.6 ptm180 -49.36 -38.45 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.337 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -64.59 -59.18 8.55 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.515 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.82 -41.47 95.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.879 -1.365 . . . . 0.0 109.849 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 92' ' ' ILE . 97.0 mt -58.88 -42.43 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 110.025 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.87 -32.92 68.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.754 -1.216 . . . . 0.0 108.548 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.22 83.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 108.934 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.3 mm -57.27 -41.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 108.84 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.65 -40.41 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.82 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.34 85.46 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.58 -37.55 76.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.424 -1.045 . . . . 0.0 109.088 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.89 95.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -56.72 -42.99 80.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 108.507 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.03 70.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.45 -0.781 . . . . 0.0 108.965 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.16 -42.92 99.73 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.52 -31.62 70.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.32 -40.43 90.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.128 -0.983 . . . . 0.0 110.322 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.683 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 71.3 mtp -71.73 -39.33 70.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.958 -1.089 . . . . 0.0 108.803 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.41 -41.81 88.75 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.819 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.83 -21.37 66.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -92.9 -11.05 34.43 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.59 26.57 74.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -118.42 101.5 50.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.243 -1.151 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 145.01 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.237 1.958 . . . . 0.0 112.414 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.683 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 31.7 m-85 -60.8 -43.42 98.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.27 -33.29 75.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 111.139 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.36 -48.52 80.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.033 -1.042 . . . . 0.0 112.133 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.3 p90 -70.16 -45.18 67.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.685 -1.259 . . . . 0.0 111.12 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.54 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 2.9 p -59.84 -50.09 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.468 -1.395 . . . . 0.0 109.581 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.631 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 17.0 m95 -54.99 -24.48 24.39 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.527 ' HG ' ' N ' ' A' ' 119' ' ' PHE . 5.3 p -70.61 -38.86 74.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.496 -0.753 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.527 ' N ' ' HG ' ' A' ' 118' ' ' SER . 32.6 m-85 -64.96 -32.17 73.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.718 -1.239 . . . . 0.0 109.476 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.0 m -96.92 17.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.366 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 121' ' ' ASN . 1.3 m120 57.74 40.93 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.544 -0.722 . . . . 0.0 110.059 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 121' ' ' ASN . 49.8 t-80 43.16 27.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.992 . . . . 0.0 109.805 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 2.6 mm-40 -126.9 149.72 69.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.43 147.99 87.56 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.532 2.154 . . . . 0.0 112.157 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.32 139.45 50.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.3 mtt -100.34 122.15 42.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.98 118.11 24.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 108.571 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.82 19.88 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.12 129.43 36.77 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.274 -0.892 . . . . 0.0 109.365 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.9 p -100.96 -21.32 15.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.7 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.42 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 10.8 p -131.64 162.78 29.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.2 mt -58.78 -37.32 76.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 108.823 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.7 m -76.32 -3.2 35.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 131' ' ' THR . 31.9 tp10 -101.69 12.53 36.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -100.48 106.96 45.93 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.71 137.7 82.46 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.83 1.686 . . . . 0.0 112.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 p -103.78 4.09 34.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.4 ' HG ' HG21 ' A' ' 159' ' ' THR . 3.8 m -142.29 85.74 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.401 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 14.2 p -102.35 151.49 38.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -52.73 -35.73 70.01 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.508 1.472 . . . . 0.0 111.284 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.49 -43.05 61.03 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 166' ' ' MET . 56.8 m -66.17 -43.57 86.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -66.17 -37.47 85.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.91 -31.2 66.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.42 -46.65 79.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.642 -0.661 . . . . 0.0 109.537 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.594 ' CA ' ' HG ' ' A' ' 162' ' ' CYS . 19.4 m -61.3 -40.88 95.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.077 -1.015 . . . . 0.0 109.518 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -61.22 -43.57 98.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 110.039 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.17 70.79 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.49 -37.92 83.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 109.223 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -61.57 -40.0 93.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.034 -1.041 . . . . 0.0 109.498 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.6 -15.34 57.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.907 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -83.0 4.16 27.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.156 -0.965 . . . . 0.0 108.835 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.53 24.78 49.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.57 112.89 25.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.983 . . . . 0.0 108.849 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -93.44 172.93 7.97 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.648 -0.657 . . . . 0.0 109.231 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 57.84 61.31 2.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.843 . . . . 0.0 109.055 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.85 39.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.51 162.91 0.07 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.4 HG21 ' HG ' ' A' ' 138' ' ' SER . 30.6 m -55.03 -31.39 61.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.457 -1.026 . . . . 0.0 109.005 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.6 p -72.34 -31.89 66.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.36 -45.02 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.594 ' HG ' ' CA ' ' A' ' 146' ' ' SER . 1.7 m -67.0 -41.81 86.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -0.764 . . . . 0.0 109.407 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.44 -46.84 68.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.589 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 18.3 m -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.853 -1.154 . . . . 0.0 109.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -59.29 -47.71 84.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 110.652 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 11.9 ptp -66.42 -29.19 69.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.132 . . . . 0.0 110.657 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -57.35 -40.0 77.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.872 -1.143 . . . . 0.0 110.746 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.14 -33.16 11.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 111.124 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -54.62 -27.64 40.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.975 -1.078 . . . . 0.0 109.69 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.55 54.36 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.069 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 169' ' ' CYS . 6.4 mt -63.3 -30.69 71.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.199 -1.177 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.9 m -125.77 137.88 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.834 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.4 m120 -104.32 164.3 11.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.745 . . . . 0.0 109.413 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 89.58 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.425 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 17.7 m170 -51.55 -44.74 62.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 108.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 28.2 m -157.91 37.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.73 . . . . 0.0 109.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 176' ' ' VAL . 16.0 t 37.84 93.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.24 -4.35 7.26 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 182' ' ' TYR . 8.7 t -57.08 133.38 54.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 108.482 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 179' ' ' CYS . 42.5 t -43.07 -43.74 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.944 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 88.4 m -70.11 -13.61 62.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 36.0 t80 -60.04 136.36 90.78 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.698 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.25 125.16 9.52 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.098 1.866 . . . . 0.0 112.018 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -95.84 12.55 67.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.89 23.93 8.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.484 -1.01 . . . . 0.0 109.045 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.8 150.2 38.38 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 C--N 1.311 -1.436 0 C-N-CA 122.445 2.097 . . . . 0.0 112.208 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.889 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' O ' ' A' ' 180' ' ' CYS . 59.6 ttp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.213 0.53 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 180' ' ' CYS . 38.0 tp10 -100.46 138.53 37.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.56 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -66.85 165.3 15.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 145.87 55.03 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.83 49.84 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.408 -0.808 . . . . 0.0 111.833 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.895 ' CZ3' H3A2 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -84.37 2.97 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.536 -1.567 . . . . 0.0 109.77 -179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.84 -46.45 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 109.158 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -73.17 -2.02 19.94 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.895 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 62.8 tt0 -67.81 -41.7 82.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -154.63 159.92 31.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 109.984 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.8 -38.47 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.991 2.46 . . . . 0.0 112.463 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' CD1' ' HZ1' ' A' ' 51' ' ' LYS . 96.9 mt -61.72 -32.88 73.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.59 ' HH ' ' C3A' ' A' ' 189' ' ' ADK . 0.3 OUTLIER -62.96 -41.84 99.65 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.296 -0.878 . . . . 0.0 110.207 -179.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.27 -38.29 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 110.523 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.654 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.48 -50.65 58.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 109.539 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 1.2 t80 -60.91 -37.21 81.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 110.01 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -59.1 -43.05 91.85 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.416 -0.803 . . . . 0.0 110.651 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -80.36 -16.06 55.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 110.712 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.654 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 34.8 m-80 -64.58 -53.94 39.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 177.57 57.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 108.829 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 1.003 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 4.2 t90 -97.66 63.93 1.76 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . 108.87 59.85 0.53 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.857 -1.164 . . . . 0.0 111.562 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -157.88 -36.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.486 . . . . 0.0 112.037 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 46.5 Cg_endo -96.15 152.05 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.702 2.268 . . . . 0.0 114.032 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 26' ' ' THR . 86.2 tt0 -68.9 160.15 31.26 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.425 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 2.3 p -95.06 152.48 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.492 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -103.65 151.46 22.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -62.79 -36.23 82.44 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.911 -1.118 . . . . 0.0 109.418 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -74.89 -50.33 17.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 110.811 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.75 -25.16 68.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.958 -1.089 . . . . 0.0 108.69 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.58 -39.47 76.85 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -69.32 -44.52 71.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.695 -0.628 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.54 -28.37 66.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.14 . . . . 0.0 110.21 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.5 ttm -71.47 -52.06 20.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.867 -1.146 . . . . 0.0 110.444 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.1 -29.02 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.749 -1.219 . . . . 0.0 109.709 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.01 -44.1 90.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.065 -1.022 . . . . 0.0 109.038 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -43.58 68.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 31.5 mm-40 -62.81 -33.52 75.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -0.806 . . . . 0.0 109.104 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.14 -36.32 88.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.77 -3.63 39.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -1.174 . . . . 0.0 109.992 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -79.26 -0.69 33.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.04 122.76 18.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.162 -0.961 . . . . 0.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.04 -32.85 0.92 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.9 mm? -98.47 150.03 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.286 . . . . 0.0 109.996 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.5 p -65.61 157.29 30.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -61.33 -31.08 70.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -40.8 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.413 -0.804 . . . . 0.0 109.877 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 m -57.37 -38.92 74.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.081 -1.012 . . . . 0.0 108.35 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -64.17 -36.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.23 -47.48 78.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -0.966 . . . . 0.0 109.046 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HZ1' ' CD1' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -62.5 -34.09 76.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' C ' HD21 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -84.52 -10.65 57.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.005 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 41.1 ttm180 -66.72 -51.16 59.17 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.54 -36.13 76.08 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.229 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.603 ' ND2' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.13 -34.88 68.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.015 -1.053 . . . . 0.0 109.929 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 82.9 t80 -60.7 -47.47 86.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 7.9 ptm180 -66.86 -28.23 68.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.919 -1.113 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -67.7 -37.98 83.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 111.267 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -77.41 -45.66 25.16 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.749 -1.219 . . . . 0.0 110.768 -178.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' C ' ' H ' ' A' ' 62' ' ' GLN . 86.7 m-85 -84.5 -48.39 9.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 110.334 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 55.89 -4.0 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.019 -1.051 . . . . 0.0 109.552 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.649 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 26.0 mt-30 -75.75 -18.39 59.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.037 -1.039 . . . . 0.0 108.759 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.649 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 3.4 m-30 101.07 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.086 0.555 . . . . 0.0 109.579 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.5 OUTLIER 165.46 -42.77 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.419 0 O-C-N 120.554 -1.341 . . . . 0.0 113.786 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 64' ' ' ASP . 50.8 Cg_exo -49.88 -146.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.341 0 C-N-CA 123.721 2.948 . . . . 0.0 116.982 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.3 -30.13 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.917 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.483 ' C ' ' NE2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -54.18 -39.82 66.97 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.331 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.34 -40.71 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.766 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.33 -16.28 59.89 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.02 -6.38 58.75 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.476 ' SD ' ' OE1' ' A' ' 62' ' ' GLN . 67.6 mmm -82.74 117.24 22.52 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -94.89 172.27 8.26 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.12 -0.988 . . . . 0.0 109.857 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -54.33 -31.47 54.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.486 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.31 -44.41 75.78 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.651 -1.28 . . . . 0.0 108.37 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.24 -37.81 86.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.93 -44.83 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 0.0 109.591 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.76 -38.06 89.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 108.628 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -60.93 -39.95 91.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 109.373 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.01 -33.24 75.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.16 -33.8 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -109.34 -4.04 16.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.557 -0.714 . . . . 0.0 110.949 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 84' ' ' GLY . 35.7 t0 -82.0 108.68 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.281 -1.512 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 70.91 -16.06 0.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.421 -0.799 . . . . 0.0 109.548 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.01 33.18 57.7 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 22.1 pt -54.73 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -1.114 . . . . 0.0 110.205 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 10.6 tt -57.71 86.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -54.21 138.64 38.01 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.698 0.761 . . . . 0.0 110.434 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 3.1 m-70 160.58 77.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.491 ' CD ' ' H ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.18 -35.27 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.533 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 -56.26 25.63 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -65.8 -41.43 91.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.295 . . . . 0.0 110.614 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.66 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 0.0 110.443 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -34.52 65.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.667 -1.271 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.13 -37.51 87.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.948 . . . . 0.0 109.153 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.62 -44.27 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 108.821 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.45 -41.12 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.59 90.86 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -40.53 87.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 0.0 109.264 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.23 -43.89 93.56 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.072 -1.017 . . . . 0.0 109.001 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.644 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -52.16 -42.07 63.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 108.793 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.417 ' HA ' HE21 ' A' ' 104' ' ' GLN . . . -65.44 -29.32 69.99 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.713 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 45.9 t80 -62.79 -44.86 95.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.9 mm? -62.82 -33.36 75.07 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' A' ' 101' ' ' ALA . 54.9 mt-30 -66.08 -36.94 84.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.392 -0.817 . . . . 0.0 110.444 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 82.9 mmm -71.56 -40.3 70.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.71 -39.33 70.23 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.19 -20.03 64.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -85.89 -8.98 57.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.77 26.34 73.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.04 101.79 49.62 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.497 -1.002 . . . . 0.0 109.678 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.25 143.7 41.83 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.342 2.028 . . . . 0.0 112.204 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.713 ' CZ ' ' CD1' ' A' ' 102' ' ' TYR . 58.5 m-85 -64.66 -45.33 87.21 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.039 0.924 . . . . 0.0 110.665 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.6 -26.91 68.9 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.473 -0.767 . . . . 0.0 110.947 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.5 ' O ' ' OG ' ' A' ' 118' ' ' SER . 60.4 t0 -66.24 -49.35 67.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.863 -1.148 . . . . 0.0 111.862 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.3 p90 -69.74 -44.51 70.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.864 -1.148 . . . . 0.0 111.355 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.559 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 3.3 p -61.0 -53.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.512 -1.367 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.43 ' H ' ' CG1' ' A' ' 116' ' ' VAL . 37.5 m95 -55.82 -23.09 28.32 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.496 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 13.3 m -69.26 -38.87 78.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.084 -1.01 . . . . 0.0 109.782 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -64.55 -33.9 77.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.0 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 m -91.82 18.58 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.055 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.61 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 59.2 m-80 58.62 43.96 18.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 0.0 109.496 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 28.9 p-80 41.51 24.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.491 -0.756 . . . . 0.0 110.058 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -135.46 153.76 78.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.086 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 147.46 95.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.653 2.235 . . . . 0.0 112.376 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -100.36 131.7 46.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.761 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.7 mtt -96.88 113.25 24.77 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -93.24 115.9 28.49 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -87.84 19.31 3.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 140.75 52.29 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.261 -0.899 . . . . 0.0 109.122 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.29 -28.65 10.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.3 p -128.18 162.37 27.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.52 -0.737 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.91 -36.87 70.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.054 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.2 m -61.84 -30.34 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.19 -6.5 57.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 109.816 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.52 131.8 76.7 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 138' ' ' SER . 74.3 Cg_endo -79.41 -21.58 8.78 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.844 1.696 . . . . 0.0 112.649 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 136' ' ' PRO . 0.2 OUTLIER 52.36 -1.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.767 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -148.37 83.15 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.065 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -95.62 159.08 33.34 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.9 -38.13 85.88 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.843 1.695 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.01 -45.02 52.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.465 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 18.1 m -62.95 -43.0 99.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.735 . . . . 0.0 109.061 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.83 -42.05 97.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 108.932 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.1 -29.0 66.99 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.81 83.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.648 -0.657 . . . . 0.0 109.484 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.606 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 3.8 m -66.19 -41.02 90.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 0.0 110.161 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -58.3 -38.66 77.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.845 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.13 6.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.93 -31.94 70.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 109.968 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -61.05 -45.12 96.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.789 -1.195 . . . . 0.0 109.581 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -84.48 -13.5 51.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.411 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -81.75 2.99 27.38 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.864 -1.148 . . . . 0.0 109.484 -178.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.1 21.18 33.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -109.66 111.13 22.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -1.073 . . . . 0.0 109.308 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -94.64 -178.31 4.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 55.32 40.48 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 108.93 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.03 48.37 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.61 162.2 0.5 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -58.18 -30.61 66.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.496 -1.002 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.5 m -72.32 -37.24 68.97 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.141 -0.974 . . . . 0.0 108.674 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.74 -39.88 87.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.606 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 1.4 m -62.2 -49.35 76.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.87 . . . . 0.0 109.828 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.716 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -65.16 -41.0 95.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 20.1 m -64.38 -43.02 95.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.11 -0.994 . . . . 0.0 109.56 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.9 88.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 98.8 mtp -60.89 -40.55 93.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 111.289 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.716 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 46.9 mt-30 -64.04 -44.74 91.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 111.222 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.26 63.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.019 . . . . 0.0 110.612 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -39.09 67.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 0.0 111.288 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.9 0.61 17.3 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -1.188 . . . . 0.0 109.887 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.32 150.34 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 21.4 m120 -128.57 163.56 24.74 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.386 0.612 . . . . 0.0 110.72 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.9 t0 89.52 74.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.471 0.653 . . . . 0.0 109.755 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.418 ' O ' ' CG1' ' A' ' 176' ' ' VAL . 9.2 m170 -58.35 -44.6 88.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 177' ' ' VAL . 12.9 m -157.99 29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.905 . . . . 0.0 109.992 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 176' ' ' VAL . 85.8 t 55.24 113.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.888 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.14 33.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.626 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -73.58 91.9 1.88 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -1.086 . . . . 0.0 109.45 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 59.95 -42.64 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.793 -0.567 . . . . 0.0 110.791 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.1 t -172.59 57.02 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 56.1 t80 -70.14 135.99 87.0 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.039 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.476 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 37.1 Cg_endo -69.72 136.41 33.03 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 112.737 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.29 -30.92 0.08 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.26 4.25 31.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -1.039 . . . . 0.0 108.822 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.41 86.11 32.96 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.452 2.101 . . . . 0.0 112.401 -179.284 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 1.003 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtm . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -110.83 140.03 45.62 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -70.17 161.74 29.67 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.572 -0.705 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 133.67 51.15 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.918 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.78 -30.8 76.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.795 ' CZ2' ' C3A' ' A' ' 189' ' ' ADK . 1.7 t90 -76.08 -1.51 26.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 108.334 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' ND1' ' A' ' 17' ' ' HIS . 1.1 t -102.29 -28.0 3.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.392 0.615 . . . . 0.0 109.395 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.1 m -70.66 5.2 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.9 . . . . 0.0 110.634 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -84.11 -149.18 0.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.789 -1.195 . . . . 0.0 109.275 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.67 158.6 11.42 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.575 ' C ' ' H ' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 -160.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.837 2.358 . . . . 0.0 111.468 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 -40.42 0.27 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.012 -1.055 . . . . 0.0 109.135 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.903 ' OH ' H3A1 ' A' ' 189' ' ' ADK . 1.3 m-85 -64.48 -36.63 84.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.894 -1.129 . . . . 0.0 109.413 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 2.1 mp -56.78 -46.83 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.544 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.04 69.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.995 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.2 t80 -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.011 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.401 ' ND1' HG23 ' A' ' 7' ' ' VAL . 14.6 t-80 -76.08 -32.12 59.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.94 -10.33 59.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.956 -1.09 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 19.7 p30 -90.95 -70.41 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.602 -1.311 . . . . 0.0 112.464 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.676 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.2 mt-10 -126.5 -69.09 0.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.943 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.734 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 30.1 t-105 51.72 44.83 28.96 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.68 41.45 19.67 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 120.491 -1.381 . . . . 0.0 110.969 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -106.98 -41.88 0.14 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.218 . . . . 0.0 109.993 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 95.4 Cg_endo -98.57 154.03 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.794 2.996 . . . . 0.0 112.821 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.36 144.2 55.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.418 ' HG1' ' HG ' ' A' ' 169' ' ' CYS . 67.4 p -105.46 155.44 19.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.773 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -92.16 167.1 12.28 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -59.95 -36.8 77.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 111.197 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.1 -41.55 90.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 112.264 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -62.34 -38.68 90.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.603 -1.311 . . . . 0.0 108.855 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -56.76 -39.1 73.41 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.231 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.404 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 81.9 t80 -60.73 -40.3 91.83 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -70.69 -43.38 69.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.905 -1.122 . . . . 0.0 108.778 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.479 ' SD ' ' CD1' ' A' ' 165' ' ' PHE . 58.2 ttm -63.82 -47.36 81.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 110.462 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -65.46 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 67.2 m -69.36 -51.11 40.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.99 -1.068 . . . . 0.0 109.652 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 2.2 mp -68.44 -42.0 79.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.196 -0.94 . . . . 0.0 108.965 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 9.1 tp10 -62.55 -35.74 80.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.619 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.29 -28.1 49.0 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -79.41 -12.87 59.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 109.807 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -74.79 11.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 111.303 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -68.62 112.94 5.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.367 -1.458 . . . . 0.0 109.238 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.27 -0.35 0.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 17.3 tp -106.66 145.2 32.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.193 -1.18 . . . . 0.0 109.857 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.7 m -64.39 157.06 27.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.837 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.626 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 2.8 t-105 -71.13 -43.81 66.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.489 -0.757 . . . . 0.0 110.708 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -27.22 35.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.959 -1.088 . . . . 0.0 109.097 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -63.86 -40.23 96.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -0.935 . . . . 0.0 109.895 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.2 m -69.82 -28.83 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.084 -1.01 . . . . 0.0 108.993 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.06 -47.31 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -56.64 -45.85 81.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' TYR . 21.3 ttpp -59.82 -32.59 70.8 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -55.35 -45.25 76.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.531 -0.731 . . . . 0.0 109.576 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -68.66 -46.11 69.98 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.02 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 14.0 m-80 -64.34 -34.65 78.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.776 . . . . 0.0 109.142 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.1 t80 -56.6 -42.29 78.49 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 61' ' ' HIS . 7.2 mmm180 -63.37 -38.22 90.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.09 -41.25 86.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.667 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -75.15 -45.39 41.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.0 111.229 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 81.4 m-85 -89.9 -45.69 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.533 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 2.2 t60 60.97 -47.0 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.051 0.453 . . . . 0.0 110.416 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 64' ' ' ASP . 91.6 mm-40 -81.29 -37.88 27.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.792 . . . . 0.0 109.931 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 62' ' ' GLN . 46.5 p90 35.88 21.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.772 -0.58 . . . . 0.0 111.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -91.08 131.86 35.84 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.238 -1.539 . . . . 0.0 109.1 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -37.6 -52.92 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.986 2.457 . . . . 0.0 114.75 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.07 -44.83 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 111.121 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.49 -40.6 95.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.5 -41.77 93.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.801 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.68 60.73 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.18 -14.53 28.92 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.739 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.5 mtp -82.78 113.14 20.22 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.61 -177.64 3.99 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.766 -1.209 . . . . 0.0 110.958 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.42 -36.65 69.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 109.136 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.81 -49.04 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.581 -1.325 . . . . 0.0 108.128 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.34 -35.66 74.26 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.55 -37.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.28 -0.887 . . . . 0.0 108.748 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.02 -39.8 83.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -65.37 -33.48 76.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.361 0.6 . . . . 0.0 109.507 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.29 -34.47 74.75 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.266 -0.896 . . . . 0.0 110.447 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.1 t -56.03 -17.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -109.73 -17.26 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -1.0 . . . . 0.0 110.077 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.6 m-20 -80.04 109.78 14.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.75 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.98 -16.21 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.675 . . . . 0.0 109.246 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.7 42.73 86.87 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.8 pt -52.52 -166.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.836 -0.802 . . . . 0.0 109.846 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.07 98.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.511 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 11.2 ptp180 -52.68 116.82 2.5 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.675 0.75 . . . . 0.0 109.696 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 168.23 70.56 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.023 -1.048 . . . . 0.0 108.197 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -44.34 -42.44 6.79 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.694 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -47.97 -51.85 18.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -65.18 -45.38 85.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -1.128 . . . . 0.0 109.861 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 mm -60.75 -44.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.631 -0.668 . . . . 0.0 110.005 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -56.83 -38.31 72.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.823 -1.173 . . . . 0.0 110.167 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.97 82.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.41 -39.46 74.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 96' ' ' ILE . 25.5 mm -59.16 -46.22 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.591 0.71 . . . . 0.0 110.269 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.85 -28.78 73.94 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.55 -40.52 97.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -1.16 . . . . 0.0 110.009 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -49.83 61.23 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 108.95 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -55.81 -38.08 69.51 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' HE21 ' A' ' 104' ' ' GLN . . . -65.46 -29.54 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.083 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.01 -42.27 94.59 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.2 mm? -62.78 -33.52 75.35 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 101' ' ' ALA . 51.8 mt-30 -62.59 -36.54 83.05 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.533 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 39.1 tpp -61.01 -47.64 85.52 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.121 -0.987 . . . . 0.0 108.337 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.67 -35.73 70.96 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.3 t-20 -91.43 -18.12 24.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.51 27.57 73.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.3 mt-10 -114.26 108.58 50.04 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.72 -0.87 . . . . 0.0 109.57 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -51.73 139.75 48.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.965 1.777 . . . . 0.0 112.069 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.01 -37.84 67.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.756 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.27 64.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.636 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -62.96 -45.05 94.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.688 -1.257 . . . . 0.0 111.249 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -77.39 -40.51 43.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.91 -1.119 . . . . 0.0 111.601 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 115' ' ' PHE . 21.6 m -63.2 -48.84 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 119.547 -1.97 . . . . 0.0 108.662 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 122' ' ' HIS . 46.3 m95 -61.26 -23.67 65.83 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.8 t -70.22 -44.48 68.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.095 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.447 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 24.1 m-85 -61.19 -30.28 70.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 109.812 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.5 18.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 123' ' ' GLN . 82.0 m-20 56.99 42.31 26.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 110.176 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 37.67 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.67 -0.644 . . . . 0.0 109.361 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.3 mm100 -122.84 112.37 30.61 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.349 -0.844 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.27 150.45 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.882 1.722 . . . . 0.0 111.227 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 142.44 46.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.044 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.7 mtt -91.2 130.27 37.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.78 . . . . 0.0 109.638 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.441 HG23 ' N ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -93.44 -58.91 2.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 109.745 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.447 ' H ' ' HB2' ' A' ' 174' ' ' ASP . 71.7 mt-30 59.26 44.26 15.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.34 156.23 28.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.451 -0.781 . . . . 0.0 109.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -92.53 -12.79 30.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -168.55 -179.34 3.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -36.39 83.48 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 t -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.897 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -81.7 5.41 18.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.621 -1.299 . . . . 0.0 109.334 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.61 136.01 20.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.13 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.89 140.37 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.415 2.077 . . . . 0.0 112.883 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.7 -1.47 24.45 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 108.957 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -145.97 92.3 2.18 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.501 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.63 154.82 39.79 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.195 -0.941 . . . . 0.0 108.979 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -54.1 -34.65 79.03 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.715 1.61 . . . . 0.0 111.105 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -48.63 51.06 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.467 -0.771 . . . . 0.0 109.029 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -64.06 -42.06 97.14 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.644 0.735 . . . . 0.0 109.362 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.03 -39.11 77.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.581 -0.7 . . . . 0.0 109.47 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -65.64 -31.74 72.92 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.6 -46.74 88.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 26.3 t -60.47 -43.62 96.75 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.428 ' HG2' ' HZ1' ' A' ' 151' ' ' LYS . 28.8 ttpt -64.56 -47.3 79.28 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.518 -0.739 . . . . 0.0 110.17 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.63 77.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.404 ' HG ' ' NH2' ' A' ' 152' ' ' ARG . 35.1 mt -66.25 -36.77 83.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.8 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.34 -40.86 92.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.608 -1.308 . . . . 0.0 110.01 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.428 ' HZ1' ' HG2' ' A' ' 147' ' ' LYS . 44.3 mttp -68.82 -36.6 78.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.969 . . . . 0.0 111.47 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' NH2' ' CE2' ' A' ' 115' ' ' PHE . 74.2 mtm180 -72.26 3.7 4.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.64 20.15 52.03 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -96.93 110.34 22.88 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.29 . . . . 0.0 109.796 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -90.62 178.28 6.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.887 -0.508 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 58.33 47.69 13.59 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.238 1.018 . . . . 0.0 108.889 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.7 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.11 160.41 0.79 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.6 m -59.66 -33.18 71.22 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.512 -0.993 . . . . 0.0 109.188 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.0 m -71.86 -36.07 70.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.91 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.907 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 146' ' ' SER . 20.6 m -67.84 -39.97 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.245 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -44.01 97.35 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.605 -0.685 . . . . 0.0 110.077 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 59.2 p -61.54 -35.45 77.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CD1' ' SD ' ' A' ' 34' ' ' MET . 18.5 t80 -61.5 -41.43 97.28 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 110.063 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.563 ' CG ' HE21 ' A' ' 167' ' ' GLN . 2.4 ptm -67.48 -36.92 82.07 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.902 -1.124 . . . . 0.0 110.795 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.563 HE21 ' CG ' ' A' ' 166' ' ' MET . 85.5 mm-40 -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.842 -1.162 . . . . 0.0 110.893 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.0 -16.0 21.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.39 -0.819 . . . . 0.0 111.937 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 2.2 t -74.56 -46.11 41.04 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.381 -1.449 . . . . 0.0 110.407 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 -1.42 3.9 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.488 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 8.8 mp -61.51 -31.57 71.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.025 -1.279 . . . . 0.0 110.685 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.9 154.54 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.959 -1.088 . . . . 0.0 109.049 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 28.6 p30 -124.06 162.77 22.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.171 -0.956 . . . . 0.0 110.046 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.589 ' OD1' ' CE2' ' A' ' 182' ' ' TYR . 7.4 m-20 91.56 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -51.73 -39.62 58.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.026 . . . . 0.0 108.623 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.633 ' CG1' ' H ' ' A' ' 177' ' ' VAL . 2.8 p -145.15 -104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.622 -0.674 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.633 ' H ' ' CG1' ' A' ' 176' ' ' VAL . 1.1 t -138.4 -41.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 108.292 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.28 67.55 0.52 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t -100.22 119.99 39.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.338 . . . . 0.0 110.17 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.23 46.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.56 -37.08 67.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.961 -1.087 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.598 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 6.6 t80 -120.29 83.96 33.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 109.626 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.25 123.08 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.834 2.356 . . . . 0.0 111.769 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.66 -18.39 73.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' LYS . 1.0 OUTLIER -101.1 -18.61 16.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.527 -0.984 . . . . 0.0 110.237 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 185' ' ' ASN . 0.5 OUTLIER 47.16 70.36 2.13 Favored Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 120.874 -1.141 . . . . 0.0 109.148 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.876 2.384 . . . . 0.0 112.089 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.903 H3A1 ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.85 150.32 45.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.048 -1.033 . . . . 0.0 110.879 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.47 ' HG3' HH11 ' A' ' 3' ' ' ARG . 30.4 mtm-85 -60.25 -171.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.813 0.816 . . . . 0.0 111.235 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.47 131.17 42.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.612 0.72 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.83 -18.42 53.31 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.767 ' CE2' H3A2 ' A' ' 189' ' ' ADK . 0.9 OUTLIER -89.19 -4.02 58.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -1.141 . . . . 0.0 109.984 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER -111.43 -10.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.205 -0.934 . . . . 0.0 109.8 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.5 m -70.78 5.99 1.69 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 108.799 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.0 mt-30 -63.1 -88.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.804 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 165.88 -38.06 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 0.0 111.556 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' ASP . 61.1 Cg_endo -91.12 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.775 2.317 . . . . 0.0 115.532 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' TYR . 26.0 mt -32.34 -32.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.941 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.687 ' OH ' H3A3 ' A' ' 189' ' ' ADK . 4.3 m-85 -44.98 -40.59 6.57 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.843 -1.16 . . . . 0.0 109.913 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.8 mt -61.76 -46.38 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.54 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.02 39.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.126 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 10.0 t80 -62.51 -41.85 99.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -63.05 -38.07 89.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.79 -1.72 58.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 112.217 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.695 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -100.95 -34.03 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.506 -1.371 . . . . 0.0 111.13 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.695 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 93.5 mt-10 -153.19 -73.98 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.577 -1.327 . . . . 0.0 110.554 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.823 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 8.4 t-105 39.76 45.83 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.098 0.951 . . . . 0.0 108.804 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' ALA . . . 74.45 49.2 12.0 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.487 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.657 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 t -108.69 -35.93 0.15 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.195 -1.18 . . . . 0.0 109.074 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.657 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.2 Cg_endo -92.13 154.69 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 123.367 2.711 . . . . 0.0 112.148 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HE2' ' C ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -64.39 151.95 42.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.91 27.2 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.506 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -102.83 158.62 16.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 m -56.33 -33.73 65.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.777 -1.202 . . . . 0.0 109.006 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' NZ ' ' OH ' ' A' ' 102' ' ' TYR . 14.2 mmtt -67.14 -39.0 86.49 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.747 -0.595 . . . . 0.0 110.933 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -62.27 -44.31 96.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.005 -1.06 . . . . 0.0 110.003 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -62.24 -37.97 87.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.0 -53.08 60.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.09 -1.006 . . . . 0.0 110.511 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.01 -40.71 78.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 108.872 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.659 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 3.3 ttm -62.87 -49.33 75.28 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 111.125 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 tp -62.21 -27.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.948 -1.095 . . . . 0.0 108.962 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.41 -54.26 11.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -0.973 . . . . 0.0 109.798 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.0 mm? -71.07 -39.87 71.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 0.0 109.017 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 9.7 tp10 -59.57 -32.01 69.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.13 80.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.669 HE21 ' CD1' ' A' ' 44' ' ' LEU . 55.2 tp60 -69.25 -30.7 68.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.095 -1.238 . . . . 0.0 109.952 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.583 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -51.03 -3.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 110.368 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -63.28 112.42 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.877 -1.14 . . . . 0.0 109.319 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.05 -13.5 0.49 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.669 ' CD1' HE21 ' A' ' 40' ' ' GLN . 9.7 mt -101.98 159.52 15.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.043 -1.269 . . . . 0.0 110.354 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.495 ' OG ' ' OG1' ' A' ' 48' ' ' THR . 1.2 p -85.29 147.18 26.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.463 -0.773 . . . . 0.0 108.916 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.622 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 1.0 OUTLIER -60.95 -40.75 94.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.422 -0.798 . . . . 0.0 110.592 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -39.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.004 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.495 ' OG1' ' OG ' ' A' ' 45' ' ' SER . 84.8 m -61.55 -40.53 95.04 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -66.37 -35.57 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.49 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 7.5 tt -58.83 -52.33 66.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -58.49 -41.9 86.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.592 -1.317 . . . . 0.0 107.966 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -65.64 -25.73 67.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.81 -43.23 76.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 47.0 mp0 -68.36 -39.95 81.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 10.7 m-80 -69.85 -37.88 76.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 0.0 109.606 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -60.69 -48.79 80.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.798 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -64.4 -25.79 68.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.164 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.09 82.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 110.7 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.15 -46.26 61.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.865 -1.147 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 62' ' ' GLN . 43.3 m-85 -85.19 -48.46 9.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.002 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 t-80 47.81 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.348 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.603 ' N ' ' O ' ' A' ' 60' ' ' PHE . 92.5 mt-30 -78.34 -30.77 48.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.519 -1.363 . . . . 0.0 109.937 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 33.8 p90 42.17 18.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -125.56 101.16 30.8 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 108.959 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.34 -32.16 32.51 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.251 1.968 . . . . 0.0 113.102 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -63.35 -46.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.777 -1.202 . . . . 0.0 109.753 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -32.68 73.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.385 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.42 -39.34 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.351 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.93 65.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.7 59.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.4 mtp -85.15 113.22 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.527 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -95.92 176.08 6.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.465 -0.772 . . . . 0.0 109.524 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.4 mt-10 -52.84 -31.04 37.0 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.143 -0.973 . . . . 0.0 109.44 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.79 -49.65 76.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.175 -0.953 . . . . 0.0 108.454 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.21 -38.39 88.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.8 -43.37 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.733 . . . . 0.0 110.193 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.13 -33.69 72.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.23 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 43.1 ttm180 -64.25 -46.26 84.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 110.104 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' C ' ' N ' ' A' ' 81' ' ' GLN . 47.1 mt -67.32 -33.4 75.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 110.756 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.08 -18.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' N ' ' C ' ' A' ' 79' ' ' LEU . 22.0 mt-30 -110.4 -17.82 13.38 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.659 -0.65 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 84' ' ' GLY . 54.1 m-20 -76.78 108.68 9.97 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.86 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 71.14 -18.71 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.54 -0.725 . . . . 0.0 109.817 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.66 34.69 84.29 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 84' ' ' GLY . 7.7 pt -42.82 160.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 tt -63.85 -29.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.31 -0.869 . . . . 0.0 110.909 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 44.9 mtt-85 -63.77 145.37 55.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 109.889 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' ARG . 34.5 m80 -122.72 162.07 22.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 109.444 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 89' ' ' ARG . 5.4 ptm180 -41.51 -40.81 1.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.56 -66.5 2.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.809 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.657 ' HZ3' HE22 ' A' ' 40' ' ' GLN . 28.1 mtmt -61.83 -38.08 86.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -1.148 . . . . 0.0 110.455 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.44 HD13 HG22 ' A' ' 92' ' ' ILE . 98.1 mt -58.64 -54.13 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.829 -1.169 . . . . 0.0 109.966 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.6 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 42.9 mt-30 -51.93 -32.44 32.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 109.443 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.94 95.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.075 -1.016 . . . . 0.0 109.851 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.4 -36.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.641 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mp -58.36 -46.86 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.723 -1.236 . . . . 0.0 108.723 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.89 -35.79 92.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 84.3 m-20 -58.77 -37.01 75.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.457 -1.025 . . . . 0.0 109.719 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.14 90.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.987 -1.071 . . . . 0.0 108.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -59.02 -36.48 75.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.59 76.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.477 ' OH ' ' NZ ' ' A' ' 29' ' ' LYS . 72.6 t80 -62.99 -42.54 99.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.42 -33.79 76.69 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -63.43 -36.34 83.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.249 -0.907 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 87.0 mmm -68.74 -42.91 76.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.914 -1.116 . . . . 0.0 110.164 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.34 -37.33 83.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.494 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -94.49 -10.45 32.25 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.04 74.26 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.42 100.43 51.46 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 149.39 75.18 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.335 2.023 . . . . 0.0 111.946 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.546 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 40.0 m-85 -60.7 -33.33 72.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.328 -0.857 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.19 -34.9 71.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.712 -1.243 . . . . 0.0 111.467 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.43 -49.55 77.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.664 -1.272 . . . . 0.0 111.523 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.2 p90 -71.23 -35.3 71.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.205 . . . . 0.0 109.381 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.3 t -64.22 -54.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.05 . . . . 0.0 109.63 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' HIS . 60.3 m95 -57.51 -21.2 36.33 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 108.555 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 16.1 p -72.24 -36.97 69.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.415 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 20.7 m-85 -69.78 -33.74 72.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.936 -1.103 . . . . 0.0 110.289 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.66 18.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.976 -1.078 . . . . 0.0 109.682 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 65.05 37.91 6.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 109.957 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 24.6 t-80 42.33 36.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 110.875 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.39 21.51 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 109.159 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.44 143.38 47.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.206 1.937 . . . . 0.0 111.577 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -108.05 145.92 33.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.924 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 126' ' ' MET . 14.8 ptt? -97.92 121.38 39.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.425 -0.797 . . . . 0.0 108.947 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 m -90.0 119.93 30.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 109.43 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -91.52 18.59 7.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.52 143.06 56.58 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.088 -1.007 . . . . 0.0 109.421 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -105.0 -26.87 11.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.3 p -130.13 163.87 25.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.94 -37.04 70.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m -82.91 4.64 24.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.832 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -98.0 5.05 49.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 127.02 34.99 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.109 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 139.75 36.26 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.901 1.734 . . . . 0.0 112.253 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 t -103.18 -2.49 27.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.822 . . . . 0.0 108.811 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.0 t -134.85 96.34 3.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.6 159.79 35.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -53.94 -40.74 79.68 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.317 1.344 . . . . 0.0 111.399 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.93 67.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 m -60.21 -42.63 95.52 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.56 -0.713 . . . . 0.0 109.467 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -64.76 -41.21 96.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.191 -0.943 . . . . 0.0 109.161 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.415 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -72.76 -29.49 63.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.404 -0.81 . . . . 0.0 108.859 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -47.74 66.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.393 -0.817 . . . . 0.0 109.148 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.521 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 12.1 t -63.82 -42.65 97.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.857 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.47 -42.18 95.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.288 -0.883 . . . . 0.0 110.374 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.33 79.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.721 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.54 -38.87 84.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 109.352 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.11 -38.6 86.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.926 -1.108 . . . . 0.0 108.709 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -81.8 -14.26 56.59 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.451 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -83.38 0.74 44.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.732 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.41 19.92 43.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -100.61 112.83 25.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.623 -0.928 . . . . 0.0 108.622 179.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -97.27 166.46 11.55 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.498 ' O ' ' OG ' ' A' ' 146' ' ' SER . 7.4 p -158.81 41.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.29 174.5 0.2 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.8 p -62.31 -24.28 67.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.14 . . . . 0.0 109.224 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.0 m -66.34 -38.63 88.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 161' ' ' ILE . 23.1 mm -70.04 -44.69 78.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.9 m -61.91 -33.95 75.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.159 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -72.02 -47.83 48.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.969 -1.082 . . . . 0.0 110.709 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 92.7 p -67.35 -32.25 73.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.028 -1.045 . . . . 0.0 109.263 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.7 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -65.53 -37.1 85.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.347 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.403 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 2.1 ttp -69.4 -42.72 74.72 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.155 -0.965 . . . . 0.0 110.849 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 2.2 pt20 -68.74 -41.48 78.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.657 -1.277 . . . . 0.0 111.404 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -77.6 -37.44 50.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.032 -1.042 . . . . 0.0 112.047 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.7 ' SG ' ' CD2' ' A' ' 165' ' ' PHE . 78.8 m -63.7 -44.18 94.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.769 -1.207 . . . . 0.0 111.699 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.39 4.67 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.435 ' CD1' ' CE1' ' A' ' 165' ' ' PHE . 15.9 mt -60.73 -37.12 80.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -1.217 . . . . 0.0 109.581 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -128.25 146.09 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 109.269 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 67.2 m-20 -109.09 164.12 12.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.408 -0.807 . . . . 0.0 110.245 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 91.35 78.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.217 0.532 . . . . 0.0 110.81 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -53.37 -69.31 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.09 155.37 41.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.22 126.87 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.0 109.487 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 80.21 40.03 14.54 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.06 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.636 ' O ' ' N ' ' A' ' 181' ' ' CYS . 17.1 t -68.07 49.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.738 -1.448 . . . . 0.0 108.511 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 60.59 -49.28 0.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.312 0.577 . . . . 0.0 110.077 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.1 t -179.4 71.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 108.703 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.705 ' CD1' ' N ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -59.48 116.37 16.15 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.45 154.53 31.64 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.321 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.97 -29.88 3.3 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -87.12 -1.15 57.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.236 . . . . 0.0 109.91 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 77.33 77.99 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.69 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 C-N-CA 122.878 2.386 . . . . 0.0 112.044 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.823 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.432 0.634 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 178' ' ' GLY . 15.0 pt-20 -95.1 160.98 14.31 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.589 ' CB ' ' CZ ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -105.88 165.99 10.8 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -45.78 127.87 8.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.778 0.799 . . . . 0.0 110.263 -179.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.67 57.04 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.909 ' CZ2' H3A2 ' A' ' 189' ' ' ADK . 2.8 t90 -53.92 -38.75 65.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' CG1' ' NH1' ' A' ' 3' ' ' ARG . 63.3 t -69.53 -36.38 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.64 -0.662 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -71.17 -3.41 19.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.035 . . . . 0.0 110.267 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.34 -38.73 91.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.227 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.77 160.43 30.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.047 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -34.67 14.68 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.91 2.406 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.43 -34.51 76.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.833 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.869 ' OH ' H3A1 ' A' ' 189' ' ' ADK . 2.4 m-85 -57.5 -40.24 78.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.603 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.407 ' H ' HD13 ' A' ' 14' ' ' ILE . 2.5 mp -52.68 -39.54 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.942 -1.099 . . . . 0.0 109.238 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.594 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.85 -48.63 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 109.223 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' HA ' HD21 ' A' ' 19' ' ' ASN . 28.9 t80 -61.49 -38.8 88.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 110.019 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.93 -43.9 94.49 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.451 -0.781 . . . . 0.0 111.707 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -77.51 -10.76 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 78.6 m-20 -78.31 -70.99 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.652 -1.28 . . . . 0.0 110.322 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -167.59 54.88 0.07 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.045 . . . . 0.0 109.362 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 21' ' ' TRP . 7.4 t90 -96.35 63.26 2.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.115 -0.991 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . 105.41 62.15 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.087 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.669 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -159.41 -36.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.227 -1.161 . . . . 0.0 110.742 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 68.4 Cg_endo -99.57 150.92 0.54 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 122.845 2.363 . . . . 0.0 113.204 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.05 147.8 44.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.0 p -109.5 150.96 27.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.662 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.41 164.17 13.12 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -58.98 -34.47 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.901 -1.124 . . . . 0.0 109.72 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -65.17 -40.41 94.27 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.387 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -59.52 -40.89 88.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 mt -60.71 -35.17 75.66 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.619 -0.676 . . . . 0.0 109.698 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -63.37 -52.65 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 110.595 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -68.75 -33.36 73.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.512 -1.367 . . . . 0.0 108.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.98 -39.52 83.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.671 . . . . 0.0 110.149 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 165' ' ' PHE . 1.2 tp -66.56 -28.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 109.519 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.9 m -68.81 -49.79 55.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.944 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -68.86 -45.07 71.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.022 -1.049 . . . . 0.0 109.458 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -63.99 -32.96 74.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.89 44.05 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -72.95 -36.41 67.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.538 -0.978 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.28 -19.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -66.34 112.57 4.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.903 -1.123 . . . . 0.0 109.071 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.72 -36.41 3.53 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 2.4 mm? -103.25 171.2 7.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.136 -1.214 . . . . 0.0 110.203 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.0 m -92.53 154.14 18.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.653 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.58 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.9 OUTLIER -60.61 -41.6 95.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.682 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -44.47 91.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.954 -1.091 . . . . 0.0 108.895 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.7 m -58.11 -39.21 78.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.0 t -64.51 -32.34 57.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.73 -45.86 85.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.051 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.21 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 108.606 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -12.59 59.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.396 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -71.35 -46.49 60.38 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.26 -41.02 90.49 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.62 -34.33 72.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.588 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.566 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 79.6 t80 -58.45 -46.56 86.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.085 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.3 ptm180 -65.29 -28.4 69.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.32 86.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 110.545 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -77.42 -45.77 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.934 -1.104 . . . . 0.0 110.749 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.643 ' C ' ' H ' ' A' ' 62' ' ' GLN . 74.9 m-85 -86.62 -48.75 8.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.838 -1.164 . . . . 0.0 109.918 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 55.71 -26.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.692 -0.63 . . . . 0.0 112.003 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.643 ' H ' ' C ' ' A' ' 60' ' ' PHE . 6.5 pt20 -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.648 -1.283 . . . . 0.0 110.281 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.35 -3.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.386 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 62' ' ' GLN . 6.1 m-20 -98.41 125.67 42.27 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.915 -1.116 . . . . 0.0 108.342 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -38.67 32.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.568 1.512 . . . . 0.0 112.709 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.34 -41.69 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -62.44 -33.71 75.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.038 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.0 -38.41 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.41 -18.0 64.97 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.55 -5.36 59.29 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.3 mmm -80.91 115.32 20.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -95.44 173.48 7.5 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.455 -0.778 . . . . 0.0 110.39 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.54 -31.86 66.5 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.398 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.08 -31.48 72.0 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.766 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.47 -46.63 79.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 110.614 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.49 -37.56 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.681 -1.262 . . . . 0.0 109.413 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.537 ' CD ' HH21 ' A' ' 89' ' ' ARG . 81.2 mm-40 -55.9 -38.29 70.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.875 -1.14 . . . . 0.0 108.145 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -65.69 -41.67 92.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 82' ' ' ASP . 43.1 mt -69.99 -33.08 71.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.843 -0.535 . . . . 0.0 110.742 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' LEU . 24.5 t -47.97 -31.04 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.92 -6.33 32.5 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.619 ' C ' ' H ' ' A' ' 84' ' ' GLY . 64.6 t0 -81.53 106.55 13.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.592 -1.317 . . . . 0.0 109.622 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.06 -16.05 0.12 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.599 -0.688 . . . . 0.0 109.55 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.1 39.81 36.38 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 pt -47.27 151.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -1.038 . . . . 0.0 109.97 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.4 tt -63.89 -26.75 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.459 -0.775 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 87' ' ' ARG . 39.9 mtt-85 -66.64 148.34 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 89' ' ' ARG . 70.9 t60 -132.12 -179.04 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.491 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.631 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 37.7 ttm180 -52.98 -38.0 61.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.917 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.33 -59.62 7.63 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.955 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.57 -44.3 96.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -1.221 . . . . 0.0 111.084 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.24 -46.23 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.711 -1.243 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -51.41 -35.93 41.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.628 -1.295 . . . . 0.0 108.009 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.39 75.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.324 -0.86 . . . . 0.0 109.083 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.2 mt -71.99 -40.97 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 111.176 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.29 -43.03 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.587 -1.321 . . . . 0.0 108.989 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.17 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.415 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 3.5 m120 -60.32 -36.96 79.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -1.148 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.8 89.13 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 0.0 108.334 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -65.97 -34.34 77.89 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.95 -31.72 72.88 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -62.51 -42.48 99.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.5 -31.6 72.42 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.49 -39.87 94.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.186 -0.946 . . . . 0.0 110.364 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.698 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 5.8 ttm -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.795 -1.191 . . . . 0.0 108.94 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.24 -35.27 80.28 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -21.9 66.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -88.47 -13.02 41.36 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.2 27.28 73.79 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.197 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.595 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.1 mt-10 -126.02 100.52 30.23 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.291 . . . . 0.0 109.35 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.81 144.08 27.86 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.263 1.976 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.698 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 71.4 m-85 -60.68 -34.93 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.56 -33.01 66.49 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.293 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -63.19 -48.19 79.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.696 -1.252 . . . . 0.0 111.598 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.502 ' O ' ' OG ' ' A' ' 118' ' ' SER . 2.1 p90 -75.34 -32.93 61.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.808 -1.182 . . . . 0.0 109.886 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 t -59.69 -55.4 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 108.934 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' HIS . 71.9 m95 -62.01 -21.59 65.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 21.6 p -76.04 -34.21 59.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -0.974 . . . . 0.0 109.744 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.435 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 1.8 m-85 -64.7 -36.12 83.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.008 -1.057 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.76 18.02 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.192 -0.943 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 68.01 17.04 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.493 -0.755 . . . . 0.0 109.924 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' N ' ' O ' ' A' ' 117' ' ' TRP . 2.1 t60 61.18 29.2 18.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.116 -0.99 . . . . 0.0 110.122 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -133.3 150.03 74.1 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.213 -0.929 . . . . 0.0 109.866 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.34 145.16 53.0 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.559 2.172 . . . . 0.0 111.989 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.575 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -111.5 131.38 55.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.101 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.575 ' C ' HE22 ' A' ' 125' ' ' GLN . 64.4 mtt -104.85 117.09 33.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 129' ' ' ALA . 1.1 m -97.09 -47.7 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.037 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 59.43 47.13 11.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.543 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 177' ' ' VAL . . . -77.85 157.75 29.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.456 -0.777 . . . . 0.0 109.189 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 t -105.09 -26.18 12.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.61 ' HG1' ' HG ' ' A' ' 133' ' ' SER . 40.3 p -131.5 163.66 27.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -0.903 . . . . 0.0 109.678 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.92 -32.44 70.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.61 ' HG ' ' HG1' ' A' ' 131' ' ' THR . 87.8 p -63.62 -26.25 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.798 . . . . 0.0 110.27 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -87.69 -0.81 57.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.292 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -87.98 128.68 53.0 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.61 140.25 26.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.313 2.009 . . . . 0.0 112.999 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.2 p -118.7 5.91 11.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.3 p -159.05 85.82 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.561 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -98.24 162.16 22.96 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.868 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.32 -40.72 76.96 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.402 1.401 . . . . 0.0 111.071 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -42.87 70.11 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.561 ' OG ' ' N ' ' A' ' 139' ' ' THR . 59.7 p -64.17 -45.47 88.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.466 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -63.93 -40.46 96.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.658 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -70.05 -29.28 66.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.272 -0.892 . . . . 0.0 108.825 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.409 HD11 ' CE2' ' A' ' 115' ' ' PHE . 13.3 tp -64.72 -43.09 94.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.655 -0.653 . . . . 0.0 109.875 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.662 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.05 -43.25 83.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.44 ' CG ' ' NZ ' ' A' ' 151' ' ' LYS . 34.3 ttpt -57.19 -44.77 83.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.478 -0.764 . . . . 0.0 110.788 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.63 70.75 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.001 -1.062 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.76 -38.44 90.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.431 -0.793 . . . . 0.0 109.832 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -41.96 98.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.034 -1.041 . . . . 0.0 109.06 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.44 ' NZ ' ' CG ' ' A' ' 147' ' ' LYS . 60.9 mttp -77.42 -13.45 59.92 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.99 -1.069 . . . . 0.0 110.233 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -7.05 59.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.96 -1.088 . . . . 0.0 108.717 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.46 25.07 8.95 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -104.56 113.59 27.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -1.077 . . . . 0.0 109.145 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 43.2 mttt -90.98 -176.69 4.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.863 . . . . 0.0 110.433 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 6.4 p90 42.48 47.72 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.0 0.905 . . . . 0.0 109.285 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 157' ' ' VAL . 7.3 p -128.62 46.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.37 172.96 1.76 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.5 m -57.86 -33.79 69.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -1.021 . . . . 0.0 110.06 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.429 ' HG1' ' N ' ' A' ' 161' ' ' ILE . 48.2 p -68.6 -31.67 71.01 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.04 -1.037 . . . . 0.0 108.279 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.502 ' O ' ' CE2' ' A' ' 165' ' ' PHE . 31.5 mm -65.88 -44.75 92.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.045 0.926 . . . . 0.0 108.986 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.662 ' SG ' ' N ' ' A' ' 146' ' ' SER . 53.1 m -58.12 -47.82 82.09 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.609 0.718 . . . . 0.0 110.576 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -64.17 -31.36 72.52 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.466 -0.771 . . . . 0.0 110.88 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.414 ' HA ' HE21 ' A' ' 167' ' ' GLN . 98.5 p -61.33 -48.32 81.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.502 ' CE2' ' O ' ' A' ' 161' ' ' ILE . 21.4 m-85 -64.35 -39.28 93.58 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 109.899 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 87.7 mtp -53.33 -37.49 62.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.665 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.703 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 36.1 mt-30 -68.02 -39.46 83.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.652 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.73 -40.16 14.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 111.136 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.8 -28.12 46.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.945 . . . . 0.0 110.634 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.26 -2.75 47.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 171' ' ' LEU . 6.9 mp -60.82 -38.52 85.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.381 -1.07 . . . . 0.0 109.853 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 3.9 p -138.1 151.19 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 111.457 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.406 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 0.7 OUTLIER -114.87 98.09 6.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 53.1 p30 -132.6 21.13 4.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 176' ' ' VAL . 5.9 m170 -49.05 -45.69 43.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.486 -1.384 . . . . 0.0 108.912 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.543 ' CB ' ' O ' ' A' ' 175' ' ' HIS . 3.0 p 145.43 155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' ALA . 69.6 t -57.6 -38.76 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.965 -1.084 . . . . 0.0 110.341 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 2' ' ' GLU . . . -80.16 29.4 2.48 Favored Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.077 -1.014 . . . . 0.0 111.073 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.599 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 26.8 t -76.84 20.48 0.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.869 -1.371 . . . . 0.0 109.34 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.465 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.0 OUTLIER 56.23 3.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 110.273 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.497 ' H ' ' C ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER -134.31 -1.01 2.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 0.0 109.814 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.51 80.49 65.82 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.62 130.67 19.92 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.025 1.817 . . . . 0.0 111.945 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.466 ' O ' ' CG ' ' A' ' 185' ' ' ASN . . . -95.25 -18.79 32.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 184' ' ' GLY . 76.5 m-20 -162.03 -30.32 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -1.148 . . . . 0.0 110.614 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.08 157.45 78.57 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.887 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.773 2.316 . . . . 0.0 112.165 179.761 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.909 H3A2 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.25 0.548 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.548 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 70.0 tt0 -99.34 148.58 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -89.35 175.65 7.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.25 152.99 38.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.803 0.811 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.27 -40.73 60.88 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.711 -0.618 . . . . 0.0 111.967 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.767 ' CZ3' H3A2 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.92 -3.74 58.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.487 -1.596 . . . . 0.0 110.055 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.89 -40.36 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.997 -1.064 . . . . 0.0 109.315 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -77.01 -0.95 26.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 108.811 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 42.8 tt0 -64.46 -41.85 96.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.485 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 173.35 166.13 0.28 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.95 -1.094 . . . . 0.0 109.753 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 13' ' ' TYR . 50.6 Cg_exo -48.18 -167.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.534 2.156 . . . . 0.0 113.075 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.0 mt 63.57 -47.21 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.864 -0.523 . . . . 0.0 109.789 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.8 m-85 -62.51 -39.98 95.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.994 -1.066 . . . . 0.0 109.395 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.91 -44.29 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 110.304 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.631 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.2 -50.23 64.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.767 -1.208 . . . . 0.0 109.361 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.4 t80 -62.03 -42.58 99.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.822 . . . . 0.0 109.769 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -69.76 -41.6 74.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.459 -0.775 . . . . 0.0 110.349 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -74.96 -6.69 50.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 110.55 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-80 -71.77 -76.92 0.1 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.023 -1.048 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' C ' ' A' ' 21' ' ' TRP . 84.5 mt-10 -151.13 -51.85 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.967 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 3.8 t90 24.62 72.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . 116.85 48.92 0.44 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.019 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.753 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.5 m -163.9 -27.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.252 -1.146 . . . . 0.0 112.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.753 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 44.9 Cg_endo -87.14 151.16 8.16 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.661 1.574 . . . . 0.0 113.79 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.11 152.06 29.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.659 ' HG1' ' HE1' ' A' ' 117' ' ' TRP . 2.9 p -94.98 137.87 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.918 -1.114 . . . . 0.0 111.186 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -98.15 157.64 16.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.574 ' C ' ' HH ' ' A' ' 102' ' ' TYR . 16.3 m -55.25 -35.43 64.98 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.503 -1.373 . . . . 0.0 109.067 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -69.45 -36.55 76.71 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.816 -0.552 . . . . 0.0 111.672 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -63.81 -41.46 97.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.746 -1.221 . . . . 0.0 110.619 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 6.7 mp -57.09 -39.0 74.18 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.763 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 78.2 t80 -66.53 -52.58 44.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 110.597 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -67.34 -38.52 84.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 108.923 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 ttm -70.28 -47.9 59.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.505 -0.747 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.86 -31.85 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.868 -1.145 . . . . 0.0 109.441 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.8 m -69.65 -45.9 67.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.008 -1.057 . . . . 0.0 108.983 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.402 HD11 HH11 ' A' ' 53' ' ' ARG . 79.8 mt -67.33 -38.33 84.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.469 -0.77 . . . . 0.0 109.468 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.604 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 65.3 mm-40 -64.82 -35.55 81.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.952 . . . . 0.0 109.862 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.95 -35.27 53.3 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.027 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . 24.8 mt-30 -63.52 -33.65 76.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.275 . . . . 0.0 110.747 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -43.62 -22.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.779 -1.201 . . . . 0.0 110.265 -179.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -54.95 112.65 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.929 -1.107 . . . . 0.0 109.148 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.61 -25.84 1.69 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.7 mm? -102.56 164.97 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -99.47 148.3 24.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.682 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.4 OUTLIER -55.78 -39.98 72.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.006 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.97 -1.081 . . . . 0.0 109.122 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.7 m -64.4 -40.03 95.0 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' ARG . 1.4 t -65.89 -35.79 75.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -55.89 -50.39 70.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.3 mttt -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.596 -1.315 . . . . 0.0 108.864 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mmpp? -63.26 -26.43 68.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' VAL . 17.3 ttm-85 -53.68 -45.87 70.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.4 -41.03 89.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.489 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 9.4 m-80 -69.11 -36.17 77.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.47 -48.6 80.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 110.66 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -69.24 -27.22 65.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.772 -1.205 . . . . 0.0 109.143 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -36.91 75.52 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 m -76.62 -45.9 28.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.948 -1.095 . . . . 0.0 110.193 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' C ' ' H ' ' A' ' 62' ' ' GLN . 25.8 m-85 -83.94 -47.43 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 49.82 7.11 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 109.869 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.613 ' O ' ' N ' ' A' ' 64' ' ' ASP . 89.8 mt-30 -81.11 -29.0 34.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 52.6 p90 44.1 6.96 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.638 -0.664 . . . . 0.0 111.291 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -124.24 135.63 26.66 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.937 -1.102 . . . . 0.0 108.906 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 -15.08 16.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.241 1.96 . . . . 0.0 113.121 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.77 -45.61 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.722 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -34.53 72.73 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -41.41 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.955 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -17.3 63.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.05 55.99 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 95.2 mtp -85.35 114.23 22.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.86 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -95.68 -177.83 4.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.2 -31.19 67.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 110.596 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.58 -49.26 75.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.751 -1.218 . . . . 0.0 108.988 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.92 -38.99 90.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -58.46 -41.95 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -0.76 . . . . 0.0 109.306 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' C ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -60.48 -33.33 72.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.96 . . . . 0.0 109.359 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -69.61 -46.93 65.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.988 . . . . 0.0 110.239 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.89 -32.44 69.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.76 -0.587 . . . . 0.0 112.182 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.7 t -49.47 -27.1 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.746 -1.221 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.42 -9.36 14.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 84' ' ' GLY . 43.3 m-20 -73.49 111.09 8.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.549 -1.344 . . . . 0.0 109.169 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 73.22 -15.75 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.763 . . . . 0.0 109.214 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 76.71 38.94 30.51 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.0 pt -52.03 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.374 -1.074 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.3 mt -65.03 98.07 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.967 -1.083 . . . . 0.0 108.889 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.648 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 3.0 mtt-85 -55.49 132.76 49.25 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.648 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.4 m-70 156.51 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.642 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.6 OUTLIER -54.47 -35.67 63.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.167 -0.958 . . . . 0.0 108.809 -179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.21 -54.43 37.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.93 -43.63 95.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -1.178 . . . . 0.0 109.599 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 92' ' ' ILE . 92.6 mt -58.23 -45.21 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.03 -1.044 . . . . 0.0 109.251 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.65 -33.71 68.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.921 -1.112 . . . . 0.0 109.339 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.3 82.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.045 -1.034 . . . . 0.0 108.459 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.61 -43.6 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.47 -0.769 . . . . 0.0 109.767 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.33 -46.4 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 108.583 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.33 95.41 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -59.07 -37.07 76.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -1.176 . . . . 0.0 109.411 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.0 86.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -0.983 . . . . 0.0 109.641 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -57.87 -38.27 75.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.176 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.27 79.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.574 ' HH ' ' C ' ' A' ' 28' ' ' SER . 41.7 t80 -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -64.16 -42.04 96.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.17 -0.957 . . . . 0.0 109.443 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.643 ' SD ' ' CE1' ' A' ' 112' ' ' PHE . 80.5 mtp -68.66 -39.5 80.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.15 -41.23 86.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.428 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.73 -19.54 65.83 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -92.52 -9.5 41.1 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.41 25.2 75.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -115.45 102.47 54.41 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.372 -1.075 . . . . 0.0 109.297 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.14 148.99 29.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.643 ' CE1' ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -68.73 -43.36 76.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.76 0.791 . . . . 0.0 110.352 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.36 -26.69 64.8 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.053 -1.029 . . . . 0.0 110.689 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -57.41 -49.15 77.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.742 -1.224 . . . . 0.0 110.923 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 8.6 p90 -76.0 -36.35 59.21 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 110.19 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.76 -55.13 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.706 -1.246 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HE1' ' HG1' ' A' ' 26' ' ' THR . 67.5 m95 -58.24 -21.71 49.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.181 -0.949 . . . . 0.0 108.654 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 25.1 p -73.57 -32.59 64.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.927 -1.108 . . . . 0.0 109.846 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -69.63 -30.54 68.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.832 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.09 19.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.098 -1.001 . . . . 0.0 109.405 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 122' ' ' HIS . 69.3 m-20 61.94 42.03 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.0 110.799 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER 41.89 29.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.6 178.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.0 147.67 35.65 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.857 -1.152 . . . . 0.0 109.853 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.62 139.34 88.5 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.302 2.001 . . . . 0.0 111.811 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.9 147.55 36.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.825 . . . . 0.0 109.65 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.6 mtt -95.11 125.97 40.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.188 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -40.92 83.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 108.841 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 62.48 44.94 6.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.635 -0.665 . . . . 0.0 110.401 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -106.74 139.22 41.52 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.5 p -101.05 -14.22 17.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.011 -1.056 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -151.05 169.38 21.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.071 . . . . 0.0 109.963 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.1 -34.72 73.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.43 -0.794 . . . . 0.0 109.338 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -73.89 -11.48 60.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -98.68 14.9 26.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.59 98.34 17.11 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.474 1.449 . . . . 0.0 112.227 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.5 p -97.38 1.86 49.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.393 -0.817 . . . . 0.0 109.446 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -138.79 91.16 2.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.269 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.2 156.16 37.34 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -52.29 -39.2 73.03 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.041 1.827 . . . . 0.0 111.628 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.41 -44.36 52.25 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.066 -1.021 . . . . 0.0 108.605 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 83.6 p -68.02 -37.48 81.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -66.22 -35.64 80.97 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 108.598 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.1 93.06 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.559 -0.713 . . . . 0.0 109.37 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.96 -46.78 87.21 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.097 -1.041 . . . . 0.0 108.517 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.593 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 23.6 m -56.44 -40.63 75.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.692 -1.255 . . . . 0.0 108.921 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -65.9 -50.65 63.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.426 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.37 88.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.33 -38.82 85.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.973 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -61.25 -40.19 93.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.877 -1.14 . . . . 0.0 109.195 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -65.87 -33.55 76.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 110.374 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.568 ' O ' ' NE2' ' A' ' 104' ' ' GLN . 2.5 mmp_? -72.24 2.94 5.14 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.04 -1.038 . . . . 0.0 108.876 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.16 52.46 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.72 115.44 27.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.723 -0.869 . . . . 0.0 108.781 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -89.34 167.41 13.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.624 -0.673 . . . . 0.0 110.397 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 57.62 59.87 3.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.619 -0.676 . . . . 0.0 109.956 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 22.6 m -131.56 33.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.539 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.08 164.19 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.4 p -58.91 -22.88 60.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -1.137 . . . . 0.0 108.889 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -75.76 -32.69 60.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.445 HD13 HG22 ' A' ' 161' ' ' ILE . 22.5 mm -67.69 -45.25 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.593 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 94.6 m -63.04 -40.21 97.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.399 0.618 . . . . 0.0 109.867 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -70.07 -41.92 73.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.556 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.3 m -60.66 -44.54 96.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -0.838 . . . . 0.0 108.97 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.573 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 3.0 t80 -62.92 -40.05 96.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.823 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.93 -40.23 88.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.569 -0.707 . . . . 0.0 112.765 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.4 pt20 -79.66 -46.34 17.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.193 -1.567 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -73.28 -28.63 62.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.955 -1.091 . . . . 0.0 111.364 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 30.4 p -67.1 -29.75 69.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 111.39 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 109.01 -1.8 31.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.515 ' H ' ' HG ' ' A' ' 169' ' ' CYS . 27.5 mt -61.01 -36.31 79.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.091 -1.241 . . . . 0.0 110.324 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.4 151.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.055 -1.028 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 81.8 m-20 -114.77 162.98 16.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.606 -0.684 . . . . 0.0 110.102 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 96.42 75.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.098 0.475 . . . . 0.0 110.008 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.457 ' NE2' ' O ' ' A' ' 21' ' ' TRP . 21.0 m170 -52.11 -41.05 62.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.116 -0.99 . . . . 0.0 108.71 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 176' ' ' VAL . 7.7 p -168.54 28.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 176' ' ' VAL . 42.0 t 56.19 118.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.0 109.906 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . 91.56 9.52 62.87 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.236 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 181' ' ' CYS . 1.7 t -70.38 149.53 47.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.279 . . . . 0.0 108.951 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 96.4 m -50.01 -27.45 5.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 179' ' ' CYS . 26.8 p -109.43 45.47 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 108.996 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -103.99 105.61 49.3 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.183 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.94 150.4 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.27 1.98 . . . . 0.0 112.077 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 146.5 -24.74 1.68 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 186' ' ' LYS . 3.3 m120 -91.8 8.02 39.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.423 -1.045 . . . . 0.0 110.191 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 185' ' ' ASN . 0.0 OUTLIER 56.81 153.05 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 186' ' ' LYS . 97.3 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 122.939 2.426 . . . . 0.0 112.56 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.967 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -100.39 144.81 28.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.972 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -53.73 -42.35 68.02 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.428 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -178.1 154.55 0.88 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.17 -45.3 95.54 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.548 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.765 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.8 -4.41 58.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.361 -1.67 . . . . 0.0 109.988 -178.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.14 -41.1 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.131 -0.98 . . . . 0.0 109.333 178.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.7 -9.59 58.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 108.875 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -69.63 -39.97 76.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -0.791 . . . . 0.0 111.257 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.26 157.59 30.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.508 -1.37 . . . . 0.0 111.239 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' TYR . 18.3 Cg_endo -63.5 179.96 0.81 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.251 2.634 . . . . 0.0 112.286 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.1 mt 66.24 -44.14 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.598 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.2 OUTLIER -55.44 -35.69 65.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.15 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 1.9 mp -54.24 -43.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.07 . . . . 0.0 108.984 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.661 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -64.88 -49.27 71.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -58.36 -37.0 74.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.204 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -62.49 -45.33 93.49 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.141 -0.975 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -83.27 -2.59 56.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.661 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 25.6 m-80 -76.5 -75.17 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.838 -1.164 . . . . 0.0 109.159 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -168.98 69.11 0.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.143 -0.973 . . . . 0.0 109.76 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.852 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.4 t90 -79.83 60.71 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.978 -1.076 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.45 64.19 1.46 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.583 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.716 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -137.87 -33.73 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.2 -1.176 . . . . 0.0 111.041 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.716 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 64.8 Cg_endo -97.08 150.45 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.737 2.291 . . . . 0.0 113.395 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.9 147.64 51.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -101.71 151.45 22.02 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.543 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 5.9 t70 -94.35 157.01 16.23 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 m -50.29 -32.76 17.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -178.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -71.51 -39.31 70.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.681 -0.637 . . . . 0.0 111.63 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -62.66 -39.12 92.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.836 -1.165 . . . . 0.0 110.276 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 27' ' ' ASP . 6.1 mp -56.45 -40.08 74.22 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.786 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 89.8 t80 -62.56 -46.66 87.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -71.53 -36.45 71.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.051 -1.031 . . . . 0.0 109.078 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.1 ttm -69.13 -47.9 63.83 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.047 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.15 -29.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.52 -1.362 . . . . 0.0 109.912 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 86.1 m -68.49 -52.75 28.84 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.493 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.6 mt -64.9 -40.19 94.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.585 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 66.1 mm-40 -63.43 -31.13 72.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.026 -1.046 . . . . 0.0 108.573 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 -37.08 85.07 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 42' ' ' ALA . 96.2 mt-30 -58.65 -35.05 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.826 -0.808 . . . . 0.0 111.459 -178.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.762 ' NE2' ' N7 ' ' A' ' 189' ' ' ADK . 6.4 pt20 -70.96 9.59 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.631 -1.293 . . . . 0.0 110.177 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -54.96 112.92 1.15 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.937 -1.102 . . . . 0.0 108.589 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.15 -14.37 0.44 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 42' ' ' ALA . 31.2 tp -106.77 145.95 31.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.562 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.0 157.13 4.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.702 0.763 . . . . 0.0 111.198 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.692 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.1 OUTLIER -74.82 -37.07 62.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.796 -0.565 . . . . 0.0 110.119 179.316 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -40.36 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.021 -1.049 . . . . 0.0 110.077 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.7 m -57.6 -38.5 75.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.09 -1.006 . . . . 0.0 108.34 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.5 t -65.06 -33.75 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.722 -0.611 . . . . 0.0 109.367 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.47 -48.66 78.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -63.02 -45.8 90.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.968 -1.083 . . . . 0.0 109.441 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -79.26 -8.99 59.47 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.266 -179.08 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.99 -54.45 13.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.756 -1.215 . . . . 0.0 108.492 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -39.96 94.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.498 -0.751 . . . . 0.0 109.733 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 85' ' ' ILE . 39.7 t30 -74.96 -46.49 35.15 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.15 -0.969 . . . . 0.0 110.893 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 59.4 t80 -63.41 -49.2 74.71 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.095 -1.003 . . . . 0.0 110.139 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.656 HH12 ' CD2' ' A' ' 61' ' ' HIS . 3.6 ptm180 -58.12 -33.92 69.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.89 -1.131 . . . . 0.0 109.13 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.88 82.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 110.177 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.4 -43.67 63.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.819 -1.176 . . . . 0.0 110.505 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 84.1 m-85 -93.32 7.67 43.5 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 110.134 -179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.656 ' CD2' HH12 ' A' ' 57' ' ' ARG . 6.6 t-80 -53.73 -53.54 50.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.869 -1.145 . . . . 0.0 109.61 -179.325 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -68.16 -30.44 69.56 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.433 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 58.2 m-85 -109.32 73.53 0.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -46.35 0.12 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -97.11 -113.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.353 2.035 . . . . 0.0 115.584 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.77 -34.97 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.909 -1.12 . . . . 0.0 108.853 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 -38.19 68.88 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 63' ' ' PHE . 65.7 t -63.73 -36.4 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.7 -17.59 64.72 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.25 -14.86 25.06 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.466 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 42.5 mmm -73.86 111.21 8.79 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.594 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 8.8 mt-30 -97.06 172.17 8.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.12 -29.25 29.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.46 -45.9 80.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.892 -1.13 . . . . 0.0 109.323 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.7 p30 -66.05 -36.36 83.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 108.577 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 80.7 t -62.19 -44.13 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 110.487 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.84 -39.64 78.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -66.23 -39.56 89.65 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.59 0.709 . . . . 0.0 109.349 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mt -64.56 -32.68 74.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.654 -0.654 . . . . 0.0 111.136 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.6 t -48.91 -35.2 6.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -113.61 4.24 16.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.87 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 43.4 t0 -90.58 111.21 22.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.546 -1.346 . . . . 0.0 110.625 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 76.6 -16.73 0.6 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.547 -0.721 . . . . 0.0 109.658 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.34 28.32 60.12 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.301 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 87' ' ' ARG . 23.2 pt -57.03 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.083 -1.246 . . . . 0.0 109.779 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.568 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 1.5 tt -58.63 76.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.174 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.26 117.39 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.3 OUTLIER -158.69 -34.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.44 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.541 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 65.45 -36.66 0.23 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.902 -0.498 . . . . 0.0 110.401 178.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 88' ' ' HIS . . . -73.51 -59.49 4.11 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.269 -1.443 . . . . 0.0 109.585 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.61 -33.55 72.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -1.069 . . . . 0.0 109.9 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.8 mt -64.98 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -32.38 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.89 -39.26 90.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 109.159 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.07 -35.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.189 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 96' ' ' ILE . 20.8 mm -62.26 -47.63 92.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 109.489 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.69 71.95 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 98' ' ' ASN . 1.6 m-80 -68.97 -35.54 76.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.128 -1.219 . . . . 0.0 110.536 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.05 90.69 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 108.854 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.59 -35.92 81.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.05 179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.33 70.5 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.68 -40.46 96.86 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.28 -34.08 77.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.78 -37.12 86.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 110.087 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CD1' ' A' ' 112' ' ' PHE . 8.6 ttm -65.92 -43.05 89.25 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.923 -1.11 . . . . 0.0 109.316 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -63.18 -36.75 84.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.613 -0.679 . . . . 0.0 109.352 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.77 -18.75 64.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.57 -16.36 25.78 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.91 27.06 73.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.545 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.5 mm-40 -114.58 101.57 54.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 110.065 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.97 141.67 45.89 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.16 1.907 . . . . 0.0 112.485 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CD1' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -55.5 -44.0 76.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.701 0.762 . . . . 0.0 111.246 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.42 -27.75 64.51 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 111.023 -178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -61.86 -47.71 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.014 -1.054 . . . . 0.0 111.368 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 4.5 p90 -76.56 -33.48 58.52 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.708 -1.245 . . . . 0.0 109.671 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.48 -55.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.826 -1.171 . . . . 0.0 110.45 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CH2' HD21 ' A' ' 171' ' ' LEU . 73.8 m95 -60.02 -22.89 63.2 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 109.268 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 83.1 p -70.74 -37.04 73.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.017 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.438 ' N ' ' HG ' ' A' ' 118' ' ' SER . 14.2 m-85 -65.67 -35.97 82.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.691 -1.256 . . . . 0.0 108.596 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.22 14.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.317 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 59.16 37.05 24.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 117' ' ' TRP . 4.9 m80 46.39 24.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.061 -1.024 . . . . 0.0 109.768 179.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 149.01 71.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.502 -0.749 . . . . 0.0 110.239 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.56 144.41 66.55 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.056 2.504 . . . . 0.0 111.841 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -111.52 137.2 49.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.866 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 87.9 mtp -92.3 131.09 37.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.728 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -78.62 -41.98 30.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 56.85 45.11 22.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.987 -1.071 . . . . 0.0 109.376 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.404 ' H ' HG21 ' A' ' 127' ' ' THR . . . -102.03 140.44 36.31 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.6 p -97.1 -24.0 15.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.101 -0.999 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -140.99 166.2 25.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 108.834 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.34 -35.07 76.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.55 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -64.74 -27.57 68.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.787 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.85 3.74 16.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 135' ' ' ILE . 2.3 tp -91.29 123.84 63.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.56 138.19 13.49 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.023 1.815 . . . . 0.0 112.409 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.5 p -108.27 14.37 24.97 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.2 p -153.92 84.61 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.64 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.588 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.6 OUTLIER -105.15 157.14 34.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.101 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.14 -40.65 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.466 1.444 . . . . 0.0 111.848 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -41.55 70.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.021 -1.05 . . . . 0.0 108.306 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.616 ' HG ' ' N ' ' A' ' 143' ' ' ASP . 97.4 p -64.53 -43.9 92.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.687 . . . . 0.0 109.373 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.616 ' N ' ' HG ' ' A' ' 142' ' ' SER . 95.5 m-20 -62.57 -36.5 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.143 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.77 -31.16 72.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.759 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.64 -47.46 59.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.944 -1.097 . . . . 0.0 109.575 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.606 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 1.7 m -57.8 -46.1 85.13 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.536 -1.353 . . . . 0.0 110.532 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -70.5 -39.3 74.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.814 -1.179 . . . . 0.0 109.653 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.14 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.543 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.46 -35.96 81.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.057 -1.027 . . . . 0.0 109.415 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.07 -42.42 98.47 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 109.582 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -67.79 -32.43 73.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.469 -0.769 . . . . 0.0 111.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -68.14 -8.31 37.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.749 -1.219 . . . . 0.0 109.103 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.09 31.36 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -95.99 117.62 31.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.586 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 23.1 mtmt -90.47 -175.28 4.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.506 0.67 . . . . 0.0 110.813 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 8.5 p90 47.45 48.6 16.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.525 0.678 . . . . 0.0 110.344 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.59 39.95 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.17 164.06 0.44 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -57.17 -33.57 67.58 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.32 -1.106 . . . . 0.0 109.862 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.3 p -71.29 -34.36 70.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 108.844 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 161' ' ' ILE . 16.2 mm -60.54 -44.15 95.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.606 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 63.2 m -65.45 -32.67 74.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.647 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -68.79 -44.77 72.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.005 -1.06 . . . . 0.0 109.564 179.728 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.3 p -63.92 -37.37 87.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 108.762 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 57.7 t80 -60.82 -41.43 95.73 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.826 0.822 . . . . 0.0 109.142 178.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 37.1 mmm -59.33 -40.31 85.94 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.838 -0.539 . . . . 0.0 111.457 -178.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.647 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.7 pt20 -80.21 -47.27 14.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.606 -1.309 . . . . 0.0 110.997 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.68 -17.84 64.16 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.805 -1.184 . . . . 0.0 110.634 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 66.4 m -83.32 -19.6 35.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.836 -1.165 . . . . 0.0 111.822 -178.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.51 1.25 64.23 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.404 HD21 ' CH2' ' A' ' 117' ' ' TRP . 94.2 mt -65.77 -35.24 80.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.704 -0.88 . . . . 0.0 109.357 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.14 135.93 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 108.915 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 58.8 m-20 -114.52 162.69 16.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.92 -179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.7 OUTLIER 92.05 79.11 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.224 0.535 . . . . 0.0 110.605 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -54.84 -70.6 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.158 -0.964 . . . . 0.0 108.629 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.62 148.28 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 108.831 179.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.16 130.92 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.617 -1.302 . . . . 0.0 109.121 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.29 40.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -95.43 123.42 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.041 -1.27 . . . . 0.0 109.13 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.475 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 39.56 27.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 179' ' ' CYS . 11.1 t 51.73 45.64 27.83 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -61.34 129.25 90.78 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.65 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 17.3 Cg_exo -51.85 121.52 8.85 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.583 1.522 . . . . 0.0 111.671 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.54 -24.12 0.05 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -89.46 -72.94 0.53 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.326 -1.102 . . . . 0.0 109.508 -179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -67.15 149.69 98.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo . . . . . 0 C--N 1.308 -1.586 0 C-N-CA 122.575 2.183 . . . . 0.0 112.468 179.908 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.852 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.313 0.578 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 178' ' ' GLY . 7.7 tp10 -99.07 142.69 30.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -58.79 -59.04 6.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.72 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.46 -25.04 57.39 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.715 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 2.7 t90 -99.06 27.8 4.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -1.23 . . . . 0.0 109.986 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.54 -27.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.903 -1.123 . . . . 0.0 111.321 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.7 m -79.86 -2.75 44.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.701 -1.249 . . . . 0.0 109.16 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 6' ' ' TRP . 59.4 mt-30 -66.63 -37.74 85.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.341 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.36 158.77 8.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.669 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.6 Cg_endo -60.57 -163.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.809 2.339 . . . . 0.0 112.164 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp 61.0 -46.52 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.919 -0.488 . . . . 0.0 110.054 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.88 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 1.6 m-85 -59.39 -37.86 79.05 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 109.451 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 14' ' ' ILE . 3.0 mp -54.89 -44.75 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.638 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.4 85.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.907 -1.121 . . . . 0.0 108.995 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.552 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 23.5 t80 -65.52 -36.17 83.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -58.91 -44.29 91.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 112.214 -178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.79 -0.55 45.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.917 -1.115 . . . . 0.0 112.271 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.784 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -99.98 -30.66 11.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.536 -1.352 . . . . 0.0 112.068 -178.48 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.784 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 89.9 mt-10 -160.29 22.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.431 -1.418 . . . . 0.0 109.825 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.552 ' CE3' ' CE2' ' A' ' 16' ' ' TYR . 3.1 t90 -106.15 72.43 0.93 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 110.461 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.04 4.41 35.85 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.285 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.0 m -115.0 -21.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.0 112.431 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 85.8 Cg_endo -86.75 150.46 8.62 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.925 1.75 . . . . 0.0 114.293 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -88.08 159.31 18.29 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.541 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 2.6 p -84.08 122.53 28.93 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.776 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -106.12 167.25 9.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -74.52 -38.08 62.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.101 -1.624 . . . . 0.0 110.681 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -74.12 -50.46 19.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -0.901 . . . . 0.0 112.343 -177.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -57.82 -36.79 72.75 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.072 -1.018 . . . . 0.0 109.804 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 5.8 mp -66.76 -35.32 79.81 Favored 'General case' 0 C--N 1.286 -2.168 0 O-C-N 121.634 -0.666 . . . . 0.0 109.923 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.07 -48.11 83.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.538 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.62 -27.62 60.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.842 -1.161 . . . . 0.0 109.598 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.551 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 60.1 ttm -66.72 -50.93 61.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.664 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.44 -34.22 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 0.0 108.924 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 85.6 m -71.8 -51.95 20.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.927 . . . . 0.0 109.604 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.494 HD13 HH11 ' A' ' 53' ' ' ARG . 24.6 mt -67.16 -38.69 85.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.728 ' HE2' HN61 ' A' ' 189' ' ' ADK . 6.8 tp10 -62.75 -33.38 75.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.72 -36.4 93.24 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 4.8 mp0 -63.11 -26.58 68.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.047 -1.267 . . . . 0.0 110.691 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.627 ' CD ' ' H8 ' ' A' ' 189' ' ' ADK . 1.9 pt20 -66.37 -2.94 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.853 -1.154 . . . . 0.0 110.856 -178.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -60.31 112.47 1.95 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.612 -1.305 . . . . 0.0 108.595 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.97 -7.93 2.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . 25.5 tp -109.95 144.8 37.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -1.205 . . . . 0.0 109.957 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.3 m -64.12 149.98 46.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.516 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.88 -38.48 61.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.698 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -35.81 63.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.98 -1.075 . . . . 0.0 108.309 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.1 m -61.06 -44.24 97.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -69.1 -25.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.0 tt -63.79 -51.65 63.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 54.7 mttt -60.33 -44.41 95.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.661 -1.275 . . . . 0.0 108.13 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -74.29 -10.46 59.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 53' ' ' ARG . 16.3 ttm-85 -64.63 -45.13 88.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 57.2 mp0 -70.69 -44.15 67.57 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.608 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 11.0 m-80 -69.92 -39.81 75.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.93 -1.106 . . . . 0.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.81 -48.19 82.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 111.097 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -65.7 -27.33 68.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 109.266 -179.729 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.31 -42.54 99.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.907 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -74.38 -45.57 46.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.923 -1.111 . . . . 0.0 109.983 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' HIS . 61.7 m-85 -79.72 -45.79 18.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.021 -1.049 . . . . 0.0 110.258 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER 43.24 29.92 0.25 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.5 pt20 -54.12 -45.41 71.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.697 . . . . 0.0 111.067 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER 42.63 18.92 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.368 -0.832 . . . . 0.0 110.391 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 62' ' ' GLN . 2.5 m-20 -171.9 136.73 0.94 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.036 -1.04 . . . . 0.0 109.459 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.16 -35.4 8.76 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.43 2.086 . . . . 0.0 112.995 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.08 -41.07 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.949 -1.094 . . . . 0.0 109.164 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -33.94 76.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.73 -41.68 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.643 -0.661 . . . . 0.0 109.552 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.85 -14.23 62.79 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.65 -9.49 49.41 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.281 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.9 mtp -78.18 113.07 15.79 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -95.31 177.95 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.974 . . . . 0.0 109.964 -178.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -55.13 -28.68 54.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.783 . . . . 0.0 110.667 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -63.17 -41.24 99.2 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.106 -1.621 . . . . 0.0 109.134 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.53 -38.72 90.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.393 -0.817 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -31.27 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.667 -1.27 . . . . 0.0 109.204 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.03 -39.63 90.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.085 -1.009 . . . . 0.0 110.548 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' ' N ' ' A' ' 79' ' ' LEU . 7.6 ptp180 -74.33 -40.79 61.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.709 -1.244 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 15.9 mt -65.8 -33.21 75.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -48.57 -30.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.453 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -106.53 -0.33 24.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.443 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 84' ' ' GLY . 66.5 t0 -80.43 107.95 13.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.499 -1.376 . . . . 0.0 109.55 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.68 -14.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.668 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 68.42 35.9 82.88 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -28.0 -91.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.165 -0.609 . . . . 0.0 110.592 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -175.98 -44.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -0.967 . . . . 0.0 109.575 179.679 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -64.22 156.04 29.98 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.155 -0.966 . . . . 0.0 110.034 -178.65 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -106.68 169.52 8.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.589 0.709 . . . . 0.0 109.631 -179.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.14 -33.72 63.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.51 -59.18 5.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.406 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 11.6 tptm -60.63 -42.64 97.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.723 -1.457 . . . . 0.0 110.163 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -57.17 -47.38 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.992 -1.068 . . . . 0.0 109.766 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.07 -31.99 44.69 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.742 -1.224 . . . . 0.0 108.289 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.03 77.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.013 -1.054 . . . . 0.0 109.089 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.86 -45.54 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.187 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.39 -36.35 72.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.899 -1.126 . . . . 0.0 109.078 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.41 -36.39 83.81 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -60.51 -35.9 77.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.537 -0.978 . . . . 0.0 108.573 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.462 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -53.27 -41.19 65.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' ' CE2' ' A' ' 154' ' ' PHE . . . -65.28 -31.55 72.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.887 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.06 -44.36 97.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -61.41 -35.81 78.58 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.55 -34.0 77.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.331 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 36.0 ttm -63.78 -40.93 97.88 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -38.42 91.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.1 m120 -90.47 -14.73 32.2 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.48 27.87 73.54 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.965 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.4 tp10 -124.79 102.03 32.4 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.996 -1.296 . . . . 0.0 110.124 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.69 150.09 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.012 1.808 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -61.23 -45.08 96.04 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.127 0.965 . . . . 0.0 110.052 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.37 66.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.702 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -68.83 -45.18 71.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.438 -1.414 . . . . 0.0 112.214 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.0 p90 -70.99 -36.22 72.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.471 -1.393 . . . . 0.0 110.501 -178.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 ' CG1' ' CZ ' ' A' ' 115' ' ' PHE . 31.3 m -65.42 -52.44 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 119.961 -1.712 . . . . 0.0 109.542 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.541 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 50.9 m95 -56.63 -22.68 35.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 108.508 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.6 p -74.39 -35.7 63.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.978 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 9.7 m-85 -68.22 -29.43 68.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.195 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.67 18.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.513 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 122' ' ' HIS . 15.7 m120 58.95 39.43 23.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.3 t60 40.57 29.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -127.26 146.93 59.9 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.38 140.39 52.7 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.606 2.204 . . . . 0.0 112.186 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -107.23 127.97 54.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 108.783 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 mtt -101.72 122.73 44.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.67 116.41 28.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -93.38 21.86 5.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.988 . . . . 0.0 109.988 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.38 51.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.383 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 99.0 m -93.65 -31.21 14.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.4 p -133.52 162.89 30.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.02 -35.48 71.33 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.136 -0.978 . . . . 0.0 108.952 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 m -60.55 -25.38 66.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -88.89 -4.38 58.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 0.0 109.713 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.85 130.7 37.7 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 147.45 26.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.233 1.956 . . . . 0.0 112.513 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -103.44 9.53 37.68 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -144.93 98.82 3.24 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.234 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.425 ' N ' ' OG ' ' A' ' 142' ' ' SER . 10.0 p -109.14 155.01 41.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.59 -39.37 75.61 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.979 1.786 . . . . 0.0 111.441 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.38 62.31 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.386 -0.926 . . . . 0.0 108.786 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 139' ' ' THR . 94.7 p -65.31 -39.22 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.428 -0.795 . . . . 0.0 109.981 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.482 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -63.12 -34.31 77.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.537 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.67 -47.84 81.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.942 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.566 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 27.8 m -60.87 -44.96 96.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.845 -1.159 . . . . 0.0 109.543 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -67.81 -44.22 77.83 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.487 -0.758 . . . . 0.0 109.598 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.38 -41.8 80.03 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.498 -0.751 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.439 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 26.2 mt -68.01 -44.35 76.74 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -62.21 -42.44 99.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.66 -31.54 70.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 111.371 -178.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.439 ' NH2' ' CD2' ' A' ' 149' ' ' LEU . 86.5 mtm180 -80.25 4.25 18.25 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.963 -1.085 . . . . 0.0 110.159 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.41 20.74 34.14 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.946 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' ' CB ' ' A' ' 101' ' ' ALA . 36.4 m-85 -102.82 110.91 23.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.132 -1.216 . . . . 0.0 108.772 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -91.72 172.59 8.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.404 ' CE1' ' HE3' ' A' ' 91' ' ' LYS . 63.4 m-85 58.27 69.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.185 0.993 . . . . 0.0 108.842 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 158' ' ' GLY . 30.2 m -150.93 38.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -43.72 166.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -58.07 -28.96 65.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.558 -0.966 . . . . 0.0 109.217 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.7 p -73.31 -31.39 63.99 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.1 mm -69.76 -44.96 78.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.566 ' SG ' ' OG ' ' A' ' 146' ' ' SER . 35.9 m -66.26 -34.84 78.91 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.537 0.684 . . . . 0.0 109.871 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -70.57 -45.29 65.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.911 . . . . 0.0 109.644 -179.613 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.509 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 93.3 p -67.81 -32.03 72.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.038 . . . . 0.0 108.422 178.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.581 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 42.9 t80 -58.67 -45.25 89.82 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.753 -0.592 . . . . 0.0 109.706 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 81.3 mtp -66.4 -38.71 88.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.538 ' CG ' ' HE1' ' A' ' 21' ' ' TRP . 1.2 tp-100 -64.26 -46.08 85.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.371 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.63 -37.75 49.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 58.3 m -56.77 -28.68 61.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 110.03 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.52 2.95 56.48 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.84 -33.85 76.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -1.089 . . . . 0.0 109.814 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.36 130.09 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 70.0 m-20 -108.55 163.82 12.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.434 -0.791 . . . . 0.0 109.939 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.7 m-20 86.13 74.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.228 0.537 . . . . 0.0 110.016 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.48 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 23.3 m80 -54.93 -61.4 2.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.815 . . . . 0.0 109.065 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.25 152.66 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.627 -0.671 . . . . 0.0 109.197 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.76 130.81 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.02 -1.05 . . . . 0.0 109.026 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 2' ' ' GLU . . . 90.12 10.54 64.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -73.1 144.48 46.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.15 . . . . 0.0 109.329 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -42.98 -33.5 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 109.553 -179.592 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.41 34.6 1.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.193 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 t80 -123.43 85.96 52.25 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.463 -0.773 . . . . 0.0 109.476 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 185' ' ' ASN . 69.4 Cg_endo -83.98 -71.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.674 2.249 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.54 -51.04 0.64 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 186' ' ' LYS . 21.9 p-10 -130.22 -20.43 3.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -1.081 . . . . 0.0 109.804 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 17.4 mmtm -63.79 149.1 93.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 108.776 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 186' ' ' LYS . 11.0 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 C-N-CA 122.107 1.871 . . . . 0.0 111.844 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.88 H3A2 ' OH ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' A' ' 1' ' ' MET . 49.9 tp10 -103.07 144.97 30.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 110.069 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -66.46 160.31 25.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 126.47 27.44 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.878 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.89 -20.67 20.33 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.931 ' CE2' H3A3 ' A' ' 189' ' ' ADK . 1.3 t90 -95.53 -4.31 45.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 110.21 -179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.88 -26.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -3.61 28.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 110.065 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 89.6 mm-40 -65.96 -48.45 71.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.987 -1.071 . . . . 0.0 110.67 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.89 153.8 23.21 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.848 -1.158 . . . . 0.0 109.837 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -54.77 -32.87 78.53 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.159 1.906 . . . . 0.0 113.421 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.3 mt -59.86 -35.16 74.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.774 -1.204 . . . . 0.0 110.328 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -62.21 -34.61 76.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.881 -1.137 . . . . 0.0 109.942 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.63 -42.74 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.917 -1.114 . . . . 0.0 108.935 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.84 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.68 ' HH ' HN62 ' A' ' 189' ' ' ADK . 61.7 t80 -65.42 -42.83 92.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.53 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -64.89 -36.25 83.76 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.2 -0.938 . . . . 0.0 110.684 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -74.6 -19.03 60.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 112.303 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 33.4 p30 -88.31 -55.18 3.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.47 -177.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.689 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 16.0 pt-20 -163.73 68.74 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.093 -1.63 . . . . 0.0 111.856 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.779 ' CZ3' ' HC2' ' A' ' 189' ' ' ADK . 31.3 t-105 -77.6 64.35 2.89 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.24 44.66 27.89 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.3 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.666 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.4 t -107.01 -32.85 0.18 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.344 -1.092 . . . . 0.0 110.682 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.0 Cg_endo -87.57 154.76 7.7 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 123.116 2.544 . . . . 0.0 112.705 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.94 162.17 17.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.08 115.25 26.48 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.421 -176.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 93.8 m-20 -89.77 157.98 17.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 178.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 20.7 m -65.89 -45.86 80.46 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.051 -1.656 . . . . 0.0 111.325 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 32' ' ' PHE . 39.1 mmtm -63.6 -51.06 66.91 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.338 -0.851 . . . . 0.0 112.362 -177.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -56.9 -36.76 70.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 108.148 -179.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 31' ' ' LEU . 9.4 mp -65.8 -30.6 71.27 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.24 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 28' ' ' SER . 4.8 m-30 -58.92 -50.84 72.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.39 -1.324 . . . . 0.0 107.89 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -68.38 -44.63 74.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.283 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 36.4 tpp -50.84 -49.99 57.63 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.256 -0.902 . . . . 0.0 111.121 -178.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.87 -29.09 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.6 -1.313 . . . . 0.0 109.25 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -71.25 -47.93 54.14 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.8 -40.35 83.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.867 -1.146 . . . . 0.0 109.503 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 70.6 mm-40 -59.11 -36.51 75.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 108.983 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.46 -32.62 78.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.1 -1.4 44.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -1.1 . . . . 0.0 109.991 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -89.4 -7.51 55.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.005 -179.837 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.53 120.14 13.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.997 -1.064 . . . . 0.0 109.073 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.65 -37.84 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 44' ' ' LEU . 5.7 mp -98.98 148.79 23.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 109.883 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -66.67 153.71 42.46 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.651 ' CE3' ' C5 ' ' A' ' 189' ' ' ADK . 0.9 OUTLIER -58.13 -35.21 71.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.295 -179.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -29.12 46.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.9 m -61.27 -41.36 96.81 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.893 -1.13 . . . . 0.0 109.37 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -70.26 -30.24 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 109.181 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.73 -46.76 88.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.6 mtmt -63.29 -44.63 94.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.85 -1.156 . . . . 0.0 108.784 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -77.02 -9.62 58.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 108.723 179.345 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.5 ttm180 -67.12 -46.26 74.67 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.23 -42.88 92.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 17.1 m-80 -69.41 -41.73 76.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.822 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.9 t80 -61.39 -44.52 97.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.504 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NH2' ' CE1' ' A' ' 61' ' ' HIS . 17.7 mmm180 -57.6 -38.48 74.98 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.414 -0.803 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.9 -34.51 75.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.283 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.0 m -72.94 -43.75 61.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.234 -0.916 . . . . 0.0 111.161 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -99.3 10.28 41.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.664 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' CE1' ' NH2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -62.29 10.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.908 -1.12 . . . . 0.0 110.195 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.602 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 77.2 mt-30 -72.05 -37.21 69.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.611 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 90.2 m-85 -159.64 -95.36 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 149.36 -41.04 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.285 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 64' ' ' ASP . 42.4 Cg_endo -102.4 -103.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.638 2.226 . . . . 0.0 115.689 -176.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 0.0 112.077 -176.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -33.83 64.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.751 -1.218 . . . . 0.0 108.921 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.78 -37.41 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 0.0 108.355 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.15 64.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.53 -6.22 50.12 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.059 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.44 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 89.8 mtp -75.62 114.16 13.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.597 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 6.3 tt0 -95.32 171.68 8.56 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.508 0.67 . . . . 0.0 110.128 -177.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 99.2 mt-10 -53.24 -28.52 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -56.56 -50.7 71.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.882 -1.136 . . . . 0.0 108.898 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.6 p30 -63.83 -37.02 85.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 108.786 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 76.3 t -56.47 -41.84 73.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 108.983 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -57.82 -40.8 80.85 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -62.32 -43.7 98.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' GLN . 53.2 mt -67.53 -33.69 75.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.03 -16.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 108.736 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -122.87 -9.76 8.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.271 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 84' ' ' GLY . 76.1 m-20 -74.07 109.18 7.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.279 -1.513 . . . . 0.0 109.966 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.4 -13.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.58 -0.7 . . . . 0.0 109.615 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.11 37.2 38.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.5 pt -53.0 -166.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mm -54.07 90.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 85' ' ' ILE . 24.4 ttp180 -62.02 112.75 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.013 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.3 m-70 169.46 81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' HIS . 25.6 ptt180 -42.64 -38.52 2.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.581 -0.7 . . . . 0.0 110.114 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.79 -54.5 36.89 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -62.54 -39.96 95.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.245 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -60.9 -39.81 83.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.836 -1.165 . . . . 0.0 108.798 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.591 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 93.3 mt-30 -55.39 -36.8 66.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.845 -1.159 . . . . 0.0 108.463 178.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.24 87.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 108.974 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.58 -44.24 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.805 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.1 mm -59.58 -42.06 86.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 108.486 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.07 91.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 12.9 m120 -57.05 -39.16 74.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.64 71.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.252 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -62.73 -38.64 91.31 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.88 70.31 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.33 -0.856 . . . . 0.0 108.723 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.597 ' OH ' ' CZ ' ' A' ' 32' ' ' PHE . 64.4 t80 -64.65 -42.88 95.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.91 -32.7 71.01 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.11 -32.12 71.8 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.176 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 89.9 mmm -65.66 -42.39 91.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 109' ' ' GLY . 96.9 mt-10 -71.88 -41.16 68.34 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.45 -26.74 43.94 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.88 -9.1 29.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . 68.89 26.68 74.47 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -117.6 101.2 52.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.75 154.36 26.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.426 2.084 . . . . 0.0 112.541 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -62.18 -45.4 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.864 0.84 . . . . 0.0 109.324 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.67 -27.38 64.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 111.123 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -70.63 -52.74 19.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.711 -1.243 . . . . 0.0 111.607 -178.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 2.2 p90 -67.16 -39.89 86.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.936 -1.103 . . . . 0.0 111.041 -178.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' A' ' 115' ' ' PHE . 8.1 p -65.88 -48.94 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -179.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.503 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 12.8 m95 -56.45 -25.48 50.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -67.18 -45.46 76.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 110.552 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CE1' ' CB ' ' A' ' 144' ' ' ALA . 32.0 m-85 -62.96 -32.25 73.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.002 -1.061 . . . . 0.0 110.17 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.68 18.41 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.714 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 123' ' ' GLN . 62.5 m-20 59.31 40.54 21.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.728 -0.608 . . . . 0.0 109.78 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 43.48 26.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.802 179.332 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 121' ' ' ASN . 1.9 pt20 -139.8 154.62 71.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.63 152.31 59.19 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.858 2.372 . . . . 0.0 112.951 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 126' ' ' MET . 10.7 tm0? -109.4 127.83 54.67 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.62 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 61.1 mtm -91.03 118.63 30.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 109.692 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 116.3 26.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.347 -0.845 . . . . 0.0 109.482 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -93.78 14.0 20.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 136.54 53.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -93.63 -22.63 18.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.504 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.5 p -133.68 163.01 30.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.2 mt -59.24 -39.62 83.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.1 t -60.61 -33.23 72.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -81.96 2.64 29.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.836 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.92 142.87 25.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.117 -0.989 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.91 143.63 37.07 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.365 2.043 . . . . 0.0 112.655 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -123.98 2.58 8.69 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.8 p -154.7 85.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.11 166.87 9.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.22 -41.45 65.63 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.624 1.549 . . . . 0.0 112.283 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -41.73 80.03 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.025 -1.047 . . . . 0.0 108.676 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.0 p -66.81 -45.24 78.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.56 -40.69 96.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 119' ' ' PHE . . . -67.89 -30.76 70.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.7 tp -69.19 -42.0 76.39 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -0.752 . . . . 0.0 110.321 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.573 ' CA ' ' SG ' ' A' ' 162' ' ' CYS . 0.3 OUTLIER -63.72 -50.28 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.449 -179.1 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -65.77 -36.14 82.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.948 -1.095 . . . . 0.0 109.366 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.22 -50.47 39.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.762 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.65 -36.36 83.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 109.661 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -60.49 -38.5 84.49 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.959 -1.088 . . . . 0.0 108.767 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 153' ' ' GLY . 1.4 mmmp? -62.52 -33.71 75.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.326 -0.859 . . . . 0.0 110.09 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -70.55 3.86 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.02 -1.05 . . . . 0.0 108.844 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 82.1 26.79 47.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -94.42 115.58 27.8 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.531 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -93.41 169.03 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 56.21 55.11 7.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.068 -1.02 . . . . 0.0 108.54 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.444 ' O ' ' CG1' ' A' ' 157' ' ' VAL . 7.3 p -142.08 47.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.03 -178.5 3.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.1 m -61.1 -33.47 73.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.631 -0.923 . . . . 0.0 110.511 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.4 p -67.79 -35.38 78.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.898 -1.126 . . . . 0.0 108.05 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.58 -42.38 92.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.573 ' SG ' ' CA ' ' A' ' 146' ' ' SER . 77.1 m -63.89 -41.29 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.691 -0.631 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.3 -44.37 65.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.838 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.462 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 23.2 m -65.19 -38.98 92.22 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.571 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 87.1 t80 -60.21 -49.65 76.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.702 -0.624 . . . . 0.0 111.051 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 12.8 ptm -71.5 -38.62 71.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.868 -1.145 . . . . 0.0 109.746 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.577 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -62.55 -42.48 99.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 110.498 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.564 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -89.05 -27.56 20.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.968 -1.082 . . . . 0.0 111.018 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.571 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 24.3 m -60.87 -21.12 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.818 -1.176 . . . . 0.0 110.119 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.75 0.09 34.27 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.37 -34.09 76.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.099 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.16 138.1 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 91.0 m-20 -115.06 163.13 16.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.628 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.0 t70 86.07 77.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.465 0.65 . . . . 0.0 109.778 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 4.6 m170 -55.72 -53.13 60.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 0.0 109.084 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.8 m -147.43 38.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.2 t 61.27 111.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.472 0.653 . . . . 0.0 110.276 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 44.86 71.02 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.635 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 7.6 p -92.41 107.03 18.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.285 . . . . 0.0 109.388 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 63.06 -63.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.997 . . . . 0.0 109.706 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 179' ' ' CYS . 39.6 t -176.36 47.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.57 -0.707 . . . . 0.0 109.402 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -68.31 152.14 96.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 109.321 -179.862 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.35 145.55 97.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.625 2.217 . . . . 0.0 112.104 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 176.44 -28.08 0.07 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' O ' ' C ' ' A' ' 186' ' ' LYS . 79.7 m-20 -103.48 -35.41 8.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -1.09 . . . . 0.0 109.18 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 185' ' ' ASN . 6.1 mtpt 29.99 62.7 0.9 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.992 -0.442 . . . . 0.0 110.802 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.303 -1.85 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.89 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.931 H3A3 ' CE2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mmm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -91.46 147.64 22.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.34 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -78.09 167.01 22.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.259 -0.901 . . . . 0.0 110.471 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.84 149.93 43.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.052 0.93 . . . . 0.0 110.817 -178.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.78 -41.64 94.07 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.635 -0.665 . . . . 0.0 111.458 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.697 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -85.74 -2.37 58.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.544 -1.563 . . . . 0.0 109.645 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.5 t -78.16 -37.85 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.983 -1.073 . . . . 0.0 108.502 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -80.88 0.68 34.13 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.644 -0.822 . . . . 0.0 108.795 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.36 -55.43 5.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 110.867 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.52 161.0 61.27 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.37 -35.82 13.04 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.083 2.522 . . . . 0.0 112.981 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.422 ' CD1' ' NZ ' ' A' ' 51' ' ' LYS . 55.8 mt -62.61 -34.02 76.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.868 -1.145 . . . . 0.0 109.737 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.828 ' OH ' H3A1 ' A' ' 189' ' ' ADK . 0.7 OUTLIER -59.2 -36.91 76.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 14' ' ' ILE . 1.5 mp -52.7 -46.21 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 110.394 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.7 64.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.957 -1.089 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.1 t80 -63.49 -39.96 95.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.64 ' CE1' ' HG ' ' A' ' 181' ' ' CYS . 48.5 t-80 -76.07 -40.53 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 111.507 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.91 -15.14 63.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 112.008 -177.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 6.9 p30 -71.14 -77.09 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.255 -1.528 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -149.1 -49.07 0.15 Allowed 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.756 -1.215 . . . . 0.0 110.256 -179.443 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.886 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.9 t-105 59.03 87.22 0.08 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.185 -178.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.66 73.06 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.79 176.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.668 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 77.2 t -110.33 -32.85 0.14 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-N 119.353 1.577 . . . . 0.0 110.542 177.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.1 Cg_endo -85.54 152.07 10.33 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.2 1.933 . . . . 0.0 112.729 -178.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' OE1' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -67.48 169.03 9.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.8 p -94.09 141.14 28.88 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.05 -178.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD1' ' OE1' ' A' ' 25' ' ' GLU . 92.0 m-20 -102.92 150.2 23.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -61.98 -35.99 80.14 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.666 -1.271 . . . . 0.0 110.052 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -74.95 -50.37 16.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD3' ' H ' ' A' ' 27' ' ' ASP . 7.4 ptmm? -62.54 -32.18 73.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.819 -1.175 . . . . 0.0 109.584 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 165' ' ' PHE . 45.8 mt -57.38 -37.5 72.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 108.539 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -65.73 -45.45 82.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.882 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.38 -40.19 95.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.895 -1.128 . . . . 0.0 109.3 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 35' ' ' ILE . 8.5 tmm? -62.12 -47.04 86.35 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 111.339 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.588 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.2 tp -62.48 -27.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 -178.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.8 m -70.24 -49.98 44.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 110.003 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 3.9 mm? -69.33 -42.23 75.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.068 -1.02 . . . . 0.0 109.566 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.672 ' HE2' ' C8 ' ' A' ' 189' ' ' ADK . 28.6 tp10 -66.51 -32.07 73.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.785 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.62 40.15 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -88.51 -0.64 57.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -1.218 . . . . 0.0 110.076 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.6 3.34 22.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 109.665 -179.567 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -75.42 117.17 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.36 -6.75 1.06 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.604 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 4.3 tp -103.51 169.18 8.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -1.116 . . . . 0.0 108.862 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.419 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 3.9 t -94.84 141.68 28.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 108.763 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.659 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 5.5 t-105 -55.58 -34.12 64.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -37.69 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.793 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 m -57.9 -45.36 86.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.903 -1.123 . . . . 0.0 108.616 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.85 -29.37 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 108.679 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.59 -41.33 76.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 108.673 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.611 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 12.2 mmtt -57.8 -41.49 82.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.9 -18.98 61.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -60.63 -42.48 97.0 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -69.32 -46.03 68.08 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.685 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.7 m-80 -64.12 -32.81 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 108.516 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 52' ' ' LYS . 75.3 t80 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' HIS . 46.8 mtp180 -60.04 -38.31 82.39 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.452 178.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.09 82.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.854 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 85' ' ' ILE . 1.8 m -71.67 -45.08 63.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 110.258 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.582 ' O ' ' N ' ' A' ' 62' ' ' GLN . 29.2 m-85 -111.74 -47.22 3.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.291 -0.881 . . . . 0.0 109.765 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.6 t-160 61.67 -39.88 0.13 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.631 -0.668 . . . . 0.0 110.398 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 64' ' ' ASP . 2.8 pt20 -74.77 -35.05 62.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.417 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 22.8 p90 41.09 17.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.502 -0.749 . . . . 0.0 110.269 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -79.11 142.82 60.01 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.866 -1.146 . . . . 0.0 108.626 179.802 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.85 -52.52 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.122 1.881 . . . . 0.0 112.766 -179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.14 -44.23 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 110.219 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -36.99 85.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 109.946 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 64' ' ' ASP . 57.3 t -63.42 -39.38 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.92 -16.23 63.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.93 58.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 mmm -78.01 113.21 15.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 7.4 tt0 -95.68 167.43 11.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 108.906 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 96.2 mt-10 -52.63 -30.31 30.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.243 -0.911 . . . . 0.0 110.855 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -57.39 -45.19 84.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.541 -1.35 . . . . 0.0 107.704 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -62.95 -39.76 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 HG22 HE21 ' A' ' 93' ' ' GLN . 75.5 t -59.6 -42.7 89.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.536 -0.728 . . . . 0.0 110.026 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 74.9 mm-40 -57.38 -37.11 72.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.069 -1.019 . . . . 0.0 108.396 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG3' HH11 ' A' ' 78' ' ' ARG . 16.2 ttm-85 -66.19 -36.98 84.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.504 -0.747 . . . . 0.0 109.521 179.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.26 -40.34 93.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.718 . . . . 0.0 112.445 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 77' ' ' GLU . 4.4 m -59.01 -16.83 10.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.478 -1.389 . . . . 0.0 108.024 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -104.67 -14.36 15.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.507 -0.746 . . . . 0.0 109.153 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 84' ' ' GLY . 63.0 m-20 -81.78 105.52 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.09 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.15 -15.57 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.545 -0.722 . . . . 0.0 109.984 179.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 66.19 35.96 91.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.5 pt -28.68 -101.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.156 -0.614 . . . . 0.0 111.541 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 85' ' ' ILE . 9.1 tt -168.77 -34.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.06 -179.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 87' ' ' ARG . 5.0 mtt-85 -59.22 149.2 29.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.623 -0.673 . . . . 0.0 109.419 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.404 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -106.36 160.19 15.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.244 -0.91 . . . . 0.0 109.327 179.902 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.77 -46.24 15.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 110.049 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -53.11 36.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 51.1 mttp -61.13 -40.7 94.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 92' ' ' ILE . 66.7 mt -58.76 -47.76 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.153 -0.967 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.444 HE21 HG22 ' A' ' 76' ' ' VAL . 46.9 mm-40 -52.97 -35.03 58.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.824 -1.173 . . . . 0.0 108.941 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.42 80.63 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.7 -47.38 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.56 -0.712 . . . . 0.0 109.422 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.9 mp -60.08 -38.97 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 108.952 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.6 -35.75 89.99 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -62.33 -37.81 87.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -1.067 . . . . 0.0 109.693 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.38 96.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.02 . . . . 0.0 109.804 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.87 -39.2 90.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.981 -1.074 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.06 68.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.603 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 75.8 t80 -63.41 -44.41 94.7 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.86 -31.71 72.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -64.81 -35.97 82.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.916 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 81.0 mmm -67.93 -40.0 83.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.732 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.99 -40.07 78.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.542 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.35 -23.8 66.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' OD1' ' CD ' ' A' ' 110' ' ' GLU . 10.4 t-20 -85.71 -7.15 58.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 26.23 74.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CD ' ' OD1' ' A' ' 108' ' ' ASN . 96.1 mt-10 -124.48 102.06 33.35 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -1.071 . . . . 0.0 109.729 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.478 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 18.4 Cg_exo -60.64 147.47 94.63 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.004 1.803 . . . . 0.0 112.066 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 102' ' ' TYR . 25.2 m-85 -57.5 -37.64 73.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.103 -0.998 . . . . 0.0 109.45 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.84 -29.86 70.83 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.526 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.56 -50.65 62.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 112.174 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.483 ' CZ ' ' NH2' ' A' ' 152' ' ' ARG . 4.1 p90 -72.4 -38.1 68.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.754 -1.216 . . . . 0.0 111.308 -177.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.45 -49.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.117 -1.614 . . . . 0.0 109.354 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -60.32 -24.15 64.78 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 108.622 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -64.66 -42.33 95.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.0 109.912 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -68.11 -32.74 73.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.64 16.92 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.62 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 122' ' ' HIS . 16.6 m120 56.98 36.92 28.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.698 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 121' ' ' ASN . 78.0 m80 44.03 33.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -139.15 151.83 68.47 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.01 . . . . 0.0 109.867 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.03 144.48 34.11 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.789 2.326 . . . . 0.0 112.205 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.472 ' NE2' ' H ' ' A' ' 126' ' ' MET . 2.3 tm0? -112.26 141.99 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.337 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.472 ' H ' ' NE2' ' A' ' 125' ' ' GLN . 85.2 mmm -96.65 118.01 32.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -88.63 117.49 27.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.194 -0.941 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.52 20.77 3.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.225 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 127' ' ' THR . . . -66.93 135.21 53.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 109.536 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.1 p -100.67 -19.88 15.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.399 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.0 p -128.75 158.84 37.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.47 -0.769 . . . . 0.0 109.097 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.2 mt -57.82 -40.74 80.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -73.84 -19.14 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.827 . . . . 0.0 109.568 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -74.44 -9.29 58.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 108.509 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.6 132.53 46.47 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.39 135.34 22.22 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.931 1.754 . . . . 0.0 112.442 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.9 p -101.06 3.88 41.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 138' ' ' SER . 59.6 p -141.06 91.76 2.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 109.064 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.649 ' HG1' ' H ' ' A' ' 142' ' ' SER . 40.1 p -110.89 156.88 40.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.07 -39.49 70.17 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.147 1.231 . . . . 0.0 111.222 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.72 71.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.649 ' H ' ' HG1' ' A' ' 139' ' ' THR . 86.6 p -63.41 -42.06 98.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -0.789 . . . . 0.0 109.834 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.0 -39.78 94.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.883 . . . . 0.0 110.229 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.85 79.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.38 -46.24 77.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 110.725 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.636 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 15.0 m -61.06 -48.82 79.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.223 -0.923 . . . . 0.0 110.726 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -37.56 81.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.01 -1.056 . . . . 0.0 109.349 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.27 74.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.118 -0.988 . . . . 0.0 109.66 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.61 ' CD2' ' NH2' ' A' ' 152' ' ' ARG . 19.1 mt -67.86 -42.35 81.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.966 -1.084 . . . . 0.0 108.841 179.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -59.47 -37.44 78.22 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.274 -0.891 . . . . 0.0 110.594 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -74.34 -23.04 58.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.877 -1.139 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.61 ' NH2' ' CD2' ' A' ' 149' ' ' LEU . 81.6 mtm180 -83.67 6.05 22.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.31 21.14 39.13 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -99.69 112.23 24.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -1.208 . . . . 0.0 108.976 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -89.75 178.59 6.21 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 55.95 56.71 5.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 108.824 -179.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.3 40.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -50.04 157.87 1.74 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.8 m -52.73 -32.67 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.319 -1.106 . . . . 0.0 108.742 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 m -69.09 -36.01 77.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 161' ' ' ILE . 21.2 mm -62.06 -45.02 99.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.595 0.712 . . . . 0.0 109.394 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.636 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.2 m -64.32 -39.7 94.44 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.503 -0.748 . . . . 0.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -43.25 77.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.95 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.3 m -61.8 -36.54 81.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 109.589 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.591 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -61.13 -50.49 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.428 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.2 ptm -62.52 -37.62 86.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.044 -1.035 . . . . 0.0 110.268 -178.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -40.82 87.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 111.627 -178.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.39 15.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.957 -1.089 . . . . 0.0 112.752 -177.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -50.19 70.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.664 -1.272 . . . . 0.0 112.047 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.43 2.36 0.96 Allowed Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.2 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.93 -33.91 72.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.616 -1.52 . . . . 0.0 109.121 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.25 150.91 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.599 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 83.7 m-20 -117.89 164.09 15.58 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.599 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 18.9 t0 96.05 84.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.605 0.717 . . . . 0.0 110.017 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -55.74 -49.71 72.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.604 -0.685 . . . . 0.0 109.848 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 7.1 m -157.54 24.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.71 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.9 t 56.11 111.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.429 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.36 10.0 52.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 0.3 OUTLIER -81.18 148.97 29.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.924 -1.339 . . . . 0.0 109.215 179.806 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -58.71 -50.8 72.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 -179.573 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.64 ' HG ' ' CE1' ' A' ' 17' ' ' HIS . 59.6 m -61.5 -12.51 15.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 109.018 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -116.82 84.09 15.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.635 -0.666 . . . . 0.0 110.139 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.93 -93.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.551 2.168 . . . . 0.0 111.881 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.16 -14.0 65.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -85.55 -50.77 6.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -1.147 . . . . 0.0 109.088 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -82.96 149.95 60.54 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.569 2.18 . . . . 0.0 112.314 -179.859 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.886 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.617 ' H3 ' ' N ' ' A' ' 180' ' ' CYS . 42.1 mtm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -98.38 153.27 18.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 108.875 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.477 ' HG3' HH11 ' A' ' 3' ' ' ARG . 22.0 mtm-85 -50.38 155.17 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.961 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -69.95 156.57 38.91 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.793 0.806 . . . . 0.0 109.516 -179.556 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.13 95.73 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.146 -0.971 . . . . 0.0 112.844 -177.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.883 ' CH2' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.76 -3.82 58.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.323 -1.693 . . . . 0.0 111.608 -177.673 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 4' ' ' CYS . 2.7 m -87.25 -31.61 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.384 -1.448 . . . . 0.0 108.58 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -62.97 -18.07 62.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -59.85 -40.97 90.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.241 0.544 . . . . 0.0 109.98 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.35 160.37 51.91 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.02 -55.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.219 2.613 . . . . 0.0 113.44 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.98 -32.01 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.703 ' CE1' ' CZ2' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -56.78 -39.17 73.59 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.896 -1.128 . . . . 0.0 109.584 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.09 -41.27 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -49.62 73.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 109.847 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 27.9 t80 -61.5 -42.73 99.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.357 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' A' ' 17' ' ' HIS . 8.5 t-80 -66.66 -37.63 85.18 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.516 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.41 -13.19 61.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 12.0 p30 -86.89 -70.88 0.58 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 119.855 -1.778 . . . . 0.0 110.276 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.591 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.4 mt-10 -136.86 -72.61 0.44 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.017 -1.052 . . . . 0.0 110.038 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.59 ' CD1' ' O ' ' A' ' 21' ' ' TRP . 8.8 t90 47.39 49.72 15.42 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.926 -0.484 . . . . 0.0 110.721 -178.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.38 72.3 0.99 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.513 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.682 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -166.23 -30.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.01 -1.288 . . . . 0.0 112.837 179.37 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 28.6 Cg_endo -91.98 154.22 3.3 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 123.022 2.481 . . . . 0.0 112.615 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 26' ' ' THR . 85.8 tt0 -66.55 156.36 35.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.401 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 1.5 p -91.43 134.09 34.92 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.594 -177.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -99.85 158.14 16.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.656 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 1.3 m -57.69 -37.69 73.91 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.541 -1.349 . . . . 0.0 109.832 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -61.29 -46.14 91.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 111.165 -178.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -36.93 81.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.567 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.17 -39.32 75.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.564 -0.71 . . . . 0.0 110.501 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CE1' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -70.18 -54.09 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.456 -178.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -71.02 -30.41 66.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.902 -1.124 . . . . 0.0 109.774 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 27.8 ttm -67.16 -52.15 45.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.885 -1.134 . . . . 0.0 110.984 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.25 -31.06 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.519 -1.363 . . . . 0.0 111.117 -178.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 60.4 m -70.31 -37.21 74.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.476 -1.39 . . . . 0.0 109.802 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.0 mp -73.46 -40.27 64.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.189 -0.945 . . . . 0.0 110.247 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' CD ' ' HG ' ' A' ' 164' ' ' SER . 72.2 mm-40 -63.17 -36.83 84.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.0 108.685 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.44 -36.73 78.42 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -69.01 -28.51 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -1.123 . . . . 0.0 109.885 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.549 HE22 ' C8 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -74.38 -3.05 28.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.987 -1.071 . . . . 0.0 110.309 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.59 117.82 4.24 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.726 -1.233 . . . . 0.0 108.809 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.48 -36.72 2.02 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 3.6 mm? -90.92 150.58 21.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.077 -1.249 . . . . 0.0 109.984 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.5 m -63.98 154.56 33.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.785 . . . . 0.0 109.447 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.3 OUTLIER -61.2 -40.92 95.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.656 179.604 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -59.22 -35.86 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -58.74 -39.26 80.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.146 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.85 -49.6 76.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 0.0 109.403 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.622 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -57.45 -43.37 83.91 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.425 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' NH2' ' CZ2' ' A' ' 46' ' ' TRP . 37.1 ttm180 -60.64 -42.02 96.1 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.623 -1.298 . . . . 0.0 107.8 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.09 -42.41 66.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.91 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 23.4 m-80 -75.12 -43.4 53.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.021 -1.05 . . . . 0.0 110.023 -179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.478 ' N ' ' O ' ' A' ' 52' ' ' LYS . 63.4 t80 -58.23 -49.1 78.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.743 -0.598 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 2.5 ppt_? -63.04 -33.86 76.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.969 -1.082 . . . . 0.0 109.142 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.66 76.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.143 -0.973 . . . . 0.0 109.586 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.643 ' SG ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -73.66 -44.86 55.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.604 -179.253 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 78.0 m-85 -88.06 -49.1 7.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.903 -1.123 . . . . 0.0 110.636 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' NE2' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 52.56 -6.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 111.099 -179.898 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 60' ' ' PHE . 95.5 mt-30 -69.66 -35.71 75.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.558 -1.339 . . . . 0.0 110.612 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 53.31 16.69 0.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.083 -1.011 . . . . 0.0 110.063 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -137.64 98.62 9.76 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 0.0 109.382 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.3 -34.08 4.36 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.545 2.163 . . . . 0.0 113.866 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.73 -45.8 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.899 -1.126 . . . . 0.0 109.788 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.94 -33.37 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.038 -1.039 . . . . 0.0 109.479 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.13 -38.98 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.204 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.89 -21.51 66.06 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.88 -6.39 59.34 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.9 mtp -88.42 111.6 21.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.33 -172.93 2.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -57.16 -25.55 59.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.061 -1.025 . . . . 0.0 110.504 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.02 -45.34 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.766 -1.208 . . . . 0.0 109.113 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -68.82 -36.75 78.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 109.155 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.11 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.027 . . . . 0.0 110.081 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -65.54 -43.7 89.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 11.1 ptp180 -75.16 -32.8 61.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.632 -1.292 . . . . 0.0 109.322 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' C ' ' N ' ' A' ' 81' ' ' GLN . 61.3 mt -70.61 -35.58 73.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 111.851 -179.187 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.8 m -50.39 -17.94 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.686 -1.259 . . . . 0.0 109.161 -179.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.424 ' N ' ' C ' ' A' ' 79' ' ' LEU . 16.1 pt20 -117.84 -8.17 10.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 46.3 m-20 -77.95 107.86 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.61 -1.307 . . . . 0.0 109.51 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 82' ' ' ASP . . . 82.27 -13.24 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.835 -0.541 . . . . 0.0 109.896 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.45 37.9 30.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.2 pt -58.49 -168.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.002 -1.293 . . . . 0.0 109.498 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -65.86 93.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.313 -0.867 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 88' ' ' HIS . 32.5 ttt-85 -55.23 106.46 0.23 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 2.5 m-70 179.88 72.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 15.3 ptm180 -45.56 -42.51 11.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -51.23 -54.17 24.62 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.211 -178.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -64.09 -42.33 96.97 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.037 -1.272 . . . . 0.0 109.774 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.04 -44.26 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.405 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.2 mt-30 -56.97 -36.13 69.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.653 -1.279 . . . . 0.0 109.736 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.79 83.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 109.079 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.45 -39.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 108.926 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.88 -43.3 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.7 -35.43 81.44 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.49 -35.88 78.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.378 -1.072 . . . . 0.0 108.93 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.04 91.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.847 . . . . 0.0 108.843 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -61.13 -36.28 79.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.42 74.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.187 -0.946 . . . . 0.0 109.024 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -61.76 -44.23 97.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.99 -36.64 80.0 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -64.8 -36.81 85.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.945 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.459 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 94.4 mmm -64.68 -40.09 94.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.869 -1.144 . . . . 0.0 108.826 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 109' ' ' GLY . 80.7 mm-40 -67.64 -38.06 83.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -58.09 -25.67 61.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -93.46 -12.6 29.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.63 22.53 71.69 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -114.56 102.78 55.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 109.556 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.52 152.68 46.21 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.953 1.768 . . . . 0.0 112.274 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.09 -40.27 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.618 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.43 69.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 111.074 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.55 -53.03 39.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.082 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.533 ' O ' ' OG ' ' A' ' 118' ' ' SER . 3.3 p90 -72.1 -41.43 67.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.667 -1.27 . . . . 0.0 111.75 -177.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 117' ' ' TRP . 30.4 m -59.69 -50.35 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 119.945 -1.722 . . . . 0.0 109.794 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.419 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 15.0 m95 -57.26 -24.41 54.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.533 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 45.9 p -66.32 -42.13 88.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.063 -1.023 . . . . 0.0 110.404 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.17 -33.35 74.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.076 -1.015 . . . . 0.0 110.283 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.06 15.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 109.19 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.14 37.52 26.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.699 . . . . 0.0 110.554 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 48.71 29.45 2.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -0.952 . . . . 0.0 110.424 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.43 148.97 42.62 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.784 -1.197 . . . . 0.0 109.856 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.44 147.64 90.6 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.92 2.413 . . . . 0.0 112.905 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 126' ' ' MET . 11.5 tm0? -105.4 135.24 47.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.232 -0.917 . . . . 0.0 109.223 179.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.482 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 62.9 mtt -93.04 134.66 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.2 -54.72 3.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -0.989 . . . . 0.0 109.354 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 58.63 50.11 9.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.406 ' H ' HG23 ' A' ' 127' ' ' THR . . . -90.02 142.35 27.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.6 p -81.13 -24.6 37.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.003 -1.061 . . . . 0.0 108.916 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 p -143.51 164.67 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.13 -31.86 72.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.026 -1.046 . . . . 0.0 108.841 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -64.29 -28.73 69.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -78.2 -2.4 37.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.56 127.17 86.45 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.75 -1.219 . . . . 0.0 107.965 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.412 ' O ' ' CE2' ' A' ' 163' ' ' TYR . 56.9 Cg_endo -73.49 137.74 25.87 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.132 1.888 . . . . 0.0 113.292 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.3 p -110.29 6.54 22.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 m -147.97 90.89 1.87 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.204 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 139' ' ' THR . 1.0 OUTLIER -108.0 155.52 39.89 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -52.82 -33.89 62.91 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 120.946 1.097 . . . . 0.0 111.539 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.67 -46.21 55.0 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.24 -0.913 . . . . 0.0 109.176 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.9 p -63.47 -41.4 98.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.073 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.57 -43.92 97.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.57 67.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.483 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -47.21 84.39 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.627 -0.671 . . . . 0.0 110.338 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' VAL . 35.9 t -65.59 -41.62 92.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 109.841 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -60.57 -38.71 85.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.13 -54.62 16.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.045 -1.035 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.09 -31.69 69.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -60.5 -43.26 97.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.503 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -72.12 -27.75 62.83 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 110.358 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.459 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.7 OUTLIER -73.9 5.35 4.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.006 . . . . 0.0 109.019 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.63 25.72 52.78 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.4 116.39 32.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.436 -1.037 . . . . 0.0 109.452 179.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -94.6 176.4 6.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 56.92 53.34 8.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 146' ' ' SER . 31.4 m -130.19 43.82 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.29 165.69 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.592 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 18.7 m -54.06 -33.82 58.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.614 -0.933 . . . . 0.0 109.214 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.6 m -72.72 -33.59 66.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.54 -44.63 99.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.642 -0.661 . . . . 0.0 110.047 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' A' ' 159' ' ' THR . 0.8 OUTLIER -65.46 -46.65 78.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.093 -1.004 . . . . 0.0 109.682 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -63.74 -38.8 92.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 109.581 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.544 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 79.4 p -63.37 -37.21 86.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -63.7 -40.72 97.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.772 . . . . 0.0 110.203 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 25.6 mtm -66.85 -39.24 87.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 111.014 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.401 HE22 ' CB ' ' A' ' 172' ' ' VAL . 73.5 mm-40 -64.72 -36.15 83.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.983 -1.073 . . . . 0.0 111.084 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.51 19.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 112.295 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -68.06 -48.95 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.796 -1.19 . . . . 0.0 111.717 -177.878 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.32 -11.06 2.76 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.923 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.5 mt -51.13 -30.78 17.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -1.198 . . . . 0.0 109.749 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.401 ' CB ' HE22 ' A' ' 167' ' ' GLN . 22.0 t -119.82 150.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -137.69 163.76 30.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.657 . . . . 0.0 109.853 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 90.17 75.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.147 0.498 . . . . 0.0 110.62 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -52.37 -53.3 46.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.6 m -151.37 -162.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.18 122.92 39.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.43 68.59 1.62 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . 0.578 ' O ' ' N ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -106.63 154.63 20.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.034 -1.274 . . . . 0.0 109.18 179.002 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.617 ' N ' ' H3 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -36.92 -64.97 0.32 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.628 -0.67 . . . . 0.0 110.066 -179.71 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -24.27 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.9 t80 -97.79 110.28 54.71 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.75 125.71 6.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.954 1.769 . . . . 0.0 112.208 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.53 -3.71 6.52 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -80.42 -1.03 39.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -1.131 . . . . 0.0 109.661 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.79 147.56 36.35 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.054 -1.029 . . . . 0.0 109.256 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 C--N 1.311 -1.416 0 C-N-CA 122.296 1.997 . . . . 0.0 112.263 179.845 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' ADK . . . . . 0.883 H3A3 ' CH2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.555 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.499 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' NE2' ' A' ' 175' ' ' HIS . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' CZ2' ' CZ ' ' A' ' 16' ' ' TYR . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 53.3 m-85 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.946 0.311 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.442 ' O ' HG21 ' A' ' 96' ' ' ILE . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.408 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.408 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 25.4 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.457 ' HG1' ' HG ' ' A' ' 133' ' ' SER . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.457 ' HG ' ' HG1' ' A' ' 131' ' ' THR . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' A' ' 7' ' ' VAL . 62.1 mtp180 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.631 0.729 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.2 m -53.08 144.77 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 0.0 109.618 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.14 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.525 -0.734 . . . . 0.0 112.13 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.686 ' CZ2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -83.7 -1.03 53.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.58 -1.541 . . . . 0.0 109.478 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' A' ' 3' ' ' ARG . 1.4 t -84.93 -42.37 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 108.823 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.4 m -78.66 5.09 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.78 -108.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.632 -0.668 . . . . 0.0 109.775 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.35 143.61 93.69 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.806 . . . . 0.0 109.838 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 -28.29 58.25 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.083 1.855 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.32 -36.18 82.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.894 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 6' ' ' TRP . 4.6 m-85 -55.41 -42.11 73.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.039 . . . . 0.0 110.603 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.85 -40.82 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 110.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -66.19 -50.35 64.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.678 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' A' ' 168' ' ' ALA . 23.8 t80 -66.58 -39.78 88.6 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.696 -1.252 . . . . 0.0 110.164 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -69.34 -50.33 47.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 112.523 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -75.14 -5.98 47.19 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.941 -1.099 . . . . 0.0 110.567 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.537 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 2.8 m120 -94.9 -35.48 12.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.832 -1.168 . . . . 0.0 112.294 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 22' ' ' GLY . 13.0 pt-20 -174.42 48.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.374 -1.454 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' CH2' ' CZ2' ' A' ' 6' ' ' TRP . 20.5 t-105 -70.87 66.76 0.37 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 60.72 52.81 50.15 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.2 t -108.59 -42.29 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.36 -1.082 . . . . 0.0 109.13 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.7 Cg_endo -95.94 150.55 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.558 2.839 . . . . 0.0 112.649 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -68.27 141.63 55.82 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -99.83 147.82 25.09 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.06 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 90.9 m-20 -80.88 167.91 19.35 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 m -59.87 -35.07 74.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -67.15 -39.96 86.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 0.0 112.461 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -59.04 -38.92 80.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 0.0 110.309 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.718 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.5 mp -58.62 -36.94 74.84 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.686 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -63.26 -48.12 79.52 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -69.82 -30.97 68.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.783 -1.198 . . . . 0.0 109.473 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.22 -48.56 56.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.791 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 35' ' ' ILE . 8.4 tp -61.43 -28.6 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 109.476 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.6 -51.32 29.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.956 -1.09 . . . . 0.0 109.418 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.85 -37.49 73.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 108.98 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.593 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 17.6 tp10 -61.65 -37.06 82.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.4 -35.33 90.84 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.538 ' OE1' HG13 ' A' ' 49' ' ' VAL . 86.9 mt-30 -62.06 -31.48 71.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.459 -1.024 . . . . 0.0 110.995 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.593 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -61.26 6.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.837 -1.165 . . . . 0.0 110.53 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.59 123.3 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.3 -33.78 0.16 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 42' ' ' ALA . 73.2 mt -94.44 155.99 16.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -1.213 . . . . 0.0 110.439 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.3 m -73.18 156.62 38.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -59.85 -32.42 70.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.42 -0.8 . . . . 0.0 109.725 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -35.82 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -57.6 -37.37 73.12 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.538 HG13 ' OE1' ' A' ' 40' ' ' GLN . 85.1 t -66.69 -36.81 78.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.885 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.97 -47.64 84.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.911 -1.118 . . . . 0.0 109.806 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.49 -49.68 74.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.818 -1.176 . . . . 0.0 108.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -65.72 -26.19 67.64 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.253 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 49' ' ' VAL . 38.1 ttm180 -55.12 -42.49 73.03 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.49 -40.85 76.78 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.093 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 3.7 m-20 -64.34 -34.86 79.11 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' OH ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -60.95 -39.25 88.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -59.66 -36.43 76.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.398 -0.814 . . . . 0.0 109.054 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.79 89.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.838 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.607 ' HB3' HD22 ' A' ' 79' ' ' LEU . 64.9 m -75.0 -44.95 45.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.64 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 83.1 m-85 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 19.2 Cg_exo . . . . . 0 N--CA 1.491 1.374 0 CA-C-O 121.245 0.435 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.94 -36.33 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 0.0 110.236 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -47.07 83.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 111.271 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 96' ' ' ILE . 19.4 m -67.66 -33.46 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.517 -1.364 . . . . 0.0 109.326 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.585 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.28 -20.58 65.59 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.01 -9.14 40.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.0 mmm -82.75 119.68 24.64 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.57 173.81 7.43 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.347 -0.846 . . . . 0.0 110.449 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.61 -29.85 39.71 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.52 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -60.96 -48.46 81.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.987 -1.07 . . . . 0.0 108.177 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.16 -41.52 98.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 92' ' ' ILE . 70.3 t -56.7 -42.36 76.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.682 -0.636 . . . . 0.0 109.983 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -58.18 -39.18 78.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 108.661 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 35.0 ttm-85 -61.74 -40.29 94.58 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 0.0 109.294 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 59' ' ' CYS . 63.1 mt -65.43 -33.25 75.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.608 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.18 -36.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 108.404 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -106.49 -2.93 21.44 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.829 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 84' ' ' GLY . 46.4 t0 -78.38 106.71 10.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.15 -1.594 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 67.56 -19.81 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.575 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 71.5 36.03 62.79 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.4 pt -29.28 -94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 122.127 -0.631 . . . . 0.0 110.544 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.3 tt -170.58 -37.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.128 -0.982 . . . . 0.0 109.07 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 86' ' ' ILE . 17.9 mmt180 -72.03 156.02 39.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.802 0.81 . . . . 0.0 110.595 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -111.01 178.87 4.21 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 10.3 ptp180 -56.7 -43.8 80.9 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 110.58 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -56.38 -57.95 16.75 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.342 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.46 -43.25 97.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.071 -1.252 . . . . 0.0 110.161 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.631 HG21 HG13 ' A' ' 76' ' ' VAL . 19.4 mm -57.64 -52.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -50.91 -32.64 21.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.843 -1.161 . . . . 0.0 108.881 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -64.35 -42.02 96.45 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -0.925 . . . . 0.0 108.563 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 92' ' ' ILE . 80.2 mt -65.66 -42.23 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.388 -0.82 . . . . 0.0 109.121 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 68' ' ' VAL . 15.9 mm -60.02 -44.24 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.73 92.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -57.67 -37.85 74.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -1.11 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.58 -47.14 76.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 109.197 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.585 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 12.2 mmt180 -56.67 -38.19 71.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.92 -30.61 70.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.94 -44.0 90.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.0 -37.16 83.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.028 -1.045 . . . . 0.0 109.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.09 -38.63 88.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.0 108.704 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -70.13 -40.35 74.9 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.641 0.734 . . . . 0.0 109.321 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.03 -23.74 65.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.93 -6.18 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.26 26.29 74.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -118.07 108.26 42.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -52.79 145.64 38.92 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.985 1.79 . . . . 0.0 112.381 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.618 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -59.26 -46.88 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.209 1.004 . . . . 0.0 109.372 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.82 68.33 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 109.846 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.81 -47.92 82.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.97 -1.081 . . . . 0.0 111.806 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.618 ' CD2' ' O ' ' A' ' 112' ' ' PHE . 12.5 p90 -71.62 -43.62 65.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.804 -1.185 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.598 HG11 ' CD2' ' A' ' 31' ' ' LEU . 1.9 p -65.16 -54.45 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.358 -1.464 . . . . 0.0 110.129 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.552 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 53.7 m95 -55.14 -23.45 21.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.05 -1.032 . . . . 0.0 108.25 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.72 -29.58 70.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 108.966 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 171' ' ' LEU . 2.9 t -86.94 9.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.025 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 65.1 35.21 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 44.2 35.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.748 . . . . 0.0 110.373 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -146.97 147.52 29.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.62 142.05 62.86 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.462 2.108 . . . . 0.0 112.023 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.0 132.06 55.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 108.814 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 34.6 ttp -89.55 127.35 35.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.93 -1.107 . . . . 0.0 109.415 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.55 130.12 43.79 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 109.29 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -91.92 27.31 2.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.194 -0.941 . . . . 0.0 110.754 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.728 ' CB ' HD13 ' A' ' 135' ' ' ILE . . . -64.61 142.56 58.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.728 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.6 p -109.02 -35.46 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.68 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 26.7 p -124.96 162.34 24.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.474 -0.766 . . . . 0.0 109.609 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.8 -36.28 71.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 109.177 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -79.27 0.14 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 108.992 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HB3' ' H ' ' A' ' 131' ' ' THR . 40.7 tp10 -103.01 8.4 38.92 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.728 HD13 ' CB ' ' A' ' 129' ' ' ALA . 5.5 mm -93.58 126.0 51.64 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -70.91 139.74 36.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.489 1.459 . . . . 0.0 112.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -111.73 5.03 18.92 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -145.72 86.91 1.75 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.682 . . . . 0.0 109.304 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.17 162.77 18.63 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.94 -41.14 77.47 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.25 1.3 . . . . 0.0 111.8 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.95 74.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 108.585 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -64.32 -44.71 90.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.501 -0.749 . . . . 0.0 109.643 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.95 -37.61 86.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.21 -31.98 64.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.54 -48.16 73.4 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.369 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -57.41 -42.27 81.98 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.63 -1.293 . . . . 0.0 108.493 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -65.0 -42.28 94.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.494 -0.754 . . . . 0.0 109.887 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.608 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.4 -47.9 68.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.48 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 1.8 mm? -63.48 -40.23 96.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.21 -0.931 . . . . 0.0 109.157 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -60.28 -39.11 85.7 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.959 -1.088 . . . . 0.0 110.123 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -71.42 -35.74 71.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 111.304 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.608 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.64 -1.87 10.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.775 -1.203 . . . . 0.0 109.653 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.6 17.8 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 18.3 m-85 -93.49 111.33 22.97 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.746 -1.182 . . . . 0.0 107.816 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -97.35 174.07 6.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 0.0 110.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.432 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 91.3 m-85 61.71 61.51 1.43 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.193 0.997 . . . . 0.0 109.092 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.0 m -137.13 41.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -37.44 160.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.572 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 28.0 m -57.78 -30.02 65.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.57 -0.959 . . . . 0.0 109.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -77.73 -34.91 52.4 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.01 -37.56 77.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.568 . . . . 0.0 110.072 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 159' ' ' THR . 32.0 p -67.27 -47.2 71.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.176 -0.952 . . . . 0.0 109.045 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.27 -42.21 84.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.069 . . . . 0.0 109.888 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.49 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 20.8 m -58.79 -42.46 89.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -38.3 81.4 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.203 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 19.2 mtm -63.46 -36.14 82.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 110.869 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 164' ' ' SER . 35.3 mt-30 -57.57 -44.29 85.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.926 -1.109 . . . . 0.0 110.782 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.426 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . . . -89.84 -17.85 27.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.995 -1.065 . . . . 0.0 110.334 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.37 -26.06 68.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.486 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.53 50.09 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 120' ' ' VAL . 88.4 mt -62.53 -37.3 85.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.633 -0.922 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.8 138.27 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 109.555 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 84.1 m-20 -121.69 135.99 54.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.544 -0.722 . . . . 0.0 110.622 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER 156.06 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.715 -0.616 . . . . 0.0 110.914 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.472 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.6 m170 55.88 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.126 -0.984 . . . . 0.0 108.664 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 178' ' ' GLY . 21.5 m -136.57 40.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 177' ' ' VAL . 0.4 OUTLIER 34.8 27.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.749 0.785 . . . . 0.0 109.966 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -162.4 34.66 0.34 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 17.7 t . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.447 -1.031 . . . . 0.0 109.438 -179.726 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -117.07 159.31 22.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.546 -0.721 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -44.57 97.99 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.273 -0.892 . . . . 0.0 111.214 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.607 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -83.5 -0.45 50.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.76 -1.435 . . . . 0.0 109.493 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.53 -48.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.1 m -77.79 -0.59 27.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -81.46 -49.0 11.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.495 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -147.82 158.1 42.97 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 108.945 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.755 ' HA ' HD12 ' A' ' 14' ' ' ILE . 52.8 Cg_endo -71.48 -24.52 22.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.526 2.151 . . . . 0.0 113.002 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.28 -38.53 89.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.844 -1.16 . . . . 0.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.66 -36.56 84.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 11' ' ' PRO . 40.4 mt -58.06 -44.38 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 110.41 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -68.71 -50.98 46.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.423 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -62.15 -37.89 86.91 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.667 -1.27 . . . . 0.0 109.48 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -73.62 -44.27 57.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.619 -0.676 . . . . 0.0 111.633 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -72.37 -7.74 51.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 3.6 m-20 -91.33 -72.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.767 -1.208 . . . . 0.0 111.344 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.57 81.67 1.1 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.867 -1.146 . . . . 0.0 110.892 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.607 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 16.9 t-105 -80.34 71.16 7.13 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.69 55.42 22.78 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.635 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.3 t -107.01 -39.74 0.16 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.401 -1.058 . . . . 0.0 109.545 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 83.1 Cg_endo -97.88 153.24 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.497 2.798 . . . . 0.0 112.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -66.36 148.38 51.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 169' ' ' CYS . 82.8 p -95.2 159.29 15.08 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.977 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -96.2 167.94 10.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -61.98 -37.18 83.82 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.932 -1.105 . . . . 0.0 110.664 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -71.47 -39.83 70.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 112.596 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 15.3 mmmt -56.26 -37.04 69.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.653 -1.279 . . . . 0.0 109.108 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 31' ' ' LEU . 3.1 mt -57.33 -37.59 72.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.567 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.8 -47.03 85.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.575 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -69.9 -38.87 76.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.232 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 39.9 tpp -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.54 -0.725 . . . . 0.0 111.212 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -69.55 -27.58 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -70.03 -42.3 73.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.814 -1.179 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 5.4 mp -73.89 -39.05 64.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -63.43 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.86 -38.42 59.79 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.295 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 42' ' ' ALA . 12.0 tt0 -62.62 -24.73 67.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.963 -1.316 . . . . 0.0 110.194 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 6.5 mm100 -48.27 -6.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.802 -1.186 . . . . 0.0 110.522 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -67.02 112.75 4.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.833 -1.167 . . . . 0.0 109.825 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.13 -27.11 0.2 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.691 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.798 HD12 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -98.16 151.14 20.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.336 . . . . 0.0 110.649 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.5 m -75.79 162.85 27.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -62.6 -38.37 89.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 0.0 110.868 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.934 -1.104 . . . . 0.0 109.127 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.798 HG21 HD12 ' A' ' 44' ' ' LEU . 15.4 m -63.45 -40.11 96.26 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.728 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -73.64 -33.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 109.635 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.17 -45.18 75.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -42.89 90.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.589 ' HA ' HD22 ' A' ' 55' ' ' ASN . 25.0 ttpp -62.86 -33.81 76.05 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.301 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -57.61 -40.33 78.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -73.33 -47.17 44.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.075 -1.016 . . . . 0.0 111.18 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.589 HD22 ' HA ' ' A' ' 52' ' ' LYS . 20.7 p30 -75.77 -37.56 59.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.689 -1.257 . . . . 0.0 110.427 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 79.0 t80 -58.74 -46.36 87.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.906 -1.121 . . . . 0.0 109.1 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.76 -31.27 71.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 108.898 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.69 38.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.148 -0.97 . . . . 0.0 111.293 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.64 -44.31 43.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.974 -1.079 . . . . 0.0 111.34 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 56' ' ' TYR . 66.5 m-85 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.96 -1.087 . . . . 0.0 110.562 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 N-CA-C 114.844 1.055 . . . . 0.0 114.844 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.78 -29.86 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 109.033 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.05 -35.64 79.21 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.61 -36.3 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -62.48 -20.21 64.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.32 -10.39 32.88 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 93.2 mtp -74.08 109.69 7.77 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.3 pt20 -97.38 -176.17 3.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.787 -0.571 . . . . 0.0 110.017 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -59.86 -32.49 70.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.327 -0.858 . . . . 0.0 110.884 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.507 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 88.5 tt0 -59.49 -47.01 87.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.368 -1.457 . . . . 0.0 109.042 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -35.77 74.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.088 -1.008 . . . . 0.0 108.816 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -57.38 -43.92 83.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.436 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.93 ' O ' HG22 ' A' ' 80' ' ' VAL . 75.5 mt-10 -56.95 -35.7 69.39 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.8 ttm-85 -59.27 -37.57 77.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 76' ' ' VAL . 1.5 mt -68.0 -33.08 73.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.665 -0.647 . . . . 0.0 112.659 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 77' ' ' GLU . 13.5 m -52.0 -17.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.7 -1.25 . . . . 0.0 110.334 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -124.0 13.79 9.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.179 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.8 m-20 -96.99 104.89 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.895 -1.128 . . . . 0.0 110.559 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.84 -15.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.886 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.03 37.82 49.08 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 30.7 pt -47.86 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.567 -0.961 . . . . 0.0 110.019 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.971 HG23 ' H ' ' A' ' 87' ' ' ARG . 11.1 tt -55.63 -105.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.971 ' H ' HG23 ' A' ' 86' ' ' ILE . 13.3 tpt180 -85.03 153.5 22.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.564 -1.335 . . . . 0.0 108.262 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.499 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.42 -33.79 3.78 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.535 -0.728 . . . . 0.0 111.211 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -125.73 -22.8 4.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 111.431 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.24 -91.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.635 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.95 -29.19 68.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.126 -1.22 . . . . 0.0 109.934 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ILE . 12.2 mm -56.9 -56.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.765 -1.209 . . . . 0.0 109.484 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 92' ' ' ILE . 92.9 mt-30 -50.91 -35.41 32.98 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.295 -1.503 . . . . 0.0 108.015 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.0 80.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.78 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' ILE . 96.1 mt -69.24 -33.14 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 110.847 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.79 -48.71 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.729 -1.232 . . . . 0.0 108.82 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.88 -35.04 90.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 95' ' ' ILE . 67.3 m-20 -55.38 -38.66 69.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.186 -1.185 . . . . 0.0 109.574 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.72 79.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.849 -1.157 . . . . 0.0 109.362 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.42 -37.56 86.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.029 -1.044 . . . . 0.0 109.866 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.74 -31.4 72.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 108.905 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.721 ' CE1' ' CE1' ' A' ' 112' ' ' PHE . 63.7 t80 -61.46 -44.18 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.7 mm? -61.84 -33.96 75.1 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -64.24 -38.43 91.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.882 . . . . 0.0 111.459 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.704 ' SD ' ' CG ' ' A' ' 112' ' ' PHE . 8.2 ttm -64.49 -42.76 95.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.69 -1.256 . . . . 0.0 108.757 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.95 -37.99 84.29 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.267 0.556 . . . . 0.0 109.576 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.0 -24.55 67.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -88.18 -10.9 48.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.129 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.33 27.67 73.55 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.226 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 4.8 tt0 -116.88 103.47 52.19 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.103 -1.233 . . . . 0.0 110.343 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.77 138.59 41.29 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.833 1.689 . . . . 0.0 112.011 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.721 ' CE1' ' CE1' ' A' ' 102' ' ' TYR . 65.0 m-85 -58.8 -41.78 87.55 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.9 0.857 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.33 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 110.577 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.98 -48.3 79.44 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.109 -0.994 . . . . 0.0 112.346 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.7 p90 -70.79 -43.85 67.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.663 -1.273 . . . . 0.0 110.507 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 117' ' ' TRP . 2.4 p -65.41 -55.39 20.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.848 -1.157 . . . . 0.0 110.868 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.634 ' H ' HG13 ' A' ' 116' ' ' VAL . 48.6 m95 -55.35 -23.07 22.08 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.198 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -75.58 -33.56 60.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.094 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -65.88 -32.5 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.037 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.52 17.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 108.994 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 123' ' ' GLN . 45.3 t30 60.13 43.85 13.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.829 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 11.3 t-160 41.92 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -126.46 151.28 72.5 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.604 -0.685 . . . . 0.0 109.285 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.76 153.73 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.523 2.149 . . . . 0.0 112.184 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -110.29 137.58 47.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 0.0 108.807 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 95.8 mmm -95.14 118.86 32.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.416 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -88.81 122.65 32.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.258 -0.901 . . . . 0.0 108.798 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -93.44 23.1 4.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -72.05 139.11 48.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 109.62 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 m -100.01 -21.88 15.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 108.63 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -140.88 163.82 31.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.248 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.58 -39.53 76.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.323 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.1 p -64.22 -29.65 70.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -80.36 5.64 14.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 108.954 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 135' ' ' ILE . 4.5 tp -83.05 129.19 62.22 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.891 . . . . 0.0 108.905 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.73 137.0 31.71 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.132 1.888 . . . . 0.0 112.248 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.5 p -105.66 0.1 26.06 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.529 -0.732 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.1 t -147.18 92.34 2.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.39 -0.819 . . . . 0.0 108.995 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.405 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -105.03 158.26 32.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -54.17 -40.41 82.08 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.835 1.69 . . . . 0.0 111.186 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.91 -40.48 63.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 139' ' ' THR . 67.7 p -67.81 -38.02 82.75 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.176 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.12 -41.09 95.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -0.97 . . . . 0.0 108.669 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.29 64.35 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.417 HD12 ' HE2' ' A' ' 115' ' ' PHE . 9.4 tp -64.26 -45.5 87.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.579 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 11.6 m -62.88 -40.47 97.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.147 -0.97 . . . . 0.0 109.595 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -60.3 -41.67 93.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.504 -0.747 . . . . 0.0 111.111 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -46.06 66.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.814 -1.178 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.23 -36.9 82.64 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.128 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -60.6 -41.55 94.97 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.063 -1.023 . . . . 0.0 110.016 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -80.15 -16.63 54.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.742 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -84.44 2.72 39.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.71 19.09 49.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 6.5 m-85 -98.87 113.47 25.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.214 -1.168 . . . . 0.0 109.123 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -89.13 175.1 7.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.388 0.613 . . . . 0.0 110.002 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 55.13 59.31 4.08 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.701 0.762 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 157' ' ' VAL . 8.0 m -135.67 35.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.336 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.0 166.06 1.06 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.2 p -58.45 -30.7 67.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -1.104 . . . . 0.0 109.365 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.3 m -67.48 -39.63 85.27 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.02 -44.13 88.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.9 m -64.11 -41.02 97.41 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.452 -0.78 . . . . 0.0 109.846 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -44.19 89.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.241 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -61.78 -40.14 94.14 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.65 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -61.45 -38.5 87.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 82.1 mtp -65.58 -34.64 78.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 111.629 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 6.7 pt20 -63.68 -42.01 98.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.684 -1.26 . . . . 0.0 111.683 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.492 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -85.91 -24.65 26.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 111.697 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.718 ' O ' HG23 ' A' ' 26' ' ' THR . 0.9 OUTLIER -65.97 -22.38 66.47 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.762 -1.211 . . . . 0.0 110.431 -178.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.0 2.7 58.16 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.453 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 12.3 mt -65.92 -32.01 73.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.77 -0.841 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.94 148.32 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.062 -1.024 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 20.5 m120 -113.76 164.85 13.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 3.9 m-20 90.26 81.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.082 0.468 . . . . 0.0 110.257 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.543 ' O ' HG13 ' A' ' 176' ' ' VAL . 53.3 m170 -52.68 -46.14 67.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.042 -1.036 . . . . 0.0 108.825 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 178' ' ' GLY . 4.8 m -158.1 29.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.458 -0.777 . . . . 0.0 110.202 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 129' ' ' ALA . 25.9 t 53.01 2.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 109.927 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -141.05 32.37 2.11 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.943 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 109.024 179.756 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.3 mtm-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.699 0.761 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 1.2 m -64.34 153.46 38.35 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.78 98.47 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.345 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.598 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.31 -3.21 58.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.61 -1.524 . . . . 0.0 109.448 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.2 t -80.86 -35.15 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -76.88 4.93 8.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 10' ' ' ASP . 1.3 mm-40 -90.64 -159.38 0.61 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -44.75 155.6 0.38 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.001 -1.062 . . . . 0.0 108.914 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HA ' HD12 ' A' ' 14' ' ' ILE . 20.4 Cg_endo -63.25 -16.65 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 0.0 112.228 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.2 mt -58.42 -39.68 80.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -67.92 -36.24 79.84 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.061 -1.024 . . . . 0.0 109.335 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 11' ' ' PRO . 91.7 mt -58.39 -44.85 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.781 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.11 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.737 -1.227 . . . . 0.0 109.554 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.438 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 3.1 t80 -66.62 -35.84 81.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 55.4 t-80 -61.58 -41.17 97.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 111.69 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 6.2 m-20 -96.6 -1.67 46.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.827 -1.17 . . . . 0.0 112.358 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -103.41 -30.05 10.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.529 -1.357 . . . . 0.0 112.324 -178.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.7 mt-10 -155.97 24.73 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.144 -1.597 . . . . 0.0 111.507 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.598 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.6 t90 -98.87 65.25 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 98.49 62.58 0.87 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.687 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.796 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -157.89 -35.61 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.152 -1.205 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.796 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 98.6 Cg_endo -98.41 149.97 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.363 2.042 . . . . 0.0 112.331 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.2 166.77 22.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -99.45 130.16 45.69 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.567 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.91 157.1 16.99 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 m -56.69 -34.68 67.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.901 -1.125 . . . . 0.0 109.187 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -67.53 -41.57 84.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -63.92 -38.96 93.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.987 -1.071 . . . . 0.0 110.152 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -61.04 -35.97 78.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 109.656 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -66.96 -50.25 62.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 110.95 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -66.84 -40.14 87.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.79 -1.194 . . . . 0.0 109.629 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.583 ' C ' ' SD ' ' A' ' 34' ' ' MET . 10.0 tmm? -62.75 -50.72 69.95 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.684 -0.635 . . . . 0.0 110.763 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.546 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.1 tp -62.32 -27.49 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.07 -45.35 74.07 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.552 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' HE ' ' A' ' 53' ' ' ARG . 39.0 mt -70.39 -44.37 68.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.125 -0.985 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 161' ' ' ILE . 47.0 mm-40 -61.94 -32.79 73.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -37.3 76.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -87.07 -2.99 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -1.119 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 HG11 ' A' ' 49' ' ' VAL . 73.2 mt-30 -81.5 -0.92 44.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.088 -1.007 . . . . 0.0 109.86 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.99 112.99 7.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.205 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.81 -33.62 5.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 48' ' ' THR . 5.6 mp -102.61 152.55 21.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.266 . . . . 0.0 110.325 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 m -64.56 156.73 28.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.419 -0.801 . . . . 0.0 108.97 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -60.71 -35.09 75.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.74 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -30.92 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.84 -1.163 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.691 HG21 HD23 ' A' ' 44' ' ' LEU . 87.7 m -58.12 -42.41 85.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.836 -1.165 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -71.17 -31.93 45.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.535 -0.728 . . . . 0.0 109.379 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 tp -55.35 -49.25 72.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.085 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -58.35 -42.73 87.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -65.32 -31.05 71.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.211 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 37.7 ttm180 -54.38 -44.78 72.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -69.59 -38.95 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.597 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.16 -42.71 59.5 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 111.012 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.73 -49.99 75.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.912 -1.117 . . . . 0.0 110.495 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.1 ptm180 -59.69 -30.79 69.03 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.939 -1.1 . . . . 0.0 109.005 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.4 93.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB3' HD22 ' A' ' 79' ' ' LEU . 71.2 m -75.15 -43.83 50.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.979 -1.075 . . . . 0.0 110.291 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.075 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo . . . . . 0 N--CA 1.49 1.305 0 CA-C-O 121.059 0.358 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.87 -44.09 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.953 -1.092 . . . . 0.0 109.871 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 68' ' ' VAL . 5.3 pttp -65.93 -33.21 75.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.109 -0.994 . . . . 0.0 109.044 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 84.4 t -60.25 -38.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 108.951 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.532 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.04 -19.24 65.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.19 -15.51 18.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 78.1 mtp -68.88 113.78 6.6 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 18.7 tt0 -96.16 174.12 7.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.328 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 95.7 mt-10 -52.17 -32.06 34.28 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.98 -45.45 82.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.2 -38.1 87.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.947 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 92' ' ' ILE . 53.8 t -62.04 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 2.5 pt-20 -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.978 -1.077 . . . . 0.0 108.156 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.3 ttm-85 -63.77 -48.01 78.66 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 59' ' ' CYS . 66.2 mt -70.78 -34.47 71.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.761 -0.587 . . . . 0.0 110.99 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' LEU . 4.2 t -48.28 -17.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.513 ' N ' ' C ' ' A' ' 79' ' ' LEU . 5.7 mt-30 -110.8 -12.14 14.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.2 t0 -83.15 109.66 17.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.98 -17.35 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.145 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 78.79 36.89 27.66 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLY . 6.4 pt -47.19 175.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -1.197 . . . . 0.0 108.35 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.64 95.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.13 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 31.5 ptt180 -54.92 125.09 18.83 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.714 0.769 . . . . 0.0 109.305 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.7 m-70 166.96 78.36 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -48.73 -32.33 8.32 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.91 2.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -60.55 -39.96 89.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.327 . . . . 0.0 109.409 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.601 HG21 HG13 ' A' ' 76' ' ' VAL . 99.1 mt -59.8 -40.3 82.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.177 -0.952 . . . . 0.0 109.09 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.413 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 8.0 mm-40 -55.44 -36.35 66.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 108.893 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.69 85.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.05 -43.26 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.2 mm -59.59 -43.63 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.42 -36.09 90.29 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -60.06 -35.82 75.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -1.111 . . . . 0.0 109.834 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.23 83.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.045 . . . . 0.0 109.214 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.532 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.0 mtt180 -62.2 -36.09 80.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.364 -0.835 . . . . 0.0 109.318 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.74 81.89 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.242 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.98 -43.49 95.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.8 mt -60.97 -25.62 66.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.513 ' NE2' ' OD1' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -67.37 -41.58 84.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 110.057 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' GLN . 94.2 mmm -66.13 -40.28 90.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.125 -0.984 . . . . 0.0 108.688 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.3 mm-40 -70.69 -39.93 73.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.275 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.14 -23.85 64.23 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.513 ' OD1' ' NE2' ' A' ' 104' ' ' GLN . 4.4 m120 -93.89 -9.76 36.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.3 24.35 74.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -117.46 101.64 52.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.17 147.33 66.14 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.325 2.017 . . . . 0.0 112.523 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.772 ' HB3' HD12 ' A' ' 31' ' ' LEU . 35.9 m-85 -60.7 -39.35 88.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.523 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.35 -32.57 74.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.946 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.35 -46.7 82.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.669 -1.27 . . . . 0.0 112.204 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.8 p90 -73.02 -43.84 61.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.632 -1.292 . . . . 0.0 110.999 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 112' ' ' PHE . 2.1 p -62.87 -54.0 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.629 -1.294 . . . . 0.0 110.37 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.574 ' H ' HG13 ' A' ' 116' ' ' VAL . 34.2 m95 -53.94 -27.04 28.51 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -76.26 -35.52 58.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.576 -0.702 . . . . 0.0 109.941 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -61.89 -31.09 71.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.8 p -97.99 17.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 63.41 33.56 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.685 -0.634 . . . . 0.0 110.401 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' TRP . 95.9 m-70 51.44 29.32 5.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.136 -0.978 . . . . 0.0 110.95 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.448 ' H ' HG13 ' A' ' 120' ' ' VAL . 62.2 mt-30 -135.34 142.56 41.95 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.961 -1.087 . . . . 0.0 109.906 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.27 147.98 43.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.266 1.977 . . . . 0.0 111.671 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.417 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -120.0 126.48 50.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 90.2 mtp -102.74 116.0 31.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 108.753 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.613 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -89.72 144.43 25.98 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.43 28.35 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 111.78 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.64 134.87 51.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 0.0 108.504 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.9 p -97.17 -21.59 17.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 110.228 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.3 p -129.3 162.15 28.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.91 -36.35 76.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.412 -0.805 . . . . 0.0 109.38 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 62.4 p -68.2 -29.7 68.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.96 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -83.41 6.42 20.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -86.86 143.2 35.01 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.06 145.6 31.42 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.525 2.15 . . . . 0.0 112.865 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.43 0.6 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.481 ' O ' ' OG ' ' A' ' 138' ' ' SER . 10.8 p -145.68 94.74 2.54 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.503 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -106.02 153.98 39.83 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.65 -37.61 91.16 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.752 1.635 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.89 58.12 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.642 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.503 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 60.6 m -63.15 -42.24 99.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.966 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -60.81 -39.62 89.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 109.231 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.54 77.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.41 -47.84 83.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 109.625 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.641 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 13.8 t -63.48 -43.71 96.51 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.196 -0.94 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.58 -44.26 94.57 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB1' ' NH1' ' A' ' 152' ' ' ARG . . . -72.17 -44.35 63.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.137 -0.977 . . . . 0.0 109.367 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.566 HD23 HH21 ' A' ' 152' ' ' ARG . 75.3 mt -65.39 -39.1 91.82 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.287 -0.883 . . . . 0.0 109.738 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.47 -39.35 90.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.973 -1.079 . . . . 0.0 109.695 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.32 -30.61 71.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 110.071 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.566 HH21 HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -72.86 0.66 10.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.954 -1.092 . . . . 0.0 108.642 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.88 26.55 24.12 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.815 -1.184 . . . . 0.0 110.297 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -97.11 112.43 24.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 0.0 109.745 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -91.38 168.96 11.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.97 64.19 1.8 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 108.482 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.69 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.1 p -153.52 41.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.95 -175.39 0.08 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 p -66.62 -26.7 67.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -1.048 . . . . 0.0 110.415 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -70.99 -34.05 71.01 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 38' ' ' GLU . 34.2 mm -70.5 -44.56 76.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.094 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 146' ' ' SER . 7.3 m -64.95 -36.02 83.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.522 -0.736 . . . . 0.0 109.655 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.687 ' CD2' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -69.69 -45.96 67.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 110.87 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.607 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 87.1 p -63.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.875 -1.141 . . . . 0.0 109.188 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -62.44 -49.28 76.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.576 -0.702 . . . . 0.0 110.365 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.05 -40.62 96.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.008 -1.057 . . . . 0.0 111.148 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.687 ' NE2' ' CD2' ' A' ' 163' ' ' TYR . 2.9 mp0 -74.76 -40.77 61.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.906 -1.121 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.86 60.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.051 -1.031 . . . . 0.0 112.536 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.436 ' HB3' HG22 ' A' ' 26' ' ' THR . 36.1 m -65.65 -48.72 71.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.676 -1.265 . . . . 0.0 111.964 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.65 -2.38 1.46 Allowed Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.579 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 5.9 mt -59.97 -35.33 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.94 -1.33 . . . . 0.0 110.126 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.54 140.32 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.719 -1.238 . . . . 0.0 110.075 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -110.37 124.04 50.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.613 ' HB3' ' H ' ' A' ' 127' ' ' THR . 13.7 p30 180.0 54.33 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.234 -0.916 . . . . 0.0 111.475 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.9 ' O ' HG13 ' A' ' 176' ' ' VAL . 25.6 m170 -57.94 -46.34 85.22 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.48 -1.387 . . . . 0.0 108.788 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -175.23 18.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.2 t 62.32 -41.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.752 -0.593 . . . . 0.0 110.587 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -81.66 4.87 71.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.27 . . . . 0.0 109.643 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.441 0.639 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.35 146.74 47.11 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.551 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.3 -24.33 21.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' A' ' 6' ' ' TRP . 4.5 t90 -81.47 9.51 7.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -1.219 . . . . 0.0 109.731 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.4 -25.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 0.0 110.669 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -81.19 6.34 14.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.087 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -86.22 -59.7 2.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -111.4 156.29 41.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 110.311 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HA ' HD13 ' A' ' 14' ' ' ILE . 51.2 Cg_endo -71.28 -37.22 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.966 2.444 . . . . 0.0 113.198 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.23 -35.03 77.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.129 -0.982 . . . . 0.0 110.441 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CD1' ' OD1' ' A' ' 10' ' ' ASP . 6.4 m-85 -56.55 -36.25 69.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.971 -1.081 . . . . 0.0 109.791 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.9 mp -52.35 -43.94 41.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -67.69 -48.77 65.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.34 -43.13 99.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.57 -43.04 91.0 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.448 -0.782 . . . . 0.0 111.549 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.29 -14.19 61.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 111.605 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 20.6 m120 -73.77 -69.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.626 -1.296 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -175.83 59.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' C ' ' CD1' ' A' ' 21' ' ' TRP . 7.7 t90 -96.42 68.92 2.59 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.04 -3.8 6.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.705 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -105.51 -16.98 0.16 Allowed Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.6 -0.941 . . . . 0.0 111.861 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 91.7 Cg_endo -86.44 150.87 9.07 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 121.833 1.688 . . . . 0.0 113.088 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.04 170.86 10.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.74 HG22 ' SG ' ' A' ' 169' ' ' CYS . 1.8 p -91.18 120.36 32.05 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.772 -1.205 . . . . 0.0 111.043 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.2 m-20 -105.74 154.14 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -61.58 -36.66 81.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.811 -1.181 . . . . 0.0 109.825 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -73.17 -50.81 20.53 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 110.97 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -63.94 -25.37 68.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.903 -1.123 . . . . 0.0 108.691 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -59.02 -44.29 91.7 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.5 t80 -68.94 -46.5 68.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 111.155 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.69 -35.29 77.01 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.509 -1.369 . . . . 0.0 109.761 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 38.7 ttm -68.72 -43.79 75.25 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.927 -1.108 . . . . 0.0 110.991 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.895 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.4 tp -63.19 -29.32 46.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.953 -1.092 . . . . 0.0 109.831 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.8 m -71.77 -49.21 40.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.043 -1.036 . . . . 0.0 110.413 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 1.7 mm? -66.23 -42.06 89.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.632 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.646 ' CD ' ' HG ' ' A' ' 164' ' ' SER . 32.5 tp10 -66.39 -38.22 87.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.893 . . . . 0.0 109.746 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.55 -36.63 78.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -82.84 -7.77 59.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.221 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -89.48 4.17 50.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.075 . . . . 0.0 110.722 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 161' ' ' ILE . . . -63.88 118.82 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 0.0 110.07 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 83.19 -1.01 89.41 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 43' ' ' GLY . 4.5 mm? -107.13 163.36 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.243 -1.151 . . . . 0.0 110.121 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 47' ' ' ILE . 60.6 m -80.98 22.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.669 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.7 OUTLIER 62.96 -39.85 0.17 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 109.758 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.591 ' N ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -62.06 -35.47 68.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.921 -1.112 . . . . 0.0 108.225 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.415 ' CB ' HD12 ' A' ' 44' ' ' LEU . 79.0 m -59.24 -44.48 92.36 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.068 -1.02 . . . . 0.0 108.622 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.3 t -69.03 -35.83 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.11 -48.93 72.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.034 -1.041 . . . . 0.0 109.03 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -59.83 -42.62 93.97 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.566 ' HZ3' HG21 ' A' ' 86' ' ' ILE . 1.6 ttmt -62.34 -32.33 73.09 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 40.9 ttm180 -53.66 -45.68 70.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.234 -0.916 . . . . 0.0 109.244 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.02 -44.26 85.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.816 -1.153 . . . . 0.0 108.614 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.532 ' OD1' HG22 ' A' ' 85' ' ' ILE . 24.3 t-20 -63.27 -37.95 89.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 45.1 t80 -56.84 -42.92 80.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 57' ' ' ARG . 15.8 mmm-85 -59.34 -35.59 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 108.906 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.48 96.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 110.399 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.639 ' SG ' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -78.3 -45.87 21.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 111.434 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 87.4 m-85 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.9 -1.125 . . . . 0.0 109.629 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 114.041 0.746 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.1 t -76.41 -38.93 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.621 -1.299 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 67' ' ' LYS . 8.6 mmpt? -63.83 -42.65 97.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.082 -1.011 . . . . 0.0 108.579 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.97 -37.89 81.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.258 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.64 63.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.8 -8.5 46.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.7 mtp -83.25 115.76 22.1 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.24 167.44 11.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.65 -31.89 39.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.021 -1.049 . . . . 0.0 110.132 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -55.09 -41.48 71.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 85.3 m-20 -62.45 -37.99 88.02 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 80' ' ' VAL . 55.7 t -63.2 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.472 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 80' ' ' VAL . 79.3 mm-40 -61.96 -40.79 96.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 110.136 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 5.0 ptp180 -75.54 -33.01 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 109.274 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 85' ' ' ILE . 53.6 mt -65.99 -33.23 75.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.907 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 77' ' ' GLU . 20.1 m -54.19 -17.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.67 -1.269 . . . . 0.0 108.843 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.41 -2.33 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.1 t0 -81.55 108.25 14.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.701 -1.249 . . . . 0.0 109.273 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.32 -11.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.612 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.39 34.41 57.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.532 HG22 ' OD1' ' A' ' 55' ' ' ASN . 20.6 pt -52.56 -177.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -1.006 . . . . 0.0 110.344 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.814 HG23 ' O ' ' A' ' 86' ' ' ILE . 19.7 tt -56.98 89.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 32.2 ptt180 -51.91 134.25 31.67 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.628 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.636 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.0 m-70 164.31 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 89' ' ' ARG . 15.6 ptt-85 -42.87 -32.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.079 . . . . 0.0 110.184 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.86 -62.35 6.18 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.912 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 3.2 mptt -63.79 -38.28 90.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.869 -1.371 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.425 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 3.8 pt20 -55.65 -33.08 63.74 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.82 -1.175 . . . . 0.0 108.305 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -63.04 -38.59 91.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 108.811 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.5 -47.35 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 109.224 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.448 -0.783 . . . . 0.0 109.942 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.27 -39.8 90.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -58.93 -35.71 73.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.542 -0.975 . . . . 0.0 109.683 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.78 -46.19 83.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -56.4 -41.61 76.57 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.985 -1.072 . . . . 0.0 108.693 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -62.66 -30.04 71.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.636 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 48.7 t80 -63.32 -43.02 98.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -65.25 -31.9 73.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.6 -40.04 94.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -0.854 . . . . 0.0 110.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.685 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 80.6 mtp -67.52 -37.7 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.63 -41.08 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.085 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.05 -22.15 66.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -93.34 -12.19 30.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.81 27.19 73.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.34 100.46 52.93 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.247 -1.149 . . . . 0.0 109.877 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.2 149.63 84.14 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.381 2.054 . . . . 0.0 112.146 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 33.6 m-85 -63.06 -40.07 96.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 111.195 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.17 77.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.077 -1.014 . . . . 0.0 111.062 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -63.02 -47.02 84.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.184 -0.948 . . . . 0.0 112.606 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -72.14 -44.52 63.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.538 -1.351 . . . . 0.0 110.718 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.584 HG13 ' N ' ' A' ' 117' ' ' TRP . 3.9 p -60.49 -52.09 65.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.603 -1.311 . . . . 0.0 109.446 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 20.7 m95 -55.66 -24.36 33.53 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 6.3 p -65.57 -42.72 91.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 109.98 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.699 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 40.5 m-85 -63.58 -36.47 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.988 -1.07 . . . . 0.0 109.171 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.719 HG21 HD22 ' A' ' 171' ' ' LEU . 1.7 t -86.37 13.9 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.697 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 57.17 31.97 20.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 56.17 32.67 20.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 111.437 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.69 149.75 41.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 110.066 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.58 145.0 68.77 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.809 2.34 . . . . 0.0 112.874 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.58 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.58 132.42 55.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.467 -0.771 . . . . 0.0 109.8 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.58 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.0 mtt -101.46 123.44 45.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.917 -1.114 . . . . 0.0 108.952 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -92.96 -20.41 20.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.879 -1.138 . . . . 0.0 110.16 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 57.22 44.77 21.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.383 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.616 ' CB ' HD12 ' A' ' 135' ' ' ILE . . . -65.01 148.77 51.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.45 ' C ' HG23 ' A' ' 176' ' ' VAL . 0.3 OUTLIER -110.25 -28.3 8.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.447 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 5.2 p -131.9 164.15 26.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.15 -42.22 85.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 108.857 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 95.9 p -72.43 -19.33 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.447 ' CB ' ' H ' ' A' ' 131' ' ' THR . 39.2 tp10 -71.9 -10.42 59.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.807 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.1 tp -74.11 127.13 88.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 120.997 -1.064 . . . . 0.0 108.191 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.61 135.34 17.87 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.979 1.786 . . . . 0.0 113.014 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.6 p -112.13 4.94 18.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.6 t -138.77 93.19 2.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.384 -0.822 . . . . 0.0 109.003 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.57 158.9 50.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.15 -39.06 92.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.901 1.734 . . . . 0.0 111.21 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.64 -44.29 67.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 108.698 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.1 p -62.72 -40.72 98.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -63.28 -37.99 89.4 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.185 -0.947 . . . . 0.0 108.787 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.82 -37.45 84.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.494 -0.754 . . . . 0.0 109.991 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 145' ' ' LEU . 86.4 mt -61.93 -40.49 95.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 109.998 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.627 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 25.2 t -64.35 -51.53 62.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.9 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -67.99 -39.64 83.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.84 -1.162 . . . . 0.0 109.299 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.87 83.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.5 mt -68.02 -35.76 78.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.003 -1.061 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.71 84.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.976 -1.077 . . . . 0.0 109.68 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.09 -32.39 71.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.21 -0.932 . . . . 0.0 110.455 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.474 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 2.6 mmp_? -72.33 -1.0 13.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.969 -1.082 . . . . 0.0 108.826 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.08 26.93 42.5 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 2.9 m-85 -98.45 112.59 24.56 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.758 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -89.8 170.97 9.96 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 59.39 65.84 1.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.921 0.867 . . . . 0.0 109.679 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HA ' HG21 ' A' ' 161' ' ' ILE . 19.8 m -140.97 38.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.43 168.35 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.3 m -57.42 -31.67 66.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.583 -0.951 . . . . 0.0 109.134 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.4 p -71.36 -33.92 70.01 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 42' ' ' ALA . 36.3 mm -65.82 -45.43 91.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.057 0.932 . . . . 0.0 108.533 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 146' ' ' SER . 28.3 m -63.8 -45.18 90.82 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.446 0.641 . . . . 0.0 109.9 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -31.81 73.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.969 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.646 ' HG ' ' CD ' ' A' ' 38' ' ' GLU . 29.9 t -59.56 -49.25 78.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.895 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 10.6 m-85 -59.75 -47.6 85.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.471 -1.393 . . . . 0.0 109.131 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' VAL . 95.8 mmm -52.55 -42.22 64.22 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.576 -1.249 . . . . 0.0 108.389 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -43.16 18.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.51 -0.743 . . . . 0.0 111.064 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.22 13.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -0.943 . . . . 0.0 113.088 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.74 ' SG ' HG22 ' A' ' 26' ' ' THR . 0.5 OUTLIER -54.16 -18.91 4.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.628 -1.295 . . . . 0.0 110.861 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.98 -0.47 59.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.719 HD22 HG21 ' A' ' 120' ' ' VAL . 11.7 mt -58.67 -35.14 72.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.403 -1.057 . . . . 0.0 109.348 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 166' ' ' MET . 1.5 m -131.06 143.98 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.14 117.69 34.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.807 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.9 p-10 -178.85 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 174' ' ' ASP . 35.8 m170 -49.1 -39.25 27.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 176' ' ' VAL . 6.2 p 175.62 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' VAL . 1.4 p 30.69 112.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.261 1.029 . . . . 0.0 112.206 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.51 48.47 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 120.696 -1.252 . . . . 0.0 110.569 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 120.715 -1.462 . . . . 0.0 108.676 179.433 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.505 HH12 ' CG1' ' A' ' 14' ' ' ILE . 80.5 mtm180 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.19 143.24 58.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.192 0.996 . . . . 0.0 110.226 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.22 -21.51 32.98 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -77.3 -4.28 44.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.953 -1.322 . . . . 0.0 108.864 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.31 -31.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -70.54 6.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.393 -0.817 . . . . 0.0 110.035 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.36 -105.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.953 -1.092 . . . . 0.0 110.511 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.47 159.97 63.07 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.935 . . . . 0.0 110.439 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 14' ' ' ILE . 38.1 Cg_endo -68.36 -35.58 17.99 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.188 2.592 . . . . 0.0 113.245 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.89 -31.8 71.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.075 -1.015 . . . . 0.0 110.608 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.42 -33.56 69.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 110.964 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.505 ' CG1' HH12 ' A' ' 3' ' ' ARG . 3.4 mp -58.53 -41.03 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.746 -1.221 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -68.01 -50.74 53.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.062 . . . . 0.0 109.452 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -63.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.363 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -66.58 -42.86 86.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 110.373 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -74.65 -10.28 59.38 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.2 m120 -69.6 -76.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.885 -1.134 . . . . 0.0 108.426 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' O ' ' C ' ' A' ' 21' ' ' TRP . 94.6 mt-10 -151.92 -39.5 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 1.052 ' HE1' ' NE2' ' A' ' 167' ' ' GLN . 8.4 t90 -3.38 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.808 0.813 . . . . 0.0 111.241 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 142.41 -23.68 2.36 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.142 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.71 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 11.6 m -125.5 10.87 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.663 -0.904 . . . . 0.0 112.676 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 73.5 Cg_endo -75.72 143.79 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.346 1.364 . . . . 0.0 112.874 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -86.12 148.3 25.76 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.64 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.6 p -88.25 120.6 29.77 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.522 -1.271 . . . . 0.0 111.436 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.881 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -105.89 159.26 16.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 m -64.67 -38.08 89.78 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.466 -1.396 . . . . 0.0 110.469 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -75.13 -49.92 18.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 111.866 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -59.23 -40.49 86.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.949 -1.094 . . . . 0.0 109.398 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.881 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.5 mp -62.69 -38.24 89.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.317 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 1.3 t80 -59.88 -39.46 85.39 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.472 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 37' ' ' LEU . 61.3 mt-10 -74.12 -39.82 63.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.311 -0.868 . . . . 0.0 108.936 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.471 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 26.0 ttm -59.5 -49.61 77.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.835 . . . . 0.0 110.848 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 10.9 tp -62.13 -35.26 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.673 -1.267 . . . . 0.0 108.817 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 72.2 m -67.23 -36.98 82.8 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.599 ' CD1' HH21 ' A' ' 57' ' ' ARG . 1.8 mp -73.21 -48.76 32.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 164' ' ' SER . 72.1 mm-40 -63.19 -37.55 87.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.826 . . . . 0.0 108.859 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.46 -35.88 92.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -74.48 -8.63 56.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.966 . . . . 0.0 109.382 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -74.21 -5.64 43.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.51 122.87 14.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.011 -1.055 . . . . 0.0 109.283 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.62 -25.99 0.28 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 42' ' ' ALA . 87.6 mt -105.48 144.61 32.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -1.144 . . . . 0.0 110.233 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -75.75 157.52 33.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -56.91 -34.51 68.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.498 -0.752 . . . . 0.0 110.296 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -35.35 67.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -62.69 -44.31 96.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.333 -0.855 . . . . 0.0 109.983 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.31 -24.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.219 -0.926 . . . . 0.0 109.168 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.54 -47.87 82.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.0 110.003 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -61.4 -49.68 75.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.913 -1.117 . . . . 0.0 109.033 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.21 -5.82 50.68 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.067 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.3 ttm180 -65.9 -55.74 15.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -66.2 -45.84 79.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.663 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -66.24 -45.87 79.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.956 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 92' ' ' ILE . 56.7 t80 -63.44 -46.3 86.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.875 -1.14 . . . . 0.0 110.476 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.599 HH21 ' CD1' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -54.31 -34.42 60.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.856 -1.153 . . . . 0.0 109.676 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.29 79.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.087 -1.008 . . . . 0.0 110.469 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.79 -43.7 62.45 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 112.638 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.794 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 66.6 m-85 . . . . . 0 N--CA 1.501 2.091 0 O-C-N 120.739 -1.225 . . . . 0.0 112.079 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 CA-C-O 121.279 0.45 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.71 -46.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -65.4 -34.61 78.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 96' ' ' ILE . 96.6 t -60.34 -37.55 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.818 . . . . 0.0 109.53 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -69.75 -15.28 63.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.53 -5.07 49.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 0.0 109.853 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.672 ' O ' HG21 ' A' ' 96' ' ' ILE . 72.1 mmm -77.97 116.5 18.51 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -95.12 175.69 6.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.201 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.86 -33.57 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.716 -0.615 . . . . 0.0 110.542 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -57.83 -42.0 83.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 84.8 m-20 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.822 ' O ' HG23 ' A' ' 80' ' ' VAL . 88.1 t -62.53 -40.09 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.461 -0.774 . . . . 0.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -66.04 -40.26 90.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 7.1 ptp180 -74.61 -38.71 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.717 -1.239 . . . . 0.0 109.225 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 10.4 mt -65.49 -32.35 73.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.73 . . . . 0.0 110.615 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.3 t -48.24 -38.36 8.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.14 2.02 45.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.738 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.7 t70 -87.43 110.6 20.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 81.67 -15.13 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.676 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.05 37.41 49.72 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 85' ' ' ILE . 1.4 pt -58.74 -166.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.197 -1.178 . . . . 0.0 110.107 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 86' ' ' ILE . 15.7 tt -66.98 94.46 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 0.0 109.463 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.615 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 4.6 mtt-85 -51.78 117.86 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.915 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.699 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 1.4 m80 170.62 68.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -48.73 -34.16 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.26 -62.65 6.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.699 ' HZ1' ' CG ' ' A' ' 88' ' ' HIS . 33.7 mtmm -62.44 -40.68 97.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.085 -1.244 . . . . 0.0 110.322 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 56' ' ' TYR . 43.8 mm -61.18 -43.89 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.959 -1.088 . . . . 0.0 110.513 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 3.2 pt20 -58.99 -36.43 74.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.796 -1.19 . . . . 0.0 109.368 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -68.49 -36.59 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.17 -31.14 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.672 HG21 ' O ' ' A' ' 71' ' ' MET . 15.8 mm -58.56 -46.25 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.807 -1.183 . . . . 0.0 108.395 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.1 -33.19 86.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -56.16 -42.2 76.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.194 . . . . 0.0 109.826 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.28 -47.6 67.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.087 . . . . 0.0 108.894 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 34.1 ttm180 -56.77 -36.25 69.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.458 -0.776 . . . . 0.0 109.1 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.43 72.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.057 -1.027 . . . . 0.0 108.927 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.7 -42.66 97.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.0 mm? -61.44 -32.95 72.94 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -63.62 -36.69 84.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.587 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.3 tpp -64.23 -40.76 96.71 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.028 0.918 . . . . 0.0 108.899 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.6 -38.98 92.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.5 -24.31 66.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -90.97 -15.84 29.02 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.6 27.19 73.58 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.644 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.99 101.93 47.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.195 -1.179 . . . . 0.0 109.565 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.53 138.16 14.46 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.769 1.646 . . . . 0.0 112.383 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -51.88 -39.12 58.46 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.237 1.018 . . . . 0.0 109.198 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.12 65.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 109.957 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -66.63 -48.64 68.82 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 111.892 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.658 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 7.8 p90 -73.95 -38.29 64.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.54 -1.35 . . . . 0.0 111.274 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.658 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.5 m -66.92 -52.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.318 -1.489 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.589 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.3 m95 -55.03 -27.13 42.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 t -76.14 -40.0 53.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.464 -0.773 . . . . 0.0 110.541 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.28 -24.88 65.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.284 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.0 m -100.84 19.11 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.418 -0.801 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.63 36.19 22.55 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.76 -0.588 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 52.68 37.3 23.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 111.218 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.08 149.85 25.94 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 109.315 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.83 150.78 62.27 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 112.2 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 172' ' ' VAL . 4.6 tm0? -102.43 132.0 48.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 98.2 mmm -94.23 117.81 30.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 109.233 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -93.07 119.46 32.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.64 21.45 4.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.031 -1.043 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -67.48 142.22 56.68 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.484 -0.76 . . . . 0.0 109.697 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.512 HG22 ' CG2' ' A' ' 177' ' ' VAL . 58.2 p -106.61 -25.01 11.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 108.865 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -130.12 164.27 24.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.549 -0.72 . . . . 0.0 109.092 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.4 mt -57.66 -35.0 69.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 108.773 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.2 t -61.06 -35.95 78.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.53 0.52 25.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.2 tp -79.84 125.9 81.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.26 132.36 13.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.764 1.643 . . . . 0.0 112.725 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 p -111.65 7.15 20.35 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -144.92 89.35 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.527 -0.733 . . . . 0.0 109.462 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.1 p -108.99 151.93 42.16 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.601 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.63 -34.69 74.57 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.667 1.578 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HB1' ' HE1' ' A' ' 166' ' ' MET . . . -72.95 -45.76 56.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.451 -0.781 . . . . 0.0 109.0 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.7 p -69.01 -36.69 78.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.28 -0.887 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.49 -38.95 93.1 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.76 -27.24 63.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.642 ' CD1' HG12 ' A' ' 116' ' ' VAL . 6.5 tp -69.03 -44.95 71.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.723 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 7.7 t -62.62 -47.09 85.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.913 . . . . 0.0 110.868 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -65.06 -37.83 88.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.775 -1.203 . . . . 0.0 109.879 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.36 -44.83 70.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.1 -1.0 . . . . 0.0 109.389 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.55 ' HB3' HG11 ' A' ' 157' ' ' VAL . 1.2 mm? -63.24 -38.31 90.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -61.29 -41.08 96.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.144 -0.972 . . . . 0.0 110.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -68.65 -36.58 78.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.97 -1.081 . . . . 0.0 111.762 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.474 ' NH2' HD22 ' A' ' 149' ' ' LEU . 14.5 mtm180 -71.11 7.05 1.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.78 -1.2 . . . . 0.0 110.143 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.68 57.2 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -95.34 112.57 24.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.218 -1.166 . . . . 0.0 108.015 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.44 174.95 6.6 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 59.68 48.65 9.12 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.564 0.697 . . . . 0.0 109.875 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 149' ' ' LEU . 35.9 m -122.27 43.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.67 160.1 0.48 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -56.8 -30.91 64.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.64 -0.917 . . . . 0.0 109.881 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -75.6 -31.45 59.95 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -72.48 -35.99 53.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.2 m -69.28 -40.58 77.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.803 . . . . 0.0 109.38 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.51 -45.24 76.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.499 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 33.6 t -61.35 -39.34 90.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.563 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 47.9 t80 -58.54 -47.78 83.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.714 -0.616 . . . . 0.0 110.445 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.499 ' HE1' ' HB1' ' A' ' 141' ' ' ALA . 63.9 mtp -72.43 -39.56 67.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.055 -1.028 . . . . 0.0 109.536 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 1.052 ' NE2' ' HE1' ' A' ' 21' ' ' TRP . 1.4 tm0? -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 110.211 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.34 -38.71 41.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 109.882 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 44.3 m -54.53 -16.95 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.343 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.55 -1.31 58.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 26' ' ' THR . 85.3 mt -61.95 -30.91 71.23 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -1.078 . . . . 0.0 109.525 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 125' ' ' GLN . 5.3 t -116.14 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 6.4 m-80 -125.01 162.41 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 15.3 t0 89.3 69.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.126 0.489 . . . . 0.0 110.563 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -51.59 -59.09 4.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.78 160.71 36.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.512 ' CG2' HG22 ' A' ' 130' ' ' THR . 56.3 t -60.14 113.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.524 -1.36 . . . . 0.0 108.793 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.75 67.33 1.69 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.747 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.565 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 5.3 t . . . . . 0 N--CA 1.495 1.808 0 O-C-N 120.816 -1.403 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.643 ' CG ' HH11 ' A' ' 3' ' ' ARG . 2.2 mtt-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.693 0.759 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 3.4 m -57.94 154.75 11.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.618 0.723 . . . . 0.0 110.254 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.13 -44.79 96.11 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.487 -0.758 . . . . 0.0 112.478 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.646 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -80.49 1.22 30.23 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.474 -1.604 . . . . 0.0 109.828 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 3' ' ' ARG . 2.2 t -89.39 -47.7 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.829 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -77.77 6.28 7.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 0.8 OUTLIER -91.58 -58.93 2.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.787 -0.571 . . . . 0.0 110.492 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.88 160.0 67.15 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.615 ' HA ' HD12 ' A' ' 14' ' ' ILE . 31.5 Cg_endo -69.66 -32.11 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.041 2.494 . . . . 0.0 112.728 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.31 -40.26 89.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.121 -0.987 . . . . 0.0 109.477 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 6' ' ' TRP . 29.5 m-85 -65.92 -38.52 88.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.977 -1.077 . . . . 0.0 109.702 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 11' ' ' PRO . 89.3 mt -55.69 -40.56 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.394 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -72.5 -51.74 18.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.974 -1.079 . . . . 0.0 109.419 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.9 -41.54 96.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.776 . . . . 0.0 109.991 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CG ' HG21 ' A' ' 7' ' ' VAL . 57.9 t-80 -62.47 -45.5 92.75 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.639 -0.663 . . . . 0.0 110.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -74.06 -7.38 52.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.448 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.511 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 11.1 m120 -81.01 -77.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 110.288 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' GLY . 92.7 mt-10 -154.71 71.69 0.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 110.343 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.641 ' NE1' ' NE2' ' A' ' 167' ' ' GLN . 31.4 t-105 -70.14 63.31 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 67.83 64.99 2.88 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.018 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.731 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 25.5 t -114.67 -36.2 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.425 -1.044 . . . . 0.0 109.742 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.731 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 41.6 Cg_endo -95.21 151.8 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.962 2.441 . . . . 0.0 112.989 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.34 143.24 56.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 169' ' ' CYS . 23.7 p -99.01 155.51 17.39 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.95 . . . . 0.0 111.863 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -97.72 166.68 11.37 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 m -57.33 -37.09 71.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.091 -1.006 . . . . 0.0 110.398 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -65.46 -42.47 92.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 111.035 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -59.05 -34.87 72.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.175 -0.953 . . . . 0.0 109.035 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.7 mt -65.54 -33.26 75.5 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.84 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.92 -50.33 64.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 0.0 110.181 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -68.81 -30.21 68.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.83 -1.169 . . . . 0.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 168' ' ' ALA . 6.0 tpt -70.28 -50.23 41.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.64 -29.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.62 -48.18 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.043 . . . . 0.0 110.022 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.67 -39.01 84.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -62.89 -31.19 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 109.939 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.34 -41.6 55.2 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.123 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 57.7 mm-40 -67.89 -29.82 69.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.694 -1.474 . . . . 0.0 110.974 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.533 HE22 ' CB ' ' A' ' 164' ' ' SER . 9.6 pt20 -41.3 -31.94 0.26 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 0.0 109.829 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.63 116.98 7.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.01 -1.056 . . . . 0.0 108.716 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.451 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 86.66 -36.74 3.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.024 HD12 HG21 ' A' ' 48' ' ' THR . 4.5 mm? -105.14 150.04 25.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.164 -1.198 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 t -76.62 150.28 36.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 1.1 t-105 -54.72 -35.59 63.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -41.04 90.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.067 -1.021 . . . . 0.0 108.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 1.024 HG21 HD12 ' A' ' 44' ' ' LEU . 44.0 m -57.84 -38.42 75.59 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.8 t -66.5 -37.25 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD12 ' CZ ' ' A' ' 53' ' ' ARG . 37.1 tp -56.21 -50.6 70.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.06 -1.025 . . . . 0.0 108.671 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -57.49 -37.76 73.46 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -73.18 -24.25 60.53 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 42.2 ttm180 -55.12 -45.06 75.53 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.08 -40.71 91.07 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 3.5 m-20 -69.08 -31.92 71.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.886 0.85 . . . . 0.0 108.984 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 52' ' ' LYS . 58.7 t80 -56.14 -50.89 69.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.31 -28.0 67.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.048 -1.033 . . . . 0.0 109.22 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.57 -36.47 82.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 110.262 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.96 -45.62 26.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.602 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 98.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.926 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.499 0 N-CA-C 113.168 0.411 . . . . 0.0 113.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.91 -46.52 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.716 -1.24 . . . . 0.0 109.975 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.78 -33.02 74.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.774 -1.204 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.91 -37.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.762 ' HB1' ' NH2' ' A' ' 100' ' ' ARG . . . -65.61 -17.2 64.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.2 -10.94 29.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.642 -0.662 . . . . 0.0 109.734 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.58 114.39 9.61 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.062 -1.024 . . . . 0.0 108.686 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 62.6 tt0 -95.89 172.77 7.81 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 94.3 mt-10 -51.79 -30.48 23.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.825 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -55.48 -44.33 76.38 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 119.909 -1.744 . . . . 0.0 108.44 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 70.6 m-20 -70.86 -35.26 72.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.478 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.96 -34.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.258 -1.526 . . . . 0.0 109.3 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.72 -40.86 98.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -70.68 -34.42 71.98 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.443 -1.303 . . . . 0.0 108.967 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.456 ' C ' ' N ' ' A' ' 81' ' ' GLN . 72.9 mt -68.26 -34.94 77.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.3 t -49.38 -19.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 79' ' ' LEU . 12.8 mt-30 -106.52 -15.42 14.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.483 -0.76 . . . . 0.0 109.912 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 82.1 m-20 -78.9 109.86 13.57 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.703 -1.199 . . . . 0.0 109.948 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.0 -18.9 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.32 33.01 61.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLY . 9.7 pt -36.22 156.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.649 -0.912 . . . . 0.0 110.234 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.45 -35.04 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.301 -0.874 . . . . 0.0 110.39 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.5 147.29 53.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.935 -178.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 97.7 m-70 -124.16 170.69 10.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.59 -0.694 . . . . 0.0 109.38 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 88' ' ' HIS . 35.3 ttp180 -40.14 -35.78 0.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.19 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.66 -64.02 2.34 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.472 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 7.5 mptt -60.39 -36.99 79.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -1.19 . . . . 0.0 110.107 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.548 HG21 ' HB ' ' A' ' 76' ' ' VAL . 97.7 mt -59.87 -47.48 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.632 -1.292 . . . . 0.0 109.292 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -52.5 -34.82 51.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.06 -1.025 . . . . 0.0 108.71 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.67 89.02 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.507 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.83 -43.75 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 108.673 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.41 -41.77 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 108.646 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -38.07 93.44 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.78 -37.97 71.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.446 -1.032 . . . . 0.0 109.482 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.02 83.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.027 -1.045 . . . . 0.0 109.406 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.762 ' NH2' ' HB1' ' A' ' 69' ' ' ALA . 5.1 tpp180 -55.0 -39.44 69.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.268 -0.895 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.82 -29.93 69.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 59.2 t80 -64.24 -43.06 96.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.1 mm? -63.2 -28.95 70.4 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.69 -41.55 83.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.219 -0.926 . . . . 0.0 111.362 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.678 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.8 mtp -69.1 -37.29 78.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.749 -1.22 . . . . 0.0 109.293 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.65 -39.85 84.58 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -70.47 -15.77 62.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -92.95 -11.98 31.96 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.39 21.44 79.59 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.68 101.24 53.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.192 -1.181 . . . . 0.0 109.374 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.35 146.1 95.86 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.157 1.905 . . . . 0.0 112.273 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.6 m-85 -59.66 -45.21 92.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.98 -28.41 69.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 118' ' ' SER . 17.3 t70 -59.45 -52.46 65.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.964 -1.085 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -75.08 -39.87 60.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.64 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 18.5 t -59.0 -54.75 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 120.619 -1.301 . . . . 0.0 109.9 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 122' ' ' HIS . 56.1 m95 -62.02 -21.99 65.34 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 108.958 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 50.6 m -68.46 -37.47 80.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 109.254 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 18.3 m-85 -69.37 -31.26 69.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.403 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.611 ' O ' HG12 ' A' ' 120' ' ' VAL . 39.3 t -87.99 15.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.836 -1.165 . . . . 0.0 109.711 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.585 ' OD1' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER 78.78 11.38 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.699 -0.626 . . . . 0.0 109.836 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 65.7 20.57 11.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 110.893 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 58.0 mt-30 -146.51 150.94 42.07 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.941 -1.099 . . . . 0.0 109.236 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -49.24 142.25 22.11 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.862 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -110.77 142.62 42.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.565 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 92.1 mmm -99.93 130.26 46.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -92.73 123.04 35.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.093 -1.005 . . . . 0.0 109.879 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -91.93 27.35 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.79 . . . . 0.0 110.284 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -91.06 132.97 35.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.5 p -93.51 -22.36 18.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.127 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 49.4 p -133.64 167.85 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.016 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 -33.56 73.41 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.6 t -73.92 -13.17 60.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 110.43 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -94.16 4.05 54.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mm -92.49 122.35 64.57 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.83 140.78 32.56 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.84 1.693 . . . . 0.0 112.516 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.9 p -101.62 3.35 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.8 p -144.99 87.5 1.83 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.442 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.76 155.17 36.64 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -54.51 -36.52 88.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.879 1.719 . . . . 0.0 110.741 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.74 -43.12 59.99 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.809 -0.756 . . . . 0.0 108.984 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.8 p -70.18 -38.13 75.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.139 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.28 -38.93 91.23 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.177 -0.952 . . . . 0.0 108.881 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -68.83 -34.55 75.68 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.298 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mp -57.5 -46.29 83.95 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 0.0 108.639 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.545 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 8.9 t -60.7 -50.29 74.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.105 -0.997 . . . . 0.0 108.954 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -61.29 -40.41 94.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 109.267 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.99 22.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.83 -33.13 74.6 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -61.32 -42.24 98.34 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.982 -1.074 . . . . 0.0 109.671 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -68.45 -28.4 67.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.945 . . . . 0.0 110.55 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.408 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 3.3 mmp_? -72.7 1.35 8.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.906 -1.121 . . . . 0.0 108.675 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 78.59 27.32 57.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.64 112.88 24.58 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.652 0.739 . . . . 0.0 109.848 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -88.1 176.77 7.14 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.13 62.72 1.56 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.011 -1.056 . . . . 0.0 108.23 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.6 m -144.03 41.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.42 154.79 4.07 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 m -52.54 -32.01 38.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.27 -1.135 . . . . 0.0 109.557 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -72.09 -29.93 64.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.25 -0.906 . . . . 0.0 108.725 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.67 -44.92 96.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.815 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 146' ' ' SER . 97.9 m -60.8 -39.02 87.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.47 -47.81 53.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 111.063 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.533 ' CB ' HE22 ' A' ' 41' ' ' GLN . 19.9 m -63.43 -36.77 84.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.044 -1.035 . . . . 0.0 108.696 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 5.3 t80 -60.15 -46.24 90.35 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.153 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 171' ' ' LEU . 12.5 ptp -71.49 -34.08 69.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.511 -1.368 . . . . 0.0 110.626 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' NE1' ' A' ' 21' ' ' TRP . 2.7 tm0? -61.48 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.818 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.564 ' HB3' ' CE ' ' A' ' 34' ' ' MET . . . -87.14 -22.98 25.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.199 -0.938 . . . . 0.0 111.592 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.609 ' O ' HG23 ' A' ' 26' ' ' THR . 1.5 m -68.76 -19.31 64.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.964 -1.085 . . . . 0.0 111.102 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.49 0.83 57.93 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 166' ' ' MET . 11.5 mt -63.37 -30.97 72.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.615 -0.932 . . . . 0.0 109.426 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.07 142.15 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 75.0 m-20 -111.71 164.11 13.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.794 ' OD2' HG22 ' A' ' 177' ' ' VAL . 5.5 t0 86.71 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.597 0.713 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.477 ' CD2' ' CD1' ' A' ' 21' ' ' TRP . 20.9 m170 -54.35 -48.26 71.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -152.07 38.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.484 -179.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.794 HG22 ' OD2' ' A' ' 174' ' ' ASP . 24.0 t 45.15 13.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.0 110.672 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -157.4 31.74 0.53 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.117 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.122 -1.222 . . . . 0.0 109.873 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.39 0.614 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.37 152.93 40.69 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.274 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.03 -25.86 25.59 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.78 13.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.028 -1.278 . . . . 0.0 109.623 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.9 t -138.74 -23.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 110.269 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -71.83 5.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 109.949 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -115.39 -75.45 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.341 -0.85 . . . . 0.0 110.57 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.02 139.46 90.46 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.986 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 -53.21 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.526 2.151 . . . . 0.0 113.194 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -54.91 -33.91 62.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.912 -1.118 . . . . 0.0 109.742 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -52.89 -40.18 63.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.12 -39.84 43.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.447 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -72.18 -51.1 22.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.96 -1.087 . . . . 0.0 109.535 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 22.7 t80 -60.76 -41.08 94.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 0.0 109.72 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -58.66 -44.85 90.26 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.47 -0.769 . . . . 0.0 109.618 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.92 -30.36 68.81 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.645 -0.659 . . . . 0.0 110.836 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 18.5 m120 -60.21 -53.56 56.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 111.126 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' GLY . 10.9 pt-20 176.05 72.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.2 -0.938 . . . . 0.0 110.334 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.401 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 44.9 t-105 -70.52 60.73 0.22 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 71.27 49.67 25.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.604 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -107.18 -42.63 0.13 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.322 -1.105 . . . . 0.0 110.563 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.9 Cg_endo -91.14 151.87 3.8 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.261 2.641 . . . . 0.0 113.183 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.39 144.21 54.82 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 p -99.16 148.79 23.73 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.102 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 31' ' ' LEU . 76.8 m-20 -96.41 166.43 11.7 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -56.01 -31.5 63.13 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.777 -1.202 . . . . 0.0 109.632 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -65.65 -43.0 90.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.565 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmtm -63.72 -34.96 79.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.131 -0.981 . . . . 0.0 109.125 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.4 mm? -56.22 -41.67 76.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.718 -0.614 . . . . 0.0 109.643 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -69.57 -43.17 73.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' O ' HD22 ' A' ' 37' ' ' LEU . 77.1 mt-10 -69.35 -45.39 69.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.86 -1.15 . . . . 0.0 109.332 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.9 ttm -62.19 -51.05 69.38 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.493 -0.754 . . . . 0.0 111.146 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.27 -26.16 38.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.853 -1.154 . . . . 0.0 109.716 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.45 -54.02 19.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.941 -1.099 . . . . 0.0 109.737 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.634 ' H ' HD22 ' A' ' 37' ' ' LEU . 2.0 mm? -71.88 -38.51 69.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.145 . . . . 0.0 108.843 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' CG ' ' OG ' ' A' ' 164' ' ' SER . 3.5 tp10 -62.13 -32.34 72.91 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.514 -0.741 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.68 -13.73 82.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.533 HE21 HD13 ' A' ' 95' ' ' ILE . 89.5 mt-30 -92.91 -8.38 43.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.311 . . . . 0.0 111.319 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 2.4 pt20 -80.38 1.83 27.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.573 -1.329 . . . . 0.0 110.176 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -62.87 117.58 6.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -29.31 1.66 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . 19.1 mt -98.46 146.12 26.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -1.114 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 m -67.81 152.66 45.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -60.21 -37.13 79.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.675 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -67.73 -35.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.088 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -59.57 -42.12 91.73 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.959 -1.088 . . . . 0.0 108.125 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 54.0 t -67.72 -35.06 71.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HB3' HD13 ' A' ' 47' ' ' ILE . 7.3 tt -56.36 -51.67 67.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.148 -0.97 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -57.9 -43.13 85.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -66.92 -28.84 68.62 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.06 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.7 ttm180 -53.52 -43.79 68.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.822 -1.174 . . . . 0.0 109.097 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -73.25 -49.14 29.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.216 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 24.0 p30 -80.95 -42.62 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.757 -1.214 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.601 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 53.1 t80 -62.76 -44.64 95.67 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.809 -1.182 . . . . 0.0 109.937 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.61 -31.82 71.92 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.37 -42.7 98.88 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.018 -1.052 . . . . 0.0 110.335 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB3' HD22 ' A' ' 79' ' ' LEU . 35.3 m -78.37 -43.26 28.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.0 113.087 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 93.3 m-85 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 120.734 -1.229 . . . . 0.0 112.398 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.486 1.077 0 CA-C-O 121.401 0.5 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.43 -43.65 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 3.1 mtmp? -67.45 -38.18 84.09 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 60' ' ' PHE . 85.8 t -61.69 -39.25 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.83 -14.94 63.37 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 -9.64 53.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.648 ' O ' HG21 ' A' ' 96' ' ' ILE . 82.3 mmm -77.77 112.28 14.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.467 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.6 pt20 -95.87 -177.07 3.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.341 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.03 -33.44 72.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 110.801 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.0 tt0 -58.58 -43.33 89.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.7 -1.25 . . . . 0.0 109.08 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -65.23 -38.89 91.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.696 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 80' ' ' VAL . 47.3 t -57.75 -44.31 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.726 . . . . 0.0 110.576 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.7 pt-20 -63.18 -35.83 81.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.637 -1.289 . . . . 0.0 108.943 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -69.18 -44.03 73.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLN . 90.2 mt -69.56 -32.86 71.9 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.5 m -47.83 -16.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.438 -1.414 . . . . 0.0 108.928 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LEU . 20.6 pt20 -124.55 -2.18 7.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.637 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -83.76 111.01 18.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.474 -1.391 . . . . 0.0 109.222 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 85.27 -5.46 0.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.899 -0.501 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.91 37.68 60.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -162.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -1.147 . . . . 0.0 109.493 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 98.6 mt -77.25 118.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.942 0.877 . . . . 0.0 109.133 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.6 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.3 mtp180 -80.68 125.64 30.28 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.81 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 77' ' ' GLU . 41.8 ttm180 -44.79 -33.31 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 0.0 109.763 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.63 -59.79 6.82 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.975 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -60.65 -42.21 96.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.843 -1.386 . . . . 0.0 110.862 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.589 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 29.0 mm -62.63 -43.49 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.939 -1.101 . . . . 0.0 110.203 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -31.63 65.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 109.258 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.29 83.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.518 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.533 HD13 HE21 ' A' ' 40' ' ' GLN . 91.4 mt -66.07 -35.73 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.811 . . . . 0.0 110.675 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 71' ' ' MET . 17.0 mm -58.06 -39.88 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.466 -1.396 . . . . 0.0 107.25 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.39 -34.19 89.25 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.06 -40.3 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -1.222 . . . . 0.0 108.472 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.35 86.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.604 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.481 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 98.0 mtt180 -61.49 -36.98 82.0 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.04 -30.75 71.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 108.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.03 -43.32 99.02 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -63.7 -34.52 78.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.97 -39.38 94.52 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.321 -0.862 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.6 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 29.8 tpp -63.91 -46.58 84.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.42 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.37 -38.6 80.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.03 -24.59 64.64 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -91.93 -12.01 34.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.63 26.8 73.65 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.427 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.6 ' O ' ' SD ' ' A' ' 105' ' ' MET . 2.0 mt-10 -120.33 101.93 46.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.219 -1.165 . . . . 0.0 109.868 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.79 142.49 25.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.805 1.67 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 43.9 m-85 -59.86 -38.88 83.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.321 -0.862 . . . . 0.0 110.905 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.23 68.14 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.962 -1.086 . . . . 0.0 110.433 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.82 -47.45 74.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.063 . . . . 0.0 112.292 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.646 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.0 p90 -74.27 -37.66 63.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.52 -1.362 . . . . 0.0 111.154 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 145' ' ' LEU . 30.7 m -63.41 -52.46 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.328 -1.482 . . . . 0.0 109.894 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.609 ' N ' HG23 ' A' ' 116' ' ' VAL . 54.1 m95 -58.41 -25.07 61.71 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.115 . . . . 0.0 108.033 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.9 m -75.86 -38.0 58.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.481 -0.762 . . . . 0.0 110.28 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -62.88 -32.47 73.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 109.819 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.4 p -92.62 19.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.125 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 122' ' ' HIS . 6.4 m120 66.25 34.89 6.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.757 -0.59 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 117' ' ' TRP . 86.2 t60 38.31 33.94 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 0.0 109.907 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.7 pt20 -130.89 153.18 81.63 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.91 140.52 35.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.183 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.26 123.89 50.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.073 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.7 mtm -94.71 117.08 29.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.029 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.0 115.35 24.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.268 -0.895 . . . . 0.0 108.974 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.61 19.9 5.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 109.416 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 136.03 55.23 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 176' ' ' VAL . 81.8 p -97.16 -12.22 23.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 0.0 108.969 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 p -140.02 163.62 32.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.499 -0.751 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.42 -34.29 76.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.136 -0.978 . . . . 0.0 109.134 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.9 p -72.92 -19.52 61.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.768 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -84.15 3.88 32.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.452 HD13 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -92.36 138.84 23.97 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.26 135.9 30.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.303 2.002 . . . . 0.0 112.601 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -111.45 1.95 17.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.039 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -147.32 90.06 1.84 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.71 156.71 39.28 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 109.042 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.5 -37.48 90.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.021 1.814 . . . . 0.0 111.338 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.11 -41.92 66.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.899 . . . . 0.0 108.666 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -68.03 -42.28 80.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.82 . . . . 0.0 109.351 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.88 -42.31 90.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.65 74.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.829 HD11 HG12 ' A' ' 116' ' ' VAL . 2.0 tp -60.72 -46.07 91.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.363 -0.836 . . . . 0.0 108.861 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.44 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 5.7 t -58.41 -46.81 85.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 109.669 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.67 -44.63 96.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 109.946 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.77 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.25 -44.8 78.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.36 -36.34 83.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -60.61 -39.44 88.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.448 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 153' ' ' GLY . 25.4 mmtm -64.98 -36.49 84.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.77 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.8 5.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.99 24.98 63.01 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.435 ' HB3' HG11 ' A' ' 157' ' ' VAL . 0.3 OUTLIER -96.86 111.92 23.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.503 -0.998 . . . . 0.0 108.412 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 157' ' ' VAL . 37.4 mtmt -96.28 176.72 5.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 109.71 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 57.61 47.14 16.42 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 154' ' ' PHE . 28.1 m -126.52 36.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.73 171.38 0.05 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.0 p -60.81 -28.13 68.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.148 . . . . 0.0 109.325 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -65.59 -38.31 89.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 38' ' ' GLU . 12.3 mm -68.94 -44.42 81.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 146' ' ' SER . 84.7 m -63.68 -42.64 98.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.611 -0.68 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.428 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.59 -40.95 80.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 110.035 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 38' ' ' GLU . 76.9 p -63.34 -40.21 96.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.916 . . . . 0.0 109.873 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 1.7 t80 -59.32 -43.85 92.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.099 -1.001 . . . . 0.0 109.388 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.0 mtp -62.26 -38.87 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 135' ' ' ILE . 4.6 tp60 -66.17 -41.88 89.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.451 -0.78 . . . . 0.0 111.244 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.63 5.8 41.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.049 -1.032 . . . . 0.0 111.362 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.592 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 21.0 t -96.76 -13.01 22.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.737 -1.227 . . . . 0.0 110.31 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.55 -5.98 57.25 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.592 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -62.94 -33.58 75.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.951 -1.323 . . . . 0.0 109.613 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.02 138.68 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.6 m120 -113.27 164.02 14.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.434 -0.791 . . . . 0.0 110.132 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.6 OUTLIER 92.4 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.377 0.608 . . . . 0.0 110.332 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 16.2 m170 -53.45 -38.6 63.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 176' ' ' VAL . 2.9 p -162.18 55.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 177' ' ' VAL . 13.5 p 23.51 67.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.335 0.588 . . . . 0.0 111.156 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.47 35.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 31.0 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.119 -1.224 . . . . 0.0 109.487 179.503 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.555 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.499 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' NE2' ' A' ' 175' ' ' HIS . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' CZ2' ' CZ ' ' A' ' 16' ' ' TYR . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 53.3 m-85 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.946 0.311 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.442 ' O ' HG21 ' A' ' 96' ' ' ILE . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.408 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.408 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 25.4 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.457 ' HG1' ' HG ' ' A' ' 133' ' ' SER . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.457 ' HG ' ' HG1' ' A' ' 131' ' ' THR . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 131.38 28.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.819 . . . . 0.0 110.043 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.01 -27.97 52.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -2.96 58.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.379 -1.071 . . . . 0.0 108.987 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER -95.42 -23.29 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.586 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -63.7 6.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 109.439 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 7' ' ' VAL . 85.0 mt-30 -91.63 -168.37 2.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.4 153.42 1.33 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.4 -0.813 . . . . 0.0 109.869 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.19 -20.72 32.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.63 -37.56 76.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 109.875 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CE2' ' OE1' ' A' ' 9' ' ' GLN . 2.6 m-85 -67.05 -35.33 79.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.72 -36.68 67.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -68.14 -49.9 58.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.882 -1.136 . . . . 0.0 108.899 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 21' ' ' TRP . 19.6 t80 -63.79 -41.29 97.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 108.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -70.85 -42.07 70.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.683 -0.636 . . . . 0.0 110.8 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.87 -10.45 58.52 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 110.517 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 19.8 m120 -80.02 -76.13 0.23 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.788 -1.195 . . . . 0.0 109.364 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 21' ' ' TRP . 95.6 mt-10 -146.88 -65.41 0.28 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.565 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.3 t90 26.35 63.12 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.377 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.5 57.55 0.24 Allowed Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.829 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.841 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 p -176.49 -21.16 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 113.487 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.841 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 72.8 Cg_endo -89.24 150.89 5.55 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.612 1.541 . . . . 0.0 113.258 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.02 156.21 39.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.661 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -91.06 132.12 36.22 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.595 -177.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.93 147.15 29.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -60.85 -35.62 77.03 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -75.26 -50.62 15.55 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.508 -0.745 . . . . 0.0 111.072 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -34.96 77.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.963 -1.086 . . . . 0.0 109.291 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.673 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 65.8 mt -63.29 -36.5 83.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.149 -0.969 . . . . 0.0 109.199 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.29 -43.0 92.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.61 -38.02 80.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.984 -1.072 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.552 ' CE ' ' HB1' ' A' ' 168' ' ' ALA . 53.2 tpp -63.3 -50.65 69.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.679 -0.638 . . . . 0.0 111.006 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 35' ' ' ILE . 11.0 tp -62.94 -27.08 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.228 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.8 t -71.02 -53.92 13.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 108.861 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.07 -38.91 92.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 108.512 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.572 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -67.5 -39.24 85.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 108.891 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.57 94.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.11 -4.89 43.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 109.661 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -78.15 2.82 16.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.116 . . . . 0.0 109.977 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -65.22 132.09 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.043 . . . . 0.0 109.093 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.15 -29.77 0.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 79.7 mt -98.14 139.89 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.608 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.7 m -69.18 154.39 42.13 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.247 -0.908 . . . . 0.0 108.661 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 1.2 t-105 -55.15 -39.56 69.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.0 . . . . 0.0 109.841 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -37.64 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -0.956 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.451 HG21 HD22 ' A' ' 44' ' ' LEU . 99.9 m -57.98 -41.76 83.65 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.954 -1.091 . . . . 0.0 108.531 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -67.05 -31.65 54.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.809 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -48.59 81.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.088 -1.008 . . . . 0.0 109.939 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 53.1 mttt -62.21 -46.37 89.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.784 -1.197 . . . . 0.0 108.1 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.31 -16.44 61.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttm180 -63.69 -46.51 85.19 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -65.9 -45.41 82.09 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.2 m-80 -67.88 -43.09 80.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.895 ' OH ' HG21 ' A' ' 95' ' ' ILE . 89.8 t80 -60.44 -47.22 87.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 0.0 110.24 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -58.04 -34.2 69.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.042 -1.036 . . . . 0.0 109.837 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.77 95.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.896 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.6 m -72.98 -43.96 61.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.039 . . . . 0.0 111.079 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 84.9 m-85 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.055 . . . . 0.0 110.906 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 68' ' ' VAL . 50.9 Cg_endo . . . . . 0 N--CA 1.489 1.24 0 N-CA-C 115.287 1.226 . . . . 0.0 115.287 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -37.45 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.615 -1.303 . . . . 0.0 110.891 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -35.34 69.62 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.112 -0.993 . . . . 0.0 110.982 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 65' ' ' PRO . 3.7 m -73.94 -36.35 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.282 -1.511 . . . . 0.0 108.246 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.39 -20.54 59.96 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.91 -11.3 36.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.552 ' CE ' ' OD2' ' A' ' 75' ' ' ASP . 4.1 mmm -75.57 119.86 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.564 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 54.0 tt0 -95.57 168.49 10.66 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 109.901 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 98.1 mt-10 -49.75 -25.74 3.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.955 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 108.076 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -70.13 -37.8 75.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.918 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.606 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 49.5 t -61.8 -44.06 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.63 -0.669 . . . . 0.0 110.749 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.69 -32.81 74.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 108.14 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -67.95 -42.88 80.27 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.605 0.716 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 25.1 mt -69.6 -33.58 72.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 111.722 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 ' NH1' ' A' ' 89' ' ' ARG . 55.2 t -48.24 -31.28 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.892 -1.13 . . . . 0.0 108.527 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -100.43 -4.48 28.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.18 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 57.5 t0 -88.22 109.32 19.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.763 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.34 -16.34 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.472 -0.768 . . . . 0.0 109.656 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.48 35.33 47.59 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.0 pt -54.8 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -1.109 . . . . 0.0 110.207 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -53.53 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' ILE . 59.8 mtp180 -53.19 106.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.407 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.53 92.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.892 ' NH1' HG21 ' A' ' 80' ' ' VAL . 5.4 mtt-85 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.545 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.31 -59.32 7.98 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.229 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -61.42 -43.43 98.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.923 -1.339 . . . . 0.0 110.914 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.563 HG22 HG22 ' A' ' 76' ' ' VAL . 70.0 mt -60.58 -49.15 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.0 110.529 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -57.98 -29.89 65.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.83 -1.169 . . . . 0.0 109.019 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.56 94.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.174 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.895 HG21 ' OH ' ' A' ' 56' ' ' TYR . 84.9 mt -60.61 -40.81 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 mp -58.18 -45.16 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.09 94.13 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -51.38 -44.09 62.06 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.054 -1.262 . . . . 0.0 108.965 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -64.54 -39.93 94.67 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.274 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.97 -37.74 61.46 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.29 70.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' ALA . 42.0 t80 -63.43 -43.43 97.49 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 103' ' ' LEU . 8.4 mp -63.56 -34.76 78.52 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.2 -37.26 84.64 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.329 -0.949 . . . . 0.0 109.546 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 99.1 mmm -70.71 -41.69 71.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 108.339 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.1 mm-40 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -58.75 -24.35 61.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.03 -12.56 28.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.96 24.03 74.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -120.52 101.83 45.8 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.358 -1.084 . . . . 0.0 109.584 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.88 150.23 73.17 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.145 1.897 . . . . 0.0 112.377 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 73.0 m-85 -58.05 -40.68 81.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.351 -0.843 . . . . 0.0 110.489 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.6 72.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.779 . . . . 0.0 112.442 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.93 -53.92 22.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 0.0 111.873 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 1.9 p90 -68.27 -40.93 81.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.006 -1.059 . . . . 0.0 111.658 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 117' ' ' TRP . 14.7 p -64.88 -48.93 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 110.377 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.619 ' N ' HG13 ' A' ' 116' ' ' VAL . 10.9 m95 -55.14 -27.5 45.88 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.3 t -71.8 -36.49 70.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.44 -0.787 . . . . 0.0 110.598 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -66.72 -28.78 68.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -97.25 19.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 20.0 m120 64.11 44.02 4.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.7 -0.625 . . . . 0.0 110.222 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 44.94 12.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 110.527 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mt-30 -131.16 149.92 75.07 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.208 -0.933 . . . . 0.0 109.267 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.444 ' HB2' HD21 ' A' ' 173' ' ' ASN . 32.8 Cg_endo -67.22 162.16 39.76 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.298 1.999 . . . . 0.0 111.722 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.65 135.39 49.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 109.673 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.2 mtt -90.31 116.45 28.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 109.093 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 127' ' ' THR . 1.2 m -89.89 111.4 22.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.209 -0.932 . . . . 0.0 109.1 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -92.51 17.53 9.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 109.286 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.07 141.9 57.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 134' ' ' GLU . 42.6 p -98.82 -11.37 21.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.669 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.408 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 23.7 p -145.34 160.09 42.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.29 -42.71 96.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -65.24 -31.78 73.11 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.494 ' OE1' ' OG1' ' A' ' 130' ' ' THR . 63.6 tt0 -80.85 1.47 30.56 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.597 -0.689 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.83 143.74 27.0 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 108.732 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.15 136.54 12.93 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.202 1.935 . . . . 0.0 112.414 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.3 p -107.17 2.99 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.019 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t -147.24 90.66 1.9 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.416 -0.802 . . . . 0.0 108.988 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.6 p -100.32 152.06 37.72 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.45 -36.6 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.582 1.521 . . . . 0.0 111.269 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -39.65 63.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.515 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 68.5 m -66.42 -46.73 75.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.6 -38.88 82.43 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.029 -1.044 . . . . 0.0 109.154 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.38 63.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -59.47 -46.33 89.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.05 -46.14 88.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.478 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -59.18 -37.91 78.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.752 -0.593 . . . . 0.0 109.614 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.07 68.6 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.286 -0.883 . . . . 0.0 109.854 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 91.9 mt -60.81 -36.4 78.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.6 -39.95 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.088 . . . . 0.0 108.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -65.73 -33.58 76.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 3.7 mmp_? -71.4 3.08 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 109.202 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.1 26.11 38.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.66 116.25 30.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.475 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -92.06 174.47 7.3 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.562 0.696 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 58.78 58.76 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.572 0.701 . . . . 0.0 109.772 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.2 OUTLIER -126.75 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.53 150.5 0.36 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.1 m -53.17 -29.47 31.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.315 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -74.24 -35.51 63.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -66.33 -36.74 78.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -69.48 -38.37 77.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.041 . . . . 0.0 109.394 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.497 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.66 -46.8 74.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.509 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 95.0 p -65.19 -33.34 75.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 108.824 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 49.4 t80 -59.25 -46.07 89.48 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.614 -0.679 . . . . 0.0 109.679 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.447 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 22.0 mtm -63.33 -38.0 89.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.54 ' OE1' HG21 ' A' ' 172' ' ' VAL . 25.9 mm100 -60.44 -42.67 96.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.962 -1.086 . . . . 0.0 109.811 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.552 ' HB1' ' CE ' ' A' ' 34' ' ' MET . . . -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.411 -0.806 . . . . 0.0 109.983 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 66.9 m -58.36 -31.11 67.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.928 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.08 0.44 44.74 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 120' ' ' VAL . 95.8 mt -62.33 -28.72 69.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.969 . . . . 0.0 109.777 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.54 HG21 ' OE1' ' A' ' 167' ' ' GLN . 21.6 t -112.94 147.83 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.038 . . . . 0.0 110.544 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.444 HD21 ' HB2' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -125.57 164.34 20.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.2 m-20 76.58 70.39 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.665 -0.647 . . . . 0.0 110.457 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -47.24 -38.19 11.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 108.418 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 176' ' ' VAL . 3.5 p -166.04 18.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.62 HG23 ' C ' ' A' ' 176' ' ' VAL . 1.3 t 65.39 -44.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -83.48 29.6 3.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.444 -1.033 . . . . 0.0 109.721 -179.605 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.438 0.637 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.14 147.76 52.85 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.439 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.16 96.14 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 121.669 -0.644 . . . . 0.0 112.045 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -87.73 -0.68 57.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.486 -1.596 . . . . 0.0 110.124 -179.045 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.21 -44.56 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.141 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m -76.59 7.07 4.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 108.756 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 57.6 tt0 -91.99 -116.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.467 -0.771 . . . . 0.0 109.745 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.5 m-20 -79.41 154.79 76.72 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 108.962 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' O ' ' N ' ' A' ' 13' ' ' TYR . 19.4 Cg_endo -65.16 -160.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.438 2.092 . . . . 0.0 111.88 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' HD11 ' A' ' 47' ' ' ILE . 96.6 mt 61.96 -39.47 0.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.472 -0.768 . . . . 0.0 110.004 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.7 m-85 -63.4 -39.13 93.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.23 -43.73 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -65.49 -51.09 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.424 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 16' ' ' TYR . 1.2 t80 -61.36 -41.52 97.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -70.53 -36.07 73.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.07 -5.04 58.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.081 -1.012 . . . . 0.0 111.008 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.2 m120 -83.75 -77.01 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.692 -1.255 . . . . 0.0 110.492 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -153.18 55.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.687 ' CH2' ' CE2' ' A' ' 6' ' ' TRP . 6.7 t90 -103.07 73.65 1.25 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' H ' ' HD3' ' A' ' 24' ' ' PRO . . . 152.4 -20.71 0.83 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.637 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.712 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 7.9 m -123.4 7.1 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.429 -1.042 . . . . 0.0 113.18 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 71.7 Cg_endo -76.51 149.75 31.1 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.592 1.528 . . . . 0.0 113.416 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -91.88 166.01 12.95 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.606 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 10.5 p -91.71 107.84 19.49 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.481 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD21 ' A' ' 31' ' ' LEU . 96.2 m-20 -84.69 168.58 15.12 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 m -76.99 -41.5 42.64 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.845 -1.16 . . . . 0.0 111.558 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' CD ' ' OH ' ' A' ' 102' ' ' TYR . 26.9 mmtp -76.19 -42.8 45.13 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -58.46 -40.5 82.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.811 -1.18 . . . . 0.0 110.848 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.75 -40.26 79.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 109.712 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 102' ' ' TYR . 80.8 t80 -62.09 -47.76 83.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.57 -40.06 73.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.915 -1.116 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.57 -52.51 63.11 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.0 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.52 -28.21 44.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.037 -1.039 . . . . 0.0 110.132 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.34 -46.85 66.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.014 -1.054 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD12 HG13 ' A' ' 49' ' ' VAL . 4.6 mm? -69.29 -38.83 78.51 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 108.992 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -57.75 -36.29 71.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.414 -0.804 . . . . 0.0 109.253 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.7 -42.85 59.39 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' ALA . 62.6 tp60 -65.73 -32.56 74.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 0.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 40' ' ' GLN . 2.2 pp0? -41.89 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.005 -1.059 . . . . 0.0 109.688 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.98 -1.075 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 82.05 -35.62 2.55 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.309 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.0 mm? -95.7 144.39 26.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -1.214 . . . . 0.0 110.304 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.9 m -68.67 153.2 44.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 108.764 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.663 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -62.07 -37.0 83.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.003 -1.061 . . . . 0.0 109.81 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.56 -38.52 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.53 -1.356 . . . . 0.0 109.033 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 44' ' ' LEU . 75.1 m -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.643 HG13 HD12 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -63.01 -40.84 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.673 . . . . 0.0 109.401 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.85 -45.68 85.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.779 -1.201 . . . . 0.0 109.11 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -64.41 -37.15 86.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 108.401 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.632 ' HA ' HD22 ' A' ' 55' ' ' ASN . 23.9 ttpp -59.66 -37.27 78.28 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.663 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 77.3 mtt180 -59.39 -39.78 84.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.012 -1.055 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.96 -45.23 78.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.216 -1.552 . . . . 0.0 110.732 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.632 HD22 ' HA ' ' A' ' 52' ' ' LYS . 22.8 p30 -81.69 -39.86 23.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.861 -1.149 . . . . 0.0 110.476 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.525 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 54.2 t80 -60.88 -47.0 88.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.899 -1.125 . . . . 0.0 109.477 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.47 HH11 ' HG3' ' A' ' 57' ' ' ARG . 21.3 mmm-85 -63.08 -33.87 76.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.117 -0.989 . . . . 0.0 108.829 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.38 70.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.8 m -75.04 -43.3 54.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.039 -1.038 . . . . 0.0 111.448 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.083 . . . . 0.0 111.044 -178.833 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.973 ' O ' HG22 ' A' ' 68' ' ' VAL . 97.1 Cg_exo . . . . . 0 N--CA 1.487 1.103 0 N-CA-C 114.011 0.735 . . . . 0.0 114.011 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.39 -38.17 68.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.266 -1.521 . . . . 0.0 109.177 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.14 -32.87 74.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.99 -1.069 . . . . 0.0 110.379 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 65' ' ' PRO . 20.5 m -63.83 -37.25 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.209 -1.557 . . . . 0.0 108.96 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.6 -23.43 58.74 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.46 -9.04 36.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 68' ' ' VAL . 45.0 ttm -77.8 121.34 23.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 6.5 pt20 -95.49 176.7 6.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.23 -35.63 77.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.487 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 41.1 tp10 -54.05 -45.72 71.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.936 -1.102 . . . . 0.0 108.198 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -64.37 -38.13 89.95 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.574 0.702 . . . . 0.0 109.141 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.8 t -60.83 -38.64 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 110.183 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 3.7 pt-20 -72.93 -42.29 63.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.921 -1.112 . . . . 0.0 111.818 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.2 -38.18 63.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.691 -1.256 . . . . 0.0 110.417 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.726 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -67.11 -32.3 73.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.985 . . . . 0.0 109.829 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.8 t -49.71 -24.75 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -85.64 -6.66 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.132 -0.98 . . . . 0.0 108.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.573 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 97.1 m-20 -77.97 108.13 11.01 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.509 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 69.63 -15.49 0.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.698 . . . . 0.0 109.839 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 73.4 34.67 57.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.652 ' O ' ' N ' ' A' ' 87' ' ' ARG . 21.9 pt -46.3 176.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.432 -1.04 . . . . 0.0 109.41 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' ILE . 4.5 tt -52.29 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 85' ' ' ILE . 9.3 ptp180 -54.07 133.33 43.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.863 0.839 . . . . 0.0 110.342 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 4.0 m-70 175.15 65.94 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -46.05 -29.33 1.45 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 110.09 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.35 -61.06 5.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.01 -38.38 85.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.99 -44.43 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 110.043 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.422 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.69 -32.35 67.27 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.9 -1.125 . . . . 0.0 108.767 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.75 -37.7 82.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 0.0 109.437 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.1 -32.22 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.7 mm -59.12 -43.97 90.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 108.245 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.23 -29.86 76.34 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -58.62 -43.44 89.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.061 -1.258 . . . . 0.0 109.235 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -63.46 -44.55 94.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.86 -1.15 . . . . 0.0 109.449 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.29 -35.53 69.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.898 -1.126 . . . . 0.0 108.939 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.32 -28.89 64.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.048 -1.033 . . . . 0.0 108.398 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' CD ' ' A' ' 29' ' ' LYS . 80.8 t80 -64.33 -43.22 95.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.0 mp -65.05 -32.95 74.92 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 108' ' ' ASN . 14.5 mm100 -59.4 -39.28 82.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.811 -1.155 . . . . 0.0 108.753 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.525 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 97.6 mmm -67.6 -40.27 84.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.996 -1.065 . . . . 0.0 109.049 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 109' ' ' GLY . 75.9 mm-40 -72.06 -42.24 66.47 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.413 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -57.71 -25.17 59.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 104' ' ' GLN . 41.5 m-80 -92.62 -10.08 38.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.69 23.64 73.96 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -116.53 105.07 50.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.142 -1.211 . . . . 0.0 109.934 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -56.18 152.28 38.92 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.35 2.034 . . . . 0.0 113.01 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.709 ' HB3' HD12 ' A' ' 31' ' ' LEU . 25.5 m-85 -62.42 -38.94 91.63 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.774 0.797 . . . . 0.0 110.706 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.62 -35.48 79.7 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.535 -0.728 . . . . 0.0 111.724 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.46 -43.42 98.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.65 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -74.93 -43.99 51.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.321 -1.487 . . . . 0.0 111.01 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.65 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 14.9 m -58.43 -49.38 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 120.073 -1.642 . . . . 0.0 109.053 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.2 m95 -55.94 -27.41 52.27 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.12 -0.988 . . . . 0.0 108.629 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m -70.58 -41.49 72.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.238 -0.914 . . . . 0.0 111.103 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 30.9 m-85 -67.02 -30.31 70.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.767 -1.208 . . . . 0.0 110.377 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -91.85 15.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 109.597 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.89 36.08 21.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.84 . . . . 0.0 110.371 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 47.38 29.9 1.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -0.992 . . . . 0.0 109.821 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.439 ' H ' HG13 ' A' ' 120' ' ' VAL . 2.6 mm-40 -131.94 148.33 69.43 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.092 -1.005 . . . . 0.0 109.881 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.82 149.37 86.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.51 2.14 . . . . 0.0 111.959 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 126' ' ' MET . 4.2 tm0? -115.34 139.49 49.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.0 109.835 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.555 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.1 mpp? -100.54 118.3 36.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.142 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -72.14 -35.47 69.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 109.21 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 54.4 41.09 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.126 -0.984 . . . . 0.0 109.837 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.53 145.58 29.39 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.47 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.4 p -106.96 -29.55 9.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.696 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 134' ' ' GLU . 24.0 p -134.77 165.67 24.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.658 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.87 -31.99 67.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.494 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -72.79 -10.96 60.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 109.577 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 131' ' ' THR . 79.9 mm-40 -100.92 10.74 40.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.9 mm -98.33 111.91 60.92 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.92 142.86 28.62 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.729 1.619 . . . . 0.0 111.779 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 48.6 p -110.99 7.57 21.63 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -135.14 95.48 3.31 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -116.58 154.42 49.16 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.92 -38.6 86.23 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.719 1.613 . . . . 0.0 111.488 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.27 -43.12 64.76 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.531 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.8 p -62.73 -39.03 92.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 108.651 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.57 -37.55 84.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -66.51 -39.04 88.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.721 -0.612 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 165' ' ' PHE . 5.7 mp -65.62 -40.07 92.18 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.998 -1.064 . . . . 0.0 109.517 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.503 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 14.5 m -59.85 -47.37 86.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.707 -1.246 . . . . 0.0 110.44 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -74.02 -38.03 64.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.867 -1.145 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.53 -43.19 70.08 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.558 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.03 -43.15 79.41 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.19 -0.944 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -64.33 -39.92 94.85 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.863 -1.148 . . . . 0.0 109.727 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -70.18 -26.37 63.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.673 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -76.23 1.85 14.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.056 -1.028 . . . . 0.0 108.38 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.06 26.94 29.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.77 116.03 31.56 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.768 -0.842 . . . . 0.0 108.811 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.12 171.12 9.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 56.47 61.22 2.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 0.0 108.938 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.6 m -139.89 40.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.45 173.72 0.04 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.5 m -59.17 -31.13 68.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.905 -0.762 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 50.4 p -72.36 -34.78 68.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 108.74 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.26 -44.34 97.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 108.813 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 146' ' ' SER . 87.7 m -62.71 -43.98 97.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.76 -44.93 76.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.897 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.522 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 15.9 m -59.62 -41.57 90.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 109.441 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.651 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 3.3 t80 -59.56 -47.29 86.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 109.767 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 76.1 mtp -63.42 -32.71 74.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.29 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -58.18 -44.98 88.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 110.785 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 111.731 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -55.48 -23.61 26.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.95 -1.094 . . . . 0.0 110.441 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.91 -2.16 59.91 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.7 mt -62.79 -27.94 69.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.542 -0.975 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.85 133.07 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.117 -0.989 . . . . 0.0 109.46 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 19.3 m-80 -108.7 163.07 13.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.428 -0.795 . . . . 0.0 109.645 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 85.49 69.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.787 -0.57 . . . . 0.0 110.982 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.434 ' O ' HD11 ' A' ' 135' ' ' ILE . 3.4 m170 -55.69 -48.99 74.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 0.0 108.945 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 177' ' ' VAL . 5.7 m -139.33 30.19 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 109.588 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.5 t 52.58 105.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.74 45.0 6.57 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.33 . . . . 0.0 108.677 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.686 0.755 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.78 154.07 26.76 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.696 0.76 . . . . 0.0 109.508 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -52.85 -47.96 58.14 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.682 -0.636 . . . . 0.0 112.413 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.563 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -88.12 -0.52 57.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.433 -1.628 . . . . 0.0 110.496 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 17' ' ' HIS . 7.6 t -77.0 -41.03 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.858 -1.152 . . . . 0.0 109.241 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -71.7 -4.66 28.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 68.9 tp60 -60.62 -42.97 97.93 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.881 -0.512 . . . . 0.0 110.38 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -161.76 159.35 22.52 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.672 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.694 ' HA ' HD12 ' A' ' 14' ' ' ILE . 18.8 Cg_endo -63.29 -35.39 62.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.81 2.34 . . . . 0.0 112.483 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.5 mt -61.83 -39.59 92.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.31 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.536 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -64.48 -40.59 95.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.408 -0.807 . . . . 0.0 109.252 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 11' ' ' PRO . 50.4 mt -56.77 -40.01 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.11 76.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.835 -1.166 . . . . 0.0 109.587 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 2.0 t80 -65.68 -40.14 92.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.778 . . . . 0.0 110.17 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.421 ' CG ' HG21 ' A' ' 7' ' ' VAL . 47.4 t-80 -73.58 -35.53 65.44 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 110.791 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -80.51 -8.72 59.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.168 -0.957 . . . . 0.0 111.775 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 2.9 p30 -84.14 -58.0 2.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.52 -1.362 . . . . 0.0 110.849 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.2 mt-10 -148.69 -54.07 0.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.492 -1.38 . . . . 0.0 109.666 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.594 ' C ' ' O ' ' A' ' 20' ' ' GLU . 5.8 t90 2.24 66.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.592 0.711 . . . . 0.0 111.607 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 148.63 -21.35 1.32 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.286 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.6 m -119.31 3.09 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.623 0 O-C-N 121.62 -0.929 . . . . 0.0 112.814 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 84.7 Cg_endo -79.93 150.68 21.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.468 1.445 . . . . 0.0 112.837 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -97.98 168.41 10.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.621 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 36.8 p -91.8 118.0 30.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.708 -1.245 . . . . 0.0 110.29 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -108.06 144.47 35.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.9 m -59.99 -35.94 76.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.882 -1.136 . . . . 0.0 109.027 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.62 -50.2 22.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.689 -0.632 . . . . 0.0 110.316 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -27.31 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.84 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 116' ' ' VAL . 2.4 mp -66.86 -36.99 83.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.017 -1.052 . . . . 0.0 109.214 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.8 t80 -64.77 -48.43 74.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.62 -32.09 65.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.757 -1.214 . . . . 0.0 109.11 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -48.82 63.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.633 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.23 -27.8 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.423 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 97.9 m -69.19 -50.05 50.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.185 -0.947 . . . . 0.0 109.898 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' NE ' ' A' ' 53' ' ' ARG . 56.4 mt -67.95 -37.4 81.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.087 -1.008 . . . . 0.0 108.927 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -66.88 -39.15 87.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.623 -0.673 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.44 -35.86 92.31 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -72.23 -6.46 43.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -1.202 . . . . 0.0 109.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -77.04 -1.98 31.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -69.07 121.56 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 108.851 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.58 -31.83 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 42' ' ' ALA . 30.2 mt -101.48 144.09 30.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.117 . . . . 0.0 109.838 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -69.49 156.25 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -56.99 -36.5 70.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.173 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -35.49 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.428 HG21 HD22 ' A' ' 44' ' ' LEU . 83.5 m -59.24 -41.83 89.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.868 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -68.0 -32.56 56.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.132 -0.98 . . . . 0.0 109.492 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.94 -43.97 94.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.183 -0.948 . . . . 0.0 110.354 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.89 75.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 14.6 mtmm -78.89 -7.4 57.92 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.323 -0.861 . . . . 0.0 109.295 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.2 ttm180 -65.68 -46.86 77.49 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.7 -45.99 67.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.978 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.474 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 38.9 t30 -66.25 -43.16 87.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.537 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 68.9 t80 -59.79 -45.47 92.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.872 . . . . 0.0 110.94 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -61.76 -29.5 70.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.828 -1.17 . . . . 0.0 108.986 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -66.36 -36.21 82.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m -66.95 -45.22 78.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.827 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 44.8 m-85 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 34.2 Cg_endo . . . . . 0 N--CA 1.495 1.595 0 N-CA-C 113.455 0.521 . . . . 0.0 113.455 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.875 HG22 HD21 ' A' ' 103' ' ' LEU . 91.5 t -61.52 -45.93 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.917 -1.115 . . . . 0.0 110.156 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.14 -37.8 86.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.403 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.63 -36.91 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.216 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -65.1 -18.94 65.72 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.84 -7.88 57.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 96' ' ' ILE . 98.3 mtp -82.99 113.15 20.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.88 177.59 5.72 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.29 -31.78 61.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.224 -0.922 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 -45.08 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 108.237 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -64.27 -38.67 91.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG13 ' CG2' ' A' ' 92' ' ' ILE . 86.9 t -61.23 -42.7 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.423 -0.798 . . . . 0.0 109.856 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.6 -44.22 89.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.519 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 2.4 ptp180 -75.78 -33.62 60.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.857 -1.152 . . . . 0.0 110.001 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -61.6 -32.83 72.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.299 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.6 t -49.3 -34.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 108.662 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.84 -1.02 30.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.6 t0 -80.7 108.82 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.447 -1.408 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.27 -12.21 1.05 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.438 -0.788 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.07 33.29 45.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt -57.47 -166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -1.213 . . . . 0.0 109.332 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.01 95.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.155 -0.965 . . . . 0.0 109.129 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -57.66 109.65 0.75 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.714 0.769 . . . . 0.0 109.34 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 1.8 m80 -178.14 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -50.32 -31.59 14.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.318 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.71 -62.52 6.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -64.52 -40.82 96.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.785 -1.42 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG13 ' A' ' 76' ' ' VAL . 82.9 mt -61.17 -48.91 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.085 -1.01 . . . . 0.0 110.449 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.56 -29.22 66.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.661 -1.275 . . . . 0.0 108.953 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.448 ' N ' ' HG3' ' A' ' 93' ' ' GLN . . . -64.3 -37.59 88.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.45 -40.16 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 71' ' ' MET . 20.6 mm -59.93 -43.01 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 108.76 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.93 -35.91 88.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.12 -37.03 76.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -1.118 . . . . 0.0 109.163 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.05 -44.91 87.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.981 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 27.8 mmt180 -60.62 -38.16 83.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.093 -1.004 . . . . 0.0 109.446 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.84 71.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 108.593 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.53 -43.74 96.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.875 HD21 HG22 ' A' ' 66' ' ' VAL . 77.5 mt -63.62 -32.66 74.21 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.22 -35.11 79.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.305 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.59 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.1 tpp -63.8 -43.6 95.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.492 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -37.02 78.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.24 -24.71 66.56 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -93.21 -15.05 26.35 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.91 27.17 73.71 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.442 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' A' ' 105' ' ' MET . 2.0 tt0 -121.52 102.21 42.55 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.136 -1.214 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.53 141.6 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.933 1.755 . . . . 0.0 112.641 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -56.08 -38.76 71.11 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.229 1.014 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.36 -27.76 66.53 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.708 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -68.09 -48.44 65.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.095 . . . . 0.0 111.969 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.633 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.2 p90 -70.8 -37.37 73.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.763 -1.211 . . . . 0.0 110.943 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 145' ' ' LEU . 24.5 m -62.29 -49.05 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.382 -1.449 . . . . 0.0 109.956 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.621 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 26.4 m95 -56.56 -27.1 56.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.2 t -75.73 -36.69 59.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.253 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.2 -26.02 65.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.965 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -96.64 19.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.717 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 69.28 35.93 2.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.765 . . . . 0.0 110.557 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 117' ' ' TRP . 1.1 t-80 45.01 30.23 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.393 -0.817 . . . . 0.0 111.344 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.66 147.99 20.04 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.637 -1.29 . . . . 0.0 110.134 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.05 148.6 85.72 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.613 2.209 . . . . 0.0 111.93 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.623 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -122.06 128.37 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.623 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.2 mtt -103.35 120.73 41.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -87.73 -26.43 22.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.439 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 57.03 45.35 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.77 149.4 50.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.469 ' C ' HG23 ' A' ' 176' ' ' VAL . 53.3 p -102.9 -25.1 13.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.051 -1.031 . . . . 0.0 109.412 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 p -136.17 162.66 32.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.158 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.31 -37.04 79.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 108.945 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.2 m -62.75 -31.42 72.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.372 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -75.19 -0.66 20.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 110.081 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.6 tp -76.46 125.57 87.35 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.999 -1.063 . . . . 0.0 108.314 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 163' ' ' TYR . 55.9 Cg_endo -74.94 136.4 20.48 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.926 1.75 . . . . 0.0 112.454 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.5 p -114.37 6.53 16.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.0 t -152.16 88.28 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.432 -0.792 . . . . 0.0 109.448 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.532 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.7 OUTLIER -102.43 155.4 36.55 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.74 -38.96 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.727 1.618 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.52 -42.06 59.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 139' ' ' THR . 88.2 p -65.86 -39.03 90.35 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.525 -0.735 . . . . 0.0 109.443 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.31 -44.77 86.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.195 -0.941 . . . . 0.0 109.144 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.08 74.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -55.37 -43.78 75.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.656 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.96 -39.29 83.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.168 -0.957 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.45 -43.79 88.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 110.389 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.581 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.49 -45.98 74.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.43 -38.05 89.66 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.88 -40.24 94.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.971 -1.081 . . . . 0.0 110.242 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 153' ' ' GLY . 18.4 mttp -65.28 -38.56 90.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 111.641 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.581 HH21 ' HB1' ' A' ' 148' ' ' ALA . 8.2 mtm180 -71.27 9.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 0.0 110.085 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 76.04 26.14 65.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.97 112.61 24.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 157' ' ' VAL . 34.8 mtmt -93.1 176.62 6.34 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 57.58 54.9 6.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.451 -0.781 . . . . 0.0 109.2 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.3 m -139.16 38.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.57 164.36 0.52 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.9 m -53.98 -34.42 59.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.499 -1.001 . . . . 0.0 109.431 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.5 ' O ' ' OG ' ' A' ' 164' ' ' SER . 32.8 m -68.62 -37.25 79.58 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.1 -44.31 98.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.656 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.1 m -58.05 -51.56 69.17 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -71.66 -37.88 70.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 0.0 111.733 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 160' ' ' THR . 13.4 m -59.12 -40.73 86.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 111.131 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.4 OUTLIER -78.36 -35.47 47.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 110.569 -179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.4 mtp -57.92 -36.15 72.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.657 -1.277 . . . . 0.0 109.291 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.525 ' NE2' ' OD1' ' A' ' 174' ' ' ASP . 9.5 tp60 -61.66 -42.42 98.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.34 -37.8 22.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.536 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -26.12 48.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.273 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.54 -2.39 57.38 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -37.36 73.74 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.243 -1.151 . . . . 0.0 108.753 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 0.9 OUTLIER -137.2 129.66 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 109.063 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.457 ' C ' ' CG ' ' A' ' 174' ' ' ASP . 37.9 t-20 -104.98 125.23 50.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.371 -0.831 . . . . 0.0 108.878 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.525 ' OD1' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -178.98 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.895 -1.128 . . . . 0.0 111.587 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.475 ' C ' ' O ' ' A' ' 174' ' ' ASP . 1.4 m-70 -48.96 -52.12 26.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.97 -1.706 . . . . 0.0 107.13 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 130' ' ' THR . 15.0 p 178.03 150.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 129' ' ' ALA . 27.6 t -62.21 135.37 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.893 -1.129 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.76 38.85 12.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.552 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.125 -1.221 . . . . 0.0 109.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 4' ' ' CYS . 26.9 ttm180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 3' ' ' ARG . 4.3 m -42.35 149.3 0.17 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -0.865 . . . . 0.0 109.248 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.29 -33.58 61.59 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 121.153 -0.967 . . . . 0.0 112.75 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.572 ' CD1' HG13 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -85.56 2.1 46.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.298 -1.707 . . . . 0.0 111.759 -177.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 6' ' ' TRP . 16.7 m -110.57 -45.24 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 109.971 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 7' ' ' VAL . 88.7 p -65.25 -17.43 64.49 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -65.43 -40.68 93.6 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.873 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.18 163.21 24.3 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.933 . . . . 0.0 109.845 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 13' ' ' TYR . 35.7 Cg_endo -68.92 -161.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.943 2.429 . . . . 0.0 112.51 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 5.9 mt 62.54 -54.86 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.774 -0.579 . . . . 0.0 109.555 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -57.15 -45.76 83.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.279 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.415 HG12 HH11 ' A' ' 3' ' ' ARG . 85.9 mt -54.68 -42.86 63.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.733 -0.605 . . . . 0.0 110.585 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.13 98.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.711 -1.243 . . . . 0.0 108.419 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.658 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.0 t80 -71.67 -31.47 66.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.623 0.725 . . . . 0.0 110.001 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -64.14 -44.68 91.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 112.382 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.69 -4.52 37.1 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.717 -1.239 . . . . 0.0 112.815 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 16' ' ' TYR . 51.0 p-10 -96.01 -15.68 22.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.462 -1.399 . . . . 0.0 112.243 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.401 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 14.0 pt-20 177.07 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.728 -1.232 . . . . 0.0 109.276 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.458 ' CH2' ' CZ2' ' A' ' 6' ' ' TRP . 4.8 t90 -131.88 83.52 2.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.186 0.993 . . . . 0.0 108.887 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.3 -20.31 11.33 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.701 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 28.9 m -110.71 -12.38 0.12 Allowed Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 112.957 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 75.5 Cg_endo -80.05 150.68 20.68 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.358 1.372 . . . . 0.0 114.122 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -96.18 159.75 14.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.759 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.7 p -86.72 111.48 20.74 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.566 -1.334 . . . . 0.0 110.886 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.906 ' O ' HD13 ' A' ' 31' ' ' LEU . 70.1 m-20 -94.24 156.73 16.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -67.4 -39.71 85.59 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.565 -1.334 . . . . 0.0 110.282 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -75.19 -50.12 17.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 111.804 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -61.3 -30.1 70.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.589 -1.319 . . . . 0.0 109.19 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 27' ' ' ASP . 4.7 mp -57.14 -39.56 75.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.092 -1.005 . . . . 0.0 108.45 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.572 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 63.2 t80 -63.25 -45.46 91.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.467 -0.771 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -67.45 -40.69 85.42 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.827 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.4 tpp -65.07 -52.55 54.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.451 -0.781 . . . . 0.0 110.223 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.75 -27.17 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 109.03 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 47.7 m -70.57 -52.4 21.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' NE ' ' A' ' 53' ' ' ARG . 48.3 mt -66.79 -39.23 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 108.764 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' OE2' ' CB ' ' A' ' 164' ' ' SER . 13.3 tp10 -64.19 -37.72 88.49 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.642 -0.661 . . . . 0.0 109.865 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.51 -33.14 70.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 25.6 mm-40 -81.71 -1.45 47.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.514 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 2.4 pp0? -78.78 -2.25 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.015 . . . . 0.0 109.323 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.71 113.84 10.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 87.26 -34.63 3.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -95.62 145.43 25.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -1.095 . . . . 0.0 109.63 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -71.97 152.88 42.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 109.203 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.658 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 2.5 t-105 -59.64 -28.9 67.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 110.161 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -29.36 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.564 -1.335 . . . . 0.0 109.487 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 44' ' ' LEU . 72.7 m -68.54 -44.04 75.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.112 -0.992 . . . . 0.0 108.829 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 46' ' ' TRP . 1.3 p -63.69 -26.08 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -54.98 -43.94 74.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.483 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -63.92 -37.04 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.656 ' HA ' HD22 ' A' ' 55' ' ' ASN . 7.6 ttpp -63.12 -36.88 85.08 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NE ' HD13 ' A' ' 37' ' ' LEU . 37.2 ttm180 -57.93 -46.53 84.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.803 -0.561 . . . . 0.0 111.769 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 55' ' ' ASN . 15.2 pt-20 -72.5 -44.32 62.4 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.787 -1.196 . . . . 0.0 110.727 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.656 HD22 ' HA ' ' A' ' 52' ' ' LYS . 24.5 p30 -73.06 -32.17 64.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.746 -1.221 . . . . 0.0 109.396 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.659 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 71.4 t80 -58.57 -46.5 86.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 109.525 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -65.05 -32.13 73.7 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.014 -1.075 . . . . 0.0 109.034 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.15 99.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.863 -1.148 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.579 ' HB3' HD22 ' A' ' 79' ' ' LEU . 51.4 m -77.49 -44.6 28.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 109.675 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.659 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 96.8 m-85 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.53 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.491 1.325 0 CA-C-O 120.95 0.312 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.63 -43.24 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.606 -1.309 . . . . 0.0 108.302 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -65.73 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.263 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 96' ' ' ILE . 69.6 t -60.7 -38.72 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 108.825 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.37 -14.53 63.01 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -93.5 -12.37 29.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.473 ' O ' HG21 ' A' ' 96' ' ' ILE . 90.8 mtp -76.74 110.31 11.23 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.8 -174.75 3.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.408 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 96.9 mt-10 -55.38 -30.59 60.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.813 -0.554 . . . . 0.0 110.791 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.0 pt-20 -60.6 -42.22 96.32 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.119 -1.613 . . . . 0.0 109.452 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' CG ' ' A' ' 74' ' ' GLU . 90.3 m-20 -66.92 -38.92 87.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -67.19 -36.22 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.838 -1.164 . . . . 0.0 109.71 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 80' ' ' VAL . 99.2 mt-10 -59.36 -36.31 75.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.712 -1.242 . . . . 0.0 107.794 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.4 ttm-85 -70.32 -42.03 72.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.568 -0.708 . . . . 0.0 110.304 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 59' ' ' CYS . 94.3 mt -69.76 -34.66 74.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.423 -0.798 . . . . 0.0 112.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.9 m -50.1 -16.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.521 -1.362 . . . . 0.0 108.868 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' LEU . 23.0 pt20 -120.87 -4.43 9.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.203 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -81.5 109.58 16.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.691 -1.256 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.6 -17.02 0.54 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.456 -0.778 . . . . 0.0 109.3 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 80.47 32.36 34.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 79' ' ' LEU . 15.5 pt -54.48 -179.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.02 -1.282 . . . . 0.0 109.332 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 86' ' ' ILE . 12.4 tt -60.82 89.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.571 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 6.2 ptp180 -56.06 144.24 29.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 111.115 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER 159.14 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 89' ' ' ARG . 1.1 mtt-85 -51.02 -38.07 49.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.424 -0.797 . . . . 0.0 108.941 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.13 -49.19 59.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.34 -45.08 94.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -1.133 . . . . 0.0 110.056 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.75 -44.12 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.069 -1.019 . . . . 0.0 109.726 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.462 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 49.4 mt-30 -54.64 -34.05 61.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.862 -1.149 . . . . 0.0 108.995 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.65 99.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.59 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.556 HG21 ' OH ' ' A' ' 56' ' ' TYR . 32.1 mm -61.93 -39.15 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 109.115 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 71' ' ' MET . 12.3 mm -59.67 -43.1 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 108.912 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.44 -32.86 85.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.52 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 m120 -61.2 -41.44 96.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.157 . . . . 0.0 109.842 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.91 98.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.49 -40.21 95.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.253 -0.904 . . . . 0.0 109.269 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.4 -34.58 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.35 -43.12 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.0 -33.2 75.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -62.91 -37.44 86.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 109.583 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 24.0 ttm -62.86 -40.89 98.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.994 -1.066 . . . . 0.0 108.447 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.04 -35.27 79.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -64.88 -20.96 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -92.28 -17.63 24.49 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.76 73.61 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.35 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.583 ' O ' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -116.92 107.37 46.12 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.88 144.47 15.17 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.83 1.687 . . . . 0.0 112.637 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.59 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -61.65 -44.52 96.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.893 0.854 . . . . 0.0 109.917 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.29 -27.68 62.62 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.019 -1.051 . . . . 0.0 111.192 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -62.85 -49.01 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.835 -1.166 . . . . 0.0 111.118 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.2 p90 -72.04 -34.4 68.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.816 -1.178 . . . . 0.0 110.022 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.725 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 2.3 t -63.05 -54.86 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.749 -1.219 . . . . 0.0 109.87 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.63 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 57.5 m95 -59.32 -22.2 60.89 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.072 -1.017 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -66.68 -45.05 80.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 110.406 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.647 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.1 m-85 -67.92 -29.14 68.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.094 -1.004 . . . . 0.0 109.918 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.578 HG21 HD22 ' A' ' 171' ' ' LEU . 7.2 t -87.26 18.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.525 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 123' ' ' GLN . 75.4 m-20 60.86 39.76 16.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.436 0.636 . . . . 0.0 110.007 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 42.05 25.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.404 -0.81 . . . . 0.0 110.536 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -145.66 148.28 36.02 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 120.933 -1.104 . . . . 0.0 109.511 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 19.1 Cg_endo -62.98 146.8 94.94 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.278 1.986 . . . . 0.0 111.434 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -103.59 137.63 41.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.6 mtt -93.02 120.01 32.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.427 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -88.26 120.37 29.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -91.0 16.63 9.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.03 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.57 136.49 49.31 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.7 p -99.07 -22.21 15.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.544 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 p -136.41 165.6 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -0.931 . . . . 0.0 109.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.1 mt -59.26 -34.39 72.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.046 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.3 m -69.79 -11.96 61.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -0.792 . . . . 0.0 109.697 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.09 6.44 47.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 mm -97.3 118.09 64.89 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.23 137.95 19.64 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.943 1.762 . . . . 0.0 112.227 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.2 p -95.71 4.21 53.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.6 t -137.8 95.3 3.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 32.4 p -109.27 150.83 41.58 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.35 -36.03 77.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.579 1.519 . . . . 0.0 111.432 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.15 -43.23 58.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.248 -0.908 . . . . 0.0 108.858 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.406 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 95.6 p -65.16 -39.9 93.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 109.723 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.9 -37.59 85.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.57 -37.26 86.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 109.91 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.62 -46.42 87.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.017 -1.052 . . . . 0.0 109.054 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.6 t -62.1 -43.18 99.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 110.149 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -62.52 -45.43 93.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.45 -44.73 67.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.99 -36.67 80.39 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.245 -0.91 . . . . 0.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -60.45 -38.65 84.85 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.705 -1.247 . . . . 0.0 108.581 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.73 -19.94 54.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.572 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -78.97 0.9 25.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.119 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.42 26.64 32.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.52 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 1.3 m-85 -101.11 113.51 26.6 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.38 -1.071 . . . . 0.0 109.575 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -91.81 173.9 7.62 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 55.73 45.27 24.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.089 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.3 p -132.09 49.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.42 177.1 6.07 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 54.9 m -58.6 -32.67 69.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.588 -0.948 . . . . 0.0 110.178 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.6 p -72.82 -28.25 62.44 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.917 -1.114 . . . . 0.0 109.061 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.2 mm -68.03 -45.31 83.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 110.152 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 159' ' ' THR . 3.1 p -65.89 -36.87 84.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.454 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.09 -45.97 79.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.454 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.4 m -61.98 -39.1 91.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.075 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -59.2 -41.09 87.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.082 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.415 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 73.2 mtp -62.51 -39.75 94.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -74.29 -39.21 63.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.823 -1.173 . . . . 0.0 111.455 -178.499 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 167' ' ' GLN . . . -79.22 -40.2 31.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 110.889 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 166' ' ' MET . 21.6 p -60.51 -28.77 68.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.99 2.57 42.27 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 120' ' ' VAL . 35.1 mt -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.74 143.32 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.209 -0.932 . . . . 0.0 109.583 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 34.7 m120 -111.41 163.54 13.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.437 -0.79 . . . . 0.0 110.205 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER 83.28 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.242 0.544 . . . . 0.0 109.947 179.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -50.95 -44.47 60.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 108.7 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.646 ' C ' ' H ' ' A' ' 178' ' ' GLY . 30.6 m -149.5 28.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.412 -0.805 . . . . 0.0 109.624 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 129' ' ' ALA . 46.2 t 60.56 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.415 -0.803 . . . . 0.0 110.409 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -137.3 60.05 0.62 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.283 -1.128 . . . . 0.0 110.107 -179.432 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.466 HH11 ' HG3' ' A' ' 3' ' ' ARG . 28.3 mtm-85 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.523 0.678 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.45 141.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.558 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.19 94.91 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.543 -0.723 . . . . 0.0 112.097 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -84.55 1.32 46.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.642 -1.504 . . . . 0.0 109.887 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.526 HG13 HD13 ' A' ' 14' ' ' ILE . 1.8 t -83.81 -50.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -67.99 -3.82 11.25 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.86 -39.31 94.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.404 0.621 . . . . 0.0 109.587 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -174.01 158.47 2.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.41 -0.807 . . . . 0.0 109.208 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' TYR . 12.0 Cg_endo -57.46 -161.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.478 2.119 . . . . 0.0 111.742 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -52.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 11' ' ' PRO . 14.1 m-85 -60.38 -31.66 70.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.131 -0.98 . . . . 0.0 108.893 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.526 HD13 HG13 ' A' ' 7' ' ' VAL . 7.8 mm -56.26 -40.33 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.98 -50.47 28.49 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.182 -0.949 . . . . 0.0 109.82 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 42.7 t80 -63.13 -40.78 98.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 110.579 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 7' ' ' VAL . 34.8 t-80 -60.28 -43.9 95.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.035 -1.041 . . . . 0.0 109.835 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -82.09 -14.48 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.419 -0.801 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.771 ' ND2' ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -79.28 -57.18 3.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.528 -1.357 . . . . 0.0 110.597 -178.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.771 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 2.2 pt-20 -175.45 78.82 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.596 -1.315 . . . . 0.0 110.03 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CZ3' ' NE1' ' A' ' 6' ' ' TRP . 7.7 t90 -100.77 68.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.01 -1.056 . . . . 0.0 108.523 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.55 9.75 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 96.9 t -111.01 -30.88 0.14 Allowed Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.649 -0.912 . . . . 0.0 111.927 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 67.7 Cg_endo -86.17 154.07 9.58 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.543 2.162 . . . . 0.0 113.539 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -65.93 170.5 5.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.585 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 4.8 p -92.13 124.6 36.34 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.811 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.601 ' O ' HD13 ' A' ' 31' ' ' LEU . 66.1 m-20 -102.48 149.13 24.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -65.07 -38.8 91.98 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.825 -1.172 . . . . 0.0 110.576 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -72.87 -50.71 22.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 111.61 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -63.34 -33.37 75.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.647 -1.283 . . . . 0.0 109.496 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 27' ' ' ASP . 5.1 mp -61.3 -39.13 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.267 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -59.29 -41.79 89.77 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.106 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CD ' ' NH2' ' A' ' 57' ' ' ARG . 40.5 mt-10 -71.68 -36.26 70.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.114 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.628 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -64.99 -47.15 78.56 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 111.377 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -65.98 -36.12 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.733 -1.23 . . . . 0.0 110.038 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m -70.17 -38.81 75.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.019 -1.05 . . . . 0.0 109.261 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' GLU . 3.1 mp -66.79 -44.59 80.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.489 -0.757 . . . . 0.0 109.817 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -67.83 -32.3 72.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.36 -33.58 32.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 42' ' ' ALA . 56.3 tp60 -75.44 -35.46 60.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.422 -1.046 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.613 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -44.15 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.314 -0.866 . . . . 0.0 110.741 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -60.68 112.78 2.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.677 -1.264 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.0 -36.83 2.13 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.602 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.8 mt -91.64 146.71 23.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.088 -1.242 . . . . 0.0 110.529 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.1 m -69.71 156.15 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -62.72 -37.8 87.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 110.297 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -63.52 -39.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 109.733 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -58.8 -38.31 78.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.899 -1.126 . . . . 0.0 108.198 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.3 t -64.34 -37.58 80.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.601 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.67 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.1 tt -55.73 -47.15 77.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -61.91 -46.97 87.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.947 -1.096 . . . . 0.0 109.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.04 -11.81 59.85 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.942 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.674 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 38.4 ttm180 -63.19 -46.12 88.53 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.67 -41.62 68.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.009 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.945 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -70.04 -45.2 67.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.063 . . . . 0.0 111.054 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 49.8 t80 -60.86 -48.47 81.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.897 -1.127 . . . . 0.0 110.523 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.522 ' NH2' ' CD ' ' A' ' 33' ' ' GLU . 16.7 mmm180 -57.77 -31.95 67.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.06 65.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.832 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.1 m -73.16 -26.06 61.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 112.189 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 79.6 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 120.536 -1.353 . . . . 0.0 111.336 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.491 1.349 0 CA-C-O 120.994 0.331 . . . . 0.0 112.853 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 HD21 ' A' ' 103' ' ' LEU . 76.8 t -72.79 -37.35 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.887 -1.133 . . . . 0.0 108.856 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -35.73 66.38 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.6 t -59.52 -38.82 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.32 -16.44 63.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.97 -5.13 53.62 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.8 mmm -79.3 116.78 19.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 2.8 pt20 -95.67 177.33 5.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.439 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 96.5 mt-10 -59.41 -35.04 73.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.812 . . . . 0.0 110.304 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.6 tt0 -58.4 -46.44 86.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.807 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -64.93 -38.88 92.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.836 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 92' ' ' ILE . 46.3 t -56.55 -43.54 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.45 -0.781 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.28 -39.18 92.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.508 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 28.7 ttm-85 -60.81 -39.27 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 108.733 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' N ' ' A' ' 81' ' ' GLN . 80.2 mt -68.97 -33.24 73.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.652 -0.655 . . . . 0.0 110.874 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.11 -18.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 108.675 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.3 mt-30 -118.76 -11.47 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 17.5 t70 -79.47 109.75 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 72.73 -19.01 0.32 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 64.2 35.47 92.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.945 HG22 ' ND2' ' A' ' 55' ' ' ASN . 3.5 pt -31.81 -105.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.208 -0.583 . . . . 0.0 111.823 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 87' ' ' ARG . 6.4 tt -161.44 -48.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.685 -1.259 . . . . 0.0 110.218 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.634 ' N ' HG23 ' A' ' 86' ' ' ILE . 9.2 mtt180 -63.33 149.04 46.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.001 -1.062 . . . . 0.0 109.409 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' ARG . 88.8 m-70 -108.04 167.74 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 109.765 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -43.33 -40.74 3.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.136 -0.977 . . . . 0.0 109.992 -179.142 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.23 -59.26 7.56 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.303 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.55 -40.18 96.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -1.086 . . . . 0.0 110.193 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.514 HG21 HG13 ' A' ' 76' ' ' VAL . 85.2 mt -59.66 -52.91 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 110.1 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.439 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 66.8 mt-30 -52.41 -33.81 45.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.906 -1.121 . . . . 0.0 110.099 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.57 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.874 -1.141 . . . . 0.0 109.226 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.624 HG21 ' OH ' ' A' ' 56' ' ' TYR . 96.2 mt -72.09 -32.56 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.0 -42.61 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.542 -1.348 . . . . 0.0 108.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.93 72.69 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.66 -43.37 96.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -1.184 . . . . 0.0 109.945 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.92 73.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.048 -1.032 . . . . 0.0 108.787 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -61.54 -35.67 78.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.804 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.685 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.76 -32.23 73.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 108.649 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -64.48 -43.17 95.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 103' ' ' LEU . 39.0 mt -61.14 -27.75 68.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -68.06 -38.18 82.15 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.697 0.76 . . . . 0.0 109.245 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.571 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 34.5 ttm -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.942 0.877 . . . . 0.0 108.95 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.0 -36.89 85.07 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.48 -25.69 66.23 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -91.12 -12.27 36.07 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.57 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.93 27.51 73.64 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.48 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -117.37 102.8 52.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.84 144.18 21.49 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.024 1.816 . . . . 0.0 112.813 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -55.46 -40.66 71.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.033 0.921 . . . . 0.0 108.989 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.23 -27.09 64.19 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 110.494 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.96 -53.6 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.905 -1.122 . . . . 0.0 111.202 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.5 p90 -70.73 -32.61 69.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.953 -1.092 . . . . 0.0 109.611 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -64.96 -54.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.16 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.585 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 54.3 m95 -57.36 -26.72 61.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 108.532 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 66.3 p -77.68 -31.53 52.57 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.322 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -68.78 -32.32 71.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -88.61 18.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 66.36 27.4 10.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.867 . . . . 0.0 109.534 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 51.19 33.11 8.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.454 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.512 ' H ' HG13 ' A' ' 120' ' ' VAL . 15.1 mm100 -137.09 150.0 68.02 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.22 145.67 39.31 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.488 2.126 . . . . 0.0 111.847 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.15 129.2 55.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.0 mtm -117.7 108.48 15.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.509 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -102.68 128.74 49.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.099 -1.0 . . . . 0.0 109.271 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.86 34.58 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.097 -1.002 . . . . 0.0 110.607 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -58.32 145.82 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 108.762 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.1 p -91.84 -15.22 28.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.065 -1.022 . . . . 0.0 110.343 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -142.46 162.9 34.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 109.685 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.0 mt -59.61 -33.05 70.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -65.42 -29.09 69.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.329 -0.857 . . . . 0.0 110.886 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.601 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.1 mm-40 -85.49 -1.8 57.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.996 -1.065 . . . . 0.0 109.854 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -80.14 143.78 57.43 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 108.851 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.67 142.94 40.89 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.423 2.082 . . . . 0.0 112.848 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 t -125.55 4.89 7.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.9 p -157.41 87.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 163.56 16.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.509 -0.745 . . . . 0.0 109.054 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.18 -39.72 85.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.702 1.601 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.67 -43.18 66.48 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.109 -1.036 . . . . 0.0 108.549 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 p -63.51 -44.07 95.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.25 -37.55 85.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.078 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.4 95.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 109.798 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.11 -45.54 75.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -59.0 -40.23 84.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.748 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -62.68 -49.42 75.2 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 110.653 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.69 76.81 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.121 -0.987 . . . . 0.0 109.473 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.445 ' HG ' HH21 ' A' ' 152' ' ' ARG . 32.5 mt -66.91 -39.74 87.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -0.902 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -38.78 87.75 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.754 -1.216 . . . . 0.0 110.34 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -84.62 -14.68 47.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 111.948 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.685 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 85.9 mtm180 -88.53 8.2 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.687 -1.258 . . . . 0.0 109.521 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.37 21.04 53.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -100.99 110.37 22.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 108.6 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -93.68 175.13 6.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 57.18 57.59 4.43 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.106 0.955 . . . . 0.0 109.124 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 157' ' ' VAL . 12.4 m -128.91 42.27 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.24 162.7 0.4 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.7 m -53.65 -29.49 38.6 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -1.089 . . . . 0.0 108.921 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -73.52 -32.29 64.15 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 108.547 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 157' ' ' VAL . 45.6 mm -62.57 -45.74 98.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.48 -0.762 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.64 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.525 -0.734 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.95 -45.94 72.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 0.0 109.692 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 97.0 p -68.81 -31.13 69.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 108.414 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.579 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 79.5 t80 -64.3 -48.0 77.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.864 -0.522 . . . . 0.0 110.277 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ptm -72.91 -32.35 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.18 -42.18 85.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.701 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -92.98 -32.97 14.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 111.136 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 76.3 m -54.62 -24.09 19.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.864 -1.147 . . . . 0.0 110.517 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.82 0.56 48.96 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 116' ' ' VAL . 76.7 mt -63.66 -34.0 76.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.34 -1.094 . . . . 0.0 110.165 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.1 147.52 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.093 0.949 . . . . 0.0 111.003 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.85 103.52 9.42 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 127' ' ' THR . 58.9 p30 -173.86 70.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.067 -1.021 . . . . 0.0 111.284 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.635 ' C ' HG12 ' A' ' 176' ' ' VAL . 30.8 m170 -57.95 -43.09 86.19 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.58 -1.325 . . . . 0.0 108.244 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 168.23 3.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.454 ' H ' ' H ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER 71.87 -35.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -83.8 11.92 54.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.043 . . . . 0.0 109.344 -179.661 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.526 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 56.1 mtp180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.806 0.812 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.29 146.85 2.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.9 80.47 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.429 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.56 ' CZ2' ' CH2' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.617 -1.519 . . . . 0.0 110.461 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.22 -41.9 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.907 -1.121 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.6 m -79.4 5.7 12.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 108.872 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.72 -60.48 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.763 . . . . 0.0 109.973 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.16 157.04 75.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HA ' HD12 ' A' ' 14' ' ' ILE . 27.6 Cg_endo -65.92 -30.32 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.584 2.189 . . . . 0.0 112.143 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 47' ' ' ILE . 71.4 mt -62.69 -37.34 86.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 -39.93 95.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.136 -0.978 . . . . 0.0 109.27 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 11' ' ' PRO . 32.0 mt -54.68 -44.51 70.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.474 -0.766 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -65.93 -47.93 73.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.728 -1.232 . . . . 0.0 109.224 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.7 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.7 t80 -62.12 -40.74 96.93 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.913 0.863 . . . . 0.0 108.805 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -71.48 -39.22 71.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -78.46 -5.9 53.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.189 -0.944 . . . . 0.0 111.863 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.6 m120 -76.87 -75.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.527 -1.358 . . . . 0.0 110.001 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 21' ' ' TRP . 96.0 mt-10 -145.56 -40.96 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.139 -0.975 . . . . 0.0 108.724 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.592 ' C ' ' O ' ' A' ' 20' ' ' GLU . 6.4 t90 -4.68 74.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.106 0.955 . . . . 0.0 111.084 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 149.47 -25.32 1.22 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 19.6 m -120.06 4.01 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.575 -0.956 . . . . 0.0 112.766 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 69.8 Cg_endo -75.69 147.21 31.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.174 1.25 . . . . 0.0 112.987 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.68 166.37 13.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.619 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 7.6 p -99.32 108.84 21.47 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.338 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -89.32 167.17 13.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 m -73.13 -37.33 66.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.474 -1.391 . . . . 0.0 110.465 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -74.85 -41.53 59.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -59.66 -37.0 77.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.593 -1.317 . . . . 0.0 110.487 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -59.33 -38.15 79.58 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.981 -178.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.68 -45.85 90.87 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.452 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -71.22 -40.69 70.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.022 -1.049 . . . . 0.0 108.636 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.3 tpp -64.64 -48.44 74.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.641 -0.662 . . . . 0.0 110.62 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 2.7 tp -64.21 -29.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.999 -1.063 . . . . 0.0 109.469 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.9 m -70.74 -48.83 52.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.022 -1.049 . . . . 0.0 109.042 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 53' ' ' ARG . 10.8 mp -68.66 -39.7 80.54 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.295 -0.878 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.07 -37.82 86.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.421 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.54 -36.87 91.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.42 -24.18 67.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.469 -1.018 . . . . 0.0 110.061 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.8 pp0? -69.74 -3.29 14.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.711 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.43 112.71 1.67 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.725 -1.235 . . . . 0.0 109.084 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.8 -14.68 1.4 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.0 mm? -103.93 154.93 19.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.184 -1.186 . . . . 0.0 110.178 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -71.5 153.71 42.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 109.773 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.7 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -64.77 -41.99 95.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 110.434 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -54.63 -31.25 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 109.728 -179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 m -58.11 -40.86 82.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.84 -28.04 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.097 -1.002 . . . . 0.0 109.43 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -53.44 53.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 109.827 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -61.34 -44.46 97.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.673 -1.267 . . . . 0.0 108.154 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -65.62 -26.71 67.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 37' ' ' LEU . 40.3 ttm180 -53.96 -44.04 70.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.779 -1.201 . . . . 0.0 107.918 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.49 -37.05 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.397 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -78.35 -45.65 22.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.873 -1.142 . . . . 0.0 111.155 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.663 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 40.2 t80 -58.87 -46.43 87.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.159 . . . . 0.0 109.945 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -66.6 -29.47 69.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.11 -0.993 . . . . 0.0 109.37 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.24 74.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.746 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.52 -45.46 68.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.858 -1.151 . . . . 0.0 110.648 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.462 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 20.5 m-85 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.985 -1.072 . . . . 0.0 109.997 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.024 0.343 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.79 -46.18 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.939 -1.1 . . . . 0.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.12 75.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.095 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.02 -38.22 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.766 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -68.67 -14.91 63.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.08 -9.57 45.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.57 -0.707 . . . . 0.0 109.094 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.588 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.1 mtp -82.18 112.84 19.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.434 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 2.3 tp60 -95.77 -176.49 3.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 109.98 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.3 mt-10 -57.61 -33.12 67.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 110.617 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.0 -33.13 75.3 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 108.506 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 62.3 m-20 -68.22 -40.1 82.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.528 -0.733 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.1 m -66.69 -33.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.743 -1.223 . . . . 0.0 109.254 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.511 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.8 mt-10 -63.99 -36.56 84.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.072 -1.017 . . . . 0.0 108.648 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 78' ' ' ARG . 19.6 ttm-85 -61.77 -47.03 87.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.439 ' C ' ' N ' ' A' ' 81' ' ' GLN . 91.9 mt -69.88 -33.49 72.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 111.209 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -49.6 -18.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 108.689 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.5 mt-30 -113.31 -13.78 12.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.551 -0.718 . . . . 0.0 109.775 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.0 t70 -81.23 109.1 15.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.685 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.29 -17.17 0.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 72.04 36.47 60.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.517 HG22 ' ND2' ' A' ' 55' ' ' ASN . 7.6 pt -50.33 -172.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.446 -1.032 . . . . 0.0 110.337 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -59.41 93.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 94.1 mtt180 -52.27 139.73 23.33 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.593 -0.692 . . . . 0.0 109.794 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 164.76 63.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 11.6 ptm180 -49.36 -38.45 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.337 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -64.59 -59.18 8.55 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.515 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.82 -41.47 95.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.879 -1.365 . . . . 0.0 109.849 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.88 -42.43 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 110.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.87 -32.92 68.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.754 -1.216 . . . . 0.0 108.548 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.22 83.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 108.934 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.631 HG21 ' OH ' ' A' ' 56' ' ' TYR . 50.3 mm -57.27 -41.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 108.84 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 71' ' ' MET . 7.6 mm -59.65 -40.41 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.82 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.34 85.46 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -58.58 -37.55 76.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.424 -1.045 . . . . 0.0 109.088 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -62.78 -44.89 95.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -56.72 -42.99 80.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 108.507 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.03 70.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.45 -0.781 . . . . 0.0 108.965 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.16 -42.92 99.73 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.1 mp -68.52 -31.62 70.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.32 -40.43 90.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.128 -0.983 . . . . 0.0 110.322 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.683 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 71.3 mtp -71.73 -39.33 70.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.958 -1.089 . . . . 0.0 108.803 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.41 -41.81 88.75 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.819 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.83 -21.37 66.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -92.9 -11.05 34.43 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.59 26.57 74.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -118.42 101.5 50.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.243 -1.151 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 145.01 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.237 1.958 . . . . 0.0 112.414 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 31' ' ' LEU . 31.7 m-85 -60.8 -43.42 98.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.27 -33.29 75.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 111.139 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.36 -48.52 80.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.033 -1.042 . . . . 0.0 112.133 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.3 p90 -70.16 -45.18 67.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.685 -1.259 . . . . 0.0 111.12 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -59.84 -50.09 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.468 -1.395 . . . . 0.0 109.581 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.619 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 17.0 m95 -54.99 -24.48 24.39 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 5.3 p -70.61 -38.86 74.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.496 -0.753 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.517 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.6 m-85 -64.96 -32.17 73.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.718 -1.239 . . . . 0.0 109.476 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.698 HG21 ' CD2' ' A' ' 171' ' ' LEU . 29.0 m -96.92 17.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.366 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 122' ' ' HIS . 7.2 m-20 57.74 40.93 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.544 -0.722 . . . . 0.0 110.059 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 121' ' ' ASN . 49.8 t-80 43.16 27.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.992 . . . . 0.0 109.805 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 2.6 mm-40 -126.9 149.72 69.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.43 147.99 87.56 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.532 2.154 . . . . 0.0 112.157 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -117.32 139.45 50.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.3 mtt -100.34 122.15 42.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.413 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -84.98 118.11 24.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 108.571 179.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.82 19.88 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -76.12 129.43 36.77 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.274 -0.892 . . . . 0.0 109.365 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.9 p -100.96 -21.32 15.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.7 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 10.8 p -131.64 162.78 29.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.2 mt -58.78 -37.32 76.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 108.823 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.7 m -76.32 -3.2 35.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HB3' ' H ' ' A' ' 131' ' ' THR . 31.9 tp10 -101.69 12.53 36.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -100.48 106.96 45.93 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.71 137.7 82.46 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.83 1.686 . . . . 0.0 112.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 p -103.78 4.09 34.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -142.29 85.74 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.439 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 14.2 p -102.35 151.49 38.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -52.73 -35.73 70.01 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.508 1.472 . . . . 0.0 111.284 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.49 -43.05 61.03 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.439 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 56.8 m -66.17 -43.57 86.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -66.17 -37.47 85.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -71.91 -31.2 66.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.54 HD23 ' SG ' ' A' ' 162' ' ' CYS . 7.1 tp -65.42 -46.65 79.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.642 -0.661 . . . . 0.0 109.537 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.574 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 19.4 m -61.3 -40.88 95.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.077 -1.015 . . . . 0.0 109.518 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -61.22 -43.57 98.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 110.039 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.17 70.79 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.49 -37.92 83.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 109.223 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -61.57 -40.0 93.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.034 -1.041 . . . . 0.0 109.498 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.6 -15.34 57.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.907 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.448 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -83.0 4.16 27.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.156 -0.965 . . . . 0.0 108.835 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.53 24.78 49.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -100.57 112.89 25.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.983 . . . . 0.0 108.849 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -93.44 172.93 7.97 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.648 -0.657 . . . . 0.0 109.231 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 57.84 61.31 2.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.843 . . . . 0.0 109.055 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.3 m -140.85 39.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.51 162.91 0.07 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.6 m -55.03 -31.39 61.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.457 -1.026 . . . . 0.0 109.005 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.6 p -72.34 -31.89 66.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.36 -45.02 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.574 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.7 m -67.0 -41.81 86.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -0.764 . . . . 0.0 109.407 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.44 -46.84 68.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.589 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 18.3 m -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.853 -1.154 . . . . 0.0 109.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -59.29 -47.71 84.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 110.652 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 11.9 ptp -66.42 -29.19 69.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.132 . . . . 0.0 110.657 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -57.35 -40.0 77.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.872 -1.143 . . . . 0.0 110.746 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.14 -33.16 11.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 111.124 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.662 ' SG ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -54.62 -27.64 40.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.975 -1.078 . . . . 0.0 109.69 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.55 54.36 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.069 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.698 ' CD2' HG21 ' A' ' 120' ' ' VAL . 6.4 mt -63.3 -30.69 71.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.199 -1.177 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 125' ' ' GLN . 10.9 m -125.77 137.88 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 82.3 m-20 -104.32 164.3 11.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.745 . . . . 0.0 109.413 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 89.58 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.465 ' O ' HG13 ' A' ' 176' ' ' VAL . 17.7 m170 -51.55 -44.74 62.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 108.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 28.2 m -157.91 37.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.73 . . . . 0.0 109.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 176' ' ' VAL . 16.0 t 37.84 93.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.24 -4.35 7.26 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 3' ' ' ARG . 8.7 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 108.482 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.717 0.77 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 145.87 55.03 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.83 49.84 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.408 -0.808 . . . . 0.0 111.833 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -84.37 2.97 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.536 -1.567 . . . . 0.0 109.77 -179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -76.84 -46.45 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 109.158 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.1 m -73.17 -2.02 19.94 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.895 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 62.8 tt0 -67.81 -41.7 82.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -154.63 159.92 31.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 109.984 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.8 -38.47 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.991 2.46 . . . . 0.0 112.463 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.72 -32.88 73.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CZ ' ' CD1' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -62.96 -41.84 99.65 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.296 -0.878 . . . . 0.0 110.207 -179.364 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.27 -38.29 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 110.523 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -67.48 -50.65 58.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 109.539 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 16' ' ' TYR . 1.2 t80 -60.91 -37.21 81.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 110.01 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -59.1 -43.05 91.85 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.416 -0.803 . . . . 0.0 110.651 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -80.36 -16.06 55.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 110.712 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 10.1 m120 -64.58 -53.94 39.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 177.57 57.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 108.829 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 167' ' ' GLN . 4.2 t90 -97.66 63.93 1.76 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 108.87 59.85 0.53 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.857 -1.164 . . . . 0.0 111.562 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.729 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -157.88 -36.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.486 . . . . 0.0 112.037 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.729 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 46.5 Cg_endo -96.15 152.05 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.702 2.268 . . . . 0.0 114.032 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 26' ' ' THR . 86.2 tt0 -68.9 160.15 31.26 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.437 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 2.3 p -95.06 152.48 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.492 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' LYS . 24.1 t70 -103.65 151.46 22.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -62.79 -36.23 82.44 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.911 -1.118 . . . . 0.0 109.418 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -74.89 -50.33 17.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 110.811 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' CD ' ' H ' ' A' ' 27' ' ' ASP . 1.3 ptmm? -62.75 -25.16 68.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.958 -1.089 . . . . 0.0 108.69 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.58 -39.47 76.85 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -69.32 -44.52 71.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.695 -0.628 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.54 -28.37 66.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.14 . . . . 0.0 110.21 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.5 ttm -71.47 -52.06 20.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.867 -1.146 . . . . 0.0 110.444 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 35' ' ' ILE . 9.5 tp -61.1 -29.02 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.749 -1.219 . . . . 0.0 109.709 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.01 -44.1 90.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.065 -1.022 . . . . 0.0 109.038 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 53' ' ' ARG . 3.7 mm? -70.71 -43.58 68.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 31.5 mm-40 -62.81 -33.52 75.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -0.806 . . . . 0.0 109.104 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.14 -36.32 88.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.77 -3.63 39.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -1.174 . . . . 0.0 109.992 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -79.26 -0.69 33.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.04 122.76 18.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.162 -0.961 . . . . 0.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.514 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 74.04 -32.85 0.92 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.9 mm? -98.47 150.03 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.286 . . . . 0.0 109.996 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.5 p -65.61 157.29 30.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.33 -31.08 70.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -40.8 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.413 -0.804 . . . . 0.0 109.877 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 m -57.37 -38.92 74.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.081 -1.012 . . . . 0.0 108.35 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -64.17 -36.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.23 -47.48 78.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -0.966 . . . . 0.0 109.046 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.5 -34.09 76.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' C ' HD22 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -84.52 -10.65 57.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.005 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 41.1 ttm180 -66.72 -51.16 59.17 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.54 -36.13 76.08 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.229 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -72.13 -34.88 68.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.015 -1.053 . . . . 0.0 109.929 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 82.9 t80 -60.7 -47.47 86.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 7.9 ptm180 -66.86 -28.23 68.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.919 -1.113 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -67.7 -37.98 83.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 111.267 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -77.41 -45.66 25.16 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.749 -1.219 . . . . 0.0 110.768 -178.743 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 110.334 -179.527 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.508 2.341 0 N-CA-C 116.982 1.878 . . . . 0.0 116.982 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 103' ' ' LEU . 59.4 t -57.3 -30.13 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.917 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -39.82 66.97 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.331 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.34 -40.71 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.766 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.711 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.33 -16.28 59.89 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.02 -6.38 58.75 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.57 ' O ' HG21 ' A' ' 96' ' ' ILE . 67.6 mmm -82.74 117.24 22.52 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.89 172.27 8.26 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.12 -0.988 . . . . 0.0 109.857 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -54.33 -31.47 54.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.486 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.31 -44.41 75.78 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.651 -1.28 . . . . 0.0 108.37 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.24 -37.81 86.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 92' ' ' ILE . 99.5 t -56.93 -44.83 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 0.0 109.591 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.76 -38.06 89.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 108.628 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -60.93 -39.95 91.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 109.373 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 85' ' ' ILE . 95.9 mt -63.01 -33.24 75.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.16 -33.8 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -109.34 -4.04 16.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.557 -0.714 . . . . 0.0 110.949 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 35.7 t0 -82.0 108.68 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.281 -1.512 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.91 -16.06 0.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.421 -0.799 . . . . 0.0 109.548 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.01 33.18 57.7 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.663 HG22 ' OD1' ' A' ' 55' ' ' ASN . 22.1 pt -54.73 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -1.114 . . . . 0.0 110.205 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 86' ' ' ILE . 10.6 tt -57.71 86.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -54.21 138.64 38.01 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.698 0.761 . . . . 0.0 110.434 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 160.58 77.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.585 ' CD ' ' H ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.18 -35.27 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.533 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 -56.26 25.63 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -65.8 -41.43 91.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.295 . . . . 0.0 110.614 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 76' ' ' VAL . 74.6 mt -62.66 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 0.0 110.443 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 2.7 pt20 -55.82 -34.52 65.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.667 -1.271 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -63.13 -37.51 87.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.948 . . . . 0.0 109.153 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.62 -44.27 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 108.821 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.57 HG21 ' O ' ' A' ' 71' ' ' MET . 9.3 mm -60.45 -41.12 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.59 90.86 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -40.53 87.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 0.0 109.264 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.23 -43.89 93.56 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.072 -1.017 . . . . 0.0 109.001 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.711 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -52.16 -42.07 63.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 108.793 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.44 -29.32 69.99 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.713 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 45.9 t80 -62.79 -44.86 95.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.9 mm? -62.82 -33.36 75.07 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.08 -36.94 84.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.392 -0.817 . . . . 0.0 110.444 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 82.9 mmm -71.56 -40.3 70.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.71 -39.33 70.23 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.19 -20.03 64.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -85.89 -8.98 57.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.77 26.34 73.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.04 101.79 49.62 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.497 -1.002 . . . . 0.0 109.678 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.25 143.7 41.83 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.342 2.028 . . . . 0.0 112.204 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.713 ' CZ ' ' CD1' ' A' ' 102' ' ' TYR . 58.5 m-85 -64.66 -45.33 87.21 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.039 0.924 . . . . 0.0 110.665 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.6 -26.91 68.9 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.473 -0.767 . . . . 0.0 110.947 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.479 ' O ' ' OG ' ' A' ' 118' ' ' SER . 60.4 t0 -66.24 -49.35 67.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.863 -1.148 . . . . 0.0 111.862 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.3 p90 -69.74 -44.51 70.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.864 -1.148 . . . . 0.0 111.355 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 117' ' ' TRP . 3.3 p -61.0 -53.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.512 -1.367 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.617 ' H ' HG13 ' A' ' 116' ' ' VAL . 37.5 m95 -55.82 -23.09 28.32 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.496 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 13.3 m -69.26 -38.87 78.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.084 -1.01 . . . . 0.0 109.782 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 29.8 m-85 -64.55 -33.9 77.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 120' ' ' VAL . 3.6 m -91.82 18.58 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.055 . . . . 0.0 109.178 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.61 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 59.2 m-80 58.62 43.96 18.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 0.0 109.496 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 28.9 p-80 41.51 24.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.491 -0.756 . . . . 0.0 110.058 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -135.46 153.76 78.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.086 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 147.46 95.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.653 2.235 . . . . 0.0 112.376 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -100.36 131.7 46.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.761 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.7 mtt -96.88 113.25 24.77 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -93.24 115.9 28.49 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -87.84 19.31 3.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.33 140.75 52.29 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.261 -0.899 . . . . 0.0 109.122 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.29 -28.65 10.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.3 p -128.18 162.37 27.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.52 -0.737 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.91 -36.87 70.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.054 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.2 m -61.84 -30.34 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.19 -6.5 57.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 109.816 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -75.52 131.8 76.7 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 74.3 Cg_endo -79.41 -21.58 8.78 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.844 1.696 . . . . 0.0 112.649 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.482 HG22 ' CE1' ' A' ' 163' ' ' TYR . 0.2 OUTLIER 52.36 -1.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.767 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -148.37 83.15 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.065 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.416 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -95.62 159.08 33.34 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.9 -38.13 85.88 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.843 1.695 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.01 -45.02 52.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.416 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 18.1 m -62.95 -43.0 99.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.735 . . . . 0.0 109.061 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.83 -42.05 97.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 108.932 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.1 -29.0 66.99 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -61.52 -47.81 83.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.648 -0.657 . . . . 0.0 109.484 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.546 ' HG ' ' CB ' ' A' ' 162' ' ' CYS . 3.8 m -66.19 -41.02 90.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 0.0 110.161 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -58.3 -38.66 77.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.845 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.13 6.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 145' ' ' LEU . 10.1 mp -59.93 -31.94 70.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 109.968 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -61.05 -45.12 96.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.789 -1.195 . . . . 0.0 109.581 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -84.48 -13.5 51.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -81.75 2.99 27.38 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.864 -1.148 . . . . 0.0 109.484 -178.844 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.1 21.18 33.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 15.2 m-85 -109.66 111.13 22.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -1.073 . . . . 0.0 109.308 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -94.64 -178.31 4.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 55.32 40.48 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 108.93 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.2 p -125.03 48.37 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.61 162.2 0.5 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -58.18 -30.61 66.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.496 -1.002 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.5 m -72.32 -37.24 68.97 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.141 -0.974 . . . . 0.0 108.674 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.74 -39.88 87.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.546 ' CB ' ' HG ' ' A' ' 146' ' ' SER . 1.4 m -62.2 -49.35 76.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.87 . . . . 0.0 109.828 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.566 ' CZ ' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -65.16 -41.0 95.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 20.1 m -64.38 -43.02 95.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.11 -0.994 . . . . 0.0 109.56 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.9 88.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 98.8 mtp -60.89 -40.55 93.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 111.289 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.566 ' OE1' ' CZ ' ' A' ' 163' ' ' TYR . 59.8 mt-30 -64.04 -44.74 91.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 111.222 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.26 63.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.019 . . . . 0.0 110.612 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -39.09 67.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 0.0 111.288 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.9 0.61 17.3 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -1.188 . . . . 0.0 109.887 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.32 150.34 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 79.2 m-20 -128.57 163.56 24.74 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.386 0.612 . . . . 0.0 110.72 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.9 t0 89.52 74.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.471 0.653 . . . . 0.0 109.755 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 176' ' ' VAL . 9.2 m170 -58.35 -44.6 88.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 175' ' ' HIS . 12.9 m -157.99 29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.905 . . . . 0.0 109.992 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 129' ' ' ALA . 85.8 t 55.24 113.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.888 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.14 33.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.354 -1.086 . . . . 0.0 109.45 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.346 0.593 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 133.67 51.15 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.918 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.78 -30.8 76.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.08 -1.51 26.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 108.334 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' ND1' ' A' ' 17' ' ' HIS . 1.1 t -102.29 -28.0 3.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.392 0.615 . . . . 0.0 109.395 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.1 m -70.66 5.2 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.9 . . . . 0.0 110.634 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -84.11 -149.18 0.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.789 -1.195 . . . . 0.0 109.275 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.67 158.6 11.42 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 -160.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.837 2.358 . . . . 0.0 111.468 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 -40.42 0.27 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.012 -1.055 . . . . 0.0 109.135 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.3 m-85 -64.48 -36.63 84.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.894 -1.129 . . . . 0.0 109.413 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.78 -46.83 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.544 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.04 69.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.995 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.2 t80 -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.011 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.498 ' ND1' HG21 ' A' ' 7' ' ' VAL . 14.6 t-80 -76.08 -32.12 59.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.94 -10.33 59.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.956 -1.09 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 19.7 p30 -90.95 -70.41 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.602 -1.311 . . . . 0.0 112.464 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.676 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.2 mt-10 -126.5 -69.09 0.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.943 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.452 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 30.1 t-105 51.72 44.83 28.96 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.68 41.45 19.67 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 120.491 -1.381 . . . . 0.0 110.969 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.574 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -106.98 -41.88 0.14 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.218 . . . . 0.0 109.993 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 95.4 Cg_endo -98.57 154.03 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.794 2.996 . . . . 0.0 112.821 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.36 144.2 55.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 169' ' ' CYS . 67.4 p -105.46 155.44 19.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.773 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -92.16 167.1 12.28 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -59.95 -36.8 77.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 111.197 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.1 -41.55 90.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 112.264 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -62.34 -38.68 90.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.603 -1.311 . . . . 0.0 108.855 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -56.76 -39.1 73.41 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.231 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -60.73 -40.3 91.83 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.04 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -70.69 -43.38 69.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.905 -1.122 . . . . 0.0 108.778 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.479 ' SD ' ' CD1' ' A' ' 165' ' ' PHE . 58.2 ttm -63.82 -47.36 81.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 110.462 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -65.46 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.2 m -69.36 -51.11 40.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.99 -1.068 . . . . 0.0 109.652 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 2.2 mp -68.44 -42.0 79.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.196 -0.94 . . . . 0.0 108.965 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 9.1 tp10 -62.55 -35.74 80.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.619 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.29 -28.1 49.0 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -79.41 -12.87 59.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 109.807 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -74.79 11.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 111.303 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -68.62 112.94 5.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.367 -1.458 . . . . 0.0 109.238 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.27 -0.35 0.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.604 HD21 ' CG2' ' A' ' 48' ' ' THR . 17.3 tp -106.66 145.2 32.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.193 -1.18 . . . . 0.0 109.857 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.7 m -64.39 157.06 27.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.837 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.612 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 2.8 t-105 -71.13 -43.81 66.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.489 -0.757 . . . . 0.0 110.708 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.562 HD12 ' HZ2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -58.96 -27.22 35.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.959 -1.088 . . . . 0.0 109.097 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.604 ' CG2' HD21 ' A' ' 44' ' ' LEU . 29.6 m -63.86 -40.23 96.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -0.935 . . . . 0.0 109.895 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 46' ' ' TRP . 1.2 m -69.82 -28.83 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.084 -1.01 . . . . 0.0 108.993 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.06 -47.31 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -56.64 -45.85 81.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' TYR . 21.3 ttpp -59.82 -32.59 70.8 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -55.35 -45.25 76.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.531 -0.731 . . . . 0.0 109.576 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -68.66 -46.11 69.98 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.02 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 14.0 m-80 -64.34 -34.65 78.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.776 . . . . 0.0 109.142 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.1 t80 -56.6 -42.29 78.49 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -63.37 -38.22 90.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.09 -41.25 86.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.744 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -45.39 41.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.0 111.229 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 81.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 N-CA-C 114.75 1.019 . . . . 0.0 114.75 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.07 -44.83 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 111.121 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.49 -40.6 95.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.5 -41.77 93.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.801 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.68 60.73 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.18 -14.53 28.92 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.739 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.5 mtp -82.78 113.14 20.22 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.61 -177.64 3.99 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.766 -1.209 . . . . 0.0 110.958 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.42 -36.65 69.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 109.136 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.81 -49.04 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.581 -1.325 . . . . 0.0 108.128 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.34 -35.66 74.26 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.507 ' HA ' HD12 ' A' ' 79' ' ' LEU . 55.6 t -60.55 -37.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.28 -0.887 . . . . 0.0 108.748 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.02 -39.8 83.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -65.37 -33.48 76.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.361 0.6 . . . . 0.0 109.507 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.744 HD22 ' SG ' ' A' ' 59' ' ' CYS . 87.8 mt -69.29 -34.47 74.75 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.266 -0.896 . . . . 0.0 110.447 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.1 t -56.03 -17.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -109.73 -17.26 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -1.0 . . . . 0.0 110.077 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 59.6 m-20 -80.04 109.78 14.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.75 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.98 -16.21 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.675 . . . . 0.0 109.246 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.7 42.73 86.87 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.8 pt -52.52 -166.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.836 -0.802 . . . . 0.0 109.846 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.07 98.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.511 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 11.2 ptp180 -52.68 116.82 2.5 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.675 0.75 . . . . 0.0 109.696 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 168.23 70.56 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.023 -1.048 . . . . 0.0 108.197 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 29.3 ptt180 -44.34 -42.44 6.79 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.694 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -47.97 -51.85 18.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -65.18 -45.38 85.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -1.128 . . . . 0.0 109.861 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 mm -60.75 -44.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.631 -0.668 . . . . 0.0 110.005 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -56.83 -38.31 72.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.823 -1.173 . . . . 0.0 110.167 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.97 82.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.41 -39.46 74.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 71' ' ' MET . 25.5 mm -59.16 -46.22 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.591 0.71 . . . . 0.0 110.269 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.85 -28.78 73.94 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -63.55 -40.52 97.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -1.16 . . . . 0.0 110.009 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -49.83 61.23 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 108.95 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -55.81 -38.08 69.51 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.46 -29.54 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.083 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.01 -42.27 94.59 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.2 mm? -62.78 -33.52 75.35 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.59 -36.54 83.05 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.533 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 39.1 tpp -61.01 -47.64 85.52 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.121 -0.987 . . . . 0.0 108.337 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 109' ' ' GLY . 84.3 tt0 -57.67 -35.73 70.96 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.3 t-20 -91.43 -18.12 24.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.51 27.57 73.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.3 mt-10 -114.26 108.58 50.04 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.72 -0.87 . . . . 0.0 109.57 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -51.73 139.75 48.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.965 1.777 . . . . 0.0 112.069 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.713 ' HB3' HD12 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -55.01 -37.84 67.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.756 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.27 64.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.636 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -62.96 -45.05 94.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.688 -1.257 . . . . 0.0 111.249 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.659 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 5.4 p90 -77.39 -40.51 43.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.91 -1.119 . . . . 0.0 111.601 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.659 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 21.6 m -63.2 -48.84 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 119.547 -1.97 . . . . 0.0 108.662 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.567 ' N ' HG23 ' A' ' 116' ' ' VAL . 46.3 m95 -61.26 -23.67 65.83 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.8 t -70.22 -44.48 68.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.095 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 24.1 m-85 -61.19 -30.28 70.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 109.812 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -96.5 18.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 123' ' ' GLN . 82.0 m-20 56.99 42.31 26.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 110.176 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 37.67 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.67 -0.644 . . . . 0.0 109.361 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.3 mm100 -122.84 112.37 30.61 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.349 -0.844 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.27 150.45 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.882 1.722 . . . . 0.0 111.227 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 142.44 46.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.044 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.7 mtt -91.2 130.27 37.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.78 . . . . 0.0 109.638 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.595 HG22 ' N ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -93.44 -58.91 2.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 109.745 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.595 ' N ' HG22 ' A' ' 127' ' ' THR . 71.7 mt-30 59.26 44.26 15.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.34 156.23 28.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.451 -0.781 . . . . 0.0 109.687 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -92.53 -12.79 30.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -168.55 -179.34 3.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -36.39 83.48 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 t -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.897 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 74.9 mm-40 -81.7 5.41 18.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.621 -1.299 . . . . 0.0 109.334 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.61 136.01 20.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.13 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.89 140.37 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.415 2.077 . . . . 0.0 112.883 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.409 ' HA ' ' CG ' ' A' ' 163' ' ' TYR . 0.6 OUTLIER -105.7 -1.47 24.45 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 108.957 179.197 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -145.97 92.3 2.18 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.501 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.63 154.82 39.79 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.195 -0.941 . . . . 0.0 108.979 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -54.1 -34.65 79.03 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.715 1.61 . . . . 0.0 111.105 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -48.63 51.06 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.467 -0.771 . . . . 0.0 109.029 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -64.06 -42.06 97.14 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.644 0.735 . . . . 0.0 109.362 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.03 -39.11 77.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.581 -0.7 . . . . 0.0 109.47 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.743 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.64 -31.74 72.92 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.656 HD22 HG12 ' A' ' 116' ' ' VAL . 69.9 mt -59.6 -46.74 88.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 26.3 t -60.47 -43.62 96.75 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -64.56 -47.3 79.28 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.518 -0.739 . . . . 0.0 110.17 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.63 77.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.418 ' HG ' ' NH2' ' A' ' 152' ' ' ARG . 35.1 mt -66.25 -36.77 83.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.8 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.34 -40.86 92.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.608 -1.308 . . . . 0.0 110.01 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -68.82 -36.6 78.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.969 . . . . 0.0 111.47 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.515 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 74.2 mtm180 -72.26 3.7 4.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.64 20.15 52.03 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 11.2 m-85 -96.93 110.34 22.88 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.29 . . . . 0.0 109.796 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -90.62 178.28 6.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.887 -0.508 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 58.33 47.69 13.59 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.238 1.018 . . . . 0.0 108.889 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.7 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.11 160.41 0.79 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.6 m -59.66 -33.18 71.22 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.512 -0.993 . . . . 0.0 109.188 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.0 m -71.86 -36.07 70.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.91 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.907 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 146' ' ' SER . 20.6 m -67.84 -39.97 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.245 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CG ' ' HA ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -62.66 -44.01 97.35 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.605 -0.685 . . . . 0.0 110.077 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 59.2 p -61.54 -35.45 77.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CD1' ' SD ' ' A' ' 34' ' ' MET . 18.5 t80 -61.5 -41.43 97.28 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 110.063 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.451 ' HG2' ' N ' ' A' ' 167' ' ' GLN . 2.4 ptm -67.48 -36.92 82.07 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.902 -1.124 . . . . 0.0 110.795 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.451 ' N ' ' HG2' ' A' ' 166' ' ' MET . 27.1 mm100 -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.842 -1.162 . . . . 0.0 110.893 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.0 -16.0 21.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.39 -0.819 . . . . 0.0 111.937 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 26' ' ' THR . 2.2 t -74.56 -46.11 41.04 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.381 -1.449 . . . . 0.0 110.407 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 -1.42 3.9 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 171' ' ' LEU . 8.8 mp -61.51 -31.57 71.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.025 -1.279 . . . . 0.0 110.685 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.9 154.54 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.959 -1.088 . . . . 0.0 109.049 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 28.6 p30 -124.06 162.77 22.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.171 -0.956 . . . . 0.0 110.046 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 91.56 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -51.73 -39.62 58.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.026 . . . . 0.0 108.623 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.863 HG13 ' H ' ' A' ' 177' ' ' VAL . 2.8 p -145.15 -104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.622 -0.674 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.863 ' H ' HG13 ' A' ' 176' ' ' VAL . 1.1 t -138.4 -41.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 108.292 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.28 67.55 0.52 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.338 . . . . 0.0 110.17 179.899 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 3' ' ' ARG . 30.4 mtm-85 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.813 0.816 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.47 131.17 42.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.612 0.72 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.83 -18.42 53.31 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -4.02 58.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -1.141 . . . . 0.0 109.984 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER -111.43 -10.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.205 -0.934 . . . . 0.0 109.8 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.5 m -70.78 5.99 1.69 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 108.799 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.0 mt-30 -63.1 -88.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.804 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 165.88 -38.06 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 0.0 111.556 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' ASP . 61.1 Cg_endo -91.12 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.775 2.317 . . . . 0.0 115.532 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' TYR . 26.0 mt -32.34 -32.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.941 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' PRO . 4.3 m-85 -44.98 -40.59 6.57 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.843 -1.16 . . . . 0.0 109.913 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.8 mt -61.76 -46.38 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.54 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.02 39.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.126 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.477 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 t80 -62.51 -41.85 99.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -63.05 -38.07 89.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.79 -1.72 58.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 112.217 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 1.4 p-10 -100.95 -34.03 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.506 -1.371 . . . . 0.0 111.13 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 93.5 mt-10 -153.19 -73.98 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.577 -1.327 . . . . 0.0 110.554 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.477 ' CE3' ' CE2' ' A' ' 16' ' ' TYR . 8.4 t-105 39.76 45.83 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.098 0.951 . . . . 0.0 108.804 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' ALA . . . 74.45 49.2 12.0 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.487 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.709 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 t -108.69 -35.93 0.15 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.195 -1.18 . . . . 0.0 109.074 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.709 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.2 Cg_endo -92.13 154.69 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 123.367 2.711 . . . . 0.0 112.148 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' C ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -64.39 151.95 42.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.769 ' OG1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -91.3 142.91 27.2 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.506 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -102.83 158.62 16.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 m -56.33 -33.73 65.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.777 -1.202 . . . . 0.0 109.006 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -67.14 -39.0 86.49 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.747 -0.595 . . . . 0.0 110.933 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -62.27 -44.31 96.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.005 -1.06 . . . . 0.0 110.003 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -62.24 -37.97 87.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.0 -53.08 60.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.09 -1.006 . . . . 0.0 110.511 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.01 -40.71 78.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 108.872 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.659 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 3.3 ttm -62.87 -49.33 75.28 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 111.125 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 157' ' ' VAL . 2.7 tp -62.21 -27.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.948 -1.095 . . . . 0.0 108.962 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.41 -54.26 11.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -0.973 . . . . 0.0 109.798 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -71.07 -39.87 71.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 0.0 109.017 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 9.7 tp10 -59.57 -32.01 69.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.13 80.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.708 HE21 ' CD1' ' A' ' 44' ' ' LEU . 55.2 tp60 -69.25 -30.7 68.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.095 -1.238 . . . . 0.0 109.952 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.583 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -51.03 -3.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 110.368 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -63.28 112.42 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.877 -1.14 . . . . 0.0 109.319 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.05 -13.5 0.49 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.708 ' CD1' HE21 ' A' ' 40' ' ' GLN . 9.7 mt -101.98 159.52 15.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.043 -1.269 . . . . 0.0 110.354 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.6 ' HG ' ' HG1' ' A' ' 48' ' ' THR . 1.2 p -85.29 147.18 26.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.463 -0.773 . . . . 0.0 108.916 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.583 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -60.95 -40.75 94.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.422 -0.798 . . . . 0.0 110.592 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -39.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.004 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.6 ' HG1' ' HG ' ' A' ' 45' ' ' SER . 84.8 m -61.55 -40.53 95.04 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -66.37 -35.57 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -58.83 -52.33 66.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -58.49 -41.9 86.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.592 -1.317 . . . . 0.0 107.966 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -65.64 -25.73 67.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.81 -43.23 76.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 47.0 mp0 -68.36 -39.95 81.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 51' ' ' LYS . 10.2 m120 -69.85 -37.88 76.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 0.0 109.606 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -60.69 -48.79 80.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.798 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -25.79 68.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.164 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.09 82.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 110.7 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.15 -46.26 61.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.865 -1.147 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.002 179.826 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.494 1.515 0 N-CA-C 113.102 0.385 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.861 HG22 HD21 ' A' ' 103' ' ' LEU . 67.4 t -63.35 -46.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.777 -1.202 . . . . 0.0 109.753 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.81 -32.68 73.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.385 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.42 -39.34 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.351 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.26 -18.93 65.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -86.06 -5.7 59.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.475 ' HE1' HD11 ' A' ' 79' ' ' LEU . 98.4 mtp -85.15 113.22 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -95.92 176.08 6.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.465 -0.772 . . . . 0.0 109.524 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 97.4 mt-10 -52.84 -31.04 37.0 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.143 -0.973 . . . . 0.0 109.44 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.79 -49.65 76.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.175 -0.953 . . . . 0.0 108.454 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.21 -38.39 88.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.62 HG13 HG21 ' A' ' 92' ' ' ILE . 99.0 t -59.8 -43.37 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.733 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.13 -33.69 72.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.23 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 43.1 ttm180 -64.25 -46.26 84.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 110.104 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.475 HD11 ' HE1' ' A' ' 71' ' ' MET . 47.1 mt -67.32 -33.4 75.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 110.756 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.08 -18.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' N ' ' C ' ' A' ' 79' ' ' LEU . 22.0 mt-30 -110.4 -17.82 13.38 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.659 -0.65 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 54.1 m-20 -76.78 108.68 9.97 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.86 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 71.14 -18.71 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.54 -0.725 . . . . 0.0 109.817 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.66 34.69 84.29 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 84' ' ' GLY . 7.7 pt -42.82 160.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 44' ' ' LEU . 2.2 tt -63.85 -29.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.31 -0.869 . . . . 0.0 110.909 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 44.9 mtt-85 -63.77 145.37 55.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 109.889 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' ARG . 34.5 m80 -122.72 162.07 22.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 109.444 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.461 HH11 ' HG3' ' A' ' 89' ' ' ARG . 5.4 ptm180 -41.51 -40.81 1.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.56 -66.5 2.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.809 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -61.83 -38.08 86.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -1.148 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.62 HG21 HG13 ' A' ' 76' ' ' VAL . 98.1 mt -58.64 -54.13 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.829 -1.169 . . . . 0.0 109.966 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.453 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 61.3 mt-30 -51.93 -32.44 32.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 109.443 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.94 95.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.075 -1.016 . . . . 0.0 109.851 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.4 -36.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.641 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mp -58.36 -46.86 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.723 -1.236 . . . . 0.0 108.723 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.89 -35.79 92.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 84.3 m-20 -58.77 -37.01 75.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.457 -1.025 . . . . 0.0 109.719 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.14 90.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.987 -1.071 . . . . 0.0 108.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.407 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -59.02 -36.48 75.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.59 76.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.99 -42.54 99.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 HG22 ' A' ' 66' ' ' VAL . 87.8 mt -64.42 -33.79 76.69 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -63.43 -36.34 83.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.249 -0.907 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 87.0 mmm -68.74 -42.91 76.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.914 -1.116 . . . . 0.0 110.164 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.34 -37.33 83.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.494 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -94.49 -10.45 32.25 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.04 74.26 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.42 100.43 51.46 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 149.39 75.18 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.335 2.023 . . . . 0.0 111.946 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.548 ' HB3' HD12 ' A' ' 31' ' ' LEU . 40.0 m-85 -60.7 -33.33 72.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.328 -0.857 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.19 -34.9 71.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.712 -1.243 . . . . 0.0 111.467 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.43 -49.55 77.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.664 -1.272 . . . . 0.0 111.523 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.589 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 3.2 p90 -71.23 -35.3 71.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.205 . . . . 0.0 109.381 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.91 HG22 HD21 ' A' ' 145' ' ' LEU . 1.3 t -64.22 -54.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.05 . . . . 0.0 109.63 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.529 ' N ' HG12 ' A' ' 116' ' ' VAL . 60.3 m95 -57.51 -21.2 36.33 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 108.555 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 16.1 p -72.24 -36.97 69.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.738 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 20.7 m-85 -69.78 -33.74 72.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.936 -1.103 . . . . 0.0 110.289 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.66 18.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.976 -1.078 . . . . 0.0 109.682 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 65.05 37.91 6.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 109.957 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 24.6 t-80 42.33 36.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 110.875 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.39 21.51 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 109.159 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.44 143.38 47.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.206 1.937 . . . . 0.0 111.577 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -108.05 145.92 33.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.924 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 126' ' ' MET . 14.8 ptt? -97.92 121.38 39.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.425 -0.797 . . . . 0.0 108.947 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 m -90.0 119.93 30.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 109.43 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -91.52 18.59 7.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.906 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -61.52 143.06 56.58 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.088 -1.007 . . . . 0.0 109.421 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.403 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 81.6 p -105.0 -26.87 11.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.3 p -130.13 163.87 25.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.94 -37.04 70.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m -82.91 4.64 24.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.832 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' THR . 39.0 tp10 -98.0 5.05 49.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 127.02 34.99 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.109 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 139.75 36.26 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.901 1.734 . . . . 0.0 112.253 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 t -103.18 -2.49 27.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.822 . . . . 0.0 108.811 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.0 t -134.85 96.34 3.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.406 ' H ' ' HB2' ' A' ' 142' ' ' SER . 0.6 OUTLIER -114.6 159.79 35.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -53.94 -40.74 79.68 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.317 1.344 . . . . 0.0 111.399 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.93 67.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 139' ' ' THR . 22.9 m -60.21 -42.63 95.52 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.56 -0.713 . . . . 0.0 109.467 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -64.76 -41.21 96.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.191 -0.943 . . . . 0.0 109.161 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -72.76 -29.49 63.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.404 -0.81 . . . . 0.0 108.859 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.91 HD21 HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -68.37 -47.74 66.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.393 -0.817 . . . . 0.0 109.148 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.521 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 12.1 t -63.82 -42.65 97.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.857 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.47 -42.18 95.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.288 -0.883 . . . . 0.0 110.374 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.33 79.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.721 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.54 -38.87 84.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 109.352 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.11 -38.6 86.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.926 -1.108 . . . . 0.0 108.709 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -81.8 -14.26 56.59 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.451 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -83.38 0.74 44.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.732 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.41 19.92 43.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -100.61 112.83 25.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.623 -0.928 . . . . 0.0 108.622 179.134 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -97.27 166.46 11.55 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.4 p -158.81 41.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.29 174.5 0.2 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.8 p -62.31 -24.28 67.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.14 . . . . 0.0 109.224 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.0 m -66.34 -38.63 88.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.04 -44.69 78.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.9 m -61.91 -33.95 75.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.159 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -72.02 -47.83 48.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.969 -1.082 . . . . 0.0 110.709 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 92.7 p -67.35 -32.25 73.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.028 -1.045 . . . . 0.0 109.263 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.696 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -65.53 -37.1 85.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.347 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.59 ' HA ' HD12 ' A' ' 171' ' ' LEU . 2.1 ttp -69.4 -42.72 74.72 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.155 -0.965 . . . . 0.0 110.849 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 2.2 pt20 -68.74 -41.48 78.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.657 -1.277 . . . . 0.0 111.404 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -77.6 -37.44 50.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.032 -1.042 . . . . 0.0 112.047 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.696 ' SG ' ' CD2' ' A' ' 165' ' ' PHE . 78.8 m -63.7 -44.18 94.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.769 -1.207 . . . . 0.0 111.699 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.39 4.67 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 166' ' ' MET . 15.9 mt -60.73 -37.12 80.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -1.217 . . . . 0.0 109.581 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -128.25 146.09 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 109.269 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 67.2 m-20 -109.09 164.12 12.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.408 -0.807 . . . . 0.0 110.245 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 91.35 78.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.217 0.532 . . . . 0.0 110.81 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -53.37 -69.31 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.09 155.37 41.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' ALA . 59.9 t -63.22 126.87 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.0 109.487 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.21 40.03 14.54 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.738 -1.448 . . . . 0.0 108.511 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.974 ' NH1' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.406 0.622 . . . . 0.0 109.599 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -45.78 127.87 8.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.778 0.799 . . . . 0.0 110.263 -179.134 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.67 57.04 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -53.92 -38.75 65.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.974 HG11 ' NH1' ' A' ' 3' ' ' ARG . 63.3 t -69.53 -36.38 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.64 -0.662 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -71.17 -3.41 19.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.035 . . . . 0.0 110.267 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.34 -38.73 91.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.227 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.77 160.43 30.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.047 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -34.67 14.68 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.91 2.406 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.43 -34.51 76.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.833 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.5 -40.24 78.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.603 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -52.68 -39.54 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.942 -1.099 . . . . 0.0 109.238 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -66.85 -48.63 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 109.223 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.49 -38.8 88.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 110.019 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.93 -43.9 94.49 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.451 -0.781 . . . . 0.0 111.707 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -77.51 -10.76 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 20.1 m120 -78.31 -70.99 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.652 -1.28 . . . . 0.0 110.322 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -167.59 54.88 0.07 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.045 . . . . 0.0 109.362 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TRP . 7.4 t90 -96.35 63.26 2.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.115 -0.991 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.456 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 105.41 62.15 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.087 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.763 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -159.41 -36.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.227 -1.161 . . . . 0.0 110.742 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.763 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 68.4 Cg_endo -99.57 150.92 0.54 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 122.845 2.363 . . . . 0.0 113.204 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.05 147.8 44.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.0 p -109.5 150.96 27.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.662 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.41 164.17 13.12 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -58.98 -34.47 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.901 -1.124 . . . . 0.0 109.72 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -65.17 -40.41 94.27 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.387 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 25.4 mmtp -59.52 -40.89 88.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.1 mt -60.71 -35.17 75.66 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.619 -0.676 . . . . 0.0 109.698 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.2 t80 -63.37 -52.65 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 110.595 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -68.75 -33.36 73.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.512 -1.367 . . . . 0.0 108.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.98 -39.52 83.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.671 . . . . 0.0 110.149 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.917 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.2 tp -66.56 -28.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 109.519 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.9 m -68.81 -49.79 55.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.944 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -68.86 -45.07 71.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.022 -1.049 . . . . 0.0 109.458 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -63.99 -32.96 74.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.89 44.05 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -72.95 -36.41 67.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.538 -0.978 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.62 ' CA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -44.28 -19.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -66.34 112.57 4.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.903 -1.123 . . . . 0.0 109.071 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.72 -36.41 3.53 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 2.4 mm? -103.25 171.2 7.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.136 -1.214 . . . . 0.0 110.203 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.0 m -92.53 154.14 18.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.653 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.539 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -60.61 -41.6 95.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.682 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -59.02 -44.47 91.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.954 -1.091 . . . . 0.0 108.895 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.548 HG21 HD12 ' A' ' 44' ' ' LEU . 59.7 m -58.11 -39.21 78.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.0 t -64.51 -32.34 57.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.73 -45.86 85.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.051 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.21 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 108.606 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -12.59 59.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.396 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -71.35 -46.49 60.38 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.26 -41.02 90.49 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.82 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -70.62 -34.33 72.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.588 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 79.6 t80 -58.45 -46.56 86.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.085 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -65.29 -28.4 69.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.32 86.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 110.545 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.628 ' CB ' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -77.42 -45.77 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.934 -1.104 . . . . 0.0 110.749 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 120.838 -1.164 . . . . 0.0 109.918 -179.783 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.491 1.379 0 CA-C-O 121.095 0.373 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.34 -41.69 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -62.44 -33.71 75.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.038 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.0 -38.41 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.41 -18.0 64.97 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -85.55 -5.36 59.29 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.3 mmm -80.91 115.32 20.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -95.44 173.48 7.5 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.455 -0.778 . . . . 0.0 110.39 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.54 -31.86 66.5 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.398 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.08 -31.48 72.0 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.766 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.47 -46.63 79.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 110.614 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 92' ' ' ILE . 2.0 p -61.49 -37.56 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.681 -1.262 . . . . 0.0 109.413 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.556 ' CD ' HH21 ' A' ' 89' ' ' ARG . 81.2 mm-40 -55.9 -38.29 70.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.875 -1.14 . . . . 0.0 108.145 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -65.69 -41.67 92.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 ' CB ' ' A' ' 59' ' ' CYS . 43.1 mt -69.99 -33.08 71.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.843 -0.535 . . . . 0.0 110.742 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' LEU . 24.5 t -47.97 -31.04 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.92 -6.33 32.5 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 84' ' ' GLY . 64.6 t0 -81.53 106.55 13.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.592 -1.317 . . . . 0.0 109.622 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.06 -16.05 0.12 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.599 -0.688 . . . . 0.0 109.55 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.1 39.81 36.38 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.82 HG22 ' OD1' ' A' ' 55' ' ' ASN . 15.7 pt -47.27 151.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -1.038 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 86' ' ' ILE . 8.4 tt -63.89 -26.75 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.459 -0.775 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' A' ' 87' ' ' ARG . 39.9 mtt-85 -66.64 148.34 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 89' ' ' ARG . 50.7 t-80 -132.12 -179.04 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.491 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.59 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 37.7 ttm180 -52.98 -38.0 61.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.917 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.33 -59.62 7.63 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.955 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.57 -44.3 96.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -1.221 . . . . 0.0 111.084 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 95' ' ' ILE . 37.2 mm -59.24 -46.23 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.711 -1.243 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -51.41 -35.93 41.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.628 -1.295 . . . . 0.0 108.009 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.39 75.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.324 -0.86 . . . . 0.0 109.083 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.758 HD12 HD13 ' A' ' 92' ' ' ILE . 82.2 mt -71.99 -40.97 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.29 -43.03 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.587 -1.321 . . . . 0.0 108.989 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.17 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.415 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 3.5 m120 -60.32 -36.96 79.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -1.148 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.8 89.13 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 0.0 108.334 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -65.97 -34.34 77.89 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.95 -31.72 72.88 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -62.51 -42.48 99.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.5 -31.6 72.42 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.49 -39.87 94.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.186 -0.946 . . . . 0.0 110.364 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.698 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 5.8 ttm -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.795 -1.191 . . . . 0.0 108.94 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.24 -35.27 80.28 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -21.9 66.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -88.47 -13.02 41.36 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.2 27.28 73.79 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.197 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.595 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.1 mt-10 -126.02 100.52 30.23 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.291 . . . . 0.0 109.35 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.81 144.08 27.86 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.263 1.976 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.698 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 71.4 m-85 -60.68 -34.93 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.56 -33.01 66.49 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.293 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -63.19 -48.19 79.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.696 -1.252 . . . . 0.0 111.598 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 116' ' ' VAL . 2.1 p90 -75.34 -32.93 61.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.808 -1.182 . . . . 0.0 109.886 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 145' ' ' LEU . 8.5 t -59.69 -55.4 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 108.934 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' HIS . 71.9 m95 -62.01 -21.59 65.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.6 p -76.04 -34.21 59.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -0.974 . . . . 0.0 109.744 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 1.8 m-85 -64.7 -36.12 83.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.008 -1.057 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 120' ' ' VAL . 2.8 p -89.76 18.02 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.192 -0.943 . . . . 0.0 109.191 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 68.01 17.04 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.493 -0.755 . . . . 0.0 109.924 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' N ' ' O ' ' A' ' 117' ' ' TRP . 2.1 t60 61.18 29.2 18.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.116 -0.99 . . . . 0.0 110.122 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -133.3 150.03 74.1 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.213 -0.929 . . . . 0.0 109.866 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.34 145.16 53.0 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.559 2.172 . . . . 0.0 111.989 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.606 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -111.5 131.38 55.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.101 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.606 ' C ' HE22 ' A' ' 125' ' ' GLN . 64.4 mtt -104.85 117.09 33.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 129' ' ' ALA . 1.1 m -97.09 -47.7 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.037 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 59.43 47.13 11.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.543 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.657 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -77.85 157.75 29.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.456 -0.777 . . . . 0.0 109.189 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.673 HG22 ' OE1' ' A' ' 134' ' ' GLU . 1.6 t -105.09 -26.18 12.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 130' ' ' THR . 40.3 p -131.5 163.66 27.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -0.903 . . . . 0.0 109.678 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.92 -32.44 70.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -63.62 -26.25 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.798 . . . . 0.0 110.27 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.673 ' OE1' HG22 ' A' ' 130' ' ' THR . 89.2 mt-10 -87.69 -0.81 57.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.292 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.755 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -87.98 128.68 53.0 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.61 140.25 26.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.313 2.009 . . . . 0.0 112.999 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.2 p -118.7 5.91 11.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.3 p -159.05 85.82 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.552 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -98.24 162.16 22.96 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.868 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.32 -40.72 76.96 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.402 1.401 . . . . 0.0 111.071 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -42.87 70.11 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 139' ' ' THR . 59.7 p -64.17 -45.47 88.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.466 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -63.93 -40.46 96.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.658 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.729 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -70.05 -29.28 66.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.272 -0.892 . . . . 0.0 108.825 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.021 HD11 HG22 ' A' ' 116' ' ' VAL . 13.3 tp -64.72 -43.09 94.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.655 -0.653 . . . . 0.0 109.875 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.662 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.05 -43.25 83.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.44 ' CG ' ' NZ ' ' A' ' 151' ' ' LYS . 34.3 ttpt -57.19 -44.77 83.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.478 -0.764 . . . . 0.0 110.788 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.63 70.75 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.001 -1.062 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 149' ' ' LEU . 95.9 mt -64.76 -38.44 90.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.431 -0.793 . . . . 0.0 109.832 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -41.96 98.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.034 -1.041 . . . . 0.0 109.06 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.44 ' NZ ' ' CG ' ' A' ' 147' ' ' LYS . 60.9 mttp -77.42 -13.45 59.92 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.99 -1.069 . . . . 0.0 110.233 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -85.03 -7.05 59.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.96 -1.088 . . . . 0.0 108.717 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.46 25.07 8.95 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -104.56 113.59 27.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -1.077 . . . . 0.0 109.145 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 43.2 mttt -90.98 -176.69 4.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.863 . . . . 0.0 110.433 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 6.4 p90 42.48 47.72 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.0 0.905 . . . . 0.0 109.285 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.74 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -128.62 46.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.37 172.96 1.76 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.5 m -57.86 -33.79 69.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -1.021 . . . . 0.0 110.06 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.2 p -68.6 -31.67 71.01 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.04 -1.037 . . . . 0.0 108.279 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.728 HG22 ' CE2' ' A' ' 165' ' ' PHE . 31.5 mm -65.88 -44.75 92.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.045 0.926 . . . . 0.0 108.986 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.662 ' SG ' ' N ' ' A' ' 146' ' ' SER . 53.1 m -58.12 -47.82 82.09 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.609 0.718 . . . . 0.0 110.576 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.581 ' OH ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -64.17 -31.36 72.52 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.466 -0.771 . . . . 0.0 110.88 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 98.5 p -61.33 -48.32 81.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 21.4 m-85 -64.35 -39.28 93.58 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 109.899 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 87.7 mtp -53.33 -37.49 62.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.665 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.581 ' NE2' ' OH ' ' A' ' 163' ' ' TYR . 78.1 mt-30 -68.02 -39.46 83.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.652 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.73 -40.16 14.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 111.136 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 171' ' ' LEU . 86.4 m -54.8 -28.12 46.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.945 . . . . 0.0 110.634 -178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.26 -2.75 47.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.596 HD21 HG12 ' A' ' 116' ' ' VAL . 6.9 mp -60.82 -38.52 85.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.381 -1.07 . . . . 0.0 109.853 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 173' ' ' ASN . 3.9 p -138.1 151.19 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 111.457 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.425 ' N ' HG22 ' A' ' 172' ' ' VAL . 50.2 t-20 -114.87 98.09 6.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.755 ' O ' HD11 ' A' ' 135' ' ' ILE . 53.1 p30 -132.6 21.13 4.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.555 ' C ' HG12 ' A' ' 176' ' ' VAL . 5.9 m170 -49.05 -45.69 43.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.486 -1.384 . . . . 0.0 108.912 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 178' ' ' GLY . 3.0 p 145.43 155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 129' ' ' ALA . 69.6 t -57.6 -38.76 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.965 -1.084 . . . . 0.0 110.341 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -80.16 29.4 2.48 Favored Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.077 -1.014 . . . . 0.0 111.073 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 26.8 t . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.869 -1.371 . . . . 0.0 109.34 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.678 0.752 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.25 152.99 38.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.803 0.811 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.27 -40.73 60.88 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.711 -0.618 . . . . 0.0 111.967 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -88.92 -3.74 58.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.487 -1.596 . . . . 0.0 110.055 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.89 -40.36 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.997 -1.064 . . . . 0.0 109.315 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -77.01 -0.95 26.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 108.811 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 42.8 tt0 -64.46 -41.85 96.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.485 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 173.35 166.13 0.28 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.95 -1.094 . . . . 0.0 109.753 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' TYR . 50.6 Cg_exo -48.18 -167.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.534 2.156 . . . . 0.0 113.075 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.0 mt 63.57 -47.21 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.864 -0.523 . . . . 0.0 109.789 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.8 m-85 -62.51 -39.98 95.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.994 -1.066 . . . . 0.0 109.395 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.91 -44.29 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -66.2 -50.23 64.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.767 -1.208 . . . . 0.0 109.361 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.4 t80 -62.03 -42.58 99.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.822 . . . . 0.0 109.769 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -69.76 -41.6 74.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.459 -0.775 . . . . 0.0 110.349 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -74.96 -6.69 50.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 110.55 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m120 -71.77 -76.92 0.1 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.023 -1.048 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' C ' ' A' ' 21' ' ' TRP . 84.5 mt-10 -151.13 -51.85 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.567 ' C ' ' O ' ' A' ' 20' ' ' GLU . 3.8 t90 24.62 72.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.56 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 116.85 48.92 0.44 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.019 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.858 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.5 m -163.9 -27.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.252 -1.146 . . . . 0.0 112.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.858 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 44.9 Cg_endo -87.14 151.16 8.16 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.661 1.574 . . . . 0.0 113.79 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.11 152.06 29.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 p -94.98 137.87 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.918 -1.114 . . . . 0.0 111.186 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -98.15 157.64 16.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m -55.25 -35.43 64.98 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.503 -1.373 . . . . 0.0 109.067 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -69.45 -36.55 76.71 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.816 -0.552 . . . . 0.0 111.672 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -63.81 -41.46 97.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.746 -1.221 . . . . 0.0 110.619 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 116' ' ' VAL . 6.7 mp -57.09 -39.0 74.18 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.763 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 78.2 t80 -66.53 -52.58 44.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 110.597 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -67.34 -38.52 84.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 108.923 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 ttm -70.28 -47.9 59.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.505 -0.747 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.86 -31.85 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.868 -1.145 . . . . 0.0 109.441 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.8 m -69.65 -45.9 67.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.008 -1.057 . . . . 0.0 108.983 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HH11 ' A' ' 53' ' ' ARG . 79.8 mt -67.33 -38.33 84.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.469 -0.77 . . . . 0.0 109.468 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -64.82 -35.55 81.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.952 . . . . 0.0 109.862 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.95 -35.27 53.3 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.027 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . 76.4 mt-30 -63.52 -33.65 76.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.275 . . . . 0.0 110.747 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -43.62 -22.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.779 -1.201 . . . . 0.0 110.265 -179.591 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -54.95 112.65 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.929 -1.107 . . . . 0.0 109.148 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 76.61 -25.84 1.69 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 43' ' ' GLY . 3.7 mm? -102.56 164.97 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -99.47 148.3 24.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.78 -39.98 72.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.006 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.97 -1.081 . . . . 0.0 109.122 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.7 m -64.4 -40.03 95.0 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' ARG . 1.4 t -65.89 -35.79 75.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -55.89 -50.39 70.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 20.3 mttt -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.596 -1.315 . . . . 0.0 108.864 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mmpp? -63.26 -26.43 68.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.527 HH11 HD13 ' A' ' 37' ' ' LEU . 17.3 ttm-85 -53.68 -45.87 70.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.4 -41.03 89.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.489 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 51' ' ' LYS . 9.6 m120 -69.11 -36.17 77.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.47 -48.6 80.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 110.66 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -69.24 -27.22 65.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.772 -1.205 . . . . 0.0 109.143 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -36.91 75.52 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.704 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.5 m -76.62 -45.9 28.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.948 -1.095 . . . . 0.0 110.193 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.847 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.494 1.533 0 N-CA-C 113.121 0.393 . . . . 0.0 113.121 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 103' ' ' LEU . 87.3 t -72.77 -45.61 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.722 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -34.53 72.73 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -41.41 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.955 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.735 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -64.0 -17.3 63.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.05 55.99 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 95.2 mtp -85.35 114.23 22.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.86 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -95.68 -177.83 4.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.2 -31.19 67.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 110.596 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.58 -49.26 75.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.751 -1.218 . . . . 0.0 108.988 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.92 -38.99 90.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 t -58.46 -41.95 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -0.76 . . . . 0.0 109.306 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' C ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -60.48 -33.33 72.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.96 . . . . 0.0 109.359 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -69.61 -46.93 65.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.988 . . . . 0.0 110.239 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.704 HD22 ' HB3' ' A' ' 59' ' ' CYS . 17.5 mt -70.89 -32.44 69.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.76 -0.587 . . . . 0.0 112.182 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 76' ' ' VAL . 44.7 t -49.47 -27.1 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.746 -1.221 . . . . 0.0 109.638 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.42 -9.36 14.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.3 m-20 -73.49 111.09 8.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.549 -1.344 . . . . 0.0 109.169 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.22 -15.75 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.763 . . . . 0.0 109.214 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 76.71 38.94 30.51 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.0 pt -52.03 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.374 -1.074 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.3 mt -65.03 98.07 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.967 -1.083 . . . . 0.0 108.889 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.648 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 3.0 mtt-85 -55.49 132.76 49.25 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.648 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.4 m-70 156.51 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.655 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.6 OUTLIER -54.47 -35.67 63.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.167 -0.958 . . . . 0.0 108.809 -179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.21 -54.43 37.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.93 -43.63 95.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -1.178 . . . . 0.0 109.599 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.6 mt -58.23 -45.21 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.03 -1.044 . . . . 0.0 109.251 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.65 -33.71 68.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.921 -1.112 . . . . 0.0 109.339 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.3 82.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.045 -1.034 . . . . 0.0 108.459 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.61 -43.6 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.47 -0.769 . . . . 0.0 109.767 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.33 -46.4 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 108.583 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.33 95.41 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -59.07 -37.07 76.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -1.176 . . . . 0.0 109.411 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.0 86.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -0.983 . . . . 0.0 109.641 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.735 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 8.9 tpp180 -57.87 -38.27 75.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.176 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -62.8 -35.27 79.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.625 HD11 HG22 ' A' ' 66' ' ' VAL . 3.6 mm? -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -64.16 -42.04 96.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.17 -0.957 . . . . 0.0 109.443 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.643 ' SD ' ' CE1' ' A' ' 112' ' ' PHE . 80.5 mtp -68.66 -39.5 80.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.15 -41.23 86.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.428 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.73 -19.54 65.83 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -92.52 -9.5 41.1 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.41 25.2 75.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -115.45 102.47 54.41 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.372 -1.075 . . . . 0.0 109.297 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.14 148.99 29.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.643 ' CE1' ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -68.73 -43.36 76.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.76 0.791 . . . . 0.0 110.352 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 117' ' ' TRP . . . -69.36 -26.69 64.8 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.053 -1.029 . . . . 0.0 110.689 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -57.41 -49.15 77.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.742 -1.224 . . . . 0.0 110.923 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.746 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 8.6 p90 -76.0 -36.35 59.21 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 110.19 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.746 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 10.9 t -64.76 -55.13 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.706 -1.246 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 67.5 m95 -58.24 -21.71 49.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.181 -0.949 . . . . 0.0 108.654 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.1 p -73.57 -32.59 64.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.927 -1.108 . . . . 0.0 109.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 12.6 m-85 -69.63 -30.54 68.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.832 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 HD22 ' A' ' 171' ' ' LEU . 29.2 m -96.09 19.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.098 -1.001 . . . . 0.0 109.405 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 122' ' ' HIS . 69.3 m-20 61.94 42.03 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.0 110.799 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.413 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 41.89 29.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.6 178.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.0 147.67 35.65 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.857 -1.152 . . . . 0.0 109.853 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.62 139.34 88.5 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.302 2.001 . . . . 0.0 111.811 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.9 147.55 36.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.825 . . . . 0.0 109.65 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.6 mtt -95.11 125.97 40.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.188 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -67.87 -40.92 83.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 108.841 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 62.48 44.94 6.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.635 -0.665 . . . . 0.0 110.401 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -106.74 139.22 41.52 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.5 p -101.05 -14.22 17.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.011 -1.056 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -151.05 169.38 21.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.071 . . . . 0.0 109.963 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.1 -34.72 73.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.43 -0.794 . . . . 0.0 109.338 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -73.89 -11.48 60.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -98.68 14.9 26.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.0 mm -105.59 98.34 17.11 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.474 1.449 . . . . 0.0 112.227 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.5 p -97.38 1.86 49.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.393 -0.817 . . . . 0.0 109.446 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -138.79 91.16 2.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.269 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.494 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -106.2 156.16 37.34 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -52.29 -39.2 73.03 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.041 1.827 . . . . 0.0 111.628 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.41 -44.36 52.25 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.066 -1.021 . . . . 0.0 108.605 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.494 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 83.6 p -68.02 -37.48 81.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -66.22 -35.64 80.97 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 108.598 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -64.76 -39.1 93.06 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.559 -0.713 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 HG22 ' A' ' 116' ' ' VAL . 96.8 mt -58.96 -46.78 87.21 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.097 -1.041 . . . . 0.0 108.517 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.434 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 23.6 m -56.44 -40.63 75.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.692 -1.255 . . . . 0.0 108.921 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -65.9 -50.65 63.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.426 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.37 88.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.33 -38.82 85.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.973 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -61.25 -40.19 93.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.877 -1.14 . . . . 0.0 109.195 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -65.87 -33.55 76.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 110.374 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.472 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 2.5 mmp_? -72.24 2.94 5.14 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.04 -1.038 . . . . 0.0 108.876 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.16 52.46 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.72 115.44 27.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.723 -0.869 . . . . 0.0 108.781 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -89.34 167.41 13.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.624 -0.673 . . . . 0.0 110.397 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 57.62 59.87 3.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.619 -0.676 . . . . 0.0 109.956 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 22.6 m -131.56 33.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.539 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.08 164.19 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.4 p -58.91 -22.88 60.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -1.137 . . . . 0.0 108.889 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -75.76 -32.69 60.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.69 -45.25 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 146' ' ' SER . 94.6 m -63.04 -40.21 97.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.399 0.618 . . . . 0.0 109.867 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -70.07 -41.92 73.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.556 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.3 m -60.66 -44.54 96.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -0.838 . . . . 0.0 108.97 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.573 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 3.0 t80 -62.92 -40.05 96.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.823 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.401 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 1.1 ttp -59.93 -40.23 88.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.569 -0.707 . . . . 0.0 112.765 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.4 pt20 -79.66 -46.34 17.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.193 -1.567 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.47 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -73.28 -28.63 62.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.955 -1.091 . . . . 0.0 111.364 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 30.4 p -67.1 -29.75 69.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 111.39 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 109.01 -1.8 31.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.576 HD11 ' CG1' ' A' ' 116' ' ' VAL . 27.5 mt -61.01 -36.31 79.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.091 -1.241 . . . . 0.0 110.324 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.4 151.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.055 -1.028 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 81.8 m-20 -114.77 162.98 16.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.606 -0.684 . . . . 0.0 110.102 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 96.42 75.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.098 0.475 . . . . 0.0 110.008 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.467 ' O ' HD11 ' A' ' 135' ' ' ILE . 21.0 m170 -52.11 -41.05 62.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.116 -0.99 . . . . 0.0 108.71 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.79 ' O ' HG22 ' A' ' 176' ' ' VAL . 7.7 p -168.54 28.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 176' ' ' VAL . 42.0 t 56.19 118.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.0 109.906 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.56 9.52 62.87 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.236 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.279 . . . . 0.0 108.951 179.889 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.537 ' HB2' HG11 ' A' ' 7' ' ' VAL . 85.7 mtt180 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.71 0.767 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -178.1 154.55 0.88 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.17 -45.3 95.54 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.548 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.686 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -88.8 -4.41 58.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.361 -1.67 . . . . 0.0 109.988 -178.776 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 3' ' ' ARG . 4.5 t -75.14 -41.1 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.131 -0.98 . . . . 0.0 109.333 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.7 -9.59 58.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 108.875 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -69.63 -39.97 76.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -0.791 . . . . 0.0 111.257 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.26 157.59 30.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.508 -1.37 . . . . 0.0 111.239 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.3 Cg_endo -63.5 179.96 0.81 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.251 2.634 . . . . 0.0 112.286 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.1 mt 66.24 -44.14 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -55.44 -35.69 65.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.15 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.9 mp -54.24 -43.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.07 . . . . 0.0 108.984 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -64.88 -49.27 71.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -58.36 -37.0 74.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.204 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -62.49 -45.33 93.49 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.141 -0.975 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -83.27 -2.59 56.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 7.5 m120 -76.5 -75.17 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.838 -1.164 . . . . 0.0 109.159 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -168.98 69.11 0.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.143 -0.973 . . . . 0.0 109.76 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.4 t90 -79.83 60.71 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.978 -1.076 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.45 64.19 1.46 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.583 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.807 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -137.87 -33.73 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.2 -1.176 . . . . 0.0 111.041 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.807 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 64.8 Cg_endo -97.08 150.45 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.737 2.291 . . . . 0.0 113.395 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.9 147.64 51.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 169' ' ' CYS . 69.5 p -101.71 151.45 22.02 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.543 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 5.9 t70 -94.35 157.01 16.23 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 m -50.29 -32.76 17.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -178.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -71.51 -39.31 70.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.681 -0.637 . . . . 0.0 111.63 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -62.66 -39.12 92.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.836 -1.165 . . . . 0.0 110.276 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.1 mp -56.45 -40.08 74.22 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.786 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.56 -46.66 87.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.94 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -71.53 -36.45 71.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.051 -1.031 . . . . 0.0 109.078 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.1 ttm -69.13 -47.9 63.83 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.047 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.15 -29.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.52 -1.362 . . . . 0.0 109.912 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.49 -52.75 28.84 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.493 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.6 mt -64.9 -40.19 94.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 66.1 mm-40 -63.43 -31.13 72.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.026 -1.046 . . . . 0.0 108.573 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 161' ' ' ILE . . . -68.49 -37.08 85.07 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 42' ' ' ALA . 96.2 mt-30 -58.65 -35.05 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.826 -0.808 . . . . 0.0 111.459 -178.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 38' ' ' GLU . 6.3 pt20 -70.96 9.59 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.631 -1.293 . . . . 0.0 110.177 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -54.96 112.92 1.15 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.937 -1.102 . . . . 0.0 108.589 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.15 -14.37 0.44 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 48' ' ' THR . 31.2 tp -106.77 145.95 31.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.562 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.0 157.13 4.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.702 0.763 . . . . 0.0 111.198 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.82 -37.07 62.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.796 -0.565 . . . . 0.0 110.119 179.316 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -40.36 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.021 -1.049 . . . . 0.0 110.077 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.733 HG21 HD21 ' A' ' 44' ' ' LEU . 37.7 m -57.6 -38.5 75.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.09 -1.006 . . . . 0.0 108.34 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.5 t -65.06 -33.75 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.722 -0.611 . . . . 0.0 109.367 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.47 -48.66 78.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -63.02 -45.8 90.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.968 -1.083 . . . . 0.0 109.441 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -79.26 -8.99 59.47 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.266 -179.08 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.99 -54.45 13.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.756 -1.215 . . . . 0.0 108.492 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -39.96 94.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.498 -0.751 . . . . 0.0 109.733 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.695 ' OD1' HG22 ' A' ' 85' ' ' ILE . 17.9 t-20 -74.96 -46.49 35.15 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.15 -0.969 . . . . 0.0 110.893 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 59.4 t80 -63.41 -49.2 74.71 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.095 -1.003 . . . . 0.0 110.139 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.6 ptm180 -58.12 -33.92 69.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.89 -1.131 . . . . 0.0 109.13 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.88 82.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 110.177 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.4 -43.67 63.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.819 -1.176 . . . . 0.0 110.505 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 84.1 m-85 . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 110.134 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 N-CA-C 115.584 1.34 . . . . 0.0 115.584 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 103' ' ' LEU . 99.4 t -58.77 -34.97 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.909 -1.12 . . . . 0.0 108.853 -178.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 38.0 mttm -55.51 -38.19 68.88 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.73 -36.4 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.7 -17.59 64.72 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -94.25 -14.86 25.06 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.491 ' O ' HG21 ' A' ' 96' ' ' ILE . 42.5 mmm -73.86 111.21 8.79 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.594 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 8.8 mt-30 -97.06 172.17 8.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.12 -29.25 29.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.46 -45.9 80.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.892 -1.13 . . . . 0.0 109.323 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.7 p30 -66.05 -36.36 83.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 108.577 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 79' ' ' LEU . 80.7 t -62.19 -44.13 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 110.487 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.84 -39.64 78.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -66.23 -39.56 89.65 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.59 0.709 . . . . 0.0 109.349 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 85' ' ' ILE . 8.2 mt -64.56 -32.68 74.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.654 -0.654 . . . . 0.0 111.136 -178.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.6 t -48.91 -35.2 6.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 4.1 pt20 -113.61 4.24 16.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.87 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.4 t0 -90.58 111.21 22.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.546 -1.346 . . . . 0.0 110.625 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.6 -16.73 0.6 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.547 -0.721 . . . . 0.0 109.658 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.34 28.32 60.12 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.301 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.695 HG22 ' OD1' ' A' ' 55' ' ' ASN . 23.2 pt -57.03 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.083 -1.246 . . . . 0.0 109.779 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.5 tt -58.63 76.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.174 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -58.26 117.39 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.3 OUTLIER -158.69 -34.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.44 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.581 ' HG2' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 65.45 -36.66 0.23 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.902 -0.498 . . . . 0.0 110.401 178.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 88' ' ' HIS . . . -73.51 -59.49 4.11 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.269 -1.443 . . . . 0.0 109.585 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.61 -33.55 72.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -1.069 . . . . 0.0 109.9 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.8 mt -64.98 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.67 -32.38 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.89 -39.26 90.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 109.159 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.07 -35.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.189 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 71' ' ' MET . 20.8 mm -62.26 -47.63 92.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 109.489 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.69 71.95 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.508 ' N ' HD22 ' A' ' 98' ' ' ASN . 1.6 m-80 -68.97 -35.54 76.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.128 -1.219 . . . . 0.0 110.536 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.05 90.69 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 108.854 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.2 mtt180 -62.59 -35.92 81.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.05 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.95 -29.33 70.5 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.68 -40.46 96.86 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.738 HD21 HG22 ' A' ' 66' ' ' VAL . 69.3 mt -64.28 -34.08 77.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -63.78 -37.12 86.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 110.087 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CD1' ' A' ' 112' ' ' PHE . 8.6 ttm -65.92 -43.05 89.25 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.923 -1.11 . . . . 0.0 109.316 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -63.18 -36.75 84.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.613 -0.679 . . . . 0.0 109.352 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.77 -18.75 64.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -16.36 25.78 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.91 27.06 73.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.545 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.5 mm-40 -114.58 101.57 54.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 110.065 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.97 141.67 45.89 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.16 1.907 . . . . 0.0 112.485 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CD1' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -55.5 -44.0 76.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.701 0.762 . . . . 0.0 111.246 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB1' ' HD1' ' A' ' 117' ' ' TRP . . . -70.42 -27.75 64.51 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 111.023 -178.238 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -61.86 -47.71 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.014 -1.054 . . . . 0.0 111.368 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.842 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.5 p90 -76.56 -33.48 58.52 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.708 -1.245 . . . . 0.0 109.671 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.842 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 1.4 t -69.48 -55.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.826 -1.171 . . . . 0.0 110.45 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.542 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 73.8 m95 -60.02 -22.89 63.2 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 109.268 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 83.1 p -70.74 -37.04 73.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.017 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 14.2 m-85 -65.67 -35.97 82.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.691 -1.256 . . . . 0.0 108.596 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 123' ' ' GLN . 4.0 t -89.22 14.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.317 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 59.16 37.05 24.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m80 46.39 24.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.061 -1.024 . . . . 0.0 109.768 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -129.74 149.01 71.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.502 -0.749 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.56 144.41 66.55 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.056 2.504 . . . . 0.0 111.841 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -111.52 137.2 49.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.866 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 87.9 mtp -92.3 131.09 37.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.728 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -78.62 -41.98 30.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.251 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 56.85 45.11 22.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.987 -1.071 . . . . 0.0 109.376 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.03 140.44 36.31 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.6 p -97.1 -24.0 15.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.101 -0.999 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -140.99 166.2 25.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 108.834 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.34 -35.07 76.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.55 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -64.74 -27.57 68.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.787 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.85 3.74 16.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 2.3 tp -91.29 123.84 63.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.56 138.19 13.49 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.023 1.815 . . . . 0.0 112.409 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.5 p -108.27 14.37 24.97 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.2 p -153.92 84.61 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.64 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.588 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.6 OUTLIER -105.15 157.14 34.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.101 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.14 -40.65 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.466 1.444 . . . . 0.0 111.848 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -41.55 70.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.021 -1.05 . . . . 0.0 108.306 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.588 ' OG ' ' N ' ' A' ' 139' ' ' THR . 97.4 p -64.53 -43.9 92.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.687 . . . . 0.0 109.373 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.57 -36.5 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.143 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -63.77 -31.16 72.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.759 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 116' ' ' VAL . 91.2 mt -70.64 -47.46 59.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.944 -1.097 . . . . 0.0 109.575 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.45 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 1.7 m -57.8 -46.1 85.13 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.536 -1.353 . . . . 0.0 110.532 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -70.5 -39.3 74.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.814 -1.179 . . . . 0.0 109.653 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.14 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.543 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.46 -35.96 81.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.057 -1.027 . . . . 0.0 109.415 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.07 -42.42 98.47 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 109.582 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -67.79 -32.43 73.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.469 -0.769 . . . . 0.0 111.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.676 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 4.0 mmp_? -68.14 -8.31 37.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.749 -1.219 . . . . 0.0 109.103 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.09 31.36 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 8.8 m-85 -95.99 117.62 31.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.84 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.586 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 23.1 mtmt -90.47 -175.28 4.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.506 0.67 . . . . 0.0 110.813 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 8.5 p90 47.45 48.6 16.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.525 0.678 . . . . 0.0 110.344 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 155' ' ' LYS . 29.6 m -119.59 39.95 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.17 164.06 0.44 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -57.17 -33.57 67.58 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.32 -1.106 . . . . 0.0 109.862 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.3 p -71.29 -34.36 70.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 108.844 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.443 HD12 ' HA2' ' A' ' 39' ' ' GLY . 16.2 mm -60.54 -44.15 95.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 146' ' ' SER . 63.2 m -65.45 -32.67 74.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.647 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -68.79 -44.77 72.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.005 -1.06 . . . . 0.0 109.564 179.728 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.3 p -63.92 -37.37 87.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 108.762 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 57.7 t80 -60.82 -41.43 95.73 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.826 0.822 . . . . 0.0 109.142 178.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 37.1 mmm -59.33 -40.31 85.94 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.838 -0.539 . . . . 0.0 111.457 -178.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.647 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.7 pt20 -80.21 -47.27 14.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.606 -1.309 . . . . 0.0 110.997 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.68 -17.84 64.16 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.805 -1.184 . . . . 0.0 110.634 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 66.4 m -83.32 -19.6 35.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.836 -1.165 . . . . 0.0 111.822 -178.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.51 1.25 64.23 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.542 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 94.2 mt -65.77 -35.24 80.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.704 -0.88 . . . . 0.0 109.357 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.14 135.93 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 108.915 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 58.8 m-20 -114.52 162.69 16.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.92 -179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.7 OUTLIER 92.05 79.11 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.224 0.535 . . . . 0.0 110.605 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -54.84 -70.6 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.158 -0.964 . . . . 0.0 108.629 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.62 148.28 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 108.831 179.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 129' ' ' ALA . 61.5 t -64.16 130.92 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.617 -1.302 . . . . 0.0 109.121 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.29 40.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.041 -1.27 . . . . 0.0 109.13 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.72 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.46 -25.04 57.39 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -99.06 27.8 4.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -1.23 . . . . 0.0 109.986 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.54 -27.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.903 -1.123 . . . . 0.0 111.321 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.7 m -79.86 -2.75 44.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.701 -1.249 . . . . 0.0 109.16 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -66.63 -37.74 85.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.341 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.36 158.77 8.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.669 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.6 Cg_endo -60.57 -163.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.809 2.339 . . . . 0.0 112.164 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp 61.0 -46.52 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.919 -0.488 . . . . 0.0 110.054 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.6 m-85 -59.39 -37.86 79.05 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 109.451 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.0 mp -54.89 -44.75 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.638 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.4 85.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.907 -1.121 . . . . 0.0 108.995 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.552 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 23.5 t80 -65.52 -36.17 83.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -58.91 -44.29 91.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 112.214 -178.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.79 -0.55 45.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.917 -1.115 . . . . 0.0 112.271 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.633 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 6.1 p-10 -99.98 -30.66 11.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.536 -1.352 . . . . 0.0 112.068 -178.48 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.633 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 89.9 mt-10 -160.29 22.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.431 -1.418 . . . . 0.0 109.825 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.582 ' HE1' ' CG ' ' A' ' 167' ' ' GLN . 3.1 t90 -106.15 72.43 0.93 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 110.461 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.04 4.41 35.85 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.285 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.0 m -115.0 -21.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.0 112.431 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 85.8 Cg_endo -86.75 150.46 8.62 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.925 1.75 . . . . 0.0 114.293 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -88.08 159.31 18.29 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.742 ' HB ' HD21 ' A' ' 31' ' ' LEU . 2.6 p -84.08 122.53 28.93 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.776 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 31' ' ' LEU . 37.8 t0 -106.12 167.25 9.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -74.52 -38.08 62.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.101 -1.624 . . . . 0.0 110.681 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -74.12 -50.46 19.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -0.901 . . . . 0.0 112.343 -177.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -57.82 -36.79 72.75 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.072 -1.018 . . . . 0.0 109.804 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 26' ' ' THR . 5.8 mp -66.76 -35.32 79.81 Favored 'General case' 0 C--N 1.286 -2.168 0 O-C-N 121.634 -0.666 . . . . 0.0 109.923 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.07 -48.11 83.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.538 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.62 -27.62 60.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.842 -1.161 . . . . 0.0 109.598 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.551 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 60.1 ttm -66.72 -50.93 61.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.664 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.44 -34.22 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 0.0 108.924 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.631 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 85.6 m -71.8 -51.95 20.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.927 . . . . 0.0 109.604 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 HH11 ' A' ' 53' ' ' ARG . 24.6 mt -67.16 -38.69 85.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.675 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 6.8 tp10 -62.75 -33.38 75.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.72 -36.4 93.24 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 36' ' ' CYS . 2.9 mp0 -63.11 -26.58 68.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.047 -1.267 . . . . 0.0 110.691 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.675 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -66.37 -2.94 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.853 -1.154 . . . . 0.0 110.856 -178.507 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -60.31 112.47 1.95 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.612 -1.305 . . . . 0.0 108.595 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.97 -7.93 2.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' ALA . 25.5 tp -109.95 144.8 37.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -1.205 . . . . 0.0 109.957 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.3 m -64.12 149.98 46.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.88 -38.48 61.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.698 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -35.81 63.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.98 -1.075 . . . . 0.0 108.309 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CE ' ' A' ' 52' ' ' LYS . 91.1 m -61.06 -44.24 97.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -69.1 -25.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.0 tt -63.79 -51.65 63.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 54.7 mttt -60.33 -44.41 95.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.661 -1.275 . . . . 0.0 108.13 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 86' ' ' ILE . 45.6 mtmt -74.29 -10.46 59.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.69 HH11 HD13 ' A' ' 37' ' ' LEU . 16.3 ttm-85 -64.63 -45.13 88.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 57.2 mp0 -70.69 -44.15 67.57 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.608 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 11.0 m-80 -69.92 -39.81 75.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.93 -1.106 . . . . 0.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.81 -48.19 82.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 111.097 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -27.33 68.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 109.266 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.54 99.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.907 . . . . 0.0 109.806 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 85' ' ' ILE . 2.7 m -74.38 -45.57 46.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.923 -1.111 . . . . 0.0 109.983 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.021 -1.049 . . . . 0.0 110.258 179.623 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 102' ' ' TYR . 55.3 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 N-CA-C 112.995 0.344 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.08 -41.07 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.949 -1.094 . . . . 0.0 109.164 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -62.99 -33.94 76.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 108.9 179.262 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.73 -41.68 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.643 -0.661 . . . . 0.0 109.552 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.755 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -67.85 -14.23 62.79 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.65 -9.49 49.41 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.281 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.9 mtp -78.18 113.07 15.79 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -95.31 177.95 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.974 . . . . 0.0 109.964 -178.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 76' ' ' VAL . 89.4 mt-10 -55.13 -28.68 54.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.783 . . . . 0.0 110.667 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -63.17 -41.24 99.2 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.106 -1.621 . . . . 0.0 109.134 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.53 -38.72 90.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.393 -0.817 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -68.67 -31.27 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.667 -1.27 . . . . 0.0 109.204 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 80' ' ' VAL . 93.4 mt-10 -66.03 -39.63 90.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.085 -1.009 . . . . 0.0 110.548 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' ' N ' ' A' ' 79' ' ' LEU . 7.6 ptp180 -74.33 -40.79 61.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.709 -1.244 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 15.9 mt -65.8 -33.21 75.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -48.57 -30.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.453 -179.417 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -106.53 -0.33 24.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.443 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 66.5 t0 -80.43 107.95 13.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.499 -1.376 . . . . 0.0 109.55 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.68 -14.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.668 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . 68.42 35.9 82.88 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -28.0 -91.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.165 -0.609 . . . . 0.0 110.592 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -175.98 -44.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -0.967 . . . . 0.0 109.575 179.679 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -64.22 156.04 29.98 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.155 -0.966 . . . . 0.0 110.034 -178.65 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -106.68 169.52 8.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.589 0.709 . . . . 0.0 109.631 -179.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.14 -33.72 63.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.51 -59.18 5.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.436 ' HB2' HH21 ' A' ' 87' ' ' ARG . 11.6 tptm -60.63 -42.64 97.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.723 -1.457 . . . . 0.0 110.163 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -57.17 -47.38 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.992 -1.068 . . . . 0.0 109.766 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -31.99 44.69 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.742 -1.224 . . . . 0.0 108.289 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.03 77.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.013 -1.054 . . . . 0.0 109.089 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.86 -45.54 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.187 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -61.39 -36.35 72.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.899 -1.126 . . . . 0.0 109.078 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.41 -36.39 83.81 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -60.51 -35.9 77.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.537 -0.978 . . . . 0.0 108.573 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.462 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.755 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -53.27 -41.19 65.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' ' CE2' ' A' ' 154' ' ' PHE . . . -65.28 -31.55 72.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.887 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 65' ' ' PRO . 54.9 t80 -61.06 -44.36 97.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -61.41 -35.81 78.58 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -64.55 -34.0 77.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.331 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 36.0 ttm -63.78 -40.93 97.88 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -63.28 -38.42 91.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.636 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.417 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 95.8 mt-30 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -90.47 -14.73 32.2 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.48 27.87 73.54 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.965 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.4 tp10 -124.79 102.03 32.4 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.996 -1.296 . . . . 0.0 110.124 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.69 150.09 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.012 1.808 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -61.23 -45.08 96.04 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.127 0.965 . . . . 0.0 110.052 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.37 66.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.702 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -68.83 -45.18 71.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.438 -1.414 . . . . 0.0 112.214 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CE1' HG13 ' A' ' 116' ' ' VAL . 7.0 p90 -70.99 -36.22 72.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.471 -1.393 . . . . 0.0 110.501 -178.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 117' ' ' TRP . 31.3 m -65.42 -52.44 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 119.961 -1.712 . . . . 0.0 109.542 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.591 ' N ' HG23 ' A' ' 116' ' ' VAL . 50.9 m95 -56.63 -22.68 35.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 108.508 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 51.6 p -74.39 -35.7 63.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.978 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 9.7 m-85 -68.22 -29.43 68.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.195 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -94.67 18.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.513 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 122' ' ' HIS . 78.2 m-20 58.95 39.43 23.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.3 t60 40.57 29.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -127.26 146.93 59.9 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.38 140.39 52.7 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.606 2.204 . . . . 0.0 112.186 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -107.23 127.97 54.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 108.783 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 mtt -101.72 122.73 44.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.67 116.41 28.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -93.38 21.86 5.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.988 . . . . 0.0 109.988 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.43 143.38 51.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.383 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 99.0 m -93.65 -31.21 14.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.4 p -133.52 162.89 30.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.02 -35.48 71.33 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.136 -0.978 . . . . 0.0 108.952 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 m -60.55 -25.38 66.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -88.89 -4.38 58.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 0.0 109.713 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.85 130.7 37.7 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 147.45 26.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.233 1.956 . . . . 0.0 112.513 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -103.44 9.53 37.68 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -144.93 98.82 3.24 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.234 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.566 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 10.0 p -109.14 155.01 41.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.59 -39.37 75.61 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.979 1.786 . . . . 0.0 111.441 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.38 62.31 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.386 -0.926 . . . . 0.0 108.786 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.566 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 94.7 p -65.31 -39.22 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.428 -0.795 . . . . 0.0 109.981 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -63.12 -34.31 77.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.537 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.67 -47.84 81.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.942 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 27.8 m -60.87 -44.96 96.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.845 -1.159 . . . . 0.0 109.543 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -67.81 -44.22 77.83 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.487 -0.758 . . . . 0.0 109.598 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.38 -41.8 80.03 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.498 -0.751 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.521 HD23 ' NH2' ' A' ' 152' ' ' ARG . 26.2 mt -68.01 -44.35 76.74 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -62.21 -42.44 99.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.66 -31.54 70.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 111.371 -178.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.521 ' NH2' HD23 ' A' ' 149' ' ' LEU . 86.5 mtm180 -80.25 4.25 18.25 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.963 -1.085 . . . . 0.0 110.159 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.41 20.74 34.14 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.946 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' ' CB ' ' A' ' 101' ' ' ALA . 36.4 m-85 -102.82 110.91 23.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.132 -1.216 . . . . 0.0 108.772 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -91.72 172.59 8.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.435 ' CE1' ' HE3' ' A' ' 91' ' ' LYS . 63.4 m-85 58.27 69.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.185 0.993 . . . . 0.0 108.842 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 158' ' ' GLY . 30.2 m -150.93 38.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -43.72 166.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -58.07 -28.96 65.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.558 -0.966 . . . . 0.0 109.217 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.7 p -73.31 -31.39 63.99 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.1 mm -69.76 -44.96 78.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 146' ' ' SER . 35.9 m -66.26 -34.84 78.91 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.537 0.684 . . . . 0.0 109.871 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -70.57 -45.29 65.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.911 . . . . 0.0 109.644 -179.613 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.509 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 93.3 p -67.81 -32.03 72.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.038 . . . . 0.0 108.422 178.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.581 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 42.9 t80 -58.67 -45.25 89.82 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.753 -0.592 . . . . 0.0 109.706 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 81.3 mtp -66.4 -38.71 88.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.582 ' CG ' ' HE1' ' A' ' 21' ' ' TRP . 1.2 tp-100 -64.26 -46.08 85.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.371 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.63 -37.75 49.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 58.3 m -56.77 -28.68 61.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 110.03 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.52 2.95 56.48 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.84 -33.85 76.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -1.089 . . . . 0.0 109.814 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.36 130.09 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 70.0 m-20 -108.55 163.82 12.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.434 -0.791 . . . . 0.0 109.939 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.7 m-20 86.13 74.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.228 0.537 . . . . 0.0 110.016 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.48 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 23.3 m80 -54.93 -61.4 2.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.815 . . . . 0.0 109.065 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.25 152.66 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.627 -0.671 . . . . 0.0 109.197 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 129' ' ' ALA . 94.0 t -60.76 130.81 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.02 -1.05 . . . . 0.0 109.026 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.12 10.54 64.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.15 . . . . 0.0 109.329 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 126.47 27.44 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.878 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.89 -20.67 20.33 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -95.53 -4.31 45.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 110.21 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.88 -26.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -3.61 28.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 110.065 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 89.6 mm-40 -65.96 -48.45 71.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.987 -1.071 . . . . 0.0 110.67 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.89 153.8 23.21 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.848 -1.158 . . . . 0.0 109.837 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.65 ' HA ' HD13 ' A' ' 14' ' ' ILE . 29.4 Cg_exo -54.77 -32.87 78.53 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.159 1.906 . . . . 0.0 113.421 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.3 mt -59.86 -35.16 74.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.774 -1.204 . . . . 0.0 110.328 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -62.21 -34.61 76.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.881 -1.137 . . . . 0.0 109.942 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.5 mp -52.63 -42.74 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.917 -1.114 . . . . 0.0 108.935 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.84 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 61.7 t80 -65.42 -42.83 92.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.53 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -64.89 -36.25 83.76 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.2 -0.938 . . . . 0.0 110.684 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -74.6 -19.03 60.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 112.303 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 33.4 p30 -88.31 -55.18 3.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.47 -177.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.689 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 16.0 pt-20 -163.73 68.74 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.093 -1.63 . . . . 0.0 111.856 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.727 ' NE1' ' NE2' ' A' ' 167' ' ' GLN . 31.3 t-105 -77.6 64.35 2.89 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.24 44.66 27.89 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.3 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.666 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.4 t -107.01 -32.85 0.18 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.344 -1.092 . . . . 0.0 110.682 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.0 Cg_endo -87.57 154.76 7.7 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 123.116 2.544 . . . . 0.0 112.705 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.94 162.17 17.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -89.08 115.25 26.48 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.421 -176.944 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.981 ' O ' HD13 ' A' ' 31' ' ' LEU . 93.8 m-20 -89.77 157.98 17.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 178.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 20.7 m -65.89 -45.86 80.46 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.051 -1.656 . . . . 0.0 111.325 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 32' ' ' PHE . 39.1 mmtm -63.6 -51.06 66.91 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.338 -0.851 . . . . 0.0 112.362 -177.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -56.9 -36.76 70.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 108.148 -179.035 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.4 mp -65.8 -30.6 71.27 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.24 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 28' ' ' SER . 4.8 m-30 -58.92 -50.84 72.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.39 -1.324 . . . . 0.0 107.89 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -68.38 -44.63 74.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.283 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 36.4 tpp -50.84 -49.99 57.63 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.256 -0.902 . . . . 0.0 111.121 -178.138 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.87 -29.09 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.6 -1.313 . . . . 0.0 109.25 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -71.25 -47.93 54.14 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -67.8 -40.35 83.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.867 -1.146 . . . . 0.0 109.503 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HB3' HG23 ' A' ' 161' ' ' ILE . 70.6 mm-40 -59.11 -36.51 75.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 108.983 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.46 -32.62 78.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.1 -1.4 44.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -1.1 . . . . 0.0 109.991 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -89.4 -7.51 55.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.005 -179.837 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.53 120.14 13.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.997 -1.064 . . . . 0.0 109.073 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.65 -37.84 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.7 mp -98.98 148.79 23.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 109.883 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -66.67 153.71 42.46 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -58.13 -35.21 71.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.295 -179.79 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -29.12 46.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 44' ' ' LEU . 16.9 m -61.27 -41.36 96.81 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.893 -1.13 . . . . 0.0 109.37 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -70.26 -30.24 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 109.181 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.73 -46.76 88.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.6 mtmt -63.29 -44.63 94.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.85 -1.156 . . . . 0.0 108.784 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -9.62 58.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 108.723 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.5 ttm180 -67.12 -46.26 74.67 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.168 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.23 -42.88 92.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 17.1 m-80 -69.41 -41.73 76.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.822 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.9 t80 -61.39 -44.52 97.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.504 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -57.6 -38.48 74.98 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.414 -0.803 . . . . 0.0 109.948 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.9 -34.51 75.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.283 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.589 ' HB3' HD22 ' A' ' 79' ' ' LEU . 87.0 m -72.94 -43.75 61.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.234 -0.916 . . . . 0.0 111.161 -178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.664 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 CA--C 1.543 0.949 0 N-CA-C 115.689 1.38 . . . . 0.0 115.689 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 0.0 112.077 -176.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -33.83 64.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.751 -1.218 . . . . 0.0 108.921 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.78 -37.41 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 0.0 108.355 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.77 -18.15 64.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.53 -6.22 50.12 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.059 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.44 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 89.8 mtp -75.62 114.16 13.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.597 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 44.3 tt0 -95.32 171.68 8.56 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.508 0.67 . . . . 0.0 110.128 -177.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.437 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 99.2 mt-10 -53.24 -28.52 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -56.56 -50.7 71.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.882 -1.136 . . . . 0.0 108.898 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.6 p30 -63.83 -37.02 85.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 108.786 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 76.3 t -56.47 -41.84 73.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 108.983 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -57.82 -40.8 80.85 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -62.32 -43.7 98.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 59' ' ' CYS . 53.2 mt -67.53 -33.69 75.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.03 -16.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 108.736 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -122.87 -9.76 8.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.271 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 76.1 m-20 -74.07 109.18 7.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.279 -1.513 . . . . 0.0 109.966 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.4 -13.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.58 -0.7 . . . . 0.0 109.615 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.11 37.2 38.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 79' ' ' LEU . 6.5 pt -53.0 -166.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mm -54.07 90.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 85' ' ' ILE . 24.4 ttp180 -62.02 112.75 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.013 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 169.46 81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.339 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' HIS . 25.6 ptt180 -42.64 -38.52 2.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.581 -0.7 . . . . 0.0 110.114 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.79 -54.5 36.89 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -62.54 -39.96 95.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.245 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -60.9 -39.81 83.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.836 -1.165 . . . . 0.0 108.798 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 22.0 mt-30 -55.39 -36.8 66.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.845 -1.159 . . . . 0.0 108.463 178.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.24 87.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 108.974 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' HA ' ' ND2' ' A' ' 98' ' ' ASN . 35.6 mm -61.58 -44.24 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.805 . . . . 0.0 109.367 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.1 mm -59.58 -42.06 86.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 108.486 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.07 91.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 95' ' ' ILE . 89.3 m-20 -57.05 -39.16 74.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.64 71.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.252 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 95.9 mtt180 -62.73 -38.64 91.31 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.88 70.31 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.33 -0.856 . . . . 0.0 108.723 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.597 ' OH ' ' CZ ' ' A' ' 32' ' ' PHE . 64.4 t80 -64.65 -42.88 95.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.91 -32.7 71.01 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.11 -32.12 71.8 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.176 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.419 ' SD ' ' HD2' ' A' ' 152' ' ' ARG . 89.9 mmm -65.66 -42.39 91.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 109' ' ' GLY . 96.9 mt-10 -71.88 -41.16 68.34 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.45 -26.74 43.94 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.88 -9.1 29.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.89 26.68 74.47 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -117.6 101.2 52.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.75 154.36 26.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.426 2.084 . . . . 0.0 112.541 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -62.18 -45.4 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.864 0.84 . . . . 0.0 109.324 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.67 -27.38 64.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 111.123 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -70.63 -52.74 19.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.711 -1.243 . . . . 0.0 111.607 -178.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 2.2 p90 -67.16 -39.89 86.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.936 -1.103 . . . . 0.0 111.041 -178.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 117' ' ' TRP . 8.1 p -65.88 -48.94 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 116' ' ' VAL . 12.8 m95 -56.45 -25.48 50.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -67.18 -45.46 76.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 110.552 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.6 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.0 m-85 -62.96 -32.25 73.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.002 -1.061 . . . . 0.0 110.17 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 171' ' ' LEU . 2.5 t -89.68 18.41 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.714 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 123' ' ' GLN . 62.5 m-20 59.31 40.54 21.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.728 -0.608 . . . . 0.0 109.78 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 43.48 26.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.802 179.332 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 120' ' ' VAL . 1.9 pt20 -139.8 154.62 71.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.63 152.31 59.19 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.858 2.372 . . . . 0.0 112.951 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 126' ' ' MET . 10.7 tm0? -109.4 127.83 54.67 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.62 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 61.1 mtm -91.03 118.63 30.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 109.692 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 116.3 26.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.347 -0.845 . . . . 0.0 109.482 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -93.78 14.0 20.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 136.54 53.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -93.63 -22.63 18.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.504 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.5 p -133.68 163.01 30.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.2 mt -59.24 -39.62 83.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.1 t -60.61 -33.23 72.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -81.96 2.64 29.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.836 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.92 142.87 25.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.117 -0.989 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.91 143.63 37.07 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.365 2.043 . . . . 0.0 112.655 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -123.98 2.58 8.69 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.8 p -154.7 85.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.11 166.87 9.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.22 -41.45 65.63 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.624 1.549 . . . . 0.0 112.283 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -41.73 80.03 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.025 -1.047 . . . . 0.0 108.676 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.0 p -66.81 -45.24 78.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.56 -40.69 96.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -67.89 -30.76 70.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 116' ' ' VAL . 2.7 tp -69.19 -42.0 76.39 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -0.752 . . . . 0.0 110.321 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.573 ' CA ' ' SG ' ' A' ' 162' ' ' CYS . 0.3 OUTLIER -63.72 -50.28 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.449 -179.1 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -65.77 -36.14 82.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.948 -1.095 . . . . 0.0 109.366 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.22 -50.47 39.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.762 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 115' ' ' PHE . 91.0 mt -63.65 -36.36 83.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 109.661 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -60.49 -38.5 84.49 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.959 -1.088 . . . . 0.0 108.767 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -62.52 -33.71 75.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.326 -0.859 . . . . 0.0 110.09 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 1.6 mmp_? -70.55 3.86 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.02 -1.05 . . . . 0.0 108.844 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.79 47.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.42 115.58 27.8 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.531 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -93.41 169.03 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 56.21 55.11 7.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.068 -1.02 . . . . 0.0 108.54 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -142.08 47.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.03 -178.5 3.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.1 m -61.1 -33.47 73.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.631 -0.923 . . . . 0.0 110.511 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.4 p -67.79 -35.38 78.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.898 -1.126 . . . . 0.0 108.05 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 38' ' ' GLU . 32.6 mm -65.58 -42.38 92.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.573 ' SG ' ' CA ' ' A' ' 146' ' ' SER . 77.1 m -63.89 -41.29 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.691 -0.631 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.3 -44.37 65.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.838 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.462 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 23.2 m -65.19 -38.98 92.22 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.571 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 87.1 t80 -60.21 -49.65 76.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.702 -0.624 . . . . 0.0 111.051 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 166' ' ' MET . 12.8 ptm -71.5 -38.62 71.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.868 -1.145 . . . . 0.0 109.746 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.727 ' NE2' ' NE1' ' A' ' 21' ' ' TRP . 1.1 tm0? -62.55 -42.48 99.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 110.498 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.05 -27.56 20.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.968 -1.082 . . . . 0.0 111.018 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.571 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 24.3 m -60.87 -21.12 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.818 -1.176 . . . . 0.0 110.119 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.75 0.09 34.27 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 120' ' ' VAL . 86.0 mt -63.37 -34.09 76.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.099 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.16 138.1 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 91.0 m-20 -115.06 163.13 16.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.628 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.0 t70 86.07 77.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.465 0.65 . . . . 0.0 109.778 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 4.6 m170 -55.72 -53.13 60.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 0.0 109.084 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.8 m -147.43 38.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.468 HG22 ' OD2' ' A' ' 174' ' ' ASP . 16.2 t 61.27 111.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.472 0.653 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 44.86 71.02 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' CYS . . . . . 0.635 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 7.6 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.285 . . . . 0.0 109.388 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HE ' HG11 ' A' ' 7' ' ' VAL . 50.5 mtp180 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.691 0.758 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.1 m -62.84 149.93 43.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.052 0.93 . . . . 0.0 110.817 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.78 -41.64 94.07 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.635 -0.665 . . . . 0.0 111.458 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.697 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -85.74 -2.37 58.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.544 -1.563 . . . . 0.0 109.645 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.539 HG11 ' HE ' ' A' ' 3' ' ' ARG . 2.5 t -78.16 -37.85 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.983 -1.073 . . . . 0.0 108.502 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -80.88 0.68 34.13 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.644 -0.822 . . . . 0.0 108.795 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.36 -55.43 5.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 110.867 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.52 161.0 61.27 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.125 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.37 -35.82 13.04 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.083 2.522 . . . . 0.0 112.981 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD11 ' NZ ' ' A' ' 51' ' ' LYS . 55.8 mt -62.61 -34.02 76.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.868 -1.145 . . . . 0.0 109.737 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -36.91 76.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.5 mp -52.7 -46.21 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 110.394 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.7 64.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.957 -1.089 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.1 t80 -63.49 -39.96 95.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.41 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 48.5 t-80 -76.07 -40.53 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 111.507 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.91 -15.14 63.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 112.008 -177.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 6.9 p30 -71.14 -77.09 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.255 -1.528 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -149.1 -49.07 0.15 Allowed 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.756 -1.215 . . . . 0.0 110.256 -179.443 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.697 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.9 t-105 59.03 87.22 0.08 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.185 -178.331 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.66 73.06 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.79 176.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 77.2 t -110.33 -32.85 0.14 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-N 119.353 1.577 . . . . 0.0 110.542 177.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.1 Cg_endo -85.54 152.07 10.33 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.2 1.933 . . . . 0.0 112.729 -178.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' OE1' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -67.48 169.03 9.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.8 p -94.09 141.14 28.88 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.05 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD1' ' OE1' ' A' ' 25' ' ' GLU . 92.0 m-20 -102.92 150.2 23.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -61.98 -35.99 80.14 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.666 -1.271 . . . . 0.0 110.052 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -74.95 -50.37 16.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 27' ' ' ASP . 7.4 ptmm? -62.54 -32.18 73.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.819 -1.175 . . . . 0.0 109.584 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.503 HD21 ' HB ' ' A' ' 26' ' ' THR . 45.8 mt -57.38 -37.5 72.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 108.539 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 35' ' ' ILE . 86.4 t80 -65.73 -45.45 82.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.882 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.38 -40.19 95.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.895 -1.128 . . . . 0.0 109.3 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 35' ' ' ILE . 8.5 tmm? -62.12 -47.04 86.35 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 111.339 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.588 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.2 tp -62.48 -27.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 -178.582 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.8 m -70.24 -49.98 44.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 110.003 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.9 mm? -69.33 -42.23 75.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.068 -1.02 . . . . 0.0 109.566 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -66.51 -32.07 73.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.785 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.62 40.15 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.401 ' HG3' ' NH2' ' A' ' 87' ' ' ARG . 10.3 mm100 -88.51 -0.64 57.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -1.218 . . . . 0.0 110.076 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' OE1' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.6 3.34 22.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 109.665 -179.567 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -75.42 117.17 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.36 -6.75 1.06 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.3 tp -103.51 169.18 8.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -1.116 . . . . 0.0 108.862 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -94.84 141.68 28.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 108.763 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.449 ' HB2' HE21 ' A' ' 41' ' ' GLN . 5.5 t-105 -55.58 -34.12 64.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -37.69 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.793 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 m -57.9 -45.36 86.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.903 -1.123 . . . . 0.0 108.616 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.85 -29.37 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 108.679 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 50' ' ' LEU . 6.8 tt -56.59 -41.33 76.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 108.673 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.611 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 12.2 mmtt -57.8 -41.49 82.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.9 -18.98 61.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -60.63 -42.48 97.0 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -69.32 -46.03 68.08 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.685 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.7 m-80 -64.12 -32.81 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 108.516 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 52' ' ' LYS . 75.3 t80 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -60.04 -38.31 82.39 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.452 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.09 82.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.854 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 79' ' ' LEU . 1.8 m -71.67 -45.08 63.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 110.258 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 29.2 m-85 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.291 -0.881 . . . . 0.0 109.765 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.494 1.503 0 CA-C-O 121.223 0.426 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.69 HG22 HD21 ' A' ' 103' ' ' LEU . 84.4 t -65.14 -44.23 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 110.219 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -63.62 -36.99 85.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 109.946 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.42 -39.38 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.92 -16.23 63.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.93 58.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 mmm -78.01 113.21 15.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 60.1 tt0 -95.68 167.43 11.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 108.906 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 96.2 mt-10 -52.63 -30.31 30.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.243 -0.911 . . . . 0.0 110.855 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -57.39 -45.19 84.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.541 -1.35 . . . . 0.0 107.704 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -62.95 -39.76 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.56 ' HA ' HD12 ' A' ' 79' ' ' LEU . 75.5 t -59.6 -42.7 89.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.536 -0.728 . . . . 0.0 110.026 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 80' ' ' VAL . 74.9 mm-40 -57.38 -37.11 72.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.069 -1.019 . . . . 0.0 108.396 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 78' ' ' ARG . 16.2 ttm-85 -66.19 -36.98 84.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.504 -0.747 . . . . 0.0 109.521 179.087 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 59' ' ' CYS . 81.4 mt -65.26 -40.34 93.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.718 . . . . 0.0 112.445 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 77' ' ' GLU . 4.4 m -59.01 -16.83 10.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.478 -1.389 . . . . 0.0 108.024 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -104.67 -14.36 15.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.507 -0.746 . . . . 0.0 109.153 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 84' ' ' GLY . 63.0 m-20 -81.78 105.52 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.09 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 65.15 -15.57 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.545 -0.722 . . . . 0.0 109.984 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 66.19 35.96 91.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 87' ' ' ARG . 2.5 pt -28.68 -101.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.156 -0.614 . . . . 0.0 111.541 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 87' ' ' ARG . 9.1 tt -168.77 -34.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.06 -179.119 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.631 HH11 HD11 ' A' ' 95' ' ' ILE . 5.0 mtt-85 -59.22 149.2 29.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.623 -0.673 . . . . 0.0 109.419 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -106.36 160.19 15.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.244 -0.91 . . . . 0.0 109.327 179.902 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.77 -46.24 15.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 110.049 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -53.11 36.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 51.1 mttp -61.13 -40.7 94.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 76' ' ' VAL . 66.7 mt -58.76 -47.76 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.153 -0.967 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -52.97 -35.03 58.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.824 -1.173 . . . . 0.0 108.941 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.42 80.63 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.631 HD11 HH11 ' A' ' 87' ' ' ARG . 81.6 mt -63.7 -47.38 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.56 -0.712 . . . . 0.0 109.422 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.614 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.9 mp -60.08 -38.97 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 108.952 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.6 -35.75 89.99 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -62.33 -37.81 87.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -1.067 . . . . 0.0 109.693 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.38 96.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.02 . . . . 0.0 109.804 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.499 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -65.87 -39.2 90.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.981 -1.074 . . . . 0.0 109.453 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -67.61 -29.06 68.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.57 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.603 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 75.8 t80 -63.41 -44.41 94.7 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.69 HD21 HG22 ' A' ' 66' ' ' VAL . 34.9 mt -62.86 -31.71 72.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -64.81 -35.97 82.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.916 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 81.0 mmm -67.93 -40.0 83.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.732 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.99 -40.07 78.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.542 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.35 -23.8 66.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.441 ' OD1' ' CD ' ' A' ' 110' ' ' GLU . 10.4 t-20 -85.71 -7.15 58.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 26.23 74.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CD ' ' OD1' ' A' ' 108' ' ' ASN . 96.1 mt-10 -124.48 102.06 33.35 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -1.071 . . . . 0.0 109.729 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -60.64 147.47 94.63 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.004 1.803 . . . . 0.0 112.066 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 102' ' ' TYR . 25.2 m-85 -57.5 -37.64 73.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.103 -0.998 . . . . 0.0 109.45 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.84 -29.86 70.83 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.526 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.56 -50.65 62.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 112.174 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 116' ' ' VAL . 4.1 p90 -72.4 -38.1 68.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.754 -1.216 . . . . 0.0 111.308 -177.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 115' ' ' PHE . 27.7 m -60.45 -49.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.117 -1.614 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.577 ' N ' HG23 ' A' ' 116' ' ' VAL . 26.1 m95 -60.32 -24.15 64.78 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 108.622 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -64.66 -42.33 95.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.0 109.912 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.59 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 37.9 m-85 -68.11 -32.74 73.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.64 16.92 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.62 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 122' ' ' HIS . 16.6 m120 56.98 36.92 28.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.698 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 121' ' ' ASN . 92.3 m-70 44.03 33.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -139.15 151.83 68.47 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.01 . . . . 0.0 109.867 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.03 144.48 34.11 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.789 2.326 . . . . 0.0 112.205 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -112.26 141.99 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.337 179.686 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 85.2 mmm -96.65 118.01 32.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -88.63 117.49 27.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.194 -0.941 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.52 20.77 3.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.225 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.93 135.21 53.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 109.536 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.1 p -100.67 -19.88 15.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.399 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.455 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 5.0 p -128.75 158.84 37.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.47 -0.769 . . . . 0.0 109.097 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.2 mt -57.82 -40.74 80.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -73.84 -19.14 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.827 . . . . 0.0 109.568 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 131' ' ' THR . 46.6 tp10 -74.44 -9.29 58.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 108.509 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.6 132.53 46.47 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.39 135.34 22.22 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.931 1.754 . . . . 0.0 112.442 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.9 p -101.06 3.88 41.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 138' ' ' SER . 59.6 p -141.06 91.76 2.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 109.064 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.543 ' N ' ' OG ' ' A' ' 142' ' ' SER . 40.1 p -110.89 156.88 40.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.07 -39.49 70.17 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.147 1.231 . . . . 0.0 111.222 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.72 71.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 139' ' ' THR . 86.6 p -63.41 -42.06 98.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -0.789 . . . . 0.0 109.834 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.0 -39.78 94.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.883 . . . . 0.0 110.229 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.59 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -65.58 -34.85 79.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 116' ' ' VAL . 61.5 mt -66.38 -46.24 77.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 110.725 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.636 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 15.0 m -61.06 -48.82 79.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.223 -0.923 . . . . 0.0 110.726 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -37.56 81.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.01 -1.056 . . . . 0.0 109.349 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.27 74.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.118 -0.988 . . . . 0.0 109.66 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.623 HD23 ' NH2' ' A' ' 152' ' ' ARG . 19.1 mt -67.86 -42.35 81.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.966 -1.084 . . . . 0.0 108.841 179.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -59.47 -37.44 78.22 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.274 -0.891 . . . . 0.0 110.594 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -74.34 -23.04 58.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.877 -1.139 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.623 ' NH2' HD23 ' A' ' 149' ' ' LEU . 81.6 mtm180 -83.67 6.05 22.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.31 21.14 39.13 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 3.0 m-85 -99.69 112.23 24.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -1.208 . . . . 0.0 108.976 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -89.75 178.59 6.21 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 55.95 56.71 5.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 108.824 -179.091 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.3 40.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -50.04 157.87 1.74 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.169 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.8 m -52.73 -32.67 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.319 -1.106 . . . . 0.0 108.742 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 m -69.09 -36.01 77.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.06 -45.02 99.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.595 0.712 . . . . 0.0 109.394 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.636 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.2 m -64.32 -39.7 94.44 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.503 -0.748 . . . . 0.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -43.25 77.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.95 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.3 m -61.8 -36.54 81.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 109.589 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.591 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -61.13 -50.49 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.428 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.466 ' H ' ' HG2' ' A' ' 166' ' ' MET . 4.2 ptm -62.52 -37.62 86.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.044 -1.035 . . . . 0.0 110.268 -178.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -67.09 -40.82 87.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 111.627 -178.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.39 15.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.957 -1.089 . . . . 0.0 112.752 -177.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.481 ' HB3' HG22 ' A' ' 26' ' ' THR . 0.1 OUTLIER -63.53 -50.19 70.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.664 -1.272 . . . . 0.0 112.047 -177.385 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.43 2.36 0.96 Allowed Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.2 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 77.1 mt -59.93 -33.91 72.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.616 -1.52 . . . . 0.0 109.121 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.25 150.91 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.599 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 83.7 m-20 -117.89 164.09 15.58 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.789 ' OD2' HG22 ' A' ' 177' ' ' VAL . 18.9 t0 96.05 84.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.605 0.717 . . . . 0.0 110.017 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.516 ' O ' HG13 ' A' ' 176' ' ' VAL . 43.4 m170 -55.74 -49.71 72.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.604 -0.685 . . . . 0.0 109.848 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 175' ' ' HIS . 7.1 m -157.54 24.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.71 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.789 HG22 ' OD2' ' A' ' 174' ' ' ASP . 33.9 t 56.11 111.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.429 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.36 10.0 52.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 120.924 -1.339 . . . . 0.0 109.215 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' A' ' 3' ' ' ARG . 22.0 mtm-85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -69.95 156.57 38.91 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.793 0.806 . . . . 0.0 109.516 -179.556 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.13 95.73 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.146 -0.971 . . . . 0.0 112.844 -177.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.703 ' CZ2' ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -88.76 -3.82 58.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.323 -1.693 . . . . 0.0 111.608 -177.673 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 17' ' ' HIS . 2.7 m -87.25 -31.61 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.384 -1.448 . . . . 0.0 108.58 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -62.97 -18.07 62.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -59.85 -40.97 90.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.241 0.544 . . . . 0.0 109.98 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.35 160.37 51.91 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.02 -55.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.219 2.613 . . . . 0.0 113.44 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 47' ' ' ILE . 2.3 pp -53.98 -32.01 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.703 ' CE1' ' CZ2' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -56.78 -39.17 73.59 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.896 -1.128 . . . . 0.0 109.584 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.09 -41.27 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -49.62 73.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 109.847 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 27.9 t80 -61.5 -42.73 99.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.357 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.5 t-80 -66.66 -37.63 85.18 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.516 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.41 -13.19 61.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 12.0 p30 -86.89 -70.88 0.58 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 119.855 -1.778 . . . . 0.0 110.276 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.591 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.4 mt-10 -136.86 -72.61 0.44 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.017 -1.052 . . . . 0.0 110.038 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.59 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.8 t90 47.39 49.72 15.42 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.926 -0.484 . . . . 0.0 110.721 -178.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.38 72.3 0.99 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.513 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.77 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -166.23 -30.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.01 -1.288 . . . . 0.0 112.837 179.37 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.77 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 28.6 Cg_endo -91.98 154.22 3.3 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 123.022 2.481 . . . . 0.0 112.615 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 26' ' ' THR . 85.8 tt0 -66.55 156.36 35.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.418 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 1.5 p -91.43 134.09 34.92 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.594 -177.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.8 t0 -99.85 158.14 16.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.656 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 1.3 m -57.69 -37.69 73.91 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.541 -1.349 . . . . 0.0 109.832 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 13.5 mmtt -61.29 -46.14 91.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 111.165 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -61.29 -36.93 81.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.567 -178.862 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 27' ' ' ASP . 4.0 mm? -57.17 -39.32 75.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.564 -0.71 . . . . 0.0 110.501 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CE1' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -70.18 -54.09 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.456 -178.166 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 37' ' ' LEU . 19.4 pt-20 -71.02 -30.41 66.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.902 -1.124 . . . . 0.0 109.774 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 27.8 ttm -67.16 -52.15 45.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.885 -1.134 . . . . 0.0 110.984 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.25 -31.06 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.519 -1.363 . . . . 0.0 111.117 -178.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.31 -37.21 74.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.476 -1.39 . . . . 0.0 109.802 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.471 HD21 ' HG3' ' A' ' 53' ' ' ARG . 9.0 mp -73.46 -40.27 64.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.189 -0.945 . . . . 0.0 110.247 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -36.83 84.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.0 108.685 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.44 -36.73 78.42 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -69.01 -28.51 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -1.123 . . . . 0.0 109.885 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' ' CB ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -74.38 -3.05 28.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.987 -1.071 . . . . 0.0 110.309 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.59 117.82 4.24 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.726 -1.233 . . . . 0.0 108.809 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.48 -36.72 2.02 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.6 mm? -90.92 150.58 21.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.077 -1.249 . . . . 0.0 109.984 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.5 m -63.98 154.56 33.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.785 . . . . 0.0 109.447 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -61.2 -40.92 95.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.656 179.604 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.454 HD11 HD11 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -59.22 -35.86 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -58.74 -39.26 80.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.146 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.85 -49.6 76.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 0.0 109.403 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -57.45 -43.37 83.91 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.425 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' NH2' ' CZ2' ' A' ' 46' ' ' TRP . 37.1 ttm180 -60.64 -42.02 96.1 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.623 -1.298 . . . . 0.0 107.8 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.09 -42.41 66.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.91 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 51' ' ' LYS . 14.1 m120 -75.12 -43.4 53.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.021 -1.05 . . . . 0.0 110.023 -179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.4 t80 -58.23 -49.1 78.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.743 -0.598 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -63.04 -33.86 76.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.969 -1.082 . . . . 0.0 109.142 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.66 76.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.143 -0.973 . . . . 0.0 109.586 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.66 -44.86 55.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.604 -179.253 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.634 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 78.0 m-85 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 120.903 -1.123 . . . . 0.0 110.636 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 N--CA 1.496 1.667 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.73 -45.8 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.899 -1.126 . . . . 0.0 109.788 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.94 -33.37 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.038 -1.039 . . . . 0.0 109.479 179.435 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.13 -38.98 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.204 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.408 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -62.89 -21.51 66.06 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -84.88 -6.39 59.34 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.9 mtp -88.42 111.6 21.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.33 -172.93 2.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.16 -25.55 59.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.061 -1.025 . . . . 0.0 110.504 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.02 -45.34 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.766 -1.208 . . . . 0.0 109.113 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -68.82 -36.75 78.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 109.155 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.936 ' O ' HG13 ' A' ' 80' ' ' VAL . 95.7 t -64.11 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.027 . . . . 0.0 110.081 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 80' ' ' VAL . 2.1 pt-20 -65.54 -43.7 89.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 11.1 ptp180 -75.16 -32.8 61.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.632 -1.292 . . . . 0.0 109.322 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 59' ' ' CYS . 61.3 mt -70.61 -35.58 73.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 111.851 -179.187 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 76' ' ' VAL . 34.8 m -50.39 -17.94 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.686 -1.259 . . . . 0.0 109.161 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.424 ' N ' ' C ' ' A' ' 79' ' ' LEU . 16.1 pt20 -117.84 -8.17 10.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.717 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 46.3 m-20 -77.95 107.86 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.61 -1.307 . . . . 0.0 109.51 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.27 -13.24 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.835 -0.541 . . . . 0.0 109.896 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.45 37.9 30.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 85' ' ' ILE . 6.2 pt -58.49 -168.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.002 -1.293 . . . . 0.0 109.498 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -65.86 93.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.313 -0.867 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 87' ' ' ARG . 32.5 ttt-85 -55.23 106.46 0.23 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 179.88 72.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 15.3 ptm180 -45.56 -42.51 11.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -51.23 -54.17 24.62 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.211 -178.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -64.09 -42.33 96.97 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.037 -1.272 . . . . 0.0 109.774 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.04 -44.26 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -56.97 -36.13 69.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.653 -1.279 . . . . 0.0 109.736 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.79 83.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 109.079 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.45 -39.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 108.926 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.88 -43.3 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.7 -35.43 81.44 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 88.5 m-20 -61.49 -35.88 78.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.378 -1.072 . . . . 0.0 108.93 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.04 91.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.847 . . . . 0.0 108.843 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 16.5 mmt180 -61.13 -36.28 79.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.48 -32.42 74.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.187 -0.946 . . . . 0.0 109.024 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -61.76 -44.23 97.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.99 -36.64 80.0 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.8 -36.81 85.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.945 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.459 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 94.4 mmm -64.68 -40.09 94.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.869 -1.144 . . . . 0.0 108.826 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' GLY . 80.7 mm-40 -67.64 -38.06 83.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -58.09 -25.67 61.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -93.46 -12.6 29.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.63 22.53 71.69 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -114.56 102.78 55.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 109.556 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.52 152.68 46.21 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.953 1.768 . . . . 0.0 112.274 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.09 -40.27 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.618 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.43 69.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 111.074 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.55 -53.03 39.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.082 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CE1' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -72.1 -41.43 67.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.667 -1.27 . . . . 0.0 111.75 -177.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.816 HG12 HD21 ' A' ' 145' ' ' LEU . 30.4 m -59.69 -50.35 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 119.945 -1.722 . . . . 0.0 109.794 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.611 ' N ' HG23 ' A' ' 116' ' ' VAL . 15.0 m95 -57.26 -24.41 54.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 45.9 p -66.32 -42.13 88.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.063 -1.023 . . . . 0.0 110.404 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 39.8 m-85 -68.17 -33.35 74.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.076 -1.015 . . . . 0.0 110.283 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -88.06 15.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 109.19 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.14 37.52 26.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.699 . . . . 0.0 110.554 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 48.71 29.45 2.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -0.952 . . . . 0.0 110.424 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.43 148.97 42.62 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.784 -1.197 . . . . 0.0 109.856 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.44 147.64 90.6 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.92 2.413 . . . . 0.0 112.905 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 126' ' ' MET . 11.5 tm0? -105.4 135.24 47.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.232 -0.917 . . . . 0.0 109.223 179.626 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.482 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 62.9 mtt -93.04 134.66 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.2 -54.72 3.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -0.989 . . . . 0.0 109.354 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 127' ' ' THR . 73.6 mt-30 58.63 50.11 9.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 127' ' ' THR . . . -90.02 142.35 27.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.6 p -81.13 -24.6 37.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.003 -1.061 . . . . 0.0 108.916 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 p -143.51 164.67 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.13 -31.86 72.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.026 -1.046 . . . . 0.0 108.841 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -64.29 -28.73 69.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 79.8 mm-40 -78.2 -2.4 37.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -179.252 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.56 127.17 86.45 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.75 -1.219 . . . . 0.0 107.965 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.412 ' O ' ' CE2' ' A' ' 163' ' ' TYR . 56.9 Cg_endo -73.49 137.74 25.87 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.132 1.888 . . . . 0.0 113.292 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 163' ' ' TYR . 57.3 p -110.29 6.54 22.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 m -147.97 90.89 1.87 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.204 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.0 155.52 39.89 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -52.82 -33.89 62.91 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 120.946 1.097 . . . . 0.0 111.539 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.67 -46.21 55.0 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.24 -0.913 . . . . 0.0 109.176 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.9 p -63.47 -41.4 98.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.073 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.57 -43.92 97.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.552 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.45 -29.57 67.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.483 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.816 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -62.83 -47.21 84.39 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.627 -0.671 . . . . 0.0 110.338 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.9 t -65.59 -41.62 92.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 109.841 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -60.57 -38.71 85.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.13 -54.62 16.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.045 -1.035 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -59.09 -31.69 69.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -60.5 -43.26 97.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.503 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -72.12 -27.75 62.83 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 110.358 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.486 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -73.9 5.35 4.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.006 . . . . 0.0 109.019 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.63 25.72 52.78 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -101.4 116.39 32.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.436 -1.037 . . . . 0.0 109.452 179.203 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -94.6 176.4 6.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 56.92 53.34 8.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.19 43.82 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.29 165.69 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.59 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 18.7 m -54.06 -33.82 58.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.614 -0.933 . . . . 0.0 109.214 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.6 m -72.72 -33.59 66.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.54 -44.63 99.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.642 -0.661 . . . . 0.0 110.047 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' CYS . . . . . 0.59 ' SG ' ' O ' ' A' ' 159' ' ' THR . 0.8 OUTLIER -65.46 -46.65 78.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.093 -1.004 . . . . 0.0 109.682 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -63.74 -38.8 92.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 109.581 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.544 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 79.4 p -63.37 -37.21 86.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -63.7 -40.72 97.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.772 . . . . 0.0 110.203 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.52 ' HG2' HD12 ' A' ' 171' ' ' LEU . 25.6 mtm -66.85 -39.24 87.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 111.014 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -64.72 -36.15 83.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.983 -1.073 . . . . 0.0 111.084 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.51 19.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 112.295 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -68.06 -48.95 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.796 -1.19 . . . . 0.0 111.717 -177.878 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.32 -11.06 2.76 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.923 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.751 HD22 HG21 ' A' ' 120' ' ' VAL . 81.5 mt -51.13 -30.78 17.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -1.198 . . . . 0.0 109.749 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.82 150.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -137.69 163.76 30.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.657 . . . . 0.0 109.853 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 90.17 75.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.147 0.498 . . . . 0.0 110.62 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -52.37 -53.3 46.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.6 m -151.37 -162.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.18 122.92 39.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.43 68.59 1.62 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.034 -1.274 . . . . 0.0 109.18 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.385 0.612 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.34 154.43 19.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.262 -0.899 . . . . 0.0 109.282 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -92.29 0.1 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.776 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.995 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.676 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.74 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.696 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' C ' ' H ' ' A' ' 62' ' ' GLN . 53.3 m-85 -85.85 18.58 2.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ARG . 9.2 t-80 -56.97 17.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.353 -0.842 . . . . 0.0 111.112 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 60' ' ' PHE . 9.4 pt20 -79.43 -17.98 53.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.951 -1.093 . . . . 0.0 110.651 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 42.3 p90 38.32 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.454 -0.779 . . . . 0.0 110.035 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' GLN . 71.2 m-20 -127.39 91.9 44.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.03 -30.23 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.244 1.963 . . . . 0.0 112.402 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.619 ' SD ' ' NE2' ' A' ' 62' ' ' GLN . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.408 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.408 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 25.4 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.4 t -67.84 79.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 68.93 -48.3 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 179' ' ' CYS . 31.5 t -170.27 71.71 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 183' ' ' PRO . 1.9 t80 -71.66 122.53 87.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 45.5 Cg_endo -74.77 176.01 10.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.231 1.954 . . . . 0.0 112.112 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.72 2.96 34.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.69 -72.83 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -1.113 . . . . 0.0 108.725 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 187' ' ' PRO . 1.4 mptt -111.98 -25.19 0.13 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 110.943 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 186' ' ' LYS . 31.3 Cg_exo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.691 1.594 . . . . 0.0 112.089 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.995 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.601 0.715 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 178' ' ' GLY . 53.7 tp10 -101.95 143.11 32.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' A' ' 7' ' ' VAL . 62.1 mtp180 -94.34 160.89 14.47 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 110.26 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.2 m -53.08 144.77 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 0.0 109.618 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.14 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.525 -0.734 . . . . 0.0 112.13 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.861 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -83.7 -1.03 53.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.58 -1.541 . . . . 0.0 109.478 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' A' ' 3' ' ' ARG . 1.4 t -84.93 -42.37 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 108.823 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.4 m -78.66 5.09 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.78 -108.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.632 -0.668 . . . . 0.0 109.775 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.35 143.61 93.69 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.806 . . . . 0.0 109.838 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 -28.29 58.25 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.083 1.855 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.32 -36.18 82.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.894 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 6' ' ' TRP . 4.6 m-85 -55.41 -42.11 73.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.039 . . . . 0.0 110.603 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.85 -40.82 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 110.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -66.19 -50.35 64.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.678 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' A' ' 168' ' ' ALA . 23.8 t80 -66.58 -39.78 88.6 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.696 -1.252 . . . . 0.0 110.164 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -69.34 -50.33 47.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 112.523 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -75.14 -5.98 47.19 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.941 -1.099 . . . . 0.0 110.567 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.537 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 2.8 m120 -94.9 -35.48 12.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.832 -1.168 . . . . 0.0 112.294 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 22' ' ' GLY . 13.0 pt-20 -174.42 48.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.374 -1.454 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.715 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 20.5 t-105 -70.87 66.76 0.37 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 60.72 52.81 50.15 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.2 t -108.59 -42.29 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.36 -1.082 . . . . 0.0 109.13 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.7 Cg_endo -95.94 150.55 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.558 2.839 . . . . 0.0 112.649 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -68.27 141.63 55.82 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -99.83 147.82 25.09 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.06 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 90.9 m-20 -80.88 167.91 19.35 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 m -59.87 -35.07 74.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -67.15 -39.96 86.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 0.0 112.461 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -59.04 -38.92 80.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 0.0 110.309 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.718 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.5 mp -58.62 -36.94 74.84 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.686 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -63.26 -48.12 79.52 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -69.82 -30.97 68.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.783 -1.198 . . . . 0.0 109.473 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.22 -48.56 56.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.791 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 35' ' ' ILE . 8.4 tp -61.43 -28.6 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 109.476 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.6 -51.32 29.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.956 -1.09 . . . . 0.0 109.418 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.85 -37.49 73.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 108.98 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.593 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 17.6 tp10 -61.65 -37.06 82.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.4 -35.33 90.84 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.538 ' OE1' HG13 ' A' ' 49' ' ' VAL . 86.9 mt-30 -62.06 -31.48 71.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.459 -1.024 . . . . 0.0 110.995 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.593 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -61.26 6.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.837 -1.165 . . . . 0.0 110.53 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.59 123.3 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.3 -33.78 0.16 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 42' ' ' ALA . 73.2 mt -94.44 155.99 16.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -1.213 . . . . 0.0 110.439 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.3 m -73.18 156.62 38.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.644 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.8 OUTLIER -59.85 -32.42 70.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.42 -0.8 . . . . 0.0 109.725 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -35.82 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -57.6 -37.37 73.12 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.538 HG13 ' OE1' ' A' ' 40' ' ' GLN . 85.1 t -66.69 -36.81 78.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.885 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.97 -47.64 84.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.911 -1.118 . . . . 0.0 109.806 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.49 -49.68 74.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.818 -1.176 . . . . 0.0 108.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -65.72 -26.19 67.64 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.253 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 49' ' ' VAL . 38.1 ttm180 -55.12 -42.49 73.03 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.49 -40.85 76.78 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.093 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 3.7 m-20 -64.34 -34.86 79.11 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' OH ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -60.95 -39.25 88.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 61' ' ' HIS . 46.1 mtp180 -59.66 -36.43 76.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.398 -0.814 . . . . 0.0 109.054 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.79 89.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.838 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.607 ' HB3' HD22 ' A' ' 79' ' ' LEU . 64.9 m -75.0 -44.95 45.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.64 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.596 ' O ' ' N ' ' A' ' 62' ' ' GLN . 83.1 m-85 -111.7 -41.96 3.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 33.9 t-80 63.79 -56.18 0.21 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 60' ' ' PHE . 64.6 mt-30 -71.6 -31.84 67.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 61' ' ' HIS . 17.2 p90 38.73 27.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.472 -0.767 . . . . 0.0 110.174 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -82.99 138.34 42.94 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.374 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 19.2 Cg_exo -49.97 -48.92 17.63 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.107 1.871 . . . . 0.0 112.933 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.94 -36.33 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 0.0 110.236 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -47.07 83.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 111.271 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 96' ' ' ILE . 19.4 m -67.66 -33.46 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.517 -1.364 . . . . 0.0 109.326 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.585 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.28 -20.58 65.59 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.01 -9.14 40.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.0 mmm -82.75 119.68 24.64 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.57 173.81 7.43 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.347 -0.846 . . . . 0.0 110.449 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.61 -29.85 39.71 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.52 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -60.96 -48.46 81.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.987 -1.07 . . . . 0.0 108.177 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.16 -41.52 98.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 92' ' ' ILE . 70.3 t -56.7 -42.36 76.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.682 -0.636 . . . . 0.0 109.983 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -58.18 -39.18 78.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 108.661 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 35.0 ttm-85 -61.74 -40.29 94.58 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 0.0 109.294 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 59' ' ' CYS . 63.1 mt -65.43 -33.25 75.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.608 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.18 -36.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 108.404 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -106.49 -2.93 21.44 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.829 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 84' ' ' GLY . 46.4 t0 -78.38 106.71 10.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.15 -1.594 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 67.56 -19.81 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.575 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 71.5 36.03 62.79 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.4 pt -29.28 -94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 122.127 -0.631 . . . . 0.0 110.544 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.3 tt -170.58 -37.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.128 -0.982 . . . . 0.0 109.07 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 86' ' ' ILE . 17.9 mmt180 -72.03 156.02 39.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.802 0.81 . . . . 0.0 110.595 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -111.01 178.87 4.21 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 10.3 ptp180 -56.7 -43.8 80.9 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 110.58 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -56.38 -57.95 16.75 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.342 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.46 -43.25 97.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.071 -1.252 . . . . 0.0 110.161 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.631 HG21 HG13 ' A' ' 76' ' ' VAL . 19.4 mm -57.64 -52.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -50.91 -32.64 21.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.843 -1.161 . . . . 0.0 108.881 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -64.35 -42.02 96.45 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -0.925 . . . . 0.0 108.563 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 92' ' ' ILE . 80.2 mt -65.66 -42.23 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.388 -0.82 . . . . 0.0 109.121 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 68' ' ' VAL . 15.9 mm -60.02 -44.24 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.73 92.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -57.67 -37.85 74.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -1.11 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.58 -47.14 76.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 109.197 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.585 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 12.2 mmt180 -56.67 -38.19 71.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.92 -30.61 70.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.94 -44.0 90.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.0 -37.16 83.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.028 -1.045 . . . . 0.0 109.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.09 -38.63 88.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.0 108.704 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -70.13 -40.35 74.9 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.641 0.734 . . . . 0.0 109.321 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.03 -23.74 65.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.93 -6.18 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.26 26.29 74.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -118.07 108.26 42.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -52.79 145.64 38.92 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.985 1.79 . . . . 0.0 112.381 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.618 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -59.26 -46.88 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.209 1.004 . . . . 0.0 109.372 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.82 68.33 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 109.846 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.81 -47.92 82.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.97 -1.081 . . . . 0.0 111.806 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.618 ' CD2' ' O ' ' A' ' 112' ' ' PHE . 12.5 p90 -71.62 -43.62 65.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.804 -1.185 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.598 HG11 ' CD2' ' A' ' 31' ' ' LEU . 1.9 p -65.16 -54.45 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.358 -1.464 . . . . 0.0 110.129 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.552 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 53.7 m95 -55.14 -23.45 21.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.05 -1.032 . . . . 0.0 108.25 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.72 -29.58 70.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 108.966 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 171' ' ' LEU . 2.9 t -86.94 9.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.025 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 65.1 35.21 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 44.2 35.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.748 . . . . 0.0 110.373 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -146.97 147.52 29.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.62 142.05 62.86 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.462 2.108 . . . . 0.0 112.023 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.0 132.06 55.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 108.814 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 34.6 ttp -89.55 127.35 35.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.93 -1.107 . . . . 0.0 109.415 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.55 130.12 43.79 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 109.29 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -91.92 27.31 2.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.194 -0.941 . . . . 0.0 110.754 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.728 ' CB ' HD13 ' A' ' 135' ' ' ILE . . . -64.61 142.56 58.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.728 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.6 p -109.02 -35.46 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.68 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 26.7 p -124.96 162.34 24.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.474 -0.766 . . . . 0.0 109.609 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.8 -36.28 71.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 109.177 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -79.27 0.14 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 108.992 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HB3' ' H ' ' A' ' 131' ' ' THR . 40.7 tp10 -103.01 8.4 38.92 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.728 HD13 ' CB ' ' A' ' 129' ' ' ALA . 5.5 mm -93.58 126.0 51.64 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -70.91 139.74 36.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.489 1.459 . . . . 0.0 112.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -111.73 5.03 18.92 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -145.72 86.91 1.75 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.682 . . . . 0.0 109.304 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.17 162.77 18.63 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.94 -41.14 77.47 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.25 1.3 . . . . 0.0 111.8 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.95 74.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 108.585 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -64.32 -44.71 90.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.501 -0.749 . . . . 0.0 109.643 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.95 -37.61 86.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.21 -31.98 64.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.54 -48.16 73.4 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.369 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -57.41 -42.27 81.98 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.63 -1.293 . . . . 0.0 108.493 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -65.0 -42.28 94.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.494 -0.754 . . . . 0.0 109.887 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.608 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.4 -47.9 68.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.48 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 1.8 mm? -63.48 -40.23 96.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.21 -0.931 . . . . 0.0 109.157 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -60.28 -39.11 85.7 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.959 -1.088 . . . . 0.0 110.123 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -71.42 -35.74 71.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 111.304 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.608 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.64 -1.87 10.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.775 -1.203 . . . . 0.0 109.653 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.6 17.8 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 18.3 m-85 -93.49 111.33 22.97 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.746 -1.182 . . . . 0.0 107.816 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -97.35 174.07 6.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 0.0 110.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.432 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 91.3 m-85 61.71 61.51 1.43 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.193 0.997 . . . . 0.0 109.092 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.0 m -137.13 41.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -37.44 160.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.572 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 28.0 m -57.78 -30.02 65.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.57 -0.959 . . . . 0.0 109.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -77.73 -34.91 52.4 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.01 -37.56 77.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.568 . . . . 0.0 110.072 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 159' ' ' THR . 32.0 p -67.27 -47.2 71.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.176 -0.952 . . . . 0.0 109.045 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.27 -42.21 84.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.069 . . . . 0.0 109.888 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.49 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 20.8 m -58.79 -42.46 89.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -38.3 81.4 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.203 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 19.2 mtm -63.46 -36.14 82.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 110.869 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 164' ' ' SER . 35.3 mt-30 -57.57 -44.29 85.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.926 -1.109 . . . . 0.0 110.782 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.426 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . . . -89.84 -17.85 27.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.995 -1.065 . . . . 0.0 110.334 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.37 -26.06 68.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.486 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.53 50.09 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 120' ' ' VAL . 88.4 mt -62.53 -37.3 85.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.633 -0.922 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.8 138.27 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 109.555 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 84.1 m-20 -121.69 135.99 54.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.544 -0.722 . . . . 0.0 110.622 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER 156.06 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.715 -0.616 . . . . 0.0 110.914 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.472 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.6 m170 55.88 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.126 -0.984 . . . . 0.0 108.664 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 178' ' ' GLY . 21.5 m -136.57 40.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 177' ' ' VAL . 0.4 OUTLIER 34.8 27.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.749 0.785 . . . . 0.0 109.966 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -162.4 34.66 0.34 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.64 130.2 39.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.447 -1.031 . . . . 0.0 109.438 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 86.3 m -50.72 -39.39 51.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.0 m -70.5 -32.62 70.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.693 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 183' ' ' PRO . 69.0 t80 -77.97 135.75 62.75 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 185' ' ' ASN . 37.3 Cg_endo -68.17 129.71 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.016 1.81 . . . . 0.0 111.902 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.91 6.54 9.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 183' ' ' PRO . 7.3 m120 59.03 25.01 13.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.854 -0.792 . . . . 0.0 109.211 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 185' ' ' ASN . 3.1 mptp? 44.65 73.33 0.99 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.612 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo . . . . . 0 C--N 1.306 -1.676 0 C-N-CA 122.536 2.158 . . . . 0.0 112.198 -179.489 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.861 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -94.96 155.29 16.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.192 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD3' ' H ' ' A' ' 3' ' ' ARG . 0.7 OUTLIER -57.26 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 109.505 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -117.07 159.31 22.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.546 -0.721 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -44.57 97.99 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.273 -0.892 . . . . 0.0 111.214 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.82 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -83.5 -0.45 50.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.76 -1.435 . . . . 0.0 109.493 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.53 -48.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.1 m -77.79 -0.59 27.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -81.46 -49.0 11.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.495 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -147.82 158.1 42.97 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 108.945 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.755 ' HA ' HD12 ' A' ' 14' ' ' ILE . 52.8 Cg_endo -71.48 -24.52 22.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.526 2.151 . . . . 0.0 113.002 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.28 -38.53 89.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.844 -1.16 . . . . 0.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.66 -36.56 84.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 11' ' ' PRO . 40.4 mt -58.06 -44.38 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 110.41 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -68.71 -50.98 46.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.423 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -62.15 -37.89 86.91 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.667 -1.27 . . . . 0.0 109.48 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -73.62 -44.27 57.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.619 -0.676 . . . . 0.0 111.633 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -72.37 -7.74 51.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 3.6 m-20 -91.33 -72.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.767 -1.208 . . . . 0.0 111.344 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.57 81.67 1.1 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.867 -1.146 . . . . 0.0 110.892 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.865 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 16.9 t-105 -80.34 71.16 7.13 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.69 55.42 22.78 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.635 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.3 t -107.01 -39.74 0.16 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.401 -1.058 . . . . 0.0 109.545 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 83.1 Cg_endo -97.88 153.24 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.497 2.798 . . . . 0.0 112.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -66.36 148.38 51.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 169' ' ' CYS . 82.8 p -95.2 159.29 15.08 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.977 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -96.2 167.94 10.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -61.98 -37.18 83.82 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.932 -1.105 . . . . 0.0 110.664 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -71.47 -39.83 70.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 112.596 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 15.3 mmmt -56.26 -37.04 69.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.653 -1.279 . . . . 0.0 109.108 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 31' ' ' LEU . 3.1 mt -57.33 -37.59 72.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.567 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.8 -47.03 85.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.575 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -69.9 -38.87 76.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.232 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 39.9 tpp -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.54 -0.725 . . . . 0.0 111.212 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -69.55 -27.58 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -70.03 -42.3 73.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.814 -1.179 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 5.4 mp -73.89 -39.05 64.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 72.1 mm-40 -63.43 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 110.202 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.86 -38.42 59.79 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.295 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 42' ' ' ALA . 12.0 tt0 -62.62 -24.73 67.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.963 -1.316 . . . . 0.0 110.194 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.626 ' NE2' ' H8 ' ' A' ' 189' ' ' ADK . 6.5 mm100 -48.27 -6.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.802 -1.186 . . . . 0.0 110.522 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -67.02 112.75 4.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.833 -1.167 . . . . 0.0 109.825 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.13 -27.11 0.2 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.691 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.798 HD12 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -98.16 151.14 20.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.336 . . . . 0.0 110.649 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.5 m -75.79 162.85 27.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.654 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.3 OUTLIER -62.6 -38.37 89.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 0.0 110.868 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.934 -1.104 . . . . 0.0 109.127 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.798 HG21 HD12 ' A' ' 44' ' ' LEU . 15.4 m -63.45 -40.11 96.26 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.728 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -73.64 -33.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 109.635 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.17 -45.18 75.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -42.89 90.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.589 ' HA ' HD22 ' A' ' 55' ' ' ASN . 25.0 ttpp -62.86 -33.81 76.05 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.301 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -57.61 -40.33 78.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -73.33 -47.17 44.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.075 -1.016 . . . . 0.0 111.18 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.589 HD22 ' HA ' ' A' ' 52' ' ' LYS . 20.7 p30 -75.77 -37.56 59.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.689 -1.257 . . . . 0.0 110.427 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 79.0 t80 -58.74 -46.36 87.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.906 -1.121 . . . . 0.0 109.1 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.621 ' O ' ' ND1' ' A' ' 61' ' ' HIS . 20.0 mmm180 -61.76 -31.27 71.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 108.898 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.69 38.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.148 -0.97 . . . . 0.0 111.293 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.64 -44.31 43.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.974 -1.079 . . . . 0.0 111.34 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 56' ' ' TYR . 66.5 m-85 -82.08 -2.99 53.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.96 -1.087 . . . . 0.0 110.562 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' ND1' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -53.9 -30.37 45.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.952 -1.093 . . . . 0.0 109.286 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.67 -35.39 77.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 108.901 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 39.3 m-85 -109.91 -88.76 0.49 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 1.2 m-20 87.62 -73.09 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.74 0 C-N-CA 124.961 1.304 . . . . 0.0 113.938 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 63' ' ' PHE . 24.4 Cg_endo -97.19 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 122.362 1.879 . . . . 0.0 114.844 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.78 -29.86 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 109.033 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.05 -35.64 79.21 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 64' ' ' ASP . 47.3 t -64.61 -36.3 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -62.48 -20.21 64.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.32 -10.39 32.88 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 93.2 mtp -74.08 109.69 7.77 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.3 pt20 -97.38 -176.17 3.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.787 -0.571 . . . . 0.0 110.017 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -59.86 -32.49 70.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.327 -0.858 . . . . 0.0 110.884 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.507 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 88.5 tt0 -59.49 -47.01 87.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.368 -1.457 . . . . 0.0 109.042 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -35.77 74.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.088 -1.008 . . . . 0.0 108.816 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -57.38 -43.92 83.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.436 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.93 ' O ' HG22 ' A' ' 80' ' ' VAL . 75.5 mt-10 -56.95 -35.7 69.39 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.8 ttm-85 -59.27 -37.57 77.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 76' ' ' VAL . 1.5 mt -68.0 -33.08 73.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.665 -0.647 . . . . 0.0 112.659 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 77' ' ' GLU . 13.5 m -52.0 -17.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.7 -1.25 . . . . 0.0 110.334 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -124.0 13.79 9.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.179 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.8 m-20 -96.99 104.89 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.895 -1.128 . . . . 0.0 110.559 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.84 -15.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.886 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.03 37.82 49.08 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 30.7 pt -47.86 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.567 -0.961 . . . . 0.0 110.019 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.971 HG23 ' H ' ' A' ' 87' ' ' ARG . 11.1 tt -55.63 -105.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.971 ' H ' HG23 ' A' ' 86' ' ' ILE . 13.3 tpt180 -85.03 153.5 22.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.564 -1.335 . . . . 0.0 108.262 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.499 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.42 -33.79 3.78 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.535 -0.728 . . . . 0.0 111.211 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -125.73 -22.8 4.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 111.431 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.24 -91.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.635 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.95 -29.19 68.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.126 -1.22 . . . . 0.0 109.934 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ILE . 12.2 mm -56.9 -56.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.765 -1.209 . . . . 0.0 109.484 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 92' ' ' ILE . 92.9 mt-30 -50.91 -35.41 32.98 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.295 -1.503 . . . . 0.0 108.015 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.0 80.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.78 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' ILE . 96.1 mt -69.24 -33.14 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 110.847 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.79 -48.71 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.729 -1.232 . . . . 0.0 108.82 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.88 -35.04 90.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 95' ' ' ILE . 67.3 m-20 -55.38 -38.66 69.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.186 -1.185 . . . . 0.0 109.574 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.72 79.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.849 -1.157 . . . . 0.0 109.362 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.42 -37.56 86.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.029 -1.044 . . . . 0.0 109.866 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.74 -31.4 72.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 108.905 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.721 ' CE1' ' CE1' ' A' ' 112' ' ' PHE . 63.7 t80 -61.46 -44.18 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.7 mm? -61.84 -33.96 75.1 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -64.24 -38.43 91.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.882 . . . . 0.0 111.459 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.704 ' SD ' ' CG ' ' A' ' 112' ' ' PHE . 8.2 ttm -64.49 -42.76 95.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.69 -1.256 . . . . 0.0 108.757 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.95 -37.99 84.29 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.267 0.556 . . . . 0.0 109.576 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.0 -24.55 67.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -88.18 -10.9 48.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.129 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.33 27.67 73.55 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.226 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 4.8 tt0 -116.88 103.47 52.19 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.103 -1.233 . . . . 0.0 110.343 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.77 138.59 41.29 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.833 1.689 . . . . 0.0 112.011 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.721 ' CE1' ' CE1' ' A' ' 102' ' ' TYR . 65.0 m-85 -58.8 -41.78 87.55 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.9 0.857 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.33 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 110.577 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.98 -48.3 79.44 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.109 -0.994 . . . . 0.0 112.346 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.7 p90 -70.79 -43.85 67.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.663 -1.273 . . . . 0.0 110.507 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 117' ' ' TRP . 2.4 p -65.41 -55.39 20.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.848 -1.157 . . . . 0.0 110.868 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.634 ' H ' HG13 ' A' ' 116' ' ' VAL . 48.6 m95 -55.35 -23.07 22.08 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.198 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -75.58 -33.56 60.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.094 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -65.88 -32.5 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.037 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.52 17.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 108.994 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 123' ' ' GLN . 45.3 t30 60.13 43.85 13.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.829 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 11.3 t-160 41.92 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -126.46 151.28 72.5 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.604 -0.685 . . . . 0.0 109.285 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.76 153.73 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.523 2.149 . . . . 0.0 112.184 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -110.29 137.58 47.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 0.0 108.807 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 95.8 mmm -95.14 118.86 32.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.416 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -88.81 122.65 32.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.258 -0.901 . . . . 0.0 108.798 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -93.44 23.1 4.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -72.05 139.11 48.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 109.62 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 m -100.01 -21.88 15.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 108.63 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -140.88 163.82 31.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.248 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.58 -39.53 76.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.323 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.1 p -64.22 -29.65 70.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -80.36 5.64 14.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 108.954 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 135' ' ' ILE . 4.5 tp -83.05 129.19 62.22 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.891 . . . . 0.0 108.905 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.73 137.0 31.71 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.132 1.888 . . . . 0.0 112.248 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.5 p -105.66 0.1 26.06 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.529 -0.732 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.1 t -147.18 92.34 2.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.39 -0.819 . . . . 0.0 108.995 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.405 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -105.03 158.26 32.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -54.17 -40.41 82.08 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.835 1.69 . . . . 0.0 111.186 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.91 -40.48 63.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 139' ' ' THR . 67.7 p -67.81 -38.02 82.75 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.176 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.12 -41.09 95.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -0.97 . . . . 0.0 108.669 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.29 64.35 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.417 HD12 ' HE2' ' A' ' 115' ' ' PHE . 9.4 tp -64.26 -45.5 87.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.579 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 11.6 m -62.88 -40.47 97.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.147 -0.97 . . . . 0.0 109.595 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -60.3 -41.67 93.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.504 -0.747 . . . . 0.0 111.111 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -46.06 66.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.814 -1.178 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.23 -36.9 82.64 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.128 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -60.6 -41.55 94.97 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.063 -1.023 . . . . 0.0 110.016 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -80.15 -16.63 54.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.742 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -84.44 2.72 39.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.71 19.09 49.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 6.5 m-85 -98.87 113.47 25.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.214 -1.168 . . . . 0.0 109.123 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -89.13 175.1 7.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.388 0.613 . . . . 0.0 110.002 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 55.13 59.31 4.08 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.701 0.762 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 157' ' ' VAL . 8.0 m -135.67 35.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.336 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.0 166.06 1.06 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.2 p -58.45 -30.7 67.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -1.104 . . . . 0.0 109.365 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.3 m -67.48 -39.63 85.27 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.02 -44.13 88.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.9 m -64.11 -41.02 97.41 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.452 -0.78 . . . . 0.0 109.846 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -44.19 89.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.241 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -61.78 -40.14 94.14 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.65 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -61.45 -38.5 87.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 82.1 mtp -65.58 -34.64 78.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 111.629 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 6.7 pt20 -63.68 -42.01 98.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.684 -1.26 . . . . 0.0 111.683 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.492 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -85.91 -24.65 26.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 111.697 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.718 ' O ' HG23 ' A' ' 26' ' ' THR . 0.9 OUTLIER -65.97 -22.38 66.47 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.762 -1.211 . . . . 0.0 110.431 -178.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.0 2.7 58.16 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.453 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 12.3 mt -65.92 -32.01 73.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.77 -0.841 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.94 148.32 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.062 -1.024 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 20.5 m120 -113.76 164.85 13.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 3.9 m-20 90.26 81.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.082 0.468 . . . . 0.0 110.257 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.543 ' O ' HG13 ' A' ' 176' ' ' VAL . 53.3 m170 -52.68 -46.14 67.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.042 -1.036 . . . . 0.0 108.825 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 178' ' ' GLY . 4.8 m -158.1 29.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.458 -0.777 . . . . 0.0 110.202 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 129' ' ' ALA . 25.9 t 53.01 2.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 109.927 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -141.05 32.37 2.11 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.943 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 182' ' ' TYR . 50.6 t -90.61 112.08 23.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 109.024 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.5 ' C ' ' H ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -42.55 -39.33 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.03 24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.627 -0.67 . . . . 0.0 109.623 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 180' ' ' CYS . 55.4 t80 -105.46 103.14 41.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.748 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.55 135.65 70.31 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.895 1.73 . . . . 0.0 112.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.16 -14.17 0.56 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -84.78 8.76 16.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 108.972 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 150.44 96.75 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.942 . . . . 0.0 109.358 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 C--N 1.311 -1.409 0 C-N-CA 122.735 2.29 . . . . 0.0 112.367 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.865 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.419 0.628 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -94.31 170.3 9.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.329 -0.857 . . . . 0.0 108.866 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.3 mtm-85 -107.0 168.39 9.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.597 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 1.2 m -64.34 153.46 38.35 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.78 98.47 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.345 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.818 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -84.31 -3.21 58.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.61 -1.524 . . . . 0.0 109.448 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.2 t -80.86 -35.15 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -76.88 4.93 8.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 10' ' ' ASP . 1.3 mm-40 -90.64 -159.38 0.61 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -44.75 155.6 0.38 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.001 -1.062 . . . . 0.0 108.914 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HA ' HD12 ' A' ' 14' ' ' ILE . 20.4 Cg_endo -63.25 -16.65 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 0.0 112.228 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.2 mt -58.42 -39.68 80.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -67.92 -36.24 79.84 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.061 -1.024 . . . . 0.0 109.335 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 11' ' ' PRO . 91.7 mt -58.39 -44.85 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.781 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.11 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.737 -1.227 . . . . 0.0 109.554 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.438 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 3.1 t80 -66.62 -35.84 81.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 55.4 t-80 -61.58 -41.17 97.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 111.69 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 6.2 m-20 -96.6 -1.67 46.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.827 -1.17 . . . . 0.0 112.358 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -103.41 -30.05 10.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.529 -1.357 . . . . 0.0 112.324 -178.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.7 mt-10 -155.97 24.73 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.144 -1.597 . . . . 0.0 111.507 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.925 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.6 t90 -98.87 65.25 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 98.49 62.58 0.87 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.687 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.796 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -157.89 -35.61 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.152 -1.205 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.796 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 98.6 Cg_endo -98.41 149.97 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.363 2.042 . . . . 0.0 112.331 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.2 166.77 22.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -99.45 130.16 45.69 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.567 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.91 157.1 16.99 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 m -56.69 -34.68 67.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.901 -1.125 . . . . 0.0 109.187 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -67.53 -41.57 84.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -63.92 -38.96 93.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.987 -1.071 . . . . 0.0 110.152 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -61.04 -35.97 78.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 109.656 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -66.96 -50.25 62.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 110.95 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -66.84 -40.14 87.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.79 -1.194 . . . . 0.0 109.629 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.583 ' C ' ' SD ' ' A' ' 34' ' ' MET . 10.0 tmm? -62.75 -50.72 69.95 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.684 -0.635 . . . . 0.0 110.763 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.546 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.1 tp -62.32 -27.49 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.07 -45.35 74.07 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.552 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' HE ' ' A' ' 53' ' ' ARG . 39.0 mt -70.39 -44.37 68.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.125 -0.985 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 161' ' ' ILE . 47.0 mm-40 -61.94 -32.79 73.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -37.3 76.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -87.07 -2.99 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -1.119 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 HG11 ' A' ' 49' ' ' VAL . 73.2 mt-30 -81.5 -0.92 44.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.088 -1.007 . . . . 0.0 109.86 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.99 112.99 7.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.205 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.81 -33.62 5.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 48' ' ' THR . 5.6 mp -102.61 152.55 21.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.266 . . . . 0.0 110.325 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 m -64.56 156.73 28.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.419 -0.801 . . . . 0.0 108.97 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.667 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.2 OUTLIER -60.71 -35.09 75.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.74 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -30.92 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.84 -1.163 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.691 HG21 HD23 ' A' ' 44' ' ' LEU . 87.7 m -58.12 -42.41 85.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.836 -1.165 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -71.17 -31.93 45.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.535 -0.728 . . . . 0.0 109.379 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 tp -55.35 -49.25 72.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.085 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -58.35 -42.73 87.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -65.32 -31.05 71.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.211 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 37.7 ttm180 -54.38 -44.78 72.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -69.59 -38.95 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.597 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.16 -42.71 59.5 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 111.012 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.73 -49.99 75.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.912 -1.117 . . . . 0.0 110.495 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 61' ' ' HIS . 3.1 ptm180 -59.69 -30.79 69.03 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.939 -1.1 . . . . 0.0 109.005 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.4 93.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB3' HD22 ' A' ' 79' ' ' LEU . 71.2 m -75.15 -43.83 50.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.979 -1.075 . . . . 0.0 110.291 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 62' ' ' GLN . 76.6 m-85 -96.55 18.69 13.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.075 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' ARG . 19.7 t60 -42.36 -24.5 0.05 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.513 -0.742 . . . . 0.0 111.367 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . 75.3 mm-40 -51.07 -29.59 13.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.74 -1.225 . . . . 0.0 109.08 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.67 50.51 10.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -0.931 . . . . 0.0 111.614 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.669 ' H ' ' CE ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -140.82 80.49 17.69 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.609 -1.307 . . . . 0.0 108.678 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -40.22 -22.78 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.272 1.981 . . . . 0.0 112.981 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' ASP . 74.0 t -65.87 -44.09 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.953 -1.092 . . . . 0.0 109.871 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.669 ' CE ' ' H ' ' A' ' 64' ' ' ASP . 5.3 pttp -65.93 -33.21 75.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.109 -0.994 . . . . 0.0 109.044 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 84.4 t -60.25 -38.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 108.951 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.532 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.04 -19.24 65.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.19 -15.51 18.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 78.1 mtp -68.88 113.78 6.6 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 18.7 tt0 -96.16 174.12 7.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.328 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 95.7 mt-10 -52.17 -32.06 34.28 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.98 -45.45 82.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.2 -38.1 87.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.947 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 92' ' ' ILE . 53.8 t -62.04 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 2.5 pt-20 -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.978 -1.077 . . . . 0.0 108.156 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.3 ttm-85 -63.77 -48.01 78.66 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 59' ' ' CYS . 66.2 mt -70.78 -34.47 71.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.761 -0.587 . . . . 0.0 110.99 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' LEU . 4.2 t -48.28 -17.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.513 ' N ' ' C ' ' A' ' 79' ' ' LEU . 5.7 mt-30 -110.8 -12.14 14.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.2 t0 -83.15 109.66 17.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.98 -17.35 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.145 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 78.79 36.89 27.66 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLY . 6.4 pt -47.19 175.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -1.197 . . . . 0.0 108.35 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.64 95.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.13 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 31.5 ptt180 -54.92 125.09 18.83 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.714 0.769 . . . . 0.0 109.305 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.7 m-70 166.96 78.36 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -48.73 -32.33 8.32 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.91 2.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -60.55 -39.96 89.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.327 . . . . 0.0 109.409 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.601 HG21 HG13 ' A' ' 76' ' ' VAL . 99.1 mt -59.8 -40.3 82.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.177 -0.952 . . . . 0.0 109.09 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 8.0 mm-40 -55.44 -36.35 66.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 108.893 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.69 85.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.05 -43.26 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.2 mm -59.59 -43.63 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.42 -36.09 90.29 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -60.06 -35.82 75.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -1.111 . . . . 0.0 109.834 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.23 83.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.045 . . . . 0.0 109.214 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.0 mtt180 -62.2 -36.09 80.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.364 -0.835 . . . . 0.0 109.318 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.74 81.89 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.242 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.98 -43.49 95.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.8 mt -60.97 -25.62 66.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.513 ' NE2' ' OD1' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -67.37 -41.58 84.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 110.057 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' GLN . 94.2 mmm -66.13 -40.28 90.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.125 -0.984 . . . . 0.0 108.688 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.3 mm-40 -70.69 -39.93 73.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.275 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.14 -23.85 64.23 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.513 ' OD1' ' NE2' ' A' ' 104' ' ' GLN . 4.4 m120 -93.89 -9.76 36.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.3 24.35 74.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -117.46 101.64 52.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.17 147.33 66.14 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.325 2.017 . . . . 0.0 112.523 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.772 ' HB3' HD12 ' A' ' 31' ' ' LEU . 35.9 m-85 -60.7 -39.35 88.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.523 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.35 -32.57 74.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.946 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.35 -46.7 82.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.669 -1.27 . . . . 0.0 112.204 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.8 p90 -73.02 -43.84 61.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.632 -1.292 . . . . 0.0 110.999 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 112' ' ' PHE . 2.1 p -62.87 -54.0 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.629 -1.294 . . . . 0.0 110.37 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.574 ' H ' HG13 ' A' ' 116' ' ' VAL . 34.2 m95 -53.94 -27.04 28.51 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -76.26 -35.52 58.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.576 -0.702 . . . . 0.0 109.941 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -61.89 -31.09 71.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.8 p -97.99 17.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 63.41 33.56 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.685 -0.634 . . . . 0.0 110.401 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' TRP . 95.9 m-70 51.44 29.32 5.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.136 -0.978 . . . . 0.0 110.95 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.448 ' H ' HG13 ' A' ' 120' ' ' VAL . 62.2 mt-30 -135.34 142.56 41.95 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.961 -1.087 . . . . 0.0 109.906 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.27 147.98 43.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.266 1.977 . . . . 0.0 111.671 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.417 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -120.0 126.48 50.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 90.2 mtp -102.74 116.0 31.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 108.753 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.613 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -89.72 144.43 25.98 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.43 28.35 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 111.78 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.64 134.87 51.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 0.0 108.504 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.9 p -97.17 -21.59 17.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 110.228 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.3 p -129.3 162.15 28.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.91 -36.35 76.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.412 -0.805 . . . . 0.0 109.38 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 62.4 p -68.2 -29.7 68.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.96 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -83.41 6.42 20.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -86.86 143.2 35.01 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.06 145.6 31.42 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.525 2.15 . . . . 0.0 112.865 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.43 0.6 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.481 ' O ' ' OG ' ' A' ' 138' ' ' SER . 10.8 p -145.68 94.74 2.54 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.503 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -106.02 153.98 39.83 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.65 -37.61 91.16 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.752 1.635 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.89 58.12 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.642 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.503 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 60.6 m -63.15 -42.24 99.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.966 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -60.81 -39.62 89.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 109.231 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.54 77.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.41 -47.84 83.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 109.625 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.641 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 13.8 t -63.48 -43.71 96.51 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.196 -0.94 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.58 -44.26 94.57 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB1' ' NH1' ' A' ' 152' ' ' ARG . . . -72.17 -44.35 63.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.137 -0.977 . . . . 0.0 109.367 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.566 HD23 HH21 ' A' ' 152' ' ' ARG . 75.3 mt -65.39 -39.1 91.82 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.287 -0.883 . . . . 0.0 109.738 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.47 -39.35 90.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.973 -1.079 . . . . 0.0 109.695 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.32 -30.61 71.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 110.071 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.566 HH21 HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -72.86 0.66 10.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.954 -1.092 . . . . 0.0 108.642 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.88 26.55 24.12 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.815 -1.184 . . . . 0.0 110.297 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -97.11 112.43 24.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 0.0 109.745 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -91.38 168.96 11.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.97 64.19 1.8 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 108.482 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.69 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.1 p -153.52 41.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.95 -175.39 0.08 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 p -66.62 -26.7 67.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -1.048 . . . . 0.0 110.415 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -70.99 -34.05 71.01 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 38' ' ' GLU . 34.2 mm -70.5 -44.56 76.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.094 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 146' ' ' SER . 7.3 m -64.95 -36.02 83.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.522 -0.736 . . . . 0.0 109.655 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.687 ' CD2' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -69.69 -45.96 67.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 110.87 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.607 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 87.1 p -63.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.875 -1.141 . . . . 0.0 109.188 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -62.44 -49.28 76.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.576 -0.702 . . . . 0.0 110.365 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.05 -40.62 96.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.008 -1.057 . . . . 0.0 111.148 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.687 ' NE2' ' CD2' ' A' ' 163' ' ' TYR . 2.9 mp0 -74.76 -40.77 61.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.906 -1.121 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.86 60.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.051 -1.031 . . . . 0.0 112.536 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.436 ' HB3' HG22 ' A' ' 26' ' ' THR . 36.1 m -65.65 -48.72 71.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.676 -1.265 . . . . 0.0 111.964 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.65 -2.38 1.46 Allowed Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.579 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 5.9 mt -59.97 -35.33 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.94 -1.33 . . . . 0.0 110.126 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.54 140.32 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.719 -1.238 . . . . 0.0 110.075 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -110.37 124.04 50.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.613 ' HB3' ' H ' ' A' ' 127' ' ' THR . 13.7 p30 180.0 54.33 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.234 -0.916 . . . . 0.0 111.475 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.9 ' O ' HG13 ' A' ' 176' ' ' VAL . 25.6 m170 -57.94 -46.34 85.22 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.48 -1.387 . . . . 0.0 108.788 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -175.23 18.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.2 t 62.32 -41.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.752 -0.593 . . . . 0.0 110.587 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -81.66 4.87 71.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 49.2 t -69.75 135.18 49.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.27 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -54.16 -37.48 64.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 99.2 m -62.15 -19.71 63.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.345 -0.847 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -60.5 135.46 91.82 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.128 -0.983 . . . . 0.0 109.895 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.54 172.63 15.32 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.54 2.16 . . . . 0.0 112.22 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.97 0.93 54.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -88.3 -69.53 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -1.013 . . . . 0.0 109.065 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -118.38 80.3 16.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.722 2.281 . . . . 0.0 112.367 -179.604 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.925 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.504 ' C ' ' SG ' ' A' ' 180' ' ' CYS . 62.8 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -100.01 139.91 34.99 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -65.96 154.58 38.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.405 -0.809 . . . . 0.0 109.844 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.35 146.74 47.11 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.551 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.3 -24.33 21.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.337 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 4.5 t90 -81.47 9.51 7.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -1.219 . . . . 0.0 109.731 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.4 -25.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 0.0 110.669 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -81.19 6.34 14.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.087 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -86.22 -59.7 2.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -111.4 156.29 41.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 110.311 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HA ' HD13 ' A' ' 14' ' ' ILE . 51.2 Cg_endo -71.28 -37.22 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.966 2.444 . . . . 0.0 113.198 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.23 -35.03 77.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.129 -0.982 . . . . 0.0 110.441 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.687 ' HE2' H3A1 ' A' ' 189' ' ' ADK . 6.4 m-85 -56.55 -36.25 69.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.971 -1.081 . . . . 0.0 109.791 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.9 mp -52.35 -43.94 41.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -67.69 -48.77 65.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.34 -43.13 99.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.57 -43.04 91.0 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.448 -0.782 . . . . 0.0 111.549 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.29 -14.19 61.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 111.605 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 20.6 m120 -73.77 -69.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.626 -1.296 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -175.83 59.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' C ' ' CD1' ' A' ' 21' ' ' TRP . 7.7 t90 -96.42 68.92 2.59 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 129.04 -3.8 6.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.705 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -105.51 -16.98 0.16 Allowed Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.6 -0.941 . . . . 0.0 111.861 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 91.7 Cg_endo -86.44 150.87 9.07 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 121.833 1.688 . . . . 0.0 113.088 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.04 170.86 10.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.74 HG22 ' SG ' ' A' ' 169' ' ' CYS . 1.8 p -91.18 120.36 32.05 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.772 -1.205 . . . . 0.0 111.043 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.2 m-20 -105.74 154.14 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -61.58 -36.66 81.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.811 -1.181 . . . . 0.0 109.825 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -73.17 -50.81 20.53 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 110.97 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -63.94 -25.37 68.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.903 -1.123 . . . . 0.0 108.691 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -59.02 -44.29 91.7 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.5 t80 -68.94 -46.5 68.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 111.155 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.69 -35.29 77.01 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.509 -1.369 . . . . 0.0 109.761 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 38.7 ttm -68.72 -43.79 75.25 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.927 -1.108 . . . . 0.0 110.991 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.895 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.4 tp -63.19 -29.32 46.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.953 -1.092 . . . . 0.0 109.831 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.8 m -71.77 -49.21 40.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.043 -1.036 . . . . 0.0 110.413 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 1.7 mm? -66.23 -42.06 89.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.632 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 32.5 tp10 -66.39 -38.22 87.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.893 . . . . 0.0 109.746 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.55 -36.63 78.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -82.84 -7.77 59.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.221 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.549 ' OE1' ' H8 ' ' A' ' 189' ' ' ADK . 0.9 OUTLIER -89.48 4.17 50.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.075 . . . . 0.0 110.722 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 161' ' ' ILE . . . -63.88 118.82 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 0.0 110.07 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 83.19 -1.01 89.41 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 43' ' ' GLY . 4.5 mm? -107.13 163.36 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.243 -1.151 . . . . 0.0 110.121 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 47' ' ' ILE . 60.6 m -80.98 22.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.669 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.7 OUTLIER 62.96 -39.85 0.17 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 109.758 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' N ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -62.06 -35.47 68.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.921 -1.112 . . . . 0.0 108.225 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.415 ' CB ' HD12 ' A' ' 44' ' ' LEU . 79.0 m -59.24 -44.48 92.36 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.068 -1.02 . . . . 0.0 108.622 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.3 t -69.03 -35.83 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.11 -48.93 72.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.034 -1.041 . . . . 0.0 109.03 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -59.83 -42.62 93.97 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.566 ' HZ3' HG21 ' A' ' 86' ' ' ILE . 1.6 ttmt -62.34 -32.33 73.09 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 40.9 ttm180 -53.66 -45.68 70.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.234 -0.916 . . . . 0.0 109.244 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.02 -44.26 85.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.816 -1.153 . . . . 0.0 108.614 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.532 ' OD1' HG22 ' A' ' 85' ' ' ILE . 24.3 t-20 -63.27 -37.95 89.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 45.1 t80 -56.84 -42.92 80.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 57' ' ' ARG . 15.8 mmm-85 -59.34 -35.59 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 108.906 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.48 96.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 110.399 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.639 ' SG ' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -78.3 -45.87 21.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 111.434 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 87.4 m-85 -95.39 -47.15 6.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.9 -1.125 . . . . 0.0 109.629 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.45 ' CA ' ' O ' ' A' ' 57' ' ' ARG . 77.8 t60 61.98 -51.17 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.851 -0.531 . . . . 0.0 110.106 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.602 ' N ' ' O ' ' A' ' 60' ' ' PHE . 24.8 pt20 -81.61 -35.4 30.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.41 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 43.2 p90 40.26 24.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.517 -0.74 . . . . 0.0 111.144 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.653 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -78.61 153.02 78.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.506 -1.371 . . . . 0.0 108.612 179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.1 -41.77 26.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.607 2.205 . . . . 0.0 114.041 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.1 t -76.41 -38.93 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.621 -1.299 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 8.6 mmpt? -63.83 -42.65 97.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.082 -1.011 . . . . 0.0 108.579 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 64' ' ' ASP . 93.1 t -64.97 -37.89 81.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.258 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.64 63.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.8 -8.5 46.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.7 mtp -83.25 115.76 22.1 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.24 167.44 11.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.65 -31.89 39.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.021 -1.049 . . . . 0.0 110.132 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -55.09 -41.48 71.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 85.3 m-20 -62.45 -37.99 88.02 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 80' ' ' VAL . 55.7 t -63.2 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.472 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 80' ' ' VAL . 79.3 mm-40 -61.96 -40.79 96.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 110.136 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 5.0 ptp180 -75.54 -33.01 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 109.274 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 85' ' ' ILE . 53.6 mt -65.99 -33.23 75.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.907 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 77' ' ' GLU . 20.1 m -54.19 -17.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.67 -1.269 . . . . 0.0 108.843 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.41 -2.33 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.1 t0 -81.55 108.25 14.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.701 -1.249 . . . . 0.0 109.273 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.32 -11.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.612 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.39 34.41 57.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.532 HG22 ' OD1' ' A' ' 55' ' ' ASN . 20.6 pt -52.56 -177.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -1.006 . . . . 0.0 110.344 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.814 HG23 ' O ' ' A' ' 86' ' ' ILE . 19.7 tt -56.98 89.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 32.2 ptt180 -51.91 134.25 31.67 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.628 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.636 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.0 m-70 164.31 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 89' ' ' ARG . 15.6 ptt-85 -42.87 -32.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.079 . . . . 0.0 110.184 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.86 -62.35 6.18 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.912 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 3.2 mptt -63.79 -38.28 90.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.869 -1.371 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.425 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 3.8 pt20 -55.65 -33.08 63.74 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.82 -1.175 . . . . 0.0 108.305 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -63.04 -38.59 91.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 108.811 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.5 -47.35 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 109.224 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.448 -0.783 . . . . 0.0 109.942 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.27 -39.8 90.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -58.93 -35.71 73.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.542 -0.975 . . . . 0.0 109.683 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.78 -46.19 83.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -56.4 -41.61 76.57 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.985 -1.072 . . . . 0.0 108.693 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -62.66 -30.04 71.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.636 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 48.7 t80 -63.32 -43.02 98.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -65.25 -31.9 73.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.6 -40.04 94.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -0.854 . . . . 0.0 110.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.685 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 80.6 mtp -67.52 -37.7 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.63 -41.08 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.085 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.05 -22.15 66.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -93.34 -12.19 30.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.81 27.19 73.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.34 100.46 52.93 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.247 -1.149 . . . . 0.0 109.877 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.2 149.63 84.14 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.381 2.054 . . . . 0.0 112.146 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 33.6 m-85 -63.06 -40.07 96.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 111.195 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.17 77.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.077 -1.014 . . . . 0.0 111.062 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -63.02 -47.02 84.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.184 -0.948 . . . . 0.0 112.606 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -72.14 -44.52 63.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.538 -1.351 . . . . 0.0 110.718 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.584 HG13 ' N ' ' A' ' 117' ' ' TRP . 3.9 p -60.49 -52.09 65.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.603 -1.311 . . . . 0.0 109.446 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 20.7 m95 -55.66 -24.36 33.53 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 6.3 p -65.57 -42.72 91.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 109.98 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.699 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 40.5 m-85 -63.58 -36.47 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.988 -1.07 . . . . 0.0 109.171 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.719 HG21 HD22 ' A' ' 171' ' ' LEU . 1.7 t -86.37 13.9 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.697 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 57.17 31.97 20.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 56.17 32.67 20.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 111.437 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.69 149.75 41.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 110.066 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.58 145.0 68.77 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.809 2.34 . . . . 0.0 112.874 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.58 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.58 132.42 55.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.467 -0.771 . . . . 0.0 109.8 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.58 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.0 mtt -101.46 123.44 45.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.917 -1.114 . . . . 0.0 108.952 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -92.96 -20.41 20.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.879 -1.138 . . . . 0.0 110.16 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 57.22 44.77 21.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.383 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.616 ' CB ' HD12 ' A' ' 135' ' ' ILE . . . -65.01 148.77 51.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.45 ' C ' HG23 ' A' ' 176' ' ' VAL . 0.3 OUTLIER -110.25 -28.3 8.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.447 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 5.2 p -131.9 164.15 26.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.15 -42.22 85.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 108.857 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 95.9 p -72.43 -19.33 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.447 ' CB ' ' H ' ' A' ' 131' ' ' THR . 39.2 tp10 -71.9 -10.42 59.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.807 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.1 tp -74.11 127.13 88.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 120.997 -1.064 . . . . 0.0 108.191 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.61 135.34 17.87 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.979 1.786 . . . . 0.0 113.014 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.6 p -112.13 4.94 18.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.6 t -138.77 93.19 2.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.384 -0.822 . . . . 0.0 109.003 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.57 158.9 50.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.15 -39.06 92.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.901 1.734 . . . . 0.0 111.21 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.64 -44.29 67.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 108.698 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.1 p -62.72 -40.72 98.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -63.28 -37.99 89.4 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.185 -0.947 . . . . 0.0 108.787 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.82 -37.45 84.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.494 -0.754 . . . . 0.0 109.991 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 145' ' ' LEU . 86.4 mt -61.93 -40.49 95.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 109.998 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.627 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 25.2 t -64.35 -51.53 62.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.9 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -67.99 -39.64 83.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.84 -1.162 . . . . 0.0 109.299 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.87 83.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.5 mt -68.02 -35.76 78.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.003 -1.061 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.71 84.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.976 -1.077 . . . . 0.0 109.68 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.09 -32.39 71.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.21 -0.932 . . . . 0.0 110.455 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.474 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 2.6 mmp_? -72.33 -1.0 13.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.969 -1.082 . . . . 0.0 108.826 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.08 26.93 42.5 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 2.9 m-85 -98.45 112.59 24.56 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.758 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -89.8 170.97 9.96 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 59.39 65.84 1.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.921 0.867 . . . . 0.0 109.679 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HA ' HG21 ' A' ' 161' ' ' ILE . 19.8 m -140.97 38.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.43 168.35 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.3 m -57.42 -31.67 66.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.583 -0.951 . . . . 0.0 109.134 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.4 p -71.36 -33.92 70.01 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 42' ' ' ALA . 36.3 mm -65.82 -45.43 91.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.057 0.932 . . . . 0.0 108.533 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 146' ' ' SER . 28.3 m -63.8 -45.18 90.82 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.446 0.641 . . . . 0.0 109.9 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -31.81 73.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.969 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.463 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 29.9 t -59.56 -49.25 78.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.895 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 10.6 m-85 -59.75 -47.6 85.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.471 -1.393 . . . . 0.0 109.131 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' VAL . 95.8 mmm -52.55 -42.22 64.22 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.576 -1.249 . . . . 0.0 108.389 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -43.16 18.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.51 -0.743 . . . . 0.0 111.064 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.22 13.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -0.943 . . . . 0.0 113.088 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.74 ' SG ' HG22 ' A' ' 26' ' ' THR . 0.5 OUTLIER -54.16 -18.91 4.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.628 -1.295 . . . . 0.0 110.861 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.98 -0.47 59.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.719 HD22 HG21 ' A' ' 120' ' ' VAL . 11.7 mt -58.67 -35.14 72.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.403 -1.057 . . . . 0.0 109.348 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 166' ' ' MET . 1.5 m -131.06 143.98 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.14 117.69 34.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.807 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.9 p-10 -178.85 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 174' ' ' ASP . 35.8 m170 -49.1 -39.25 27.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 176' ' ' VAL . 6.2 p 175.62 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' VAL . 1.4 p 30.69 112.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.261 1.029 . . . . 0.0 112.206 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.51 48.47 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 120.696 -1.252 . . . . 0.0 110.569 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 182' ' ' TYR . 1.2 t -66.44 149.83 49.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.715 -1.462 . . . . 0.0 108.676 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.504 ' SG ' ' C ' ' A' ' 1' ' ' MET . 76.4 m -46.25 -38.41 8.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 0.0 109.11 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.6 t -75.31 13.63 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 108.889 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.581 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.6 t80 -118.74 79.22 16.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.685 -0.634 . . . . 0.0 109.467 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.68 151.66 28.64 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.582 2.188 . . . . 0.0 112.176 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 153.1 -28.28 0.8 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 186' ' ' LYS . 53.4 t30 -100.45 -28.16 13.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -1.127 . . . . 0.0 109.292 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 185' ' ' ASN . 25.7 mmtm 42.16 65.47 4.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.54 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.304 -1.767 0 C-N-CA 122.72 2.28 . . . . 0.0 112.138 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.337 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 70.2 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -104.58 141.61 36.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.505 HH12 ' CG1' ' A' ' 14' ' ' ILE . 80.5 mtm180 -83.3 171.01 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.19 143.24 58.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.192 0.996 . . . . 0.0 110.226 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.22 -21.51 32.98 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.186 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 2.5 t90 -77.3 -4.28 44.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.953 -1.322 . . . . 0.0 108.864 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.31 -31.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -70.54 6.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.393 -0.817 . . . . 0.0 110.035 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.36 -105.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.953 -1.092 . . . . 0.0 110.511 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.47 159.97 63.07 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.935 . . . . 0.0 110.439 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 14' ' ' ILE . 38.1 Cg_endo -68.36 -35.58 17.99 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.188 2.592 . . . . 0.0 113.245 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.89 -31.8 71.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.075 -1.015 . . . . 0.0 110.608 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE1' H3A1 ' A' ' 189' ' ' ADK . 14.5 m-85 -58.42 -33.56 69.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 110.964 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.505 ' CG1' HH12 ' A' ' 3' ' ' ARG . 3.4 mp -58.53 -41.03 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.746 -1.221 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -68.01 -50.74 53.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.062 . . . . 0.0 109.452 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -63.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.363 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -66.58 -42.86 86.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 110.373 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -74.65 -10.28 59.38 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.2 m120 -69.6 -76.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.885 -1.134 . . . . 0.0 108.426 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' O ' ' C ' ' A' ' 21' ' ' TRP . 94.6 mt-10 -151.92 -39.5 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 1.052 ' HE1' ' NE2' ' A' ' 167' ' ' GLN . 8.4 t90 -3.38 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.808 0.813 . . . . 0.0 111.241 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 142.41 -23.68 2.36 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.142 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.71 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 11.6 m -125.5 10.87 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.663 -0.904 . . . . 0.0 112.676 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 73.5 Cg_endo -75.72 143.79 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.346 1.364 . . . . 0.0 112.874 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -86.12 148.3 25.76 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.64 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.6 p -88.25 120.6 29.77 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.522 -1.271 . . . . 0.0 111.436 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.881 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -105.89 159.26 16.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 m -64.67 -38.08 89.78 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.466 -1.396 . . . . 0.0 110.469 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -75.13 -49.92 18.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 111.866 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -59.23 -40.49 86.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.949 -1.094 . . . . 0.0 109.398 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.881 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.5 mp -62.69 -38.24 89.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.317 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 1.3 t80 -59.88 -39.46 85.39 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.472 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 37' ' ' LEU . 61.3 mt-10 -74.12 -39.82 63.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.311 -0.868 . . . . 0.0 108.936 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.471 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 26.0 ttm -59.5 -49.61 77.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.835 . . . . 0.0 110.848 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 10.9 tp -62.13 -35.26 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.673 -1.267 . . . . 0.0 108.817 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 72.2 m -67.23 -36.98 82.8 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.599 ' CD1' HH21 ' A' ' 57' ' ' ARG . 1.8 mp -73.21 -48.76 32.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 72.1 mm-40 -63.19 -37.55 87.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.826 . . . . 0.0 108.859 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.46 -35.88 92.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -74.48 -8.63 56.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.966 . . . . 0.0 109.382 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -74.21 -5.64 43.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.51 122.87 14.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.011 -1.055 . . . . 0.0 109.283 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.62 -25.99 0.28 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 42' ' ' ALA . 87.6 mt -105.48 144.61 32.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -1.144 . . . . 0.0 110.233 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -75.75 157.52 33.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.5 OUTLIER -56.91 -34.51 68.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.498 -0.752 . . . . 0.0 110.296 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -35.35 67.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -62.69 -44.31 96.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.333 -0.855 . . . . 0.0 109.983 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.31 -24.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.219 -0.926 . . . . 0.0 109.168 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.54 -47.87 82.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.0 110.003 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -61.4 -49.68 75.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.913 -1.117 . . . . 0.0 109.033 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.21 -5.82 50.68 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.067 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.3 ttm180 -65.9 -55.74 15.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -66.2 -45.84 79.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.663 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -66.24 -45.87 79.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.956 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 92' ' ' ILE . 56.7 t80 -63.44 -46.3 86.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.875 -1.14 . . . . 0.0 110.476 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.701 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -54.31 -34.42 60.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.856 -1.153 . . . . 0.0 109.676 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.29 79.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.087 -1.008 . . . . 0.0 110.469 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.79 -43.7 62.45 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 112.638 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.794 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 66.6 m-85 -111.72 -46.22 3.27 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.739 -1.225 . . . . 0.0 112.079 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.701 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -91.25 61.23 4.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.235 -177.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.619 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 88.1 mt-30 -49.78 -35.68 23.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 156.65 -0.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.275 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.45 94.81 48.81 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.916 -1.115 . . . . 0.0 109.892 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -51.44 -26.9 22.77 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.319 2.013 . . . . 0.0 112.063 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.71 -46.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -65.4 -34.61 78.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 96' ' ' ILE . 96.6 t -60.34 -37.55 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.818 . . . . 0.0 109.53 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -69.75 -15.28 63.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.53 -5.07 49.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 0.0 109.853 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.672 ' O ' HG21 ' A' ' 96' ' ' ILE . 72.1 mmm -77.97 116.5 18.51 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -95.12 175.69 6.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.201 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.86 -33.57 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.716 -0.615 . . . . 0.0 110.542 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -57.83 -42.0 83.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 84.8 m-20 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.822 ' O ' HG23 ' A' ' 80' ' ' VAL . 88.1 t -62.53 -40.09 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.461 -0.774 . . . . 0.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -66.04 -40.26 90.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 7.1 ptp180 -74.61 -38.71 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.717 -1.239 . . . . 0.0 109.225 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 10.4 mt -65.49 -32.35 73.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.73 . . . . 0.0 110.615 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.3 t -48.24 -38.36 8.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.14 2.02 45.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.738 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.7 t70 -87.43 110.6 20.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 81.67 -15.13 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.676 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.05 37.41 49.72 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 85' ' ' ILE . 1.4 pt -58.74 -166.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.197 -1.178 . . . . 0.0 110.107 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 86' ' ' ILE . 15.7 tt -66.98 94.46 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 0.0 109.463 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.615 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 4.6 mtt-85 -51.78 117.86 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.915 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.699 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 1.4 m80 170.62 68.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -48.73 -34.16 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.26 -62.65 6.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.699 ' HZ1' ' CG ' ' A' ' 88' ' ' HIS . 33.7 mtmm -62.44 -40.68 97.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.085 -1.244 . . . . 0.0 110.322 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 56' ' ' TYR . 43.8 mm -61.18 -43.89 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.959 -1.088 . . . . 0.0 110.513 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 3.2 pt20 -58.99 -36.43 74.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.796 -1.19 . . . . 0.0 109.368 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -68.49 -36.59 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.17 -31.14 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.672 HG21 ' O ' ' A' ' 71' ' ' MET . 15.8 mm -58.56 -46.25 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.807 -1.183 . . . . 0.0 108.395 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.1 -33.19 86.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -56.16 -42.2 76.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.194 . . . . 0.0 109.826 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.28 -47.6 67.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.087 . . . . 0.0 108.894 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 34.1 ttm180 -56.77 -36.25 69.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.458 -0.776 . . . . 0.0 109.1 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.43 72.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.057 -1.027 . . . . 0.0 108.927 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.7 -42.66 97.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.0 mm? -61.44 -32.95 72.94 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -63.62 -36.69 84.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.587 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.3 tpp -64.23 -40.76 96.71 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.028 0.918 . . . . 0.0 108.899 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.6 -38.98 92.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.5 -24.31 66.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -90.97 -15.84 29.02 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.6 27.19 73.58 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.644 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.99 101.93 47.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.195 -1.179 . . . . 0.0 109.565 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.53 138.16 14.46 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.769 1.646 . . . . 0.0 112.383 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -51.88 -39.12 58.46 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.237 1.018 . . . . 0.0 109.198 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.12 65.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 109.957 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -66.63 -48.64 68.82 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 111.892 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.658 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 7.8 p90 -73.95 -38.29 64.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.54 -1.35 . . . . 0.0 111.274 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.658 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.5 m -66.92 -52.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.318 -1.489 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.589 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.3 m95 -55.03 -27.13 42.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 t -76.14 -40.0 53.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.464 -0.773 . . . . 0.0 110.541 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.28 -24.88 65.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.284 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.0 m -100.84 19.11 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.418 -0.801 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.63 36.19 22.55 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.76 -0.588 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 52.68 37.3 23.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 111.218 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.08 149.85 25.94 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 109.315 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.83 150.78 62.27 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 112.2 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 172' ' ' VAL . 4.6 tm0? -102.43 132.0 48.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 98.2 mmm -94.23 117.81 30.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 109.233 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -93.07 119.46 32.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.64 21.45 4.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.031 -1.043 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -67.48 142.22 56.68 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.484 -0.76 . . . . 0.0 109.697 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.512 HG22 ' CG2' ' A' ' 177' ' ' VAL . 58.2 p -106.61 -25.01 11.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 108.865 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -130.12 164.27 24.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.549 -0.72 . . . . 0.0 109.092 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.4 mt -57.66 -35.0 69.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 108.773 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.2 t -61.06 -35.95 78.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.53 0.52 25.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.2 tp -79.84 125.9 81.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.26 132.36 13.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.764 1.643 . . . . 0.0 112.725 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 p -111.65 7.15 20.35 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -144.92 89.35 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.527 -0.733 . . . . 0.0 109.462 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.1 p -108.99 151.93 42.16 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.601 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.63 -34.69 74.57 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.667 1.578 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HB1' ' HE1' ' A' ' 166' ' ' MET . . . -72.95 -45.76 56.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.451 -0.781 . . . . 0.0 109.0 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.7 p -69.01 -36.69 78.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.28 -0.887 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.49 -38.95 93.1 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.76 -27.24 63.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.642 ' CD1' HG12 ' A' ' 116' ' ' VAL . 6.5 tp -69.03 -44.95 71.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.723 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 7.7 t -62.62 -47.09 85.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.913 . . . . 0.0 110.868 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -65.06 -37.83 88.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.775 -1.203 . . . . 0.0 109.879 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.36 -44.83 70.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.1 -1.0 . . . . 0.0 109.389 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.55 ' HB3' HG11 ' A' ' 157' ' ' VAL . 1.2 mm? -63.24 -38.31 90.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -61.29 -41.08 96.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.144 -0.972 . . . . 0.0 110.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -68.65 -36.58 78.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.97 -1.081 . . . . 0.0 111.762 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.474 ' NH2' HD22 ' A' ' 149' ' ' LEU . 14.5 mtm180 -71.11 7.05 1.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.78 -1.2 . . . . 0.0 110.143 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.68 57.2 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -95.34 112.57 24.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.218 -1.166 . . . . 0.0 108.015 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.44 174.95 6.6 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 59.68 48.65 9.12 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.564 0.697 . . . . 0.0 109.875 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 149' ' ' LEU . 35.9 m -122.27 43.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.67 160.1 0.48 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -56.8 -30.91 64.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.64 -0.917 . . . . 0.0 109.881 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -75.6 -31.45 59.95 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -72.48 -35.99 53.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.2 m -69.28 -40.58 77.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.803 . . . . 0.0 109.38 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.51 -45.24 76.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.632 ' OG ' ' N7 ' ' A' ' 189' ' ' ADK . 33.6 t -61.35 -39.34 90.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.563 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 47.9 t80 -58.54 -47.78 83.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.714 -0.616 . . . . 0.0 110.445 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.499 ' HE1' ' HB1' ' A' ' 141' ' ' ALA . 63.9 mtp -72.43 -39.56 67.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.055 -1.028 . . . . 0.0 109.536 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 1.052 ' NE2' ' HE1' ' A' ' 21' ' ' TRP . 1.4 tm0? -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 110.211 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.502 ' HB2' ' N6 ' ' A' ' 189' ' ' ADK . . . -78.34 -38.71 41.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 109.882 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 44.3 m -54.53 -16.95 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.343 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.55 -1.31 58.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 26' ' ' THR . 85.3 mt -61.95 -30.91 71.23 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -1.078 . . . . 0.0 109.525 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 125' ' ' GLN . 5.3 t -116.14 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 6.4 m-80 -125.01 162.41 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 15.3 t0 89.3 69.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.126 0.489 . . . . 0.0 110.563 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -51.59 -59.09 4.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.78 160.71 36.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.512 ' CG2' HG22 ' A' ' 130' ' ' THR . 56.3 t -60.14 113.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.524 -1.36 . . . . 0.0 108.793 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.75 67.33 1.69 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.747 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.565 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 5.3 t -84.33 72.17 10.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.816 -1.403 . . . . 0.0 109.222 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.5 OUTLIER 31.55 33.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.68 -0.637 . . . . 0.0 111.488 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER 178.88 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.59 -1.319 . . . . 0.0 110.391 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.526 ' CE2' ' CG ' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -87.29 114.69 59.79 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.412 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 59.1 Cg_endo -76.88 136.9 17.15 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.108 1.872 . . . . 0.0 112.054 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -135.21 -7.19 2.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.589 ' OD1' ' N ' ' A' ' 186' ' ' LYS . 31.0 p-10 -98.31 -57.37 2.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.18 . . . . 0.0 109.991 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.589 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 16.5 mttt -99.41 153.29 37.86 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.938 . . . . 0.0 109.491 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.634 2.223 . . . . 0.0 111.985 179.818 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.186 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 41.6 mtm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 3' ' ' ARG . 1.1 tm-20 -88.92 140.75 29.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 108.955 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.643 ' CG ' HH11 ' A' ' 3' ' ' ARG . 2.2 mtt-85 -93.65 170.65 9.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 3.4 m -57.94 154.75 11.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.618 0.723 . . . . 0.0 110.254 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.13 -44.79 96.11 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.487 -0.758 . . . . 0.0 112.478 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.879 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -80.49 1.22 30.23 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.474 -1.604 . . . . 0.0 109.828 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 3' ' ' ARG . 2.2 t -89.39 -47.7 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.829 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -77.77 6.28 7.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 0.8 OUTLIER -91.58 -58.93 2.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.787 -0.571 . . . . 0.0 110.492 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.88 160.0 67.15 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.615 ' HA ' HD12 ' A' ' 14' ' ' ILE . 31.5 Cg_endo -69.66 -32.11 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.041 2.494 . . . . 0.0 112.728 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.31 -40.26 89.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.121 -0.987 . . . . 0.0 109.477 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 6' ' ' TRP . 29.5 m-85 -65.92 -38.52 88.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.977 -1.077 . . . . 0.0 109.702 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 11' ' ' PRO . 89.3 mt -55.69 -40.56 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.394 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -72.5 -51.74 18.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.974 -1.079 . . . . 0.0 109.419 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.9 -41.54 96.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.776 . . . . 0.0 109.991 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CG ' HG21 ' A' ' 7' ' ' VAL . 57.9 t-80 -62.47 -45.5 92.75 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.639 -0.663 . . . . 0.0 110.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -74.06 -7.38 52.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.448 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.511 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 11.1 m120 -81.01 -77.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 110.288 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' GLY . 92.7 mt-10 -154.71 71.69 0.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 110.343 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.873 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 31.4 t-105 -70.14 63.31 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 67.83 64.99 2.88 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.018 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.731 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 25.5 t -114.67 -36.2 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.425 -1.044 . . . . 0.0 109.742 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.731 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 41.6 Cg_endo -95.21 151.8 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.962 2.441 . . . . 0.0 112.989 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.34 143.24 56.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 169' ' ' CYS . 23.7 p -99.01 155.51 17.39 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.95 . . . . 0.0 111.863 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -97.72 166.68 11.37 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 m -57.33 -37.09 71.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.091 -1.006 . . . . 0.0 110.398 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -65.46 -42.47 92.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 111.035 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -59.05 -34.87 72.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.175 -0.953 . . . . 0.0 109.035 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.7 mt -65.54 -33.26 75.5 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.84 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.92 -50.33 64.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 0.0 110.181 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -68.81 -30.21 68.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.83 -1.169 . . . . 0.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 168' ' ' ALA . 6.0 tpt -70.28 -50.23 41.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.64 -29.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.62 -48.18 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.043 . . . . 0.0 110.022 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.67 -39.01 84.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 69.2 mm-40 -62.89 -31.19 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 109.939 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.34 -41.6 55.2 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.123 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 57.7 mm-40 -67.89 -29.82 69.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.694 -1.474 . . . . 0.0 110.974 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.533 HE22 ' CB ' ' A' ' 164' ' ' SER . 9.6 pt20 -41.3 -31.94 0.26 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 0.0 109.829 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.63 116.98 7.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.01 -1.056 . . . . 0.0 108.716 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.451 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 86.66 -36.74 3.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.024 HD12 HG21 ' A' ' 48' ' ' THR . 4.5 mm? -105.14 150.04 25.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.164 -1.198 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 t -76.62 150.28 36.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 1.1 t-105 -54.72 -35.59 63.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -41.04 90.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.067 -1.021 . . . . 0.0 108.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 1.024 HG21 HD12 ' A' ' 44' ' ' LEU . 44.0 m -57.84 -38.42 75.59 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.8 t -66.5 -37.25 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD12 ' CZ ' ' A' ' 53' ' ' ARG . 37.1 tp -56.21 -50.6 70.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.06 -1.025 . . . . 0.0 108.671 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -57.49 -37.76 73.46 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -73.18 -24.25 60.53 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 42.2 ttm180 -55.12 -45.06 75.53 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.08 -40.71 91.07 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 3.5 m-20 -69.08 -31.92 71.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.886 0.85 . . . . 0.0 108.984 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 52' ' ' LYS . 58.7 t80 -56.14 -50.89 69.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.2 ptm180 -67.31 -28.0 67.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.048 -1.033 . . . . 0.0 109.22 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.57 -36.47 82.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 110.262 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.96 -45.62 26.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.66 ' O ' ' N ' ' A' ' 62' ' ' GLN . 98.4 m-85 -91.43 -48.59 6.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.926 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER 59.94 -45.32 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.694 -0.628 . . . . 0.0 111.102 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -57.73 -32.86 67.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.322 -0.861 . . . . 0.0 111.259 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.15 26.66 2.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.722 -1.236 . . . . 0.0 109.658 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.659 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -118.64 96.03 49.55 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -31.65 17.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.26 1.974 . . . . 0.0 113.168 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.91 -46.52 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.716 -1.24 . . . . 0.0 109.975 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.515 ' HB2' HE21 ' A' ' 62' ' ' GLN . 0.3 OUTLIER -66.78 -33.02 74.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.774 -1.204 . . . . 0.0 109.207 179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.91 -37.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.762 ' HB1' ' NH2' ' A' ' 100' ' ' ARG . . . -65.61 -17.2 64.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.2 -10.94 29.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.642 -0.662 . . . . 0.0 109.734 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.58 114.39 9.61 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.062 -1.024 . . . . 0.0 108.686 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 62.6 tt0 -95.89 172.77 7.81 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 94.3 mt-10 -51.79 -30.48 23.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.825 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -55.48 -44.33 76.38 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 119.909 -1.744 . . . . 0.0 108.44 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 70.6 m-20 -70.86 -35.26 72.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.478 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.96 -34.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.258 -1.526 . . . . 0.0 109.3 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.72 -40.86 98.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -70.68 -34.42 71.98 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.443 -1.303 . . . . 0.0 108.967 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' C ' ' N ' ' A' ' 81' ' ' GLN . 72.9 mt -68.26 -34.94 77.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.3 t -49.38 -19.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 79' ' ' LEU . 12.8 mt-30 -106.52 -15.42 14.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.483 -0.76 . . . . 0.0 109.912 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 82.1 m-20 -78.9 109.86 13.57 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.703 -1.199 . . . . 0.0 109.948 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.0 -18.9 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.32 33.01 61.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLY . 9.7 pt -36.22 156.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.649 -0.912 . . . . 0.0 110.234 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.45 -35.04 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.301 -0.874 . . . . 0.0 110.39 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.5 147.29 53.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.935 -178.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 97.7 m-70 -124.16 170.69 10.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.59 -0.694 . . . . 0.0 109.38 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 88' ' ' HIS . 35.3 ttp180 -40.14 -35.78 0.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.19 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.66 -64.02 2.34 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 7.5 mptt -60.39 -36.99 79.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -1.19 . . . . 0.0 110.107 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.548 HG21 ' HB ' ' A' ' 76' ' ' VAL . 97.7 mt -59.87 -47.48 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.632 -1.292 . . . . 0.0 109.292 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -52.5 -34.82 51.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.06 -1.025 . . . . 0.0 108.71 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.67 89.02 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.507 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.83 -43.75 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 108.673 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.41 -41.77 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 108.646 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -38.07 93.44 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.78 -37.97 71.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.446 -1.032 . . . . 0.0 109.482 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.02 83.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.027 -1.045 . . . . 0.0 109.406 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.762 ' NH2' ' HB1' ' A' ' 69' ' ' ALA . 5.1 tpp180 -55.0 -39.44 69.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.268 -0.895 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.82 -29.93 69.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 59.2 t80 -64.24 -43.06 96.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.1 mm? -63.2 -28.95 70.4 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.69 -41.55 83.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.219 -0.926 . . . . 0.0 111.362 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.678 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.8 mtp -69.1 -37.29 78.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.749 -1.22 . . . . 0.0 109.293 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.65 -39.85 84.58 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -70.47 -15.77 62.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -92.95 -11.98 31.96 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.39 21.44 79.59 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.68 101.24 53.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.192 -1.181 . . . . 0.0 109.374 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.35 146.1 95.86 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.157 1.905 . . . . 0.0 112.273 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.6 m-85 -59.66 -45.21 92.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.98 -28.41 69.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 118' ' ' SER . 17.3 t70 -59.45 -52.46 65.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.964 -1.085 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -75.08 -39.87 60.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.64 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 18.5 t -59.0 -54.75 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 120.619 -1.301 . . . . 0.0 109.9 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 122' ' ' HIS . 56.1 m95 -62.02 -21.99 65.34 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 108.958 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 50.6 m -68.46 -37.47 80.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 109.254 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 18.3 m-85 -69.37 -31.26 69.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.403 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.611 ' O ' HG12 ' A' ' 120' ' ' VAL . 39.3 t -87.99 15.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.836 -1.165 . . . . 0.0 109.711 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.585 ' OD1' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER 78.78 11.38 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.699 -0.626 . . . . 0.0 109.836 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 65.7 20.57 11.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 110.893 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 58.0 mt-30 -146.51 150.94 42.07 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.941 -1.099 . . . . 0.0 109.236 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -49.24 142.25 22.11 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.862 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -110.77 142.62 42.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.565 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 92.1 mmm -99.93 130.26 46.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -92.73 123.04 35.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.093 -1.005 . . . . 0.0 109.879 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -91.93 27.35 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.79 . . . . 0.0 110.284 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -91.06 132.97 35.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.5 p -93.51 -22.36 18.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.127 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 49.4 p -133.64 167.85 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.016 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 -33.56 73.41 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.6 t -73.92 -13.17 60.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 110.43 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -94.16 4.05 54.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mm -92.49 122.35 64.57 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.83 140.78 32.56 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.84 1.693 . . . . 0.0 112.516 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.9 p -101.62 3.35 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.8 p -144.99 87.5 1.83 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.442 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.76 155.17 36.64 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -54.51 -36.52 88.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.879 1.719 . . . . 0.0 110.741 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.74 -43.12 59.99 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.809 -0.756 . . . . 0.0 108.984 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.8 p -70.18 -38.13 75.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.139 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.28 -38.93 91.23 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.177 -0.952 . . . . 0.0 108.881 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -68.83 -34.55 75.68 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.298 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mp -57.5 -46.29 83.95 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 0.0 108.639 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.545 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 8.9 t -60.7 -50.29 74.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.105 -0.997 . . . . 0.0 108.954 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -61.29 -40.41 94.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 109.267 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.99 22.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.83 -33.13 74.6 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -61.32 -42.24 98.34 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.982 -1.074 . . . . 0.0 109.671 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -68.45 -28.4 67.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.945 . . . . 0.0 110.55 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.408 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 3.3 mmp_? -72.7 1.35 8.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.906 -1.121 . . . . 0.0 108.675 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 78.59 27.32 57.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.64 112.88 24.58 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.652 0.739 . . . . 0.0 109.848 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -88.1 176.77 7.14 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.13 62.72 1.56 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.011 -1.056 . . . . 0.0 108.23 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.6 m -144.03 41.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.42 154.79 4.07 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 m -52.54 -32.01 38.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.27 -1.135 . . . . 0.0 109.557 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -72.09 -29.93 64.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.25 -0.906 . . . . 0.0 108.725 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.67 -44.92 96.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.815 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 146' ' ' SER . 97.9 m -60.8 -39.02 87.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.47 -47.81 53.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 111.063 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.533 ' CB ' HE22 ' A' ' 41' ' ' GLN . 19.9 m -63.43 -36.77 84.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.044 -1.035 . . . . 0.0 108.696 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 5.3 t80 -60.15 -46.24 90.35 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.153 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 171' ' ' LEU . 12.5 ptp -71.49 -34.08 69.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.511 -1.368 . . . . 0.0 110.626 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' NE1' ' A' ' 21' ' ' TRP . 2.7 tm0? -61.48 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.818 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.564 ' HB3' ' CE ' ' A' ' 34' ' ' MET . . . -87.14 -22.98 25.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.199 -0.938 . . . . 0.0 111.592 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.609 ' O ' HG23 ' A' ' 26' ' ' THR . 1.5 m -68.76 -19.31 64.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.964 -1.085 . . . . 0.0 111.102 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.49 0.83 57.93 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 166' ' ' MET . 11.5 mt -63.37 -30.97 72.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.615 -0.932 . . . . 0.0 109.426 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.07 142.15 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 75.0 m-20 -111.71 164.11 13.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.794 ' OD2' HG22 ' A' ' 177' ' ' VAL . 5.5 t0 86.71 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.597 0.713 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.477 ' CD2' ' CD1' ' A' ' 21' ' ' TRP . 20.9 m170 -54.35 -48.26 71.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -152.07 38.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.484 -179.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.794 HG22 ' OD2' ' A' ' 174' ' ' ASP . 24.0 t 45.15 13.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.0 110.672 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -157.4 31.74 0.53 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.117 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 7.1 t -93.77 146.25 24.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -1.222 . . . . 0.0 109.873 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -67.84 -21.4 65.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.702 . . . . 0.0 110.762 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.5 t -97.59 -29.41 13.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.942 -1.099 . . . . 0.0 112.573 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.46 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -67.47 133.05 92.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.215 -1.553 . . . . 0.0 109.81 -178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.82 126.98 11.82 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.433 2.089 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.96 -32.52 0.8 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -155.52 11.95 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -1.001 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.34 82.7 24.33 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.516 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 -179.598 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.879 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' H3 ' ' HA ' ' A' ' 180' ' ' CYS . 70.5 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.69 154.38 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -75.04 159.31 31.88 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.37 152.93 40.69 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.274 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.03 -25.86 25.59 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.303 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 1.8 t90 -75.78 13.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.028 -1.278 . . . . 0.0 109.623 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.9 t -138.74 -23.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 110.269 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -71.83 5.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 109.949 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -115.39 -75.45 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.341 -0.85 . . . . 0.0 110.57 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.02 139.46 90.46 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.986 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 -53.21 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.526 2.151 . . . . 0.0 113.194 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -54.91 -33.91 62.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.912 -1.118 . . . . 0.0 109.742 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.701 ' HE2' H3A1 ' A' ' 189' ' ' ADK . 3.3 m-85 -52.89 -40.18 63.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.12 -39.84 43.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.447 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -72.18 -51.1 22.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.96 -1.087 . . . . 0.0 109.535 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 22.7 t80 -60.76 -41.08 94.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 0.0 109.72 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.608 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 39.3 t-80 -58.66 -44.85 90.26 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.47 -0.769 . . . . 0.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.92 -30.36 68.81 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.645 -0.659 . . . . 0.0 110.836 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 18.5 m120 -60.21 -53.56 56.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 111.126 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' GLY . 10.9 pt-20 176.05 72.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.2 -0.938 . . . . 0.0 110.334 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.709 ' CZ3' ' HC2' ' A' ' 189' ' ' ADK . 44.9 t-105 -70.52 60.73 0.22 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 71.27 49.67 25.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.604 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -107.18 -42.63 0.13 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.322 -1.105 . . . . 0.0 110.563 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.9 Cg_endo -91.14 151.87 3.8 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.261 2.641 . . . . 0.0 113.183 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.39 144.21 54.82 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 p -99.16 148.79 23.73 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.102 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 31' ' ' LEU . 76.8 m-20 -96.41 166.43 11.7 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -56.01 -31.5 63.13 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.777 -1.202 . . . . 0.0 109.632 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -65.65 -43.0 90.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.565 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmtm -63.72 -34.96 79.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.131 -0.981 . . . . 0.0 109.125 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.4 mm? -56.22 -41.67 76.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.718 -0.614 . . . . 0.0 109.643 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -69.57 -43.17 73.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' O ' HD22 ' A' ' 37' ' ' LEU . 77.1 mt-10 -69.35 -45.39 69.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.86 -1.15 . . . . 0.0 109.332 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.9 ttm -62.19 -51.05 69.38 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.493 -0.754 . . . . 0.0 111.146 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.27 -26.16 38.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.853 -1.154 . . . . 0.0 109.716 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.45 -54.02 19.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.941 -1.099 . . . . 0.0 109.737 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.634 ' H ' HD22 ' A' ' 37' ' ' LEU . 2.0 mm? -71.88 -38.51 69.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.145 . . . . 0.0 108.843 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 3.5 tp10 -62.13 -32.34 72.91 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.514 -0.741 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.68 -13.73 82.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.533 HE21 HD13 ' A' ' 95' ' ' ILE . 89.5 mt-30 -92.91 -8.38 43.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.311 . . . . 0.0 111.319 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.667 ' NE2' ' N7 ' ' A' ' 189' ' ' ADK . 2.2 pt20 -80.38 1.83 27.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.573 -1.329 . . . . 0.0 110.176 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -62.87 117.58 6.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -29.31 1.66 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . 19.1 mt -98.46 146.12 26.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -1.114 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 m -67.81 152.66 45.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.507 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.4 OUTLIER -60.21 -37.13 79.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.675 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -67.73 -35.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.088 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -59.57 -42.12 91.73 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.959 -1.088 . . . . 0.0 108.125 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 54.0 t -67.72 -35.06 71.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HB3' HD13 ' A' ' 47' ' ' ILE . 7.3 tt -56.36 -51.67 67.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.148 -0.97 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -57.9 -43.13 85.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -66.92 -28.84 68.62 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.06 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.7 ttm180 -53.52 -43.79 68.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.822 -1.174 . . . . 0.0 109.097 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -73.25 -49.14 29.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.216 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 24.0 p30 -80.95 -42.62 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.757 -1.214 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.601 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 53.1 t80 -62.76 -44.64 95.67 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.809 -1.182 . . . . 0.0 109.937 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.61 -31.82 71.92 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.37 -42.7 98.88 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.018 -1.052 . . . . 0.0 110.335 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB3' HD22 ' A' ' 79' ' ' LEU . 35.3 m -78.37 -43.26 28.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.0 113.087 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 93.3 m-85 -107.4 7.38 29.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.734 -1.229 . . . . 0.0 112.398 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 19.1 t-80 -151.82 60.18 0.86 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.551 -1.343 . . . . 0.0 108.562 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.679 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 89.6 mt-30 -57.41 -42.93 83.25 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.441 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.679 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 85.9 m-85 -163.8 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.217 -0.993 . . . . 0.0 112.288 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' H ' ' HE3' ' A' ' 67' ' ' LYS . 0.8 OUTLIER -100.03 146.24 31.58 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 111.136 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.43 -17.41 30.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.26 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.43 -43.65 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 3.1 mtmp? -67.45 -38.18 84.09 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 60' ' ' PHE . 85.8 t -61.69 -39.25 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.83 -14.94 63.37 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 -9.64 53.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.648 ' O ' HG21 ' A' ' 96' ' ' ILE . 82.3 mmm -77.77 112.28 14.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.467 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.6 pt20 -95.87 -177.07 3.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.341 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.03 -33.44 72.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 110.801 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.0 tt0 -58.58 -43.33 89.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.7 -1.25 . . . . 0.0 109.08 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -65.23 -38.89 91.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.696 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 80' ' ' VAL . 47.3 t -57.75 -44.31 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.726 . . . . 0.0 110.576 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.7 pt-20 -63.18 -35.83 81.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.637 -1.289 . . . . 0.0 108.943 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -69.18 -44.03 73.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLN . 90.2 mt -69.56 -32.86 71.9 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.5 m -47.83 -16.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.438 -1.414 . . . . 0.0 108.928 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LEU . 20.6 pt20 -124.55 -2.18 7.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.637 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -83.76 111.01 18.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.474 -1.391 . . . . 0.0 109.222 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 85.27 -5.46 0.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.899 -0.501 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.91 37.68 60.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -162.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -1.147 . . . . 0.0 109.493 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 98.6 mt -77.25 118.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.942 0.877 . . . . 0.0 109.133 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.6 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.3 mtp180 -80.68 125.64 30.28 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.81 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 77' ' ' GLU . 41.8 ttm180 -44.79 -33.31 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 0.0 109.763 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.63 -59.79 6.82 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.975 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -60.65 -42.21 96.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.843 -1.386 . . . . 0.0 110.862 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.589 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 29.0 mm -62.63 -43.49 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.939 -1.101 . . . . 0.0 110.203 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -31.63 65.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 109.258 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.29 83.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.518 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.533 HD13 HE21 ' A' ' 40' ' ' GLN . 91.4 mt -66.07 -35.73 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.811 . . . . 0.0 110.675 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 71' ' ' MET . 17.0 mm -58.06 -39.88 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.466 -1.396 . . . . 0.0 107.25 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.39 -34.19 89.25 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.06 -40.3 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -1.222 . . . . 0.0 108.472 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.35 86.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.604 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.481 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 98.0 mtt180 -61.49 -36.98 82.0 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.04 -30.75 71.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 108.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.03 -43.32 99.02 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -63.7 -34.52 78.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.97 -39.38 94.52 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.321 -0.862 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.6 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 29.8 tpp -63.91 -46.58 84.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.42 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.37 -38.6 80.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.03 -24.59 64.64 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -91.93 -12.01 34.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.63 26.8 73.65 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.427 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.6 ' O ' ' SD ' ' A' ' 105' ' ' MET . 2.0 mt-10 -120.33 101.93 46.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.219 -1.165 . . . . 0.0 109.868 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.79 142.49 25.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.805 1.67 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 43.9 m-85 -59.86 -38.88 83.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.321 -0.862 . . . . 0.0 110.905 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.23 68.14 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.962 -1.086 . . . . 0.0 110.433 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.82 -47.45 74.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.063 . . . . 0.0 112.292 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.646 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.0 p90 -74.27 -37.66 63.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.52 -1.362 . . . . 0.0 111.154 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 145' ' ' LEU . 30.7 m -63.41 -52.46 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.328 -1.482 . . . . 0.0 109.894 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.609 ' N ' HG23 ' A' ' 116' ' ' VAL . 54.1 m95 -58.41 -25.07 61.71 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.115 . . . . 0.0 108.033 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.9 m -75.86 -38.0 58.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.481 -0.762 . . . . 0.0 110.28 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -62.88 -32.47 73.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 109.819 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.4 p -92.62 19.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.125 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 122' ' ' HIS . 6.4 m120 66.25 34.89 6.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.757 -0.59 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 117' ' ' TRP . 86.2 t60 38.31 33.94 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 0.0 109.907 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.7 pt20 -130.89 153.18 81.63 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.91 140.52 35.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.183 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.26 123.89 50.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.073 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 71.7 mtm -94.71 117.08 29.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.029 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.0 115.35 24.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.268 -0.895 . . . . 0.0 108.974 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.61 19.9 5.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 109.416 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 136.03 55.23 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 176' ' ' VAL . 81.8 p -97.16 -12.22 23.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 0.0 108.969 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 p -140.02 163.62 32.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.499 -0.751 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.42 -34.29 76.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.136 -0.978 . . . . 0.0 109.134 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.9 p -72.92 -19.52 61.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.768 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -84.15 3.88 32.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.452 HD13 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -92.36 138.84 23.97 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.26 135.9 30.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.303 2.002 . . . . 0.0 112.601 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -111.45 1.95 17.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.039 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -147.32 90.06 1.84 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.71 156.71 39.28 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 109.042 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.5 -37.48 90.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.021 1.814 . . . . 0.0 111.338 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.11 -41.92 66.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.899 . . . . 0.0 108.666 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -68.03 -42.28 80.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.82 . . . . 0.0 109.351 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.88 -42.31 90.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.65 74.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.829 HD11 HG12 ' A' ' 116' ' ' VAL . 2.0 tp -60.72 -46.07 91.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.363 -0.836 . . . . 0.0 108.861 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.44 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 5.7 t -58.41 -46.81 85.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 109.669 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.67 -44.63 96.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 109.946 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.77 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.25 -44.8 78.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.36 -36.34 83.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -60.61 -39.44 88.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.448 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 153' ' ' GLY . 25.4 mmtm -64.98 -36.49 84.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.77 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.8 5.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.99 24.98 63.01 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.435 ' HB3' HG11 ' A' ' 157' ' ' VAL . 0.3 OUTLIER -96.86 111.92 23.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.503 -0.998 . . . . 0.0 108.412 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 157' ' ' VAL . 37.4 mtmt -96.28 176.72 5.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 109.71 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 57.61 47.14 16.42 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 154' ' ' PHE . 28.1 m -126.52 36.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.73 171.38 0.05 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.0 p -60.81 -28.13 68.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.148 . . . . 0.0 109.325 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -65.59 -38.31 89.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 38' ' ' GLU . 12.3 mm -68.94 -44.42 81.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 146' ' ' SER . 84.7 m -63.68 -42.64 98.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.611 -0.68 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.428 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.59 -40.95 80.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 110.035 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 38' ' ' GLU . 76.9 p -63.34 -40.21 96.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.916 . . . . 0.0 109.873 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 1.7 t80 -59.32 -43.85 92.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.099 -1.001 . . . . 0.0 109.388 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.0 mtp -62.26 -38.87 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 135' ' ' ILE . 4.6 tp60 -66.17 -41.88 89.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.451 -0.78 . . . . 0.0 111.244 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.63 5.8 41.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.049 -1.032 . . . . 0.0 111.362 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.592 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 21.0 t -96.76 -13.01 22.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.737 -1.227 . . . . 0.0 110.31 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.55 -5.98 57.25 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.592 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -62.94 -33.58 75.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.951 -1.323 . . . . 0.0 109.613 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.02 138.68 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.6 m120 -113.27 164.02 14.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.434 -0.791 . . . . 0.0 110.132 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.6 OUTLIER 92.4 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.377 0.608 . . . . 0.0 110.332 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 16.2 m170 -53.45 -38.6 63.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 176' ' ' VAL . 2.9 p -162.18 55.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 177' ' ' VAL . 13.5 p 23.51 67.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.335 0.588 . . . . 0.0 111.156 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.47 35.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 31.0 t -105.05 148.37 26.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.119 -1.224 . . . . 0.0 109.487 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.481 ' HA ' ' H3 ' ' A' ' 1' ' ' MET . 49.0 t -56.0 -41.42 74.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.821 . . . . 0.0 109.687 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.608 ' SG ' ' CE1' ' A' ' 17' ' ' HIS . 0.8 OUTLIER -59.02 -38.64 79.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.444 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.514 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -102.48 106.83 51.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.87 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 185' ' ' ASN . 39.4 Cg_endo -74.57 141.22 27.72 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.003 1.802 . . . . 0.0 112.67 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 185' ' ' ASN . . . -75.79 11.22 11.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 184' ' ' GLY . 11.5 t-20 78.54 22.59 0.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.689 -0.889 . . . . 0.0 109.768 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -96.92 151.57 37.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo . . . . . 0 C--N 1.313 -1.297 0 C-N-CA 122.451 2.101 . . . . 0.0 112.258 179.874 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.303 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.385 0.612 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.34 154.43 19.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.262 -0.899 . . . . 0.0 109.282 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -92.29 0.1 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.776 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.995 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.676 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.74 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.696 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' C ' ' H ' ' A' ' 62' ' ' GLN . 53.3 m-85 -85.85 18.58 2.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ARG . 9.2 t-80 -56.97 17.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.353 -0.842 . . . . 0.0 111.112 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 60' ' ' PHE . 9.4 pt20 -79.43 -17.98 53.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.951 -1.093 . . . . 0.0 110.651 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 42.3 p90 38.32 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.454 -0.779 . . . . 0.0 110.035 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' GLN . 71.2 m-20 -127.39 91.9 44.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.03 -30.23 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.244 1.963 . . . . 0.0 112.402 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.619 ' SD ' ' NE2' ' A' ' 62' ' ' GLN . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.408 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.408 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 25.4 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.4 t -67.84 79.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 68.93 -48.3 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 179' ' ' CYS . 31.5 t -170.27 71.71 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 183' ' ' PRO . 1.9 t80 -71.66 122.53 87.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 45.5 Cg_endo -74.77 176.01 10.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.231 1.954 . . . . 0.0 112.112 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.72 2.96 34.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.69 -72.83 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -1.113 . . . . 0.0 108.725 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 187' ' ' PRO . 1.4 mptt -111.98 -25.19 0.13 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 110.943 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 186' ' ' LYS . 31.3 Cg_exo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.691 1.594 . . . . 0.0 112.089 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.995 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.199 0.523 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -92.69 167.35 11.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.34 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -118.11 154.66 31.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 131.38 28.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.819 . . . . 0.0 110.043 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.01 -27.97 52.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.23 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 0.7 OUTLIER -85.35 -2.96 58.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.379 -1.071 . . . . 0.0 108.987 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER -95.42 -23.29 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.586 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -63.7 6.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 109.439 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 7' ' ' VAL . 85.0 mt-30 -91.63 -168.37 2.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.4 153.42 1.33 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.4 -0.813 . . . . 0.0 109.869 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.19 -20.72 32.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.63 -37.56 76.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 109.875 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.835 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 2.6 m-85 -67.05 -35.33 79.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.72 -36.68 67.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -68.14 -49.9 58.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.882 -1.136 . . . . 0.0 108.899 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 21' ' ' TRP . 19.6 t80 -63.79 -41.29 97.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 108.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -70.85 -42.07 70.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.683 -0.636 . . . . 0.0 110.8 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.87 -10.45 58.52 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 110.517 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 19.8 m120 -80.02 -76.13 0.23 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.788 -1.195 . . . . 0.0 109.364 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 21' ' ' TRP . 95.6 mt-10 -146.88 -65.41 0.28 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.565 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.3 t90 26.35 63.12 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.377 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 120.5 57.55 0.24 Allowed Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.829 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.841 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 p -176.49 -21.16 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 113.487 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.841 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 72.8 Cg_endo -89.24 150.89 5.55 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.612 1.541 . . . . 0.0 113.258 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.02 156.21 39.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.661 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -91.06 132.12 36.22 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.595 -177.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.93 147.15 29.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -60.85 -35.62 77.03 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -75.26 -50.62 15.55 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.508 -0.745 . . . . 0.0 111.072 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -34.96 77.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.963 -1.086 . . . . 0.0 109.291 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.673 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 65.8 mt -63.29 -36.5 83.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.149 -0.969 . . . . 0.0 109.199 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.29 -43.0 92.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.61 -38.02 80.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.984 -1.072 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.552 ' CE ' ' HB1' ' A' ' 168' ' ' ALA . 53.2 tpp -63.3 -50.65 69.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.679 -0.638 . . . . 0.0 111.006 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 35' ' ' ILE . 11.0 tp -62.94 -27.08 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.228 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.8 t -71.02 -53.92 13.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 108.861 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.07 -38.91 92.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 108.512 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.572 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -67.5 -39.24 85.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 108.891 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.57 94.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.11 -4.89 43.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 109.661 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -78.15 2.82 16.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.116 . . . . 0.0 109.977 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -65.22 132.09 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.043 . . . . 0.0 109.093 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.15 -29.77 0.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 79.7 mt -98.14 139.89 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.608 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.7 m -69.18 154.39 42.13 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.247 -0.908 . . . . 0.0 108.661 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.656 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 1.2 t-105 -55.15 -39.56 69.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.0 . . . . 0.0 109.841 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -37.64 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -0.956 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.451 HG21 HD22 ' A' ' 44' ' ' LEU . 99.9 m -57.98 -41.76 83.65 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.954 -1.091 . . . . 0.0 108.531 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -67.05 -31.65 54.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.809 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -48.59 81.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.088 -1.008 . . . . 0.0 109.939 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 53.1 mttt -62.21 -46.37 89.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.784 -1.197 . . . . 0.0 108.1 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.31 -16.44 61.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttm180 -63.69 -46.51 85.19 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -65.9 -45.41 82.09 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.2 m-80 -67.88 -43.09 80.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.895 ' OH ' HG21 ' A' ' 95' ' ' ILE . 89.8 t80 -60.44 -47.22 87.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 0.0 110.24 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -58.04 -34.2 69.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.042 -1.036 . . . . 0.0 109.837 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.77 95.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.896 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.6 m -72.98 -43.96 61.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.039 . . . . 0.0 111.079 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 84.9 m-85 -96.27 10.03 39.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.055 . . . . 0.0 110.906 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 21.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.839 -1.163 . . . . 0.0 109.662 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 99.3 mm-40 -79.04 -34.78 43.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 91.2 m-85 -161.53 -104.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.0 m-20 154.23 -42.36 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 68' ' ' VAL . 50.9 Cg_endo -94.77 -108.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.657 2.238 . . . . 0.0 115.287 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -37.45 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.615 -1.303 . . . . 0.0 110.891 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -35.34 69.62 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.112 -0.993 . . . . 0.0 110.982 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 65' ' ' PRO . 3.7 m -73.94 -36.35 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.282 -1.511 . . . . 0.0 108.246 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.39 -20.54 59.96 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.91 -11.3 36.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.552 ' CE ' ' OD2' ' A' ' 75' ' ' ASP . 4.1 mmm -75.57 119.86 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.564 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 54.0 tt0 -95.57 168.49 10.66 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 109.901 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 98.1 mt-10 -49.75 -25.74 3.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.955 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 108.076 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -70.13 -37.8 75.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.918 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.606 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 49.5 t -61.8 -44.06 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.63 -0.669 . . . . 0.0 110.749 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.69 -32.81 74.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 108.14 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -67.95 -42.88 80.27 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.605 0.716 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 25.1 mt -69.6 -33.58 72.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 111.722 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 ' NH1' ' A' ' 89' ' ' ARG . 55.2 t -48.24 -31.28 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.892 -1.13 . . . . 0.0 108.527 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -100.43 -4.48 28.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.18 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 57.5 t0 -88.22 109.32 19.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.763 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.34 -16.34 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.472 -0.768 . . . . 0.0 109.656 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.48 35.33 47.59 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.0 pt -54.8 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -1.109 . . . . 0.0 110.207 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -53.53 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' ILE . 59.8 mtp180 -53.19 106.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.407 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.53 92.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.892 ' NH1' HG21 ' A' ' 80' ' ' VAL . 5.4 mtt-85 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.545 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.31 -59.32 7.98 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.229 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -61.42 -43.43 98.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.923 -1.339 . . . . 0.0 110.914 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.563 HG22 HG22 ' A' ' 76' ' ' VAL . 70.0 mt -60.58 -49.15 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.0 110.529 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -57.98 -29.89 65.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.83 -1.169 . . . . 0.0 109.019 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.56 94.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.174 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.895 HG21 ' OH ' ' A' ' 56' ' ' TYR . 84.9 mt -60.61 -40.81 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 mp -58.18 -45.16 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.09 94.13 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -51.38 -44.09 62.06 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.054 -1.262 . . . . 0.0 108.965 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -64.54 -39.93 94.67 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.274 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.97 -37.74 61.46 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.29 70.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' ALA . 42.0 t80 -63.43 -43.43 97.49 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 103' ' ' LEU . 8.4 mp -63.56 -34.76 78.52 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.2 -37.26 84.64 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.329 -0.949 . . . . 0.0 109.546 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 99.1 mmm -70.71 -41.69 71.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 108.339 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.1 mm-40 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -58.75 -24.35 61.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.03 -12.56 28.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.96 24.03 74.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -120.52 101.83 45.8 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.358 -1.084 . . . . 0.0 109.584 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.88 150.23 73.17 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.145 1.897 . . . . 0.0 112.377 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 73.0 m-85 -58.05 -40.68 81.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.351 -0.843 . . . . 0.0 110.489 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.6 72.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.779 . . . . 0.0 112.442 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.93 -53.92 22.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 0.0 111.873 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 1.9 p90 -68.27 -40.93 81.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.006 -1.059 . . . . 0.0 111.658 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 117' ' ' TRP . 14.7 p -64.88 -48.93 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 110.377 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.619 ' N ' HG13 ' A' ' 116' ' ' VAL . 10.9 m95 -55.14 -27.5 45.88 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.3 t -71.8 -36.49 70.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.44 -0.787 . . . . 0.0 110.598 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -66.72 -28.78 68.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -97.25 19.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 20.0 m120 64.11 44.02 4.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.7 -0.625 . . . . 0.0 110.222 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 44.94 12.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 110.527 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mt-30 -131.16 149.92 75.07 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.208 -0.933 . . . . 0.0 109.267 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.444 ' HB2' HD21 ' A' ' 173' ' ' ASN . 32.8 Cg_endo -67.22 162.16 39.76 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.298 1.999 . . . . 0.0 111.722 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.65 135.39 49.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 109.673 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.2 mtt -90.31 116.45 28.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 109.093 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 127' ' ' THR . 1.2 m -89.89 111.4 22.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.209 -0.932 . . . . 0.0 109.1 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -92.51 17.53 9.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 109.286 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.07 141.9 57.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 134' ' ' GLU . 42.6 p -98.82 -11.37 21.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.669 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.408 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 23.7 p -145.34 160.09 42.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.29 -42.71 96.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -65.24 -31.78 73.11 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.494 ' OE1' ' OG1' ' A' ' 130' ' ' THR . 63.6 tt0 -80.85 1.47 30.56 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.597 -0.689 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.83 143.74 27.0 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 108.732 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.15 136.54 12.93 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.202 1.935 . . . . 0.0 112.414 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.3 p -107.17 2.99 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.019 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t -147.24 90.66 1.9 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.416 -0.802 . . . . 0.0 108.988 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.6 p -100.32 152.06 37.72 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.45 -36.6 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.582 1.521 . . . . 0.0 111.269 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -39.65 63.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.515 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 68.5 m -66.42 -46.73 75.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.6 -38.88 82.43 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.029 -1.044 . . . . 0.0 109.154 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.38 63.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -59.47 -46.33 89.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.05 -46.14 88.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.478 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -59.18 -37.91 78.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.752 -0.593 . . . . 0.0 109.614 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.07 68.6 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.286 -0.883 . . . . 0.0 109.854 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 91.9 mt -60.81 -36.4 78.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.6 -39.95 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.088 . . . . 0.0 108.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -65.73 -33.58 76.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 3.7 mmp_? -71.4 3.08 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 109.202 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.1 26.11 38.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.66 116.25 30.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.475 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -92.06 174.47 7.3 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.562 0.696 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 58.78 58.76 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.572 0.701 . . . . 0.0 109.772 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.2 OUTLIER -126.75 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.53 150.5 0.36 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.1 m -53.17 -29.47 31.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.315 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -74.24 -35.51 63.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -66.33 -36.74 78.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -69.48 -38.37 77.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.041 . . . . 0.0 109.394 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.497 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.66 -46.8 74.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.509 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 95.0 p -65.19 -33.34 75.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 108.824 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 49.4 t80 -59.25 -46.07 89.48 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.614 -0.679 . . . . 0.0 109.679 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.447 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 22.0 mtm -63.33 -38.0 89.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.54 ' OE1' HG21 ' A' ' 172' ' ' VAL . 25.9 mm100 -60.44 -42.67 96.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.962 -1.086 . . . . 0.0 109.811 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.552 ' HB1' ' CE ' ' A' ' 34' ' ' MET . . . -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.411 -0.806 . . . . 0.0 109.983 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 66.9 m -58.36 -31.11 67.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.928 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.08 0.44 44.74 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 120' ' ' VAL . 95.8 mt -62.33 -28.72 69.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.969 . . . . 0.0 109.777 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.54 HG21 ' OE1' ' A' ' 167' ' ' GLN . 21.6 t -112.94 147.83 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.038 . . . . 0.0 110.544 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.444 HD21 ' HB2' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -125.57 164.34 20.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.588 ' OD1' ' CZ ' ' A' ' 182' ' ' TYR . 2.2 m-20 76.58 70.39 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.665 -0.647 . . . . 0.0 110.457 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.47 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 22.0 m170 -47.24 -38.19 11.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 108.418 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 176' ' ' VAL . 3.5 p -166.04 18.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.62 HG23 ' C ' ' A' ' 176' ' ' VAL . 1.3 t 65.39 -44.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -83.48 29.6 3.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 182' ' ' TYR . 26.2 t -93.64 120.52 34.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.444 -1.033 . . . . 0.0 109.721 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -46.17 -43.15 14.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.774 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -61.69 -3.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.588 ' CZ ' ' OD1' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -126.04 81.28 66.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 185' ' ' ASN . 1.2 Cg_endo -77.74 -78.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.721 2.281 . . . . 0.0 111.885 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 54.73 4.45 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 183' ' ' PRO . 9.7 p30 -97.49 -13.11 21.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -1.137 . . . . 0.0 109.937 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -93.91 154.77 40.75 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.319 -0.863 . . . . 0.0 109.655 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 122.67 2.247 . . . . 0.0 112.108 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.23 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.02 142.92 33.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.204 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -83.7 168.11 16.58 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.256 -0.903 . . . . 0.0 109.702 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.14 147.76 52.85 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.439 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.16 96.14 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 121.669 -0.644 . . . . 0.0 112.045 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -87.73 -0.68 57.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.486 -1.596 . . . . 0.0 110.124 -179.045 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.21 -44.56 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.141 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m -76.59 7.07 4.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 108.756 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 57.6 tt0 -91.99 -116.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.467 -0.771 . . . . 0.0 109.745 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.5 m-20 -79.41 154.79 76.72 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 108.962 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' O ' ' N ' ' A' ' 13' ' ' TYR . 19.4 Cg_endo -65.16 -160.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.438 2.092 . . . . 0.0 111.88 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' HD11 ' A' ' 47' ' ' ILE . 96.6 mt 61.96 -39.47 0.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.472 -0.768 . . . . 0.0 110.004 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.7 m-85 -63.4 -39.13 93.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.23 -43.73 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -65.49 -51.09 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.424 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 16' ' ' TYR . 1.2 t80 -61.36 -41.52 97.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 48.1 t-80 -70.53 -36.07 73.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.07 -5.04 58.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.081 -1.012 . . . . 0.0 111.008 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.2 m120 -83.75 -77.01 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.692 -1.255 . . . . 0.0 110.492 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -153.18 55.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.961 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 6.7 t90 -103.07 73.65 1.25 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 152.4 -20.71 0.83 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.637 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.712 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 7.9 m -123.4 7.1 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.429 -1.042 . . . . 0.0 113.18 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 71.7 Cg_endo -76.51 149.75 31.1 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.592 1.528 . . . . 0.0 113.416 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -91.88 166.01 12.95 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.606 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 10.5 p -91.71 107.84 19.49 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.481 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD21 ' A' ' 31' ' ' LEU . 96.2 m-20 -84.69 168.58 15.12 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 m -76.99 -41.5 42.64 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.845 -1.16 . . . . 0.0 111.558 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' CD ' ' OH ' ' A' ' 102' ' ' TYR . 26.9 mmtp -76.19 -42.8 45.13 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -58.46 -40.5 82.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.811 -1.18 . . . . 0.0 110.848 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.75 -40.26 79.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 109.712 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 102' ' ' TYR . 80.8 t80 -62.09 -47.76 83.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.57 -40.06 73.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.915 -1.116 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.57 -52.51 63.11 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.0 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.52 -28.21 44.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.037 -1.039 . . . . 0.0 110.132 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.34 -46.85 66.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.014 -1.054 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD12 HG13 ' A' ' 49' ' ' VAL . 4.6 mm? -69.29 -38.83 78.51 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 108.992 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.606 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 59.0 mm-40 -57.75 -36.29 71.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.414 -0.804 . . . . 0.0 109.253 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.7 -42.85 59.39 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' ALA . 62.6 tp60 -65.73 -32.56 74.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 0.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 40' ' ' GLN . 2.2 pp0? -41.89 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.005 -1.059 . . . . 0.0 109.688 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.98 -1.075 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 82.05 -35.62 2.55 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.309 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.0 mm? -95.7 144.39 26.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -1.214 . . . . 0.0 110.304 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.9 m -68.67 153.2 44.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 108.764 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CE3' ' C5 ' ' A' ' 189' ' ' ADK . 0.8 OUTLIER -62.07 -37.0 83.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.003 -1.061 . . . . 0.0 109.81 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.56 -38.52 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.53 -1.356 . . . . 0.0 109.033 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 44' ' ' LEU . 75.1 m -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.643 HG13 HD12 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -63.01 -40.84 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.673 . . . . 0.0 109.401 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.85 -45.68 85.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.779 -1.201 . . . . 0.0 109.11 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -64.41 -37.15 86.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 108.401 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.632 ' HA ' HD22 ' A' ' 55' ' ' ASN . 23.9 ttpp -59.66 -37.27 78.28 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.663 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 77.3 mtt180 -59.39 -39.78 84.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.012 -1.055 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.96 -45.23 78.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.216 -1.552 . . . . 0.0 110.732 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.632 HD22 ' HA ' ' A' ' 52' ' ' LYS . 22.8 p30 -81.69 -39.86 23.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.861 -1.149 . . . . 0.0 110.476 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.525 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 54.2 t80 -60.88 -47.0 88.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.899 -1.125 . . . . 0.0 109.477 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' ND1' ' A' ' 61' ' ' HIS . 21.3 mmm-85 -63.08 -33.87 76.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.117 -0.989 . . . . 0.0 108.829 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.38 70.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.8 m -75.04 -43.3 54.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.039 -1.038 . . . . 0.0 111.448 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -85.04 -1.99 57.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.083 . . . . 0.0 111.044 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.48 ' ND1' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -52.03 -51.8 55.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.99 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.5 -25.49 68.04 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' HG13 ' A' ' 68' ' ' VAL . 98.8 m-85 -102.74 60.49 0.8 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.13 164.17 0.39 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.471 -0.768 . . . . 0.0 109.924 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.973 ' O ' HG22 ' A' ' 68' ' ' VAL . 97.1 Cg_exo -31.55 -66.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 123.694 2.929 . . . . 0.0 114.011 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.39 -38.17 68.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.266 -1.521 . . . . 0.0 109.177 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.14 -32.87 74.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.99 -1.069 . . . . 0.0 110.379 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 65' ' ' PRO . 20.5 m -63.83 -37.25 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.209 -1.557 . . . . 0.0 108.96 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.6 -23.43 58.74 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.46 -9.04 36.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 68' ' ' VAL . 45.0 ttm -77.8 121.34 23.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 6.5 pt20 -95.49 176.7 6.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.23 -35.63 77.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.487 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 41.1 tp10 -54.05 -45.72 71.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.936 -1.102 . . . . 0.0 108.198 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -64.37 -38.13 89.95 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.574 0.702 . . . . 0.0 109.141 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.8 t -60.83 -38.64 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 110.183 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 3.7 pt-20 -72.93 -42.29 63.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.921 -1.112 . . . . 0.0 111.818 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.2 -38.18 63.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.691 -1.256 . . . . 0.0 110.417 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.726 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -67.11 -32.3 73.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.985 . . . . 0.0 109.829 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.8 t -49.71 -24.75 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -85.64 -6.66 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.132 -0.98 . . . . 0.0 108.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.573 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 97.1 m-20 -77.97 108.13 11.01 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.509 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 69.63 -15.49 0.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.698 . . . . 0.0 109.839 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 73.4 34.67 57.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.652 ' O ' ' N ' ' A' ' 87' ' ' ARG . 21.9 pt -46.3 176.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.432 -1.04 . . . . 0.0 109.41 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' ILE . 4.5 tt -52.29 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 85' ' ' ILE . 9.3 ptp180 -54.07 133.33 43.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.863 0.839 . . . . 0.0 110.342 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 4.0 m-70 175.15 65.94 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -46.05 -29.33 1.45 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 110.09 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.35 -61.06 5.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.01 -38.38 85.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.99 -44.43 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 110.043 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.69 -32.35 67.27 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.9 -1.125 . . . . 0.0 108.767 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.75 -37.7 82.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 0.0 109.437 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.1 -32.22 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.7 mm -59.12 -43.97 90.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 108.245 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.23 -29.86 76.34 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -58.62 -43.44 89.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.061 -1.258 . . . . 0.0 109.235 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -63.46 -44.55 94.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.86 -1.15 . . . . 0.0 109.449 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.29 -35.53 69.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.898 -1.126 . . . . 0.0 108.939 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.32 -28.89 64.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.048 -1.033 . . . . 0.0 108.398 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' CD ' ' A' ' 29' ' ' LYS . 80.8 t80 -64.33 -43.22 95.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.0 mp -65.05 -32.95 74.92 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 108' ' ' ASN . 14.5 mm100 -59.4 -39.28 82.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.811 -1.155 . . . . 0.0 108.753 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.525 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 97.6 mmm -67.6 -40.27 84.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.996 -1.065 . . . . 0.0 109.049 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 109' ' ' GLY . 75.9 mm-40 -72.06 -42.24 66.47 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.413 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -57.71 -25.17 59.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 104' ' ' GLN . 41.5 m-80 -92.62 -10.08 38.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.69 23.64 73.96 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -116.53 105.07 50.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.142 -1.211 . . . . 0.0 109.934 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -56.18 152.28 38.92 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.35 2.034 . . . . 0.0 113.01 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.709 ' HB3' HD12 ' A' ' 31' ' ' LEU . 25.5 m-85 -62.42 -38.94 91.63 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.774 0.797 . . . . 0.0 110.706 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.62 -35.48 79.7 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.535 -0.728 . . . . 0.0 111.724 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.46 -43.42 98.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.65 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -74.93 -43.99 51.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.321 -1.487 . . . . 0.0 111.01 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.65 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 14.9 m -58.43 -49.38 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 120.073 -1.642 . . . . 0.0 109.053 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.2 m95 -55.94 -27.41 52.27 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.12 -0.988 . . . . 0.0 108.629 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m -70.58 -41.49 72.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.238 -0.914 . . . . 0.0 111.103 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 30.9 m-85 -67.02 -30.31 70.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.767 -1.208 . . . . 0.0 110.377 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -91.85 15.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 109.597 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.89 36.08 21.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.84 . . . . 0.0 110.371 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 47.38 29.9 1.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -0.992 . . . . 0.0 109.821 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.439 ' H ' HG13 ' A' ' 120' ' ' VAL . 2.6 mm-40 -131.94 148.33 69.43 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.092 -1.005 . . . . 0.0 109.881 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.82 149.37 86.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.51 2.14 . . . . 0.0 111.959 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 126' ' ' MET . 4.2 tm0? -115.34 139.49 49.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.0 109.835 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.555 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.1 mpp? -100.54 118.3 36.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.142 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -72.14 -35.47 69.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 109.21 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 54.4 41.09 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.126 -0.984 . . . . 0.0 109.837 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.53 145.58 29.39 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.47 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.4 p -106.96 -29.55 9.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.696 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 134' ' ' GLU . 24.0 p -134.77 165.67 24.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.658 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.87 -31.99 67.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.494 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -72.79 -10.96 60.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 109.577 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 131' ' ' THR . 79.9 mm-40 -100.92 10.74 40.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.9 mm -98.33 111.91 60.92 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.92 142.86 28.62 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.729 1.619 . . . . 0.0 111.779 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 48.6 p -110.99 7.57 21.63 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -135.14 95.48 3.31 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -116.58 154.42 49.16 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.92 -38.6 86.23 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.719 1.613 . . . . 0.0 111.488 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.27 -43.12 64.76 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.531 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.8 p -62.73 -39.03 92.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 108.651 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.57 -37.55 84.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -66.51 -39.04 88.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.721 -0.612 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 165' ' ' PHE . 5.7 mp -65.62 -40.07 92.18 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.998 -1.064 . . . . 0.0 109.517 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.503 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 14.5 m -59.85 -47.37 86.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.707 -1.246 . . . . 0.0 110.44 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -74.02 -38.03 64.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.867 -1.145 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.53 -43.19 70.08 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.558 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.03 -43.15 79.41 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.19 -0.944 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -64.33 -39.92 94.85 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.863 -1.148 . . . . 0.0 109.727 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -70.18 -26.37 63.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.673 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -76.23 1.85 14.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.056 -1.028 . . . . 0.0 108.38 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.06 26.94 29.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.77 116.03 31.56 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.768 -0.842 . . . . 0.0 108.811 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.12 171.12 9.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 56.47 61.22 2.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 0.0 108.938 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.6 m -139.89 40.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.45 173.72 0.04 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.5 m -59.17 -31.13 68.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.905 -0.762 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 50.4 p -72.36 -34.78 68.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 108.74 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.26 -44.34 97.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 108.813 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 146' ' ' SER . 87.7 m -62.71 -43.98 97.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.76 -44.93 76.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.897 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.522 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 15.9 m -59.62 -41.57 90.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 109.441 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.651 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 3.3 t80 -59.56 -47.29 86.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 109.767 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 76.1 mtp -63.42 -32.71 74.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.29 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -58.18 -44.98 88.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 110.785 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 111.731 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -55.48 -23.61 26.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.95 -1.094 . . . . 0.0 110.441 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.91 -2.16 59.91 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.7 mt -62.79 -27.94 69.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.542 -0.975 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.85 133.07 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.117 -0.989 . . . . 0.0 109.46 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 19.3 m-80 -108.7 163.07 13.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.428 -0.795 . . . . 0.0 109.645 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 85.49 69.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.787 -0.57 . . . . 0.0 110.982 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.493 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 3.4 m170 -55.69 -48.99 74.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 0.0 108.945 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 177' ' ' VAL . 5.7 m -139.33 30.19 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 109.588 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.5 t 52.58 105.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.524 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . 83.74 45.0 6.57 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 145.19 24.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.33 . . . . 0.0 108.677 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 94.3 m -51.53 -47.72 63.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.391 -0.818 . . . . 0.0 111.969 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 17' ' ' HIS . 72.5 m -77.71 11.83 1.94 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.775 -1.203 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -126.32 80.36 69.03 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.451 -0.781 . . . . 0.0 110.182 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -87.13 -73.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 123.241 2.628 . . . . 0.0 111.505 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.87 -49.29 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.57 -75.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -1.07 . . . . 0.0 109.201 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -76.24 150.05 82.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 C-N-CA 122.569 2.179 . . . . 0.0 112.321 -179.793 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.961 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.25 146.33 28.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.861 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -63.32 161.28 14.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.435 -0.791 . . . . 0.0 110.406 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.78 154.07 26.76 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.696 0.76 . . . . 0.0 109.508 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -52.85 -47.96 58.14 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.682 -0.636 . . . . 0.0 112.413 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.872 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.12 -0.52 57.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.433 -1.628 . . . . 0.0 110.496 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 17' ' ' HIS . 7.6 t -77.0 -41.03 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.858 -1.152 . . . . 0.0 109.241 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -71.7 -4.66 28.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 68.9 tp60 -60.62 -42.97 97.93 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.881 -0.512 . . . . 0.0 110.38 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -161.76 159.35 22.52 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.672 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.694 ' HA ' HD12 ' A' ' 14' ' ' ILE . 18.8 Cg_endo -63.29 -35.39 62.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.81 2.34 . . . . 0.0 112.483 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.5 mt -61.83 -39.59 92.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.31 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.759 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.2 OUTLIER -64.48 -40.59 95.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.408 -0.807 . . . . 0.0 109.252 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 11' ' ' PRO . 50.4 mt -56.77 -40.01 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.11 76.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.835 -1.166 . . . . 0.0 109.587 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 2.0 t80 -65.68 -40.14 92.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.778 . . . . 0.0 110.17 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.421 ' CG ' HG21 ' A' ' 7' ' ' VAL . 47.4 t-80 -73.58 -35.53 65.44 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 110.791 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -80.51 -8.72 59.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.168 -0.957 . . . . 0.0 111.775 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 2.9 p30 -84.14 -58.0 2.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.52 -1.362 . . . . 0.0 110.849 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.2 mt-10 -148.69 -54.07 0.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.492 -1.38 . . . . 0.0 109.666 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.96 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 5.8 t90 2.24 66.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.592 0.711 . . . . 0.0 111.607 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 148.63 -21.35 1.32 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.286 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.6 m -119.31 3.09 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.623 0 O-C-N 121.62 -0.929 . . . . 0.0 112.814 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 84.7 Cg_endo -79.93 150.68 21.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.468 1.445 . . . . 0.0 112.837 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -97.98 168.41 10.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.621 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 36.8 p -91.8 118.0 30.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.708 -1.245 . . . . 0.0 110.29 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -108.06 144.47 35.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.9 m -59.99 -35.94 76.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.882 -1.136 . . . . 0.0 109.027 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.62 -50.2 22.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.689 -0.632 . . . . 0.0 110.316 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -27.31 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.84 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 116' ' ' VAL . 2.4 mp -66.86 -36.99 83.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.017 -1.052 . . . . 0.0 109.214 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.8 t80 -64.77 -48.43 74.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.62 -32.09 65.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.757 -1.214 . . . . 0.0 109.11 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -48.82 63.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.633 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.23 -27.8 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.423 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 97.9 m -69.19 -50.05 50.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.185 -0.947 . . . . 0.0 109.898 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' NE ' ' A' ' 53' ' ' ARG . 56.4 mt -67.95 -37.4 81.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.087 -1.008 . . . . 0.0 108.927 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE2' ' N7 ' ' A' ' 189' ' ' ADK . 4.6 tp10 -66.88 -39.15 87.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.623 -0.673 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.44 -35.86 92.31 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -72.23 -6.46 43.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -1.202 . . . . 0.0 109.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -77.04 -1.98 31.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -69.07 121.56 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 108.851 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.58 -31.83 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 42' ' ' ALA . 30.2 mt -101.48 144.09 30.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.117 . . . . 0.0 109.838 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -69.49 156.25 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.663 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.5 OUTLIER -56.99 -36.5 70.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.173 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -35.49 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.428 HG21 HD22 ' A' ' 44' ' ' LEU . 83.5 m -59.24 -41.83 89.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.868 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -68.0 -32.56 56.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.132 -0.98 . . . . 0.0 109.492 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.94 -43.97 94.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.183 -0.948 . . . . 0.0 110.354 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.89 75.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 14.6 mtmm -78.89 -7.4 57.92 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.323 -0.861 . . . . 0.0 109.295 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.2 ttm180 -65.68 -46.86 77.49 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.7 -45.99 67.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.978 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.474 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 38.9 t30 -66.25 -43.16 87.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.537 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 68.9 t80 -59.79 -45.47 92.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.872 . . . . 0.0 110.94 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -61.76 -29.5 70.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.828 -1.17 . . . . 0.0 108.986 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -66.36 -36.21 82.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m -66.95 -45.22 78.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.827 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' A' ' 62' ' ' GLN . 44.8 m-85 -83.26 -43.03 16.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.596 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 64.81 -47.84 0.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 109.928 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 83.4 mt-30 -74.88 -34.13 62.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' HIS . 23.1 p90 40.86 21.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.239 -0.913 . . . . 0.0 110.525 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.7 m-20 -92.54 144.55 28.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 108.991 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 34.2 Cg_endo -67.25 -51.0 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.514 2.143 . . . . 0.0 113.455 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.875 HG22 HD21 ' A' ' 103' ' ' LEU . 91.5 t -61.52 -45.93 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.917 -1.115 . . . . 0.0 110.156 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.14 -37.8 86.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.403 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 64' ' ' ASP . 56.1 t -63.63 -36.91 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -65.1 -18.94 65.72 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.84 -7.88 57.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 96' ' ' ILE . 98.3 mtp -82.99 113.15 20.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.88 177.59 5.72 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.29 -31.78 61.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.224 -0.922 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 -45.08 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 108.237 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -64.27 -38.67 91.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG13 ' CG2' ' A' ' 92' ' ' ILE . 86.9 t -61.23 -42.7 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.423 -0.798 . . . . 0.0 109.856 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.6 -44.22 89.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.519 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 2.4 ptp180 -75.78 -33.62 60.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.857 -1.152 . . . . 0.0 110.001 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -61.6 -32.83 72.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.299 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.6 t -49.3 -34.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 108.662 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.84 -1.02 30.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.6 t0 -80.7 108.82 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.447 -1.408 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.27 -12.21 1.05 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.438 -0.788 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.07 33.29 45.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt -57.47 -166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -1.213 . . . . 0.0 109.332 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.01 95.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.155 -0.965 . . . . 0.0 109.129 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -57.66 109.65 0.75 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.714 0.769 . . . . 0.0 109.34 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 1.8 m80 -178.14 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -50.32 -31.59 14.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.318 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.71 -62.52 6.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -64.52 -40.82 96.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.785 -1.42 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG13 ' A' ' 76' ' ' VAL . 82.9 mt -61.17 -48.91 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.085 -1.01 . . . . 0.0 110.449 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.56 -29.22 66.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.661 -1.275 . . . . 0.0 108.953 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' N ' ' HG3' ' A' ' 93' ' ' GLN . . . -64.3 -37.59 88.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.45 -40.16 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 71' ' ' MET . 20.6 mm -59.93 -43.01 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 108.76 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.93 -35.91 88.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.12 -37.03 76.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -1.118 . . . . 0.0 109.163 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.05 -44.91 87.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.981 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 27.8 mmt180 -60.62 -38.16 83.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.093 -1.004 . . . . 0.0 109.446 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.84 71.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 108.593 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.53 -43.74 96.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.875 HD21 HG22 ' A' ' 66' ' ' VAL . 77.5 mt -63.62 -32.66 74.21 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.22 -35.11 79.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.305 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.59 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.1 tpp -63.8 -43.6 95.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.492 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -37.02 78.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.24 -24.71 66.56 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -93.21 -15.05 26.35 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.91 27.17 73.71 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.442 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' A' ' 105' ' ' MET . 2.0 tt0 -121.52 102.21 42.55 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.136 -1.214 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.53 141.6 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.933 1.755 . . . . 0.0 112.641 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -56.08 -38.76 71.11 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.229 1.014 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.36 -27.76 66.53 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.708 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -68.09 -48.44 65.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.095 . . . . 0.0 111.969 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.633 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.2 p90 -70.8 -37.37 73.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.763 -1.211 . . . . 0.0 110.943 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 145' ' ' LEU . 24.5 m -62.29 -49.05 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.382 -1.449 . . . . 0.0 109.956 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.621 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 26.4 m95 -56.56 -27.1 56.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.2 t -75.73 -36.69 59.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.253 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.2 -26.02 65.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.965 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -96.64 19.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.717 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 69.28 35.93 2.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.765 . . . . 0.0 110.557 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 117' ' ' TRP . 1.1 t-80 45.01 30.23 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.393 -0.817 . . . . 0.0 111.344 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.66 147.99 20.04 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.637 -1.29 . . . . 0.0 110.134 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.05 148.6 85.72 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.613 2.209 . . . . 0.0 111.93 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.623 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -122.06 128.37 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.623 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.2 mtt -103.35 120.73 41.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -87.73 -26.43 22.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.439 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 57.03 45.35 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.77 149.4 50.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.469 ' C ' HG23 ' A' ' 176' ' ' VAL . 53.3 p -102.9 -25.1 13.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.051 -1.031 . . . . 0.0 109.412 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 p -136.17 162.66 32.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.158 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.31 -37.04 79.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 108.945 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.2 m -62.75 -31.42 72.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.372 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -75.19 -0.66 20.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 110.081 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.6 tp -76.46 125.57 87.35 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.999 -1.063 . . . . 0.0 108.314 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 163' ' ' TYR . 55.9 Cg_endo -74.94 136.4 20.48 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.926 1.75 . . . . 0.0 112.454 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.5 p -114.37 6.53 16.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.0 t -152.16 88.28 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.432 -0.792 . . . . 0.0 109.448 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.532 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.7 OUTLIER -102.43 155.4 36.55 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.74 -38.96 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.727 1.618 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.52 -42.06 59.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 139' ' ' THR . 88.2 p -65.86 -39.03 90.35 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.525 -0.735 . . . . 0.0 109.443 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.31 -44.77 86.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.195 -0.941 . . . . 0.0 109.144 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.08 74.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -55.37 -43.78 75.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.656 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.96 -39.29 83.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.168 -0.957 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.45 -43.79 88.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 110.389 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.581 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.49 -45.98 74.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.43 -38.05 89.66 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.88 -40.24 94.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.971 -1.081 . . . . 0.0 110.242 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 153' ' ' GLY . 18.4 mttp -65.28 -38.56 90.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 111.641 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.581 HH21 ' HB1' ' A' ' 148' ' ' ALA . 8.2 mtm180 -71.27 9.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 0.0 110.085 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 76.04 26.14 65.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.97 112.61 24.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 157' ' ' VAL . 34.8 mtmt -93.1 176.62 6.34 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 57.58 54.9 6.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.451 -0.781 . . . . 0.0 109.2 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.3 m -139.16 38.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.57 164.36 0.52 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.9 m -53.98 -34.42 59.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.499 -1.001 . . . . 0.0 109.431 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.5 ' O ' ' OG ' ' A' ' 164' ' ' SER . 32.8 m -68.62 -37.25 79.58 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.1 -44.31 98.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.656 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.1 m -58.05 -51.56 69.17 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -71.66 -37.88 70.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 0.0 111.733 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 160' ' ' THR . 13.4 m -59.12 -40.73 86.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 111.131 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.4 OUTLIER -78.36 -35.47 47.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 110.569 -179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.4 mtp -57.92 -36.15 72.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.657 -1.277 . . . . 0.0 109.291 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.525 ' NE2' ' OD1' ' A' ' 174' ' ' ASP . 9.5 tp60 -61.66 -42.42 98.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.34 -37.8 22.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.536 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -26.12 48.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.273 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.54 -2.39 57.38 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -37.36 73.74 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.243 -1.151 . . . . 0.0 108.753 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 0.9 OUTLIER -137.2 129.66 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 109.063 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.457 ' C ' ' CG ' ' A' ' 174' ' ' ASP . 37.9 t-20 -104.98 125.23 50.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.371 -0.831 . . . . 0.0 108.878 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.525 ' OD1' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -178.98 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.895 -1.128 . . . . 0.0 111.587 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.566 ' H ' ' CD2' ' A' ' 175' ' ' HIS . 3.2 m170 -48.96 -52.12 26.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.97 -1.706 . . . . 0.0 107.13 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 130' ' ' THR . 15.0 p 178.03 150.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 129' ' ' ALA . 27.6 t -62.21 135.37 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.893 -1.129 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 81.76 38.85 12.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.591 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -95.45 107.04 19.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -1.221 . . . . 0.0 109.971 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER 63.87 -55.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 179' ' ' CYS . 94.4 m -157.47 13.76 0.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.89 . . . . 0.0 110.384 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.468 ' HB3' ' H ' ' A' ' 178' ' ' GLY . 1.0 OUTLIER -65.14 119.3 57.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.8 -1.188 . . . . 0.0 108.937 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -75.45 150.3 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 112.498 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 149.59 -26.27 1.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -86.49 6.59 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 109.824 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -79.79 154.26 75.67 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.212 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.307 -1.633 0 C-N-CA 122.556 2.17 . . . . 0.0 112.203 179.902 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.96 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 1.9 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.552 ' H ' ' CG ' ' A' ' 1' ' ' MET . 82.8 tt0 -99.21 144.23 28.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 4' ' ' CYS . 26.9 ttm180 -68.99 170.26 10.16 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 3' ' ' ARG . 4.3 m -42.35 149.3 0.17 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -0.865 . . . . 0.0 109.248 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.29 -33.58 61.59 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 121.153 -0.967 . . . . 0.0 112.75 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.857 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -85.56 2.1 46.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.298 -1.707 . . . . 0.0 111.759 -177.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 6' ' ' TRP . 16.7 m -110.57 -45.24 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 109.971 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 7' ' ' VAL . 88.7 p -65.25 -17.43 64.49 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -65.43 -40.68 93.6 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.873 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.18 163.21 24.3 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.933 . . . . 0.0 109.845 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 13' ' ' TYR . 35.7 Cg_endo -68.92 -161.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.943 2.429 . . . . 0.0 112.51 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 5.9 mt 62.54 -54.86 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.774 -0.579 . . . . 0.0 109.555 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.752 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.3 OUTLIER -57.15 -45.76 83.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.279 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.415 HG12 HH11 ' A' ' 3' ' ' ARG . 85.9 mt -54.68 -42.86 63.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.733 -0.605 . . . . 0.0 110.585 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.13 98.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.711 -1.243 . . . . 0.0 108.419 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.658 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.0 t80 -71.67 -31.47 66.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.623 0.725 . . . . 0.0 110.001 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -64.14 -44.68 91.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 112.382 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.69 -4.52 37.1 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.717 -1.239 . . . . 0.0 112.815 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 16' ' ' TYR . 51.0 p-10 -96.01 -15.68 22.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.462 -1.399 . . . . 0.0 112.243 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 14.0 pt-20 177.07 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.728 -1.232 . . . . 0.0 109.276 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.942 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 4.8 t90 -131.88 83.52 2.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.186 0.993 . . . . 0.0 108.887 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 117.3 -20.31 11.33 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.701 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 28.9 m -110.71 -12.38 0.12 Allowed Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 112.957 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 75.5 Cg_endo -80.05 150.68 20.68 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.358 1.372 . . . . 0.0 114.122 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -96.18 159.75 14.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.759 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.7 p -86.72 111.48 20.74 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.566 -1.334 . . . . 0.0 110.886 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.906 ' O ' HD13 ' A' ' 31' ' ' LEU . 70.1 m-20 -94.24 156.73 16.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -67.4 -39.71 85.59 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.565 -1.334 . . . . 0.0 110.282 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -75.19 -50.12 17.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 111.804 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -61.3 -30.1 70.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.589 -1.319 . . . . 0.0 109.19 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 27' ' ' ASP . 4.7 mp -57.14 -39.56 75.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.092 -1.005 . . . . 0.0 108.45 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.572 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 63.2 t80 -63.25 -45.46 91.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.467 -0.771 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -67.45 -40.69 85.42 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.827 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.4 tpp -65.07 -52.55 54.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.451 -0.781 . . . . 0.0 110.223 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.75 -27.17 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 109.03 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 47.7 m -70.57 -52.4 21.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' NE ' ' A' ' 53' ' ' ARG . 48.3 mt -66.79 -39.23 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 108.764 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' OE2' ' CB ' ' A' ' 164' ' ' SER . 13.3 tp10 -64.19 -37.72 88.49 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.642 -0.661 . . . . 0.0 109.865 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.51 -33.14 70.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 25.6 mm-40 -81.71 -1.45 47.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.514 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 2.4 pp0? -78.78 -2.25 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.015 . . . . 0.0 109.323 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.71 113.84 10.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 87.26 -34.63 3.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -95.62 145.43 25.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -1.095 . . . . 0.0 109.63 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -71.97 152.88 42.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 109.203 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.664 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 2.5 t-105 -59.64 -28.9 67.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 110.161 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -29.36 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.564 -1.335 . . . . 0.0 109.487 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 44' ' ' LEU . 72.7 m -68.54 -44.04 75.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.112 -0.992 . . . . 0.0 108.829 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 46' ' ' TRP . 1.3 p -63.69 -26.08 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -54.98 -43.94 74.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.483 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -63.92 -37.04 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.656 ' HA ' HD22 ' A' ' 55' ' ' ASN . 7.6 ttpp -63.12 -36.88 85.08 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NE ' HD13 ' A' ' 37' ' ' LEU . 37.2 ttm180 -57.93 -46.53 84.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.803 -0.561 . . . . 0.0 111.769 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 55' ' ' ASN . 15.2 pt-20 -72.5 -44.32 62.4 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.787 -1.196 . . . . 0.0 110.727 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.656 HD22 ' HA ' ' A' ' 52' ' ' LYS . 24.5 p30 -73.06 -32.17 64.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.746 -1.221 . . . . 0.0 109.396 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.659 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 71.4 t80 -58.57 -46.5 86.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 109.525 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 61' ' ' HIS . 13.4 ptm180 -65.05 -32.13 73.7 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.014 -1.075 . . . . 0.0 109.034 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.15 99.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.863 -1.148 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.579 ' HB3' HD22 ' A' ' 79' ' ' LEU . 51.4 m -77.49 -44.6 28.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 109.675 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.659 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 96.8 m-85 -94.67 19.76 9.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.53 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 t60 -41.03 -15.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.562 -0.711 . . . . 0.0 110.519 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 60' ' ' PHE . 95.3 mt-30 -51.09 -31.33 18.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.848 -1.157 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 51.04 27.27 3.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.697 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -125.07 92.49 47.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.195 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.43 -34.68 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.527 2.151 . . . . 0.0 112.667 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.63 -43.24 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.606 -1.309 . . . . 0.0 108.302 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -65.73 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.263 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 96' ' ' ILE . 69.6 t -60.7 -38.72 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 108.825 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.37 -14.53 63.01 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -93.5 -12.37 29.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.473 ' O ' HG21 ' A' ' 96' ' ' ILE . 90.8 mtp -76.74 110.31 11.23 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.8 -174.75 3.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.408 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 96.9 mt-10 -55.38 -30.59 60.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.813 -0.554 . . . . 0.0 110.791 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.0 pt-20 -60.6 -42.22 96.32 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.119 -1.613 . . . . 0.0 109.452 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' CG ' ' A' ' 74' ' ' GLU . 90.3 m-20 -66.92 -38.92 87.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -67.19 -36.22 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.838 -1.164 . . . . 0.0 109.71 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 80' ' ' VAL . 99.2 mt-10 -59.36 -36.31 75.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.712 -1.242 . . . . 0.0 107.794 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.4 ttm-85 -70.32 -42.03 72.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.568 -0.708 . . . . 0.0 110.304 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 59' ' ' CYS . 94.3 mt -69.76 -34.66 74.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.423 -0.798 . . . . 0.0 112.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.9 m -50.1 -16.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.521 -1.362 . . . . 0.0 108.868 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' LEU . 23.0 pt20 -120.87 -4.43 9.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.203 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -81.5 109.58 16.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.691 -1.256 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.6 -17.02 0.54 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.456 -0.778 . . . . 0.0 109.3 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 80.47 32.36 34.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 79' ' ' LEU . 15.5 pt -54.48 -179.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.02 -1.282 . . . . 0.0 109.332 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 86' ' ' ILE . 12.4 tt -60.82 89.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.571 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 6.2 ptp180 -56.06 144.24 29.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 111.115 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER 159.14 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 89' ' ' ARG . 1.1 mtt-85 -51.02 -38.07 49.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.424 -0.797 . . . . 0.0 108.941 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.13 -49.19 59.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.34 -45.08 94.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -1.133 . . . . 0.0 110.056 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.75 -44.12 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.069 -1.019 . . . . 0.0 109.726 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.462 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 49.4 mt-30 -54.64 -34.05 61.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.862 -1.149 . . . . 0.0 108.995 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.65 99.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.59 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.556 HG21 ' OH ' ' A' ' 56' ' ' TYR . 32.1 mm -61.93 -39.15 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 109.115 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 71' ' ' MET . 12.3 mm -59.67 -43.1 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 108.912 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.44 -32.86 85.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.52 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 m120 -61.2 -41.44 96.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.157 . . . . 0.0 109.842 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.91 98.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.49 -40.21 95.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.253 -0.904 . . . . 0.0 109.269 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.4 -34.58 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.35 -43.12 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.0 -33.2 75.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -62.91 -37.44 86.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 109.583 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 24.0 ttm -62.86 -40.89 98.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.994 -1.066 . . . . 0.0 108.447 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.04 -35.27 79.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -64.88 -20.96 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -92.28 -17.63 24.49 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.76 73.61 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.35 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.583 ' O ' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -116.92 107.37 46.12 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.88 144.47 15.17 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.83 1.687 . . . . 0.0 112.637 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.59 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -61.65 -44.52 96.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.893 0.854 . . . . 0.0 109.917 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.29 -27.68 62.62 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.019 -1.051 . . . . 0.0 111.192 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -62.85 -49.01 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.835 -1.166 . . . . 0.0 111.118 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.2 p90 -72.04 -34.4 68.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.816 -1.178 . . . . 0.0 110.022 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.725 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 2.3 t -63.05 -54.86 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.749 -1.219 . . . . 0.0 109.87 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.63 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 57.5 m95 -59.32 -22.2 60.89 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.072 -1.017 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -66.68 -45.05 80.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 110.406 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.647 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.1 m-85 -67.92 -29.14 68.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.094 -1.004 . . . . 0.0 109.918 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.578 HG21 HD22 ' A' ' 171' ' ' LEU . 7.2 t -87.26 18.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.525 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 123' ' ' GLN . 75.4 m-20 60.86 39.76 16.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.436 0.636 . . . . 0.0 110.007 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 42.05 25.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.404 -0.81 . . . . 0.0 110.536 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -145.66 148.28 36.02 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 120.933 -1.104 . . . . 0.0 109.511 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 19.1 Cg_endo -62.98 146.8 94.94 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.278 1.986 . . . . 0.0 111.434 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -103.59 137.63 41.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.6 mtt -93.02 120.01 32.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.427 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -88.26 120.37 29.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -91.0 16.63 9.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.03 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.57 136.49 49.31 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.7 p -99.07 -22.21 15.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.544 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 p -136.41 165.6 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -0.931 . . . . 0.0 109.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.1 mt -59.26 -34.39 72.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.046 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.3 m -69.79 -11.96 61.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -0.792 . . . . 0.0 109.697 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.09 6.44 47.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 mm -97.3 118.09 64.89 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.23 137.95 19.64 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.943 1.762 . . . . 0.0 112.227 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.2 p -95.71 4.21 53.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.6 t -137.8 95.3 3.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 32.4 p -109.27 150.83 41.58 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.35 -36.03 77.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.579 1.519 . . . . 0.0 111.432 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.15 -43.23 58.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.248 -0.908 . . . . 0.0 108.858 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.406 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 95.6 p -65.16 -39.9 93.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 109.723 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.9 -37.59 85.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.57 -37.26 86.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 109.91 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.62 -46.42 87.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.017 -1.052 . . . . 0.0 109.054 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.6 t -62.1 -43.18 99.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 110.149 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -62.52 -45.43 93.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.45 -44.73 67.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.99 -36.67 80.39 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.245 -0.91 . . . . 0.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -60.45 -38.65 84.85 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.705 -1.247 . . . . 0.0 108.581 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.73 -19.94 54.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.572 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -78.97 0.9 25.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.119 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.42 26.64 32.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.52 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 1.3 m-85 -101.11 113.51 26.6 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.38 -1.071 . . . . 0.0 109.575 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -91.81 173.9 7.62 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 55.73 45.27 24.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.089 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.3 p -132.09 49.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.42 177.1 6.07 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 54.9 m -58.6 -32.67 69.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.588 -0.948 . . . . 0.0 110.178 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.6 p -72.82 -28.25 62.44 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.917 -1.114 . . . . 0.0 109.061 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.2 mm -68.03 -45.31 83.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 110.152 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 159' ' ' THR . 3.1 p -65.89 -36.87 84.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.454 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.09 -45.97 79.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.454 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.4 m -61.98 -39.1 91.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.075 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -59.2 -41.09 87.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.082 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.415 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 73.2 mtp -62.51 -39.75 94.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -74.29 -39.21 63.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.823 -1.173 . . . . 0.0 111.455 -178.499 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 167' ' ' GLN . . . -79.22 -40.2 31.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 110.889 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 166' ' ' MET . 21.6 p -60.51 -28.77 68.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.99 2.57 42.27 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 120' ' ' VAL . 35.1 mt -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.74 143.32 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.209 -0.932 . . . . 0.0 109.583 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 34.7 m120 -111.41 163.54 13.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.437 -0.79 . . . . 0.0 110.205 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER 83.28 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.242 0.544 . . . . 0.0 109.947 179.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.421 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 10.8 m170 -50.95 -44.47 60.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 108.7 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.646 ' C ' ' H ' ' A' ' 178' ' ' GLY . 30.6 m -149.5 28.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.412 -0.805 . . . . 0.0 109.624 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 129' ' ' ALA . 46.2 t 60.56 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.415 -0.803 . . . . 0.0 110.409 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -137.3 60.05 0.62 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 6.3 t -96.77 114.09 25.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -1.128 . . . . 0.0 110.107 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 64.03 -57.37 0.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 109.715 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 42.2 t -176.71 59.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.39 123.53 71.17 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.52 -83.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.998 1.799 . . . . 0.0 112.071 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 88.71 -27.86 6.89 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.74 -3.82 59.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.731 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.24 156.24 40.3 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.133 -0.979 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--N 1.305 -1.73 0 C-N-CA 122.443 2.095 . . . . 0.0 111.941 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.942 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.3 151.56 22.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.171 -0.956 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.466 HH11 ' HG3' ' A' ' 3' ' ' ARG . 28.3 mtm-85 -70.36 177.7 3.24 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.523 0.678 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.45 141.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.558 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.19 94.91 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.543 -0.723 . . . . 0.0 112.097 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.727 ' CH2' H3A1 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -84.55 1.32 46.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.642 -1.504 . . . . 0.0 109.887 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.526 HG13 HD13 ' A' ' 14' ' ' ILE . 1.8 t -83.81 -50.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -67.99 -3.82 11.25 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.86 -39.31 94.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.404 0.621 . . . . 0.0 109.587 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -174.01 158.47 2.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.41 -0.807 . . . . 0.0 109.208 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' TYR . 12.0 Cg_endo -57.46 -161.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.478 2.119 . . . . 0.0 111.742 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -52.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 11' ' ' PRO . 14.1 m-85 -60.38 -31.66 70.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.131 -0.98 . . . . 0.0 108.893 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.526 HD13 HG13 ' A' ' 7' ' ' VAL . 7.8 mm -56.26 -40.33 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.98 -50.47 28.49 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.182 -0.949 . . . . 0.0 109.82 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 42.7 t80 -63.13 -40.78 98.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 110.579 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 7' ' ' VAL . 34.8 t-80 -60.28 -43.9 95.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.035 -1.041 . . . . 0.0 109.835 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -82.09 -14.48 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.419 -0.801 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.771 ' ND2' ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -79.28 -57.18 3.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.528 -1.357 . . . . 0.0 110.597 -178.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.771 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 2.2 pt-20 -175.45 78.82 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.596 -1.315 . . . . 0.0 110.03 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CZ3' ' NE1' ' A' ' 6' ' ' TRP . 7.7 t90 -100.77 68.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.01 -1.056 . . . . 0.0 108.523 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.55 9.75 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 96.9 t -111.01 -30.88 0.14 Allowed Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.649 -0.912 . . . . 0.0 111.927 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 67.7 Cg_endo -86.17 154.07 9.58 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.543 2.162 . . . . 0.0 113.539 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -65.93 170.5 5.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.585 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 4.8 p -92.13 124.6 36.34 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.811 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.601 ' O ' HD13 ' A' ' 31' ' ' LEU . 66.1 m-20 -102.48 149.13 24.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -65.07 -38.8 91.98 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.825 -1.172 . . . . 0.0 110.576 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -72.87 -50.71 22.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 111.61 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -63.34 -33.37 75.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.647 -1.283 . . . . 0.0 109.496 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 27' ' ' ASP . 5.1 mp -61.3 -39.13 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.267 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -59.29 -41.79 89.77 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.106 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CD ' ' NH2' ' A' ' 57' ' ' ARG . 40.5 mt-10 -71.68 -36.26 70.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.114 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.628 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -64.99 -47.15 78.56 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 111.377 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -65.98 -36.12 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.733 -1.23 . . . . 0.0 110.038 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m -70.17 -38.81 75.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.019 -1.05 . . . . 0.0 109.261 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' GLU . 3.1 mp -66.79 -44.59 80.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.489 -0.757 . . . . 0.0 109.817 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.609 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 66.4 mm-40 -67.83 -32.3 72.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.36 -33.58 32.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 42' ' ' ALA . 56.3 tp60 -75.44 -35.46 60.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.422 -1.046 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.613 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -44.15 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.314 -0.866 . . . . 0.0 110.741 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -60.68 112.78 2.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.677 -1.264 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.0 -36.83 2.13 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.602 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.8 mt -91.64 146.71 23.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.088 -1.242 . . . . 0.0 110.529 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.1 m -69.71 156.15 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.734 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -62.72 -37.8 87.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 110.297 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -63.52 -39.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 109.733 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -58.8 -38.31 78.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.899 -1.126 . . . . 0.0 108.198 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.3 t -64.34 -37.58 80.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.601 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.67 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.1 tt -55.73 -47.15 77.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -61.91 -46.97 87.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.947 -1.096 . . . . 0.0 109.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.04 -11.81 59.85 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.942 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.674 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 38.4 ttm180 -63.19 -46.12 88.53 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.67 -41.62 68.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.009 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.945 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -70.04 -45.2 67.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.063 . . . . 0.0 111.054 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 49.8 t80 -60.86 -48.47 81.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.897 -1.127 . . . . 0.0 110.523 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.522 ' NH2' ' CD ' ' A' ' 33' ' ' GLU . 16.7 mmm180 -57.77 -31.95 67.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.06 65.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.832 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.1 m -73.16 -26.06 61.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 112.189 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 79.6 m-85 -113.11 -48.36 2.98 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.536 -1.353 . . . . 0.0 111.336 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' CG ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -176.81 112.36 0.09 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' HIS . 93.6 mt-30 -47.42 -35.67 8.75 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.133 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.3 p90 -177.93 39.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.191 -0.943 . . . . 0.0 111.404 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -131.88 81.08 63.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.615 -1.303 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.59 -14.35 1.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.78 2.32 . . . . 0.0 112.853 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 HD21 ' A' ' 103' ' ' LEU . 76.8 t -72.79 -37.35 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.887 -1.133 . . . . 0.0 108.856 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -35.73 66.38 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' ' CG ' ' A' ' 61' ' ' HIS . 64.6 t -59.52 -38.82 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.429 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.32 -16.44 63.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.97 -5.13 53.62 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.8 mmm -79.3 116.78 19.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 2.8 pt20 -95.67 177.33 5.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.439 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 96.5 mt-10 -59.41 -35.04 73.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.812 . . . . 0.0 110.304 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.6 tt0 -58.4 -46.44 86.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.807 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -64.93 -38.88 92.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.836 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 92' ' ' ILE . 46.3 t -56.55 -43.54 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.45 -0.781 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.28 -39.18 92.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.508 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 28.7 ttm-85 -60.81 -39.27 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 108.733 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' N ' ' A' ' 81' ' ' GLN . 80.2 mt -68.97 -33.24 73.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.652 -0.655 . . . . 0.0 110.874 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.11 -18.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 108.675 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.3 mt-30 -118.76 -11.47 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 17.5 t70 -79.47 109.75 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 72.73 -19.01 0.32 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 64.2 35.47 92.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.945 HG22 ' ND2' ' A' ' 55' ' ' ASN . 3.5 pt -31.81 -105.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.208 -0.583 . . . . 0.0 111.823 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 87' ' ' ARG . 6.4 tt -161.44 -48.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.685 -1.259 . . . . 0.0 110.218 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.634 ' N ' HG23 ' A' ' 86' ' ' ILE . 9.2 mtt180 -63.33 149.04 46.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.001 -1.062 . . . . 0.0 109.409 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' ARG . 88.8 m-70 -108.04 167.74 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 109.765 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -43.33 -40.74 3.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.136 -0.977 . . . . 0.0 109.992 -179.142 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.23 -59.26 7.56 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.303 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.55 -40.18 96.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -1.086 . . . . 0.0 110.193 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.514 HG21 HG13 ' A' ' 76' ' ' VAL . 85.2 mt -59.66 -52.91 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 110.1 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.439 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 66.8 mt-30 -52.41 -33.81 45.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.906 -1.121 . . . . 0.0 110.099 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.57 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.874 -1.141 . . . . 0.0 109.226 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.624 HG21 ' OH ' ' A' ' 56' ' ' TYR . 96.2 mt -72.09 -32.56 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.0 -42.61 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.542 -1.348 . . . . 0.0 108.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.93 72.69 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.66 -43.37 96.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -1.184 . . . . 0.0 109.945 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.92 73.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.048 -1.032 . . . . 0.0 108.787 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -61.54 -35.67 78.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.804 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.685 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.76 -32.23 73.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 108.649 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -64.48 -43.17 95.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 103' ' ' LEU . 39.0 mt -61.14 -27.75 68.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -68.06 -38.18 82.15 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.697 0.76 . . . . 0.0 109.245 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.571 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 34.5 ttm -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.942 0.877 . . . . 0.0 108.95 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.0 -36.89 85.07 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.48 -25.69 66.23 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -91.12 -12.27 36.07 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.57 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.93 27.51 73.64 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.48 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -117.37 102.8 52.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.84 144.18 21.49 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.024 1.816 . . . . 0.0 112.813 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -55.46 -40.66 71.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.033 0.921 . . . . 0.0 108.989 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.23 -27.09 64.19 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 110.494 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.96 -53.6 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.905 -1.122 . . . . 0.0 111.202 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.5 p90 -70.73 -32.61 69.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.953 -1.092 . . . . 0.0 109.611 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -64.96 -54.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.16 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.585 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 54.3 m95 -57.36 -26.72 61.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 108.532 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 66.3 p -77.68 -31.53 52.57 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.322 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -68.78 -32.32 71.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -88.61 18.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 66.36 27.4 10.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.867 . . . . 0.0 109.534 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 51.19 33.11 8.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.454 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.512 ' H ' HG13 ' A' ' 120' ' ' VAL . 15.1 mm100 -137.09 150.0 68.02 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.22 145.67 39.31 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.488 2.126 . . . . 0.0 111.847 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.15 129.2 55.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.0 mtm -117.7 108.48 15.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.509 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -102.68 128.74 49.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.099 -1.0 . . . . 0.0 109.271 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.86 34.58 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.097 -1.002 . . . . 0.0 110.607 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -58.32 145.82 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 108.762 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.1 p -91.84 -15.22 28.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.065 -1.022 . . . . 0.0 110.343 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -142.46 162.9 34.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 109.685 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.0 mt -59.61 -33.05 70.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -65.42 -29.09 69.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.329 -0.857 . . . . 0.0 110.886 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.601 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.1 mm-40 -85.49 -1.8 57.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.996 -1.065 . . . . 0.0 109.854 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -80.14 143.78 57.43 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 108.851 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.67 142.94 40.89 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.423 2.082 . . . . 0.0 112.848 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 t -125.55 4.89 7.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.9 p -157.41 87.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 163.56 16.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.509 -0.745 . . . . 0.0 109.054 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.18 -39.72 85.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.702 1.601 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.67 -43.18 66.48 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.109 -1.036 . . . . 0.0 108.549 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 p -63.51 -44.07 95.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.25 -37.55 85.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.078 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.4 95.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 109.798 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.11 -45.54 75.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -59.0 -40.23 84.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.748 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -62.68 -49.42 75.2 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 110.653 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.69 76.81 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.121 -0.987 . . . . 0.0 109.473 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.445 ' HG ' HH21 ' A' ' 152' ' ' ARG . 32.5 mt -66.91 -39.74 87.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -0.902 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -38.78 87.75 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.754 -1.216 . . . . 0.0 110.34 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -84.62 -14.68 47.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 111.948 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.685 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 85.9 mtm180 -88.53 8.2 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.687 -1.258 . . . . 0.0 109.521 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.37 21.04 53.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -100.99 110.37 22.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 108.6 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -93.68 175.13 6.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 57.18 57.59 4.43 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.106 0.955 . . . . 0.0 109.124 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 157' ' ' VAL . 12.4 m -128.91 42.27 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.24 162.7 0.4 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.7 m -53.65 -29.49 38.6 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -1.089 . . . . 0.0 108.921 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -73.52 -32.29 64.15 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 108.547 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 157' ' ' VAL . 45.6 mm -62.57 -45.74 98.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.48 -0.762 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.64 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.525 -0.734 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.95 -45.94 72.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 0.0 109.692 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 97.0 p -68.81 -31.13 69.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 108.414 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.579 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 79.5 t80 -64.3 -48.0 77.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.864 -0.522 . . . . 0.0 110.277 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ptm -72.91 -32.35 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.18 -42.18 85.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.701 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -92.98 -32.97 14.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 111.136 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 76.3 m -54.62 -24.09 19.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.864 -1.147 . . . . 0.0 110.517 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.82 0.56 48.96 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 116' ' ' VAL . 76.7 mt -63.66 -34.0 76.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.34 -1.094 . . . . 0.0 110.165 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.1 147.52 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.093 0.949 . . . . 0.0 111.003 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.85 103.52 9.42 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 127' ' ' THR . 58.9 p30 -173.86 70.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.067 -1.021 . . . . 0.0 111.284 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.635 ' C ' HG12 ' A' ' 176' ' ' VAL . 30.8 m170 -57.95 -43.09 86.19 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.58 -1.325 . . . . 0.0 108.244 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 168.23 3.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.454 ' H ' ' H ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER 71.87 -35.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -83.8 11.92 54.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 12.8 t -85.75 121.53 28.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.043 . . . . 0.0 109.344 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.478 ' C ' ' H ' ' A' ' 182' ' ' TYR . 49.3 t -52.69 -34.59 52.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.629 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.84 17.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.635 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 180' ' ' CYS . 20.4 t80 -118.45 83.7 21.82 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.85 141.59 65.74 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.644 2.229 . . . . 0.0 111.919 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.68 -21.13 0.8 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -84.09 3.34 35.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.177 . . . . 0.0 109.397 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.458 ' HZ3' ' HB2' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -86.91 162.41 44.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 0.0 109.764 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 112.262 179.647 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.734 ' N6 ' ' CZ3' ' A' ' 46' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -109.89 142.77 40.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.392 -0.817 . . . . 0.0 109.77 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 56.1 mtp180 -58.81 -46.36 87.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 108.887 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' N ' ' OE1' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -170.29 146.85 2.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.9 80.47 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.429 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE3' H3A3 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.617 -1.519 . . . . 0.0 110.461 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.22 -41.9 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.907 -1.121 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.5 ' OG ' ' OE2' ' A' ' 2' ' ' GLU . 67.6 m -79.4 5.7 12.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 108.872 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.72 -60.48 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.763 . . . . 0.0 109.973 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.16 157.04 75.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HA ' HD12 ' A' ' 14' ' ' ILE . 27.6 Cg_endo -65.92 -30.32 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.584 2.189 . . . . 0.0 112.143 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 47' ' ' ILE . 71.4 mt -62.69 -37.34 86.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.631 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 1.6 m-85 -63.86 -39.93 95.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.136 -0.978 . . . . 0.0 109.27 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 11' ' ' PRO . 32.0 mt -54.68 -44.51 70.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.474 -0.766 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -65.93 -47.93 73.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.728 -1.232 . . . . 0.0 109.224 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.7 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.7 t80 -62.12 -40.74 96.93 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.913 0.863 . . . . 0.0 108.805 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -71.48 -39.22 71.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -78.46 -5.9 53.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.189 -0.944 . . . . 0.0 111.863 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 22.6 m120 -76.87 -75.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.527 -1.358 . . . . 0.0 110.001 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 21' ' ' TRP . 96.0 mt-10 -145.56 -40.96 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.139 -0.975 . . . . 0.0 108.724 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.897 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 6.4 t90 -4.68 74.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.106 0.955 . . . . 0.0 111.084 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 149.47 -25.32 1.22 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 19.6 m -120.06 4.01 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.575 -0.956 . . . . 0.0 112.766 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 69.8 Cg_endo -75.69 147.21 31.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.174 1.25 . . . . 0.0 112.987 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.68 166.37 13.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.619 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 7.6 p -99.32 108.84 21.47 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.338 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -89.32 167.17 13.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 m -73.13 -37.33 66.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.474 -1.391 . . . . 0.0 110.465 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -74.85 -41.53 59.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -59.66 -37.0 77.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.593 -1.317 . . . . 0.0 110.487 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -59.33 -38.15 79.58 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.981 -178.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.68 -45.85 90.87 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.452 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -71.22 -40.69 70.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.022 -1.049 . . . . 0.0 108.636 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.3 tpp -64.64 -48.44 74.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.641 -0.662 . . . . 0.0 110.62 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 2.7 tp -64.21 -29.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.999 -1.063 . . . . 0.0 109.469 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.9 m -70.74 -48.83 52.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.022 -1.049 . . . . 0.0 109.042 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 53' ' ' ARG . 10.8 mp -68.66 -39.7 80.54 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.295 -0.878 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.07 -37.82 86.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.421 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.54 -36.87 91.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.42 -24.18 67.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.469 -1.018 . . . . 0.0 110.061 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.8 pp0? -69.74 -3.29 14.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.711 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.43 112.71 1.67 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.725 -1.235 . . . . 0.0 109.084 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.8 -14.68 1.4 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.0 mm? -103.93 154.93 19.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.184 -1.186 . . . . 0.0 110.178 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -71.5 153.71 42.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 109.773 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.7 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -64.77 -41.99 95.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 110.434 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -54.63 -31.25 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 109.728 -179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 m -58.11 -40.86 82.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.84 -28.04 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.097 -1.002 . . . . 0.0 109.43 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -53.44 53.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 109.827 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -61.34 -44.46 97.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.673 -1.267 . . . . 0.0 108.154 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -65.62 -26.71 67.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 37' ' ' LEU . 40.3 ttm180 -53.96 -44.04 70.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.779 -1.201 . . . . 0.0 107.918 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.49 -37.05 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.397 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -78.35 -45.65 22.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.873 -1.142 . . . . 0.0 111.155 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.663 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 40.2 t80 -58.87 -46.43 87.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.159 . . . . 0.0 109.945 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.673 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 2.4 ppt_? -66.6 -29.47 69.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.11 -0.993 . . . . 0.0 109.37 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.24 74.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.746 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.52 -45.46 68.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.858 -1.151 . . . . 0.0 110.648 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' O ' ' N ' ' A' ' 62' ' ' GLN . 20.5 m-85 -79.23 -47.72 15.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.985 -1.072 . . . . 0.0 109.997 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' CE1' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 48.06 5.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.334 -0.854 . . . . 0.0 110.071 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 60' ' ' PHE . 96.4 mm-40 -65.39 -38.76 90.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.947 -1.096 . . . . 0.0 109.974 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.28 3.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -128.13 99.29 25.18 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 108.911 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.73 -23.07 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.784 . . . . 0.0 112.439 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.79 -46.18 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.939 -1.1 . . . . 0.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.12 75.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.095 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.02 -38.22 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.766 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -68.67 -14.91 63.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.08 -9.57 45.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.57 -0.707 . . . . 0.0 109.094 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.588 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.1 mtp -82.18 112.84 19.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.434 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 2.3 tp60 -95.77 -176.49 3.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 109.98 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.3 mt-10 -57.61 -33.12 67.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 110.617 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.0 -33.13 75.3 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 108.506 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 62.3 m-20 -68.22 -40.1 82.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.528 -0.733 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.1 m -66.69 -33.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.743 -1.223 . . . . 0.0 109.254 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.511 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.8 mt-10 -63.99 -36.56 84.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.072 -1.017 . . . . 0.0 108.648 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 78' ' ' ARG . 19.6 ttm-85 -61.77 -47.03 87.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.439 ' C ' ' N ' ' A' ' 81' ' ' GLN . 91.9 mt -69.88 -33.49 72.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 111.209 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -49.6 -18.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 108.689 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.5 mt-30 -113.31 -13.78 12.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.551 -0.718 . . . . 0.0 109.775 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.0 t70 -81.23 109.1 15.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.685 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.29 -17.17 0.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 72.04 36.47 60.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.517 HG22 ' ND2' ' A' ' 55' ' ' ASN . 7.6 pt -50.33 -172.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.446 -1.032 . . . . 0.0 110.337 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -59.41 93.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 94.1 mtt180 -52.27 139.73 23.33 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.593 -0.692 . . . . 0.0 109.794 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 164.76 63.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 11.6 ptm180 -49.36 -38.45 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.337 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -64.59 -59.18 8.55 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.515 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.82 -41.47 95.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.879 -1.365 . . . . 0.0 109.849 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.88 -42.43 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 110.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.87 -32.92 68.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.754 -1.216 . . . . 0.0 108.548 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.22 83.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 108.934 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.631 HG21 ' OH ' ' A' ' 56' ' ' TYR . 50.3 mm -57.27 -41.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 108.84 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 71' ' ' MET . 7.6 mm -59.65 -40.41 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.82 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.34 85.46 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -58.58 -37.55 76.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.424 -1.045 . . . . 0.0 109.088 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -62.78 -44.89 95.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -56.72 -42.99 80.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 108.507 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.03 70.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.45 -0.781 . . . . 0.0 108.965 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.16 -42.92 99.73 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.1 mp -68.52 -31.62 70.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.32 -40.43 90.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.128 -0.983 . . . . 0.0 110.322 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.683 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 71.3 mtp -71.73 -39.33 70.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.958 -1.089 . . . . 0.0 108.803 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.41 -41.81 88.75 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.819 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.83 -21.37 66.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -92.9 -11.05 34.43 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.59 26.57 74.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -118.42 101.5 50.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.243 -1.151 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 145.01 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.237 1.958 . . . . 0.0 112.414 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 31' ' ' LEU . 31.7 m-85 -60.8 -43.42 98.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.27 -33.29 75.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 111.139 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.36 -48.52 80.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.033 -1.042 . . . . 0.0 112.133 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.3 p90 -70.16 -45.18 67.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.685 -1.259 . . . . 0.0 111.12 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -59.84 -50.09 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.468 -1.395 . . . . 0.0 109.581 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.619 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 17.0 m95 -54.99 -24.48 24.39 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 5.3 p -70.61 -38.86 74.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.496 -0.753 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.517 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.6 m-85 -64.96 -32.17 73.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.718 -1.239 . . . . 0.0 109.476 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.698 HG21 ' CD2' ' A' ' 171' ' ' LEU . 29.0 m -96.92 17.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.366 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 122' ' ' HIS . 7.2 m-20 57.74 40.93 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.544 -0.722 . . . . 0.0 110.059 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 121' ' ' ASN . 49.8 t-80 43.16 27.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.992 . . . . 0.0 109.805 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 2.6 mm-40 -126.9 149.72 69.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.43 147.99 87.56 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.532 2.154 . . . . 0.0 112.157 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -117.32 139.45 50.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.3 mtt -100.34 122.15 42.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.413 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -84.98 118.11 24.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 108.571 179.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.82 19.88 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -76.12 129.43 36.77 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.274 -0.892 . . . . 0.0 109.365 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.9 p -100.96 -21.32 15.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.7 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 10.8 p -131.64 162.78 29.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.2 mt -58.78 -37.32 76.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 108.823 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.7 m -76.32 -3.2 35.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HB3' ' H ' ' A' ' 131' ' ' THR . 31.9 tp10 -101.69 12.53 36.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -100.48 106.96 45.93 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.71 137.7 82.46 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.83 1.686 . . . . 0.0 112.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 p -103.78 4.09 34.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -142.29 85.74 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.2 p -102.35 151.49 38.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -52.73 -35.73 70.01 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.508 1.472 . . . . 0.0 111.284 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.49 -43.05 61.03 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 166' ' ' MET . 56.8 m -66.17 -43.57 86.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -66.17 -37.47 85.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -71.91 -31.2 66.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.54 HD23 ' SG ' ' A' ' 162' ' ' CYS . 7.1 tp -65.42 -46.65 79.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.642 -0.661 . . . . 0.0 109.537 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.574 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 19.4 m -61.3 -40.88 95.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.077 -1.015 . . . . 0.0 109.518 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -61.22 -43.57 98.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 110.039 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.17 70.79 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.49 -37.92 83.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 109.223 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -61.57 -40.0 93.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.034 -1.041 . . . . 0.0 109.498 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.6 -15.34 57.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.907 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.448 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -83.0 4.16 27.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.156 -0.965 . . . . 0.0 108.835 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.53 24.78 49.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -100.57 112.89 25.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.983 . . . . 0.0 108.849 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -93.44 172.93 7.97 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.648 -0.657 . . . . 0.0 109.231 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 57.84 61.31 2.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.843 . . . . 0.0 109.055 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.3 m -140.85 39.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.51 162.91 0.07 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.6 m -55.03 -31.39 61.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.457 -1.026 . . . . 0.0 109.005 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.6 p -72.34 -31.89 66.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.36 -45.02 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.574 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.7 m -67.0 -41.81 86.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -0.764 . . . . 0.0 109.407 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.44 -46.84 68.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.589 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 18.3 m -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.853 -1.154 . . . . 0.0 109.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -59.29 -47.71 84.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 110.652 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 11.9 ptp -66.42 -29.19 69.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.132 . . . . 0.0 110.657 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -57.35 -40.0 77.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.872 -1.143 . . . . 0.0 110.746 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.14 -33.16 11.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 111.124 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.662 ' SG ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -54.62 -27.64 40.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.975 -1.078 . . . . 0.0 109.69 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.55 54.36 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.069 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.698 ' CD2' HG21 ' A' ' 120' ' ' VAL . 6.4 mt -63.3 -30.69 71.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.199 -1.177 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 125' ' ' GLN . 10.9 m -125.77 137.88 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 82.3 m-20 -104.32 164.3 11.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.745 . . . . 0.0 109.413 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 89.58 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.465 ' O ' HG13 ' A' ' 176' ' ' VAL . 17.7 m170 -51.55 -44.74 62.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 108.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 28.2 m -157.91 37.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.73 . . . . 0.0 109.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 176' ' ' VAL . 16.0 t 37.84 93.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.24 -4.35 7.26 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 182' ' ' TYR . 8.7 t -57.08 133.38 54.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 108.482 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 179' ' ' CYS . 42.5 t -43.07 -43.74 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.944 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 88.4 m -70.11 -13.61 62.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 36.0 t80 -60.04 136.36 90.78 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.698 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.25 125.16 9.52 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.098 1.866 . . . . 0.0 112.018 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -95.84 12.55 67.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.89 23.93 8.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.484 -1.01 . . . . 0.0 109.045 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -104.8 150.2 38.38 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 C--N 1.311 -1.436 0 C-N-CA 122.445 2.097 . . . . 0.0 112.208 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.897 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' O ' ' A' ' 180' ' ' CYS . 59.6 ttp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.213 0.53 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 180' ' ' CYS . 38.0 tp10 -100.46 138.53 37.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.56 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -66.85 165.3 15.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 145.87 55.03 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.83 49.84 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.408 -0.808 . . . . 0.0 111.833 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.837 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -84.37 2.97 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.536 -1.567 . . . . 0.0 109.77 -179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -76.84 -46.45 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 109.158 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.1 m -73.17 -2.02 19.94 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.895 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 62.8 tt0 -67.81 -41.7 82.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -154.63 159.92 31.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 109.984 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.8 -38.47 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.991 2.46 . . . . 0.0 112.463 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.72 -32.88 73.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.725 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.3 OUTLIER -62.96 -41.84 99.65 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.296 -0.878 . . . . 0.0 110.207 -179.364 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.27 -38.29 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 110.523 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -67.48 -50.65 58.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 109.539 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 16' ' ' TYR . 1.2 t80 -60.91 -37.21 81.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 110.01 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -59.1 -43.05 91.85 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.416 -0.803 . . . . 0.0 110.651 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -80.36 -16.06 55.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 110.712 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 10.1 m120 -64.58 -53.94 39.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 177.57 57.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 108.829 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 1.012 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 4.2 t90 -97.66 63.93 1.76 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 108.87 59.85 0.53 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.857 -1.164 . . . . 0.0 111.562 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.729 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -157.88 -36.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.486 . . . . 0.0 112.037 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.729 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 46.5 Cg_endo -96.15 152.05 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.702 2.268 . . . . 0.0 114.032 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 26' ' ' THR . 86.2 tt0 -68.9 160.15 31.26 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.437 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 2.3 p -95.06 152.48 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.492 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' LYS . 24.1 t70 -103.65 151.46 22.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -62.79 -36.23 82.44 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.911 -1.118 . . . . 0.0 109.418 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -74.89 -50.33 17.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 110.811 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' CD ' ' H ' ' A' ' 27' ' ' ASP . 1.3 ptmm? -62.75 -25.16 68.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.958 -1.089 . . . . 0.0 108.69 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.58 -39.47 76.85 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -69.32 -44.52 71.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.695 -0.628 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.54 -28.37 66.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.14 . . . . 0.0 110.21 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.5 ttm -71.47 -52.06 20.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.867 -1.146 . . . . 0.0 110.444 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 35' ' ' ILE . 9.5 tp -61.1 -29.02 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.749 -1.219 . . . . 0.0 109.709 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.01 -44.1 90.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.065 -1.022 . . . . 0.0 109.038 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 53' ' ' ARG . 3.7 mm? -70.71 -43.58 68.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -62.81 -33.52 75.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -0.806 . . . . 0.0 109.104 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.14 -36.32 88.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.77 -3.63 39.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -1.174 . . . . 0.0 109.992 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 161' ' ' ILE . 3.3 pt20 -79.26 -0.69 33.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.04 122.76 18.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.162 -0.961 . . . . 0.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.514 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 74.04 -32.85 0.92 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.9 mm? -98.47 150.03 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.286 . . . . 0.0 109.996 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.5 p -65.61 157.29 30.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -61.33 -31.08 70.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -40.8 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.413 -0.804 . . . . 0.0 109.877 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 m -57.37 -38.92 74.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.081 -1.012 . . . . 0.0 108.35 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -64.17 -36.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.23 -47.48 78.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -0.966 . . . . 0.0 109.046 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.5 -34.09 76.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' C ' HD22 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -84.52 -10.65 57.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.005 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 41.1 ttm180 -66.72 -51.16 59.17 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.54 -36.13 76.08 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.229 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -72.13 -34.88 68.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.015 -1.053 . . . . 0.0 109.929 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 82.9 t80 -60.7 -47.47 86.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 7.9 ptm180 -66.86 -28.23 68.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.919 -1.113 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -67.7 -37.98 83.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 111.267 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -77.41 -45.66 25.16 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.749 -1.219 . . . . 0.0 110.768 -178.743 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.606 ' C ' ' H ' ' A' ' 62' ' ' GLN . 86.7 m-85 -84.5 -48.39 9.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 110.334 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 55.89 -4.0 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.019 -1.051 . . . . 0.0 109.552 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.649 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 81.4 mt-30 -75.75 -18.39 59.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.037 -1.039 . . . . 0.0 108.759 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.649 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 3.4 m-30 101.07 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.086 0.555 . . . . 0.0 109.579 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.5 OUTLIER 165.46 -42.77 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.419 0 O-C-N 120.554 -1.341 . . . . 0.0 113.786 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 64' ' ' ASP . 50.8 Cg_exo -49.88 -146.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.341 0 C-N-CA 123.721 2.948 . . . . 0.0 116.982 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 103' ' ' LEU . 59.4 t -57.3 -30.13 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.917 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -39.82 66.97 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.331 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 64' ' ' ASP . 72.3 t -69.34 -40.71 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.766 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.711 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.33 -16.28 59.89 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.02 -6.38 58.75 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.626 ' SD ' ' NE2' ' A' ' 62' ' ' GLN . 67.6 mmm -82.74 117.24 22.52 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.89 172.27 8.26 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.12 -0.988 . . . . 0.0 109.857 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -54.33 -31.47 54.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.486 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.31 -44.41 75.78 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.651 -1.28 . . . . 0.0 108.37 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.24 -37.81 86.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 92' ' ' ILE . 99.5 t -56.93 -44.83 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 0.0 109.591 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.76 -38.06 89.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 108.628 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -60.93 -39.95 91.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 109.373 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 85' ' ' ILE . 95.9 mt -63.01 -33.24 75.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.16 -33.8 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -109.34 -4.04 16.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.557 -0.714 . . . . 0.0 110.949 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 35.7 t0 -82.0 108.68 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.281 -1.512 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.91 -16.06 0.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.421 -0.799 . . . . 0.0 109.548 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.01 33.18 57.7 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.663 HG22 ' OD1' ' A' ' 55' ' ' ASN . 22.1 pt -54.73 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -1.114 . . . . 0.0 110.205 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 86' ' ' ILE . 10.6 tt -57.71 86.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -54.21 138.64 38.01 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.698 0.761 . . . . 0.0 110.434 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 160.58 77.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.585 ' CD ' ' H ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.18 -35.27 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.533 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 -56.26 25.63 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -65.8 -41.43 91.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.295 . . . . 0.0 110.614 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 76' ' ' VAL . 74.6 mt -62.66 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 0.0 110.443 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 2.7 pt20 -55.82 -34.52 65.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.667 -1.271 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -63.13 -37.51 87.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.948 . . . . 0.0 109.153 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.62 -44.27 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 108.821 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.57 HG21 ' O ' ' A' ' 71' ' ' MET . 9.3 mm -60.45 -41.12 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.59 90.86 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -40.53 87.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 0.0 109.264 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.23 -43.89 93.56 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.072 -1.017 . . . . 0.0 109.001 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.711 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -52.16 -42.07 63.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 108.793 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.44 -29.32 69.99 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.713 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 45.9 t80 -62.79 -44.86 95.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.9 mm? -62.82 -33.36 75.07 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.08 -36.94 84.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.392 -0.817 . . . . 0.0 110.444 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 82.9 mmm -71.56 -40.3 70.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.71 -39.33 70.23 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.19 -20.03 64.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -85.89 -8.98 57.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.77 26.34 73.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.04 101.79 49.62 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.497 -1.002 . . . . 0.0 109.678 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.25 143.7 41.83 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.342 2.028 . . . . 0.0 112.204 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.713 ' CZ ' ' CD1' ' A' ' 102' ' ' TYR . 58.5 m-85 -64.66 -45.33 87.21 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.039 0.924 . . . . 0.0 110.665 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.6 -26.91 68.9 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.473 -0.767 . . . . 0.0 110.947 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.479 ' O ' ' OG ' ' A' ' 118' ' ' SER . 60.4 t0 -66.24 -49.35 67.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.863 -1.148 . . . . 0.0 111.862 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.3 p90 -69.74 -44.51 70.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.864 -1.148 . . . . 0.0 111.355 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 117' ' ' TRP . 3.3 p -61.0 -53.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.512 -1.367 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.617 ' H ' HG13 ' A' ' 116' ' ' VAL . 37.5 m95 -55.82 -23.09 28.32 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.496 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 13.3 m -69.26 -38.87 78.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.084 -1.01 . . . . 0.0 109.782 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 29.8 m-85 -64.55 -33.9 77.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 120' ' ' VAL . 3.6 m -91.82 18.58 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.055 . . . . 0.0 109.178 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.61 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 59.2 m-80 58.62 43.96 18.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 0.0 109.496 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 28.9 p-80 41.51 24.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.491 -0.756 . . . . 0.0 110.058 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -135.46 153.76 78.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.086 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 147.46 95.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.653 2.235 . . . . 0.0 112.376 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -100.36 131.7 46.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.761 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.7 mtt -96.88 113.25 24.77 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -93.24 115.9 28.49 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -87.84 19.31 3.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.33 140.75 52.29 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.261 -0.899 . . . . 0.0 109.122 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.29 -28.65 10.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.3 p -128.18 162.37 27.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.52 -0.737 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.91 -36.87 70.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.054 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.2 m -61.84 -30.34 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.19 -6.5 57.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 109.816 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -75.52 131.8 76.7 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 74.3 Cg_endo -79.41 -21.58 8.78 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.844 1.696 . . . . 0.0 112.649 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.482 HG22 ' CE1' ' A' ' 163' ' ' TYR . 0.2 OUTLIER 52.36 -1.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.767 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -148.37 83.15 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.065 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.416 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -95.62 159.08 33.34 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.9 -38.13 85.88 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.843 1.695 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.01 -45.02 52.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.416 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 18.1 m -62.95 -43.0 99.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.735 . . . . 0.0 109.061 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.83 -42.05 97.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 108.932 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.1 -29.0 66.99 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -61.52 -47.81 83.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.648 -0.657 . . . . 0.0 109.484 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.546 ' HG ' ' CB ' ' A' ' 162' ' ' CYS . 3.8 m -66.19 -41.02 90.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 0.0 110.161 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -58.3 -38.66 77.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.845 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.13 6.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 145' ' ' LEU . 10.1 mp -59.93 -31.94 70.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 109.968 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -61.05 -45.12 96.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.789 -1.195 . . . . 0.0 109.581 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -84.48 -13.5 51.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -81.75 2.99 27.38 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.864 -1.148 . . . . 0.0 109.484 -178.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.1 21.18 33.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 15.2 m-85 -109.66 111.13 22.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -1.073 . . . . 0.0 109.308 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -94.64 -178.31 4.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 55.32 40.48 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 108.93 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.2 p -125.03 48.37 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.61 162.2 0.5 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -58.18 -30.61 66.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.496 -1.002 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.5 m -72.32 -37.24 68.97 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.141 -0.974 . . . . 0.0 108.674 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.417 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 1.1 mt -64.74 -39.88 87.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.546 ' CB ' ' HG ' ' A' ' 146' ' ' SER . 1.4 m -62.2 -49.35 76.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.87 . . . . 0.0 109.828 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.566 ' CZ ' ' OE1' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -65.16 -41.0 95.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 20.1 m -64.38 -43.02 95.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.11 -0.994 . . . . 0.0 109.56 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.9 88.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 98.8 mtp -60.89 -40.55 93.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 111.289 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.566 ' OE1' ' CZ ' ' A' ' 163' ' ' TYR . 59.8 mt-30 -64.04 -44.74 91.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 111.222 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.26 63.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.019 . . . . 0.0 110.612 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -39.09 67.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 0.0 111.288 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.9 0.61 17.3 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -1.188 . . . . 0.0 109.887 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.32 150.34 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 79.2 m-20 -128.57 163.56 24.74 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.386 0.612 . . . . 0.0 110.72 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.9 t0 89.52 74.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.471 0.653 . . . . 0.0 109.755 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 176' ' ' VAL . 9.2 m170 -58.35 -44.6 88.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 175' ' ' HIS . 12.9 m -157.99 29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.905 . . . . 0.0 109.992 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 129' ' ' ALA . 85.8 t 55.24 113.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.888 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.14 33.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.641 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -73.58 91.9 1.88 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -1.086 . . . . 0.0 109.45 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 59.95 -42.64 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.793 -0.567 . . . . 0.0 110.791 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.1 t -172.59 57.02 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 56.1 t80 -70.14 135.99 87.0 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.039 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.476 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 37.1 Cg_endo -69.72 136.41 33.03 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 112.737 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.29 -30.92 0.08 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.26 4.25 31.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -1.039 . . . . 0.0 108.822 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.41 86.11 32.96 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.452 2.101 . . . . 0.0 112.401 -179.284 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.012 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtm . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -110.83 140.03 45.62 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -70.17 161.74 29.67 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.572 -0.705 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 133.67 51.15 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.918 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.78 -30.8 76.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.31 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 1.7 t90 -76.08 -1.51 26.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 108.334 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' ND1' ' A' ' 17' ' ' HIS . 1.1 t -102.29 -28.0 3.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.392 0.615 . . . . 0.0 109.395 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.1 m -70.66 5.2 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.9 . . . . 0.0 110.634 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -84.11 -149.18 0.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.789 -1.195 . . . . 0.0 109.275 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.67 158.6 11.42 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 -160.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.837 2.358 . . . . 0.0 111.468 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 -40.42 0.27 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.012 -1.055 . . . . 0.0 109.135 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.657 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 1.3 m-85 -64.48 -36.63 84.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.894 -1.129 . . . . 0.0 109.413 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.78 -46.83 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.544 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.04 69.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.995 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.2 t80 -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.011 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.498 ' ND1' HG21 ' A' ' 7' ' ' VAL . 14.6 t-80 -76.08 -32.12 59.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.94 -10.33 59.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.956 -1.09 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 19.7 p30 -90.95 -70.41 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.602 -1.311 . . . . 0.0 112.464 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.676 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.2 mt-10 -126.5 -69.09 0.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.943 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.69 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 30.1 t-105 51.72 44.83 28.96 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.68 41.45 19.67 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 120.491 -1.381 . . . . 0.0 110.969 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.574 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -106.98 -41.88 0.14 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.218 . . . . 0.0 109.993 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 95.4 Cg_endo -98.57 154.03 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.794 2.996 . . . . 0.0 112.821 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.36 144.2 55.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 169' ' ' CYS . 67.4 p -105.46 155.44 19.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.773 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -92.16 167.1 12.28 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -59.95 -36.8 77.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 111.197 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.1 -41.55 90.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 112.264 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -62.34 -38.68 90.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.603 -1.311 . . . . 0.0 108.855 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -56.76 -39.1 73.41 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.231 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -60.73 -40.3 91.83 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.04 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -70.69 -43.38 69.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.905 -1.122 . . . . 0.0 108.778 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.479 ' SD ' ' CD1' ' A' ' 165' ' ' PHE . 58.2 ttm -63.82 -47.36 81.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 110.462 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -65.46 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.2 m -69.36 -51.11 40.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.99 -1.068 . . . . 0.0 109.652 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 2.2 mp -68.44 -42.0 79.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.196 -0.94 . . . . 0.0 108.965 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 9.1 tp10 -62.55 -35.74 80.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.619 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.29 -28.1 49.0 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -79.41 -12.87 59.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 109.807 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.519 ' NE2' ' H8 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -74.79 11.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 111.303 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -68.62 112.94 5.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.367 -1.458 . . . . 0.0 109.238 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.27 -0.35 0.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.604 HD21 ' CG2' ' A' ' 48' ' ' THR . 17.3 tp -106.66 145.2 32.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.193 -1.18 . . . . 0.0 109.857 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.7 m -64.39 157.06 27.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.837 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.626 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 2.8 t-105 -71.13 -43.81 66.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.489 -0.757 . . . . 0.0 110.708 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.562 HD12 ' HZ2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -58.96 -27.22 35.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.959 -1.088 . . . . 0.0 109.097 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.604 ' CG2' HD21 ' A' ' 44' ' ' LEU . 29.6 m -63.86 -40.23 96.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -0.935 . . . . 0.0 109.895 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 46' ' ' TRP . 1.2 m -69.82 -28.83 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.084 -1.01 . . . . 0.0 108.993 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.06 -47.31 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -56.64 -45.85 81.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' TYR . 21.3 ttpp -59.82 -32.59 70.8 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -55.35 -45.25 76.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.531 -0.731 . . . . 0.0 109.576 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -68.66 -46.11 69.98 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.02 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 14.0 m-80 -64.34 -34.65 78.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.776 . . . . 0.0 109.142 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.1 t80 -56.6 -42.29 78.49 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 61' ' ' HIS . 7.2 mmm180 -63.37 -38.22 90.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.09 -41.25 86.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.744 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -45.39 41.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.0 111.229 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 81.4 m-85 -89.9 -45.69 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.533 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 2.2 t60 60.97 -47.0 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.051 0.453 . . . . 0.0 110.416 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' PHE . 91.6 mm-40 -81.29 -37.88 27.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.792 . . . . 0.0 109.931 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 62' ' ' GLN . 46.5 p90 35.88 21.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.772 -0.58 . . . . 0.0 111.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -91.08 131.86 35.84 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.238 -1.539 . . . . 0.0 109.1 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -37.6 -52.92 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.986 2.457 . . . . 0.0 114.75 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.07 -44.83 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 111.121 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.49 -40.6 95.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 64' ' ' ASP . 38.1 t -63.5 -41.77 93.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.801 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.68 60.73 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.18 -14.53 28.92 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.739 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.5 mtp -82.78 113.14 20.22 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.61 -177.64 3.99 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.766 -1.209 . . . . 0.0 110.958 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.42 -36.65 69.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 109.136 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.81 -49.04 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.581 -1.325 . . . . 0.0 108.128 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.34 -35.66 74.26 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.507 ' HA ' HD12 ' A' ' 79' ' ' LEU . 55.6 t -60.55 -37.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.28 -0.887 . . . . 0.0 108.748 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.02 -39.8 83.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -65.37 -33.48 76.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.361 0.6 . . . . 0.0 109.507 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.744 HD22 ' SG ' ' A' ' 59' ' ' CYS . 87.8 mt -69.29 -34.47 74.75 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.266 -0.896 . . . . 0.0 110.447 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.1 t -56.03 -17.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -109.73 -17.26 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -1.0 . . . . 0.0 110.077 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 59.6 m-20 -80.04 109.78 14.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.75 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.98 -16.21 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.675 . . . . 0.0 109.246 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.7 42.73 86.87 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.8 pt -52.52 -166.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.836 -0.802 . . . . 0.0 109.846 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.07 98.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.511 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 11.2 ptp180 -52.68 116.82 2.5 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.675 0.75 . . . . 0.0 109.696 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 168.23 70.56 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.023 -1.048 . . . . 0.0 108.197 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 29.3 ptt180 -44.34 -42.44 6.79 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.694 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -47.97 -51.85 18.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -65.18 -45.38 85.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -1.128 . . . . 0.0 109.861 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 mm -60.75 -44.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.631 -0.668 . . . . 0.0 110.005 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -56.83 -38.31 72.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.823 -1.173 . . . . 0.0 110.167 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.97 82.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.41 -39.46 74.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 71' ' ' MET . 25.5 mm -59.16 -46.22 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.591 0.71 . . . . 0.0 110.269 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.85 -28.78 73.94 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -63.55 -40.52 97.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -1.16 . . . . 0.0 110.009 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -49.83 61.23 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 108.95 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -55.81 -38.08 69.51 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.46 -29.54 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.083 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.01 -42.27 94.59 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.2 mm? -62.78 -33.52 75.35 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.59 -36.54 83.05 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.533 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 39.1 tpp -61.01 -47.64 85.52 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.121 -0.987 . . . . 0.0 108.337 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 109' ' ' GLY . 84.3 tt0 -57.67 -35.73 70.96 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.3 t-20 -91.43 -18.12 24.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.51 27.57 73.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.3 mt-10 -114.26 108.58 50.04 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.72 -0.87 . . . . 0.0 109.57 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -51.73 139.75 48.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.965 1.777 . . . . 0.0 112.069 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.713 ' HB3' HD12 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -55.01 -37.84 67.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.756 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.27 64.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.636 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -62.96 -45.05 94.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.688 -1.257 . . . . 0.0 111.249 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.659 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 5.4 p90 -77.39 -40.51 43.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.91 -1.119 . . . . 0.0 111.601 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.659 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 21.6 m -63.2 -48.84 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 119.547 -1.97 . . . . 0.0 108.662 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.567 ' N ' HG23 ' A' ' 116' ' ' VAL . 46.3 m95 -61.26 -23.67 65.83 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.8 t -70.22 -44.48 68.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.095 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 24.1 m-85 -61.19 -30.28 70.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 109.812 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -96.5 18.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 123' ' ' GLN . 82.0 m-20 56.99 42.31 26.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 110.176 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 37.67 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.67 -0.644 . . . . 0.0 109.361 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.3 mm100 -122.84 112.37 30.61 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.349 -0.844 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.27 150.45 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.882 1.722 . . . . 0.0 111.227 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 142.44 46.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.044 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.7 mtt -91.2 130.27 37.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.78 . . . . 0.0 109.638 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.595 HG22 ' N ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -93.44 -58.91 2.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 109.745 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.595 ' N ' HG22 ' A' ' 127' ' ' THR . 71.7 mt-30 59.26 44.26 15.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.34 156.23 28.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.451 -0.781 . . . . 0.0 109.687 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -92.53 -12.79 30.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -168.55 -179.34 3.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -36.39 83.48 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 t -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.897 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 74.9 mm-40 -81.7 5.41 18.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.621 -1.299 . . . . 0.0 109.334 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.61 136.01 20.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.13 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.89 140.37 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.415 2.077 . . . . 0.0 112.883 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.409 ' HA ' ' CG ' ' A' ' 163' ' ' TYR . 0.6 OUTLIER -105.7 -1.47 24.45 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 108.957 179.197 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -145.97 92.3 2.18 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.501 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.63 154.82 39.79 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.195 -0.941 . . . . 0.0 108.979 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -54.1 -34.65 79.03 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.715 1.61 . . . . 0.0 111.105 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -48.63 51.06 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.467 -0.771 . . . . 0.0 109.029 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -64.06 -42.06 97.14 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.644 0.735 . . . . 0.0 109.362 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.03 -39.11 77.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.581 -0.7 . . . . 0.0 109.47 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.743 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.64 -31.74 72.92 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.656 HD22 HG12 ' A' ' 116' ' ' VAL . 69.9 mt -59.6 -46.74 88.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 26.3 t -60.47 -43.62 96.75 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -64.56 -47.3 79.28 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.518 -0.739 . . . . 0.0 110.17 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.63 77.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.418 ' HG ' ' NH2' ' A' ' 152' ' ' ARG . 35.1 mt -66.25 -36.77 83.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.8 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.34 -40.86 92.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.608 -1.308 . . . . 0.0 110.01 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -68.82 -36.6 78.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.969 . . . . 0.0 111.47 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.515 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 74.2 mtm180 -72.26 3.7 4.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.64 20.15 52.03 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 11.2 m-85 -96.93 110.34 22.88 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.29 . . . . 0.0 109.796 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -90.62 178.28 6.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.887 -0.508 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 58.33 47.69 13.59 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.238 1.018 . . . . 0.0 108.889 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.7 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.11 160.41 0.79 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.6 m -59.66 -33.18 71.22 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.512 -0.993 . . . . 0.0 109.188 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.0 m -71.86 -36.07 70.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.91 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.907 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 146' ' ' SER . 20.6 m -67.84 -39.97 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.245 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CG ' ' HA ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -62.66 -44.01 97.35 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.605 -0.685 . . . . 0.0 110.077 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 59.2 p -61.54 -35.45 77.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CD1' ' SD ' ' A' ' 34' ' ' MET . 18.5 t80 -61.5 -41.43 97.28 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 110.063 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.451 ' HG2' ' N ' ' A' ' 167' ' ' GLN . 2.4 ptm -67.48 -36.92 82.07 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.902 -1.124 . . . . 0.0 110.795 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.451 ' N ' ' HG2' ' A' ' 166' ' ' MET . 27.1 mm100 -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.842 -1.162 . . . . 0.0 110.893 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.0 -16.0 21.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.39 -0.819 . . . . 0.0 111.937 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 26' ' ' THR . 2.2 t -74.56 -46.11 41.04 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.381 -1.449 . . . . 0.0 110.407 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 -1.42 3.9 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 171' ' ' LEU . 8.8 mp -61.51 -31.57 71.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.025 -1.279 . . . . 0.0 110.685 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.9 154.54 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.959 -1.088 . . . . 0.0 109.049 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 28.6 p30 -124.06 162.77 22.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.171 -0.956 . . . . 0.0 110.046 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.589 ' OD1' ' CE2' ' A' ' 182' ' ' TYR . 7.4 m-20 91.56 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -51.73 -39.62 58.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.026 . . . . 0.0 108.623 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.863 HG13 ' H ' ' A' ' 177' ' ' VAL . 2.8 p -145.15 -104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.622 -0.674 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.863 ' H ' HG13 ' A' ' 176' ' ' VAL . 1.1 t -138.4 -41.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 108.292 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.28 67.55 0.52 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t -100.22 119.99 39.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.338 . . . . 0.0 110.17 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.23 46.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.56 -37.08 67.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.961 -1.087 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.598 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 6.6 t80 -120.29 83.96 33.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 109.626 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' A' ' 186' ' ' LYS . 24.5 Cg_exo -58.25 123.08 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.834 2.356 . . . . 0.0 111.769 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.66 -18.39 73.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' LYS . 1.0 OUTLIER -101.1 -18.61 16.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.527 -0.984 . . . . 0.0 110.237 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 183' ' ' PRO . 0.5 OUTLIER 47.16 70.36 2.13 Favored Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 120.874 -1.141 . . . . 0.0 109.148 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.876 2.384 . . . . 0.0 112.089 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.31 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.85 150.32 45.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.048 -1.033 . . . . 0.0 110.879 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 3' ' ' ARG . 30.4 mtm-85 -60.25 -171.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.813 0.816 . . . . 0.0 111.235 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.47 131.17 42.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.612 0.72 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.83 -18.42 53.31 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.317 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 0.9 OUTLIER -89.19 -4.02 58.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -1.141 . . . . 0.0 109.984 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER -111.43 -10.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.205 -0.934 . . . . 0.0 109.8 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.5 m -70.78 5.99 1.69 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 108.799 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.0 mt-30 -63.1 -88.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.804 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 165.88 -38.06 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 0.0 111.556 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' ASP . 61.1 Cg_endo -91.12 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.775 2.317 . . . . 0.0 115.532 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' TYR . 26.0 mt -32.34 -32.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.941 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' PRO . 4.3 m-85 -44.98 -40.59 6.57 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.843 -1.16 . . . . 0.0 109.913 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.8 mt -61.76 -46.38 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.54 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.02 39.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.126 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.477 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 t80 -62.51 -41.85 99.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -63.05 -38.07 89.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.79 -1.72 58.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 112.217 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 1.4 p-10 -100.95 -34.03 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.506 -1.371 . . . . 0.0 111.13 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 93.5 mt-10 -153.19 -73.98 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.577 -1.327 . . . . 0.0 110.554 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.783 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 8.4 t-105 39.76 45.83 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.098 0.951 . . . . 0.0 108.804 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' ALA . . . 74.45 49.2 12.0 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.487 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.709 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 t -108.69 -35.93 0.15 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.195 -1.18 . . . . 0.0 109.074 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.709 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.2 Cg_endo -92.13 154.69 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 123.367 2.711 . . . . 0.0 112.148 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' C ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -64.39 151.95 42.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.769 ' OG1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -91.3 142.91 27.2 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.506 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -102.83 158.62 16.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 m -56.33 -33.73 65.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.777 -1.202 . . . . 0.0 109.006 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -67.14 -39.0 86.49 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.747 -0.595 . . . . 0.0 110.933 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -62.27 -44.31 96.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.005 -1.06 . . . . 0.0 110.003 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -62.24 -37.97 87.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.0 -53.08 60.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.09 -1.006 . . . . 0.0 110.511 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.01 -40.71 78.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 108.872 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.659 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 3.3 ttm -62.87 -49.33 75.28 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 111.125 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 157' ' ' VAL . 2.7 tp -62.21 -27.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.948 -1.095 . . . . 0.0 108.962 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.41 -54.26 11.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -0.973 . . . . 0.0 109.798 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -71.07 -39.87 71.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 0.0 109.017 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 9.7 tp10 -59.57 -32.01 69.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.13 80.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.708 HE21 ' CD1' ' A' ' 44' ' ' LEU . 55.2 tp60 -69.25 -30.7 68.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.095 -1.238 . . . . 0.0 109.952 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.583 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -51.03 -3.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 110.368 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -63.28 112.42 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.877 -1.14 . . . . 0.0 109.319 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.05 -13.5 0.49 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.708 ' CD1' HE21 ' A' ' 40' ' ' GLN . 9.7 mt -101.98 159.52 15.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.043 -1.269 . . . . 0.0 110.354 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.6 ' HG ' ' HG1' ' A' ' 48' ' ' THR . 1.2 p -85.29 147.18 26.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.463 -0.773 . . . . 0.0 108.916 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.622 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 1.0 OUTLIER -60.95 -40.75 94.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.422 -0.798 . . . . 0.0 110.592 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -39.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.004 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.6 ' HG1' ' HG ' ' A' ' 45' ' ' SER . 84.8 m -61.55 -40.53 95.04 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -66.37 -35.57 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -58.83 -52.33 66.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -58.49 -41.9 86.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.592 -1.317 . . . . 0.0 107.966 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -65.64 -25.73 67.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.81 -43.23 76.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 47.0 mp0 -68.36 -39.95 81.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 51' ' ' LYS . 10.2 m120 -69.85 -37.88 76.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 0.0 109.606 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -60.69 -48.79 80.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.798 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -64.4 -25.79 68.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.164 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.09 82.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 110.7 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.15 -46.26 61.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.865 -1.147 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 62' ' ' GLN . 43.3 m-85 -85.19 -48.46 9.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.002 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 t-80 47.81 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.348 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.603 ' N ' ' O ' ' A' ' 60' ' ' PHE . 92.5 mt-30 -78.34 -30.77 48.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.519 -1.363 . . . . 0.0 109.937 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 33.8 p90 42.17 18.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -125.56 101.16 30.8 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 108.959 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.34 -32.16 32.51 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.251 1.968 . . . . 0.0 113.102 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.861 HG22 HD21 ' A' ' 103' ' ' LEU . 67.4 t -63.35 -46.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.777 -1.202 . . . . 0.0 109.753 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.81 -32.68 73.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.385 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.42 -39.34 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.351 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.26 -18.93 65.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -86.06 -5.7 59.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.475 ' HE1' HD11 ' A' ' 79' ' ' LEU . 98.4 mtp -85.15 113.22 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -95.92 176.08 6.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.465 -0.772 . . . . 0.0 109.524 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 97.4 mt-10 -52.84 -31.04 37.0 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.143 -0.973 . . . . 0.0 109.44 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.79 -49.65 76.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.175 -0.953 . . . . 0.0 108.454 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.21 -38.39 88.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.62 HG13 HG21 ' A' ' 92' ' ' ILE . 99.0 t -59.8 -43.37 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.733 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.13 -33.69 72.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.23 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 43.1 ttm180 -64.25 -46.26 84.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 110.104 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.475 HD11 ' HE1' ' A' ' 71' ' ' MET . 47.1 mt -67.32 -33.4 75.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 110.756 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.08 -18.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' N ' ' C ' ' A' ' 79' ' ' LEU . 22.0 mt-30 -110.4 -17.82 13.38 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.659 -0.65 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 54.1 m-20 -76.78 108.68 9.97 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.86 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 71.14 -18.71 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.54 -0.725 . . . . 0.0 109.817 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.66 34.69 84.29 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 84' ' ' GLY . 7.7 pt -42.82 160.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 44' ' ' LEU . 2.2 tt -63.85 -29.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.31 -0.869 . . . . 0.0 110.909 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 44.9 mtt-85 -63.77 145.37 55.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 109.889 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' ARG . 34.5 m80 -122.72 162.07 22.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 109.444 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.461 HH11 ' HG3' ' A' ' 89' ' ' ARG . 5.4 ptm180 -41.51 -40.81 1.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.56 -66.5 2.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.809 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -61.83 -38.08 86.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -1.148 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.62 HG21 HG13 ' A' ' 76' ' ' VAL . 98.1 mt -58.64 -54.13 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.829 -1.169 . . . . 0.0 109.966 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.453 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 61.3 mt-30 -51.93 -32.44 32.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 109.443 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.94 95.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.075 -1.016 . . . . 0.0 109.851 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.4 -36.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.641 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mp -58.36 -46.86 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.723 -1.236 . . . . 0.0 108.723 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.89 -35.79 92.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 84.3 m-20 -58.77 -37.01 75.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.457 -1.025 . . . . 0.0 109.719 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.14 90.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.987 -1.071 . . . . 0.0 108.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -59.02 -36.48 75.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.59 76.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.99 -42.54 99.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 HG22 ' A' ' 66' ' ' VAL . 87.8 mt -64.42 -33.79 76.69 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -63.43 -36.34 83.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.249 -0.907 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 87.0 mmm -68.74 -42.91 76.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.914 -1.116 . . . . 0.0 110.164 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.34 -37.33 83.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.494 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -94.49 -10.45 32.25 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.04 74.26 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.42 100.43 51.46 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 149.39 75.18 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.335 2.023 . . . . 0.0 111.946 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.548 ' HB3' HD12 ' A' ' 31' ' ' LEU . 40.0 m-85 -60.7 -33.33 72.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.328 -0.857 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.19 -34.9 71.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.712 -1.243 . . . . 0.0 111.467 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.43 -49.55 77.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.664 -1.272 . . . . 0.0 111.523 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.589 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 3.2 p90 -71.23 -35.3 71.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.205 . . . . 0.0 109.381 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.91 HG22 HD21 ' A' ' 145' ' ' LEU . 1.3 t -64.22 -54.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.05 . . . . 0.0 109.63 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.529 ' N ' HG12 ' A' ' 116' ' ' VAL . 60.3 m95 -57.51 -21.2 36.33 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 108.555 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 16.1 p -72.24 -36.97 69.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.738 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 20.7 m-85 -69.78 -33.74 72.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.936 -1.103 . . . . 0.0 110.289 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.66 18.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.976 -1.078 . . . . 0.0 109.682 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 65.05 37.91 6.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 109.957 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 24.6 t-80 42.33 36.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 110.875 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.39 21.51 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 109.159 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.44 143.38 47.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.206 1.937 . . . . 0.0 111.577 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -108.05 145.92 33.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.924 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 126' ' ' MET . 14.8 ptt? -97.92 121.38 39.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.425 -0.797 . . . . 0.0 108.947 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 m -90.0 119.93 30.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 109.43 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -91.52 18.59 7.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.906 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -61.52 143.06 56.58 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.088 -1.007 . . . . 0.0 109.421 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.403 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 81.6 p -105.0 -26.87 11.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.3 p -130.13 163.87 25.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.94 -37.04 70.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m -82.91 4.64 24.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.832 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' THR . 39.0 tp10 -98.0 5.05 49.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 127.02 34.99 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.109 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 139.75 36.26 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.901 1.734 . . . . 0.0 112.253 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 t -103.18 -2.49 27.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.822 . . . . 0.0 108.811 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.0 t -134.85 96.34 3.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.406 ' H ' ' HB2' ' A' ' 142' ' ' SER . 0.6 OUTLIER -114.6 159.79 35.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -53.94 -40.74 79.68 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.317 1.344 . . . . 0.0 111.399 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.93 67.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 139' ' ' THR . 22.9 m -60.21 -42.63 95.52 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.56 -0.713 . . . . 0.0 109.467 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -64.76 -41.21 96.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.191 -0.943 . . . . 0.0 109.161 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -72.76 -29.49 63.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.404 -0.81 . . . . 0.0 108.859 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.91 HD21 HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -68.37 -47.74 66.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.393 -0.817 . . . . 0.0 109.148 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.521 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 12.1 t -63.82 -42.65 97.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.857 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.47 -42.18 95.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.288 -0.883 . . . . 0.0 110.374 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.33 79.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.721 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.54 -38.87 84.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 109.352 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.11 -38.6 86.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.926 -1.108 . . . . 0.0 108.709 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -81.8 -14.26 56.59 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.451 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -83.38 0.74 44.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.732 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.41 19.92 43.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -100.61 112.83 25.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.623 -0.928 . . . . 0.0 108.622 179.134 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -97.27 166.46 11.55 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.4 p -158.81 41.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.29 174.5 0.2 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.8 p -62.31 -24.28 67.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.14 . . . . 0.0 109.224 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.0 m -66.34 -38.63 88.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.04 -44.69 78.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.9 m -61.91 -33.95 75.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.159 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -72.02 -47.83 48.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.969 -1.082 . . . . 0.0 110.709 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 92.7 p -67.35 -32.25 73.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.028 -1.045 . . . . 0.0 109.263 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.696 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -65.53 -37.1 85.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.347 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.59 ' HA ' HD12 ' A' ' 171' ' ' LEU . 2.1 ttp -69.4 -42.72 74.72 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.155 -0.965 . . . . 0.0 110.849 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 2.2 pt20 -68.74 -41.48 78.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.657 -1.277 . . . . 0.0 111.404 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -77.6 -37.44 50.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.032 -1.042 . . . . 0.0 112.047 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.696 ' SG ' ' CD2' ' A' ' 165' ' ' PHE . 78.8 m -63.7 -44.18 94.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.769 -1.207 . . . . 0.0 111.699 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.39 4.67 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 166' ' ' MET . 15.9 mt -60.73 -37.12 80.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -1.217 . . . . 0.0 109.581 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -128.25 146.09 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 109.269 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 67.2 m-20 -109.09 164.12 12.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.408 -0.807 . . . . 0.0 110.245 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 91.35 78.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.217 0.532 . . . . 0.0 110.81 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -53.37 -69.31 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.09 155.37 41.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' ALA . 59.9 t -63.22 126.87 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.0 109.487 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 80.21 40.03 14.54 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.06 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.636 ' O ' ' N ' ' A' ' 181' ' ' CYS . 17.1 t -68.07 49.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.738 -1.448 . . . . 0.0 108.511 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 60.59 -49.28 0.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.312 0.577 . . . . 0.0 110.077 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.1 t -179.4 71.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 108.703 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.705 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -59.48 116.37 16.15 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.45 154.53 31.64 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.321 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.97 -29.88 3.3 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -87.12 -1.15 57.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.236 . . . . 0.0 109.91 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 77.33 77.99 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.69 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 C-N-CA 122.878 2.386 . . . . 0.0 112.044 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.317 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.432 0.634 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 178' ' ' GLY . 15.0 pt-20 -95.1 160.98 14.31 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.974 ' NH1' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -105.88 165.99 10.8 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -45.78 127.87 8.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.778 0.799 . . . . 0.0 110.263 -179.134 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.67 57.04 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.309 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 2.8 t90 -53.92 -38.75 65.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.974 HG11 ' NH1' ' A' ' 3' ' ' ARG . 63.3 t -69.53 -36.38 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.64 -0.662 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -71.17 -3.41 19.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.035 . . . . 0.0 110.267 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.34 -38.73 91.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.227 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.77 160.43 30.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.047 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -34.67 14.68 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.91 2.406 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.43 -34.51 76.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.833 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.795 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 2.4 m-85 -57.5 -40.24 78.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.603 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -52.68 -39.54 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.942 -1.099 . . . . 0.0 109.238 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -66.85 -48.63 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 109.223 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.49 -38.8 88.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 110.019 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.93 -43.9 94.49 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.451 -0.781 . . . . 0.0 111.707 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -77.51 -10.76 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 20.1 m120 -78.31 -70.99 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.652 -1.28 . . . . 0.0 110.322 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -167.59 54.88 0.07 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.045 . . . . 0.0 109.362 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TRP . 7.4 t90 -96.35 63.26 2.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.115 -0.991 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 105.41 62.15 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.087 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.763 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -159.41 -36.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.227 -1.161 . . . . 0.0 110.742 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.763 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 68.4 Cg_endo -99.57 150.92 0.54 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 122.845 2.363 . . . . 0.0 113.204 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.05 147.8 44.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.0 p -109.5 150.96 27.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.662 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.41 164.17 13.12 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -58.98 -34.47 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.901 -1.124 . . . . 0.0 109.72 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -65.17 -40.41 94.27 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.387 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 25.4 mmtp -59.52 -40.89 88.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.1 mt -60.71 -35.17 75.66 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.619 -0.676 . . . . 0.0 109.698 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.2 t80 -63.37 -52.65 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 110.595 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -68.75 -33.36 73.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.512 -1.367 . . . . 0.0 108.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.98 -39.52 83.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.671 . . . . 0.0 110.149 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.917 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.2 tp -66.56 -28.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 109.519 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.9 m -68.81 -49.79 55.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.944 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -68.86 -45.07 71.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.022 -1.049 . . . . 0.0 109.458 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -63.99 -32.96 74.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.89 44.05 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -72.95 -36.41 67.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.538 -0.978 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.62 ' CA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -44.28 -19.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -66.34 112.57 4.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.903 -1.123 . . . . 0.0 109.071 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.72 -36.41 3.53 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 2.4 mm? -103.25 171.2 7.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.136 -1.214 . . . . 0.0 110.203 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.0 m -92.53 154.14 18.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.653 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.58 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.9 OUTLIER -60.61 -41.6 95.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.682 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -59.02 -44.47 91.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.954 -1.091 . . . . 0.0 108.895 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.548 HG21 HD12 ' A' ' 44' ' ' LEU . 59.7 m -58.11 -39.21 78.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.0 t -64.51 -32.34 57.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.73 -45.86 85.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.051 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.21 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 108.606 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -12.59 59.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.396 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -71.35 -46.49 60.38 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.26 -41.02 90.49 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.82 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -70.62 -34.33 72.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.588 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 79.6 t80 -58.45 -46.56 86.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.085 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.3 ptm180 -65.29 -28.4 69.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.32 86.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 110.545 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.628 ' CB ' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -77.42 -45.77 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.934 -1.104 . . . . 0.0 110.749 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' O ' ' N ' ' A' ' 62' ' ' GLN . 74.9 m-85 -86.62 -48.75 8.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.838 -1.164 . . . . 0.0 109.918 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 55.71 -26.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.692 -0.63 . . . . 0.0 112.003 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' N ' ' O ' ' A' ' 60' ' ' PHE . 6.5 pt20 -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.648 -1.283 . . . . 0.0 110.281 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.35 -3.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.386 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 62' ' ' GLN . 6.1 m-20 -98.41 125.67 42.27 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.915 -1.116 . . . . 0.0 108.342 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -38.67 32.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.568 1.512 . . . . 0.0 112.709 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.34 -41.69 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -62.44 -33.71 75.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.038 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.0 -38.41 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.41 -18.0 64.97 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -85.55 -5.36 59.29 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.3 mmm -80.91 115.32 20.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -95.44 173.48 7.5 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.455 -0.778 . . . . 0.0 110.39 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.54 -31.86 66.5 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.398 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.08 -31.48 72.0 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.766 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.47 -46.63 79.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 110.614 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 92' ' ' ILE . 2.0 p -61.49 -37.56 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.681 -1.262 . . . . 0.0 109.413 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.556 ' CD ' HH21 ' A' ' 89' ' ' ARG . 81.2 mm-40 -55.9 -38.29 70.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.875 -1.14 . . . . 0.0 108.145 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -65.69 -41.67 92.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 ' CB ' ' A' ' 59' ' ' CYS . 43.1 mt -69.99 -33.08 71.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.843 -0.535 . . . . 0.0 110.742 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' LEU . 24.5 t -47.97 -31.04 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.92 -6.33 32.5 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 84' ' ' GLY . 64.6 t0 -81.53 106.55 13.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.592 -1.317 . . . . 0.0 109.622 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.06 -16.05 0.12 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.599 -0.688 . . . . 0.0 109.55 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.1 39.81 36.38 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.82 HG22 ' OD1' ' A' ' 55' ' ' ASN . 15.7 pt -47.27 151.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -1.038 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 86' ' ' ILE . 8.4 tt -63.89 -26.75 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.459 -0.775 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' A' ' 87' ' ' ARG . 39.9 mtt-85 -66.64 148.34 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 89' ' ' ARG . 50.7 t-80 -132.12 -179.04 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.491 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.59 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 37.7 ttm180 -52.98 -38.0 61.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.917 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.33 -59.62 7.63 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.955 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.57 -44.3 96.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -1.221 . . . . 0.0 111.084 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 95' ' ' ILE . 37.2 mm -59.24 -46.23 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.711 -1.243 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -51.41 -35.93 41.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.628 -1.295 . . . . 0.0 108.009 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.39 75.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.324 -0.86 . . . . 0.0 109.083 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.758 HD12 HD13 ' A' ' 92' ' ' ILE . 82.2 mt -71.99 -40.97 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.29 -43.03 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.587 -1.321 . . . . 0.0 108.989 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.17 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.415 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 3.5 m120 -60.32 -36.96 79.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -1.148 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.8 89.13 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 0.0 108.334 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -65.97 -34.34 77.89 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.95 -31.72 72.88 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -62.51 -42.48 99.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.5 -31.6 72.42 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.49 -39.87 94.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.186 -0.946 . . . . 0.0 110.364 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.698 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 5.8 ttm -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.795 -1.191 . . . . 0.0 108.94 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.24 -35.27 80.28 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -21.9 66.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -88.47 -13.02 41.36 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.2 27.28 73.79 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.197 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.595 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.1 mt-10 -126.02 100.52 30.23 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.291 . . . . 0.0 109.35 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.81 144.08 27.86 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.263 1.976 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.698 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 71.4 m-85 -60.68 -34.93 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.56 -33.01 66.49 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.293 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -63.19 -48.19 79.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.696 -1.252 . . . . 0.0 111.598 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 116' ' ' VAL . 2.1 p90 -75.34 -32.93 61.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.808 -1.182 . . . . 0.0 109.886 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 145' ' ' LEU . 8.5 t -59.69 -55.4 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 108.934 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' HIS . 71.9 m95 -62.01 -21.59 65.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.6 p -76.04 -34.21 59.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -0.974 . . . . 0.0 109.744 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 1.8 m-85 -64.7 -36.12 83.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.008 -1.057 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 120' ' ' VAL . 2.8 p -89.76 18.02 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.192 -0.943 . . . . 0.0 109.191 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 68.01 17.04 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.493 -0.755 . . . . 0.0 109.924 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' N ' ' O ' ' A' ' 117' ' ' TRP . 2.1 t60 61.18 29.2 18.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.116 -0.99 . . . . 0.0 110.122 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -133.3 150.03 74.1 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.213 -0.929 . . . . 0.0 109.866 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.34 145.16 53.0 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.559 2.172 . . . . 0.0 111.989 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.606 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -111.5 131.38 55.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.101 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.606 ' C ' HE22 ' A' ' 125' ' ' GLN . 64.4 mtt -104.85 117.09 33.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 129' ' ' ALA . 1.1 m -97.09 -47.7 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.037 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 59.43 47.13 11.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.543 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.657 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -77.85 157.75 29.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.456 -0.777 . . . . 0.0 109.189 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.673 HG22 ' OE1' ' A' ' 134' ' ' GLU . 1.6 t -105.09 -26.18 12.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 130' ' ' THR . 40.3 p -131.5 163.66 27.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -0.903 . . . . 0.0 109.678 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.92 -32.44 70.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -63.62 -26.25 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.798 . . . . 0.0 110.27 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.673 ' OE1' HG22 ' A' ' 130' ' ' THR . 89.2 mt-10 -87.69 -0.81 57.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.292 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.755 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -87.98 128.68 53.0 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.61 140.25 26.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.313 2.009 . . . . 0.0 112.999 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.2 p -118.7 5.91 11.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.3 p -159.05 85.82 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.552 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -98.24 162.16 22.96 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.868 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.32 -40.72 76.96 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.402 1.401 . . . . 0.0 111.071 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -42.87 70.11 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 139' ' ' THR . 59.7 p -64.17 -45.47 88.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.466 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -63.93 -40.46 96.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.658 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.729 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -70.05 -29.28 66.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.272 -0.892 . . . . 0.0 108.825 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.021 HD11 HG22 ' A' ' 116' ' ' VAL . 13.3 tp -64.72 -43.09 94.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.655 -0.653 . . . . 0.0 109.875 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.662 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.05 -43.25 83.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.44 ' CG ' ' NZ ' ' A' ' 151' ' ' LYS . 34.3 ttpt -57.19 -44.77 83.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.478 -0.764 . . . . 0.0 110.788 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.63 70.75 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.001 -1.062 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 149' ' ' LEU . 95.9 mt -64.76 -38.44 90.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.431 -0.793 . . . . 0.0 109.832 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -41.96 98.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.034 -1.041 . . . . 0.0 109.06 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.44 ' NZ ' ' CG ' ' A' ' 147' ' ' LYS . 60.9 mttp -77.42 -13.45 59.92 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.99 -1.069 . . . . 0.0 110.233 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -85.03 -7.05 59.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.96 -1.088 . . . . 0.0 108.717 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.46 25.07 8.95 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -104.56 113.59 27.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -1.077 . . . . 0.0 109.145 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 43.2 mttt -90.98 -176.69 4.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.863 . . . . 0.0 110.433 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 6.4 p90 42.48 47.72 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.0 0.905 . . . . 0.0 109.285 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.74 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -128.62 46.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.37 172.96 1.76 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.5 m -57.86 -33.79 69.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -1.021 . . . . 0.0 110.06 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.2 p -68.6 -31.67 71.01 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.04 -1.037 . . . . 0.0 108.279 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.728 HG22 ' CE2' ' A' ' 165' ' ' PHE . 31.5 mm -65.88 -44.75 92.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.045 0.926 . . . . 0.0 108.986 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.662 ' SG ' ' N ' ' A' ' 146' ' ' SER . 53.1 m -58.12 -47.82 82.09 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.609 0.718 . . . . 0.0 110.576 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.581 ' OH ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -64.17 -31.36 72.52 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.466 -0.771 . . . . 0.0 110.88 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 98.5 p -61.33 -48.32 81.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 21.4 m-85 -64.35 -39.28 93.58 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 109.899 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 87.7 mtp -53.33 -37.49 62.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.665 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.581 ' NE2' ' OH ' ' A' ' 163' ' ' TYR . 78.1 mt-30 -68.02 -39.46 83.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.652 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.73 -40.16 14.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 111.136 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 171' ' ' LEU . 86.4 m -54.8 -28.12 46.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.945 . . . . 0.0 110.634 -178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.26 -2.75 47.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.596 HD21 HG12 ' A' ' 116' ' ' VAL . 6.9 mp -60.82 -38.52 85.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.381 -1.07 . . . . 0.0 109.853 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 173' ' ' ASN . 3.9 p -138.1 151.19 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 111.457 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.425 ' N ' HG22 ' A' ' 172' ' ' VAL . 50.2 t-20 -114.87 98.09 6.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.755 ' O ' HD11 ' A' ' 135' ' ' ILE . 53.1 p30 -132.6 21.13 4.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.555 ' C ' HG12 ' A' ' 176' ' ' VAL . 5.9 m170 -49.05 -45.69 43.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.486 -1.384 . . . . 0.0 108.912 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 178' ' ' GLY . 3.0 p 145.43 155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 129' ' ' ALA . 69.6 t -57.6 -38.76 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.965 -1.084 . . . . 0.0 110.341 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -80.16 29.4 2.48 Favored Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.077 -1.014 . . . . 0.0 111.073 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 26.8 t -76.84 20.48 0.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.869 -1.371 . . . . 0.0 109.34 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.412 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.0 OUTLIER 56.23 3.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 110.273 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -134.31 -1.01 2.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 0.0 109.814 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.51 80.49 65.82 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.62 130.67 19.92 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.025 1.817 . . . . 0.0 111.945 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.466 ' O ' ' CG ' ' A' ' 185' ' ' ASN . . . -95.25 -18.79 32.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 184' ' ' GLY . 76.5 m-20 -162.03 -30.32 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -1.148 . . . . 0.0 110.614 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.08 157.45 78.57 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.887 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.773 2.316 . . . . 0.0 112.165 179.761 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.309 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.25 0.548 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.548 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 70.0 tt0 -99.34 148.58 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -89.35 175.65 7.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.25 152.99 38.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.803 0.811 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.27 -40.73 60.88 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.711 -0.618 . . . . 0.0 111.967 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.826 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.92 -3.74 58.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.487 -1.596 . . . . 0.0 110.055 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.89 -40.36 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.997 -1.064 . . . . 0.0 109.315 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -77.01 -0.95 26.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 108.811 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 42.8 tt0 -64.46 -41.85 96.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.485 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 173.35 166.13 0.28 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.95 -1.094 . . . . 0.0 109.753 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' TYR . 50.6 Cg_exo -48.18 -167.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.534 2.156 . . . . 0.0 113.075 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.0 mt 63.57 -47.21 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.864 -0.523 . . . . 0.0 109.789 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.8 m-85 -62.51 -39.98 95.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.994 -1.066 . . . . 0.0 109.395 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.91 -44.29 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -66.2 -50.23 64.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.767 -1.208 . . . . 0.0 109.361 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.4 t80 -62.03 -42.58 99.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.822 . . . . 0.0 109.769 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -69.76 -41.6 74.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.459 -0.775 . . . . 0.0 110.349 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -74.96 -6.69 50.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 110.55 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m120 -71.77 -76.92 0.1 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.023 -1.048 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' C ' ' A' ' 21' ' ' TRP . 84.5 mt-10 -151.13 -51.85 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.969 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 3.8 t90 24.62 72.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.56 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 116.85 48.92 0.44 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.019 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.858 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.5 m -163.9 -27.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.252 -1.146 . . . . 0.0 112.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.858 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 44.9 Cg_endo -87.14 151.16 8.16 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.661 1.574 . . . . 0.0 113.79 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.11 152.06 29.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 p -94.98 137.87 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.918 -1.114 . . . . 0.0 111.186 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -98.15 157.64 16.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m -55.25 -35.43 64.98 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.503 -1.373 . . . . 0.0 109.067 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -69.45 -36.55 76.71 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.816 -0.552 . . . . 0.0 111.672 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -63.81 -41.46 97.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.746 -1.221 . . . . 0.0 110.619 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 116' ' ' VAL . 6.7 mp -57.09 -39.0 74.18 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.763 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 78.2 t80 -66.53 -52.58 44.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 110.597 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -67.34 -38.52 84.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 108.923 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 ttm -70.28 -47.9 59.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.505 -0.747 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.86 -31.85 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.868 -1.145 . . . . 0.0 109.441 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.8 m -69.65 -45.9 67.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.008 -1.057 . . . . 0.0 108.983 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HH11 ' A' ' 53' ' ' ARG . 79.8 mt -67.33 -38.33 84.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.469 -0.77 . . . . 0.0 109.468 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.604 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 65.3 mm-40 -64.82 -35.55 81.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.952 . . . . 0.0 109.862 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.95 -35.27 53.3 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.027 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . 76.4 mt-30 -63.52 -33.65 76.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.275 . . . . 0.0 110.747 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -43.62 -22.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.779 -1.201 . . . . 0.0 110.265 -179.591 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -54.95 112.65 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.929 -1.107 . . . . 0.0 109.148 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 76.61 -25.84 1.69 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 43' ' ' GLY . 3.7 mm? -102.56 164.97 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -99.47 148.3 24.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.682 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.4 OUTLIER -55.78 -39.98 72.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.006 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.97 -1.081 . . . . 0.0 109.122 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.7 m -64.4 -40.03 95.0 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' ARG . 1.4 t -65.89 -35.79 75.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -55.89 -50.39 70.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 20.3 mttt -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.596 -1.315 . . . . 0.0 108.864 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mmpp? -63.26 -26.43 68.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.527 HH11 HD13 ' A' ' 37' ' ' LEU . 17.3 ttm-85 -53.68 -45.87 70.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.4 -41.03 89.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.489 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 51' ' ' LYS . 9.6 m120 -69.11 -36.17 77.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.47 -48.6 80.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 110.66 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -69.24 -27.22 65.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.772 -1.205 . . . . 0.0 109.143 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -36.91 75.52 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.704 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.5 m -76.62 -45.9 28.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.948 -1.095 . . . . 0.0 110.193 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 62' ' ' GLN . 25.8 m-85 -83.94 -47.43 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 49.82 7.11 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 109.869 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.613 ' O ' ' N ' ' A' ' 64' ' ' ASP . 89.8 mt-30 -81.11 -29.0 34.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 52.6 p90 44.1 6.96 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.638 -0.664 . . . . 0.0 111.291 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -124.24 135.63 26.66 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.937 -1.102 . . . . 0.0 108.906 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 -15.08 16.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.241 1.96 . . . . 0.0 113.121 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 103' ' ' LEU . 87.3 t -72.77 -45.61 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.722 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -34.53 72.73 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 64' ' ' ASP . 90.6 t -61.25 -41.41 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.955 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.735 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -64.0 -17.3 63.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.05 55.99 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 95.2 mtp -85.35 114.23 22.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.86 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -95.68 -177.83 4.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.2 -31.19 67.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 110.596 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.58 -49.26 75.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.751 -1.218 . . . . 0.0 108.988 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.92 -38.99 90.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 t -58.46 -41.95 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -0.76 . . . . 0.0 109.306 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' C ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -60.48 -33.33 72.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.96 . . . . 0.0 109.359 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -69.61 -46.93 65.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.988 . . . . 0.0 110.239 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.704 HD22 ' HB3' ' A' ' 59' ' ' CYS . 17.5 mt -70.89 -32.44 69.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.76 -0.587 . . . . 0.0 112.182 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 76' ' ' VAL . 44.7 t -49.47 -27.1 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.746 -1.221 . . . . 0.0 109.638 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.42 -9.36 14.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.3 m-20 -73.49 111.09 8.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.549 -1.344 . . . . 0.0 109.169 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.22 -15.75 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.763 . . . . 0.0 109.214 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 76.71 38.94 30.51 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.0 pt -52.03 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.374 -1.074 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.3 mt -65.03 98.07 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.967 -1.083 . . . . 0.0 108.889 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.648 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 3.0 mtt-85 -55.49 132.76 49.25 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.648 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.4 m-70 156.51 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.655 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.6 OUTLIER -54.47 -35.67 63.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.167 -0.958 . . . . 0.0 108.809 -179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.21 -54.43 37.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.93 -43.63 95.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -1.178 . . . . 0.0 109.599 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.6 mt -58.23 -45.21 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.03 -1.044 . . . . 0.0 109.251 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.65 -33.71 68.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.921 -1.112 . . . . 0.0 109.339 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.3 82.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.045 -1.034 . . . . 0.0 108.459 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.61 -43.6 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.47 -0.769 . . . . 0.0 109.767 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.33 -46.4 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 108.583 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.33 95.41 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -59.07 -37.07 76.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -1.176 . . . . 0.0 109.411 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.0 86.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -0.983 . . . . 0.0 109.641 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.735 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 8.9 tpp180 -57.87 -38.27 75.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.176 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -62.8 -35.27 79.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.625 HD11 HG22 ' A' ' 66' ' ' VAL . 3.6 mm? -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -64.16 -42.04 96.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.17 -0.957 . . . . 0.0 109.443 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.643 ' SD ' ' CE1' ' A' ' 112' ' ' PHE . 80.5 mtp -68.66 -39.5 80.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.15 -41.23 86.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.428 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.73 -19.54 65.83 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -92.52 -9.5 41.1 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.41 25.2 75.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -115.45 102.47 54.41 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.372 -1.075 . . . . 0.0 109.297 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.14 148.99 29.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.643 ' CE1' ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -68.73 -43.36 76.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.76 0.791 . . . . 0.0 110.352 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 117' ' ' TRP . . . -69.36 -26.69 64.8 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.053 -1.029 . . . . 0.0 110.689 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -57.41 -49.15 77.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.742 -1.224 . . . . 0.0 110.923 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.746 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 8.6 p90 -76.0 -36.35 59.21 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 110.19 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.746 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 10.9 t -64.76 -55.13 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.706 -1.246 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 67.5 m95 -58.24 -21.71 49.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.181 -0.949 . . . . 0.0 108.654 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.1 p -73.57 -32.59 64.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.927 -1.108 . . . . 0.0 109.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 12.6 m-85 -69.63 -30.54 68.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.832 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 HD22 ' A' ' 171' ' ' LEU . 29.2 m -96.09 19.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.098 -1.001 . . . . 0.0 109.405 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 122' ' ' HIS . 69.3 m-20 61.94 42.03 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.0 110.799 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.413 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 41.89 29.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.6 178.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.0 147.67 35.65 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.857 -1.152 . . . . 0.0 109.853 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.62 139.34 88.5 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.302 2.001 . . . . 0.0 111.811 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.9 147.55 36.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.825 . . . . 0.0 109.65 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.6 mtt -95.11 125.97 40.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.188 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -67.87 -40.92 83.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 108.841 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 62.48 44.94 6.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.635 -0.665 . . . . 0.0 110.401 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -106.74 139.22 41.52 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.5 p -101.05 -14.22 17.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.011 -1.056 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -151.05 169.38 21.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.071 . . . . 0.0 109.963 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.1 -34.72 73.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.43 -0.794 . . . . 0.0 109.338 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -73.89 -11.48 60.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -98.68 14.9 26.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.0 mm -105.59 98.34 17.11 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.474 1.449 . . . . 0.0 112.227 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.5 p -97.38 1.86 49.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.393 -0.817 . . . . 0.0 109.446 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -138.79 91.16 2.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.269 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.495 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -106.2 156.16 37.34 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -52.29 -39.2 73.03 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.041 1.827 . . . . 0.0 111.628 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.41 -44.36 52.25 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.066 -1.021 . . . . 0.0 108.605 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.495 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 83.6 p -68.02 -37.48 81.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -66.22 -35.64 80.97 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 108.598 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -64.76 -39.1 93.06 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.559 -0.713 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 HG22 ' A' ' 116' ' ' VAL . 96.8 mt -58.96 -46.78 87.21 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.097 -1.041 . . . . 0.0 108.517 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.434 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 23.6 m -56.44 -40.63 75.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.692 -1.255 . . . . 0.0 108.921 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -65.9 -50.65 63.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.426 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.37 88.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.33 -38.82 85.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.973 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -61.25 -40.19 93.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.877 -1.14 . . . . 0.0 109.195 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -65.87 -33.55 76.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 110.374 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.472 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 2.5 mmp_? -72.24 2.94 5.14 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.04 -1.038 . . . . 0.0 108.876 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.16 52.46 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.72 115.44 27.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.723 -0.869 . . . . 0.0 108.781 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -89.34 167.41 13.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.624 -0.673 . . . . 0.0 110.397 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 57.62 59.87 3.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.619 -0.676 . . . . 0.0 109.956 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 22.6 m -131.56 33.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.539 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.08 164.19 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.4 p -58.91 -22.88 60.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -1.137 . . . . 0.0 108.889 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -75.76 -32.69 60.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.69 -45.25 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 146' ' ' SER . 94.6 m -63.04 -40.21 97.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.399 0.618 . . . . 0.0 109.867 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -70.07 -41.92 73.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.556 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.3 m -60.66 -44.54 96.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -0.838 . . . . 0.0 108.97 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.573 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 3.0 t80 -62.92 -40.05 96.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.823 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.401 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 1.1 ttp -59.93 -40.23 88.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.569 -0.707 . . . . 0.0 112.765 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.4 pt20 -79.66 -46.34 17.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.193 -1.567 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -73.28 -28.63 62.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.955 -1.091 . . . . 0.0 111.364 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 30.4 p -67.1 -29.75 69.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 111.39 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 109.01 -1.8 31.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.576 HD11 ' CG1' ' A' ' 116' ' ' VAL . 27.5 mt -61.01 -36.31 79.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.091 -1.241 . . . . 0.0 110.324 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.4 151.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.055 -1.028 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 81.8 m-20 -114.77 162.98 16.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.606 -0.684 . . . . 0.0 110.102 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 96.42 75.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.098 0.475 . . . . 0.0 110.008 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.467 ' O ' HD11 ' A' ' 135' ' ' ILE . 21.0 m170 -52.11 -41.05 62.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.116 -0.99 . . . . 0.0 108.71 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.79 ' O ' HG22 ' A' ' 176' ' ' VAL . 7.7 p -168.54 28.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 176' ' ' VAL . 42.0 t 56.19 118.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.0 109.906 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . 91.56 9.52 62.87 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.236 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 181' ' ' CYS . 1.7 t -70.38 149.53 47.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.279 . . . . 0.0 108.951 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 96.4 m -50.01 -27.45 5.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 179' ' ' CYS . 26.8 p -109.43 45.47 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 108.996 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -103.99 105.61 49.3 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.183 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.94 150.4 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.27 1.98 . . . . 0.0 112.077 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 146.5 -24.74 1.68 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 186' ' ' LYS . 38.4 m-20 -91.8 8.02 39.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.423 -1.045 . . . . 0.0 110.191 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 185' ' ' ASN . 0.0 OUTLIER 56.81 153.05 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 186' ' ' LYS . 97.3 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 122.939 2.426 . . . . 0.0 112.56 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.969 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -100.39 144.81 28.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.972 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.537 ' HB2' HG11 ' A' ' 7' ' ' VAL . 85.7 mtt180 -53.73 -42.35 68.02 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.428 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -178.1 154.55 0.88 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.17 -45.3 95.54 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.548 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.724 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.8 -4.41 58.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.361 -1.67 . . . . 0.0 109.988 -178.776 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 3' ' ' ARG . 4.5 t -75.14 -41.1 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.131 -0.98 . . . . 0.0 109.333 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.7 -9.59 58.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 108.875 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -69.63 -39.97 76.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -0.791 . . . . 0.0 111.257 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.26 157.59 30.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.508 -1.37 . . . . 0.0 111.239 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.3 Cg_endo -63.5 179.96 0.81 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.251 2.634 . . . . 0.0 112.286 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.1 mt 66.24 -44.14 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.652 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.2 OUTLIER -55.44 -35.69 65.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.15 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.9 mp -54.24 -43.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.07 . . . . 0.0 108.984 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -64.88 -49.27 71.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -58.36 -37.0 74.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.204 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -62.49 -45.33 93.49 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.141 -0.975 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -83.27 -2.59 56.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 7.5 m120 -76.5 -75.17 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.838 -1.164 . . . . 0.0 109.159 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -168.98 69.11 0.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.143 -0.973 . . . . 0.0 109.76 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.852 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.4 t90 -79.83 60.71 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.978 -1.076 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.45 64.19 1.46 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.583 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.807 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -137.87 -33.73 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.2 -1.176 . . . . 0.0 111.041 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.807 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 64.8 Cg_endo -97.08 150.45 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.737 2.291 . . . . 0.0 113.395 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.9 147.64 51.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 169' ' ' CYS . 69.5 p -101.71 151.45 22.02 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.543 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 5.9 t70 -94.35 157.01 16.23 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 m -50.29 -32.76 17.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -178.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -71.51 -39.31 70.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.681 -0.637 . . . . 0.0 111.63 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -62.66 -39.12 92.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.836 -1.165 . . . . 0.0 110.276 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.1 mp -56.45 -40.08 74.22 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.786 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.56 -46.66 87.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.94 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -71.53 -36.45 71.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.051 -1.031 . . . . 0.0 109.078 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.1 ttm -69.13 -47.9 63.83 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.047 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.15 -29.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.52 -1.362 . . . . 0.0 109.912 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.49 -52.75 28.84 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.493 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.6 mt -64.9 -40.19 94.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.585 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 66.1 mm-40 -63.43 -31.13 72.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.026 -1.046 . . . . 0.0 108.573 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 161' ' ' ILE . . . -68.49 -37.08 85.07 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 42' ' ' ALA . 96.2 mt-30 -58.65 -35.05 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.826 -0.808 . . . . 0.0 111.459 -178.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.762 ' NE2' ' N7 ' ' A' ' 189' ' ' ADK . 6.4 pt20 -70.96 9.59 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.631 -1.293 . . . . 0.0 110.177 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -54.96 112.92 1.15 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.937 -1.102 . . . . 0.0 108.589 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.15 -14.37 0.44 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 48' ' ' THR . 31.2 tp -106.77 145.95 31.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.562 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.0 157.13 4.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.702 0.763 . . . . 0.0 111.198 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.692 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.1 OUTLIER -74.82 -37.07 62.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.796 -0.565 . . . . 0.0 110.119 179.316 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -40.36 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.021 -1.049 . . . . 0.0 110.077 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.733 HG21 HD21 ' A' ' 44' ' ' LEU . 37.7 m -57.6 -38.5 75.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.09 -1.006 . . . . 0.0 108.34 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.5 t -65.06 -33.75 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.722 -0.611 . . . . 0.0 109.367 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.47 -48.66 78.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -63.02 -45.8 90.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.968 -1.083 . . . . 0.0 109.441 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -79.26 -8.99 59.47 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.266 -179.08 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.99 -54.45 13.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.756 -1.215 . . . . 0.0 108.492 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -39.96 94.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.498 -0.751 . . . . 0.0 109.733 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.695 ' OD1' HG22 ' A' ' 85' ' ' ILE . 17.9 t-20 -74.96 -46.49 35.15 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.15 -0.969 . . . . 0.0 110.893 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 59.4 t80 -63.41 -49.2 74.71 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.095 -1.003 . . . . 0.0 110.139 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 61' ' ' HIS . 3.6 ptm180 -58.12 -33.92 69.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.89 -1.131 . . . . 0.0 109.13 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.88 82.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 110.177 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.4 -43.67 63.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.819 -1.176 . . . . 0.0 110.505 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 84.1 m-85 -93.32 7.67 43.5 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 110.134 -179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 57' ' ' ARG . 35.6 t60 -53.73 -53.54 50.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.869 -1.145 . . . . 0.0 109.61 -179.325 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -68.16 -30.44 69.56 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.433 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 58.2 m-85 -109.32 73.53 0.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -46.35 0.12 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -97.11 -113.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.353 2.035 . . . . 0.0 115.584 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 103' ' ' LEU . 99.4 t -58.77 -34.97 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.909 -1.12 . . . . 0.0 108.853 -178.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 38.0 mttm -55.51 -38.19 68.88 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 63' ' ' PHE . 65.7 t -63.73 -36.4 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.7 -17.59 64.72 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -94.25 -14.86 25.06 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.491 ' O ' HG21 ' A' ' 96' ' ' ILE . 42.5 mmm -73.86 111.21 8.79 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.594 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 8.8 mt-30 -97.06 172.17 8.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.12 -29.25 29.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.46 -45.9 80.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.892 -1.13 . . . . 0.0 109.323 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.7 p30 -66.05 -36.36 83.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 108.577 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 79' ' ' LEU . 80.7 t -62.19 -44.13 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 110.487 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.84 -39.64 78.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -66.23 -39.56 89.65 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.59 0.709 . . . . 0.0 109.349 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 85' ' ' ILE . 8.2 mt -64.56 -32.68 74.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.654 -0.654 . . . . 0.0 111.136 -178.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.6 t -48.91 -35.2 6.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 4.1 pt20 -113.61 4.24 16.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.87 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.4 t0 -90.58 111.21 22.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.546 -1.346 . . . . 0.0 110.625 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.6 -16.73 0.6 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.547 -0.721 . . . . 0.0 109.658 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.34 28.32 60.12 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.301 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.695 HG22 ' OD1' ' A' ' 55' ' ' ASN . 23.2 pt -57.03 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.083 -1.246 . . . . 0.0 109.779 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.5 tt -58.63 76.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.174 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -58.26 117.39 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.3 OUTLIER -158.69 -34.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.44 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.581 ' HG2' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 65.45 -36.66 0.23 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.902 -0.498 . . . . 0.0 110.401 178.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 88' ' ' HIS . . . -73.51 -59.49 4.11 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.269 -1.443 . . . . 0.0 109.585 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.61 -33.55 72.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -1.069 . . . . 0.0 109.9 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.8 mt -64.98 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.67 -32.38 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.89 -39.26 90.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 109.159 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.07 -35.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.189 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 71' ' ' MET . 20.8 mm -62.26 -47.63 92.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 109.489 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.69 71.95 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.508 ' N ' HD22 ' A' ' 98' ' ' ASN . 1.6 m-80 -68.97 -35.54 76.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.128 -1.219 . . . . 0.0 110.536 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.05 90.69 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 108.854 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.2 mtt180 -62.59 -35.92 81.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.05 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.95 -29.33 70.5 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.68 -40.46 96.86 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.738 HD21 HG22 ' A' ' 66' ' ' VAL . 69.3 mt -64.28 -34.08 77.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -63.78 -37.12 86.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 110.087 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CD1' ' A' ' 112' ' ' PHE . 8.6 ttm -65.92 -43.05 89.25 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.923 -1.11 . . . . 0.0 109.316 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -63.18 -36.75 84.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.613 -0.679 . . . . 0.0 109.352 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.77 -18.75 64.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -16.36 25.78 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.91 27.06 73.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.545 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.5 mm-40 -114.58 101.57 54.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 110.065 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.97 141.67 45.89 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.16 1.907 . . . . 0.0 112.485 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CD1' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -55.5 -44.0 76.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.701 0.762 . . . . 0.0 111.246 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB1' ' HD1' ' A' ' 117' ' ' TRP . . . -70.42 -27.75 64.51 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 111.023 -178.238 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -61.86 -47.71 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.014 -1.054 . . . . 0.0 111.368 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.842 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.5 p90 -76.56 -33.48 58.52 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.708 -1.245 . . . . 0.0 109.671 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.842 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 1.4 t -69.48 -55.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.826 -1.171 . . . . 0.0 110.45 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.542 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 73.8 m95 -60.02 -22.89 63.2 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 109.268 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 83.1 p -70.74 -37.04 73.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.017 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 14.2 m-85 -65.67 -35.97 82.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.691 -1.256 . . . . 0.0 108.596 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 123' ' ' GLN . 4.0 t -89.22 14.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.317 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 59.16 37.05 24.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m80 46.39 24.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.061 -1.024 . . . . 0.0 109.768 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -129.74 149.01 71.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.502 -0.749 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.56 144.41 66.55 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.056 2.504 . . . . 0.0 111.841 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -111.52 137.2 49.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.866 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 87.9 mtp -92.3 131.09 37.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.728 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -78.62 -41.98 30.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.251 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 56.85 45.11 22.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.987 -1.071 . . . . 0.0 109.376 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.03 140.44 36.31 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.6 p -97.1 -24.0 15.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.101 -0.999 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -140.99 166.2 25.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 108.834 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.34 -35.07 76.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.55 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -64.74 -27.57 68.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.787 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.85 3.74 16.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 2.3 tp -91.29 123.84 63.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.56 138.19 13.49 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.023 1.815 . . . . 0.0 112.409 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.5 p -108.27 14.37 24.97 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.2 p -153.92 84.61 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.64 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.588 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.6 OUTLIER -105.15 157.14 34.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.101 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.14 -40.65 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.466 1.444 . . . . 0.0 111.848 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -41.55 70.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.021 -1.05 . . . . 0.0 108.306 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.588 ' OG ' ' N ' ' A' ' 139' ' ' THR . 97.4 p -64.53 -43.9 92.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.687 . . . . 0.0 109.373 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.57 -36.5 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.143 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -63.77 -31.16 72.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.759 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 116' ' ' VAL . 91.2 mt -70.64 -47.46 59.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.944 -1.097 . . . . 0.0 109.575 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.45 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 1.7 m -57.8 -46.1 85.13 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.536 -1.353 . . . . 0.0 110.532 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -70.5 -39.3 74.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.814 -1.179 . . . . 0.0 109.653 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.14 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.543 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.46 -35.96 81.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.057 -1.027 . . . . 0.0 109.415 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.07 -42.42 98.47 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 109.582 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -67.79 -32.43 73.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.469 -0.769 . . . . 0.0 111.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.676 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 4.0 mmp_? -68.14 -8.31 37.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.749 -1.219 . . . . 0.0 109.103 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.09 31.36 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 8.8 m-85 -95.99 117.62 31.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.84 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.586 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 23.1 mtmt -90.47 -175.28 4.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.506 0.67 . . . . 0.0 110.813 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 8.5 p90 47.45 48.6 16.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.525 0.678 . . . . 0.0 110.344 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 155' ' ' LYS . 29.6 m -119.59 39.95 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.17 164.06 0.44 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -57.17 -33.57 67.58 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.32 -1.106 . . . . 0.0 109.862 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.3 p -71.29 -34.36 70.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 108.844 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.443 HD12 ' HA2' ' A' ' 39' ' ' GLY . 16.2 mm -60.54 -44.15 95.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 146' ' ' SER . 63.2 m -65.45 -32.67 74.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.647 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -68.79 -44.77 72.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.005 -1.06 . . . . 0.0 109.564 179.728 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.407 ' HB2' ' N7 ' ' A' ' 189' ' ' ADK . 88.3 p -63.92 -37.37 87.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 108.762 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 57.7 t80 -60.82 -41.43 95.73 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.826 0.822 . . . . 0.0 109.142 178.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 37.1 mmm -59.33 -40.31 85.94 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.838 -0.539 . . . . 0.0 111.457 -178.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.647 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.7 pt20 -80.21 -47.27 14.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.606 -1.309 . . . . 0.0 110.997 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.68 -17.84 64.16 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.805 -1.184 . . . . 0.0 110.634 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 66.4 m -83.32 -19.6 35.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.836 -1.165 . . . . 0.0 111.822 -178.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.51 1.25 64.23 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.542 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 94.2 mt -65.77 -35.24 80.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.704 -0.88 . . . . 0.0 109.357 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.14 135.93 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 108.915 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 58.8 m-20 -114.52 162.69 16.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.92 -179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.7 OUTLIER 92.05 79.11 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.224 0.535 . . . . 0.0 110.605 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -54.84 -70.6 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.158 -0.964 . . . . 0.0 108.629 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.62 148.28 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 108.831 179.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 129' ' ' ALA . 61.5 t -64.16 130.92 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.617 -1.302 . . . . 0.0 109.121 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.29 40.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -95.43 123.42 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.041 -1.27 . . . . 0.0 109.13 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.475 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 39.56 27.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.781 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 179' ' ' CYS . 11.1 t 51.73 45.64 27.83 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -61.34 129.25 90.78 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.65 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 17.3 Cg_exo -51.85 121.52 8.85 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.583 1.522 . . . . 0.0 111.671 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.54 -24.12 0.05 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -89.46 -72.94 0.53 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.326 -1.102 . . . . 0.0 109.508 -179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -67.15 149.69 98.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo . . . . . 0 C--N 1.308 -1.586 0 C-N-CA 122.575 2.183 . . . . 0.0 112.468 179.908 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.852 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.313 0.578 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 178' ' ' GLY . 7.7 tp10 -99.07 142.69 30.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -58.79 -59.04 6.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.72 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.46 -25.04 57.39 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.269 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 2.7 t90 -99.06 27.8 4.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -1.23 . . . . 0.0 109.986 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.54 -27.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.903 -1.123 . . . . 0.0 111.321 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.7 m -79.86 -2.75 44.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.701 -1.249 . . . . 0.0 109.16 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -66.63 -37.74 85.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.341 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.36 158.77 8.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.669 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.6 Cg_endo -60.57 -163.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.809 2.339 . . . . 0.0 112.164 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp 61.0 -46.52 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.919 -0.488 . . . . 0.0 110.054 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.644 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 1.6 m-85 -59.39 -37.86 79.05 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 109.451 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.0 mp -54.89 -44.75 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.638 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.4 85.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.907 -1.121 . . . . 0.0 108.995 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.552 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 23.5 t80 -65.52 -36.17 83.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -58.91 -44.29 91.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 112.214 -178.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.79 -0.55 45.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.917 -1.115 . . . . 0.0 112.271 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.633 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 6.1 p-10 -99.98 -30.66 11.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.536 -1.352 . . . . 0.0 112.068 -178.48 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.633 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 89.9 mt-10 -160.29 22.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.431 -1.418 . . . . 0.0 109.825 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.582 ' HE1' ' CG ' ' A' ' 167' ' ' GLN . 3.1 t90 -106.15 72.43 0.93 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 110.461 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.04 4.41 35.85 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.285 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.0 m -115.0 -21.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.0 112.431 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 85.8 Cg_endo -86.75 150.46 8.62 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.925 1.75 . . . . 0.0 114.293 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -88.08 159.31 18.29 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.742 ' HB ' HD21 ' A' ' 31' ' ' LEU . 2.6 p -84.08 122.53 28.93 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.776 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 31' ' ' LEU . 37.8 t0 -106.12 167.25 9.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -74.52 -38.08 62.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.101 -1.624 . . . . 0.0 110.681 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -74.12 -50.46 19.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -0.901 . . . . 0.0 112.343 -177.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -57.82 -36.79 72.75 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.072 -1.018 . . . . 0.0 109.804 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 26' ' ' THR . 5.8 mp -66.76 -35.32 79.81 Favored 'General case' 0 C--N 1.286 -2.168 0 O-C-N 121.634 -0.666 . . . . 0.0 109.923 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.07 -48.11 83.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.538 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.62 -27.62 60.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.842 -1.161 . . . . 0.0 109.598 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.551 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 60.1 ttm -66.72 -50.93 61.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.664 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.44 -34.22 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 0.0 108.924 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.631 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 85.6 m -71.8 -51.95 20.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.927 . . . . 0.0 109.604 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 HH11 ' A' ' 53' ' ' ARG . 24.6 mt -67.16 -38.69 85.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.675 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 6.8 tp10 -62.75 -33.38 75.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.72 -36.4 93.24 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 36' ' ' CYS . 2.9 mp0 -63.11 -26.58 68.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.047 -1.267 . . . . 0.0 110.691 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.675 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -66.37 -2.94 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.853 -1.154 . . . . 0.0 110.856 -178.507 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -60.31 112.47 1.95 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.612 -1.305 . . . . 0.0 108.595 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.97 -7.93 2.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' ALA . 25.5 tp -109.95 144.8 37.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -1.205 . . . . 0.0 109.957 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.3 m -64.12 149.98 46.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.88 -38.48 61.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.698 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -35.81 63.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.98 -1.075 . . . . 0.0 108.309 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CE ' ' A' ' 52' ' ' LYS . 91.1 m -61.06 -44.24 97.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -69.1 -25.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.0 tt -63.79 -51.65 63.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 54.7 mttt -60.33 -44.41 95.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.661 -1.275 . . . . 0.0 108.13 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 86' ' ' ILE . 45.6 mtmt -74.29 -10.46 59.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.69 HH11 HD13 ' A' ' 37' ' ' LEU . 16.3 ttm-85 -64.63 -45.13 88.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 57.2 mp0 -70.69 -44.15 67.57 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.608 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 11.0 m-80 -69.92 -39.81 75.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.93 -1.106 . . . . 0.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.81 -48.19 82.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 111.097 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -65.7 -27.33 68.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 109.266 -179.729 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.54 99.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.907 . . . . 0.0 109.806 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 85' ' ' ILE . 2.7 m -74.38 -45.57 46.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.923 -1.111 . . . . 0.0 109.983 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' HIS . 61.7 m-85 -79.72 -45.79 18.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.021 -1.049 . . . . 0.0 110.258 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER 43.24 29.92 0.25 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.5 pt20 -54.12 -45.41 71.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.697 . . . . 0.0 111.067 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER 42.63 18.92 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.368 -0.832 . . . . 0.0 110.391 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.5 m-20 -171.9 136.73 0.94 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.036 -1.04 . . . . 0.0 109.459 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 102' ' ' TYR . 55.3 Cg_endo -71.16 -35.4 8.76 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.43 2.086 . . . . 0.0 112.995 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.08 -41.07 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.949 -1.094 . . . . 0.0 109.164 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -62.99 -33.94 76.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 108.9 179.262 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 64' ' ' ASP . 47.1 t -68.73 -41.68 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.643 -0.661 . . . . 0.0 109.552 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.755 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -67.85 -14.23 62.79 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.65 -9.49 49.41 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.281 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.9 mtp -78.18 113.07 15.79 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -95.31 177.95 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.974 . . . . 0.0 109.964 -178.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 76' ' ' VAL . 89.4 mt-10 -55.13 -28.68 54.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.783 . . . . 0.0 110.667 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -63.17 -41.24 99.2 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.106 -1.621 . . . . 0.0 109.134 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.53 -38.72 90.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.393 -0.817 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -68.67 -31.27 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.667 -1.27 . . . . 0.0 109.204 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 80' ' ' VAL . 93.4 mt-10 -66.03 -39.63 90.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.085 -1.009 . . . . 0.0 110.548 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' ' N ' ' A' ' 79' ' ' LEU . 7.6 ptp180 -74.33 -40.79 61.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.709 -1.244 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 15.9 mt -65.8 -33.21 75.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -48.57 -30.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.453 -179.417 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -106.53 -0.33 24.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.443 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 66.5 t0 -80.43 107.95 13.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.499 -1.376 . . . . 0.0 109.55 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.68 -14.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.668 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . 68.42 35.9 82.88 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -28.0 -91.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.165 -0.609 . . . . 0.0 110.592 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -175.98 -44.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -0.967 . . . . 0.0 109.575 179.679 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -64.22 156.04 29.98 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.155 -0.966 . . . . 0.0 110.034 -178.65 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -106.68 169.52 8.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.589 0.709 . . . . 0.0 109.631 -179.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.14 -33.72 63.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.51 -59.18 5.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.436 ' HB2' HH21 ' A' ' 87' ' ' ARG . 11.6 tptm -60.63 -42.64 97.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.723 -1.457 . . . . 0.0 110.163 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -57.17 -47.38 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.992 -1.068 . . . . 0.0 109.766 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -31.99 44.69 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.742 -1.224 . . . . 0.0 108.289 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.03 77.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.013 -1.054 . . . . 0.0 109.089 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.86 -45.54 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.187 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -61.39 -36.35 72.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.899 -1.126 . . . . 0.0 109.078 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.41 -36.39 83.81 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -60.51 -35.9 77.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.537 -0.978 . . . . 0.0 108.573 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.462 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.755 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -53.27 -41.19 65.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' ' CE2' ' A' ' 154' ' ' PHE . . . -65.28 -31.55 72.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.887 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 65' ' ' PRO . 54.9 t80 -61.06 -44.36 97.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -61.41 -35.81 78.58 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -64.55 -34.0 77.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.331 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 36.0 ttm -63.78 -40.93 97.88 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -63.28 -38.42 91.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.636 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.417 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 95.8 mt-30 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -90.47 -14.73 32.2 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.48 27.87 73.54 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.965 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.4 tp10 -124.79 102.03 32.4 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.996 -1.296 . . . . 0.0 110.124 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.69 150.09 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.012 1.808 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -61.23 -45.08 96.04 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.127 0.965 . . . . 0.0 110.052 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.37 66.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.702 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -68.83 -45.18 71.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.438 -1.414 . . . . 0.0 112.214 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CE1' HG13 ' A' ' 116' ' ' VAL . 7.0 p90 -70.99 -36.22 72.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.471 -1.393 . . . . 0.0 110.501 -178.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 117' ' ' TRP . 31.3 m -65.42 -52.44 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 119.961 -1.712 . . . . 0.0 109.542 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.591 ' N ' HG23 ' A' ' 116' ' ' VAL . 50.9 m95 -56.63 -22.68 35.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 108.508 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 51.6 p -74.39 -35.7 63.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.978 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 9.7 m-85 -68.22 -29.43 68.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.195 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -94.67 18.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.513 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 122' ' ' HIS . 78.2 m-20 58.95 39.43 23.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.3 t60 40.57 29.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -127.26 146.93 59.9 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.38 140.39 52.7 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.606 2.204 . . . . 0.0 112.186 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -107.23 127.97 54.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 108.783 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 mtt -101.72 122.73 44.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.67 116.41 28.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -93.38 21.86 5.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.988 . . . . 0.0 109.988 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.43 143.38 51.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.383 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 99.0 m -93.65 -31.21 14.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.4 p -133.52 162.89 30.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.02 -35.48 71.33 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.136 -0.978 . . . . 0.0 108.952 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 m -60.55 -25.38 66.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -88.89 -4.38 58.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 0.0 109.713 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.85 130.7 37.7 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 147.45 26.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.233 1.956 . . . . 0.0 112.513 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -103.44 9.53 37.68 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -144.93 98.82 3.24 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.234 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.566 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 10.0 p -109.14 155.01 41.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.59 -39.37 75.61 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.979 1.786 . . . . 0.0 111.441 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.38 62.31 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.386 -0.926 . . . . 0.0 108.786 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.566 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 94.7 p -65.31 -39.22 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.428 -0.795 . . . . 0.0 109.981 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -63.12 -34.31 77.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.537 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.67 -47.84 81.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.942 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 27.8 m -60.87 -44.96 96.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.845 -1.159 . . . . 0.0 109.543 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -67.81 -44.22 77.83 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.487 -0.758 . . . . 0.0 109.598 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.38 -41.8 80.03 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.498 -0.751 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.521 HD23 ' NH2' ' A' ' 152' ' ' ARG . 26.2 mt -68.01 -44.35 76.74 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -62.21 -42.44 99.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.66 -31.54 70.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 111.371 -178.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.521 ' NH2' HD23 ' A' ' 149' ' ' LEU . 86.5 mtm180 -80.25 4.25 18.25 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.963 -1.085 . . . . 0.0 110.159 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.41 20.74 34.14 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.946 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' ' CB ' ' A' ' 101' ' ' ALA . 36.4 m-85 -102.82 110.91 23.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.132 -1.216 . . . . 0.0 108.772 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -91.72 172.59 8.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.435 ' CE1' ' HE3' ' A' ' 91' ' ' LYS . 63.4 m-85 58.27 69.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.185 0.993 . . . . 0.0 108.842 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 158' ' ' GLY . 30.2 m -150.93 38.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -43.72 166.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -58.07 -28.96 65.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.558 -0.966 . . . . 0.0 109.217 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.7 p -73.31 -31.39 63.99 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.1 mm -69.76 -44.96 78.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 146' ' ' SER . 35.9 m -66.26 -34.84 78.91 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.537 0.684 . . . . 0.0 109.871 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -70.57 -45.29 65.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.911 . . . . 0.0 109.644 -179.613 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.509 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 93.3 p -67.81 -32.03 72.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.038 . . . . 0.0 108.422 178.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.581 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 42.9 t80 -58.67 -45.25 89.82 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.753 -0.592 . . . . 0.0 109.706 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 81.3 mtp -66.4 -38.71 88.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.596 HE21 ' HD2' ' A' ' 175' ' ' HIS . 12.6 tp60 -64.26 -46.08 85.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.371 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.63 -37.75 49.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 58.3 m -56.77 -28.68 61.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 110.03 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.52 2.95 56.48 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.84 -33.85 76.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -1.089 . . . . 0.0 109.814 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.36 130.09 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 70.0 m-20 -108.55 163.82 12.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.434 -0.791 . . . . 0.0 109.939 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.7 m-20 86.13 74.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.228 0.537 . . . . 0.0 110.016 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.596 ' HD2' HE21 ' A' ' 167' ' ' GLN . 23.3 m80 -54.93 -61.4 2.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.815 . . . . 0.0 109.065 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.25 152.66 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.627 -0.671 . . . . 0.0 109.197 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 129' ' ' ALA . 94.0 t -60.76 130.81 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.02 -1.05 . . . . 0.0 109.026 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 2' ' ' GLU . . . 90.12 10.54 64.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -73.1 144.48 46.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.15 . . . . 0.0 109.329 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -42.98 -33.5 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 109.553 -179.592 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.41 34.6 1.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.193 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 t80 -123.43 85.96 52.25 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.463 -0.773 . . . . 0.0 109.476 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 185' ' ' ASN . 69.4 Cg_endo -83.98 -71.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.674 2.249 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.54 -51.04 0.64 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 186' ' ' LYS . 21.9 p-10 -130.22 -20.43 3.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -1.081 . . . . 0.0 109.804 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 17.4 mmtm -63.79 149.1 93.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 108.776 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 186' ' ' LYS . 11.0 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 C-N-CA 122.107 1.871 . . . . 0.0 111.844 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.269 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' H ' ' CG ' ' A' ' 1' ' ' MET . 49.9 tp10 -103.07 144.97 30.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 110.069 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -66.46 160.31 25.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 126.47 27.44 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.878 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.89 -20.67 20.33 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.308 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 1.3 t90 -95.53 -4.31 45.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 110.21 -179.328 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.88 -26.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -3.61 28.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 110.065 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 89.6 mm-40 -65.96 -48.45 71.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.987 -1.071 . . . . 0.0 110.67 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.89 153.8 23.21 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.848 -1.158 . . . . 0.0 109.837 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.65 ' HA ' HD13 ' A' ' 14' ' ' ILE . 29.4 Cg_exo -54.77 -32.87 78.53 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.159 1.906 . . . . 0.0 113.421 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.3 mt -59.86 -35.16 74.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.774 -1.204 . . . . 0.0 110.328 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -62.21 -34.61 76.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.881 -1.137 . . . . 0.0 109.942 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.5 mp -52.63 -42.74 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.917 -1.114 . . . . 0.0 108.935 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.84 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 61.7 t80 -65.42 -42.83 92.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.53 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -64.89 -36.25 83.76 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.2 -0.938 . . . . 0.0 110.684 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -74.6 -19.03 60.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 112.303 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 33.4 p30 -88.31 -55.18 3.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.47 -177.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.689 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 16.0 pt-20 -163.73 68.74 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.093 -1.63 . . . . 0.0 111.856 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.763 ' CZ3' ' HC2' ' A' ' 189' ' ' ADK . 31.3 t-105 -77.6 64.35 2.89 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.24 44.66 27.89 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.3 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.666 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.4 t -107.01 -32.85 0.18 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.344 -1.092 . . . . 0.0 110.682 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.0 Cg_endo -87.57 154.76 7.7 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 123.116 2.544 . . . . 0.0 112.705 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.94 162.17 17.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -89.08 115.25 26.48 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.421 -176.944 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.981 ' O ' HD13 ' A' ' 31' ' ' LEU . 93.8 m-20 -89.77 157.98 17.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 178.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 20.7 m -65.89 -45.86 80.46 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.051 -1.656 . . . . 0.0 111.325 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 32' ' ' PHE . 39.1 mmtm -63.6 -51.06 66.91 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.338 -0.851 . . . . 0.0 112.362 -177.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -56.9 -36.76 70.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 108.148 -179.035 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.4 mp -65.8 -30.6 71.27 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.24 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 28' ' ' SER . 4.8 m-30 -58.92 -50.84 72.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.39 -1.324 . . . . 0.0 107.89 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -68.38 -44.63 74.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.283 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 36.4 tpp -50.84 -49.99 57.63 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.256 -0.902 . . . . 0.0 111.121 -178.138 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.87 -29.09 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.6 -1.313 . . . . 0.0 109.25 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -71.25 -47.93 54.14 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -67.8 -40.35 83.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.867 -1.146 . . . . 0.0 109.503 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 70.6 mm-40 -59.11 -36.51 75.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 108.983 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.46 -32.62 78.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.1 -1.4 44.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -1.1 . . . . 0.0 109.991 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -89.4 -7.51 55.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.005 -179.837 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.53 120.14 13.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.997 -1.064 . . . . 0.0 109.073 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.65 -37.84 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.7 mp -98.98 148.79 23.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 109.883 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -66.67 153.71 42.46 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.754 ' HB3' H3A2 ' A' ' 189' ' ' ADK . 0.9 OUTLIER -58.13 -35.21 71.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.295 -179.79 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -29.12 46.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 44' ' ' LEU . 16.9 m -61.27 -41.36 96.81 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.893 -1.13 . . . . 0.0 109.37 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -70.26 -30.24 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 109.181 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.73 -46.76 88.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.6 mtmt -63.29 -44.63 94.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.85 -1.156 . . . . 0.0 108.784 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -9.62 58.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 108.723 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.5 ttm180 -67.12 -46.26 74.67 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.23 -42.88 92.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 17.1 m-80 -69.41 -41.73 76.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.822 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.9 t80 -61.39 -44.52 97.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.504 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NH2' ' CE1' ' A' ' 61' ' ' HIS . 17.7 mmm180 -57.6 -38.48 74.98 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.414 -0.803 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.9 -34.51 75.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.283 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.589 ' HB3' HD22 ' A' ' 79' ' ' LEU . 87.0 m -72.94 -43.75 61.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.234 -0.916 . . . . 0.0 111.161 -178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -99.3 10.28 41.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.664 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' CE1' ' NH2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -62.29 10.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.908 -1.12 . . . . 0.0 110.195 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.602 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 77.2 mt-30 -72.05 -37.21 69.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.611 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 90.2 m-85 -159.64 -95.36 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 149.36 -41.04 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.285 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 64' ' ' ASP . 42.4 Cg_endo -102.4 -103.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.638 2.226 . . . . 0.0 115.689 -176.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 0.0 112.077 -176.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -33.83 64.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.751 -1.218 . . . . 0.0 108.921 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.78 -37.41 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 0.0 108.355 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.77 -18.15 64.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.53 -6.22 50.12 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.059 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.44 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 89.8 mtp -75.62 114.16 13.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.597 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 44.3 tt0 -95.32 171.68 8.56 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.508 0.67 . . . . 0.0 110.128 -177.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.437 ' OE2' ' OE1' ' A' ' 93' ' ' GLN . 99.2 mt-10 -53.24 -28.52 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -56.56 -50.7 71.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.882 -1.136 . . . . 0.0 108.898 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.6 p30 -63.83 -37.02 85.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 108.786 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 76.3 t -56.47 -41.84 73.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 108.983 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -57.82 -40.8 80.85 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -62.32 -43.7 98.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 59' ' ' CYS . 53.2 mt -67.53 -33.69 75.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.03 -16.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 108.736 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -122.87 -9.76 8.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.271 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 76.1 m-20 -74.07 109.18 7.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.279 -1.513 . . . . 0.0 109.966 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.4 -13.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.58 -0.7 . . . . 0.0 109.615 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.11 37.2 38.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 79' ' ' LEU . 6.5 pt -53.0 -166.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mm -54.07 90.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 85' ' ' ILE . 24.4 ttp180 -62.02 112.75 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.013 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.424 ' CB ' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 169.46 81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.339 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' HIS . 25.6 ptt180 -42.64 -38.52 2.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.581 -0.7 . . . . 0.0 110.114 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.79 -54.5 36.89 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -62.54 -39.96 95.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.245 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -60.9 -39.81 83.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.836 -1.165 . . . . 0.0 108.798 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' OE2' ' A' ' 73' ' ' GLU . 22.0 mt-30 -55.39 -36.8 66.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.845 -1.159 . . . . 0.0 108.463 178.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.24 87.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 108.974 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' HA ' ' ND2' ' A' ' 98' ' ' ASN . 35.6 mm -61.58 -44.24 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.805 . . . . 0.0 109.367 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.1 mm -59.58 -42.06 86.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 108.486 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.07 91.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 95' ' ' ILE . 89.3 m-20 -57.05 -39.16 74.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.64 71.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.252 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 95.9 mtt180 -62.73 -38.64 91.31 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.88 70.31 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.33 -0.856 . . . . 0.0 108.723 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.597 ' OH ' ' CZ ' ' A' ' 32' ' ' PHE . 64.4 t80 -64.65 -42.88 95.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.91 -32.7 71.01 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.11 -32.12 71.8 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.176 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.419 ' SD ' ' HD2' ' A' ' 152' ' ' ARG . 89.9 mmm -65.66 -42.39 91.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 109' ' ' GLY . 96.9 mt-10 -71.88 -41.16 68.34 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.45 -26.74 43.94 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.88 -9.1 29.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.89 26.68 74.47 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -117.6 101.2 52.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.75 154.36 26.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.426 2.084 . . . . 0.0 112.541 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -62.18 -45.4 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.864 0.84 . . . . 0.0 109.324 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.67 -27.38 64.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 111.123 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -70.63 -52.74 19.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.711 -1.243 . . . . 0.0 111.607 -178.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 2.2 p90 -67.16 -39.89 86.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.936 -1.103 . . . . 0.0 111.041 -178.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 117' ' ' TRP . 8.1 p -65.88 -48.94 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 116' ' ' VAL . 12.8 m95 -56.45 -25.48 50.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -67.18 -45.46 76.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 110.552 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.6 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.0 m-85 -62.96 -32.25 73.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.002 -1.061 . . . . 0.0 110.17 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 171' ' ' LEU . 2.5 t -89.68 18.41 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.714 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 123' ' ' GLN . 62.5 m-20 59.31 40.54 21.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.728 -0.608 . . . . 0.0 109.78 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 43.48 26.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.802 179.332 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 120' ' ' VAL . 1.9 pt20 -139.8 154.62 71.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.63 152.31 59.19 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.858 2.372 . . . . 0.0 112.951 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 126' ' ' MET . 10.7 tm0? -109.4 127.83 54.67 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.62 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 61.1 mtm -91.03 118.63 30.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 109.692 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 116.3 26.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.347 -0.845 . . . . 0.0 109.482 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -93.78 14.0 20.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 136.54 53.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -93.63 -22.63 18.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.504 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.5 p -133.68 163.01 30.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.2 mt -59.24 -39.62 83.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.1 t -60.61 -33.23 72.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -81.96 2.64 29.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.836 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.92 142.87 25.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.117 -0.989 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.91 143.63 37.07 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.365 2.043 . . . . 0.0 112.655 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -123.98 2.58 8.69 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.8 p -154.7 85.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.11 166.87 9.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.22 -41.45 65.63 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.624 1.549 . . . . 0.0 112.283 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -41.73 80.03 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.025 -1.047 . . . . 0.0 108.676 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.0 p -66.81 -45.24 78.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.56 -40.69 96.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -67.89 -30.76 70.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 116' ' ' VAL . 2.7 tp -69.19 -42.0 76.39 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -0.752 . . . . 0.0 110.321 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.573 ' CA ' ' SG ' ' A' ' 162' ' ' CYS . 0.3 OUTLIER -63.72 -50.28 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.449 -179.1 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -65.77 -36.14 82.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.948 -1.095 . . . . 0.0 109.366 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.22 -50.47 39.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.762 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 115' ' ' PHE . 91.0 mt -63.65 -36.36 83.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 109.661 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -60.49 -38.5 84.49 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.959 -1.088 . . . . 0.0 108.767 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -62.52 -33.71 75.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.326 -0.859 . . . . 0.0 110.09 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 1.6 mmp_? -70.55 3.86 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.02 -1.05 . . . . 0.0 108.844 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.79 47.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.42 115.58 27.8 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.531 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -93.41 169.03 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 56.21 55.11 7.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.068 -1.02 . . . . 0.0 108.54 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -142.08 47.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.03 -178.5 3.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.1 m -61.1 -33.47 73.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.631 -0.923 . . . . 0.0 110.511 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.4 p -67.79 -35.38 78.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.898 -1.126 . . . . 0.0 108.05 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 38' ' ' GLU . 32.6 mm -65.58 -42.38 92.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.573 ' SG ' ' CA ' ' A' ' 146' ' ' SER . 77.1 m -63.89 -41.29 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.691 -0.631 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.3 -44.37 65.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.838 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.462 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 23.2 m -65.19 -38.98 92.22 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.571 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 87.1 t80 -60.21 -49.65 76.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.702 -0.624 . . . . 0.0 111.051 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 166' ' ' MET . 12.8 ptm -71.5 -38.62 71.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.868 -1.145 . . . . 0.0 109.746 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.727 ' NE2' ' NE1' ' A' ' 21' ' ' TRP . 1.1 tm0? -62.55 -42.48 99.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 110.498 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.05 -27.56 20.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.968 -1.082 . . . . 0.0 111.018 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.571 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 24.3 m -60.87 -21.12 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.818 -1.176 . . . . 0.0 110.119 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.75 0.09 34.27 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 120' ' ' VAL . 86.0 mt -63.37 -34.09 76.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.099 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.16 138.1 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 91.0 m-20 -115.06 163.13 16.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.628 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.0 t70 86.07 77.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.465 0.65 . . . . 0.0 109.778 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 4.6 m170 -55.72 -53.13 60.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 0.0 109.084 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.8 m -147.43 38.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.468 HG22 ' OD2' ' A' ' 174' ' ' ASP . 16.2 t 61.27 111.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.472 0.653 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 44.86 71.02 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.635 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 7.6 p -92.41 107.03 18.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.285 . . . . 0.0 109.388 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 63.06 -63.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.997 . . . . 0.0 109.706 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 179' ' ' CYS . 39.6 t -176.36 47.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.57 -0.707 . . . . 0.0 109.402 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -68.31 152.14 96.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 109.321 -179.862 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.35 145.55 97.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.625 2.217 . . . . 0.0 112.104 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 176.44 -28.08 0.07 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' O ' ' C ' ' A' ' 186' ' ' LYS . 79.7 m-20 -103.48 -35.41 8.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -1.09 . . . . 0.0 109.18 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 185' ' ' ASN . 6.1 mtpt 29.99 62.7 0.9 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.992 -0.442 . . . . 0.0 110.802 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.303 -1.85 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.89 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 1.308 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mmm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -91.46 147.64 22.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.34 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HE ' HG11 ' A' ' 7' ' ' VAL . 50.5 mtp180 -78.09 167.01 22.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.259 -0.901 . . . . 0.0 110.471 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.1 m -62.84 149.93 43.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.052 0.93 . . . . 0.0 110.817 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.78 -41.64 94.07 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.635 -0.665 . . . . 0.0 111.458 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.789 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -85.74 -2.37 58.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.544 -1.563 . . . . 0.0 109.645 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.539 HG11 ' HE ' ' A' ' 3' ' ' ARG . 2.5 t -78.16 -37.85 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.983 -1.073 . . . . 0.0 108.502 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -80.88 0.68 34.13 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.644 -0.822 . . . . 0.0 108.795 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.36 -55.43 5.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 110.867 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.52 161.0 61.27 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.125 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.37 -35.82 13.04 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.083 2.522 . . . . 0.0 112.981 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD11 ' NZ ' ' A' ' 51' ' ' LYS . 55.8 mt -62.61 -34.02 76.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.868 -1.145 . . . . 0.0 109.737 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.7 OUTLIER -59.2 -36.91 76.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.5 mp -52.7 -46.21 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 110.394 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.7 64.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.957 -1.089 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.1 t80 -63.49 -39.96 95.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.599 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 48.5 t-80 -76.07 -40.53 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 111.507 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.91 -15.14 63.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 112.008 -177.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 6.9 p30 -71.14 -77.09 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.255 -1.528 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -149.1 -49.07 0.15 Allowed 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.756 -1.215 . . . . 0.0 110.256 -179.443 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.89 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.9 t-105 59.03 87.22 0.08 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.185 -178.331 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.66 73.06 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.79 176.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 77.2 t -110.33 -32.85 0.14 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-N 119.353 1.577 . . . . 0.0 110.542 177.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.1 Cg_endo -85.54 152.07 10.33 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.2 1.933 . . . . 0.0 112.729 -178.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' OE1' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -67.48 169.03 9.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.8 p -94.09 141.14 28.88 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.05 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD1' ' OE1' ' A' ' 25' ' ' GLU . 92.0 m-20 -102.92 150.2 23.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -61.98 -35.99 80.14 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.666 -1.271 . . . . 0.0 110.052 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -74.95 -50.37 16.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 27' ' ' ASP . 7.4 ptmm? -62.54 -32.18 73.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.819 -1.175 . . . . 0.0 109.584 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.503 HD21 ' HB ' ' A' ' 26' ' ' THR . 45.8 mt -57.38 -37.5 72.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 108.539 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 35' ' ' ILE . 86.4 t80 -65.73 -45.45 82.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.882 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.38 -40.19 95.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.895 -1.128 . . . . 0.0 109.3 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 35' ' ' ILE . 8.5 tmm? -62.12 -47.04 86.35 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 111.339 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.588 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.2 tp -62.48 -27.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 -178.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.8 m -70.24 -49.98 44.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 110.003 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.9 mm? -69.33 -42.23 75.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.068 -1.02 . . . . 0.0 109.566 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -66.51 -32.07 73.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.785 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.62 40.15 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.401 ' HG3' ' NH2' ' A' ' 87' ' ' ARG . 10.3 mm100 -88.51 -0.64 57.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -1.218 . . . . 0.0 110.076 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.6 3.34 22.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 109.665 -179.567 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -75.42 117.17 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.36 -6.75 1.06 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.604 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 4.3 tp -103.51 169.18 8.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -1.116 . . . . 0.0 108.862 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -94.84 141.68 28.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 108.763 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.659 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 5.5 t-105 -55.58 -34.12 64.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -37.69 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.793 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 m -57.9 -45.36 86.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.903 -1.123 . . . . 0.0 108.616 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.85 -29.37 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 108.679 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 50' ' ' LEU . 6.8 tt -56.59 -41.33 76.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 108.673 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.611 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 12.2 mmtt -57.8 -41.49 82.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.9 -18.98 61.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -60.63 -42.48 97.0 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -69.32 -46.03 68.08 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.685 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.7 m-80 -64.12 -32.81 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 108.516 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 52' ' ' LYS . 75.3 t80 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' HIS . 46.8 mtp180 -60.04 -38.31 82.39 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.452 178.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.09 82.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.854 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 79' ' ' LEU . 1.8 m -71.67 -45.08 63.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 110.258 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 62' ' ' GLN . 29.2 m-85 -111.74 -47.22 3.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.291 -0.881 . . . . 0.0 109.765 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.6 t-160 61.67 -39.88 0.13 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.631 -0.668 . . . . 0.0 110.398 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.619 ' N ' ' O ' ' A' ' 60' ' ' PHE . 21.5 pt20 -74.77 -35.05 62.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.417 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 22.8 p90 41.09 17.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.502 -0.749 . . . . 0.0 110.269 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.836 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.11 142.82 60.01 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.866 -1.146 . . . . 0.0 108.626 179.802 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.85 -52.52 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.122 1.881 . . . . 0.0 112.766 -179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.69 HG22 HD21 ' A' ' 103' ' ' LEU . 84.4 t -65.14 -44.23 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 110.219 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -63.62 -36.99 85.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 109.946 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 64' ' ' ASP . 57.3 t -63.42 -39.38 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.92 -16.23 63.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.93 58.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 mmm -78.01 113.21 15.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 60.1 tt0 -95.68 167.43 11.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 108.906 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 96.2 mt-10 -52.63 -30.31 30.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.243 -0.911 . . . . 0.0 110.855 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -57.39 -45.19 84.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.541 -1.35 . . . . 0.0 107.704 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -62.95 -39.76 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.56 ' HA ' HD12 ' A' ' 79' ' ' LEU . 75.5 t -59.6 -42.7 89.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.536 -0.728 . . . . 0.0 110.026 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 80' ' ' VAL . 74.9 mm-40 -57.38 -37.11 72.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.069 -1.019 . . . . 0.0 108.396 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 78' ' ' ARG . 16.2 ttm-85 -66.19 -36.98 84.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.504 -0.747 . . . . 0.0 109.521 179.087 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 59' ' ' CYS . 81.4 mt -65.26 -40.34 93.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.718 . . . . 0.0 112.445 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 77' ' ' GLU . 4.4 m -59.01 -16.83 10.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.478 -1.389 . . . . 0.0 108.024 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -104.67 -14.36 15.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.507 -0.746 . . . . 0.0 109.153 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 84' ' ' GLY . 63.0 m-20 -81.78 105.52 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.09 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 65.15 -15.57 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.545 -0.722 . . . . 0.0 109.984 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 66.19 35.96 91.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 87' ' ' ARG . 2.5 pt -28.68 -101.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.156 -0.614 . . . . 0.0 111.541 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 87' ' ' ARG . 9.1 tt -168.77 -34.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.06 -179.119 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.631 HH11 HD11 ' A' ' 95' ' ' ILE . 5.0 mtt-85 -59.22 149.2 29.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.623 -0.673 . . . . 0.0 109.419 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -106.36 160.19 15.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.244 -0.91 . . . . 0.0 109.327 179.902 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.77 -46.24 15.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 110.049 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -53.11 36.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 51.1 mttp -61.13 -40.7 94.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 76' ' ' VAL . 66.7 mt -58.76 -47.76 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.153 -0.967 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -52.97 -35.03 58.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.824 -1.173 . . . . 0.0 108.941 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.42 80.63 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.631 HD11 HH11 ' A' ' 87' ' ' ARG . 81.6 mt -63.7 -47.38 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.56 -0.712 . . . . 0.0 109.422 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.614 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.9 mp -60.08 -38.97 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 108.952 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.6 -35.75 89.99 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -62.33 -37.81 87.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -1.067 . . . . 0.0 109.693 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.38 96.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.02 . . . . 0.0 109.804 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.499 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -65.87 -39.2 90.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.981 -1.074 . . . . 0.0 109.453 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -67.61 -29.06 68.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.603 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 75.8 t80 -63.41 -44.41 94.7 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.69 HD21 HG22 ' A' ' 66' ' ' VAL . 34.9 mt -62.86 -31.71 72.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -64.81 -35.97 82.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.916 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 81.0 mmm -67.93 -40.0 83.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.732 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.99 -40.07 78.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.542 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.35 -23.8 66.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' OD1' ' CD ' ' A' ' 110' ' ' GLU . 10.4 t-20 -85.71 -7.15 58.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 26.23 74.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CD ' ' OD1' ' A' ' 108' ' ' ASN . 96.1 mt-10 -124.48 102.06 33.35 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -1.071 . . . . 0.0 109.729 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -60.64 147.47 94.63 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.004 1.803 . . . . 0.0 112.066 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 102' ' ' TYR . 25.2 m-85 -57.5 -37.64 73.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.103 -0.998 . . . . 0.0 109.45 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.84 -29.86 70.83 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.526 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.56 -50.65 62.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 112.174 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 116' ' ' VAL . 4.1 p90 -72.4 -38.1 68.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.754 -1.216 . . . . 0.0 111.308 -177.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 115' ' ' PHE . 27.7 m -60.45 -49.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.117 -1.614 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.577 ' N ' HG23 ' A' ' 116' ' ' VAL . 26.1 m95 -60.32 -24.15 64.78 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 108.622 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -64.66 -42.33 95.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.0 109.912 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.59 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 37.9 m-85 -68.11 -32.74 73.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.64 16.92 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.62 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 122' ' ' HIS . 16.6 m120 56.98 36.92 28.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.698 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 121' ' ' ASN . 92.3 m-70 44.03 33.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -139.15 151.83 68.47 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.01 . . . . 0.0 109.867 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.03 144.48 34.11 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.789 2.326 . . . . 0.0 112.205 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -112.26 141.99 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.337 179.686 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 85.2 mmm -96.65 118.01 32.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -88.63 117.49 27.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.194 -0.941 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.52 20.77 3.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.225 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.93 135.21 53.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 109.536 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.1 p -100.67 -19.88 15.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.399 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.455 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 5.0 p -128.75 158.84 37.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.47 -0.769 . . . . 0.0 109.097 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.2 mt -57.82 -40.74 80.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -73.84 -19.14 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.827 . . . . 0.0 109.568 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 131' ' ' THR . 46.6 tp10 -74.44 -9.29 58.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 108.509 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.6 132.53 46.47 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.39 135.34 22.22 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.931 1.754 . . . . 0.0 112.442 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.9 p -101.06 3.88 41.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 138' ' ' SER . 59.6 p -141.06 91.76 2.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 109.064 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.543 ' N ' ' OG ' ' A' ' 142' ' ' SER . 40.1 p -110.89 156.88 40.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.07 -39.49 70.17 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.147 1.231 . . . . 0.0 111.222 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.72 71.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 139' ' ' THR . 86.6 p -63.41 -42.06 98.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -0.789 . . . . 0.0 109.834 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.0 -39.78 94.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.883 . . . . 0.0 110.229 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.59 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -65.58 -34.85 79.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 116' ' ' VAL . 61.5 mt -66.38 -46.24 77.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 110.725 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.636 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 15.0 m -61.06 -48.82 79.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.223 -0.923 . . . . 0.0 110.726 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -37.56 81.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.01 -1.056 . . . . 0.0 109.349 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.27 74.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.118 -0.988 . . . . 0.0 109.66 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.623 HD23 ' NH2' ' A' ' 152' ' ' ARG . 19.1 mt -67.86 -42.35 81.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.966 -1.084 . . . . 0.0 108.841 179.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -59.47 -37.44 78.22 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.274 -0.891 . . . . 0.0 110.594 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -74.34 -23.04 58.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.877 -1.139 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.623 ' NH2' HD23 ' A' ' 149' ' ' LEU . 81.6 mtm180 -83.67 6.05 22.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.31 21.14 39.13 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 3.0 m-85 -99.69 112.23 24.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -1.208 . . . . 0.0 108.976 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -89.75 178.59 6.21 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 55.95 56.71 5.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 108.824 -179.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.3 40.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -50.04 157.87 1.74 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.169 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.8 m -52.73 -32.67 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.319 -1.106 . . . . 0.0 108.742 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 m -69.09 -36.01 77.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.06 -45.02 99.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.595 0.712 . . . . 0.0 109.394 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.636 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.2 m -64.32 -39.7 94.44 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.503 -0.748 . . . . 0.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -43.25 77.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.95 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.3 m -61.8 -36.54 81.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 109.589 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.591 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -61.13 -50.49 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.428 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.466 ' H ' ' HG2' ' A' ' 166' ' ' MET . 4.2 ptm -62.52 -37.62 86.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.044 -1.035 . . . . 0.0 110.268 -178.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -67.09 -40.82 87.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 111.627 -178.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.39 15.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.957 -1.089 . . . . 0.0 112.752 -177.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.481 ' HB3' HG22 ' A' ' 26' ' ' THR . 0.1 OUTLIER -63.53 -50.19 70.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.664 -1.272 . . . . 0.0 112.047 -177.385 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.43 2.36 0.96 Allowed Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.2 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 77.1 mt -59.93 -33.91 72.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.616 -1.52 . . . . 0.0 109.121 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.25 150.91 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.599 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 83.7 m-20 -117.89 164.09 15.58 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.789 ' OD2' HG22 ' A' ' 177' ' ' VAL . 18.9 t0 96.05 84.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.605 0.717 . . . . 0.0 110.017 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.516 ' O ' HG13 ' A' ' 176' ' ' VAL . 43.4 m170 -55.74 -49.71 72.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.604 -0.685 . . . . 0.0 109.848 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 175' ' ' HIS . 7.1 m -157.54 24.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.71 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.789 HG22 ' OD2' ' A' ' 174' ' ' ASP . 33.9 t 56.11 111.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.429 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.36 10.0 52.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 0.3 OUTLIER -81.18 148.97 29.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.924 -1.339 . . . . 0.0 109.215 179.806 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -58.71 -50.8 72.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 -179.573 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 59.6 m -61.5 -12.51 15.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 109.018 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 174' ' ' ASP . 66.7 t80 -116.82 84.09 15.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.635 -0.666 . . . . 0.0 110.139 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.93 -93.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.551 2.168 . . . . 0.0 111.881 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.16 -14.0 65.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -85.55 -50.77 6.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -1.147 . . . . 0.0 109.088 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -82.96 149.95 60.54 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.569 2.18 . . . . 0.0 112.314 -179.859 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.89 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.656 ' H2 ' ' N ' ' A' ' 180' ' ' CYS . 42.1 mtm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -98.38 153.27 18.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 108.875 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' A' ' 3' ' ' ARG . 22.0 mtm-85 -50.38 155.17 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.961 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -69.95 156.57 38.91 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.793 0.806 . . . . 0.0 109.516 -179.556 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.13 95.73 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.146 -0.971 . . . . 0.0 112.844 -177.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.746 ' CH2' ' C3A' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.76 -3.82 58.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.323 -1.693 . . . . 0.0 111.608 -177.673 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 17' ' ' HIS . 2.7 m -87.25 -31.61 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.384 -1.448 . . . . 0.0 108.58 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -62.97 -18.07 62.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -59.85 -40.97 90.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.241 0.544 . . . . 0.0 109.98 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.35 160.37 51.91 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.02 -55.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.219 2.613 . . . . 0.0 113.44 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 47' ' ' ILE . 2.3 pp -53.98 -32.01 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.703 ' CE1' ' CZ2' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -56.78 -39.17 73.59 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.896 -1.128 . . . . 0.0 109.584 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.09 -41.27 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -49.62 73.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 109.847 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 27.9 t80 -61.5 -42.73 99.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.357 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.5 t-80 -66.66 -37.63 85.18 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.516 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.41 -13.19 61.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 12.0 p30 -86.89 -70.88 0.58 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 119.855 -1.778 . . . . 0.0 110.276 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.591 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.4 mt-10 -136.86 -72.61 0.44 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.017 -1.052 . . . . 0.0 110.038 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.59 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.8 t90 47.39 49.72 15.42 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.926 -0.484 . . . . 0.0 110.721 -178.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.38 72.3 0.99 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.513 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.77 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -166.23 -30.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.01 -1.288 . . . . 0.0 112.837 179.37 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.77 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 28.6 Cg_endo -91.98 154.22 3.3 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 123.022 2.481 . . . . 0.0 112.615 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 26' ' ' THR . 85.8 tt0 -66.55 156.36 35.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.418 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 1.5 p -91.43 134.09 34.92 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.594 -177.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.8 t0 -99.85 158.14 16.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.656 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 1.3 m -57.69 -37.69 73.91 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.541 -1.349 . . . . 0.0 109.832 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 13.5 mmtt -61.29 -46.14 91.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 111.165 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -61.29 -36.93 81.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.567 -178.862 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 27' ' ' ASP . 4.0 mm? -57.17 -39.32 75.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.564 -0.71 . . . . 0.0 110.501 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CE1' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -70.18 -54.09 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.456 -178.166 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 37' ' ' LEU . 19.4 pt-20 -71.02 -30.41 66.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.902 -1.124 . . . . 0.0 109.774 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 27.8 ttm -67.16 -52.15 45.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.885 -1.134 . . . . 0.0 110.984 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.25 -31.06 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.519 -1.363 . . . . 0.0 111.117 -178.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.31 -37.21 74.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.476 -1.39 . . . . 0.0 109.802 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD21 ' HG3' ' A' ' 53' ' ' ARG . 9.0 mp -73.46 -40.27 64.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.189 -0.945 . . . . 0.0 110.247 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -36.83 84.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.0 108.685 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.44 -36.73 78.42 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -69.01 -28.51 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -1.123 . . . . 0.0 109.885 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.582 HE22 ' C8 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -74.38 -3.05 28.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.987 -1.071 . . . . 0.0 110.309 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.59 117.82 4.24 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.726 -1.233 . . . . 0.0 108.809 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.48 -36.72 2.02 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.6 mm? -90.92 150.58 21.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.077 -1.249 . . . . 0.0 109.984 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.5 m -63.98 154.56 33.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.785 . . . . 0.0 109.447 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.3 OUTLIER -61.2 -40.92 95.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.656 179.604 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.454 HD11 HD11 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -59.22 -35.86 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -58.74 -39.26 80.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.146 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.85 -49.6 76.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 0.0 109.403 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -57.45 -43.37 83.91 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.425 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' NH2' ' CZ2' ' A' ' 46' ' ' TRP . 37.1 ttm180 -60.64 -42.02 96.1 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.623 -1.298 . . . . 0.0 107.8 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.09 -42.41 66.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.91 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 51' ' ' LYS . 14.1 m120 -75.12 -43.4 53.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.021 -1.05 . . . . 0.0 110.023 -179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.4 t80 -58.23 -49.1 78.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.743 -0.598 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 2.5 ppt_? -63.04 -33.86 76.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.969 -1.082 . . . . 0.0 109.142 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.66 76.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.143 -0.973 . . . . 0.0 109.586 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.66 -44.86 55.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.604 -179.253 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.634 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 78.0 m-85 -88.06 -49.1 7.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.903 -1.123 . . . . 0.0 110.636 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' NE2' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 52.56 -6.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 111.099 -179.898 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.61 ' H ' ' C ' ' A' ' 60' ' ' PHE . 95.5 mt-30 -69.66 -35.71 75.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.558 -1.339 . . . . 0.0 110.612 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 53.31 16.69 0.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.083 -1.011 . . . . 0.0 110.063 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -137.64 98.62 9.76 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 0.0 109.382 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.3 -34.08 4.36 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.545 2.163 . . . . 0.0 113.866 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.73 -45.8 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.899 -1.126 . . . . 0.0 109.788 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.94 -33.37 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.038 -1.039 . . . . 0.0 109.479 179.435 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.13 -38.98 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.204 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.408 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -62.89 -21.51 66.06 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -84.88 -6.39 59.34 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.9 mtp -88.42 111.6 21.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.33 -172.93 2.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.16 -25.55 59.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.061 -1.025 . . . . 0.0 110.504 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.02 -45.34 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.766 -1.208 . . . . 0.0 109.113 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -68.82 -36.75 78.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 109.155 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.936 ' O ' HG13 ' A' ' 80' ' ' VAL . 95.7 t -64.11 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.027 . . . . 0.0 110.081 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 80' ' ' VAL . 2.1 pt-20 -65.54 -43.7 89.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 11.1 ptp180 -75.16 -32.8 61.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.632 -1.292 . . . . 0.0 109.322 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 59' ' ' CYS . 61.3 mt -70.61 -35.58 73.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 111.851 -179.187 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 76' ' ' VAL . 34.8 m -50.39 -17.94 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.686 -1.259 . . . . 0.0 109.161 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.424 ' N ' ' C ' ' A' ' 79' ' ' LEU . 16.1 pt20 -117.84 -8.17 10.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.717 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 46.3 m-20 -77.95 107.86 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.61 -1.307 . . . . 0.0 109.51 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.27 -13.24 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.835 -0.541 . . . . 0.0 109.896 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.45 37.9 30.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 85' ' ' ILE . 6.2 pt -58.49 -168.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.002 -1.293 . . . . 0.0 109.498 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -65.86 93.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.313 -0.867 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 87' ' ' ARG . 32.5 ttt-85 -55.23 106.46 0.23 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER 179.88 72.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 15.3 ptm180 -45.56 -42.51 11.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -51.23 -54.17 24.62 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.211 -178.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -64.09 -42.33 96.97 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.037 -1.272 . . . . 0.0 109.774 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.04 -44.26 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -56.97 -36.13 69.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.653 -1.279 . . . . 0.0 109.736 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.79 83.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 109.079 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.45 -39.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 108.926 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.88 -43.3 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.7 -35.43 81.44 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 88.5 m-20 -61.49 -35.88 78.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.378 -1.072 . . . . 0.0 108.93 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.04 91.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.847 . . . . 0.0 108.843 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 16.5 mmt180 -61.13 -36.28 79.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.48 -32.42 74.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.187 -0.946 . . . . 0.0 109.024 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -61.76 -44.23 97.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.99 -36.64 80.0 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.8 -36.81 85.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.945 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.459 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 94.4 mmm -64.68 -40.09 94.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.869 -1.144 . . . . 0.0 108.826 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' GLY . 80.7 mm-40 -67.64 -38.06 83.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -58.09 -25.67 61.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -93.46 -12.6 29.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.63 22.53 71.69 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -114.56 102.78 55.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 109.556 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.52 152.68 46.21 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.953 1.768 . . . . 0.0 112.274 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.09 -40.27 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.618 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.43 69.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 111.074 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.55 -53.03 39.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.082 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CE1' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -72.1 -41.43 67.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.667 -1.27 . . . . 0.0 111.75 -177.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.816 HG12 HD21 ' A' ' 145' ' ' LEU . 30.4 m -59.69 -50.35 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 119.945 -1.722 . . . . 0.0 109.794 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.611 ' N ' HG23 ' A' ' 116' ' ' VAL . 15.0 m95 -57.26 -24.41 54.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 45.9 p -66.32 -42.13 88.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.063 -1.023 . . . . 0.0 110.404 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 39.8 m-85 -68.17 -33.35 74.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.076 -1.015 . . . . 0.0 110.283 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -88.06 15.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 109.19 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.14 37.52 26.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.699 . . . . 0.0 110.554 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 48.71 29.45 2.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -0.952 . . . . 0.0 110.424 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.43 148.97 42.62 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.784 -1.197 . . . . 0.0 109.856 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.44 147.64 90.6 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.92 2.413 . . . . 0.0 112.905 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 126' ' ' MET . 11.5 tm0? -105.4 135.24 47.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.232 -0.917 . . . . 0.0 109.223 179.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.482 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 62.9 mtt -93.04 134.66 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.2 -54.72 3.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -0.989 . . . . 0.0 109.354 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 127' ' ' THR . 73.6 mt-30 58.63 50.11 9.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 127' ' ' THR . . . -90.02 142.35 27.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.6 p -81.13 -24.6 37.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.003 -1.061 . . . . 0.0 108.916 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 p -143.51 164.67 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.13 -31.86 72.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.026 -1.046 . . . . 0.0 108.841 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -64.29 -28.73 69.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 79.8 mm-40 -78.2 -2.4 37.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -179.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.56 127.17 86.45 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.75 -1.219 . . . . 0.0 107.965 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.412 ' O ' ' CE2' ' A' ' 163' ' ' TYR . 56.9 Cg_endo -73.49 137.74 25.87 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.132 1.888 . . . . 0.0 113.292 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 163' ' ' TYR . 57.3 p -110.29 6.54 22.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 m -147.97 90.89 1.87 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.204 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.0 155.52 39.89 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -52.82 -33.89 62.91 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 120.946 1.097 . . . . 0.0 111.539 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.67 -46.21 55.0 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.24 -0.913 . . . . 0.0 109.176 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.9 p -63.47 -41.4 98.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.073 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.57 -43.92 97.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.552 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.45 -29.57 67.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.483 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.816 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -62.83 -47.21 84.39 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.627 -0.671 . . . . 0.0 110.338 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.9 t -65.59 -41.62 92.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 109.841 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -60.57 -38.71 85.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.13 -54.62 16.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.045 -1.035 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -59.09 -31.69 69.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -60.5 -43.26 97.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.503 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -72.12 -27.75 62.83 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 110.358 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.486 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -73.9 5.35 4.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.006 . . . . 0.0 109.019 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.63 25.72 52.78 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -101.4 116.39 32.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.436 -1.037 . . . . 0.0 109.452 179.203 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -94.6 176.4 6.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 56.92 53.34 8.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.19 43.82 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.29 165.69 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.59 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 18.7 m -54.06 -33.82 58.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.614 -0.933 . . . . 0.0 109.214 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.6 m -72.72 -33.59 66.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.54 -44.63 99.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.642 -0.661 . . . . 0.0 110.047 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' CYS . . . . . 0.59 ' SG ' ' O ' ' A' ' 159' ' ' THR . 0.8 OUTLIER -65.46 -46.65 78.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.093 -1.004 . . . . 0.0 109.682 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -63.74 -38.8 92.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 109.581 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.544 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 79.4 p -63.37 -37.21 86.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -63.7 -40.72 97.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.772 . . . . 0.0 110.203 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.52 ' HG2' HD12 ' A' ' 171' ' ' LEU . 25.6 mtm -66.85 -39.24 87.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 111.014 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -64.72 -36.15 83.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.983 -1.073 . . . . 0.0 111.084 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.632 ' HB2' ' N6 ' ' A' ' 189' ' ' ADK . . . -84.73 -38.51 19.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 112.295 -177.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -68.06 -48.95 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.796 -1.19 . . . . 0.0 111.717 -177.878 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.32 -11.06 2.76 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.923 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.751 HD22 HG21 ' A' ' 120' ' ' VAL . 81.5 mt -51.13 -30.78 17.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -1.198 . . . . 0.0 109.749 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.82 150.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -137.69 163.76 30.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.657 . . . . 0.0 109.853 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 90.17 75.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.147 0.498 . . . . 0.0 110.62 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -52.37 -53.3 46.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.6 m -151.37 -162.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.18 122.92 39.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.43 68.59 1.62 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -106.63 154.63 20.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.034 -1.274 . . . . 0.0 109.18 179.002 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.656 ' N ' ' H2 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -36.92 -64.97 0.32 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.628 -0.67 . . . . 0.0 110.066 -179.71 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -24.27 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.9 t80 -97.79 110.28 54.71 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.75 125.71 6.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.954 1.769 . . . . 0.0 112.208 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.53 -3.71 6.52 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -80.42 -1.03 39.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -1.131 . . . . 0.0 109.661 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.79 147.56 36.35 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.054 -1.029 . . . . 0.0 109.256 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 C--N 1.311 -1.416 0 C-N-CA 122.296 1.997 . . . . 0.0 112.263 179.845 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 189' ' ' ADK . . . . . 0.746 ' C3A' ' CH2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.555 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.499 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' NE2' ' A' ' 175' ' ' HIS . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' CZ2' ' CZ ' ' A' ' 16' ' ' TYR . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 53.3 m-85 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.946 0.311 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.442 ' O ' HG21 ' A' ' 96' ' ' ILE . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.457 ' HG1' ' HG ' ' A' ' 133' ' ' SER . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.457 ' HG ' ' HG1' ' A' ' 131' ' ' THR . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' A' ' 7' ' ' VAL . 62.1 mtp180 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.631 0.729 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.2 m -53.08 144.77 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 0.0 109.618 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.14 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.525 -0.734 . . . . 0.0 112.13 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.686 ' CZ2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -83.7 -1.03 53.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.58 -1.541 . . . . 0.0 109.478 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' A' ' 3' ' ' ARG . 1.4 t -84.93 -42.37 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 108.823 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.4 m -78.66 5.09 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.78 -108.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.632 -0.668 . . . . 0.0 109.775 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.35 143.61 93.69 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.806 . . . . 0.0 109.838 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 -28.29 58.25 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.083 1.855 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.32 -36.18 82.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.894 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 6' ' ' TRP . 4.6 m-85 -55.41 -42.11 73.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.039 . . . . 0.0 110.603 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.85 -40.82 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 110.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.682 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.19 -50.35 64.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.678 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' A' ' 168' ' ' ALA . 23.8 t80 -66.58 -39.78 88.6 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.696 -1.252 . . . . 0.0 110.164 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -69.34 -50.33 47.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 112.523 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -75.14 -5.98 47.19 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.941 -1.099 . . . . 0.0 110.567 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -94.9 -35.48 12.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.832 -1.168 . . . . 0.0 112.294 -177.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 22' ' ' GLY . 13.0 pt-20 -174.42 48.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.374 -1.454 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' CH2' ' CZ2' ' A' ' 6' ' ' TRP . 20.5 t-105 -70.87 66.76 0.37 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 60.72 52.81 50.15 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.2 t -108.59 -42.29 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.36 -1.082 . . . . 0.0 109.13 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.7 Cg_endo -95.94 150.55 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.558 2.839 . . . . 0.0 112.649 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -68.27 141.63 55.82 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -99.83 147.82 25.09 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.06 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 90.9 m-20 -80.88 167.91 19.35 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 m -59.87 -35.07 74.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -67.15 -39.96 86.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 0.0 112.461 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -59.04 -38.92 80.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 0.0 110.309 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.718 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.5 mp -58.62 -36.94 74.84 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.686 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -63.26 -48.12 79.52 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -69.82 -30.97 68.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.783 -1.198 . . . . 0.0 109.473 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.22 -48.56 56.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.791 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 35' ' ' ILE . 8.4 tp -61.43 -28.6 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 109.476 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.6 -51.32 29.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.956 -1.09 . . . . 0.0 109.418 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.85 -37.49 73.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 108.98 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 tp10 -61.65 -37.06 82.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.4 -35.33 90.84 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.538 ' OE1' HG13 ' A' ' 49' ' ' VAL . 86.9 mt-30 -62.06 -31.48 71.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.459 -1.024 . . . . 0.0 110.995 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.631 HE22 ' CB ' ' A' ' 164' ' ' SER . 5.4 pt20 -61.26 6.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.837 -1.165 . . . . 0.0 110.53 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.59 123.3 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.3 -33.78 0.16 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 42' ' ' ALA . 73.2 mt -94.44 155.99 16.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -1.213 . . . . 0.0 110.439 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.3 m -73.18 156.62 38.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -59.85 -32.42 70.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.42 -0.8 . . . . 0.0 109.725 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -35.82 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -57.6 -37.37 73.12 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.538 HG13 ' OE1' ' A' ' 40' ' ' GLN . 85.1 t -66.69 -36.81 78.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.885 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.97 -47.64 84.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.911 -1.118 . . . . 0.0 109.806 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.49 -49.68 74.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.818 -1.176 . . . . 0.0 108.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -65.72 -26.19 67.64 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.253 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 49' ' ' VAL . 38.1 ttm180 -55.12 -42.49 73.03 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.49 -40.85 76.78 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.093 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.777 ' N ' HD22 ' A' ' 55' ' ' ASN . 0.8 OUTLIER -64.34 -34.86 79.11 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' OH ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -60.95 -39.25 88.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -59.66 -36.43 76.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.398 -0.814 . . . . 0.0 109.054 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.79 89.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.838 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.607 ' HB3' HD22 ' A' ' 79' ' ' LEU . 64.9 m -75.0 -44.95 45.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.64 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 83.1 m-85 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 19.2 Cg_exo . . . . . 0 N--CA 1.491 1.374 0 CA-C-O 121.245 0.435 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.94 -36.33 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 0.0 110.236 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -47.07 83.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 111.271 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 96' ' ' ILE . 19.4 m -67.66 -33.46 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.517 -1.364 . . . . 0.0 109.326 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.585 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.28 -20.58 65.59 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.01 -9.14 40.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.0 mmm -82.75 119.68 24.64 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.57 173.81 7.43 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.347 -0.846 . . . . 0.0 110.449 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.61 -29.85 39.71 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.52 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -60.96 -48.46 81.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.987 -1.07 . . . . 0.0 108.177 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.16 -41.52 98.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 92' ' ' ILE . 70.3 t -56.7 -42.36 76.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.682 -0.636 . . . . 0.0 109.983 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -58.18 -39.18 78.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 108.661 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 35.0 ttm-85 -61.74 -40.29 94.58 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 0.0 109.294 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 59' ' ' CYS . 63.1 mt -65.43 -33.25 75.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.608 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.18 -36.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 108.404 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -106.49 -2.93 21.44 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.829 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 84' ' ' GLY . 46.4 t0 -78.38 106.71 10.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.15 -1.594 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 67.56 -19.81 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.575 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 71.5 36.03 62.79 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.4 pt -29.28 -94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 122.127 -0.631 . . . . 0.0 110.544 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.3 tt -170.58 -37.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.128 -0.982 . . . . 0.0 109.07 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 86' ' ' ILE . 17.9 mmt180 -72.03 156.02 39.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.802 0.81 . . . . 0.0 110.595 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -111.01 178.87 4.21 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 10.3 ptp180 -56.7 -43.8 80.9 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 110.58 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -56.38 -57.95 16.75 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.342 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.46 -43.25 97.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.071 -1.252 . . . . 0.0 110.161 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.631 HG21 HG13 ' A' ' 76' ' ' VAL . 19.4 mm -57.64 -52.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -50.91 -32.64 21.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.843 -1.161 . . . . 0.0 108.881 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -64.35 -42.02 96.45 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -0.925 . . . . 0.0 108.563 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 92' ' ' ILE . 80.2 mt -65.66 -42.23 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.388 -0.82 . . . . 0.0 109.121 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 68' ' ' VAL . 15.9 mm -60.02 -44.24 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.73 92.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.67 -37.85 74.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -1.11 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.58 -47.14 76.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 109.197 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.585 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 12.2 mmt180 -56.67 -38.19 71.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.92 -30.61 70.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.94 -44.0 90.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.0 -37.16 83.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.028 -1.045 . . . . 0.0 109.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.09 -38.63 88.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.0 108.704 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -70.13 -40.35 74.9 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.641 0.734 . . . . 0.0 109.321 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.03 -23.74 65.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -91.93 -6.18 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.26 26.29 74.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -118.07 108.26 42.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -52.79 145.64 38.92 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.985 1.79 . . . . 0.0 112.381 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.618 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -59.26 -46.88 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.209 1.004 . . . . 0.0 109.372 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.82 68.33 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 109.846 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.81 -47.92 82.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.97 -1.081 . . . . 0.0 111.806 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.618 ' CD2' ' O ' ' A' ' 112' ' ' PHE . 12.5 p90 -71.62 -43.62 65.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.804 -1.185 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.598 HG11 ' CD2' ' A' ' 31' ' ' LEU . 1.9 p -65.16 -54.45 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.358 -1.464 . . . . 0.0 110.129 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.552 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 53.7 m95 -55.14 -23.45 21.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.05 -1.032 . . . . 0.0 108.25 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.72 -29.58 70.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 108.966 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 171' ' ' LEU . 2.9 t -86.94 9.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.025 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.1 35.21 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 44.2 35.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.748 . . . . 0.0 110.373 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -146.97 147.52 29.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.62 142.05 62.86 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.462 2.108 . . . . 0.0 112.023 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.576 HE21 ' C ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -113.0 132.06 55.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 108.814 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.576 ' C ' HE21 ' A' ' 125' ' ' GLN . 34.6 ttp -89.55 127.35 35.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.93 -1.107 . . . . 0.0 109.415 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.55 130.12 43.79 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 109.29 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -91.92 27.31 2.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.194 -0.941 . . . . 0.0 110.754 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.728 ' CB ' HD13 ' A' ' 135' ' ' ILE . . . -64.61 142.56 58.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.728 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.6 p -109.02 -35.46 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.68 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 26.7 p -124.96 162.34 24.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.474 -0.766 . . . . 0.0 109.609 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.8 -36.28 71.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 109.177 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -79.27 0.14 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 108.992 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HB3' ' H ' ' A' ' 131' ' ' THR . 40.7 tp10 -103.01 8.4 38.92 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.728 HD13 ' CB ' ' A' ' 129' ' ' ALA . 5.5 mm -93.58 126.0 51.64 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -70.91 139.74 36.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.489 1.459 . . . . 0.0 112.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -111.73 5.03 18.92 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -145.72 86.91 1.75 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.682 . . . . 0.0 109.304 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.17 162.77 18.63 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.94 -41.14 77.47 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.25 1.3 . . . . 0.0 111.8 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.95 74.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 108.585 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -64.32 -44.71 90.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.501 -0.749 . . . . 0.0 109.643 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.95 -37.61 86.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.21 -31.98 64.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.54 -48.16 73.4 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.369 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -57.41 -42.27 81.98 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.63 -1.293 . . . . 0.0 108.493 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -65.0 -42.28 94.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.494 -0.754 . . . . 0.0 109.887 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.608 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.4 -47.9 68.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.48 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 1.8 mm? -63.48 -40.23 96.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.21 -0.931 . . . . 0.0 109.157 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -60.28 -39.11 85.7 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.959 -1.088 . . . . 0.0 110.123 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -71.42 -35.74 71.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 111.304 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.608 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.64 -1.87 10.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.775 -1.203 . . . . 0.0 109.653 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.6 17.8 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 18.3 m-85 -93.49 111.33 22.97 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.746 -1.182 . . . . 0.0 107.816 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -97.35 174.07 6.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 0.0 110.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.432 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 91.3 m-85 61.71 61.51 1.43 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.193 0.997 . . . . 0.0 109.092 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.0 m -137.13 41.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -37.44 160.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.572 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 28.0 m -57.78 -30.02 65.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.57 -0.959 . . . . 0.0 109.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -77.73 -34.91 52.4 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.01 -37.56 77.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.568 . . . . 0.0 110.072 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 159' ' ' THR . 32.0 p -67.27 -47.2 71.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.176 -0.952 . . . . 0.0 109.045 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.27 -42.21 84.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.069 . . . . 0.0 109.888 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.631 ' CB ' HE22 ' A' ' 41' ' ' GLN . 20.8 m -58.79 -42.46 89.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -38.3 81.4 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.203 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 19.2 mtm -63.46 -36.14 82.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 110.869 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 164' ' ' SER . 35.3 mt-30 -57.57 -44.29 85.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.926 -1.109 . . . . 0.0 110.782 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.426 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . . . -89.84 -17.85 27.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.995 -1.065 . . . . 0.0 110.334 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.37 -26.06 68.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.486 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.53 50.09 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 120' ' ' VAL . 88.4 mt -62.53 -37.3 85.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.633 -0.922 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.8 138.27 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 109.555 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 84.1 m-20 -121.69 135.99 54.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.544 -0.722 . . . . 0.0 110.622 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER 156.06 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.715 -0.616 . . . . 0.0 110.914 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.472 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.6 m170 55.88 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.126 -0.984 . . . . 0.0 108.664 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 178' ' ' GLY . 21.5 m -136.57 40.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 177' ' ' VAL . 0.4 OUTLIER 34.8 27.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.749 0.785 . . . . 0.0 109.966 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -162.4 34.66 0.34 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 17.7 t . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.447 -1.031 . . . . 0.0 109.438 -179.726 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -117.07 159.31 22.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.546 -0.721 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -44.57 97.99 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.273 -0.892 . . . . 0.0 111.214 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.607 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -83.5 -0.45 50.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.76 -1.435 . . . . 0.0 109.493 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.53 -48.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.1 m -77.79 -0.59 27.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -81.46 -49.0 11.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.495 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -147.82 158.1 42.97 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 108.945 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.755 ' HA ' HD12 ' A' ' 14' ' ' ILE . 52.8 Cg_endo -71.48 -24.52 22.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.526 2.151 . . . . 0.0 113.002 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.28 -38.53 89.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.844 -1.16 . . . . 0.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.66 -36.56 84.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 11' ' ' PRO . 40.4 mt -58.06 -44.38 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 110.41 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.683 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.71 -50.98 46.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.423 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -62.15 -37.89 86.91 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.667 -1.27 . . . . 0.0 109.48 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -73.62 -44.27 57.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.619 -0.676 . . . . 0.0 111.633 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.455 ' C ' HD22 ' A' ' 19' ' ' ASN . 64.1 m-20 -72.37 -7.74 51.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.787 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -91.33 -72.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.767 -1.208 . . . . 0.0 111.344 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.57 81.67 1.1 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.867 -1.146 . . . . 0.0 110.892 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.607 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 16.9 t-105 -80.34 71.16 7.13 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.69 55.42 22.78 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.635 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.3 t -107.01 -39.74 0.16 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.401 -1.058 . . . . 0.0 109.545 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 83.1 Cg_endo -97.88 153.24 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.497 2.798 . . . . 0.0 112.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -66.36 148.38 51.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 169' ' ' CYS . 82.8 p -95.2 159.29 15.08 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.977 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -96.2 167.94 10.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -61.98 -37.18 83.82 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.932 -1.105 . . . . 0.0 110.664 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -71.47 -39.83 70.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 112.596 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 15.3 mmmt -56.26 -37.04 69.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.653 -1.279 . . . . 0.0 109.108 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 31' ' ' LEU . 3.1 mt -57.33 -37.59 72.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.567 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.8 -47.03 85.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.575 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -69.9 -38.87 76.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.232 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 39.9 tpp -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.54 -0.725 . . . . 0.0 111.212 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -69.55 -27.58 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -70.03 -42.3 73.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.814 -1.179 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 5.4 mp -73.89 -39.05 64.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -63.43 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 110.202 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.86 -38.42 59.79 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.295 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 42' ' ' ALA . 12.0 tt0 -62.62 -24.73 67.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.963 -1.316 . . . . 0.0 110.194 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 6.5 mm100 -48.27 -6.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.802 -1.186 . . . . 0.0 110.522 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -67.02 112.75 4.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.833 -1.167 . . . . 0.0 109.825 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.13 -27.11 0.2 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.691 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.798 HD12 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -98.16 151.14 20.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.336 . . . . 0.0 110.649 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.5 m -75.79 162.85 27.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -62.6 -38.37 89.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 0.0 110.868 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.934 -1.104 . . . . 0.0 109.127 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.798 HG21 HD12 ' A' ' 44' ' ' LEU . 15.4 m -63.45 -40.11 96.26 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.728 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -73.64 -33.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 109.635 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.17 -45.18 75.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -42.89 90.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.512 ' HD3' HG21 ' A' ' 86' ' ' ILE . 25.0 ttpp -62.86 -33.81 76.05 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.301 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -57.61 -40.33 78.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -73.33 -47.17 44.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.075 -1.016 . . . . 0.0 111.18 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.765 HD22 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -75.77 -37.56 59.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.689 -1.257 . . . . 0.0 110.427 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.765 ' N ' HD22 ' A' ' 55' ' ' ASN . 79.0 t80 -58.74 -46.36 87.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.906 -1.121 . . . . 0.0 109.1 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.76 -31.27 71.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 108.898 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.69 38.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.148 -0.97 . . . . 0.0 111.293 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.64 -44.31 43.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.974 -1.079 . . . . 0.0 111.34 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 56' ' ' TYR . 66.5 m-85 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.96 -1.087 . . . . 0.0 110.562 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 N-CA-C 114.844 1.055 . . . . 0.0 114.844 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.78 -29.86 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 109.033 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.05 -35.64 79.21 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.61 -36.3 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -62.48 -20.21 64.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.32 -10.39 32.88 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 93.2 mtp -74.08 109.69 7.77 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.3 pt20 -97.38 -176.17 3.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.787 -0.571 . . . . 0.0 110.017 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -59.86 -32.49 70.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.327 -0.858 . . . . 0.0 110.884 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.507 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 88.5 tt0 -59.49 -47.01 87.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.368 -1.457 . . . . 0.0 109.042 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -35.77 74.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.088 -1.008 . . . . 0.0 108.816 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -57.38 -43.92 83.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.436 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.93 ' O ' HG22 ' A' ' 80' ' ' VAL . 75.5 mt-10 -56.95 -35.7 69.39 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.8 ttm-85 -59.27 -37.57 77.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 76' ' ' VAL . 1.5 mt -68.0 -33.08 73.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.665 -0.647 . . . . 0.0 112.659 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 77' ' ' GLU . 13.5 m -52.0 -17.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.7 -1.25 . . . . 0.0 110.334 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -124.0 13.79 9.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.179 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.8 m-20 -96.99 104.89 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.895 -1.128 . . . . 0.0 110.559 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.84 -15.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.886 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.03 37.82 49.08 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 30.7 pt -47.86 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.567 -0.961 . . . . 0.0 110.019 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.971 HG23 ' H ' ' A' ' 87' ' ' ARG . 11.1 tt -55.63 -105.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.971 ' H ' HG23 ' A' ' 86' ' ' ILE . 13.3 tpt180 -85.03 153.5 22.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.564 -1.335 . . . . 0.0 108.262 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.499 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.42 -33.79 3.78 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.535 -0.728 . . . . 0.0 111.211 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -125.73 -22.8 4.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 111.431 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.24 -91.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.635 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.95 -29.19 68.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.126 -1.22 . . . . 0.0 109.934 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ILE . 12.2 mm -56.9 -56.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.765 -1.209 . . . . 0.0 109.484 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 92' ' ' ILE . 92.9 mt-30 -50.91 -35.41 32.98 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.295 -1.503 . . . . 0.0 108.015 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.0 80.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.78 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' ILE . 96.1 mt -69.24 -33.14 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 110.847 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.79 -48.71 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.729 -1.232 . . . . 0.0 108.82 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.88 -35.04 90.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -55.38 -38.66 69.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.186 -1.185 . . . . 0.0 109.574 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.72 79.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.849 -1.157 . . . . 0.0 109.362 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.42 -37.56 86.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.029 -1.044 . . . . 0.0 109.866 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.74 -31.4 72.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 108.905 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.721 ' CE1' ' CE1' ' A' ' 112' ' ' PHE . 63.7 t80 -61.46 -44.18 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.7 mm? -61.84 -33.96 75.1 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -64.24 -38.43 91.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.882 . . . . 0.0 111.459 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.704 ' SD ' ' CG ' ' A' ' 112' ' ' PHE . 8.2 ttm -64.49 -42.76 95.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.69 -1.256 . . . . 0.0 108.757 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.95 -37.99 84.29 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.267 0.556 . . . . 0.0 109.576 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.0 -24.55 67.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -88.18 -10.9 48.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.129 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.33 27.67 73.55 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.226 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 4.8 tt0 -116.88 103.47 52.19 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.103 -1.233 . . . . 0.0 110.343 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.77 138.59 41.29 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.833 1.689 . . . . 0.0 112.011 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.721 ' CE1' ' CE1' ' A' ' 102' ' ' TYR . 65.0 m-85 -58.8 -41.78 87.55 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.9 0.857 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.33 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 110.577 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.98 -48.3 79.44 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.109 -0.994 . . . . 0.0 112.346 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.7 p90 -70.79 -43.85 67.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.663 -1.273 . . . . 0.0 110.507 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 117' ' ' TRP . 2.4 p -65.41 -55.39 20.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.848 -1.157 . . . . 0.0 110.868 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.634 ' H ' HG13 ' A' ' 116' ' ' VAL . 48.6 m95 -55.35 -23.07 22.08 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.198 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -75.58 -33.56 60.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.094 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -65.88 -32.5 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.037 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.52 17.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 108.994 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 123' ' ' GLN . 45.3 t30 60.13 43.85 13.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.829 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 11.3 t-160 41.92 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -126.46 151.28 72.5 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.604 -0.685 . . . . 0.0 109.285 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.76 153.73 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.523 2.149 . . . . 0.0 112.184 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 137.58 47.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 95.8 mmm -95.14 118.86 32.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.416 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -88.81 122.65 32.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.258 -0.901 . . . . 0.0 108.798 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -93.44 23.1 4.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -72.05 139.11 48.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 109.62 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 m -100.01 -21.88 15.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 108.63 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -140.88 163.82 31.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.248 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.58 -39.53 76.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.323 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.1 p -64.22 -29.65 70.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -80.36 5.64 14.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 108.954 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 135' ' ' ILE . 4.5 tp -83.05 129.19 62.22 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.891 . . . . 0.0 108.905 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.73 137.0 31.71 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.132 1.888 . . . . 0.0 112.248 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.5 p -105.66 0.1 26.06 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.529 -0.732 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.1 t -147.18 92.34 2.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.39 -0.819 . . . . 0.0 108.995 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.405 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -105.03 158.26 32.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -54.17 -40.41 82.08 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.835 1.69 . . . . 0.0 111.186 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.91 -40.48 63.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 139' ' ' THR . 67.7 p -67.81 -38.02 82.75 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.176 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.12 -41.09 95.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -0.97 . . . . 0.0 108.669 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.29 64.35 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.417 HD12 ' HE2' ' A' ' 115' ' ' PHE . 9.4 tp -64.26 -45.5 87.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.579 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 11.6 m -62.88 -40.47 97.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.147 -0.97 . . . . 0.0 109.595 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -60.3 -41.67 93.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.504 -0.747 . . . . 0.0 111.111 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -46.06 66.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.814 -1.178 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.23 -36.9 82.64 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.128 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -60.6 -41.55 94.97 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.063 -1.023 . . . . 0.0 110.016 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -80.15 -16.63 54.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.742 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -84.44 2.72 39.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.71 19.09 49.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 6.5 m-85 -98.87 113.47 25.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.214 -1.168 . . . . 0.0 109.123 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -89.13 175.1 7.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.388 0.613 . . . . 0.0 110.002 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 55.13 59.31 4.08 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.701 0.762 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 157' ' ' VAL . 8.0 m -135.67 35.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.336 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.0 166.06 1.06 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.2 p -58.45 -30.7 67.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -1.104 . . . . 0.0 109.365 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.3 m -67.48 -39.63 85.27 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.02 -44.13 88.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.9 m -64.11 -41.02 97.41 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.452 -0.78 . . . . 0.0 109.846 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -44.19 89.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.241 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -61.78 -40.14 94.14 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.65 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -61.45 -38.5 87.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 82.1 mtp -65.58 -34.64 78.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 111.629 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 3.9 pt20 -63.68 -42.01 98.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.684 -1.26 . . . . 0.0 111.683 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.492 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -85.91 -24.65 26.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 111.697 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.718 ' O ' HG23 ' A' ' 26' ' ' THR . 0.9 OUTLIER -65.97 -22.38 66.47 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.762 -1.211 . . . . 0.0 110.431 -178.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.0 2.7 58.16 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.453 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 12.3 mt -65.92 -32.01 73.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.77 -0.841 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.94 148.32 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.062 -1.024 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 20.5 m120 -113.76 164.85 13.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 3.9 m-20 90.26 81.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.082 0.468 . . . . 0.0 110.257 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.543 ' O ' HG13 ' A' ' 176' ' ' VAL . 53.3 m170 -52.68 -46.14 67.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.042 -1.036 . . . . 0.0 108.825 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 178' ' ' GLY . 4.8 m -158.1 29.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.458 -0.777 . . . . 0.0 110.202 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 129' ' ' ALA . 25.9 t 53.01 2.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 109.927 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -141.05 32.37 2.11 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.943 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 109.024 179.756 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.3 mtm-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.699 0.761 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 1.2 m -64.34 153.46 38.35 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.78 98.47 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.345 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.598 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.31 -3.21 58.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.61 -1.524 . . . . 0.0 109.448 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.2 t -80.86 -35.15 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -76.88 4.93 8.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 10' ' ' ASP . 1.3 mm-40 -90.64 -159.38 0.61 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -44.75 155.6 0.38 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.001 -1.062 . . . . 0.0 108.914 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HA ' HD12 ' A' ' 14' ' ' ILE . 20.4 Cg_endo -63.25 -16.65 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 0.0 112.228 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.2 mt -58.42 -39.68 80.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -67.92 -36.24 79.84 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.061 -1.024 . . . . 0.0 109.335 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 11' ' ' PRO . 91.7 mt -58.39 -44.85 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.781 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.11 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.737 -1.227 . . . . 0.0 109.554 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.438 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 3.1 t80 -66.62 -35.84 81.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 55.4 t-80 -61.58 -41.17 97.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 111.69 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 6.2 m-20 -96.6 -1.67 46.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.827 -1.17 . . . . 0.0 112.358 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -103.41 -30.05 10.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.529 -1.357 . . . . 0.0 112.324 -178.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 94.7 mt-10 -155.97 24.73 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.144 -1.597 . . . . 0.0 111.507 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.598 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.6 t90 -98.87 65.25 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 98.49 62.58 0.87 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.687 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.796 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -157.89 -35.61 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.152 -1.205 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.796 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 98.6 Cg_endo -98.41 149.97 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.363 2.042 . . . . 0.0 112.331 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.2 166.77 22.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -99.45 130.16 45.69 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.567 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.91 157.1 16.99 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 m -56.69 -34.68 67.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.901 -1.125 . . . . 0.0 109.187 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -67.53 -41.57 84.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -63.92 -38.96 93.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.987 -1.071 . . . . 0.0 110.152 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -61.04 -35.97 78.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 109.656 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -66.96 -50.25 62.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 110.95 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -66.84 -40.14 87.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.79 -1.194 . . . . 0.0 109.629 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.583 ' C ' ' SD ' ' A' ' 34' ' ' MET . 10.0 tmm? -62.75 -50.72 69.95 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.684 -0.635 . . . . 0.0 110.763 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.546 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.1 tp -62.32 -27.49 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.07 -45.35 74.07 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.552 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' HE ' ' A' ' 53' ' ' ARG . 39.0 mt -70.39 -44.37 68.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.125 -0.985 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 161' ' ' ILE . 47.0 mm-40 -61.94 -32.79 73.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -37.3 76.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.536 ' NE2' HD11 ' A' ' 95' ' ' ILE . 91.1 mm-40 -87.07 -2.99 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -1.119 . . . . 0.0 110.085 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 HG11 ' A' ' 49' ' ' VAL . 73.2 mt-30 -81.5 -0.92 44.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.088 -1.007 . . . . 0.0 109.86 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.99 112.99 7.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.205 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.81 -33.62 5.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 48' ' ' THR . 5.6 mp -102.61 152.55 21.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.266 . . . . 0.0 110.325 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 m -64.56 156.73 28.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.419 -0.801 . . . . 0.0 108.97 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -60.71 -35.09 75.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.74 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -30.92 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.84 -1.163 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.691 HG21 HD23 ' A' ' 44' ' ' LEU . 87.7 m -58.12 -42.41 85.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.836 -1.165 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -71.17 -31.93 45.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.535 -0.728 . . . . 0.0 109.379 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 tp -55.35 -49.25 72.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.085 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -58.35 -42.73 87.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -65.32 -31.05 71.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.211 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 37.7 ttm180 -54.38 -44.78 72.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -69.59 -38.95 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.597 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.16 -42.71 59.5 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 111.012 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.73 -49.99 75.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.912 -1.117 . . . . 0.0 110.495 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.1 ptm180 -59.69 -30.79 69.03 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.939 -1.1 . . . . 0.0 109.005 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.4 93.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB3' HD22 ' A' ' 79' ' ' LEU . 71.2 m -75.15 -43.83 50.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.979 -1.075 . . . . 0.0 110.291 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.075 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo . . . . . 0 N--CA 1.49 1.305 0 CA-C-O 121.059 0.358 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.87 -44.09 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.953 -1.092 . . . . 0.0 109.871 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 68' ' ' VAL . 5.3 pttp -65.93 -33.21 75.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.109 -0.994 . . . . 0.0 109.044 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 84.4 t -60.25 -38.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 108.951 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.532 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.04 -19.24 65.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.19 -15.51 18.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 78.1 mtp -68.88 113.78 6.6 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.3 tt0 -96.16 174.12 7.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.328 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 95.7 mt-10 -52.17 -32.06 34.28 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.98 -45.45 82.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.2 -38.1 87.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.947 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 92' ' ' ILE . 53.8 t -62.04 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 2.5 pt-20 -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.978 -1.077 . . . . 0.0 108.156 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.3 ttm-85 -63.77 -48.01 78.66 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 59' ' ' CYS . 66.2 mt -70.78 -34.47 71.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.761 -0.587 . . . . 0.0 110.99 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' LEU . 4.2 t -48.28 -17.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.513 ' N ' ' C ' ' A' ' 79' ' ' LEU . 5.7 mt-30 -110.8 -12.14 14.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.2 t0 -83.15 109.66 17.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.98 -17.35 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.145 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 78.79 36.89 27.66 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLY . 6.4 pt -47.19 175.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -1.197 . . . . 0.0 108.35 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.64 95.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.13 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 31.5 ptt180 -54.92 125.09 18.83 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.714 0.769 . . . . 0.0 109.305 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.7 m-70 166.96 78.36 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -48.73 -32.33 8.32 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.91 2.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -60.55 -39.96 89.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.327 . . . . 0.0 109.409 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.601 HG21 HG13 ' A' ' 76' ' ' VAL . 99.1 mt -59.8 -40.3 82.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.177 -0.952 . . . . 0.0 109.09 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.563 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 6.9 mm100 -55.44 -36.35 66.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 108.893 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.69 85.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.536 HD11 ' NE2' ' A' ' 40' ' ' GLN . 44.6 mm -61.05 -43.26 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.2 mm -59.59 -43.63 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.42 -36.09 90.29 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -60.06 -35.82 75.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -1.111 . . . . 0.0 109.834 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.23 83.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.045 . . . . 0.0 109.214 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.532 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.0 mtt180 -62.2 -36.09 80.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.364 -0.835 . . . . 0.0 109.318 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.74 81.89 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.242 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.98 -43.49 95.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.8 mt -60.97 -25.62 66.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.458 ' CD ' ' C ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -67.37 -41.58 84.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 110.057 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' GLN . 94.2 mmm -66.13 -40.28 90.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.125 -0.984 . . . . 0.0 108.688 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.3 mm-40 -70.69 -39.93 73.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.275 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.14 -23.85 64.23 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -93.89 -9.76 36.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.3 24.35 74.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -117.46 101.64 52.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.17 147.33 66.14 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.325 2.017 . . . . 0.0 112.523 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.772 ' HB3' HD12 ' A' ' 31' ' ' LEU . 35.9 m-85 -60.7 -39.35 88.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.523 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.35 -32.57 74.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.946 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.35 -46.7 82.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.669 -1.27 . . . . 0.0 112.204 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.8 p90 -73.02 -43.84 61.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.632 -1.292 . . . . 0.0 110.999 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 112' ' ' PHE . 2.1 p -62.87 -54.0 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.629 -1.294 . . . . 0.0 110.37 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.574 ' H ' HG13 ' A' ' 116' ' ' VAL . 34.2 m95 -53.94 -27.04 28.51 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -76.26 -35.52 58.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.576 -0.702 . . . . 0.0 109.941 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -61.89 -31.09 71.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.8 p -97.99 17.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 63.41 33.56 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.685 -0.634 . . . . 0.0 110.401 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' TRP . 95.9 m-70 51.44 29.32 5.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.136 -0.978 . . . . 0.0 110.95 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.448 ' H ' HG13 ' A' ' 120' ' ' VAL . 19.8 mt-30 -135.34 142.56 41.95 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.961 -1.087 . . . . 0.0 109.906 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.27 147.98 43.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.266 1.977 . . . . 0.0 111.671 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.417 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -120.0 126.48 50.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 90.2 mtp -102.74 116.0 31.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 108.753 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.613 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -89.72 144.43 25.98 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.43 28.35 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 111.78 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.64 134.87 51.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 0.0 108.504 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.9 p -97.17 -21.59 17.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 110.228 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.3 p -129.3 162.15 28.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.91 -36.35 76.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.412 -0.805 . . . . 0.0 109.38 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 62.4 p -68.2 -29.7 68.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.96 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -83.41 6.42 20.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -86.86 143.2 35.01 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.06 145.6 31.42 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.525 2.15 . . . . 0.0 112.865 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.43 0.6 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.481 ' O ' ' OG ' ' A' ' 138' ' ' SER . 10.8 p -145.68 94.74 2.54 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.503 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -106.02 153.98 39.83 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.65 -37.61 91.16 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.752 1.635 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.89 58.12 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.642 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.503 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 60.6 m -63.15 -42.24 99.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.966 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -60.81 -39.62 89.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 109.231 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.54 77.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.41 -47.84 83.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 109.625 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.641 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 13.8 t -63.48 -43.71 96.51 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.196 -0.94 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.58 -44.26 94.57 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB1' ' NH1' ' A' ' 152' ' ' ARG . . . -72.17 -44.35 63.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.137 -0.977 . . . . 0.0 109.367 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.566 HD23 HH21 ' A' ' 152' ' ' ARG . 75.3 mt -65.39 -39.1 91.82 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.287 -0.883 . . . . 0.0 109.738 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.47 -39.35 90.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.973 -1.079 . . . . 0.0 109.695 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.32 -30.61 71.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 110.071 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.566 HH21 HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -72.86 0.66 10.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.954 -1.092 . . . . 0.0 108.642 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.88 26.55 24.12 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.815 -1.184 . . . . 0.0 110.297 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -97.11 112.43 24.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 0.0 109.745 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -91.38 168.96 11.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.97 64.19 1.8 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 108.482 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.69 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.1 p -153.52 41.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.95 -175.39 0.08 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 p -66.62 -26.7 67.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -1.048 . . . . 0.0 110.415 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -70.99 -34.05 71.01 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 38' ' ' GLU . 34.2 mm -70.5 -44.56 76.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.094 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 146' ' ' SER . 7.3 m -64.95 -36.02 83.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.522 -0.736 . . . . 0.0 109.655 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -69.69 -45.96 67.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 110.87 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.607 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 87.1 p -63.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.875 -1.141 . . . . 0.0 109.188 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -62.44 -49.28 76.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.576 -0.702 . . . . 0.0 110.365 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.05 -40.62 96.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.008 -1.057 . . . . 0.0 111.148 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.538 ' OE1' ' CD2' ' A' ' 163' ' ' TYR . 4.6 mp0 -74.76 -40.77 61.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.906 -1.121 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.86 60.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.051 -1.031 . . . . 0.0 112.536 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.436 ' HB3' HG22 ' A' ' 26' ' ' THR . 36.1 m -65.65 -48.72 71.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.676 -1.265 . . . . 0.0 111.964 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.65 -2.38 1.46 Allowed Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.579 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 5.9 mt -59.97 -35.33 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.94 -1.33 . . . . 0.0 110.126 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.436 ' CG1' HE21 ' A' ' 167' ' ' GLN . 0.4 OUTLIER -140.54 140.32 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.719 -1.238 . . . . 0.0 110.075 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -110.37 124.04 50.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.613 ' HB3' ' H ' ' A' ' 127' ' ' THR . 13.7 p30 180.0 54.33 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.234 -0.916 . . . . 0.0 111.475 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.9 ' O ' HG13 ' A' ' 176' ' ' VAL . 25.6 m170 -57.94 -46.34 85.22 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.48 -1.387 . . . . 0.0 108.788 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -175.23 18.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.2 t 62.32 -41.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.752 -0.593 . . . . 0.0 110.587 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -81.66 4.87 71.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.27 . . . . 0.0 109.643 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.441 0.639 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.35 146.74 47.11 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.551 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.3 -24.33 21.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' A' ' 6' ' ' TRP . 4.5 t90 -81.47 9.51 7.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -1.219 . . . . 0.0 109.731 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.4 -25.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 0.0 110.669 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -81.19 6.34 14.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.087 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -86.22 -59.7 2.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -111.4 156.29 41.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 110.311 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HA ' HD13 ' A' ' 14' ' ' ILE . 51.2 Cg_endo -71.28 -37.22 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.966 2.444 . . . . 0.0 113.198 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.23 -35.03 77.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.129 -0.982 . . . . 0.0 110.441 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CD1' ' OD1' ' A' ' 10' ' ' ASP . 6.4 m-85 -56.55 -36.25 69.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.971 -1.081 . . . . 0.0 109.791 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.9 mp -52.35 -43.94 41.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.69 -48.77 65.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.497 ' HA ' HD22 ' A' ' 19' ' ' ASN . 16.4 t80 -62.34 -43.13 99.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.57 -43.04 91.0 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.448 -0.782 . . . . 0.0 111.549 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.29 -14.19 61.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 111.605 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 80.6 m-20 -73.77 -69.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.626 -1.296 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -175.83 59.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' C ' ' CD1' ' A' ' 21' ' ' TRP . 7.7 t90 -96.42 68.92 2.59 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.04 -3.8 6.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.705 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -105.51 -16.98 0.16 Allowed Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.6 -0.941 . . . . 0.0 111.861 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 91.7 Cg_endo -86.44 150.87 9.07 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 121.833 1.688 . . . . 0.0 113.088 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.04 170.86 10.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.74 HG22 ' SG ' ' A' ' 169' ' ' CYS . 1.8 p -91.18 120.36 32.05 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.772 -1.205 . . . . 0.0 111.043 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.2 m-20 -105.74 154.14 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -61.58 -36.66 81.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.811 -1.181 . . . . 0.0 109.825 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -73.17 -50.81 20.53 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 110.97 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -63.94 -25.37 68.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.903 -1.123 . . . . 0.0 108.691 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -59.02 -44.29 91.7 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.5 t80 -68.94 -46.5 68.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 111.155 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.69 -35.29 77.01 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.509 -1.369 . . . . 0.0 109.761 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 38.7 ttm -68.72 -43.79 75.25 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.927 -1.108 . . . . 0.0 110.991 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.895 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.4 tp -63.19 -29.32 46.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.953 -1.092 . . . . 0.0 109.831 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.8 m -71.77 -49.21 40.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.043 -1.036 . . . . 0.0 110.413 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 1.7 mm? -66.23 -42.06 89.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.632 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.646 ' CD ' ' HG ' ' A' ' 164' ' ' SER . 32.5 tp10 -66.39 -38.22 87.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.893 . . . . 0.0 109.746 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.55 -36.63 78.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -82.84 -7.77 59.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.221 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -89.48 4.17 50.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.075 . . . . 0.0 110.722 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 161' ' ' ILE . . . -63.88 118.82 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 0.0 110.07 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 83.19 -1.01 89.41 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 43' ' ' GLY . 4.5 mm? -107.13 163.36 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.243 -1.151 . . . . 0.0 110.121 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 47' ' ' ILE . 60.6 m -80.98 22.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.669 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.7 OUTLIER 62.96 -39.85 0.17 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 109.758 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.591 ' N ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -62.06 -35.47 68.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.921 -1.112 . . . . 0.0 108.225 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.415 ' CB ' HD12 ' A' ' 44' ' ' LEU . 79.0 m -59.24 -44.48 92.36 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.068 -1.02 . . . . 0.0 108.622 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.3 t -69.03 -35.83 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.11 -48.93 72.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.034 -1.041 . . . . 0.0 109.03 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -59.83 -42.62 93.97 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.566 ' HZ3' HG21 ' A' ' 86' ' ' ILE . 1.6 ttmt -62.34 -32.33 73.09 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 40.9 ttm180 -53.66 -45.68 70.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.234 -0.916 . . . . 0.0 109.244 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.02 -44.26 85.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.816 -1.153 . . . . 0.0 108.614 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.76 HD21 HG22 ' A' ' 85' ' ' ILE . 27.5 t30 -63.27 -37.95 89.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 45.1 t80 -56.84 -42.92 80.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 57' ' ' ARG . 15.8 mmm-85 -59.34 -35.59 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 108.906 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.48 96.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 110.399 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.639 ' SG ' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -78.3 -45.87 21.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 111.434 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 87.4 m-85 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.9 -1.125 . . . . 0.0 109.629 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 114.041 0.746 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.1 t -76.41 -38.93 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.621 -1.299 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 67' ' ' LYS . 8.6 mmpt? -63.83 -42.65 97.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.082 -1.011 . . . . 0.0 108.579 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.97 -37.89 81.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.258 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.64 63.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.8 -8.5 46.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.7 mtp -83.25 115.76 22.1 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.24 167.44 11.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.65 -31.89 39.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.021 -1.049 . . . . 0.0 110.132 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -55.09 -41.48 71.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 85.3 m-20 -62.45 -37.99 88.02 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 80' ' ' VAL . 55.7 t -63.2 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.472 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 80' ' ' VAL . 79.3 mm-40 -61.96 -40.79 96.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 110.136 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 5.0 ptp180 -75.54 -33.01 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 109.274 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 85' ' ' ILE . 53.6 mt -65.99 -33.23 75.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.907 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 77' ' ' GLU . 20.1 m -54.19 -17.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.67 -1.269 . . . . 0.0 108.843 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.41 -2.33 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.1 t0 -81.55 108.25 14.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.701 -1.249 . . . . 0.0 109.273 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.32 -11.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.612 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.39 34.41 57.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.76 HG22 HD21 ' A' ' 55' ' ' ASN . 20.6 pt -52.56 -177.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -1.006 . . . . 0.0 110.344 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.814 HG23 ' O ' ' A' ' 86' ' ' ILE . 19.7 tt -56.98 89.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 32.2 ptt180 -51.91 134.25 31.67 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.628 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.636 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.0 m-70 164.31 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 89' ' ' ARG . 15.6 ptt-85 -42.87 -32.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.079 . . . . 0.0 110.184 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.86 -62.35 6.18 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.912 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 3.2 mptt -63.79 -38.28 90.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.869 -1.371 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.425 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 2.1 pt20 -55.65 -33.08 63.74 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.82 -1.175 . . . . 0.0 108.305 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -63.04 -38.59 91.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 108.811 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.5 -47.35 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 109.224 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.448 -0.783 . . . . 0.0 109.942 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.27 -39.8 90.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -58.93 -35.71 73.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.542 -0.975 . . . . 0.0 109.683 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.78 -46.19 83.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -56.4 -41.61 76.57 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.985 -1.072 . . . . 0.0 108.693 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -62.66 -30.04 71.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.636 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 48.7 t80 -63.32 -43.02 98.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -65.25 -31.9 73.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.6 -40.04 94.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -0.854 . . . . 0.0 110.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.685 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 80.6 mtp -67.52 -37.7 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.63 -41.08 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.085 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.05 -22.15 66.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -12.19 30.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.81 27.19 73.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.34 100.46 52.93 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.247 -1.149 . . . . 0.0 109.877 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.2 149.63 84.14 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.381 2.054 . . . . 0.0 112.146 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 33.6 m-85 -63.06 -40.07 96.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 111.195 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.17 77.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.077 -1.014 . . . . 0.0 111.062 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -63.02 -47.02 84.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.184 -0.948 . . . . 0.0 112.606 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -72.14 -44.52 63.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.538 -1.351 . . . . 0.0 110.718 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.584 HG13 ' N ' ' A' ' 117' ' ' TRP . 3.9 p -60.49 -52.09 65.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.603 -1.311 . . . . 0.0 109.446 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 20.7 m95 -55.66 -24.36 33.53 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 6.3 p -65.57 -42.72 91.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 109.98 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.699 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 40.5 m-85 -63.58 -36.47 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.988 -1.07 . . . . 0.0 109.171 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.719 HG21 HD22 ' A' ' 171' ' ' LEU . 1.7 t -86.37 13.9 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.697 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 121' ' ' ASN . 2.2 m120 57.17 31.97 20.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 56.17 32.67 20.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 111.437 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.69 149.75 41.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 110.066 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.58 145.0 68.77 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.809 2.34 . . . . 0.0 112.874 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.58 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.58 132.42 55.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.467 -0.771 . . . . 0.0 109.8 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.58 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.0 mtt -101.46 123.44 45.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.917 -1.114 . . . . 0.0 108.952 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -92.96 -20.41 20.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.879 -1.138 . . . . 0.0 110.16 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 57.22 44.77 21.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.383 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.616 ' CB ' HD12 ' A' ' 135' ' ' ILE . . . -65.01 148.77 51.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.45 ' C ' HG23 ' A' ' 176' ' ' VAL . 0.3 OUTLIER -110.25 -28.3 8.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.447 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 5.2 p -131.9 164.15 26.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.15 -42.22 85.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 108.857 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 95.9 p -72.43 -19.33 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.447 ' CB ' ' H ' ' A' ' 131' ' ' THR . 39.2 tp10 -71.9 -10.42 59.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.807 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.1 tp -74.11 127.13 88.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 120.997 -1.064 . . . . 0.0 108.191 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.61 135.34 17.87 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.979 1.786 . . . . 0.0 113.014 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.6 p -112.13 4.94 18.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.6 t -138.77 93.19 2.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.384 -0.822 . . . . 0.0 109.003 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.57 158.9 50.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.15 -39.06 92.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.901 1.734 . . . . 0.0 111.21 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.64 -44.29 67.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 108.698 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.1 p -62.72 -40.72 98.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -63.28 -37.99 89.4 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.185 -0.947 . . . . 0.0 108.787 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.82 -37.45 84.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.494 -0.754 . . . . 0.0 109.991 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 145' ' ' LEU . 86.4 mt -61.93 -40.49 95.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 109.998 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.627 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 25.2 t -64.35 -51.53 62.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.9 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -67.99 -39.64 83.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.84 -1.162 . . . . 0.0 109.299 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.87 83.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.5 mt -68.02 -35.76 78.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.003 -1.061 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.71 84.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.976 -1.077 . . . . 0.0 109.68 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.09 -32.39 71.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.21 -0.932 . . . . 0.0 110.455 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.474 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 2.6 mmp_? -72.33 -1.0 13.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.969 -1.082 . . . . 0.0 108.826 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.08 26.93 42.5 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 2.9 m-85 -98.45 112.59 24.56 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.758 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -89.8 170.97 9.96 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 59.39 65.84 1.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.921 0.867 . . . . 0.0 109.679 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HA ' HG21 ' A' ' 161' ' ' ILE . 19.8 m -140.97 38.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.43 168.35 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.3 m -57.42 -31.67 66.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.583 -0.951 . . . . 0.0 109.134 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.4 p -71.36 -33.92 70.01 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 42' ' ' ALA . 36.3 mm -65.82 -45.43 91.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.057 0.932 . . . . 0.0 108.533 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 146' ' ' SER . 28.3 m -63.8 -45.18 90.82 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.446 0.641 . . . . 0.0 109.9 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -31.81 73.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.969 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.646 ' HG ' ' CD ' ' A' ' 38' ' ' GLU . 29.9 t -59.56 -49.25 78.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.895 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 10.6 m-85 -59.75 -47.6 85.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.471 -1.393 . . . . 0.0 109.131 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' VAL . 95.8 mmm -52.55 -42.22 64.22 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.576 -1.249 . . . . 0.0 108.389 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -43.16 18.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.51 -0.743 . . . . 0.0 111.064 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.22 13.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -0.943 . . . . 0.0 113.088 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.74 ' SG ' HG22 ' A' ' 26' ' ' THR . 0.5 OUTLIER -54.16 -18.91 4.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.628 -1.295 . . . . 0.0 110.861 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.98 -0.47 59.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.719 HD22 HG21 ' A' ' 120' ' ' VAL . 11.7 mt -58.67 -35.14 72.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.403 -1.057 . . . . 0.0 109.348 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 166' ' ' MET . 1.5 m -131.06 143.98 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.14 117.69 34.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.807 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.9 p-10 -178.85 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 174' ' ' ASP . 35.8 m170 -49.1 -39.25 27.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 176' ' ' VAL . 6.2 p 175.62 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' VAL . 1.4 p 30.69 112.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.261 1.029 . . . . 0.0 112.206 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.51 48.47 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 120.696 -1.252 . . . . 0.0 110.569 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 120.715 -1.462 . . . . 0.0 108.676 179.433 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.505 HH12 ' CG1' ' A' ' 14' ' ' ILE . 80.5 mtm180 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.19 143.24 58.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.192 0.996 . . . . 0.0 110.226 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.22 -21.51 32.98 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -77.3 -4.28 44.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.953 -1.322 . . . . 0.0 108.864 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.31 -31.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -70.54 6.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.393 -0.817 . . . . 0.0 110.035 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.36 -105.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.953 -1.092 . . . . 0.0 110.511 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.47 159.97 63.07 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.935 . . . . 0.0 110.439 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 14' ' ' ILE . 38.1 Cg_endo -68.36 -35.58 17.99 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.188 2.592 . . . . 0.0 113.245 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.89 -31.8 71.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.075 -1.015 . . . . 0.0 110.608 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.42 -33.56 69.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 110.964 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.505 ' CG1' HH12 ' A' ' 3' ' ' ARG . 3.4 mp -58.53 -41.03 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.746 -1.221 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.614 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.01 -50.74 53.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.062 . . . . 0.0 109.452 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.459 ' HA ' HD22 ' A' ' 19' ' ' ASN . 28.9 t80 -63.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.363 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -66.58 -42.86 86.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 110.373 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -74.65 -10.28 59.38 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 20.7 m-80 -69.6 -76.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.885 -1.134 . . . . 0.0 108.426 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' O ' ' C ' ' A' ' 21' ' ' TRP . 94.6 mt-10 -151.92 -39.5 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.613 ' C ' ' O ' ' A' ' 20' ' ' GLU . 8.4 t90 -3.38 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.808 0.813 . . . . 0.0 111.241 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 142.41 -23.68 2.36 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.142 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.71 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 11.6 m -125.5 10.87 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.663 -0.904 . . . . 0.0 112.676 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 73.5 Cg_endo -75.72 143.79 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.346 1.364 . . . . 0.0 112.874 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -86.12 148.3 25.76 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.64 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.6 p -88.25 120.6 29.77 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.522 -1.271 . . . . 0.0 111.436 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.881 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -105.89 159.26 16.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 m -64.67 -38.08 89.78 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.466 -1.396 . . . . 0.0 110.469 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -75.13 -49.92 18.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 111.866 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -59.23 -40.49 86.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.949 -1.094 . . . . 0.0 109.398 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.881 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.5 mp -62.69 -38.24 89.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.317 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 1.3 t80 -59.88 -39.46 85.39 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.472 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 37' ' ' LEU . 61.3 mt-10 -74.12 -39.82 63.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.311 -0.868 . . . . 0.0 108.936 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.471 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 26.0 ttm -59.5 -49.61 77.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.835 . . . . 0.0 110.848 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 10.9 tp -62.13 -35.26 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.673 -1.267 . . . . 0.0 108.817 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 72.2 m -67.23 -36.98 82.8 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.599 ' CD1' HH21 ' A' ' 57' ' ' ARG . 1.8 mp -73.21 -48.76 32.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 164' ' ' SER . 72.1 mm-40 -63.19 -37.55 87.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.826 . . . . 0.0 108.859 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.46 -35.88 92.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -74.48 -8.63 56.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.966 . . . . 0.0 109.382 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -74.21 -5.64 43.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.51 122.87 14.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.011 -1.055 . . . . 0.0 109.283 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.62 -25.99 0.28 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 42' ' ' ALA . 87.6 mt -105.48 144.61 32.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -1.144 . . . . 0.0 110.233 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -75.75 157.52 33.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -56.91 -34.51 68.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.498 -0.752 . . . . 0.0 110.296 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -35.35 67.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -62.69 -44.31 96.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.333 -0.855 . . . . 0.0 109.983 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.31 -24.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.219 -0.926 . . . . 0.0 109.168 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.54 -47.87 82.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.0 110.003 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -61.4 -49.68 75.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.913 -1.117 . . . . 0.0 109.033 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.21 -5.82 50.68 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.067 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.3 ttm180 -65.9 -55.74 15.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -66.2 -45.84 79.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.663 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.524 ' ND2' HG22 ' A' ' 85' ' ' ILE . 39.6 t30 -66.24 -45.87 79.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.956 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 92' ' ' ILE . 56.7 t80 -63.44 -46.3 86.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.875 -1.14 . . . . 0.0 110.476 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.599 HH21 ' CD1' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -54.31 -34.42 60.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.856 -1.153 . . . . 0.0 109.676 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.29 79.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.087 -1.008 . . . . 0.0 110.469 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.79 -43.7 62.45 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 112.638 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.794 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 66.6 m-85 . . . . . 0 N--CA 1.501 2.091 0 O-C-N 120.739 -1.225 . . . . 0.0 112.079 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 CA-C-O 121.279 0.45 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.71 -46.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -65.4 -34.61 78.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 96' ' ' ILE . 96.6 t -60.34 -37.55 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.818 . . . . 0.0 109.53 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -69.75 -15.28 63.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.53 -5.07 49.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 0.0 109.853 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.672 ' O ' HG21 ' A' ' 96' ' ' ILE . 72.1 mmm -77.97 116.5 18.51 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -95.12 175.69 6.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.201 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.86 -33.57 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.716 -0.615 . . . . 0.0 110.542 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -57.83 -42.0 83.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 84.8 m-20 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.822 ' O ' HG23 ' A' ' 80' ' ' VAL . 88.1 t -62.53 -40.09 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.461 -0.774 . . . . 0.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -66.04 -40.26 90.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 7.1 ptp180 -74.61 -38.71 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.717 -1.239 . . . . 0.0 109.225 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 10.4 mt -65.49 -32.35 73.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.73 . . . . 0.0 110.615 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.3 t -48.24 -38.36 8.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.14 2.02 45.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.738 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.7 t70 -87.43 110.6 20.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 81.67 -15.13 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.676 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.05 37.41 49.72 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.524 HG22 ' ND2' ' A' ' 55' ' ' ASN . 1.4 pt -58.74 -166.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.197 -1.178 . . . . 0.0 110.107 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 86' ' ' ILE . 15.7 tt -66.98 94.46 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 0.0 109.463 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.615 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 4.6 mtt-85 -51.78 117.86 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.915 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.748 ' CD2' ' HZ1' ' A' ' 91' ' ' LYS . 3.5 m-70 170.62 68.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -48.73 -34.16 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.26 -62.65 6.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.748 ' HZ1' ' CD2' ' A' ' 88' ' ' HIS . 33.7 mtmm -62.44 -40.68 97.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.085 -1.244 . . . . 0.0 110.322 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 56' ' ' TYR . 43.8 mm -61.18 -43.89 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.959 -1.088 . . . . 0.0 110.513 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.99 -36.43 74.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.796 -1.19 . . . . 0.0 109.368 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -68.49 -36.59 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.17 -31.14 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.672 HG21 ' O ' ' A' ' 71' ' ' MET . 15.8 mm -58.56 -46.25 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.807 -1.183 . . . . 0.0 108.395 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.1 -33.19 86.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -56.16 -42.2 76.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.194 . . . . 0.0 109.826 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.28 -47.6 67.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.087 . . . . 0.0 108.894 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 34.1 ttm180 -56.77 -36.25 69.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.458 -0.776 . . . . 0.0 109.1 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.43 72.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.057 -1.027 . . . . 0.0 108.927 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.7 -42.66 97.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.0 mm? -61.44 -32.95 72.94 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -63.62 -36.69 84.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.587 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.3 tpp -64.23 -40.76 96.71 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.028 0.918 . . . . 0.0 108.899 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.6 -38.98 92.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.5 -24.31 66.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -90.97 -15.84 29.02 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.6 27.19 73.58 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.644 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.99 101.93 47.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.195 -1.179 . . . . 0.0 109.565 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.53 138.16 14.46 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.769 1.646 . . . . 0.0 112.383 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -51.88 -39.12 58.46 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.237 1.018 . . . . 0.0 109.198 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.12 65.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 109.957 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -66.63 -48.64 68.82 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 111.892 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.658 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 7.8 p90 -73.95 -38.29 64.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.54 -1.35 . . . . 0.0 111.274 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.658 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.5 m -66.92 -52.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.318 -1.489 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.589 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.3 m95 -55.03 -27.13 42.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 t -76.14 -40.0 53.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.464 -0.773 . . . . 0.0 110.541 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.28 -24.88 65.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.284 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.0 m -100.84 19.11 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.418 -0.801 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.63 36.19 22.55 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.76 -0.588 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 52.68 37.3 23.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 111.218 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.08 149.85 25.94 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 109.315 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.83 150.78 62.27 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 112.2 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 172' ' ' VAL . 4.6 tm0? -102.43 132.0 48.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 98.2 mmm -94.23 117.81 30.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 109.233 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -93.07 119.46 32.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.64 21.45 4.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.031 -1.043 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -67.48 142.22 56.68 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.484 -0.76 . . . . 0.0 109.697 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.512 HG22 ' CG2' ' A' ' 177' ' ' VAL . 58.2 p -106.61 -25.01 11.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 108.865 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -130.12 164.27 24.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.549 -0.72 . . . . 0.0 109.092 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.4 mt -57.66 -35.0 69.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 108.773 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.2 t -61.06 -35.95 78.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.53 0.52 25.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.2 tp -79.84 125.9 81.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.26 132.36 13.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.764 1.643 . . . . 0.0 112.725 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 p -111.65 7.15 20.35 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -144.92 89.35 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.527 -0.733 . . . . 0.0 109.462 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.1 p -108.99 151.93 42.16 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.601 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.63 -34.69 74.57 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.667 1.578 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HB1' ' HE1' ' A' ' 166' ' ' MET . . . -72.95 -45.76 56.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.451 -0.781 . . . . 0.0 109.0 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.7 p -69.01 -36.69 78.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.28 -0.887 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.49 -38.95 93.1 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.76 -27.24 63.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.642 ' CD1' HG12 ' A' ' 116' ' ' VAL . 6.5 tp -69.03 -44.95 71.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.723 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 7.7 t -62.62 -47.09 85.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.913 . . . . 0.0 110.868 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -65.06 -37.83 88.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.775 -1.203 . . . . 0.0 109.879 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.36 -44.83 70.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.1 -1.0 . . . . 0.0 109.389 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.55 ' HB3' HG11 ' A' ' 157' ' ' VAL . 1.2 mm? -63.24 -38.31 90.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -61.29 -41.08 96.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.144 -0.972 . . . . 0.0 110.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -68.65 -36.58 78.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.97 -1.081 . . . . 0.0 111.762 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.474 ' NH2' HD22 ' A' ' 149' ' ' LEU . 14.5 mtm180 -71.11 7.05 1.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.78 -1.2 . . . . 0.0 110.143 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.68 57.2 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -95.34 112.57 24.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.218 -1.166 . . . . 0.0 108.015 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.44 174.95 6.6 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 59.68 48.65 9.12 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.564 0.697 . . . . 0.0 109.875 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 149' ' ' LEU . 35.9 m -122.27 43.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.67 160.1 0.48 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -56.8 -30.91 64.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.64 -0.917 . . . . 0.0 109.881 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -75.6 -31.45 59.95 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -72.48 -35.99 53.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.2 m -69.28 -40.58 77.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.803 . . . . 0.0 109.38 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.51 -45.24 76.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.499 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 33.6 t -61.35 -39.34 90.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.563 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 47.9 t80 -58.54 -47.78 83.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.714 -0.616 . . . . 0.0 110.445 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.499 ' HE1' ' HB1' ' A' ' 141' ' ' ALA . 63.9 mtp -72.43 -39.56 67.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.055 -1.028 . . . . 0.0 109.536 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.668 HE21 ' N ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 110.211 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.668 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -78.34 -38.71 41.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 109.882 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 44.3 m -54.53 -16.95 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.343 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.55 -1.31 58.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 26' ' ' THR . 85.3 mt -61.95 -30.91 71.23 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -1.078 . . . . 0.0 109.525 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 125' ' ' GLN . 5.3 t -116.14 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 6.4 m-80 -125.01 162.41 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 15.3 t0 89.3 69.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.126 0.489 . . . . 0.0 110.563 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -51.59 -59.09 4.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.78 160.71 36.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.512 ' CG2' HG22 ' A' ' 130' ' ' THR . 56.3 t -60.14 113.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.524 -1.36 . . . . 0.0 108.793 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.75 67.33 1.69 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.747 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.565 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 5.3 t . . . . . 0 N--CA 1.495 1.808 0 O-C-N 120.816 -1.403 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.643 ' CG ' HH11 ' A' ' 3' ' ' ARG . 2.2 mtt-85 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.693 0.759 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 3.4 m -57.94 154.75 11.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.618 0.723 . . . . 0.0 110.254 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.13 -44.79 96.11 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.487 -0.758 . . . . 0.0 112.478 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.646 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -80.49 1.22 30.23 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.474 -1.604 . . . . 0.0 109.828 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 3' ' ' ARG . 2.2 t -89.39 -47.7 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.829 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -77.77 6.28 7.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 0.8 OUTLIER -91.58 -58.93 2.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.787 -0.571 . . . . 0.0 110.492 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.88 160.0 67.15 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.615 ' HA ' HD12 ' A' ' 14' ' ' ILE . 31.5 Cg_endo -69.66 -32.11 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.041 2.494 . . . . 0.0 112.728 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.31 -40.26 89.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.121 -0.987 . . . . 0.0 109.477 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 6' ' ' TRP . 29.5 m-85 -65.92 -38.52 88.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.977 -1.077 . . . . 0.0 109.702 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 11' ' ' PRO . 89.3 mt -55.69 -40.56 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.394 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.5 -51.74 18.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.974 -1.079 . . . . 0.0 109.419 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' HA ' HD22 ' A' ' 19' ' ' ASN . 31.8 t80 -60.9 -41.54 96.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.776 . . . . 0.0 109.991 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CG ' HG21 ' A' ' 7' ' ' VAL . 57.9 t-80 -62.47 -45.5 92.75 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.639 -0.663 . . . . 0.0 110.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -74.06 -7.38 52.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.448 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.673 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 38.1 m-80 -81.01 -77.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 110.288 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' GLY . 92.7 mt-10 -154.71 71.69 0.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 110.343 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.503 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 31.4 t-105 -70.14 63.31 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 67.83 64.99 2.88 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.018 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.731 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 25.5 t -114.67 -36.2 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.425 -1.044 . . . . 0.0 109.742 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.731 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 41.6 Cg_endo -95.21 151.8 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.962 2.441 . . . . 0.0 112.989 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.34 143.24 56.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 169' ' ' CYS . 23.7 p -99.01 155.51 17.39 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.95 . . . . 0.0 111.863 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -97.72 166.68 11.37 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 m -57.33 -37.09 71.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.091 -1.006 . . . . 0.0 110.398 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -65.46 -42.47 92.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 111.035 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -59.05 -34.87 72.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.175 -0.953 . . . . 0.0 109.035 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.7 mt -65.54 -33.26 75.5 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.84 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.92 -50.33 64.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 0.0 110.181 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -68.81 -30.21 68.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.83 -1.169 . . . . 0.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 168' ' ' ALA . 6.0 tpt -70.28 -50.23 41.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.64 -29.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.62 -48.18 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.043 . . . . 0.0 110.022 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.67 -39.01 84.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -62.89 -31.19 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 109.939 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.34 -41.6 55.2 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.123 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 57.7 mm-40 -67.89 -29.82 69.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.694 -1.474 . . . . 0.0 110.974 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' GLN . 4.5 pt20 -41.3 -31.94 0.26 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 0.0 109.829 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.63 116.98 7.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.01 -1.056 . . . . 0.0 108.716 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.451 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 86.66 -36.74 3.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.024 HD12 HG21 ' A' ' 48' ' ' THR . 4.5 mm? -105.14 150.04 25.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.164 -1.198 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 t -76.62 150.28 36.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 1.1 t-105 -54.72 -35.59 63.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -41.04 90.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.067 -1.021 . . . . 0.0 108.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 1.024 HG21 HD12 ' A' ' 44' ' ' LEU . 44.0 m -57.84 -38.42 75.59 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.8 t -66.5 -37.25 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD12 ' CZ ' ' A' ' 53' ' ' ARG . 37.1 tp -56.21 -50.6 70.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.06 -1.025 . . . . 0.0 108.671 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -57.49 -37.76 73.46 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -73.18 -24.25 60.53 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 42.2 ttm180 -55.12 -45.06 75.53 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.08 -40.71 91.07 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.813 ' N ' HD22 ' A' ' 55' ' ' ASN . 0.7 OUTLIER -69.08 -31.92 71.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.886 0.85 . . . . 0.0 108.984 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 52' ' ' LYS . 58.7 t80 -56.14 -50.89 69.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.31 -28.0 67.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.048 -1.033 . . . . 0.0 109.22 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.57 -36.47 82.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 110.262 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.96 -45.62 26.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.602 ' CD2' ' SG ' ' A' ' 59' ' ' CYS . 98.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.926 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.493 1.499 0 N-CA-C 113.168 0.411 . . . . 0.0 113.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.91 -46.52 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.716 -1.24 . . . . 0.0 109.975 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.78 -33.02 74.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.774 -1.204 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.91 -37.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.762 ' HB1' ' NH2' ' A' ' 100' ' ' ARG . . . -65.61 -17.2 64.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.2 -10.94 29.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.642 -0.662 . . . . 0.0 109.734 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.58 114.39 9.61 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.062 -1.024 . . . . 0.0 108.686 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 8.1 tt0 -95.89 172.77 7.81 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 94.3 mt-10 -51.79 -30.48 23.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.825 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -55.48 -44.33 76.38 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 119.909 -1.744 . . . . 0.0 108.44 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 70.6 m-20 -70.86 -35.26 72.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.478 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.96 -34.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.258 -1.526 . . . . 0.0 109.3 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.72 -40.86 98.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -70.68 -34.42 71.98 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.443 -1.303 . . . . 0.0 108.967 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.456 ' C ' ' N ' ' A' ' 81' ' ' GLN . 72.9 mt -68.26 -34.94 77.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.3 t -49.38 -19.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 79' ' ' LEU . 12.8 mt-30 -106.52 -15.42 14.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.483 -0.76 . . . . 0.0 109.912 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 82.1 m-20 -78.9 109.86 13.57 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.703 -1.199 . . . . 0.0 109.948 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.0 -18.9 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.32 33.01 61.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLY . 9.7 pt -36.22 156.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.649 -0.912 . . . . 0.0 110.234 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.45 -35.04 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.301 -0.874 . . . . 0.0 110.39 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.5 147.29 53.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.935 -178.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 97.7 m-70 -124.16 170.69 10.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.59 -0.694 . . . . 0.0 109.38 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 88' ' ' HIS . 35.3 ttp180 -40.14 -35.78 0.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.19 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.66 -64.02 2.34 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.472 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 7.5 mptt -60.39 -36.99 79.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -1.19 . . . . 0.0 110.107 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.548 HG21 ' HB ' ' A' ' 76' ' ' VAL . 97.7 mt -59.87 -47.48 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.632 -1.292 . . . . 0.0 109.292 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.48 HE21 HG11 ' A' ' 76' ' ' VAL . 33.4 mm-40 -52.5 -34.82 51.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.06 -1.025 . . . . 0.0 108.71 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.67 89.02 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.507 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.83 -43.75 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 108.673 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.41 -41.77 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 108.646 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -38.07 93.44 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.78 -37.97 71.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.446 -1.032 . . . . 0.0 109.482 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.02 83.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.027 -1.045 . . . . 0.0 109.406 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.762 ' NH2' ' HB1' ' A' ' 69' ' ' ALA . 5.1 tpp180 -55.0 -39.44 69.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.268 -0.895 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.82 -29.93 69.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 59.2 t80 -64.24 -43.06 96.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.1 mm? -63.2 -28.95 70.4 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.69 -41.55 83.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.219 -0.926 . . . . 0.0 111.362 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.678 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.8 mtp -69.1 -37.29 78.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.749 -1.22 . . . . 0.0 109.293 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.65 -39.85 84.58 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -15.77 62.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -92.95 -11.98 31.96 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.39 21.44 79.59 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.68 101.24 53.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.192 -1.181 . . . . 0.0 109.374 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.35 146.1 95.86 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.157 1.905 . . . . 0.0 112.273 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.6 m-85 -59.66 -45.21 92.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.98 -28.41 69.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 118' ' ' SER . 17.3 t70 -59.45 -52.46 65.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.964 -1.085 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -75.08 -39.87 60.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.64 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 18.5 t -59.0 -54.75 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 120.619 -1.301 . . . . 0.0 109.9 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 122' ' ' HIS . 56.1 m95 -62.02 -21.99 65.34 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 108.958 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 50.6 m -68.46 -37.47 80.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 109.254 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 18.3 m-85 -69.37 -31.26 69.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.403 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.611 ' O ' HG12 ' A' ' 120' ' ' VAL . 39.3 t -87.99 15.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.836 -1.165 . . . . 0.0 109.711 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.585 ' OD1' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER 78.78 11.38 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.699 -0.626 . . . . 0.0 109.836 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 65.7 20.57 11.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 110.893 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 15.1 mt-30 -146.51 150.94 42.07 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.941 -1.099 . . . . 0.0 109.236 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -49.24 142.25 22.11 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.862 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -110.77 142.62 42.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.565 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 92.1 mmm -99.93 130.26 46.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -92.73 123.04 35.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.093 -1.005 . . . . 0.0 109.879 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -91.93 27.35 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.79 . . . . 0.0 110.284 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -91.06 132.97 35.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.5 p -93.51 -22.36 18.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.127 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 49.4 p -133.64 167.85 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.016 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 -33.56 73.41 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.6 t -73.92 -13.17 60.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 110.43 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -94.16 4.05 54.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mm -92.49 122.35 64.57 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.83 140.78 32.56 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.84 1.693 . . . . 0.0 112.516 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.9 p -101.62 3.35 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.8 p -144.99 87.5 1.83 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.442 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.76 155.17 36.64 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -54.51 -36.52 88.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.879 1.719 . . . . 0.0 110.741 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.74 -43.12 59.99 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.809 -0.756 . . . . 0.0 108.984 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.8 p -70.18 -38.13 75.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.139 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.28 -38.93 91.23 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.177 -0.952 . . . . 0.0 108.881 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -68.83 -34.55 75.68 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.298 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mp -57.5 -46.29 83.95 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 0.0 108.639 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.545 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 8.9 t -60.7 -50.29 74.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.105 -0.997 . . . . 0.0 108.954 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -61.29 -40.41 94.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 109.267 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.99 22.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.83 -33.13 74.6 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -61.32 -42.24 98.34 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.982 -1.074 . . . . 0.0 109.671 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -68.45 -28.4 67.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.945 . . . . 0.0 110.55 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.408 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 3.3 mmp_? -72.7 1.35 8.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.906 -1.121 . . . . 0.0 108.675 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 78.59 27.32 57.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.64 112.88 24.58 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.652 0.739 . . . . 0.0 109.848 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -88.1 176.77 7.14 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.13 62.72 1.56 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.011 -1.056 . . . . 0.0 108.23 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.6 m -144.03 41.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.42 154.79 4.07 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 m -52.54 -32.01 38.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.27 -1.135 . . . . 0.0 109.557 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -72.09 -29.93 64.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.25 -0.906 . . . . 0.0 108.725 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.67 -44.92 96.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.815 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 146' ' ' SER . 97.9 m -60.8 -39.02 87.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.47 -47.81 53.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 111.063 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.499 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 19.9 m -63.43 -36.77 84.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.044 -1.035 . . . . 0.0 108.696 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 5.3 t80 -60.15 -46.24 90.35 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.153 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 171' ' ' LEU . 12.5 ptp -71.49 -34.08 69.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.511 -1.368 . . . . 0.0 110.626 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.503 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -61.48 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.818 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.564 ' HB3' ' CE ' ' A' ' 34' ' ' MET . . . -87.14 -22.98 25.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.199 -0.938 . . . . 0.0 111.592 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.609 ' O ' HG23 ' A' ' 26' ' ' THR . 1.5 m -68.76 -19.31 64.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.964 -1.085 . . . . 0.0 111.102 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.49 0.83 57.93 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 166' ' ' MET . 11.5 mt -63.37 -30.97 72.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.615 -0.932 . . . . 0.0 109.426 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.07 142.15 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 75.0 m-20 -111.71 164.11 13.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.794 ' OD2' HG22 ' A' ' 177' ' ' VAL . 5.5 t0 86.71 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.597 0.713 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.477 ' CD2' ' CD1' ' A' ' 21' ' ' TRP . 20.9 m170 -54.35 -48.26 71.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -152.07 38.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.484 -179.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.794 HG22 ' OD2' ' A' ' 174' ' ' ASP . 24.0 t 45.15 13.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.0 110.672 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -157.4 31.74 0.53 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.117 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.122 -1.222 . . . . 0.0 109.873 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.39 0.614 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.37 152.93 40.69 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.274 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.03 -25.86 25.59 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.78 13.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.028 -1.278 . . . . 0.0 109.623 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.9 t -138.74 -23.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 110.269 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -71.83 5.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 109.949 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -115.39 -75.45 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.341 -0.85 . . . . 0.0 110.57 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.02 139.46 90.46 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.986 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 -53.21 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.526 2.151 . . . . 0.0 113.194 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -54.91 -33.91 62.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.912 -1.118 . . . . 0.0 109.742 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -52.89 -40.18 63.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.12 -39.84 43.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.447 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.636 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.18 -51.1 22.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.96 -1.087 . . . . 0.0 109.535 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 19' ' ' ASN . 22.7 t80 -60.76 -41.08 94.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 0.0 109.72 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -58.66 -44.85 90.26 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.47 -0.769 . . . . 0.0 109.618 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.92 -30.36 68.81 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.645 -0.659 . . . . 0.0 110.836 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 55.9 m-80 -60.21 -53.56 56.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 111.126 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' GLY . 10.9 pt-20 176.05 72.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.2 -0.938 . . . . 0.0 110.334 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.401 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 44.9 t-105 -70.52 60.73 0.22 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 71.27 49.67 25.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.604 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -107.18 -42.63 0.13 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.322 -1.105 . . . . 0.0 110.563 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.9 Cg_endo -91.14 151.87 3.8 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.261 2.641 . . . . 0.0 113.183 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.39 144.21 54.82 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 p -99.16 148.79 23.73 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.102 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 31' ' ' LEU . 76.8 m-20 -96.41 166.43 11.7 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -56.01 -31.5 63.13 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.777 -1.202 . . . . 0.0 109.632 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -65.65 -43.0 90.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.565 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmtm -63.72 -34.96 79.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.131 -0.981 . . . . 0.0 109.125 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.4 mm? -56.22 -41.67 76.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.718 -0.614 . . . . 0.0 109.643 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -69.57 -43.17 73.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' O ' HD22 ' A' ' 37' ' ' LEU . 77.1 mt-10 -69.35 -45.39 69.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.86 -1.15 . . . . 0.0 109.332 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.9 ttm -62.19 -51.05 69.38 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.493 -0.754 . . . . 0.0 111.146 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.27 -26.16 38.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.853 -1.154 . . . . 0.0 109.716 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.45 -54.02 19.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.941 -1.099 . . . . 0.0 109.737 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.634 ' H ' HD22 ' A' ' 37' ' ' LEU . 2.0 mm? -71.88 -38.51 69.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.145 . . . . 0.0 108.843 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.564 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 3.5 tp10 -62.13 -32.34 72.91 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.514 -0.741 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.68 -13.73 82.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.533 HE21 HD13 ' A' ' 95' ' ' ILE . 89.5 mt-30 -92.91 -8.38 43.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.311 . . . . 0.0 111.319 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 2.2 pt20 -80.38 1.83 27.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.573 -1.329 . . . . 0.0 110.176 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -62.87 117.58 6.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -29.31 1.66 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . 19.1 mt -98.46 146.12 26.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -1.114 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 m -67.81 152.66 45.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -60.21 -37.13 79.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.675 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -67.73 -35.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.088 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -59.57 -42.12 91.73 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.959 -1.088 . . . . 0.0 108.125 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 54.0 t -67.72 -35.06 71.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HB3' HD13 ' A' ' 47' ' ' ILE . 7.3 tt -56.36 -51.67 67.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.148 -0.97 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -57.9 -43.13 85.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -66.92 -28.84 68.62 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.06 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.7 ttm180 -53.52 -43.79 68.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.822 -1.174 . . . . 0.0 109.097 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -73.25 -49.14 29.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.216 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 24.0 p30 -80.95 -42.62 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.757 -1.214 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.601 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 53.1 t80 -62.76 -44.64 95.67 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.809 -1.182 . . . . 0.0 109.937 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.61 -31.82 71.92 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.37 -42.7 98.88 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.018 -1.052 . . . . 0.0 110.335 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB3' HD22 ' A' ' 79' ' ' LEU . 35.3 m -78.37 -43.26 28.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.0 113.087 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 93.3 m-85 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 120.734 -1.229 . . . . 0.0 112.398 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.486 1.077 0 CA-C-O 121.401 0.5 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.43 -43.65 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 3.1 mtmp? -67.45 -38.18 84.09 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 60' ' ' PHE . 85.8 t -61.69 -39.25 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.83 -14.94 63.37 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 -9.64 53.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.648 ' O ' HG21 ' A' ' 96' ' ' ILE . 82.3 mmm -77.77 112.28 14.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.467 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.6 pt20 -95.87 -177.07 3.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.341 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.03 -33.44 72.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 110.801 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.0 tt0 -58.58 -43.33 89.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.7 -1.25 . . . . 0.0 109.08 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -65.23 -38.89 91.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.696 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 80' ' ' VAL . 47.3 t -57.75 -44.31 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.726 . . . . 0.0 110.576 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.7 pt-20 -63.18 -35.83 81.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.637 -1.289 . . . . 0.0 108.943 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -69.18 -44.03 73.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLN . 90.2 mt -69.56 -32.86 71.9 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.5 m -47.83 -16.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.438 -1.414 . . . . 0.0 108.928 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LEU . 20.6 pt20 -124.55 -2.18 7.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.637 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -83.76 111.01 18.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.474 -1.391 . . . . 0.0 109.222 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 85.27 -5.46 0.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.899 -0.501 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.91 37.68 60.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -162.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -1.147 . . . . 0.0 109.493 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 98.6 mt -77.25 118.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.942 0.877 . . . . 0.0 109.133 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.6 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.3 mtp180 -80.68 125.64 30.28 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.81 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 77' ' ' GLU . 41.8 ttm180 -44.79 -33.31 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 0.0 109.763 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.63 -59.79 6.82 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.975 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -60.65 -42.21 96.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.843 -1.386 . . . . 0.0 110.862 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.589 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 29.0 mm -62.63 -43.49 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.939 -1.101 . . . . 0.0 110.203 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.33 -31.63 65.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 109.258 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.433 ' HA ' HE21 ' A' ' 93' ' ' GLN . . . -67.92 -39.29 83.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.518 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.533 HD13 HE21 ' A' ' 40' ' ' GLN . 91.4 mt -66.07 -35.73 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.811 . . . . 0.0 110.675 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 71' ' ' MET . 17.0 mm -58.06 -39.88 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.466 -1.396 . . . . 0.0 107.25 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.39 -34.19 89.25 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.06 -40.3 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -1.222 . . . . 0.0 108.472 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.35 86.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.604 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.481 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 98.0 mtt180 -61.49 -36.98 82.0 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.04 -30.75 71.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 108.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.03 -43.32 99.02 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -63.7 -34.52 78.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.97 -39.38 94.52 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.321 -0.862 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.6 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 29.8 tpp -63.91 -46.58 84.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.42 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.37 -38.6 80.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.03 -24.59 64.64 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -91.93 -12.01 34.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.63 26.8 73.65 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.427 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.6 ' O ' ' SD ' ' A' ' 105' ' ' MET . 2.0 mt-10 -120.33 101.93 46.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.219 -1.165 . . . . 0.0 109.868 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.79 142.49 25.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.805 1.67 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 43.9 m-85 -59.86 -38.88 83.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.321 -0.862 . . . . 0.0 110.905 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.23 68.14 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.962 -1.086 . . . . 0.0 110.433 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.82 -47.45 74.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.063 . . . . 0.0 112.292 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.646 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.0 p90 -74.27 -37.66 63.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.52 -1.362 . . . . 0.0 111.154 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 145' ' ' LEU . 30.7 m -63.41 -52.46 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.328 -1.482 . . . . 0.0 109.894 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.609 ' N ' HG23 ' A' ' 116' ' ' VAL . 54.1 m95 -58.41 -25.07 61.71 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.115 . . . . 0.0 108.033 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.9 m -75.86 -38.0 58.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.481 -0.762 . . . . 0.0 110.28 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -62.88 -32.47 73.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 109.819 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.4 p -92.62 19.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.125 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 122' ' ' HIS . 6.4 m120 66.25 34.89 6.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.757 -0.59 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 117' ' ' TRP . 86.2 t60 38.31 33.94 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 0.0 109.907 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -130.89 153.18 81.63 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.91 140.52 35.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.183 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.605 HE21 ' C ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -109.26 123.89 50.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.073 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.605 ' C ' HE21 ' A' ' 125' ' ' GLN . 71.7 mtm -94.71 117.08 29.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.029 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.0 115.35 24.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.268 -0.895 . . . . 0.0 108.974 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.61 19.9 5.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 109.416 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 136.03 55.23 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 176' ' ' VAL . 81.8 p -97.16 -12.22 23.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 0.0 108.969 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 p -140.02 163.62 32.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.499 -0.751 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.42 -34.29 76.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.136 -0.978 . . . . 0.0 109.134 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.9 p -72.92 -19.52 61.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.768 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -84.15 3.88 32.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.36 138.84 23.97 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.26 135.9 30.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.303 2.002 . . . . 0.0 112.601 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -111.45 1.95 17.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.039 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -147.32 90.06 1.84 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.71 156.71 39.28 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 109.042 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.5 -37.48 90.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.021 1.814 . . . . 0.0 111.338 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.11 -41.92 66.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.899 . . . . 0.0 108.666 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -68.03 -42.28 80.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.82 . . . . 0.0 109.351 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.88 -42.31 90.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.65 74.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.829 HD11 HG12 ' A' ' 116' ' ' VAL . 2.0 tp -60.72 -46.07 91.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.363 -0.836 . . . . 0.0 108.861 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.44 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 5.7 t -58.41 -46.81 85.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 109.669 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.67 -44.63 96.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 109.946 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.77 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.25 -44.8 78.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.36 -36.34 83.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -60.61 -39.44 88.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.448 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 153' ' ' GLY . 25.4 mmtm -64.98 -36.49 84.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.77 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.8 5.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.99 24.98 63.01 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.435 ' HB3' HG11 ' A' ' 157' ' ' VAL . 0.3 OUTLIER -96.86 111.92 23.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.503 -0.998 . . . . 0.0 108.412 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 157' ' ' VAL . 37.4 mtmt -96.28 176.72 5.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 109.71 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 57.61 47.14 16.42 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 154' ' ' PHE . 28.1 m -126.52 36.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.73 171.38 0.05 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.0 p -60.81 -28.13 68.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.148 . . . . 0.0 109.325 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -65.59 -38.31 89.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 38' ' ' GLU . 12.3 mm -68.94 -44.42 81.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 146' ' ' SER . 84.7 m -63.68 -42.64 98.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.611 -0.68 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.428 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.59 -40.95 80.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 110.035 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 38' ' ' GLU . 76.9 p -63.34 -40.21 96.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.916 . . . . 0.0 109.873 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 1.7 t80 -59.32 -43.85 92.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.099 -1.001 . . . . 0.0 109.388 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.0 mtp -62.26 -38.87 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.401 ' CA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -66.17 -41.88 89.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.451 -0.78 . . . . 0.0 111.244 -178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.63 5.8 41.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.049 -1.032 . . . . 0.0 111.362 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.592 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 21.0 t -96.76 -13.01 22.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.737 -1.227 . . . . 0.0 110.31 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.55 -5.98 57.25 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.592 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -62.94 -33.58 75.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.951 -1.323 . . . . 0.0 109.613 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.02 138.68 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.6 m120 -113.27 164.02 14.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.434 -0.791 . . . . 0.0 110.132 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.6 OUTLIER 92.4 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.377 0.608 . . . . 0.0 110.332 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 16.2 m170 -53.45 -38.6 63.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 176' ' ' VAL . 2.9 p -162.18 55.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 177' ' ' VAL . 13.5 p 23.51 67.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.335 0.588 . . . . 0.0 111.156 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.47 35.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 31.0 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.119 -1.224 . . . . 0.0 109.487 179.503 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.555 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.499 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' NE2' ' A' ' 175' ' ' HIS . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.519 ' CZ2' ' CZ ' ' A' ' 16' ' ' TYR . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CE1' ' CE1' ' A' ' 56' ' ' TYR . 53.3 m-85 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.946 0.311 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.442 ' O ' HG21 ' A' ' 96' ' ' ILE . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.457 ' HG1' ' HG ' ' A' ' 133' ' ' SER . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.457 ' HG ' ' HG1' ' A' ' 131' ' ' THR . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 8.4 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 131.38 28.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.819 . . . . 0.0 110.043 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.01 -27.97 52.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -2.96 58.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.379 -1.071 . . . . 0.0 108.987 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER -95.42 -23.29 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.586 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -63.7 6.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 109.439 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 7' ' ' VAL . 85.0 mt-30 -91.63 -168.37 2.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.4 153.42 1.33 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.4 -0.813 . . . . 0.0 109.869 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.19 -20.72 32.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.63 -37.56 76.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 109.875 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CE2' ' OE1' ' A' ' 9' ' ' GLN . 2.6 m-85 -67.05 -35.33 79.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.72 -36.68 67.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.586 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.14 -49.9 58.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.882 -1.136 . . . . 0.0 108.899 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 21' ' ' TRP . 19.6 t80 -63.79 -41.29 97.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 108.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -70.85 -42.07 70.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.683 -0.636 . . . . 0.0 110.8 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.87 -10.45 58.52 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 110.517 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 83.7 m-20 -80.02 -76.13 0.23 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.788 -1.195 . . . . 0.0 109.364 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 21' ' ' TRP . 95.6 mt-10 -146.88 -65.41 0.28 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.565 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.3 t90 26.35 63.12 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.377 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.5 57.55 0.24 Allowed Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.829 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.841 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 p -176.49 -21.16 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 113.487 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.841 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 72.8 Cg_endo -89.24 150.89 5.55 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.612 1.541 . . . . 0.0 113.258 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.02 156.21 39.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.661 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -91.06 132.12 36.22 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.595 -177.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.93 147.15 29.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -60.85 -35.62 77.03 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -75.26 -50.62 15.55 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.508 -0.745 . . . . 0.0 111.072 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -34.96 77.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.963 -1.086 . . . . 0.0 109.291 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.673 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 65.8 mt -63.29 -36.5 83.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.149 -0.969 . . . . 0.0 109.199 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.29 -43.0 92.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.61 -38.02 80.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.984 -1.072 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.552 ' CE ' ' HB1' ' A' ' 168' ' ' ALA . 53.2 tpp -63.3 -50.65 69.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.679 -0.638 . . . . 0.0 111.006 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 35' ' ' ILE . 11.0 tp -62.94 -27.08 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.228 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.8 t -71.02 -53.92 13.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 108.861 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.07 -38.91 92.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 108.512 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.572 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -67.5 -39.24 85.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 108.891 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.57 94.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.11 -4.89 43.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 109.661 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -78.15 2.82 16.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.116 . . . . 0.0 109.977 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -65.22 132.09 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.043 . . . . 0.0 109.093 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.15 -29.77 0.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 79.7 mt -98.14 139.89 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.608 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.7 m -69.18 154.39 42.13 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.247 -0.908 . . . . 0.0 108.661 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 1.2 t-105 -55.15 -39.56 69.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.0 . . . . 0.0 109.841 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -37.64 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -0.956 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.451 HG21 HD22 ' A' ' 44' ' ' LEU . 99.9 m -57.98 -41.76 83.65 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.954 -1.091 . . . . 0.0 108.531 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -67.05 -31.65 54.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.809 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -48.59 81.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.088 -1.008 . . . . 0.0 109.939 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 53.1 mttt -62.21 -46.37 89.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.784 -1.197 . . . . 0.0 108.1 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.31 -16.44 61.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttm180 -63.69 -46.51 85.19 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -65.9 -45.41 82.09 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.2 m-80 -67.88 -43.09 80.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.895 ' OH ' HG21 ' A' ' 95' ' ' ILE . 89.8 t80 -60.44 -47.22 87.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 0.0 110.24 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -58.04 -34.2 69.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.042 -1.036 . . . . 0.0 109.837 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.77 95.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.896 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.6 m -72.98 -43.96 61.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.039 . . . . 0.0 111.079 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 84.9 m-85 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.055 . . . . 0.0 110.906 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 68' ' ' VAL . 50.9 Cg_endo . . . . . 0 N--CA 1.489 1.24 0 N-CA-C 115.287 1.226 . . . . 0.0 115.287 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -37.45 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.615 -1.303 . . . . 0.0 110.891 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -35.34 69.62 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.112 -0.993 . . . . 0.0 110.982 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 65' ' ' PRO . 3.7 m -73.94 -36.35 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.282 -1.511 . . . . 0.0 108.246 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.39 -20.54 59.96 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.91 -11.3 36.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.552 ' CE ' ' OD2' ' A' ' 75' ' ' ASP . 4.1 mmm -75.57 119.86 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.564 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 7.0 tt0 -95.57 168.49 10.66 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 109.901 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 98.1 mt-10 -49.75 -25.74 3.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.955 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 108.076 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -70.13 -37.8 75.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.918 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.606 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 49.5 t -61.8 -44.06 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.63 -0.669 . . . . 0.0 110.749 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.69 -32.81 74.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 108.14 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -67.95 -42.88 80.27 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.605 0.716 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 25.1 mt -69.6 -33.58 72.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 111.722 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 ' NH1' ' A' ' 89' ' ' ARG . 55.2 t -48.24 -31.28 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.892 -1.13 . . . . 0.0 108.527 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -100.43 -4.48 28.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.18 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 57.5 t0 -88.22 109.32 19.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.763 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.34 -16.34 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.472 -0.768 . . . . 0.0 109.656 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.48 35.33 47.59 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.0 pt -54.8 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -1.109 . . . . 0.0 110.207 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -53.53 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' ILE . 59.8 mtp180 -53.19 106.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.407 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.53 92.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.892 ' NH1' HG21 ' A' ' 80' ' ' VAL . 5.4 mtt-85 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.545 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.31 -59.32 7.98 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.229 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -61.42 -43.43 98.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.923 -1.339 . . . . 0.0 110.914 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.563 HG22 HG22 ' A' ' 76' ' ' VAL . 70.0 mt -60.58 -49.15 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.0 110.529 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.89 65.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.83 -1.169 . . . . 0.0 109.019 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.56 94.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.174 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.895 HG21 ' OH ' ' A' ' 56' ' ' TYR . 84.9 mt -60.61 -40.81 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 mp -58.18 -45.16 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.09 94.13 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -51.38 -44.09 62.06 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.054 -1.262 . . . . 0.0 108.965 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -64.54 -39.93 94.67 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.274 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.97 -37.74 61.46 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.29 70.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' ALA . 42.0 t80 -63.43 -43.43 97.49 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 103' ' ' LEU . 8.4 mp -63.56 -34.76 78.52 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.2 -37.26 84.64 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.329 -0.949 . . . . 0.0 109.546 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 99.1 mmm -70.71 -41.69 71.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 108.339 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.1 mm-40 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -58.75 -24.35 61.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.03 -12.56 28.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.96 24.03 74.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -120.52 101.83 45.8 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.358 -1.084 . . . . 0.0 109.584 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.88 150.23 73.17 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.145 1.897 . . . . 0.0 112.377 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 73.0 m-85 -58.05 -40.68 81.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.351 -0.843 . . . . 0.0 110.489 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.6 72.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.779 . . . . 0.0 112.442 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.93 -53.92 22.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 0.0 111.873 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 1.9 p90 -68.27 -40.93 81.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.006 -1.059 . . . . 0.0 111.658 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 117' ' ' TRP . 14.7 p -64.88 -48.93 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 110.377 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.619 ' N ' HG13 ' A' ' 116' ' ' VAL . 10.9 m95 -55.14 -27.5 45.88 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.3 t -71.8 -36.49 70.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.44 -0.787 . . . . 0.0 110.598 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -66.72 -28.78 68.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -97.25 19.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 20.0 m120 64.11 44.02 4.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.7 -0.625 . . . . 0.0 110.222 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 44.94 12.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 110.527 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mt-30 -131.16 149.92 75.07 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.208 -0.933 . . . . 0.0 109.267 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.444 ' HB2' HD21 ' A' ' 173' ' ' ASN . 32.8 Cg_endo -67.22 162.16 39.76 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.298 1.999 . . . . 0.0 111.722 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.65 135.39 49.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 109.673 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.2 mtt -90.31 116.45 28.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 109.093 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 127' ' ' THR . 1.2 m -89.89 111.4 22.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.209 -0.932 . . . . 0.0 109.1 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -92.51 17.53 9.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 109.286 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.07 141.9 57.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 134' ' ' GLU . 42.6 p -98.82 -11.37 21.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.669 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.408 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 23.7 p -145.34 160.09 42.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.29 -42.71 96.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -65.24 -31.78 73.11 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.494 ' OE1' ' OG1' ' A' ' 130' ' ' THR . 63.6 tt0 -80.85 1.47 30.56 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.597 -0.689 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.83 143.74 27.0 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 108.732 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.15 136.54 12.93 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.202 1.935 . . . . 0.0 112.414 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.3 p -107.17 2.99 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.019 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t -147.24 90.66 1.9 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.416 -0.802 . . . . 0.0 108.988 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.6 p -100.32 152.06 37.72 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.45 -36.6 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.582 1.521 . . . . 0.0 111.269 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -39.65 63.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.515 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 68.5 m -66.42 -46.73 75.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.6 -38.88 82.43 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.029 -1.044 . . . . 0.0 109.154 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.38 63.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -59.47 -46.33 89.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.05 -46.14 88.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.478 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -59.18 -37.91 78.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.752 -0.593 . . . . 0.0 109.614 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.07 68.6 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.286 -0.883 . . . . 0.0 109.854 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 91.9 mt -60.81 -36.4 78.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.6 -39.95 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.088 . . . . 0.0 108.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -65.73 -33.58 76.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 3.7 mmp_? -71.4 3.08 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 109.202 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.1 26.11 38.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.66 116.25 30.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.475 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -92.06 174.47 7.3 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.562 0.696 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 58.78 58.76 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.572 0.701 . . . . 0.0 109.772 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.2 OUTLIER -126.75 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.53 150.5 0.36 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.1 m -53.17 -29.47 31.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.315 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -74.24 -35.51 63.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -66.33 -36.74 78.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -69.48 -38.37 77.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.041 . . . . 0.0 109.394 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.497 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.66 -46.8 74.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.509 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 95.0 p -65.19 -33.34 75.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 108.824 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 49.4 t80 -59.25 -46.07 89.48 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.614 -0.679 . . . . 0.0 109.679 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.447 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 22.0 mtm -63.33 -38.0 89.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.69 ' NE2' HG21 ' A' ' 172' ' ' VAL . 84.0 mm-40 -60.44 -42.67 96.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.962 -1.086 . . . . 0.0 109.811 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.552 ' HB1' ' CE ' ' A' ' 34' ' ' MET . . . -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.411 -0.806 . . . . 0.0 109.983 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 66.9 m -58.36 -31.11 67.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.928 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.08 0.44 44.74 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 120' ' ' VAL . 95.8 mt -62.33 -28.72 69.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.969 . . . . 0.0 109.777 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.69 HG21 ' NE2' ' A' ' 167' ' ' GLN . 21.6 t -112.94 147.83 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.038 . . . . 0.0 110.544 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.444 HD21 ' HB2' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -125.57 164.34 20.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.2 m-20 76.58 70.39 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.665 -0.647 . . . . 0.0 110.457 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -47.24 -38.19 11.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 108.418 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 176' ' ' VAL . 3.5 p -166.04 18.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.62 HG23 ' C ' ' A' ' 176' ' ' VAL . 1.3 t 65.39 -44.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -83.48 29.6 3.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.444 -1.033 . . . . 0.0 109.721 -179.605 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.438 0.637 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.14 147.76 52.85 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.439 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.16 96.14 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 121.669 -0.644 . . . . 0.0 112.045 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -87.73 -0.68 57.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.486 -1.596 . . . . 0.0 110.124 -179.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.21 -44.56 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.141 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m -76.59 7.07 4.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 108.756 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 7.4 tt0 -91.99 -116.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.467 -0.771 . . . . 0.0 109.745 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.5 m-20 -79.41 154.79 76.72 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 108.962 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' O ' ' N ' ' A' ' 13' ' ' TYR . 19.4 Cg_endo -65.16 -160.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.438 2.092 . . . . 0.0 111.88 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' HD11 ' A' ' 47' ' ' ILE . 96.6 mt 61.96 -39.47 0.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.472 -0.768 . . . . 0.0 110.004 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.7 m-85 -63.4 -39.13 93.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.23 -43.73 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.624 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.49 -51.09 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.424 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.47 ' HA ' HD22 ' A' ' 19' ' ' ASN . 1.2 t80 -61.36 -41.52 97.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -70.53 -36.07 73.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.07 -5.04 58.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.081 -1.012 . . . . 0.0 111.008 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 85.5 m-20 -83.75 -77.01 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.692 -1.255 . . . . 0.0 110.492 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -153.18 55.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.687 ' CH2' ' CE2' ' A' ' 6' ' ' TRP . 6.7 t90 -103.07 73.65 1.25 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' H ' ' HD3' ' A' ' 24' ' ' PRO . . . 152.4 -20.71 0.83 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.637 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.712 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 7.9 m -123.4 7.1 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.429 -1.042 . . . . 0.0 113.18 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 71.7 Cg_endo -76.51 149.75 31.1 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.592 1.528 . . . . 0.0 113.416 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -91.88 166.01 12.95 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.606 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 10.5 p -91.71 107.84 19.49 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.481 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD21 ' A' ' 31' ' ' LEU . 96.2 m-20 -84.69 168.58 15.12 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 m -76.99 -41.5 42.64 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.845 -1.16 . . . . 0.0 111.558 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' CD ' ' OH ' ' A' ' 102' ' ' TYR . 26.9 mmtp -76.19 -42.8 45.13 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -58.46 -40.5 82.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.811 -1.18 . . . . 0.0 110.848 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.75 -40.26 79.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 109.712 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 102' ' ' TYR . 80.8 t80 -62.09 -47.76 83.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.57 -40.06 73.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.915 -1.116 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.57 -52.51 63.11 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.0 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.52 -28.21 44.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.037 -1.039 . . . . 0.0 110.132 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.34 -46.85 66.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.014 -1.054 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD12 HG13 ' A' ' 49' ' ' VAL . 4.6 mm? -69.29 -38.83 78.51 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 108.992 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -57.75 -36.29 71.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.414 -0.804 . . . . 0.0 109.253 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.7 -42.85 59.39 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' ALA . 62.6 tp60 -65.73 -32.56 74.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 0.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 40' ' ' GLN . 2.2 pp0? -41.89 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.005 -1.059 . . . . 0.0 109.688 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.98 -1.075 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 82.05 -35.62 2.55 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.309 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.0 mm? -95.7 144.39 26.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -1.214 . . . . 0.0 110.304 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.9 m -68.67 153.2 44.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 108.764 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.663 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -62.07 -37.0 83.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.003 -1.061 . . . . 0.0 109.81 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.56 -38.52 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.53 -1.356 . . . . 0.0 109.033 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 44' ' ' LEU . 75.1 m -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.643 HG13 HD12 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -63.01 -40.84 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.673 . . . . 0.0 109.401 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.85 -45.68 85.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.779 -1.201 . . . . 0.0 109.11 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -64.41 -37.15 86.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 108.401 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -59.66 -37.27 78.28 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.663 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 77.3 mtt180 -59.39 -39.78 84.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.012 -1.055 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.96 -45.23 78.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.216 -1.552 . . . . 0.0 110.732 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.714 HD22 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -81.69 -39.86 23.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.861 -1.149 . . . . 0.0 110.476 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.714 ' N ' HD22 ' A' ' 55' ' ' ASN . 54.2 t80 -60.88 -47.0 88.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.899 -1.125 . . . . 0.0 109.477 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.47 HH11 ' HG3' ' A' ' 57' ' ' ARG . 21.3 mmm-85 -63.08 -33.87 76.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.117 -0.989 . . . . 0.0 108.829 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.38 70.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.8 m -75.04 -43.3 54.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.039 -1.038 . . . . 0.0 111.448 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.083 . . . . 0.0 111.044 -178.833 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.973 ' O ' HG22 ' A' ' 68' ' ' VAL . 97.1 Cg_exo . . . . . 0 N--CA 1.487 1.103 0 N-CA-C 114.011 0.735 . . . . 0.0 114.011 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.39 -38.17 68.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.266 -1.521 . . . . 0.0 109.177 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.14 -32.87 74.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.99 -1.069 . . . . 0.0 110.379 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 65' ' ' PRO . 20.5 m -63.83 -37.25 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.209 -1.557 . . . . 0.0 108.96 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.6 -23.43 58.74 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.46 -9.04 36.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 68' ' ' VAL . 45.0 ttm -77.8 121.34 23.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 20.6 pt20 -95.49 176.7 6.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.23 -35.63 77.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.487 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 41.1 tp10 -54.05 -45.72 71.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.936 -1.102 . . . . 0.0 108.198 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -64.37 -38.13 89.95 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.574 0.702 . . . . 0.0 109.141 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.8 t -60.83 -38.64 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 110.183 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 3.7 pt-20 -72.93 -42.29 63.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.921 -1.112 . . . . 0.0 111.818 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.2 -38.18 63.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.691 -1.256 . . . . 0.0 110.417 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.726 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -67.11 -32.3 73.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.985 . . . . 0.0 109.829 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.8 t -49.71 -24.75 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -85.64 -6.66 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.132 -0.98 . . . . 0.0 108.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.573 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 97.1 m-20 -77.97 108.13 11.01 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.509 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 69.63 -15.49 0.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.698 . . . . 0.0 109.839 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 73.4 34.67 57.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.652 ' O ' ' N ' ' A' ' 87' ' ' ARG . 21.9 pt -46.3 176.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.432 -1.04 . . . . 0.0 109.41 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' ILE . 4.5 tt -52.29 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 85' ' ' ILE . 9.3 ptp180 -54.07 133.33 43.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.863 0.839 . . . . 0.0 110.342 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 4.0 m-70 175.15 65.94 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -46.05 -29.33 1.45 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 110.09 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.35 -61.06 5.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.01 -38.38 85.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.99 -44.43 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 110.043 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.422 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -57.69 -32.35 67.27 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.9 -1.125 . . . . 0.0 108.767 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' ' NE2' ' A' ' 93' ' ' GLN . . . -67.75 -37.7 82.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 0.0 109.437 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.1 -32.22 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.7 mm -59.12 -43.97 90.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 108.245 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.23 -29.86 76.34 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -58.62 -43.44 89.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.061 -1.258 . . . . 0.0 109.235 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -63.46 -44.55 94.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.86 -1.15 . . . . 0.0 109.449 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.29 -35.53 69.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.898 -1.126 . . . . 0.0 108.939 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.32 -28.89 64.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.048 -1.033 . . . . 0.0 108.398 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' CD ' ' A' ' 29' ' ' LYS . 80.8 t80 -64.33 -43.22 95.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.0 mp -65.05 -32.95 74.92 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.561 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 14.5 mm100 -59.4 -39.28 82.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.811 -1.155 . . . . 0.0 108.753 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.525 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 97.6 mmm -67.6 -40.27 84.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.996 -1.065 . . . . 0.0 109.049 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 109' ' ' GLY . 75.9 mm-40 -72.06 -42.24 66.47 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.413 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -57.71 -25.17 59.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.561 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 17.0 m120 -92.62 -10.08 38.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.69 23.64 73.96 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -116.53 105.07 50.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.142 -1.211 . . . . 0.0 109.934 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -56.18 152.28 38.92 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.35 2.034 . . . . 0.0 113.01 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.709 ' HB3' HD12 ' A' ' 31' ' ' LEU . 25.5 m-85 -62.42 -38.94 91.63 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.774 0.797 . . . . 0.0 110.706 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.62 -35.48 79.7 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.535 -0.728 . . . . 0.0 111.724 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.46 -43.42 98.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.65 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -74.93 -43.99 51.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.321 -1.487 . . . . 0.0 111.01 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.65 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 14.9 m -58.43 -49.38 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 120.073 -1.642 . . . . 0.0 109.053 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.2 m95 -55.94 -27.41 52.27 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.12 -0.988 . . . . 0.0 108.629 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m -70.58 -41.49 72.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.238 -0.914 . . . . 0.0 111.103 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 30.9 m-85 -67.02 -30.31 70.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.767 -1.208 . . . . 0.0 110.377 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -91.85 15.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 109.597 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.461 HD22 ' HG3' ' A' ' 123' ' ' GLN . 5.2 t30 59.89 36.08 21.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.84 . . . . 0.0 110.371 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 47.38 29.9 1.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -0.992 . . . . 0.0 109.821 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' A' ' 121' ' ' ASN . 2.6 mm-40 -131.94 148.33 69.43 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.092 -1.005 . . . . 0.0 109.881 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.82 149.37 86.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.51 2.14 . . . . 0.0 111.959 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 126' ' ' MET . 4.2 tm0? -115.34 139.49 49.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.0 109.835 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.555 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.1 mpp? -100.54 118.3 36.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.142 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -72.14 -35.47 69.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 109.21 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 54.4 41.09 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.126 -0.984 . . . . 0.0 109.837 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.53 145.58 29.39 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.47 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.4 p -106.96 -29.55 9.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.696 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 134' ' ' GLU . 24.0 p -134.77 165.67 24.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.658 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.87 -31.99 67.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.494 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -72.79 -10.96 60.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 109.577 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 131' ' ' THR . 79.9 mm-40 -100.92 10.74 40.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.9 mm -98.33 111.91 60.92 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.92 142.86 28.62 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.729 1.619 . . . . 0.0 111.779 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 48.6 p -110.99 7.57 21.63 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -135.14 95.48 3.31 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -116.58 154.42 49.16 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.92 -38.6 86.23 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.719 1.613 . . . . 0.0 111.488 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.27 -43.12 64.76 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.531 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.8 p -62.73 -39.03 92.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 108.651 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.57 -37.55 84.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -66.51 -39.04 88.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.721 -0.612 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 165' ' ' PHE . 5.7 mp -65.62 -40.07 92.18 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.998 -1.064 . . . . 0.0 109.517 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.503 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 14.5 m -59.85 -47.37 86.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.707 -1.246 . . . . 0.0 110.44 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -74.02 -38.03 64.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.867 -1.145 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.53 -43.19 70.08 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.558 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.03 -43.15 79.41 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.19 -0.944 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -64.33 -39.92 94.85 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.863 -1.148 . . . . 0.0 109.727 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -70.18 -26.37 63.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.673 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -76.23 1.85 14.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.056 -1.028 . . . . 0.0 108.38 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.06 26.94 29.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.77 116.03 31.56 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.768 -0.842 . . . . 0.0 108.811 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.12 171.12 9.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 56.47 61.22 2.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 0.0 108.938 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.6 m -139.89 40.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.45 173.72 0.04 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.5 m -59.17 -31.13 68.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.905 -0.762 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 50.4 p -72.36 -34.78 68.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 108.74 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.26 -44.34 97.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 108.813 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 146' ' ' SER . 87.7 m -62.71 -43.98 97.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.76 -44.93 76.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.897 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.522 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 15.9 m -59.62 -41.57 90.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 109.441 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.651 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 3.3 t80 -59.56 -47.29 86.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 109.767 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 76.1 mtp -63.42 -32.71 74.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.29 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -44.98 88.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 110.785 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 111.731 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -55.48 -23.61 26.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.95 -1.094 . . . . 0.0 110.441 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.91 -2.16 59.91 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.7 mt -62.79 -27.94 69.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.542 -0.975 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.85 133.07 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.117 -0.989 . . . . 0.0 109.46 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 19.3 m-80 -108.7 163.07 13.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.428 -0.795 . . . . 0.0 109.645 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 85.49 69.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.787 -0.57 . . . . 0.0 110.982 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.434 ' O ' HD11 ' A' ' 135' ' ' ILE . 3.4 m170 -55.69 -48.99 74.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 0.0 108.945 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 177' ' ' VAL . 5.7 m -139.33 30.19 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 109.588 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.5 t 52.58 105.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.74 45.0 6.57 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.33 . . . . 0.0 108.677 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.686 0.755 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.78 154.07 26.76 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.696 0.76 . . . . 0.0 109.508 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -52.85 -47.96 58.14 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.682 -0.636 . . . . 0.0 112.413 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.563 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -88.12 -0.52 57.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.433 -1.628 . . . . 0.0 110.496 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 17' ' ' HIS . 7.6 t -77.0 -41.03 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.858 -1.152 . . . . 0.0 109.241 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -71.7 -4.66 28.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 68.9 tp60 -60.62 -42.97 97.93 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.881 -0.512 . . . . 0.0 110.38 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -161.76 159.35 22.52 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.672 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.694 ' HA ' HD12 ' A' ' 14' ' ' ILE . 18.8 Cg_endo -63.29 -35.39 62.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.81 2.34 . . . . 0.0 112.483 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.5 mt -61.83 -39.59 92.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.31 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.536 ' OH ' ' CD1' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -64.48 -40.59 95.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.408 -0.807 . . . . 0.0 109.252 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 11' ' ' PRO . 50.4 mt -56.77 -40.01 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.11 76.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.835 -1.166 . . . . 0.0 109.587 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 2.0 t80 -65.68 -40.14 92.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.778 . . . . 0.0 110.17 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.421 ' CG ' HG21 ' A' ' 7' ' ' VAL . 47.4 t-80 -73.58 -35.53 65.44 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 110.791 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -80.51 -8.72 59.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.168 -0.957 . . . . 0.0 111.775 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 2.9 p30 -84.14 -58.0 2.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.52 -1.362 . . . . 0.0 110.849 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.2 mt-10 -148.69 -54.07 0.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.492 -1.38 . . . . 0.0 109.666 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.594 ' C ' ' O ' ' A' ' 20' ' ' GLU . 5.8 t90 2.24 66.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.592 0.711 . . . . 0.0 111.607 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 148.63 -21.35 1.32 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.286 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.6 m -119.31 3.09 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.623 0 O-C-N 121.62 -0.929 . . . . 0.0 112.814 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 84.7 Cg_endo -79.93 150.68 21.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.468 1.445 . . . . 0.0 112.837 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -97.98 168.41 10.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.621 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 36.8 p -91.8 118.0 30.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.708 -1.245 . . . . 0.0 110.29 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -108.06 144.47 35.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.9 m -59.99 -35.94 76.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.882 -1.136 . . . . 0.0 109.027 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.62 -50.2 22.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.689 -0.632 . . . . 0.0 110.316 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -27.31 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.84 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 116' ' ' VAL . 2.4 mp -66.86 -36.99 83.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.017 -1.052 . . . . 0.0 109.214 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.8 t80 -64.77 -48.43 74.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.62 -32.09 65.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.757 -1.214 . . . . 0.0 109.11 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -48.82 63.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.633 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.23 -27.8 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.423 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 97.9 m -69.19 -50.05 50.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.185 -0.947 . . . . 0.0 109.898 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' NE ' ' A' ' 53' ' ' ARG . 56.4 mt -67.95 -37.4 81.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.087 -1.008 . . . . 0.0 108.927 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -66.88 -39.15 87.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.623 -0.673 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.44 -35.86 92.31 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -72.23 -6.46 43.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -1.202 . . . . 0.0 109.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -77.04 -1.98 31.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -69.07 121.56 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 108.851 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.58 -31.83 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 42' ' ' ALA . 30.2 mt -101.48 144.09 30.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.117 . . . . 0.0 109.838 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -69.49 156.25 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -56.99 -36.5 70.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.173 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -35.49 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.428 HG21 HD22 ' A' ' 44' ' ' LEU . 83.5 m -59.24 -41.83 89.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.868 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -68.0 -32.56 56.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.132 -0.98 . . . . 0.0 109.492 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.94 -43.97 94.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.183 -0.948 . . . . 0.0 110.354 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.89 75.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 14.6 mtmm -78.89 -7.4 57.92 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.323 -0.861 . . . . 0.0 109.295 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.2 ttm180 -65.68 -46.86 77.49 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.7 -45.99 67.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.978 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.474 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 38.9 t30 -66.25 -43.16 87.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.537 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 68.9 t80 -59.79 -45.47 92.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.872 . . . . 0.0 110.94 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -61.76 -29.5 70.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.828 -1.17 . . . . 0.0 108.986 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -66.36 -36.21 82.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m -66.95 -45.22 78.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.827 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 44.8 m-85 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 34.2 Cg_endo . . . . . 0 N--CA 1.495 1.595 0 N-CA-C 113.455 0.521 . . . . 0.0 113.455 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.875 HG22 HD21 ' A' ' 103' ' ' LEU . 91.5 t -61.52 -45.93 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.917 -1.115 . . . . 0.0 110.156 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.14 -37.8 86.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.403 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.63 -36.91 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.216 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -65.1 -18.94 65.72 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.84 -7.88 57.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 96' ' ' ILE . 98.3 mtp -82.99 113.15 20.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.88 177.59 5.72 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.29 -31.78 61.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.224 -0.922 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 -45.08 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 108.237 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -64.27 -38.67 91.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG13 ' CG2' ' A' ' 92' ' ' ILE . 86.9 t -61.23 -42.7 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.423 -0.798 . . . . 0.0 109.856 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.6 -44.22 89.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.519 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 2.4 ptp180 -75.78 -33.62 60.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.857 -1.152 . . . . 0.0 110.001 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -61.6 -32.83 72.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.299 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.6 t -49.3 -34.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 108.662 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.84 -1.02 30.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.6 t0 -80.7 108.82 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.447 -1.408 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.27 -12.21 1.05 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.438 -0.788 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.07 33.29 45.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt -57.47 -166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -1.213 . . . . 0.0 109.332 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.01 95.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.155 -0.965 . . . . 0.0 109.129 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -57.66 109.65 0.75 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.714 0.769 . . . . 0.0 109.34 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 1.8 m80 -178.14 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -50.32 -31.59 14.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.318 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.71 -62.52 6.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -64.52 -40.82 96.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.785 -1.42 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG13 ' A' ' 76' ' ' VAL . 82.9 mt -61.17 -48.91 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.085 -1.01 . . . . 0.0 110.449 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.56 -29.22 66.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.661 -1.275 . . . . 0.0 108.953 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.448 ' N ' ' HG3' ' A' ' 93' ' ' GLN . . . -64.3 -37.59 88.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.45 -40.16 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 71' ' ' MET . 20.6 mm -59.93 -43.01 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 108.76 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.93 -35.91 88.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.12 -37.03 76.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -1.118 . . . . 0.0 109.163 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.05 -44.91 87.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.981 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 27.8 mmt180 -60.62 -38.16 83.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.093 -1.004 . . . . 0.0 109.446 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.84 71.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 108.593 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.53 -43.74 96.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.875 HD21 HG22 ' A' ' 66' ' ' VAL . 77.5 mt -63.62 -32.66 74.21 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.22 -35.11 79.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.305 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.59 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.1 tpp -63.8 -43.6 95.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.492 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -37.02 78.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.24 -24.71 66.56 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.519 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.1 m120 -93.21 -15.05 26.35 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.91 27.17 73.71 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.442 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' A' ' 105' ' ' MET . 2.0 tt0 -121.52 102.21 42.55 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.136 -1.214 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.53 141.6 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.933 1.755 . . . . 0.0 112.641 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -56.08 -38.76 71.11 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.229 1.014 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.36 -27.76 66.53 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.708 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -68.09 -48.44 65.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.095 . . . . 0.0 111.969 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.633 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.2 p90 -70.8 -37.37 73.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.763 -1.211 . . . . 0.0 110.943 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 145' ' ' LEU . 24.5 m -62.29 -49.05 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.382 -1.449 . . . . 0.0 109.956 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.621 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 26.4 m95 -56.56 -27.1 56.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.2 t -75.73 -36.69 59.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.253 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.2 -26.02 65.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.965 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -96.64 19.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.717 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 69.28 35.93 2.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.765 . . . . 0.0 110.557 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 117' ' ' TRP . 1.1 t-80 45.01 30.23 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.393 -0.817 . . . . 0.0 111.344 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.66 147.99 20.04 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.637 -1.29 . . . . 0.0 110.134 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.05 148.6 85.72 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.613 2.209 . . . . 0.0 111.93 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.623 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -122.06 128.37 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.623 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.2 mtt -103.35 120.73 41.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -87.73 -26.43 22.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.439 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 57.03 45.35 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.77 149.4 50.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.469 ' C ' HG23 ' A' ' 176' ' ' VAL . 53.3 p -102.9 -25.1 13.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.051 -1.031 . . . . 0.0 109.412 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 p -136.17 162.66 32.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.158 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.31 -37.04 79.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 108.945 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.2 m -62.75 -31.42 72.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.372 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -75.19 -0.66 20.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 110.081 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.6 tp -76.46 125.57 87.35 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.999 -1.063 . . . . 0.0 108.314 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 163' ' ' TYR . 55.9 Cg_endo -74.94 136.4 20.48 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.926 1.75 . . . . 0.0 112.454 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.5 p -114.37 6.53 16.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.0 t -152.16 88.28 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.432 -0.792 . . . . 0.0 109.448 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.532 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.7 OUTLIER -102.43 155.4 36.55 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.74 -38.96 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.727 1.618 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.52 -42.06 59.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 139' ' ' THR . 88.2 p -65.86 -39.03 90.35 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.525 -0.735 . . . . 0.0 109.443 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.31 -44.77 86.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.195 -0.941 . . . . 0.0 109.144 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.08 74.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -55.37 -43.78 75.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.656 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.96 -39.29 83.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.168 -0.957 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.45 -43.79 88.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 110.389 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.581 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.49 -45.98 74.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.43 -38.05 89.66 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.88 -40.24 94.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.971 -1.081 . . . . 0.0 110.242 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 153' ' ' GLY . 18.4 mttp -65.28 -38.56 90.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 111.641 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.581 HH21 ' HB1' ' A' ' 148' ' ' ALA . 8.2 mtm180 -71.27 9.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 0.0 110.085 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 76.04 26.14 65.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.97 112.61 24.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 157' ' ' VAL . 34.8 mtmt -93.1 176.62 6.34 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 57.58 54.9 6.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.451 -0.781 . . . . 0.0 109.2 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.3 m -139.16 38.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.57 164.36 0.52 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.9 m -53.98 -34.42 59.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.499 -1.001 . . . . 0.0 109.431 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.5 ' O ' ' OG ' ' A' ' 164' ' ' SER . 32.8 m -68.62 -37.25 79.58 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.1 -44.31 98.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.656 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.1 m -58.05 -51.56 69.17 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -71.66 -37.88 70.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 0.0 111.733 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 160' ' ' THR . 13.4 m -59.12 -40.73 86.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 111.131 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.4 OUTLIER -78.36 -35.47 47.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 110.569 -179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.4 mtp -57.92 -36.15 72.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.657 -1.277 . . . . 0.0 109.291 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.66 -42.42 98.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.34 -37.8 22.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.536 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -26.12 48.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.273 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.54 -2.39 57.38 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -37.36 73.74 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.243 -1.151 . . . . 0.0 108.753 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 0.9 OUTLIER -137.2 129.66 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 109.063 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.457 ' C ' ' CG ' ' A' ' 174' ' ' ASP . 37.9 t-20 -104.98 125.23 50.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.371 -0.831 . . . . 0.0 108.878 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -178.98 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.895 -1.128 . . . . 0.0 111.587 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.566 ' H ' ' CD2' ' A' ' 175' ' ' HIS . 3.2 m170 -48.96 -52.12 26.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.97 -1.706 . . . . 0.0 107.13 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 130' ' ' THR . 15.0 p 178.03 150.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 129' ' ' ALA . 27.6 t -62.21 135.37 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.893 -1.129 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.76 38.85 12.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.552 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.125 -1.221 . . . . 0.0 109.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 4' ' ' CYS . 26.9 ttm180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 3' ' ' ARG . 4.3 m -42.35 149.3 0.17 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -0.865 . . . . 0.0 109.248 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.29 -33.58 61.59 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 121.153 -0.967 . . . . 0.0 112.75 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.572 ' CD1' HG13 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -85.56 2.1 46.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.298 -1.707 . . . . 0.0 111.759 -177.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 6' ' ' TRP . 16.7 m -110.57 -45.24 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 109.971 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 7' ' ' VAL . 88.7 p -65.25 -17.43 64.49 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -65.43 -40.68 93.6 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.873 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.18 163.21 24.3 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.933 . . . . 0.0 109.845 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 13' ' ' TYR . 35.7 Cg_endo -68.92 -161.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.943 2.429 . . . . 0.0 112.51 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 5.9 mt 62.54 -54.86 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.774 -0.579 . . . . 0.0 109.555 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -57.15 -45.76 83.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.279 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.415 HG12 HH11 ' A' ' 3' ' ' ARG . 85.9 mt -54.68 -42.86 63.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.733 -0.605 . . . . 0.0 110.585 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.13 98.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.711 -1.243 . . . . 0.0 108.419 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.658 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.0 t80 -71.67 -31.47 66.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.623 0.725 . . . . 0.0 110.001 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -64.14 -44.68 91.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 112.382 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.69 -4.52 37.1 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.717 -1.239 . . . . 0.0 112.815 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.763 HD22 ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -96.01 -15.68 22.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.462 -1.399 . . . . 0.0 112.243 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.763 ' N ' HD22 ' A' ' 19' ' ' ASN . 14.0 pt-20 177.07 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.728 -1.232 . . . . 0.0 109.276 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.458 ' CH2' ' CZ2' ' A' ' 6' ' ' TRP . 4.8 t90 -131.88 83.52 2.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.186 0.993 . . . . 0.0 108.887 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.3 -20.31 11.33 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.701 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 28.9 m -110.71 -12.38 0.12 Allowed Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 112.957 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 75.5 Cg_endo -80.05 150.68 20.68 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.358 1.372 . . . . 0.0 114.122 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -96.18 159.75 14.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.759 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.7 p -86.72 111.48 20.74 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.566 -1.334 . . . . 0.0 110.886 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.906 ' O ' HD13 ' A' ' 31' ' ' LEU . 70.1 m-20 -94.24 156.73 16.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -67.4 -39.71 85.59 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.565 -1.334 . . . . 0.0 110.282 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -75.19 -50.12 17.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 111.804 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -61.3 -30.1 70.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.589 -1.319 . . . . 0.0 109.19 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 27' ' ' ASP . 4.7 mp -57.14 -39.56 75.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.092 -1.005 . . . . 0.0 108.45 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.572 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 63.2 t80 -63.25 -45.46 91.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.467 -0.771 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -67.45 -40.69 85.42 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.827 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.4 tpp -65.07 -52.55 54.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.451 -0.781 . . . . 0.0 110.223 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.75 -27.17 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 109.03 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 47.7 m -70.57 -52.4 21.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' NE ' ' A' ' 53' ' ' ARG . 48.3 mt -66.79 -39.23 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 108.764 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' OE2' ' CB ' ' A' ' 164' ' ' SER . 13.3 tp10 -64.19 -37.72 88.49 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.642 -0.661 . . . . 0.0 109.865 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.51 -33.14 70.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 25.6 mm-40 -81.71 -1.45 47.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.514 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -78.78 -2.25 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.015 . . . . 0.0 109.323 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.71 113.84 10.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 87.26 -34.63 3.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -95.62 145.43 25.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -1.095 . . . . 0.0 109.63 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -71.97 152.88 42.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 109.203 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.658 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 2.5 t-105 -59.64 -28.9 67.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 110.161 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -29.36 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.564 -1.335 . . . . 0.0 109.487 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 44' ' ' LEU . 72.7 m -68.54 -44.04 75.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.112 -0.992 . . . . 0.0 108.829 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 46' ' ' TRP . 1.3 p -63.69 -26.08 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -54.98 -43.94 74.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -63.92 -37.04 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HA ' HD21 ' A' ' 55' ' ' ASN . 7.6 ttpp -63.12 -36.88 85.08 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NE ' HD13 ' A' ' 37' ' ' LEU . 37.2 ttm180 -57.93 -46.53 84.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.803 -0.561 . . . . 0.0 111.769 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 55' ' ' ASN . 15.2 pt-20 -72.5 -44.32 62.4 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.787 -1.196 . . . . 0.0 110.727 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.742 HD22 ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -73.06 -32.17 64.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.746 -1.221 . . . . 0.0 109.396 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.742 ' N ' HD22 ' A' ' 55' ' ' ASN . 71.4 t80 -58.57 -46.5 86.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 109.525 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -65.05 -32.13 73.7 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.014 -1.075 . . . . 0.0 109.034 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.15 99.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.863 -1.148 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.579 ' HB3' HD22 ' A' ' 79' ' ' LEU . 51.4 m -77.49 -44.6 28.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 109.675 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.659 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 96.8 m-85 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.53 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.491 1.325 0 CA-C-O 120.95 0.312 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.63 -43.24 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.606 -1.309 . . . . 0.0 108.302 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -65.73 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 96' ' ' ILE . 69.6 t -60.7 -38.72 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 108.825 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.37 -14.53 63.01 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -93.5 -12.37 29.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.473 ' O ' HG21 ' A' ' 96' ' ' ILE . 90.8 mtp -76.74 110.31 11.23 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.578 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -96.8 -174.75 3.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.408 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -55.38 -30.59 60.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.813 -0.554 . . . . 0.0 110.791 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.0 pt-20 -60.6 -42.22 96.32 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.119 -1.613 . . . . 0.0 109.452 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' CG ' ' A' ' 74' ' ' GLU . 90.3 m-20 -66.92 -38.92 87.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -67.19 -36.22 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.838 -1.164 . . . . 0.0 109.71 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 80' ' ' VAL . 99.2 mt-10 -59.36 -36.31 75.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.712 -1.242 . . . . 0.0 107.794 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.4 ttm-85 -70.32 -42.03 72.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.568 -0.708 . . . . 0.0 110.304 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 59' ' ' CYS . 94.3 mt -69.76 -34.66 74.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.423 -0.798 . . . . 0.0 112.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.9 m -50.1 -16.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.521 -1.362 . . . . 0.0 108.868 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' LEU . 23.0 pt20 -120.87 -4.43 9.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.203 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -81.5 109.58 16.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.691 -1.256 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.6 -17.02 0.54 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.456 -0.778 . . . . 0.0 109.3 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 80.47 32.36 34.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 79' ' ' LEU . 15.5 pt -54.48 -179.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.02 -1.282 . . . . 0.0 109.332 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 86' ' ' ILE . 12.4 tt -60.82 89.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.587 ' O ' ' CD2' ' A' ' 88' ' ' HIS . 6.2 ptp180 -56.06 144.24 29.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 111.115 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 159.14 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 89' ' ' ARG . 1.1 mtt-85 -51.02 -38.07 49.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.424 -0.797 . . . . 0.0 108.941 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.13 -49.19 59.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.34 -45.08 94.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -1.133 . . . . 0.0 110.056 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.75 -44.12 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.069 -1.019 . . . . 0.0 109.726 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.616 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 44.5 mt-30 -54.64 -34.05 61.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.862 -1.149 . . . . 0.0 108.995 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.65 99.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.59 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.556 HG21 ' OH ' ' A' ' 56' ' ' TYR . 32.1 mm -61.93 -39.15 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 109.115 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 71' ' ' MET . 12.3 mm -59.67 -43.1 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 108.912 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.44 -32.86 85.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.52 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 m120 -61.2 -41.44 96.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.157 . . . . 0.0 109.842 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.91 98.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.49 -40.21 95.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.253 -0.904 . . . . 0.0 109.269 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.4 -34.58 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.35 -43.12 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.0 -33.2 75.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -62.91 -37.44 86.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 109.583 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 24.0 ttm -62.86 -40.89 98.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.994 -1.066 . . . . 0.0 108.447 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.04 -35.27 79.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -64.88 -20.96 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -92.28 -17.63 24.49 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.76 73.61 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.35 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.583 ' O ' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -116.92 107.37 46.12 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.88 144.47 15.17 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.83 1.687 . . . . 0.0 112.637 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.59 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -61.65 -44.52 96.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.893 0.854 . . . . 0.0 109.917 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.29 -27.68 62.62 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.019 -1.051 . . . . 0.0 111.192 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -62.85 -49.01 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.835 -1.166 . . . . 0.0 111.118 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.2 p90 -72.04 -34.4 68.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.816 -1.178 . . . . 0.0 110.022 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.725 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 2.3 t -63.05 -54.86 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.749 -1.219 . . . . 0.0 109.87 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.63 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 57.5 m95 -59.32 -22.2 60.89 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.072 -1.017 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -66.68 -45.05 80.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 110.406 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.647 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.1 m-85 -67.92 -29.14 68.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.094 -1.004 . . . . 0.0 109.918 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.578 HG21 HD22 ' A' ' 171' ' ' LEU . 7.2 t -87.26 18.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.525 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 123' ' ' GLN . 75.4 m-20 60.86 39.76 16.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.436 0.636 . . . . 0.0 110.007 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 42.05 25.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.404 -0.81 . . . . 0.0 110.536 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -145.66 148.28 36.02 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 120.933 -1.104 . . . . 0.0 109.511 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 19.1 Cg_endo -62.98 146.8 94.94 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.278 1.986 . . . . 0.0 111.434 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -103.59 137.63 41.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.6 mtt -93.02 120.01 32.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.427 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -88.26 120.37 29.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -91.0 16.63 9.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.03 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.57 136.49 49.31 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.7 p -99.07 -22.21 15.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.544 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 p -136.41 165.6 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -0.931 . . . . 0.0 109.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.1 mt -59.26 -34.39 72.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.046 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.3 m -69.79 -11.96 61.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -0.792 . . . . 0.0 109.697 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.09 6.44 47.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 mm -97.3 118.09 64.89 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.23 137.95 19.64 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.943 1.762 . . . . 0.0 112.227 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.2 p -95.71 4.21 53.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.6 t -137.8 95.3 3.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 32.4 p -109.27 150.83 41.58 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.35 -36.03 77.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.579 1.519 . . . . 0.0 111.432 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.15 -43.23 58.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.248 -0.908 . . . . 0.0 108.858 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.406 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 95.6 p -65.16 -39.9 93.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 109.723 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.9 -37.59 85.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.57 -37.26 86.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 109.91 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.62 -46.42 87.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.017 -1.052 . . . . 0.0 109.054 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.6 t -62.1 -43.18 99.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 110.149 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -62.52 -45.43 93.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.45 -44.73 67.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.99 -36.67 80.39 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.245 -0.91 . . . . 0.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -60.45 -38.65 84.85 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.705 -1.247 . . . . 0.0 108.581 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.73 -19.94 54.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.572 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -78.97 0.9 25.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.119 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.42 26.64 32.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.52 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 1.3 m-85 -101.11 113.51 26.6 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.38 -1.071 . . . . 0.0 109.575 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -91.81 173.9 7.62 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 55.73 45.27 24.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.089 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.3 p -132.09 49.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.42 177.1 6.07 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 54.9 m -58.6 -32.67 69.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.588 -0.948 . . . . 0.0 110.178 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.6 p -72.82 -28.25 62.44 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.917 -1.114 . . . . 0.0 109.061 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.2 mm -68.03 -45.31 83.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 110.152 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 159' ' ' THR . 3.1 p -65.89 -36.87 84.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.454 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.09 -45.97 79.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.454 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.4 m -61.98 -39.1 91.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.075 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -59.2 -41.09 87.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.082 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.415 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 73.2 mtp -62.51 -39.75 94.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -74.29 -39.21 63.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.823 -1.173 . . . . 0.0 111.455 -178.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 167' ' ' GLN . . . -79.22 -40.2 31.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 110.889 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 166' ' ' MET . 21.6 p -60.51 -28.77 68.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.99 2.57 42.27 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 120' ' ' VAL . 35.1 mt -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.74 143.32 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.209 -0.932 . . . . 0.0 109.583 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 34.7 m120 -111.41 163.54 13.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.437 -0.79 . . . . 0.0 110.205 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER 83.28 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.242 0.544 . . . . 0.0 109.947 179.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -50.95 -44.47 60.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 108.7 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.646 ' C ' ' H ' ' A' ' 178' ' ' GLY . 30.6 m -149.5 28.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.412 -0.805 . . . . 0.0 109.624 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 129' ' ' ALA . 46.2 t 60.56 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.415 -0.803 . . . . 0.0 110.409 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -137.3 60.05 0.62 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.283 -1.128 . . . . 0.0 110.107 -179.432 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.466 HH11 ' HG3' ' A' ' 3' ' ' ARG . 28.3 mtm-85 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.523 0.678 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.45 141.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.558 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.19 94.91 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.543 -0.723 . . . . 0.0 112.097 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -84.55 1.32 46.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.642 -1.504 . . . . 0.0 109.887 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.526 HG13 HD13 ' A' ' 14' ' ' ILE . 1.8 t -83.81 -50.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -67.99 -3.82 11.25 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.86 -39.31 94.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.404 0.621 . . . . 0.0 109.587 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -174.01 158.47 2.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.41 -0.807 . . . . 0.0 109.208 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' TYR . 12.0 Cg_endo -57.46 -161.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.478 2.119 . . . . 0.0 111.742 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -52.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 11' ' ' PRO . 14.1 m-85 -60.38 -31.66 70.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.131 -0.98 . . . . 0.0 108.893 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.526 HD13 HG13 ' A' ' 7' ' ' VAL . 7.8 mm -56.26 -40.33 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.98 -50.47 28.49 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.182 -0.949 . . . . 0.0 109.82 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 42.7 t80 -63.13 -40.78 98.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 110.579 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 7' ' ' VAL . 34.8 t-80 -60.28 -43.9 95.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.035 -1.041 . . . . 0.0 109.835 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -82.09 -14.48 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.419 -0.801 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.771 ' ND2' ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -79.28 -57.18 3.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.528 -1.357 . . . . 0.0 110.597 -178.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.771 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 2.2 pt-20 -175.45 78.82 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.596 -1.315 . . . . 0.0 110.03 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CZ3' ' NE1' ' A' ' 6' ' ' TRP . 7.7 t90 -100.77 68.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.01 -1.056 . . . . 0.0 108.523 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.55 9.75 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 96.9 t -111.01 -30.88 0.14 Allowed Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.649 -0.912 . . . . 0.0 111.927 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 67.7 Cg_endo -86.17 154.07 9.58 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.543 2.162 . . . . 0.0 113.539 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -65.93 170.5 5.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.585 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 4.8 p -92.13 124.6 36.34 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.811 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.601 ' O ' HD13 ' A' ' 31' ' ' LEU . 66.1 m-20 -102.48 149.13 24.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -65.07 -38.8 91.98 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.825 -1.172 . . . . 0.0 110.576 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -72.87 -50.71 22.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 111.61 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -63.34 -33.37 75.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.647 -1.283 . . . . 0.0 109.496 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 27' ' ' ASP . 5.1 mp -61.3 -39.13 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.267 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -59.29 -41.79 89.77 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.106 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CD ' ' NH2' ' A' ' 57' ' ' ARG . 40.5 mt-10 -71.68 -36.26 70.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.114 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.628 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -64.99 -47.15 78.56 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 111.377 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -65.98 -36.12 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.733 -1.23 . . . . 0.0 110.038 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m -70.17 -38.81 75.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.019 -1.05 . . . . 0.0 109.261 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' GLU . 3.1 mp -66.79 -44.59 80.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.489 -0.757 . . . . 0.0 109.817 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -67.83 -32.3 72.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.36 -33.58 32.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 42' ' ' ALA . 56.3 tp60 -75.44 -35.46 60.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.422 -1.046 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.613 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -44.15 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.314 -0.866 . . . . 0.0 110.741 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -60.68 112.78 2.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.677 -1.264 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.0 -36.83 2.13 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.602 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.8 mt -91.64 146.71 23.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.088 -1.242 . . . . 0.0 110.529 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.1 m -69.71 156.15 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -62.72 -37.8 87.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 110.297 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -63.52 -39.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 109.733 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -58.8 -38.31 78.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.899 -1.126 . . . . 0.0 108.198 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.3 t -64.34 -37.58 80.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.601 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.67 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.1 tt -55.73 -47.15 77.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -61.91 -46.97 87.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.947 -1.096 . . . . 0.0 109.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.04 -11.81 59.85 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.942 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.674 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 38.4 ttm180 -63.19 -46.12 88.53 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.67 -41.62 68.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.009 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.945 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -70.04 -45.2 67.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.063 . . . . 0.0 111.054 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 49.8 t80 -60.86 -48.47 81.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.897 -1.127 . . . . 0.0 110.523 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.522 ' NH2' ' CD ' ' A' ' 33' ' ' GLU . 16.7 mmm180 -57.77 -31.95 67.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.06 65.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.832 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.1 m -73.16 -26.06 61.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 112.189 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 79.6 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 120.536 -1.353 . . . . 0.0 111.336 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.491 1.349 0 CA-C-O 120.994 0.331 . . . . 0.0 112.853 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 HD21 ' A' ' 103' ' ' LEU . 76.8 t -72.79 -37.35 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.887 -1.133 . . . . 0.0 108.856 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -35.73 66.38 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.6 t -59.52 -38.82 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.32 -16.44 63.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.97 -5.13 53.62 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.8 mmm -79.3 116.78 19.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 2.8 pt20 -95.67 177.33 5.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.5 mt-10 -59.41 -35.04 73.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.812 . . . . 0.0 110.304 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.6 tt0 -58.4 -46.44 86.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.807 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -64.93 -38.88 92.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.836 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 92' ' ' ILE . 46.3 t -56.55 -43.54 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.45 -0.781 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.28 -39.18 92.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.508 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 28.7 ttm-85 -60.81 -39.27 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 108.733 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' N ' ' A' ' 81' ' ' GLN . 80.2 mt -68.97 -33.24 73.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.652 -0.655 . . . . 0.0 110.874 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.11 -18.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 108.675 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.3 mt-30 -118.76 -11.47 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 17.5 t70 -79.47 109.75 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 72.73 -19.01 0.32 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 64.2 35.47 92.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.945 HG22 ' ND2' ' A' ' 55' ' ' ASN . 3.5 pt -31.81 -105.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.208 -0.583 . . . . 0.0 111.823 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 87' ' ' ARG . 6.4 tt -161.44 -48.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.685 -1.259 . . . . 0.0 110.218 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.634 ' N ' HG23 ' A' ' 86' ' ' ILE . 9.2 mtt180 -63.33 149.04 46.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.001 -1.062 . . . . 0.0 109.409 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' ARG . 88.8 m-70 -108.04 167.74 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 109.765 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -43.33 -40.74 3.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.136 -0.977 . . . . 0.0 109.992 -179.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.23 -59.26 7.56 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.303 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.55 -40.18 96.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -1.086 . . . . 0.0 110.193 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.514 HG21 HG13 ' A' ' 76' ' ' VAL . 85.2 mt -59.66 -52.91 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 110.1 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.599 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 39.1 mt-30 -52.41 -33.81 45.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.906 -1.121 . . . . 0.0 110.099 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.57 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.874 -1.141 . . . . 0.0 109.226 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.624 HG21 ' OH ' ' A' ' 56' ' ' TYR . 96.2 mt -72.09 -32.56 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.0 -42.61 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.542 -1.348 . . . . 0.0 108.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.93 72.69 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.66 -43.37 96.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -1.184 . . . . 0.0 109.945 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.92 73.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.048 -1.032 . . . . 0.0 108.787 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -61.54 -35.67 78.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.804 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.685 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.76 -32.23 73.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 108.649 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -64.48 -43.17 95.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 103' ' ' LEU . 39.0 mt -61.14 -27.75 68.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -68.06 -38.18 82.15 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.697 0.76 . . . . 0.0 109.245 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.571 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 34.5 ttm -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.942 0.877 . . . . 0.0 108.95 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.0 -36.89 85.07 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.48 -25.69 66.23 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -91.12 -12.27 36.07 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.57 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.93 27.51 73.64 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.48 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -117.37 102.8 52.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.84 144.18 21.49 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.024 1.816 . . . . 0.0 112.813 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -55.46 -40.66 71.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.033 0.921 . . . . 0.0 108.989 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.23 -27.09 64.19 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 110.494 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.96 -53.6 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.905 -1.122 . . . . 0.0 111.202 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.5 p90 -70.73 -32.61 69.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.953 -1.092 . . . . 0.0 109.611 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -64.96 -54.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.16 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.585 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 54.3 m95 -57.36 -26.72 61.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 108.532 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 66.3 p -77.68 -31.53 52.57 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.322 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -68.78 -32.32 71.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -88.61 18.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 66.36 27.4 10.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.867 . . . . 0.0 109.534 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 51.19 33.11 8.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.454 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.512 ' H ' HG13 ' A' ' 120' ' ' VAL . 15.1 mm100 -137.09 150.0 68.02 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.22 145.67 39.31 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.488 2.126 . . . . 0.0 111.847 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.509 ' NE2' ' N ' ' A' ' 126' ' ' MET . 2.2 tm0? -108.15 129.2 55.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.509 ' N ' ' NE2' ' A' ' 125' ' ' GLN . 9.0 mtm -117.7 108.48 15.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.068 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.509 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -102.68 128.74 49.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.099 -1.0 . . . . 0.0 109.271 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.86 34.58 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.097 -1.002 . . . . 0.0 110.607 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -58.32 145.82 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 108.762 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.1 p -91.84 -15.22 28.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.065 -1.022 . . . . 0.0 110.343 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -142.46 162.9 34.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 109.685 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.0 mt -59.61 -33.05 70.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -65.42 -29.09 69.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.329 -0.857 . . . . 0.0 110.886 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.601 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.1 mm-40 -85.49 -1.8 57.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.996 -1.065 . . . . 0.0 109.854 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -80.14 143.78 57.43 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 108.851 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.67 142.94 40.89 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.423 2.082 . . . . 0.0 112.848 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 t -125.55 4.89 7.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.9 p -157.41 87.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 163.56 16.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.509 -0.745 . . . . 0.0 109.054 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.18 -39.72 85.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.702 1.601 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.67 -43.18 66.48 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.109 -1.036 . . . . 0.0 108.549 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 p -63.51 -44.07 95.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.25 -37.55 85.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.078 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.4 95.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 109.798 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.11 -45.54 75.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -59.0 -40.23 84.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.748 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -62.68 -49.42 75.2 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 110.653 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.69 76.81 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.121 -0.987 . . . . 0.0 109.473 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.445 ' HG ' HH21 ' A' ' 152' ' ' ARG . 32.5 mt -66.91 -39.74 87.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -0.902 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -38.78 87.75 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.754 -1.216 . . . . 0.0 110.34 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -84.62 -14.68 47.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 111.948 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.685 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 85.9 mtm180 -88.53 8.2 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.687 -1.258 . . . . 0.0 109.521 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.37 21.04 53.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -100.99 110.37 22.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 108.6 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -93.68 175.13 6.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 57.18 57.59 4.43 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.106 0.955 . . . . 0.0 109.124 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 157' ' ' VAL . 12.4 m -128.91 42.27 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.24 162.7 0.4 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.7 m -53.65 -29.49 38.6 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -1.089 . . . . 0.0 108.921 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -73.52 -32.29 64.15 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 108.547 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 157' ' ' VAL . 45.6 mm -62.57 -45.74 98.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.48 -0.762 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.64 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.525 -0.734 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.95 -45.94 72.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 0.0 109.692 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 97.0 p -68.81 -31.13 69.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 108.414 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.579 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 79.5 t80 -64.3 -48.0 77.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.864 -0.522 . . . . 0.0 110.277 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ptm -72.91 -32.35 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -58.18 -42.18 85.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.701 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -92.98 -32.97 14.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 111.136 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 76.3 m -54.62 -24.09 19.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.864 -1.147 . . . . 0.0 110.517 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.82 0.56 48.96 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 116' ' ' VAL . 76.7 mt -63.66 -34.0 76.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.34 -1.094 . . . . 0.0 110.165 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.1 147.52 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.093 0.949 . . . . 0.0 111.003 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.85 103.52 9.42 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 127' ' ' THR . 58.9 p30 -173.86 70.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.067 -1.021 . . . . 0.0 111.284 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.635 ' C ' HG12 ' A' ' 176' ' ' VAL . 30.8 m170 -57.95 -43.09 86.19 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.58 -1.325 . . . . 0.0 108.244 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 168.23 3.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.454 ' H ' ' H ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER 71.87 -35.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -83.8 11.92 54.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.043 . . . . 0.0 109.344 -179.661 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.526 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 56.1 mtp180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.806 0.812 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.29 146.85 2.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.9 80.47 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.429 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.56 ' CZ2' ' CH2' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.617 -1.519 . . . . 0.0 110.461 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.22 -41.9 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.907 -1.121 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.6 m -79.4 5.7 12.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 108.872 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.72 -60.48 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.763 . . . . 0.0 109.973 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.16 157.04 75.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HA ' HD12 ' A' ' 14' ' ' ILE . 27.6 Cg_endo -65.92 -30.32 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.584 2.189 . . . . 0.0 112.143 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 47' ' ' ILE . 71.4 mt -62.69 -37.34 86.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 -39.93 95.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.136 -0.978 . . . . 0.0 109.27 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 11' ' ' PRO . 32.0 mt -54.68 -44.51 70.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.474 -0.766 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.93 -47.93 73.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.728 -1.232 . . . . 0.0 109.224 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.7 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.7 t80 -62.12 -40.74 96.93 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.913 0.863 . . . . 0.0 108.805 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -71.48 -39.22 71.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -78.46 -5.9 53.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.189 -0.944 . . . . 0.0 111.863 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 87.1 m-20 -76.87 -75.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.527 -1.358 . . . . 0.0 110.001 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 21' ' ' TRP . 96.0 mt-10 -145.56 -40.96 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.139 -0.975 . . . . 0.0 108.724 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.592 ' C ' ' O ' ' A' ' 20' ' ' GLU . 6.4 t90 -4.68 74.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.106 0.955 . . . . 0.0 111.084 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 149.47 -25.32 1.22 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 19.6 m -120.06 4.01 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.575 -0.956 . . . . 0.0 112.766 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 69.8 Cg_endo -75.69 147.21 31.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.174 1.25 . . . . 0.0 112.987 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.68 166.37 13.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.619 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 7.6 p -99.32 108.84 21.47 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.338 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -89.32 167.17 13.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 m -73.13 -37.33 66.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.474 -1.391 . . . . 0.0 110.465 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -74.85 -41.53 59.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -59.66 -37.0 77.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.593 -1.317 . . . . 0.0 110.487 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -59.33 -38.15 79.58 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.981 -178.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.68 -45.85 90.87 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.452 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -71.22 -40.69 70.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.022 -1.049 . . . . 0.0 108.636 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.3 tpp -64.64 -48.44 74.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.641 -0.662 . . . . 0.0 110.62 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 2.7 tp -64.21 -29.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.999 -1.063 . . . . 0.0 109.469 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.9 m -70.74 -48.83 52.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.022 -1.049 . . . . 0.0 109.042 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 53' ' ' ARG . 10.8 mp -68.66 -39.7 80.54 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.295 -0.878 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.07 -37.82 86.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.421 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.54 -36.87 91.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.42 -24.18 67.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.469 -1.018 . . . . 0.0 110.061 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.8 pp0? -69.74 -3.29 14.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.711 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.43 112.71 1.67 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.725 -1.235 . . . . 0.0 109.084 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.8 -14.68 1.4 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.0 mm? -103.93 154.93 19.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.184 -1.186 . . . . 0.0 110.178 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -71.5 153.71 42.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 109.773 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.7 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -64.77 -41.99 95.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 110.434 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -54.63 -31.25 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 109.728 -179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 m -58.11 -40.86 82.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.84 -28.04 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.097 -1.002 . . . . 0.0 109.43 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -53.44 53.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 109.827 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -61.34 -44.46 97.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.673 -1.267 . . . . 0.0 108.154 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -65.62 -26.71 67.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 37' ' ' LEU . 40.3 ttm180 -53.96 -44.04 70.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.779 -1.201 . . . . 0.0 107.918 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.49 -37.05 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.397 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -78.35 -45.65 22.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.873 -1.142 . . . . 0.0 111.155 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.663 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 40.2 t80 -58.87 -46.43 87.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.159 . . . . 0.0 109.945 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -66.6 -29.47 69.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.11 -0.993 . . . . 0.0 109.37 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.24 74.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.746 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.52 -45.46 68.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.858 -1.151 . . . . 0.0 110.648 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.462 ' CD2' ' SD ' ' A' ' 71' ' ' MET . 20.5 m-85 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.985 -1.072 . . . . 0.0 109.997 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.024 0.343 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.79 -46.18 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.939 -1.1 . . . . 0.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.12 75.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.095 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.02 -38.22 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.766 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -68.67 -14.91 63.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.08 -9.57 45.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.57 -0.707 . . . . 0.0 109.094 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.588 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.1 mtp -82.18 112.84 19.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.456 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -95.77 -176.49 3.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 109.98 -178.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.3 mt-10 -57.61 -33.12 67.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 110.617 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.0 -33.13 75.3 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 108.506 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 62.3 m-20 -68.22 -40.1 82.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.528 -0.733 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.1 m -66.69 -33.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.743 -1.223 . . . . 0.0 109.254 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.511 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.8 mt-10 -63.99 -36.56 84.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.072 -1.017 . . . . 0.0 108.648 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 78' ' ' ARG . 19.6 ttm-85 -61.77 -47.03 87.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.439 ' C ' ' N ' ' A' ' 81' ' ' GLN . 91.9 mt -69.88 -33.49 72.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 111.209 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -49.6 -18.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 108.689 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.5 mt-30 -113.31 -13.78 12.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.551 -0.718 . . . . 0.0 109.775 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.0 t70 -81.23 109.1 15.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.685 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.29 -17.17 0.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 72.04 36.47 60.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.517 HG22 ' ND2' ' A' ' 55' ' ' ASN . 7.6 pt -50.33 -172.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.446 -1.032 . . . . 0.0 110.337 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -59.41 93.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 94.1 mtt180 -52.27 139.73 23.33 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.593 -0.692 . . . . 0.0 109.794 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 164.76 63.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 11.6 ptm180 -49.36 -38.45 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.337 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -64.59 -59.18 8.55 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.515 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.82 -41.47 95.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.879 -1.365 . . . . 0.0 109.849 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.88 -42.43 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 110.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.87 -32.92 68.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.754 -1.216 . . . . 0.0 108.548 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.22 83.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 108.934 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.631 HG21 ' OH ' ' A' ' 56' ' ' TYR . 50.3 mm -57.27 -41.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 108.84 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 71' ' ' MET . 7.6 mm -59.65 -40.41 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.82 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.34 85.46 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.58 -37.55 76.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.424 -1.045 . . . . 0.0 109.088 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -62.78 -44.89 95.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -56.72 -42.99 80.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 108.507 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.03 70.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.45 -0.781 . . . . 0.0 108.965 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.16 -42.92 99.73 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.1 mp -68.52 -31.62 70.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.32 -40.43 90.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.128 -0.983 . . . . 0.0 110.322 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.683 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 71.3 mtp -71.73 -39.33 70.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.958 -1.089 . . . . 0.0 108.803 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.41 -41.81 88.75 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.819 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.83 -21.37 66.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -92.9 -11.05 34.43 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.59 26.57 74.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -118.42 101.5 50.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.243 -1.151 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 145.01 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.237 1.958 . . . . 0.0 112.414 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 31' ' ' LEU . 31.7 m-85 -60.8 -43.42 98.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.27 -33.29 75.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 111.139 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.36 -48.52 80.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.033 -1.042 . . . . 0.0 112.133 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.3 p90 -70.16 -45.18 67.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.685 -1.259 . . . . 0.0 111.12 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -59.84 -50.09 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.468 -1.395 . . . . 0.0 109.581 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.619 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 17.0 m95 -54.99 -24.48 24.39 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 5.3 p -70.61 -38.86 74.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.496 -0.753 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.517 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.6 m-85 -64.96 -32.17 73.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.718 -1.239 . . . . 0.0 109.476 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.698 HG21 ' CD2' ' A' ' 171' ' ' LEU . 29.0 m -96.92 17.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.366 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.657 HD22 ' N ' ' A' ' 121' ' ' ASN . 1.3 m120 57.74 40.93 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.544 -0.722 . . . . 0.0 110.059 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 121' ' ' ASN . 49.8 t-80 43.16 27.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.992 . . . . 0.0 109.805 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 2.6 mm-40 -126.9 149.72 69.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.43 147.99 87.56 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.532 2.154 . . . . 0.0 112.157 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -117.32 139.45 50.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.3 mtt -100.34 122.15 42.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.413 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -84.98 118.11 24.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 108.571 179.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.82 19.88 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -76.12 129.43 36.77 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.274 -0.892 . . . . 0.0 109.365 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.9 p -100.96 -21.32 15.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.7 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 10.8 p -131.64 162.78 29.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.2 mt -58.78 -37.32 76.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 108.823 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.7 m -76.32 -3.2 35.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HB3' ' H ' ' A' ' 131' ' ' THR . 31.9 tp10 -101.69 12.53 36.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -100.48 106.96 45.93 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.71 137.7 82.46 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.83 1.686 . . . . 0.0 112.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 p -103.78 4.09 34.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -142.29 85.74 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.439 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 14.2 p -102.35 151.49 38.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -52.73 -35.73 70.01 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.508 1.472 . . . . 0.0 111.284 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.49 -43.05 61.03 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.439 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 56.8 m -66.17 -43.57 86.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -66.17 -37.47 85.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -71.91 -31.2 66.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.54 HD23 ' SG ' ' A' ' 162' ' ' CYS . 7.1 tp -65.42 -46.65 79.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.642 -0.661 . . . . 0.0 109.537 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.574 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 19.4 m -61.3 -40.88 95.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.077 -1.015 . . . . 0.0 109.518 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -61.22 -43.57 98.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 110.039 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.17 70.79 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.49 -37.92 83.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 109.223 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -61.57 -40.0 93.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.034 -1.041 . . . . 0.0 109.498 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.6 -15.34 57.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.907 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.448 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -83.0 4.16 27.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.156 -0.965 . . . . 0.0 108.835 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.53 24.78 49.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -100.57 112.89 25.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.983 . . . . 0.0 108.849 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -93.44 172.93 7.97 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.648 -0.657 . . . . 0.0 109.231 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 57.84 61.31 2.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.843 . . . . 0.0 109.055 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.3 m -140.85 39.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.51 162.91 0.07 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.6 m -55.03 -31.39 61.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.457 -1.026 . . . . 0.0 109.005 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.6 p -72.34 -31.89 66.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.36 -45.02 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.574 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.7 m -67.0 -41.81 86.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -0.764 . . . . 0.0 109.407 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.44 -46.84 68.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.589 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 18.3 m -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.853 -1.154 . . . . 0.0 109.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -59.29 -47.71 84.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 110.652 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 11.9 ptp -66.42 -29.19 69.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.132 . . . . 0.0 110.657 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.415 HE22 HG21 ' A' ' 172' ' ' VAL . 52.1 mm-40 -57.35 -40.0 77.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.872 -1.143 . . . . 0.0 110.746 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.14 -33.16 11.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 111.124 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.662 ' SG ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -54.62 -27.64 40.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.975 -1.078 . . . . 0.0 109.69 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.55 54.36 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.069 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.698 ' CD2' HG21 ' A' ' 120' ' ' VAL . 6.4 mt -63.3 -30.69 71.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.199 -1.177 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 125' ' ' GLN . 10.9 m -125.77 137.88 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.4 m120 -104.32 164.3 11.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.745 . . . . 0.0 109.413 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 89.58 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.465 ' O ' HG13 ' A' ' 176' ' ' VAL . 17.7 m170 -51.55 -44.74 62.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 108.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 28.2 m -157.91 37.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.73 . . . . 0.0 109.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 176' ' ' VAL . 16.0 t 37.84 93.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.24 -4.35 7.26 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 3' ' ' ARG . 8.7 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 108.482 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.717 0.77 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 145.87 55.03 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.83 49.84 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.408 -0.808 . . . . 0.0 111.833 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -84.37 2.97 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.536 -1.567 . . . . 0.0 109.77 -179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -76.84 -46.45 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 109.158 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.1 m -73.17 -2.02 19.94 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.895 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 62.8 tt0 -67.81 -41.7 82.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -154.63 159.92 31.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 109.984 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.8 -38.47 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.991 2.46 . . . . 0.0 112.463 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.72 -32.88 73.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CZ ' ' CD1' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -62.96 -41.84 99.65 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.296 -0.878 . . . . 0.0 110.207 -179.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.27 -38.29 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 110.523 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.654 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.48 -50.65 58.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 109.539 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.5 ' HA ' HD22 ' A' ' 19' ' ' ASN . 1.2 t80 -60.91 -37.21 81.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 110.01 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -59.1 -43.05 91.85 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.416 -0.803 . . . . 0.0 110.651 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -80.36 -16.06 55.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 110.712 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.654 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 34.8 m-80 -64.58 -53.94 39.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 177.57 57.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 108.829 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 167' ' ' GLN . 4.2 t90 -97.66 63.93 1.76 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 108.87 59.85 0.53 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.857 -1.164 . . . . 0.0 111.562 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.729 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -157.88 -36.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.486 . . . . 0.0 112.037 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.729 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 46.5 Cg_endo -96.15 152.05 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.702 2.268 . . . . 0.0 114.032 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 26' ' ' THR . 86.2 tt0 -68.9 160.15 31.26 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.437 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 2.3 p -95.06 152.48 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.492 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' LYS . 24.1 t70 -103.65 151.46 22.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -62.79 -36.23 82.44 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.911 -1.118 . . . . 0.0 109.418 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -74.89 -50.33 17.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 110.811 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' CD ' ' H ' ' A' ' 27' ' ' ASP . 1.3 ptmm? -62.75 -25.16 68.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.958 -1.089 . . . . 0.0 108.69 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.58 -39.47 76.85 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -69.32 -44.52 71.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.695 -0.628 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.54 -28.37 66.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.14 . . . . 0.0 110.21 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.5 ttm -71.47 -52.06 20.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.867 -1.146 . . . . 0.0 110.444 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 35' ' ' ILE . 9.5 tp -61.1 -29.02 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.749 -1.219 . . . . 0.0 109.709 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.01 -44.1 90.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.065 -1.022 . . . . 0.0 109.038 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 53' ' ' ARG . 3.7 mm? -70.71 -43.58 68.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 31.5 mm-40 -62.81 -33.52 75.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -0.806 . . . . 0.0 109.104 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.14 -36.32 88.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.77 -3.63 39.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -1.174 . . . . 0.0 109.992 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -79.26 -0.69 33.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.04 122.76 18.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.162 -0.961 . . . . 0.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.514 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 74.04 -32.85 0.92 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.9 mm? -98.47 150.03 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.286 . . . . 0.0 109.996 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.5 p -65.61 157.29 30.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' CH2' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.33 -31.08 70.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -40.8 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.413 -0.804 . . . . 0.0 109.877 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 m -57.37 -38.92 74.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.081 -1.012 . . . . 0.0 108.35 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -64.17 -36.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.23 -47.48 78.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -0.966 . . . . 0.0 109.046 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.5 -34.09 76.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' C ' HD22 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -84.52 -10.65 57.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.005 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 41.1 ttm180 -66.72 -51.16 59.17 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.54 -36.13 76.08 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.229 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -72.13 -34.88 68.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.015 -1.053 . . . . 0.0 109.929 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 82.9 t80 -60.7 -47.47 86.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 7.9 ptm180 -66.86 -28.23 68.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.919 -1.113 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -67.7 -37.98 83.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 111.267 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -77.41 -45.66 25.16 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.749 -1.219 . . . . 0.0 110.768 -178.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 110.334 -179.527 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.508 2.341 0 N-CA-C 116.982 1.878 . . . . 0.0 116.982 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 103' ' ' LEU . 59.4 t -57.3 -30.13 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.917 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -39.82 66.97 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.331 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.34 -40.71 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.766 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.711 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.33 -16.28 59.89 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.02 -6.38 58.75 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.57 ' O ' HG21 ' A' ' 96' ' ' ILE . 67.6 mmm -82.74 117.24 22.52 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -94.89 172.27 8.26 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.12 -0.988 . . . . 0.0 109.857 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -54.33 -31.47 54.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.486 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.31 -44.41 75.78 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.651 -1.28 . . . . 0.0 108.37 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.24 -37.81 86.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 92' ' ' ILE . 99.5 t -56.93 -44.83 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 0.0 109.591 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.76 -38.06 89.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 108.628 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -60.93 -39.95 91.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 109.373 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 85' ' ' ILE . 95.9 mt -63.01 -33.24 75.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.16 -33.8 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -109.34 -4.04 16.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.557 -0.714 . . . . 0.0 110.949 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 35.7 t0 -82.0 108.68 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.281 -1.512 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.91 -16.06 0.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.421 -0.799 . . . . 0.0 109.548 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.01 33.18 57.7 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.663 HG22 ' OD1' ' A' ' 55' ' ' ASN . 22.1 pt -54.73 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -1.114 . . . . 0.0 110.205 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 86' ' ' ILE . 10.6 tt -57.71 86.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -54.21 138.64 38.01 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.698 0.761 . . . . 0.0 110.434 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 3.1 m-70 160.58 77.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.585 ' CD ' ' H ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.18 -35.27 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.533 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 -56.26 25.63 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -65.8 -41.43 91.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.295 . . . . 0.0 110.614 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 76' ' ' VAL . 74.6 mt -62.66 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 0.0 110.443 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -55.82 -34.52 65.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.667 -1.271 . . . . 0.0 108.882 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -63.13 -37.51 87.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.948 . . . . 0.0 109.153 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.62 -44.27 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 108.821 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.57 HG21 ' O ' ' A' ' 71' ' ' MET . 9.3 mm -60.45 -41.12 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.59 90.86 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -40.53 87.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 0.0 109.264 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.23 -43.89 93.56 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.072 -1.017 . . . . 0.0 109.001 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.711 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -52.16 -42.07 63.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 108.793 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.44 -29.32 69.99 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.713 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 45.9 t80 -62.79 -44.86 95.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.9 mm? -62.82 -33.36 75.07 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' A' ' 101' ' ' ALA . 54.9 mt-30 -66.08 -36.94 84.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.392 -0.817 . . . . 0.0 110.444 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 82.9 mmm -71.56 -40.3 70.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.71 -39.33 70.23 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.19 -20.03 64.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -85.89 -8.98 57.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.77 26.34 73.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.04 101.79 49.62 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.497 -1.002 . . . . 0.0 109.678 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.25 143.7 41.83 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.342 2.028 . . . . 0.0 112.204 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.713 ' CZ ' ' CD1' ' A' ' 102' ' ' TYR . 58.5 m-85 -64.66 -45.33 87.21 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.039 0.924 . . . . 0.0 110.665 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.6 -26.91 68.9 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.473 -0.767 . . . . 0.0 110.947 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.479 ' O ' ' OG ' ' A' ' 118' ' ' SER . 60.4 t0 -66.24 -49.35 67.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.863 -1.148 . . . . 0.0 111.862 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.3 p90 -69.74 -44.51 70.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.864 -1.148 . . . . 0.0 111.355 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 117' ' ' TRP . 3.3 p -61.0 -53.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.512 -1.367 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.617 ' H ' HG13 ' A' ' 116' ' ' VAL . 37.5 m95 -55.82 -23.09 28.32 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.496 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 13.3 m -69.26 -38.87 78.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.084 -1.01 . . . . 0.0 109.782 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 29.8 m-85 -64.55 -33.9 77.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 120' ' ' VAL . 3.6 m -91.82 18.58 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.055 . . . . 0.0 109.178 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.61 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 59.2 m-80 58.62 43.96 18.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 0.0 109.496 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 28.9 p-80 41.51 24.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.491 -0.756 . . . . 0.0 110.058 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -135.46 153.76 78.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.086 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 147.46 95.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.653 2.235 . . . . 0.0 112.376 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -100.36 131.7 46.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.761 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.7 mtt -96.88 113.25 24.77 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -93.24 115.9 28.49 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -87.84 19.31 3.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.33 140.75 52.29 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.261 -0.899 . . . . 0.0 109.122 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.29 -28.65 10.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.3 p -128.18 162.37 27.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.52 -0.737 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.91 -36.87 70.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.054 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.2 m -61.84 -30.34 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.19 -6.5 57.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 109.816 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -75.52 131.8 76.7 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 74.3 Cg_endo -79.41 -21.58 8.78 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.844 1.696 . . . . 0.0 112.649 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.482 HG22 ' CE1' ' A' ' 163' ' ' TYR . 0.2 OUTLIER 52.36 -1.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.767 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -148.37 83.15 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.065 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.416 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -95.62 159.08 33.34 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.9 -38.13 85.88 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.843 1.695 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.01 -45.02 52.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.416 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 18.1 m -62.95 -43.0 99.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.735 . . . . 0.0 109.061 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.83 -42.05 97.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 108.932 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.1 -29.0 66.99 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -61.52 -47.81 83.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.648 -0.657 . . . . 0.0 109.484 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.546 ' HG ' ' CB ' ' A' ' 162' ' ' CYS . 3.8 m -66.19 -41.02 90.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 0.0 110.161 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -58.3 -38.66 77.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.845 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.13 6.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 145' ' ' LEU . 10.1 mp -59.93 -31.94 70.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 109.968 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -61.05 -45.12 96.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.789 -1.195 . . . . 0.0 109.581 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -84.48 -13.5 51.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -81.75 2.99 27.38 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.864 -1.148 . . . . 0.0 109.484 -178.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.1 21.18 33.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 15.2 m-85 -109.66 111.13 22.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -1.073 . . . . 0.0 109.308 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -94.64 -178.31 4.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 55.32 40.48 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 108.93 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.2 p -125.03 48.37 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.61 162.2 0.5 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -58.18 -30.61 66.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.496 -1.002 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.5 m -72.32 -37.24 68.97 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.141 -0.974 . . . . 0.0 108.674 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.74 -39.88 87.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.546 ' CB ' ' HG ' ' A' ' 146' ' ' SER . 1.4 m -62.2 -49.35 76.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.87 . . . . 0.0 109.828 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.716 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -65.16 -41.0 95.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 20.1 m -64.38 -43.02 95.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.11 -0.994 . . . . 0.0 109.56 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.9 88.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 98.8 mtp -60.89 -40.55 93.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 111.289 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.716 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 46.9 mt-30 -64.04 -44.74 91.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 111.222 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.26 63.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.019 . . . . 0.0 110.612 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -39.09 67.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 0.0 111.288 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.9 0.61 17.3 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -1.188 . . . . 0.0 109.887 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.32 150.34 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 21.4 m120 -128.57 163.56 24.74 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.386 0.612 . . . . 0.0 110.72 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.9 t0 89.52 74.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.471 0.653 . . . . 0.0 109.755 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 176' ' ' VAL . 9.2 m170 -58.35 -44.6 88.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 175' ' ' HIS . 12.9 m -157.99 29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.905 . . . . 0.0 109.992 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 129' ' ' ALA . 85.8 t 55.24 113.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.888 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.14 33.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.354 -1.086 . . . . 0.0 109.45 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.346 0.593 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 133.67 51.15 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.918 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.78 -30.8 76.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.08 -1.51 26.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 108.334 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' ND1' ' A' ' 17' ' ' HIS . 1.1 t -102.29 -28.0 3.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.392 0.615 . . . . 0.0 109.395 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.1 m -70.66 5.2 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.9 . . . . 0.0 110.634 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -84.11 -149.18 0.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.789 -1.195 . . . . 0.0 109.275 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.67 158.6 11.42 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 -160.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.837 2.358 . . . . 0.0 111.468 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 -40.42 0.27 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.012 -1.055 . . . . 0.0 109.135 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.3 m-85 -64.48 -36.63 84.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.894 -1.129 . . . . 0.0 109.413 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.78 -46.83 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.544 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.04 69.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.995 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.2 t80 -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.011 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.498 ' ND1' HG21 ' A' ' 7' ' ' VAL . 14.6 t-80 -76.08 -32.12 59.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.94 -10.33 59.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.956 -1.09 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 19.7 p30 -90.95 -70.41 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.602 -1.311 . . . . 0.0 112.464 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.676 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.2 mt-10 -126.5 -69.09 0.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.943 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.452 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 30.1 t-105 51.72 44.83 28.96 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.68 41.45 19.67 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 120.491 -1.381 . . . . 0.0 110.969 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.574 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -106.98 -41.88 0.14 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.218 . . . . 0.0 109.993 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 95.4 Cg_endo -98.57 154.03 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.794 2.996 . . . . 0.0 112.821 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.36 144.2 55.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 169' ' ' CYS . 67.4 p -105.46 155.44 19.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.773 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -92.16 167.1 12.28 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -59.95 -36.8 77.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 111.197 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.1 -41.55 90.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 112.264 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -62.34 -38.68 90.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.603 -1.311 . . . . 0.0 108.855 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -56.76 -39.1 73.41 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.231 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -60.73 -40.3 91.83 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.04 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -70.69 -43.38 69.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.905 -1.122 . . . . 0.0 108.778 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.479 ' SD ' ' CD1' ' A' ' 165' ' ' PHE . 58.2 ttm -63.82 -47.36 81.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 110.462 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -65.46 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.2 m -69.36 -51.11 40.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.99 -1.068 . . . . 0.0 109.652 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 2.2 mp -68.44 -42.0 79.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.196 -0.94 . . . . 0.0 108.965 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 9.1 tp10 -62.55 -35.74 80.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.619 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.29 -28.1 49.0 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -79.41 -12.87 59.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 109.807 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -74.79 11.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 111.303 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -68.62 112.94 5.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.367 -1.458 . . . . 0.0 109.238 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.27 -0.35 0.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.604 HD21 ' CG2' ' A' ' 48' ' ' THR . 17.3 tp -106.66 145.2 32.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.193 -1.18 . . . . 0.0 109.857 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.7 m -64.39 157.06 27.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.837 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.612 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 2.8 t-105 -71.13 -43.81 66.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.489 -0.757 . . . . 0.0 110.708 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.562 HD12 ' HZ2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -58.96 -27.22 35.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.959 -1.088 . . . . 0.0 109.097 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.604 ' CG2' HD21 ' A' ' 44' ' ' LEU . 29.6 m -63.86 -40.23 96.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -0.935 . . . . 0.0 109.895 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 46' ' ' TRP . 1.2 m -69.82 -28.83 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.084 -1.01 . . . . 0.0 108.993 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.06 -47.31 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -56.64 -45.85 81.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' TYR . 21.3 ttpp -59.82 -32.59 70.8 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -55.35 -45.25 76.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.531 -0.731 . . . . 0.0 109.576 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -68.66 -46.11 69.98 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.02 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 14.0 m-80 -64.34 -34.65 78.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.776 . . . . 0.0 109.142 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.1 t80 -56.6 -42.29 78.49 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -63.37 -38.22 90.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.09 -41.25 86.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.744 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -45.39 41.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.0 111.229 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 81.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 N-CA-C 114.75 1.019 . . . . 0.0 114.75 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.07 -44.83 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 111.121 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.49 -40.6 95.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.5 -41.77 93.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.801 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.68 60.73 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.18 -14.53 28.92 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.739 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.5 mtp -82.78 113.14 20.22 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.61 -177.64 3.99 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.766 -1.209 . . . . 0.0 110.958 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.42 -36.65 69.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 109.136 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.81 -49.04 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.581 -1.325 . . . . 0.0 108.128 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.34 -35.66 74.26 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.507 ' HA ' HD12 ' A' ' 79' ' ' LEU . 55.6 t -60.55 -37.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.28 -0.887 . . . . 0.0 108.748 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.02 -39.8 83.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -65.37 -33.48 76.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.361 0.6 . . . . 0.0 109.507 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.744 HD22 ' SG ' ' A' ' 59' ' ' CYS . 87.8 mt -69.29 -34.47 74.75 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.266 -0.896 . . . . 0.0 110.447 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' HB ' HE21 ' A' ' 81' ' ' GLN . 96.1 t -56.03 -17.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.417 HE21 ' HB ' ' A' ' 80' ' ' VAL . 33.5 mm-40 -109.73 -17.26 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -1.0 . . . . 0.0 110.077 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 59.6 m-20 -80.04 109.78 14.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.75 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.98 -16.21 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.675 . . . . 0.0 109.246 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.7 42.73 86.87 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.8 pt -52.52 -166.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.836 -0.802 . . . . 0.0 109.846 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.07 98.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.511 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 11.2 ptp180 -52.68 116.82 2.5 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.675 0.75 . . . . 0.0 109.696 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 168.23 70.56 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.023 -1.048 . . . . 0.0 108.197 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 29.3 ptt180 -44.34 -42.44 6.79 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.694 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -47.97 -51.85 18.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -65.18 -45.38 85.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -1.128 . . . . 0.0 109.861 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 mm -60.75 -44.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.631 -0.668 . . . . 0.0 110.005 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -56.83 -38.31 72.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.823 -1.173 . . . . 0.0 110.167 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.97 82.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.41 -39.46 74.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 71' ' ' MET . 25.5 mm -59.16 -46.22 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.591 0.71 . . . . 0.0 110.269 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.85 -28.78 73.94 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.55 -40.52 97.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -1.16 . . . . 0.0 110.009 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -49.83 61.23 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 108.95 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -55.81 -38.08 69.51 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.46 -29.54 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.083 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.01 -42.27 94.59 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.2 mm? -62.78 -33.52 75.35 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.438 HE21 ' HA ' ' A' ' 101' ' ' ALA . 51.8 mt-30 -62.59 -36.54 83.05 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.533 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 39.1 tpp -61.01 -47.64 85.52 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.121 -0.987 . . . . 0.0 108.337 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 109' ' ' GLY . 84.3 tt0 -57.67 -35.73 70.96 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.3 t-20 -91.43 -18.12 24.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.51 27.57 73.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.3 mt-10 -114.26 108.58 50.04 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.72 -0.87 . . . . 0.0 109.57 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -51.73 139.75 48.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.965 1.777 . . . . 0.0 112.069 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.713 ' HB3' HD12 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -55.01 -37.84 67.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.756 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.27 64.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.636 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -62.96 -45.05 94.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.688 -1.257 . . . . 0.0 111.249 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.659 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 5.4 p90 -77.39 -40.51 43.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.91 -1.119 . . . . 0.0 111.601 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.659 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 21.6 m -63.2 -48.84 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 119.547 -1.97 . . . . 0.0 108.662 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.567 ' N ' HG23 ' A' ' 116' ' ' VAL . 46.3 m95 -61.26 -23.67 65.83 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.8 t -70.22 -44.48 68.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.095 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 24.1 m-85 -61.19 -30.28 70.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 109.812 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -96.5 18.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 123' ' ' GLN . 82.0 m-20 56.99 42.31 26.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 110.176 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 37.67 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.67 -0.644 . . . . 0.0 109.361 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.3 mm100 -122.84 112.37 30.61 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.349 -0.844 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.27 150.45 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.882 1.722 . . . . 0.0 111.227 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 142.44 46.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.044 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.7 mtt -91.2 130.27 37.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.78 . . . . 0.0 109.638 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.595 HG22 ' N ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -93.44 -58.91 2.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 109.745 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.595 ' N ' HG22 ' A' ' 127' ' ' THR . 71.7 mt-30 59.26 44.26 15.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.34 156.23 28.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.451 -0.781 . . . . 0.0 109.687 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -92.53 -12.79 30.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -168.55 -179.34 3.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -36.39 83.48 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 t -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.897 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 74.9 mm-40 -81.7 5.41 18.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.621 -1.299 . . . . 0.0 109.334 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.61 136.01 20.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.13 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.89 140.37 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.415 2.077 . . . . 0.0 112.883 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.409 ' HA ' ' CG ' ' A' ' 163' ' ' TYR . 0.6 OUTLIER -105.7 -1.47 24.45 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 108.957 179.197 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -145.97 92.3 2.18 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.501 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.63 154.82 39.79 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.195 -0.941 . . . . 0.0 108.979 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -54.1 -34.65 79.03 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.715 1.61 . . . . 0.0 111.105 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -48.63 51.06 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.467 -0.771 . . . . 0.0 109.029 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -64.06 -42.06 97.14 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.644 0.735 . . . . 0.0 109.362 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.03 -39.11 77.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.581 -0.7 . . . . 0.0 109.47 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.743 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.64 -31.74 72.92 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.656 HD22 HG12 ' A' ' 116' ' ' VAL . 69.9 mt -59.6 -46.74 88.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 26.3 t -60.47 -43.62 96.75 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -64.56 -47.3 79.28 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.518 -0.739 . . . . 0.0 110.17 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.63 77.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.418 ' HG ' ' NH2' ' A' ' 152' ' ' ARG . 35.1 mt -66.25 -36.77 83.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.8 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.34 -40.86 92.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.608 -1.308 . . . . 0.0 110.01 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -68.82 -36.6 78.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.969 . . . . 0.0 111.47 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.515 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 74.2 mtm180 -72.26 3.7 4.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.64 20.15 52.03 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 11.2 m-85 -96.93 110.34 22.88 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.29 . . . . 0.0 109.796 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -90.62 178.28 6.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.887 -0.508 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 58.33 47.69 13.59 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.238 1.018 . . . . 0.0 108.889 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.7 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.11 160.41 0.79 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.6 m -59.66 -33.18 71.22 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.512 -0.993 . . . . 0.0 109.188 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.0 m -71.86 -36.07 70.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.91 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.907 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 146' ' ' SER . 20.6 m -67.84 -39.97 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.245 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CG ' ' HA ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -62.66 -44.01 97.35 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.605 -0.685 . . . . 0.0 110.077 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 59.2 p -61.54 -35.45 77.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CD1' ' SD ' ' A' ' 34' ' ' MET . 18.5 t80 -61.5 -41.43 97.28 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 110.063 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.592 ' CG ' HE21 ' A' ' 167' ' ' GLN . 2.4 ptm -67.48 -36.92 82.07 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.902 -1.124 . . . . 0.0 110.795 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.592 HE21 ' CG ' ' A' ' 166' ' ' MET . 85.5 mm-40 -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.842 -1.162 . . . . 0.0 110.893 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.0 -16.0 21.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.39 -0.819 . . . . 0.0 111.937 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 26' ' ' THR . 2.2 t -74.56 -46.11 41.04 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.381 -1.449 . . . . 0.0 110.407 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 -1.42 3.9 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 171' ' ' LEU . 8.8 mp -61.51 -31.57 71.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.025 -1.279 . . . . 0.0 110.685 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.9 154.54 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.959 -1.088 . . . . 0.0 109.049 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 28.6 p30 -124.06 162.77 22.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.171 -0.956 . . . . 0.0 110.046 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 91.56 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -51.73 -39.62 58.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.026 . . . . 0.0 108.623 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.863 HG13 ' H ' ' A' ' 177' ' ' VAL . 2.8 p -145.15 -104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.622 -0.674 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.863 ' H ' HG13 ' A' ' 176' ' ' VAL . 1.1 t -138.4 -41.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 108.292 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.28 67.55 0.52 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.338 . . . . 0.0 110.17 179.899 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 3' ' ' ARG . 30.4 mtm-85 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.813 0.816 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.47 131.17 42.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.612 0.72 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.83 -18.42 53.31 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -4.02 58.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -1.141 . . . . 0.0 109.984 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER -111.43 -10.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.205 -0.934 . . . . 0.0 109.8 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.5 m -70.78 5.99 1.69 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 108.799 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.0 mt-30 -63.1 -88.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.804 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 165.88 -38.06 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 0.0 111.556 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' ASP . 61.1 Cg_endo -91.12 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.775 2.317 . . . . 0.0 115.532 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' TYR . 26.0 mt -32.34 -32.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.941 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' PRO . 4.3 m-85 -44.98 -40.59 6.57 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.843 -1.16 . . . . 0.0 109.913 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.8 mt -61.76 -46.38 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.54 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.02 39.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.126 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 10.0 t80 -62.51 -41.85 99.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -63.05 -38.07 89.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.79 -1.72 58.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 112.217 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.695 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -100.95 -34.03 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.506 -1.371 . . . . 0.0 111.13 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.695 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 93.5 mt-10 -153.19 -73.98 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.577 -1.327 . . . . 0.0 110.554 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.477 ' CE3' ' CE2' ' A' ' 16' ' ' TYR . 8.4 t-105 39.76 45.83 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.098 0.951 . . . . 0.0 108.804 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' ALA . . . 74.45 49.2 12.0 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.487 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.709 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 t -108.69 -35.93 0.15 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.195 -1.18 . . . . 0.0 109.074 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.709 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.2 Cg_endo -92.13 154.69 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 123.367 2.711 . . . . 0.0 112.148 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' C ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -64.39 151.95 42.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.769 ' OG1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -91.3 142.91 27.2 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.506 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -102.83 158.62 16.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 m -56.33 -33.73 65.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.777 -1.202 . . . . 0.0 109.006 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -67.14 -39.0 86.49 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.747 -0.595 . . . . 0.0 110.933 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -62.27 -44.31 96.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.005 -1.06 . . . . 0.0 110.003 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -62.24 -37.97 87.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.0 -53.08 60.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.09 -1.006 . . . . 0.0 110.511 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.01 -40.71 78.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 108.872 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.659 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 3.3 ttm -62.87 -49.33 75.28 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 111.125 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 157' ' ' VAL . 2.7 tp -62.21 -27.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.948 -1.095 . . . . 0.0 108.962 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.41 -54.26 11.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -0.973 . . . . 0.0 109.798 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -71.07 -39.87 71.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 0.0 109.017 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 9.7 tp10 -59.57 -32.01 69.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.13 80.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.708 HE21 ' CD1' ' A' ' 44' ' ' LEU . 55.2 tp60 -69.25 -30.7 68.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.095 -1.238 . . . . 0.0 109.952 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.583 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -51.03 -3.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 110.368 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -63.28 112.42 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.877 -1.14 . . . . 0.0 109.319 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.05 -13.5 0.49 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.708 ' CD1' HE21 ' A' ' 40' ' ' GLN . 9.7 mt -101.98 159.52 15.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.043 -1.269 . . . . 0.0 110.354 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.6 ' HG ' ' HG1' ' A' ' 48' ' ' THR . 1.2 p -85.29 147.18 26.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.463 -0.773 . . . . 0.0 108.916 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.583 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -60.95 -40.75 94.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.422 -0.798 . . . . 0.0 110.592 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -39.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.004 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.6 ' HG1' ' HG ' ' A' ' 45' ' ' SER . 84.8 m -61.55 -40.53 95.04 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -66.37 -35.57 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -58.83 -52.33 66.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -58.49 -41.9 86.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.592 -1.317 . . . . 0.0 107.966 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -65.64 -25.73 67.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.81 -43.23 76.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 47.0 mp0 -68.36 -39.95 81.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 10.7 m-80 -69.85 -37.88 76.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 0.0 109.606 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -60.69 -48.79 80.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.798 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -25.79 68.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.164 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.09 82.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 110.7 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.15 -46.26 61.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.865 -1.147 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.002 179.826 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.494 1.515 0 N-CA-C 113.102 0.385 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.861 HG22 HD21 ' A' ' 103' ' ' LEU . 67.4 t -63.35 -46.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.777 -1.202 . . . . 0.0 109.753 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.81 -32.68 73.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.385 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.42 -39.34 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.351 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.26 -18.93 65.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -86.06 -5.7 59.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.475 ' HE1' HD11 ' A' ' 79' ' ' LEU . 98.4 mtp -85.15 113.22 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.551 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -95.92 176.08 6.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.465 -0.772 . . . . 0.0 109.524 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.4 mt-10 -52.84 -31.04 37.0 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.143 -0.973 . . . . 0.0 109.44 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.79 -49.65 76.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.175 -0.953 . . . . 0.0 108.454 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.21 -38.39 88.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.62 HG13 HG21 ' A' ' 92' ' ' ILE . 99.0 t -59.8 -43.37 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.733 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.13 -33.69 72.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.23 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 43.1 ttm180 -64.25 -46.26 84.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 110.104 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.475 HD11 ' HE1' ' A' ' 71' ' ' MET . 47.1 mt -67.32 -33.4 75.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 110.756 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.08 -18.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' N ' ' C ' ' A' ' 79' ' ' LEU . 22.0 mt-30 -110.4 -17.82 13.38 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.659 -0.65 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 54.1 m-20 -76.78 108.68 9.97 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.86 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 71.14 -18.71 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.54 -0.725 . . . . 0.0 109.817 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.66 34.69 84.29 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 84' ' ' GLY . 7.7 pt -42.82 160.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 44' ' ' LEU . 2.2 tt -63.85 -29.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.31 -0.869 . . . . 0.0 110.909 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 44.9 mtt-85 -63.77 145.37 55.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 109.889 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' ARG . 34.5 m80 -122.72 162.07 22.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 109.444 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.461 HH11 ' HG3' ' A' ' 89' ' ' ARG . 5.4 ptm180 -41.51 -40.81 1.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.56 -66.5 2.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.809 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -61.83 -38.08 86.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -1.148 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.62 HG21 HG13 ' A' ' 76' ' ' VAL . 98.1 mt -58.64 -54.13 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.829 -1.169 . . . . 0.0 109.966 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.6 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 42.9 mt-30 -51.93 -32.44 32.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 109.443 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.94 95.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.075 -1.016 . . . . 0.0 109.851 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.4 -36.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.641 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mp -58.36 -46.86 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.723 -1.236 . . . . 0.0 108.723 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.89 -35.79 92.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 84.3 m-20 -58.77 -37.01 75.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.457 -1.025 . . . . 0.0 109.719 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.14 90.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.987 -1.071 . . . . 0.0 108.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.407 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -59.02 -36.48 75.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.59 76.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.99 -42.54 99.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 HG22 ' A' ' 66' ' ' VAL . 87.8 mt -64.42 -33.79 76.69 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -63.43 -36.34 83.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.249 -0.907 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 87.0 mmm -68.74 -42.91 76.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.914 -1.116 . . . . 0.0 110.164 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.34 -37.33 83.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.494 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -94.49 -10.45 32.25 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.04 74.26 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.42 100.43 51.46 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 149.39 75.18 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.335 2.023 . . . . 0.0 111.946 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.548 ' HB3' HD12 ' A' ' 31' ' ' LEU . 40.0 m-85 -60.7 -33.33 72.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.328 -0.857 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.19 -34.9 71.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.712 -1.243 . . . . 0.0 111.467 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.43 -49.55 77.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.664 -1.272 . . . . 0.0 111.523 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.589 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 3.2 p90 -71.23 -35.3 71.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.205 . . . . 0.0 109.381 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.91 HG22 HD21 ' A' ' 145' ' ' LEU . 1.3 t -64.22 -54.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.05 . . . . 0.0 109.63 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.529 ' N ' HG12 ' A' ' 116' ' ' VAL . 60.3 m95 -57.51 -21.2 36.33 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 108.555 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 16.1 p -72.24 -36.97 69.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.738 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 20.7 m-85 -69.78 -33.74 72.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.936 -1.103 . . . . 0.0 110.289 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.66 18.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.976 -1.078 . . . . 0.0 109.682 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 65.05 37.91 6.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 109.957 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 24.6 t-80 42.33 36.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 110.875 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.39 21.51 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 109.159 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.44 143.38 47.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.206 1.937 . . . . 0.0 111.577 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -108.05 145.92 33.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.924 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 126' ' ' MET . 14.8 ptt? -97.92 121.38 39.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.425 -0.797 . . . . 0.0 108.947 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 m -90.0 119.93 30.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 109.43 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -91.52 18.59 7.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.906 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -61.52 143.06 56.58 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.088 -1.007 . . . . 0.0 109.421 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.403 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 81.6 p -105.0 -26.87 11.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.3 p -130.13 163.87 25.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.94 -37.04 70.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m -82.91 4.64 24.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.832 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' THR . 39.0 tp10 -98.0 5.05 49.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 127.02 34.99 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.109 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 139.75 36.26 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.901 1.734 . . . . 0.0 112.253 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 t -103.18 -2.49 27.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.822 . . . . 0.0 108.811 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.0 t -134.85 96.34 3.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.406 ' H ' ' HB2' ' A' ' 142' ' ' SER . 0.6 OUTLIER -114.6 159.79 35.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -53.94 -40.74 79.68 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.317 1.344 . . . . 0.0 111.399 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.93 67.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 139' ' ' THR . 22.9 m -60.21 -42.63 95.52 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.56 -0.713 . . . . 0.0 109.467 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -64.76 -41.21 96.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.191 -0.943 . . . . 0.0 109.161 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -72.76 -29.49 63.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.404 -0.81 . . . . 0.0 108.859 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.91 HD21 HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -68.37 -47.74 66.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.393 -0.817 . . . . 0.0 109.148 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.521 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 12.1 t -63.82 -42.65 97.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.857 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.47 -42.18 95.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.288 -0.883 . . . . 0.0 110.374 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.33 79.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.721 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.54 -38.87 84.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 109.352 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.11 -38.6 86.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.926 -1.108 . . . . 0.0 108.709 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -81.8 -14.26 56.59 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.451 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -83.38 0.74 44.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.732 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.41 19.92 43.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -100.61 112.83 25.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.623 -0.928 . . . . 0.0 108.622 179.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -97.27 166.46 11.55 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.4 p -158.81 41.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.29 174.5 0.2 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.8 p -62.31 -24.28 67.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.14 . . . . 0.0 109.224 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.0 m -66.34 -38.63 88.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.04 -44.69 78.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.9 m -61.91 -33.95 75.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.159 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -72.02 -47.83 48.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.969 -1.082 . . . . 0.0 110.709 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 92.7 p -67.35 -32.25 73.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.028 -1.045 . . . . 0.0 109.263 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.696 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -65.53 -37.1 85.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.347 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.59 ' HA ' HD12 ' A' ' 171' ' ' LEU . 2.1 ttp -69.4 -42.72 74.72 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.155 -0.965 . . . . 0.0 110.849 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 2.2 pt20 -68.74 -41.48 78.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.657 -1.277 . . . . 0.0 111.404 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -77.6 -37.44 50.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.032 -1.042 . . . . 0.0 112.047 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.696 ' SG ' ' CD2' ' A' ' 165' ' ' PHE . 78.8 m -63.7 -44.18 94.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.769 -1.207 . . . . 0.0 111.699 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.39 4.67 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 166' ' ' MET . 15.9 mt -60.73 -37.12 80.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -1.217 . . . . 0.0 109.581 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -128.25 146.09 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 109.269 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 67.2 m-20 -109.09 164.12 12.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.408 -0.807 . . . . 0.0 110.245 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 91.35 78.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.217 0.532 . . . . 0.0 110.81 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -53.37 -69.31 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.09 155.37 41.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' ALA . 59.9 t -63.22 126.87 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.0 109.487 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.21 40.03 14.54 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.738 -1.448 . . . . 0.0 108.511 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.974 ' NH1' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.406 0.622 . . . . 0.0 109.599 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -45.78 127.87 8.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.778 0.799 . . . . 0.0 110.263 -179.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.67 57.04 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -53.92 -38.75 65.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.974 HG11 ' NH1' ' A' ' 3' ' ' ARG . 63.3 t -69.53 -36.38 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.64 -0.662 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -71.17 -3.41 19.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.035 . . . . 0.0 110.267 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.34 -38.73 91.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.227 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.77 160.43 30.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.047 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -34.67 14.68 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.91 2.406 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.43 -34.51 76.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.833 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.5 -40.24 78.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.603 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -52.68 -39.54 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.942 -1.099 . . . . 0.0 109.238 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.594 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.85 -48.63 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 109.223 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.565 ' HA ' HD22 ' A' ' 19' ' ' ASN . 28.9 t80 -61.49 -38.8 88.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 110.019 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.93 -43.9 94.49 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.451 -0.781 . . . . 0.0 111.707 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -77.51 -10.76 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 78.6 m-20 -78.31 -70.99 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.652 -1.28 . . . . 0.0 110.322 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -167.59 54.88 0.07 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.045 . . . . 0.0 109.362 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TRP . 7.4 t90 -96.35 63.26 2.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.115 -0.991 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.456 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 105.41 62.15 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.087 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.763 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -159.41 -36.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.227 -1.161 . . . . 0.0 110.742 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.763 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 68.4 Cg_endo -99.57 150.92 0.54 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 122.845 2.363 . . . . 0.0 113.204 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.05 147.8 44.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.0 p -109.5 150.96 27.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.662 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.41 164.17 13.12 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -58.98 -34.47 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.901 -1.124 . . . . 0.0 109.72 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -65.17 -40.41 94.27 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.387 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 25.4 mmtp -59.52 -40.89 88.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.1 mt -60.71 -35.17 75.66 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.619 -0.676 . . . . 0.0 109.698 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.2 t80 -63.37 -52.65 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 110.595 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -68.75 -33.36 73.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.512 -1.367 . . . . 0.0 108.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.98 -39.52 83.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.671 . . . . 0.0 110.149 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.917 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.2 tp -66.56 -28.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 109.519 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.9 m -68.81 -49.79 55.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.944 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -68.86 -45.07 71.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.022 -1.049 . . . . 0.0 109.458 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -63.99 -32.96 74.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.89 44.05 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -72.95 -36.41 67.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.538 -0.978 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.62 ' CA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -44.28 -19.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -66.34 112.57 4.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.903 -1.123 . . . . 0.0 109.071 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.72 -36.41 3.53 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 2.4 mm? -103.25 171.2 7.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.136 -1.214 . . . . 0.0 110.203 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.0 m -92.53 154.14 18.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.653 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.539 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -60.61 -41.6 95.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.682 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -59.02 -44.47 91.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.954 -1.091 . . . . 0.0 108.895 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.548 HG21 HD12 ' A' ' 44' ' ' LEU . 59.7 m -58.11 -39.21 78.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.0 t -64.51 -32.34 57.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.73 -45.86 85.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.051 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.21 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 108.606 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -12.59 59.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.396 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -71.35 -46.49 60.38 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.26 -41.02 90.49 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.82 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -70.62 -34.33 72.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.588 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 79.6 t80 -58.45 -46.56 86.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.085 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -65.29 -28.4 69.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.32 86.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 110.545 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.628 ' CB ' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -77.42 -45.77 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.934 -1.104 . . . . 0.0 110.749 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 120.838 -1.164 . . . . 0.0 109.918 -179.783 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.491 1.379 0 CA-C-O 121.095 0.373 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.34 -41.69 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -62.44 -33.71 75.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.038 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.0 -38.41 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.41 -18.0 64.97 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -85.55 -5.36 59.29 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.3 mmm -80.91 115.32 20.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -95.44 173.48 7.5 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.455 -0.778 . . . . 0.0 110.39 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.54 -31.86 66.5 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.398 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.08 -31.48 72.0 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.766 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.47 -46.63 79.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 110.614 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 92' ' ' ILE . 2.0 p -61.49 -37.56 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.681 -1.262 . . . . 0.0 109.413 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.556 ' CD ' HH21 ' A' ' 89' ' ' ARG . 81.2 mm-40 -55.9 -38.29 70.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.875 -1.14 . . . . 0.0 108.145 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -65.69 -41.67 92.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 ' CB ' ' A' ' 59' ' ' CYS . 43.1 mt -69.99 -33.08 71.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.843 -0.535 . . . . 0.0 110.742 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' LEU . 24.5 t -47.97 -31.04 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.92 -6.33 32.5 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 84' ' ' GLY . 64.6 t0 -81.53 106.55 13.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.592 -1.317 . . . . 0.0 109.622 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.06 -16.05 0.12 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.599 -0.688 . . . . 0.0 109.55 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.1 39.81 36.38 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.82 HG22 ' OD1' ' A' ' 55' ' ' ASN . 15.7 pt -47.27 151.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -1.038 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 86' ' ' ILE . 8.4 tt -63.89 -26.75 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.459 -0.775 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' A' ' 87' ' ' ARG . 39.9 mtt-85 -66.64 148.34 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.637 ' CD2' ' H ' ' A' ' 89' ' ' ARG . 70.9 t60 -132.12 -179.04 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.491 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.637 ' H ' ' CD2' ' A' ' 88' ' ' HIS . 37.7 ttm180 -52.98 -38.0 61.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.917 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.33 -59.62 7.63 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.955 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.57 -44.3 96.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -1.221 . . . . 0.0 111.084 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 95' ' ' ILE . 37.2 mm -59.24 -46.23 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.711 -1.243 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -51.41 -35.93 41.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.628 -1.295 . . . . 0.0 108.009 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.39 75.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.324 -0.86 . . . . 0.0 109.083 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.758 HD12 HD13 ' A' ' 92' ' ' ILE . 82.2 mt -71.99 -40.97 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.29 -43.03 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.587 -1.321 . . . . 0.0 108.989 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.17 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.415 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 3.5 m120 -60.32 -36.96 79.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -1.148 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.8 89.13 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 0.0 108.334 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -65.97 -34.34 77.89 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.95 -31.72 72.88 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -62.51 -42.48 99.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.5 -31.6 72.42 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.49 -39.87 94.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.186 -0.946 . . . . 0.0 110.364 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.698 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 5.8 ttm -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.795 -1.191 . . . . 0.0 108.94 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.24 -35.27 80.28 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -21.9 66.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -88.47 -13.02 41.36 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.2 27.28 73.79 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.197 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.595 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.1 mt-10 -126.02 100.52 30.23 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.291 . . . . 0.0 109.35 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.81 144.08 27.86 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.263 1.976 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.698 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 71.4 m-85 -60.68 -34.93 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.56 -33.01 66.49 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.293 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -63.19 -48.19 79.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.696 -1.252 . . . . 0.0 111.598 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 116' ' ' VAL . 2.1 p90 -75.34 -32.93 61.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.808 -1.182 . . . . 0.0 109.886 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 145' ' ' LEU . 8.5 t -59.69 -55.4 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 108.934 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' HIS . 71.9 m95 -62.01 -21.59 65.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.6 p -76.04 -34.21 59.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -0.974 . . . . 0.0 109.744 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 1.8 m-85 -64.7 -36.12 83.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.008 -1.057 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 120' ' ' VAL . 2.8 p -89.76 18.02 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.192 -0.943 . . . . 0.0 109.191 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 68.01 17.04 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.493 -0.755 . . . . 0.0 109.924 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' N ' ' O ' ' A' ' 117' ' ' TRP . 2.1 t60 61.18 29.2 18.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.116 -0.99 . . . . 0.0 110.122 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -133.3 150.03 74.1 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.213 -0.929 . . . . 0.0 109.866 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.34 145.16 53.0 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.559 2.172 . . . . 0.0 111.989 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.606 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -111.5 131.38 55.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.101 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.606 ' C ' HE22 ' A' ' 125' ' ' GLN . 64.4 mtt -104.85 117.09 33.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 129' ' ' ALA . 1.1 m -97.09 -47.7 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.037 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 59.43 47.13 11.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.543 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.657 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -77.85 157.75 29.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.456 -0.777 . . . . 0.0 109.189 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.673 HG22 ' OE1' ' A' ' 134' ' ' GLU . 1.6 t -105.09 -26.18 12.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 130' ' ' THR . 40.3 p -131.5 163.66 27.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -0.903 . . . . 0.0 109.678 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.92 -32.44 70.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -63.62 -26.25 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.798 . . . . 0.0 110.27 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.673 ' OE1' HG22 ' A' ' 130' ' ' THR . 89.2 mt-10 -87.69 -0.81 57.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.292 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.755 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -87.98 128.68 53.0 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.61 140.25 26.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.313 2.009 . . . . 0.0 112.999 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.2 p -118.7 5.91 11.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.3 p -159.05 85.82 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.552 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -98.24 162.16 22.96 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.868 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.32 -40.72 76.96 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.402 1.401 . . . . 0.0 111.071 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -42.87 70.11 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 139' ' ' THR . 59.7 p -64.17 -45.47 88.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.466 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -63.93 -40.46 96.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.658 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.729 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -70.05 -29.28 66.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.272 -0.892 . . . . 0.0 108.825 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.021 HD11 HG22 ' A' ' 116' ' ' VAL . 13.3 tp -64.72 -43.09 94.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.655 -0.653 . . . . 0.0 109.875 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.662 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.05 -43.25 83.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.44 ' CG ' ' NZ ' ' A' ' 151' ' ' LYS . 34.3 ttpt -57.19 -44.77 83.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.478 -0.764 . . . . 0.0 110.788 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.63 70.75 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.001 -1.062 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 149' ' ' LEU . 95.9 mt -64.76 -38.44 90.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.431 -0.793 . . . . 0.0 109.832 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -41.96 98.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.034 -1.041 . . . . 0.0 109.06 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.44 ' NZ ' ' CG ' ' A' ' 147' ' ' LYS . 60.9 mttp -77.42 -13.45 59.92 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.99 -1.069 . . . . 0.0 110.233 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -85.03 -7.05 59.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.96 -1.088 . . . . 0.0 108.717 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.46 25.07 8.95 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -104.56 113.59 27.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -1.077 . . . . 0.0 109.145 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 43.2 mttt -90.98 -176.69 4.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.863 . . . . 0.0 110.433 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 6.4 p90 42.48 47.72 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.0 0.905 . . . . 0.0 109.285 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.74 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -128.62 46.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.37 172.96 1.76 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.5 m -57.86 -33.79 69.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -1.021 . . . . 0.0 110.06 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.2 p -68.6 -31.67 71.01 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.04 -1.037 . . . . 0.0 108.279 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.728 HG22 ' CE2' ' A' ' 165' ' ' PHE . 31.5 mm -65.88 -44.75 92.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.045 0.926 . . . . 0.0 108.986 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.662 ' SG ' ' N ' ' A' ' 146' ' ' SER . 53.1 m -58.12 -47.82 82.09 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.609 0.718 . . . . 0.0 110.576 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -64.17 -31.36 72.52 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.466 -0.771 . . . . 0.0 110.88 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.464 ' HA ' HE21 ' A' ' 167' ' ' GLN . 98.5 p -61.33 -48.32 81.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 21.4 m-85 -64.35 -39.28 93.58 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 109.899 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 87.7 mtp -53.33 -37.49 62.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.665 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.703 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 36.1 mt-30 -68.02 -39.46 83.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.652 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.73 -40.16 14.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 111.136 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 171' ' ' LEU . 86.4 m -54.8 -28.12 46.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.945 . . . . 0.0 110.634 -178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.26 -2.75 47.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.596 HD21 HG12 ' A' ' 116' ' ' VAL . 6.9 mp -60.82 -38.52 85.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.381 -1.07 . . . . 0.0 109.853 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 173' ' ' ASN . 3.9 p -138.1 151.19 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 111.457 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.425 ' N ' HG22 ' A' ' 172' ' ' VAL . 0.7 OUTLIER -114.87 98.09 6.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.755 ' O ' HD11 ' A' ' 135' ' ' ILE . 53.1 p30 -132.6 21.13 4.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.555 ' C ' HG12 ' A' ' 176' ' ' VAL . 5.9 m170 -49.05 -45.69 43.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.486 -1.384 . . . . 0.0 108.912 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 178' ' ' GLY . 3.0 p 145.43 155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 129' ' ' ALA . 69.6 t -57.6 -38.76 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.965 -1.084 . . . . 0.0 110.341 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -80.16 29.4 2.48 Favored Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.077 -1.014 . . . . 0.0 111.073 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 26.8 t . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.869 -1.371 . . . . 0.0 109.34 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.678 0.752 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.25 152.99 38.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.803 0.811 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.27 -40.73 60.88 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.711 -0.618 . . . . 0.0 111.967 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.526 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -88.92 -3.74 58.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.487 -1.596 . . . . 0.0 110.055 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.89 -40.36 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.997 -1.064 . . . . 0.0 109.315 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -77.01 -0.95 26.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 108.811 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 42.8 tt0 -64.46 -41.85 96.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.485 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 173.35 166.13 0.28 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.95 -1.094 . . . . 0.0 109.753 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' TYR . 50.6 Cg_exo -48.18 -167.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.534 2.156 . . . . 0.0 113.075 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.0 mt 63.57 -47.21 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.864 -0.523 . . . . 0.0 109.789 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.8 m-85 -62.51 -39.98 95.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.994 -1.066 . . . . 0.0 109.395 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.91 -44.29 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.631 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.2 -50.23 64.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.767 -1.208 . . . . 0.0 109.361 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.505 ' HA ' HD22 ' A' ' 19' ' ' ASN . 2.4 t80 -62.03 -42.58 99.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.822 . . . . 0.0 109.769 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -69.76 -41.6 74.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.459 -0.775 . . . . 0.0 110.349 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -74.96 -6.69 50.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 110.55 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-80 -71.77 -76.92 0.1 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.023 -1.048 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' C ' ' A' ' 21' ' ' TRP . 84.5 mt-10 -151.13 -51.85 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.567 ' C ' ' O ' ' A' ' 20' ' ' GLU . 3.8 t90 24.62 72.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.56 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 116.85 48.92 0.44 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.019 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.858 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.5 m -163.9 -27.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.252 -1.146 . . . . 0.0 112.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.858 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 44.9 Cg_endo -87.14 151.16 8.16 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.661 1.574 . . . . 0.0 113.79 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.11 152.06 29.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 p -94.98 137.87 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.918 -1.114 . . . . 0.0 111.186 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -98.15 157.64 16.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m -55.25 -35.43 64.98 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.503 -1.373 . . . . 0.0 109.067 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -69.45 -36.55 76.71 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.816 -0.552 . . . . 0.0 111.672 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -63.81 -41.46 97.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.746 -1.221 . . . . 0.0 110.619 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 116' ' ' VAL . 6.7 mp -57.09 -39.0 74.18 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.763 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 78.2 t80 -66.53 -52.58 44.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 110.597 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -67.34 -38.52 84.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 108.923 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 ttm -70.28 -47.9 59.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.505 -0.747 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.86 -31.85 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.868 -1.145 . . . . 0.0 109.441 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.8 m -69.65 -45.9 67.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.008 -1.057 . . . . 0.0 108.983 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HH11 ' A' ' 53' ' ' ARG . 79.8 mt -67.33 -38.33 84.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.469 -0.77 . . . . 0.0 109.468 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -64.82 -35.55 81.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.952 . . . . 0.0 109.862 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.95 -35.27 53.3 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.027 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . 24.8 mt-30 -63.52 -33.65 76.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.275 . . . . 0.0 110.747 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -43.62 -22.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.779 -1.201 . . . . 0.0 110.265 -179.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -54.95 112.65 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.929 -1.107 . . . . 0.0 109.148 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 76.61 -25.84 1.69 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 43' ' ' GLY . 3.7 mm? -102.56 164.97 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -99.47 148.3 24.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -55.78 -39.98 72.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.006 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.97 -1.081 . . . . 0.0 109.122 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.7 m -64.4 -40.03 95.0 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' ARG . 1.4 t -65.89 -35.79 75.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -55.89 -50.39 70.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.3 mttt -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.596 -1.315 . . . . 0.0 108.864 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mmpp? -63.26 -26.43 68.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.527 HH11 HD13 ' A' ' 37' ' ' LEU . 17.3 ttm-85 -53.68 -45.87 70.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.4 -41.03 89.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.489 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 9.4 m-80 -69.11 -36.17 77.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.47 -48.6 80.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 110.66 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -69.24 -27.22 65.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.772 -1.205 . . . . 0.0 109.143 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -36.91 75.52 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.704 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.5 m -76.62 -45.9 28.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.948 -1.095 . . . . 0.0 110.193 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.847 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.494 1.533 0 N-CA-C 113.121 0.393 . . . . 0.0 113.121 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 103' ' ' LEU . 87.3 t -72.77 -45.61 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.722 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -34.53 72.73 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -41.41 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.955 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.735 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -64.0 -17.3 63.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.05 55.99 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 95.2 mtp -85.35 114.23 22.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.86 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -95.68 -177.83 4.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.2 -31.19 67.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 110.596 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.58 -49.26 75.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.751 -1.218 . . . . 0.0 108.988 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.92 -38.99 90.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 t -58.46 -41.95 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -0.76 . . . . 0.0 109.306 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' C ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -60.48 -33.33 72.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.96 . . . . 0.0 109.359 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -69.61 -46.93 65.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.988 . . . . 0.0 110.239 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.704 HD22 ' HB3' ' A' ' 59' ' ' CYS . 17.5 mt -70.89 -32.44 69.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.76 -0.587 . . . . 0.0 112.182 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 76' ' ' VAL . 44.7 t -49.47 -27.1 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.746 -1.221 . . . . 0.0 109.638 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.42 -9.36 14.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.3 m-20 -73.49 111.09 8.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.549 -1.344 . . . . 0.0 109.169 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.22 -15.75 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.763 . . . . 0.0 109.214 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 76.71 38.94 30.51 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.0 pt -52.03 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.374 -1.074 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.3 mt -65.03 98.07 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.967 -1.083 . . . . 0.0 108.889 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.648 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 3.0 mtt-85 -55.49 132.76 49.25 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.648 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.4 m-70 156.51 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.655 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.6 OUTLIER -54.47 -35.67 63.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.167 -0.958 . . . . 0.0 108.809 -179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.21 -54.43 37.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.93 -43.63 95.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -1.178 . . . . 0.0 109.599 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.6 mt -58.23 -45.21 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.03 -1.044 . . . . 0.0 109.251 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.65 -33.71 68.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.921 -1.112 . . . . 0.0 109.339 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.3 82.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.045 -1.034 . . . . 0.0 108.459 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.61 -43.6 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.47 -0.769 . . . . 0.0 109.767 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.33 -46.4 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 108.583 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.33 95.41 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -59.07 -37.07 76.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -1.176 . . . . 0.0 109.411 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.0 86.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -0.983 . . . . 0.0 109.641 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.735 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 8.9 tpp180 -57.87 -38.27 75.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.176 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -62.8 -35.27 79.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.625 HD11 HG22 ' A' ' 66' ' ' VAL . 3.6 mm? -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -64.16 -42.04 96.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.17 -0.957 . . . . 0.0 109.443 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.643 ' SD ' ' CE1' ' A' ' 112' ' ' PHE . 80.5 mtp -68.66 -39.5 80.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.15 -41.23 86.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.428 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.73 -19.54 65.83 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -92.52 -9.5 41.1 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.41 25.2 75.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -115.45 102.47 54.41 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.372 -1.075 . . . . 0.0 109.297 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.14 148.99 29.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.643 ' CE1' ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -68.73 -43.36 76.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.76 0.791 . . . . 0.0 110.352 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 117' ' ' TRP . . . -69.36 -26.69 64.8 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.053 -1.029 . . . . 0.0 110.689 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -57.41 -49.15 77.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.742 -1.224 . . . . 0.0 110.923 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.746 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 8.6 p90 -76.0 -36.35 59.21 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 110.19 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.746 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 10.9 t -64.76 -55.13 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.706 -1.246 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 67.5 m95 -58.24 -21.71 49.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.181 -0.949 . . . . 0.0 108.654 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.1 p -73.57 -32.59 64.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.927 -1.108 . . . . 0.0 109.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 12.6 m-85 -69.63 -30.54 68.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.832 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 HD22 ' A' ' 171' ' ' LEU . 29.2 m -96.09 19.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.098 -1.001 . . . . 0.0 109.405 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 122' ' ' HIS . 69.3 m-20 61.94 42.03 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.0 110.799 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.413 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 41.89 29.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.6 178.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.0 147.67 35.65 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.857 -1.152 . . . . 0.0 109.853 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.62 139.34 88.5 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.302 2.001 . . . . 0.0 111.811 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.9 147.55 36.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.825 . . . . 0.0 109.65 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.6 mtt -95.11 125.97 40.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.188 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -67.87 -40.92 83.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 108.841 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 62.48 44.94 6.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.635 -0.665 . . . . 0.0 110.401 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -106.74 139.22 41.52 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.5 p -101.05 -14.22 17.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.011 -1.056 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -151.05 169.38 21.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.071 . . . . 0.0 109.963 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.1 -34.72 73.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.43 -0.794 . . . . 0.0 109.338 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -73.89 -11.48 60.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -98.68 14.9 26.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.0 mm -105.59 98.34 17.11 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.474 1.449 . . . . 0.0 112.227 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.5 p -97.38 1.86 49.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.393 -0.817 . . . . 0.0 109.446 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -138.79 91.16 2.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.269 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.494 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -106.2 156.16 37.34 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -52.29 -39.2 73.03 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.041 1.827 . . . . 0.0 111.628 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.41 -44.36 52.25 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.066 -1.021 . . . . 0.0 108.605 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.494 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 83.6 p -68.02 -37.48 81.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -66.22 -35.64 80.97 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 108.598 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -64.76 -39.1 93.06 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.559 -0.713 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 HG22 ' A' ' 116' ' ' VAL . 96.8 mt -58.96 -46.78 87.21 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.097 -1.041 . . . . 0.0 108.517 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.434 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 23.6 m -56.44 -40.63 75.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.692 -1.255 . . . . 0.0 108.921 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -65.9 -50.65 63.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.426 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.37 88.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.33 -38.82 85.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.973 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -61.25 -40.19 93.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.877 -1.14 . . . . 0.0 109.195 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -65.87 -33.55 76.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 110.374 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.568 ' O ' ' NE2' ' A' ' 104' ' ' GLN . 2.5 mmp_? -72.24 2.94 5.14 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.04 -1.038 . . . . 0.0 108.876 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.16 52.46 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.72 115.44 27.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.723 -0.869 . . . . 0.0 108.781 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -89.34 167.41 13.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.624 -0.673 . . . . 0.0 110.397 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 57.62 59.87 3.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.619 -0.676 . . . . 0.0 109.956 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 22.6 m -131.56 33.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.539 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.08 164.19 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.4 p -58.91 -22.88 60.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -1.137 . . . . 0.0 108.889 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -75.76 -32.69 60.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.69 -45.25 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 146' ' ' SER . 94.6 m -63.04 -40.21 97.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.399 0.618 . . . . 0.0 109.867 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -70.07 -41.92 73.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.556 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.3 m -60.66 -44.54 96.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -0.838 . . . . 0.0 108.97 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.573 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 3.0 t80 -62.92 -40.05 96.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.823 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.401 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 1.1 ttp -59.93 -40.23 88.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.569 -0.707 . . . . 0.0 112.765 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.4 pt20 -79.66 -46.34 17.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.193 -1.567 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.47 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -73.28 -28.63 62.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.955 -1.091 . . . . 0.0 111.364 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 30.4 p -67.1 -29.75 69.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 111.39 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 109.01 -1.8 31.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.576 HD11 ' CG1' ' A' ' 116' ' ' VAL . 27.5 mt -61.01 -36.31 79.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.091 -1.241 . . . . 0.0 110.324 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.4 151.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.055 -1.028 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 81.8 m-20 -114.77 162.98 16.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.606 -0.684 . . . . 0.0 110.102 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 96.42 75.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.098 0.475 . . . . 0.0 110.008 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.467 ' O ' HD11 ' A' ' 135' ' ' ILE . 21.0 m170 -52.11 -41.05 62.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.116 -0.99 . . . . 0.0 108.71 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.79 ' O ' HG22 ' A' ' 176' ' ' VAL . 7.7 p -168.54 28.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 176' ' ' VAL . 42.0 t 56.19 118.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.0 109.906 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.56 9.52 62.87 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.236 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.279 . . . . 0.0 108.951 179.889 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.537 ' HB2' HG11 ' A' ' 7' ' ' VAL . 85.7 mtt180 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.71 0.767 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -178.1 154.55 0.88 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.17 -45.3 95.54 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.548 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.686 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -88.8 -4.41 58.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.361 -1.67 . . . . 0.0 109.988 -178.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 3' ' ' ARG . 4.5 t -75.14 -41.1 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.131 -0.98 . . . . 0.0 109.333 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.7 -9.59 58.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 108.875 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -69.63 -39.97 76.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -0.791 . . . . 0.0 111.257 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.26 157.59 30.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.508 -1.37 . . . . 0.0 111.239 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.3 Cg_endo -63.5 179.96 0.81 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.251 2.634 . . . . 0.0 112.286 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.1 mt 66.24 -44.14 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -55.44 -35.69 65.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.15 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.9 mp -54.24 -43.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.07 . . . . 0.0 108.984 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.661 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -64.88 -49.27 71.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -58.36 -37.0 74.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.204 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -62.49 -45.33 93.49 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.141 -0.975 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -83.27 -2.59 56.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.661 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 25.6 m-80 -76.5 -75.17 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.838 -1.164 . . . . 0.0 109.159 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -168.98 69.11 0.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.143 -0.973 . . . . 0.0 109.76 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.686 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.4 t90 -79.83 60.71 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.978 -1.076 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.45 64.19 1.46 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.583 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.807 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -137.87 -33.73 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.2 -1.176 . . . . 0.0 111.041 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.807 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 64.8 Cg_endo -97.08 150.45 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.737 2.291 . . . . 0.0 113.395 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.9 147.64 51.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 169' ' ' CYS . 69.5 p -101.71 151.45 22.02 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.543 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 5.9 t70 -94.35 157.01 16.23 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 m -50.29 -32.76 17.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -178.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -71.51 -39.31 70.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.681 -0.637 . . . . 0.0 111.63 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -62.66 -39.12 92.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.836 -1.165 . . . . 0.0 110.276 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.1 mp -56.45 -40.08 74.22 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.786 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.56 -46.66 87.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.94 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -71.53 -36.45 71.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.051 -1.031 . . . . 0.0 109.078 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.1 ttm -69.13 -47.9 63.83 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.047 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.15 -29.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.52 -1.362 . . . . 0.0 109.912 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.49 -52.75 28.84 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.493 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.6 mt -64.9 -40.19 94.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.585 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 66.1 mm-40 -63.43 -31.13 72.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.026 -1.046 . . . . 0.0 108.573 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 161' ' ' ILE . . . -68.49 -37.08 85.07 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 42' ' ' ALA . 96.2 mt-30 -58.65 -35.05 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.826 -0.808 . . . . 0.0 111.459 -178.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.585 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 6.4 pt20 -70.96 9.59 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.631 -1.293 . . . . 0.0 110.177 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -54.96 112.92 1.15 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.937 -1.102 . . . . 0.0 108.589 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.15 -14.37 0.44 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 48' ' ' THR . 31.2 tp -106.77 145.95 31.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.562 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.0 157.13 4.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.702 0.763 . . . . 0.0 111.198 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.82 -37.07 62.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.796 -0.565 . . . . 0.0 110.119 179.316 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -40.36 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.021 -1.049 . . . . 0.0 110.077 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.733 HG21 HD21 ' A' ' 44' ' ' LEU . 37.7 m -57.6 -38.5 75.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.09 -1.006 . . . . 0.0 108.34 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.5 t -65.06 -33.75 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.722 -0.611 . . . . 0.0 109.367 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.47 -48.66 78.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -63.02 -45.8 90.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.968 -1.083 . . . . 0.0 109.441 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -79.26 -8.99 59.47 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.266 -179.08 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.99 -54.45 13.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.756 -1.215 . . . . 0.0 108.492 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -39.96 94.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.498 -0.751 . . . . 0.0 109.733 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.845 ' ND2' HG22 ' A' ' 85' ' ' ILE . 39.7 t30 -74.96 -46.49 35.15 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.15 -0.969 . . . . 0.0 110.893 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 59.4 t80 -63.41 -49.2 74.71 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.095 -1.003 . . . . 0.0 110.139 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.6 ptm180 -58.12 -33.92 69.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.89 -1.131 . . . . 0.0 109.13 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.88 82.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 110.177 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.4 -43.67 63.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.819 -1.176 . . . . 0.0 110.505 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 84.1 m-85 . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 110.134 -179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 N-CA-C 115.584 1.34 . . . . 0.0 115.584 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 103' ' ' LEU . 99.4 t -58.77 -34.97 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.909 -1.12 . . . . 0.0 108.853 -178.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 38.0 mttm -55.51 -38.19 68.88 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.73 -36.4 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.7 -17.59 64.72 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -94.25 -14.86 25.06 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.491 ' O ' HG21 ' A' ' 96' ' ' ILE . 42.5 mmm -73.86 111.21 8.79 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.594 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 8.8 mt-30 -97.06 172.17 8.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.12 -29.25 29.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.46 -45.9 80.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.892 -1.13 . . . . 0.0 109.323 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.7 p30 -66.05 -36.36 83.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 108.577 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 79' ' ' LEU . 80.7 t -62.19 -44.13 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 110.487 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.84 -39.64 78.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -66.23 -39.56 89.65 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.59 0.709 . . . . 0.0 109.349 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 85' ' ' ILE . 8.2 mt -64.56 -32.68 74.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.654 -0.654 . . . . 0.0 111.136 -178.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.6 t -48.91 -35.2 6.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 4.1 pt20 -113.61 4.24 16.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.87 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.4 t0 -90.58 111.21 22.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.546 -1.346 . . . . 0.0 110.625 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.6 -16.73 0.6 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.547 -0.721 . . . . 0.0 109.658 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.34 28.32 60.12 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.301 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.845 HG22 ' ND2' ' A' ' 55' ' ' ASN . 23.2 pt -57.03 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.083 -1.246 . . . . 0.0 109.779 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.5 tt -58.63 76.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.174 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -58.26 117.39 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.3 OUTLIER -158.69 -34.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.44 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.581 ' HG2' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 65.45 -36.66 0.23 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.902 -0.498 . . . . 0.0 110.401 178.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 88' ' ' HIS . . . -73.51 -59.49 4.11 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.269 -1.443 . . . . 0.0 109.585 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.61 -33.55 72.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -1.069 . . . . 0.0 109.9 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.8 mt -64.98 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -32.38 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.89 -39.26 90.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 109.159 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.07 -35.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.189 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 71' ' ' MET . 20.8 mm -62.26 -47.63 92.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 109.489 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.69 71.95 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.508 ' N ' HD22 ' A' ' 98' ' ' ASN . 1.6 m-80 -68.97 -35.54 76.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.128 -1.219 . . . . 0.0 110.536 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.05 90.69 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 108.854 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.2 mtt180 -62.59 -35.92 81.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.05 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.95 -29.33 70.5 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.68 -40.46 96.86 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.738 HD21 HG22 ' A' ' 66' ' ' VAL . 69.3 mt -64.28 -34.08 77.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.78 -37.12 86.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 110.087 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CD1' ' A' ' 112' ' ' PHE . 8.6 ttm -65.92 -43.05 89.25 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.923 -1.11 . . . . 0.0 109.316 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -63.18 -36.75 84.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.613 -0.679 . . . . 0.0 109.352 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.77 -18.75 64.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.57 -16.36 25.78 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.91 27.06 73.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.545 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.5 mm-40 -114.58 101.57 54.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 110.065 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.97 141.67 45.89 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.16 1.907 . . . . 0.0 112.485 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CD1' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -55.5 -44.0 76.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.701 0.762 . . . . 0.0 111.246 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB1' ' HD1' ' A' ' 117' ' ' TRP . . . -70.42 -27.75 64.51 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 111.023 -178.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -61.86 -47.71 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.014 -1.054 . . . . 0.0 111.368 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.842 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.5 p90 -76.56 -33.48 58.52 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.708 -1.245 . . . . 0.0 109.671 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.842 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 1.4 t -69.48 -55.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.826 -1.171 . . . . 0.0 110.45 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.542 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 73.8 m95 -60.02 -22.89 63.2 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 109.268 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 83.1 p -70.74 -37.04 73.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.017 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 14.2 m-85 -65.67 -35.97 82.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.691 -1.256 . . . . 0.0 108.596 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 123' ' ' GLN . 4.0 t -89.22 14.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.317 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 59.16 37.05 24.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m80 46.39 24.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.061 -1.024 . . . . 0.0 109.768 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -129.74 149.01 71.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.502 -0.749 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.56 144.41 66.55 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.056 2.504 . . . . 0.0 111.841 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -111.52 137.2 49.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.866 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 87.9 mtp -92.3 131.09 37.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.728 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -78.62 -41.98 30.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 56.85 45.11 22.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.987 -1.071 . . . . 0.0 109.376 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.03 140.44 36.31 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.6 p -97.1 -24.0 15.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.101 -0.999 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -140.99 166.2 25.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 108.834 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.34 -35.07 76.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.55 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -64.74 -27.57 68.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.787 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.85 3.74 16.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 2.3 tp -91.29 123.84 63.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.56 138.19 13.49 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.023 1.815 . . . . 0.0 112.409 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.5 p -108.27 14.37 24.97 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.2 p -153.92 84.61 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.64 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.588 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.6 OUTLIER -105.15 157.14 34.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.101 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.14 -40.65 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.466 1.444 . . . . 0.0 111.848 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -41.55 70.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.021 -1.05 . . . . 0.0 108.306 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.588 ' OG ' ' N ' ' A' ' 139' ' ' THR . 97.4 p -64.53 -43.9 92.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.687 . . . . 0.0 109.373 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.57 -36.5 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.143 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -63.77 -31.16 72.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.759 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 116' ' ' VAL . 91.2 mt -70.64 -47.46 59.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.944 -1.097 . . . . 0.0 109.575 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.45 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 1.7 m -57.8 -46.1 85.13 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.536 -1.353 . . . . 0.0 110.532 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -70.5 -39.3 74.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.814 -1.179 . . . . 0.0 109.653 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.14 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.543 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.46 -35.96 81.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.057 -1.027 . . . . 0.0 109.415 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.07 -42.42 98.47 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 109.582 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -67.79 -32.43 73.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.469 -0.769 . . . . 0.0 111.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.676 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 4.0 mmp_? -68.14 -8.31 37.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.749 -1.219 . . . . 0.0 109.103 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.09 31.36 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 8.8 m-85 -95.99 117.62 31.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.84 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.586 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 23.1 mtmt -90.47 -175.28 4.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.506 0.67 . . . . 0.0 110.813 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 8.5 p90 47.45 48.6 16.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.525 0.678 . . . . 0.0 110.344 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 155' ' ' LYS . 29.6 m -119.59 39.95 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.17 164.06 0.44 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -57.17 -33.57 67.58 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.32 -1.106 . . . . 0.0 109.862 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.3 p -71.29 -34.36 70.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 108.844 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.443 HD12 ' HA2' ' A' ' 39' ' ' GLY . 16.2 mm -60.54 -44.15 95.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 146' ' ' SER . 63.2 m -65.45 -32.67 74.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.647 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -68.79 -44.77 72.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.005 -1.06 . . . . 0.0 109.564 179.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.3 p -63.92 -37.37 87.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 108.762 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 57.7 t80 -60.82 -41.43 95.73 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.826 0.822 . . . . 0.0 109.142 178.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 37.1 mmm -59.33 -40.31 85.94 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.838 -0.539 . . . . 0.0 111.457 -178.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.647 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.7 pt20 -80.21 -47.27 14.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.606 -1.309 . . . . 0.0 110.997 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.68 -17.84 64.16 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.805 -1.184 . . . . 0.0 110.634 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 66.4 m -83.32 -19.6 35.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.836 -1.165 . . . . 0.0 111.822 -178.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.51 1.25 64.23 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.542 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 94.2 mt -65.77 -35.24 80.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.704 -0.88 . . . . 0.0 109.357 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.14 135.93 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 108.915 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 58.8 m-20 -114.52 162.69 16.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.92 -179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.7 OUTLIER 92.05 79.11 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.224 0.535 . . . . 0.0 110.605 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -54.84 -70.6 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.158 -0.964 . . . . 0.0 108.629 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.62 148.28 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 108.831 179.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 129' ' ' ALA . 61.5 t -64.16 130.92 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.617 -1.302 . . . . 0.0 109.121 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.29 40.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.041 -1.27 . . . . 0.0 109.13 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.72 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.46 -25.04 57.39 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.504 ' HA ' HE21 ' A' ' 9' ' ' GLN . 2.7 t90 -99.06 27.8 4.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -1.23 . . . . 0.0 109.986 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.54 -27.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.903 -1.123 . . . . 0.0 111.321 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.7 m -79.86 -2.75 44.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.701 -1.249 . . . . 0.0 109.16 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 6' ' ' TRP . 59.4 mt-30 -66.63 -37.74 85.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.341 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.36 158.77 8.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.669 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.6 Cg_endo -60.57 -163.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.809 2.339 . . . . 0.0 112.164 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp 61.0 -46.52 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.919 -0.488 . . . . 0.0 110.054 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.6 m-85 -59.39 -37.86 79.05 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 109.451 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.0 mp -54.89 -44.75 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.638 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.4 85.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.907 -1.121 . . . . 0.0 108.995 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.552 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 23.5 t80 -65.52 -36.17 83.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -58.91 -44.29 91.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 112.214 -178.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.79 -0.55 45.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.917 -1.115 . . . . 0.0 112.271 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.784 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -99.98 -30.66 11.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.536 -1.352 . . . . 0.0 112.068 -178.48 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.784 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 89.9 mt-10 -160.29 22.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.431 -1.418 . . . . 0.0 109.825 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.582 ' HE1' ' CG ' ' A' ' 167' ' ' GLN . 3.1 t90 -106.15 72.43 0.93 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 110.461 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.04 4.41 35.85 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.285 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.0 m -115.0 -21.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.0 112.431 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 85.8 Cg_endo -86.75 150.46 8.62 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.925 1.75 . . . . 0.0 114.293 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -88.08 159.31 18.29 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.742 ' HB ' HD21 ' A' ' 31' ' ' LEU . 2.6 p -84.08 122.53 28.93 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.776 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 31' ' ' LEU . 37.8 t0 -106.12 167.25 9.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -74.52 -38.08 62.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.101 -1.624 . . . . 0.0 110.681 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -74.12 -50.46 19.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -0.901 . . . . 0.0 112.343 -177.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -57.82 -36.79 72.75 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.072 -1.018 . . . . 0.0 109.804 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 26' ' ' THR . 5.8 mp -66.76 -35.32 79.81 Favored 'General case' 0 C--N 1.286 -2.168 0 O-C-N 121.634 -0.666 . . . . 0.0 109.923 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.07 -48.11 83.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.538 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.62 -27.62 60.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.842 -1.161 . . . . 0.0 109.598 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.551 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 60.1 ttm -66.72 -50.93 61.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.664 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.44 -34.22 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 0.0 108.924 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 85.6 m -71.8 -51.95 20.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.927 . . . . 0.0 109.604 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 HH11 ' A' ' 53' ' ' ARG . 24.6 mt -67.16 -38.69 85.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 6.8 tp10 -62.75 -33.38 75.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.72 -36.4 93.24 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 4.8 mp0 -63.11 -26.58 68.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.047 -1.267 . . . . 0.0 110.691 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' OE1' ' OE2' ' A' ' 38' ' ' GLU . 1.9 pt20 -66.37 -2.94 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.853 -1.154 . . . . 0.0 110.856 -178.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -60.31 112.47 1.95 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.612 -1.305 . . . . 0.0 108.595 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.97 -7.93 2.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' ALA . 25.5 tp -109.95 144.8 37.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -1.205 . . . . 0.0 109.957 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.3 m -64.12 149.98 46.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.88 -38.48 61.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.698 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -35.81 63.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.98 -1.075 . . . . 0.0 108.309 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CE ' ' A' ' 52' ' ' LYS . 91.1 m -61.06 -44.24 97.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -69.1 -25.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.0 tt -63.79 -51.65 63.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 54.7 mttt -60.33 -44.41 95.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.661 -1.275 . . . . 0.0 108.13 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 86' ' ' ILE . 45.6 mtmt -74.29 -10.46 59.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.69 HH11 HD13 ' A' ' 37' ' ' LEU . 16.3 ttm-85 -64.63 -45.13 88.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 57.2 mp0 -70.69 -44.15 67.57 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.608 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 11.0 m-80 -69.92 -39.81 75.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.93 -1.106 . . . . 0.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.81 -48.19 82.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 111.097 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -27.33 68.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 109.266 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.54 99.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.907 . . . . 0.0 109.806 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 85' ' ' ILE . 2.7 m -74.38 -45.57 46.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.923 -1.111 . . . . 0.0 109.983 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.021 -1.049 . . . . 0.0 110.258 179.623 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 102' ' ' TYR . 55.3 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 N-CA-C 112.995 0.344 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.08 -41.07 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.949 -1.094 . . . . 0.0 109.164 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -62.99 -33.94 76.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 108.9 179.262 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.73 -41.68 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.643 -0.661 . . . . 0.0 109.552 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.755 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -67.85 -14.23 62.79 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.65 -9.49 49.41 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.281 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.9 mtp -78.18 113.07 15.79 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -95.31 177.95 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.974 . . . . 0.0 109.964 -178.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 76' ' ' VAL . 89.4 mt-10 -55.13 -28.68 54.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.783 . . . . 0.0 110.667 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -63.17 -41.24 99.2 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.106 -1.621 . . . . 0.0 109.134 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.53 -38.72 90.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.393 -0.817 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -68.67 -31.27 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.667 -1.27 . . . . 0.0 109.204 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 80' ' ' VAL . 93.4 mt-10 -66.03 -39.63 90.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.085 -1.009 . . . . 0.0 110.548 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' ' N ' ' A' ' 79' ' ' LEU . 7.6 ptp180 -74.33 -40.79 61.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.709 -1.244 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 15.9 mt -65.8 -33.21 75.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -48.57 -30.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.453 -179.417 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -106.53 -0.33 24.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.443 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 66.5 t0 -80.43 107.95 13.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.499 -1.376 . . . . 0.0 109.55 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.68 -14.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.668 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . 68.42 35.9 82.88 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -28.0 -91.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.165 -0.609 . . . . 0.0 110.592 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -175.98 -44.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -0.967 . . . . 0.0 109.575 179.679 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -64.22 156.04 29.98 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.155 -0.966 . . . . 0.0 110.034 -178.65 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -106.68 169.52 8.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.589 0.709 . . . . 0.0 109.631 -179.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.14 -33.72 63.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.51 -59.18 5.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 11.6 tptm -60.63 -42.64 97.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.723 -1.457 . . . . 0.0 110.163 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -57.17 -47.38 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.992 -1.068 . . . . 0.0 109.766 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.07 -31.99 44.69 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.742 -1.224 . . . . 0.0 108.289 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.03 77.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.013 -1.054 . . . . 0.0 109.089 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.86 -45.54 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.187 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -61.39 -36.35 72.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.899 -1.126 . . . . 0.0 109.078 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.41 -36.39 83.81 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -60.51 -35.9 77.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.537 -0.978 . . . . 0.0 108.573 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.462 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.755 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -53.27 -41.19 65.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' ' CE2' ' A' ' 154' ' ' PHE . . . -65.28 -31.55 72.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.887 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 65' ' ' PRO . 54.9 t80 -61.06 -44.36 97.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -61.41 -35.81 78.58 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.55 -34.0 77.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.331 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 36.0 ttm -63.78 -40.93 97.88 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -63.28 -38.42 91.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.636 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.417 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 95.8 mt-30 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.513 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.1 m120 -90.47 -14.73 32.2 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.48 27.87 73.54 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.965 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.4 tp10 -124.79 102.03 32.4 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.996 -1.296 . . . . 0.0 110.124 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.69 150.09 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.012 1.808 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -61.23 -45.08 96.04 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.127 0.965 . . . . 0.0 110.052 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.37 66.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.702 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -68.83 -45.18 71.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.438 -1.414 . . . . 0.0 112.214 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CE1' HG13 ' A' ' 116' ' ' VAL . 7.0 p90 -70.99 -36.22 72.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.471 -1.393 . . . . 0.0 110.501 -178.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 117' ' ' TRP . 31.3 m -65.42 -52.44 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 119.961 -1.712 . . . . 0.0 109.542 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.591 ' N ' HG23 ' A' ' 116' ' ' VAL . 50.9 m95 -56.63 -22.68 35.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 108.508 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 51.6 p -74.39 -35.7 63.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.978 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 9.7 m-85 -68.22 -29.43 68.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.195 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -94.67 18.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.513 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 122' ' ' HIS . 15.7 m120 58.95 39.43 23.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.3 t60 40.57 29.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -127.26 146.93 59.9 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.38 140.39 52.7 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.606 2.204 . . . . 0.0 112.186 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -107.23 127.97 54.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 108.783 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 mtt -101.72 122.73 44.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.67 116.41 28.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -93.38 21.86 5.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.988 . . . . 0.0 109.988 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.43 143.38 51.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.383 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 99.0 m -93.65 -31.21 14.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.4 p -133.52 162.89 30.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.02 -35.48 71.33 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.136 -0.978 . . . . 0.0 108.952 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 m -60.55 -25.38 66.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -88.89 -4.38 58.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 0.0 109.713 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.85 130.7 37.7 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 147.45 26.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.233 1.956 . . . . 0.0 112.513 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -103.44 9.53 37.68 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -144.93 98.82 3.24 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.234 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.566 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 10.0 p -109.14 155.01 41.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.59 -39.37 75.61 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.979 1.786 . . . . 0.0 111.441 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.38 62.31 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.386 -0.926 . . . . 0.0 108.786 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.566 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 94.7 p -65.31 -39.22 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.428 -0.795 . . . . 0.0 109.981 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -63.12 -34.31 77.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.537 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.67 -47.84 81.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.942 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 27.8 m -60.87 -44.96 96.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.845 -1.159 . . . . 0.0 109.543 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -67.81 -44.22 77.83 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.487 -0.758 . . . . 0.0 109.598 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.38 -41.8 80.03 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.498 -0.751 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.521 HD23 ' NH2' ' A' ' 152' ' ' ARG . 26.2 mt -68.01 -44.35 76.74 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -62.21 -42.44 99.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.66 -31.54 70.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 111.371 -178.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.521 ' NH2' HD23 ' A' ' 149' ' ' LEU . 86.5 mtm180 -80.25 4.25 18.25 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.963 -1.085 . . . . 0.0 110.159 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.41 20.74 34.14 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.946 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' ' CB ' ' A' ' 101' ' ' ALA . 36.4 m-85 -102.82 110.91 23.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.132 -1.216 . . . . 0.0 108.772 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -91.72 172.59 8.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.435 ' CE1' ' HE3' ' A' ' 91' ' ' LYS . 63.4 m-85 58.27 69.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.185 0.993 . . . . 0.0 108.842 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 158' ' ' GLY . 30.2 m -150.93 38.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -43.72 166.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -58.07 -28.96 65.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.558 -0.966 . . . . 0.0 109.217 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.7 p -73.31 -31.39 63.99 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.1 mm -69.76 -44.96 78.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 146' ' ' SER . 35.9 m -66.26 -34.84 78.91 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.537 0.684 . . . . 0.0 109.871 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -70.57 -45.29 65.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.911 . . . . 0.0 109.644 -179.613 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.509 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 93.3 p -67.81 -32.03 72.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.038 . . . . 0.0 108.422 178.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.581 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 42.9 t80 -58.67 -45.25 89.82 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.753 -0.592 . . . . 0.0 109.706 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 81.3 mtp -66.4 -38.71 88.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.582 ' CG ' ' HE1' ' A' ' 21' ' ' TRP . 1.2 tp-100 -64.26 -46.08 85.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.371 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.63 -37.75 49.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 58.3 m -56.77 -28.68 61.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 110.03 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.52 2.95 56.48 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.84 -33.85 76.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -1.089 . . . . 0.0 109.814 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.36 130.09 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 70.0 m-20 -108.55 163.82 12.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.434 -0.791 . . . . 0.0 109.939 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.7 m-20 86.13 74.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.228 0.537 . . . . 0.0 110.016 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.48 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 23.3 m80 -54.93 -61.4 2.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.815 . . . . 0.0 109.065 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.25 152.66 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.627 -0.671 . . . . 0.0 109.197 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 129' ' ' ALA . 94.0 t -60.76 130.81 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.02 -1.05 . . . . 0.0 109.026 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.12 10.54 64.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.15 . . . . 0.0 109.329 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 126.47 27.44 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.878 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.89 -20.67 20.33 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -95.53 -4.31 45.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 110.21 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.88 -26.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -3.61 28.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 110.065 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 89.6 mm-40 -65.96 -48.45 71.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.987 -1.071 . . . . 0.0 110.67 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.89 153.8 23.21 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.848 -1.158 . . . . 0.0 109.837 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.65 ' HA ' HD13 ' A' ' 14' ' ' ILE . 29.4 Cg_exo -54.77 -32.87 78.53 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.159 1.906 . . . . 0.0 113.421 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.3 mt -59.86 -35.16 74.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.774 -1.204 . . . . 0.0 110.328 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -62.21 -34.61 76.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.881 -1.137 . . . . 0.0 109.942 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.5 mp -52.63 -42.74 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.917 -1.114 . . . . 0.0 108.935 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.84 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 61.7 t80 -65.42 -42.83 92.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.53 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -64.89 -36.25 83.76 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.2 -0.938 . . . . 0.0 110.684 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -74.6 -19.03 60.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 112.303 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 33.4 p30 -88.31 -55.18 3.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.47 -177.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.689 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 16.0 pt-20 -163.73 68.74 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.093 -1.63 . . . . 0.0 111.856 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.577 ' NE1' ' OE1' ' A' ' 167' ' ' GLN . 31.3 t-105 -77.6 64.35 2.89 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.24 44.66 27.89 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.3 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.666 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.4 t -107.01 -32.85 0.18 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.344 -1.092 . . . . 0.0 110.682 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.0 Cg_endo -87.57 154.76 7.7 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 123.116 2.544 . . . . 0.0 112.705 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.94 162.17 17.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -89.08 115.25 26.48 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.421 -176.944 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.981 ' O ' HD13 ' A' ' 31' ' ' LEU . 93.8 m-20 -89.77 157.98 17.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 178.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 20.7 m -65.89 -45.86 80.46 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.051 -1.656 . . . . 0.0 111.325 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 32' ' ' PHE . 39.1 mmtm -63.6 -51.06 66.91 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.338 -0.851 . . . . 0.0 112.362 -177.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -56.9 -36.76 70.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 108.148 -179.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.4 mp -65.8 -30.6 71.27 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.24 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 28' ' ' SER . 4.8 m-30 -58.92 -50.84 72.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.39 -1.324 . . . . 0.0 107.89 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -68.38 -44.63 74.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.283 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 36.4 tpp -50.84 -49.99 57.63 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.256 -0.902 . . . . 0.0 111.121 -178.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.87 -29.09 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.6 -1.313 . . . . 0.0 109.25 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -71.25 -47.93 54.14 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -67.8 -40.35 83.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.867 -1.146 . . . . 0.0 109.503 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HB3' HG23 ' A' ' 161' ' ' ILE . 70.6 mm-40 -59.11 -36.51 75.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 108.983 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.46 -32.62 78.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.1 -1.4 44.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -1.1 . . . . 0.0 109.991 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -89.4 -7.51 55.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.005 -179.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.53 120.14 13.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.997 -1.064 . . . . 0.0 109.073 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.65 -37.84 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.7 mp -98.98 148.79 23.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 109.883 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -66.67 153.71 42.46 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -58.13 -35.21 71.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.295 -179.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -29.12 46.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 44' ' ' LEU . 16.9 m -61.27 -41.36 96.81 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.893 -1.13 . . . . 0.0 109.37 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -70.26 -30.24 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 109.181 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.73 -46.76 88.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.6 mtmt -63.29 -44.63 94.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.85 -1.156 . . . . 0.0 108.784 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -9.62 58.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 108.723 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.5 ttm180 -67.12 -46.26 74.67 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.23 -42.88 92.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 17.1 m-80 -69.41 -41.73 76.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.822 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.9 t80 -61.39 -44.52 97.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.504 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -57.6 -38.48 74.98 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.414 -0.803 . . . . 0.0 109.948 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.9 -34.51 75.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.283 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.589 ' HB3' HD22 ' A' ' 79' ' ' LEU . 87.0 m -72.94 -43.75 61.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.234 -0.916 . . . . 0.0 111.161 -178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.664 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 CA--C 1.543 0.949 0 N-CA-C 115.689 1.38 . . . . 0.0 115.689 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 0.0 112.077 -176.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -33.83 64.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.751 -1.218 . . . . 0.0 108.921 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.78 -37.41 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 0.0 108.355 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.77 -18.15 64.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.53 -6.22 50.12 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.059 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.44 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 89.8 mtp -75.62 114.16 13.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.597 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 6.3 tt0 -95.32 171.68 8.56 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.508 0.67 . . . . 0.0 110.128 -177.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 99.2 mt-10 -53.24 -28.52 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -56.56 -50.7 71.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.882 -1.136 . . . . 0.0 108.898 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.6 p30 -63.83 -37.02 85.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 108.786 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 76.3 t -56.47 -41.84 73.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 108.983 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -57.82 -40.8 80.85 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -62.32 -43.7 98.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 59' ' ' CYS . 53.2 mt -67.53 -33.69 75.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.03 -16.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 108.736 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -122.87 -9.76 8.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.271 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 76.1 m-20 -74.07 109.18 7.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.279 -1.513 . . . . 0.0 109.966 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.4 -13.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.58 -0.7 . . . . 0.0 109.615 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.11 37.2 38.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 79' ' ' LEU . 6.5 pt -53.0 -166.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mm -54.07 90.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 85' ' ' ILE . 24.4 ttp180 -62.02 112.75 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.013 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.3 m-70 169.46 81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' HIS . 25.6 ptt180 -42.64 -38.52 2.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.581 -0.7 . . . . 0.0 110.114 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.79 -54.5 36.89 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -62.54 -39.96 95.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.245 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -60.9 -39.81 83.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.836 -1.165 . . . . 0.0 108.798 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.591 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 93.3 mt-30 -55.39 -36.8 66.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.845 -1.159 . . . . 0.0 108.463 178.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.24 87.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 108.974 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.58 -44.24 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.805 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.1 mm -59.58 -42.06 86.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 108.486 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.07 91.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 12.9 m120 -57.05 -39.16 74.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.64 71.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.252 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 95.9 mtt180 -62.73 -38.64 91.31 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.88 70.31 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.33 -0.856 . . . . 0.0 108.723 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.597 ' OH ' ' CZ ' ' A' ' 32' ' ' PHE . 64.4 t80 -64.65 -42.88 95.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.91 -32.7 71.01 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.11 -32.12 71.8 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.176 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.419 ' SD ' ' HD2' ' A' ' 152' ' ' ARG . 89.9 mmm -65.66 -42.39 91.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 109' ' ' GLY . 96.9 mt-10 -71.88 -41.16 68.34 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.45 -26.74 43.94 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.88 -9.1 29.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.89 26.68 74.47 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -117.6 101.2 52.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.75 154.36 26.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.426 2.084 . . . . 0.0 112.541 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -62.18 -45.4 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.864 0.84 . . . . 0.0 109.324 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.67 -27.38 64.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 111.123 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -70.63 -52.74 19.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.711 -1.243 . . . . 0.0 111.607 -178.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 2.2 p90 -67.16 -39.89 86.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.936 -1.103 . . . . 0.0 111.041 -178.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 117' ' ' TRP . 8.1 p -65.88 -48.94 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 116' ' ' VAL . 12.8 m95 -56.45 -25.48 50.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -67.18 -45.46 76.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 110.552 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.6 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.0 m-85 -62.96 -32.25 73.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.002 -1.061 . . . . 0.0 110.17 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 171' ' ' LEU . 2.5 t -89.68 18.41 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.714 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 123' ' ' GLN . 62.5 m-20 59.31 40.54 21.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.728 -0.608 . . . . 0.0 109.78 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 43.48 26.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.802 179.332 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 120' ' ' VAL . 1.9 pt20 -139.8 154.62 71.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.63 152.31 59.19 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.858 2.372 . . . . 0.0 112.951 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 126' ' ' MET . 10.7 tm0? -109.4 127.83 54.67 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.62 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 61.1 mtm -91.03 118.63 30.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 109.692 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 116.3 26.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.347 -0.845 . . . . 0.0 109.482 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -93.78 14.0 20.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 136.54 53.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -93.63 -22.63 18.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.504 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.5 p -133.68 163.01 30.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.2 mt -59.24 -39.62 83.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.1 t -60.61 -33.23 72.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -81.96 2.64 29.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.836 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.92 142.87 25.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.117 -0.989 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.91 143.63 37.07 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.365 2.043 . . . . 0.0 112.655 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -123.98 2.58 8.69 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.8 p -154.7 85.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.11 166.87 9.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.22 -41.45 65.63 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.624 1.549 . . . . 0.0 112.283 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -41.73 80.03 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.025 -1.047 . . . . 0.0 108.676 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.0 p -66.81 -45.24 78.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.56 -40.69 96.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -67.89 -30.76 70.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 116' ' ' VAL . 2.7 tp -69.19 -42.0 76.39 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -0.752 . . . . 0.0 110.321 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.573 ' CA ' ' SG ' ' A' ' 162' ' ' CYS . 0.3 OUTLIER -63.72 -50.28 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.449 -179.1 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -65.77 -36.14 82.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.948 -1.095 . . . . 0.0 109.366 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.22 -50.47 39.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.762 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 115' ' ' PHE . 91.0 mt -63.65 -36.36 83.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 109.661 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -60.49 -38.5 84.49 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.959 -1.088 . . . . 0.0 108.767 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -62.52 -33.71 75.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.326 -0.859 . . . . 0.0 110.09 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 1.6 mmp_? -70.55 3.86 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.02 -1.05 . . . . 0.0 108.844 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.79 47.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -94.42 115.58 27.8 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.531 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -93.41 169.03 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 56.21 55.11 7.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.068 -1.02 . . . . 0.0 108.54 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -142.08 47.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.03 -178.5 3.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.1 m -61.1 -33.47 73.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.631 -0.923 . . . . 0.0 110.511 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.4 p -67.79 -35.38 78.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.898 -1.126 . . . . 0.0 108.05 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 38' ' ' GLU . 32.6 mm -65.58 -42.38 92.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.573 ' SG ' ' CA ' ' A' ' 146' ' ' SER . 77.1 m -63.89 -41.29 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.691 -0.631 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.3 -44.37 65.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.838 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.462 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 23.2 m -65.19 -38.98 92.22 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.571 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 87.1 t80 -60.21 -49.65 76.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.702 -0.624 . . . . 0.0 111.051 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 166' ' ' MET . 12.8 ptm -71.5 -38.62 71.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.868 -1.145 . . . . 0.0 109.746 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.588 HE21 ' N ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -62.55 -42.48 99.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 110.498 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.588 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -89.05 -27.56 20.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.968 -1.082 . . . . 0.0 111.018 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.571 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 24.3 m -60.87 -21.12 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.818 -1.176 . . . . 0.0 110.119 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.75 0.09 34.27 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 120' ' ' VAL . 86.0 mt -63.37 -34.09 76.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.099 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.16 138.1 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 91.0 m-20 -115.06 163.13 16.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.628 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.0 t70 86.07 77.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.465 0.65 . . . . 0.0 109.778 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 4.6 m170 -55.72 -53.13 60.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 0.0 109.084 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.8 m -147.43 38.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.468 HG22 ' OD2' ' A' ' 174' ' ' ASP . 16.2 t 61.27 111.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.472 0.653 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 44.86 71.02 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . 0.635 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 7.6 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.285 . . . . 0.0 109.388 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HE ' HG11 ' A' ' 7' ' ' VAL . 50.5 mtp180 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.691 0.758 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.1 m -62.84 149.93 43.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.052 0.93 . . . . 0.0 110.817 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.78 -41.64 94.07 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.635 -0.665 . . . . 0.0 111.458 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.697 ' CZ2' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -85.74 -2.37 58.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.544 -1.563 . . . . 0.0 109.645 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.539 HG11 ' HE ' ' A' ' 3' ' ' ARG . 2.5 t -78.16 -37.85 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.983 -1.073 . . . . 0.0 108.502 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -80.88 0.68 34.13 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.644 -0.822 . . . . 0.0 108.795 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.36 -55.43 5.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 110.867 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.52 161.0 61.27 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.37 -35.82 13.04 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.083 2.522 . . . . 0.0 112.981 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD11 ' NZ ' ' A' ' 51' ' ' LYS . 55.8 mt -62.61 -34.02 76.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.868 -1.145 . . . . 0.0 109.737 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -36.91 76.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.5 mp -52.7 -46.21 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 110.394 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.7 64.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.957 -1.089 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.1 t80 -63.49 -39.96 95.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.41 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 48.5 t-80 -76.07 -40.53 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 111.507 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.91 -15.14 63.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 112.008 -177.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 6.9 p30 -71.14 -77.09 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.255 -1.528 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -149.1 -49.07 0.15 Allowed 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.756 -1.215 . . . . 0.0 110.256 -179.443 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.697 ' CZ2' ' CZ2' ' A' ' 6' ' ' TRP . 2.9 t-105 59.03 87.22 0.08 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.185 -178.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.66 73.06 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.79 176.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 77.2 t -110.33 -32.85 0.14 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-N 119.353 1.577 . . . . 0.0 110.542 177.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.1 Cg_endo -85.54 152.07 10.33 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.2 1.933 . . . . 0.0 112.729 -178.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' OE1' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -67.48 169.03 9.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.8 p -94.09 141.14 28.88 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.05 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD1' ' OE1' ' A' ' 25' ' ' GLU . 92.0 m-20 -102.92 150.2 23.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -61.98 -35.99 80.14 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.666 -1.271 . . . . 0.0 110.052 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -74.95 -50.37 16.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 27' ' ' ASP . 7.4 ptmm? -62.54 -32.18 73.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.819 -1.175 . . . . 0.0 109.584 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.503 HD21 ' HB ' ' A' ' 26' ' ' THR . 45.8 mt -57.38 -37.5 72.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 108.539 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 35' ' ' ILE . 86.4 t80 -65.73 -45.45 82.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.882 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.38 -40.19 95.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.895 -1.128 . . . . 0.0 109.3 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 35' ' ' ILE . 8.5 tmm? -62.12 -47.04 86.35 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 111.339 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.588 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.2 tp -62.48 -27.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 -178.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.8 m -70.24 -49.98 44.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 110.003 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.9 mm? -69.33 -42.23 75.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.068 -1.02 . . . . 0.0 109.566 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -66.51 -32.07 73.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.785 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.62 40.15 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.401 ' HG3' ' NH2' ' A' ' 87' ' ' ARG . 10.3 mm100 -88.51 -0.64 57.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -1.218 . . . . 0.0 110.076 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.6 3.34 22.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 109.665 -179.567 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -75.42 117.17 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.36 -6.75 1.06 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.604 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 4.3 tp -103.51 169.18 8.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -1.116 . . . . 0.0 108.862 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -94.84 141.68 28.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 108.763 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 5.5 t-105 -55.58 -34.12 64.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -37.69 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.793 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 m -57.9 -45.36 86.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.903 -1.123 . . . . 0.0 108.616 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.85 -29.37 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 108.679 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 50' ' ' LEU . 6.8 tt -56.59 -41.33 76.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 108.673 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.611 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 12.2 mmtt -57.8 -41.49 82.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.9 -18.98 61.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -60.63 -42.48 97.0 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -69.32 -46.03 68.08 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.685 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.7 m-80 -64.12 -32.81 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 108.516 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 52' ' ' LYS . 75.3 t80 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -60.04 -38.31 82.39 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.452 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.09 82.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.854 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 79' ' ' LEU . 1.8 m -71.67 -45.08 63.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 110.258 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 29.2 m-85 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.291 -0.881 . . . . 0.0 109.765 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.494 1.503 0 CA-C-O 121.223 0.426 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.69 HG22 HD21 ' A' ' 103' ' ' LEU . 84.4 t -65.14 -44.23 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 110.219 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -63.62 -36.99 85.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 109.946 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.42 -39.38 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.92 -16.23 63.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.93 58.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 mmm -78.01 113.21 15.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 7.4 tt0 -95.68 167.43 11.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 108.906 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 96.2 mt-10 -52.63 -30.31 30.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.243 -0.911 . . . . 0.0 110.855 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -57.39 -45.19 84.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.541 -1.35 . . . . 0.0 107.704 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -62.95 -39.76 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.632 HG21 HE21 ' A' ' 93' ' ' GLN . 75.5 t -59.6 -42.7 89.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.536 -0.728 . . . . 0.0 110.026 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 80' ' ' VAL . 74.9 mm-40 -57.38 -37.11 72.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.069 -1.019 . . . . 0.0 108.396 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 78' ' ' ARG . 16.2 ttm-85 -66.19 -36.98 84.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.504 -0.747 . . . . 0.0 109.521 179.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 59' ' ' CYS . 81.4 mt -65.26 -40.34 93.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.718 . . . . 0.0 112.445 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 77' ' ' GLU . 4.4 m -59.01 -16.83 10.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.478 -1.389 . . . . 0.0 108.024 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -104.67 -14.36 15.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.507 -0.746 . . . . 0.0 109.153 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 84' ' ' GLY . 63.0 m-20 -81.78 105.52 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.09 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 65.15 -15.57 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.545 -0.722 . . . . 0.0 109.984 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 66.19 35.96 91.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 87' ' ' ARG . 2.5 pt -28.68 -101.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.156 -0.614 . . . . 0.0 111.541 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 87' ' ' ARG . 9.1 tt -168.77 -34.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.06 -179.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.631 HH11 HD11 ' A' ' 95' ' ' ILE . 5.0 mtt-85 -59.22 149.2 29.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.623 -0.673 . . . . 0.0 109.419 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -106.36 160.19 15.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.244 -0.91 . . . . 0.0 109.327 179.902 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.77 -46.24 15.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 110.049 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -53.11 36.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 51.1 mttp -61.13 -40.7 94.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 76' ' ' VAL . 66.7 mt -58.76 -47.76 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.153 -0.967 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.632 HE21 HG21 ' A' ' 76' ' ' VAL . 46.9 mm-40 -52.97 -35.03 58.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.824 -1.173 . . . . 0.0 108.941 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.42 80.63 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.631 HD11 HH11 ' A' ' 87' ' ' ARG . 81.6 mt -63.7 -47.38 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.56 -0.712 . . . . 0.0 109.422 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.614 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.9 mp -60.08 -38.97 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 108.952 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.6 -35.75 89.99 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -62.33 -37.81 87.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -1.067 . . . . 0.0 109.693 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.38 96.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.02 . . . . 0.0 109.804 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.499 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -65.87 -39.2 90.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.981 -1.074 . . . . 0.0 109.453 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -67.61 -29.06 68.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.603 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 75.8 t80 -63.41 -44.41 94.7 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.69 HD21 HG22 ' A' ' 66' ' ' VAL . 34.9 mt -62.86 -31.71 72.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -64.81 -35.97 82.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.916 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 81.0 mmm -67.93 -40.0 83.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.732 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.99 -40.07 78.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.542 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.35 -23.8 66.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.441 ' OD1' ' CD ' ' A' ' 110' ' ' GLU . 10.4 t-20 -85.71 -7.15 58.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 26.23 74.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CD ' ' OD1' ' A' ' 108' ' ' ASN . 96.1 mt-10 -124.48 102.06 33.35 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -1.071 . . . . 0.0 109.729 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -60.64 147.47 94.63 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.004 1.803 . . . . 0.0 112.066 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 102' ' ' TYR . 25.2 m-85 -57.5 -37.64 73.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.103 -0.998 . . . . 0.0 109.45 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.84 -29.86 70.83 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.526 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.56 -50.65 62.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 112.174 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 116' ' ' VAL . 4.1 p90 -72.4 -38.1 68.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.754 -1.216 . . . . 0.0 111.308 -177.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 115' ' ' PHE . 27.7 m -60.45 -49.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.117 -1.614 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.577 ' N ' HG23 ' A' ' 116' ' ' VAL . 26.1 m95 -60.32 -24.15 64.78 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 108.622 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -64.66 -42.33 95.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.0 109.912 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.59 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 37.9 m-85 -68.11 -32.74 73.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.64 16.92 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.62 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 122' ' ' HIS . 16.6 m120 56.98 36.92 28.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.698 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 121' ' ' ASN . 78.0 m80 44.03 33.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -139.15 151.83 68.47 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.01 . . . . 0.0 109.867 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.03 144.48 34.11 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.789 2.326 . . . . 0.0 112.205 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 126' ' ' MET . 2.3 tm0? -112.26 141.99 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.337 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.497 ' H ' ' NE2' ' A' ' 125' ' ' GLN . 85.2 mmm -96.65 118.01 32.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -88.63 117.49 27.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.194 -0.941 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.52 20.77 3.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.225 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.93 135.21 53.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 109.536 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.1 p -100.67 -19.88 15.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.399 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.455 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 5.0 p -128.75 158.84 37.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.47 -0.769 . . . . 0.0 109.097 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.2 mt -57.82 -40.74 80.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -73.84 -19.14 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.827 . . . . 0.0 109.568 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 131' ' ' THR . 46.6 tp10 -74.44 -9.29 58.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 108.509 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.6 132.53 46.47 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.39 135.34 22.22 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.931 1.754 . . . . 0.0 112.442 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.9 p -101.06 3.88 41.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 138' ' ' SER . 59.6 p -141.06 91.76 2.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 109.064 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.543 ' N ' ' OG ' ' A' ' 142' ' ' SER . 40.1 p -110.89 156.88 40.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.07 -39.49 70.17 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.147 1.231 . . . . 0.0 111.222 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.72 71.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 139' ' ' THR . 86.6 p -63.41 -42.06 98.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -0.789 . . . . 0.0 109.834 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.0 -39.78 94.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.883 . . . . 0.0 110.229 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.59 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -65.58 -34.85 79.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 116' ' ' VAL . 61.5 mt -66.38 -46.24 77.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 110.725 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.636 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 15.0 m -61.06 -48.82 79.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.223 -0.923 . . . . 0.0 110.726 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -37.56 81.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.01 -1.056 . . . . 0.0 109.349 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.27 74.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.118 -0.988 . . . . 0.0 109.66 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.623 HD23 ' NH2' ' A' ' 152' ' ' ARG . 19.1 mt -67.86 -42.35 81.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.966 -1.084 . . . . 0.0 108.841 179.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -59.47 -37.44 78.22 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.274 -0.891 . . . . 0.0 110.594 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -74.34 -23.04 58.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.877 -1.139 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.623 ' NH2' HD23 ' A' ' 149' ' ' LEU . 81.6 mtm180 -83.67 6.05 22.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.31 21.14 39.13 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 3.0 m-85 -99.69 112.23 24.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -1.208 . . . . 0.0 108.976 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -89.75 178.59 6.21 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 55.95 56.71 5.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 108.824 -179.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.3 40.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -50.04 157.87 1.74 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.8 m -52.73 -32.67 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.319 -1.106 . . . . 0.0 108.742 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 m -69.09 -36.01 77.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.06 -45.02 99.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.595 0.712 . . . . 0.0 109.394 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.636 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.2 m -64.32 -39.7 94.44 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.503 -0.748 . . . . 0.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -43.25 77.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.95 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.3 m -61.8 -36.54 81.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 109.589 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.591 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -61.13 -50.49 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.428 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.466 ' H ' ' HG2' ' A' ' 166' ' ' MET . 4.2 ptm -62.52 -37.62 86.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.044 -1.035 . . . . 0.0 110.268 -178.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.446 ' NE2' HG21 ' A' ' 172' ' ' VAL . 0.6 OUTLIER -67.09 -40.82 87.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 111.627 -178.652 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.39 15.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.957 -1.089 . . . . 0.0 112.752 -177.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.481 ' HB3' HG22 ' A' ' 26' ' ' THR . 0.1 OUTLIER -63.53 -50.19 70.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.664 -1.272 . . . . 0.0 112.047 -177.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.43 2.36 0.96 Allowed Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.2 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 77.1 mt -59.93 -33.91 72.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.616 -1.52 . . . . 0.0 109.121 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.446 HG21 ' NE2' ' A' ' 167' ' ' GLN . 3.3 m -129.25 150.91 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.599 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 83.7 m-20 -117.89 164.09 15.58 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.789 ' OD2' HG22 ' A' ' 177' ' ' VAL . 18.9 t0 96.05 84.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.605 0.717 . . . . 0.0 110.017 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.516 ' O ' HG13 ' A' ' 176' ' ' VAL . 43.4 m170 -55.74 -49.71 72.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.604 -0.685 . . . . 0.0 109.848 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 175' ' ' HIS . 7.1 m -157.54 24.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.71 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.789 HG22 ' OD2' ' A' ' 174' ' ' ASP . 33.9 t 56.11 111.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.429 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.36 10.0 52.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 120.924 -1.339 . . . . 0.0 109.215 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' A' ' 3' ' ' ARG . 22.0 mtm-85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -69.95 156.57 38.91 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.793 0.806 . . . . 0.0 109.516 -179.556 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.13 95.73 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.146 -0.971 . . . . 0.0 112.844 -177.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.703 ' CZ2' ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -88.76 -3.82 58.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.323 -1.693 . . . . 0.0 111.608 -177.673 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 17' ' ' HIS . 2.7 m -87.25 -31.61 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.384 -1.448 . . . . 0.0 108.58 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -62.97 -18.07 62.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -59.85 -40.97 90.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.241 0.544 . . . . 0.0 109.98 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.35 160.37 51.91 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.02 -55.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.219 2.613 . . . . 0.0 113.44 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 47' ' ' ILE . 2.3 pp -53.98 -32.01 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.703 ' CE1' ' CZ2' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -56.78 -39.17 73.59 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.896 -1.128 . . . . 0.0 109.584 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.09 -41.27 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -49.62 73.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 109.847 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 27.9 t80 -61.5 -42.73 99.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.357 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.5 t-80 -66.66 -37.63 85.18 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.516 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.41 -13.19 61.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 12.0 p30 -86.89 -70.88 0.58 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 119.855 -1.778 . . . . 0.0 110.276 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.591 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.4 mt-10 -136.86 -72.61 0.44 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.017 -1.052 . . . . 0.0 110.038 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.59 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.8 t90 47.39 49.72 15.42 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.926 -0.484 . . . . 0.0 110.721 -178.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.38 72.3 0.99 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.513 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.77 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -166.23 -30.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.01 -1.288 . . . . 0.0 112.837 179.37 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.77 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 28.6 Cg_endo -91.98 154.22 3.3 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 123.022 2.481 . . . . 0.0 112.615 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 26' ' ' THR . 85.8 tt0 -66.55 156.36 35.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.418 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 1.5 p -91.43 134.09 34.92 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.594 -177.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.8 t0 -99.85 158.14 16.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.656 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 1.3 m -57.69 -37.69 73.91 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.541 -1.349 . . . . 0.0 109.832 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 13.5 mmtt -61.29 -46.14 91.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 111.165 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -61.29 -36.93 81.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.567 -178.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 27' ' ' ASP . 4.0 mm? -57.17 -39.32 75.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.564 -0.71 . . . . 0.0 110.501 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CE1' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -70.18 -54.09 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.456 -178.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 37' ' ' LEU . 19.4 pt-20 -71.02 -30.41 66.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.902 -1.124 . . . . 0.0 109.774 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 27.8 ttm -67.16 -52.15 45.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.885 -1.134 . . . . 0.0 110.984 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.25 -31.06 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.519 -1.363 . . . . 0.0 111.117 -178.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.31 -37.21 74.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.476 -1.39 . . . . 0.0 109.802 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.471 HD21 ' HG3' ' A' ' 53' ' ' ARG . 9.0 mp -73.46 -40.27 64.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.189 -0.945 . . . . 0.0 110.247 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -36.83 84.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.0 108.685 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.44 -36.73 78.42 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -69.01 -28.51 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -1.123 . . . . 0.0 109.885 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' ' CB ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -74.38 -3.05 28.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.987 -1.071 . . . . 0.0 110.309 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.59 117.82 4.24 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.726 -1.233 . . . . 0.0 108.809 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.48 -36.72 2.02 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.6 mm? -90.92 150.58 21.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.077 -1.249 . . . . 0.0 109.984 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.5 m -63.98 154.56 33.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.785 . . . . 0.0 109.447 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -61.2 -40.92 95.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.656 179.604 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.454 HD11 HD11 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -59.22 -35.86 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -58.74 -39.26 80.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.146 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.85 -49.6 76.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 0.0 109.403 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.622 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -57.45 -43.37 83.91 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.425 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' NH2' ' CZ2' ' A' ' 46' ' ' TRP . 37.1 ttm180 -60.64 -42.02 96.1 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.623 -1.298 . . . . 0.0 107.8 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.09 -42.41 66.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.91 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 23.4 m-80 -75.12 -43.4 53.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.021 -1.05 . . . . 0.0 110.023 -179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.4 t80 -58.23 -49.1 78.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.743 -0.598 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -63.04 -33.86 76.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.969 -1.082 . . . . 0.0 109.142 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.66 76.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.143 -0.973 . . . . 0.0 109.586 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.66 -44.86 55.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.604 -179.253 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.634 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 78.0 m-85 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 120.903 -1.123 . . . . 0.0 110.636 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 N--CA 1.496 1.667 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.73 -45.8 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.899 -1.126 . . . . 0.0 109.788 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.94 -33.37 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.038 -1.039 . . . . 0.0 109.479 179.435 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.13 -38.98 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.204 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.408 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -62.89 -21.51 66.06 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -84.88 -6.39 59.34 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.9 mtp -88.42 111.6 21.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.33 -172.93 2.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -57.16 -25.55 59.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.061 -1.025 . . . . 0.0 110.504 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.02 -45.34 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.766 -1.208 . . . . 0.0 109.113 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -68.82 -36.75 78.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 109.155 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.936 ' O ' HG13 ' A' ' 80' ' ' VAL . 95.7 t -64.11 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.027 . . . . 0.0 110.081 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 80' ' ' VAL . 2.1 pt-20 -65.54 -43.7 89.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 11.1 ptp180 -75.16 -32.8 61.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.632 -1.292 . . . . 0.0 109.322 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 59' ' ' CYS . 61.3 mt -70.61 -35.58 73.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 111.851 -179.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 76' ' ' VAL . 34.8 m -50.39 -17.94 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.686 -1.259 . . . . 0.0 109.161 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.424 ' N ' ' C ' ' A' ' 79' ' ' LEU . 16.1 pt20 -117.84 -8.17 10.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.717 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 46.3 m-20 -77.95 107.86 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.61 -1.307 . . . . 0.0 109.51 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.27 -13.24 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.835 -0.541 . . . . 0.0 109.896 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.45 37.9 30.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 85' ' ' ILE . 6.2 pt -58.49 -168.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.002 -1.293 . . . . 0.0 109.498 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -65.86 93.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.313 -0.867 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 87' ' ' ARG . 32.5 ttt-85 -55.23 106.46 0.23 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 2.5 m-70 179.88 72.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 15.3 ptm180 -45.56 -42.51 11.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -51.23 -54.17 24.62 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.211 -178.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -64.09 -42.33 96.97 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.037 -1.272 . . . . 0.0 109.774 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.04 -44.26 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.405 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.2 mt-30 -56.97 -36.13 69.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.653 -1.279 . . . . 0.0 109.736 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.79 83.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 109.079 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.45 -39.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 108.926 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.88 -43.3 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.7 -35.43 81.44 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 88.5 m-20 -61.49 -35.88 78.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.378 -1.072 . . . . 0.0 108.93 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.04 91.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.847 . . . . 0.0 108.843 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 16.5 mmt180 -61.13 -36.28 79.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.48 -32.42 74.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.187 -0.946 . . . . 0.0 109.024 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -61.76 -44.23 97.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.99 -36.64 80.0 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 101' ' ' ALA . 52.8 mt-30 -64.8 -36.81 85.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.459 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 94.4 mmm -64.68 -40.09 94.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.869 -1.144 . . . . 0.0 108.826 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' GLY . 80.7 mm-40 -67.64 -38.06 83.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -58.09 -25.67 61.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -93.46 -12.6 29.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.63 22.53 71.69 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -114.56 102.78 55.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 109.556 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.52 152.68 46.21 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.953 1.768 . . . . 0.0 112.274 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.09 -40.27 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.618 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.43 69.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 111.074 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.55 -53.03 39.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.082 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CE1' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -72.1 -41.43 67.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.667 -1.27 . . . . 0.0 111.75 -177.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.816 HG12 HD21 ' A' ' 145' ' ' LEU . 30.4 m -59.69 -50.35 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 119.945 -1.722 . . . . 0.0 109.794 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.611 ' N ' HG23 ' A' ' 116' ' ' VAL . 15.0 m95 -57.26 -24.41 54.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 45.9 p -66.32 -42.13 88.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.063 -1.023 . . . . 0.0 110.404 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 39.8 m-85 -68.17 -33.35 74.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.076 -1.015 . . . . 0.0 110.283 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -88.06 15.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 109.19 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.14 37.52 26.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.699 . . . . 0.0 110.554 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 48.71 29.45 2.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -0.952 . . . . 0.0 110.424 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.43 148.97 42.62 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.784 -1.197 . . . . 0.0 109.856 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.44 147.64 90.6 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.92 2.413 . . . . 0.0 112.905 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 126' ' ' MET . 11.5 tm0? -105.4 135.24 47.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.232 -0.917 . . . . 0.0 109.223 179.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.482 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 62.9 mtt -93.04 134.66 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.2 -54.72 3.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -0.989 . . . . 0.0 109.354 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 127' ' ' THR . 22.3 mt-30 58.63 50.11 9.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 127' ' ' THR . . . -90.02 142.35 27.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.6 p -81.13 -24.6 37.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.003 -1.061 . . . . 0.0 108.916 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 p -143.51 164.67 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.13 -31.86 72.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.026 -1.046 . . . . 0.0 108.841 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -64.29 -28.73 69.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 79.8 mm-40 -78.2 -2.4 37.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -179.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.56 127.17 86.45 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.75 -1.219 . . . . 0.0 107.965 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.412 ' O ' ' CE2' ' A' ' 163' ' ' TYR . 56.9 Cg_endo -73.49 137.74 25.87 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.132 1.888 . . . . 0.0 113.292 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 163' ' ' TYR . 57.3 p -110.29 6.54 22.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 m -147.97 90.89 1.87 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.204 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.0 155.52 39.89 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -52.82 -33.89 62.91 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 120.946 1.097 . . . . 0.0 111.539 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.67 -46.21 55.0 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.24 -0.913 . . . . 0.0 109.176 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.9 p -63.47 -41.4 98.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.073 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.57 -43.92 97.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.552 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.45 -29.57 67.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.483 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.816 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -62.83 -47.21 84.39 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.627 -0.671 . . . . 0.0 110.338 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.9 t -65.59 -41.62 92.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 109.841 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -60.57 -38.71 85.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.13 -54.62 16.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.045 -1.035 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -59.09 -31.69 69.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -60.5 -43.26 97.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.503 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -72.12 -27.75 62.83 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 110.358 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.486 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -73.9 5.35 4.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.006 . . . . 0.0 109.019 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.63 25.72 52.78 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -101.4 116.39 32.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.436 -1.037 . . . . 0.0 109.452 179.203 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -94.6 176.4 6.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 56.92 53.34 8.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.19 43.82 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.29 165.69 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.59 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 18.7 m -54.06 -33.82 58.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.614 -0.933 . . . . 0.0 109.214 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.6 m -72.72 -33.59 66.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.54 -44.63 99.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.642 -0.661 . . . . 0.0 110.047 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' CYS . . . . . 0.59 ' SG ' ' O ' ' A' ' 159' ' ' THR . 0.8 OUTLIER -65.46 -46.65 78.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.093 -1.004 . . . . 0.0 109.682 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -63.74 -38.8 92.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 109.581 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.544 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 79.4 p -63.37 -37.21 86.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -63.7 -40.72 97.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.772 . . . . 0.0 110.203 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.52 ' HG2' HD12 ' A' ' 171' ' ' LEU . 25.6 mtm -66.85 -39.24 87.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 111.014 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.484 HE22 HG11 ' A' ' 172' ' ' VAL . 73.5 mm-40 -64.72 -36.15 83.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.983 -1.073 . . . . 0.0 111.084 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.51 19.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 112.295 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -68.06 -48.95 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.796 -1.19 . . . . 0.0 111.717 -177.878 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.32 -11.06 2.76 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.923 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.751 HD22 HG21 ' A' ' 120' ' ' VAL . 81.5 mt -51.13 -30.78 17.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -1.198 . . . . 0.0 109.749 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.484 HG11 HE22 ' A' ' 167' ' ' GLN . 22.0 t -119.82 150.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -137.69 163.76 30.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.657 . . . . 0.0 109.853 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 90.17 75.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.147 0.498 . . . . 0.0 110.62 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -52.37 -53.3 46.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.6 m -151.37 -162.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.18 122.92 39.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.43 68.59 1.62 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.034 -1.274 . . . . 0.0 109.18 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.385 0.612 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.34 154.43 19.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.262 -0.899 . . . . 0.0 109.282 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -92.29 0.1 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.776 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.995 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.676 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.74 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.696 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' C ' ' H ' ' A' ' 62' ' ' GLN . 53.3 m-85 -85.85 18.58 2.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ARG . 9.2 t-80 -56.97 17.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.353 -0.842 . . . . 0.0 111.112 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 60' ' ' PHE . 20.1 pt20 -79.43 -17.98 53.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.951 -1.093 . . . . 0.0 110.651 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 42.3 p90 38.32 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.454 -0.779 . . . . 0.0 110.035 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' GLN . 71.2 m-20 -127.39 91.9 44.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.03 -30.23 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.244 1.963 . . . . 0.0 112.402 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' N ' HE22 ' A' ' 62' ' ' GLN . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OE1' ' A' ' 62' ' ' GLN . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.4 t -67.84 79.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 68.93 -48.3 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 179' ' ' CYS . 31.5 t -170.27 71.71 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 183' ' ' PRO . 1.9 t80 -71.66 122.53 87.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 45.5 Cg_endo -74.77 176.01 10.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.231 1.954 . . . . 0.0 112.112 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.72 2.96 34.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.69 -72.83 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -1.113 . . . . 0.0 108.725 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 187' ' ' PRO . 1.4 mptt -111.98 -25.19 0.13 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 110.943 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 186' ' ' LYS . 31.3 Cg_exo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.691 1.594 . . . . 0.0 112.089 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.995 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.601 0.715 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 178' ' ' GLY . 53.7 tp10 -101.95 143.11 32.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' A' ' 7' ' ' VAL . 62.1 mtp180 -94.34 160.89 14.47 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 110.26 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.2 m -53.08 144.77 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 0.0 109.618 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.14 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.525 -0.734 . . . . 0.0 112.13 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.861 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -83.7 -1.03 53.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.58 -1.541 . . . . 0.0 109.478 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' A' ' 3' ' ' ARG . 1.4 t -84.93 -42.37 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 108.823 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.4 m -78.66 5.09 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.78 -108.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.632 -0.668 . . . . 0.0 109.775 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.35 143.61 93.69 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.806 . . . . 0.0 109.838 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 -28.29 58.25 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.083 1.855 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.32 -36.18 82.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.894 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 6' ' ' TRP . 4.6 m-85 -55.41 -42.11 73.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.039 . . . . 0.0 110.603 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.85 -40.82 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 110.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.682 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.19 -50.35 64.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.678 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' A' ' 168' ' ' ALA . 23.8 t80 -66.58 -39.78 88.6 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.696 -1.252 . . . . 0.0 110.164 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -69.34 -50.33 47.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 112.523 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -75.14 -5.98 47.19 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.941 -1.099 . . . . 0.0 110.567 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -94.9 -35.48 12.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.832 -1.168 . . . . 0.0 112.294 -177.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 22' ' ' GLY . 13.0 pt-20 -174.42 48.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.374 -1.454 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.715 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 20.5 t-105 -70.87 66.76 0.37 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 60.72 52.81 50.15 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.2 t -108.59 -42.29 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.36 -1.082 . . . . 0.0 109.13 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.7 Cg_endo -95.94 150.55 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.558 2.839 . . . . 0.0 112.649 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -68.27 141.63 55.82 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -99.83 147.82 25.09 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.06 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 90.9 m-20 -80.88 167.91 19.35 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.9 m -59.87 -35.07 74.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -67.15 -39.96 86.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 0.0 112.461 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -59.04 -38.92 80.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 0.0 110.309 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.718 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.5 mp -58.62 -36.94 74.84 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.686 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -63.26 -48.12 79.52 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -69.82 -30.97 68.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.783 -1.198 . . . . 0.0 109.473 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.22 -48.56 56.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.791 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 35' ' ' ILE . 8.4 tp -61.43 -28.6 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 109.476 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.6 -51.32 29.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.956 -1.09 . . . . 0.0 109.418 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.85 -37.49 73.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 108.98 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 tp10 -61.65 -37.06 82.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.4 -35.33 90.84 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.538 ' OE1' HG13 ' A' ' 49' ' ' VAL . 86.9 mt-30 -62.06 -31.48 71.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.459 -1.024 . . . . 0.0 110.995 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.631 HE22 ' CB ' ' A' ' 164' ' ' SER . 5.4 pt20 -61.26 6.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.837 -1.165 . . . . 0.0 110.53 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.59 123.3 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.3 -33.78 0.16 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 42' ' ' ALA . 73.2 mt -94.44 155.99 16.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -1.213 . . . . 0.0 110.439 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.3 m -73.18 156.62 38.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.644 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.8 OUTLIER -59.85 -32.42 70.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.42 -0.8 . . . . 0.0 109.725 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -35.82 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.993 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -57.6 -37.37 73.12 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.538 HG13 ' OE1' ' A' ' 40' ' ' GLN . 85.1 t -66.69 -36.81 78.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.885 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.97 -47.64 84.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.911 -1.118 . . . . 0.0 109.806 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.49 -49.68 74.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.818 -1.176 . . . . 0.0 108.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -65.72 -26.19 67.64 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.253 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 49' ' ' VAL . 38.1 ttm180 -55.12 -42.49 73.03 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.49 -40.85 76.78 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.093 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.777 ' N ' HD22 ' A' ' 55' ' ' ASN . 0.8 OUTLIER -64.34 -34.86 79.11 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' OH ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -60.95 -39.25 88.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 61' ' ' HIS . 46.1 mtp180 -59.66 -36.43 76.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.398 -0.814 . . . . 0.0 109.054 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.79 89.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.838 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.607 ' HB3' HD22 ' A' ' 79' ' ' LEU . 64.9 m -75.0 -44.95 45.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.64 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.596 ' O ' ' N ' ' A' ' 62' ' ' GLN . 83.1 m-85 -111.7 -41.96 3.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 33.9 t-80 63.79 -56.18 0.21 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 60' ' ' PHE . 64.6 mt-30 -71.6 -31.84 67.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 109.833 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 61' ' ' HIS . 17.2 p90 38.73 27.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.472 -0.767 . . . . 0.0 110.174 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -82.99 138.34 42.94 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.969 -1.082 . . . . 0.0 109.374 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 19.2 Cg_exo -49.97 -48.92 17.63 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.107 1.871 . . . . 0.0 112.933 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.94 -36.33 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 0.0 110.236 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -47.07 83.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 111.271 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 96' ' ' ILE . 19.4 m -67.66 -33.46 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.517 -1.364 . . . . 0.0 109.326 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.585 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.28 -20.58 65.59 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.01 -9.14 40.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.0 mmm -82.75 119.68 24.64 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.57 173.81 7.43 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.347 -0.846 . . . . 0.0 110.449 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.61 -29.85 39.71 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.52 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -60.96 -48.46 81.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.987 -1.07 . . . . 0.0 108.177 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.16 -41.52 98.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 92' ' ' ILE . 70.3 t -56.7 -42.36 76.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.682 -0.636 . . . . 0.0 109.983 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -58.18 -39.18 78.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 108.661 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 35.0 ttm-85 -61.74 -40.29 94.58 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 0.0 109.294 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 59' ' ' CYS . 63.1 mt -65.43 -33.25 75.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.608 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.18 -36.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 108.404 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -106.49 -2.93 21.44 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.829 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 84' ' ' GLY . 46.4 t0 -78.38 106.71 10.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.15 -1.594 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 67.56 -19.81 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.575 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 71.5 36.03 62.79 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 84' ' ' GLY . 1.4 pt -29.28 -94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 122.127 -0.631 . . . . 0.0 110.544 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.3 tt -170.58 -37.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.128 -0.982 . . . . 0.0 109.07 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 86' ' ' ILE . 17.9 mmt180 -72.03 156.02 39.68 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.802 0.81 . . . . 0.0 110.595 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -111.01 178.87 4.21 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 10.3 ptp180 -56.7 -43.8 80.9 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 110.58 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -56.38 -57.95 16.75 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.342 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.46 -43.25 97.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.071 -1.252 . . . . 0.0 110.161 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.631 HG21 HG13 ' A' ' 76' ' ' VAL . 19.4 mm -57.64 -52.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -50.91 -32.64 21.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.843 -1.161 . . . . 0.0 108.881 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -64.35 -42.02 96.45 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -0.925 . . . . 0.0 108.563 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 92' ' ' ILE . 80.2 mt -65.66 -42.23 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.388 -0.82 . . . . 0.0 109.121 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 68' ' ' VAL . 15.9 mm -60.02 -44.24 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.73 92.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.67 -37.85 74.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -1.11 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.58 -47.14 76.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 109.197 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.585 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 12.2 mmt180 -56.67 -38.19 71.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.92 -30.61 70.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.94 -44.0 90.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.7 mt -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.0 -37.16 83.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.028 -1.045 . . . . 0.0 109.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.09 -38.63 88.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.0 108.704 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -70.13 -40.35 74.9 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.641 0.734 . . . . 0.0 109.321 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.03 -23.74 65.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -91.93 -6.18 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.26 26.29 74.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -118.07 108.26 42.57 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -52.79 145.64 38.92 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.985 1.79 . . . . 0.0 112.381 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.618 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -59.26 -46.88 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.209 1.004 . . . . 0.0 109.372 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.82 68.33 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 109.846 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.81 -47.92 82.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.97 -1.081 . . . . 0.0 111.806 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.618 ' CD2' ' O ' ' A' ' 112' ' ' PHE . 12.5 p90 -71.62 -43.62 65.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.804 -1.185 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.598 HG11 ' CD2' ' A' ' 31' ' ' LEU . 1.9 p -65.16 -54.45 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.358 -1.464 . . . . 0.0 110.129 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.552 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 53.7 m95 -55.14 -23.45 21.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.05 -1.032 . . . . 0.0 108.25 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.72 -29.58 70.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 108.966 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 171' ' ' LEU . 2.9 t -86.94 9.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.025 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.1 35.21 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 44.2 35.22 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.748 . . . . 0.0 110.373 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -146.97 147.52 29.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.747 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.62 142.05 62.86 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.462 2.108 . . . . 0.0 112.023 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.576 HE21 ' C ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -113.0 132.06 55.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 108.814 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.576 ' C ' HE21 ' A' ' 125' ' ' GLN . 34.6 ttp -89.55 127.35 35.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.93 -1.107 . . . . 0.0 109.415 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.55 130.12 43.79 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 109.29 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -91.92 27.31 2.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.194 -0.941 . . . . 0.0 110.754 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.728 ' CB ' HD13 ' A' ' 135' ' ' ILE . . . -64.61 142.56 58.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.728 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.6 p -109.02 -35.46 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.68 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 26.7 p -124.96 162.34 24.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.474 -0.766 . . . . 0.0 109.609 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.8 -36.28 71.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 109.177 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -79.27 0.14 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 108.992 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' HB3' ' H ' ' A' ' 131' ' ' THR . 40.7 tp10 -103.01 8.4 38.92 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.728 HD13 ' CB ' ' A' ' 129' ' ' ALA . 5.5 mm -93.58 126.0 51.64 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -70.91 139.74 36.88 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.489 1.459 . . . . 0.0 112.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -111.73 5.03 18.92 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -145.72 86.91 1.75 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.682 . . . . 0.0 109.304 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.17 162.77 18.63 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.94 -41.14 77.47 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.25 1.3 . . . . 0.0 111.8 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.95 74.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 108.585 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -64.32 -44.71 90.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.501 -0.749 . . . . 0.0 109.643 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.95 -37.61 86.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.21 -31.98 64.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.54 -48.16 73.4 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.369 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -57.41 -42.27 81.98 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.63 -1.293 . . . . 0.0 108.493 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -65.0 -42.28 94.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.494 -0.754 . . . . 0.0 109.887 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.608 ' CB ' HH21 ' A' ' 152' ' ' ARG . . . -67.4 -47.9 68.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.48 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 1.8 mm? -63.48 -40.23 96.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.21 -0.931 . . . . 0.0 109.157 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -60.28 -39.11 85.7 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.959 -1.088 . . . . 0.0 110.123 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -71.42 -35.74 71.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 111.304 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.608 HH21 ' CB ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.64 -1.87 10.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.775 -1.203 . . . . 0.0 109.653 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.6 17.8 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 18.3 m-85 -93.49 111.33 22.97 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.746 -1.182 . . . . 0.0 107.816 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -97.35 174.07 6.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 0.0 110.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.432 ' CG ' ' NZ ' ' A' ' 91' ' ' LYS . 91.3 m-85 61.71 61.51 1.43 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.193 0.997 . . . . 0.0 109.092 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 158' ' ' GLY . 19.0 m -137.13 41.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -37.44 160.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.572 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 28.0 m -57.78 -30.02 65.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.57 -0.959 . . . . 0.0 109.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -77.73 -34.91 52.4 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.01 -37.56 77.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.568 . . . . 0.0 110.072 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 159' ' ' THR . 32.0 p -67.27 -47.2 71.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.176 -0.952 . . . . 0.0 109.045 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.27 -42.21 84.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.069 . . . . 0.0 109.888 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.631 ' CB ' HE22 ' A' ' 41' ' ' GLN . 20.8 m -58.79 -42.46 89.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -38.3 81.4 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 110.203 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 19.2 mtm -63.46 -36.14 82.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 110.869 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 164' ' ' SER . 35.3 mt-30 -57.57 -44.29 85.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.926 -1.109 . . . . 0.0 110.782 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.426 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . . . -89.84 -17.85 27.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.995 -1.065 . . . . 0.0 110.334 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.7 t -63.37 -26.06 68.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.486 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.53 50.09 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 120' ' ' VAL . 88.4 mt -62.53 -37.3 85.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.633 -0.922 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.8 138.27 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 109.555 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 84.1 m-20 -121.69 135.99 54.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.544 -0.722 . . . . 0.0 110.622 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER 156.06 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.715 -0.616 . . . . 0.0 110.914 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.472 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.6 m170 55.88 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.126 -0.984 . . . . 0.0 108.664 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 178' ' ' GLY . 21.5 m -136.57 40.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 177' ' ' VAL . 0.4 OUTLIER 34.8 27.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.749 0.785 . . . . 0.0 109.966 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -162.4 34.66 0.34 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.64 130.2 39.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.447 -1.031 . . . . 0.0 109.438 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 86.3 m -50.72 -39.39 51.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.0 m -70.5 -32.62 70.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.693 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 183' ' ' PRO . 69.0 t80 -77.97 135.75 62.75 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.484 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 37.3 Cg_endo -68.17 129.71 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.016 1.81 . . . . 0.0 111.902 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.91 6.54 9.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 183' ' ' PRO . 2.0 m-80 59.03 25.01 13.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.854 -0.792 . . . . 0.0 109.211 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 185' ' ' ASN . 3.1 mptp? 44.65 73.33 0.99 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.0 109.612 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo . . . . . 0 C--N 1.306 -1.676 0 C-N-CA 122.536 2.158 . . . . 0.0 112.198 -179.489 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.861 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -94.96 155.29 16.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.192 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD3' ' H ' ' A' ' 3' ' ' ARG . 0.7 OUTLIER -57.26 -103.2 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 109.505 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -117.07 159.31 22.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.546 -0.721 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.94 -44.57 97.99 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.273 -0.892 . . . . 0.0 111.214 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.82 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -83.5 -0.45 50.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.76 -1.435 . . . . 0.0 109.493 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.53 -48.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.1 m -77.79 -0.59 27.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -81.46 -49.0 11.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.495 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -147.82 158.1 42.97 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 108.945 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.755 ' HA ' HD12 ' A' ' 14' ' ' ILE . 52.8 Cg_endo -71.48 -24.52 22.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.526 2.151 . . . . 0.0 113.002 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.28 -38.53 89.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.844 -1.16 . . . . 0.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.66 -36.56 84.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 11' ' ' PRO . 40.4 mt -58.06 -44.38 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 110.41 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.683 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.71 -50.98 46.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.423 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -62.15 -37.89 86.91 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.667 -1.27 . . . . 0.0 109.48 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -73.62 -44.27 57.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.619 -0.676 . . . . 0.0 111.633 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.455 ' C ' HD22 ' A' ' 19' ' ' ASN . 64.1 m-20 -72.37 -7.74 51.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.787 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -91.33 -72.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.767 -1.208 . . . . 0.0 111.344 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.57 81.67 1.1 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.867 -1.146 . . . . 0.0 110.892 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.865 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 16.9 t-105 -80.34 71.16 7.13 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.69 55.42 22.78 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.635 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.3 t -107.01 -39.74 0.16 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.401 -1.058 . . . . 0.0 109.545 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 83.1 Cg_endo -97.88 153.24 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.497 2.798 . . . . 0.0 112.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -66.36 148.38 51.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 169' ' ' CYS . 82.8 p -95.2 159.29 15.08 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.977 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -96.2 167.94 10.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -61.98 -37.18 83.82 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.932 -1.105 . . . . 0.0 110.664 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -71.47 -39.83 70.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 112.596 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 15.3 mmmt -56.26 -37.04 69.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.653 -1.279 . . . . 0.0 109.108 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 31' ' ' LEU . 3.1 mt -57.33 -37.59 72.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.567 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -62.8 -47.03 85.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.575 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -69.9 -38.87 76.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.232 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 39.9 tpp -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.54 -0.725 . . . . 0.0 111.212 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -69.55 -27.58 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -70.03 -42.3 73.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.814 -1.179 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 5.4 mp -73.89 -39.05 64.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 72.1 mm-40 -63.43 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 110.202 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.86 -38.42 59.79 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.295 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 42' ' ' ALA . 12.0 tt0 -62.62 -24.73 67.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.963 -1.316 . . . . 0.0 110.194 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.626 ' NE2' ' H8 ' ' A' ' 189' ' ' ADK . 6.5 mm100 -48.27 -6.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.802 -1.186 . . . . 0.0 110.522 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -67.02 112.75 4.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.833 -1.167 . . . . 0.0 109.825 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.13 -27.11 0.2 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.691 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.798 HD12 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -98.16 151.14 20.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.336 . . . . 0.0 110.649 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.5 m -75.79 162.85 27.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.654 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.3 OUTLIER -62.6 -38.37 89.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.846 . . . . 0.0 110.868 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.934 -1.104 . . . . 0.0 109.127 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.798 HG21 HD12 ' A' ' 44' ' ' LEU . 15.4 m -63.45 -40.11 96.26 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.728 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -73.64 -33.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 109.635 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.17 -45.18 75.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -42.89 90.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.512 ' HD3' HG21 ' A' ' 86' ' ' ILE . 25.0 ttpp -62.86 -33.81 76.05 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.301 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -57.61 -40.33 78.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -73.33 -47.17 44.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.075 -1.016 . . . . 0.0 111.18 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.765 HD22 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -75.77 -37.56 59.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.689 -1.257 . . . . 0.0 110.427 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.765 ' N ' HD22 ' A' ' 55' ' ' ASN . 79.0 t80 -58.74 -46.36 87.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.906 -1.121 . . . . 0.0 109.1 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.621 ' O ' ' ND1' ' A' ' 61' ' ' HIS . 20.0 mmm180 -61.76 -31.27 71.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 108.898 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.6 -47.69 38.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.148 -0.97 . . . . 0.0 111.293 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.64 -44.31 43.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.974 -1.079 . . . . 0.0 111.34 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 56' ' ' TYR . 66.5 m-85 -82.08 -2.99 53.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.96 -1.087 . . . . 0.0 110.562 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' ND1' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -53.9 -30.37 45.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.952 -1.093 . . . . 0.0 109.286 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.67 -35.39 77.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 108.901 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' CG ' ' SD ' ' A' ' 71' ' ' MET . 39.3 m-85 -109.91 -88.76 0.49 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 1.2 m-20 87.62 -73.09 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.74 0 C-N-CA 124.961 1.304 . . . . 0.0 113.938 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 63' ' ' PHE . 24.4 Cg_endo -97.19 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 122.362 1.879 . . . . 0.0 114.844 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.78 -29.86 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 109.033 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.05 -35.64 79.21 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 64' ' ' ASP . 47.3 t -64.61 -36.3 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -62.48 -20.21 64.34 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.32 -10.39 32.88 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.573 ' SD ' ' CG ' ' A' ' 63' ' ' PHE . 93.2 mtp -74.08 109.69 7.77 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.3 pt20 -97.38 -176.17 3.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.787 -0.571 . . . . 0.0 110.017 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -59.86 -32.49 70.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.327 -0.858 . . . . 0.0 110.884 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.507 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 88.5 tt0 -59.49 -47.01 87.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.368 -1.457 . . . . 0.0 109.042 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -35.77 74.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.088 -1.008 . . . . 0.0 108.816 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -57.38 -43.92 83.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.436 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.93 ' O ' HG22 ' A' ' 80' ' ' VAL . 75.5 mt-10 -56.95 -35.7 69.39 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 78' ' ' ARG . 22.8 ttm-85 -59.27 -37.57 77.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 76' ' ' VAL . 1.5 mt -68.0 -33.08 73.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.665 -0.647 . . . . 0.0 112.659 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 77' ' ' GLU . 13.5 m -52.0 -17.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.7 -1.25 . . . . 0.0 110.334 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -124.0 13.79 9.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.179 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' A' ' 84' ' ' GLY . 59.8 m-20 -96.99 104.89 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.895 -1.128 . . . . 0.0 110.559 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.84 -15.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.886 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.03 37.82 49.08 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' GLY . 30.7 pt -47.86 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.567 -0.961 . . . . 0.0 110.019 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.971 HG23 ' H ' ' A' ' 87' ' ' ARG . 11.1 tt -55.63 -105.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.971 ' H ' HG23 ' A' ' 86' ' ' ILE . 13.3 tpt180 -85.03 153.5 22.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.564 -1.335 . . . . 0.0 108.262 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.499 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.42 -33.79 3.78 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.535 -0.728 . . . . 0.0 111.211 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -125.73 -22.8 4.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 111.431 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -68.24 -91.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.635 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -59.95 -29.19 68.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.126 -1.22 . . . . 0.0 109.934 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ILE . 12.2 mm -56.9 -56.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.765 -1.209 . . . . 0.0 109.484 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 92' ' ' ILE . 92.9 mt-30 -50.91 -35.41 32.98 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.295 -1.503 . . . . 0.0 108.015 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.0 80.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.78 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' ILE . 96.1 mt -69.24 -33.14 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 110.847 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.79 -48.71 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.729 -1.232 . . . . 0.0 108.82 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.88 -35.04 90.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -55.38 -38.66 69.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.186 -1.185 . . . . 0.0 109.574 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.72 79.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.849 -1.157 . . . . 0.0 109.362 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.42 -37.56 86.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.029 -1.044 . . . . 0.0 109.866 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.74 -31.4 72.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 108.905 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.721 ' CE1' ' CE1' ' A' ' 112' ' ' PHE . 63.7 t80 -61.46 -44.18 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.7 mm? -61.84 -33.96 75.1 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -64.24 -38.43 91.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.882 . . . . 0.0 111.459 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.704 ' SD ' ' CG ' ' A' ' 112' ' ' PHE . 8.2 ttm -64.49 -42.76 95.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.69 -1.256 . . . . 0.0 108.757 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.95 -37.99 84.29 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.267 0.556 . . . . 0.0 109.576 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.0 -24.55 67.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -88.18 -10.9 48.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.129 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.33 27.67 73.55 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.226 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 4.8 tt0 -116.88 103.47 52.19 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.103 -1.233 . . . . 0.0 110.343 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.77 138.59 41.29 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.833 1.689 . . . . 0.0 112.011 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.721 ' CE1' ' CE1' ' A' ' 102' ' ' TYR . 65.0 m-85 -58.8 -41.78 87.55 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.9 0.857 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.33 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 110.577 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.98 -48.3 79.44 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.109 -0.994 . . . . 0.0 112.346 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.7 p90 -70.79 -43.85 67.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.663 -1.273 . . . . 0.0 110.507 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 117' ' ' TRP . 2.4 p -65.41 -55.39 20.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.848 -1.157 . . . . 0.0 110.868 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.634 ' H ' HG13 ' A' ' 116' ' ' VAL . 48.6 m95 -55.35 -23.07 22.08 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.198 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -75.58 -33.56 60.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.094 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -65.88 -32.5 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.037 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.52 17.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 108.994 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 123' ' ' GLN . 45.3 t30 60.13 43.85 13.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.527 -0.733 . . . . 0.0 109.829 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 11.3 t-160 41.92 24.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 121' ' ' ASN . 12.5 mt-30 -126.46 151.28 72.5 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.604 -0.685 . . . . 0.0 109.285 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.76 153.73 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.523 2.149 . . . . 0.0 112.184 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 137.58 47.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 95.8 mmm -95.14 118.86 32.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.124 -0.985 . . . . 0.0 109.238 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.416 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -88.81 122.65 32.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.258 -0.901 . . . . 0.0 108.798 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -93.44 23.1 4.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -72.05 139.11 48.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 109.62 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.8 m -100.01 -21.88 15.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 108.63 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 p -140.88 163.82 31.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.248 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.58 -39.53 76.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.323 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.1 p -64.22 -29.65 70.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -80.36 5.64 14.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 108.954 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 135' ' ' ILE . 4.5 tp -83.05 129.19 62.22 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.274 -0.891 . . . . 0.0 108.905 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.73 137.0 31.71 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.132 1.888 . . . . 0.0 112.248 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 81.5 p -105.66 0.1 26.06 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.529 -0.732 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.1 t -147.18 92.34 2.1 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.39 -0.819 . . . . 0.0 108.995 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.405 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -105.03 158.26 32.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -54.17 -40.41 82.08 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.835 1.69 . . . . 0.0 111.186 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.91 -40.48 63.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 139' ' ' THR . 67.7 p -67.81 -38.02 82.75 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.176 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.12 -41.09 95.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.148 -0.97 . . . . 0.0 108.669 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.29 64.35 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.417 HD12 ' HE2' ' A' ' 115' ' ' PHE . 9.4 tp -64.26 -45.5 87.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.579 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 11.6 m -62.88 -40.47 97.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.147 -0.97 . . . . 0.0 109.595 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -60.3 -41.67 93.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.504 -0.747 . . . . 0.0 111.111 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -46.06 66.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.814 -1.178 . . . . 0.0 109.531 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.23 -36.9 82.64 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.128 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -60.6 -41.55 94.97 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.063 -1.023 . . . . 0.0 110.016 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -80.15 -16.63 54.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.742 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -84.44 2.72 39.52 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.71 19.09 49.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 6.5 m-85 -98.87 113.47 25.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.214 -1.168 . . . . 0.0 109.123 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -89.13 175.1 7.51 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.388 0.613 . . . . 0.0 110.002 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 55.13 59.31 4.08 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.701 0.762 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 157' ' ' VAL . 8.0 m -135.67 35.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.336 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.0 166.06 1.06 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.2 p -58.45 -30.7 67.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -1.104 . . . . 0.0 109.365 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.3 m -67.48 -39.63 85.27 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.02 -44.13 88.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.9 m -64.11 -41.02 97.41 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.452 -0.78 . . . . 0.0 109.846 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -44.19 89.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.241 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -61.78 -40.14 94.14 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.441 -0.787 . . . . 0.0 109.956 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.65 ' CE2' ' SG ' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -61.45 -38.5 87.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 82.1 mtp -65.58 -34.64 78.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 111.629 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.492 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 3.9 pt20 -63.68 -42.01 98.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.684 -1.26 . . . . 0.0 111.683 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.492 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -85.91 -24.65 26.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 111.697 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.718 ' O ' HG23 ' A' ' 26' ' ' THR . 0.9 OUTLIER -65.97 -22.38 66.47 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.762 -1.211 . . . . 0.0 110.431 -178.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.0 2.7 58.16 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.453 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 12.3 mt -65.92 -32.01 73.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.77 -0.841 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.3 m -127.94 148.32 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.062 -1.024 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 20.5 m120 -113.76 164.85 13.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 3.9 m-20 90.26 81.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.082 0.468 . . . . 0.0 110.257 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.543 ' O ' HG13 ' A' ' 176' ' ' VAL . 53.3 m170 -52.68 -46.14 67.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.042 -1.036 . . . . 0.0 108.825 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 178' ' ' GLY . 4.8 m -158.1 29.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.458 -0.777 . . . . 0.0 110.202 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 129' ' ' ALA . 25.9 t 53.01 2.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 109.927 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -141.05 32.37 2.11 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.943 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 182' ' ' TYR . 50.6 t -90.61 112.08 23.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 109.024 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.5 ' C ' ' H ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -42.55 -39.33 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.03 24.08 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.627 -0.67 . . . . 0.0 109.623 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 180' ' ' CYS . 55.4 t80 -105.46 103.14 41.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.748 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.55 135.65 70.31 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.895 1.73 . . . . 0.0 112.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.16 -14.17 0.56 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -84.78 8.76 16.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 108.972 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 150.44 96.75 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.942 . . . . 0.0 109.358 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 C--N 1.311 -1.409 0 C-N-CA 122.735 2.29 . . . . 0.0 112.367 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.865 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.419 0.628 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -94.31 170.3 9.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.329 -0.857 . . . . 0.0 108.866 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' A' ' 3' ' ' ARG . 38.3 mtm-85 -107.0 168.39 9.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.597 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 1.2 m -64.34 153.46 38.35 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.78 98.47 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.345 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.818 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -84.31 -3.21 58.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.61 -1.524 . . . . 0.0 109.448 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' CG2' ' CG ' ' A' ' 17' ' ' HIS . 2.2 t -80.86 -35.15 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -76.88 4.93 8.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 10' ' ' ASP . 1.3 mm-40 -90.64 -159.38 0.61 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -44.75 155.6 0.38 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.001 -1.062 . . . . 0.0 108.914 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HA ' HD12 ' A' ' 14' ' ' ILE . 20.4 Cg_endo -63.25 -16.65 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.621 2.214 . . . . 0.0 112.228 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.2 mt -58.42 -39.68 80.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.715 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -67.92 -36.24 79.84 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.061 -1.024 . . . . 0.0 109.335 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 11' ' ' PRO . 91.7 mt -58.39 -44.85 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.781 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.11 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.737 -1.227 . . . . 0.0 109.554 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.438 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 3.1 t80 -66.62 -35.84 81.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CG ' ' CG2' ' A' ' 7' ' ' VAL . 55.4 t-80 -61.58 -41.17 97.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 111.69 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 6.2 m-20 -96.6 -1.67 46.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.827 -1.17 . . . . 0.0 112.358 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -103.41 -30.05 10.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.529 -1.357 . . . . 0.0 112.324 -178.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 94.7 mt-10 -155.97 24.73 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.144 -1.597 . . . . 0.0 111.507 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.925 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.6 t90 -98.87 65.25 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.658 -1.276 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 98.49 62.58 0.87 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.687 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.796 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -157.89 -35.61 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.152 -1.205 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.796 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 98.6 Cg_endo -98.41 149.97 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.363 2.042 . . . . 0.0 112.331 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.2 166.77 22.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 169' ' ' CYS . 0.2 OUTLIER -99.45 130.16 45.69 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.567 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.91 157.1 16.99 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 m -56.69 -34.68 67.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.901 -1.125 . . . . 0.0 109.187 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -67.53 -41.57 84.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -63.92 -38.96 93.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.987 -1.071 . . . . 0.0 110.152 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -61.04 -35.97 78.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 109.656 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -66.96 -50.25 62.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 110.95 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -66.84 -40.14 87.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.79 -1.194 . . . . 0.0 109.629 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.583 ' C ' ' SD ' ' A' ' 34' ' ' MET . 10.0 tmm? -62.75 -50.72 69.95 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.684 -0.635 . . . . 0.0 110.763 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.546 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.1 tp -62.32 -27.49 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.063 -1.023 . . . . 0.0 109.978 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.07 -45.35 74.07 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.552 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' HE ' ' A' ' 53' ' ' ARG . 39.0 mt -70.39 -44.37 68.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.125 -0.985 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 161' ' ' ILE . 47.0 mm-40 -61.94 -32.79 73.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -37.3 76.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.536 ' NE2' HD11 ' A' ' 95' ' ' ILE . 91.1 mm-40 -87.07 -2.99 59.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -1.119 . . . . 0.0 110.085 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 HG11 ' A' ' 49' ' ' VAL . 73.2 mt-30 -81.5 -0.92 44.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.088 -1.007 . . . . 0.0 109.86 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.99 112.99 7.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.205 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.81 -33.62 5.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 48' ' ' THR . 5.6 mp -102.61 152.55 21.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.266 . . . . 0.0 110.325 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 m -64.56 156.73 28.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.419 -0.801 . . . . 0.0 108.97 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.667 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.2 OUTLIER -60.71 -35.09 75.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.74 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -30.92 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.84 -1.163 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.691 HG21 HD23 ' A' ' 44' ' ' LEU . 87.7 m -58.12 -42.41 85.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.836 -1.165 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -71.17 -31.93 45.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.535 -0.728 . . . . 0.0 109.379 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 tp -55.35 -49.25 72.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.085 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -58.35 -42.73 87.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -65.32 -31.05 71.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.211 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 37.7 ttm180 -54.38 -44.78 72.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -69.59 -38.95 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.597 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.16 -42.71 59.5 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 111.012 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.73 -49.99 75.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.912 -1.117 . . . . 0.0 110.495 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 61' ' ' HIS . 3.1 ptm180 -59.69 -30.79 69.03 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.939 -1.1 . . . . 0.0 109.005 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.4 93.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB3' HD22 ' A' ' 79' ' ' LEU . 71.2 m -75.15 -43.83 50.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.979 -1.075 . . . . 0.0 110.291 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 62' ' ' GLN . 76.6 m-85 -96.55 18.69 13.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.075 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' ARG . 5.1 t-80 -42.36 -24.5 0.05 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.513 -0.742 . . . . 0.0 111.367 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.435 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . 75.3 mm-40 -51.07 -29.59 13.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.74 -1.225 . . . . 0.0 109.08 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.67 50.51 10.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -0.931 . . . . 0.0 111.614 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.669 ' H ' ' CE ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -140.82 80.49 17.69 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.609 -1.307 . . . . 0.0 108.678 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -40.22 -22.78 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.272 1.981 . . . . 0.0 112.981 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' ASP . 74.0 t -65.87 -44.09 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.953 -1.092 . . . . 0.0 109.871 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.669 ' CE ' ' H ' ' A' ' 64' ' ' ASP . 5.3 pttp -65.93 -33.21 75.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.109 -0.994 . . . . 0.0 109.044 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 84.4 t -60.25 -38.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 108.951 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.532 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.04 -19.24 65.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.19 -15.51 18.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 78.1 mtp -68.88 113.78 6.6 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.3 tt0 -96.16 174.12 7.06 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.328 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 95.7 mt-10 -52.17 -32.06 34.28 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.187 -0.946 . . . . 0.0 109.779 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.98 -45.45 82.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.2 -38.1 87.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.947 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 92' ' ' ILE . 53.8 t -62.04 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 2.5 pt-20 -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.978 -1.077 . . . . 0.0 108.156 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.3 ttm-85 -63.77 -48.01 78.66 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 59' ' ' CYS . 66.2 mt -70.78 -34.47 71.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.761 -0.587 . . . . 0.0 110.99 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' LEU . 4.2 t -48.28 -17.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.513 ' N ' ' C ' ' A' ' 79' ' ' LEU . 5.7 mt-30 -110.8 -12.14 14.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 53.2 t0 -83.15 109.66 17.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.98 -17.35 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.145 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 78.79 36.89 27.66 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLY . 6.4 pt -47.19 175.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -1.197 . . . . 0.0 108.35 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.64 95.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.13 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 31.5 ptt180 -54.92 125.09 18.83 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.714 0.769 . . . . 0.0 109.305 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.7 m-70 166.96 78.36 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -48.73 -32.33 8.32 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 109.15 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.91 2.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -60.55 -39.96 89.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.327 . . . . 0.0 109.409 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.601 HG21 HG13 ' A' ' 76' ' ' VAL . 99.1 mt -59.8 -40.3 82.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.177 -0.952 . . . . 0.0 109.09 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.563 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 6.9 mm100 -55.44 -36.35 66.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 108.893 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.69 85.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.536 HD11 ' NE2' ' A' ' 40' ' ' GLN . 44.6 mm -61.05 -43.26 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.2 mm -59.59 -43.63 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.42 -36.09 90.29 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -60.06 -35.82 75.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -1.111 . . . . 0.0 109.834 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.82 -45.23 83.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.045 . . . . 0.0 109.214 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.0 mtt180 -62.2 -36.09 80.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.364 -0.835 . . . . 0.0 109.318 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.74 81.89 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.242 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.98 -43.49 95.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.8 mt -60.97 -25.62 66.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.458 ' CD ' ' C ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -67.37 -41.58 84.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 110.057 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 104' ' ' GLN . 94.2 mmm -66.13 -40.28 90.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.125 -0.984 . . . . 0.0 108.688 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.3 mm-40 -70.69 -39.93 73.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.275 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.14 -23.85 64.23 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -93.89 -9.76 36.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.3 24.35 74.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -117.46 101.64 52.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -1.117 . . . . 0.0 109.439 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.17 147.33 66.14 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.325 2.017 . . . . 0.0 112.523 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.772 ' HB3' HD12 ' A' ' 31' ' ' LEU . 35.9 m-85 -60.7 -39.35 88.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.523 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.35 -32.57 74.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.946 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.35 -46.7 82.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.669 -1.27 . . . . 0.0 112.204 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 3.8 p90 -73.02 -43.84 61.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.632 -1.292 . . . . 0.0 110.999 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 112' ' ' PHE . 2.1 p -62.87 -54.0 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.629 -1.294 . . . . 0.0 110.37 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.574 ' H ' HG13 ' A' ' 116' ' ' VAL . 34.2 m95 -53.94 -27.04 28.51 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -76.26 -35.52 58.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.576 -0.702 . . . . 0.0 109.941 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -61.89 -31.09 71.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.8 p -97.99 17.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 63.41 33.56 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.685 -0.634 . . . . 0.0 110.401 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' TRP . 95.9 m-70 51.44 29.32 5.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.136 -0.978 . . . . 0.0 110.95 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.448 ' H ' HG13 ' A' ' 120' ' ' VAL . 19.8 mt-30 -135.34 142.56 41.95 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.961 -1.087 . . . . 0.0 109.906 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.27 147.98 43.0 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.266 1.977 . . . . 0.0 111.671 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.417 ' CD ' ' N ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -120.0 126.48 50.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 90.2 mtp -102.74 116.0 31.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 108.753 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.613 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -89.72 144.43 25.98 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.43 28.35 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 111.78 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -67.64 134.87 51.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.775 -1.203 . . . . 0.0 108.504 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.9 p -97.17 -21.59 17.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 110.228 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.3 p -129.3 162.15 28.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 109.711 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.91 -36.35 76.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.412 -0.805 . . . . 0.0 109.38 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 62.4 p -68.2 -29.7 68.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.96 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -83.41 6.42 20.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -86.86 143.2 35.01 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.06 145.6 31.42 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.525 2.15 . . . . 0.0 112.865 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.43 0.6 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.481 ' O ' ' OG ' ' A' ' 138' ' ' SER . 10.8 p -145.68 94.74 2.54 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.503 ' OG1' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -106.02 153.98 39.83 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.65 -37.61 91.16 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.752 1.635 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.89 58.12 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.642 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.503 ' OG ' ' OG1' ' A' ' 139' ' ' THR . 60.6 m -63.15 -42.24 99.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.966 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -60.81 -39.62 89.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 109.231 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.54 77.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.41 -47.84 83.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 109.625 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.641 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 13.8 t -63.48 -43.71 96.51 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.196 -0.94 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.58 -44.26 94.57 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB1' ' NH1' ' A' ' 152' ' ' ARG . . . -72.17 -44.35 63.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.137 -0.977 . . . . 0.0 109.367 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.566 HD23 HH21 ' A' ' 152' ' ' ARG . 75.3 mt -65.39 -39.1 91.82 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.287 -0.883 . . . . 0.0 109.738 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.47 -39.35 90.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.973 -1.079 . . . . 0.0 109.695 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.32 -30.61 71.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 110.071 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.566 HH21 HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -72.86 0.66 10.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.954 -1.092 . . . . 0.0 108.642 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.88 26.55 24.12 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.815 -1.184 . . . . 0.0 110.297 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -97.11 112.43 24.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 0.0 109.745 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -91.38 168.96 11.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.97 64.19 1.8 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 108.482 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.69 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.1 p -153.52 41.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -53.95 -175.39 0.08 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 p -66.62 -26.7 67.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -1.048 . . . . 0.0 110.415 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -70.99 -34.05 71.01 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 38' ' ' GLU . 34.2 mm -70.5 -44.56 76.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.094 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 146' ' ' SER . 7.3 m -64.95 -36.02 83.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.522 -0.736 . . . . 0.0 109.655 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -69.69 -45.96 67.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 110.87 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.607 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 87.1 p -63.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.875 -1.141 . . . . 0.0 109.188 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -62.44 -49.28 76.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.576 -0.702 . . . . 0.0 110.365 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.05 -40.62 96.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.008 -1.057 . . . . 0.0 111.148 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.538 ' OE1' ' CD2' ' A' ' 163' ' ' TYR . 4.6 mp0 -74.76 -40.77 61.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.906 -1.121 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.86 60.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.051 -1.031 . . . . 0.0 112.536 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.436 ' HB3' HG22 ' A' ' 26' ' ' THR . 36.1 m -65.65 -48.72 71.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.676 -1.265 . . . . 0.0 111.964 -177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.65 -2.38 1.46 Allowed Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.579 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 5.9 mt -59.97 -35.33 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.94 -1.33 . . . . 0.0 110.126 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.436 ' CG1' HE21 ' A' ' 167' ' ' GLN . 0.4 OUTLIER -140.54 140.32 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.719 -1.238 . . . . 0.0 110.075 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -110.37 124.04 50.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.613 ' HB3' ' H ' ' A' ' 127' ' ' THR . 13.7 p30 180.0 54.33 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.234 -0.916 . . . . 0.0 111.475 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.9 ' O ' HG13 ' A' ' 176' ' ' VAL . 25.6 m170 -57.94 -46.34 85.22 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.48 -1.387 . . . . 0.0 108.788 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -175.23 18.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.2 t 62.32 -41.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.752 -0.593 . . . . 0.0 110.587 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -81.66 4.87 71.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 49.2 t -69.75 135.18 49.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.27 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -54.16 -37.48 64.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 99.2 m -62.15 -19.71 63.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.345 -0.847 . . . . 0.0 109.994 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -60.5 135.46 91.82 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.128 -0.983 . . . . 0.0 109.895 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.54 172.63 15.32 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.54 2.16 . . . . 0.0 112.22 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.97 0.93 54.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -88.3 -69.53 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -1.013 . . . . 0.0 109.065 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -118.38 80.3 16.08 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.703 . . . . 0.0 109.475 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.722 2.281 . . . . 0.0 112.367 -179.604 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.925 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.504 ' C ' ' SG ' ' A' ' 180' ' ' CYS . 62.8 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -100.01 139.91 34.99 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -65.96 154.58 38.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.405 -0.809 . . . . 0.0 109.844 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.35 146.74 47.11 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.551 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.3 -24.33 21.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.337 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 4.5 t90 -81.47 9.51 7.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -1.219 . . . . 0.0 109.731 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.4 -25.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.124 -0.985 . . . . 0.0 110.669 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -81.19 6.34 14.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.087 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -86.22 -59.7 2.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -111.4 156.29 41.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.229 -0.92 . . . . 0.0 110.311 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HA ' HD13 ' A' ' 14' ' ' ILE . 51.2 Cg_endo -71.28 -37.22 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.966 2.444 . . . . 0.0 113.198 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.23 -35.03 77.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.129 -0.982 . . . . 0.0 110.441 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.687 ' HE2' H3A1 ' A' ' 189' ' ' ADK . 6.4 m-85 -56.55 -36.25 69.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.971 -1.081 . . . . 0.0 109.791 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.9 mp -52.35 -43.94 41.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.69 -48.77 65.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.497 ' HA ' HD22 ' A' ' 19' ' ' ASN . 16.4 t80 -62.34 -43.13 99.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.57 -43.04 91.0 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.448 -0.782 . . . . 0.0 111.549 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.29 -14.19 61.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 111.605 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 80.6 m-20 -73.77 -69.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.626 -1.296 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -175.83 59.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' C ' ' CD1' ' A' ' 21' ' ' TRP . 7.7 t90 -96.42 68.92 2.59 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 129.04 -3.8 6.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.705 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -105.51 -16.98 0.16 Allowed Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.6 -0.941 . . . . 0.0 111.861 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 91.7 Cg_endo -86.44 150.87 9.07 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 121.833 1.688 . . . . 0.0 113.088 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.04 170.86 10.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.74 HG22 ' SG ' ' A' ' 169' ' ' CYS . 1.8 p -91.18 120.36 32.05 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.772 -1.205 . . . . 0.0 111.043 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.2 m-20 -105.74 154.14 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 m -61.58 -36.66 81.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.811 -1.181 . . . . 0.0 109.825 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -73.17 -50.81 20.53 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 110.97 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -63.94 -25.37 68.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.903 -1.123 . . . . 0.0 108.691 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -59.02 -44.29 91.7 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.5 t80 -68.94 -46.5 68.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 111.155 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.69 -35.29 77.01 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.509 -1.369 . . . . 0.0 109.761 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 38.7 ttm -68.72 -43.79 75.25 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.927 -1.108 . . . . 0.0 110.991 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.895 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.4 tp -63.19 -29.32 46.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.953 -1.092 . . . . 0.0 109.831 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.8 m -71.77 -49.21 40.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.043 -1.036 . . . . 0.0 110.413 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 1.7 mm? -66.23 -42.06 89.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.632 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 32.5 tp10 -66.39 -38.22 87.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.893 . . . . 0.0 109.746 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.55 -36.63 78.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -82.84 -7.77 59.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.221 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.549 ' OE1' ' H8 ' ' A' ' 189' ' ' ADK . 0.9 OUTLIER -89.48 4.17 50.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.075 . . . . 0.0 110.722 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 161' ' ' ILE . . . -63.88 118.82 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 0.0 110.07 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 83.19 -1.01 89.41 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 43' ' ' GLY . 4.5 mm? -107.13 163.36 13.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.243 -1.151 . . . . 0.0 110.121 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 47' ' ' ILE . 60.6 m -80.98 22.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.669 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.7 OUTLIER 62.96 -39.85 0.17 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 109.758 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' N ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -62.06 -35.47 68.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.921 -1.112 . . . . 0.0 108.225 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.415 ' CB ' HD12 ' A' ' 44' ' ' LEU . 79.0 m -59.24 -44.48 92.36 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.068 -1.02 . . . . 0.0 108.622 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.3 t -69.03 -35.83 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.11 -48.93 72.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.034 -1.041 . . . . 0.0 109.03 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -59.83 -42.62 93.97 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.566 ' HZ3' HG21 ' A' ' 86' ' ' ILE . 1.6 ttmt -62.34 -32.33 73.09 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 40.9 ttm180 -53.66 -45.68 70.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.234 -0.916 . . . . 0.0 109.244 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.02 -44.26 85.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.816 -1.153 . . . . 0.0 108.614 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.76 HD21 HG22 ' A' ' 85' ' ' ILE . 27.5 t30 -63.27 -37.95 89.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.688 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 45.1 t80 -56.84 -42.92 80.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 61' ' ' HIS . 15.8 mmm-85 -59.34 -35.59 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 108.906 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.48 96.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 110.399 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.639 ' SG ' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -78.3 -45.87 21.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 111.434 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 56' ' ' TYR . 87.4 m-85 -95.39 -47.15 6.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.9 -1.125 . . . . 0.0 109.629 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.64 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 35.1 t-80 61.98 -51.17 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.851 -0.531 . . . . 0.0 110.106 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.602 ' N ' ' O ' ' A' ' 60' ' ' PHE . 2.6 pt20 -81.61 -35.4 30.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.41 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 43.2 p90 40.26 24.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.517 -0.74 . . . . 0.0 111.144 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.653 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -78.61 153.02 78.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.506 -1.371 . . . . 0.0 108.612 179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.1 -41.77 26.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.607 2.205 . . . . 0.0 114.041 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.1 t -76.41 -38.93 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.621 -1.299 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 67' ' ' LYS . 8.6 mmpt? -63.83 -42.65 97.59 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.082 -1.011 . . . . 0.0 108.579 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 64' ' ' ASP . 93.1 t -64.97 -37.89 81.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.258 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.14 -15.64 63.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.8 -8.5 46.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.7 mtp -83.25 115.76 22.1 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.24 167.44 11.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.65 -31.89 39.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.021 -1.049 . . . . 0.0 110.132 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -55.09 -41.48 71.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 85.3 m-20 -62.45 -37.99 88.02 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 80' ' ' VAL . 55.7 t -63.2 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.472 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 80' ' ' VAL . 79.3 mm-40 -61.96 -40.79 96.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 110.136 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 5.0 ptp180 -75.54 -33.01 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 109.274 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 85' ' ' ILE . 53.6 mt -65.99 -33.23 75.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.907 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 77' ' ' GLU . 20.1 m -54.19 -17.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.67 -1.269 . . . . 0.0 108.843 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.41 -2.33 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.1 t0 -81.55 108.25 14.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.701 -1.249 . . . . 0.0 109.273 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.32 -11.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.612 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 73.39 34.41 57.54 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.76 HG22 HD21 ' A' ' 55' ' ' ASN . 20.6 pt -52.56 -177.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -1.006 . . . . 0.0 110.344 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.814 HG23 ' O ' ' A' ' 86' ' ' ILE . 19.7 tt -56.98 89.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 32.2 ptt180 -51.91 134.25 31.67 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.56 -0.713 . . . . 0.0 109.628 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.636 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.0 m-70 164.31 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 89' ' ' ARG . 15.6 ptt-85 -42.87 -32.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.079 . . . . 0.0 110.184 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.86 -62.35 6.18 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.912 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 3.2 mptt -63.79 -38.28 90.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.869 -1.371 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.425 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 2.1 pt20 -55.65 -33.08 63.74 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.82 -1.175 . . . . 0.0 108.305 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 91' ' ' LYS . . . -63.04 -38.59 91.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 108.811 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.5 -47.35 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 109.224 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.448 -0.783 . . . . 0.0 109.942 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.27 -39.8 90.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -58.93 -35.71 73.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.542 -0.975 . . . . 0.0 109.683 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.78 -46.19 83.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -56.4 -41.61 76.57 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.985 -1.072 . . . . 0.0 108.693 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -62.66 -30.04 71.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.636 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 48.7 t80 -63.32 -43.02 98.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.6 mm? -65.25 -31.9 73.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.6 -40.04 94.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -0.854 . . . . 0.0 110.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.685 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 80.6 mtp -67.52 -37.7 83.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.63 -41.08 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.085 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.05 -22.15 66.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -12.19 30.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.81 27.19 73.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.34 100.46 52.93 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.247 -1.149 . . . . 0.0 109.877 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.2 149.63 84.14 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.381 2.054 . . . . 0.0 112.146 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 33.6 m-85 -63.06 -40.07 96.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 111.195 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.17 77.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.077 -1.014 . . . . 0.0 111.062 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -63.02 -47.02 84.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.184 -0.948 . . . . 0.0 112.606 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.4 p90 -72.14 -44.52 63.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.538 -1.351 . . . . 0.0 110.718 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.584 HG13 ' N ' ' A' ' 117' ' ' TRP . 3.9 p -60.49 -52.09 65.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.603 -1.311 . . . . 0.0 109.446 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 20.7 m95 -55.66 -24.36 33.53 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 6.3 p -65.57 -42.72 91.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 109.98 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.699 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 40.5 m-85 -63.58 -36.47 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.988 -1.07 . . . . 0.0 109.171 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.719 HG21 HD22 ' A' ' 171' ' ' LEU . 1.7 t -86.37 13.9 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.697 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 121' ' ' ASN . 2.2 m120 57.17 31.97 20.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 56.17 32.67 20.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 111.437 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.69 149.75 41.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 110.066 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.58 145.0 68.77 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.809 2.34 . . . . 0.0 112.874 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.58 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.58 132.42 55.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.467 -0.771 . . . . 0.0 109.8 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.58 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.0 mtt -101.46 123.44 45.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.917 -1.114 . . . . 0.0 108.952 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -92.96 -20.41 20.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.879 -1.138 . . . . 0.0 110.16 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 57.22 44.77 21.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.383 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.616 ' CB ' HD12 ' A' ' 135' ' ' ILE . . . -65.01 148.77 51.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.45 ' C ' HG23 ' A' ' 176' ' ' VAL . 0.3 OUTLIER -110.25 -28.3 8.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.447 ' H ' ' CB ' ' A' ' 134' ' ' GLU . 5.2 p -131.9 164.15 26.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.15 -42.22 85.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 108.857 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 95.9 p -72.43 -19.33 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.447 ' CB ' ' H ' ' A' ' 131' ' ' THR . 39.2 tp10 -71.9 -10.42 59.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.807 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.1 tp -74.11 127.13 88.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 120.997 -1.064 . . . . 0.0 108.191 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.61 135.34 17.87 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.979 1.786 . . . . 0.0 113.014 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.6 p -112.13 4.94 18.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.6 t -138.77 93.19 2.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.384 -0.822 . . . . 0.0 109.003 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.57 158.9 50.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.15 -39.06 92.89 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.901 1.734 . . . . 0.0 111.21 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.64 -44.29 67.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 108.698 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 87.1 p -62.72 -40.72 98.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -63.28 -37.99 89.4 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.185 -0.947 . . . . 0.0 108.787 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -66.82 -37.45 84.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.494 -0.754 . . . . 0.0 109.991 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 145' ' ' LEU . 86.4 mt -61.93 -40.49 95.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 109.998 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.627 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 25.2 t -64.35 -51.53 62.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.9 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -67.99 -39.64 83.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.84 -1.162 . . . . 0.0 109.299 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.87 83.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.5 mt -68.02 -35.76 78.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.003 -1.061 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.71 84.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.976 -1.077 . . . . 0.0 109.68 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.09 -32.39 71.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.21 -0.932 . . . . 0.0 110.455 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.474 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 2.6 mmp_? -72.33 -1.0 13.78 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.969 -1.082 . . . . 0.0 108.826 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.08 26.93 42.5 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 2.9 m-85 -98.45 112.59 24.56 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.758 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -89.8 170.97 9.96 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 59.39 65.84 1.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.921 0.867 . . . . 0.0 109.679 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HA ' HG21 ' A' ' 161' ' ' ILE . 19.8 m -140.97 38.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -44.43 168.35 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 45.3 m -57.42 -31.67 66.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.583 -0.951 . . . . 0.0 109.134 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.4 p -71.36 -33.92 70.01 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 42' ' ' ALA . 36.3 mm -65.82 -45.43 91.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.057 0.932 . . . . 0.0 108.533 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 146' ' ' SER . 28.3 m -63.8 -45.18 90.82 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.446 0.641 . . . . 0.0 109.9 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -31.81 73.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.969 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.463 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 29.9 t -59.56 -49.25 78.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.895 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 10.6 m-85 -59.75 -47.6 85.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.471 -1.393 . . . . 0.0 109.131 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' VAL . 95.8 mmm -52.55 -42.22 64.22 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.576 -1.249 . . . . 0.0 108.389 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -43.16 18.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.51 -0.743 . . . . 0.0 111.064 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.22 13.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -0.943 . . . . 0.0 113.088 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.74 ' SG ' HG22 ' A' ' 26' ' ' THR . 0.5 OUTLIER -54.16 -18.91 4.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.628 -1.295 . . . . 0.0 110.861 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.98 -0.47 59.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.719 HD22 HG21 ' A' ' 120' ' ' VAL . 11.7 mt -58.67 -35.14 72.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.403 -1.057 . . . . 0.0 109.348 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 166' ' ' MET . 1.5 m -131.06 143.98 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.14 117.69 34.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.807 ' O ' HD11 ' A' ' 135' ' ' ILE . 12.9 p-10 -178.85 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.258 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 174' ' ' ASP . 35.8 m170 -49.1 -39.25 27.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 176' ' ' VAL . 6.2 p 175.62 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' VAL . 1.4 p 30.69 112.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.261 1.029 . . . . 0.0 112.206 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.51 48.47 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 120.696 -1.252 . . . . 0.0 110.569 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 182' ' ' TYR . 1.2 t -66.44 149.83 49.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.715 -1.462 . . . . 0.0 108.676 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.504 ' SG ' ' C ' ' A' ' 1' ' ' MET . 76.4 m -46.25 -38.41 8.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 0.0 109.11 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.6 t -75.31 13.63 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 108.889 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.581 ' N ' ' O ' ' A' ' 179' ' ' CYS . 5.6 t80 -118.74 79.22 16.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.685 -0.634 . . . . 0.0 109.467 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.68 151.66 28.64 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.582 2.188 . . . . 0.0 112.176 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 153.1 -28.28 0.8 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 186' ' ' LYS . 53.4 t30 -100.45 -28.16 13.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -1.127 . . . . 0.0 109.292 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 185' ' ' ASN . 25.7 mmtm 42.16 65.47 4.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.54 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.304 -1.767 0 C-N-CA 122.72 2.28 . . . . 0.0 112.138 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.337 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 70.2 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -104.58 141.61 36.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.505 HH12 ' CG1' ' A' ' 14' ' ' ILE . 80.5 mtm180 -83.3 171.01 14.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.19 143.24 58.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.192 0.996 . . . . 0.0 110.226 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.22 -21.51 32.98 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.186 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 2.5 t90 -77.3 -4.28 44.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.953 -1.322 . . . . 0.0 108.864 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.31 -31.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -70.54 6.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.393 -0.817 . . . . 0.0 110.035 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.36 -105.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.953 -1.092 . . . . 0.0 110.511 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.47 159.97 63.07 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.935 . . . . 0.0 110.439 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 14' ' ' ILE . 38.1 Cg_endo -68.36 -35.58 17.99 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.188 2.592 . . . . 0.0 113.245 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.89 -31.8 71.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.075 -1.015 . . . . 0.0 110.608 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE1' H3A1 ' A' ' 189' ' ' ADK . 14.5 m-85 -58.42 -33.56 69.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.073 -1.017 . . . . 0.0 110.964 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.505 ' CG1' HH12 ' A' ' 3' ' ' ARG . 3.4 mp -58.53 -41.03 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.746 -1.221 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.614 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.01 -50.74 53.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.062 . . . . 0.0 109.452 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.459 ' HA ' HD22 ' A' ' 19' ' ' ASN . 28.9 t80 -63.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.363 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -66.58 -42.86 86.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 110.373 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -74.65 -10.28 59.38 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 20.7 m-80 -69.6 -76.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.885 -1.134 . . . . 0.0 108.426 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' O ' ' C ' ' A' ' 21' ' ' TRP . 94.6 mt-10 -151.92 -39.5 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.613 ' C ' ' O ' ' A' ' 20' ' ' GLU . 8.4 t90 -3.38 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.808 0.813 . . . . 0.0 111.241 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 142.41 -23.68 2.36 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.142 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.71 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 11.6 m -125.5 10.87 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.663 -0.904 . . . . 0.0 112.676 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 73.5 Cg_endo -75.72 143.79 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.346 1.364 . . . . 0.0 112.874 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -86.12 148.3 25.76 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.64 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.6 p -88.25 120.6 29.77 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.522 -1.271 . . . . 0.0 111.436 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.881 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -105.89 159.26 16.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 m -64.67 -38.08 89.78 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.466 -1.396 . . . . 0.0 110.469 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -75.13 -49.92 18.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 111.866 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -59.23 -40.49 86.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.949 -1.094 . . . . 0.0 109.398 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.881 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.5 mp -62.69 -38.24 89.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.317 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 1.3 t80 -59.88 -39.46 85.39 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.472 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 37' ' ' LEU . 61.3 mt-10 -74.12 -39.82 63.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.311 -0.868 . . . . 0.0 108.936 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.471 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 26.0 ttm -59.5 -49.61 77.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.835 . . . . 0.0 110.848 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.436 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 10.9 tp -62.13 -35.26 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.673 -1.267 . . . . 0.0 108.817 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' CE1' ' A' ' 32' ' ' PHE . 72.2 m -67.23 -36.98 82.8 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.599 ' CD1' HH21 ' A' ' 57' ' ' ARG . 1.8 mp -73.21 -48.76 32.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 72.1 mm-40 -63.19 -37.55 87.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.826 . . . . 0.0 108.859 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.46 -35.88 92.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -74.48 -8.63 56.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.966 . . . . 0.0 109.382 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -74.21 -5.64 43.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.51 122.87 14.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.011 -1.055 . . . . 0.0 109.283 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.62 -25.99 0.28 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 42' ' ' ALA . 87.6 mt -105.48 144.61 32.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -1.144 . . . . 0.0 110.233 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -75.75 157.52 33.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.5 OUTLIER -56.91 -34.51 68.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.498 -0.752 . . . . 0.0 110.296 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -35.35 67.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -62.69 -44.31 96.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.333 -0.855 . . . . 0.0 109.983 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.31 -24.78 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.219 -0.926 . . . . 0.0 109.168 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.54 -47.87 82.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.0 110.003 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -61.4 -49.68 75.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.913 -1.117 . . . . 0.0 109.033 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.21 -5.82 50.68 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.067 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.3 ttm180 -65.9 -55.74 15.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -66.2 -45.84 79.35 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.663 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.524 ' ND2' HG22 ' A' ' 85' ' ' ILE . 39.6 t30 -66.24 -45.87 79.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.956 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 92' ' ' ILE . 56.7 t80 -63.44 -46.3 86.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.875 -1.14 . . . . 0.0 110.476 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.701 ' NH1' ' CD2' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -54.31 -34.42 60.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.856 -1.153 . . . . 0.0 109.676 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.29 79.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.087 -1.008 . . . . 0.0 110.469 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.0 m -72.79 -43.7 62.45 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 112.638 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.794 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 66.6 m-85 -111.72 -46.22 3.27 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.739 -1.225 . . . . 0.0 112.079 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.701 ' CD2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -91.25 61.23 4.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.235 -177.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.619 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 88.1 mt-30 -49.78 -35.68 23.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 156.65 -0.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.275 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.45 94.81 48.81 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.916 -1.115 . . . . 0.0 109.892 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -51.44 -26.9 22.77 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.319 2.013 . . . . 0.0 112.063 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.71 -46.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -65.4 -34.61 78.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 96' ' ' ILE . 96.6 t -60.34 -37.55 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.818 . . . . 0.0 109.53 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -69.75 -15.28 63.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.53 -5.07 49.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.525 -0.735 . . . . 0.0 109.853 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.672 ' O ' HG21 ' A' ' 96' ' ' ILE . 72.1 mmm -77.97 116.5 18.51 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -95.12 175.69 6.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.201 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.86 -33.57 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.716 -0.615 . . . . 0.0 110.542 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -57.83 -42.0 83.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' NH2' ' A' ' 78' ' ' ARG . 84.8 m-20 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.822 ' O ' HG23 ' A' ' 80' ' ' VAL . 88.1 t -62.53 -40.09 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.461 -0.774 . . . . 0.0 110.3 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 2.1 pt-20 -66.04 -40.26 90.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' NH2' ' OD1' ' A' ' 75' ' ' ASP . 7.1 ptp180 -74.61 -38.71 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.717 -1.239 . . . . 0.0 109.225 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 10.4 mt -65.49 -32.35 73.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.73 . . . . 0.0 110.615 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 76' ' ' VAL . 41.3 t -48.24 -38.36 8.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.14 2.02 45.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.738 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.7 t70 -87.43 110.6 20.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 81.67 -15.13 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.676 . . . . 0.0 109.727 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.05 37.41 49.72 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.524 HG22 ' ND2' ' A' ' 55' ' ' ASN . 1.4 pt -58.74 -166.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.197 -1.178 . . . . 0.0 110.107 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 86' ' ' ILE . 15.7 tt -66.98 94.46 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 0.0 109.463 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.615 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 4.6 mtt-85 -51.78 117.86 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.915 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.748 ' CD2' ' HZ1' ' A' ' 91' ' ' LYS . 3.5 m-70 170.62 68.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -48.73 -34.16 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.26 -62.65 6.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.748 ' HZ1' ' CD2' ' A' ' 88' ' ' HIS . 33.7 mtmm -62.44 -40.68 97.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.085 -1.244 . . . . 0.0 110.322 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 56' ' ' TYR . 43.8 mm -61.18 -43.89 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.959 -1.088 . . . . 0.0 110.513 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.99 -36.43 74.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.796 -1.19 . . . . 0.0 109.368 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -68.49 -36.59 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.17 -31.14 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.672 HG21 ' O ' ' A' ' 71' ' ' MET . 15.8 mm -58.56 -46.25 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.807 -1.183 . . . . 0.0 108.395 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.1 -33.19 86.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -56.16 -42.2 76.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.194 . . . . 0.0 109.826 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.28 -47.6 67.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.087 . . . . 0.0 108.894 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 34.1 ttm180 -56.77 -36.25 69.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.458 -0.776 . . . . 0.0 109.1 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.43 72.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.057 -1.027 . . . . 0.0 108.927 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -63.7 -42.66 97.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.0 mm? -61.44 -32.95 72.94 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -63.62 -36.69 84.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.587 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.3 tpp -64.23 -40.76 96.71 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.028 0.918 . . . . 0.0 108.899 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.6 -38.98 92.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.5 -24.31 66.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -90.97 -15.84 29.02 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.6 27.19 73.58 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.644 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.99 101.93 47.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.195 -1.179 . . . . 0.0 109.565 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.53 138.16 14.46 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.769 1.646 . . . . 0.0 112.383 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -51.88 -39.12 58.46 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.237 1.018 . . . . 0.0 109.198 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.12 65.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 109.957 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -66.63 -48.64 68.82 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 111.892 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.658 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 7.8 p90 -73.95 -38.29 64.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.54 -1.35 . . . . 0.0 111.274 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.658 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.5 m -66.92 -52.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.318 -1.489 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.589 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.3 m95 -55.03 -27.13 42.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 t -76.14 -40.0 53.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.464 -0.773 . . . . 0.0 110.541 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.28 -24.88 65.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.284 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.0 m -100.84 19.11 2.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.418 -0.801 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.63 36.19 22.55 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.76 -0.588 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 52.68 37.3 23.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 111.218 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.08 149.85 25.94 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 109.315 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.83 150.78 62.27 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 112.2 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 172' ' ' VAL . 4.6 tm0? -102.43 132.0 48.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 125' ' ' GLN . 98.2 mmm -94.23 117.81 30.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 109.233 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -93.07 119.46 32.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.64 21.45 4.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.031 -1.043 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' A' ' 127' ' ' THR . . . -67.48 142.22 56.68 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.484 -0.76 . . . . 0.0 109.697 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.512 HG22 ' CG2' ' A' ' 177' ' ' VAL . 58.2 p -106.61 -25.01 11.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 108.865 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -130.12 164.27 24.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.549 -0.72 . . . . 0.0 109.092 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.4 mt -57.66 -35.0 69.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 108.773 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.2 t -61.06 -35.95 78.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.53 0.52 25.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.2 tp -79.84 125.9 81.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.26 132.36 13.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.764 1.643 . . . . 0.0 112.725 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.0 p -111.65 7.15 20.35 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -144.92 89.35 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.527 -0.733 . . . . 0.0 109.462 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.1 p -108.99 151.93 42.16 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.601 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.63 -34.69 74.57 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.667 1.578 . . . . 0.0 111.008 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HB1' ' HE1' ' A' ' 166' ' ' MET . . . -72.95 -45.76 56.25 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.451 -0.781 . . . . 0.0 109.0 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 82.7 p -69.01 -36.69 78.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.28 -0.887 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.49 -38.95 93.1 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.76 -27.24 63.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.642 ' CD1' HG12 ' A' ' 116' ' ' VAL . 6.5 tp -69.03 -44.95 71.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.723 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 7.7 t -62.62 -47.09 85.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.913 . . . . 0.0 110.868 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -65.06 -37.83 88.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.775 -1.203 . . . . 0.0 109.879 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.36 -44.83 70.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.1 -1.0 . . . . 0.0 109.389 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.55 ' HB3' HG11 ' A' ' 157' ' ' VAL . 1.2 mm? -63.24 -38.31 90.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -61.29 -41.08 96.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.144 -0.972 . . . . 0.0 110.727 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -68.65 -36.58 78.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.97 -1.081 . . . . 0.0 111.762 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.474 ' NH2' HD22 ' A' ' 149' ' ' LEU . 14.5 mtm180 -71.11 7.05 1.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.78 -1.2 . . . . 0.0 110.143 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.68 57.2 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -95.34 112.57 24.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.218 -1.166 . . . . 0.0 108.015 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.44 174.95 6.6 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 59.68 48.65 9.12 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.564 0.697 . . . . 0.0 109.875 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 149' ' ' LEU . 35.9 m -122.27 43.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.67 160.1 0.48 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -56.8 -30.91 64.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.64 -0.917 . . . . 0.0 109.881 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -75.6 -31.45 59.95 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -72.48 -35.99 53.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.2 m -69.28 -40.58 77.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.803 . . . . 0.0 109.38 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.51 -45.24 76.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.632 ' OG ' ' N7 ' ' A' ' 189' ' ' ADK . 33.6 t -61.35 -39.34 90.23 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 109.173 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.563 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 47.9 t80 -58.54 -47.78 83.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.714 -0.616 . . . . 0.0 110.445 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.499 ' HE1' ' HB1' ' A' ' 141' ' ' ALA . 63.9 mtp -72.43 -39.56 67.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.055 -1.028 . . . . 0.0 109.536 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.668 HE21 ' N ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 110.211 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.668 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -78.34 -38.71 41.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 109.882 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 44.3 m -54.53 -16.95 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.343 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.55 -1.31 58.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 26' ' ' THR . 85.3 mt -61.95 -30.91 71.23 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -1.078 . . . . 0.0 109.525 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 125' ' ' GLN . 5.3 t -116.14 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 6.4 m-80 -125.01 162.41 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 15.3 t0 89.3 69.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.126 0.489 . . . . 0.0 110.563 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -51.59 -59.09 4.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.78 160.71 36.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.512 ' CG2' HG22 ' A' ' 130' ' ' THR . 56.3 t -60.14 113.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 120.524 -1.36 . . . . 0.0 108.793 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.75 67.33 1.69 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.747 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.565 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 5.3 t -84.33 72.17 10.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.816 -1.403 . . . . 0.0 109.222 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.5 OUTLIER 31.55 33.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.68 -0.637 . . . . 0.0 111.488 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER 178.88 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.59 -1.319 . . . . 0.0 110.391 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.526 ' CE2' ' CG ' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -87.29 114.69 59.79 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.412 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 59.1 Cg_endo -76.88 136.9 17.15 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.108 1.872 . . . . 0.0 112.054 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -135.21 -7.19 2.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.589 ' OD1' ' N ' ' A' ' 186' ' ' LYS . 31.0 p-10 -98.31 -57.37 2.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -1.18 . . . . 0.0 109.991 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.589 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 16.5 mttt -99.41 153.29 37.86 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.938 . . . . 0.0 109.491 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.634 2.223 . . . . 0.0 111.985 179.818 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.186 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 41.6 mtm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 3' ' ' ARG . 1.1 tm-20 -88.92 140.75 29.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 108.955 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.643 ' CG ' HH11 ' A' ' 3' ' ' ARG . 2.2 mtt-85 -93.65 170.65 9.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 110.502 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 3.4 m -57.94 154.75 11.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.618 0.723 . . . . 0.0 110.254 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.13 -44.79 96.11 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.487 -0.758 . . . . 0.0 112.478 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.879 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -80.49 1.22 30.23 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.474 -1.604 . . . . 0.0 109.828 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 3' ' ' ARG . 2.2 t -89.39 -47.7 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.829 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -77.77 6.28 7.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 0.8 OUTLIER -91.58 -58.93 2.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.787 -0.571 . . . . 0.0 110.492 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.88 160.0 67.15 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.615 ' HA ' HD12 ' A' ' 14' ' ' ILE . 31.5 Cg_endo -69.66 -32.11 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.041 2.494 . . . . 0.0 112.728 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.31 -40.26 89.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.121 -0.987 . . . . 0.0 109.477 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 6' ' ' TRP . 29.5 m-85 -65.92 -38.52 88.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.977 -1.077 . . . . 0.0 109.702 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 11' ' ' PRO . 89.3 mt -55.69 -40.56 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.394 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.5 -51.74 18.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.974 -1.079 . . . . 0.0 109.419 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' HA ' HD22 ' A' ' 19' ' ' ASN . 31.8 t80 -60.9 -41.54 96.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.776 . . . . 0.0 109.991 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CG ' HG21 ' A' ' 7' ' ' VAL . 57.9 t-80 -62.47 -45.5 92.75 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.639 -0.663 . . . . 0.0 110.493 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -74.06 -7.38 52.28 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.448 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.673 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 38.1 m-80 -81.01 -77.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 110.288 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' GLY . 92.7 mt-10 -154.71 71.69 0.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 110.343 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.873 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 31.4 t-105 -70.14 63.31 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 67.83 64.99 2.88 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.018 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.731 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 25.5 t -114.67 -36.2 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.425 -1.044 . . . . 0.0 109.742 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.731 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 41.6 Cg_endo -95.21 151.8 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.962 2.441 . . . . 0.0 112.989 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.34 143.24 56.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 169' ' ' CYS . 23.7 p -99.01 155.51 17.39 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.95 . . . . 0.0 111.863 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -97.72 166.68 11.37 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 m -57.33 -37.09 71.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.091 -1.006 . . . . 0.0 110.398 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -65.46 -42.47 92.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 111.035 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -59.05 -34.87 72.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.175 -0.953 . . . . 0.0 109.035 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.7 mt -65.54 -33.26 75.5 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.84 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.92 -50.33 64.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 0.0 110.181 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -68.81 -30.21 68.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.83 -1.169 . . . . 0.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 168' ' ' ALA . 6.0 tpt -70.28 -50.23 41.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.64 -29.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.62 -48.18 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.043 . . . . 0.0 110.022 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.67 -39.01 84.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 69.2 mm-40 -62.89 -31.19 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 109.939 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.34 -41.6 55.2 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.123 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 57.7 mm-40 -67.89 -29.82 69.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.694 -1.474 . . . . 0.0 110.974 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' GLN . 4.5 pt20 -41.3 -31.94 0.26 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 0.0 109.829 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.63 116.98 7.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.01 -1.056 . . . . 0.0 108.716 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.451 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 86.66 -36.74 3.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.024 HD12 HG21 ' A' ' 48' ' ' THR . 4.5 mm? -105.14 150.04 25.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.164 -1.198 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 t -76.62 150.28 36.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 1.1 t-105 -54.72 -35.59 63.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -41.04 90.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.067 -1.021 . . . . 0.0 108.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 1.024 HG21 HD12 ' A' ' 44' ' ' LEU . 44.0 m -57.84 -38.42 75.59 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 65.8 t -66.5 -37.25 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD12 ' CZ ' ' A' ' 53' ' ' ARG . 37.1 tp -56.21 -50.6 70.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.06 -1.025 . . . . 0.0 108.671 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -57.49 -37.76 73.46 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -73.18 -24.25 60.53 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 42.2 ttm180 -55.12 -45.06 75.53 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.08 -40.71 91.07 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.813 ' N ' HD22 ' A' ' 55' ' ' ASN . 0.7 OUTLIER -69.08 -31.92 71.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.886 0.85 . . . . 0.0 108.984 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 52' ' ' LYS . 58.7 t80 -56.14 -50.89 69.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.2 ptm180 -67.31 -28.0 67.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.048 -1.033 . . . . 0.0 109.22 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.57 -36.47 82.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 110.262 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.96 -45.62 26.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.66 ' O ' ' N ' ' A' ' 62' ' ' GLN . 98.4 m-85 -91.43 -48.59 6.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.926 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER 59.94 -45.32 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.694 -0.628 . . . . 0.0 111.102 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 60' ' ' PHE . 2.0 pp0? -57.73 -32.86 67.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.322 -0.861 . . . . 0.0 111.259 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.15 26.66 2.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.722 -1.236 . . . . 0.0 109.658 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.659 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -118.64 96.03 49.55 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -31.65 17.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.26 1.974 . . . . 0.0 113.168 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.91 -46.52 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.716 -1.24 . . . . 0.0 109.975 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.78 -33.02 74.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.774 -1.204 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.91 -37.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.762 ' HB1' ' NH2' ' A' ' 100' ' ' ARG . . . -65.61 -17.2 64.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.2 -10.94 29.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.642 -0.662 . . . . 0.0 109.734 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.58 114.39 9.61 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.062 -1.024 . . . . 0.0 108.686 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 8.1 tt0 -95.89 172.77 7.81 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 94.3 mt-10 -51.79 -30.48 23.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.825 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -55.48 -44.33 76.38 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 119.909 -1.744 . . . . 0.0 108.44 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 70.6 m-20 -70.86 -35.26 72.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.478 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.96 -34.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.258 -1.526 . . . . 0.0 109.3 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.72 -40.86 98.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -70.68 -34.42 71.98 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.443 -1.303 . . . . 0.0 108.967 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' C ' ' N ' ' A' ' 81' ' ' GLN . 72.9 mt -68.26 -34.94 77.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 76' ' ' VAL . 55.3 t -49.38 -19.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 79' ' ' LEU . 12.8 mt-30 -106.52 -15.42 14.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.483 -0.76 . . . . 0.0 109.912 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 82.1 m-20 -78.9 109.86 13.57 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.703 -1.199 . . . . 0.0 109.948 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.0 -18.9 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 72.32 33.01 61.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLY . 9.7 pt -36.22 156.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.649 -0.912 . . . . 0.0 110.234 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.45 -35.04 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.301 -0.874 . . . . 0.0 110.39 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.5 147.29 53.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.935 -178.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 97.7 m-70 -124.16 170.69 10.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.59 -0.694 . . . . 0.0 109.38 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 88' ' ' HIS . 35.3 ttp180 -40.14 -35.78 0.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.19 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.66 -64.02 2.34 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 7.5 mptt -60.39 -36.99 79.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -1.19 . . . . 0.0 110.107 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.548 HG21 ' HB ' ' A' ' 76' ' ' VAL . 97.7 mt -59.87 -47.48 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.632 -1.292 . . . . 0.0 109.292 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.48 HE21 HG11 ' A' ' 76' ' ' VAL . 33.4 mm-40 -52.5 -34.82 51.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.06 -1.025 . . . . 0.0 108.71 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.67 89.02 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.507 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.83 -43.75 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 108.673 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -60.41 -41.77 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 108.646 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -38.07 93.44 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.78 -37.97 71.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.446 -1.032 . . . . 0.0 109.482 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.02 83.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.027 -1.045 . . . . 0.0 109.406 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.762 ' NH2' ' HB1' ' A' ' 69' ' ' ALA . 5.1 tpp180 -55.0 -39.44 69.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.268 -0.895 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -66.82 -29.93 69.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.446 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 59.2 t80 -64.24 -43.06 96.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 103' ' ' LEU . 3.1 mm? -63.2 -28.95 70.4 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.69 -41.55 83.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.219 -0.926 . . . . 0.0 111.362 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.678 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.8 mtp -69.1 -37.29 78.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.749 -1.22 . . . . 0.0 109.293 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.65 -39.85 84.58 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.486 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -15.77 62.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -92.95 -11.98 31.96 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.39 21.44 79.59 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.68 101.24 53.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.192 -1.181 . . . . 0.0 109.374 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.35 146.1 95.86 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.157 1.905 . . . . 0.0 112.273 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.678 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 24.6 m-85 -59.66 -45.21 92.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.98 -28.41 69.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 118' ' ' SER . 17.3 t70 -59.45 -52.46 65.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.964 -1.085 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -75.08 -39.87 60.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.64 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 18.5 t -59.0 -54.75 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 120.619 -1.301 . . . . 0.0 109.9 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 122' ' ' HIS . 56.1 m95 -62.02 -21.99 65.34 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 108.958 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 50.6 m -68.46 -37.47 80.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 109.254 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 18.3 m-85 -69.37 -31.26 69.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.403 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.611 ' O ' HG12 ' A' ' 120' ' ' VAL . 39.3 t -87.99 15.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.836 -1.165 . . . . 0.0 109.711 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.585 ' OD1' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER 78.78 11.38 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.699 -0.626 . . . . 0.0 109.836 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER 65.7 20.57 11.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 110.893 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 15.1 mt-30 -146.51 150.94 42.07 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.941 -1.099 . . . . 0.0 109.236 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -49.24 142.25 22.11 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.862 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -110.77 142.62 42.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.565 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 92.1 mmm -99.93 130.26 46.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -92.73 123.04 35.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.093 -1.005 . . . . 0.0 109.879 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -91.93 27.35 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.79 . . . . 0.0 110.284 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -91.06 132.97 35.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.5 p -93.51 -22.36 18.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.127 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 49.4 p -133.64 167.85 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.016 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 -33.56 73.41 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.6 t -73.92 -13.17 60.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 110.43 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -94.16 4.05 54.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mm -92.49 122.35 64.57 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.83 140.78 32.56 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.84 1.693 . . . . 0.0 112.516 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.9 p -101.62 3.35 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.8 p -144.99 87.5 1.83 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.442 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.76 155.17 36.64 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -54.51 -36.52 88.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.879 1.719 . . . . 0.0 110.741 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.74 -43.12 59.99 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.809 -0.756 . . . . 0.0 108.984 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.8 p -70.18 -38.13 75.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.139 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.28 -38.93 91.23 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.177 -0.952 . . . . 0.0 108.881 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -68.83 -34.55 75.68 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.298 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mp -57.5 -46.29 83.95 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 0.0 108.639 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.545 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 8.9 t -60.7 -50.29 74.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.105 -0.997 . . . . 0.0 108.954 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -61.29 -40.41 94.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 109.267 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.99 22.34 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.83 -33.13 74.6 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -61.32 -42.24 98.34 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.982 -1.074 . . . . 0.0 109.671 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -68.45 -28.4 67.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.945 . . . . 0.0 110.55 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.408 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 3.3 mmp_? -72.7 1.35 8.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.906 -1.121 . . . . 0.0 108.675 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 78.59 27.32 57.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.64 112.88 24.58 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.652 0.739 . . . . 0.0 109.848 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -88.1 176.77 7.14 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.13 62.72 1.56 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.011 -1.056 . . . . 0.0 108.23 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.6 m -144.03 41.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -51.42 154.79 4.07 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 m -52.54 -32.01 38.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.27 -1.135 . . . . 0.0 109.557 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -72.09 -29.93 64.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.25 -0.906 . . . . 0.0 108.725 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.67 -44.92 96.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.815 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 146' ' ' SER . 97.9 m -60.8 -39.02 87.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 110.05 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.47 -47.81 53.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 111.063 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.499 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 19.9 m -63.43 -36.77 84.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.044 -1.035 . . . . 0.0 108.696 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.52 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 5.3 t80 -60.15 -46.24 90.35 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.153 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 171' ' ' LEU . 12.5 ptp -71.49 -34.08 69.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.511 -1.368 . . . . 0.0 110.626 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.503 ' OE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -61.48 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.818 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.564 ' HB3' ' CE ' ' A' ' 34' ' ' MET . . . -87.14 -22.98 25.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.199 -0.938 . . . . 0.0 111.592 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.609 ' O ' HG23 ' A' ' 26' ' ' THR . 1.5 m -68.76 -19.31 64.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.964 -1.085 . . . . 0.0 111.102 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.49 0.83 57.93 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 166' ' ' MET . 11.5 mt -63.37 -30.97 72.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.615 -0.932 . . . . 0.0 109.426 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.07 142.15 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 75.0 m-20 -111.71 164.11 13.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.794 ' OD2' HG22 ' A' ' 177' ' ' VAL . 5.5 t0 86.71 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.597 0.713 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.477 ' CD2' ' CD1' ' A' ' 21' ' ' TRP . 20.9 m170 -54.35 -48.26 71.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 178' ' ' GLY . 0.3 OUTLIER -152.07 38.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.484 -179.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.794 HG22 ' OD2' ' A' ' 174' ' ' ASP . 24.0 t 45.15 13.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.0 110.672 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -157.4 31.74 0.53 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.117 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 7.1 t -93.77 146.25 24.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -1.222 . . . . 0.0 109.873 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -67.84 -21.4 65.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.702 . . . . 0.0 110.762 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.5 t -97.59 -29.41 13.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.942 -1.099 . . . . 0.0 112.573 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.46 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -67.47 133.05 92.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.215 -1.553 . . . . 0.0 109.81 -178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.82 126.98 11.82 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.433 2.089 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.96 -32.52 0.8 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -155.52 11.95 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -1.001 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.34 82.7 24.33 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.516 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 -179.598 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.879 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' H3 ' ' HA ' ' A' ' 180' ' ' CYS . 70.5 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.69 154.38 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -75.04 159.31 31.88 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.37 152.93 40.69 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.274 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.03 -25.86 25.59 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.303 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 1.8 t90 -75.78 13.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.028 -1.278 . . . . 0.0 109.623 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.9 t -138.74 -23.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 110.269 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -71.83 5.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 109.949 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -115.39 -75.45 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.341 -0.85 . . . . 0.0 110.57 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.02 139.46 90.46 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.986 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 -53.21 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.526 2.151 . . . . 0.0 113.194 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -54.91 -33.91 62.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.912 -1.118 . . . . 0.0 109.742 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.701 ' HE2' H3A1 ' A' ' 189' ' ' ADK . 3.3 m-85 -52.89 -40.18 63.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.12 -39.84 43.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.412 -0.805 . . . . 0.0 109.447 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.636 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -72.18 -51.1 22.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.96 -1.087 . . . . 0.0 109.535 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 19' ' ' ASN . 22.7 t80 -60.76 -41.08 94.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 0.0 109.72 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.608 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 39.3 t-80 -58.66 -44.85 90.26 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.47 -0.769 . . . . 0.0 109.618 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.92 -30.36 68.81 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.645 -0.659 . . . . 0.0 110.836 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 55.9 m-80 -60.21 -53.56 56.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 111.126 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' GLY . 10.9 pt-20 176.05 72.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.2 -0.938 . . . . 0.0 110.334 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.709 ' CZ3' ' HC2' ' A' ' 189' ' ' ADK . 44.9 t-105 -70.52 60.73 0.22 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 71.27 49.67 25.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.604 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -107.18 -42.63 0.13 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.322 -1.105 . . . . 0.0 110.563 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.9 Cg_endo -91.14 151.87 3.8 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.261 2.641 . . . . 0.0 113.183 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.39 144.21 54.82 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 p -99.16 148.79 23.73 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.102 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 31' ' ' LEU . 76.8 m-20 -96.41 166.43 11.7 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -56.01 -31.5 63.13 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.777 -1.202 . . . . 0.0 109.632 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -65.65 -43.0 90.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.565 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmtm -63.72 -34.96 79.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.131 -0.981 . . . . 0.0 109.125 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 27' ' ' ASP . 1.4 mm? -56.22 -41.67 76.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.718 -0.614 . . . . 0.0 109.643 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -69.57 -43.17 73.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' O ' HD22 ' A' ' 37' ' ' LEU . 77.1 mt-10 -69.35 -45.39 69.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.86 -1.15 . . . . 0.0 109.332 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.9 ttm -62.19 -51.05 69.38 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.493 -0.754 . . . . 0.0 111.146 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 tp -61.27 -26.16 38.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.853 -1.154 . . . . 0.0 109.716 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.45 -54.02 19.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.941 -1.099 . . . . 0.0 109.737 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.634 ' H ' HD22 ' A' ' 37' ' ' LEU . 2.0 mm? -71.88 -38.51 69.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.145 . . . . 0.0 108.843 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 3.5 tp10 -62.13 -32.34 72.91 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.514 -0.741 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.68 -13.73 82.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.533 HE21 HD13 ' A' ' 95' ' ' ILE . 89.5 mt-30 -92.91 -8.38 43.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.311 . . . . 0.0 111.319 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.667 ' NE2' ' N7 ' ' A' ' 189' ' ' ADK . 2.2 pt20 -80.38 1.83 27.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.573 -1.329 . . . . 0.0 110.176 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -62.87 117.58 6.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -29.31 1.66 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . 19.1 mt -98.46 146.12 26.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -1.114 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 m -67.81 152.66 45.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.507 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.4 OUTLIER -60.21 -37.13 79.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.675 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -67.73 -35.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.088 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.5 m -59.57 -42.12 91.73 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.959 -1.088 . . . . 0.0 108.125 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 54.0 t -67.72 -35.06 71.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HB3' HD13 ' A' ' 47' ' ' ILE . 7.3 tt -56.36 -51.67 67.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.148 -0.97 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -57.9 -43.13 85.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -66.92 -28.84 68.62 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.06 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.7 ttm180 -53.52 -43.79 68.61 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.822 -1.174 . . . . 0.0 109.097 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -73.25 -49.14 29.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.216 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 24.0 p30 -80.95 -42.62 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.757 -1.214 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.601 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 53.1 t80 -62.76 -44.64 95.67 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.809 -1.182 . . . . 0.0 109.937 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.415 HH21 ' CD2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -61.61 -31.82 71.92 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.37 -42.7 98.88 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.018 -1.052 . . . . 0.0 110.335 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB3' HD22 ' A' ' 79' ' ' LEU . 35.3 m -78.37 -43.26 28.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.0 113.087 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 93.3 m-85 -107.4 7.38 29.03 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.734 -1.229 . . . . 0.0 112.398 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 65.2 t60 -151.82 60.18 0.86 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.551 -1.343 . . . . 0.0 108.562 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.679 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 89.6 mt-30 -57.41 -42.93 83.25 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.441 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.679 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 85.9 m-85 -163.8 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.217 -0.993 . . . . 0.0 112.288 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' H ' ' HE3' ' A' ' 67' ' ' LYS . 0.8 OUTLIER -100.03 146.24 31.58 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 111.136 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.43 -17.41 30.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.26 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.43 -43.65 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 3.1 mtmp? -67.45 -38.18 84.09 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 60' ' ' PHE . 85.8 t -61.69 -39.25 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.83 -14.94 63.37 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 -9.64 53.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.648 ' O ' HG21 ' A' ' 96' ' ' ILE . 82.3 mmm -77.77 112.28 14.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.467 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 21.6 pt20 -95.87 -177.07 3.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.341 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.03 -33.44 72.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 110.801 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.0 tt0 -58.58 -43.33 89.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.7 -1.25 . . . . 0.0 109.08 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -65.23 -38.89 91.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.696 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 80' ' ' VAL . 47.3 t -57.75 -44.31 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.726 . . . . 0.0 110.576 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.7 pt-20 -63.18 -35.83 81.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.637 -1.289 . . . . 0.0 108.943 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -69.18 -44.03 73.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLN . 90.2 mt -69.56 -32.86 71.9 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.5 m -47.83 -16.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.438 -1.414 . . . . 0.0 108.928 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LEU . 20.6 pt20 -124.55 -2.18 7.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.637 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -83.76 111.01 18.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.474 -1.391 . . . . 0.0 109.222 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 85.27 -5.46 0.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.899 -0.501 . . . . 0.0 109.936 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.91 37.68 60.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -162.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -1.147 . . . . 0.0 109.493 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 98.6 mt -77.25 118.45 23.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.942 0.877 . . . . 0.0 109.133 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.6 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 15.3 mtp180 -80.68 125.64 30.28 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.1 m-70 170.81 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 77' ' ' GLU . 41.8 ttm180 -44.79 -33.31 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.868 -1.145 . . . . 0.0 109.763 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.63 -59.79 6.82 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.975 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -60.65 -42.21 96.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.843 -1.386 . . . . 0.0 110.862 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.589 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 29.0 mm -62.63 -43.49 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.939 -1.101 . . . . 0.0 110.203 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.33 -31.63 65.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 109.258 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.433 ' HA ' HE21 ' A' ' 93' ' ' GLN . . . -67.92 -39.29 83.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.518 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.533 HD13 HE21 ' A' ' 40' ' ' GLN . 91.4 mt -66.07 -35.73 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.811 . . . . 0.0 110.675 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 71' ' ' MET . 17.0 mm -58.06 -39.88 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.466 -1.396 . . . . 0.0 107.25 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.39 -34.19 89.25 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.06 -40.3 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -1.222 . . . . 0.0 108.472 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.35 86.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.604 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.481 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 98.0 mtt180 -61.49 -36.98 82.0 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.04 -30.75 71.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 108.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.03 -43.32 99.02 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -63.7 -34.52 78.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.97 -39.38 94.52 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.321 -0.862 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.6 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 29.8 tpp -63.91 -46.58 84.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 108.42 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.37 -38.6 80.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.03 -24.59 64.64 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -91.93 -12.01 34.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.63 26.8 73.65 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.01 -1.091 . . . . 0.0 110.427 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.6 ' O ' ' SD ' ' A' ' 105' ' ' MET . 2.0 mt-10 -120.33 101.93 46.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.219 -1.165 . . . . 0.0 109.868 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.79 142.49 25.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.805 1.67 . . . . 0.0 112.123 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 43.9 m-85 -59.86 -38.88 83.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.321 -0.862 . . . . 0.0 110.905 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.23 68.14 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.962 -1.086 . . . . 0.0 110.433 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.82 -47.45 74.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.063 . . . . 0.0 112.292 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.646 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.0 p90 -74.27 -37.66 63.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.52 -1.362 . . . . 0.0 111.154 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 145' ' ' LEU . 30.7 m -63.41 -52.46 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.328 -1.482 . . . . 0.0 109.894 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.609 ' N ' HG23 ' A' ' 116' ' ' VAL . 54.1 m95 -58.41 -25.07 61.71 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.115 . . . . 0.0 108.033 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.9 m -75.86 -38.0 58.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.481 -0.762 . . . . 0.0 110.28 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -62.88 -32.47 73.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 109.819 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.4 p -92.62 19.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.125 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 122' ' ' HIS . 6.4 m120 66.25 34.89 6.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.757 -0.59 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 117' ' ' TRP . 86.2 t60 38.31 33.94 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 0.0 109.907 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -130.89 153.18 81.63 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.91 140.52 35.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.183 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.605 HE21 ' C ' ' A' ' 126' ' ' MET . 0.8 OUTLIER -109.26 123.89 50.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.073 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.605 ' C ' HE21 ' A' ' 125' ' ' GLN . 71.7 mtm -94.71 117.08 29.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.029 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.0 115.35 24.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.268 -0.895 . . . . 0.0 108.974 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.61 19.9 5.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 109.416 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 136.03 55.23 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 176' ' ' VAL . 81.8 p -97.16 -12.22 23.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 0.0 108.969 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 p -140.02 163.62 32.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.499 -0.751 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.42 -34.29 76.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.136 -0.978 . . . . 0.0 109.134 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.9 p -72.92 -19.52 61.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.768 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -84.15 3.88 32.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.36 138.84 23.97 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.26 135.9 30.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.303 2.002 . . . . 0.0 112.601 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -111.45 1.95 17.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.039 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -147.32 90.06 1.84 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.71 156.71 39.28 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 109.042 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.5 -37.48 90.05 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.021 1.814 . . . . 0.0 111.338 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.11 -41.92 66.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.899 . . . . 0.0 108.666 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.5 p -68.03 -42.28 80.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.82 . . . . 0.0 109.351 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.88 -42.31 90.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.65 74.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.829 HD11 HG12 ' A' ' 116' ' ' VAL . 2.0 tp -60.72 -46.07 91.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.363 -0.836 . . . . 0.0 108.861 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.44 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 5.7 t -58.41 -46.81 85.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 109.669 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.67 -44.63 96.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 109.946 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.77 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.25 -44.8 78.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.36 -36.34 83.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -60.61 -39.44 88.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.448 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 153' ' ' GLY . 25.4 mmtm -64.98 -36.49 84.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.77 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -69.8 5.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.487 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.99 24.98 63.01 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.435 ' HB3' HG11 ' A' ' 157' ' ' VAL . 0.3 OUTLIER -96.86 111.92 23.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.503 -0.998 . . . . 0.0 108.412 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 157' ' ' VAL . 37.4 mtmt -96.28 176.72 5.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 109.71 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 57.61 47.14 16.42 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 154' ' ' PHE . 28.1 m -126.52 36.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -47.73 171.38 0.05 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.0 p -60.81 -28.13 68.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.148 . . . . 0.0 109.325 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -65.59 -38.31 89.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 38' ' ' GLU . 12.3 mm -68.94 -44.42 81.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 146' ' ' SER . 84.7 m -63.68 -42.64 98.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.611 -0.68 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.428 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.59 -40.95 80.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 0.0 110.035 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 38' ' ' GLU . 76.9 p -63.34 -40.21 96.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.916 . . . . 0.0 109.873 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 1.7 t80 -59.32 -43.85 92.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.099 -1.001 . . . . 0.0 109.388 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.0 mtp -62.26 -38.87 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.401 ' CA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -66.17 -41.88 89.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.451 -0.78 . . . . 0.0 111.244 -178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.63 5.8 41.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.049 -1.032 . . . . 0.0 111.362 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.592 ' SG ' ' CD1' ' A' ' 171' ' ' LEU . 21.0 t -96.76 -13.01 22.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.737 -1.227 . . . . 0.0 110.31 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.55 -5.98 57.25 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.592 ' CD1' ' SG ' ' A' ' 169' ' ' CYS . 6.0 mp -62.94 -33.58 75.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.951 -1.323 . . . . 0.0 109.613 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.02 138.68 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.6 m120 -113.27 164.02 14.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.434 -0.791 . . . . 0.0 110.132 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.6 OUTLIER 92.4 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.377 0.608 . . . . 0.0 110.332 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 16.2 m170 -53.45 -38.6 63.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 176' ' ' VAL . 2.9 p -162.18 55.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 177' ' ' VAL . 13.5 p 23.51 67.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.335 0.588 . . . . 0.0 111.156 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.47 35.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 31.0 t -105.05 148.37 26.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.119 -1.224 . . . . 0.0 109.487 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.481 ' HA ' ' H3 ' ' A' ' 1' ' ' MET . 49.0 t -56.0 -41.42 74.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.821 . . . . 0.0 109.687 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.608 ' SG ' ' CE1' ' A' ' 17' ' ' HIS . 0.8 OUTLIER -59.02 -38.64 79.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 0.0 109.444 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.514 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -102.48 106.83 51.2 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.87 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 185' ' ' ASN . 39.4 Cg_endo -74.57 141.22 27.72 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.003 1.802 . . . . 0.0 112.67 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 185' ' ' ASN . . . -75.79 11.22 11.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 184' ' ' GLY . 11.5 t-20 78.54 22.59 0.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.689 -0.889 . . . . 0.0 109.768 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -96.92 151.57 37.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo . . . . . 0 C--N 1.313 -1.297 0 C-N-CA 122.451 2.101 . . . . 0.0 112.258 179.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.303 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.385 0.612 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.34 154.43 19.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.262 -0.899 . . . . 0.0 109.282 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -92.29 0.1 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.776 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -128.7 149.67 50.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 110.476 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.99 -49.63 66.16 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.621 -0.675 . . . . 0.0 111.834 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.995 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -79.79 0.98 28.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.614 -1.521 . . . . 0.0 109.203 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.44 -45.64 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.281 -0.887 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -71.26 -1.54 13.06 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.541 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.12 -46.35 67.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.752 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.06 158.19 6.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 110.229 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HA ' HD12 ' A' ' 14' ' ' ILE . 17.3 Cg_exo -53.56 -36.13 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.542 2.162 . . . . 0.0 113.177 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.93 -42.25 84.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.943 -1.098 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.676 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -70.49 -37.77 74.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.81 -1.182 . . . . 0.0 108.283 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 11' ' ' PRO . 33.0 mt -55.97 -41.14 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.135 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.05 70.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 108.913 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 35.9 t80 -61.45 -41.73 97.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.5 -0.75 . . . . 0.0 109.4 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.25 -41.17 92.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.297 -0.877 . . . . 0.0 109.121 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.14 -24.81 30.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.42 -0.8 . . . . 0.0 111.17 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -66.93 -42.86 84.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.295 . . . . 0.0 110.524 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 173.11 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.526 -1.359 . . . . 0.0 110.942 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.74 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 22.9 t-105 -80.36 65.26 5.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.5 48.88 74.11 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.628 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -111.01 -32.66 0.13 Allowed Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 52.3 Cg_endo -95.99 152.62 1.4 Allowed 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 123.182 2.588 . . . . 0.0 112.648 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 117' ' ' TRP . 86.7 tt0 -67.4 145.15 55.32 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 169' ' ' CYS . 65.8 p -96.96 155.84 16.61 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.337 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -102.09 160.38 14.56 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -61.2 -35.05 76.13 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -64.46 -50.53 67.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.593 -0.692 . . . . 0.0 110.199 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' HG22 ' A' ' 26' ' ' THR . 0.0 OUTLIER -66.36 -29.63 69.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.019 . . . . 0.0 109.279 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -60.25 -38.84 84.71 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.279 -0.888 . . . . 0.0 108.714 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -68.59 -41.51 79.54 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 109.953 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -66.99 -42.72 84.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.863 -1.148 . . . . 0.0 109.341 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.6 ttm -61.73 -48.03 82.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.229 -0.919 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.38 -26.04 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.857 -1.152 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.32 -53.83 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.625 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -71.36 -38.42 71.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.892 -1.13 . . . . 0.0 108.855 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.45 -34.98 73.2 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.595 -0.69 . . . . 0.0 110.198 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.72 -33.73 88.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.363 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.83 -20.7 65.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -1.129 . . . . 0.0 112.022 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.821 HE22 HG11 ' A' ' 49' ' ' VAL . 20.4 mm-40 -69.07 1.96 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.263 -1.523 . . . . 0.0 110.262 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -63.87 116.17 5.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.776 -1.203 . . . . 0.0 108.866 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.96 -18.51 0.65 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 42' ' ' ALA . 3.6 mm? -100.93 167.25 10.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.558 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.7 m -91.77 150.34 21.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.696 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 3.9 t-105 -60.46 -36.56 78.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.394 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -36.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 44' ' ' LEU . 93.9 m -57.38 -44.15 84.19 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.809 -1.182 . . . . 0.0 108.534 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.821 HG11 HE22 ' A' ' 41' ' ' GLN . 41.1 t -74.5 -31.63 28.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.67 -0.644 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -48.35 73.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 109.601 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -62.43 -40.67 97.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.764 -1.21 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -28.55 68.49 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.35 -41.3 84.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.16 -0.963 . . . . 0.0 108.685 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -63.92 -47.13 81.77 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -72.44 -40.85 66.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.083 -1.011 . . . . 0.0 110.041 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 75.2 t80 -60.27 -48.71 80.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.684 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.9 OUTLIER -62.14 -32.19 72.75 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.048 -1.032 . . . . 0.0 108.832 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.08 81.16 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -0.901 . . . . 0.0 109.139 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -44.17 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.979 . . . . 0.0 109.583 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' C ' ' H ' ' A' ' 62' ' ' GLN . 53.3 m-85 -85.85 18.58 2.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.73 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 57' ' ' ARG . 9.2 t-80 -56.97 17.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.353 -0.842 . . . . 0.0 111.112 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 60' ' ' PHE . 20.1 pt20 -79.43 -17.98 53.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.951 -1.093 . . . . 0.0 110.651 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 42.3 p90 38.32 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.454 -0.779 . . . . 0.0 110.035 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' GLN . 71.2 m-20 -127.39 91.9 44.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.369 -0.832 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.03 -30.23 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.244 1.963 . . . . 0.0 112.402 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.21 -46.7 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.51 -32.14 73.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.982 . . . . 0.0 108.811 178.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' N ' HE22 ' A' ' 62' ' ' GLN . 65.1 t -58.91 -39.58 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -67.59 -15.6 63.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.47 -10.51 32.11 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OE1' ' A' ' 62' ' ' GLN . 96.2 mtp -77.93 110.44 12.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.69 -175.71 3.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 110.235 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.1 mt-10 -58.09 -29.55 65.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.459 -0.775 . . . . 0.0 110.458 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -57.75 -39.73 78.06 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.074 -1.641 . . . . 0.0 107.605 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.51 -30.66 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.664 -1.272 . . . . 0.0 108.729 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.529 ' OE1' ' CZ ' ' A' ' 89' ' ' ARG . 61.4 mm-40 -60.32 -44.97 94.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.879 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -77.51 -35.48 53.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 111.092 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.08 -38.65 87.0 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.209 -0.932 . . . . 0.0 112.434 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 77' ' ' GLU . 15.5 m -55.96 -18.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.453 -1.404 . . . . 0.0 108.389 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -102.56 -12.54 17.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.5 t70 -76.04 107.23 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.314 -0.955 . . . . 0.0 109.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.2 -11.5 0.57 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.66 36.84 41.77 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.3 pt -52.18 -172.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 86' ' ' ILE . 6.3 tt -61.68 92.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 108.978 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -53.51 112.94 1.0 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.7 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -178.36 73.77 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' CZ ' ' OE1' ' A' ' 77' ' ' GLU . 91.4 mtt180 -50.87 -38.55 50.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.556 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.8 -61.24 7.29 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.617 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -60.62 -37.7 82.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.289 . . . . 0.0 109.331 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.5 mt -60.91 -41.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.008 -1.057 . . . . 0.0 109.492 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.558 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.8 mt-30 -55.49 -35.91 66.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.654 -1.279 . . . . 0.0 108.449 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.98 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 108.835 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 56' ' ' TYR . 82.0 mt -61.23 -42.66 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.766 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' MET . 7.3 mm -62.34 -42.41 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.995 -1.066 . . . . 0.0 108.849 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.61 92.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 98' ' ' ASN . 2.5 m120 -59.39 -35.91 74.83 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.535 -0.979 . . . . 0.0 109.348 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.55 87.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.636 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 12.1 mmt180 -55.31 -37.44 67.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 108.62 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.06 69.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.472 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 44.4 t80 -63.48 -45.8 89.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -62.05 -41.24 97.92 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.063 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.66 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 79.7 mtp -68.66 -37.16 79.42 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 109.118 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 109' ' ' GLY . 95.6 mt-10 -67.64 -40.64 84.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.24 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.14 -24.27 64.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -9.47 41.96 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.55 27.55 73.74 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.29 103.04 55.2 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 110.249 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -59.24 148.28 86.84 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.19 1.927 . . . . 0.0 111.624 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.66 ' CZ ' ' SD ' ' A' ' 105' ' ' MET . 19.7 m-85 -62.17 -40.74 97.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.024 -1.047 . . . . 0.0 110.524 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.45 67.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 110.213 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.69 -52.45 64.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.064 . . . . 0.0 111.138 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' HG23 ' A' ' 116' ' ' VAL . 3.5 p90 -74.23 -33.7 63.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.812 -1.18 . . . . 0.0 110.456 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 145' ' ' LEU . 22.6 t -65.85 -56.64 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.678 -1.264 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 122' ' ' HIS . 62.1 m95 -57.67 -23.76 53.16 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -73.25 -32.28 64.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.609 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -64.55 -35.31 80.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.235 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 m -93.22 19.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 59.86 38.48 21.23 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.473 0.654 . . . . 0.0 109.673 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 117' ' ' TRP . 21.8 m80 48.78 26.1 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.06 151.04 77.72 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.195 -0.94 . . . . 0.0 109.827 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.99 150.13 60.23 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.516 2.144 . . . . 0.0 112.428 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 126' ' ' MET . 1.1 tm0? -109.12 131.42 55.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.475 -0.765 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' A' ' 125' ' ' GLN . 78.4 mtm -100.17 120.26 39.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 108.713 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.811 HG22 ' H ' ' A' ' 129' ' ' ALA . 4.4 m -91.33 130.28 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -93.03 19.17 8.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 110.312 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.811 ' H ' HG22 ' A' ' 127' ' ' THR . . . -72.52 169.52 16.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.7 p -127.55 -31.53 2.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.068 -1.02 . . . . 0.0 110.092 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 p -126.41 165.91 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.358 -0.839 . . . . 0.0 109.739 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.27 -34.31 70.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -66.62 -29.2 69.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.159 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.15 -3.12 57.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.422 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.73 131.97 56.06 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.61 139.2 14.09 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.076 1.85 . . . . 0.0 112.675 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.8 p -106.23 3.31 27.64 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 88.91 1.99 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.455 -0.778 . . . . 0.0 109.524 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.05 159.79 28.18 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.92 -40.23 81.6 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.31 1.34 . . . . 0.0 111.969 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.21 65.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 108.92 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 53.2 p -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.311 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 159' ' ' THR . 90.6 m-20 -66.92 -40.97 87.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.555 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.01 69.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.104 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 116' ' ' VAL . 5.7 tp -70.33 -46.59 63.89 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.485 -0.759 . . . . 0.0 110.938 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.564 ' OG ' ' SG ' ' A' ' 162' ' ' CYS . 13.7 m -62.08 -46.78 87.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.802 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.73 -35.23 80.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.905 -1.122 . . . . 0.0 109.517 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.767 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -69.79 -50.42 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 115' ' ' PHE . 94.9 mt -65.57 -35.51 81.05 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.215 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -59.97 -38.19 81.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.987 -1.07 . . . . 0.0 108.829 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -64.73 -37.59 88.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 110.386 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.767 HH21 ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.63 4.86 3.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.07 26.68 43.59 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.1 115.66 28.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.258 -1.142 . . . . 0.0 108.593 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -90.09 168.93 11.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.821 0.819 . . . . 0.0 110.806 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 58.29 57.63 3.84 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.598 0.713 . . . . 0.0 109.952 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 161' ' ' ILE . 34.8 m -131.34 39.26 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.39 165.58 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.589 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 37.2 m -55.97 -31.42 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.502 -0.999 . . . . 0.0 109.377 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.4 p -76.22 -28.61 57.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 108.544 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 157' ' ' VAL . 48.0 mm -65.96 -45.24 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.627 -0.671 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 159' ' ' THR . 2.5 p -66.44 -44.37 83.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.127 -0.983 . . . . 0.0 109.497 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.55 -43.27 77.01 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.292 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.526 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 33.0 m -64.06 -38.46 91.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.89 -1.132 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.15 -50.22 72.74 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.2 mtm -63.02 -31.96 73.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 109.761 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -58.06 -45.76 86.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.52 -0.738 . . . . 0.0 111.151 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . . . -93.38 -21.7 19.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.131 -0.981 . . . . 0.0 111.855 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.724 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.5 OUTLIER -65.04 -46.25 82.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.708 -1.245 . . . . 0.0 110.252 -178.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.677 ' N ' ' SG ' ' A' ' 169' ' ' CYS . . . 131.22 -0.37 5.2 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 169' ' ' CYS . 11.5 mt -68.87 -34.37 75.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.265 -1.138 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 173' ' ' ASN . 1.9 p -133.86 150.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 122.052 0.93 . . . . 0.0 111.337 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.449 ' N ' ' CG2' ' A' ' 172' ' ' VAL . 66.2 m-20 -109.51 114.95 29.02 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 167' ' ' GLN . 26.3 p-10 -161.58 42.56 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.507 -1.371 . . . . 0.0 111.839 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.941 ' O ' HG13 ' A' ' 176' ' ' VAL . 11.1 m170 -52.54 -48.98 65.76 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.25 -1.531 . . . . 0.0 107.672 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 175' ' ' HIS . 0.1 OUTLIER 175.51 11.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 129' ' ' ALA . 22.3 t 58.37 117.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 94.33 12.59 55.93 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 181' ' ' CYS . 8.4 t -67.84 79.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -1.023 . . . . 0.0 109.143 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 68.93 -48.3 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 179' ' ' CYS . 31.5 t -170.27 71.71 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 183' ' ' PRO . 1.9 t80 -71.66 122.53 87.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CZ ' ' A' ' 182' ' ' TYR . 45.5 Cg_endo -74.77 176.01 10.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.231 1.954 . . . . 0.0 112.112 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.72 2.96 34.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.69 -72.83 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -1.113 . . . . 0.0 108.725 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 187' ' ' PRO . 1.4 mptt -111.98 -25.19 0.13 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 110.943 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 186' ' ' LYS . 31.3 Cg_exo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.691 1.594 . . . . 0.0 112.089 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.995 H3A3 ' CZ3' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.199 0.523 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -92.69 167.35 11.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.34 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -118.11 154.66 31.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 131.38 28.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.819 . . . . 0.0 110.043 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.01 -27.97 52.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.23 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 0.7 OUTLIER -85.35 -2.96 58.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.379 -1.071 . . . . 0.0 108.987 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.9 OUTLIER -95.42 -23.29 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.586 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 m -63.7 6.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 109.439 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 7' ' ' VAL . 85.0 mt-30 -91.63 -168.37 2.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.4 153.42 1.33 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.4 -0.813 . . . . 0.0 109.869 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.19 -20.72 32.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.63 -37.56 76.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 109.875 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.835 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 2.6 m-85 -67.05 -35.33 79.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.72 -36.68 67.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.586 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -68.14 -49.9 58.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.882 -1.136 . . . . 0.0 108.899 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE2' ' CD2' ' A' ' 21' ' ' TRP . 19.6 t80 -63.79 -41.29 97.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 108.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -70.85 -42.07 70.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.683 -0.636 . . . . 0.0 110.8 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.87 -10.45 58.52 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 110.517 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 83.7 m-20 -80.02 -76.13 0.23 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.788 -1.195 . . . . 0.0 109.364 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 21' ' ' TRP . 95.6 mt-10 -146.88 -65.41 0.28 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.565 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.3 t90 26.35 63.12 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.377 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 120.5 57.55 0.24 Allowed Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.829 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.841 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 p -176.49 -21.16 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 113.487 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.841 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 72.8 Cg_endo -89.24 150.89 5.55 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.612 1.541 . . . . 0.0 113.258 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.02 156.21 39.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.661 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -91.06 132.12 36.22 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.595 -177.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.93 147.15 29.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -60.85 -35.62 77.03 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -75.26 -50.62 15.55 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.508 -0.745 . . . . 0.0 111.072 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -34.96 77.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.963 -1.086 . . . . 0.0 109.291 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.673 HD22 ' CZ ' ' A' ' 165' ' ' PHE . 65.8 mt -63.29 -36.5 83.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.149 -0.969 . . . . 0.0 109.199 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.29 -43.0 92.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.61 -38.02 80.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.984 -1.072 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.552 ' CE ' ' HB1' ' A' ' 168' ' ' ALA . 53.2 tpp -63.3 -50.65 69.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.679 -0.638 . . . . 0.0 111.006 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 35' ' ' ILE . 11.0 tp -62.94 -27.08 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.909 -1.119 . . . . 0.0 109.228 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.8 t -71.02 -53.92 13.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 108.861 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.07 -38.91 92.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 108.512 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.572 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 4.6 tp10 -67.5 -39.24 85.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 108.891 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.57 94.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.11 -4.89 43.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 109.661 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -78.15 2.82 16.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.915 -1.116 . . . . 0.0 109.977 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -65.22 132.09 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.043 . . . . 0.0 109.093 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.15 -29.77 0.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' ALA . 79.7 mt -98.14 139.89 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.608 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.7 m -69.18 154.39 42.13 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.247 -0.908 . . . . 0.0 108.661 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.656 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 1.2 t-105 -55.15 -39.56 69.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.0 . . . . 0.0 109.841 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -37.64 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -0.956 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.451 HG21 HD22 ' A' ' 44' ' ' LEU . 99.9 m -57.98 -41.76 83.65 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.954 -1.091 . . . . 0.0 108.531 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -67.05 -31.65 54.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.809 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -48.59 81.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.088 -1.008 . . . . 0.0 109.939 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 53.1 mttt -62.21 -46.37 89.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.784 -1.197 . . . . 0.0 108.1 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.31 -16.44 61.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.2 ttm180 -63.69 -46.51 85.19 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -65.9 -45.41 82.09 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.2 m-80 -67.88 -43.09 80.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.895 ' OH ' HG21 ' A' ' 95' ' ' ILE . 89.8 t80 -60.44 -47.22 87.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 0.0 110.24 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -58.04 -34.2 69.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.042 -1.036 . . . . 0.0 109.837 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.77 95.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.896 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.6 m -72.98 -43.96 61.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.039 . . . . 0.0 111.079 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 84.9 m-85 -96.27 10.03 39.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.055 . . . . 0.0 110.906 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 21.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.839 -1.163 . . . . 0.0 109.662 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 99.3 mm-40 -79.04 -34.78 43.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 91.2 m-85 -161.53 -104.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 2.0 m-20 154.23 -42.36 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 68' ' ' VAL . 50.9 Cg_endo -94.77 -108.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.657 2.238 . . . . 0.0 115.287 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -37.45 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.615 -1.303 . . . . 0.0 110.891 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -35.34 69.62 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.112 -0.993 . . . . 0.0 110.982 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 65' ' ' PRO . 3.7 m -73.94 -36.35 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.282 -1.511 . . . . 0.0 108.246 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.39 -20.54 59.96 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.91 -11.3 36.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.552 ' CE ' ' OD2' ' A' ' 75' ' ' ASP . 4.1 mmm -75.57 119.86 20.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.564 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 7.0 tt0 -95.57 168.49 10.66 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 109.901 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 72' ' ' GLN . 98.1 mt-10 -49.75 -25.74 3.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.955 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 108.076 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -70.13 -37.8 75.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.918 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.606 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 49.5 t -61.8 -44.06 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.63 -0.669 . . . . 0.0 110.749 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.69 -32.81 74.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 108.14 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -67.95 -42.88 80.27 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.605 0.716 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 25.1 mt -69.6 -33.58 72.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 111.722 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 ' NH1' ' A' ' 89' ' ' ARG . 55.2 t -48.24 -31.28 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.892 -1.13 . . . . 0.0 108.527 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -100.43 -4.48 28.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.18 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 57.5 t0 -88.22 109.32 19.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.763 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.34 -16.34 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.472 -0.768 . . . . 0.0 109.656 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 75.48 35.33 47.59 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' ARG . 6.0 pt -54.8 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -1.109 . . . . 0.0 110.207 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -53.53 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' ILE . 59.8 mtp180 -53.19 106.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.407 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.53 92.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.892 ' NH1' HG21 ' A' ' 80' ' ' VAL . 5.4 mtt-85 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.545 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.31 -59.32 7.98 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.229 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -61.42 -43.43 98.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.923 -1.339 . . . . 0.0 110.914 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.563 HG22 HG22 ' A' ' 76' ' ' VAL . 70.0 mt -60.58 -49.15 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.0 110.529 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.89 65.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.83 -1.169 . . . . 0.0 109.019 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.56 94.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.174 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.895 HG21 ' OH ' ' A' ' 56' ' ' TYR . 84.9 mt -60.61 -40.81 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 mp -58.18 -45.16 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.09 94.13 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -51.38 -44.09 62.06 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.054 -1.262 . . . . 0.0 108.965 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -64.54 -39.93 94.67 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.274 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.97 -37.74 61.46 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.29 70.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' ALA . 42.0 t80 -63.43 -43.43 97.49 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 103' ' ' LEU . 8.4 mp -63.56 -34.76 78.52 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.2 -37.26 84.64 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.329 -0.949 . . . . 0.0 109.546 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 99.1 mmm -70.71 -41.69 71.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 108.339 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 109' ' ' GLY . 76.1 mm-40 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -58.75 -24.35 61.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.03 -12.56 28.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.96 24.03 74.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -120.52 101.83 45.8 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.358 -1.084 . . . . 0.0 109.584 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.88 150.23 73.17 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.145 1.897 . . . . 0.0 112.377 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 105' ' ' MET . 73.0 m-85 -58.05 -40.68 81.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.351 -0.843 . . . . 0.0 110.489 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.6 72.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.779 . . . . 0.0 112.442 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.93 -53.92 22.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 0.0 111.873 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 1.9 p90 -68.27 -40.93 81.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.006 -1.059 . . . . 0.0 111.658 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 117' ' ' TRP . 14.7 p -64.88 -48.93 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 110.377 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.619 ' N ' HG13 ' A' ' 116' ' ' VAL . 10.9 m95 -55.14 -27.5 45.88 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.3 t -71.8 -36.49 70.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.44 -0.787 . . . . 0.0 110.598 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -66.72 -28.78 68.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -97.25 19.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 20.0 m120 64.11 44.02 4.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.7 -0.625 . . . . 0.0 110.222 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 44.94 12.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 110.527 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mt-30 -131.16 149.92 75.07 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.208 -0.933 . . . . 0.0 109.267 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.444 ' HB2' HD21 ' A' ' 173' ' ' ASN . 32.8 Cg_endo -67.22 162.16 39.76 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.298 1.999 . . . . 0.0 111.722 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.65 135.39 49.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 109.673 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 63.2 mtt -90.31 116.45 28.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 109.093 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 127' ' ' THR . 1.2 m -89.89 111.4 22.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.209 -0.932 . . . . 0.0 109.1 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -92.51 17.53 9.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 0.0 109.286 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.07 141.9 57.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.494 ' OG1' ' OE1' ' A' ' 134' ' ' GLU . 42.6 p -98.82 -11.37 21.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.669 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.408 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 23.7 p -145.34 160.09 42.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.29 -42.71 96.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -65.24 -31.78 73.11 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.494 ' OE1' ' OG1' ' A' ' 130' ' ' THR . 63.6 tt0 -80.85 1.47 30.56 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.597 -0.689 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.83 143.74 27.0 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 108.732 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.15 136.54 12.93 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.202 1.935 . . . . 0.0 112.414 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.3 p -107.17 2.99 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.019 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t -147.24 90.66 1.9 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.416 -0.802 . . . . 0.0 108.988 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.6 p -100.32 152.06 37.72 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.45 -36.6 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.582 1.521 . . . . 0.0 111.269 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -39.65 63.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.515 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 68.5 m -66.42 -46.73 75.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.6 -38.88 82.43 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.029 -1.044 . . . . 0.0 109.154 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.38 63.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 145' ' ' LEU . 2.8 tm? -59.47 -46.33 89.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.05 -46.14 88.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.478 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -59.18 -37.91 78.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.752 -0.593 . . . . 0.0 109.614 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.07 68.6 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.286 -0.883 . . . . 0.0 109.854 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 149' ' ' LEU . 91.9 mt -60.81 -36.4 78.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.6 -39.95 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.088 . . . . 0.0 108.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -65.73 -33.58 76.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 3.7 mmp_? -71.4 3.08 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 109.202 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.1 26.11 38.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.66 116.25 30.47 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.475 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -92.06 174.47 7.3 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.562 0.696 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 58.78 58.76 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.572 0.701 . . . . 0.0 109.772 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 158' ' ' GLY . 0.2 OUTLIER -126.75 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -42.53 150.5 0.36 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 28.1 m -53.17 -29.47 31.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 109.315 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -74.24 -35.51 63.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 mt -66.33 -36.74 78.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 142' ' ' SER . 0.5 OUTLIER -69.48 -38.37 77.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.041 . . . . 0.0 109.394 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.497 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.66 -46.8 74.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.509 ' OG ' ' OE2' ' A' ' 38' ' ' GLU . 95.0 p -65.19 -33.34 75.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 108.824 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.673 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 49.4 t80 -59.25 -46.07 89.48 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.614 -0.679 . . . . 0.0 109.679 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.447 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 22.0 mtm -63.33 -38.0 89.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.69 ' NE2' HG21 ' A' ' 172' ' ' VAL . 84.0 mm-40 -60.44 -42.67 96.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.962 -1.086 . . . . 0.0 109.811 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.552 ' HB1' ' CE ' ' A' ' 34' ' ' MET . . . -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.411 -0.806 . . . . 0.0 109.983 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.615 ' SG ' ' CD2' ' A' ' 31' ' ' LEU . 66.9 m -58.36 -31.11 67.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.928 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.08 0.44 44.74 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 120' ' ' VAL . 95.8 mt -62.33 -28.72 69.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.969 . . . . 0.0 109.777 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.69 HG21 ' NE2' ' A' ' 167' ' ' GLN . 21.6 t -112.94 147.83 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.038 . . . . 0.0 110.544 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.444 HD21 ' HB2' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -125.57 164.34 20.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.588 ' OD1' ' CZ ' ' A' ' 182' ' ' TYR . 2.2 m-20 76.58 70.39 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.665 -0.647 . . . . 0.0 110.457 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.47 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 22.0 m170 -47.24 -38.19 11.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 108.418 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 176' ' ' VAL . 3.5 p -166.04 18.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.62 HG23 ' C ' ' A' ' 176' ' ' VAL . 1.3 t 65.39 -44.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . -83.48 29.6 3.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 182' ' ' TYR . 26.2 t -93.64 120.52 34.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.444 -1.033 . . . . 0.0 109.721 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -46.17 -43.15 14.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.774 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -61.69 -3.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.588 ' CZ ' ' OD1' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -126.04 81.28 66.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 185' ' ' ASN . 1.2 Cg_endo -77.74 -78.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.721 2.281 . . . . 0.0 111.885 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 54.73 4.45 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 183' ' ' PRO . 9.7 p30 -97.49 -13.11 21.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -1.137 . . . . 0.0 109.937 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -93.91 154.77 40.75 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.319 -0.863 . . . . 0.0 109.655 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 122.67 2.247 . . . . 0.0 112.108 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.23 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.02 142.92 33.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.204 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -83.7 168.11 16.58 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.256 -0.903 . . . . 0.0 109.702 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.14 147.76 52.85 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.439 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.16 96.14 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 121.669 -0.644 . . . . 0.0 112.045 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE2' ' CH2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -87.73 -0.68 57.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.486 -1.596 . . . . 0.0 110.124 -179.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.21 -44.56 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.141 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.6 m -76.59 7.07 4.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 108.756 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 7.4 tt0 -91.99 -116.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.467 -0.771 . . . . 0.0 109.745 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 9' ' ' GLN . 1.5 m-20 -79.41 154.79 76.72 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 108.962 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' O ' ' N ' ' A' ' 13' ' ' TYR . 19.4 Cg_endo -65.16 -160.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.438 2.092 . . . . 0.0 111.88 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' HD11 ' A' ' 47' ' ' ILE . 96.6 mt 61.96 -39.47 0.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.472 -0.768 . . . . 0.0 110.004 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.7 m-85 -63.4 -39.13 93.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.23 -43.73 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.624 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.49 -51.09 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.424 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.47 ' HA ' HD22 ' A' ' 19' ' ' ASN . 1.2 t80 -61.36 -41.52 97.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 48.1 t-80 -70.53 -36.07 73.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.07 -5.04 58.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.081 -1.012 . . . . 0.0 111.008 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 85.5 m-20 -83.75 -77.01 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.692 -1.255 . . . . 0.0 110.492 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -153.18 55.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.961 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 6.7 t90 -103.07 73.65 1.25 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 152.4 -20.71 0.83 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.637 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.712 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 7.9 m -123.4 7.1 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.429 -1.042 . . . . 0.0 113.18 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 71.7 Cg_endo -76.51 149.75 31.1 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.592 1.528 . . . . 0.0 113.416 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -91.88 166.01 12.95 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.606 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 10.5 p -91.71 107.84 19.49 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.481 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.707 ' O ' HD21 ' A' ' 31' ' ' LEU . 96.2 m-20 -84.69 168.58 15.12 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 m -76.99 -41.5 42.64 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.845 -1.16 . . . . 0.0 111.558 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' CD ' ' OH ' ' A' ' 102' ' ' TYR . 26.9 mmtp -76.19 -42.8 45.13 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -58.46 -40.5 82.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.811 -1.18 . . . . 0.0 110.848 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.75 -40.26 79.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 109.712 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 102' ' ' TYR . 80.8 t80 -62.09 -47.76 83.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.57 -40.06 73.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.915 -1.116 . . . . 0.0 109.058 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.57 -52.51 63.11 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.0 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.52 -28.21 44.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.037 -1.039 . . . . 0.0 110.132 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.34 -46.85 66.05 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.014 -1.054 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD12 HG13 ' A' ' 49' ' ' VAL . 4.6 mm? -69.29 -38.83 78.51 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 108.992 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.606 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 59.0 mm-40 -57.75 -36.29 71.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.414 -0.804 . . . . 0.0 109.253 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.7 -42.85 59.39 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' ALA . 62.6 tp60 -65.73 -32.56 74.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 0.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 40' ' ' GLN . 2.2 pp0? -41.89 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.005 -1.059 . . . . 0.0 109.688 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.98 -1.075 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 82.05 -35.62 2.55 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.309 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.0 mm? -95.7 144.39 26.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -1.214 . . . . 0.0 110.304 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.9 m -68.67 153.2 44.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 108.764 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CE3' ' C5 ' ' A' ' 189' ' ' ADK . 0.8 OUTLIER -62.07 -37.0 83.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.003 -1.061 . . . . 0.0 109.81 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.56 -38.52 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.53 -1.356 . . . . 0.0 109.033 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 HG21 HD12 ' A' ' 44' ' ' LEU . 75.1 m -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.643 HG13 HD12 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -63.01 -40.84 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.673 . . . . 0.0 109.401 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.85 -45.68 85.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.779 -1.201 . . . . 0.0 109.11 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -64.41 -37.15 86.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 108.401 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -59.66 -37.27 78.28 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.663 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 77.3 mtt180 -59.39 -39.78 84.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.012 -1.055 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.96 -45.23 78.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.216 -1.552 . . . . 0.0 110.732 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.714 HD22 ' N ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -81.69 -39.86 23.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.861 -1.149 . . . . 0.0 110.476 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.714 ' N ' HD22 ' A' ' 55' ' ' ASN . 54.2 t80 -60.88 -47.0 88.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.899 -1.125 . . . . 0.0 109.477 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' ND1' ' A' ' 61' ' ' HIS . 21.3 mmm-85 -63.08 -33.87 76.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.117 -0.989 . . . . 0.0 108.829 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.38 70.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.8 m -75.04 -43.3 54.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.039 -1.038 . . . . 0.0 111.448 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -85.04 -1.99 57.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.083 . . . . 0.0 111.044 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.48 ' ND1' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -52.03 -51.8 55.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.99 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.5 -25.49 68.04 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' HG13 ' A' ' 68' ' ' VAL . 98.8 m-85 -102.74 60.49 0.8 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.13 164.17 0.39 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.471 -0.768 . . . . 0.0 109.924 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.973 ' O ' HG22 ' A' ' 68' ' ' VAL . 97.1 Cg_exo -31.55 -66.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 123.694 2.929 . . . . 0.0 114.011 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.39 -38.17 68.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.266 -1.521 . . . . 0.0 109.177 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.14 -32.87 74.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.99 -1.069 . . . . 0.0 110.379 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 65' ' ' PRO . 20.5 m -63.83 -37.25 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.209 -1.557 . . . . 0.0 108.96 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.6 -23.43 58.74 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.46 -9.04 36.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 68' ' ' VAL . 45.0 ttm -77.8 121.34 23.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 20.6 pt20 -95.49 176.7 6.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.23 -35.63 77.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.487 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 41.1 tp10 -54.05 -45.72 71.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.936 -1.102 . . . . 0.0 108.198 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -64.37 -38.13 89.95 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.574 0.702 . . . . 0.0 109.141 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.8 t -60.83 -38.64 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 110.183 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' CG ' ' N ' ' A' ' 78' ' ' ARG . 3.7 pt-20 -72.93 -42.29 63.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.921 -1.112 . . . . 0.0 111.818 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.2 -38.18 63.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.691 -1.256 . . . . 0.0 110.417 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.726 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -67.11 -32.3 73.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.985 . . . . 0.0 109.829 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' VAL . 6.8 t -49.71 -24.75 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -85.64 -6.66 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.132 -0.98 . . . . 0.0 108.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.573 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 97.1 m-20 -77.97 108.13 11.01 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.509 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 69.63 -15.49 0.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.698 . . . . 0.0 109.839 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 73.4 34.67 57.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.652 ' O ' ' N ' ' A' ' 87' ' ' ARG . 21.9 pt -46.3 176.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.432 -1.04 . . . . 0.0 109.41 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' ILE . 4.5 tt -52.29 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 85' ' ' ILE . 9.3 ptp180 -54.07 133.33 43.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.863 0.839 . . . . 0.0 110.342 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 4.0 m-70 175.15 65.94 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -46.05 -29.33 1.45 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 110.09 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.35 -61.06 5.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.01 -38.38 85.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.99 -44.43 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 110.043 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -57.69 -32.35 67.27 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.9 -1.125 . . . . 0.0 108.767 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' ' NE2' ' A' ' 93' ' ' GLN . . . -67.75 -37.7 82.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 0.0 109.437 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.1 -32.22 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.7 mm -59.12 -43.97 90.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 108.245 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.23 -29.86 76.34 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -58.62 -43.44 89.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.061 -1.258 . . . . 0.0 109.235 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . . . -63.46 -44.55 94.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.86 -1.15 . . . . 0.0 109.449 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.29 -35.53 69.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.898 -1.126 . . . . 0.0 108.939 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.32 -28.89 64.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.048 -1.033 . . . . 0.0 108.398 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.424 ' OH ' ' CD ' ' A' ' 29' ' ' LYS . 80.8 t80 -64.33 -43.22 95.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.0 mp -65.05 -32.95 74.92 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.561 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 14.5 mm100 -59.4 -39.28 82.91 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.811 -1.155 . . . . 0.0 108.753 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.525 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 97.6 mmm -67.6 -40.27 84.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.996 -1.065 . . . . 0.0 109.049 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 109' ' ' GLY . 75.9 mm-40 -72.06 -42.24 66.47 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.413 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -57.71 -25.17 59.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.561 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 17.0 m120 -92.62 -10.08 38.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.69 23.64 73.96 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -116.53 105.07 50.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.142 -1.211 . . . . 0.0 109.934 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -56.18 152.28 38.92 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.35 2.034 . . . . 0.0 113.01 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.709 ' HB3' HD12 ' A' ' 31' ' ' LEU . 25.5 m-85 -62.42 -38.94 91.63 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.774 0.797 . . . . 0.0 110.706 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.62 -35.48 79.7 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.535 -0.728 . . . . 0.0 111.724 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.46 -43.42 98.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.65 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -74.93 -43.99 51.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.321 -1.487 . . . . 0.0 111.01 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.65 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 14.9 m -58.43 -49.38 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 120.073 -1.642 . . . . 0.0 109.053 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.606 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 22.2 m95 -55.94 -27.41 52.27 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.12 -0.988 . . . . 0.0 108.629 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m -70.58 -41.49 72.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.238 -0.914 . . . . 0.0 111.103 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 30.9 m-85 -67.02 -30.31 70.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.767 -1.208 . . . . 0.0 110.377 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -91.85 15.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 109.597 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.461 HD22 ' HG3' ' A' ' 123' ' ' GLN . 5.2 t30 59.89 36.08 21.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.84 . . . . 0.0 110.371 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 47.38 29.9 1.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -0.992 . . . . 0.0 109.821 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' A' ' 121' ' ' ASN . 2.6 mm-40 -131.94 148.33 69.43 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.092 -1.005 . . . . 0.0 109.881 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.82 149.37 86.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.51 2.14 . . . . 0.0 111.959 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 126' ' ' MET . 4.2 tm0? -115.34 139.49 49.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.14 -0.975 . . . . 0.0 109.835 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.555 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 3.1 mpp? -100.54 118.3 36.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.142 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -72.14 -35.47 69.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 109.21 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 54.4 41.09 32.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.126 -0.984 . . . . 0.0 109.837 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.53 145.58 29.39 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.47 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.4 p -106.96 -29.55 9.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.696 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 134' ' ' GLU . 24.0 p -134.77 165.67 24.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.658 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.87 -31.99 67.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.494 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -72.79 -10.96 60.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 109.577 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 131' ' ' THR . 79.9 mm-40 -100.92 10.74 40.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.9 mm -98.33 111.91 60.92 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.92 142.86 28.62 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.729 1.619 . . . . 0.0 111.779 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 48.6 p -110.99 7.57 21.63 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -135.14 95.48 3.31 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 p -116.58 154.42 49.16 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.92 -38.6 86.23 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.719 1.613 . . . . 0.0 111.488 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.27 -43.12 64.76 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.531 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.8 p -62.73 -39.03 92.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 108.651 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.57 -37.55 84.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -66.51 -39.04 88.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.721 -0.612 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 165' ' ' PHE . 5.7 mp -65.62 -40.07 92.18 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.998 -1.064 . . . . 0.0 109.517 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.503 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 14.5 m -59.85 -47.37 86.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.707 -1.246 . . . . 0.0 110.44 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -74.02 -38.03 64.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.867 -1.145 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.53 -43.19 70.08 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.558 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.03 -43.15 79.41 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.19 -0.944 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -64.33 -39.92 94.85 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.863 -1.148 . . . . 0.0 109.727 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -70.18 -26.37 63.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.673 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -76.23 1.85 14.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.056 -1.028 . . . . 0.0 108.38 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.06 26.94 29.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.77 116.03 31.56 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.768 -0.842 . . . . 0.0 108.811 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.12 171.12 9.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 56.47 61.22 2.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 0.0 108.938 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.6 m -139.89 40.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.45 173.72 0.04 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.5 m -59.17 -31.13 68.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.905 -0.762 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 50.4 p -72.36 -34.78 68.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 108.74 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.26 -44.34 97.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 108.813 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 146' ' ' SER . 87.7 m -62.71 -43.98 97.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.76 -44.93 76.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.897 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.522 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 15.9 m -59.62 -41.57 90.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 109.441 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.651 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 3.3 t80 -59.56 -47.29 86.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 109.767 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 76.1 mtp -63.42 -32.71 74.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.29 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -44.98 88.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 110.785 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 111.731 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.651 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -55.48 -23.61 26.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.95 -1.094 . . . . 0.0 110.441 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.91 -2.16 59.91 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.7 mt -62.79 -27.94 69.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.542 -0.975 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.85 133.07 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.117 -0.989 . . . . 0.0 109.46 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 19.3 m-80 -108.7 163.07 13.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.428 -0.795 . . . . 0.0 109.645 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 85.49 69.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.787 -0.57 . . . . 0.0 110.982 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.493 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 3.4 m170 -55.69 -48.99 74.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 0.0 108.945 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 177' ' ' VAL . 5.7 m -139.33 30.19 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 109.588 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 129' ' ' ALA . 37.5 t 52.58 105.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.524 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . 83.74 45.0 6.57 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 145.19 24.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.33 . . . . 0.0 108.677 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 94.3 m -51.53 -47.72 63.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.391 -0.818 . . . . 0.0 111.969 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 17' ' ' HIS . 72.5 m -77.71 11.83 1.94 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.775 -1.203 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -126.32 80.36 69.03 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.451 -0.781 . . . . 0.0 110.182 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -87.13 -73.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 123.241 2.628 . . . . 0.0 111.505 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.87 -49.29 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.57 -75.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -1.07 . . . . 0.0 109.201 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -76.24 150.05 82.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 C-N-CA 122.569 2.179 . . . . 0.0 112.321 -179.793 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.961 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.25 146.33 28.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.861 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -63.32 161.28 14.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.435 -0.791 . . . . 0.0 110.406 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.78 154.07 26.76 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.696 0.76 . . . . 0.0 109.508 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -52.85 -47.96 58.14 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.682 -0.636 . . . . 0.0 112.413 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.872 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.12 -0.52 57.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.433 -1.628 . . . . 0.0 110.496 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 17' ' ' HIS . 7.6 t -77.0 -41.03 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.858 -1.152 . . . . 0.0 109.241 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -71.7 -4.66 28.73 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 68.9 tp60 -60.62 -42.97 97.93 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.881 -0.512 . . . . 0.0 110.38 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -161.76 159.35 22.52 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.672 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.694 ' HA ' HD12 ' A' ' 14' ' ' ILE . 18.8 Cg_endo -63.29 -35.39 62.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.81 2.34 . . . . 0.0 112.483 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.5 mt -61.83 -39.59 92.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.31 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.759 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.2 OUTLIER -64.48 -40.59 95.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.408 -0.807 . . . . 0.0 109.252 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 11' ' ' PRO . 50.4 mt -56.77 -40.01 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.11 76.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.835 -1.166 . . . . 0.0 109.587 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 2.0 t80 -65.68 -40.14 92.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.778 . . . . 0.0 110.17 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.421 ' CG ' HG21 ' A' ' 7' ' ' VAL . 47.4 t-80 -73.58 -35.53 65.44 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 110.791 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -80.51 -8.72 59.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.168 -0.957 . . . . 0.0 111.775 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 2.9 p30 -84.14 -58.0 2.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.52 -1.362 . . . . 0.0 110.849 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.2 mt-10 -148.69 -54.07 0.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.492 -1.38 . . . . 0.0 109.666 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.96 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 5.8 t90 2.24 66.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.592 0.711 . . . . 0.0 111.607 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 148.63 -21.35 1.32 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.286 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 1.6 m -119.31 3.09 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.623 0 O-C-N 121.62 -0.929 . . . . 0.0 112.814 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 84.7 Cg_endo -79.93 150.68 21.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.468 1.445 . . . . 0.0 112.837 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -97.98 168.41 10.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.621 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 36.8 p -91.8 118.0 30.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.708 -1.245 . . . . 0.0 110.29 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -108.06 144.47 35.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.9 m -59.99 -35.94 76.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.882 -1.136 . . . . 0.0 109.027 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.62 -50.2 22.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.689 -0.632 . . . . 0.0 110.316 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -27.31 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.84 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 116' ' ' VAL . 2.4 mp -66.86 -36.99 83.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.017 -1.052 . . . . 0.0 109.214 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 88.8 t80 -64.77 -48.43 74.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.62 -32.09 65.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.757 -1.214 . . . . 0.0 109.11 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -48.82 63.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.633 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.23 -27.8 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.423 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 97.9 m -69.19 -50.05 50.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.185 -0.947 . . . . 0.0 109.898 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' NE ' ' A' ' 53' ' ' ARG . 56.4 mt -67.95 -37.4 81.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.087 -1.008 . . . . 0.0 108.927 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' OE2' ' N7 ' ' A' ' 189' ' ' ADK . 4.6 tp10 -66.88 -39.15 87.41 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.623 -0.673 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.44 -35.86 92.31 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -72.23 -6.46 43.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -1.202 . . . . 0.0 109.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -77.04 -1.98 31.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -69.07 121.56 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 108.851 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.58 -31.83 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 42' ' ' ALA . 30.2 mt -101.48 144.09 30.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.117 . . . . 0.0 109.838 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -69.49 156.25 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.663 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.5 OUTLIER -56.99 -36.5 70.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.173 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -35.49 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.146 -0.972 . . . . 0.0 110.255 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.428 HG21 HD22 ' A' ' 44' ' ' LEU . 83.5 m -59.24 -41.83 89.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.868 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -68.0 -32.56 56.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.132 -0.98 . . . . 0.0 109.492 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.94 -43.97 94.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.183 -0.948 . . . . 0.0 110.354 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.89 75.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 108.963 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 14.6 mtmm -78.89 -7.4 57.92 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.323 -0.861 . . . . 0.0 109.295 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 39.2 ttm180 -65.68 -46.86 77.49 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.7 -45.99 67.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.978 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.474 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 38.9 t30 -66.25 -43.16 87.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.537 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 68.9 t80 -59.79 -45.47 92.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.872 . . . . 0.0 110.94 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -61.76 -29.5 70.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.828 -1.17 . . . . 0.0 108.986 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -66.36 -36.21 82.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 83' ' ' ALA . 87.4 m -66.95 -45.22 78.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.827 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' A' ' 62' ' ' GLN . 44.8 m-85 -83.26 -43.03 16.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.596 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 64.81 -47.84 0.33 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 109.928 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 26.0 mt-30 -74.88 -34.13 62.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' HIS . 23.1 p90 40.86 21.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.239 -0.913 . . . . 0.0 110.525 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.7 m-20 -92.54 144.55 28.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 108.991 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 34.2 Cg_endo -67.25 -51.0 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.514 2.143 . . . . 0.0 113.455 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.875 HG22 HD21 ' A' ' 103' ' ' LEU . 91.5 t -61.52 -45.93 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.917 -1.115 . . . . 0.0 110.156 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.14 -37.8 86.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.403 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 64' ' ' ASP . 56.1 t -63.63 -36.91 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' O ' ' NH2' ' A' ' 100' ' ' ARG . . . -65.1 -18.94 65.72 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.84 -7.88 57.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 96' ' ' ILE . 98.3 mtp -82.99 113.15 20.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.88 177.59 5.72 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.29 -31.78 61.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.224 -0.922 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 -45.08 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 108.237 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -64.27 -38.67 91.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG13 ' CG2' ' A' ' 92' ' ' ILE . 86.9 t -61.23 -42.7 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.423 -0.798 . . . . 0.0 109.856 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.6 -44.22 89.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.519 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 2.4 ptp180 -75.78 -33.62 60.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.857 -1.152 . . . . 0.0 110.001 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -61.6 -32.83 72.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 110.299 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 76' ' ' VAL . 73.6 t -49.3 -34.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.114 -0.991 . . . . 0.0 108.662 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.84 -1.02 30.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 55.6 t0 -80.7 108.82 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.447 -1.408 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.27 -12.21 1.05 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.438 -0.788 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.07 33.29 45.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt -57.47 -166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -1.213 . . . . 0.0 109.332 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.01 95.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.155 -0.965 . . . . 0.0 109.129 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -57.66 109.65 0.75 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.714 0.769 . . . . 0.0 109.34 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 87' ' ' ARG . 1.8 m80 -178.14 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -50.32 -31.59 14.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.318 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.71 -62.52 6.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -64.52 -40.82 96.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.785 -1.42 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG13 ' A' ' 76' ' ' VAL . 82.9 mt -61.17 -48.91 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.085 -1.01 . . . . 0.0 110.449 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -58.56 -29.22 66.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.661 -1.275 . . . . 0.0 108.953 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' N ' ' HG3' ' A' ' 93' ' ' GLN . . . -64.3 -37.59 88.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.45 -40.16 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 71' ' ' MET . 20.6 mm -59.93 -43.01 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 108.76 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.93 -35.91 88.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.12 -37.03 76.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -1.118 . . . . 0.0 109.163 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 65' ' ' PRO . . . -65.05 -44.91 87.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.981 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 69' ' ' ALA . 27.8 mmt180 -60.62 -38.16 83.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.093 -1.004 . . . . 0.0 109.446 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.84 71.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 108.593 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.53 -43.74 96.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.875 HD21 HG22 ' A' ' 66' ' ' VAL . 77.5 mt -63.62 -32.66 74.21 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.22 -35.11 79.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.305 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.59 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 50.1 tpp -63.8 -43.6 95.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.492 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -37.02 78.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.24 -24.71 66.56 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.519 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.1 m120 -93.21 -15.05 26.35 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.91 27.17 73.71 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.442 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' A' ' 105' ' ' MET . 2.0 tt0 -121.52 102.21 42.55 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.136 -1.214 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.53 141.6 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.933 1.755 . . . . 0.0 112.641 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -56.08 -38.76 71.11 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.229 1.014 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.36 -27.76 66.53 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.708 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -68.09 -48.44 65.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.095 . . . . 0.0 111.969 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.633 ' CE1' HG13 ' A' ' 116' ' ' VAL . 6.2 p90 -70.8 -37.37 73.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.763 -1.211 . . . . 0.0 110.943 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 145' ' ' LEU . 24.5 m -62.29 -49.05 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.382 -1.449 . . . . 0.0 109.956 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.621 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 26.4 m95 -56.56 -27.1 56.92 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.2 t -75.73 -36.69 59.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.253 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.2 -26.02 65.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.965 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -96.64 19.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.717 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 69.28 35.93 2.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.765 . . . . 0.0 110.557 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 117' ' ' TRP . 1.1 t-80 45.01 30.23 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.393 -0.817 . . . . 0.0 111.344 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -152.66 147.99 20.04 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.637 -1.29 . . . . 0.0 110.134 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.05 148.6 85.72 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.613 2.209 . . . . 0.0 111.93 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.623 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -122.06 128.37 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.623 ' C ' HE22 ' A' ' 125' ' ' GLN . 65.2 mtt -103.35 120.73 41.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -87.73 -26.43 22.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.439 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 57.03 45.35 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.77 149.4 50.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.469 ' C ' HG23 ' A' ' 176' ' ' VAL . 53.3 p -102.9 -25.1 13.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.051 -1.031 . . . . 0.0 109.412 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 p -136.17 162.66 32.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.158 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.31 -37.04 79.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 108.945 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.2 m -62.75 -31.42 72.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.372 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -75.19 -0.66 20.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 110.081 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 174' ' ' ASP . 1.6 tp -76.46 125.57 87.35 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.999 -1.063 . . . . 0.0 108.314 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 163' ' ' TYR . 55.9 Cg_endo -74.94 136.4 20.48 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.926 1.75 . . . . 0.0 112.454 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.5 p -114.37 6.53 16.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.0 t -152.16 88.28 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.432 -0.792 . . . . 0.0 109.448 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.532 ' H ' ' HG1' ' A' ' 139' ' ' THR . 0.7 OUTLIER -102.43 155.4 36.55 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.74 -38.96 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.727 1.618 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.52 -42.06 59.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 139' ' ' THR . 88.2 p -65.86 -39.03 90.35 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.525 -0.735 . . . . 0.0 109.443 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.31 -44.77 86.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.195 -0.941 . . . . 0.0 109.144 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.08 74.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -55.37 -43.78 75.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.656 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.96 -39.29 83.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.168 -0.957 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.45 -43.79 88.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 110.389 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.581 ' HB1' HH21 ' A' ' 152' ' ' ARG . . . -67.49 -45.98 74.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.43 -38.05 89.66 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.88 -40.24 94.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.971 -1.081 . . . . 0.0 110.242 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 153' ' ' GLY . 18.4 mttp -65.28 -38.56 90.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 111.641 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.581 HH21 ' HB1' ' A' ' 148' ' ' ALA . 8.2 mtm180 -71.27 9.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 0.0 110.085 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 76.04 26.14 65.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.97 112.61 24.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 157' ' ' VAL . 34.8 mtmt -93.1 176.62 6.34 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 57.58 54.9 6.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.451 -0.781 . . . . 0.0 109.2 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 157' ' ' VAL . 6.3 m -139.16 38.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.57 164.36 0.52 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.9 m -53.98 -34.42 59.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.499 -1.001 . . . . 0.0 109.431 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.5 ' O ' ' OG ' ' A' ' 164' ' ' SER . 32.8 m -68.62 -37.25 79.58 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.1 -44.31 98.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.656 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.1 m -58.05 -51.56 69.17 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.557 ' CD2' ' O ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -71.66 -37.88 70.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 0.0 111.733 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 160' ' ' THR . 13.4 m -59.12 -40.73 86.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 111.131 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.4 OUTLIER -78.36 -35.47 47.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 110.569 -179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 95.4 mtp -57.92 -36.15 72.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.657 -1.277 . . . . 0.0 109.291 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.66 -42.42 98.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.34 -37.8 22.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.536 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -26.12 48.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.273 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.54 -2.39 57.38 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.85 -37.36 73.74 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.243 -1.151 . . . . 0.0 108.753 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 0.9 OUTLIER -137.2 129.66 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 109.063 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.457 ' C ' ' CG ' ' A' ' 174' ' ' ASP . 37.9 t-20 -104.98 125.23 50.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.371 -0.831 . . . . 0.0 108.878 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -178.98 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.895 -1.128 . . . . 0.0 111.587 -178.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.566 ' H ' ' CD2' ' A' ' 175' ' ' HIS . 3.2 m170 -48.96 -52.12 26.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.97 -1.706 . . . . 0.0 107.13 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 130' ' ' THR . 15.0 p 178.03 150.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 129' ' ' ALA . 27.6 t -62.21 135.37 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.893 -1.129 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 182' ' ' TYR . . . 81.76 38.85 12.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.591 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -95.45 107.04 19.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -1.221 . . . . 0.0 109.971 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER 63.87 -55.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 179' ' ' CYS . 94.4 m -157.47 13.76 0.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.89 . . . . 0.0 110.384 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.468 ' HB3' ' H ' ' A' ' 178' ' ' GLY . 1.0 OUTLIER -65.14 119.3 57.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.8 -1.188 . . . . 0.0 108.937 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -75.45 150.3 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 112.498 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 149.59 -26.27 1.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -86.49 6.59 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 109.824 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -79.79 154.26 75.67 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.212 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.307 -1.633 0 C-N-CA 122.556 2.17 . . . . 0.0 112.203 179.902 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.96 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 1.9 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.552 ' H ' ' CG ' ' A' ' 1' ' ' MET . 82.8 tt0 -99.21 144.23 28.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 4' ' ' CYS . 26.9 ttm180 -68.99 170.26 10.16 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' C ' ' O ' ' A' ' 3' ' ' ARG . 4.3 m -42.35 149.3 0.17 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -0.865 . . . . 0.0 109.248 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.29 -33.58 61.59 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 121.153 -0.967 . . . . 0.0 112.75 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.857 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -85.56 2.1 46.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.298 -1.707 . . . . 0.0 111.759 -177.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 6' ' ' TRP . 16.7 m -110.57 -45.24 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 109.971 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 7' ' ' VAL . 88.7 p -65.25 -17.43 64.49 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -65.43 -40.68 93.6 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.873 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.18 163.21 24.3 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.933 . . . . 0.0 109.845 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 13' ' ' TYR . 35.7 Cg_endo -68.92 -161.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.943 2.429 . . . . 0.0 112.51 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 5.9 mt 62.54 -54.86 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.774 -0.579 . . . . 0.0 109.555 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.752 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.3 OUTLIER -57.15 -45.76 83.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.279 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.415 HG12 HH11 ' A' ' 3' ' ' ARG . 85.9 mt -54.68 -42.86 63.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.733 -0.605 . . . . 0.0 110.585 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.13 98.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.711 -1.243 . . . . 0.0 108.419 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.658 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.0 t80 -71.67 -31.47 66.83 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.623 0.725 . . . . 0.0 110.001 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -64.14 -44.68 91.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 112.382 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.69 -4.52 37.1 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.717 -1.239 . . . . 0.0 112.815 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.763 HD22 ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -96.01 -15.68 22.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.462 -1.399 . . . . 0.0 112.243 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.763 ' N ' HD22 ' A' ' 19' ' ' ASN . 14.0 pt-20 177.07 47.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.728 -1.232 . . . . 0.0 109.276 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.942 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 4.8 t90 -131.88 83.52 2.1 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.186 0.993 . . . . 0.0 108.887 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' ' HE2' ' A' ' 175' ' ' HIS . . . 117.3 -20.31 11.33 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.701 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 28.9 m -110.71 -12.38 0.12 Allowed Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 112.957 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 75.5 Cg_endo -80.05 150.68 20.68 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.358 1.372 . . . . 0.0 114.122 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -96.18 159.75 14.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.759 ' HB ' HD11 ' A' ' 31' ' ' LEU . 1.7 p -86.72 111.48 20.74 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.566 -1.334 . . . . 0.0 110.886 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.906 ' O ' HD13 ' A' ' 31' ' ' LEU . 70.1 m-20 -94.24 156.73 16.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -67.4 -39.71 85.59 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.565 -1.334 . . . . 0.0 110.282 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -75.19 -50.12 17.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 111.804 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -61.3 -30.1 70.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.589 -1.319 . . . . 0.0 109.19 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 27' ' ' ASP . 4.7 mp -57.14 -39.56 75.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.092 -1.005 . . . . 0.0 108.45 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.572 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 63.2 t80 -63.25 -45.46 91.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.467 -0.771 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -67.45 -40.69 85.42 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.827 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.4 tpp -65.07 -52.55 54.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.451 -0.781 . . . . 0.0 110.223 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.75 -27.17 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 109.03 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 47.7 m -70.57 -52.4 21.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.424 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' NE ' ' A' ' 53' ' ' ARG . 48.3 mt -66.79 -39.23 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 108.764 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' OE2' ' CB ' ' A' ' 164' ' ' SER . 13.3 tp10 -64.19 -37.72 88.49 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.642 -0.661 . . . . 0.0 109.865 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.51 -33.14 70.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 25.6 mm-40 -81.71 -1.45 47.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.514 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -78.78 -2.25 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.015 . . . . 0.0 109.323 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.71 113.84 10.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 87.26 -34.63 3.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -95.62 145.43 25.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -1.095 . . . . 0.0 109.63 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -71.97 152.88 42.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 109.203 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.664 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 2.5 t-105 -59.64 -28.9 67.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 110.161 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -29.36 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.564 -1.335 . . . . 0.0 109.487 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 44' ' ' LEU . 72.7 m -68.54 -44.04 75.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.112 -0.992 . . . . 0.0 108.829 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 46' ' ' TRP . 1.3 p -63.69 -26.08 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -54.98 -43.94 74.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -63.92 -37.04 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HA ' HD21 ' A' ' 55' ' ' ASN . 7.6 ttpp -63.12 -36.88 85.08 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NE ' HD13 ' A' ' 37' ' ' LEU . 37.2 ttm180 -57.93 -46.53 84.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.803 -0.561 . . . . 0.0 111.769 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 55' ' ' ASN . 15.2 pt-20 -72.5 -44.32 62.4 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.787 -1.196 . . . . 0.0 110.727 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.742 HD22 ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -73.06 -32.17 64.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.746 -1.221 . . . . 0.0 109.396 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.742 ' N ' HD22 ' A' ' 55' ' ' ASN . 71.4 t80 -58.57 -46.5 86.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 109.525 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 61' ' ' HIS . 13.4 ptm180 -65.05 -32.13 73.7 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.014 -1.075 . . . . 0.0 109.034 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.15 99.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.863 -1.148 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.579 ' HB3' HD22 ' A' ' 79' ' ' LEU . 51.4 m -77.49 -44.6 28.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 109.675 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.659 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 96.8 m-85 -94.67 19.76 9.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.563 -0.711 . . . . 0.0 109.53 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 t60 -41.03 -15.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.562 -0.711 . . . . 0.0 110.519 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 60' ' ' PHE . 95.3 mt-30 -51.09 -31.33 18.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.848 -1.157 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 51.04 27.27 3.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.697 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -125.07 92.49 47.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.195 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.43 -34.68 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.527 2.151 . . . . 0.0 112.667 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.63 -43.24 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.606 -1.309 . . . . 0.0 108.302 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -65.73 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 96' ' ' ILE . 69.6 t -60.7 -38.72 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 108.825 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -67.37 -14.53 63.01 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -93.5 -12.37 29.83 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.473 ' O ' HG21 ' A' ' 96' ' ' ILE . 90.8 mtp -76.74 110.31 11.23 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.578 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -96.8 -174.75 3.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.408 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -55.38 -30.59 60.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.813 -0.554 . . . . 0.0 110.791 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 75' ' ' ASP . 17.0 pt-20 -60.6 -42.22 96.32 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.119 -1.613 . . . . 0.0 109.452 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' CG ' ' A' ' 74' ' ' GLU . 90.3 m-20 -66.92 -38.92 87.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -67.19 -36.22 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.838 -1.164 . . . . 0.0 109.71 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 80' ' ' VAL . 99.2 mt-10 -59.36 -36.31 75.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.712 -1.242 . . . . 0.0 107.794 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.486 HH11 ' HG3' ' A' ' 78' ' ' ARG . 24.4 ttm-85 -70.32 -42.03 72.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.568 -0.708 . . . . 0.0 110.304 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 59' ' ' CYS . 94.3 mt -69.76 -34.66 74.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.423 -0.798 . . . . 0.0 112.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 77' ' ' GLU . 34.9 m -50.1 -16.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.521 -1.362 . . . . 0.0 108.868 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' LEU . 23.0 pt20 -120.87 -4.43 9.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.203 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 56.2 t0 -81.5 109.58 16.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.691 -1.256 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 75.6 -17.02 0.54 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.456 -0.778 . . . . 0.0 109.3 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 80.47 32.36 34.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 79' ' ' LEU . 15.5 pt -54.48 -179.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.02 -1.282 . . . . 0.0 109.332 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 86' ' ' ILE . 12.4 tt -60.82 89.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.587 ' O ' ' CD2' ' A' ' 88' ' ' HIS . 6.2 ptp180 -56.06 144.24 29.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.34 -0.85 . . . . 0.0 111.115 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 159.14 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 89' ' ' ARG . 1.1 mtt-85 -51.02 -38.07 49.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.424 -0.797 . . . . 0.0 108.941 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.13 -49.19 59.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.34 -45.08 94.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -1.133 . . . . 0.0 110.056 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.75 -44.12 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.069 -1.019 . . . . 0.0 109.726 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.616 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 44.5 mt-30 -54.64 -34.05 61.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.862 -1.149 . . . . 0.0 108.995 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.65 99.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.59 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.556 HG21 ' OH ' ' A' ' 56' ' ' TYR . 32.1 mm -61.93 -39.15 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 109.115 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 71' ' ' MET . 12.3 mm -59.67 -43.1 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 108.912 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.44 -32.86 85.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.52 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 22.0 m120 -61.2 -41.44 96.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.157 . . . . 0.0 109.842 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.91 98.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.0 mtt180 -62.49 -40.21 95.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.253 -0.904 . . . . 0.0 109.269 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.4 -34.58 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.35 -43.12 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.0 -33.2 75.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -62.91 -37.44 86.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 109.583 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.583 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 24.0 ttm -62.86 -40.89 98.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.994 -1.066 . . . . 0.0 108.447 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.04 -35.27 79.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -64.88 -20.96 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -92.28 -17.63 24.49 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.76 73.61 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.35 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.583 ' O ' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -116.92 107.37 46.12 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.88 144.47 15.17 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.83 1.687 . . . . 0.0 112.637 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.59 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -61.65 -44.52 96.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.893 0.854 . . . . 0.0 109.917 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.29 -27.68 62.62 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.019 -1.051 . . . . 0.0 111.192 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -62.85 -49.01 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.835 -1.166 . . . . 0.0 111.118 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.2 p90 -72.04 -34.4 68.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.816 -1.178 . . . . 0.0 110.022 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.725 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 2.3 t -63.05 -54.86 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.749 -1.219 . . . . 0.0 109.87 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.63 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 57.5 m95 -59.32 -22.2 60.89 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.072 -1.017 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -66.68 -45.05 80.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 110.406 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.647 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.1 m-85 -67.92 -29.14 68.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.094 -1.004 . . . . 0.0 109.918 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.578 HG21 HD22 ' A' ' 171' ' ' LEU . 7.2 t -87.26 18.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.525 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 123' ' ' GLN . 75.4 m-20 60.86 39.76 16.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.436 0.636 . . . . 0.0 110.007 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 42.05 25.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.404 -0.81 . . . . 0.0 110.536 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -145.66 148.28 36.02 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 120.933 -1.104 . . . . 0.0 109.511 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 19.1 Cg_endo -62.98 146.8 94.94 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.278 1.986 . . . . 0.0 111.434 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -103.59 137.63 41.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.6 mtt -93.02 120.01 32.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.427 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.2 m -88.26 120.37 29.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -91.0 16.63 9.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.03 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.57 136.49 49.31 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.7 p -99.07 -22.21 15.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.544 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.6 p -136.41 165.6 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -0.931 . . . . 0.0 109.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.1 mt -59.26 -34.39 72.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.046 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.3 m -69.79 -11.96 61.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -0.792 . . . . 0.0 109.697 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.09 6.44 47.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 mm -97.3 118.09 64.89 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.23 137.95 19.64 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.943 1.762 . . . . 0.0 112.227 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.2 p -95.71 4.21 53.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.6 t -137.8 95.3 3.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 32.4 p -109.27 150.83 41.58 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.35 -36.03 77.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.579 1.519 . . . . 0.0 111.432 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.15 -43.23 58.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.248 -0.908 . . . . 0.0 108.858 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.406 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 95.6 p -65.16 -39.9 93.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 109.723 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -61.9 -37.59 85.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.57 -37.26 86.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 109.91 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.62 -46.42 87.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.017 -1.052 . . . . 0.0 109.054 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.6 t -62.1 -43.18 99.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 110.149 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -62.52 -45.43 93.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.45 -44.73 67.2 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.99 -36.67 80.39 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.245 -0.91 . . . . 0.0 110.013 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -60.45 -38.65 84.85 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.705 -1.247 . . . . 0.0 108.581 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.73 -19.94 54.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.572 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -78.97 0.9 25.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.119 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.42 26.64 32.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.52 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 1.3 m-85 -101.11 113.51 26.6 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.38 -1.071 . . . . 0.0 109.575 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -91.81 173.9 7.62 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 55.73 45.27 24.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.089 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.3 p -132.09 49.09 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.42 177.1 6.07 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 54.9 m -58.6 -32.67 69.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.588 -0.948 . . . . 0.0 110.178 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 66.6 p -72.82 -28.25 62.44 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.917 -1.114 . . . . 0.0 109.061 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.2 mm -68.03 -45.31 83.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 110.152 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 159' ' ' THR . 3.1 p -65.89 -36.87 84.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.454 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -66.09 -45.97 79.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.454 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.4 m -61.98 -39.1 91.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.075 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -59.2 -41.09 87.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.082 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.415 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 73.2 mtp -62.51 -39.75 94.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.972 . . . . 0.0 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -74.29 -39.21 63.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.823 -1.173 . . . . 0.0 111.455 -178.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 167' ' ' GLN . . . -79.22 -40.2 31.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 110.889 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 166' ' ' MET . 21.6 p -60.51 -28.77 68.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.99 2.57 42.27 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 120' ' ' VAL . 35.1 mt -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.74 143.32 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.209 -0.932 . . . . 0.0 109.583 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 34.7 m120 -111.41 163.54 13.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.437 -0.79 . . . . 0.0 110.205 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER 83.28 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.242 0.544 . . . . 0.0 109.947 179.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.421 ' HE2' ' HA3' ' A' ' 22' ' ' GLY . 10.8 m170 -50.95 -44.47 60.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 108.7 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.646 ' C ' ' H ' ' A' ' 178' ' ' GLY . 30.6 m -149.5 28.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.412 -0.805 . . . . 0.0 109.624 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 129' ' ' ALA . 46.2 t 60.56 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.415 -0.803 . . . . 0.0 110.409 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -137.3 60.05 0.62 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.597 ' O ' ' N ' ' A' ' 181' ' ' CYS . 6.3 t -96.77 114.09 25.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -1.128 . . . . 0.0 110.107 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 64.03 -57.37 0.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 109.715 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.597 ' N ' ' O ' ' A' ' 179' ' ' CYS . 42.2 t -176.71 59.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.39 123.53 71.17 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.52 -83.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.998 1.799 . . . . 0.0 112.071 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 88.71 -27.86 6.89 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.74 -3.82 59.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.731 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.24 156.24 40.3 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.133 -0.979 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--N 1.305 -1.73 0 C-N-CA 122.443 2.095 . . . . 0.0 111.941 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.942 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.3 151.56 22.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.171 -0.956 . . . . 0.0 110.587 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.466 HH11 ' HG3' ' A' ' 3' ' ' ARG . 28.3 mtm-85 -70.36 177.7 3.24 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.523 0.678 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.45 141.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.558 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.19 94.91 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.543 -0.723 . . . . 0.0 112.097 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.727 ' CH2' H3A1 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -84.55 1.32 46.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.642 -1.504 . . . . 0.0 109.887 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.526 HG13 HD13 ' A' ' 14' ' ' ILE . 1.8 t -83.81 -50.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -67.99 -3.82 11.25 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.86 -39.31 94.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.404 0.621 . . . . 0.0 109.587 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -174.01 158.47 2.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.41 -0.807 . . . . 0.0 109.208 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 13' ' ' TYR . 12.0 Cg_endo -57.46 -161.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.478 2.119 . . . . 0.0 111.742 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -52.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.336 -0.853 . . . . 0.0 109.074 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 11' ' ' PRO . 14.1 m-85 -60.38 -31.66 70.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.131 -0.98 . . . . 0.0 108.893 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.526 HD13 HG13 ' A' ' 7' ' ' VAL . 7.8 mm -56.26 -40.33 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.98 -50.47 28.49 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.182 -0.949 . . . . 0.0 109.82 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CZ ' ' CZ2' ' A' ' 46' ' ' TRP . 42.7 t80 -63.13 -40.78 98.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 110.579 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 7' ' ' VAL . 34.8 t-80 -60.28 -43.9 95.82 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.035 -1.041 . . . . 0.0 109.835 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -82.09 -14.48 55.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.419 -0.801 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.771 ' ND2' ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -79.28 -57.18 3.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.528 -1.357 . . . . 0.0 110.597 -178.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.771 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 2.2 pt-20 -175.45 78.82 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.596 -1.315 . . . . 0.0 110.03 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.565 ' CZ3' ' NE1' ' A' ' 6' ' ' TRP . 7.7 t90 -100.77 68.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.01 -1.056 . . . . 0.0 108.523 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.55 9.75 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 96.9 t -111.01 -30.88 0.14 Allowed Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.649 -0.912 . . . . 0.0 111.927 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 67.7 Cg_endo -86.17 154.07 9.58 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.543 2.162 . . . . 0.0 113.539 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -65.93 170.5 5.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.585 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 4.8 p -92.13 124.6 36.34 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.811 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.601 ' O ' HD13 ' A' ' 31' ' ' LEU . 66.1 m-20 -102.48 149.13 24.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -65.07 -38.8 91.98 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.825 -1.172 . . . . 0.0 110.576 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -72.87 -50.71 22.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 111.61 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -63.34 -33.37 75.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.647 -1.283 . . . . 0.0 109.496 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 27' ' ' ASP . 5.1 mp -61.3 -39.13 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 109.267 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -59.29 -41.79 89.77 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.106 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CD ' ' NH2' ' A' ' 57' ' ' ARG . 40.5 mt-10 -71.68 -36.26 70.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.114 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.628 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -64.99 -47.15 78.56 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 111.377 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -65.98 -36.12 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.733 -1.23 . . . . 0.0 110.038 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m -70.17 -38.81 75.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.019 -1.05 . . . . 0.0 109.261 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' GLU . 3.1 mp -66.79 -44.59 80.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.489 -0.757 . . . . 0.0 109.817 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.609 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 66.4 mm-40 -67.83 -32.3 72.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.662 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.36 -33.58 32.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 42' ' ' ALA . 56.3 tp60 -75.44 -35.46 60.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.422 -1.046 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.613 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -44.15 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.314 -0.866 . . . . 0.0 110.741 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -60.68 112.78 2.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.677 -1.264 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.0 -36.83 2.13 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.602 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.8 mt -91.64 146.71 23.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.088 -1.242 . . . . 0.0 110.529 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.1 m -69.71 156.15 39.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.734 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -62.72 -37.8 87.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 110.297 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -63.52 -39.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 109.733 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -58.8 -38.31 78.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.899 -1.126 . . . . 0.0 108.198 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.3 t -64.34 -37.58 80.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.478 -0.764 . . . . 0.0 109.601 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.67 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.1 tt -55.73 -47.15 77.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.648 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -61.91 -46.97 87.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.947 -1.096 . . . . 0.0 109.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.04 -11.81 59.85 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.942 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.674 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 38.4 ttm180 -63.19 -46.12 88.53 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.67 -41.62 68.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.009 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.945 ' ND2' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -70.04 -45.2 67.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.063 . . . . 0.0 111.054 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 49.8 t80 -60.86 -48.47 81.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.897 -1.127 . . . . 0.0 110.523 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.522 ' NH2' ' CD ' ' A' ' 33' ' ' GLU . 16.7 mmm180 -57.77 -31.95 67.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.37 -39.06 65.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.832 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.1 m -73.16 -26.06 61.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 112.189 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 79.6 m-85 -113.11 -48.36 2.98 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.536 -1.353 . . . . 0.0 111.336 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' CG ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -176.81 112.36 0.09 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' HIS . 93.6 mt-30 -47.42 -35.67 8.75 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.133 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.3 p90 -177.93 39.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.191 -0.943 . . . . 0.0 111.404 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -131.88 81.08 63.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.615 -1.303 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.59 -14.35 1.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.78 2.32 . . . . 0.0 112.853 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 HD21 ' A' ' 103' ' ' LEU . 76.8 t -72.79 -37.35 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.887 -1.133 . . . . 0.0 108.856 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -35.73 66.38 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' ' CG ' ' A' ' 61' ' ' HIS . 64.6 t -59.52 -38.82 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.429 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.32 -16.44 63.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.97 -5.13 53.62 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.8 mmm -79.3 116.78 19.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 2.8 pt20 -95.67 177.33 5.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.5 mt-10 -59.41 -35.04 73.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.812 . . . . 0.0 110.304 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 85.6 tt0 -58.4 -46.44 86.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.807 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -64.93 -38.88 92.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.836 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 92' ' ' ILE . 46.3 t -56.55 -43.54 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.45 -0.781 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.28 -39.18 92.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.508 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 78' ' ' ARG . 28.7 ttm-85 -60.81 -39.27 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 108.733 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' N ' ' A' ' 81' ' ' GLN . 80.2 mt -68.97 -33.24 73.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.652 -0.655 . . . . 0.0 110.874 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.11 -18.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 108.675 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.3 mt-30 -118.76 -11.47 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 17.5 t70 -79.47 109.75 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 72.73 -19.01 0.32 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 109.404 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 64.2 35.47 92.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.945 HG22 ' ND2' ' A' ' 55' ' ' ASN . 3.5 pt -31.81 -105.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.208 -0.583 . . . . 0.0 111.823 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 87' ' ' ARG . 6.4 tt -161.44 -48.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.685 -1.259 . . . . 0.0 110.218 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.634 ' N ' HG23 ' A' ' 86' ' ' ILE . 9.2 mtt180 -63.33 149.04 46.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.001 -1.062 . . . . 0.0 109.409 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 89' ' ' ARG . 88.8 m-70 -108.04 167.74 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 109.765 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -43.33 -40.74 3.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.136 -0.977 . . . . 0.0 109.992 -179.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -66.23 -59.26 7.56 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.303 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.55 -40.18 96.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -1.086 . . . . 0.0 110.193 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.514 HG21 HG13 ' A' ' 76' ' ' VAL . 85.2 mt -59.66 -52.91 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 110.1 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.599 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 39.1 mt-30 -52.41 -33.81 45.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.906 -1.121 . . . . 0.0 110.099 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.57 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.874 -1.141 . . . . 0.0 109.226 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.624 HG21 ' OH ' ' A' ' 56' ' ' TYR . 96.2 mt -72.09 -32.56 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.0 -42.61 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.542 -1.348 . . . . 0.0 108.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.93 72.69 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.66 -43.37 96.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -1.184 . . . . 0.0 109.945 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.79 -46.92 73.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.048 -1.032 . . . . 0.0 108.787 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -61.54 -35.67 78.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 108.804 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.685 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.76 -32.23 73.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 108.649 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -64.48 -43.17 95.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 103' ' ' LEU . 39.0 mt -61.14 -27.75 68.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -68.06 -38.18 82.15 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.697 0.76 . . . . 0.0 109.245 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.571 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 34.5 ttm -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.942 0.877 . . . . 0.0 108.95 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.0 -36.89 85.07 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.48 -25.69 66.23 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -91.12 -12.27 36.07 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.57 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.93 27.51 73.64 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.48 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -117.37 102.8 52.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.84 144.18 21.49 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.024 1.816 . . . . 0.0 112.813 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -55.46 -40.66 71.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.033 0.921 . . . . 0.0 108.989 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.23 -27.09 64.19 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.474 -0.766 . . . . 0.0 110.494 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.96 -53.6 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.905 -1.122 . . . . 0.0 111.202 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 6.5 p90 -70.73 -32.61 69.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.953 -1.092 . . . . 0.0 109.611 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -64.96 -54.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.16 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.585 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 54.3 m95 -57.36 -26.72 61.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 108.532 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 66.3 p -77.68 -31.53 52.57 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.322 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -68.78 -32.32 71.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.6 p -88.61 18.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 66.36 27.4 10.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.867 . . . . 0.0 109.534 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 51.19 33.11 8.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.454 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.512 ' H ' HG13 ' A' ' 120' ' ' VAL . 15.1 mm100 -137.09 150.0 68.02 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.074 -1.016 . . . . 0.0 109.956 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.22 145.67 39.31 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.488 2.126 . . . . 0.0 111.847 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.509 ' NE2' ' N ' ' A' ' 126' ' ' MET . 2.2 tm0? -108.15 129.2 55.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.509 ' N ' ' NE2' ' A' ' 125' ' ' GLN . 9.0 mtm -117.7 108.48 15.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.068 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.509 ' H ' ' HB3' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -102.68 128.74 49.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.099 -1.0 . . . . 0.0 109.271 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.86 34.58 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.097 -1.002 . . . . 0.0 110.607 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -58.32 145.82 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 108.762 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.1 p -91.84 -15.22 28.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.065 -1.022 . . . . 0.0 110.343 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -142.46 162.9 34.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 109.685 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 78.0 mt -59.61 -33.05 70.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -65.42 -29.09 69.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.329 -0.857 . . . . 0.0 110.886 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.601 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 77.1 mm-40 -85.49 -1.8 57.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.996 -1.065 . . . . 0.0 109.854 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -80.14 143.78 57.43 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 108.851 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.67 142.94 40.89 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.423 2.082 . . . . 0.0 112.848 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 t -125.55 4.89 7.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.9 p -157.41 87.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 163.56 16.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.509 -0.745 . . . . 0.0 109.054 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.18 -39.72 85.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.702 1.601 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.67 -43.18 66.48 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.109 -1.036 . . . . 0.0 108.549 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 p -63.51 -44.07 95.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.421 -0.799 . . . . 0.0 109.351 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.25 -37.55 85.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.078 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.4 95.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 109.798 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.11 -45.54 75.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -59.0 -40.23 84.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.748 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -62.68 -49.42 75.2 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 110.653 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.69 76.81 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.121 -0.987 . . . . 0.0 109.473 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.445 ' HG ' HH21 ' A' ' 152' ' ' ARG . 32.5 mt -66.91 -39.74 87.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -0.902 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -38.78 87.75 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.754 -1.216 . . . . 0.0 110.34 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -84.62 -14.68 47.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 111.948 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.685 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 85.9 mtm180 -88.53 8.2 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.687 -1.258 . . . . 0.0 109.521 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.37 21.04 53.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -100.99 110.37 22.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 108.6 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -93.68 175.13 6.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 57.18 57.59 4.43 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.106 0.955 . . . . 0.0 109.124 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 157' ' ' VAL . 12.4 m -128.91 42.27 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.24 162.7 0.4 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.7 m -53.65 -29.49 38.6 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -1.089 . . . . 0.0 108.921 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.2 p -73.52 -32.29 64.15 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 108.547 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 157' ' ' VAL . 45.6 mm -62.57 -45.74 98.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.48 -0.762 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.64 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.525 -0.734 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -67.95 -45.94 72.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 0.0 109.692 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 97.0 p -68.81 -31.13 69.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 108.414 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.579 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 79.5 t80 -64.3 -48.0 77.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.864 -0.522 . . . . 0.0 110.277 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ptm -72.91 -32.35 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -58.18 -42.18 85.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.701 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.628 ' HB3' ' SD ' ' A' ' 34' ' ' MET . . . -92.98 -32.97 14.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 111.136 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 76.3 m -54.62 -24.09 19.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.864 -1.147 . . . . 0.0 110.517 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.82 0.56 48.96 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 116' ' ' VAL . 76.7 mt -63.66 -34.0 76.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.34 -1.094 . . . . 0.0 110.165 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.1 147.52 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.093 0.949 . . . . 0.0 111.003 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.85 103.52 9.42 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 127' ' ' THR . 58.9 p30 -173.86 70.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.067 -1.021 . . . . 0.0 111.284 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.635 ' C ' HG12 ' A' ' 176' ' ' VAL . 30.8 m170 -57.95 -43.09 86.19 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.58 -1.325 . . . . 0.0 108.244 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 175' ' ' HIS . 0.5 OUTLIER 168.23 3.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.454 ' H ' ' H ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER 71.87 -35.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 176' ' ' VAL . . . -83.8 11.92 54.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 12.8 t -85.75 121.53 28.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.043 . . . . 0.0 109.344 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.478 ' C ' ' H ' ' A' ' 182' ' ' TYR . 49.3 t -52.69 -34.59 52.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.629 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.84 17.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.635 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 180' ' ' CYS . 20.4 t80 -118.45 83.7 21.82 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.589 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.85 141.59 65.74 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.644 2.229 . . . . 0.0 111.919 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.68 -21.13 0.8 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -84.09 3.34 35.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.177 . . . . 0.0 109.397 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.458 ' HZ3' ' HB2' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -86.91 162.41 44.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 0.0 109.764 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 112.262 179.647 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.734 ' N6 ' ' CZ3' ' A' ' 46' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -109.89 142.77 40.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.392 -0.817 . . . . 0.0 109.77 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 179' ' ' CYS . 56.1 mtp180 -58.81 -46.36 87.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 108.887 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' N ' ' OE1' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -170.29 146.85 2.98 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.9 80.47 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.429 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.687 ' CE3' H3A3 ' A' ' 189' ' ' ADK . 0.1 OUTLIER -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.617 -1.519 . . . . 0.0 110.461 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.22 -41.9 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.907 -1.121 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.5 ' OG ' ' OE2' ' A' ' 2' ' ' GLU . 67.6 m -79.4 5.7 12.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 108.872 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.72 -60.48 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.763 . . . . 0.0 109.973 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.16 157.04 75.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.386 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.639 ' HA ' HD12 ' A' ' 14' ' ' ILE . 27.6 Cg_endo -65.92 -30.32 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.584 2.189 . . . . 0.0 112.143 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 47' ' ' ILE . 71.4 mt -62.69 -37.34 86.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.588 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.631 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 1.6 m-85 -63.86 -39.93 95.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.136 -0.978 . . . . 0.0 109.27 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 11' ' ' PRO . 32.0 mt -54.68 -44.51 70.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.474 -0.766 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -65.93 -47.93 73.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.728 -1.232 . . . . 0.0 109.224 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.7 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.7 t80 -62.12 -40.74 96.93 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.913 0.863 . . . . 0.0 108.805 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -71.48 -39.22 71.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -78.46 -5.9 53.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.189 -0.944 . . . . 0.0 111.863 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 87.1 m-20 -76.87 -75.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.527 -1.358 . . . . 0.0 110.001 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 21' ' ' TRP . 96.0 mt-10 -145.56 -40.96 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.139 -0.975 . . . . 0.0 108.724 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.897 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 6.4 t90 -4.68 74.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.106 0.955 . . . . 0.0 111.084 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . 149.47 -25.32 1.22 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.721 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 19.6 m -120.06 4.01 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.575 -0.956 . . . . 0.0 112.766 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 69.8 Cg_endo -75.69 147.21 31.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.174 1.25 . . . . 0.0 112.987 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.68 166.37 13.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.619 ' OG1' ' NE1' ' A' ' 117' ' ' TRP . 7.6 p -99.32 108.84 21.47 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.338 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -89.32 167.17 13.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 m -73.13 -37.33 66.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.474 -1.391 . . . . 0.0 110.465 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -74.85 -41.53 59.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -59.66 -37.0 77.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.593 -1.317 . . . . 0.0 110.487 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -59.33 -38.15 79.58 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.981 -178.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.68 -45.85 90.87 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.452 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -71.22 -40.69 70.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.022 -1.049 . . . . 0.0 108.636 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.3 tpp -64.64 -48.44 74.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.641 -0.662 . . . . 0.0 110.62 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 2.7 tp -64.21 -29.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.999 -1.063 . . . . 0.0 109.469 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.9 m -70.74 -48.83 52.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.022 -1.049 . . . . 0.0 109.042 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 53' ' ' ARG . 10.8 mp -68.66 -39.7 80.54 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.295 -0.878 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -62.07 -37.82 86.46 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.421 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.54 -36.87 91.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.42 -24.18 67.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.469 -1.018 . . . . 0.0 110.061 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.8 pp0? -69.74 -3.29 14.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.711 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -58.43 112.71 1.67 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.725 -1.235 . . . . 0.0 109.084 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.8 -14.68 1.4 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 42' ' ' ALA . 4.0 mm? -103.93 154.93 19.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.184 -1.186 . . . . 0.0 110.178 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -71.5 153.71 42.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 109.773 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.7 ' CZ2' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -64.77 -41.99 95.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 110.434 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -54.63 -31.25 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -0.977 . . . . 0.0 109.728 -179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 m -58.11 -40.86 82.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -70.84 -28.04 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.097 -1.002 . . . . 0.0 109.43 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -53.44 53.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 109.827 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -61.34 -44.46 97.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.673 -1.267 . . . . 0.0 108.154 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -65.62 -26.71 67.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 37' ' ' LEU . 40.3 ttm180 -53.96 -44.04 70.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.779 -1.201 . . . . 0.0 107.918 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.49 -37.05 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.397 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -78.35 -45.65 22.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.873 -1.142 . . . . 0.0 111.155 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.663 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 40.2 t80 -58.87 -46.43 87.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.159 . . . . 0.0 109.945 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.673 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 2.4 ppt_? -66.6 -29.47 69.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.11 -0.993 . . . . 0.0 109.37 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.24 74.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.746 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.52 -45.46 68.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.858 -1.151 . . . . 0.0 110.648 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' O ' ' N ' ' A' ' 62' ' ' GLN . 20.5 m-85 -79.23 -47.72 15.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.985 -1.072 . . . . 0.0 109.997 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' CE1' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 48.06 5.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.334 -0.854 . . . . 0.0 110.071 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.604 ' N ' ' O ' ' A' ' 60' ' ' PHE . 96.4 mm-40 -65.39 -38.76 90.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.947 -1.096 . . . . 0.0 109.974 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.28 3.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -128.13 99.29 25.18 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 108.911 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.73 -23.07 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.784 . . . . 0.0 112.439 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.79 -46.18 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.939 -1.1 . . . . 0.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.12 75.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.095 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.02 -38.22 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.766 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -68.67 -14.91 63.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.08 -9.57 45.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.57 -0.707 . . . . 0.0 109.094 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.588 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.1 mtp -82.18 112.84 19.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.456 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -95.77 -176.49 3.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 109.98 -178.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 76' ' ' VAL . 97.3 mt-10 -57.61 -33.12 67.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 110.617 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.0 -33.13 75.3 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 108.506 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 62.3 m-20 -68.22 -40.1 82.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.528 -0.733 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 1.1 m -66.69 -33.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.743 -1.223 . . . . 0.0 109.254 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.511 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.8 mt-10 -63.99 -36.56 84.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.072 -1.017 . . . . 0.0 108.648 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 78' ' ' ARG . 19.6 ttm-85 -61.77 -47.03 87.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.51 -0.744 . . . . 0.0 109.781 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.439 ' C ' ' N ' ' A' ' 81' ' ' GLN . 91.9 mt -69.88 -33.49 72.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 111.209 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 76' ' ' VAL . 38.9 t -49.6 -18.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 108.689 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' A' ' 79' ' ' LEU . 3.5 mt-30 -113.31 -13.78 12.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.551 -0.718 . . . . 0.0 109.775 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.0 t70 -81.23 109.1 15.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.685 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.29 -17.17 0.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 72.04 36.47 60.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.517 HG22 ' ND2' ' A' ' 55' ' ' ASN . 7.6 pt -50.33 -172.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.446 -1.032 . . . . 0.0 110.337 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 86' ' ' ILE . 18.9 tt -59.41 93.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 94.1 mtt180 -52.27 139.73 23.33 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.593 -0.692 . . . . 0.0 109.794 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER 164.76 63.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 11.6 ptm180 -49.36 -38.45 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.337 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -64.59 -59.18 8.55 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.515 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.82 -41.47 95.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.879 -1.365 . . . . 0.0 109.849 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.88 -42.43 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 110.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -57.87 -32.92 68.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.754 -1.216 . . . . 0.0 108.548 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.22 83.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 108.934 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.631 HG21 ' OH ' ' A' ' 56' ' ' TYR . 50.3 mm -57.27 -41.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 108.84 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 71' ' ' MET . 7.6 mm -59.65 -40.41 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.82 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.34 85.46 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.58 -37.55 76.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.424 -1.045 . . . . 0.0 109.088 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -62.78 -44.89 95.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -56.72 -42.99 80.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 108.507 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.03 70.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.45 -0.781 . . . . 0.0 108.965 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.16 -42.92 99.73 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 103' ' ' LEU . 7.1 mp -68.52 -31.62 70.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.32 -40.43 90.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.128 -0.983 . . . . 0.0 110.322 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.683 ' SD ' ' CZ ' ' A' ' 112' ' ' PHE . 71.3 mtp -71.73 -39.33 70.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.958 -1.089 . . . . 0.0 108.803 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.41 -41.81 88.75 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.819 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.83 -21.37 66.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -92.9 -11.05 34.43 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.59 26.57 74.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -118.42 101.5 50.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.243 -1.151 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.17 145.01 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.237 1.958 . . . . 0.0 112.414 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 31' ' ' LEU . 31.7 m-85 -60.8 -43.42 98.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 110.169 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.27 -33.29 75.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 111.139 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.36 -48.52 80.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.033 -1.042 . . . . 0.0 112.133 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 5.3 p90 -70.16 -45.18 67.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.685 -1.259 . . . . 0.0 111.12 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 117' ' ' TRP . 2.9 p -59.84 -50.09 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.468 -1.395 . . . . 0.0 109.581 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.619 ' NE1' ' OG1' ' A' ' 26' ' ' THR . 17.0 m95 -54.99 -24.48 24.39 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 5.3 p -70.61 -38.86 74.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.496 -0.753 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.517 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.6 m-85 -64.96 -32.17 73.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.718 -1.239 . . . . 0.0 109.476 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.698 HG21 ' CD2' ' A' ' 171' ' ' LEU . 29.0 m -96.92 17.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.366 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.657 HD22 ' N ' ' A' ' 121' ' ' ASN . 1.3 m120 57.74 40.93 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.544 -0.722 . . . . 0.0 110.059 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 121' ' ' ASN . 49.8 t-80 43.16 27.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.114 -0.992 . . . . 0.0 109.805 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 2.6 mm-40 -126.9 149.72 69.74 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.291 -0.881 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.43 147.99 87.56 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.532 2.154 . . . . 0.0 112.157 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -117.32 139.45 50.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.3 mtt -100.34 122.15 42.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.413 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -84.98 118.11 24.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 108.571 179.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.82 19.88 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -76.12 129.43 36.77 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.274 -0.892 . . . . 0.0 109.365 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.9 p -100.96 -21.32 15.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 109.7 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 10.8 p -131.64 162.78 29.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.2 mt -58.78 -37.32 76.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 108.823 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.7 m -76.32 -3.2 35.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HB3' ' H ' ' A' ' 131' ' ' THR . 31.9 tp10 -101.69 12.53 36.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -100.48 106.96 45.93 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.71 137.7 82.46 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.83 1.686 . . . . 0.0 112.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 p -103.78 4.09 34.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 m -142.29 85.74 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.2 p -102.35 151.49 38.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -52.73 -35.73 70.01 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.508 1.472 . . . . 0.0 111.284 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.49 -43.05 61.03 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 166' ' ' MET . 56.8 m -66.17 -43.57 86.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -66.17 -37.47 85.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -71.91 -31.2 66.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.54 HD23 ' SG ' ' A' ' 162' ' ' CYS . 7.1 tp -65.42 -46.65 79.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.642 -0.661 . . . . 0.0 109.537 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.574 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 19.4 m -61.3 -40.88 95.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.077 -1.015 . . . . 0.0 109.518 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -61.22 -43.57 98.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 110.039 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.17 70.79 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.49 -37.92 83.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 109.223 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -61.57 -40.0 93.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.034 -1.041 . . . . 0.0 109.498 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.6 -15.34 57.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.907 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.448 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -83.0 4.16 27.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.156 -0.965 . . . . 0.0 108.835 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.53 24.78 49.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -100.57 112.89 25.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.983 . . . . 0.0 108.849 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -93.44 172.93 7.97 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.648 -0.657 . . . . 0.0 109.231 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 57.84 61.31 2.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.843 . . . . 0.0 109.055 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 157' ' ' VAL . 17.3 m -140.85 39.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -44.51 162.91 0.07 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.6 m -55.03 -31.39 61.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.457 -1.026 . . . . 0.0 109.005 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.6 p -72.34 -31.89 66.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.36 -45.02 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.574 ' SG ' ' N ' ' A' ' 146' ' ' SER . 1.7 m -67.0 -41.81 86.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -0.764 . . . . 0.0 109.407 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -68.44 -46.84 68.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.589 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 18.3 m -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.853 -1.154 . . . . 0.0 109.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -59.29 -47.71 84.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 110.652 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 142' ' ' SER . 11.9 ptp -66.42 -29.19 69.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.132 . . . . 0.0 110.657 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.415 HE22 HG21 ' A' ' 172' ' ' VAL . 52.1 mm-40 -57.35 -40.0 77.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.872 -1.143 . . . . 0.0 110.746 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.14 -33.16 11.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 111.124 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.662 ' SG ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -54.62 -27.64 40.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.975 -1.078 . . . . 0.0 109.69 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.55 54.36 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.069 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.698 ' CD2' HG21 ' A' ' 120' ' ' VAL . 6.4 mt -63.3 -30.69 71.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.199 -1.177 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 125' ' ' GLN . 10.9 m -125.77 137.88 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.834 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 23.4 m120 -104.32 164.3 11.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.745 . . . . 0.0 109.413 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.4 OUTLIER 89.58 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.465 ' O ' HG13 ' A' ' 176' ' ' VAL . 17.7 m170 -51.55 -44.74 62.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 108.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 177' ' ' VAL . 28.2 m -157.91 37.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.73 . . . . 0.0 109.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 176' ' ' VAL . 16.0 t 37.84 93.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.24 -4.35 7.26 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.593 ' O ' ' N ' ' A' ' 182' ' ' TYR . 8.7 t -57.08 133.38 54.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 108.482 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 179' ' ' CYS . 42.5 t -43.07 -43.74 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.944 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 88.4 m -70.11 -13.61 62.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 109.751 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 179' ' ' CYS . 36.0 t80 -60.04 136.36 90.78 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.698 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.25 125.16 9.52 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.098 1.866 . . . . 0.0 112.018 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -95.84 12.55 67.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.89 23.93 8.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.484 -1.01 . . . . 0.0 109.045 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -104.8 150.2 38.38 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 C--N 1.311 -1.436 0 C-N-CA 122.445 2.097 . . . . 0.0 112.208 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.897 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' O ' ' A' ' 180' ' ' CYS . 59.6 ttp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.213 0.53 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 180' ' ' CYS . 38.0 tp10 -100.46 138.53 37.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.56 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -66.85 165.3 15.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 110.77 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.8 145.87 55.03 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.83 49.84 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.408 -0.808 . . . . 0.0 111.833 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.837 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -84.37 2.97 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.536 -1.567 . . . . 0.0 109.77 -179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -76.84 -46.45 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 109.158 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.1 m -73.17 -2.02 19.94 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.895 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 62.8 tt0 -67.81 -41.7 82.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -154.63 159.92 31.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 109.984 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.8 -38.47 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.991 2.46 . . . . 0.0 112.463 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.72 -32.88 73.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.725 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.3 OUTLIER -62.96 -41.84 99.65 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.296 -0.878 . . . . 0.0 110.207 -179.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.27 -38.29 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 110.523 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.654 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -67.48 -50.65 58.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 109.539 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.5 ' HA ' HD22 ' A' ' 19' ' ' ASN . 1.2 t80 -60.91 -37.21 81.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 110.01 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -59.1 -43.05 91.85 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.416 -0.803 . . . . 0.0 110.651 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -80.36 -16.06 55.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 110.712 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.654 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 34.8 m-80 -64.58 -53.94 39.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 177.57 57.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 108.829 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 1.012 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 4.2 t90 -97.66 63.93 1.76 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 108.87 59.85 0.53 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.857 -1.164 . . . . 0.0 111.562 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.729 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.7 m -157.88 -36.82 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.486 . . . . 0.0 112.037 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.729 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 46.5 Cg_endo -96.15 152.05 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.702 2.268 . . . . 0.0 114.032 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 26' ' ' THR . 86.2 tt0 -68.9 160.15 31.26 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.437 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 2.3 p -95.06 152.48 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.492 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' LYS . 24.1 t70 -103.65 151.46 22.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -62.79 -36.23 82.44 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.911 -1.118 . . . . 0.0 109.418 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -74.89 -50.33 17.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.629 -0.67 . . . . 0.0 110.811 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' CD ' ' H ' ' A' ' 27' ' ' ASP . 1.3 ptmm? -62.75 -25.16 68.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.958 -1.089 . . . . 0.0 108.69 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.58 -39.47 76.85 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -69.32 -44.52 71.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.695 -0.628 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.54 -28.37 66.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.14 . . . . 0.0 110.21 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.5 ttm -71.47 -52.06 20.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.867 -1.146 . . . . 0.0 110.444 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 35' ' ' ILE . 9.5 tp -61.1 -29.02 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.749 -1.219 . . . . 0.0 109.709 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.01 -44.1 90.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.065 -1.022 . . . . 0.0 109.038 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 53' ' ' ARG . 3.7 mm? -70.71 -43.58 68.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 31.5 mm-40 -62.81 -33.52 75.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -0.806 . . . . 0.0 109.104 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.14 -36.32 88.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.77 -3.63 39.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -1.174 . . . . 0.0 109.992 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' NE2' ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -79.26 -0.69 33.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -66.04 122.76 18.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.162 -0.961 . . . . 0.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.514 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 74.04 -32.85 0.92 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.9 mm? -98.47 150.03 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.014 -1.286 . . . . 0.0 109.996 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.5 p -65.61 157.29 30.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -61.33 -31.08 70.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -40.8 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.413 -0.804 . . . . 0.0 109.877 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 m -57.37 -38.92 74.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.081 -1.012 . . . . 0.0 108.35 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -64.17 -36.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.23 -47.48 78.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -0.966 . . . . 0.0 109.046 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.5 -34.09 76.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' C ' HD22 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -84.52 -10.65 57.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.005 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' CH2' ' A' ' 46' ' ' TRP . 41.1 ttm180 -66.72 -51.16 59.17 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.54 -36.13 76.08 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.229 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.663 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -72.13 -34.88 68.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.015 -1.053 . . . . 0.0 109.929 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 82.9 t80 -60.7 -47.47 86.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.163 -0.96 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 7.9 ptm180 -66.86 -28.23 68.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.919 -1.113 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -67.7 -37.98 83.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 111.267 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -77.41 -45.66 25.16 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.749 -1.219 . . . . 0.0 110.768 -178.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.606 ' C ' ' H ' ' A' ' 62' ' ' GLN . 86.7 m-85 -84.5 -48.39 9.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 110.334 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 55.89 -4.0 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.019 -1.051 . . . . 0.0 109.552 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.649 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 26.0 mt-30 -75.75 -18.39 59.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.037 -1.039 . . . . 0.0 108.759 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.649 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 3.4 m-30 101.07 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.086 0.555 . . . . 0.0 109.579 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.5 OUTLIER 165.46 -42.77 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.419 0 O-C-N 120.554 -1.341 . . . . 0.0 113.786 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 64' ' ' ASP . 50.8 Cg_exo -49.88 -146.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.341 0 C-N-CA 123.721 2.948 . . . . 0.0 116.982 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 103' ' ' LEU . 59.4 t -57.3 -30.13 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.917 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.483 ' C ' ' NE2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -54.18 -39.82 66.97 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.331 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 64' ' ' ASP . 72.3 t -69.34 -40.71 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.766 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.711 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -63.33 -16.28 59.89 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.02 -6.38 58.75 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.57 ' O ' HG21 ' A' ' 96' ' ' ILE . 67.6 mmm -82.74 117.24 22.52 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -94.89 172.27 8.26 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.12 -0.988 . . . . 0.0 109.857 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -54.33 -31.47 54.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.486 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.31 -44.41 75.78 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.651 -1.28 . . . . 0.0 108.37 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -66.24 -37.81 86.39 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 92' ' ' ILE . 99.5 t -56.93 -44.83 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 0.0 109.591 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.76 -38.06 89.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 108.628 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -60.93 -39.95 91.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 109.373 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 85' ' ' ILE . 95.9 mt -63.01 -33.24 75.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.16 -33.8 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -109.34 -4.04 16.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.557 -0.714 . . . . 0.0 110.949 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 35.7 t0 -82.0 108.68 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.281 -1.512 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.91 -16.06 0.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.421 -0.799 . . . . 0.0 109.548 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 74.01 33.18 57.7 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.663 HG22 ' OD1' ' A' ' 55' ' ' ASN . 22.1 pt -54.73 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -1.114 . . . . 0.0 110.205 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 86' ' ' ILE . 10.6 tt -57.71 86.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -54.21 138.64 38.01 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.698 0.761 . . . . 0.0 110.434 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 3.1 m-70 160.58 77.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.585 ' CD ' ' H ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.18 -35.27 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.533 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 -56.26 25.63 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -65.8 -41.43 91.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.295 . . . . 0.0 110.614 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 76' ' ' VAL . 74.6 mt -62.66 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 0.0 110.443 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -55.82 -34.52 65.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.667 -1.271 . . . . 0.0 108.882 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' N ' ' HG2' ' A' ' 93' ' ' GLN . . . -63.13 -37.51 87.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.948 . . . . 0.0 109.153 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.62 -44.27 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 108.821 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.57 HG21 ' O ' ' A' ' 71' ' ' MET . 9.3 mm -60.45 -41.12 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.59 90.86 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -40.53 87.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 0.0 109.264 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 69' ' ' ALA . . . -64.23 -43.89 93.56 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.072 -1.017 . . . . 0.0 109.001 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.711 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -52.16 -42.07 63.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.05 -1.031 . . . . 0.0 108.793 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -65.44 -29.32 69.99 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.713 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 45.9 t80 -62.79 -44.86 95.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.9 mm? -62.82 -33.36 75.07 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' A' ' 101' ' ' ALA . 54.9 mt-30 -66.08 -36.94 84.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.392 -0.817 . . . . 0.0 110.444 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 82.9 mmm -71.56 -40.3 70.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.71 -39.33 70.23 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.19 -20.03 64.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -85.89 -8.98 57.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.77 26.34 73.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.04 101.79 49.62 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.497 -1.002 . . . . 0.0 109.678 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.25 143.7 41.83 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.342 2.028 . . . . 0.0 112.204 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.713 ' CZ ' ' CD1' ' A' ' 102' ' ' TYR . 58.5 m-85 -64.66 -45.33 87.21 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.039 0.924 . . . . 0.0 110.665 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.6 -26.91 68.9 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.473 -0.767 . . . . 0.0 110.947 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.479 ' O ' ' OG ' ' A' ' 118' ' ' SER . 60.4 t0 -66.24 -49.35 67.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.863 -1.148 . . . . 0.0 111.862 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 112' ' ' PHE . 7.3 p90 -69.74 -44.51 70.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.864 -1.148 . . . . 0.0 111.355 -178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 117' ' ' TRP . 3.3 p -61.0 -53.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.512 -1.367 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.617 ' H ' HG13 ' A' ' 116' ' ' VAL . 37.5 m95 -55.82 -23.09 28.32 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.496 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 114' ' ' ASP . 13.3 m -69.26 -38.87 78.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.084 -1.01 . . . . 0.0 109.782 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 29.8 m-85 -64.55 -33.9 77.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 120' ' ' VAL . 3.6 m -91.82 18.58 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.055 . . . . 0.0 109.178 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.61 ' O ' ' CG ' ' A' ' 122' ' ' HIS . 59.2 m-80 58.62 43.96 18.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 0.0 109.496 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 121' ' ' ASN . 28.9 p-80 41.51 24.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.491 -0.756 . . . . 0.0 110.058 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -135.46 153.76 78.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.086 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 147.46 95.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.653 2.235 . . . . 0.0 112.376 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -100.36 131.7 46.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.761 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.7 mtt -96.88 113.25 24.77 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -93.24 115.9 28.49 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -87.84 19.31 3.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.33 140.75 52.29 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.261 -0.899 . . . . 0.0 109.122 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.29 -28.65 10.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.3 p -128.18 162.37 27.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.52 -0.737 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.5 mt -56.91 -36.87 70.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.054 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.2 m -61.84 -30.34 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.19 -6.5 57.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 109.816 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -75.52 131.8 76.7 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.634 ' C ' ' H ' ' A' ' 138' ' ' SER . 74.3 Cg_endo -79.41 -21.58 8.78 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.844 1.696 . . . . 0.0 112.649 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.482 HG22 ' CE1' ' A' ' 163' ' ' TYR . 0.2 OUTLIER 52.36 -1.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.767 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.634 ' H ' ' C ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -148.37 83.15 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.065 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.416 ' HG1' ' HG ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -95.62 159.08 33.34 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.9 -38.13 85.88 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.843 1.695 . . . . 0.0 111.029 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.01 -45.02 52.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.416 ' HG ' ' HG1' ' A' ' 139' ' ' THR . 18.1 m -62.95 -43.0 99.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.735 . . . . 0.0 109.061 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.83 -42.05 97.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 108.932 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.1 -29.0 66.99 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -61.52 -47.81 83.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.648 -0.657 . . . . 0.0 109.484 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.546 ' HG ' ' CB ' ' A' ' 162' ' ' CYS . 3.8 m -66.19 -41.02 90.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 0.0 110.161 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -58.3 -38.66 77.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.845 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -56.13 6.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.549 HD13 HD13 ' A' ' 145' ' ' LEU . 10.1 mp -59.93 -31.94 70.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 109.968 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -61.05 -45.12 96.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.789 -1.195 . . . . 0.0 109.581 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -84.48 -13.5 51.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -81.75 2.99 27.38 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.864 -1.148 . . . . 0.0 109.484 -178.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.1 21.18 33.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 15.2 m-85 -109.66 111.13 22.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -1.073 . . . . 0.0 109.308 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -94.64 -178.31 4.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 55.32 40.48 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 108.93 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.2 p -125.03 48.37 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.61 162.2 0.5 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.1 m -58.18 -30.61 66.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.496 -1.002 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 61.5 m -72.32 -37.24 68.97 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.141 -0.974 . . . . 0.0 108.674 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.74 -39.88 87.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.546 ' CB ' ' HG ' ' A' ' 146' ' ' SER . 1.4 m -62.2 -49.35 76.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.87 . . . . 0.0 109.828 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.716 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -65.16 -41.0 95.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.857 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 20.1 m -64.38 -43.02 95.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.11 -0.994 . . . . 0.0 109.56 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.9 88.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 98.8 mtp -60.89 -40.55 93.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 111.289 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.716 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 46.9 mt-30 -64.04 -44.74 91.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 111.222 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.26 63.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.019 . . . . 0.0 110.612 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -39.09 67.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 0.0 111.288 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.9 0.61 17.3 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -1.188 . . . . 0.0 109.887 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.32 150.34 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.249 -0.907 . . . . 0.0 109.913 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 21.4 m120 -128.57 163.56 24.74 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.386 0.612 . . . . 0.0 110.72 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.9 t0 89.52 74.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.471 0.653 . . . . 0.0 109.755 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 176' ' ' VAL . 9.2 m170 -58.35 -44.6 88.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 175' ' ' HIS . 12.9 m -157.99 29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.905 . . . . 0.0 109.992 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 129' ' ' ALA . 85.8 t 55.24 113.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.888 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.14 33.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.641 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -73.58 91.9 1.88 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -1.086 . . . . 0.0 109.45 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 59.95 -42.64 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.793 -0.567 . . . . 0.0 110.791 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 179' ' ' CYS . 26.1 t -172.59 57.02 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE1' ' O ' ' A' ' 183' ' ' PRO . 56.1 t80 -70.14 135.99 87.0 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.039 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.476 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 37.1 Cg_endo -69.72 136.41 33.03 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 112.737 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.29 -30.92 0.08 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.26 4.25 31.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -1.039 . . . . 0.0 108.822 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.41 86.11 32.96 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.452 2.101 . . . . 0.0 112.401 -179.284 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.012 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtm . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -110.83 140.03 45.62 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -70.17 161.74 29.67 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.572 -0.705 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 133.67 51.15 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.918 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.78 -30.8 76.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.31 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 1.7 t90 -76.08 -1.51 26.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 108.334 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' ND1' ' A' ' 17' ' ' HIS . 1.1 t -102.29 -28.0 3.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.392 0.615 . . . . 0.0 109.395 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.1 m -70.66 5.2 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.9 . . . . 0.0 110.634 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -84.11 -149.18 0.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.789 -1.195 . . . . 0.0 109.275 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.67 158.6 11.42 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 -160.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.837 2.358 . . . . 0.0 111.468 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 -40.42 0.27 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.012 -1.055 . . . . 0.0 109.135 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.657 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 1.3 m-85 -64.48 -36.63 84.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.894 -1.129 . . . . 0.0 109.413 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.78 -46.83 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.544 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.04 69.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.995 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CE2' ' CZ2' ' A' ' 46' ' ' TRP . 2.2 t80 -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.011 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.498 ' ND1' HG21 ' A' ' 7' ' ' VAL . 14.6 t-80 -76.08 -32.12 59.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.94 -10.33 59.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.956 -1.09 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 19.7 p30 -90.95 -70.41 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.602 -1.311 . . . . 0.0 112.464 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.676 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.2 mt-10 -126.5 -69.09 0.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.943 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.69 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 30.1 t-105 51.72 44.83 28.96 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.68 41.45 19.67 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 120.491 -1.381 . . . . 0.0 110.969 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.574 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -106.98 -41.88 0.14 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.218 . . . . 0.0 109.993 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 95.4 Cg_endo -98.57 154.03 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.794 2.996 . . . . 0.0 112.821 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.36 144.2 55.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 169' ' ' CYS . 67.4 p -105.46 155.44 19.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.773 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -92.16 167.1 12.28 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -59.95 -36.8 77.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.374 -0.829 . . . . 0.0 111.197 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.1 -41.55 90.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.42 -0.8 . . . . 0.0 112.264 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -62.34 -38.68 90.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.603 -1.311 . . . . 0.0 108.855 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -56.76 -39.1 73.41 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.231 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -60.73 -40.3 91.83 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.04 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -70.69 -43.38 69.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.905 -1.122 . . . . 0.0 108.778 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.479 ' SD ' ' CD1' ' A' ' 165' ' ' PHE . 58.2 ttm -63.82 -47.36 81.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 110.462 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -65.46 -29.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.2 m -69.36 -51.11 40.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.99 -1.068 . . . . 0.0 109.652 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 2.2 mp -68.44 -42.0 79.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.196 -0.94 . . . . 0.0 108.965 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' CD ' ' OG ' ' A' ' 164' ' ' SER . 9.1 tp10 -62.55 -35.74 80.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.619 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.29 -28.1 49.0 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -79.41 -12.87 59.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 109.807 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.519 ' NE2' ' H8 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -74.79 11.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 111.303 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -68.62 112.94 5.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.367 -1.458 . . . . 0.0 109.238 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.27 -0.35 0.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.604 HD21 ' CG2' ' A' ' 48' ' ' THR . 17.3 tp -106.66 145.2 32.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.193 -1.18 . . . . 0.0 109.857 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.7 m -64.39 157.06 27.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.837 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.626 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 2.8 t-105 -71.13 -43.81 66.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.489 -0.757 . . . . 0.0 110.708 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.562 HD12 ' HZ2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -58.96 -27.22 35.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.959 -1.088 . . . . 0.0 109.097 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.604 ' CG2' HD21 ' A' ' 44' ' ' LEU . 29.6 m -63.86 -40.23 96.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.205 -0.935 . . . . 0.0 109.895 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 46' ' ' TRP . 1.2 m -69.82 -28.83 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.084 -1.01 . . . . 0.0 108.993 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.06 -47.31 85.25 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -56.64 -45.85 81.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' TYR . 21.3 ttpp -59.82 -32.59 70.8 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -55.35 -45.25 76.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.531 -0.731 . . . . 0.0 109.576 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -68.66 -46.11 69.98 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.02 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 14.0 m-80 -64.34 -34.65 78.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.776 . . . . 0.0 109.142 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 64.1 t80 -56.6 -42.29 78.49 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 61' ' ' HIS . 7.2 mmm180 -63.37 -38.22 90.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.09 -41.25 86.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.744 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -45.39 41.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.0 111.229 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 56' ' ' TYR . 81.4 m-85 -89.9 -45.69 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.533 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 2.2 t60 60.97 -47.0 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.051 0.453 . . . . 0.0 110.416 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' PHE . 91.6 mm-40 -81.29 -37.88 27.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.792 . . . . 0.0 109.931 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 62' ' ' GLN . 46.5 p90 35.88 21.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.772 -0.58 . . . . 0.0 111.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -91.08 131.86 35.84 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.238 -1.539 . . . . 0.0 109.1 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -37.6 -52.92 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.986 2.457 . . . . 0.0 114.75 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.07 -44.83 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 111.121 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.49 -40.6 95.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 64' ' ' ASP . 38.1 t -63.5 -41.77 93.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.801 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.68 60.73 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.18 -14.53 28.92 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.739 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG21 ' A' ' 96' ' ' ILE . 97.5 mtp -82.78 113.14 20.22 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.61 -177.64 3.99 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.766 -1.209 . . . . 0.0 110.958 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.42 -36.65 69.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 109.136 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.81 -49.04 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.581 -1.325 . . . . 0.0 108.128 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.34 -35.66 74.26 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.507 ' HA ' HD12 ' A' ' 79' ' ' LEU . 55.6 t -60.55 -37.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.28 -0.887 . . . . 0.0 108.748 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.02 -39.8 83.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -65.37 -33.48 76.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.361 0.6 . . . . 0.0 109.507 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.744 HD22 ' SG ' ' A' ' 59' ' ' CYS . 87.8 mt -69.29 -34.47 74.75 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.266 -0.896 . . . . 0.0 110.447 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' HB ' HE21 ' A' ' 81' ' ' GLN . 96.1 t -56.03 -17.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.417 HE21 ' HB ' ' A' ' 80' ' ' VAL . 33.5 mm-40 -109.73 -17.26 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -1.0 . . . . 0.0 110.077 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 59.6 m-20 -80.04 109.78 14.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.75 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 70.98 -16.21 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.675 . . . . 0.0 109.246 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.7 42.73 86.87 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' GLY . 4.8 pt -52.52 -166.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.836 -0.802 . . . . 0.0 109.846 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.07 98.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.511 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 11.2 ptp180 -52.68 116.82 2.5 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.675 0.75 . . . . 0.0 109.696 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 0.8 OUTLIER 168.23 70.56 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.023 -1.048 . . . . 0.0 108.197 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 90' ' ' GLY . 29.3 ptt180 -44.34 -42.44 6.79 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.694 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 89' ' ' ARG . . . -47.97 -51.85 18.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -65.18 -45.38 85.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -1.128 . . . . 0.0 109.861 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 mm -60.75 -44.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.631 -0.668 . . . . 0.0 110.005 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -56.83 -38.31 72.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.823 -1.173 . . . . 0.0 110.167 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.97 82.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 0.0 109.169 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.41 -39.46 74.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 71' ' ' MET . 25.5 mm -59.16 -46.22 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.591 0.71 . . . . 0.0 110.269 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.85 -28.78 73.94 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.55 -40.52 97.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -1.16 . . . . 0.0 110.009 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -49.83 61.23 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 108.95 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -55.81 -38.08 69.51 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.46 -29.54 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.083 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.01 -42.27 94.59 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.2 mm? -62.78 -33.52 75.35 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.438 HE21 ' HA ' ' A' ' 101' ' ' ALA . 51.8 mt-30 -62.59 -36.54 83.05 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.533 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.593 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 39.1 tpp -61.01 -47.64 85.52 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.121 -0.987 . . . . 0.0 108.337 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 109' ' ' GLY . 84.3 tt0 -57.67 -35.73 70.96 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.3 t-20 -91.43 -18.12 24.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 67.51 27.57 73.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.593 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.3 mt-10 -114.26 108.58 50.04 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.72 -0.87 . . . . 0.0 109.57 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -51.73 139.75 48.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.965 1.777 . . . . 0.0 112.069 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.713 ' HB3' HD12 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -55.01 -37.84 67.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.756 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.27 64.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 110.636 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -62.96 -45.05 94.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.688 -1.257 . . . . 0.0 111.249 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.659 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 5.4 p90 -77.39 -40.51 43.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.91 -1.119 . . . . 0.0 111.601 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.659 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 21.6 m -63.2 -48.84 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 119.547 -1.97 . . . . 0.0 108.662 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.567 ' N ' HG23 ' A' ' 116' ' ' VAL . 46.3 m95 -61.26 -23.67 65.83 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.8 t -70.22 -44.48 68.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.095 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 24.1 m-85 -61.19 -30.28 70.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 109.812 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.7 OUTLIER -96.5 18.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 123' ' ' GLN . 82.0 m-20 56.99 42.31 26.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 110.176 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER 37.67 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.67 -0.644 . . . . 0.0 109.361 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 121' ' ' ASN . 2.3 mm100 -122.84 112.37 30.61 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.349 -0.844 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.27 150.45 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.882 1.722 . . . . 0.0 111.227 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 142.44 46.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.044 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.7 mtt -91.2 130.27 37.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.78 . . . . 0.0 109.638 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.595 HG22 ' N ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -93.44 -58.91 2.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 109.745 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.595 ' N ' HG22 ' A' ' 127' ' ' THR . 71.7 mt-30 59.26 44.26 15.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -79.34 156.23 28.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.451 -0.781 . . . . 0.0 109.687 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -92.53 -12.79 30.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 t -168.55 -179.34 3.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -36.39 83.48 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 t -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.897 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 74.9 mm-40 -81.7 5.41 18.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.621 -1.299 . . . . 0.0 109.334 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.61 136.01 20.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.13 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.89 140.37 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.415 2.077 . . . . 0.0 112.883 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.409 ' HA ' ' CG ' ' A' ' 163' ' ' TYR . 0.6 OUTLIER -105.7 -1.47 24.45 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 108.957 179.197 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -145.97 92.3 2.18 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.501 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.63 154.82 39.79 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.195 -0.941 . . . . 0.0 108.979 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -54.1 -34.65 79.03 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.715 1.61 . . . . 0.0 111.105 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.12 -48.63 51.06 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.467 -0.771 . . . . 0.0 109.029 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -64.06 -42.06 97.14 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.644 0.735 . . . . 0.0 109.362 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.03 -39.11 77.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.581 -0.7 . . . . 0.0 109.47 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.743 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -65.64 -31.74 72.92 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.656 HD22 HG12 ' A' ' 116' ' ' VAL . 69.9 mt -59.6 -46.74 88.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 26.3 t -60.47 -43.62 96.75 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -64.56 -47.3 79.28 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.518 -0.739 . . . . 0.0 110.17 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.63 77.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.418 ' HG ' ' NH2' ' A' ' 152' ' ' ARG . 35.1 mt -66.25 -36.77 83.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.8 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.34 -40.86 92.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.608 -1.308 . . . . 0.0 110.01 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -68.82 -36.6 78.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.969 . . . . 0.0 111.47 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.515 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 74.2 mtm180 -72.26 3.7 4.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.64 20.15 52.03 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 11.2 m-85 -96.93 110.34 22.88 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.29 . . . . 0.0 109.796 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -90.62 178.28 6.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.887 -0.508 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 58.33 47.69 13.59 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.238 1.018 . . . . 0.0 108.889 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.7 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.11 160.41 0.79 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.6 m -59.66 -33.18 71.22 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.512 -0.993 . . . . 0.0 109.188 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.0 m -71.86 -36.07 70.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.91 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.907 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 146' ' ' SER . 20.6 m -67.84 -39.97 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.245 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.409 ' CG ' ' HA ' ' A' ' 137' ' ' THR . 0.0 OUTLIER -62.66 -44.01 97.35 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.605 -0.685 . . . . 0.0 110.077 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 38' ' ' GLU . 59.2 p -61.54 -35.45 77.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CD1' ' SD ' ' A' ' 34' ' ' MET . 18.5 t80 -61.5 -41.43 97.28 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 110.063 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.592 ' CG ' HE21 ' A' ' 167' ' ' GLN . 2.4 ptm -67.48 -36.92 82.07 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.902 -1.124 . . . . 0.0 110.795 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.592 HE21 ' CG ' ' A' ' 166' ' ' MET . 85.5 mm-40 -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.842 -1.162 . . . . 0.0 110.893 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.0 -16.0 21.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.39 -0.819 . . . . 0.0 111.937 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 26' ' ' THR . 2.2 t -74.56 -46.11 41.04 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.381 -1.449 . . . . 0.0 110.407 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 -1.42 3.9 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 171' ' ' LEU . 8.8 mp -61.51 -31.57 71.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.025 -1.279 . . . . 0.0 110.685 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.9 154.54 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.959 -1.088 . . . . 0.0 109.049 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 28.6 p30 -124.06 162.77 22.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.171 -0.956 . . . . 0.0 110.046 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.589 ' OD1' ' CE2' ' A' ' 182' ' ' TYR . 7.4 m-20 91.56 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -51.73 -39.62 58.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.026 . . . . 0.0 108.623 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.863 HG13 ' H ' ' A' ' 177' ' ' VAL . 2.8 p -145.15 -104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.622 -0.674 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.863 ' H ' HG13 ' A' ' 176' ' ' VAL . 1.1 t -138.4 -41.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 108.292 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.28 67.55 0.52 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t -100.22 119.99 39.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.338 . . . . 0.0 110.17 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.23 46.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.56 -37.08 67.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.961 -1.087 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.598 ' O ' ' CG ' ' A' ' 182' ' ' TYR . 6.6 t80 -120.29 83.96 33.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 109.626 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' A' ' 186' ' ' LYS . 24.5 Cg_exo -58.25 123.08 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.834 2.356 . . . . 0.0 111.769 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.66 -18.39 73.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' LYS . 1.0 OUTLIER -101.1 -18.61 16.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.527 -0.984 . . . . 0.0 110.237 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 183' ' ' PRO . 0.5 OUTLIER 47.16 70.36 2.13 Favored Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 120.874 -1.141 . . . . 0.0 109.148 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.876 2.384 . . . . 0.0 112.089 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.31 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -70.85 150.32 45.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.048 -1.033 . . . . 0.0 110.879 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 3' ' ' ARG . 30.4 mtm-85 -60.25 -171.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.813 0.816 . . . . 0.0 111.235 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.47 131.17 42.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.612 0.72 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.83 -18.42 53.31 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.317 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 0.9 OUTLIER -89.19 -4.02 58.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -1.141 . . . . 0.0 109.984 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER -111.43 -10.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.205 -0.934 . . . . 0.0 109.8 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.5 m -70.78 5.99 1.69 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 108.799 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.0 mt-30 -63.1 -88.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.804 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 165.88 -38.06 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 0.0 111.556 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' ASP . 61.1 Cg_endo -91.12 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.775 2.317 . . . . 0.0 115.532 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' TYR . 26.0 mt -32.34 -32.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.941 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' PRO . 4.3 m-85 -44.98 -40.59 6.57 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.843 -1.16 . . . . 0.0 109.913 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.8 mt -61.76 -46.38 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.54 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.02 39.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.126 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 10.0 t80 -62.51 -41.85 99.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -63.05 -38.07 89.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.79 -1.72 58.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 112.217 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.695 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -100.95 -34.03 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.506 -1.371 . . . . 0.0 111.13 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.695 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 93.5 mt-10 -153.19 -73.98 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.577 -1.327 . . . . 0.0 110.554 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.783 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 8.4 t-105 39.76 45.83 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.098 0.951 . . . . 0.0 108.804 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' ALA . . . 74.45 49.2 12.0 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.487 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.709 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.4 t -108.69 -35.93 0.15 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.195 -1.18 . . . . 0.0 109.074 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.709 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 85.2 Cg_endo -92.13 154.69 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 123.367 2.711 . . . . 0.0 112.148 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' C ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -64.39 151.95 42.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.769 ' OG1' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -91.3 142.91 27.2 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.506 -176.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -102.83 158.62 16.14 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 m -56.33 -33.73 65.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.777 -1.202 . . . . 0.0 109.006 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -67.14 -39.0 86.49 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.747 -0.595 . . . . 0.0 110.933 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -62.27 -44.31 96.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.005 -1.06 . . . . 0.0 110.003 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -62.24 -37.97 87.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.0 -53.08 60.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.09 -1.006 . . . . 0.0 110.511 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.01 -40.71 78.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 108.872 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.659 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 3.3 ttm -62.87 -49.33 75.28 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 111.125 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 157' ' ' VAL . 2.7 tp -62.21 -27.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.948 -1.095 . . . . 0.0 108.962 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.41 -54.26 11.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -0.973 . . . . 0.0 109.798 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -71.07 -39.87 71.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 0.0 109.017 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' OE2' ' OG ' ' A' ' 164' ' ' SER . 9.7 tp10 -59.57 -32.01 69.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.13 80.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.055 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.708 HE21 ' CD1' ' A' ' 44' ' ' LEU . 55.2 tp60 -69.25 -30.7 68.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.095 -1.238 . . . . 0.0 109.952 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.583 ' OE1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -51.03 -3.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 110.368 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . -63.28 112.42 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.877 -1.14 . . . . 0.0 109.319 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.05 -13.5 0.49 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.708 ' CD1' HE21 ' A' ' 40' ' ' GLN . 9.7 mt -101.98 159.52 15.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.043 -1.269 . . . . 0.0 110.354 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.6 ' HG ' ' HG1' ' A' ' 48' ' ' THR . 1.2 p -85.29 147.18 26.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.463 -0.773 . . . . 0.0 108.916 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.622 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 1.0 OUTLIER -60.95 -40.75 94.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.422 -0.798 . . . . 0.0 110.592 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -39.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.004 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.6 ' HG1' ' HG ' ' A' ' 45' ' ' SER . 84.8 m -61.55 -40.53 95.04 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -66.37 -35.57 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 50' ' ' LEU . 7.5 tt -58.83 -52.33 66.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -58.49 -41.9 86.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.592 -1.317 . . . . 0.0 107.966 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -65.64 -25.73 67.49 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.81 -43.23 76.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 47.0 mp0 -68.36 -39.95 81.64 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 10.7 m-80 -69.85 -37.88 76.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 0.0 109.606 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -60.69 -48.79 80.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.798 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -64.4 -25.79 68.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.164 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.09 82.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 110.7 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.15 -46.26 61.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.865 -1.147 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 62' ' ' GLN . 43.3 m-85 -85.19 -48.46 9.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.002 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 t-80 47.81 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.348 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.603 ' N ' ' O ' ' A' ' 60' ' ' PHE . 92.5 mt-30 -78.34 -30.77 48.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.519 -1.363 . . . . 0.0 109.937 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 62' ' ' GLN . 33.8 p90 42.17 18.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -125.56 101.16 30.8 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 108.959 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.34 -32.16 32.51 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.251 1.968 . . . . 0.0 113.102 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.861 HG22 HD21 ' A' ' 103' ' ' LEU . 67.4 t -63.35 -46.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.777 -1.202 . . . . 0.0 109.753 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.81 -32.68 73.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.043 . . . . 0.0 109.385 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.42 -39.34 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.351 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.26 -18.93 65.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -86.06 -5.7 59.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.475 ' HE1' HD11 ' A' ' 79' ' ' LEU . 98.4 mtp -85.15 113.22 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.551 HE21 ' CA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -95.92 176.08 6.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.465 -0.772 . . . . 0.0 109.524 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 97.4 mt-10 -52.84 -31.04 37.0 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.143 -0.973 . . . . 0.0 109.44 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.79 -49.65 76.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.175 -0.953 . . . . 0.0 108.454 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.21 -38.39 88.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.62 HG13 HG21 ' A' ' 92' ' ' ILE . 99.0 t -59.8 -43.37 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.733 . . . . 0.0 110.193 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.13 -33.69 72.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.23 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 43.1 ttm180 -64.25 -46.26 84.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 110.104 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.475 HD11 ' HE1' ' A' ' 71' ' ' MET . 47.1 mt -67.32 -33.4 75.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 110.756 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.08 -18.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' N ' ' C ' ' A' ' 79' ' ' LEU . 22.0 mt-30 -110.4 -17.82 13.38 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.659 -0.65 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 54.1 m-20 -76.78 108.68 9.97 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.86 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 71.14 -18.71 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.54 -0.725 . . . . 0.0 109.817 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 67.66 34.69 84.29 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 84' ' ' GLY . 7.7 pt -42.82 160.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 44' ' ' LEU . 2.2 tt -63.85 -29.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.31 -0.869 . . . . 0.0 110.909 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 44.9 mtt-85 -63.77 145.37 55.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 109.889 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' ARG . 34.5 m80 -122.72 162.07 22.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 109.444 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.461 HH11 ' HG3' ' A' ' 89' ' ' ARG . 5.4 ptm180 -41.51 -40.81 1.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.56 -66.5 2.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.421 -1.371 . . . . 0.0 109.809 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -61.83 -38.08 86.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -1.148 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.62 HG21 HG13 ' A' ' 76' ' ' VAL . 98.1 mt -58.64 -54.13 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.829 -1.169 . . . . 0.0 109.966 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.6 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 42.9 mt-30 -51.93 -32.44 32.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 109.443 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.94 95.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.075 -1.016 . . . . 0.0 109.851 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.4 -36.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.641 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mp -58.36 -46.86 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.723 -1.236 . . . . 0.0 108.723 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.89 -35.79 92.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 84.3 m-20 -58.77 -37.01 75.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.457 -1.025 . . . . 0.0 109.719 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.14 90.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.987 -1.071 . . . . 0.0 108.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -59.02 -36.48 75.03 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.59 76.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.99 -42.54 99.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 HG22 ' A' ' 66' ' ' VAL . 87.8 mt -64.42 -33.79 76.69 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -63.43 -36.34 83.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.249 -0.907 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 87.0 mmm -68.74 -42.91 76.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.914 -1.116 . . . . 0.0 110.164 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.34 -37.33 83.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.584 -0.847 . . . . 0.0 109.494 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -94.49 -10.45 32.25 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.04 74.26 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -118.42 100.43 51.46 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 149.39 75.18 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.335 2.023 . . . . 0.0 111.946 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.548 ' HB3' HD12 ' A' ' 31' ' ' LEU . 40.0 m-85 -60.7 -33.33 72.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.328 -0.857 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.19 -34.9 71.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.712 -1.243 . . . . 0.0 111.467 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.43 -49.55 77.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.664 -1.272 . . . . 0.0 111.523 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.589 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 3.2 p90 -71.23 -35.3 71.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.205 . . . . 0.0 109.381 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.91 HG22 HD21 ' A' ' 145' ' ' LEU . 1.3 t -64.22 -54.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.05 . . . . 0.0 109.63 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.529 ' N ' HG12 ' A' ' 116' ' ' VAL . 60.3 m95 -57.51 -21.2 36.33 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 108.555 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 16.1 p -72.24 -36.97 69.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.738 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 20.7 m-85 -69.78 -33.74 72.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.936 -1.103 . . . . 0.0 110.289 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.66 18.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.976 -1.078 . . . . 0.0 109.682 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 65.05 37.91 6.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 109.957 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 117' ' ' TRP . 24.6 t-80 42.33 36.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 110.875 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.39 21.51 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 109.159 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.44 143.38 47.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.206 1.937 . . . . 0.0 111.577 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -108.05 145.92 33.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.924 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 126' ' ' MET . 14.8 ptt? -97.92 121.38 39.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.425 -0.797 . . . . 0.0 108.947 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.1 m -90.0 119.93 30.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 109.43 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -91.52 18.59 7.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.906 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -61.52 143.06 56.58 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.088 -1.007 . . . . 0.0 109.421 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.403 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 81.6 p -105.0 -26.87 11.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.3 p -130.13 163.87 25.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.438 -0.789 . . . . 0.0 109.632 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.94 -37.04 70.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m -82.91 4.64 24.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.832 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' THR . 39.0 tp10 -98.0 5.05 49.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 127.02 34.99 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.109 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 139.75 36.26 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.901 1.734 . . . . 0.0 112.253 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 t -103.18 -2.49 27.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.822 . . . . 0.0 108.811 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 26.0 t -134.85 96.34 3.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.406 ' H ' ' HB2' ' A' ' 142' ' ' SER . 0.6 OUTLIER -114.6 159.79 35.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -53.94 -40.74 79.68 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.317 1.344 . . . . 0.0 111.399 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.93 67.7 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 139' ' ' THR . 22.9 m -60.21 -42.63 95.52 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.56 -0.713 . . . . 0.0 109.467 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -64.76 -41.21 96.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.191 -0.943 . . . . 0.0 109.161 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -72.76 -29.49 63.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.404 -0.81 . . . . 0.0 108.859 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.91 HD21 HG22 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -68.37 -47.74 66.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.393 -0.817 . . . . 0.0 109.148 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.521 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 12.1 t -63.82 -42.65 97.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.857 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.47 -42.18 95.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.288 -0.883 . . . . 0.0 110.374 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.33 79.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 109.721 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.54 -38.87 84.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 109.352 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.11 -38.6 86.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.926 -1.108 . . . . 0.0 108.709 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -81.8 -14.26 56.59 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.451 ' CD ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -83.38 0.74 44.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.732 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.41 19.92 43.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -100.61 112.83 25.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.623 -0.928 . . . . 0.0 108.622 179.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -97.27 166.46 11.55 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 157' ' ' VAL . 7.4 p -158.81 41.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -52.29 174.5 0.2 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.8 p -62.31 -24.28 67.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.14 . . . . 0.0 109.224 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.0 m -66.34 -38.63 88.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.04 -44.69 78.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.9 m -61.91 -33.95 75.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 0.0 110.159 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -72.02 -47.83 48.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.969 -1.082 . . . . 0.0 110.709 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 92.7 p -67.35 -32.25 73.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.028 -1.045 . . . . 0.0 109.263 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.696 ' CD2' ' SG ' ' A' ' 169' ' ' CYS . 0.1 OUTLIER -65.53 -37.1 85.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.347 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.59 ' HA ' HD12 ' A' ' 171' ' ' LEU . 2.1 ttp -69.4 -42.72 74.72 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.155 -0.965 . . . . 0.0 110.849 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 168' ' ' ALA . 2.2 pt20 -68.74 -41.48 78.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.657 -1.277 . . . . 0.0 111.404 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -77.6 -37.44 50.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.032 -1.042 . . . . 0.0 112.047 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.696 ' SG ' ' CD2' ' A' ' 165' ' ' PHE . 78.8 m -63.7 -44.18 94.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.769 -1.207 . . . . 0.0 111.699 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.39 4.67 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 166' ' ' MET . 15.9 mt -60.73 -37.12 80.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -1.217 . . . . 0.0 109.581 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -128.25 146.09 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 109.269 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 67.2 m-20 -109.09 164.12 12.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.408 -0.807 . . . . 0.0 110.245 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 91.35 78.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.217 0.532 . . . . 0.0 110.81 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -53.37 -69.31 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.09 155.37 41.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 129' ' ' ALA . 59.9 t -63.22 126.87 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.0 109.487 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 180' ' ' CYS . . . 80.21 40.03 14.54 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.06 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.636 ' O ' ' N ' ' A' ' 181' ' ' CYS . 17.1 t -68.07 49.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.738 -1.448 . . . . 0.0 108.511 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 178' ' ' GLY . 2.1 t 60.59 -49.28 0.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.312 0.577 . . . . 0.0 110.077 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 179' ' ' CYS . 3.1 t -179.4 71.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 108.703 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.705 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -59.48 116.37 16.15 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.45 154.53 31.64 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.321 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.97 -29.88 3.3 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -87.12 -1.15 57.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.236 . . . . 0.0 109.91 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 77.33 77.99 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.69 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 C-N-CA 122.878 2.386 . . . . 0.0 112.044 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.317 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.432 0.634 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 178' ' ' GLY . 15.0 pt-20 -95.1 160.98 14.31 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.974 ' NH1' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -105.88 165.99 10.8 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -45.78 127.87 8.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.778 0.799 . . . . 0.0 110.263 -179.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.67 57.04 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.309 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 2.8 t90 -53.92 -38.75 65.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.974 HG11 ' NH1' ' A' ' 3' ' ' ARG . 63.3 t -69.53 -36.38 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.64 -0.662 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -71.17 -3.41 19.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.035 . . . . 0.0 110.267 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.34 -38.73 91.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.227 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.77 160.43 30.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.047 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -34.67 14.68 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.91 2.406 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.43 -34.51 76.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.833 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.795 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 2.4 m-85 -57.5 -40.24 78.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.603 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -52.68 -39.54 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.942 -1.099 . . . . 0.0 109.238 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.594 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.85 -48.63 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 109.223 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.565 ' HA ' HD22 ' A' ' 19' ' ' ASN . 28.9 t80 -61.49 -38.8 88.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 110.019 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.93 -43.9 94.49 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.451 -0.781 . . . . 0.0 111.707 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -77.51 -10.76 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -0.972 . . . . 0.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 78.6 m-20 -78.31 -70.99 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.652 -1.28 . . . . 0.0 110.322 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -167.59 54.88 0.07 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.045 . . . . 0.0 109.362 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TRP . 7.4 t90 -96.35 63.26 2.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.115 -0.991 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 105.41 62.15 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.087 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.763 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -159.41 -36.84 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.227 -1.161 . . . . 0.0 110.742 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.763 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 68.4 Cg_endo -99.57 150.92 0.54 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 122.845 2.363 . . . . 0.0 113.204 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.05 147.8 44.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.0 p -109.5 150.96 27.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.662 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.41 164.17 13.12 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -58.98 -34.47 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.901 -1.124 . . . . 0.0 109.72 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -65.17 -40.41 94.27 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.387 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 25.4 mmtp -59.52 -40.89 88.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 31' ' ' LEU . 6.1 mt -60.71 -35.17 75.66 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.619 -0.676 . . . . 0.0 109.698 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 35' ' ' ILE . 88.2 t80 -63.37 -52.65 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 110.595 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -68.75 -33.36 73.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.512 -1.367 . . . . 0.0 108.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.98 -39.52 83.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.671 . . . . 0.0 110.149 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.917 HD12 ' CZ ' ' A' ' 165' ' ' PHE . 1.2 tp -66.56 -28.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 109.519 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.9 m -68.81 -49.79 55.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.944 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -68.86 -45.07 71.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.022 -1.049 . . . . 0.0 109.458 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -63.99 -32.96 74.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.89 44.05 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -72.95 -36.41 67.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.538 -0.978 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.62 ' CA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -44.28 -19.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -66.34 112.57 4.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.903 -1.123 . . . . 0.0 109.071 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.72 -36.41 3.53 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 2.4 mm? -103.25 171.2 7.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.136 -1.214 . . . . 0.0 110.203 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.0 m -92.53 154.14 18.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.653 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.58 ' CE3' ' C6 ' ' A' ' 189' ' ' ADK . 0.9 OUTLIER -60.61 -41.6 95.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.682 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -59.02 -44.47 91.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.954 -1.091 . . . . 0.0 108.895 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.548 HG21 HD12 ' A' ' 44' ' ' LEU . 59.7 m -58.11 -39.21 78.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' ARG . 88.0 t -64.51 -32.34 57.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.73 -45.86 85.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.051 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.21 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 108.606 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -12.59 59.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.396 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -71.35 -46.49 60.38 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.26 -41.02 90.49 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.82 ' OD1' HG22 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -70.62 -34.33 72.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.588 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 79.6 t80 -58.45 -46.56 86.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.085 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' HIS . 12.3 ptm180 -65.29 -28.4 69.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.32 86.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.415 -0.803 . . . . 0.0 110.545 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.628 ' CB ' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -77.42 -45.77 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.934 -1.104 . . . . 0.0 110.749 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' O ' ' N ' ' A' ' 62' ' ' GLN . 74.9 m-85 -86.62 -48.75 8.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.838 -1.164 . . . . 0.0 109.918 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 55.71 -26.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.692 -0.63 . . . . 0.0 112.003 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' N ' ' O ' ' A' ' 60' ' ' PHE . 6.5 pt20 -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.648 -1.283 . . . . 0.0 110.281 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.35 -3.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.386 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 62' ' ' GLN . 6.1 m-20 -98.41 125.67 42.27 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.915 -1.116 . . . . 0.0 108.342 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -38.67 32.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.568 1.512 . . . . 0.0 112.709 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.34 -41.69 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -62.44 -33.71 75.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.038 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.0 -38.41 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.41 -18.0 64.97 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -85.55 -5.36 59.29 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 79.3 mmm -80.91 115.32 20.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -95.44 173.48 7.5 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.455 -0.778 . . . . 0.0 110.39 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.54 -31.86 66.5 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.398 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.08 -31.48 72.0 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.766 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.47 -46.63 79.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 110.614 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 92' ' ' ILE . 2.0 p -61.49 -37.56 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.681 -1.262 . . . . 0.0 109.413 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.556 ' CD ' HH21 ' A' ' 89' ' ' ARG . 81.2 mm-40 -55.9 -38.29 70.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.875 -1.14 . . . . 0.0 108.145 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -65.69 -41.67 92.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 ' CB ' ' A' ' 59' ' ' CYS . 43.1 mt -69.99 -33.08 71.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.843 -0.535 . . . . 0.0 110.742 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' LEU . 24.5 t -47.97 -31.04 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.92 -6.33 32.5 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.397 -0.814 . . . . 0.0 109.693 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 84' ' ' GLY . 64.6 t0 -81.53 106.55 13.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.592 -1.317 . . . . 0.0 109.622 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 66.06 -16.05 0.12 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.599 -0.688 . . . . 0.0 109.55 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 75.1 39.81 36.38 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.82 HG22 ' OD1' ' A' ' 55' ' ' ASN . 15.7 pt -47.27 151.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -1.038 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 86' ' ' ILE . 8.4 tt -63.89 -26.75 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.459 -0.775 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' A' ' 87' ' ' ARG . 39.9 mtt-85 -66.64 148.34 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.637 ' CD2' ' H ' ' A' ' 89' ' ' ARG . 70.9 t60 -132.12 -179.04 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.789 . . . . 0.0 109.491 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.637 ' H ' ' CD2' ' A' ' 88' ' ' HIS . 37.7 ttm180 -52.98 -38.0 61.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.917 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.33 -59.62 7.63 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.955 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.57 -44.3 96.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.124 -1.221 . . . . 0.0 111.084 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 95' ' ' ILE . 37.2 mm -59.24 -46.23 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.711 -1.243 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -51.41 -35.93 41.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.628 -1.295 . . . . 0.0 108.009 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.39 75.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.324 -0.86 . . . . 0.0 109.083 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.758 HD12 HD13 ' A' ' 92' ' ' ILE . 82.2 mt -71.99 -40.97 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.426 -0.796 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.29 -43.03 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.587 -1.321 . . . . 0.0 108.989 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.17 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.415 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 3.5 m120 -60.32 -36.96 79.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -1.148 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.8 89.13 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 0.0 108.334 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -65.97 -34.34 77.89 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.95 -31.72 72.88 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -62.51 -42.48 99.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.5 -31.6 72.42 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.49 -39.87 94.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.186 -0.946 . . . . 0.0 110.364 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.698 ' SD ' ' CD2' ' A' ' 112' ' ' PHE . 5.8 ttm -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.795 -1.191 . . . . 0.0 108.94 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.24 -35.27 80.28 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -21.9 66.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -88.47 -13.02 41.36 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.2 27.28 73.79 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.197 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.595 ' O ' ' SD ' ' A' ' 105' ' ' MET . 3.1 mt-10 -126.02 100.52 30.23 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.291 . . . . 0.0 109.35 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.81 144.08 27.86 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.263 1.976 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.698 ' CD2' ' SD ' ' A' ' 105' ' ' MET . 71.4 m-85 -60.68 -34.93 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.56 -33.01 66.49 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.293 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -63.19 -48.19 79.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.696 -1.252 . . . . 0.0 111.598 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 116' ' ' VAL . 2.1 p90 -75.34 -32.93 61.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.808 -1.182 . . . . 0.0 109.886 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 145' ' ' LEU . 8.5 t -59.69 -55.4 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 108.934 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' HIS . 71.9 m95 -62.01 -21.59 65.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.6 p -76.04 -34.21 59.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -0.974 . . . . 0.0 109.744 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 1.8 m-85 -64.7 -36.12 83.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.008 -1.057 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 120' ' ' VAL . 2.8 p -89.76 18.02 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.192 -0.943 . . . . 0.0 109.191 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 68.01 17.04 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.493 -0.755 . . . . 0.0 109.924 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' N ' ' O ' ' A' ' 117' ' ' TRP . 2.1 t60 61.18 29.2 18.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.116 -0.99 . . . . 0.0 110.122 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -133.3 150.03 74.1 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.213 -0.929 . . . . 0.0 109.866 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.34 145.16 53.0 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.559 2.172 . . . . 0.0 111.989 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.606 HE22 ' C ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -111.5 131.38 55.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.101 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.606 ' C ' HE22 ' A' ' 125' ' ' GLN . 64.4 mtt -104.85 117.09 33.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 129' ' ' ALA . 1.1 m -97.09 -47.7 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.037 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 59.43 47.13 11.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.543 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.657 ' HB1' ' HB2' ' A' ' 134' ' ' GLU . . . -77.85 157.75 29.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.456 -0.777 . . . . 0.0 109.189 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.673 HG22 ' OE1' ' A' ' 134' ' ' GLU . 1.6 t -105.09 -26.18 12.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 109.462 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 130' ' ' THR . 40.3 p -131.5 163.66 27.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -0.903 . . . . 0.0 109.678 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 98.7 mt -59.92 -32.44 70.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.8 p -63.62 -26.25 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.798 . . . . 0.0 110.27 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.673 ' OE1' HG22 ' A' ' 130' ' ' THR . 89.2 mt-10 -87.69 -0.81 57.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.292 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.755 HD11 ' O ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -87.98 128.68 53.0 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.61 140.25 26.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.313 2.009 . . . . 0.0 112.999 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.2 p -118.7 5.91 11.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.3 p -159.05 85.82 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.552 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -98.24 162.16 22.96 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.868 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.32 -40.72 76.96 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.402 1.401 . . . . 0.0 111.071 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.69 -42.87 70.11 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 139' ' ' THR . 59.7 p -64.17 -45.47 88.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.466 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -63.93 -40.46 96.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.658 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.729 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -70.05 -29.28 66.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.272 -0.892 . . . . 0.0 108.825 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.021 HD11 HG22 ' A' ' 116' ' ' VAL . 13.3 tp -64.72 -43.09 94.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.655 -0.653 . . . . 0.0 109.875 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.662 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 0.0 OUTLIER -67.05 -43.25 83.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.44 ' CG ' ' NZ ' ' A' ' 151' ' ' LYS . 34.3 ttpt -57.19 -44.77 83.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.478 -0.764 . . . . 0.0 110.788 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.63 70.75 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.001 -1.062 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 149' ' ' LEU . 95.9 mt -64.76 -38.44 90.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.431 -0.793 . . . . 0.0 109.832 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -41.96 98.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.034 -1.041 . . . . 0.0 109.06 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.44 ' NZ ' ' CG ' ' A' ' 147' ' ' LYS . 60.9 mttp -77.42 -13.45 59.92 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.99 -1.069 . . . . 0.0 110.233 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' CA ' ' HE ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -85.03 -7.05 59.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.96 -1.088 . . . . 0.0 108.717 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.46 25.07 8.95 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -104.56 113.59 27.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -1.077 . . . . 0.0 109.145 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 156' ' ' PHE . 43.2 mttt -90.98 -176.69 4.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.863 . . . . 0.0 110.433 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 155' ' ' LYS . 6.4 p90 42.48 47.72 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.0 0.905 . . . . 0.0 109.285 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.74 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -128.62 46.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.37 172.96 1.76 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 51.5 m -57.86 -33.79 69.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -1.021 . . . . 0.0 110.06 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.2 p -68.6 -31.67 71.01 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.04 -1.037 . . . . 0.0 108.279 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.728 HG22 ' CE2' ' A' ' 165' ' ' PHE . 31.5 mm -65.88 -44.75 92.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.045 0.926 . . . . 0.0 108.986 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.662 ' SG ' ' N ' ' A' ' 146' ' ' SER . 53.1 m -58.12 -47.82 82.09 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.609 0.718 . . . . 0.0 110.576 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -64.17 -31.36 72.52 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.466 -0.771 . . . . 0.0 110.88 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.464 ' HA ' HE21 ' A' ' 167' ' ' GLN . 98.5 p -61.33 -48.32 81.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 21.4 m-85 -64.35 -39.28 93.58 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 109.899 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 87.7 mtp -53.33 -37.49 62.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.665 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.703 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 36.1 mt-30 -68.02 -39.46 83.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.652 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.73 -40.16 14.34 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 111.136 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 171' ' ' LEU . 86.4 m -54.8 -28.12 46.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.945 . . . . 0.0 110.634 -178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.26 -2.75 47.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.596 HD21 HG12 ' A' ' 116' ' ' VAL . 6.9 mp -60.82 -38.52 85.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.381 -1.07 . . . . 0.0 109.853 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 173' ' ' ASN . 3.9 p -138.1 151.19 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 111.457 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.425 ' N ' HG22 ' A' ' 172' ' ' VAL . 0.7 OUTLIER -114.87 98.09 6.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.755 ' O ' HD11 ' A' ' 135' ' ' ILE . 53.1 p30 -132.6 21.13 4.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.555 ' C ' HG12 ' A' ' 176' ' ' VAL . 5.9 m170 -49.05 -45.69 43.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.486 -1.384 . . . . 0.0 108.912 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 178' ' ' GLY . 3.0 p 145.43 155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 129' ' ' ALA . 69.6 t -57.6 -38.76 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.965 -1.084 . . . . 0.0 110.341 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 176' ' ' VAL . . . -80.16 29.4 2.48 Favored Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.077 -1.014 . . . . 0.0 111.073 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 26.8 t -76.84 20.48 0.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.869 -1.371 . . . . 0.0 109.34 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.412 ' H ' ' C ' ' A' ' 178' ' ' GLY . 1.0 OUTLIER 56.23 3.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 110.273 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -134.31 -1.01 2.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 0.0 109.814 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.51 80.49 65.82 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.62 130.67 19.92 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.025 1.817 . . . . 0.0 111.945 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.466 ' O ' ' CG ' ' A' ' 185' ' ' ASN . . . -95.25 -18.79 32.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 184' ' ' GLY . 76.5 m-20 -162.03 -30.32 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -1.148 . . . . 0.0 110.614 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.08 157.45 78.57 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.887 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.773 2.316 . . . . 0.0 112.165 179.761 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.309 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.25 0.548 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.548 ' O ' ' SG ' ' A' ' 180' ' ' CYS . 70.0 tt0 -99.34 148.58 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -89.35 175.65 7.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.25 152.99 38.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.803 0.811 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.27 -40.73 60.88 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.711 -0.618 . . . . 0.0 111.967 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.826 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.92 -3.74 58.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.487 -1.596 . . . . 0.0 110.055 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.89 -40.36 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.997 -1.064 . . . . 0.0 109.315 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -77.01 -0.95 26.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 108.811 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 42.8 tt0 -64.46 -41.85 96.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.485 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 173.35 166.13 0.28 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.95 -1.094 . . . . 0.0 109.753 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 13' ' ' TYR . 50.6 Cg_exo -48.18 -167.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.534 2.156 . . . . 0.0 113.075 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.0 mt 63.57 -47.21 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.864 -0.523 . . . . 0.0 109.789 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 11' ' ' PRO . 1.8 m-85 -62.51 -39.98 95.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.994 -1.066 . . . . 0.0 109.395 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -56.91 -44.29 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.631 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -66.2 -50.23 64.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.767 -1.208 . . . . 0.0 109.361 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.505 ' HA ' HD22 ' A' ' 19' ' ' ASN . 2.4 t80 -62.03 -42.58 99.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.822 . . . . 0.0 109.769 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -69.76 -41.6 74.98 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.459 -0.775 . . . . 0.0 110.349 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -74.96 -6.69 50.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 110.55 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-80 -71.77 -76.92 0.1 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.023 -1.048 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' C ' ' A' ' 21' ' ' TRP . 84.5 mt-10 -151.13 -51.85 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.969 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 3.8 t90 24.62 72.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.0 0.429 . . . . 0.0 110.247 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.56 ' C ' HG12 ' A' ' 23' ' ' VAL . . . 116.85 48.92 0.44 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.019 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.858 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.5 m -163.9 -27.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.252 -1.146 . . . . 0.0 112.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.858 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 44.9 Cg_endo -87.14 151.16 8.16 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.661 1.574 . . . . 0.0 113.79 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.11 152.06 29.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 p -94.98 137.87 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.918 -1.114 . . . . 0.0 111.186 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -98.15 157.64 16.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m -55.25 -35.43 64.98 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.503 -1.373 . . . . 0.0 109.067 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -69.45 -36.55 76.71 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.816 -0.552 . . . . 0.0 111.672 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -63.81 -41.46 97.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.746 -1.221 . . . . 0.0 110.619 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.666 HD23 HG21 ' A' ' 116' ' ' VAL . 6.7 mp -57.09 -39.0 74.18 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.225 -0.922 . . . . 0.0 109.763 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 78.2 t80 -66.53 -52.58 44.22 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.04 -1.037 . . . . 0.0 110.597 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -67.34 -38.52 84.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 108.923 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 ttm -70.28 -47.9 59.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.505 -0.747 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.86 -31.85 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.868 -1.145 . . . . 0.0 109.441 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 32' ' ' PHE . 84.8 m -69.65 -45.9 67.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.008 -1.057 . . . . 0.0 108.983 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HH11 ' A' ' 53' ' ' ARG . 79.8 mt -67.33 -38.33 84.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.469 -0.77 . . . . 0.0 109.468 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.604 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 65.3 mm-40 -64.82 -35.55 81.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.952 . . . . 0.0 109.862 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.95 -35.27 53.3 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.027 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . 24.8 mt-30 -63.52 -33.65 76.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.275 . . . . 0.0 110.747 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -43.62 -22.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.779 -1.201 . . . . 0.0 110.265 -179.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' GLN . . . -54.95 112.65 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.929 -1.107 . . . . 0.0 109.148 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' C ' HD22 ' A' ' 44' ' ' LEU . . . 76.61 -25.84 1.69 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 43' ' ' GLY . 3.7 mm? -102.56 164.97 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -99.47 148.3 24.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.682 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.4 OUTLIER -55.78 -39.98 72.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.006 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.97 -1.081 . . . . 0.0 109.122 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.7 m -64.4 -40.03 95.0 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' ARG . 1.4 t -65.89 -35.79 75.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -55.89 -50.39 70.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.316 -0.865 . . . . 0.0 109.841 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.562 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.3 mttt -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.596 -1.315 . . . . 0.0 108.864 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mmpp? -63.26 -26.43 68.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.527 HH11 HD13 ' A' ' 37' ' ' LEU . 17.3 ttm-85 -53.68 -45.87 70.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.4 -41.03 89.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.489 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 9.4 m-80 -69.11 -36.17 77.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.47 -48.6 80.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 110.66 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -69.24 -27.22 65.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.772 -1.205 . . . . 0.0 109.143 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -36.91 75.52 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.704 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.5 m -76.62 -45.9 28.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.948 -1.095 . . . . 0.0 110.193 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 62' ' ' GLN . 25.8 m-85 -83.94 -47.43 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 49.82 7.11 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 109.869 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.613 ' O ' ' N ' ' A' ' 64' ' ' ASP . 89.8 mt-30 -81.11 -29.0 34.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 52.6 p90 44.1 6.96 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.638 -0.664 . . . . 0.0 111.291 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -124.24 135.63 26.66 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.937 -1.102 . . . . 0.0 108.906 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 -15.08 16.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.241 1.96 . . . . 0.0 113.121 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.625 HG22 HD11 ' A' ' 103' ' ' LEU . 87.3 t -72.77 -45.61 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.722 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -34.53 72.73 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 64' ' ' ASP . 90.6 t -61.25 -41.41 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.955 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.735 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -64.0 -17.3 63.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.05 55.99 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 95.2 mtp -85.35 114.23 22.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.86 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -95.68 -177.83 4.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.892 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.2 -31.19 67.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 110.596 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.58 -49.26 75.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.751 -1.218 . . . . 0.0 108.988 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.92 -38.99 90.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 t -58.46 -41.95 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -0.76 . . . . 0.0 109.306 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' C ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -60.48 -33.33 72.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.96 . . . . 0.0 109.359 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -69.61 -46.93 65.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.988 . . . . 0.0 110.239 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.704 HD22 ' HB3' ' A' ' 59' ' ' CYS . 17.5 mt -70.89 -32.44 69.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.76 -0.587 . . . . 0.0 112.182 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 76' ' ' VAL . 44.7 t -49.47 -27.1 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.746 -1.221 . . . . 0.0 109.638 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.42 -9.36 14.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.3 m-20 -73.49 111.09 8.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.549 -1.344 . . . . 0.0 109.169 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 73.22 -15.75 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.763 . . . . 0.0 109.214 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . 76.71 38.94 30.51 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.0 pt -52.03 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.374 -1.074 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.3 mt -65.03 98.07 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.967 -1.083 . . . . 0.0 108.889 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.648 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 3.0 mtt-85 -55.49 132.76 49.25 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.648 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 2.4 m-70 156.51 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.655 ' CG ' HH11 ' A' ' 89' ' ' ARG . 0.6 OUTLIER -54.47 -35.67 63.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.167 -0.958 . . . . 0.0 108.809 -179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.21 -54.43 37.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.93 -43.63 95.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -1.178 . . . . 0.0 109.599 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 92.6 mt -58.23 -45.21 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.03 -1.044 . . . . 0.0 109.251 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.65 -33.71 68.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.921 -1.112 . . . . 0.0 109.339 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.3 82.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.045 -1.034 . . . . 0.0 108.459 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.61 -43.6 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.47 -0.769 . . . . 0.0 109.767 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.33 -46.4 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.127 -0.983 . . . . 0.0 108.583 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.33 95.41 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -59.07 -37.07 76.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -1.176 . . . . 0.0 109.411 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.0 86.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.128 -0.983 . . . . 0.0 109.641 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.735 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 8.9 tpp180 -57.87 -38.27 75.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.176 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -62.8 -35.27 79.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.625 HD11 HG22 ' A' ' 66' ' ' VAL . 3.6 mm? -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -64.16 -42.04 96.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.17 -0.957 . . . . 0.0 109.443 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.643 ' SD ' ' CE1' ' A' ' 112' ' ' PHE . 80.5 mtp -68.66 -39.5 80.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.15 -41.23 86.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.428 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.73 -19.54 65.83 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -92.52 -9.5 41.1 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.41 25.2 75.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -115.45 102.47 54.41 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.372 -1.075 . . . . 0.0 109.297 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.14 148.99 29.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.643 ' CE1' ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -68.73 -43.36 76.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.76 0.791 . . . . 0.0 110.352 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 117' ' ' TRP . . . -69.36 -26.69 64.8 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.053 -1.029 . . . . 0.0 110.689 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -57.41 -49.15 77.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.742 -1.224 . . . . 0.0 110.923 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.746 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 8.6 p90 -76.0 -36.35 59.21 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 110.19 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.746 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 10.9 t -64.76 -55.13 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.706 -1.246 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 67.5 m95 -58.24 -21.71 49.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.181 -0.949 . . . . 0.0 108.654 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.1 p -73.57 -32.59 64.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.927 -1.108 . . . . 0.0 109.846 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 12.6 m-85 -69.63 -30.54 68.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.832 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 HD22 ' A' ' 171' ' ' LEU . 29.2 m -96.09 19.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.098 -1.001 . . . . 0.0 109.405 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 122' ' ' HIS . 69.3 m-20 61.94 42.03 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.0 110.799 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.413 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 41.89 29.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.6 178.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.0 147.67 35.65 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.857 -1.152 . . . . 0.0 109.853 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.62 139.34 88.5 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.302 2.001 . . . . 0.0 111.811 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.9 147.55 36.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.825 . . . . 0.0 109.65 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.6 mtt -95.11 125.97 40.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.188 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -67.87 -40.92 83.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 108.841 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 62.48 44.94 6.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.635 -0.665 . . . . 0.0 110.401 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 176' ' ' VAL . . . -106.74 139.22 41.52 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.5 p -101.05 -14.22 17.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.011 -1.056 . . . . 0.0 110.248 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -151.05 169.38 21.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.071 . . . . 0.0 109.963 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.1 -34.72 73.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.43 -0.794 . . . . 0.0 109.338 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.6 t -73.89 -11.48 60.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -98.68 14.9 26.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 175' ' ' HIS . 3.0 mm -105.59 98.34 17.11 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.474 1.449 . . . . 0.0 112.227 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 33.5 p -97.38 1.86 49.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.393 -0.817 . . . . 0.0 109.446 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -138.79 91.16 2.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.269 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.495 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -106.2 156.16 37.34 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -52.29 -39.2 73.03 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.041 1.827 . . . . 0.0 111.628 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.41 -44.36 52.25 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.066 -1.021 . . . . 0.0 108.605 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.495 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 83.6 p -68.02 -37.48 81.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -66.22 -35.64 80.97 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 108.598 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -64.76 -39.1 93.06 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.559 -0.713 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 HG22 ' A' ' 116' ' ' VAL . 96.8 mt -58.96 -46.78 87.21 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.097 -1.041 . . . . 0.0 108.517 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.434 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 23.6 m -56.44 -40.63 75.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.692 -1.255 . . . . 0.0 108.921 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -65.9 -50.65 63.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.426 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.37 88.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.526 -0.734 . . . . 0.0 109.759 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.33 -38.82 85.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.973 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -61.25 -40.19 93.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.877 -1.14 . . . . 0.0 109.195 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -65.87 -33.55 76.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 110.374 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.568 ' O ' ' NE2' ' A' ' 104' ' ' GLN . 2.5 mmp_? -72.24 2.94 5.14 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.04 -1.038 . . . . 0.0 108.876 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.16 52.46 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.72 115.44 27.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.723 -0.869 . . . . 0.0 108.781 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -89.34 167.41 13.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.624 -0.673 . . . . 0.0 110.397 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 57.62 59.87 3.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.619 -0.676 . . . . 0.0 109.956 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 22.6 m -131.56 33.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.539 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' VAL . . . -44.08 164.19 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.4 p -58.91 -22.88 60.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -1.137 . . . . 0.0 108.889 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.2 p -75.76 -32.69 60.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.69 -45.25 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 146' ' ' SER . 94.6 m -63.04 -40.21 97.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.399 0.618 . . . . 0.0 109.867 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -70.07 -41.92 73.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.556 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 47.3 m -60.66 -44.54 96.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -0.838 . . . . 0.0 108.97 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.573 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 3.0 t80 -62.92 -40.05 96.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.471 -0.768 . . . . 0.0 109.823 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.401 ' HA ' ' SG ' ' A' ' 169' ' ' CYS . 1.1 ttp -59.93 -40.23 88.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.569 -0.707 . . . . 0.0 112.765 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.641 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.4 pt20 -79.66 -46.34 17.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.193 -1.567 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' N ' ' CG ' ' A' ' 167' ' ' GLN . . . -73.28 -28.63 62.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.955 -1.091 . . . . 0.0 111.364 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 30.4 p -67.1 -29.75 69.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 111.39 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 109.01 -1.8 31.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.576 HD11 ' CG1' ' A' ' 116' ' ' VAL . 27.5 mt -61.01 -36.31 79.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.091 -1.241 . . . . 0.0 110.324 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.4 151.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.055 -1.028 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 81.8 m-20 -114.77 162.98 16.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.606 -0.684 . . . . 0.0 110.102 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 7.4 m-20 96.42 75.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.098 0.475 . . . . 0.0 110.008 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.467 ' O ' HD11 ' A' ' 135' ' ' ILE . 21.0 m170 -52.11 -41.05 62.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.116 -0.99 . . . . 0.0 108.71 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.79 ' O ' HG22 ' A' ' 176' ' ' VAL . 7.7 p -168.54 28.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 176' ' ' VAL . 42.0 t 56.19 118.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.0 109.906 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . 91.56 9.52 62.87 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.236 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 181' ' ' CYS . 1.7 t -70.38 149.53 47.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.279 . . . . 0.0 108.951 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 96.4 m -50.01 -27.45 5.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.549 ' SG ' ' SG ' ' A' ' 179' ' ' CYS . 26.8 p -109.43 45.47 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 108.996 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -103.99 105.61 49.3 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.183 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.94 150.4 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.27 1.98 . . . . 0.0 112.077 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 146.5 -24.74 1.68 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 186' ' ' LYS . 3.3 m120 -91.8 8.02 39.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.423 -1.045 . . . . 0.0 110.191 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 185' ' ' ASN . 0.0 OUTLIER 56.81 153.05 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 186' ' ' LYS . 97.3 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 122.939 2.426 . . . . 0.0 112.56 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.969 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -100.39 144.81 28.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.972 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.537 ' HB2' HG11 ' A' ' 7' ' ' VAL . 85.7 mtt180 -53.73 -42.35 68.02 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.428 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -178.1 154.55 0.88 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.17 -45.3 95.54 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.548 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.724 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.8 -4.41 58.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.361 -1.67 . . . . 0.0 109.988 -178.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 3' ' ' ARG . 4.5 t -75.14 -41.1 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.131 -0.98 . . . . 0.0 109.333 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.7 -9.59 58.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 108.875 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -69.63 -39.97 76.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -0.791 . . . . 0.0 111.257 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.26 157.59 30.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.508 -1.37 . . . . 0.0 111.239 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' TYR . 18.3 Cg_endo -63.5 179.96 0.81 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.251 2.634 . . . . 0.0 112.286 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.1 mt 66.24 -44.14 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.652 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.2 OUTLIER -55.44 -35.69 65.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.15 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.9 mp -54.24 -43.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.07 . . . . 0.0 108.984 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.661 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -64.88 -49.27 71.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -58.36 -37.0 74.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.204 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -62.49 -45.33 93.49 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.141 -0.975 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -83.27 -2.59 56.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.661 ' ND2' ' O ' ' A' ' 15' ' ' ALA . 25.6 m-80 -76.5 -75.17 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.838 -1.164 . . . . 0.0 109.159 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -168.98 69.11 0.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.143 -0.973 . . . . 0.0 109.76 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.852 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.4 t90 -79.83 60.71 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.978 -1.076 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.45 64.19 1.46 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.583 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.807 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 1.9 m -137.87 -33.73 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.2 -1.176 . . . . 0.0 111.041 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.807 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 64.8 Cg_endo -97.08 150.45 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.737 2.291 . . . . 0.0 113.395 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -68.9 147.64 51.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 169' ' ' CYS . 69.5 p -101.71 151.45 22.02 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.543 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 5.9 t70 -94.35 157.01 16.23 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 m -50.29 -32.76 17.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -178.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -71.51 -39.31 70.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.681 -0.637 . . . . 0.0 111.63 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -62.66 -39.12 92.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.836 -1.165 . . . . 0.0 110.276 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 31' ' ' LEU . 6.1 mp -56.45 -40.08 74.22 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.786 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -62.56 -46.66 87.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.94 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -71.53 -36.45 71.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.051 -1.031 . . . . 0.0 109.078 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.1 ttm -69.13 -47.9 63.83 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.047 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.15 -29.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.52 -1.362 . . . . 0.0 109.912 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -68.49 -52.75 28.84 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.493 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.6 mt -64.9 -40.19 94.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.585 ' OE2' ' NE2' ' A' ' 41' ' ' GLN . 66.1 mm-40 -63.43 -31.13 72.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.026 -1.046 . . . . 0.0 108.573 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 161' ' ' ILE . . . -68.49 -37.08 85.07 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 42' ' ' ALA . 96.2 mt-30 -58.65 -35.05 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.826 -0.808 . . . . 0.0 111.459 -178.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.762 ' NE2' ' N7 ' ' A' ' 189' ' ' ADK . 6.4 pt20 -70.96 9.59 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.631 -1.293 . . . . 0.0 110.177 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -54.96 112.92 1.15 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.937 -1.102 . . . . 0.0 108.589 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.15 -14.37 0.44 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 48' ' ' THR . 31.2 tp -106.77 145.95 31.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.562 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.0 157.13 4.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.702 0.763 . . . . 0.0 111.198 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.692 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.1 OUTLIER -74.82 -37.07 62.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.796 -0.565 . . . . 0.0 110.119 179.316 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -40.36 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.021 -1.049 . . . . 0.0 110.077 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.733 HG21 HD21 ' A' ' 44' ' ' LEU . 37.7 m -57.6 -38.5 75.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.09 -1.006 . . . . 0.0 108.34 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 53' ' ' ARG . 94.5 t -65.06 -33.75 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.722 -0.611 . . . . 0.0 109.367 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.47 -48.66 78.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -63.02 -45.8 90.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.968 -1.083 . . . . 0.0 109.441 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -79.26 -8.99 59.47 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.266 -179.08 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.99 -54.45 13.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.756 -1.215 . . . . 0.0 108.492 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -39.96 94.32 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.498 -0.751 . . . . 0.0 109.733 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.845 ' ND2' HG22 ' A' ' 85' ' ' ILE . 39.7 t30 -74.96 -46.49 35.15 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.15 -0.969 . . . . 0.0 110.893 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CZ ' ' CE1' ' A' ' 60' ' ' PHE . 59.4 t80 -63.41 -49.2 74.71 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.095 -1.003 . . . . 0.0 110.139 -178.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.67 HH12 ' CD2' ' A' ' 61' ' ' HIS . 3.6 ptm180 -58.12 -33.92 69.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.89 -1.131 . . . . 0.0 109.13 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.88 82.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 110.177 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.4 -43.67 63.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.819 -1.176 . . . . 0.0 110.505 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE1' ' CZ ' ' A' ' 56' ' ' TYR . 84.1 m-85 -93.32 7.67 43.5 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 110.134 -179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.67 ' CD2' HH12 ' A' ' 57' ' ' ARG . 6.6 t-80 -53.73 -53.54 50.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.869 -1.145 . . . . 0.0 109.61 -179.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -68.16 -30.44 69.56 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.433 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 58.2 m-85 -109.32 73.53 0.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -46.35 0.12 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -97.11 -113.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.353 2.035 . . . . 0.0 115.584 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 103' ' ' LEU . 99.4 t -58.77 -34.97 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.909 -1.12 . . . . 0.0 108.853 -178.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 38.0 mttm -55.51 -38.19 68.88 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 63' ' ' PHE . 65.7 t -63.73 -36.4 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.7 -17.59 64.72 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -94.25 -14.86 25.06 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.491 ' O ' HG21 ' A' ' 96' ' ' ILE . 42.5 mmm -73.86 111.21 8.79 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.594 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 8.8 mt-30 -97.06 172.17 8.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.12 -29.25 29.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.46 -45.9 80.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.892 -1.13 . . . . 0.0 109.323 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.7 p30 -66.05 -36.36 83.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 108.577 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 79' ' ' LEU . 80.7 t -62.19 -44.13 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 110.487 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.84 -39.64 78.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -66.23 -39.56 89.65 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.59 0.709 . . . . 0.0 109.349 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 85' ' ' ILE . 8.2 mt -64.56 -32.68 74.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.654 -0.654 . . . . 0.0 111.136 -178.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.6 t -48.91 -35.2 6.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 4.1 pt20 -113.61 4.24 16.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.87 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 43.4 t0 -90.58 111.21 22.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.546 -1.346 . . . . 0.0 110.625 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 76.6 -16.73 0.6 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.547 -0.721 . . . . 0.0 109.658 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.34 28.32 60.12 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.301 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.845 HG22 ' ND2' ' A' ' 55' ' ' ASN . 23.2 pt -57.03 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.083 -1.246 . . . . 0.0 109.779 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.5 tt -58.63 76.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.174 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -58.26 117.39 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.758 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.3 OUTLIER -158.69 -34.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.44 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.581 ' HG2' HH11 ' A' ' 89' ' ' ARG . 0.0 OUTLIER 65.45 -36.66 0.23 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.902 -0.498 . . . . 0.0 110.401 178.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 88' ' ' HIS . . . -73.51 -59.49 4.11 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.269 -1.443 . . . . 0.0 109.585 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.61 -33.55 72.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -1.069 . . . . 0.0 109.9 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.8 mt -64.98 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -32.38 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.89 -39.26 90.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 109.159 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.07 -35.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.189 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 71' ' ' MET . 20.8 mm -62.26 -47.63 92.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.172 -0.955 . . . . 0.0 109.489 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.69 71.95 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.508 ' N ' HD22 ' A' ' 98' ' ' ASN . 1.6 m-80 -68.97 -35.54 76.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.128 -1.219 . . . . 0.0 110.536 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.05 90.69 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 108.854 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 97.2 mtt180 -62.59 -35.92 81.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.05 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -63.95 -29.33 70.5 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.68 -40.46 96.86 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.738 HD21 HG22 ' A' ' 66' ' ' VAL . 69.3 mt -64.28 -34.08 77.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -63.78 -37.12 86.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 110.087 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.661 ' SD ' ' CD1' ' A' ' 112' ' ' PHE . 8.6 ttm -65.92 -43.05 89.25 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.923 -1.11 . . . . 0.0 109.316 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -63.18 -36.75 84.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.613 -0.679 . . . . 0.0 109.352 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.77 -18.75 64.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.57 -16.36 25.78 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.91 27.06 73.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.545 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.5 mm-40 -114.58 101.57 54.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 110.065 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.97 141.67 45.89 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.16 1.907 . . . . 0.0 112.485 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' CD1' ' SD ' ' A' ' 105' ' ' MET . 0.6 OUTLIER -55.5 -44.0 76.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.701 0.762 . . . . 0.0 111.246 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' HB1' ' HD1' ' A' ' 117' ' ' TRP . . . -70.42 -27.75 64.51 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 111.023 -178.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -61.86 -47.71 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.014 -1.054 . . . . 0.0 111.368 -178.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.842 ' CZ ' HG23 ' A' ' 116' ' ' VAL . 4.5 p90 -76.56 -33.48 58.52 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.708 -1.245 . . . . 0.0 109.671 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.842 HG23 ' CZ ' ' A' ' 115' ' ' PHE . 1.4 t -69.48 -55.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.826 -1.171 . . . . 0.0 110.45 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.542 ' CZ3' HD23 ' A' ' 171' ' ' LEU . 73.8 m95 -60.02 -22.89 63.2 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 109.268 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 83.1 p -70.74 -37.04 73.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.017 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 14.2 m-85 -65.67 -35.97 82.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.691 -1.256 . . . . 0.0 108.596 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 123' ' ' GLN . 4.0 t -89.22 14.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.317 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 59.16 37.05 24.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.9 m80 46.39 24.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.061 -1.024 . . . . 0.0 109.768 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -129.74 149.01 71.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.502 -0.749 . . . . 0.0 110.239 -179.618 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.56 144.41 66.55 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.056 2.504 . . . . 0.0 111.841 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -111.52 137.2 49.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.866 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 87.9 mtp -92.3 131.09 37.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.728 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -78.62 -41.98 30.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 56.85 45.11 22.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.987 -1.071 . . . . 0.0 109.376 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -102.03 140.44 36.31 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.6 p -97.1 -24.0 15.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.101 -0.999 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -140.99 166.2 25.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 108.834 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.34 -35.07 76.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.245 -0.91 . . . . 0.0 109.55 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -64.74 -27.57 68.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.787 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -78.85 3.74 16.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 2.3 tp -91.29 123.84 63.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.56 138.19 13.49 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.023 1.815 . . . . 0.0 112.409 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 76.5 p -108.27 14.37 24.97 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.2 p -153.92 84.61 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.64 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.588 ' N ' ' OG ' ' A' ' 142' ' ' SER . 0.6 OUTLIER -105.15 157.14 34.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.101 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.14 -40.65 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.466 1.444 . . . . 0.0 111.848 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -41.55 70.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.021 -1.05 . . . . 0.0 108.306 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.588 ' OG ' ' N ' ' A' ' 139' ' ' THR . 97.4 p -64.53 -43.9 92.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.687 . . . . 0.0 109.373 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.57 -36.5 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.143 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -63.77 -31.16 72.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.759 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 116' ' ' VAL . 91.2 mt -70.64 -47.46 59.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.944 -1.097 . . . . 0.0 109.575 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.45 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 1.7 m -57.8 -46.1 85.13 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.536 -1.353 . . . . 0.0 110.532 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -70.5 -39.3 74.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.814 -1.179 . . . . 0.0 109.653 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.14 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.543 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.46 -35.96 81.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.057 -1.027 . . . . 0.0 109.415 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.07 -42.42 98.47 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 109.582 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -67.79 -32.43 73.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.469 -0.769 . . . . 0.0 111.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.676 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 4.0 mmp_? -68.14 -8.31 37.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.749 -1.219 . . . . 0.0 109.103 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.09 31.36 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 8.8 m-85 -95.99 117.62 31.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.84 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.586 ' O ' ' CG ' ' A' ' 156' ' ' PHE . 23.1 mtmt -90.47 -175.28 4.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.506 0.67 . . . . 0.0 110.813 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 155' ' ' LYS . 8.5 p90 47.45 48.6 16.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.525 0.678 . . . . 0.0 110.344 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 155' ' ' LYS . 29.6 m -119.59 39.95 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -49.17 164.06 0.44 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -57.17 -33.57 67.58 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.32 -1.106 . . . . 0.0 109.862 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 43.3 p -71.29 -34.36 70.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 108.844 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.443 HD12 ' HA2' ' A' ' 39' ' ' GLY . 16.2 mm -60.54 -44.15 95.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 146' ' ' SER . 63.2 m -65.45 -32.67 74.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.647 ' CZ ' ' NE2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -68.79 -44.77 72.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.005 -1.06 . . . . 0.0 109.564 179.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.407 ' HB2' ' N7 ' ' A' ' 189' ' ' ADK . 88.3 p -63.92 -37.37 87.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 108.762 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 169' ' ' CYS . 57.7 t80 -60.82 -41.43 95.73 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.826 0.822 . . . . 0.0 109.142 178.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 37.1 mmm -59.33 -40.31 85.94 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.838 -0.539 . . . . 0.0 111.457 -178.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.647 ' NE2' ' CZ ' ' A' ' 163' ' ' TYR . 10.7 pt20 -80.21 -47.27 14.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.606 -1.309 . . . . 0.0 110.997 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.68 -17.84 64.16 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.805 -1.184 . . . . 0.0 110.634 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 165' ' ' PHE . 66.4 m -83.32 -19.6 35.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.836 -1.165 . . . . 0.0 111.822 -178.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.51 1.25 64.23 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.542 HD23 ' CZ3' ' A' ' 117' ' ' TRP . 94.2 mt -65.77 -35.24 80.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.704 -0.88 . . . . 0.0 109.357 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.14 135.93 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 108.915 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 58.8 m-20 -114.52 162.69 16.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.92 -179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.7 OUTLIER 92.05 79.11 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.224 0.535 . . . . 0.0 110.605 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -54.84 -70.6 0.1 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.158 -0.964 . . . . 0.0 108.629 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.62 148.28 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 108.831 179.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 129' ' ' ALA . 61.5 t -64.16 130.92 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.617 -1.302 . . . . 0.0 109.121 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.29 40.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -95.43 123.42 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.041 -1.27 . . . . 0.0 109.13 179.618 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.475 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.1 OUTLIER 39.56 27.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 179' ' ' CYS . 11.1 t 51.73 45.64 27.83 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -61.34 129.25 90.78 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.65 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 17.3 Cg_exo -51.85 121.52 8.85 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.583 1.522 . . . . 0.0 111.671 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.54 -24.12 0.05 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -89.46 -72.94 0.53 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.326 -1.102 . . . . 0.0 109.508 -179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -67.15 149.69 98.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo . . . . . 0 C--N 1.308 -1.586 0 C-N-CA 122.575 2.183 . . . . 0.0 112.468 179.908 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.852 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.313 0.578 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 178' ' ' GLY . 7.7 tp10 -99.07 142.69 30.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -58.79 -59.04 6.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.839 -1.163 . . . . 0.0 108.475 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.72 134.16 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.46 -25.04 57.39 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.269 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 2.7 t90 -99.06 27.8 4.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -1.23 . . . . 0.0 109.986 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.54 -27.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.903 -1.123 . . . . 0.0 111.321 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.7 m -79.86 -2.75 44.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.701 -1.249 . . . . 0.0 109.16 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 6' ' ' TRP . 59.4 mt-30 -66.63 -37.74 85.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.341 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -168.36 158.77 8.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.669 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.6 Cg_endo -60.57 -163.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.809 2.339 . . . . 0.0 112.164 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp 61.0 -46.52 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.919 -0.488 . . . . 0.0 110.054 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.644 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 1.6 m-85 -59.39 -37.86 79.05 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 109.451 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.0 mp -54.89 -44.75 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.638 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.4 85.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.907 -1.121 . . . . 0.0 108.995 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.552 ' CE2' ' CE3' ' A' ' 21' ' ' TRP . 23.5 t80 -65.52 -36.17 83.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -58.91 -44.29 91.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 112.214 -178.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.79 -0.55 45.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.917 -1.115 . . . . 0.0 112.271 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.784 ' ND2' ' N ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -99.98 -30.66 11.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.536 -1.352 . . . . 0.0 112.068 -178.48 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.784 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 89.9 mt-10 -160.29 22.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.431 -1.418 . . . . 0.0 109.825 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.582 ' HE1' ' CG ' ' A' ' 167' ' ' GLN . 3.1 t90 -106.15 72.43 0.93 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 110.461 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.04 4.41 35.85 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.285 177.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.0 m -115.0 -21.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.0 112.431 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 85.8 Cg_endo -86.75 150.46 8.62 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.925 1.75 . . . . 0.0 114.293 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -88.08 159.31 18.29 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.742 ' HB ' HD21 ' A' ' 31' ' ' LEU . 2.6 p -84.08 122.53 28.93 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.776 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 31' ' ' LEU . 37.8 t0 -106.12 167.25 9.94 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -74.52 -38.08 62.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.101 -1.624 . . . . 0.0 110.681 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -74.12 -50.46 19.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -0.901 . . . . 0.0 112.343 -177.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -57.82 -36.79 72.75 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.072 -1.018 . . . . 0.0 109.804 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 26' ' ' THR . 5.8 mp -66.76 -35.32 79.81 Favored 'General case' 0 C--N 1.286 -2.168 0 O-C-N 121.634 -0.666 . . . . 0.0 109.923 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.07 -48.11 83.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.538 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.62 -27.62 60.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.842 -1.161 . . . . 0.0 109.598 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.551 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 60.1 ttm -66.72 -50.93 61.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.664 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.44 -34.22 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 0.0 108.924 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 85.6 m -71.8 -51.95 20.01 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.927 . . . . 0.0 109.604 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 HH11 ' A' ' 53' ' ' ARG . 24.6 mt -67.16 -38.69 85.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' OE2' ' OE1' ' A' ' 41' ' ' GLN . 6.8 tp10 -62.75 -33.38 75.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.72 -36.4 93.24 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 36' ' ' CYS . 4.8 mp0 -63.11 -26.58 68.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.047 -1.267 . . . . 0.0 110.691 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' CD ' ' H8 ' ' A' ' 189' ' ' ADK . 1.9 pt20 -66.37 -2.94 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.853 -1.154 . . . . 0.0 110.856 -178.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -60.31 112.47 1.95 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.612 -1.305 . . . . 0.0 108.595 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.97 -7.93 2.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' ALA . 25.5 tp -109.95 144.8 37.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -1.205 . . . . 0.0 109.957 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.3 m -64.12 149.98 46.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -74.88 -38.48 61.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.698 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -35.81 63.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.98 -1.075 . . . . 0.0 108.309 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CE ' ' A' ' 52' ' ' LYS . 91.1 m -61.06 -44.24 97.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' ARG . 58.0 t -69.1 -25.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 3.0 tt -63.79 -51.65 63.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 54.7 mttt -60.33 -44.41 95.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.661 -1.275 . . . . 0.0 108.13 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 86' ' ' ILE . 45.6 mtmt -74.29 -10.46 59.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.69 HH11 HD13 ' A' ' 37' ' ' LEU . 16.3 ttm-85 -64.63 -45.13 88.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 50' ' ' LEU . 57.2 mp0 -70.69 -44.15 67.57 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.608 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 11.0 m-80 -69.92 -39.81 75.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.93 -1.106 . . . . 0.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.81 -48.19 82.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 111.097 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -65.7 -27.33 68.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 109.266 -179.729 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.54 99.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.907 . . . . 0.0 109.806 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 85' ' ' ILE . 2.7 m -74.38 -45.57 46.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.923 -1.111 . . . . 0.0 109.983 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' ' C ' ' A' ' 61' ' ' HIS . 61.7 m-85 -79.72 -45.79 18.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.021 -1.049 . . . . 0.0 110.258 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.593 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER 43.24 29.92 0.25 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.5 pt20 -54.12 -45.41 71.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.697 . . . . 0.0 111.067 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER 42.63 18.92 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.368 -0.832 . . . . 0.0 110.391 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.5 m-20 -171.9 136.73 0.94 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.036 -1.04 . . . . 0.0 109.459 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 102' ' ' TYR . 55.3 Cg_endo -71.16 -35.4 8.76 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.43 2.086 . . . . 0.0 112.995 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.08 -41.07 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.949 -1.094 . . . . 0.0 109.164 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -62.99 -33.94 76.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 108.9 179.262 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 64' ' ' ASP . 47.1 t -68.73 -41.68 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.643 -0.661 . . . . 0.0 109.552 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.755 ' HB1' ' HE ' ' A' ' 100' ' ' ARG . . . -67.85 -14.23 62.79 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.65 -9.49 49.41 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.281 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 98.9 mtp -78.18 113.07 15.79 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -95.31 177.95 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.974 . . . . 0.0 109.964 -178.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 76' ' ' VAL . 89.4 mt-10 -55.13 -28.68 54.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.783 . . . . 0.0 110.667 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -63.17 -41.24 99.2 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.106 -1.621 . . . . 0.0 109.134 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.53 -38.72 90.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.393 -0.817 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -68.67 -31.27 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.667 -1.27 . . . . 0.0 109.204 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 80' ' ' VAL . 93.4 mt-10 -66.03 -39.63 90.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.085 -1.009 . . . . 0.0 110.548 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' ' N ' ' A' ' 79' ' ' LEU . 7.6 ptp180 -74.33 -40.79 61.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.709 -1.244 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 15.9 mt -65.8 -33.21 75.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -48.57 -30.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.036 -1.04 . . . . 0.0 109.453 -179.417 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -106.53 -0.33 24.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.443 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 66.5 t0 -80.43 107.95 13.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.499 -1.376 . . . . 0.0 109.55 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.68 -14.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.668 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . 68.42 35.9 82.88 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -28.0 -91.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.165 -0.609 . . . . 0.0 110.592 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -175.98 -44.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -0.967 . . . . 0.0 109.575 179.679 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.616 ' N ' HG23 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -64.22 156.04 29.98 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.155 -0.966 . . . . 0.0 110.034 -178.65 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -106.68 169.52 8.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.589 0.709 . . . . 0.0 109.631 -179.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.14 -33.72 63.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.51 -59.18 5.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' NZ ' HE21 ' A' ' 40' ' ' GLN . 11.6 tptm -60.63 -42.64 97.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.723 -1.457 . . . . 0.0 110.163 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -57.17 -47.38 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.992 -1.068 . . . . 0.0 109.766 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.07 -31.99 44.69 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.742 -1.224 . . . . 0.0 108.289 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.03 77.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.013 -1.054 . . . . 0.0 109.089 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.86 -45.54 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.187 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -61.39 -36.35 72.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.899 -1.126 . . . . 0.0 109.078 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.41 -36.39 83.81 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -60.51 -35.9 77.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.537 -0.978 . . . . 0.0 108.573 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.5 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.462 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.755 ' HE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -53.27 -41.19 65.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' ' CE2' ' A' ' 154' ' ' PHE . . . -65.28 -31.55 72.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.887 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 65' ' ' PRO . 54.9 t80 -61.06 -44.36 97.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 3.2 mm? -61.41 -35.81 78.58 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.55 -34.0 77.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.331 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 110' ' ' GLU . 36.0 ttm -63.78 -40.93 97.88 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER -63.28 -38.42 91.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.636 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.417 ' N ' ' HG2' ' A' ' 106' ' ' GLU . 95.8 mt-30 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.513 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.1 m120 -90.47 -14.73 32.2 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.48 27.87 73.54 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.965 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.56 ' O ' ' SD ' ' A' ' 105' ' ' MET . 1.4 tp10 -124.79 102.03 32.4 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.996 -1.296 . . . . 0.0 110.124 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.69 150.09 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.012 1.808 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -61.23 -45.08 96.04 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.127 0.965 . . . . 0.0 110.052 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.37 66.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.702 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -68.83 -45.18 71.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.438 -1.414 . . . . 0.0 112.214 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CE1' HG13 ' A' ' 116' ' ' VAL . 7.0 p90 -70.99 -36.22 72.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.471 -1.393 . . . . 0.0 110.501 -178.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 117' ' ' TRP . 31.3 m -65.42 -52.44 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 119.961 -1.712 . . . . 0.0 109.542 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.591 ' N ' HG23 ' A' ' 116' ' ' VAL . 50.9 m95 -56.63 -22.68 35.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 108.508 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 51.6 p -74.39 -35.7 63.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.978 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 9.7 m-85 -68.22 -29.43 68.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.195 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -94.67 18.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.513 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 122' ' ' HIS . 15.7 m120 58.95 39.43 23.66 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' ASN . 1.3 t60 40.57 29.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -127.26 146.93 59.9 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.38 140.39 52.7 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.606 2.204 . . . . 0.0 112.186 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -107.23 127.97 54.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 108.783 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.8 mtt -101.72 122.73 44.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.67 116.41 28.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -93.38 21.86 5.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.988 . . . . 0.0 109.988 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -70.43 143.38 51.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.383 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 99.0 m -93.65 -31.21 14.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.4 p -133.52 162.89 30.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.02 -35.48 71.33 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.136 -0.978 . . . . 0.0 108.952 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.5 m -60.55 -25.38 66.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -88.89 -4.38 58.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 0.0 109.713 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.85 130.7 37.7 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 147.45 26.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.233 1.956 . . . . 0.0 112.513 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.0 t -103.44 9.53 37.68 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -144.93 98.82 3.24 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.234 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.566 ' HG1' ' CB ' ' A' ' 142' ' ' SER . 10.0 p -109.14 155.01 41.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.59 -39.37 75.61 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.979 1.786 . . . . 0.0 111.441 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.38 62.31 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.386 -0.926 . . . . 0.0 108.786 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.566 ' CB ' ' HG1' ' A' ' 139' ' ' THR . 94.7 p -65.31 -39.22 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.428 -0.795 . . . . 0.0 109.981 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -63.12 -34.31 77.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.537 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.67 -47.84 81.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.942 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 27.8 m -60.87 -44.96 96.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.845 -1.159 . . . . 0.0 109.543 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -67.81 -44.22 77.83 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.487 -0.758 . . . . 0.0 109.598 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.38 -41.8 80.03 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.498 -0.751 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.521 HD23 ' NH2' ' A' ' 152' ' ' ARG . 26.2 mt -68.01 -44.35 76.74 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -62.21 -42.44 99.29 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.66 -31.54 70.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.334 -0.853 . . . . 0.0 111.371 -178.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.521 ' NH2' HD23 ' A' ' 149' ' ' LEU . 86.5 mtm180 -80.25 4.25 18.25 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.963 -1.085 . . . . 0.0 110.159 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 92.41 20.74 34.14 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.946 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' ' CB ' ' A' ' 101' ' ' ALA . 36.4 m-85 -102.82 110.91 23.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.132 -1.216 . . . . 0.0 108.772 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -91.72 172.59 8.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.435 ' CE1' ' HE3' ' A' ' 91' ' ' LYS . 63.4 m-85 58.27 69.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.185 0.993 . . . . 0.0 108.842 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 158' ' ' GLY . 30.2 m -150.93 38.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 157' ' ' VAL . . . -43.72 166.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -58.07 -28.96 65.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.558 -0.966 . . . . 0.0 109.217 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 42.7 p -73.31 -31.39 63.99 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.1 mm -69.76 -44.96 78.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 146' ' ' SER . 35.9 m -66.26 -34.84 78.91 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.537 0.684 . . . . 0.0 109.871 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -70.57 -45.29 65.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.911 . . . . 0.0 109.644 -179.613 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.509 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 93.3 p -67.81 -32.03 72.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.038 . . . . 0.0 108.422 178.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.581 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 42.9 t80 -58.67 -45.25 89.82 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.753 -0.592 . . . . 0.0 109.706 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 81.3 mtp -66.4 -38.71 88.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.582 ' CG ' ' HE1' ' A' ' 21' ' ' TRP . 1.2 tp-100 -64.26 -46.08 85.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.371 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.63 -37.75 49.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 58.3 m -56.77 -28.68 61.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 110.03 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.52 2.95 56.48 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.84 -33.85 76.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -1.089 . . . . 0.0 109.814 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.36 130.09 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 70.0 m-20 -108.55 163.82 12.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.434 -0.791 . . . . 0.0 109.939 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.7 m-20 86.13 74.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.228 0.537 . . . . 0.0 110.016 179.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.48 ' NE2' ' CD1' ' A' ' 21' ' ' TRP . 23.3 m80 -54.93 -61.4 2.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.815 . . . . 0.0 109.065 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.25 152.66 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.627 -0.671 . . . . 0.0 109.197 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 129' ' ' ALA . 94.0 t -60.76 130.81 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.02 -1.05 . . . . 0.0 109.026 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 2' ' ' GLU . . . 90.12 10.54 64.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -73.1 144.48 46.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.15 . . . . 0.0 109.329 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 179' ' ' CYS . 0.0 OUTLIER -42.98 -33.5 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 109.553 -179.592 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.41 34.6 1.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.193 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.3 t80 -123.43 85.96 52.25 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.463 -0.773 . . . . 0.0 109.476 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 185' ' ' ASN . 69.4 Cg_endo -83.98 -71.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.674 2.249 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.54 -51.04 0.64 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 186' ' ' LYS . 21.9 p-10 -130.22 -20.43 3.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -1.081 . . . . 0.0 109.804 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 185' ' ' ASN . 17.4 mmtm -63.79 149.1 93.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 108.776 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 186' ' ' LYS . 11.0 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 C-N-CA 122.107 1.871 . . . . 0.0 111.844 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.269 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' H ' ' CG ' ' A' ' 1' ' ' MET . 49.9 tp10 -103.07 144.97 30.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 110.069 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -66.46 160.31 25.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 126.47 27.44 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.878 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.89 -20.67 20.33 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.308 ' CZ2' H3A3 ' A' ' 189' ' ' ADK . 1.3 t90 -95.53 -4.31 45.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -1.182 . . . . 0.0 110.21 -179.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.88 -26.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -3.61 28.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 110.065 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 89.6 mm-40 -65.96 -48.45 71.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.987 -1.071 . . . . 0.0 110.67 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -157.89 153.8 23.21 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.848 -1.158 . . . . 0.0 109.837 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.65 ' HA ' HD13 ' A' ' 14' ' ' ILE . 29.4 Cg_exo -54.77 -32.87 78.53 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.159 1.906 . . . . 0.0 113.421 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.3 mt -59.86 -35.16 74.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.774 -1.204 . . . . 0.0 110.328 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -62.21 -34.61 76.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.881 -1.137 . . . . 0.0 109.942 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 11' ' ' PRO . 1.5 mp -52.63 -42.74 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.917 -1.114 . . . . 0.0 108.935 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.84 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 61.7 t80 -65.42 -42.83 92.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.53 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -64.89 -36.25 83.76 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.2 -0.938 . . . . 0.0 110.684 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -74.6 -19.03 60.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 112.303 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 33.4 p30 -88.31 -55.18 3.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.47 -177.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.689 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 16.0 pt-20 -163.73 68.74 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.093 -1.63 . . . . 0.0 111.856 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.763 ' CZ3' ' HC2' ' A' ' 189' ' ' ADK . 31.3 t-105 -77.6 64.35 2.89 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.24 44.66 27.89 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.3 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.666 ' N ' ' CD ' ' A' ' 24' ' ' PRO . 2.4 t -107.01 -32.85 0.18 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.344 -1.092 . . . . 0.0 110.682 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 23' ' ' VAL . 90.0 Cg_endo -87.57 154.76 7.7 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 123.116 2.544 . . . . 0.0 112.705 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.94 162.17 17.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.712 ' HB ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -89.08 115.25 26.48 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.421 -176.944 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.981 ' O ' HD13 ' A' ' 31' ' ' LEU . 93.8 m-20 -89.77 157.98 17.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 178.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 20.7 m -65.89 -45.86 80.46 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.051 -1.656 . . . . 0.0 111.325 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 32' ' ' PHE . 39.1 mmtm -63.6 -51.06 66.91 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.338 -0.851 . . . . 0.0 112.362 -177.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -56.9 -36.76 70.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 108.148 -179.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 27' ' ' ASP . 9.4 mp -65.8 -30.6 71.27 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.24 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 28' ' ' SER . 4.8 m-30 -58.92 -50.84 72.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.39 -1.324 . . . . 0.0 107.89 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -68.38 -44.63 74.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.283 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 36.4 tpp -50.84 -49.99 57.63 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.256 -0.902 . . . . 0.0 111.121 -178.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.87 -29.09 45.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.6 -1.313 . . . . 0.0 109.25 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.4 m -71.25 -47.93 54.14 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -67.8 -40.35 83.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.867 -1.146 . . . . 0.0 109.503 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' OE1' ' N7 ' ' A' ' 189' ' ' ADK . 70.6 mm-40 -59.11 -36.51 75.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 108.983 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.46 -32.62 78.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.1 -1.4 44.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -1.1 . . . . 0.0 109.991 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -89.4 -7.51 55.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.005 -179.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.53 120.14 13.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.997 -1.064 . . . . 0.0 109.073 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.65 -37.84 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.7 mp -98.98 148.79 23.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 109.883 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -66.67 153.71 42.46 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.754 ' HB3' H3A2 ' A' ' 189' ' ' ADK . 0.9 OUTLIER -58.13 -35.21 71.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.295 -179.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -29.12 46.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 44' ' ' LEU . 16.9 m -61.27 -41.36 96.81 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.893 -1.13 . . . . 0.0 109.37 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -70.26 -30.24 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.315 -0.866 . . . . 0.0 109.181 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.73 -46.76 88.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 20.6 mtmt -63.29 -44.63 94.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.85 -1.156 . . . . 0.0 108.784 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -9.62 58.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 108.723 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 49' ' ' VAL . 40.5 ttm180 -67.12 -46.26 74.67 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.23 -42.88 92.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 17.1 m-80 -69.41 -41.73 76.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.822 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 51.9 t80 -61.39 -44.52 97.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.504 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NH2' ' CE1' ' A' ' 61' ' ' HIS . 17.7 mmm180 -57.6 -38.48 74.98 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.414 -0.803 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.9 -34.51 75.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.329 -0.857 . . . . 0.0 110.283 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.589 ' HB3' HD22 ' A' ' 79' ' ' LEU . 87.0 m -72.94 -43.75 61.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.234 -0.916 . . . . 0.0 111.161 -178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE2' ' CE2' ' A' ' 56' ' ' TYR . 97.8 m-85 -99.3 10.28 41.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.664 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' CE1' ' NH2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -62.29 10.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.908 -1.12 . . . . 0.0 110.195 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.602 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 77.2 mt-30 -72.05 -37.21 69.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.611 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 90.2 m-85 -159.64 -95.36 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER 149.36 -41.04 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.285 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 64' ' ' ASP . 42.4 Cg_endo -102.4 -103.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.638 2.226 . . . . 0.0 115.689 -176.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 0.0 112.077 -176.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -33.83 64.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.751 -1.218 . . . . 0.0 108.921 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.78 -37.41 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 0.0 108.355 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -64.77 -18.15 64.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.53 -6.22 50.12 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.059 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.44 ' C ' ' OD2' ' A' ' 75' ' ' ASP . 89.8 mtp -75.62 114.16 13.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.597 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 6.3 tt0 -95.32 171.68 8.56 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.508 0.67 . . . . 0.0 110.128 -177.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 99.2 mt-10 -53.24 -28.52 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -56.56 -50.7 71.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.882 -1.136 . . . . 0.0 108.898 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' N ' ' A' ' 72' ' ' GLN . 2.6 p30 -63.83 -37.02 85.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 108.786 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 76.3 t -56.47 -41.84 73.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.055 -1.028 . . . . 0.0 108.983 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -57.82 -40.8 80.85 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -62.32 -43.7 98.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 59' ' ' CYS . 53.2 mt -67.53 -33.69 75.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.03 -16.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 108.736 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -122.87 -9.76 8.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.271 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 76.1 m-20 -74.07 109.18 7.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.279 -1.513 . . . . 0.0 109.966 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 68.4 -13.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.58 -0.7 . . . . 0.0 109.615 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 76.11 37.2 38.3 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 79' ' ' LEU . 6.5 pt -53.0 -166.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mm -54.07 90.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 85' ' ' ILE . 24.4 ttp180 -62.02 112.75 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.013 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 1.3 m-70 169.46 81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' HIS . 25.6 ptt180 -42.64 -38.52 2.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.581 -0.7 . . . . 0.0 110.114 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.79 -54.5 36.89 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -62.54 -39.96 95.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.245 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -60.9 -39.81 83.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.836 -1.165 . . . . 0.0 108.798 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.591 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 93.3 mt-30 -55.39 -36.8 66.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.845 -1.159 . . . . 0.0 108.463 178.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.24 87.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 108.974 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.58 -44.24 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.805 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.1 mm -59.58 -42.06 86.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 108.486 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.07 91.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' ND2' ' CD1' ' A' ' 154' ' ' PHE . 12.9 m120 -57.05 -39.16 74.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.64 71.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.252 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 95.9 mtt180 -62.73 -38.64 91.31 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.88 70.31 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.33 -0.856 . . . . 0.0 108.723 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.597 ' OH ' ' CZ ' ' A' ' 32' ' ' PHE . 64.4 t80 -64.65 -42.88 95.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.91 -32.7 71.01 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.11 -32.12 71.8 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.176 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.419 ' SD ' ' HD2' ' A' ' 152' ' ' ARG . 89.9 mmm -65.66 -42.39 91.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 109' ' ' GLY . 96.9 mt-10 -71.88 -41.16 68.34 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.45 -26.74 43.94 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.88 -9.1 29.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 68.89 26.68 74.47 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -117.6 101.2 52.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.75 154.36 26.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.426 2.084 . . . . 0.0 112.541 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -62.18 -45.4 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.864 0.84 . . . . 0.0 109.324 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.67 -27.38 64.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 111.123 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -70.63 -52.74 19.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.711 -1.243 . . . . 0.0 111.607 -178.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 116' ' ' VAL . 2.2 p90 -67.16 -39.89 86.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.936 -1.103 . . . . 0.0 111.041 -178.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 117' ' ' TRP . 8.1 p -65.88 -48.94 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 116' ' ' VAL . 12.8 m95 -56.45 -25.48 50.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -67.18 -45.46 76.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 110.552 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.6 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 32.0 m-85 -62.96 -32.25 73.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.002 -1.061 . . . . 0.0 110.17 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 171' ' ' LEU . 2.5 t -89.68 18.41 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.714 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 123' ' ' GLN . 62.5 m-20 59.31 40.54 21.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.728 -0.608 . . . . 0.0 109.78 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 43.48 26.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.802 179.332 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 120' ' ' VAL . 1.9 pt20 -139.8 154.62 71.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.63 152.31 59.19 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.858 2.372 . . . . 0.0 112.951 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 126' ' ' MET . 10.7 tm0? -109.4 127.83 54.67 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.62 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 61.1 mtm -91.03 118.63 30.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 109.692 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 116.3 26.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.347 -0.845 . . . . 0.0 109.482 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -93.78 14.0 20.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 136.54 53.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -93.63 -22.63 18.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.504 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.5 p -133.68 163.01 30.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.356 -0.84 . . . . 0.0 109.301 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.2 mt -59.24 -39.62 83.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.1 t -60.61 -33.23 72.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -81.96 2.64 29.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.836 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.92 142.87 25.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.117 -0.989 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.91 143.63 37.07 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.365 2.043 . . . . 0.0 112.655 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -123.98 2.58 8.69 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.8 p -154.7 85.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.11 166.87 9.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.22 -41.45 65.63 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.624 1.549 . . . . 0.0 112.283 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.4 -41.73 80.03 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.025 -1.047 . . . . 0.0 108.676 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.0 p -66.81 -45.24 78.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.56 -40.69 96.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -67.89 -30.76 70.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 116' ' ' VAL . 2.7 tp -69.19 -42.0 76.39 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -0.752 . . . . 0.0 110.321 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.573 ' CA ' ' SG ' ' A' ' 162' ' ' CYS . 0.3 OUTLIER -63.72 -50.28 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.449 -179.1 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -65.77 -36.14 82.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.948 -1.095 . . . . 0.0 109.366 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.22 -50.47 39.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.903 . . . . 0.0 109.762 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 115' ' ' PHE . 91.0 mt -63.65 -36.36 83.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 109.661 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -60.49 -38.5 84.49 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.959 -1.088 . . . . 0.0 108.767 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -62.52 -33.71 75.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.326 -0.859 . . . . 0.0 110.09 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HD2' ' SD ' ' A' ' 105' ' ' MET . 1.6 mmp_? -70.55 3.86 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.02 -1.05 . . . . 0.0 108.844 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.79 47.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CD1' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -94.42 115.58 27.8 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.531 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -93.41 169.03 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 56.21 55.11 7.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.068 -1.02 . . . . 0.0 108.54 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 157' ' ' VAL . 7.3 p -142.08 47.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -62.03 -178.5 3.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.1 m -61.1 -33.47 73.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.631 -0.923 . . . . 0.0 110.511 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.4 p -67.79 -35.38 78.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.898 -1.126 . . . . 0.0 108.05 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 38' ' ' GLU . 32.6 mm -65.58 -42.38 92.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.573 ' SG ' ' CA ' ' A' ' 146' ' ' SER . 77.1 m -63.89 -41.29 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.691 -0.631 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -71.3 -44.37 65.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.838 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.462 ' N ' ' CD2' ' A' ' 163' ' ' TYR . 23.2 m -65.19 -38.98 92.22 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.571 ' O ' ' SG ' ' A' ' 169' ' ' CYS . 87.1 t80 -60.21 -49.65 76.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.702 -0.624 . . . . 0.0 111.051 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 166' ' ' MET . 12.8 ptm -71.5 -38.62 71.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.868 -1.145 . . . . 0.0 109.746 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.588 HE21 ' N ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -62.55 -42.48 99.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 110.498 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.588 ' N ' HE21 ' A' ' 167' ' ' GLN . . . -89.05 -27.56 20.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.968 -1.082 . . . . 0.0 111.018 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.571 ' SG ' ' O ' ' A' ' 165' ' ' PHE . 24.3 m -60.87 -21.12 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.818 -1.176 . . . . 0.0 110.119 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.75 0.09 34.27 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 120' ' ' VAL . 86.0 mt -63.37 -34.09 76.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.099 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.16 138.1 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.576 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 91.0 m-20 -115.06 163.13 16.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.628 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 2.0 t70 86.07 77.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.465 0.65 . . . . 0.0 109.778 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 4.6 m170 -55.72 -53.13 60.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 0.0 109.084 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.8 m -147.43 38.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.468 HG22 ' OD2' ' A' ' 174' ' ' ASP . 16.2 t 61.27 111.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.472 0.653 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 44.86 71.02 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.635 ' SG ' ' O ' ' A' ' 179' ' ' CYS . 7.6 p -92.41 107.03 18.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.285 . . . . 0.0 109.388 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 63.06 -63.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.997 . . . . 0.0 109.706 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 179' ' ' CYS . 39.6 t -176.36 47.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.57 -0.707 . . . . 0.0 109.402 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -68.31 152.14 96.74 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.393 -0.817 . . . . 0.0 109.321 -179.862 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.35 145.55 97.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.625 2.217 . . . . 0.0 112.104 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 176.44 -28.08 0.07 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' O ' ' C ' ' A' ' 186' ' ' LYS . 79.7 m-20 -103.48 -35.41 8.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -1.09 . . . . 0.0 109.18 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 185' ' ' ASN . 6.1 mtpt 29.99 62.7 0.9 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.992 -0.442 . . . . 0.0 110.802 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.303 -1.85 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.89 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 1.308 H3A3 ' CZ2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mmm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -91.46 147.64 22.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.34 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HE ' HG11 ' A' ' 7' ' ' VAL . 50.5 mtp180 -78.09 167.01 22.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.259 -0.901 . . . . 0.0 110.471 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . 1.1 m -62.84 149.93 43.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.052 0.93 . . . . 0.0 110.817 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.78 -41.64 94.07 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.635 -0.665 . . . . 0.0 111.458 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.789 ' CZ3' H3A3 ' A' ' 189' ' ' ADK . 0.0 OUTLIER -85.74 -2.37 58.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.544 -1.563 . . . . 0.0 109.645 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.539 HG11 ' HE ' ' A' ' 3' ' ' ARG . 2.5 t -78.16 -37.85 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.983 -1.073 . . . . 0.0 108.502 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -80.88 0.68 34.13 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.644 -0.822 . . . . 0.0 108.795 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.36 -55.43 5.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 110.867 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.52 161.0 61.27 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.37 -35.82 13.04 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.083 2.522 . . . . 0.0 112.981 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD11 ' NZ ' ' A' ' 51' ' ' LYS . 55.8 mt -62.61 -34.02 76.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.868 -1.145 . . . . 0.0 109.737 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' OH ' H3A2 ' A' ' 189' ' ' ADK . 0.7 OUTLIER -59.2 -36.91 76.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 14' ' ' ILE . 1.5 mp -52.7 -46.21 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 110.394 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.7 64.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.957 -1.089 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.593 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.1 t80 -63.49 -39.96 95.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.599 ' CE1' ' SG ' ' A' ' 181' ' ' CYS . 48.5 t-80 -76.07 -40.53 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 111.507 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.91 -15.14 63.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 112.008 -177.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 16' ' ' TYR . 6.9 p30 -71.14 -77.09 0.09 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.255 -1.528 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -149.1 -49.07 0.15 Allowed 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.756 -1.215 . . . . 0.0 110.256 -179.443 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.89 ' CH2' ' HC2' ' A' ' 189' ' ' ADK . 2.9 t-105 59.03 87.22 0.08 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.185 -178.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.66 73.06 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.79 176.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 77.2 t -110.33 -32.85 0.14 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-N 119.353 1.577 . . . . 0.0 110.542 177.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 90.1 Cg_endo -85.54 152.07 10.33 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.2 1.933 . . . . 0.0 112.729 -178.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' OE1' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -67.48 169.03 9.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' HD21 ' A' ' 31' ' ' LEU . 1.8 p -94.09 141.14 28.88 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 118.409 -1.316 . . . . 0.0 111.05 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD1' ' OE1' ' A' ' 25' ' ' GLU . 92.0 m-20 -102.92 150.2 23.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -61.98 -35.99 80.14 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.666 -1.271 . . . . 0.0 110.052 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -74.95 -50.37 16.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 27' ' ' ASP . 7.4 ptmm? -62.54 -32.18 73.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.819 -1.175 . . . . 0.0 109.584 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.503 HD21 ' HB ' ' A' ' 26' ' ' THR . 45.8 mt -57.38 -37.5 72.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 108.539 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 35' ' ' ILE . 86.4 t80 -65.73 -45.45 82.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.882 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.38 -40.19 95.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.895 -1.128 . . . . 0.0 109.3 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 35' ' ' ILE . 8.5 tmm? -62.12 -47.04 86.35 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.564 -0.71 . . . . 0.0 111.339 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.588 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.2 tp -62.48 -27.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 -178.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.8 m -70.24 -49.98 44.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 110.003 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.9 mm? -69.33 -42.23 75.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.068 -1.02 . . . . 0.0 109.566 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -66.51 -32.07 73.19 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.785 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.62 40.15 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.401 ' HG3' ' NH2' ' A' ' 87' ' ' ARG . 10.3 mm100 -88.51 -0.64 57.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -1.218 . . . . 0.0 110.076 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.6 3.34 22.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 109.665 -179.567 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . -75.42 117.17 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.36 -6.75 1.06 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.604 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 4.3 tp -103.51 169.18 8.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -1.116 . . . . 0.0 108.862 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -94.84 141.68 28.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 108.763 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.659 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 5.5 t-105 -55.58 -34.12 64.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -37.69 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.793 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 m -57.9 -45.36 86.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.903 -1.123 . . . . 0.0 108.616 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.85 -29.37 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 108.679 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 50' ' ' LEU . 6.8 tt -56.59 -41.33 76.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 108.673 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.611 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 12.2 mmtt -57.8 -41.49 82.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -72.9 -18.98 61.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -60.63 -42.48 97.0 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -69.32 -46.03 68.08 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.685 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 13.7 m-80 -64.12 -32.81 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 108.516 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 52' ' ' LYS . 75.3 t80 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' HIS . 46.8 mtp180 -60.04 -38.31 82.39 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.452 178.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.09 82.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.854 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 79' ' ' LEU . 1.8 m -71.67 -45.08 63.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 110.258 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 62' ' ' GLN . 29.2 m-85 -111.74 -47.22 3.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.291 -0.881 . . . . 0.0 109.765 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.6 t-160 61.67 -39.88 0.13 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.631 -0.668 . . . . 0.0 110.398 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.619 ' N ' ' O ' ' A' ' 60' ' ' PHE . 2.8 pt20 -74.77 -35.05 62.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.417 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 62' ' ' GLN . 22.8 p90 41.09 17.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.502 -0.749 . . . . 0.0 110.269 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.836 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.11 142.82 60.01 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.866 -1.146 . . . . 0.0 108.626 179.802 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.85 -52.52 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.122 1.881 . . . . 0.0 112.766 -179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.69 HG22 HD21 ' A' ' 103' ' ' LEU . 84.4 t -65.14 -44.23 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 110.219 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -63.62 -36.99 85.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 109.946 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 64' ' ' ASP . 57.3 t -63.42 -39.38 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 100' ' ' ARG . . . -65.92 -16.23 63.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.14 -2.93 58.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 mmm -78.01 113.21 15.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 7.4 tt0 -95.68 167.43 11.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 108.906 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' N ' ' HG2' ' A' ' 72' ' ' GLN . 96.2 mt-10 -52.63 -30.31 30.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.243 -0.911 . . . . 0.0 110.855 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -57.39 -45.19 84.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.541 -1.35 . . . . 0.0 107.704 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -62.95 -39.76 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.632 HG21 HE21 ' A' ' 93' ' ' GLN . 75.5 t -59.6 -42.7 89.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.536 -0.728 . . . . 0.0 110.026 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 80' ' ' VAL . 74.9 mm-40 -57.38 -37.11 72.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.069 -1.019 . . . . 0.0 108.396 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.487 HH11 ' HG3' ' A' ' 78' ' ' ARG . 16.2 ttm-85 -66.19 -36.98 84.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.504 -0.747 . . . . 0.0 109.521 179.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 59' ' ' CYS . 81.4 mt -65.26 -40.34 93.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.718 . . . . 0.0 112.445 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 77' ' ' GLU . 4.4 m -59.01 -16.83 10.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.478 -1.389 . . . . 0.0 108.024 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -104.67 -14.36 15.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.507 -0.746 . . . . 0.0 109.153 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 84' ' ' GLY . 63.0 m-20 -81.78 105.52 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.09 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 65.15 -15.57 0.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.545 -0.722 . . . . 0.0 109.984 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 66.19 35.96 91.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 87' ' ' ARG . 2.5 pt -28.68 -101.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.156 -0.614 . . . . 0.0 111.541 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 87' ' ' ARG . 9.1 tt -168.77 -34.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.06 -179.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.631 HH11 HD11 ' A' ' 95' ' ' ILE . 5.0 mtt-85 -59.22 149.2 29.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.623 -0.673 . . . . 0.0 109.419 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.468 ' H ' ' HB2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -106.36 160.19 15.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.244 -0.91 . . . . 0.0 109.327 179.902 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.77 -46.24 15.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 110.049 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -53.11 36.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HB2' ' H ' ' A' ' 88' ' ' HIS . 51.1 mttp -61.13 -40.7 94.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 76' ' ' VAL . 66.7 mt -58.76 -47.76 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.153 -0.967 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.632 HE21 HG21 ' A' ' 76' ' ' VAL . 46.9 mm-40 -52.97 -35.03 58.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.824 -1.173 . . . . 0.0 108.941 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.42 80.63 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.631 HD11 HH11 ' A' ' 87' ' ' ARG . 81.6 mt -63.7 -47.38 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.56 -0.712 . . . . 0.0 109.422 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.614 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.9 mp -60.08 -38.97 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 108.952 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.6 -35.75 89.99 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -62.33 -37.81 87.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -1.067 . . . . 0.0 109.693 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.38 96.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.02 . . . . 0.0 109.804 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.499 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 96.9 mtt180 -65.87 -39.2 90.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.981 -1.074 . . . . 0.0 109.453 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -67.61 -29.06 68.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.603 ' CD1' ' CE1' ' A' ' 112' ' ' PHE . 75.8 t80 -63.41 -44.41 94.7 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.69 HD21 HG22 ' A' ' 66' ' ' VAL . 34.9 mt -62.86 -31.71 72.8 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -64.81 -35.97 82.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.916 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 81.0 mmm -67.93 -40.0 83.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.732 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.99 -40.07 78.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.542 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.35 -23.8 66.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' OD1' ' CD ' ' A' ' 110' ' ' GLU . 10.4 t-20 -85.71 -7.15 58.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 26.23 74.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CD ' ' OD1' ' A' ' 108' ' ' ASN . 96.1 mt-10 -124.48 102.06 33.35 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -1.071 . . . . 0.0 109.729 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -60.64 147.47 94.63 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.004 1.803 . . . . 0.0 112.066 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 102' ' ' TYR . 25.2 m-85 -57.5 -37.64 73.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.103 -0.998 . . . . 0.0 109.45 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.84 -29.86 70.83 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.526 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.56 -50.65 62.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 112.174 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 116' ' ' VAL . 4.1 p90 -72.4 -38.1 68.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.754 -1.216 . . . . 0.0 111.308 -177.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 115' ' ' PHE . 27.7 m -60.45 -49.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.117 -1.614 . . . . 0.0 109.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.577 ' N ' HG23 ' A' ' 116' ' ' VAL . 26.1 m95 -60.32 -24.15 64.78 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 108.622 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -64.66 -42.33 95.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.0 109.912 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.59 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 37.9 m-85 -68.11 -32.74 73.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.64 16.92 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 109.62 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 122' ' ' HIS . 16.6 m120 56.98 36.92 28.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.698 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 121' ' ' ASN . 78.0 m80 44.03 33.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -139.15 151.83 68.47 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.01 . . . . 0.0 109.867 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.03 144.48 34.11 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.789 2.326 . . . . 0.0 112.205 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 126' ' ' MET . 2.3 tm0? -112.26 141.99 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 109.337 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.497 ' H ' ' NE2' ' A' ' 125' ' ' GLN . 85.2 mmm -96.65 118.01 32.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -88.63 117.49 27.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.194 -0.941 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.52 20.77 3.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.225 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 177' ' ' VAL . . . -66.93 135.21 53.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 109.536 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.1 p -100.67 -19.88 15.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.399 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.455 ' H ' ' HB3' ' A' ' 134' ' ' GLU . 5.0 p -128.75 158.84 37.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.47 -0.769 . . . . 0.0 109.097 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.2 mt -57.82 -40.74 80.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -73.84 -19.14 60.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.827 . . . . 0.0 109.568 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 131' ' ' THR . 46.6 tp10 -74.44 -9.29 58.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 108.509 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.6 132.53 46.47 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.39 135.34 22.22 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.931 1.754 . . . . 0.0 112.442 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.9 p -101.06 3.88 41.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 138' ' ' SER . 59.6 p -141.06 91.76 2.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 109.064 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.543 ' N ' ' OG ' ' A' ' 142' ' ' SER . 40.1 p -110.89 156.88 40.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.07 -39.49 70.17 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.147 1.231 . . . . 0.0 111.222 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.72 71.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 139' ' ' THR . 86.6 p -63.41 -42.06 98.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -0.789 . . . . 0.0 109.834 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.0 -39.78 94.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.883 . . . . 0.0 110.229 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.59 ' HB1' ' CZ ' ' A' ' 119' ' ' PHE . . . -65.58 -34.85 79.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 116' ' ' VAL . 61.5 mt -66.38 -46.24 77.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 110.725 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.636 ' N ' ' SG ' ' A' ' 162' ' ' CYS . 15.0 m -61.06 -48.82 79.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.223 -0.923 . . . . 0.0 110.726 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -37.56 81.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.01 -1.056 . . . . 0.0 109.349 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.27 74.58 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.118 -0.988 . . . . 0.0 109.66 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.623 HD23 ' NH2' ' A' ' 152' ' ' ARG . 19.1 mt -67.86 -42.35 81.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.966 -1.084 . . . . 0.0 108.841 179.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -59.47 -37.44 78.22 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.274 -0.891 . . . . 0.0 110.594 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -74.34 -23.04 58.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.877 -1.139 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.623 ' NH2' HD23 ' A' ' 149' ' ' LEU . 81.6 mtm180 -83.67 6.05 22.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.31 21.14 39.13 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 3.0 m-85 -99.69 112.23 24.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -1.208 . . . . 0.0 108.976 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -89.75 178.59 6.21 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 55.95 56.71 5.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 108.824 -179.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.3 40.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -50.04 157.87 1.74 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.8 m -52.73 -32.67 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.319 -1.106 . . . . 0.0 108.742 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 m -69.09 -36.01 77.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.2 mm -62.06 -45.02 99.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.595 0.712 . . . . 0.0 109.394 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.636 ' SG ' ' N ' ' A' ' 146' ' ' SER . 22.2 m -64.32 -39.7 94.44 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.503 -0.748 . . . . 0.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -43.25 77.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.95 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.3 m -61.8 -36.54 81.4 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 109.589 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.591 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -61.13 -50.49 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.428 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.466 ' H ' ' HG2' ' A' ' 166' ' ' MET . 4.2 ptm -62.52 -37.62 86.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.044 -1.035 . . . . 0.0 110.268 -178.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.446 ' NE2' HG21 ' A' ' 172' ' ' VAL . 0.6 OUTLIER -67.09 -40.82 87.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 111.627 -178.652 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.39 15.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.957 -1.089 . . . . 0.0 112.752 -177.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.481 ' HB3' HG22 ' A' ' 26' ' ' THR . 0.1 OUTLIER -63.53 -50.19 70.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.664 -1.272 . . . . 0.0 112.047 -177.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 143.43 2.36 0.96 Allowed Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.2 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.45 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 77.1 mt -59.93 -33.91 72.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.616 -1.52 . . . . 0.0 109.121 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.446 HG21 ' NE2' ' A' ' 167' ' ' GLN . 3.3 m -129.25 150.91 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.599 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 83.7 m-20 -117.89 164.09 15.58 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.789 ' OD2' HG22 ' A' ' 177' ' ' VAL . 18.9 t0 96.05 84.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.605 0.717 . . . . 0.0 110.017 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.516 ' O ' HG13 ' A' ' 176' ' ' VAL . 43.4 m170 -55.74 -49.71 72.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.604 -0.685 . . . . 0.0 109.848 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 175' ' ' HIS . 7.1 m -157.54 24.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.71 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.789 HG22 ' OD2' ' A' ' 174' ' ' ASP . 33.9 t 56.11 111.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.429 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 98.36 10.0 52.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 180' ' ' CYS . 0.3 OUTLIER -81.18 148.97 29.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.924 -1.339 . . . . 0.0 109.215 179.806 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -58.71 -50.8 72.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 -179.573 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 180' ' ' CYS . 59.6 m -61.5 -12.51 15.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 109.018 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 174' ' ' ASP . 66.7 t80 -116.82 84.09 15.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.635 -0.666 . . . . 0.0 110.139 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.93 -93.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.551 2.168 . . . . 0.0 111.881 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.16 -14.0 65.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -85.55 -50.77 6.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -1.147 . . . . 0.0 109.088 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -82.96 149.95 60.54 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.569 2.18 . . . . 0.0 112.314 -179.859 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.89 ' HC2' ' CH2' ' A' ' 21' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.656 ' H2 ' ' N ' ' A' ' 180' ' ' CYS . 42.1 mtm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -98.38 153.27 18.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 108.875 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' A' ' 3' ' ' ARG . 22.0 mtm-85 -50.38 155.17 1.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.961 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -69.95 156.57 38.91 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.793 0.806 . . . . 0.0 109.516 -179.556 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.13 95.73 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.146 -0.971 . . . . 0.0 112.844 -177.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.746 ' CH2' ' C3A' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -88.76 -3.82 58.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.323 -1.693 . . . . 0.0 111.608 -177.673 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 17' ' ' HIS . 2.7 m -87.25 -31.61 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.384 -1.448 . . . . 0.0 108.58 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -62.97 -18.07 62.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -59.85 -40.97 90.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.241 0.544 . . . . 0.0 109.98 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.35 160.37 51.91 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.02 -55.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.219 2.613 . . . . 0.0 113.44 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 47' ' ' ILE . 2.3 pp -53.98 -32.01 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.042 -1.036 . . . . 0.0 110.254 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.703 ' CE1' ' CZ2' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -56.78 -39.17 73.59 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.896 -1.128 . . . . 0.0 109.584 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.09 -41.27 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -49.62 73.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 109.847 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 27.9 t80 -61.5 -42.73 99.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.357 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' A' ' 17' ' ' HIS . 8.5 t-80 -66.66 -37.63 85.18 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.516 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.41 -13.19 61.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 20' ' ' GLU . 12.0 p30 -86.89 -70.88 0.58 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 119.855 -1.778 . . . . 0.0 110.276 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.591 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 94.4 mt-10 -136.86 -72.61 0.44 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.017 -1.052 . . . . 0.0 110.038 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.59 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 8.8 t90 47.39 49.72 15.42 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.926 -0.484 . . . . 0.0 110.721 -178.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.38 72.3 0.99 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.513 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.77 ' H ' ' CD ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -166.23 -30.68 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.01 -1.288 . . . . 0.0 112.837 179.37 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.77 ' CD ' ' H ' ' A' ' 23' ' ' VAL . 28.6 Cg_endo -91.98 154.22 3.3 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 123.022 2.481 . . . . 0.0 112.615 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 26' ' ' THR . 85.8 tt0 -66.55 156.36 35.17 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.418 ' N ' ' HG2' ' A' ' 25' ' ' GLU . 1.5 p -91.43 134.09 34.92 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.594 -177.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.8 t0 -99.85 158.14 16.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.656 ' O ' ' CE1' ' A' ' 32' ' ' PHE . 1.3 m -57.69 -37.69 73.91 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.541 -1.349 . . . . 0.0 109.832 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 13.5 mmtt -61.29 -46.14 91.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 111.165 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -61.29 -36.93 81.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.0 109.567 -178.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 27' ' ' ASP . 4.0 mm? -57.17 -39.32 75.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.564 -0.71 . . . . 0.0 110.501 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CE1' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -70.18 -54.09 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.456 -178.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 37' ' ' LEU . 19.4 pt-20 -71.02 -30.41 66.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.902 -1.124 . . . . 0.0 109.774 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' ' SG ' ' A' ' 169' ' ' CYS . 27.8 ttm -67.16 -52.15 45.04 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.885 -1.134 . . . . 0.0 110.984 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.25 -31.06 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.519 -1.363 . . . . 0.0 111.117 -178.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.31 -37.21 74.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.476 -1.39 . . . . 0.0 109.802 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD21 ' HG3' ' A' ' 53' ' ' ARG . 9.0 mp -73.46 -40.27 64.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.189 -0.945 . . . . 0.0 110.247 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -36.83 84.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.0 108.685 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.44 -36.73 78.42 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -69.01 -28.51 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -1.123 . . . . 0.0 109.885 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.582 HE22 ' C8 ' ' A' ' 189' ' ' ADK . 0.0 OUTLIER -74.38 -3.05 28.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.987 -1.071 . . . . 0.0 110.309 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.59 117.82 4.24 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.726 -1.233 . . . . 0.0 108.809 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.48 -36.72 2.02 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.6 mm? -90.92 150.58 21.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.077 -1.249 . . . . 0.0 109.984 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.5 m -63.98 154.56 33.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.785 . . . . 0.0 109.447 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ3' ' N6 ' ' A' ' 189' ' ' ADK . 0.3 OUTLIER -61.2 -40.92 95.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.656 179.604 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.454 HD11 HD11 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -59.22 -35.86 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -58.74 -39.26 80.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.146 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 61.7 t -68.09 -35.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.85 -49.6 76.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 0.0 109.403 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.622 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -57.45 -43.37 83.91 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.425 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' NH2' ' CZ2' ' A' ' 46' ' ' TRP . 37.1 ttm180 -60.64 -42.02 96.1 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.623 -1.298 . . . . 0.0 107.8 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.09 -42.41 66.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.91 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 51' ' ' LYS . 23.4 m-80 -75.12 -43.4 53.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.021 -1.05 . . . . 0.0 110.023 -179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.4 t80 -58.23 -49.1 78.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.743 -0.598 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 2.5 ppt_? -63.04 -33.86 76.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.969 -1.082 . . . . 0.0 109.142 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.66 76.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.143 -0.973 . . . . 0.0 109.586 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.66 -44.86 55.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.604 -179.253 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.634 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 78.0 m-85 -88.06 -49.1 7.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.903 -1.123 . . . . 0.0 110.636 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' NE2' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 52.56 -6.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 111.099 -179.898 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.61 ' H ' ' C ' ' A' ' 60' ' ' PHE . 95.5 mt-30 -69.66 -35.71 75.41 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.558 -1.339 . . . . 0.0 110.612 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 53.31 16.69 0.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.083 -1.011 . . . . 0.0 110.063 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -137.64 98.62 9.76 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 0.0 109.382 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.3 -34.08 4.36 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.545 2.163 . . . . 0.0 113.866 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.73 -45.8 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.899 -1.126 . . . . 0.0 109.788 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -66.94 -33.37 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.038 -1.039 . . . . 0.0 109.479 179.435 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.13 -38.98 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.204 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.408 ' HB1' ' NE ' ' A' ' 100' ' ' ARG . . . -62.89 -21.51 66.06 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 67' ' ' LYS . . . -84.88 -6.39 59.34 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 97.9 mtp -88.42 111.6 21.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.33 -172.93 2.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' OE2' ' NE2' ' A' ' 93' ' ' GLN . 96.9 mt-10 -57.16 -25.55 59.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.061 -1.025 . . . . 0.0 110.504 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.02 -45.34 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.766 -1.208 . . . . 0.0 109.113 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -68.82 -36.75 78.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 109.155 178.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.936 ' O ' HG13 ' A' ' 80' ' ' VAL . 95.7 t -64.11 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.027 . . . . 0.0 110.081 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 80' ' ' VAL . 2.1 pt-20 -65.54 -43.7 89.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' A' ' 77' ' ' GLU . 11.1 ptp180 -75.16 -32.8 61.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.632 -1.292 . . . . 0.0 109.322 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 59' ' ' CYS . 61.3 mt -70.61 -35.58 73.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 111.851 -179.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 76' ' ' VAL . 34.8 m -50.39 -17.94 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.686 -1.259 . . . . 0.0 109.161 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.424 ' N ' ' C ' ' A' ' 79' ' ' LEU . 16.1 pt20 -117.84 -8.17 10.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.717 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 46.3 m-20 -77.95 107.86 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.61 -1.307 . . . . 0.0 109.51 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 82' ' ' ASP . . . 82.27 -13.24 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.835 -0.541 . . . . 0.0 109.896 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.45 37.9 30.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 85' ' ' ILE . 6.2 pt -58.49 -168.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.002 -1.293 . . . . 0.0 109.498 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 mt -65.86 93.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.313 -0.867 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 87' ' ' ARG . 32.5 ttt-85 -55.23 106.46 0.23 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 87' ' ' ARG . 2.5 m-70 179.88 72.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 15.3 ptm180 -45.56 -42.51 11.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 89' ' ' ARG . . . -51.23 -54.17 24.62 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.211 -178.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -64.09 -42.33 96.97 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.037 -1.272 . . . . 0.0 109.774 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.04 -44.26 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.405 ' NE2' ' OE2' ' A' ' 73' ' ' GLU . 89.2 mt-30 -56.97 -36.13 69.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.653 -1.279 . . . . 0.0 109.736 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.79 83.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 109.079 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.45 -39.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 108.926 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.88 -43.3 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.7 -35.43 81.44 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 88.5 m-20 -61.49 -35.88 78.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.378 -1.072 . . . . 0.0 108.93 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.04 91.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.847 . . . . 0.0 108.843 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' NE ' ' HB1' ' A' ' 69' ' ' ALA . 16.5 mmt180 -61.13 -36.28 79.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 152' ' ' ARG . . . -65.48 -32.42 74.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.187 -0.946 . . . . 0.0 109.024 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -61.76 -44.23 97.3 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.99 -36.64 80.0 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 101' ' ' ALA . 52.8 mt-30 -64.8 -36.81 85.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.459 ' SD ' ' CD ' ' A' ' 152' ' ' ARG . 94.4 mmm -64.68 -40.09 94.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.869 -1.144 . . . . 0.0 108.826 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' GLY . 80.7 mm-40 -67.64 -38.06 83.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -58.09 -25.67 61.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -93.46 -12.6 29.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 106' ' ' GLU . . . 66.63 22.53 71.69 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -114.56 102.78 55.02 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 109.556 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.52 152.68 46.21 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.953 1.768 . . . . 0.0 112.274 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.09 -40.27 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.618 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.43 69.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 111.074 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.55 -53.03 39.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.082 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CE1' HG13 ' A' ' 116' ' ' VAL . 3.3 p90 -72.1 -41.43 67.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.667 -1.27 . . . . 0.0 111.75 -177.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.816 HG12 HD21 ' A' ' 145' ' ' LEU . 30.4 m -59.69 -50.35 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 119.945 -1.722 . . . . 0.0 109.794 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.611 ' N ' HG23 ' A' ' 116' ' ' VAL . 15.0 m95 -57.26 -24.41 54.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 115' ' ' PHE . 45.9 p -66.32 -42.13 88.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.063 -1.023 . . . . 0.0 110.404 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.552 ' CE1' ' HB1' ' A' ' 144' ' ' ALA . 39.8 m-85 -68.17 -33.35 74.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.076 -1.015 . . . . 0.0 110.283 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -88.06 15.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 109.19 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.14 37.52 26.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.581 -0.699 . . . . 0.0 110.554 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 48.71 29.45 2.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -0.952 . . . . 0.0 110.424 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.43 148.97 42.62 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.784 -1.197 . . . . 0.0 109.856 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.44 147.64 90.6 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.92 2.413 . . . . 0.0 112.905 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 126' ' ' MET . 11.5 tm0? -105.4 135.24 47.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.232 -0.917 . . . . 0.0 109.223 179.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.482 ' O ' ' NE2' ' A' ' 125' ' ' GLN . 62.9 mtt -93.04 134.66 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -96.2 -54.72 3.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -0.989 . . . . 0.0 109.354 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 127' ' ' THR . 22.3 mt-30 58.63 50.11 9.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 109.219 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 127' ' ' THR . . . -90.02 142.35 27.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.6 p -81.13 -24.6 37.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.003 -1.061 . . . . 0.0 108.916 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 p -143.51 164.67 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.13 -31.86 72.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.026 -1.046 . . . . 0.0 108.841 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.8 p -64.29 -28.73 69.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.462 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 79.8 mm-40 -78.2 -2.4 37.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -179.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.56 127.17 86.45 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.75 -1.219 . . . . 0.0 107.965 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.412 ' O ' ' CE2' ' A' ' 163' ' ' TYR . 56.9 Cg_endo -73.49 137.74 25.87 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.132 1.888 . . . . 0.0 113.292 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 163' ' ' TYR . 57.3 p -110.29 6.54 22.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 m -147.97 90.89 1.87 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.204 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.0 155.52 39.89 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -52.82 -33.89 62.91 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 120.946 1.097 . . . . 0.0 111.539 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.67 -46.21 55.0 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.24 -0.913 . . . . 0.0 109.176 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.9 p -63.47 -41.4 98.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.073 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.57 -43.92 97.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.552 ' HB1' ' CE1' ' A' ' 119' ' ' PHE . . . -69.45 -29.57 67.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.483 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.816 HD21 HG12 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -62.83 -47.21 84.39 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.627 -0.671 . . . . 0.0 110.338 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.9 t -65.59 -41.62 92.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 109.841 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -60.57 -38.71 85.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.35 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.13 -54.62 16.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.045 -1.035 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -59.09 -31.69 69.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -60.5 -43.26 97.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.503 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -72.12 -27.75 62.83 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 110.358 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.486 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -73.9 5.35 4.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.006 . . . . 0.0 109.019 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.63 25.72 52.78 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -101.4 116.39 32.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.436 -1.037 . . . . 0.0 109.452 179.203 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt -94.6 176.4 6.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 56.92 53.34 8.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.19 43.82 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -48.29 165.69 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.59 ' O ' ' SG ' ' A' ' 162' ' ' CYS . 18.7 m -54.06 -33.82 58.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.614 -0.933 . . . . 0.0 109.214 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.6 m -72.72 -33.59 66.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.54 -44.63 99.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.642 -0.661 . . . . 0.0 110.047 -179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' CYS . . . . . 0.59 ' SG ' ' O ' ' A' ' 159' ' ' THR . 0.8 OUTLIER -65.46 -46.65 78.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.093 -1.004 . . . . 0.0 109.682 -179.644 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 164' ' ' SER . 0.0 OUTLIER -63.74 -38.8 92.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 109.581 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.544 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 79.4 p -63.37 -37.21 86.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.0 OUTLIER -63.7 -40.72 97.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.772 . . . . 0.0 110.203 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.52 ' HG2' HD12 ' A' ' 171' ' ' LEU . 25.6 mtm -66.85 -39.24 87.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 111.014 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.484 HE22 HG11 ' A' ' 172' ' ' VAL . 73.5 mm-40 -64.72 -36.15 83.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.983 -1.073 . . . . 0.0 111.084 -179.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.632 ' HB2' ' N6 ' ' A' ' 189' ' ' ADK . . . -84.73 -38.51 19.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 112.295 -177.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.52 ' SG ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -68.06 -48.95 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.796 -1.19 . . . . 0.0 111.717 -177.878 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.32 -11.06 2.76 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.923 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.751 HD22 HG21 ' A' ' 120' ' ' VAL . 81.5 mt -51.13 -30.78 17.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -1.198 . . . . 0.0 109.749 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.484 HG11 HE22 ' A' ' 167' ' ' GLN . 22.0 t -119.82 150.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -137.69 163.76 30.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.657 . . . . 0.0 109.853 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 173' ' ' ASN . 0.5 OUTLIER 90.17 75.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.147 0.498 . . . . 0.0 110.62 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -52.37 -53.3 46.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.6 m -151.37 -162.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.18 122.92 39.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.43 68.59 1.62 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -106.63 154.63 20.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.034 -1.274 . . . . 0.0 109.18 179.002 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.656 ' N ' ' H2 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -36.92 -64.97 0.32 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.628 -0.67 . . . . 0.0 110.066 -179.71 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -24.27 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 179' ' ' CYS . 1.9 t80 -97.79 110.28 54.71 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.957 . . . . 0.0 110.273 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.75 125.71 6.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.954 1.769 . . . . 0.0 112.208 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.53 -3.71 6.52 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -80.42 -1.03 39.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -1.131 . . . . 0.0 109.661 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.79 147.56 36.35 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.054 -1.029 . . . . 0.0 109.256 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 C--N 1.311 -1.416 0 C-N-CA 122.296 1.997 . . . . 0.0 112.263 179.845 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' ADK . . . . . 0.746 ' C3A' ' CH2' ' A' ' 6' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_